<?xml version="1.0" encoding="UTF-8" ?><xml><records><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2039</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2039</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Soman, N. R.</author><author>Baldwin, S. L.</author><author>Hu, G.</author><author>Marsh, J. N.</author><author>Lanza, G. M.</author><author>Heuser, J. E.</author><author>Arbeit, J. M.</author><author>Wickline, S. A.</author><author>Schlesinger, P. H.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Washington University School of Medicine, St. Louis, Missouri 63110, USA.</auth-address><titles><title>Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth</title><secondary-title>J Clin Invest</secondary-title></titles><periodical><full-title>J Clin Invest</full-title></periodical><pages>2830-42</pages><volume>119</volume><number>9</number><edition>2009/09/04</edition><dates><year>2009</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1558-8238 (Electronic)</isbn><accession-num>19726870</accession-num><abstract>The in vivo application of cytolytic peptides for cancer therapeutics is hampered by toxicity, nonspecificity, and degradation. We previously developed a specific strategy to synthesize a nanoscale delivery vehicle for cytolytic peptides by incorporating the nonspecific amphipathic cytolytic peptide melittin into the outer lipid monolayer of a perfluorocarbon nanoparticle. Here, we have demonstrated that the favorable pharmacokinetics of this nanocarrier allows accumulation of melittin in murine tumors in vivo and a dramatic reduction in tumor growth without any apparent signs of toxicity. Furthermore, direct assays demonstrated that molecularly targeted nanocarriers selectively delivered melittin to multiple tumor targets, including endothelial and cancer cells, through a hemifusion mechanism. In cells, this hemifusion and transfer process did not disrupt the surface membrane but did trigger apoptosis and in animals caused regression of precancerous dysplastic lesions. Collectively, these data suggest that the ability to restrain the wide-spectrum lytic potential of a potent cytolytic peptide in a nanovehicle, combined with the flexibility of passive or active molecular targeting, represents an innovative molecular design for chemotherapy with broad-spectrum cytolytic peptides for the treatment of cancer at multiple stages.</abstract><notes>Soman, Neelesh R&#xD;Baldwin, Steven L&#xD;Hu, Grace&#xD;Marsh, Jon N&#xD;Lanza, Gregory M&#xD;Heuser, John E&#xD;Arbeit, Jeffrey M&#xD;Wickline, Samuel A&#xD;Schlesinger, Paul H&#xD;R01 HL-073646/HL/NHLBI NIH HHS/United States&#xD;U54 CA119342/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of clinical investigation&#xD;J Clin Invest. 2009 Sep;119(9):2830-42. doi: 10.1172/JCI38842. Epub 2009 Aug 10.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom2>2735896</custom2><custom4>17.089</custom4><electronic-resource-num>38842 [pii]&#xD;10.1172/JCI38842 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1872</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1872</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Westcott, N. P.</author><author>Lou, Y.</author><author>Muth, J. F.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.</auth-address><titles><title>Patterned Hybrid Nanohole Array Surfaces for Cell Adhesion and Migration</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><edition>2009/09/03</edition><dates><year>2009</year><pub-dates><date>Sep 1</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>19722551</accession-num><abstract>We report the fabrication of hybrid nanohole array surfaces to study the role of the surface nanoevironment on cell adhesion and cell migration. We use polystyrene beads and reactive ion etching to control the size and the spacing between nanoholes on a tailored self-assembled monolayer inert gold surface. The arrays were characterized by scanning electron microscopy and brightfield microscopy. For cell adhesion studies, cells were seeded to these substrates to study the effect of ligand spacing on cell spreading, stress fiber formation, and focal adhesion structure and size. Finally, comparative cell migration rates were examined on the various nanohole array surfaces using time-lapse microscopy.</abstract><notes>Journal article&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2009 Sep 1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19722551</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>4.347</custom4><electronic-resource-num>10.1021/la9023234</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1925</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1925</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J. H.</author><author>Cosgrove, B. D.</author><author>Lauffenburger, D. A.</author><author>Han, J.</author></authors></contributors><auth-address>Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Microfluidic concentration-enhanced cellular kinase activity assay</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>10340-1</pages><volume>131</volume><number>30</number><edition>2009/09/03</edition><dates><year>2009</year><pub-dates><date>Aug 5</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>19722608</accession-num><abstract>In this paper, we reported a simple, disposable PDMS micro/nanofluidic preconcentration chip for in vitro concentration-enhanced cell kinase assays. Utilizing the preconcentration (electrokinetic trapping) directly from cell lysate (1 mM ATP) samples, we could achieve at least a 25-fold increase in reaction velocity and 65-fold enhancement in sensitivity. In addition, we shorten the assay time down to less than 10 min, with the sample volume requirements of down to approximately 5 cells. This device could be a generic and powerful tool for diagnostics and systems biology studies at the single-cell level, if properly optimized and integrated with the cell culture microdevices.</abstract><notes>Lee, Jeong Hoon&#xD;Cosgrove, Benjamin D&#xD;Lauffenburger, Douglas A&#xD;Han, Jongyoon&#xD;P50-GM68672/GM/NIGMS NIH HHS/United States&#xD;R01-CA119402/CA/NCI NIH HHS/United States&#xD;R01-EB005743/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2009 Aug 5;131(30):10340-1.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2739094</custom2><custom3>NIHMS131740</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja902594f [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2520</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2520</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhou, Hui-fang</author><author>Chan, Happy W.</author><author>Wickline, Samuel A.</author><author>Lanza, Gregory M.</author><author>Pham, Christine T. N.</author></authors></contributors><titles><title>{alpha}v{beta}3-Targeted nanotherapy suppresses inflammatory arthritis in mice</title><secondary-title>FASEB J.</secondary-title></titles><periodical><full-title>FASEB J.</full-title></periodical><pages>2978-2985</pages><volume>23</volume><number>9</number><edition>2009/09</edition><dates><year>2009</year><pub-dates><date>September 1, 2009</date></pub-dates></dates><abstract>The purpose of this study was to assess whether an alternative treatment approach that targets angiogenesis, delivered through ligand-targeted nanotherapy, would ameliorate inflammatory arthritis. Arthritis was induced using the K/BxN mouse model of inflammatory arthritis. After arthritis was clearly established, mice received three consecutive daily doses of {alpha}v{beta}3-targeted fumagillin nanoparticles. Control groups received no treatment or {alpha}v{beta}3-targeted nanoparticles without drugs. Disease score and paw thickness were measured daily. Mice that received {alpha}v{beta}3-targeted fumagillin nanoparticles showed a significantly lower disease activity score (mean score of 1.4{+/-}0.4; P&lt;0.001) and change in ankle thickness (mean increase of 0.17{+/-}0.05 mm; P&lt;0.001) 7 d after arthritis induction, whereas the group that received {alpha}v{beta}3-targeted nanoparticles without drugs exhibited a mean arthritic score of 9.0 {+/-} 0.3 and mean change in ankle thickness of 1.01 {+/-} 0.09 mm. Meanwhile, the group that received no treatment showed a mean arthritic score of 9.8 {+/-} 0.5 and mean change in ankle thickness of 1.05 {+/-} 0.10 mm. Synovial tissues from animals treated with targeted fumagillin nanoparticles also showed significant decrease in inflammation and angiogenesis and preserved proteoglycan integrity. Ligand-targeted nanotherapy to deliver antiangiogenic agents may represent an effective way to treat inflammatory arthritis.--Zhou, H.-F., Chan, H. W., Wickline, S. A., Lanza, G. M., Pham, C. T. N. {alpha}v{beta}3-Targeted nanotherapy suppresses inflammatory arthritis in mice.</abstract><urls><related-urls><url>http://www.fasebj.org/cgi/content/abstract/23/9/2978</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom4>7.128</custom4><electronic-resource-num>10.1096/fj.09-129874</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2548</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2548</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Brown, K. A.</author><author>Westervelt, R. M.</author></authors></contributors><titles><title>Proposed triaxial atomic force microscope contact-free tweezers for nanoassembly</title><secondary-title>Nanotechnology</secondary-title></titles><periodical><full-title>Nanotechnology</full-title></periodical><volume>20</volume><number>38</number><edition>2009/09</edition><dates><year>2009</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0957-4484</isbn><accession-num>ISI:000269356900005</accession-num><abstract>We propose a triaxial atomic force microscope contact-free tweezer (TACT) for the controlled assembly of nanoparticles suspended in a liquid. The TACT overcomes four major challenges faced in nanoassembly, as follows. (1) The TACT can hold and position a single nanoparticle with spatial accuracy smaller than the nanoparticle size (similar to 5 nm). (2) The nanoparticle is held away from the surface of the TACT by negative dielectrophoresis to prevent van der Waals forces from making it stick to the TACT. (3) The TACT holds nanoparticles in a trap that is size-matched to the particle and surrounded by a repulsive region so that it will only trap a single particle at a time. (4) The trap can hold a semiconductor nanoparticle in water with a trapping energy greater than the thermal energy. For example, a 5 nm radius silicon nanoparticle is held with 10 k(B)T at room temperature. We propose methods for using the TACT as a nanoscale pick-and-place tool to assemble semiconductor quantum dots, biological molecules, semiconductor nanowires, and carbon nanotubes.</abstract><notes>Brown, Keith A. Westervelt, Robert M.</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000269356900005</url></related-urls></urls><custom1>CCNE - MIT</custom1><custom4>3.727</custom4><electronic-resource-num>385302&#xD;10.1088/0957-4484/20/38/385302</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2282</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2282</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McLaurin, E. J.</author><author>Greytak, A. B.</author><author>Bawendi, M. G.</author><author>Nocera, D. G.</author></authors></contributors><auth-address>Department of Chemistry, 77 Massachusetts Avenue, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA.</auth-address><titles><title>Two-photon absorbing nanocrystal sensors for ratiometric detection of oxygen</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>12994-3001</pages><volume>131</volume><number>36</number><edition>2009/08/25</edition><dates><year>2009</year><pub-dates><date>Sep 16</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>19697933</accession-num><abstract>Two nanocrystal-osmium(II) polypyridyl (NC-Os(II)PP) conjugates have been designed to detect oxygen in biological environments. Polypyridines appended with a single free amine were linked with facility to a carboxylic acid functionality of a semiconductor NC overlayer to afford a biologically stable amide bond. The Os(II)PP complexes possess broad absorptions that extend into the red spectral region; this absorption feature makes them desirable acceptors of energy from NC donors. Fluorescence resonance energy transfer (FRET) from the NC to the Os(II)PP causes an enhanced Os(II)PP emission with a concomitant quenching of the NC emission. Owing to the large two-photon absorption cross-section of the NCs, FRET from the NC to the Os(II)PP can be established under two-photon excitation conditions. In this way, two-photon processes of metal polypyridyl complexes can be exploited for sensing. The emission of the NC is insensitive to oxygen, even at 1 atm, whereas excited states of both osmium complexes are quenched in the presence of oxygen. The NC emission may thus be used as an internal reference to correct for fluctuations in the photoluminescence intensity signal. These properties taken together establish NC-Os(II)PP conjugates as competent ratiometric, two-photon oxygen sensors for application in biological microenvironments.</abstract><notes>McLaurin, Emily J&#xD;Greytak, Andrew B&#xD;Bawendi, Moungi G&#xD;Nocera, Daniel G&#xD;1U54-CA119349/CA/NCI NIH HHS/United States&#xD;R01CA126642-02/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2009 Sep 16;131(36):12994-3001.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja902712b [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2007</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2007</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lu, K. V.</author><author>Zhu, S.</author><author>Cvrljevic, A.</author><author>Huang, T. T.</author><author>Sarkaria, S.</author><author>Ahkavan, D.</author><author>Dang, J.</author><author>Dinca, E. B.</author><author>Plaisier, S. B.</author><author>Oderberg, I.</author><author>Lee, Y.</author><author>Chen, Z.</author><author>Caldwell, J. S.</author><author>Xie, Y.</author><author>Loo, J. A.</author><author>Seligson, D.</author><author>Chakravari, A.</author><author>Lee, F. Y.</author><author>Weinmann, R.</author><author>Cloughesy, T. F.</author><author>Nelson, S. F.</author><author>Bergers, G.</author><author>Graeber, T.</author><author>Furnari, F. B.</author><author>James, C. D.</author><author>Cavenee, W. K.</author><author>Johns, T. G.</author><author>Mischel, P. S.</author></authors></contributors><auth-address>Department of Pathology and Laboratory Medicine, University of California-Los Angeles David Geffen School of Medicine, USA.</auth-address><titles><title>Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>6889-98</pages><volume>69</volume><number>17</number><edition>2009/08/20</edition><dates><year>2009</year><pub-dates><date>Sep 1</date></pub-dates></dates><isbn>1538-7445 (Electronic)</isbn><accession-num>19690143</accession-num><abstract>Activating epidermal growth factor receptor (EGFR) mutations are common in many cancers including glioblastoma. However, clinical responses to EGFR inhibitors are infrequent and short-lived. We show that the Src family kinases (SFK) Fyn and Src are effectors of oncogenic EGFR signaling, enhancing invasion and tumor cell survival in vivo. Expression of a constitutively active EGFR mutant, EGFRvIII, resulted in activating phosphorylation and physical association with Src and Fyn, promoting tumor growth and motility. Gene silencing of Fyn and Src limited EGFR- and EGFRvIII-dependent tumor cell motility. The SFK inhibitor dasatinib inhibited invasion, promoted tumor regression, and induced apoptosis in vivo, significantly prolonging survival of an orthotopic glioblastoma model expressing endogenous EGFRvIII. Dasatinib enhanced the efficacy of an anti-EGFR monoclonal antibody (mAb 806) in vivo, further limiting tumor growth and extending survival. Examination of a large cohort of clinical samples showed frequent coactivation of EGFR and SFKs in glioblastoma patients. These results establish a mechanism linking EGFR signaling with Fyn and Src activation to promote tumor progression and invasion in vivo and provide rationale for combined anti-EGFR and anti-SFK targeted therapies.</abstract><notes>Lu, Kan V&#xD;Zhu, Shaojun&#xD;Cvrljevic, Anna&#xD;Huang, Tiffany T&#xD;Sarkaria, Shawn&#xD;Ahkavan, David&#xD;Dang, Julie&#xD;Dinca, Eduard B&#xD;Plaisier, Seema B&#xD;Oderberg, Isaac&#xD;Lee, Yohan&#xD;Chen, Zugen&#xD;Caldwell, Jeremy S&#xD;Xie, Yongmin&#xD;Loo, Joseph A&#xD;Seligson, David&#xD;Chakravari, Arnab&#xD;Lee, Francis Y&#xD;Weinmann, Roberto&#xD;Cloughesy, Timothy F&#xD;Nelson, Stanley F&#xD;Bergers, Gabriele&#xD;Graeber, Thomas&#xD;Furnari, Frank B&#xD;James, C David&#xD;Cavenee, Webster K&#xD;Johns, Terrance G&#xD;Mischel, Paul S&#xD;5T32CA09056/CA/NCI NIH HHS/United States&#xD;CA097257/CA/NCI NIH HHS/United States&#xD;CA108633/CA/NCI NIH HHS/United States&#xD;CA119347/CA/NCI NIH HHS/United States&#xD;NS049720/NS/NINDS NIH HHS/United States&#xD;NS050151/NS/NINDS NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2009 Sep 1;69(17):6889-98. Epub 2009 Aug 18.</notes><urls></urls><custom1>CCNE - Caltech</custom1><custom4>7.980</custom4><electronic-resource-num>0008-5472.CAN-09-0347 [pii]&#xD;10.1158/0008-5472.CAN-09-0347 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1931</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1931</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Massey, K. A.</author><author>Schnitzer, J. E.</author></authors></contributors><auth-address>Proteogenomics Research Institute for Systems Medicine, 11107 Roselle St., San Diego, CA 92121, USA.</auth-address><titles><title>Targeting and imaging signature caveolar molecules in lungs</title><secondary-title>Proc Am Thorac Soc</secondary-title></titles><periodical><full-title>Proc Am Thorac Soc</full-title></periodical><pages>419-30</pages><volume>6</volume><number>5</number><edition>2009/08/19</edition><dates><year>2009</year><pub-dates><date>Aug 15</date></pub-dates></dates><isbn>1943-5665 (Electronic)</isbn><accession-num>19687214</accession-num><abstract>A major goal of molecular medicine is to target imaging agents or therapeutic compounds to a single organ. Targeting imaging agents to a single organ could facilitate the high-resolution, in vivo imaging of molecular events. In addition, genetic and acquired diseases primary to a single organ, such as cystic fibrosis, tuberculosis, lung cancer, pulmonary fibrosis, pulmonary hypertension, and acute respiratory distress syndrome, could be specifically targeted in the lung. By targeting and concentrating imaging agents or therapeutics to the lungs, deleterious side effects can be avoided with greater efficacy at much lower dosages. Pathologic changes can be identified earlier and followed over time. In addition, therapeutics that have been abandoned due to toxicities may find renewed utility when coupled with specific targeting agents such as antibodies. To achieve these goals, distinct molecular signatures must be found for each organ or disease-state.</abstract><notes>Massey, Kerri A&#xD;Schnitzer, Jan E&#xD;P01CA104898/CA/NCI NIH HHS/United States&#xD;R01CA083989/CA/NCI NIH HHS/United States&#xD;R01CA115215/CA/NCI NIH HHS/United States&#xD;R01CA119378/CA/NCI NIH HHS/United States&#xD;R01HL052766/HL/NHLBI NIH HHS/United States&#xD;R01HL058216/HL/NHLBI NIH HHS/United States&#xD;R01HL074063/HL/NHLBI NIH HHS/United States&#xD;R24CA095893/CA/NCI NIH HHS/United States&#xD;R33CA118602/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Proceedings of the American Thoracic Society&#xD;Proc Am Thorac Soc. 2009 Aug 15;6(5):419-30.</notes><urls></urls><custom1>CNPP - S.K.C.C.</custom1><custom2>2731802</custom2><custom4>na</custom4><electronic-resource-num>6/5/419 [pii]&#xD;10.1513/pats.200903-011AW [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2281</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2281</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCarthy, J. R.</author><author>Bhaumik, J.</author><author>Merbouh, N.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Harvard Medical School and Massachusetts General Hospital, 149 13th St., Rm 5406, Charlestown, MA 02129, USA. jason_mccarthy@hms.harvard.edu</auth-address><titles><title>High-yielding syntheses of hydrophilic conjugatable chlorins and bacteriochlorins</title><secondary-title>Org Biomol Chem</secondary-title></titles><periodical><full-title>Org Biomol Chem</full-title></periodical><pages>3430-6</pages><volume>7</volume><number>17</number><edition>2009/08/14</edition><dates><year>2009</year><pub-dates><date>Sep 7</date></pub-dates></dates><isbn>1477-0539 (Electronic)</isbn><accession-num>19675897</accession-num><abstract>Next-generation photodynamic therapy agents based upon the conjugation of multiple photosensitizers to a targeting backbone will allow for more efficacious light-based therapies. To this end, we have developed glucose-modified chlorins and bacteriochlorins featuring a reactive carboxylic acid linker for conjugation to targeting moieties. The photosensitizers were synthesized in relatively high yields from meso-tetra(p-aminophenyl)porphyrin, and resulted in neutral, hydrophilic chromophores with superb absorption profiles in the far-red and near-infrared portions of the electromagnetic spectrum. In addition, conjugation of these photosensitizers to a model nanoscaffold (crosslinked dextran-coated nanoparticles) demonstrated that the inclusion of hydrophilic sugar moieties increased the number of dyes that can be loaded while maintaining suspension stability. The described compounds are expected to be particularly useful in the synthesis of a number of targeted nanotherapeutic systems.</abstract><notes>McCarthy, Jason R&#xD;Bhaumik, Jayeeta&#xD;Merbouh, Nabyl&#xD;Weissleder, Ralph&#xD;U01-HL080731/HL/NHLBI NIH HHS/United States&#xD;U24-CA092782/CA/NCI NIH HHS/United States&#xD;U54-CA119349/CA/NCI NIH HHS/United States&#xD;U54-CA126515/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Organic &amp; biomolecular chemistry&#xD;Org Biomol Chem. 2009 Sep 7;7(17):3430-6. Epub 2009 Jul 2.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>3.025</custom4><electronic-resource-num>10.1039/b908713c [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2127</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2127</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zavaleta, C. L.</author><author>Smith, B. R.</author><author>Walton, I.</author><author>Doering, W.</author><author>Davis, G.</author><author>Shojaei, B.</author><author>Natan, M. J.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Molecular Imaging Program, Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305, USA.</auth-address><titles><title>Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>13511-6</pages><volume>106</volume><number>32</number><edition>2009/08/12</edition><dates><year>2009</year><pub-dates><date>Aug 11</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>19666578</accession-num><abstract>Raman spectroscopy is a newly developed, noninvasive preclinical imaging technique that offers picomolar sensitivity and multiplexing capabilities to the field of molecular imaging. In this study, we demonstrate the ability of Raman spectroscopy to separate the spectral fingerprints of up to 10 different types of surface enhanced Raman scattering (SERS) nanoparticles in a living mouse after s.c. injection. Based on these spectral results, we simultaneously injected the five most intense and spectrally unique SERS nanoparticles i.v. to image their natural accumulation in the liver. All five types of SERS nanoparticles were successfully identified and spectrally separated using our optimized noninvasive Raman imaging system. In addition, we were able to linearly correlate Raman signal with SERS concentration after injecting four spectrally unique SERS nanoparticles either s.c. (R(2) = 0.998) or i.v. (R(2) = 0.992). These results show great potential for multiplexed imaging in living subjects in cases in which several targeted SERS probes could offer better detection of multiple biomarkers associated with a specific disease.</abstract><notes>Zavaleta, Cristina L&#xD;Smith, Bryan R&#xD;Walton, Ian&#xD;Doering, William&#xD;Davis, Glenn&#xD;Shojaei, Borzoyeh&#xD;Natan, Michael J&#xD;Gambhir, Sanjiv S&#xD;5-RO1-EBB000312/PHS HHS/United States&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;T32 CA09695-15/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13511-6. Epub 2009 Jul 28.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom2>2726370</custom2><custom4>10.228</custom4><electronic-resource-num>0813327106 [pii]&#xD;10.1073/pnas.0813327106 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2006</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2006</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lin, B.</author><author>Wang, J.</author><author>Hong, X.</author><author>Yan, X.</author><author>Hwang, D.</author><author>Cho, J. H.</author><author>Yi, D.</author><author>Utleg, A. G.</author><author>Fang, X.</author><author>Schones, D. E.</author><author>Zhao, K.</author><author>Omenn, G. S.</author><author>Hood, L.</author></authors></contributors><auth-address>Department of Urology, University of Washington, Seattle, WA, USA. biaoylin@gmail.com</auth-address><titles><title>Integrated expression profiling and ChIP-seq analyses of the growth inhibition response program of the androgen receptor</title><secondary-title>PLoS ONE</secondary-title></titles><periodical><full-title>PLoS ONE</full-title></periodical><pages>e6589</pages><volume>4</volume><number>8</number><edition>2009/08/12</edition><dates><year>2009</year></dates><isbn>1932-6203 (Electronic)</isbn><accession-num>19668381</accession-num><abstract>BACKGROUND: The androgen receptor (AR) plays important roles in the development of male phenotype and in different human diseases including prostate cancers. The AR can act either as a promoter or a tumor suppressor depending on cell types. The AR proliferative response program has been well studied, but its prohibitive response program has not yet been thoroughly studied. METHODOLOGY/PRINCIPAL FINDINGS: Previous studies found that PC3 cells expressing the wild-type AR inhibit growth and suppress invasion. We applied expression profiling to identify the response program of PC3 cells expressing the AR (PC3-AR) under different growth conditions (i.e. with or without androgens and at different concentration of androgens) and then applied the newly developed ChIP-seq technology to identify the AR binding regions in the PC3 cancer genome. A surprising finding was that the comparison of MOCK-transfected PC3 cells with AR-transfected cells identified 3,452 differentially expressed genes (two fold cutoff) even without the addition of androgens (i.e. in ethanol control), suggesting that a ligand independent activation or extremely low-level androgen activation of the AR. ChIP-Seq analysis revealed 6,629 AR binding regions in the cancer genome of PC3 cells with an FDR (false discovery rate) cut off of 0.05. About 22.4% (638 of 2,849) can be mapped to within 2 kb of the transcription start site (TSS). Three novel AR binding motifs were identified in the AR binding regions of PC3-AR cells, and two of them share a core consensus sequence CGAGCTCTTC, which together mapped to 27.3% of AR binding regions (1,808/6,629). In contrast, only about 2.9% (190/6,629) of AR binding sites contains the canonical AR matrix M00481, M00447 and M00962 (from the Transfac database), which is derived mostly from AR proliferative responsive genes in androgen dependent cells. In addition, we identified four top ranking co-occupancy transcription factors in the AR binding regions, which include TEF1 (Transcriptional enhancer factor), GATA (GATA transcription factors), OCT (octamer transcription factors) and PU1 (PU.1 transcription factor). CONCLUSIONS/SIGNIFICANCE: Our data provide a valuable data set in understanding the molecular basis for growth inhibition response program of the AR in prostate cancer cells, which can be exploited for developing novel prostate cancer therapeutic strategies.</abstract><notes>Lin, Biaoyang&#xD;Wang, Jun&#xD;Hong, Xu&#xD;Yan, Xiaowei&#xD;Hwang, Daehee&#xD;Cho, Ji-Hoon&#xD;Yi, Danielle&#xD;Utleg, Angelita G&#xD;Fang, Xuefeng&#xD;Schones, Dustin E&#xD;Zhao, Keji&#xD;Omenn, Gilbert S&#xD;Hood, Leroy&#xD;5 P50 GM076547/GM/NIGMS NIH HHS/United States&#xD;5 U54 CA119347/CA/NCI NIH HHS/United States&#xD;U54 DA021519/DA/NIDA NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;PloS one&#xD;PLoS One. 2009 Aug 11;4(8):e6589.</notes><urls></urls><custom1>CCNE - Caltech</custom1><custom2>2720376</custom2><custom4>14.662</custom4><electronic-resource-num>10.1371/journal.pone.0006589 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2210</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2210</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Harney, A. S.</author><author>Lee, J.</author><author>Manus, L. M.</author><author>Wang, P.</author><author>Ballweg, D. M.</author><author>LaBonne, C.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Targeted inhibition of Snail family zinc finger transcription factors by oligonucleotide-Co(III) Schiff base conjugate</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>13667-72</pages><volume>106</volume><number>33</number><edition>2009/08/12</edition><dates><year>2009</year><pub-dates><date>Aug 18</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>19666616</accession-num><abstract>A transition metal complex targeted for the inhibition of a subset of zinc finger transcription factors has been synthesized and tested in Xenopus laevis. A Co(III) Schiff base complex modified with a 17-bp DNA sequence is designed to selectively inhibit Snail family transcription factors. The oligonucleotide-conjugated Co(III) complex prevents Slug, Snail, and Sip1 from binding their DNA targets whereas other transcription factors are still able to interact with their target DNA. The attachment of the oligonucleotide to the Co(III) complex increases specificity 150-fold over the unconjugated complex. Studies demonstrate that neither the oligo, or the Co(III) Schiff base complex alone, are sufficient for inactivation of Slug at concentrations that the conjugated complex mediates inhibition. Slug, Snail, and Sip1 have been implicated in the regulation of epithelial-to-mesenchymal transition in development and cancer. A complex targeted to inactivate their transcriptional activity could prove valuable as an experimental tool and a cancer therapeutic.</abstract><notes>Harney, Allison S&#xD;Lee, Jiyoun&#xD;Manus, Lisa M&#xD;Wang, Peijiao&#xD;Ballweg, David M&#xD;LaBonne, Carole&#xD;Meade, Thomas J&#xD;5 U54 CA119341-02/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13667-72. Epub 2009 Aug 3.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom2>2728951</custom2><custom4>10.228</custom4><electronic-resource-num>0906423106 [pii]&#xD;10.1073/pnas.0906423106 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2209</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2209</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kang, B.</author><author>Miller, A. W.</author><author>Goyal, S.</author><author>Nguyen, S. T.</author></authors></contributors><auth-address>Department of Chemistry and the Institute for Catalysis in Energy Processes, Northwestern University, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Sc(OTf)(3)-catalyzed condensation of 2-alkyl-N-tosylaziridine with aldehydes or ketones: an efficient synthesis of 5-alkyl-1,3-oxazolidines</title><secondary-title>Chem Commun (Camb)</secondary-title></titles><periodical><full-title>Chem Commun (Camb)</full-title></periodical><pages>3928-30</pages><number>26</number><edition>2009/08/08</edition><dates><year>2009</year><pub-dates><date>Jul 14</date></pub-dates></dates><isbn>1359-7345 (Print)</isbn><accession-num>19662255</accession-num><abstract>Sc(OTf)(3) effectively catalyzes the condensation of 2-alkyl-N-tosylaziridine with a wide variety of aldehydes and ketones, producing 5-alkyl-1,3-oxazolidines in good yields and excellent regioselectivity at catalyst loadings as low as 1 mol%.</abstract><notes>Kang, Byungman&#xD;Miller, Aaron W&#xD;Goyal, Sandra&#xD;Nguyen, SonBinh T&#xD;1 U54 CA119341-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Chemical communications (Cambridge, England)&#xD;Chem Commun (Camb). 2009 Jul 14;(26):3928-30. Epub 2009 May 26.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.997</custom4><electronic-resource-num>10.1039/b902647a [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2435</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2435</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nitin, N.</author><author>LaConte, L.</author><author>Rhee, W. J.</author><author>Bao, G.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.</auth-address><titles><title>Tat peptide is capable of importing large nanoparticles across nuclear membrane in digitonin permeabilized cells</title><secondary-title>Ann Biomed Eng</secondary-title></titles><periodical><full-title>Ann Biomed Eng</full-title></periodical><pages>2018-27</pages><volume>37</volume><number>10</number><edition>2009/08/07</edition><dates><year>2009</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1521-6047 (Electronic)</isbn><accession-num>19657743</accession-num><abstract>Understanding the capabilities and limitations of nuclear import is crucial to efficient delivery of macromolecules and nanoparticles for diagnosis and targeted therapy of diseases. Here we report the Tat peptide-mediated import of different cargos into cell nucleus, including dye-labeled streptavidin protein, 43 and 90 nm fluorescent beads, as well as approximately 20 nm quantum dots for kinetic measurements. Our results revealed significant differences between Tat- and NLS-mediated nuclear import: unlike delivery with the NLS, Tat peptide-based delivery is not inhibited by WGA blockage nor does it require ATP. Surprisingly, Tat peptide was able to import 90 nm beads into the nuclei of digitonin-permeabilized cells, suggesting that its interaction with the nuclear envelope follows a mechanism different from that of NLS. The import kinetics was quantified using Tat peptide-conjugated QDs, yielding a kinetic constant of 0.0085 s(-1). Taken together, our results suggest that, compared with NLS, Tat peptide-mediated nuclear import is faster, follows a different pathway, and is capable of importing large nanoparticles. These results have significant implications for the development of new approaches for delivery of cargo into the nuclei of living cells.</abstract><notes>Nitin, Nitin&#xD;LaConte, Leslie&#xD;Rhee, Won Jong&#xD;Bao, Gang&#xD;1PN2EY018244/EY/NEI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Annals of biomedical engineering&#xD;Ann Biomed Eng. 2009 Oct;37(10):2018-27. Epub 2009 Aug 6.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>2.999</custom4><electronic-resource-num>10.1007/s10439-009-9768-0 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2437</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2437</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gao, Z.</author><author>Zhou, J.</author><author>Gu, Y.</author><author>Fei, P.</author><author>Hao, Y.</author><author>Bao, G.</author><author>Wang, Z. L.</author></authors></contributors><titles><title>Effects of piezoelectric potential on the transport characteristics of metal-ZnO nanowire-metal field effect transistor</title><secondary-title>J Appl Phys</secondary-title></titles><periodical><full-title>J Appl Phys</full-title></periodical><pages>113707</pages><volume>105</volume><number>11</number><edition>2009/08/07</edition><dates><year>2009</year><pub-dates><date>Jun 1</date></pub-dates></dates><isbn>0021-8979 (Print)</isbn><accession-num>19657403</accession-num><abstract>We have investigated the effects of piezoelectric potential in a ZnO nanowire on the transport characteristics of the nanowire based field effect transistor through numerical calculations and experimental observations. Under different straining conditions including stretching, compressing, twisting, and their combination, a piezoelectric potential is created throughout the nanowire to modulatealternate the transport property of the metal-ZnO nanowire contacts, resulting in a switch between symmetric and asymmetric contacts at the two ends, or even turning an Ohmic contact type into a diode. The commonly observed natural rectifying behavior of the as-fabricated ZnO nanowire can be attributed to the strain that was unpurposely created in the nanowire during device fabrication and material handling. This work provides further evidence on piezopotential governed electronic transport and devices, e.g., piezotronics.</abstract><notes>Journal article&#xD;Journal of applied physics&#xD;J Appl Phys. 2009 Jun 1;105(11):113707. Epub 2009 Jun 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19657403</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom2>2719466</custom2><custom4>2.479</custom4><electronic-resource-num>10.1063/1.3125449</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2436</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2436</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhou, J.</author><author>Gu, Y.</author><author>Hu, Y.</author><author>Mai, W.</author><author>Yeh, P. H.</author><author>Bao, G.</author><author>Sood, A. K.</author><author>Polla, D. L.</author><author>Wang, Z. L.</author></authors></contributors><titles><title>Gigantic enhancement in response and reset time of ZnO UV nanosensor by utilizing Schottky contact and surface functionalization</title><secondary-title>Appl Phys Lett</secondary-title></titles><periodical><full-title>Appl Phys Lett</full-title></periodical><pages>191103</pages><volume>94</volume><number>19</number><edition>2009/08/06</edition><dates><year>2009</year><pub-dates><date>May 11</date></pub-dates></dates><isbn>0003-6951 (Print)</isbn><accession-num>19654881</accession-num><abstract>UV response of ZnO nanowire nanosensor has been studied under ambient condition. By utilizing Schottky contact instead of Ohmic contact in device fabrication, the UV sensitivity of the nanosensor has been improved by four orders of magnitude, and the reset time has been drastically reduced from approximately 417 to approximately 0.8 s. By further surface functionalization with function polymers, the reset time has been reduced to approximately 20 ms even without correcting the electronic response of the measurement system. These results demonstrate an effective approach for building high response and fast reset UV detectors.</abstract><notes>Journal article&#xD;Applied physics letters&#xD;Appl Phys Lett. 2009 May 11;94(19):191103.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19654881</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom2>2719461</custom2><custom4>4.096</custom4><electronic-resource-num>10.1063/1.3133358</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2005</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2005</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Iwanami, A.</author><author>Cloughesy, T. F.</author><author>Mischel, P. S.</author></authors></contributors><auth-address>Department of Pathology and Laboratory Medicine, the Henry Singleton Brain Tumor Program at the David Geffen University of California at Los Angeles School of Medicine, Los Angeles, California 90095, USA.</auth-address><titles><title>Striking the balance between PTEN and PDK1: it all depends on the cell context</title><secondary-title>Genes Dev</secondary-title></titles><periodical><full-title>Genes Dev</full-title></periodical><pages>1699-704</pages><volume>23</volume><number>15</number><edition>2009/08/05</edition><keywords><keyword>1-Phosphatidylinositol 3-Kinase/metabolism</keyword><keyword>Animals</keyword><keyword>Humans</keyword><keyword>Neoplasms/physiopathology</keyword><keyword>Nervous System Diseases/physiopathology</keyword><keyword>PTEN Phosphohydrolase/genetics/ metabolism</keyword><keyword>Protein-Serine-Threonine Kinases/genetics/ metabolism</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2009</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>1549-5477 (Electronic)</isbn><accession-num>19651981</accession-num><abstract>The phosphatidyl-inosital-3 kinase (PI3K) signaling pathway is critical for normal brain development and function and is commonly hyperactivated in brain cancer. The PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor protein and phosphate-depended kinase 1 (PDK-1) are critical regulators of this pathway. In the July 15, 2009, issue of Genes &amp; Development, Chalhoub and colleagues (pp. 1619-1624) demonstrate PDK1-dependent and PDK1-independent effects of conditional PTEN deletion in the brain, and they identify cell type-specific differences in feedback regulation of the PI3K pathway. These studies provide important insights as to how neurons and glia may differentially regulate PI3K signaling, yielding intriguing clues about targeting PTEN-deficient brain cancers.</abstract><notes>Iwanami, Akio&#xD;Cloughesy, Timothy F&#xD;Mischel, Paul S&#xD;CA108633/CA/NCI NIH HHS/United States&#xD;CA119347/CA/NCI NIH HHS/United States&#xD;NS05051/NS/NINDS NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Genes &amp; development&#xD;Genes Dev. 2009 Aug 1;23(15):1699-704.</notes><urls></urls><custom1>CCNE - Caltech</custom1><custom2>2720262</custom2><custom4>14.795</custom4><electronic-resource-num>23/15/1699 [pii]&#xD;10.1101/gad.1832909 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1891</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1891</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Veiseh, Omid</author><author>Sun, Conroy</author><author>Fang, Chen</author><author>Bhattarai, Narayan</author><author>Gunn, Jonathan</author><author>Kievit, Forrest</author><author>Du, Kim</author><author>Pullar, Barbara</author><author>Lee, Donghoon</author><author>Ellenbogen, Richard G.</author><author>Olson, Jim</author><author>Zhang, Miqin</author></authors></contributors><titles><title>Specific Targeting of Brain Tumors with an Optical/Magnetic Resonance Imaging Nanoprobe across the Blood-Brain Barrier</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>6200-6207</pages><volume>69</volume><number>15</number><edition>2009/08</edition><dates><year>2009</year><pub-dates><date>August 1, 2009</date></pub-dates></dates><abstract>Nanoparticle-based platforms have drawn considerable attention for their potential effect on oncology and other biomedical fields. However, their in vivo application is challenged by insufficient accumulation and retention within tumors due to limited specificity to the target, and an inability to traverse biological barriers. Here, we present a nanoprobe that shows an ability to cross the blood-brain barrier and specifically target brain tumors in a genetically engineered mouse model, as established through in vivo magnetic resonance and biophotonic imaging, and histologic and biodistribution analyses. The nanoprobe is comprised of an iron oxide nanoparticle coated with biocompatible polyethylene glycol-grafted chitosan copolymer, to which a tumor-targeting agent, chlorotoxin, and a near-IR fluorophore are conjugated. The nanoprobe shows an innocuous toxicity profile and sustained retention in tumors. With the versatile affinity of the targeting ligand and the flexible conjugation chemistry for alternative diagnostic and therapeutic agents, this nanoparticle platform can be potentially used for the diagnosis and treatment of a variety of tumor types. [Cancer Res 2009;69(15):6200-7]</abstract><urls><related-urls><url>http://cancerres.aacrjournals.org/cgi/content/abstract/69/15/6200</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom4>7.980</custom4><electronic-resource-num>10.1158/0008-5472.can-09-1157</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2208</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2208</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>You, E. A.</author><author>Ahn, R. W.</author><author>Lee, M. H.</author><author>Raja, M. R.</author><author>O&apos;Halloran, T. V.</author><author>Odom, T. W.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3133, USA.</auth-address><titles><title>Size control of arsenic trioxide nanocrystals grown in nanowells</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>10863-5</pages><volume>131</volume><number>31</number><edition>2009/07/25</edition><dates><year>2009</year><pub-dates><date>Aug 12</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>19624123</accession-num><abstract>This paper describes a new strategy to generate nanocrystalline drugs through the precipitation of drug molecules in attoliter nanowells. We controlled the size of arsenic trioxide (ATO) nanocrystals by simply changing the concentration of ATO solution in the nanowells; particles with sizes ranging from 55 to 175 nm were formed. This approach only requires the drugs to be soluble in a solvent and thus can be broadly applicable to produce other drugs in nanocrystalline form.</abstract><notes>You, Eun-Ah&#xD;Ahn, Richard W&#xD;Lee, Min Hyung&#xD;Raja, Meera R&#xD;O&apos;Halloran, Thomas V&#xD;Odom, Teri W&#xD;U54CA119341/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2009 Aug 12;131(31):10863-5.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja902117b [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2004</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2004</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Guo, D.</author><author>Hildebrandt, I. J.</author><author>Prins, R. M.</author><author>Soto, H.</author><author>Mazzotta, M. M.</author><author>Dang, J.</author><author>Czernin, J.</author><author>Shyy, J. Y.</author><author>Watson, A. D.</author><author>Phelps, M.</author><author>Radu, C. G.</author><author>Cloughesy, T. F.</author><author>Mischel, P. S.</author></authors></contributors><auth-address>Department of Pathology &amp; Laboratory Medicine, The David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA.</auth-address><titles><title>The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>12932-7</pages><volume>106</volume><number>31</number><edition>2009/07/25</edition><keywords><keyword>AMP-Activated Protein Kinases/physiology</keyword><keyword>Aminoimidazole Carboxamide/ analogs &amp; derivatives/pharmacology</keyword><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation/drug effects</keyword><keyword>Glioblastoma/ drug therapy/pathology</keyword><keyword>Humans</keyword><keyword>Lipogenesis/ drug effects</keyword><keyword>Mice</keyword><keyword>PTEN Phosphohydrolase/physiology</keyword><keyword>Protein Kinases/drug effects</keyword><keyword>Receptor, Epidermal Growth Factor/analysis/ physiology</keyword><keyword>Ribonucleotides/ pharmacology</keyword><keyword>Ribosomal Protein S6 Kinases/physiology</keyword><keyword>Ribosomal Protein S6 Kinases, 90-kDa/physiology</keyword><keyword>Signal Transduction/drug effects</keyword><keyword>Sirolimus/pharmacology</keyword></keywords><dates><year>2009</year><pub-dates><date>Aug 4</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>19625624</accession-num><abstract>The EGFR/PI3K/Akt/mTOR signaling pathway is activated in many cancers including glioblastoma, yet mTOR inhibitors have largely failed to show efficacy in the clinic. Rapamycin promotes feedback activation of Akt in some patients, potentially underlying clinical resistance and raising the need for alternative approaches to block mTOR signaling. AMPK is a metabolic checkpoint that integrates growth factor signaling with cellular metabolism, in part by negatively regulating mTOR. We used pharmacological and genetic approaches to determine whether AMPK activation could block glioblastoma growth and cellular metabolism, and we examined the contribution of EGFR signaling in determining response in vitro and in vivo. The AMPK-agonist AICAR, and activated AMPK adenovirus, inhibited mTOR signaling and blocked the growth of glioblastoma cells expressing the activated EGFR mutant, EGFRvIII. Across a spectrum of EGFR-activated cancer cell lines, AICAR was more effective than rapamycin at blocking tumor cell proliferation, despite less efficient inhibition of mTORC1 signaling. Unexpectedly, addition of the metabolic products of cholesterol and fatty acid synthesis rescued the growth inhibitory effect of AICAR, whereas inhibition of these lipogenic enzymes mimicked AMPK activation, thus demonstrating that AMPK blocked tumor cell proliferation primarily through inhibition of cholesterol and fatty acid synthesis. Most importantly, AICAR treatment in mice significantly inhibited the growth and glycolysis (as measured by (18)fluoro-2-deoxyglucose microPET) of glioblastoma xenografts engineered to express EGFRvIII, but not their parental counterparts. These results suggest a mechanism by which AICAR inhibits the proliferation of EGFRvIII expressing glioblastomas and point toward a potential therapeutic strategy for targeting EGFR-activated cancers.</abstract><notes>Guo, Deliang&#xD;Hildebrandt, Isabel J&#xD;Prins, Robert M&#xD;Soto, Horacio&#xD;Mazzotta, Mary M&#xD;Dang, Julie&#xD;Czernin, Johannes&#xD;Shyy, John Y-J&#xD;Watson, Andrew D&#xD;Phelps, Michael&#xD;Radu, Caius G&#xD;Cloughesy, Timothy F&#xD;Mischel, Paul S&#xD;CA108633/CA/NCI NIH HHS/United States&#xD;CA119347/CA/NCI NIH HHS/United States&#xD;NS050151/NS/NINDS NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12932-7. Epub 2009 Jul 22.</notes><urls></urls><custom1>CCNE - Caltech</custom1><custom2>2714280</custom2><custom4>10.228</custom4><electronic-resource-num>0906606106 [pii]&#xD;10.1073/pnas.0906606106 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2280</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2280</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, H.</author><author>Yoon, T. J.</author><author>Figueiredo, J. L.</author><author>Swirski, F. K.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5206, Boston, MA 02114, USA.</auth-address><titles><title>Rapid detection and profiling of cancer cells in fine-needle aspirates</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>12459-64</pages><volume>106</volume><number>30</number><edition>2009/07/22</edition><dates><year>2009</year><pub-dates><date>Jul 28</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>19620715</accession-num><abstract>There is a growing need for fast, highly sensitive and quantitative technologies to detect and profile unaltered cells in biological samples. Technologies in current clinical use are often time consuming, expensive, or require considerable sample sizes. Here, we report a diagnostic magnetic resonance (DMR) sensor that combines a miniaturized NMR probe with targeted magnetic nanoparticles for detection and molecular profiling of cancer cells. The sensor measures the transverse relaxation rate of water molecules in biological samples in which target cells of interest are labeled with magnetic nanoparticles. We achieved remarkable sensitivity improvements over our prior DMR prototypes by synthesizing new nanoparticles with higher transverse relaxivity and by optimizing assay protocols. We detected as few as 2 cancer cells in 1-microL sample volumes of unprocessed fine-needle aspirates of tumors and profiled the expression of several cellular markers in &lt;15 min.</abstract><notes>Lee, Hakho&#xD;Yoon, Tae-Jong&#xD;Figueiredo, Jose-Luiz&#xD;Swirski, Filip K&#xD;Weissleder, Ralph&#xD;U01-HL080731/HL/NHLBI NIH HHS/United States&#xD;U54-CA119349/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12459-64. Epub 2009 Jul 20.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2718371</custom2><custom4>10.228</custom4><electronic-resource-num>0902365106 [pii]&#xD;10.1073/pnas.0902365106 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1869</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1869</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Calderon-Colon, X.</author><author>Geng, H.</author><author>Gao, B.</author><author>An, L.</author><author>Cao, G.</author><author>Zhou, O.</author></authors></contributors><auth-address>Curriculum in Applied Science and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>A carbon nanotube field emission cathode with high current density and long-term stability</title><secondary-title>Nanotechnology</secondary-title></titles><periodical><full-title>Nanotechnology</full-title></periodical><pages>325707</pages><volume>20</volume><number>32</number><edition>2009/07/22</edition><dates><year>2009</year><pub-dates><date>Aug 12</date></pub-dates></dates><isbn>1361-6528 (Electronic)</isbn><accession-num>19620758</accession-num><abstract>Carbon nanotube (CNT) field emitters are now being evaluated for a wide range of vacuum electronic applications. However, problems including short lifetime at high current density, instability under high voltage, poor emission uniformity, and pixel-to-pixel inconsistency are still major obstacles for device applications. We developed an electrophoretic process to fabricate composite CNT films with controlled nanotube orientation and surface density, and enhanced adhesion. The cathodes have significantly enhanced macroscopic field emission current density and long-term stability under high operating voltages. The application of this CNT electron source for high-resolution x-ray imaging is demonstrated.</abstract><notes>Calderon-Colon, Xiomara&#xD;Geng, Huaizhi&#xD;Gao, Bo&#xD;An, Lei&#xD;Cao, Guohua&#xD;Zhou, Otto&#xD;R33EB004204/EB/NIBIB NIH HHS/United States&#xD;R43EB004215/EB/NIBIB NIH HHS/United States&#xD;U54CA119343/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nanotechnology&#xD;Nanotechnology. 2009 Aug 12;20(32):325707. Epub 2009 Jul 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19620758</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>3.727</custom4><electronic-resource-num>S0957-4484(09)13458-X [pii]&#xD;10.1088/0957-4484/20/32/325707</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2038</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2038</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pan, D.</author><author>Senpan, A.</author><author>Caruthers, S. D.</author><author>Williams, T. A.</author><author>Scott, M. J.</author><author>Gaffney, P. J.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Division of Cardiology and C-TRAIN, Washington University School of Medicine, St. Louis, MO 63108, USA. dipanjan@wustl.edu</auth-address><titles><title>Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloids</title><secondary-title>Chem Commun (Camb)</secondary-title></titles><periodical><full-title>Chem Commun (Camb)</full-title></periodical><pages>3234-6</pages><number>22</number><edition>2009/07/10</edition><keywords><keyword>Colloids</keyword><keyword>Contrast Media/chemistry/diagnostic use/metabolism</keyword><keyword>Fibrin/ metabolism</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Manganese/ chemistry/diagnostic use/ metabolism</keyword><keyword>Manganese Compounds/chemistry/diagnostic use/metabolism</keyword><keyword>Nanostructures/ chemistry</keyword><keyword>Oleic Acid/chemistry/diagnostic use/metabolism</keyword><keyword>Oxides/chemistry/diagnostic use/metabolism</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Substrate Specificity</keyword><keyword>Thrombosis/ diagnosis</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun 14</date></pub-dates></dates><isbn>1359-7345 (Print)</isbn><accession-num>19587924</accession-num><abstract>In this work, we report novel fibrin targeted &quot;soft-type&quot; manganese-based contrast agents for MRI with the potential to noninvasively image intravascular thrombus which could warrant aggressive medical intervention to preclude subsequent myocardial infarction or stroke.</abstract><notes>Pan, Dipanjan&#xD;Senpan, Angana&#xD;Caruthers, Shelton D&#xD;Williams, Todd A&#xD;Scott, Mike J&#xD;Gaffney, Patrick J&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;CA119342/CA/NCI NIH HHS/United States&#xD;HL073646/HL/NHLBI NIH HHS/United States&#xD;N01CO37007/CO/NCI NIH HHS/United States&#xD;NS059302/NS/NINDS NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Chemical communications (Cambridge, England)&#xD;Chem Commun (Camb). 2009 Jun 14;(22):3234-6. Epub 2009 Apr 22.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom4>4.997</custom4><electronic-resource-num>10.1039/b902875g [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1798</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1798</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jones, O.</author><author>Lacson, A.</author><author>Zeng, X.</author><author>Jones, J.</author><author>Katti, K.</author><author>Cahill, R.</author><author>Ahmed, A.</author></authors></contributors><auth-address>Department of Pediatrics, Walter Reed Army Medical Center, Georgia Avenue, NW, Washington DC, USA olcay.jones@gmail.com.</auth-address><titles><title>Long-term follow-up after non-myeloablative transplant of bone and marrow in BXSB mice</title><secondary-title>Lupus</secondary-title></titles><periodical><full-title>Lupus</full-title></periodical><pages>813-21</pages><volume>18</volume><number>9</number><edition>2009/07/07</edition><dates><year>2009</year></dates><isbn>0961-2033 (Print)</isbn><accession-num>19578106</accession-num><abstract>We present long-term outcomes of BXSB mice after non-myeloablative bone marrow transplants using major histocompatability complex (MHC)-matched cells. Groups differed in sources of donor lymphocytes or mesenchymal stromal cells (MSC). Unfractionated marrow cells from green fluorescent protein (GFP) transgenic (Tg) mice (BMT group) or from RAG1-/- B6 mice (RAG group) were injected intravenously (i.v.) into irradiated (550 cGy) hosts. As a source of mesenchymal cells, bone chips from GFP-Tg were injected intraperitoneally alone (MSC group) or along with i.v. bone marrow cells (BMT + MSC group). Controls were untreated mice (UnTx) or mice exposed to radiation only (Rad Cont). At 62 weeks post-transplant, surviving mice were harvested for histopathology, flow cytometry and real time polymerase chain reaction (RT-PCR). The mice from BMT + MSC group had the best outcomes for survival rates (71.4% vs. 43.8%), renal scores (2.9% vs. 28.8% glomerular sclerosis) and percent splenic monocytes (4.2 vs. 11.3%) compared with mice from Rad Cont. Improvement in RAG and BMT groups was less prominent but were comparable with one another. Although MSC alone were not sufficient to control the renal pathology, it limited the expansion of CD4(-)CD8(-) T cell populations without a change in Foxp3 expression. The results suggest the importance of the innate immune system in disease pathogenesis and a role for MSC in immunomodulation.</abstract><notes>Jones, Oy&#xD;Lacson, A&#xD;Zeng, X&#xD;Jones, Jm&#xD;Katti, K&#xD;Cahill, Ra&#xD;Ahmed, Aa&#xD;England&#xD;Lupus&#xD;Lupus. 2009;18(9):813-21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19578106</url></related-urls></urls><custom1>CNPP - U. of Miss.</custom1><custom4>2.393</custom4><electronic-resource-num>18/9/813 [pii]&#xD;10.1177/0961203309104391</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2207</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2207</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Haley, B.</author><author>Paunesku, T.</author><author>Protic, M.</author><author>Woloschak, G. E.</author></authors></contributors><auth-address>Department of Radiation Oncology, Northwestern University, Chicago, Illinois, USA.</auth-address><titles><title>Response of heterogeneous ribonuclear proteins (hnRNP) to ionising radiation and their involvement in DNA damage repair</title><secondary-title>Int J Radiat Biol</secondary-title></titles><periodical><full-title>Int J Radiat Biol</full-title><abbr-1>International journal of radiation biology</abbr-1></periodical><pages>643-55</pages><volume>85</volume><number>8</number><edition>2009/07/07</edition><keywords><keyword>Animals</keyword><keyword>DNA/ radiation effects</keyword><keyword>DNA Damage</keyword><keyword>DNA Repair</keyword><keyword>Heterogeneous-Nuclear Ribonucleoproteins/genetics/ physiology</keyword><keyword>Humans</keyword><keyword>Radiation, Ionizing</keyword><keyword>Recombination, Genetic</keyword></keywords><dates><year>2009</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0955-3002 (Print)</isbn><accession-num>19579069</accession-num><abstract>PURPOSE: To determine the relationship between heterogeneous nuclear ribonucleoproteins (hnRNP) and DNA repair, particularly in response to ionising radiation (IR). MATERIALS AND METHODS: The literature was examined for papers related to the topics of hnRNP, IR and DNA repair. RESULTS: HnRNP orchestrate the processing of mRNA to which they are bound in response to IR. HnRNP A18, B1, C1/C2 and K interact with important proteins from DNA Damage Response (DDR) pathways, binding DNA-dependent protein kinase (DNA-PK), the Ku antigen (Ku) and tumour suppressor protein 53 (p53) respectively. Notably, irregularities in the expression of hnRNP A18, B1, K, P2 and L have been linked to cancer and radiosensitivity. Sixteen different hnRNP proteins have been reported to show either mRNA transcript or protein quantity changes following IR. Various protein modifications of hnRNP in response to IR have also been noted: hnRNP A18, C1/C2 and K are phosphorylated; hnRNP C1/C2 is a target of apoptotic proteases; and hnRNP K degradation is controlled by murine double minute ubiquitin ligase (MDM2). Evidence points to a role for hnRNP A1, A18, A2/B1, C1/C2, K and P2 in regulating double-stranded break (DSB) repair pathways by promoting either homologous recombination (HR) or non-homologous end rejoining (NHEJ) repair pathways following IR. CONCLUSIONS: HnRNP proteins play a pivotal role in coordinating repair pathways following exposure to IR, through protein-protein interactions and transcript regulation of key repair and stress response mRNA. In particular, several hnRNP proteins are critical in coordinating the choice of HR or NHEJ to repair DSB caused by IR.</abstract><notes>Haley, Benjamin&#xD;Paunesku, Tatjana&#xD;Protic, Miroslava&#xD;Woloschak, Gayle E&#xD;EB002100/EB/NIBIB NIH HHS/United States&#xD;NS21442-18/NS/NINDS NIH HHS/United States&#xD;U54CA119341/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;England&#xD;International journal of radiation biology&#xD;Int J Radiat Biol. 2009 Aug;85(8):643-55.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>2.112</custom4><electronic-resource-num>912889880 [pii]&#xD;10.1080/09553000903009548 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2003</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2003</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qin, L.</author><author>Vermesh, O.</author><author>Shi, Q.</author><author>Heath, J. R.</author></authors></contributors><auth-address>NanoSystems Biology Cancer Center(NSBCC), Kavli Nanoscience Institute, Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.</auth-address><titles><title>Self-powered microfluidic chips for multiplexed protein assays from whole blood</title><secondary-title>Lab Chip</secondary-title></titles><periodical><full-title>Lab Chip</full-title></periodical><pages>2016-20</pages><volume>9</volume><number>14</number><edition>2009/07/02</edition><keywords><keyword>Biological Markers/blood</keyword><keyword>Blood Chemical Analysis/ instrumentation</keyword><keyword>Blood Proteins/ analysis</keyword><keyword>Dimethylpolysiloxanes/chemistry</keyword><keyword>Humans</keyword><keyword>Microfluidic Analytical Techniques/ instrumentation</keyword><keyword>Nylons/chemistry</keyword><keyword>Peroxides/chemistry</keyword><keyword>Pressure</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2009</year><pub-dates><date>Jul 21</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>19568669</accession-num><abstract>We report herein on a self-powered, self-contained microfluidic-based chip designed to separate plasma from whole blood, and then execute an assay of a multiplexed panel of plasma biomarker proteins. The power source is based upon a chemical reaction that is catalytically triggered by the push of a button on the chip. We demonstrate assays of a dozen blood-based protein biomarkers using this automated, self-contained device. This platform can potentially permit high throughput, accurate, multiplexed blood diagnostic measurements in remote locations and by minimally trained individuals.</abstract><notes>Qin, Lidong&#xD;Vermesh, Ophir&#xD;Shi, Qihui&#xD;Heath, James R&#xD;5U54 CA119347/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Lab on a chip&#xD;Lab Chip. 2009 Jul 21;9(14):2016-20. Epub 2009 Apr 16.</notes><urls></urls><custom1>CCNE - Caltech</custom1><custom4>7.000</custom4><electronic-resource-num>10.1039/b821247c [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2206</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2206</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chen, H.</author><author>Ahn, R.</author><author>Van den Bossche, J.</author><author>Thompson, D. H.</author><author>O&apos;Halloran, T. V.</author></authors></contributors><auth-address>Department of Chemistry, Chemistry of Life Processes Institute, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide</title><secondary-title>Mol Cancer Ther</secondary-title></titles><periodical><full-title>Mol Cancer Ther</full-title></periodical><pages>1955-63</pages><volume>8</volume><number>7</number><edition>2009/07/02</edition><dates><year>2009</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1538-8514 (Electronic)</isbn><accession-num>19567824</accession-num><abstract>Arsenic trioxide (As(2)O(3)) is a frontline drug for treatment of acute promyelocytic leukemia and is in clinical trials for treatment of other malignancies, including multiple myeloma; however, efforts to expand clinical utility to solid tumors have been limited by toxicity. Nanoparticulate forms of As(2)O(3) encapsulated in 100-nm-scale, folate-targeted liposomes have been developed to lower systematic toxicity and provide a platform for targeting this agent. The resultant arsenic &quot;nanobins&quot; are stable under physiologic conditions but undergo triggered drug release when the pH is lowered to endosomal/lysosomal levels. Cellular uptake and antitumor efficacy of these arsenic liposomes have been evaluated in folate receptor (FR)-positive human nasopharyngeal (KB) and cervix (HeLa) cells, as well as FR-negative human breast (MCF-7) tumor cells through confocal microscopy, inductively coupled plasma mass spectroscopy, and cytotoxicity studies. Uptake of folate-targeted liposomal arsenic by KB cells was three to six times higher than that of free As(2)O(3) or nontargeted liposomal arsenic; the enhanced uptake occurs through folate-mediated endocytosis, leading to a 28-fold increase in cytotoxicity. In contrast, tumor cells with lower FR density on the surface (HeLa and MCF-7) showed much less uptake of the folate-targeted drug and lower efficacy. In cocultures of KB and MCF-7 cells, the folate-targeted arsenic liposomes were exclusively internalized by KB cells, showing high targeting specificity. Our studies further indicate that folate-targeted delivery of As(2)O(3) with coencapsulated nickel(II) ions (as a nontoxic adjuvant) potentiates the As(2)O(3) efficacy in relatively insensitive solid tumor-derived cells and holds the promise of improving drug therapeutic index.</abstract><notes>Chen, Haimei&#xD;Ahn, Richard&#xD;Van den Bossche, Jeroen&#xD;Thompson, David H&#xD;O&apos;Halloran, Thomas V&#xD;GM054111/GM/NIGMS NIH HHS/United States&#xD;GM087016/GM/NIGMS NIH HHS/United States&#xD;P30 CA060553/CA/NCI NIH HHS/United States&#xD;U54 CA119341/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Molecular cancer therapeutics&#xD;Mol Cancer Ther. 2009 Jul;8(7):1955-63. Epub 2009 Jun 30.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>5.428</custom4><electronic-resource-num>1535-7163.MCT-09-0045 [pii]&#xD;10.1158/1535-7163.MCT-09-0045 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2002</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2002</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schluep, T.</author><author>Hwang, J.</author><author>Hildebrandt, I. J.</author><author>Czernin, J.</author><author>Choi, C. H.</author><author>Alabi, C. A.</author><author>Mack, B. C.</author><author>Davis, M. E.</author></authors></contributors><auth-address>Calando Pharmaceuticals, Inc., 129 North Hill Avenue, Pasadena, CA 91106, USA.</auth-address><titles><title>Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>11394-9</pages><volume>106</volume><number>27</number><edition>2009/07/01</edition><keywords><keyword>Animals</keyword><keyword>Camptothecin/ pharmacokinetics</keyword><keyword>Cell Line, Tumor</keyword><keyword>Copper/pharmacokinetics</keyword><keyword>Cyclodextrins/ pharmacokinetics</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Kidney/metabolism</keyword><keyword>Mice</keyword><keyword>Mice, SCID</keyword><keyword>Models, Biological</keyword><keyword>Nanoparticles</keyword><keyword>Neoplasms/ pathology</keyword><keyword>Polymers/ pharmacokinetics</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Tissue Distribution</keyword><keyword>Whole Body Imaging</keyword></keywords><dates><year>2009</year><pub-dates><date>Jul 7</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>19564622</accession-num><abstract>IT-101, a cyclodextrin polymer-based nanoparticle containing camptothecin, is in clinical development for the treatment of cancer. Multiorgan pharmacokinetics and accumulation in tumor tissue of IT-101 is investigated by using PET. IT-101 is modified through the attachment of a 1,4,7,10-tetraazacyclododecane-1,4,7-Tris-acetic acid ligand to bind (64)Cu(2+). This modification does not affect the particle size and minimally affects the surface charge of the resulting nanoparticles. PET data from (64)Cu-labeled IT-101 are used to quantify the in vivo biodistribution in mice bearing Neuro2A s.c. tumors. The (64)Cu-labeled IT-101 displays a biphasic plasma elimination. Approximately 8% of the injected dose is rapidly cleared as a low-molecular-weight fraction through the kidneys. The remaining material circulates in plasma with a terminal half-life of 13.3 h. Steadily increasing concentrations, up to 11% injected dose per cm(3), are observed in the tumor over 24 h, higher than any other tissue at that time. A 3-compartment model is used to determine vascular permeability and nanoparticle retention in tumors, and is able to accurately represent the experimental data. The calculated tumor vascular permeability indicates that the majority of nanoparticles stay intact in circulation and do not disassemble into individual polymer strands. A key assumption to modeling the tumor dynamics is that there is a &quot;sink&quot; for the nanoparticles within the tumor. Histological measurements using confocal microscopy show that IT-101 localizes within tumor cells and provides the sink in the tumor for the nanoparticles.</abstract><notes>Schluep, Thomas&#xD;Hwang, Jungyeon&#xD;Hildebrandt, Isabel J&#xD;Czernin, Johannes&#xD;Choi, Chung Hang J&#xD;Alabi, Christopher A&#xD;Mack, Brendan C&#xD;Davis, Mark E&#xD;CA 119347/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11394-9. Epub 2009 Jun 29.</notes><urls></urls><custom1>CCNE - Caltech</custom1><custom2>2703672</custom2><custom4>10.228</custom4><electronic-resource-num>0905487106 [pii]&#xD;10.1073/pnas.0905487106 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1879</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1879</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, H.</author><author>Nunes, J. K.</author><author>Gratton, S. E. A.</author><author>Herlihy, K. P.</author><author>Pohlhaus, P. D.</author><author>DeSimone, J. M.</author></authors></contributors><titles><title>Fabrication of multiphasic and regio-specifically functionalized PRINT (R) particles of controlled size and shape</title><secondary-title>New Journal of Physics</secondary-title></titles><periodical><full-title>New Journal of Physics</full-title></periodical><volume>11</volume><edition>2009/07</edition><dates><year>2009</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1367-2630</isbn><accession-num>ISI:000268699200005</accession-num><abstract>Using Particle Replication In Nonwetting Templates (PRINT(R)) technology, multiphasic and regio-specifically functionalized shape-controlled particles have been fabricated that include end-labeled particles via post-functionalization; biphasic Janus particles that integrate two compositionally different chemistries into a single particle; and more complex multiphasic shape-specific particles. Controlling the anisotropic distribution of matter within a particle creates an extra parameter in the colloidal particle design, providing opportunities to generate advanced particles with versatile and tunable compositions, properties, and thus functionalities. Owing to their robust characteristics, these multiphasic and regio-specifically functionalized PRINT particles should be promising platforms for applications in life science and materials science.</abstract><notes>Zhang, H. Nunes, J. K. Gratton, S. E. A. Herlihy, K. P. Pohlhaus, P. D. DeSimone, J. M.</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000268699200005</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>3.544</custom4><electronic-resource-num>075018&#xD;10.1088/1367-2630/11/7/075018</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2401</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2401</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yang, L. L.</author><author>Peng, X. H.</author><author>Wang, Y. A.</author><author>Wang, X. X.</author><author>Cao, Z. H.</author><author>Ni, C. C.</author><author>Karna, P.</author><author>Zhang, X. J.</author><author>Wood, W. C.</author><author>Gao, X. H.</author><author>Nie, S. M.</author><author>Mao, H.</author></authors></contributors><auth-address>[Yang, Lily; Peng, Xiang-Hong; Cao, Zehong; Karna, Prasanthi; Wood, William C.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA. [Yang, Lily; Wang, Xiaoxia; Ni, Chunchun; Mao, Hui] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA. [Gao, Xiaohu; Nie, Shuming] Emory Univ, Sch Med, Dept Biomed Engn, Atlanta, GA 30322 USA. [Yang, Lily; Wood, William C.; Nie, Shuming; Mao, Hui] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA. [Zhang, Xinjian] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA. [Wang, Y. Andrew] Ocean Nanotech LLC, Springdale, AR USA.&#xD;Yang, LL, Emory Univ, Sch Med, Dept Surg, C-4088,1365 C Clifton Rd NE, Atlanta, GA 30322 USA.&#xD;Lyang02@emory.edu</auth-address><titles><title>Receptor-Targeted Nanoparticles for In vivo Imaging of Breast Cancer</title><secondary-title>Clinical Cancer Research</secondary-title><alt-title>Clin. Cancer Res.</alt-title></titles><periodical><full-title>Clinical Cancer Research</full-title></periodical><pages>4722-4732</pages><volume>15</volume><number>14</number><edition>2009/07</edition><keywords><keyword>UROKINASE PLASMINOGEN-ACTIVATOR</keyword><keyword>IRON-OXIDE NANOPARTICLES</keyword><keyword>COMPUTED-TOMOGRAPHY</keyword><keyword>EPITHELIAL-CELLS</keyword><keyword>DRUG-DELIVERY</keyword><keyword>TUMOR-CELLS</keyword><keyword>EXPRESSION</keyword><keyword>CARCINOMA</keyword><keyword>MRI</keyword><keyword>SYSTEM</keyword></keywords><dates><year>2009</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1078-0432</isbn><accession-num>ISI:000268908400027</accession-num><abstract>Purpose: Cell-surface receptor-targeted magnetic iron oxide nanoparticles provide molecular magnetic resonance imaging contrast agents for improving specificity of the detection of human cancer. Experimental Design: The present study reports the development of a novel targeted iron oxide nanoparticle using a recombinant peptide containing the amino-terminal fragment of urokinase-type plasminogen activator (uPA) conjugated to magnetic iron oxide nanoparticles amino-terminal fragment conjugated-iron oxide (ATF-IO). This nanoparticle targets uPA receptor, which is overexpressed in breast cancer tissues. Results: ATF-IO nanoparticles are able to specifically bind to and be internalized by uPA receptor - expressing tumor cells. Systemic delivery of ATF-IO nanoparticles into mice bearing s.c. and i.p. mammary tumors leads to the accumulation of the particles in tumors, generating a strong magnetic resonance imaging contrast detectable by a clinical magnetic resonance imaging scanner at a field strength of 3 tesla. Target specificity of ATF-IO nanoparticles showed by in vivo magnetic resonance imaging is further confirmed by near-IR fluorescence imaging of the mammary tumors using near-IR dye-labeled amino-terminal fragment peptides conjugated to iron oxide nanoparticles. Furthermore, mice administered ATF-IO nanoparticles exhibit lower uptake of the particles in the liver and spleen compared with those receiving nontargeted iron oxide nanoparticles. Conclusions: Our results suggest that uPA receptor-targeted ATF-IO nanoparticles have potential as molecularly targeted, dual modality imaging agents for in vivo imaging of breast cancer.</abstract><notes>ISI Document Delivery No.: 482SG&#xD;Times Cited: 0&#xD;Cited Reference Count: 49&#xD;Yang, Lily Peng, Xiang-Hong Wang, Y. Andrew Wang, Xiaoxia Cao, Zehong Ni, Chunchun Karna, Prasanthi Zhang, Xinjian Wood, William C. Gao, Xiaohu Nie, Shuming Mao, Hui&#xD;AMER ASSOC CANCER RESEARCH</notes><work-type>Article</work-type><urls><related-urls><url>&lt;Go to ISI&gt;://000268908400027</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>6.646</custom4><electronic-resource-num>10.1158/1078-0432.ccr-08-3289</electronic-resource-num><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1892</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1892</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kumar, R.</author><author>Ohulchanskyy, T. Y.</author><author>Roy, I.</author><author>Gupta, S. K.</author><author>Borek, C.</author><author>Thompson, M. E.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>[Kumar, Rajiv; Ohulchanskyy, Tymish Y.; Roy, Indrajit; Gupta, Sandesh K.; Prasad, Paras N.] SUNY Buffalo, Inst Lasers Photon &amp; Biophoton, Buffalo, NY 14226 USA. [Borek, Carsten; Thompson, Mark E.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA.&#xD;Prasad, PN, SUNY Buffalo, Inst Lasers Photon &amp; Biophoton, Buffalo, NY 14226 USA.&#xD;pnprasad@buffalo.edu</auth-address><titles><title>Near-Infrared Phosphorescent Polymeric Nanomicelles: Efficient Optical Probes for Tumor Imaging and Detection</title><secondary-title>Acs Applied Materials &amp; Interfaces</secondary-title><alt-title>ACS Appl. Mater. Interfaces</alt-title></titles><periodical><full-title>Acs Applied Materials &amp; Interfaces</full-title><abbr-1>ACS Appl. Mater. Interfaces</abbr-1></periodical><alt-periodical><full-title>Acs Applied Materials &amp; Interfaces</full-title><abbr-1>ACS Appl. Mater. Interfaces</abbr-1></alt-periodical><pages>1474-1481</pages><volume>1</volume><number>7</number><edition>2009/07</edition><keywords><keyword>metalloporphyrins</keyword><keyword>room-temperature phosphorescence</keyword><keyword>in vivo optical</keyword><keyword>imaging</keyword><keyword>polymeric nanomicelles</keyword><keyword>tumor detection</keyword><keyword>LIGHT-EMITTING DEVICES</keyword><keyword>IN-VIVO</keyword><keyword>PHOTODYNAMIC THERAPY</keyword><keyword>PLATINUM</keyword><keyword>COMPLEXES</keyword><keyword>HIGHLY EFFICIENT</keyword><keyword>CONTRAST AGENTS</keyword><keyword>BREAST-CANCER</keyword><keyword>NANOPARTICLES</keyword><keyword>FLUORESCENCE</keyword><keyword>OXYGEN</keyword></keywords><dates><year>2009</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1944-8244</isbn><accession-num>ISI:000268310800018</accession-num><abstract>We report a formulation of near-infrared (near-IR) phosphorescent polymeric nanomicelles and their use for in vivo high-contrast optical imaging, targeting, and detection of tumors in small animals. Near-IR phosphorescent molecules of Pt(II)-tetraphenyltetranaphthoporphyrin (Pt(TPNP)) were found to maintain their near-IR phosphorescence properties when encapsulated into phospholipid nanomicelles. The prepared phosphorescent micelles are of similar to 100 nm size and are highly stable in aqueous suspensions. A large spectral separation between the Pt(TPNP) absorption, with a peak at similar to 700 nm, and its phosphorescence emission, with a peak at similar to 900 nm, allows a dramatic decrease in the level of background autofluorescence and scattered excitation light in the near-IR spectral range, where the signal from the phosphorescent probe is observed. in vivo animal imaging with subcutaneously xenografted tumor-bearing mice has resulted in high contrast optical images, indicating highly specific accumulation of the phosphorescent micelles into tumors. Using optical imaging with near-IR phosphorescent nanomicelles, detection of smaller, visually undetectable tumors has also been demonstrated.</abstract><notes>ISI Document Delivery No.: 474UX&#xD;Times Cited: 0&#xD;Cited Reference Count: 69&#xD;Kumar, Rajiv Ohulchanskyy, Tymish Y. Roy, Indrajit Gupta, Sandesh K. Borek, Carsten Thompson, Mark E. Prasad, Paras N.&#xD;AMER CHEMICAL SOC</notes><work-type>Article</work-type><urls><related-urls><url>&lt;Go to ISI&gt;://000268310800018</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom4>na</custom4><electronic-resource-num>10.1021/am9001293</electronic-resource-num><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1958</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1958</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, X.</author><author>Wang, S. H.</author><author>Van Antwerp, M. E.</author><author>Chen, X.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>College of Chemistry, Chemical Engineering, and Biotechnology, Donghua University, Shanghai 210620, P. R. China. xshi@dhu.edu.cn</auth-address><titles><title>Targeting and detecting cancer cells using spontaneously formed multifunctional dendrimer-stabilized gold nanoparticles</title><secondary-title>Analyst</secondary-title></titles><periodical><full-title>Analyst</full-title></periodical><pages>1373-9</pages><volume>134</volume><number>7</number><edition>2009/06/30</edition><dates><year>2009</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1364-5528 (Electronic)</isbn><accession-num>19562204</accession-num><abstract>We develop a facile approach to fabricating multifunctional dendrimer-stabilized gold nanoparticles (Au DSNPs) for cancer cell targeting and imaging. In this work, amine-terminated generation 5 (G5) poly(amidoamine) (PAMAM) dendrimers pre-functionalized with folic acid (FA) and fluorescein isothiocyanate (FI) are complexed with Au(III) ions, followed by acetylation of the amine groups on the dendrimer surfaces. This one-step process leads to the spontaneous formation of 6 nm-sized Au nanoparticles stabilized by multifunctional dendrimers bearing both targeting and imaging functionalities. The multifunctional Au DSNPs are characterized by UV-Vis spectrometry, 1H NMR, and transmission electron microscopy (TEM). The formed Au DSNPs are water-soluble, stable, and biocompatible. Combined flow cytometry, confocal microscopy, silver staining, and inductively coupled plasma-mass spectrometry (ICP-MS) analyses show that the FA- and FI-functionalized Au DSNPs can specifically target to cancer cells expressing high-affinity FA receptors in vitro. This approach to functionalizing Au DSNPs may be extended to other targeting molecules, providing a unique nanoplatform for targeting and imaging of a variety of biological systems.</abstract><notes>Shi, Xiangyang&#xD;Wang, Su He&#xD;Van Antwerp, Mary E&#xD;Chen, Xisui&#xD;Baker, James R Jr&#xD;1 R01 CA119409/CA/NCI NIH HHS/United States&#xD;1 R01 EB002657/EB/NIBIB NIH HHS/United States&#xD;N0I-CO-97111/CO/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;The Analyst&#xD;Analyst. 2009 Jul;134(7):1373-9. Epub 2009 Apr 17.</notes><urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom4>3.472</custom4><electronic-resource-num>10.1039/b902199j [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1360</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1360</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kwong, G. A.</author><author>Radu, C. G.</author><author>Hwang, K.</author><author>Shu, C. J.</author><author>Ma, C.</author><author>Koya, R. C.</author><author>Comin-Anduix, B.</author><author>Hadrup, S. R.</author><author>Bailey, R. C.</author><author>Witte, O. N.</author><author>Schumacher, T. N.</author><author>Ribas, A.</author><author>Heath, J. R.</author></authors></contributors><auth-address>NanoSystems Biology Cancer Center, Division of Engineering and Applied Science, Bioengineering, Division of Physics, Mathematics and Astronomy, Division of Chemistry and Chemical Engineering, MC 127-72, California Institute of Technology, Pasadena, California 91125; Department of Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, Department of Medicine, Division of Hematology-Oncology, Department of Surgery, Division of Surgical Oncology, Department of Microbiology, Immunology, and Molecular Genetics, Howard Hughes Medical Institute; University of California, Los Angeles, California 90095.</auth-address><titles><title>Modular Nucleic Acid Assembled p/MHC Microarrays for Multiplexed Sorting of Antigen-Specific T Cells</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><edition>2009/06/26</edition><dates><year>2009</year><pub-dates><date>Jun 24</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>19552409</accession-num><abstract>The human immune system consists of a large number of T cells capable of recognizing and responding to antigens derived from various sources. The development of peptide-major histocompatibility (p/MHC) tetrameric complexes has enabled the direct detection of these antigen-specific T cells. With the goal of increasing throughput and multiplexing of T cell detection, protein microarrays spotted with defined p/MHC complexes have been reported, but studies have been limited due to the inherent instability and reproducibility of arrays produced via conventional spotted methods. Herein, we report on a platform for the detection of antigen-specific T cells on glass substrates that offers significant advantages over existing surface-bound schemes. In this approach, called &quot;Nucleic Acid Cell Sorting (NACS)&quot;, single-stranded DNA oligomers conjugated site-specifically to p/MHC tetramers are employed to immobilize p/MHC tetramers via hybridization to a complementary-printed substrate. Fully assembled p/MHC arrays are used to detect and enumerate T cells captured from cellular suspensions, including primary human T cells collected from cancer patients. NACS arrays outperform conventional spotted arrays assessed in key criteria such as repeatability and homogeneity. The versatility of employing DNA sequences for cell sorting is exploited to enable the programmed, selective release of target populations of immobilized T cells with restriction endonucleases for downstream analysis. Because of the performance, facile and modular assembly of p/MHC tetramer arrays, NACS holds promise as a versatile platform for multiplexed T cell detection.</abstract><notes>Journal article&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2009 Jun 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19552409</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja9006707</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2126</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2126</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, H.</author><author>Cao, F.</author><author>De, A.</author><author>Cao, Y.</author><author>Contag, C.</author><author>Gambhir, S. S.</author><author>Wu, J. C.</author><author>Chen, X.</author></authors></contributors><auth-address>Department of Radiology, Bio-X Program, Stanford University School of Medicine, Stanford, California 94305-5484, USA.</auth-address><titles><title>Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging</title><secondary-title>Stem Cells</secondary-title></titles><periodical><full-title>Stem Cells</full-title></periodical><pages>1548-58</pages><volume>27</volume><number>7</number><edition>2009/06/23</edition><dates><year>2009</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1549-4918 (Electronic)</isbn><accession-num>19544460</accession-num><abstract>The objective of the study was to track the distribution and differentiation of mesenchymal stem cells (MSCs) in tumor-bearing mice. The 4T1 murine breast cancer cells were labeled with renilla luciferase-monomeric red fluorescence protein (rLuc-mRFP) reporter gene. The MSCs labeled with firefly luciferase-enhanced green fluorescence protein (fLuc-eGFP) reporter gene (MSCs-R) were isolated from L2G85 transgenic mice that constitutively express fLuc-eGFP reporter gene. To study the tumor tropism of MSCs, we established both subcutaneous and lung metastasis models. In lung metastasis tumor mice, we injected MSCs-R intravenously either on the same day or 4 days after 4T1 tumor cell injection. In subcutaneous tumor mice, we injected MSCs-R intravenously 7 days after subcutaneous 4T1 tumor inoculation. The tumor growth was monitored by rLuc bioluminescence imaging (BLI). The fate of MSCs-R was monitored by fLuc BLI. The localization of MSCs-R in tumors was examined histologically. The osteogenic and adipogenic differentiation of MSCs-R was investigated by alizarin red S and oil red O staining, respectively. The mechanism of the dissimilar differentiation potential of MSCs-R under different tumor microenvironments was investigated. We found that the 4T1 cells were successfully labeled with rLuc-mRFP. The MSCs-R isolated from L2G85 transgenic mice constitutively express fLuc-eGFP reporter gene. When injected intravenously, MSCs-R survived, proliferated, and differentiated in tumor sites but not elsewhere. The localization of GFP(+) MSCs-R in tumor lesions was confirmed ex vivo. In conclusion, the MSCs-R can selectively localize, survive, and proliferate in both subcutaneous tumor and lung metastasis as evidenced by noninvasive bioluminescence imaging and ex vivo validation. The MSCs-R migrated to lung tumor differentiated into osteoblasts, whereas the MSCs-R targeting subcutaneous tumor differentiated into adipocytes.</abstract><notes>Wang, Hui&#xD;Cao, Feng&#xD;De, Abhijit&#xD;Cao, Yuan&#xD;Contag, Christopher&#xD;Gambhir, Sanjiv S&#xD;Wu, Joseph C&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Stem cells (Dayton, Ohio)&#xD;Stem Cells. 2009 Jul;27(7):1548-58.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>8.212</custom4><electronic-resource-num>10.1002/stem.81 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1799</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1799</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Amarasinghe, P. M.</author><author>Katti, K. S.</author><author>Katti, D. R.</author></authors></contributors><auth-address>Department of Civil Engineering, North Dakota State University, Fargo, ND 58105, USA.</auth-address><titles><title>Nature of organic fluid-montmorillonite interactions: An FTIR spectroscopic study</title><secondary-title>J Colloid Interface Sci</secondary-title></titles><periodical><full-title>J Colloid Interface Sci</full-title></periodical><pages>97-105</pages><volume>337</volume><number>1</number><edition>2009/06/23</edition><dates><year>2009</year><pub-dates><date>Sep 1</date></pub-dates></dates><isbn>1095-7103 (Electronic)</isbn><accession-num>19539947</accession-num><abstract>The changes in the H-O-H stretching vibration in the interlayer water and Si-O stretching vibration of a Na-montmorillonite (MMT) structure in the FTIR (Fourier transform infrared) spectra provide insight into the effect of fluids of different dielectric constants on the clay structure. Mechanisms by which the different fluids of varying polarities enter into the clay interlayer and the rates at which these molecules interact with the clay structure and the interlayer water are studied at the molecular level using six different fluids with dielectric constants ranging from 110 to 2.4. The shift in H-O-H bending vibrations of interlayer water and changes in the Si-O vibration bands of MMT occur almost immediately after mixing with the solvent regardless of the polarity of the solvent. However, the extent and the rate of changes in H-O-H bending and Si-O stretching are dependent on the polarity of the solvent. Results show a very good correlation between the polarity of the solvent and the shift in H-O-H bending of interlayer water, and also between the polarity of the fluids and the d((001)) spacing of the MMT-solvent samples. Low polar fluids such as methanol tend to make weak electrostatic interactions with clay surface oxygen and interlayer-water molecules, which result in an increase in interlayer spacing. Although, the alteration of the Si-O structure due to high polar molecules such as formamide is a continuous process, the influence of nonpolar fluids such as TCE (trichloroethylene) on the Si-O structure is almost instantaneous, which may result in high hydraulic conductivity in the clay.</abstract><notes>Amarasinghe, Priyanthi M&#xD;Katti, Kalpana S&#xD;Katti, Dinesh R&#xD;United States&#xD;Journal of colloid and interface science&#xD;J Colloid Interface Sci. 2009 Sep 1;337(1):97-105. Epub 2009 May 13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19539947</url></related-urls></urls><custom1>CNPP - U. of Miss.</custom1><custom4>na</custom4><electronic-resource-num>S0021-9797(09)00611-0 [pii]&#xD;10.1016/j.jcis.2009.05.011</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2359</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2359</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nitin, N.</author><author>Rhee, W. J.</author><author>Bao, G.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.</auth-address><titles><title>Translation inhibition reveals interaction of 2&apos;-deoxy and 2&apos;-O-methyl molecular beacons with mRNA targets in living cells</title><secondary-title>Nucleic Acids Res</secondary-title></titles><periodical><full-title>Nucleic Acids Res</full-title></periodical><pages>4977-86</pages><volume>37</volume><number>15</number><edition>2009/06/17</edition><keywords><keyword>1-Phosphatidylinositol 3-Kinase/antagonists &amp; inhibitors</keyword><keyword>Androstadienes/pharmacology</keyword><keyword>Cells, Cultured</keyword><keyword>Fluorescent Dyes/ chemistry</keyword><keyword>Glyceraldehyde-3-Phosphate Dehydrogenases/genetics</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword><keyword>Nucleic Acid Denaturation</keyword><keyword>Nucleic Acid Hybridization</keyword><keyword>Oligonucleotide Probes/ chemistry</keyword><keyword>Protein Biosynthesis/drug effects</keyword><keyword>Protein Kinase Inhibitors/pharmacology</keyword><keyword>Protein Kinases/metabolism</keyword><keyword>RNA, Messenger/ analysis/chemistry/metabolism</keyword><keyword>RNA, Ribosomal, 28S/analysis/chemistry</keyword><keyword>Sirolimus/pharmacology</keyword><keyword>Temperature</keyword><keyword>ras Proteins/genetics</keyword></keywords><dates><year>2009</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1362-4962 (Electronic)</isbn><accession-num>19528073</accession-num><abstract>Understanding the interaction between oligonucleotide probes and RNA targets in living cells is important for biological and clinical studies of gene expression in vivo. Here, we demonstrate that starvation of cells and translation inhibition by blocking the mTOR or PI-3 kinase pathway could significantly reduce the fluorescence signal from 2&apos;-deoxy molecular beacons (MBs) targeting K-ras and GAPDH mRNAs in living cells. However, the intensity and localization of fluorescence signal from MBs targeting nontranslated 28S rRNA remained the same in normal and translation-inhibited cells. We also found that, in targeting K-ras and GAPDH mRNAs, the signal level from MBs with 2&apos;-O-methyl backbone did not change when translation was repressed. Taken together, our findings suggest that MBs with DNA backbone hybridize preferentially with mRNAs in their translational state in living cells, whereas those with 2&apos;-O-methyl chemistry tend to hybridize to mRNA targets in both translational and nontranslational states. This work may thus provide a significant insight into probe design for detection of RNA molecules in living cells and RNA biology.</abstract><notes>Nitin, Nitin&#xD;Rhee, Won Jong&#xD;Bao, Gang&#xD;CA103103/CA/NCI NIH HHS/United States&#xD;CA119338/CA/NCI NIH HHS/United States&#xD;HL80711/HL/NHLBI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Nucleic acids research&#xD;Nucleic Acids Res. 2009 Aug;37(15):4977-86. Epub 2009 Jun 15.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom2>2731902</custom2><custom4>6.968</custom4><electronic-resource-num>gkp517 [pii]&#xD;10.1093/nar/gkp517 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2205</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2205</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, S. M.</author><author>Chen, H.</author><author>O&apos;Halloran, T. V.</author><author>Nguyen, S. T.</author></authors></contributors><auth-address>Department of Chemistry, and the Center of Cancer Nanotechnology Excellence, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>&quot;Clickable&quot; polymer-caged nanobins as a modular drug delivery platform</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9311-20</pages><volume>131</volume><number>26</number><edition>2009/06/17</edition><dates><year>2009</year><pub-dates><date>Jul 8</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>19527027</accession-num><abstract>Modularly clickable polymer-caged nanobins (PCNs) were prepared from liposome templates using a drop-in cholesterol-modified poly(acrylic acid) reagent followed by cross-linking with alkyne-functionalized diamine linker that allows for the conjugation of azide-modified targeting ligands via click ligation. These PCNs possess pH-responsive characteristics that can be used to trigger the release of encapsulated doxorubicin (DXR) payload inside the liposomal core under mild acidic conditions. After click-conjugation with azide-modified folate as an active targeting ligand, the resulting folate-conjugated, DXR-loaded PCNs (f-PCN(DXR)) demonstrated enhanced potency to folate receptor (FR)-positive tumor cells such as KB and OvCa432 over FR-negative MCF7 cells. f-PCN(DXR) can readily discriminate FR-positive tumor cells as a function of the level of cellular FR-expression, showing different degrees of potentiation in each cell. With both targeting functionalities and pH-sensitive drug-releasing triggers, f-PCN(DXR) was fifty-times more potent than the untargeted agent toward cancer cells that overexpress the folate target receptors.</abstract><notes>Lee, Sang-Min&#xD;Chen, Haimei&#xD;O&apos;Halloran, Thomas V&#xD;Nguyen, SonBinh T&#xD;P30CA060553/CA/NCI NIH HHS/United States&#xD;U54CA119341/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2009 Jul 8;131(26):9311-20.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja9017336 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2037</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2037</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Southworth, R.</author><author>Kaneda, M.</author><author>Chen, J.</author><author>Zhang, L.</author><author>Zhang, H.</author><author>Yang, X.</author><author>Razavi, R.</author><author>Lanza, G.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>King&apos;s College London, The Rayne Institute, St. Thomas&apos; Hospital, UK.</auth-address><titles><title>Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons</title><secondary-title>Nanomedicine</secondary-title></titles><periodical><full-title>Nanomedicine</full-title></periodical><pages>359-67</pages><volume>5</volume><number>3</number><edition>2009/06/16</edition><dates><year>2009</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1549-9642 (Electronic)</isbn><accession-num>19523428</accession-num><abstract>We have designed multifunctional nanoparticulate reporter bioprobes capable of targeting vascular cell adhesion molecule 1 (VCAM-1), which is up-regulated in numerous inflammatory processes. These perfluorocarbon-cored nanoparticles emit a unique (19)F magnetic resonance (MR) signature, providing the potential to localize and quantify VCAM-1 expression in early atherosclerosis. Nanoparticle-VCAM-1 targeting specificity was confirmed by in vitro binding and competition studies. ApoE-null and control C57-BL6 mice (n = 6/group), fed a Western diet for 35 weeks, were injected i.v. with targeted or non-targeted nanoparticles. After two hours, kidneys were excised and prepared for analysis. ApoE-null kidneys exhibited increased VCAM-1-targeted nanoparticle content over healthy controls by (19)F MR spectroscopy (36.5+8.8 vs. 9.3+2.2 x 10(8)/g, P &lt; .05), which correlated with increased VCAM-1 staining (2.5 +/- 1.3% vs. 0.9 +/- 0.3%, P &lt; .05); their relative biodistributions were confirmed by fluorescence microscopy and MR imaging. These molecular imaging agents offer new approaches for detection, quantification, and longitudinal evaluation of early inflammation utilising (19)F MR spectroscopy and imaging. FROM THE CLINICAL EDITOR: Multifunctional nanoparticulate reporter bioprobes capable of targeting vascular cell adhesion molecule 1 (VCAM-1) are reported in this paper. These perfluorocarbon-cored nanoparticles offer new approaches for detection, quantification, and longitudinal evaluation of early inflammation utilising 19F MR spectroscopy and imaging.</abstract><notes>Southworth, Richard&#xD;Kaneda, Megan&#xD;Chen, Junjie&#xD;Zhang, Lei&#xD;Zhang, Huiying&#xD;Yang, Xiaoxia&#xD;Razavi, Reza&#xD;Lanza, Gregory&#xD;Wickline, Samuel A&#xD;5 R01HL078631-04/HL/NHLBI NIH HHS/United States&#xD;CA119342/CA/NCI NIH HHS/United States&#xD;HL073646/HL/NHLBI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Nanomedicine : nanotechnology, biology, and medicine&#xD;Nanomedicine. 2009 Sep;5(3):359-67. Epub 2009 Jan 19.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom4>6.093</custom4><electronic-resource-num>S1549-9634(09)00002-1 [pii]&#xD;10.1016/j.nano.2008.12.002 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2125</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2125</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Niu, G.</author><author>Li, Z.</author><author>Xie, J.</author><author>Le, Q. T.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, California 94305-5484, USA.</auth-address><titles><title>PET of EGFR antibody distribution in head and neck squamous cell carcinoma models</title><secondary-title>J Nucl Med</secondary-title></titles><periodical><full-title>J Nucl Med</full-title></periodical><pages>1116-23</pages><volume>50</volume><number>7</number><edition>2009/06/16</edition><keywords><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/diagnostic use/immunology/ pharmacokinetics</keyword><keyword>Antineoplastic Agents/diagnostic use/pharmacokinetics</keyword><keyword>Carcinoma, Squamous Cell/ metabolism/radionuclide imaging</keyword><keyword>Cell Line, Tumor</keyword><keyword>Copper Radioisotopes/diagnostic use/pharmacokinetics</keyword><keyword>Disease Models, Animal</keyword><keyword>Female</keyword><keyword>Head and Neck Neoplasms/ metabolism/radionuclide imaging</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Positron-Emission Tomography/ methods</keyword><keyword>Radiopharmaceuticals/diagnostic use/pharmacokinetics</keyword><keyword>Receptor, Epidermal Growth Factor/immunology/ metabolism</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2009</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>19525473</accession-num><abstract>Epidermal growth factor receptor (EGFR) is a well-characterized protooncogene that has been shown to promote tumor progression in solid cancers. Clinical results for EGFR targeting with specific monoclonal antibodies (mAbs) such as cetuximab and panitumumab are promising; however, most studies indicate that only a subgroup of patients receiving the mAbs benefit from the immunotherapy, independent of EGFR expression level. To understand the in vivo kinetics of antibody delivery and localization, we performed small-animal PET studies with (64)Cu-labeled panitumumab in xenografts derived from 3 cell lines of human head and neck squamous cell carcinoma (HNSCC). METHODS: Nude mice bearing HNSCC tumors with different levels of EGFR expression were imaged with small-animal PET using (64)Cu-1,4,7,10-tetraazacyclododecane-N,N&apos;,N&apos;&apos;,N&apos;&apos;&apos;-tetraacetic acid (DOTA)-panitumumab. Antibody distribution in the tumors was confirmed by ex vivo immunostaining using panitumumab and fluorescein 5(6)-isothiocyanate (FITC) panitumumab. CD31 immunostaining and Evans blue assay were also performed to assess the tumor vascular density and permeability. RESULTS: Among these 3 tumor models, UM-SCC-22B tumors with the lowest EGFR protein expression showed the highest (64)Cu-DOTA-panitumumab accumulation, whereas SQB20 tumors with the highest EGFR expression showed the lowest (64)Cu-DOTA-panitumumab accumulation. Ex vivo staining demonstrated that SQB20 cells still had extremely high EGFR expression after forming tumors in nude mice, indicating that the low uptake of (64)Cu-DOTA-panitumumab in SQB20 tumors was not due to the loss of EGFR expression. The results from CD31 immunostaining and Evans blue permeability assay suggest that the low vessel density, poor vascular permeability, and binding site barrier are likely responsible for the overall low tumor uptake of the highly EGFR-expressing SQB20 tumors. CONCLUSION: The results from this study provide a possible explanation for the lack of an observed correlation between therapeutic efficacy of cetuximab and panitumumab and EGFR expression level as determined by immunohistochemistry or fluorescent in situ hybridization and may shed new light on the complications of anti-EGFR mAb therapy for HNSCC and other malignancies.</abstract><notes>Niu, Gang&#xD;Li, Zibo&#xD;Xie, Jin&#xD;Le, Quynh-Thu&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA118582/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2009 Jul;50(7):1116-23. Epub 2009 Jun 12.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.282</custom4><electronic-resource-num>jnumed.109.061820 [pii]&#xD;10.2967/jnumed.109.061820 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2124</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2124</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Li, Z. B.</author><author>Cao, Q.</author><author>Liu, S.</author><author>Wang, F.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology, Biophysics Program, and Bio-X Program, Stanford University School of Medicine, Stanford, California 94305-5484, USA.</auth-address><titles><title>Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer</title><secondary-title>J Nucl Med</secondary-title></titles><periodical><full-title>J Nucl Med</full-title></periodical><pages>1168-77</pages><volume>50</volume><number>7</number><edition>2009/06/16</edition><keywords><keyword>Animals</keyword><keyword>Bombesin/chemistry/ diagnostic use/ pharmacokinetics</keyword><keyword>Breast Neoplasms/ metabolism/ radionuclide imaging</keyword><keyword>Cell Line, Tumor</keyword><keyword>Copper Radioisotopes/diagnostic use/pharmacokinetics</keyword><keyword>Dimerization</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Mice</keyword><keyword>Oligopeptides/diagnostic use/pharmacokinetics</keyword><keyword>Organ Specificity</keyword><keyword>Positron-Emission Tomography/ methods</keyword><keyword>Prostatic Neoplasms/ metabolism/ radionuclide imaging</keyword><keyword>Radiopharmaceuticals/diagnostic use/pharmacokinetics</keyword><keyword>Receptors, Bombesin/ metabolism</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2009</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>19525469</accession-num><abstract>The overexpression of gastrin-releasing peptide receptor (GRPR) in various tumor types suggests that GRPR is an attractive target for cancer imaging and therapy with radiolabeled bombesin analogs. We recently reported the ability of (18)F-labeled RGD-bombesin heterodimer to be used for dual integrin alpha(v)beta(3)- and GRPR-targeted imaging. To further investigate the synergistic effect of the dual-receptor targeting of peptide heterodimers, we evaluated (64)Cu-labeled RGD-bombesin for PET imaging of tumors. METHODS: RGD-bombesin was coupled with 1,4,7,10-tetraazacyclododecane-N, N&apos;, N&apos;&apos;, N&apos;&apos;&apos;-tetraacetic acid (DOTA) and 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA), and the conjugates were labeled with (64)Cu. The in vitro and in vivo characteristics of (64)Cu-NOTA-RGD-bombesin were compared with those of (64)Cu-NOTA-RGD, (64)Cu-NOTA-bombesin, and (64)Cu-DOTA-RGD-bombesin. RESULTS: (64)Cu-NOTA-RGD-bombesin and (64)Cu-DOTA-RGD-bombesin had comparable dual integrin alpha(v)beta(3)- and GRPR-binding affinities in vitro, both of which were slightly lower than RGD for integrin binding and bombesin for GRPR binding. (64)Cu-NOTA-RGD-bombesin possessed significantly higher tumor uptake than did (64)Cu-NOTA-RGD, (64)Cu-NOTA-bombesin, the mixture of (64)Cu-NOTA-RGD and (64)Cu-NOTA-bombesin, or (64)Cu-DOTA-RGD-bombesin in PC-3 prostate cancer. (64)Cu-NOTA-RGD-bombesin also showed improved in vivo kinetics such as lower liver and intestinal activity accumulation than did the bombesin tracers. (64)Cu-NOTA-RGD-bombesin also outperformed (64)Cu-NOTA-RGD in a 4T1 murine mammary carcinoma model that expresses integrin on tumor vasculature but no GRPR in tumor tissue, which had no uptake of (64)Cu-NOTA-bombesin. CONCLUSION: Compared with other tracers, (64)Cu-NOTA-RGD-bombesin showed favorable in vivo kinetics and enhanced tumor uptake, which warrants its further investigation for targeting tumors that express integrin or GRPR or that coexpress integrin and GRPR for imaging and therapeutic applications. The synergistic effect of RGD-bombesin heterodimers observed in this study also encourages further investigations of novel heterodimers recognizing other cell surface receptors for tumor targeting.</abstract><notes>Liu, Zhaofei&#xD;Li, Zi-Bo&#xD;Cao, Qizhen&#xD;Liu, Shuanglong&#xD;Wang, Fan&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 120188/PHS HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2009 Jul;50(7):1168-77. Epub 2009 Jun 12.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.282</custom4><electronic-resource-num>jnumed.108.061739 [pii]&#xD;10.2967/jnumed.108.061739 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2036</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2036</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Berezin, M. Y.</author><author>Guo, K.</author><author>Teng, B.</author><author>Edwards, W. B.</author><author>Anderson, C. J.</author><author>Vasalatiy, O.</author><author>Gandjbakhche, A.</author><author>Griffiths, G. L.</author><author>Achilefu, S.</author></authors></contributors><auth-address>Department of Radiology, Washington University School of Medicine, 4525 Scott Avenue, St. Louis, Missouri 63110, USA.</auth-address><titles><title>Radioactivity-synchronized fluorescence enhancement using a radionuclide fluorescence-quenched dye</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9198-200</pages><volume>131</volume><number>26</number><edition>2009/06/12</edition><dates><year>2009</year><pub-dates><date>Jul 8</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>19514722</accession-num><abstract>We demonstrate the first evidence of radioactivity-synchronized fluorescence quenching of a near-infrared light-emitting dye by a radionuclide, (64)Cu, and subsequent fluorescence enhancement upon (64)Cu decay to the daughter isotopes (64)Ni and (64)Zn. The dynamic switch from high radioactivity and low fluorescence to low radioactivity and high fluorescence is potentially useful for developing complementary multimodal imaging and detection platforms for chemical, environmental, and biomedical applications as well as for unraveling the mechanisms of metal-induced dynamic fluorescence changes.</abstract><notes>Berezin, Mikhail Y&#xD;Guo, Kevin&#xD;Teng, Bao&#xD;Edwards, W Barry&#xD;Anderson, Carolyn J&#xD;Vasalatiy, Olga&#xD;Gandjbakhche, Amir&#xD;Griffiths, Gary L&#xD;Achilefu, Samuel&#xD;R01 CA109754/CA/NCI NIH HHS/United States&#xD;R33 CA100972/CA/NCI NIH HHS/United States&#xD;R33 CA123537/CA/NCI NIH HHS/United States&#xD;U54 CA119342/CA/NCI NIH HHS/United States&#xD;U54 CA136398/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, N.I.H., Intramural&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2009 Jul 8;131(26):9198-200.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom2>2715832</custom2><custom3>2009</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja903685b [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1511</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1511</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Peters, D.</author><author>Kastantin, M.</author><author>Kotamraju, V. R.</author><author>Karmali, P. P.</author><author>Gujraty, K.</author><author>Tirrell, M.</author><author>Ruoslahti, E.</author></authors></contributors><auth-address>Vascular Mapping Center, Burnham Institute for Medical Research, University of California, Santa Barbara, 3119 Biology II Building, CA 93106-9610, USA.</auth-address><titles><title>Targeting atherosclerosis by using modular, multifunctional micelles</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>9815-9</pages><volume>106</volume><number>24</number><edition>2009/06/03</edition><dates><year>2009</year><pub-dates><date>Jun 16</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>19487682</accession-num><abstract>Subtle clotting that occurs on the luminal surface of atherosclerotic plaques presents a novel target for nanoparticle-based diagnostics and therapeutics. We have developed modular multifunctional micelles that contain a targeting element, a fluorophore, and, when desired, a drug component in the same particle. Targeting atherosclerotic plaques in ApoE-null mice fed a high-fat diet was accomplished with the pentapeptide cysteine-arginine-glutamic acid-lysine-alanine, which binds to clotted plasma proteins. The fluorescent micelles bind to the entire surface of the plaque, and notably, concentrate at the shoulders of the plaque, a location that is prone to rupture. We also show that the targeted micelles deliver an increased concentration of the anticoagulant drug hirulog to the plaque compared with untargeted micelles.</abstract><notes>Peters, David&#xD;Kastantin, Mark&#xD;Kotamraju, Venkata Ramana&#xD;Karmali, Priya P&#xD;Gujraty, Kunal&#xD;Tirrell, Matthew&#xD;Ruoslahti, Erkki&#xD;1S10RR017753/RR/NCRR NIH HHS/United States&#xD;HL070818/HL/NHLBI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9815-9. Epub 2009 Jun 1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19487682</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom2>2689312</custom2><custom4>10.228</custom4><electronic-resource-num>0903369106 [pii]&#xD;10.1073/pnas.0903369106</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2483</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2483</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Macfarlane, Robert J.</author><author>Lee, Byeongdu</author><author>Hill, Haley D.</author><author>Senesi, Andrew J.</author><author>Seifert, Soenke</author><author>Mirkin, Chad A.</author></authors></contributors><titles><title>Assembly and organization processes in DNA-directed colloidal crystallization</title><secondary-title>Proceedings of the National Academy of Sciences</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences</full-title></periodical><pages>10493-10498</pages><volume>106</volume><number>26</number><edition>2009/06</edition><dates><year>2009</year><pub-dates><date>June 30, 2009</date></pub-dates></dates><abstract>We present an analysis of the key steps involved in the DNA-directed assembly of nanoparticles into crystallites and polycrystalline aggregates. Additionally, the rate of crystal growth as a function of increased DNA linker length, solution temperature, and self-complementary versus non-self-complementary DNA linker strands (1- versus 2-component systems) has been studied. The data show that the crystals grow via a 3-step process: an initial random binding phase resulting in disordered DNA-AuNP aggregates, followed by localized reorganization and subsequent growth of crystalline domain size, where the resulting crystals are well-ordered at all subsequent stages of growth.</abstract><urls><related-urls><url>http://www.pnas.org/content/106/26/10493.abstract</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>10.228</custom4><electronic-resource-num>10.1073/pnas.0900630106</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2455</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2455</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Braunschweig, Adam B.</author><author>Huo, Fengwei</author><author>Mirkin, Chad A.</author></authors></contributors><titles><title>Molecular printing</title><secondary-title>Nat Chem</secondary-title></titles><periodical><full-title>Nat Chem</full-title></periodical><pages>353-358</pages><volume>1</volume><number>5</number><edition>2009/06</edition><dates><year>2009</year></dates><publisher>Nature Publishing Group</publisher><isbn>1755-4330</isbn><notes>10.1038/nchem.258</notes><urls><related-urls><url>http://dx.doi.org/10.1038/nchem.258</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>na</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1800</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1800</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fent, G. M.</author><author>Casteel, S. W.</author><author>Kim, D. Y.</author><author>Kannan, R.</author><author>Katti, K.</author><author>Chanda, N.</author></authors></contributors><auth-address>Department of Veterinary Pathobiology, University of Missouri, Columbia, Missouri, USA. fentg@missouri.edu</auth-address><titles><title>Biodistribution of maltose and gum arabic hybrid gold nanoparticles after intravenous injection in juvenile swine</title><secondary-title>Nanomedicine</secondary-title></titles><periodical><full-title>Nanomedicine</full-title></periodical><pages>128-35</pages><volume>5</volume><number>2</number><edition>2009/05/30</edition><dates><year>2009</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1549-9642 (Electronic)</isbn><accession-num>19480048</accession-num><abstract>This article describes several experiments performed to test our hypothesis that the agent used to coat/stabilize gold nanoparticles (AuNPs) will act to direct the AuNPs to specific tissues within the body and that changing the coating will change the target organ. Samples were also collected for pathological examination. Gum arabic- (GA) and maltose- (MALT) stabilized AuNPs were administered intravenously to juvenile swine, and blood, tissue, and urine samples were collected for gold analysis. Our results indicate that differences do exist between the two NP constructs tested, with 50% or greater of the total gold dose being found in the liver or lung for the GA- and MALT-stabilized AuNPs, respectively. These findings indicate that the functional unit used to coat/stabilize the AuNPs has an important role in determining the tissue distribution profile for individual AuNP constructs.</abstract><notes>Fent, Genevieve M&#xD;Casteel, Stan W&#xD;Kim, Dae Young&#xD;Kannan, Raghuraman&#xD;Katti, Kavita&#xD;Chanda, Nripen&#xD;Katti, Kattesh&#xD;5R01CA119412-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Nanomedicine : nanotechnology, biology, and medicine&#xD;Nanomedicine. 2009 Jun;5(2):128-35.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19480048</url></related-urls></urls><custom1>CNPP - U. of Miss.</custom1><custom4>6.093</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1819</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1819</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dextras, P.</author><author>Burg, T. P.</author><author>Manalis, S. R.</author></authors></contributors><auth-address>Department of Biological Engineering, Massachusetts Institute of Technology, 20 Ames Street, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Integrated measurement of the mass and surface charge of discrete microparticles using a suspended microchannel resonator</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>4517-23</pages><volume>81</volume><number>11</number><edition>2009/05/30</edition><dates><year>2009</year><pub-dates><date>Jun 1</date></pub-dates></dates><isbn>1520-6882 (Electronic)</isbn><accession-num>19476391</accession-num><abstract>Measurements of the mass and surface charge of microparticles are employed in the characterization of many types of colloidal dispersions. The suspended microchannel resonator (SMR) is capable of measuring individual particle masses with femtogram resolution. Here, we employ the high sensitivity of the SMR resonance frequency to changes in particle position, relative to the cantilever tip, to determine the electrophoretic mobility of discrete particles in an applied electric field. When a sinusoidal electric field is applied to the suspended microchannel, the transient resonance frequency shift corresponding to a particle transit can be analyzed by digital signal processing to extract both the buoyant mass and electrophoretic mobility of each particle. These parameters, together with the mean particle density, can be used to compute the size, absolute mass, and surface charge of discrete microspheres, leading to a true representation of the mean and polydispersity of these quantities for a population. We have applied this technique to an aqueous suspension of two types of polystyrene microspheres, to differentiate them based on their absolute mass and their surface charge. The integrated measurement of electrophoretic mobility using the SMR is determined to be quantitative, based on comparison with commercial instruments, and exhibits favorable scaling properties that will ultimately enable measurements from mammalian cells.</abstract><notes>Dextras, Philip&#xD;Burg, Thomas P&#xD;Manalis, Scott R&#xD;R01-CA119402/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2009 Jun 1;81(11):4517-23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19476391</url></related-urls></urls><custom1>CNPP - MIT</custom1><custom4>5.918</custom4><electronic-resource-num>10.1021/ac9005149</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1837</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1837</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yong, K. T.</author><author>Roy, I.</author><author>Ding, H.</author><author>Bergey, E. J.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics, and Biophotonics Department of Chemistry University at Buffalo The State University of New York Buffalo, NY 14260-4200 (USA).</auth-address><titles><title>Biocompatible Near-Infrared Quantum Dots as Ultrasensitive Probes for Long-Term in vivo Imaging Applications</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><edition>2009/05/26</edition><dates><year>2009</year><pub-dates><date>May 22</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>19466710</accession-num><abstract>A facile synthesis method to produce monodisperse, biocompatible, lysine crosslinked mercaptoundecanoic acid (MUA) CdSe(0.25)Te(0.75)/CdS near-infrared (NIR) quantum dots and use them as probes to study their long term in vivo distribution, clearance, and toxicity is presented. Large signal enhancements are demonstrated by these quantum dots, which enables their use as efficient and sensitive probes for live-animal imaging. An important finding is that mice intravenously injected with approximately 10.5 mg kg(-1) of NIR QDs survive for more than three months without any apparent adverse effect to their health. Furthermore, it is determined that there is a significant reduction in the number of the QDs in the liver and spleen three months post injection. In addition, histological analysis of heart, kidney, liver, spleen, and lung tissue indicates that there are no acute toxic effects from these lysine cross-linked MUA NIR QDs. This study suggests that these NIR QDs can be potentially used for long-term targeted imaging and therapy studies in vivo.</abstract><notes>Journal article&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2009 May 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19466710</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200900547</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2277</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2277</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCarthy, J. R.</author><author>Patel, P.</author><author>Botnaru, I.</author><author>Haghayeghi, P.</author><author>Weissleder, R.</author><author>Jaffer, F. A.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Harvard Medical School, Massachusetts General Hospital, 149 13th Street, Room 5406, Charlestown, Massachusetts 02129, USA. jason_mccarthy@hms.harvard.edu</auth-address><titles><title>Multimodal nanoagents for the detection of intravascular thrombi</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>1251-5</pages><volume>20</volume><number>6</number><edition>2009/05/22</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Blood Coagulation</keyword><keyword>Blood Vessels/ pathology</keyword><keyword>Factor XIIIa/metabolism</keyword><keyword>Fibrin/metabolism</keyword><keyword>Fluorescence</keyword><keyword>Humans</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>Nanostructures/ diagnostic use</keyword><keyword>Peptides/ chemistry/ diagnostic use/metabolism</keyword><keyword>Thrombosis/blood/ diagnosis/metabolism/pathology</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1520-4812 (Electronic)</isbn><accession-num>19456115</accession-num><abstract>Thrombosis underlies numerous life-threatening cardiovascular syndromes. Development of thrombosis-specific molecular imaging agents to detect and monitor thrombogenesis and fibrinolysis in vivo could improve the diagnosis, risk stratification, and treatment of thrombosis syndromes. To this end, we have synthesized efficient multimodal nanoagents targeted to two different constituents of thrombi, namely, fibrin and activated factor XIII. These agents are targeted via the conjugation of peptide-targeting ligands to the surface of fluorescently labeled magnetic nanoparticles. As demonstrated by in vitro and in vivo studies, both nanoagents possess high affinities for thrombi, and enable mutimodal fluorescence and magnetic resonance imaging.</abstract><notes>McCarthy, Jason R&#xD;Patel, Purvish&#xD;Botnaru, Ion&#xD;Haghayeghi, Pouneh&#xD;Weissleder, Ralph&#xD;Jaffer, Farouc A&#xD;U01 HL080731-04/HL/NHLBI NIH HHS/United States&#xD;U01-HL080731/HL/NHLBI NIH HHS/United States&#xD;U24 CA092782-08/CA/NCI NIH HHS/United States&#xD;U24-CA092782/CA/NCI NIH HHS/United States&#xD;U54 CA119349-040003/CA/NCI NIH HHS/United States&#xD;U54 CA126515-040002/CA/NCI NIH HHS/United States&#xD;U54-CA119349/CA/NCI NIH HHS/United States&#xD;UU54-CA126515/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2009 Jun;20(6):1251-5.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2733224</custom2><custom3>NIHMS130310</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/bc9001163 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2358</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2358</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, X.</author><author>Li, J.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Emory University, 101 Woodruff Circle Suite 2001, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Stimuli-responsive SERS nanoparticles: conformational control of plasmonic coupling and surface Raman enhancement</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>7540-1</pages><volume>131</volume><number>22</number><edition>2009/05/21</edition><keywords><keyword>Colloids/chemistry</keyword><keyword>Gold/ chemistry</keyword><keyword>Metal Nanoparticles/ chemistry</keyword><keyword>Molecular Conformation</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Polymethacrylic Acids/chemistry</keyword><keyword>Spectrum Analysis, Raman/ methods</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun 10</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>19453179</accession-num><abstract>Stimuli-responsive surface-enhanced Raman scattering (SERS) nanoparticles have been developed by using colloidal gold nanocrystals and a class of thiolated block copolymers consisting of a pH-responsive polymer segment, an amphiphilic polyethylene glycol segment, and a lipoic acid anchoring group. The results demonstrate that SERS signals can be switched on and off by molecular conformations in response to pH. An important finding is that neutralized polymethacrylic acid (PMAA) molecules are able to interact with amphiphilic polyethylene glycol (PEG) chains, leading to highly compact and intermingled copolymer structures on the surface of nanoparticles. This type of molecular conformation change provides a new strategy for controlling plasmonic coupling and electromagnetic Raman enhancement and raises the possibility of using SERS nanoparticle tags for biomolecular binding and enzymatic cleavage studies.</abstract><notes>Qian, Ximei&#xD;Li, Jun&#xD;Nie, Shuming&#xD;P20 GM072069/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-01/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-02/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-03/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-04/GM/NIGMS NIH HHS/United States&#xD;R01 CA108468/CA/NCI NIH HHS/United States&#xD;R01 CA108468-01/CA/NCI NIH HHS/United States&#xD;R01 CA108468-02/CA/NCI NIH HHS/United States&#xD;R01 CA108468-03/CA/NCI NIH HHS/United States&#xD;R01 CA108468-04/CA/NCI NIH HHS/United States&#xD;R01 CA108468-05/CA/NCI NIH HHS/United States&#xD;U01HL080711/HL/NHLBI NIH HHS/United States&#xD;U54 CA119338-01/CA/NCI NIH HHS/United States&#xD;U54 CA119338-02/CA/NCI NIH HHS/United States&#xD;U54 CA119338-03/CA/NCI NIH HHS/United States&#xD;U54 CA119338-04/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2009 Jun 10;131(22):7540-1.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom2>2703497</custom2><custom3>NIHMS118288</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja902226z [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1585</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1585</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shu, C.</author><author>Corwin, F. D.</author><author>Zhang, J.</author><author>Chen, Z.</author><author>Reid, J. E.</author><author>Sun, M.</author><author>Xu, W.</author><author>Sim, J. H.</author><author>Wang, C.</author><author>Fatouros, P. P.</author><author>Esker, A. R.</author><author>Gibson, H. W.</author><author>Dorn, H. C.</author></authors></contributors><auth-address>Chemistry Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA.</auth-address><titles><title>Facile preparation of a new gadofullerene-based magnetic resonance imaging contrast agent with high 1H relaxivity</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>1186-93</pages><volume>20</volume><number>6</number><edition>2009/05/19</edition><dates><year>2009</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1520-4812 (Electronic)</isbn><accession-num>19445504</accession-num><abstract>A new magnetic resonance imaging (MRI) contrast agent based on the trimetallic nitride templated (TNT) metallofullerene Gd(3)N@C(80) was synthesized by a facile method in high yield. The observed longitudinal and transverse relaxivities r(1) and r(2) for water hydrogens in the presence of the water-soluble gadofullerene 2 Gd(3)N@C(80)(OH)(approximately 26)(CH(2)CH(2)COOM)(approximately 16) (M = Na or H) are 207 and 282 mM(-1) s(-1) (per C(80) cage) at 2.4 T, respectively; these values are 50 times larger than those of Gd(3+) poly(aminocarboxylate) complexes, such as commercial Omniscan and Magnevist. This high (1)H relaxivity for this new hydroxylated and carboxylated gadofullerene derivative provides high signal enhancement at significantly lower Gd concentration as demonstrated by in vitro and in vivo MRI studies. Dynamic light scattering data reveal a unimodal size distribution with an average hydrodynamic radius of ca. 78 nm in pure water (pH = 7), which is significantly different from other hydroxylated or carboxylated fullerene and metallofullerene derivatives reported to date. Agarose gel infusion results indicate that the gadofullerene 2 displayed diffusion properties different from those of commercial Omniscan and those of PEG5000 modified Gd(3)N@C(80). The reactive carboxyl functionality present on this highly efficient contrast agent may also serve as a precursor for biomarker tissue-targeting purposes.</abstract><notes>Shu, Chunying&#xD;Corwin, Frank D&#xD;Zhang, Jianfei&#xD;Chen, Zhijian&#xD;Reid, Jonathan E&#xD;Sun, Minghao&#xD;Xu, Wei&#xD;Sim, Jae Hyun&#xD;Wang, Chunru&#xD;Fatouros, Panos P&#xD;Esker, Alan R&#xD;Gibson, Harry W&#xD;Dorn, Harry C&#xD;1R01-CA119371/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2009 Jun;20(6):1186-93.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19445504</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom4>4.802</custom4><electronic-resource-num>10.1021/bc900051d</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1873</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1873</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pulsipher, A.</author><author>Westcott, N. P.</author><author>Luo, W.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Rapid in situ generation of two patterned chemoselective surface chemistries from a single hydroxy-terminated surface using controlled microfluidic oxidation</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>7626-32</pages><volume>131</volume><number>22</number><edition>2009/05/19</edition><keywords><keyword>Alcohols/*chemistry</keyword><keyword>Aldehydes/chemistry</keyword><keyword>Amides/chemistry</keyword><keyword>Carboxylic Acids/chemistry</keyword><keyword>Electrochemical Techniques</keyword><keyword>Microfluidic Analytical Techniques/*methods</keyword><keyword>Microscopy, Atomic Force</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Oxidation-Reduction</keyword><keyword>Oximes/chemistry</keyword><keyword>Phosphonic Acids/*chemistry</keyword><keyword>Tin Compounds/chemistry</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun 10</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>19445524</accession-num><abstract>In this work, we develop a new, rapid and inexpensive method to generate spatially controlled aldehyde and carboxylic acid surface groups by microfluidic oxidation of 11-hydroxyundecylphosphonic acid self-assembled monolayers (SAMs) on indium tin oxide (ITO) surfaces. SAMs are activated and patterned using a reversibly sealable, elastomeric polydimethylsiloxane cassette, fabricated with preformed micropatterns by soft lithography. By flowing the mild oxidant pyridinium chlorochromate through the microchannels, only selected areas of the SAM are chemically altered. This microfluidic oxidation strategy allows for ligand immobilization by two chemistries originating from a single SAM composition. ITO is robust, conductive, and transparent, making it an ideal platform for studying interfacial interactions. We display spatial control over the immobilization of a variety of ligands on ITO and characterize the resulting oxime and amide linkages by electrochemistry, X-ray photoelectron spectroscopy, contact angle, fluorescence microscopy, and atomic force microscopy. This general method may be used with many other materials to rapidly generate patterned and tailored surfaces for studies ranging from molecular electronics to biospecific cell-based assays and biomolecular microarrays.</abstract><notes>Pulsipher, Abigail&#xD;Westcott, Nathan P&#xD;Luo, Wei&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2009 Jun 10;131(22):7626-32.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19445524</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja809380e</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2276</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2276</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Daniel, K. D.</author><author>Kim, G. Y.</author><author>Vassiliou, C. C.</author><author>Galindo, M.</author><author>Guimaraes, A. R.</author><author>Weissleder, R.</author><author>Charest, A.</author><author>Langer, R.</author><author>Cima, M. J.</author></authors></contributors><auth-address>Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Implantable diagnostic device for cancer monitoring</title><secondary-title>Biosens Bioelectron</secondary-title></titles><periodical><full-title>Biosens Bioelectron</full-title></periodical><pages>3252-7</pages><volume>24</volume><number>11</number><edition>2009/05/16</edition><keywords><keyword>Animals</keyword><keyword>Biosensing Techniques/ instrumentation</keyword><keyword>Cell Line, Tumor</keyword><keyword>Choriocarcinoma/ immunology/ mortality/pathology</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Female</keyword><keyword>Immunoassay/ instrumentation</keyword><keyword>Magnetics/ instrumentation</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Monitoring, Ambulatory/ instrumentation</keyword><keyword>Prostheses and Implants</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Tumor Markers, Biological/ analysis/immunology</keyword></keywords><dates><year>2009</year><pub-dates><date>Jul 15</date></pub-dates></dates><isbn>1873-4235 (Electronic)</isbn><accession-num>19442510</accession-num><abstract>Biopsies provide required information to diagnose cancer but, because of their invasiveness, they are difficult to use for managing cancer therapy. The ability to repeatedly sample the local environment for tumor biomarker, chemotherapeutic agent, and tumor metabolite concentrations could improve early detection of metastasis and personalized therapy. Here we describe an implantable diagnostic device that senses the local in vivo environment. This device, which could be left behind during biopsy, uses a semi-permeable membrane to contain nanoparticle magnetic relaxation switches. A cell line secreting a model cancer biomarker produced ectopic tumors in mice. The transverse relaxation time (T(2)) of devices in tumor-bearing mice was 20+/-10% lower than devices in control mice after 1 day by magnetic resonance imaging (p&lt;0.01). Short term applications for this device are numerous, including verification of successful tumor resection. This may represent the first continuous monitoring device for soluble cancer biomarkers in vivo.</abstract><notes>Daniel, Karen D&#xD;Kim, Grace Y&#xD;Vassiliou, Christophoros C&#xD;Galindo, Marilyn&#xD;Guimaraes, Alexander R&#xD;Weissleder, Ralph&#xD;Charest, Al&#xD;Langer, Robert&#xD;Cima, Michael J&#xD;5 U54 CA119349-12/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Biosensors &amp; bioelectronics&#xD;Biosens Bioelectron. 2009 Jul 15;24(11):3252-7. Epub 2009 Apr 16.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2738970</custom2><custom3>NIHMS127321</custom3><custom4>5.330</custom4><electronic-resource-num>S0956-5663(09)00211-5 [pii]&#xD;10.1016/j.bios.2009.04.010 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2399</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2399</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zanuy, D.</author><author>Flores-Ortega, A.</author><author>Jimenez, A. I.</author><author>Calaza, M. I.</author><author>Cativiela, C.</author><author>Nussinov, R.</author><author>Ruoslahti, E.</author><author>Aleman, C.</author></authors></contributors><auth-address>Departament d&apos;Enginyeria Quimica, E. T. S. d&apos;Enginyeria Industrial de Barcelona, Universitat Politecnica de Catalunya, Diagonal 647, Barcelona E-08028, Spain.</auth-address><titles><title>In silico molecular engineering for a targeted replacement in a tumor-homing peptide</title><secondary-title>J Phys Chem B</secondary-title></titles><periodical><full-title>J Phys Chem B</full-title></periodical><pages>7879-89</pages><volume>113</volume><number>22</number><edition>2009/05/13</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Amino Acid Substitution</keyword><keyword>Arginine/ chemistry</keyword><keyword>Computer Simulation</keyword><keyword>Guanidine/chemistry</keyword><keyword>Models, Molecular</keyword><keyword>Oligopeptides/ chemistry</keyword><keyword>Proline/ chemistry</keyword><keyword>Protein Conformation</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun 4</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>19432404</accession-num><abstract>A new amino acid has been designed as a replacement for arginine (Arg, R) to protect the tumor-homing pentapeptide CREKA (Cys-Arg-Glu-Lys-Ala) from proteases. This amino acid, denoted (Pro)hArg, is characterized by a proline skeleton bearing a specifically oriented guanidinium side chain. This residue combines the ability of Pro to induce turn-like conformations with the Arg side-chain functionality. The conformational profile of the CREKA analogue incorporating this Arg substitute has been investigated by a combination of simulated annealing and molecular dynamics. Comparison of the results with those previously obtained for the natural CREKA shows that (Pro)hArg significantly reduces the conformational flexibility of the peptide. Although some changes are observed in the backbone...backbone and side-chain...side-chain interactions, the modified peptide exhibits a strong tendency to accommodate turn conformations centered at the (Pro)hArg residue and the overall shape of the molecule in the lowest energy conformations characterized for the natural and the modified peptides exhibit a high degree of similarity. In particular, the turn orients the backbone such that the Arg, Glu, and Lys side chains face the same side of the molecule, which is considered important for bioactivity. These results suggest that replacement of Arg by (Pro)hArg in CREKA may be useful in providing resistance against proteolytic enzymes while retaining conformational features which are essential for tumor-homing activity.</abstract><notes>Zanuy, David&#xD;Flores-Ortega, Alejandra&#xD;Jimenez, Ana I&#xD;Calaza, M Isabel&#xD;Cativiela, Carlos&#xD;Nussinov, Ruth&#xD;Ruoslahti, Erkki&#xD;Aleman, Carlos&#xD;CA 119335/CA/NCI NIH HHS/United States&#xD;CA124427/CA/NCI NIH HHS/United States&#xD;N01-CO-12400/CO/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2009 Jun 4;113(22):7879-89.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom2>2734192</custom2><custom3>NIHMS116797</custom3><custom4>4.688</custom4><electronic-resource-num>10.1021/jp9006119 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2449</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2449</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, C.</author><author>Zhu, Y.</author><author>Xie, Z.</author><author>Qian, W.</author><author>Hsieh, C. L.</author><author>Nie, S.</author><author>Su, Y.</author><author>Zhau, H. E.</author><author>Chung, L. W.</author></authors></contributors><auth-address>Department of Urology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Visualizing human prostate cancer cells in mouse skeleton using bioconjugated near-infrared fluorescent quantum dots</title><secondary-title>Urology</secondary-title></titles><periodical><full-title>Urology</full-title></periodical><pages>446-51</pages><volume>74</volume><number>2</number><edition>2009/05/12</edition><keywords><keyword>Animals</keyword><keyword>Bone Neoplasms/*diagnosis/*secondary</keyword><keyword>Cell Line, Tumor</keyword><keyword>Fluorescent Dyes/*diagnostic use</keyword><keyword>Humans</keyword><keyword>Injections, Intravenous</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Prostate-Specific Antigen/immunology/metabolism</keyword><keyword>Prostatic Neoplasms/*pathology</keyword><keyword>*Quantum Dots</keyword><keyword>Spectroscopy, Near-Infrared</keyword><keyword>Tibia</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2009</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1527-9995 (Electronic)</isbn><accession-num>19428067</accession-num><abstract>OBJECTIVES: To visualize human prostate cancer cells in mouse bone with bioconjugated near-infrared quantum dot (QD) probes. Near-infrared fluorescent probes using QDs can visualize tumors in deep tissues in vivo. METHODS: Human prostate cancer C4-2B xenografts grown in mouse tibia were detected by prostate-specific membrane antigen antibody conjugated with QDs emitting light at the near-infrared range of 800 nm (QD800). Images in culture and in vivo were acquired using the IVIS Imaging System. RESULTS: As few as 5000 cells can be detected subcutaneously when tagged with QD800 conjugate and injected directly into mice. QD800 conjugate injected intravenously in mice harboring C4-2B tumors in tibia detected signals from a minimum of 500 000 cells. The maximal light emission was detected 30 minutes after intravenous injection of QD800 conjugate in mice with established C4-2B tumors. CONCLUSIONS: Bioconjugated near-infrared QD probes are highly sensitive molecular imaging tools for human prostate cancer micrometastases in mice.</abstract><notes>Shi, Chunmeng&#xD;Zhu, Ying&#xD;Xie, Zhihui&#xD;Qian, Weiping&#xD;Hsieh, Chia-Ling&#xD;Nie, Shuming&#xD;Su, Yongping&#xD;Zhau, Haiyen E&#xD;Chung, Leland W K&#xD;P01 CA098912/CA/NCI NIH HHS/United States&#xD;R01 CA108468/CA/NCI NIH HHS/United States&#xD;R01 GM60562/GM/NIGMS NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Urology&#xD;Urology. 2009 Aug;74(2):446-51. Epub 2009 May 9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19428067</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>2.604</custom4><electronic-resource-num>S0090-4295(09)00122-8 [pii]&#xD;10.1016/j.urology.2009.01.023</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2152</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2152</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huang, Z.</author><author>Jaafari, M. R.</author><author>Szoka, F. C., Jr.</author></authors></contributors><auth-address>Department of Bioengineering and Therapeutic Sciences, University of California at San Francisco, San Francisco, CA 94143-0912, USA.</auth-address><titles><title>Disterolphospholipids: nonexchangeable lipids and their application to liposomal drug delivery</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>4146-9</pages><volume>48</volume><number>23</number><edition>2009/05/09</edition><keywords><keyword>Animals</keyword><keyword>Antibiotics, Antineoplastic/administration &amp; dosage/pharmacology</keyword><keyword>Doxorubicin/administration &amp; dosage/pharmacokinetics</keyword><keyword>Drug Delivery Systems</keyword><keyword>Liposomes/ chemistry</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Molecular Structure</keyword><keyword>Phospholipids/chemical synthesis/ chemistry</keyword></keywords><dates><year>2009</year></dates><isbn>1521-3773 (Electronic)</isbn><accession-num>19425026</accession-num><abstract>Extreme makeover of cholesterol: Cholesterol exchange is a major reason for the instability of liposomes in blood. The formation of a covalent hybrid between cholesterol and glycerophosphocholine preserves the bilayer-stabilizing effect of free cholesterol but prevents its transfer from the bilayer. Thus, disterolphospholipids (e.g. 1) are valuable new components for liposome formulation.</abstract><notes>Huang, Zhaohua&#xD;Jaafari, Mahmoud Reza&#xD;Szoka, Francis C Jr&#xD;CA119343/CA/NCI NIH HHS/United States&#xD;EB003008/EB/NIBIB NIH HHS/United States&#xD;GM61851/GM/NIGMS NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2009;48(23):4146-9.</notes><urls></urls><custom1>CCNE - UNC</custom1><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200900111 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2275</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2275</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Choi, H. S.</author><author>Ipe, B. I.</author><author>Misra, P.</author><author>Lee, J. H.</author><author>Bawendi, M. G.</author><author>Frangioni, J. V.</author></authors></contributors><auth-address>Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.</auth-address><titles><title>Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>2354-9</pages><volume>9</volume><number>6</number><edition>2009/05/09</edition><keywords><keyword>Animals</keyword><keyword>Kidney/metabolism</keyword><keyword>Liver/metabolism</keyword><keyword>Lymph Nodes/metabolism</keyword><keyword>Nanomedicine</keyword><keyword>Pancreas/metabolism</keyword><keyword>Polyethylene Glycols/metabolism</keyword><keyword>Quantum Dots</keyword><keyword>Rats</keyword><keyword>Rats, Sprague-Dawley</keyword><keyword>Spectroscopy, Near-Infrared</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1530-6992 (Electronic)</isbn><accession-num>19422261</accession-num><abstract>A significant portion of the field of nanomedicine is predicated on being able to target nanoparticles to sites of disease. However, in vivo biodistribution and clearance of nanoparticles are poorly understood. In this study, a novel formulation of near-infrared fluorescent InAs(ZnS) quantum dots was synthesized and coated with a systematically increasing chain length of PEG. We found that varying PEG chain length resulted in major changes in organ/tissue-selective biodistribution and clearance from the body.</abstract><notes>Choi, Hak Soo&#xD;Ipe, Binil Itty&#xD;Misra, Preeti&#xD;Lee, Jeong Heon&#xD;Bawendi, Moungi G&#xD;Frangioni, John V&#xD;GM68762/GM/NIGMS NIH HHS/United States&#xD;R01-CA-115296/CA/NCI NIH HHS/United States&#xD;R33-EB-000673/EB/NIBIB NIH HHS/United States&#xD;U54-CA-119349/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2009 Jun;9(6):2354-9.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>12.189</custom4><electronic-resource-num>10.1021/nl900872r [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1757</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1757</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yang, Z.</author><author>Leon, J.</author><author>Martin, M.</author><author>Harder, J. W.</author><author>Zhang, R.</author><author>Liang, D.</author><author>Lu, W.</author><author>Tian, M.</author><author>Gelovani, J. G.</author><author>Qiao, A.</author><author>Li, C.</author></authors></contributors><auth-address>Department of Experimental Diagnostic Imaging, Unit 59, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</auth-address><titles><title>Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles</title><secondary-title>Nanotechnology</secondary-title></titles><periodical><full-title>Nanotechnology</full-title></periodical><pages>165101</pages><volume>20</volume><number>16</number><edition>2009/05/08</edition><keywords><keyword>Animals</keyword><keyword>Biological Availability</keyword><keyword>Fluorescence</keyword><keyword>Injections, Intravenous</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Nanoparticles/*administration &amp; dosage/chemistry</keyword><keyword>Neoplasms/*diagnosis/metabolism</keyword><keyword>Polymers/administration &amp; dosage/*pharmacokinetics</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr 22</date></pub-dates></dates><isbn>1361-6528 (Electronic)</isbn><accession-num>19420561</accession-num><abstract>There has been increased interest in the use of polymeric nanoparticles as carriers for near-infrared fluorescence (NIRF) dyes for cancer diagnosis. However, efficient delivery of nanoparticles to the tumors after systemic administration is limited by various biobarriers. In this study, we investigated the pharmacokinetics, biodistribution, and tumor uptake of sub-nanometer sized polymeric nanoparticles (&lt;100 nm in diameter) coated with polyethylene glycol in tumor-bearing mice. To facilitate our studies, these particles were labeled with gamma emitter indium-111. We found that two NIRF nanoparticles having the same size (approximately 20 nm) and chemical composition but different structures (i.e., hydrogel versus core-shell nanolatex), or the same core-shell nanolatex particles with different sizes (20, 30, and 60 nm), had different blood circulation times, biodistribution, and tumor uptake. Interestingly, the tumor uptake of the nanolatex particles correlated well with their blood residence times (R(2) = 0.95), but similar correlations were not found between nanogel and nanolatex particles (R(2) = 0.05). These results suggest that both the blood circulation time and the extent of hydration of the nanoparticles play an important role in the tumor uptake of nanoparticles. Prolonged blood circulation of these NIRF nanoparticles allowed clear visualization of tumors with gamma-scintigraphy and optical imaging after intravenous administration. A better understanding with regard to how the characteristics of nanoparticles influence their in vivo behavior is an important step towards designing NIRF nanoparticles suitable for molecular imaging applications and for efficient tumor delivery.</abstract><notes>Yang, Zhi&#xD;Leon, Jeffrey&#xD;Martin, Mike&#xD;Harder, John W&#xD;Zhang, Rui&#xD;Liang, Dong&#xD;Lu, Wei&#xD;Tian, Mei&#xD;Gelovani, Juri G&#xD;Qiao, Alex&#xD;Li, Chun&#xD;CA 16672/CA/NCI NIH HHS/United States&#xD;R01 CA119387/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nanotechnology&#xD;Nanotechnology. 2009 Apr 22;20(16):165101. Epub 2009 Mar 31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19420561</url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom4>3.727</custom4><electronic-resource-num>S0957-4484(09)89603-7 [pii]&#xD;10.1088/0957-4484/20/16/165101</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2035</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2035</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pan, D.</author><author>Pramanik, M.</author><author>Senpan, A.</author><author>Yang, X.</author><author>Song, K. H.</author><author>Scott, M. J.</author><author>Zhang, H.</author><author>Gaffney, P. J.</author><author>Wickline, S. A.</author><author>Wang, L. V.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>C-TRAIN and Division of Cardiology, Washington University School of Medicine, 4320 Forest Park Avenue, Saint Louis, MO 63108, USA. dipanjan@wustl.edu</auth-address><titles><title>Molecular photoacoustic tomography with colloidal nanobeacons</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>4170-3</pages><volume>48</volume><number>23</number><edition>2009/05/07</edition><keywords><keyword>Colloids</keyword><keyword>Contrast Media/ chemistry</keyword><keyword>Fibrin/chemistry</keyword><keyword>Gold/ chemistry</keyword><keyword>Humans</keyword><keyword>Metal Nanoparticles/ chemistry</keyword><keyword>Tomography, Optical/ methods</keyword><keyword>Ultrasonography/ methods</keyword><keyword>Vascular Diseases/diagnosis</keyword></keywords><dates><year>2009</year></dates><isbn>1521-3773 (Electronic)</isbn><accession-num>19418503</accession-num><abstract>Spotting clots: Vascularly constrained colloidal gold nanobeacons (GNBs; see picture) can be used as exogenous photoacoustic contrast agents for the targeted detection of fibrin, a major biochemical feature of thrombus. Fibrin-targeted GNBs provide a more than tenfold signal enhancement in photoacoustic tomography in the near-IR wavelength window, indicating their potential for diagnostic imaging.</abstract><notes>Pan, Dipanjan&#xD;Pramanik, Manojit&#xD;Senpan, Angana&#xD;Yang, Xinmai&#xD;Song, Kwang H&#xD;Scott, Mike J&#xD;Zhang, Huiying&#xD;Gaffney, Patrick J&#xD;Wickline, Samuel A&#xD;Wang, Lihong V&#xD;Lanza, Gregory M&#xD;CA119342/CA/NCI NIH HHS/United States&#xD;EB008085/EB/NIBIB NIH HHS/United States&#xD;HL073646/HL/NHLBI NIH HHS/United States&#xD;NS059302/NS/NINDS NIH HHS/United States&#xD;R01EB000712/EB/NIBIB NIH HHS/United States&#xD;R01NS046214/NS/NINDS NIH HHS/United States&#xD;U54 CA136398/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2009;48(23):4170-3.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200805947 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2357</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2357</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Phan, J. H.</author><author>Moffitt, R. A.</author><author>Stokes, T. H.</author><author>Liu, J.</author><author>Young, A. N.</author><author>Nie, S.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 313 Ferst Drive, UA Whitaker Building 4106, Atlanta, GA 30332, USA.</auth-address><titles><title>Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment</title><secondary-title>Trends Biotechnol</secondary-title></titles><periodical><full-title>Trends Biotechnol</full-title></periodical><pages>350-8</pages><volume>27</volume><number>6</number><edition>2009/05/05</edition><keywords><keyword>Antineoplastic Protocols</keyword><keyword>Carcinoma, Renal Cell/diagnosis/drug therapy/therapy</keyword><keyword>Computational Biology</keyword><keyword>Humans</keyword><keyword>Kidney Neoplasms/diagnosis/drug therapy/therapy</keyword><keyword>Knowledge Bases</keyword><keyword>Nanotechnology/ methods</keyword><keyword>Neoplasms/ diagnosis/drug therapy/ therapy</keyword><keyword>Tumor Markers, Biological</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0167-7799 (Print)</isbn><accession-num>19409634</accession-num><abstract>Recent advances in biomarker discovery, biocomputing and nanotechnology have raised new opportunities in the emerging fields of personalized medicine (in which disease detection, diagnosis and therapy are tailored to each individual&apos;s molecular profile) and predictive medicine (in which genetic and molecular information is used to predict disease development, progression and clinical outcome). Here, we discuss advanced biocomputing tools for cancer biomarker discovery and multiplexed nanoparticle probes for cancer biomarker profiling, in addition to the prospects for and challenges involved in correlating biomolecular signatures with clinical outcome. This bio-nano-info convergence holds great promise for molecular diagnosis and individualized therapy of cancer and other human diseases.</abstract><notes>Phan, John H&#xD;Moffitt, Richard A&#xD;Stokes, Todd H&#xD;Liu, Jian&#xD;Young, Andrew N&#xD;Nie, Shuming&#xD;Wang, May D&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;England&#xD;Trends in biotechnology&#xD;Trends Biotechnol. 2009 Jun;27(6):350-8. Epub 2009 May 4.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>8.212</custom4><electronic-resource-num>S0167-7799(09)00073-0 [pii]&#xD;10.1016/j.tibtech.2009.02.010 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2467</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2467</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hasan, Warefta</author><author>Stender, Christopher L.</author><author>Lee, Min Hyung</author><author>Nehl, Colleen L.</author><author>Lee, Jeunghoon</author><author>Teri W. Odom</author></authors></contributors><titles><title>Tailoring the Structure of Nanopyramids for Optimal Heat Generation</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>1555-1558</pages><volume>9</volume><number>4</number><edition>2009/05</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>1530-6984</isbn><notes>doi: 10.1021/nl803647n</notes><urls><related-urls><url>http://dx.doi.org/10.1021/nl803647n</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>12.189</custom4><electronic-resource-num>10.1021/nl803647n</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2461</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2461</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Eifler, Aaron C.</author><author>Lewandowski, Robert J.</author><author>Virmani, Sumeet</author><author>Chung, Johnathan C.</author><author>Wang, Dingxin</author><author>Tang, Richard L.</author><author>Szolc-Kowalska, Barbara</author><author>Woloschak, Gayle E.</author><author>Yang, Guang-Yu</author><author>Ryu, Robert K.</author><author>Salem, Riad</author><author>Larson, Andrew C.</author><author>Cheon, Eric</author><author>Strouch, Matthew</author><author>Bentrem, David J.</author><author>Omary, Reed A.</author></authors></contributors><titles><title>Development of a VX2 Pancreatic Cancer Model in Rabbits: A Pilot Study</title><secondary-title>Journal of Vascular and Interventional Radiology</secondary-title></titles><periodical><full-title>Journal of Vascular and Interventional Radiology</full-title></periodical><pages>1075-1082</pages><volume>20</volume><number>8</number><edition>2009/05</edition><dates><year>2009</year></dates><isbn>1051-0443</isbn><notes>doi: DOI: 10.1016/j.jvir.2009.04.051</notes><urls><related-urls><url>http://www.sciencedirect.com/science/article/B8CX3-4WMKXW9-1/2/a7c9762aec4f8c6922a3667ee32d5759</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>2.956</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2356</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2356</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bao, G.</author><author>Rhee, W. J.</author><author>Tsourkas, A.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332, USA. gang.bao@bme.gatech.edu</auth-address><titles><title>Fluorescent probes for live-cell RNA detection</title><secondary-title>Annu Rev Biomed Eng</secondary-title></titles><periodical><full-title>Annu Rev Biomed Eng</full-title></periodical><pages>25-47</pages><volume>11</volume><edition>2009/04/30</edition><dates><year>2009</year></dates><isbn>1545-4274 (Electronic)</isbn><accession-num>19400712</accession-num><abstract>Commonly used techniques for analyzing gene expression, such as polymerase chain reaction (PCR), microarrays, and in situ hybridization, have proven invaluable in understanding RNA processing and regulation. However, these techniques rely on the use of lysed and/or fixed cells and are therefore limited in their ability to provide important spatial-temporal information. This has led to the development of numerous techniques for imaging RNA in living cells, some of which have already provided important insight into the dynamic role RNA plays in dictating cell behavior. Here we review the fluorescent probes that have allowed for RNA imaging in living cells and discuss their utility and limitations. Common challenges faced by fluorescent probes, such as probe design, delivery, and target accessibility, are also discussed. It is expected that continued advancements in live cell imaging of RNA will open new and exciting opportunities in a wide range of biological and medical applications.</abstract><notes>Bao, Gang&#xD;Rhee, Won Jong&#xD;Tsourkas, Andrew&#xD;CA116102/CA/NCI NIH HHS/United States&#xD;CA119338/CA/NCI NIH HHS/United States&#xD;CA125088/CA/NCI NIH HHS/United States&#xD;HL80711/HL/NHLBI NIH HHS/United States&#xD;R21 CA116102-02/CA/NCI NIH HHS/United States&#xD;R21 CA125088-01/CA/NCI NIH HHS/United States&#xD;R21 CA125088-02/CA/NCI NIH HHS/United States&#xD;U01 HL080711-04/HL/NHLBI NIH HHS/United States&#xD;U01 HL080711-05/HL/NHLBI NIH HHS/United States&#xD;U54 CA119338-040002/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Annual review of biomedical engineering&#xD;Annu Rev Biomed Eng. 2009;11:25-47.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom2>2734976</custom2><custom3>2009</custom3><custom4>13.679</custom4><electronic-resource-num>10.1146/annurev-bioeng-061008-124920 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1957</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1957</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ge, S.</author><author>Shi, X.</author><author>Baker, J. R., Jr.</author><author>Banaszak Holl, M. M.</author><author>Orr, B. G.</author></authors></contributors><auth-address>Department of Physics, University of Michigan, Ann Arbor, MI 48109, USA.</auth-address><titles><title>Development of a remanence measurement-based SQUID system with in-depth resolution for nanoparticle imaging</title><secondary-title>Phys Med Biol</secondary-title></titles><periodical><full-title>Phys Med Biol</full-title></periodical><pages>N177-88</pages><volume>54</volume><number>10</number><edition>2009/04/29</edition><keywords><keyword>Computer-Aided Design</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Image Enhancement/instrumentation</keyword><keyword>Image Interpretation, Computer-Assisted/ instrumentation</keyword><keyword>Imaging, Three-Dimensional/ instrumentation</keyword><keyword>Magnetics/ instrumentation</keyword><keyword>Nanoparticles/ ultrastructure</keyword><keyword>Nephelometry and Turbidimetry/ instrumentation</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2009</year><pub-dates><date>May 21</date></pub-dates></dates><isbn>0031-9155 (Print)</isbn><accession-num>19398816</accession-num><abstract>We present a remanence measurement method using a superconducting quantum interference device (SQUID) to detect trace amounts of magnetic nanoparticles (MNPs). Based on this method, a one-dimensional scanning system was established for imaging. The system was calibrated with 25 nm diameter Fe2O3 nanoparticles (NPs), and the sensitivity of the NPs was found to be 10 ng at a distance of 1.7 cm and the spatial resolution was approximately 1 cm. A theoretical model of this system was developed and applied to the deconvolution of scanned images of phantoms with two NP injection spots. Using the developed SQUID system, we were able to determine not only the amount and horizontal positions of the injections, but also their depths in the phantoms.</abstract><notes>Ge, Song&#xD;Shi, Xiangyang&#xD;Baker, James R Jr&#xD;Banaszak Holl, Mark M&#xD;Orr, Bradford G&#xD;1 R01 CA119409/CA/NCI NIH HHS/United States&#xD;1R01 EB002657/EB/NIBIB NIH HHS/United States&#xD;N01 CO027173/CO/NCI NIH HHS/United States&#xD;N01-CO-27173/CO/NCI NIH HHS/United States&#xD;R01 CA119409-01/CA/NCI NIH HHS/United States&#xD;R01 CA119409-02/CA/NCI NIH HHS/United States&#xD;R01 CA119409-03/CA/NCI NIH HHS/United States&#xD;R01 CA119409-04/CA/NCI NIH HHS/United States&#xD;R01 CA119409-04S1/CA/NCI NIH HHS/United States&#xD;R01 EB002657-01/EB/NIBIB NIH HHS/United States&#xD;R01 EB002657-02/EB/NIBIB NIH HHS/United States&#xD;R01 EB002657-03/EB/NIBIB NIH HHS/United States&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Physics in medicine and biology&#xD;Phys Med Biol. 2009 May 21;54(10):N177-88. Epub 2009 Apr 27.</notes><urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom2>2726008</custom2><custom3>NIHMS125457</custom3><custom4>3.173</custom4><electronic-resource-num>S0031-9155(09)08951-9 [pii]&#xD;10.1088/0031-9155/54/10/N01 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2034</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2034</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Edwards, W. B.</author><author>Akers, W. J.</author><author>Ye, Y.</author><author>Cheney, P. P.</author><author>Bloch, S.</author><author>Xu, B.</author><author>Laforest, R.</author><author>Achilefu, S.</author></authors></contributors><auth-address>Department of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA.</auth-address><titles><title>Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and single-photon emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide</title><secondary-title>Mol Imaging</secondary-title></titles><periodical><full-title>Mol Imaging</full-title></periodical><pages>101-10</pages><volume>8</volume><number>2</number><edition>2009/04/29</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Diagnostic Imaging/ methods</keyword><keyword>Heterocyclic Compounds, 1-Ring</keyword><keyword>Immunohistochemistry</keyword><keyword>Integrin alphaVbeta3/ metabolism</keyword><keyword>Luminescent Agents/diagnostic use</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neoplasms, Experimental/diagnosis/ metabolism/radionuclide imaging</keyword><keyword>Peptides, Cyclic/diagnostic use</keyword><keyword>Protein Binding</keyword><keyword>Radioisotopes</keyword><keyword>Scintillation Counting</keyword><keyword>Spectroscopy, Near-Infrared</keyword><keyword>Tissue Distribution</keyword><keyword>Tomography, Emission-Computed, Single-Photon</keyword></keywords><dates><year>2009</year><pub-dates><date>Mar-Apr</date></pub-dates></dates><isbn>1535-3508 (Print)</isbn><accession-num>19397855</accession-num><abstract>Integrins, particularly the alpha(v)beta(3) heterodimers, play important roles in tumor-induced angiogenesis and invasiveness. To image the expression pattern of the alpha(v)beta(3) integrin in tumors through a multimodality imaging paradigm, we prepared a cyclic RGDyK peptide analogue (LS308) bearing a tetraazamacrocycle 1,4,7,10-tetraazacyclododecane-N,N&apos;,N&apos;&apos;,N&apos;&apos;&apos;-tetraacetic acid (DOTA) and a lipophilic near-infrared (NIR) fluorescent dye cypate. The alpha(v)beta(3) integrin binding affinity and the internalization properties of LS308 mediated by the alpha(v)beta(3) integrin in 4t1luc cells were investigated by receptor binding assay and fluorescence microscopy, respectively. The in vivo distribution of (111)In-labeled LS308 in a 4t1luc tumor-bearing mouse model was studied by fluorescence, bioluminescence, planar gamma, and single-photon emission computed tomography (SPECT). The results show that LS308 has high affinity for alpha(v)beta(3) integrin and internalized preferentially via the alpha(v)beta(3) integrin-mediated endocytosis in 4t1luc cells. We also found that LS308 selectively accumulated in alpha(v)beta(3)-positve tumors in a receptor-specific manner and was visualized by the four imaging methods. Whereas the endogenous bioluminescence imaging identified the ensemble of the tumor tissue, the fluorescence and SPECT methods with the exogenous contrast agent LS308 reported the local expression of alpha(v)beta(3) integrin. Thus, the multimodal imaging approach could provide important complementary diagnostic information for monitoring the efficacy of new antiangiogenic drugs.</abstract><notes>Edwards, W Barry&#xD;Akers, Walter J&#xD;Ye, Yunpeng&#xD;Cheney, Philip P&#xD;Bloch, Sharon&#xD;Xu, Baogang&#xD;Laforest, Richard&#xD;Achilefu, Samuel&#xD;R01 CA109754/CA/NCI NIH HHS/United States&#xD;R33 CA100972/CA/NCI NIH HHS/United States&#xD;U54 CA119342/CA/NCI NIH HHS/United States&#xD;U54CA136398/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular imaging : official journal of the Society for Molecular Imaging&#xD;Mol Imaging. 2009 Mar-Apr;8(2):101-10.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom4>3.329</custom4><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2123</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2123</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chen, K.</author><author>Xie, J.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, Standford, CA 94305-5484, USA.</auth-address><titles><title>RGD-human serum albumin conjugates as efficient tumor targeting probes</title><secondary-title>Mol Imaging</secondary-title></titles><periodical><full-title>Mol Imaging</full-title></periodical><pages>65-73</pages><volume>8</volume><number>2</number><edition>2009/04/29</edition><keywords><keyword>Animals</keyword><keyword>Carbocyanines/metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Disease Models, Animal</keyword><keyword>Half-Life</keyword><keyword>Histocytochemistry</keyword><keyword>Humans</keyword><keyword>Indoles/metabolism</keyword><keyword>Integrin alphaVbeta3/ analysis/metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Molecular Probe Techniques</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neoplasms, Experimental/metabolism/ pathology</keyword><keyword>Peptides, Cyclic/blood/metabolism</keyword><keyword>Protein Binding</keyword><keyword>Serum Albumin/metabolism</keyword><keyword>Spectroscopy, Near-Infrared</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2009</year><pub-dates><date>Mar-Apr</date></pub-dates></dates><isbn>1535-3508 (Print)</isbn><accession-num>19397852</accession-num><abstract>Cyclic arginine-glycine-aspartate (RGD) peptides and their derivatives have been intensively studied as tumor targeting probes. One major drawback, however, is their short blood circulation half-lives, which greatly compromises their targeting efficacy. To address this issue, a cyclic peptide, c(RGDyK), and an organic dye (IRDye800 or Cy5.5) were covalently conjugated onto human serum albumin (HSA). The conjugates were subjected to in vitro cell staining, in vivo near-infrared fluorescence (NIRF) imaging, ex vivo NIRF imaging, and histologic studies to evaluate their feasibility as tumor imaging probes. As a control, RAD peptide was also coupled with HSA and labeled with IRDye800 for in vivo imaging. The HSA-RGD-IRDye800 exhibited integrin alpha(v)beta(3)-specific binding in cell staining experiment. In vivo NIRF imaging showed higher tumor accumulation and tumor to background contrast of HSA-RGD-IRDye800 over RGD-IRDye800. The integrin specificity of HSA-RGD-IRDye800 is confirmed by both successful inhibition of tumor uptake in the presence of c(RGDyK) and the inability to accumulate in integrin-positive tumors by RAD-HSA-IRDye800. Histologic examination revealed initial tumor vascular binding and eventually both tumor vasculature and tumor cell integrin binding in vivo. In summary, we successfully developed an RGD-based protein conjugate with prolonged circulation half-life for NIRF imaging of tumor integrin alpha(v)beta(3) expression. The success of this study may be generalizable for other peptide-based probes to be conjugated with HSA for prolonged tumor contrast and improved pharmacokinetics.</abstract><notes>Chen, Kai&#xD;Xie, Jin&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular imaging : official journal of the Society for Molecular Imaging&#xD;Mol Imaging. 2009 Mar-Apr;8(2):65-73.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>3.329</custom4><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1601</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1601</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Simberg, D.</author><author>Park, J. H.</author><author>Karmali, P. P.</author><author>Zhang, W. M.</author><author>Merkulov, S.</author><author>McCrae, K.</author><author>Bhatia, S. N.</author><author>Sailor, M.</author><author>Ruoslahti, E.</author></authors></contributors><auth-address>Moores UCSD Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093, USA. dsimberg@ucsd.edu</auth-address><titles><title>Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance</title><secondary-title>Biomaterials</secondary-title></titles><periodical><full-title>Biomaterials</full-title></periodical><pages>3926-33</pages><volume>30</volume><number>23-24</number><edition>2009/04/28</edition><dates><year>2009</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1878-5905 (Electronic)</isbn><accession-num>19394687</accession-num><abstract>In order to understand the role of plasma proteins in the rapid liver clearance of dextran-coated superparamagnetic iron oxide (SPIO) in vivo, we analyzed the full repertoire of SPIO-binding blood proteins using novel two-dimensional differential mass spectrometry approach. The identified proteins showed specificity for surface domains of the nanoparticles: mannan-binding lectins bound to the dextran coating, histidine-rich glycoprotein and kininogen bound to the iron oxide part, and the complement lectin and contact clotting factors were secondary binders. Nanoparticle clearance studies in knockout mice suggested that these proteins, as well as several previously identified opsonins, do not play a significant role in the SPIO clearance. However, both the dextran coat and the iron oxide core remained accessible to specific probes after incubation of SPIO in plasma, suggesting that the nanoparticle surface could be available for recognition by macrophages, regardless of protein coating. These data provide guidance to rational design of bioinert, long-circulating nanoparticles.</abstract><notes>Simberg, Dmitri&#xD;Park, Ji-Ho&#xD;Karmali, Priya P&#xD;Zhang, Wan-Ming&#xD;Merkulov, Sergei&#xD;McCrae, Keith&#xD;Bhatia, Sangeeta N&#xD;Sailor, Michael&#xD;Ruoslahti, Erkki&#xD;CA119335/CA/NCI NIH HHS/United States&#xD;CA124427/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Biomaterials&#xD;Biomaterials. 2009 Aug;30(23-24):3926-33. Epub 2009 Apr 26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19394687</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>7.325</custom4><electronic-resource-num>S0142-9612(09)00320-2 [pii]&#xD;10.1016/j.biomaterials.2009.03.056</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2033</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2033</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bai, M. Y.</author><author>Cheng, Y. J.</author><author>Wickline, S. A.</author><author>Xia, Y.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Washington University, Saint Louis, MO 63130, USA.</auth-address><titles><title>Colloidal hollow spheres of conducting polymers with smooth surface and uniform, controllable sizes</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>1747-52</pages><volume>5</volume><number>15</number><edition>2009/04/23</edition><dates><year>2009</year><pub-dates><date>Aug 3</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>19384880</accession-num><notes>Bai, Meng-Yi&#xD;Cheng, Ya-Jian&#xD;Wickline, Samuel A&#xD;Xia, Younan&#xD;CA119342/CA/NCI NIH HHS/United States&#xD;DP1 OD000798/DP/NCCDPHP CDC HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2009 Aug 3;5(15):1747-52.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom3>2009</custom3><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200900447 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2032</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2032</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhou, H. F.</author><author>Chan, H. W.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author><author>Pham, C. T.</author></authors></contributors><auth-address>Division of Rheumatology, Washington University School of Medicine, St. Louis, Missouri, USA.</auth-address><titles><title>Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice</title><secondary-title>FASEB J</secondary-title></titles><periodical><full-title>FASEB J</full-title></periodical><pages>2978-85</pages><volume>23</volume><number>9</number><edition>2009/04/21</edition><dates><year>2009</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1530-6860 (Electronic)</isbn><accession-num>19376816</accession-num><abstract>The purpose of this study was to assess whether an alternative treatment approach that targets angiogenesis, delivered through ligand-targeted nanotherapy, would ameliorate inflammatory arthritis. Arthritis was induced using the K/BxN mouse model of inflammatory arthritis. After arthritis was clearly established, mice received three consecutive daily doses of alpha(v)beta(3)-targeted fumagillin nanoparticles. Control groups received no treatment or alpha(v)beta(3)-targeted nanoparticles without drugs. Disease score and paw thickness were measured daily. Mice that received alpha(v)beta(3)-targeted fumagillin nanoparticles showed a significantly lower disease activity score (mean score of 1.4+/-0.4; P&lt;0.001) and change in ankle thickness (mean increase of 0.17+/-0.05 mm; P&lt;0.001) 7 d after arthritis induction, whereas the group that received alpha(v)beta(3)-targeted nanoparticles without drugs exhibited a mean arthritic score of 9.0 +/- 0.3 and mean change in ankle thickness of 1.01 +/- 0.09 mm. Meanwhile, the group that received no treatment showed a mean arthritic score of 9.8 +/- 0.5 and mean change in ankle thickness of 1.05 +/- 0.10 mm. Synovial tissues from animals treated with targeted fumagillin nanoparticles also showed significant decrease in inflammation and angiogenesis and preserved proteoglycan integrity. Ligand-targeted nanotherapy to deliver antiangiogenic agents may represent an effective way to treat inflammatory arthritis.</abstract><notes>Zhou, Hui-Fang&#xD;Chan, Happy W&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Pham, Christine T N&#xD;AR-056468/AR/NIAMS NIH HHS/United States&#xD;CA-119342/CA/NCI NIH HHS/United States&#xD;HL-78631/HL/NHLBI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;The FASEB journal : official publication of the Federation of American Societies for Experimental Biology&#xD;FASEB J. 2009 Sep;23(9):2978-85. Epub 2009 Apr 17.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom2>2735365</custom2><custom4>7.128</custom4><electronic-resource-num>fj.09-129874 [pii]&#xD;10.1096/fj.09-129874 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2273</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2273</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>von Maltzahn, G.</author><author>Park, J. H.</author><author>Agrawal, A.</author><author>Bandaru, N. K.</author><author>Das, S. K.</author><author>Sailor, M. J.</author><author>Bhatia, S. N.</author></authors></contributors><auth-address>Division of Health Sciences and Technology, Harvard-Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>3892-900</pages><volume>69</volume><number>9</number><edition>2009/04/16</edition><keywords><keyword>Animals</keyword><keyword>Breast Neoplasms/ therapy</keyword><keyword>Cell Line, Tumor</keyword><keyword>Gold/administration &amp; dosage/chemistry/pharmacokinetics</keyword><keyword>Humans</keyword><keyword>Hyperthermia, Induced/ instrumentation/methods</keyword><keyword>Metal Nanoparticles/ chemistry</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Nanotubes/ chemistry</keyword><keyword>Polyethylene Glycols/administration &amp; dosage/ chemistry/pharmacokinetics</keyword><keyword>Spectroscopy, Near-Infrared</keyword><keyword>Surface Plasmon Resonance</keyword><keyword>Tissue Distribution</keyword><keyword>Tomography, X-Ray Computed</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2009</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>1538-7445 (Electronic)</isbn><accession-num>19366797</accession-num><abstract>Plasmonic nanomaterials have the opportunity to considerably improve the specificity of cancer ablation by i.v. homing to tumors and acting as antennas for accepting externally applied energy. Here, we describe an integrated approach to improved plasmonic therapy composed of multimodal nanomaterial optimization and computational irradiation protocol development. We synthesized polyethylene glycol (PEG)-protected gold nanorods (NR) that exhibit superior spectral bandwidth, photothermal heat generation per gram of gold, and circulation half-life in vivo (t(1/2), approximately 17 hours) compared with the prototypical tunable plasmonic particles, gold nanoshells, as well as approximately 2-fold higher X-ray absorption than a clinical iodine contrast agent. After intratumoral or i.v. administration, we fuse PEG-NR biodistribution data derived via noninvasive X-ray computed tomography or ex vivo spectrometry, respectively, with four-dimensional computational heat transport modeling to predict photothermal heating during irradiation. In computationally driven pilot therapeutic studies, we show that a single i.v. injection of PEG-NRs enabled destruction of all irradiated human xenograft tumors in mice. These studies highlight the potential of integrating computational therapy design with nanotherapeutic development for ultraselective tumor ablation.</abstract><notes>von Maltzahn, Geoffrey&#xD;Park, Ji-Ho&#xD;Agrawal, Amit&#xD;Bandaru, Nanda Kishor&#xD;Das, Sarit K&#xD;Sailor, Michael J&#xD;Bhatia, Sangeeta N&#xD;R01CA124427-01/CA/NCI NIH HHS/United States&#xD;U54 CA119335/CA/NCI NIH HHS/United States&#xD;U54 CA119349/CA/NCI NIH HHS/United States&#xD;Howard Hughes Medical Institute/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2009 May 1;69(9):3892-900. Epub 2009 Apr 14.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2712876</custom2><custom3>NIHMS113076</custom3><custom4>7.980</custom4><electronic-resource-num>0008-5472.CAN-08-4242 [pii]&#xD;10.1158/0008-5472.CAN-08-4242 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2444</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2444</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lane, A. L.</author><author>Nyadong, L.</author><author>Galhena, A. S.</author><author>Shearer, T. L.</author><author>Stout, E. P.</author><author>Parry, R. M.</author><author>Kwasnik, M.</author><author>Wang, M. D.</author><author>Hay, M. E.</author><author>Fernandez, F. M.</author><author>Kubanek, J.</author></authors></contributors><auth-address>School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA 30332, USA.</auth-address><titles><title>Desorption electrospray ionization mass spectrometry reveals surface-mediated antifungal chemical defense of a tropical seaweed</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>7314-9</pages><volume>106</volume><number>18</number><edition>2009/04/16</edition><keywords><keyword>Antifungal Agents/*analysis/pharmacology</keyword><keyword>Ascomycota/drug effects</keyword><keyword>Seaweed/*chemistry</keyword><keyword>Spectrometry, Mass, Electrospray Ionization/*methods</keyword></keywords><dates><year>2009</year><pub-dates><date>May 5</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>19366672</accession-num><abstract>Organism surfaces represent signaling sites for attraction of allies and defense against enemies. However, our understanding of these signals has been impeded by methodological limitations that have precluded direct fine-scale evaluation of compounds on native surfaces. Here, we asked whether natural products from the red macroalga Callophycus serratus act in surface-mediated defense against pathogenic microbes. Bromophycolides and callophycoic acids from algal extracts inhibited growth of Lindra thalassiae, a marine fungal pathogen, and represent the largest group of algal antifungal chemical defenses reported to date. Desorption electrospray ionization mass spectrometry (DESI-MS) imaging revealed that surface-associated bromophycolides were found exclusively in association with distinct surface patches at concentrations sufficient for fungal inhibition; DESI-MS also indicated the presence of bromophycolides within internal algal tissue. This is among the first examples of natural product imaging on biological surfaces, suggesting the importance of secondary metabolites in localized ecological interactions, and illustrating the potential of DESI-MS in understanding chemically-mediated biological processes.</abstract><notes>Lane, Amy L&#xD;Nyadong, Leonard&#xD;Galhena, Asiri S&#xD;Shearer, Tonya L&#xD;Stout, E Paige&#xD;Parry, R Mitchell&#xD;Kwasnik, Mark&#xD;Wang, May D&#xD;Hay, Mark E&#xD;Fernandez, Facundo M&#xD;Kubanek, Julia&#xD;U01-TW007401-01/TW/FIC NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2009 May 5;106(18):7314-9. Epub 2009 Apr 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19366672</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom2>2678663</custom2><custom4>10.228</custom4><electronic-resource-num>0812020106 [pii]&#xD;10.1073/pnas.0812020106</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2397</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2397</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Krishnan, R.</author><author>Heller, M. J.</author></authors></contributors><auth-address>University of California, San Diego, Department of Nanoengineering and Department of Bioengineering, La Jolla, CA 92093-0448, USA.</auth-address><titles><title>An AC electrokinetic method for enhanced detection of DNA nanoparticles</title><secondary-title>J Biophotonics</secondary-title></titles><periodical><full-title>J Biophotonics</full-title></periodical><pages>253-61</pages><volume>2</volume><number>4</number><edition>2009/04/16</edition><keywords><keyword>Buffers</keyword><keyword>DNA/ analysis/chemistry</keyword><keyword>Electric Conductivity</keyword><keyword>Electrochemical Techniques/ methods</keyword><keyword>Fluorescence</keyword><keyword>Humans</keyword><keyword>Jurkat Cells</keyword><keyword>Molecular Weight</keyword><keyword>Nanoparticles/ analysis/chemistry</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1864-0648 (Electronic)</isbn><accession-num>19367593</accession-num><abstract>In biomedical research and diagnostics it is a challenge to isolate and detect low levels of nanoparticles and nanoscale biomarkers in blood and other biological samples. While highly sensitive epifluorescent microscope systems are available for ultra low level detection, the isolation of the specific entities from large sample volumes is often the bigger limitation. AC electrokinetic techniques like dielectrophoresis (DEP) offer an attractive mechanism for specifically concentrating nanoparticles into microscopic locations. Unfortunately, DEP requires significant sample dilution thus making the technology unsuitable for biological applications. Using a microelectrode array device, special conditions have been found for the separation of hmw-DNA and nanoparticles under high conductance (ionic strength) conditions. At AC frequencies in the 3000-10 000 Hz range, 10 mum microspheres and human T lymphocytes can be isolated into the DEP low field regions, while hmw-DNA and nanoparticles can be concentrated into microscopic high field regions for subsequent detection using an epifluorescent system.</abstract><notes>Krishnan, Rajaram&#xD;Heller, Michael J&#xD;U54-CA119335/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Journal of biophotonics&#xD;J Biophotonics. 2009 Apr;2(4):253-61.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom4>na</custom4><electronic-resource-num>10.1002/jbio.200910007 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2204</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2204</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Das, A.</author><author>Zhao, J.</author><author>Schatz, G. C.</author><author>Sligar, S. G.</author><author>Van Duyne, R. P.</author></authors></contributors><auth-address>Department of Biochemistry and Chemistry, Beckman Institute for Advanced Science and Technology, University of Illinois Urbana-Champaign, Urbana, Illinois 61801, USA.</auth-address><titles><title>Screening of type I and II drug binding to human cytochrome P450-3A4 in nanodiscs by localized surface plasmon resonance spectroscopy</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>3754-9</pages><volume>81</volume><number>10</number><edition>2009/04/15</edition><keywords><keyword>Cytochrome P-450 CYP3A/ chemistry/metabolism</keyword><keyword>Drug Discovery/ methods</keyword><keyword>Fatty Acids/chemistry</keyword><keyword>Humans</keyword><keyword>Lipid Bilayers/chemistry</keyword><keyword>Metal Nanoparticles/ chemistry</keyword><keyword>Pharmaceutical Preparations/analysis</keyword><keyword>Silver/ chemistry</keyword><keyword>Spectrophotometry, Ultraviolet</keyword><keyword>Sulfhydryl Compounds/chemistry</keyword><keyword>Surface Plasmon Resonance/ methods</keyword></keywords><dates><year>2009</year><pub-dates><date>May 15</date></pub-dates></dates><isbn>1520-6882 (Electronic)</isbn><accession-num>19364136</accession-num><abstract>A prototype nanoparticle biosensor based on localized surface plasmon resonance (LSPR) spectroscopy was developed to detect drug binding to human membrane-bound cytochrome P450 3A4 (CYP3A4). CYP3A4 is one of the most important enzymes in drug and xenobiotic metabolism in the human body. Because of the inherent propensity of CYP3A4 to aggregate, it is difficult to study drug binding to this protein in solution and on surfaces. In this paper, we use a soluble nanometer scale membrane bilayer disk (Nanodisk) to functionally stabilize monomeric CYP3A4 on Ag nanoparticle surfaces fabricated by nanosphere lithography. CYP3A4-Nanodiscs have absorption bands in the visible wavelength region, which upon binding certain drugs shift to either shorter (type I) or longer wavelengths (type II). On the basis of the coupling between the LSPR of the Ag nanoparticles and the electronic resonances of the heme chromophore in CYP3A4-Nanodiscs, LSPR spectroscopy is used to detect drug binding with high sensitivity. This paper combines LSPR and Nanodisc techniques to optically sense drug binding to a functionally stable membrane protein, with the goal of integrating this with microfluidics and expanding it into a multiarray format, enabling high-throughput screening.</abstract><notes>Das, Aditi&#xD;Zhao, Jing&#xD;Schatz, George C&#xD;Sligar, Stephen G&#xD;Van Duyne, Richard P&#xD;1 U54 CA119341-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2009 May 15;81(10):3754-9.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>5.918</custom4><electronic-resource-num>10.1021/ac802612z [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2121</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2121</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Niu, G.</author><author>Wang, F.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University School of Medicine, 1201 Welch Rd, P095, Stanford, CA 94305-5484, USA.</auth-address><titles><title>(68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging</title><secondary-title>Eur J Nucl Med Mol Imaging</secondary-title></titles><periodical><full-title>Eur J Nucl Med Mol Imaging</full-title></periodical><pages>1483-94</pages><volume>36</volume><number>9</number><edition>2009/04/11</edition><dates><year>2009</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1619-7089 (Electronic)</isbn><accession-num>19360404</accession-num><abstract>PURPOSE: Radiolabeled Arg-Gly-Asp (RGD) and bombesin (BBN) peptide analogs have been extensively investigated for the imaging of tumor integrin alpha(v)beta(3) and gastrin-releasing peptide receptor (GRPR) expression, respectively. Recently, we designed and synthesized a RGD-BBN heterodimeric peptide from c(RGDyK) and BBN(7-14) through a glutamate linker. The goal of this study was to investigate the dual receptor-targeting property and tumor diagnostic value of RGD-BBN heterodimeric peptide labeled with generator-eluted (68)Ga (t(1/2) 68 min, beta(+) 89% and EC 11%), (68)Ga-NOTA-RGD-BBN. METHODS: RGD-BBN heterodimer was conjugated with 1,4,7-triazacyclononanetriacetic acid (NOTA) and labeled with (68)Ga. The dual receptor binding affinity was investigated by a radioligand competition binding assay. The in vitro and in vivo dual receptor targeting of (68)Ga-NOTA-RGD-BBN was evaluated and compared with that of (68)Ga-NOTA-RGD and (68)Ga-NOTA-BBN. RESULTS: NOTA-RGD-BBN had integrin alpha(v)beta(3) and GRPR binding affinities comparable to those of the monomeric RGD and BBN, respectively. The dual receptor targeting property of (68)Ga-NOTA-RGD-BBN was validated by blocking studies in a PC-3 tumor model. (68)Ga-NOTA-RGD-BBN showed higher tumor uptake than (68)Ga-NOTA-RGD and (68)Ga-NOTA-BBN. (68)Ga-NOTA-RGD-BBN can also image tumors with either integrin or GRPR expression. CONCLUSION: (68)Ga-NOTA-RGD-BBN exhibited dual receptor targeting properties both in vitro and in vivo. The favorable characterizations of (68)Ga-NOTA-RGD-BBN such as convenient synthesis, high specific activity, and high tumor uptake, warrant its further investigation for clinical cancer imaging.</abstract><notes>Liu, Zhaofei&#xD;Niu, Gang&#xD;Wang, Fan&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;European journal of nuclear medicine and molecular imaging&#xD;Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1483-94. Epub 2009 Apr 10.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.625</custom4><electronic-resource-num>10.1007/s00259-009-1123-z [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1315</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1315</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kastantin, M.</author><author>Ananthanarayanan, B.</author><author>Karmali, P.</author><author>Ruoslahti, E.</author><author>Tirrell, M.</author></authors></contributors><auth-address>Department of Chemical Engineering, University of California, Santa Barbara.</auth-address><titles><title>Effect of the Lipid Chain Melting Transition on the Stability of DSPE-PEG(2000) Micelles</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>7279-86</pages><volume>25</volume><number>13</number><edition>2009/04/11</edition><dates><year>2009</year><pub-dates><date>Jul 7</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>19358585</accession-num><abstract>Micellar nanoparticles are showing promise as carriers of diagnostic and therapeutic biofunctionality, leading to increased interest in their properties and behavior, particularly their size, shape, and stability. This work investigates the physical chemistry of micelles formed from DSPE-PEG(2000) monomers as it pertains to these properties. A melting transition in the lipid core of spheroidal DSPE-PEG(2000) micelles is observed as an endothermic peak at 12.8 degrees C upon heating in differential scanning calorimetry thermograms. Bulky PEG(2000) head groups prevent regular crystalline packing of lipids in both the low-temperature glassy and high-temperature fluid phases, as evidenced by wide-angle X-ray scattering. Equilibrium micelle geometry is spheroidal above and below the transition temperature, indicating that the entropic penalty to force the PEG brush into flat geometry is greater than the enthalpic benefit to the glassy core to pack in an extended configuration. Increased micelle stability is seen in the glassy phase with monomer desorption rates significantly lower than in the fluid phase. Activation energies for monomer desorption are 156 +/- 6.7 and 79 +/- 5.0 kJ/mol for the glassy and fluid phases, respectively. The observation of a glass transition that increases micelle stability but does not perturb micelle geometry is useful for the design of more effective biofunctional micelles.</abstract><notes>Kastantin, Mark&#xD;Ananthanarayanan, Badriprasad&#xD;Karmali, Priya&#xD;Ruoslahti, Erkki&#xD;Tirrell, Matthew&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2009 Jul 7;25(13):7279-86.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19358585</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>4.347</custom4><electronic-resource-num>10.1021/la900310k</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2031</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2031</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Winter, P. M.</author><author>Caruthers, S. D.</author><author>Zhang, H.</author><author>Williams, T. A.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Washington University, St. Louis, Missouri 63108, USA.</auth-address><titles><title>Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis</title><secondary-title>JACC Cardiovasc Imaging</secondary-title></titles><periodical><full-title>JACC Cardiovasc Imaging</full-title></periodical><pages>624-34</pages><volume>1</volume><number>5</number><edition>2009/04/10</edition><keywords><keyword>Angiogenesis Inhibitors/metabolism/ pharmacology</keyword><keyword>Animals</keyword><keyword>Aorta, Thoracic/drug effects/metabolism/pathology</keyword><keyword>Atherosclerosis/ drug therapy/metabolism/pathology</keyword><keyword>Carbocyanines/ metabolism</keyword><keyword>Cyclohexanes/metabolism/ pharmacology</keyword><keyword>Disease Models, Animal</keyword><keyword>Drug Carriers</keyword><keyword>Drug Synergism</keyword><keyword>Drug Therapy, Combination</keyword><keyword>Fatty Acids, Unsaturated/metabolism/ pharmacology</keyword><keyword>Heptanoic Acids/ pharmacology</keyword><keyword>Heterocyclic Compounds, 1-Ring/ metabolism</keyword><keyword>Integrin alphaVbeta3/ metabolism</keyword><keyword>Liver/drug effects/pathology</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Nanoparticles</keyword><keyword>Neovascularization, Pathologic/metabolism/pathology/ prevention &amp; control</keyword><keyword>Pyrroles/ pharmacology</keyword><keyword>Rabbits</keyword><keyword>Sesquiterpenes/metabolism/pharmacology</keyword><keyword>Time Factors</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1876-7591 (Electronic)</isbn><accession-num>19356492</accession-num><abstract>OBJECTIVES: Studies were performed to develop a prolonged antiangiogenesis therapy regimen based on theranostic alpha(nu)beta(3)-targeted nanoparticles. BACKGROUND: Antiangiogenesis therapy may normalize atherosclerotic plaque vasculature and promote plaque stabilization. alpha(nu)beta(3)-targeted paramagnetic nanoparticles can quantify atherosclerotic angiogenesis and incorporate fumagillin to elicit acute antiangiogenic effects. METHODS: In the first experiment, hyperlipidemic rabbits received alpha(nu)beta(3)-targeted fumagillin nanoparticles (0, 30, or 90 microg/kg) with either a continued high fat diet or conversion to standard chow. The antiangiogenic response was followed for 4 weeks by cardiac magnetic resonance (CMR) molecular imaging with alpha(nu)beta(3)-targeted paramagnetic nanoparticles. In a second 8-week study, atherosclerotic rabbits received atorvastatin (0 or 44 mg/kg diet) alone or with alpha(nu)beta(3)-targeted fumagillin nanoparticles (only week 0 vs. weeks 0 and 4), and angiogenesis was monitored with CMR molecular imaging. Histology was performed to determine the location of bound nanoparticles and to correlate the level of CMR enhancement with the density of angiogenic vessels. RESULTS: The alpha(nu)beta(3)-targeted fumagillin nanoparticles reduced the neovascular signal by 50% to 75% at 1 week and maintained this effect for 3 weeks regardless of diet and drug dose. In the second study, atherosclerotic rabbits receiving statin alone had no antineovascular benefit over 8 weeks. The alpha(nu)beta(3)-targeted fumagillin nanoparticles decreased aortic angiogenesis for 3 weeks as in study 1, and readministration on week 4 reproduced the 3-week antineovascular response with no carry-over benefit. However, atorvastatin and 2 doses of alpha(nu)beta(3)-targeted fumagillin nanoparticles (0 and 4 weeks) achieved marked and sustainable antiangiogenesis. Microscopic studies corroborated the high correlation between CMR signal and neovessel counts and confirmed that the alpha(nu)beta(3)-targeted nanoparticles were constrained to the vasculature of the aortic adventia. CONCLUSIONS: The CMR molecular imaging with alpha(nu)beta(3)-targeted paramagnetic nanoparticles demonstrated that the acute antiangiogenic effects of alpha(nu)beta(3)-targeted fumagillin nanoparticles could be prolonged when combined with atorvastatin, representing a potential strategy to evaluate antiangiogenic treatment and plaque stability.</abstract><notes>Winter, Patrick M&#xD;Caruthers, Shelton D&#xD;Zhang, Huiying&#xD;Williams, Todd A&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;CA-119342/CA/NCI NIH HHS/United States&#xD;EB-01704/EB/NIBIB NIH HHS/United States&#xD;HL-73646/HL/NHLBI NIH HHS/United States&#xD;HL-78631/HL/NHLBI NIH HHS/United States&#xD;N01-CO-27031-16/CO/NCI NIH HHS/United States&#xD;N01-CO-37007/CO/NCI NIH HHS/United States&#xD;R01 EB001704-04/EB/NIBIB NIH HHS/United States&#xD;R01 HL078631-02/HL/NHLBI NIH HHS/United States&#xD;R01 HL078631-03/HL/NHLBI NIH HHS/United States&#xD;R01 HL078631-04/HL/NHLBI NIH HHS/United States&#xD;R01 NS059302-01/NS/NINDS NIH HHS/United States&#xD;R01 NS059302-02/NS/NINDS NIH HHS/United States&#xD;U54 CA119342-040001/CA/NCI NIH HHS/United States&#xD;U54 CA136398-010003/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;JACC. Cardiovascular imaging&#xD;JACC Cardiovasc Imaging. 2008 Sep;1(5):624-34.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom2>2636718</custom2><custom3>NIHMS82182</custom3><custom4>na</custom4><electronic-resource-num>S1936-878X(08)00264-7 [pii]&#xD;10.1016/j.jcmg.2008.06.003 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1874</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1874</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Westcott, N. P.</author><author>Lamb, B. M.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and The Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Electrochemical and chemical microfluidic gold etching to generate patterned and gradient substrates for cell adhesion and cell migration</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>3297-303</pages><volume>81</volume><number>9</number><edition>2009/04/10</edition><keywords><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>*Cell Movement</keyword><keyword>Electrochemistry/*methods</keyword><keyword>Glass/chemistry</keyword><keyword>Gold/*chemistry</keyword><keyword>Iodides/chemistry</keyword><keyword>Mice</keyword><keyword>Microfluidic Analytical Techniques/*methods</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2009</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>1520-6882 (Electronic)</isbn><accession-num>19354293</accession-num><abstract>To generate patterned substrates of self-assembled monolayers (SAMs) for cell adhesion and migration studies, a variety of gold/glass hybrid substrates were fabricated from gold evaporated on glass. A variety of surfaces were generated including gradients of gold height, completely etched gold/glass hybrids, and partially etched gold surfaces for pattern visualization. Etch rates were controlled by the alkanethiol present on the surface. Gradients of gold height were created using an electrochemical etch with control over the position and slope of the gold height gradient. Cells were seeded to these surfaces, and their adhesion to the gold was controlled by the surface chemistry present in the channel regions. In the future, the etched gold surfaces will be used to simulate the varying nanotopology experienced by the migrating cell in vivo.</abstract><notes>Westcott, Nathan P&#xD;Lamb, Brian M&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2009 May 1;81(9):3297-303.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19354293</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>5.918</custom4><electronic-resource-num>10.1021/ac802509y</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2120</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2120</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>De, A.</author><author>Ray, P.</author><author>Loening, A. M.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Stanford University School of Medicine, Department of Radiology, Bioengineering and Bio-X Program, The James H. Clark Center, 318 Campus Dr., Stanford, CA 94305-5427, USA.</auth-address><titles><title>BRET3: a red-shifted bioluminescence resonance energy transfer (BRET)-based integrated platform for imaging protein-protein interactions from single live cells and living animals</title><secondary-title>FASEB J</secondary-title></titles><periodical><full-title>FASEB J</full-title></periodical><pages>2702-9</pages><volume>23</volume><number>8</number><edition>2009/04/09</edition><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Fluorescence Resonance Energy Transfer/ methods</keyword><keyword>Humans</keyword><keyword>Luciferases, Renilla/genetics/metabolism</keyword><keyword>Luminescence</keyword><keyword>Luminescent Proteins/ genetics/ metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Protein Interaction Mapping/ methods</keyword><keyword>Recombinant Fusion Proteins/genetics</keyword><keyword>Tacrolimus Binding Protein 1A/metabolism</keyword></keywords><dates><year>2009</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1530-6860 (Electronic)</isbn><accession-num>19351700</accession-num><abstract>Taking advantage of the bioluminescence resonance energy transfer (BRET) phenomenon, we report the development of a highly photon-efficient, self-illuminating fusion protein combining a mutant red fluorescent protein (mOrange) and a mutant Renilla reniformis luciferase (RLuc8). This new BRET fusion protein (BRET3) exhibits severalfold improvement in light intensity in comparison with existing BRET fusion proteins. BRET3 also exhibits the most red-shifted light output (564-nm peak wavelength) of any reported bioluminescent protein that utilizes its natural substrate coelenterazine, a benefit of which is demonstrated at various tissue depths in small animals. The imaging utility of BRET3 at the single-cell level is demonstrated using an intramolecular sensor incorporating two mammalian target of rapamycin pathway proteins (FKBP12 and FRB) that dimerize only in the presence of rapamycin. With its increased photon intensity, red-shifted light output, and good spectral resolution (approximately 85 nm), BRET3 shows improved spatial and temporal resolution for measuring intracellular events in single cells and in living small animal models. The development of further BRET3-based assays will allow imaging of protein-protein interactions using a single assay directly scalable from intact living cells to small living subjects, allowing accelerated drug discovery.</abstract><notes>De, Abhijit&#xD;Ray, Pritha&#xD;Loening, Andreas Markus&#xD;Gambhir, Sanjiv Sam&#xD;5R01 CA82214/CA/NCI NIH HHS/United States&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;The FASEB journal : official publication of the Federation of American Societies for Experimental Biology&#xD;FASEB J. 2009 Aug;23(8):2702-9. Epub 2009 Apr 7.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom2>2717762</custom2><custom4>7.128</custom4><electronic-resource-num>fj.08-118919 [pii]&#xD;10.1096/fj.08-118919 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1801</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1801</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chanda, N.</author><author>Shukla, R.</author><author>Katti, K. V.</author><author>Kannan, R.</author></authors></contributors><auth-address>Department of Radiology, University of Missouri-Columbia, Columbia, Missouri 65212, USA.</auth-address><titles><title>Gastrin releasing protein receptor specific gold nanorods: breast and prostate tumor avid nanovectors for molecular imaging</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>1798-805</pages><volume>9</volume><number>5</number><edition>2009/04/09</edition><keywords><keyword>Animals</keyword><keyword>Bombesin/chemistry</keyword><keyword>Breast Neoplasms/*chemistry</keyword><keyword>Cattle</keyword><keyword>Cell Line, Tumor</keyword><keyword>Endocytosis</keyword><keyword>Female</keyword><keyword>Gold/*chemistry</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Mice</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Nanotubes/*chemistry</keyword><keyword>Prostatic Neoplasms/*chemistry</keyword><keyword>Receptors, Bombesin/*chemistry</keyword></keywords><dates><year>2009</year><pub-dates><date>May</date></pub-dates></dates><isbn>1530-6992 (Electronic)</isbn><accession-num>19351145</accession-num><abstract>Gastrin releasing protein receptor specific bombesin (BBN) peptide-gold nanoconjugates were successfully synthesized using gold nanorods and dithiolated peptide. The gold nanorod-bombesin (GNR-BBN) conjugates showed extraordinary in vitro stabilities against various biomolecules including NaCl, cysteine, histidine, bovine serum albumin, human serum albumin, and dithiothreitol. Quantitative measurements on the binding affinity (IC(50)) of GNR-BBN conjugates toward prostate and breast tumor cells were evaluated. The IC(50) values establish that GNR-BBN conjugates have strong affinity toward the gastrin releasing peptide receptors on both the tumors. Detailed cellular interaction studies of GNR-BBN conjugates revealed that nanorods internalize via a receptor-mediated endocytosis pathway. The receptor specific interactions of GNR-BBN conjugates provide realistic opportunities in the design and development of in vivo molecular imaging and therapy agents for cancer.</abstract><notes>Chanda, Nripen&#xD;Shukla, Ravi&#xD;Katti, Kattesh V&#xD;Kannan, Raghuraman&#xD;1R21CA128460-02/CA/NCI NIH HHS/United States&#xD;5R01CA119412-04/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2009 May;9(5):1798-805.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19351145</url></related-urls></urls><custom1>CNPP - U. of Miss.</custom1><custom2>2699898</custom2><custom4>12.189</custom4><electronic-resource-num>10.1021/nl8037147</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2395</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2395</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Orosco, M. M.</author><author>Pacholski, C.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, Department 0358, La Jolla, California 92093-0358, USA.</auth-address><titles><title>Real-time monitoring of enzyme activity in a mesoporous silicon double layer</title><secondary-title>Nat Nanotechnol</secondary-title></titles><periodical><full-title>Nat Nanotechnol</full-title></periodical><pages>255-8</pages><volume>4</volume><number>4</number><edition>2009/04/08</edition><keywords><keyword>Computer Systems</keyword><keyword>Crystallization/ methods</keyword><keyword>Enzyme Activation</keyword><keyword>Enzymes/ analysis/ chemistry</keyword><keyword>Kinetics</keyword><keyword>Macromolecular Substances/chemistry</keyword><keyword>Materials Testing</keyword><keyword>Membranes, Artificial</keyword><keyword>Molecular Conformation</keyword><keyword>Nanostructures/ chemistry/ultrastructure</keyword><keyword>Nanotechnology/ methods</keyword><keyword>Particle Size</keyword><keyword>Porosity</keyword><keyword>Silicon/ chemistry</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1748-3395 (Electronic)</isbn><accession-num>19350037</accession-num><abstract>The activity of certain proteolytic enzymes is often an indicator of disease states such as cancer, stroke and neurodegeneracy, so there is a need for rapid assays that can characterize the kinetics and substrate specificity of enzymatic reactions. Nanostructured membranes can efficiently separate biomolecules, but coupling a sensitive detection method to such a membrane remains difficult. Here, we demonstrate a single mesoporous nanoreactor that can isolate and quantify in real time the reaction products of proteases. The reactor consists of two layers of porous films electrochemically prepared from crystalline silicon. The upper layer, with large pore sizes ( approximately 100 nm in diameter), traps the protease and acts as the reactor. The lower layer, with smaller pore sizes ( approximately 6 nm), excludes the proteases and other large proteins and captures the reaction products. Infiltration of the digested fragments into the lower layer produces a measurable change in optical reflectivity, and this allows label-free quantification of enzyme kinetics in real time within a volume of approximately 5 nl.</abstract><notes>Orosco, Manuel M&#xD;Pacholski, Claudia&#xD;Sailor, Michael J&#xD;U54 CA 119335/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Nature nanotechnology&#xD;Nat Nanotechnol. 2009 Apr;4(4):255-8. Epub 2009 Feb 22.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom2>2736600</custom2><custom3>NIHMS88927</custom3><custom4>20.588</custom4><electronic-resource-num>nnano.2009.11 [pii]&#xD;10.1038/nnano.2009.11 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2355</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2355</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rhee, W. J.</author><author>Bao, G.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332, USA.</auth-address><titles><title>Simultaneous detection of mRNA and protein stem cell markers in live cells</title><secondary-title>BMC Biotechnol</secondary-title></titles><periodical><full-title>BMC Biotechnol</full-title></periodical><pages>30</pages><volume>9</volume><edition>2009/04/04</edition><keywords><keyword>Animals</keyword><keyword>Antigens, CD15/chemistry</keyword><keyword>Base Sequence</keyword><keyword>Biological Markers</keyword><keyword>Cell Line, Tumor</keyword><keyword>Flow Cytometry</keyword><keyword>Fluorescent Dyes/chemistry</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Molecular Probes/chemistry</keyword><keyword>Molecular Sequence Data</keyword><keyword>Neoplasm Proteins/chemistry</keyword><keyword>Neoplastic Stem Cells/ chemistry</keyword><keyword>Octamer Transcription Factor-3/chemistry</keyword><keyword>RNA, Messenger/ chemistry</keyword><keyword>Tretinoin/pharmacology</keyword></keywords><dates><year>2009</year></dates><isbn>1472-6750 (Electronic)</isbn><accession-num>19341452</accession-num><abstract>BACKGROUND: Biological studies and medical application of stem cells often require the isolation of stem cells from a mixed cell population, including the detection of cancer stem cells in tumor tissue, and isolation of induced pluripotent stem cells after eliciting the expression of specific genes in adult cells. Here we report the detection of Oct-4 mRNA and SSEA-1 protein in live carcinoma stem cells using respectively molecular beacon and dye-labeled antibody, aiming to establish a new method for stem cells detection and isolation. RESULTS: Quantification of Oct-4 mRNA and protein in P19 mouse carcinoma stem cells using respectively RT-PCR and immunocytochemistry confirmed that their levels drastically decreased after differentiation. To visualize Oct-4 mRNA in live stem cells, molecular beacons were designed, synthesized and validated, and the detection specificity was confirmed using control studies. We found that the fluorescence signal from Oct-4-targeting molecular beacons provides a clear discrimination between undifferentiated and retinoic acid-induced differentiated cells. Using deconvolution fluorescence microscopy, Oct-4 mRNAs were found to reside on one side of the cytosol. We demonstrated that, using a combination of Oct-4 mRNA-targeting molecular beacon with SSEA-1 antibody in flow cytometric analysis, undifferentiated stem cells can be clearly distinguished from differentiated cells. We revealed that Oct-4 targeting molecular beacons do not seem to affect stem cell biology. CONCLUSION: Molecular beacons have the potential to provide a powerful tool for highly specific detection and isolation of stem cells, including cancer stem cells and induced pluripotent stem (iPS) cells without disturbing cell physiology. It is advantageous to perform simultaneous detection of intracellular (mRNA) and cell-surface (protein) stem cell markers in flow cytometric analysis, which may lead to high detection sensitivity and efficiency.</abstract><notes>Rhee, Won Jong&#xD;Bao, Gang&#xD;CA103103/CA/NCI NIH HHS/United States&#xD;CA119338/CA/NCI NIH HHS/United States&#xD;HL80711/HL/NHLBI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;BMC biotechnology&#xD;BMC Biotechnol. 2009 Apr 2;9:30.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom2>2682800</custom2><custom4>2.804</custom4><electronic-resource-num>1472-6750-9-30 [pii]&#xD;10.1186/1472-6750-9-30 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2119</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2119</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chang, Y. P.</author><author>Pinaud, F.</author><author>Antelman, J.</author><author>Weiss, S.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California at Los Angeles, 607 Charles Young Drive, East Los Angeles, California 90095-1569, USA. ypchang@chem.ucla.edu</auth-address><titles><title>Tracking bio-molecules in live cells using quantum dots</title><secondary-title>J Biophotonics</secondary-title></titles><periodical><full-title>J Biophotonics</full-title></periodical><pages>287-98</pages><volume>1</volume><number>4</number><edition>2009/04/04</edition><keywords><keyword>Animals</keyword><keyword>Caveolin 1/metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Green Fluorescent Proteins/metabolism</keyword><keyword>Humans</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Quantum Dots</keyword><keyword>Receptors, Glycine/metabolism</keyword><keyword>Streptavidin/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1864-0648 (Electronic)</isbn><accession-num>19343652</accession-num><abstract>Single particle tracking (SPT) techniques were developed to explore bio-molecules dynamics in live cells at single molecule sensitivity and nanometer spatial resolution. Recent developments in quantum dots (Qdots) surface coating and bio-conjugation schemes have made them most suitable probes for live cell applications. Here we review recent advancements in using quantum dots as SPT probes for live cell experiments.</abstract><notes>Chang, Yun-Pei&#xD;Pinaud, Fabien&#xD;Antelman, Joshua&#xD;Weiss, Shimon&#xD;1R01EB006353-01A1/EB/NIBIB NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;Germany&#xD;Journal of biophotonics&#xD;J Biophotonics. 2008 Sep;1(4):287-98.</notes><urls></urls><custom1>CCNE - Caltech</custom1><custom4>na</custom4><electronic-resource-num>10.1002/jbio.200810029 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2439</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2439</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, C.</author><author>Wang, X.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245, USA.</auth-address><titles><title>Nanowire structured hybrid cell for concurrently scavenging solar and mechanical energies</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>5866-72</pages><volume>131</volume><number>16</number><edition>2009/04/03</edition><keywords><keyword>Coloring Agents/chemistry</keyword><keyword>*Electricity</keyword><keyword>Electrochemistry</keyword><keyword>Equipment Design</keyword><keyword>Nanotechnology/instrumentation/*methods</keyword><keyword>Nanowires/*chemistry</keyword><keyword>*Solar Energy</keyword><keyword>Surface Properties</keyword><keyword>*Ultrasonics</keyword><keyword>Zinc Oxide/*chemistry</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr 29</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>19338339</accession-num><abstract>Conversion cells for harvesting solar energy and mechanical energy are usually separate and independent entities that are designed and built following different physical principles. Developing a technology that harvests multiple-type energies in forms such as sun light and mechanical around the clock is desperately desired for fully utilizing the energies available in our living environment. We report a hybrid cell that is intended for simultaneously harvesting solar and mechanical energies. Using aligned ZnO nanowire arrays grown on surfaces of a flat substrate, a dye-sensitized solar cell is integrated with a piezoelectric nanogenerator. The former harvests solar energy irradiating on the top, and the latter harvests ultrasonic wave energy from the surrounding. The two energy harvesting approaches can work simultaneously or individually, and they can be integrated in parallel and serial for raising the output current and voltage, respectively, as well as power. It is found that the voltage output from the solar cell can be used to raise the output voltage of the nanogenerator, providing an effective approach for effectively storing and utilizing the power generated by the nanogenerator. Our study demonstrates a new approach for concurrently harvesting multiple types of energies using an integrated hybrid cell so that the energy resources can be effectively and complementary utilized whenever and wherever one or all of them is available.</abstract><notes>Xu, Chen&#xD;Wang, Xudong&#xD;Wang, Zhong Lin&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2009 Apr 29;131(16):5866-72.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19338339</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja810158x</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1831</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1831</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fang, C.</author><author>Bhattarai, N.</author><author>Sun, C.</author><author>Zhang, M.</author></authors></contributors><auth-address>Department of Materials Science and Engineering University of Washington Seattle, WA 98195 (USA).</auth-address><titles><title>Functionalized Nanoparticles with Long-Term Stability in Biological Media</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><edition>2009/04/01</edition><dates><year>2009</year><pub-dates><date>Mar 30</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>19334014</accession-num><notes>Journal article&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2009 Mar 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19334014</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200801647</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2494</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2494</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Emily B. Pentzer</author><author>Tendai Gadzikwa</author><author>SonBinh T. Nguyen</author></authors></contributors><auth-address>Dep. Chem., Northwest. Univ., Evanston, IL 60208, USA</auth-address><titles><title>ChemInform Abstract: Substrate Encapsulation: An Efficient Strategy for the RCM Synthesis of Unsaturated &amp;epsiv;-Lactones</title><secondary-title>ChemInform</secondary-title></titles><periodical><full-title>ChemInform</full-title></periodical><volume>40</volume><number>19</number><edition>2009/04</edition><dates><year>2009</year></dates><isbn>1522-2667</isbn><notes>10.1002/chin.200919162</notes><urls><related-urls><url>http://dx.doi.org/10.1002/chin.200919162</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>na</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2118</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2118</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, J.</author><author>Kim, Y. S.</author><author>Zhai, S.</author><author>Liu, Z.</author><author>Chen, X.</author><author>Liu, S.</author></authors></contributors><auth-address>Purdue University, West Lafayette, Indiana 47907, USA.</auth-address><titles><title>Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>750-9</pages><volume>20</volume><number>4</number><edition>2009/03/27</edition><keywords><keyword>Animals</keyword><keyword>Copper Radioisotopes/ chemistry</keyword><keyword>Dimerization</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Glioma/genetics/metabolism/pathology/radionuclide imaging</keyword><keyword>Heterocyclic Compounds, 1-Ring/chemistry</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/analysis/metabolism</keyword><keyword>Mice</keyword><keyword>Neoplasms/genetics/ metabolism/pathology/radionuclide imaging</keyword><keyword>Oligopeptides/ chemistry</keyword><keyword>Peptides, Cyclic/ chemistry/diagnostic use/ metabolism/pharmacokinetics</keyword><keyword>Polyethylene Glycols/ chemistry</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Radiochemistry</keyword><keyword>Staining and Labeling</keyword><keyword>Tissue Distribution</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1520-4812 (Electronic)</isbn><accession-num>19320477</accession-num><abstract>Radiolabeled cyclic RGD (Arg-Gly-Asp) peptides represent a new class of radiotracers with potential for early tumor detection and noninvasive monitoring of tumor metastasis and therapeutic response in cancer patients. This article describes the synthesis of two cyclic RGD peptide dimer conjugates, DOTA-PEG(4)-E[PEG(4)-c(RGDfK)](2) (DOTA-3PEG(4)-dimer: DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; PEG(4) = 15-amino-4,7,10,13-tetraoxapentadecanoic acid) and DOTA-G(3)-E[G(3)-c(RGDfK)](2) (DOTA-3G(3)-dimer: G(3) = Gly-Gly-Gly). Integrin alpha(v)beta(3) binding affinities of cyclic RGD peptides were determined by competitive displacement of (125)I-echistatin bound to U87MG human glioma cells and follow the order of DOTA-E{E[c(RGDfK)](2)}(2) (DOTA-tetramer: IC(50) = 10 +/- 2 nM) &gt; DOTA-3G(3)-dimer (IC(50) = 62 +/- 6 nM) approximately DOTA-3PEG(4)-dimer (IC(50) = 74 +/- 3 nM) &gt; DOTA-E[c(RGDfK)](2) (DOTA-dimer: IC(50) = 102 +/- 5 nM). The addition of PEG(4) and G(3) linkers between two cyclic RGD motifs in DOTA-3G(3)-dimer and DOTA-3PEG(4)-dimer makes it possible for them to achieve the simultaneous integrin alpha(v)beta(3) binding in a bivalent fashion. Both (64)Cu(DOTA-3PEG(4)-dimer) and (64)Cu(DOTA-3G(3)-dimer) were prepared in high yield with specific activity being &gt;50 Ci/mmol. Biodistribution and imaging studies were performed in athymic nude mice bearing U87MG human glioma xenografts. The results from those studies show that PEG(4) and G(3) linkers are particularly useful for improving tumor uptake and clearance kinetics of (64)Cu radiotracers from the nontumor organs, such as kidneys, liver, and lungs. There is a linear relationship between the tumor size and %ID tumor uptake, suggesting that (64)Cu(DOTA-3PEG(4)-dimer) and (64)Cu(DOTA-3PEG(4)-dimer) might be useful for noninvasive monitoring of tumor growth or shrinkage during antiangiogenic therapy. MicroPET imaging data clearly demonstrate the utility of (64)Cu(DOTA-3G(3)-dimer) as a new PET radiotracer for imaging integrin alpha(v)beta(3)-positive tumors.</abstract><notes>Shi, Jiyun&#xD;Kim, Young-Seung&#xD;Zhai, Shizhen&#xD;Liu, Zhaofei&#xD;Chen, Xiaoyuan&#xD;Liu, Shuang&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA115883 A2/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R21 HL083961-01/HL/NHLBI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2009 Apr;20(4):750-9.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom2>2676896</custom2><custom3>NIHMS105952</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/bc800455p [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1870</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1870</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cao, G.</author><author>Lee, Y. Z.</author><author>Peng, R.</author><author>Liu, Z.</author><author>Rajaram, R.</author><author>Calderon-Colon, X.</author><author>An, L.</author><author>Wang, P.</author><author>Phan, T.</author><author>Sultana, S.</author><author>Lalush, D. S.</author><author>Lu, J. P.</author><author>Zhou, O.</author></authors></contributors><auth-address>Department of Physics and Astronomy, University of North Carolina, Chapel Hill, NC 27599, USA. gcao@physics.unc.edu</auth-address><titles><title>A dynamic micro-CT scanner based on a carbon nanotube field emission x-ray source</title><secondary-title>Phys Med Biol</secondary-title></titles><periodical><full-title>Phys Med Biol</full-title></periodical><pages>2323-40</pages><volume>54</volume><number>8</number><edition>2009/03/27</edition><keywords><keyword>Anesthesia</keyword><keyword>Animals</keyword><keyword>Feasibility Studies</keyword><keyword>Linear Models</keyword><keyword>Mice</keyword><keyword>*Nanotubes, Carbon</keyword><keyword>Prospective Studies</keyword><keyword>Radiation Dosage</keyword><keyword>Respiration</keyword><keyword>Respiratory-Gated Imaging Techniques</keyword><keyword>Time Factors</keyword><keyword>X-Ray Microtomography/*instrumentation</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr 21</date></pub-dates></dates><isbn>0031-9155 (Print)</isbn><accession-num>19321922</accession-num><abstract>Current commercial micro-CT scanners have the capability of imaging objects ex vivo with high spatial resolution, but performing in vivo micro-CT on free-breathing small animals is still challenging because their physiological motions are non-periodic and much faster than those of humans. In this paper, we present a prototype physiologically gated micro-computed tomography (micro-CT) scanner based on a carbon nanotube field emission micro-focus x-ray source. The novel x-ray source allows x-ray pulses and imaging sequences to be readily synchronized and gated to non-periodic physiological signals from small animals. The system performance is evaluated using phantoms and sacrificed and anesthetized mice. Prospective respiratory-gated micro-CT images of anesthetized free-breathing mice were collected using this scanner at 50 ms temporal resolution and 6.2 lp mm(-1) at 10% system MTF. The high spatial and temporal resolutions of the micro-CT scanner make it well suited for high-resolution imaging of free-breathing small animals.</abstract><notes>Cao, G&#xD;Lee, Y Z&#xD;Peng, R&#xD;Liu, Z&#xD;Rajaram, R&#xD;Calderon-Colon, X&#xD;An, L&#xD;Wang, P&#xD;Phan, T&#xD;Sultana, S&#xD;Lalush, D S&#xD;Lu, J P&#xD;Zhou, O&#xD;4R33ER004204-01/PHS HHS/United States&#xD;U54CA119343/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Physics in medicine and biology&#xD;Phys Med Biol. 2009 Apr 21;54(8):2323-40. Epub 2009 Mar 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19321922</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>3.173</custom4><electronic-resource-num>S0031-9155(09)88660-0 [pii]&#xD;10.1088/0031-9155/54/8/005</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1588</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1588</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shu, C.</author><author>Xu, W.</author><author>Slebodnick, C.</author><author>Champion, H.</author><author>Fu, W.</author><author>Reid, J. E.</author><author>Azurmendi, H.</author><author>Wang, C.</author><author>Harich, K.</author><author>Dorn, H. C.</author><author>Gibson, H. W.</author></authors></contributors><auth-address>Chemistry Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA.</auth-address><titles><title>Syntheses and structures of phenyl-C81-butyric acid methyl esters (PCBMs) from M3N@C80</title><secondary-title>Org Lett</secondary-title></titles><periodical><full-title>Org Lett</full-title><abbr-1>Organic letters</abbr-1></periodical><pages>1753-6</pages><volume>11</volume><number>8</number><edition>2009/03/25</edition><keywords><keyword>Esters</keyword><keyword>Fullerenes/chemistry</keyword><keyword>Molecular Structure</keyword><keyword>Organometallic Compounds/*chemical synthesis/chemistry</keyword><keyword>Scandium/*chemistry</keyword><keyword>Yttrium/*chemistry</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr 16</date></pub-dates></dates><isbn>1523-7052 (Electronic)</isbn><accession-num>19309087</accession-num><abstract>Two new 6,6-open phenyl-C(81)-butyric acid methyl ester metallofulleroids, M(3)N@C(80)PCBM (M = Sc, Y), were synthesized by diazoalkane addition reactions and fully characterized. The results demonstrate that the reactive sites are the same for M(3)N@C(80) (M = Sc, Y) but dramatically different from that of C(60).</abstract><notes>Shu, Chunying&#xD;Xu, Wei&#xD;Slebodnick, Carla&#xD;Champion, Hunter&#xD;Fu, Wujun&#xD;Reid, Jonathan E&#xD;Azurmendi, Hugo&#xD;Wang, Chunru&#xD;Harich, Kim&#xD;Dorn, Harry C&#xD;Gibson, Harry W&#xD;1R01-CA119371/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Organic letters&#xD;Org Lett. 2009 Apr 16;11(8):1753-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19309087</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom4>4.742</custom4><electronic-resource-num>10.1021/ol9002527</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1838</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1838</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bonoiu, A. C.</author><author>Mahajan, S. D.</author><author>Ding, H.</author><author>Roy, I.</author><author>Yong, K. T.</author><author>Kumar, R.</author><author>Hu, R.</author><author>Bergey, E. J.</author><author>Schwartz, S. A.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers Photonics and Biophotonics, The State University of New York, Buffalo, NY 14260, USA.</auth-address><titles><title>Nanotechnology approach for drug addiction therapy: gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>5546-50</pages><volume>106</volume><number>14</number><edition>2009/03/25</edition><keywords><keyword>Blood-Brain Barrier</keyword><keyword>Dopamine</keyword><keyword>Dopamine and cAMP-Regulated Phosphoprotein 32/antagonists &amp; inhibitors</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Extracellular Signal-Regulated MAP Kinases/antagonists &amp; inhibitors</keyword><keyword>Gene Silencing</keyword><keyword>*Gold</keyword><keyword>Humans</keyword><keyword>Nanotechnology/methods</keyword><keyword>*Nanotubes</keyword><keyword>Neurons/*metabolism</keyword><keyword>RNA, Small Interfering/*administration &amp; dosage/pharmacology</keyword><keyword>Substance-Related Disorders/*therapy</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr 7</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>19307583</accession-num><abstract>Drug abuse is a worldwide health concern in which addiction involves activation of the dopaminergic signaling pathway in the brain. Here, we introduce a nanotechnology approach that utilizes gold nanorod-DARPP-32 siRNA complexes (nanoplexes) that target this dopaminergic signaling pathway in the brain. The shift in the localized longitudinal plasmon resonance peak of gold nanorods (GNRs) was used to show their interaction with siRNA. Plasmonic enhanced dark field imaging was used to visualize the uptake of these nanoplexes in dopaminergic neurons in vitro. Gene silencing of the nanoplexes in these cells was evidenced by the reduction in the expression of key proteins (DARPP-32, ERK, and PP-1) belonging to this pathway, with no observed cytotoxicity. Moreover, these nanoplexes were shown to transmigrate across an in vitro model of the blood-brain barrier (BBB). Therefore, these nanoplexes appear to be suited for brain-specific delivery of appropriate siRNA for therapy of drug addiction and other brain diseases.</abstract><notes>Bonoiu, Adela C&#xD;Mahajan, Supriya D&#xD;Ding, Hong&#xD;Roy, Indrajit&#xD;Yong, Ken-Tye&#xD;Kumar, Rajiv&#xD;Hu, Rui&#xD;Bergey, Earl J&#xD;Schwartz, Stanley A&#xD;Prasad, Paras N&#xD;CA104492/CA/NCI NIH HHS/United States&#xD;CA119397/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5546-50. Epub 2009 Mar 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19307583</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom2>2667003</custom2><custom4>10.228</custom4><electronic-resource-num>0901715106 [pii]&#xD;10.1073/pnas.0901715106</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2116</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2116</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Almogy, G.</author><author>Nolan, G. P.</author></authors></contributors><auth-address>The Department of Microbiology and Immunology, Stanford University School of Medicine, Palo Alto, CA 94305, USA.</auth-address><titles><title>Conditional protein stabilization via the small molecules Shld-1 and rapamycin increases the signal-to-noise ratio with tet-inducible gene expression</title><secondary-title>Biotechniques</secondary-title></titles><periodical><full-title>Biotechniques</full-title></periodical><pages>44-50</pages><volume>46</volume><number>1</number><edition>2009/03/24</edition><keywords><keyword>Animals</keyword><keyword>Doxycycline/ pharmacology</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Transfer Techniques</keyword><keyword>Genetic Vectors</keyword><keyword>Green Fluorescent Proteins/analysis</keyword><keyword>Mice</keyword><keyword>Morpholines/ pharmacology</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Protein Stability/drug effects</keyword><keyword>Recombinant Fusion Proteins/analysis/ biosynthesis/chemistry</keyword><keyword>Repressor Proteins/metabolism</keyword><keyword>Response Elements</keyword><keyword>Sirolimus/ pharmacology</keyword><keyword>Trans-Activators/metabolism</keyword><keyword>Transcriptional Activation</keyword><keyword>Transfection</keyword></keywords><dates><year>2009</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0736-6205 (Print)</isbn><accession-num>19301621</accession-num><abstract>Cellular mechanisms control one or more of the three basic levels of regulation (transcription, translation, and protein activity/locality), allowing for finely tuned spatial and temporal regulation of protein expression patterns. Gene regulation constructs in wide use today often employ a constitutively expressed transcription factor whose activity is determined by the presence or absence of a small molecule. A case in point is the tet transcription system, wherein transcription is regulated by doxycycline (Dox), allowing the researcher to turn protein expression on or off depending on the presence/absence of Dox. However in many applications of that system, there is basal transcription from the promoter element that is independent of Dox. Moreover, in vivo, heterogeneous distribution of Dox leads to concurrent differences in gene expression. We addressed these limitations by introducing conditional destabilizing elements to the system. First, we created a transactivator protein fusion regulated at the additional level of protein stability. This modification enabled a system that demonstrated an off state that is less sensitive to variations in Dox concentrations. We also regulated the stability of the protein expressed from the tet operator cassette, observing greatly improved signal-to-noise ratios. The results underscore how investigator-defined regulation at multiple levels of protein expression can attain afiner degree of control over the final expression of introduced genes.</abstract><notes>Almogy, Gal&#xD;Nolan, Garry P&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;BioTechniques&#xD;Biotechniques. 2009 Jan;46(1):44-50.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom3>2009</custom3><custom4>2.499</custom4><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1997</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1997</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Agnew, H. D.</author><author>Rohde, R. D.</author><author>Millward, S. W.</author><author>Nag, A.</author><author>Yeo, W. S.</author><author>Hein, J. E.</author><author>Pitram, S. M.</author><author>Tariq, A. A.</author><author>Burns, V. M.</author><author>Krom, R. J.</author><author>Fokin, V. V.</author><author>Sharpless, K. B.</author><author>Heath, J. R.</author></authors></contributors><auth-address>Division of Chemistry and Chemical Engineering, California Institute of Technology, 1200 East California Boulevard, Pasadena, CA 91125, USA.</auth-address><titles><title>Iterative in situ click chemistry creates antibody-like protein-capture agents</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>4944-8</pages><volume>48</volume><number>27</number><edition>2009/03/21</edition><keywords><keyword>Antibodies/chemistry</keyword><keyword>Catalysis</keyword><keyword>Copper/chemistry</keyword><keyword>Ligands</keyword><keyword>Peptide Library</keyword><keyword>Peptides/chemistry</keyword><keyword>Protein Binding</keyword><keyword>Proteins/ chemistry</keyword><keyword>Triazoles/ chemistry</keyword></keywords><dates><year>2009</year></dates><isbn>1521-3773 (Electronic)</isbn><accession-num>19301344</accession-num><abstract>Special agents for protein capture: Iterative in situ click chemistry (see scheme for the tertiary ligand screen) and the one-bead-one-compound method for the creation of a peptide library enable the fragment-based assembly of selective high-affinity protein-capture agents. The resulting ligands are water-soluble and stable chemically, biochemically, and thermally. They can be produced in gram quantities through copper(I)-catalyzed cycloaddition.</abstract><notes>Agnew, Heather D&#xD;Rohde, Rosemary D&#xD;Millward, Steven W&#xD;Nag, Arundhati&#xD;Yeo, Woon-Seok&#xD;Hein, Jason E&#xD;Pitram, Suresh M&#xD;Tariq, Abdul Ahad&#xD;Burns, Vanessa M&#xD;Krom, Russell J&#xD;Fokin, Valery V&#xD;Sharpless, K Barry&#xD;Heath, James R&#xD;5U54 CA119347/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2009;48(27):4944-8.</notes><urls></urls><custom1>CCNE - Caltech</custom1><custom3>2009</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200900488 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2115</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2115</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Liu, S.</author><author>Wang, F.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Biophysics, and Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305, USA.</auth-address><titles><title>Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers</title><secondary-title>Eur J Nucl Med Mol Imaging</secondary-title></titles><periodical><full-title>Eur J Nucl Med Mol Imaging</full-title></periodical><pages>1296-307</pages><volume>36</volume><number>8</number><edition>2009/03/20</edition><dates><year>2009</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1619-7089 (Electronic)</isbn><accession-num>19296102</accession-num><abstract>PURPOSE: Various radiolabeled Arg-Gly-Asp (RGD) peptides have been previously investigated for tumor integrin alpha(v)beta(3) imaging. To further develop RGD radiotracers with enhanced tumor-targeting efficacy and improved in vivo pharmacokinetics, we designed a new RGD homodimeric peptide with two PEG(4) spacers (PEG(4) = 15-amino-4,7,10,13-tetraoxapentadecanoic acid) between the two monomeric RGD motifs and one PEG(4) linker on the glutamate alpha-amino group ((18)F-labeled PEG(4)-E[PEG(4)-c(RGDfK)](2), P-PRGD2), as a promising agent for noninvasive imaging of integrin expression in mouse models. METHODS: P-PRGD2 was labeled with (18)F via 4-nitrophenyl 2-(18)F-fluoropropionate ((18)F-FP) prosthetic group. In vitro and in vivo characteristics of the new dimeric RGD peptide tracer (18)F-FP-P-PRGD2 were investigated and compared with those of (18)F-FP-P-RGD2 ((18)F-labeled RGD dimer without two PEG(4) spacers between the two RGD motifs). The ability of (18)F-FP-P-PRGD2 to image tumor vascular integrin expression was evaluated in a 4T1 murine breast tumor model. RESULTS: With the insertion of two PEG(4) spacers between the two RGD motifs, (18)F-FP-P-PRGD2 showed enhanced integrin alpha(v)beta(3)-binding affinity, increased tumor uptake and tumor-to-nontumor background ratios compared with (18)F-FP-P-RGD2 in U87MG tumors. MicroPET imaging with (18)F-FP-P-PRGD2 revealed high tumor contrast and low background in tumor-bearing nude mice. Biodistribution studies confirmed the in vivo integrin alpha(v)beta(3)-binding specificity of (18)F-FP-P-RGD2. (18)F-FP-P-PRGD2 can specifically image integrin alpha(v)beta(3) on the activated endothelial cells of tumor neovasculature. CONCLUSION: (18)F-FP-P-PRGD2 can provide important information on integrin expression on the tumor vasculature. The high integrin binding affinity and specificity, excellent pharmacokinetic properties and metabolic stability make the new RGD dimeric tracer (18)F-FP-P-PRGD2 a promising agent for PET imaging of tumor angiogenesis and for monitoring the efficacy of antiangiogenic treatment.</abstract><notes>Liu, Zhaofei&#xD;Liu, Shuanglong&#xD;Wang, Fan&#xD;Liu, Shuang&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 120188/PHS HHS/United States&#xD;R01 CA115883/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;European journal of nuclear medicine and molecular imaging&#xD;Eur J Nucl Med Mol Imaging. 2009 Aug;36(8):1296-307. Epub 2009 Mar 19.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.625</custom4><electronic-resource-num>10.1007/s00259-009-1112-2 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1209</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1209</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ganta, S.</author><author>Amiji, M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA.</auth-address><titles><title>Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells</title><secondary-title>Mol Pharm</secondary-title></titles><periodical><full-title>Mol Pharm</full-title></periodical><pages>928-39</pages><volume>6</volume><number>3</number><edition>2009/03/13</edition><dates><year>2009</year><pub-dates><date>May-Jun</date></pub-dates></dates><isbn>1543-8384 (Print)</isbn><accession-num>19278222</accession-num><abstract>Development of multidrug resistance (MDR) against a variety of conventional and novel chemotherapeutic agents is a significant challenge in effective cancer therapy. Over the last several years, we have focused on a multimodal therapeutic strategy to overcome tumor MDR by enhancing the delivery efficiency to the tumor mass and lowering the apoptotic threshold by modulation of the intracellular signaling mechanisms. In this study, we have examined augmentation of therapeutic efficacy upon coadministration of paclitaxel (PTX) and curcumin (CUR), an inhibitor of nuclear factor kappa B (NFkappaB) as well as a potent down-regulator of ABC transporters, in wild-type SKOV3 and drug resistant SKOV3(TR) human ovarian adenocarcinoma cells. PTX and CUR were encapsulated in flaxseed oil containing nanoemulsion formulations. The results showed that the encapsulated drugs were effectively delivered intracellular in both SKOV3 and SKOV3(TR) cells. CUR administration was shown to inhibit NFkappaB activity and down regulate P-glycoprotein expression in resistant cells. Combination PTX and CUR therapy, especially when administered in the nanoemulsion formulations, was very effective in enhancing the cytotoxicity in wild-type and resistant cells by promoting the apoptotic response. Overall, this cotherapy strategy has significant promise in the clinical management of refractory diseases, especially in ovarian cancer.</abstract><notes>Ganta, Srinivas&#xD;Amiji, Mansoor&#xD;R01-CA119617/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular pharmaceutics&#xD;Mol Pharm. 2009 May-Jun;6(3):928-39.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19278222</url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom4>4.388</custom4><electronic-resource-num>10.1021/mp800240j</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2354</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2354</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sajja, H. K.</author><author>East, M. P.</author><author>Mao, H.</author><author>Wang, Y. A.</author><author>Nie, S.</author><author>Yang, L.</author></authors></contributors><auth-address>Department of Surgery and Winship Cancer Institute, Emory University School of Medicine, Room C-4088, 1365-C Clifton Road, Atlanta, GA 30322, USA.</auth-address><titles><title>Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect</title><secondary-title>Curr Drug Discov Technol</secondary-title></titles><periodical><full-title>Curr Drug Discov Technol</full-title></periodical><pages>43-51</pages><volume>6</volume><number>1</number><edition>2009/03/12</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/administration &amp; dosage</keyword><keyword>Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Nanomedicine/methods</keyword><keyword>Nanoparticles</keyword><keyword>Neoplasms/diagnosis/ drug therapy</keyword><keyword>Tumor Markers, Biological/metabolism</keyword></keywords><dates><year>2009</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1570-1638 (Print)</isbn><accession-num>19275541</accession-num><abstract>Nanotechnology is a multidisciplinary scientific field undergoing explosive development. Nanometer-sized particles offer novel structural, optical and electronic properties that are not attainable with individual molecules or bulk solids. Advances in nanomedicine can be made by engineering biodegradable nanoparticles such as magnetic iron oxide nanoparticles, polymers, dendrimers and liposomes that are capable of targeted delivery of both imaging agents and anticancer drugs. This leads toward the concept and possibility of personalized medicine for the potential of early detection of cancer lesions, determination of molecular signatures of the tumor by noninvasive imaging and, most importantly, molecular targeted cancer therapy. Increasing evidence suggests that the nanoparticles, whose surface contains a targeting molecule that binds to receptors highly expressed in tumor cells, can serve as cancer image contrast agents to increase sensitivity and specificity in tumor detection. In comparison with other small molecule contrast agents, the advantage of using nanoparticles is their large surface area and the possibility of surface modifications for further conjugation or encapsulation of large amounts of therapeutic agents. Targeted nanoparticles ferry large doses of therapeutic agents into malignant cells while sparing the normal healthy cells. Such multifunctional nanodevices hold the promise of significant improvement of current clinical management of cancer patients. This review explores the development of nanoparticles for enabling and improving the targeted delivery of therapeutic agents, the potential of nanomedicine, and the development of novel and more effective diagnostic and screening techniques to extend the limits of molecular diagnostics providing point-of-care diagnosis and more personalized medicine.</abstract><notes>Sajja, Hari Krishna&#xD;East, Michael P&#xD;Mao, Hui&#xD;Wang, Y Andrew&#xD;Nie, Shuming&#xD;Yang, Lily&#xD;R01 CA095643-05/CA/NCI NIH HHS/United States&#xD;R01 CA133722-01/CA/NCI NIH HHS/United States&#xD;R01-CA95643/CA/NCI NIH HHS/United States&#xD;R01CA133722/CA/NCI NIH HHS/United States&#xD;U54 CA119338-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United Arab Emirates&#xD;Current drug discovery technologies&#xD;Curr Drug Discov Technol. 2009 Mar;6(1):43-51.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>na</custom4><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2353</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2353</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shigemura, K.</author><author>Isotani, S.</author><author>Wang, R.</author><author>Fujisawa, M.</author><author>Gotoh, A.</author><author>Marshall, F. F.</author><author>Zhau, H. E.</author><author>Chung, L. W.</author></authors></contributors><auth-address>Molecular Urology and Therapeutics Program, Department of Urology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase</title><secondary-title>Prostate</secondary-title></titles><periodical><full-title>Prostate</full-title></periodical><pages>949-55</pages><volume>69</volume><number>9</number><edition>2009/03/11</edition><keywords><keyword>Androgens/metabolism</keyword><keyword>Cell Communication/physiology</keyword><keyword>Cell Division/physiology</keyword><keyword>Coculture Techniques</keyword><keyword>Culture Media, Conditioned/pharmacology</keyword><keyword>Epithelial Cells/cytology/ metabolism</keyword><keyword>Extracellular Signal-Regulated MAP Kinases/metabolism</keyword><keyword>Fibroblasts/cytology/metabolism</keyword><keyword>Humans</keyword><keyword>Luciferases/metabolism</keyword><keyword>MAP Kinase Signaling System/ physiology</keyword><keyword>Male</keyword><keyword>Phosphorylation/physiology</keyword><keyword>Prostate-Specific Antigen/metabolism</keyword><keyword>Prostatic Neoplasms/ metabolism/ pathology</keyword><keyword>Receptors, Androgen/ metabolism</keyword><keyword>Serine/metabolism</keyword><keyword>Solubility</keyword><keyword>Stem Cells</keyword><keyword>Stromal Cells/cytology/ metabolism</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun 15</date></pub-dates></dates><isbn>1097-0045 (Electronic)</isbn><accession-num>19274665</accession-num><abstract>BACKGROUND: Accumulated evidence suggests stromal-epithelial interactions are critical to the progression of prostate cancer. In this study, we characterized AR phosphorylation in LNCaP cells co-cultured with the conditioned medium (CM) from human prostate stromal fibroblasts. METHODS: CM harvested from prostate stromal fibroblasts was added to LNCaP cells, and both anchorage-dependent and -independent growth was determined. Status of AR phosphorylation at Ser-81 and Ser-213 was assessed by immunoblot analysis. ERK kinase activity was measured using MBP-2 protein as the substrate. RESULTS: The growth of LNCaP cells on plastic dishes increased by 1.7-fold upon exposure to stromal CM or androgen, and their combination resulted in additive growth (2.4-fold). Anchorage-independent growth of LNCaP cells in soft agar, however, was induced synergistically at 80-fold by both stromal CM and androgen. Stromal CM or androgen alone induced LNCaP cell growth by 10- and 26-fold, respectively. We observed ERK kinase inhibitor, U0126, but not phosphatidylinositol 3-kinase (PI-3K), LY294002, or protein kinase A (PKA) inhibitor, H-89, inhibited stromal CM or androgen-induced PSA promoter luciferase activities, and anchorage-independent growth of LNCaP cells. Our results demonstrated for the first time how stromal CM acts in synergy with androgen by activation of ERK kinase and AR phosphorylation at Ser-81 but not Ser-213, for AR-regulated PSA promoter and anchorage-independent growth of human prostate cancer cells. CONCLUSIONS: A stromal factor-activated ERK pathway mediated by AR phosphorylation at Ser-81 could be responsible for stimulating the growth of human prostate cancer cells.</abstract><notes>Shigemura, Katsumi&#xD;Isotani, Shuji&#xD;Wang, Ruoxiang&#xD;Fujisawa, Masato&#xD;Gotoh, Akinobu&#xD;Marshall, Fray F&#xD;Zhau, Haiyen E&#xD;Chung, Leland W K&#xD;P01 CA098912/CA/NCI NIH HHS/United States&#xD;R01 CA108468/CA/NCI NIH HHS/United States&#xD;U54 CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;The Prostate&#xD;Prostate. 2009 Jun 15;69(9):949-55.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>3.258</custom4><electronic-resource-num>10.1002/pros.20944 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2394</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2394</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Meade, S. O.</author><author>Chen, M. Y.</author><author>Sailor, M. J.</author><author>Miskelly, G. M.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0358, USA.</auth-address><titles><title>Multiplexed DNA detection using spectrally encoded porous SiO2 photonic crystal particles</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>2618-25</pages><volume>81</volume><number>7</number><edition>2009/03/11</edition><keywords><keyword>Base Sequence</keyword><keyword>DNA/ analysis/genetics/metabolism</keyword><keyword>Electrochemistry</keyword><keyword>Fluorescent Dyes/chemistry</keyword><keyword>Light</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Molecular Sequence Data</keyword><keyword>Oligonucleotides/chemistry/genetics/metabolism</keyword><keyword>Oxidation-Reduction</keyword><keyword>Photons</keyword><keyword>Porosity</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Silanes/chemistry</keyword><keyword>Silicon Dioxide/ chemistry</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Temperature</keyword><keyword>Time Factors</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr 1</date></pub-dates></dates><isbn>1520-6882 (Electronic)</isbn><accession-num>19271746</accession-num><abstract>A particle-based multiplexed DNA assay based on encoded porous SiO(2) photonic crystal disks is demonstrated. A &quot;spectral barcode&quot; is generated by electrochemical etch of a single-crystal silicon wafer using a programmed current-time waveform. A lithographic procedure is used to isolate cylindrical microparticles 25 microm in diameter and 10 microm thick, which are then oxidized, modified with a silane linker, and conjugated to various amino-functionalized oligonucleotide probes via cyanuric chloride. It is shown that the particles can be decoded based on their reflectivity spectra and that a multiple analyte assay can be performed in a single sample with a modified fluorescence microscope. The homogeneity of the reflectivity and fluorescence spectra, both within and across the microparticles, is also reported.</abstract><notes>Meade, Shawn O&#xD;Chen, Michelle Y&#xD;Sailor, Michael J&#xD;Miskelly, Gordon M&#xD;U54 CA 119335/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2009 Apr 1;81(7):2618-25.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom2>2713104</custom2><custom3>NIHMS101840</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac802538x [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2201</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2201</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hasan, W.</author><author>Stender, C. L.</author><author>Lee, M. H.</author><author>Nehl, C. L.</author><author>Lee, J.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, Northwestern University, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Tailoring the structure of nanopyramids for optimal heat generation</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>1555-8</pages><volume>9</volume><number>4</number><edition>2009/03/11</edition><keywords><keyword>Gold/chemistry</keyword><keyword>Hot Temperature</keyword><keyword>Nanostructures</keyword><keyword>Spectroscopy, Near-Infrared</keyword><keyword>Surface Plasmon Resonance</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1530-6992 (Electronic)</isbn><accession-num>19271715</accession-num><abstract>This paper investigates how structural features of noble metal nanoparticles affect their photothermal properties. Using PEEL, we fabricated a range of Au nanopyramid-like particles with surface plasmon resonances tunable from visible to near-infrared wavelengths. By systematically varying geometric parameters including size, shell thickness, and presence or absence of tips, we determined which factors were most important in heat generation. For solutions with the same Au content, we discovered that pyramidal particles with thin shells and having sharp tips showed the largest photothermal response.</abstract><notes>Hasan, Warefta&#xD;Stender, Christopher L&#xD;Lee, Min Hyung&#xD;Nehl, Colleen L&#xD;Lee, Jeunghoon&#xD;DP1OD003899/DP/NCCDPHP CDC HHS/United States&#xD;U54CA119341/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2009 Apr;9(4):1555-8.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom2>2668542</custom2><custom3>NIHMS101819</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl803647n [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2271</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2271</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, J. H.</author><author>von Maltzahn, G.</author><author>Zhang, L.</author><author>Derfus, A. M.</author><author>Simberg, D.</author><author>Harris, T. J.</author><author>Ruoslahti, E.</author><author>Bhatia, S. N.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Materials Science and Engineering Program Department of Chemistry and Biochemistry University of California, San Diego 9500 Gilman, La Jolla, CA 92093, USA.</auth-address><titles><title>Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>694-700</pages><volume>5</volume><number>6</number><edition>2009/03/06</edition><keywords><keyword>Carcinoma/ metabolism/pathology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Drug Delivery Systems/ methods</keyword><keyword>Ferric Compounds</keyword><keyword>Humans</keyword><keyword>Magnetics/ methods</keyword><keyword>Materials Testing</keyword><keyword>Nanomedicine/ methods</keyword><keyword>Nanostructures/ chemistry/ ultrastructure</keyword><keyword>Particle Size</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2009</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>19263431</accession-num><abstract>In the design of nanoparticles that can target disease tissue in vivo, parameters such as targeting ligand density, type of target receptor, and nanoparticle shape can play an important role in determining the extent of accumulation. Herein, a systematic study of these parameters for the targeting of mouse xenograft tumors is performed using superparamagnetic iron oxide as a model nanoparticle system. The type of targeting peptide (recognizing cell surface versus extracellular matrix), the surface coverage of the peptide, its attachment chemistry, and the shape of the nanomaterial [elongated (nanoworm, NW) versus spherical (nanosphere, NS)] are varied. Nanoparticle circulation times and in vivo tumor-targeting efficiencies are quantified in two xenograft models of human tumors (MDA-MB-435 human carcinoma and HT1080 human fibrosarcoma). It is found that the in vivo tumor-targeting ability of the NW is superior to that of the NS, that the smaller, neutral CREKA targeting group is more effective than the larger, positively charged F3 molecule, that a maximum in tumor-targeting efficiency and blood half-life is observed with approximately 60 CREKA peptides per NW for either the HT1080 or the MDA-MB-435 tumor types, and that incorporation of a 5-kDa polyethylene glycol linker improves targeting to both tumor types relative to a short linker. It is concluded that the blood half-life of a targeting molecule-nanomaterial ensemble is a key consideration when selecting the appropriate ligand and nanoparticle chemistry for tumor targeting.</abstract><notes>Park, Ji-Ho&#xD;von Maltzahn, Geoffrey&#xD;Zhang, Lianglin&#xD;Derfus, Austin M&#xD;Simberg, Dmitri&#xD;Harris, Todd J&#xD;Ruoslahti, Erkki&#xD;Bhatia, Sangeeta N&#xD;Sailor, Michael J&#xD;R01CA124427-02/CA/NCI NIH HHS/United States&#xD;U01HL 080718/HL/NHLBI NIH HHS/United States&#xD;U54 CA 119335/CA/NCI NIH HHS/United States&#xD;U54CA119349/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2009 Mar;5(6):694-700.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200801789 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2526</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2526</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wu, J.</author><author>Sailor, M.</author></authors></contributors><auth-address>[Wu, Jianmin] Zhejiang Univ, Dept Chem, Hangzhou 310027, Peoples R China. [Sailor, Michael] Univ Calif San Diego, Dept Chem &amp; Biochem &amp; Bioengn, La Jolla, CA 92093 USA.&#xD;Wu, J, Zhejiang Univ, Dept Chem, Hangzhou 310027, Peoples R China.&#xD;msailor@ucsd.edu</auth-address><titles><title>Chitosan Hydrogel-Capped Porous SiO2 as a pH Responsive Nano-Valve for Triggered Release of Insulin</title><secondary-title>Advanced Functional Materials</secondary-title><alt-title>Adv. Funct. Mater.</alt-title></titles><periodical><full-title>Advanced Functional Materials</full-title></periodical><pages>733-741</pages><volume>19</volume><number>5</number><edition>2009/03</edition><keywords><keyword>INTERPENETRATING POLYMER NETWORKS</keyword><keyword>FOURIER-TRANSFORM SPECTROSCOPY</keyword><keyword>DRUG-DELIVERY APPLICATIONS</keyword><keyword>INORGANIC HYBRID MEMBRANE</keyword><keyword>MESOPOROUS</keyword><keyword>SILICA</keyword><keyword>PHOTONIC CRYSTALS</keyword><keyword>CARRIER SYSTEM</keyword><keyword>POLYELECTROLYTE</keyword><keyword>SENSITIVITY</keyword><keyword>GELS</keyword></keywords><dates><year>2009</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1616-301X</isbn><accession-num>ISI:000264502000008</accession-num><abstract>A pH responsive, chitosan-based hydrogel film is used to cap the pores of a porous SiO2 layer. The porous SiO2 layer is prepared by thermal oxidation of an electrochemically etched Si wafer, and the hydrogel film is prepared by reaction of chitosan with glycidoxypropyttrimethoxysilane (GPTMS). Optical reflectivity spectroscopy and scanning electron microscopy (SEM) confirm that the bio-polymer only partially infiltrates the porous SiO2 film, generating a double layer structure. The optical reflectivity spectrum displays Fabry-Perot interference fringes characteristic of a double layer, which is characterized using reflective interferometric Fourier transform spectroscopy (RIFTS). Monitoring the position of the RIFTS peak corresponding to the hydrogel layer allows direct, real-time observation of the reversible volume phase transition of the hydrogel upon cycling of pH In the range 6.0-7.4. The swelling ratio and response time are controlled by the relative amount of GPTMS in the hydrogel. The pl-l-dependent volume phase transition can be used to release insulin trapped in the porous SiO2 layer underneath the hydrogel film. At pH 7.4, the gel In the top layer effectively blocks insulin release, while at pH 6.0 Insulin penetrates the swollen hydrogel layer, resulting in a steady release into solution.</abstract><notes>ISI Document Delivery No.: 423NC&#xD;Times Cited: 0&#xD;Cited Reference Count: 51&#xD;Wu, Jianmin Sailor, Michael&#xD;WILEY-V C H VERLAG GMBH</notes><work-type>Article</work-type><urls><related-urls><url>&lt;Go to ISI&gt;://000264502000008</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>8.203</custom4><electronic-resource-num>10.1002/adfm.200800921</electronic-resource-num><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2530</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2530</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Luo Gu</author><author>Manuel Orosco</author><author>Michael J. Sailor</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Dr., La Jolla, California 92093, USA</auth-address><titles><title>Detection of protease activity by FRET using porous silicon as an energy acceptor</title><secondary-title>physica status solidi (a)</secondary-title></titles><periodical><full-title>physica status solidi (a)</full-title></periodical><pages>1374-1376</pages><volume>206</volume><number>6</number><edition>2009/03</edition><dates><year>2009</year></dates><isbn>1521-396X</isbn><notes>10.1002/pssa.200881065</notes><urls><related-urls><url>http://dx.doi.org/10.1002/pssa.200881065</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>1.179</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1839</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1839</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yong, K. T.</author><author>Ding, H.</author><author>Roy, I.</author><author>Law, W. C.</author><author>Bergey, E. J.</author><author>Maitra, A.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, University at Buffalo, The State University of New York, Buffalo, New York 14260-4200, USA. kyong2@buffalo.edu</auth-address><titles><title>Imaging pancreatic cancer using bioconjugated InP quantum dots</title><secondary-title>ACS Nano</secondary-title></titles><periodical><full-title>ACS Nano</full-title></periodical><pages>502-10</pages><volume>3</volume><number>3</number><edition>2009/02/27</edition><keywords><keyword>Antibodies, Monoclonal/metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Humans</keyword><keyword>Indium/*chemistry</keyword><keyword>Membrane Glycoproteins/metabolism</keyword><keyword>Membrane Proteins/metabolism</keyword><keyword>Microscopy, Confocal/*methods</keyword><keyword>Neoplasm Proteins/metabolism</keyword><keyword>Pancreatic Neoplasms/*diagnosis/pathology</keyword><keyword>Phosphines/*chemistry</keyword><keyword>*Quantum Dots</keyword><keyword>Sulfides/chemistry</keyword><keyword>Zinc Compounds/chemistry</keyword></keywords><dates><year>2009</year><pub-dates><date>Mar 24</date></pub-dates></dates><isbn>1936-086X (Electronic)</isbn><accession-num>19243145</accession-num><abstract>In this paper, we report the successful use of non-cadmium-based quantum dots (QDs) as highly efficient and nontoxic optical probes for imaging live pancreatic cancer cells. Indium phosphide (core)-zinc sulfide (shell), or InP/ZnS, QDs with high quality and bright luminescence were prepared by a hot colloidal synthesis method in nonaqueous media. The surfaces of these QDs were then functionalized with mercaptosuccinic acid to make them highly dispersible in aqueous media. Further bioconjugation with pancreatic cancer specific monoclonal antibodies, such as anticlaudin 4 and antiprostate stem cell antigen (anti-PSCA), to the functionalized InP/ZnS QDs, allowed specific in vitro targeting of pancreatic cancer cell lines (both immortalized and low passage ones). The receptor-mediated delivery of the bioconjugates was further confirmed by the observation of poor in vitro targeting in nonpancreatic cancer based cell lines which are negative for the claudin-4-receptor. These observations suggest the immense potential of InP/ZnS QDs as non-cadmium-based safe and efficient optical imaging nanoprobes in diagnostic imaging, particularly for early detection of cancer.</abstract><notes>Yong, Ken-Tye&#xD;Ding, Hong&#xD;Roy, Indrajit&#xD;Law, Wing-Cheung&#xD;Bergey, Earl J&#xD;Maitra, Anirban&#xD;Prasad, Paras N&#xD;R01CA119397/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;ACS nano&#xD;ACS Nano. 2009 Mar 24;3(3):502-10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19243145</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom4>5.472</custom4><electronic-resource-num>10.1021/nn8008933</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2200</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2200</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thurn, K. T.</author><author>Paunesku, T.</author><author>Wu, A.</author><author>Brown, E. M.</author><author>Lai, B.</author><author>Vogt, S.</author><author>Maser, J.</author><author>Aslam, M.</author><author>Dravid, V.</author><author>Bergan, R.</author><author>Woloschak, G. E.</author></authors></contributors><auth-address>Department of Radiation Oncology Northwestern University Feinberg School of Medicine Chicago, IL 60611, USA.</auth-address><titles><title>Labeling TiO2 nanoparticles with dyes for optical fluorescence microscopy and determination of TiO2-DNA nanoconjugate stability</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>1318-25</pages><volume>5</volume><number>11</number><edition>2009/02/27</edition><keywords><keyword>DNA/ chemistry</keyword><keyword>Fluorescent Dyes/ chemistry</keyword><keyword>Microscopy, Fluorescence/ methods</keyword><keyword>Nanoparticles/ chemistry</keyword><keyword>Nanotechnology/ methods</keyword><keyword>Titanium/ chemistry</keyword><keyword>X-Rays</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>19242946</accession-num><abstract>Visualization of nanoparticles without intrinsic optical fluorescence properties is a significant problem when performing intracellular studies. Such is the case with titanium dioxide (TiO2) nanoparticles. These nanoparticles, when electronically linked to single-stranded DNA oligonucleotides, have been proposed to be used both as gene knockout devices and as possible tumor imaging agents. By interacting with complementary target sequences in living cells, these photoinducible TiO2-DNA nanoconjugates have the potential to cleave intracellular genomic DNA in a sequence specific and inducible manner. The nanoconjugates also become detectable by magnetic resonance imaging with the addition of gadolinium Gd(III) contrast agents. Herein two approaches for labeling TiO2 nanoparticles and TiO2-DNA nanoconjugates with optically fluorescent agents are described. This permits direct quantification of fluorescently labeled TiO2 nanoparticle uptake in a large population of living cells (&gt;10(4) cells). X-ray fluorescence microscopy (XFM) is combined with fluorescent microscopy to determine the relative intracellular stability of the nanoconjugates and used to quantify intracellular nanoparticles. Imaging the DNA component of the TiO2-DNA nanoconjugate by fluorescent confocal microscopy within the same cell shows an overlap with the titanium signal as mapped by XFM. This strongly implies the intracellular integrity of the TiO2-DNA nanoconjugates in malignant cells.</abstract><notes>Thurn, Kenneth T&#xD;Paunesku, Tatjana&#xD;Wu, Aiguo&#xD;Brown, Eric M B&#xD;Lai, Barry&#xD;Vogt, Stefan&#xD;Maser, Jorg&#xD;Aslam, Mohammed&#xD;Dravid, Vinayak&#xD;Bergan, Raymond&#xD;Woloschak, Gayle E&#xD;CA107467/CA/NCI NIH HHS/United States&#xD;EB002100/EB/NIBIB NIH HHS/United States&#xD;P50 CA89018/CA/NCI NIH HHS/United States&#xD;U54CA119341/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2009 Jun;5(11):1318-25.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200801458 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1904</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1904</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Law, W. C.</author><author>Yong, K. T.</author><author>Roy, I.</author><author>Ding, H.</author><author>Hu, R.</author><author>Zhao, W.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>The Institute for Lasers, Photonics and Biophotonics and Department of Electrical Engineering The State University of New York at Buffalo Buffalo, NY 14260-4200, USA.</auth-address><titles><title>Aqueous-phase synthesis of highly luminescent CdTe/ZnTe core/shell quantum dots optimized for targeted bioimaging</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>1302-10</pages><volume>5</volume><number>11</number><edition>2009/02/27</edition><keywords><keyword>Cadmium/ chemistry</keyword><keyword>Diagnostic Imaging/ methods</keyword><keyword>Luminescence</keyword><keyword>Nanotechnology/ methods</keyword><keyword>Quantum Dots</keyword><keyword>Tellurium/ chemistry</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>19242947</accession-num><abstract>Semiconductor quantum dots (QDs) have traditionally been synthesized in organic phase and transferred to aqueous solution by functionalizing their surface with silica, polymers, short-chain thiol ligand, or phospholipid micelles. However, these complex steps result in i) a reduction of the quantum yield (QY) of QDs, ii) partial degrdation of the QDs, and iii) a drastic increase in the hydrodynamic size of QDs, which may hinder their biomedical applications. In this work, the fabrication and applications of cysteine-capped CdTe/ZnTe QDs, which are directly synthesized in aqueous media, as optical probes for specific targeting of pancreatic and esophageal cancer cells in vitro are reported, as well as their capability for in vivo imaging. The CdTe/ZnTe QDs are synthesized in a one-pot method and capped with amino acid cysteine, which contains both carboxyl and amine functional groups on their surfaces for bioconjugation. The fabricated QDs have an ultrasmall hydrodynamic diameter (3-5 nm), possess high QY (52%), and are non-toxic to cells at experimental dosages. Confocal imaging is used to demonstrate a receptor-mediated uptake of antibody-conjugated QDs into pancreatic cancer cells in vitro. In vitro cytotoxicity studies (MTS-assay) show that the IC(50) value of these QDs is approximately 160 microg mL(-1), demonstrating low toxicity. In addition, the QDs are used for small-animal imaging where the in vivo biocompatiblity of these QDs and their clearance following systemic injection is studied.</abstract><notes>Law, Wing-Cheung&#xD;Yong, Ken-Tye&#xD;Roy, Indrajit&#xD;Ding, Hong&#xD;Hu, Rui&#xD;Zhao, Weiwei&#xD;Prasad, Paras N&#xD;R01CA119397/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2009 Jun;5(11):1302-10.</notes><urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200801555 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2270</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2270</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hu, Y.</author><author>Atukorale, P. U.</author><author>Lu, J. J.</author><author>Moon, J. J.</author><author>Um, S. H.</author><author>Cho, E. C.</author><author>Wang, Y.</author><author>Chen, J.</author><author>Irvine, D. J.</author></authors></contributors><auth-address>Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Cytosolic delivery mediated via electrostatic surface binding of protein, virus, or siRNA cargos to pH-responsive core-shell gel particles</title><secondary-title>Biomacromolecules</secondary-title></titles><periodical><full-title>Biomacromolecules</full-title></periodical><pages>756-65</pages><volume>10</volume><number>4</number><edition>2009/02/26</edition><dates><year>2009</year><pub-dates><date>Apr 13</date></pub-dates></dates><isbn>1526-4602 (Electronic)</isbn><accession-num>19239276</accession-num><abstract>We recently described a strategy for intracellular delivery of macromolecules, utilizing pH-responsive &quot;core-shell&quot; structured gel particles. These cross-linked hydrogel particles disrupt endosomes with low toxicity by virtue of physical sequestration of an endosome-disrupting &quot;proton sponge&quot; core inside a nontoxic hydrophilic shell. Here we tested the efficacy of this system for cytosolic delivery of a broad range of macromolecular cargos, and demonstrate the delivery of proteins, whole viral particles, or siRNA oligonucleotides into the cytosol of dendritic cells and epithelial cells via core-shell particles. We assessed the functional impact of particle delivery for vaccine applications and found that cytosolic delivery of protein antigens in dendritic cells via the core-shell particles promotes priming of CD8(+) T-cells at 100-fold lower doses than soluble protein. Functional gene knockdown following delivery of siRNA using the particles was demonstrated in epithelial cells. Based on these findings, these materials may be of interest for a broad range of biomedical applications.</abstract><notes>Hu, Yuhua&#xD;Atukorale, Prabhani U&#xD;Lu, James J&#xD;Moon, James J&#xD;Um, Soong Ho&#xD;Cho, Eun Chol&#xD;Wang, Yana&#xD;Chen, Jianzhu&#xD;Irvine, Darrell J&#xD;CA112967/CA/NCI NIH HHS/United States&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;Howard Hughes Medical Institute/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Biomacromolecules&#xD;Biomacromolecules. 2009 Apr 13;10(4):756-65.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>4.658</custom4><electronic-resource-num>10.1021/bm801199z [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2269</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2269</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, J. H.</author><author>Gu, L.</author><author>von Maltzahn, G.</author><author>Ruoslahti, E.</author><author>Bhatia, S. N.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, USA.</auth-address><titles><title>Biodegradable luminescent porous silicon nanoparticles for in vivo applications</title><secondary-title>Nat Mater</secondary-title></titles><periodical><full-title>Nat Mater</full-title></periodical><pages>331-6</pages><volume>8</volume><number>4</number><edition>2009/02/24</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/administration &amp; dosage</keyword><keyword>Biocompatible Materials</keyword><keyword>Doxorubicin/administration &amp; dosage</keyword><keyword>Drug Carriers</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Luminescence</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Nanoparticles</keyword><keyword>Silicon</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1476-1122 (Print)</isbn><accession-num>19234444</accession-num><abstract>Nanomaterials that can circulate in the body hold great potential to diagnose and treat disease. For such applications, it is important that the nanomaterials be harmlessly eliminated from the body in a reasonable period of time after they carry out their diagnostic or therapeutic function. Despite efforts to improve their targeting efficiency, significant quantities of systemically administered nanomaterials are cleared by the mononuclear phagocytic system before finding their targets, increasing the likelihood of unintended acute or chronic toxicity. However, there has been little effort to engineer the self-destruction of errant nanoparticles into non-toxic, systemically eliminated products. Here, we present luminescent porous silicon nanoparticles (LPSiNPs) that can carry a drug payload and of which the intrinsic near-infrared photoluminescence enables monitoring of both accumulation and degradation in vivo. Furthermore, in contrast to most optically active nanomaterials (carbon nanotubes, gold nanoparticles and quantum dots), LPSiNPs self-destruct in a mouse model into renally cleared components in a relatively short period of time with no evidence of toxicity. As a preliminary in vivo application, we demonstrate tumour imaging using dextran-coated LPSiNPs (D-LPSiNPs). These results demonstrate a new type of multifunctional nanostructure with a low-toxicity degradation pathway for in vivo applications.</abstract><notes>Park, Ji-Ho&#xD;Gu, Luo&#xD;von Maltzahn, Geoffrey&#xD;Ruoslahti, Erkki&#xD;Bhatia, Sangeeta N&#xD;Sailor, Michael J&#xD;5-R01-CA124427/CA/NCI NIH HHS/United States&#xD;U54 CA 119335/CA/NCI NIH HHS/United States&#xD;U54 CA119349/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nature materials&#xD;Nat Mater. 2009 Apr;8(4):331-6. Epub 2009 Feb 22.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom4>25.759</custom4><electronic-resource-num>nmat2398 [pii]&#xD;10.1038/nmat2398 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1956</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1956</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tkaczyk, E. R.</author><author>Zhong, C. F.</author><author>Ye, J. Y.</author><author>Myc, A.</author><author>Thomas, T.</author><author>Cao, Z.</author><author>Duran-Struuck, R.</author><author>Luker, K. E.</author><author>Luker, G. D.</author><author>Norris, T. B.</author><author>Baker, J. R.</author></authors></contributors><auth-address>Center for Ultrafast Optical Science, EECS Department, University of Michigan, 2200 Bonisteel Blvd., Ann Arbor, MI 48109-2099.</auth-address><titles><title>In Vivo Monitoring of Multiple Circulating Cell Populations Using Two-photon Flow Cytometry</title><secondary-title>Opt Commun</secondary-title></titles><periodical><full-title>Opt Commun</full-title></periodical><pages>888-894</pages><volume>281</volume><number>4</number><edition>2009/02/18</edition><dates><year>2008</year><pub-dates><date>Feb 15</date></pub-dates></dates><isbn>0030-4018 (Print)</isbn><accession-num>19221581</accession-num><abstract>To detect and quantify multiple distinct populations of cells circulating simultaneously in the blood of living animals, we developed a novel optical system for two-channel, two-photon flow cytometry in vivo. We used this system to investigate the circulation dynamics in live animals of breast cancer cells with low (MCF-7) and high (MDA-MB-435) metastatic potential, showing for the first time that two different populations of circulating cells can be quantified simultaneously in the vasculature of a single live mouse. We also non-invasively monitored a population of labeled, circulating red blood cells for more than two weeks, demonstrating that this technique can also quantify the dynamics of abundant cells in the vascular system for prolonged periods of time. These data are the first in vivo application of multichannel flow cytometry utilizing two-photon excitation, which will greatly enhance our capability to study circulating cells in cancer and other disease processes.</abstract><notes>R01 CA119409-01/NCI NIH HHS/United States&#xD;R01 CA119409-02/NCI NIH HHS/United States&#xD;R01 CA119409-03/NCI NIH HHS/United States&#xD;R33 CA112141-01A1/NCI NIH HHS/United States&#xD;R33 CA112141-02/NCI NIH HHS/United States&#xD;R33 CA112141-03/NCI NIH HHS/United States&#xD;Optics communications&#xD;Opt Commun. 2008 Feb 15;281(4):888-894.</notes><urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom2>2352153</custom2><custom3>NIHMS38674</custom3><custom4>1.570</custom4><electronic-resource-num>10.1016/j.optcom.2007.10.106 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2114</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2114</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xia, Z.</author><author>Rao, J.</author></authors></contributors><auth-address>Department of Radiology &amp; Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305-5484, USA.</auth-address><titles><title>Biosensing and imaging based on bioluminescence resonance energy transfer</title><secondary-title>Curr Opin Biotechnol</secondary-title></titles><periodical><full-title>Curr Opin Biotechnol</full-title></periodical><pages>37-44</pages><volume>20</volume><number>1</number><edition>2009/02/14</edition><keywords><keyword>Biosensing Techniques/ methods</keyword><keyword>Energy Transfer</keyword><keyword>Fluorescence Resonance Energy Transfer/ methods</keyword><keyword>Luminescent Measurements/ methods</keyword><keyword>Luminescent Proteins/chemistry</keyword><keyword>Models, Theoretical</keyword><keyword>Nanotechnology/methods</keyword><keyword>Quantum Dots</keyword></keywords><dates><year>2009</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1879-0429 (Electronic)</isbn><accession-num>19216068</accession-num><abstract>Bioluminescence resonance energy transfer (BRET) operates with biochemical energy generated by bioluminescent proteins to excite fluorophores and offers additional advantages over fluorescence energy transfer (FRET) for in vivo imaging and biosensing. While fluorescent proteins are frequently used as BRET acceptors, both small molecule dyes and nanoparticles can also serve as acceptor fluorophores. Semiconductor fluorescent nanocrystals or quantum dots (QDs) are particularly well suited for use as BRET acceptors due to their high quantum yields, large Stokes shifts and long wavelength emission. This review examines the potential of QDs for BRET-based bioassays and imaging, and highlights examples of QD-BRET for biosensing and imaging applications. Future development of new BRET acceptors should further expand the multiplexing capability of BRET and improve its applicability and sensitivity for in vivo imaging applications.</abstract><notes>Xia, Zuyong&#xD;Rao, Jianghong&#xD;1R01CA135294-01/CA/NCI NIH HHS/United States&#xD;1U54CA119367-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;England&#xD;Current opinion in biotechnology&#xD;Curr Opin Biotechnol. 2009 Feb;20(1):37-44. Epub 2009 Feb 11.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom2>2680468</custom2><custom3>NIHMS93505</custom3><custom4>7.744</custom4><electronic-resource-num>S0958-1669(09)00002-0 [pii]&#xD;10.1016/j.copbio.2009.01.001 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2352</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2352</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Phan, J. H.</author><author>Yin-Goen, Q.</author><author>Young, A. N.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, 313 Ferst Drive, Atlanta, GA 30332, USA.</auth-address><titles><title>Improving the efficiency of biomarker identification using biological knowledge</title><secondary-title>Pac Symp Biocomput</secondary-title></titles><periodical><full-title>Pac Symp Biocomput</full-title></periodical><pages>427-38</pages><edition>2009/02/13</edition><keywords><keyword>Biological Markers</keyword><keyword>Biometry</keyword><keyword>Databases, Genetic</keyword><keyword>Genetic Markers</keyword><keyword>Humans</keyword><keyword>Kidney Neoplasms/classification/genetics</keyword><keyword>Knowledge Bases</keyword><keyword>Neoplasms/classification/genetics</keyword><keyword>Oligonucleotide Array Sequence Analysis/statistics &amp; numerical data</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction/statistics &amp; numerical data</keyword><keyword>Tumor Markers, Biological/genetics</keyword></keywords><dates><year>2009</year></dates><isbn>1793-5091 (Print)</isbn><accession-num>19209720</accession-num><abstract>Identifying and validating biomarkers from high-throughput gene expression data is important for understanding and treating cancer. Typically, we identify candidate biomarkers as features that are differentially expressed between two or more classes of samples. Many feature selection metrics rely on ranking by some measure of differential expression. However, interpreting these results is difficult due to the large variety of existing algorithms and metrics, each of which may produce different results. Consequently, a feature ranking metric may work well on some datasets but perform considerably worse on others. We propose a method to choose an optimal feature ranking metric on an individual dataset basis. A metric is optimal if, for a particular dataset, it favorably ranks features that are known to be relevant biomarkers. Extensive knowledge of biomarker candidates is available in public databases and literature. Using this knowledge, we can choose a ranking metric that produces the most biologically meaningful results. In this paper, we first describe a framework for assessing the ability of a ranking metric to detect known relevant biomarkers. We then apply this method to clinical renal cancer microarray data to choose an optimal metric and identify several candidate biomarkers.</abstract><notes>Phan, John H&#xD;Yin-Goen, Qiqin&#xD;Young, Andrew N&#xD;Wang, May D&#xD;P20GM072069/GM/NIGMS NIH HHS/United States&#xD;R01CA108468/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Validation Studies&#xD;Singapore&#xD;Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing&#xD;Pac Symp Biocomput. 2009:427-38.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>na</custom4><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2267</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2267</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, L.</author><author>Chan, J. M.</author><author>Gu, F. X.</author><author>Rhee, J. W.</author><author>Wang, A. Z.</author><author>Radovic-Moreno, A. F.</author><author>Alexis, F.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Department of Chemical Engineering, Division of Health Science and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform</title><secondary-title>ACS Nano</secondary-title></titles><periodical><full-title>ACS Nano</full-title></periodical><pages>1696-702</pages><volume>2</volume><number>8</number><edition>2009/02/12</edition><keywords><keyword>Crystallization/methods</keyword><keyword>Diffusion</keyword><keyword>Drug Carriers/ chemistry</keyword><keyword>Drug Design</keyword><keyword>Hydrophobicity</keyword><keyword>Lipids/ chemistry</keyword><keyword>Macromolecular Substances/chemistry</keyword><keyword>Materials Testing</keyword><keyword>Molecular Conformation</keyword><keyword>Nanomedicine/methods</keyword><keyword>Nanostructures/ chemistry/ ultrastructure</keyword><keyword>Particle Size</keyword><keyword>Pharmaceutical Preparations/administration &amp; dosage/ chemistry</keyword><keyword>Polymers/ chemistry</keyword><keyword>Solubility</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1936-086X (Electronic)</isbn><accession-num>19206374</accession-num><abstract>We report the engineering of a novel lipid-polymer hybrid nanoparticle (NP) as a robust drug delivery platform, with high drug encapsulation yield, tunable and sustained drug release profile, excellent serum stability, and potential for differential targeting of cells or tissues. The NP comprises three distinct functional components: (i) a hydrophobic polymeric core where poorly water-soluble drugs can be encapsulated; (ii) a hydrophilic polymeric shell with antibiofouling properties to enhance NP stability and systemic circulation half-life; and (iii) a lipid monolayer at the interface of the core and the shell that acts as a molecular fence to promote drug retention inside the polymeric core, thereby enhancing drug encapsulation efficiency, increasing drug loading yield, and controlling drug release. The NP is prepared by self-assembly through a single-step nanoprecipitation method in a reproducible and predictable manner, making it potentially suitable for scale-up.</abstract><notes>Zhang, Liangfang&#xD;Chan, Juliana M&#xD;Gu, Frank X&#xD;Rhee, June-Wha&#xD;Wang, Andrew Z&#xD;Radovic-Moreno, Aleksandar F&#xD;Alexis, Frank&#xD;Langer, Robert&#xD;Farokhzad, Omid C&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;EB003647/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;ACS nano&#xD;ACS Nano. 2008 Aug;2(8):1696-702.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>5.472</custom4><electronic-resource-num>10.1021/nn800275r [doi]&#xD;10.1021/nn800275r [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2351</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2351</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yang, L.</author><author>Mao, H.</author><author>Cao, Z.</author><author>Wang, Y. A.</author><author>Peng, X.</author><author>Wang, X.</author><author>Sajja, H. K.</author><author>Wang, L.</author><author>Duan, H.</author><author>Ni, C.</author><author>Staley, C. A.</author><author>Wood, W. C.</author><author>Gao, X.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Surgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA. lyang02@emory.edu</auth-address><titles><title>Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles</title><secondary-title>Gastroenterology</secondary-title></titles><periodical><full-title>Gastroenterology</full-title></periodical><pages>1514-25 e2</pages><volume>136</volume><number>5</number><edition>2009/02/12</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Humans</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Nanoparticles/ diagnostic use</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Pancreatic Neoplasms/ diagnosis/metabolism</keyword><keyword>Receptors, Urokinase Plasminogen Activator/ metabolism</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Spectroscopy, Near-Infrared</keyword></keywords><dates><year>2009</year><pub-dates><date>May</date></pub-dates></dates><isbn>1528-0012 (Electronic)</isbn><accession-num>19208341</accession-num><abstract>BACKGROUND &amp; AIMS: Identification of a ligand/receptor system that enables functionalized nanoparticles to efficiently target pancreatic cancer holds great promise for the development of novel approaches for the detection and treatment of pancreatic cancer. Urokinase plasminogen activator receptor (uPAR), a cellular receptor that is highly expressed in pancreatic cancer and tumor stromal cells, is an excellent surface molecule for receptor-targeted imaging of pancreatic cancer using multifunctional nanoparticles. METHODS: The uPAR-targeted dual-modality molecular imaging nanoparticle probe is designed and prepared by conjugating a near-infrared dye-labeled amino-terminal fragment of the receptor binding domain of urokinase plasminogen activator to the surface of functionalized magnetic iron oxide nanoparticles. RESULTS: We have shown that the systemic delivery of uPAR-targeted nanoparticles leads to their selective accumulation within tumors of orthotopically xenografted human pancreatic cancer in nude mice. The uPAR-targeted nanoparticle probe binds to and is subsequently internalized by uPAR-expressing tumor cells and tumor-associated stromal cells, which facilitates the intratumoral distribution of the nanoparticles and increases the amount and retention of the nanoparticles in a tumor mass. Imaging properties of the nanoparticles enable in vivo optical and magnetic resonance imaging of uPAR-elevated pancreatic cancer lesions. CONCLUSIONS: Targeting uPAR using biodegradable multifunctional nanoparticles allows for the selective delivery of the nanoparticles into primary and metastatic pancreatic cancer lesions. This novel receptor-targeted nanoparticle is a potential molecular imaging agent for the detection of pancreatic cancer.</abstract><notes>Yang, Lily&#xD;Mao, Hui&#xD;Cao, Zehong&#xD;Wang, Y Andrew&#xD;Peng, Xianghong&#xD;Wang, Xiaoxia&#xD;Sajja, Hari K&#xD;Wang, Liya&#xD;Duan, Hongwei&#xD;Ni, Chunchun&#xD;Staley, Charles A&#xD;Wood, William C&#xD;Gao, Xiaohu&#xD;Nie, Shuming&#xD;U54 CA119338-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Gastroenterology&#xD;Gastroenterology. 2009 May;136(5):1514-25.e2. Epub 2009 Jan 14.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>12.716</custom4><electronic-resource-num>S0016-5085(09)00012-2 [pii]&#xD;10.1053/j.gastro.2009.01.006 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2392</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2392</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wu, E. C.</author><author>Park, J. H.</author><author>Park, J.</author><author>Segal, E.</author><author>Cunin, F.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Department of Bioengineering, University of California, San Diego, La Jolla, California 92093, USA.</auth-address><titles><title>Oxidation-triggered release of fluorescent molecules or drugs from mesoporous Si microparticles</title><secondary-title>ACS Nano</secondary-title></titles><periodical><full-title>ACS Nano</full-title></periodical><pages>2401-9</pages><volume>2</volume><number>11</number><edition>2009/02/12</edition><keywords><keyword>Antineoplastic Agents/ administration &amp; dosage</keyword><keyword>Doxorubicin/ administration &amp; dosage</keyword><keyword>Drug Delivery Systems</keyword><keyword>Fluorescent Dyes/ chemistry</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Hydrazines/chemistry</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Oxygen/ chemistry</keyword><keyword>Particle Size</keyword><keyword>Peroxynitrous Acid/chemistry</keyword><keyword>Porosity</keyword><keyword>Silicon/ chemistry</keyword><keyword>Silicon Dioxide/chemistry</keyword><keyword>Spectroscopy, Fourier Transform Infrared</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov 25</date></pub-dates></dates><isbn>1936-086X (Electronic)</isbn><accession-num>19206408</accession-num><abstract>The fluorescent dye Alexa Fluor 488 or the anticancer drug doxorubicin is attached to the surface and inner pore walls of mesoporous Si particles by covalent attachment, and the oxidation-induced release of each molecule is studied. The molecules are bound to the Si matrix using a 10-undecenoic acid linker, which is attached by thermal hydrosilylation. Loading capacity of the microparticles using this method is approximately 0.5 and 45 mg/g of porous Si microparticle for Alexa Fluor 488 and doxorubicin, respectively. The Si-C-bound assembly is initially stable in aqueous solution, although oxidation of the underlying Si matrix results in conversion to silicon oxide and slow release of the linker-molecule complex by hydrolysis of the Si-O attachment points. When the attached molecule is a fluorophore (Alexa Fluor 488 or doxorubicin), its fluorescence is effectively quenched by the semiconducting silicon matrix. As the particle oxidizes in water, the fluorescence intensity of the attached dye increases due to growth of the insulating silicon oxide layer and, ultimately, dye release from the surface. The recovery of fluorescence in the microparticle and the release of the molecule into solution are monitored in real-time by fluorescence microscopy. Both processes are accelerated by introduction of the oxidizing species peroxynitrite to the aqueous solution. The oxidation-triggered release of the anticancer drug doxorubicin to HeLa cells is demonstrated.</abstract><notes>Wu, Elizabeth C&#xD;Park, Ji-Ho&#xD;Park, Jennifer&#xD;Segal, Ester&#xD;Cunin, Frederique&#xD;Sailor, Michael J&#xD;U54 CA 119335/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;ACS nano&#xD;ACS Nano. 2008 Nov 25;2(11):2401-9.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom2>2664163</custom2><custom3>NIHMS91177</custom3><custom4>5.472</custom4><electronic-resource-num>10.1021/nn800592q [doi]&#xD;10.1021/nn800592q [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1902</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1902</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Erogbogbo, F.</author><author>Yong, K. T.</author><author>Roy, I.</author><author>Xu, G.</author><author>Prasad, P. N.</author><author>Swihart, M. T.</author></authors></contributors><auth-address>Department of Chemical and Biological Engineering, University at Buffalo (SUNY), Buffalo, New York 14260-4200, USA.</auth-address><titles><title>Biocompatible luminescent silicon quantum dots for imaging of cancer cells</title><secondary-title>ACS Nano</secondary-title></titles><periodical><full-title>ACS Nano</full-title></periodical><pages>873-8</pages><volume>2</volume><number>5</number><edition>2009/02/12</edition><keywords><keyword>Biocompatible Materials/ chemistry/ diagnostic use</keyword><keyword>Cell Line, Tumor</keyword><keyword>Contrast Media/ chemistry</keyword><keyword>Humans</keyword><keyword>Image Enhancement/methods</keyword><keyword>Luminescent Measurements/ methods</keyword><keyword>Pancreatic Neoplasms/ pathology</keyword><keyword>Quantum Dots</keyword><keyword>Silicon/ chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1936-086X (Electronic)</isbn><accession-num>19206483</accession-num><abstract>Luminescent silicon quantum dots (Si QDs) have great potential for use in biological imaging and diagnostic applications. To exploit this potential, they must remain luminescent and stably dispersed in water and biological fluids over a wide range of pH and salt concentration. There have been many challenges in creating such stable water-dispersible Si QDs, including instability of photoluminescence due their fast oxidation in aqueous environments and the difficulty of attaching hydrophilic molecules to Si QD surfaces. In this paper, we report the preparation of highly stable aqueous suspensions of Si QDs using phospholipid micelles, in which the optical properties of Si nanocrystals are retained. These luminescent micelle-encapsulated Si QDs were used as luminescent labels for pancreatic cancer cells. This paves the way for silicon quantum dots to be a valuable optical probe in biomedical diagnostics.</abstract><notes>Erogbogbo, Folarin&#xD;Yong, Ken-Tye&#xD;Roy, Indrajit&#xD;Xu, Gaixia&#xD;Prasad, Paras N&#xD;Swihart, Mark T&#xD;R01 CA119397-03/CA/NCI NIH HHS/United States&#xD;R01 CA119397-04/CA/NCI NIH HHS/United States&#xD;R01CA119397/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;ACS nano&#xD;ACS Nano. 2008 May;2(5):873-8.</notes><urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom2>2676166</custom2><custom3>NIHMS99602</custom3><custom4>5.472</custom4><electronic-resource-num>10.1021/nn700319z [doi]&#xD;10.1021/nn700319z [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1996</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1996</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Laing, R. E.</author><author>Walter, M. A.</author><author>Campbell, D. O.</author><author>Herschman, H. R.</author><author>Satyamurthy, N.</author><author>Phelps, M. E.</author><author>Czernin, J.</author><author>Witte, O. N.</author><author>Radu, C. G.</author></authors></contributors><auth-address>Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.</auth-address><titles><title>Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>2847-52</pages><volume>106</volume><number>8</number><edition>2009/02/07</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/pharmacokinetics/ therapeutic use</keyword><keyword>Cytosine/analogs &amp; derivatives</keyword><keyword>Deoxycytidine/ analogs &amp; derivatives/pharmacokinetics/therapeutic use</keyword><keyword>Humans</keyword><keyword>Leukemia/drug therapy/ radionuclide imaging</keyword><keyword>Mice</keyword><keyword>Positron-Emission Tomography</keyword></keywords><dates><year>2009</year><pub-dates><date>Feb 24</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>19196993</accession-num><abstract>Gemcitabine (2&apos;,2&apos;-difluorodeoxycytidine, dFdC) and cytosine arabinoside (cytarabine, ara-C) represent a class of nucleoside analogs used in cancer chemotherapy. Administered as prodrugs, dFdC and ara-C are transported across cell membranes and are converted to cytotoxic derivatives through consecutive phosphorylation steps catalyzed by endogenous nucleoside kinases. Deoxycytidine kinase (DCK) controls the rate-limiting step in the activation cascade of dFdC and ara-C. DCK activity varies significantly among individuals and across different tumor types and is a critical determinant of tumor responses to these prodrugs. Current assays to measure DCK expression and activity require biopsy samples and are prone to sampling errors. Noninvasive methods that can detect DCK activity in tumor lesions throughout the body could circumvent these limitations. Here, we demonstrate an approach to detecting DCK activity in vivo by using positron emission tomography (PET) and (18)F-labeled 1-(2&apos;-deoxy-2&apos;-fluoroarabinofuranosyl) cytosine] ([(18)F]FAC), a PET probe recently developed by our group. We show that [(18)F]FAC is a DCK substrate with an affinity similar to that of dFdC. In vitro, accumulation of [(18)F]FAC in murine and human leukemia cell lines is critically dependent on DCK activity and correlates with dFdC sensitivity. In mice, [(18)F]FAC accumulates selectively in DCK-positive vs. DCK-negative tumors, and [(18)F]FAC microPET scans can predict responses to dFdC. We suggest that [(18)F]FAC PET might be useful for guiding treatment decisions in certain cancers by enabling individualized chemotherapy.</abstract><notes>Laing, Rachel E&#xD;Walter, Martin A&#xD;Campbell, Dean O&#xD;Herschman, Harvey R&#xD;Satyamurthy, Nagichettiar&#xD;Phelps, Michael E&#xD;Czernin, Johannes&#xD;Witte, Owen N&#xD;Radu, Caius G&#xD;5U54 CA119347/CA/NCI NIH HHS/United States&#xD;P50 CA86306/CA/NCI NIH HHS/United States&#xD;R24CA92865/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2847-52. Epub 2009 Feb 5.</notes><urls></urls><custom1>CCNE - Caltech</custom1><custom2>2636738</custom2><custom4>10.228</custom4><electronic-resource-num>0812890106 [pii]&#xD;10.1073/pnas.0812890106 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2265</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2265</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Salvador-Morales, C.</author><author>Gao, W.</author><author>Ghatalia, P.</author><author>Murshed, F.</author><author>Aizu, W.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Laboratory of Nanomedicine and Biomaterials, Department of Anaesthesia, Brigham and Women&apos;s Hospital, Harvard Medical School, Boston, MA 02115, USA.</auth-address><titles><title>Multifunctional nanoparticles for prostate cancer therapy</title><secondary-title>Expert Rev Anticancer Ther</secondary-title></titles><periodical><full-title>Expert Rev Anticancer Ther</full-title></periodical><pages>211-21</pages><volume>9</volume><number>2</number><edition>2009/02/06</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/administration &amp; dosage</keyword><keyword>Clinical Trials as Topic</keyword><keyword>Gene Therapy/methods</keyword><keyword>Humans</keyword><keyword>Hyperthermia, Induced/methods</keyword><keyword>Male</keyword><keyword>Nanoparticles</keyword><keyword>Neoplasm Staging</keyword><keyword>Prostatic Neoplasms/physiopathology/ therapy</keyword></keywords><dates><year>2009</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1744-8328 (Electronic)</isbn><accession-num>19192959</accession-num><abstract>Multifunctional nanoparticles promise significantly better treatment for prostate cancer. This review begins with a molecular and physiological overview of prostate cancer, including current treatments in various stages of disease development. Emerging nanoparticle technology in chemotherapy, hyperthermia therapy and gene therapy will be discussed. We highlight novel advances in nanoparticle technology for prostate cancer and indicate future challenges in the rational design of multifunctional nanoparticles, such as understanding tumor characteristics and the activation of the complement system.</abstract><notes>Salvador-Morales, Carolina&#xD;Gao, Weiwei&#xD;Ghatalia, Pooja&#xD;Murshed, Farhan&#xD;Aizu, Wataru&#xD;Langer, Robert&#xD;Farokhzad, Omid C&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;EB003647/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;England&#xD;Expert review of anticancer therapy&#xD;Expert Rev Anticancer Ther. 2009 Feb;9(2):211-21.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>1.988</custom4><electronic-resource-num>10.1586/14737140.9.2.211 [doi]&#xD;10.1586/14737140.9.2.211 [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1417</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1417</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lu, W.</author><author>Xiong, C.</author><author>Zhang, G.</author><author>Huang, Q.</author><author>Zhang, R.</author><author>Zhang, J. Z.</author><author>Li, C.</author></authors></contributors><auth-address>Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.</auth-address><titles><title>Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres</title><secondary-title>Clin Cancer Res</secondary-title></titles><periodical><full-title>Clin Cancer Res</full-title></periodical><pages>876-86</pages><volume>15</volume><number>3</number><edition>2009/02/04</edition><dates><year>2009</year><pub-dates><date>Feb 1</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>19188158</accession-num><abstract>PURPOSE: To develop melanoma-targeted hollow gold nanospheres (HAuNS) and evaluate their potential utility for selective photothermal ablation in melanoma. EXPERIMENTAL DESIGN: A new class of photothermal coupling agents based on HAuNS was synthesized. HAuNS were stabilized with polyethylene glycol (PEG) coating and attached with alpha-melanocyte-stimulating hormone (MSH) analog, [Nle4,D-Phe7]alpha-MSH (NDP-MSH), which is a potent agonist of melanocortin type-1 receptor overexpressed in melanoma. The intracellular uptake of the NDP-MSH-conjugated PEGylated HAuNS (NDP-MSH-PEG-HAuNS) and the distribution of beta-arrestin were examined in murine B16/F10 melanoma cells. The biodistribution of NDP-MSH-PEG-HAuNS was assessed at 4 hours post i.v. injection in tumor-bearing nude mice. Photothermal ablation effect of the nanoparticles was evaluated both histologically using excised tissue and functionally by [18F]fluorodeoxyglucose positron emission tomography. RESULTS: NDP-MSH-PEG-HAuNS consist only of a thin gold wall with hollow interior (outer diameter, 43.5 +/- 2.3 nm; shell thickness, 3-4 nm), which displays strong and tunable resonance absorption in near-IR region (peak, 808 nm). The nanoparticles were specifically taken up by melanoma cells, which initiated the recruitment of beta-arrestins, the adapters to link the activated G-protein-coupled receptors to clathrin, indicating the involvement of receptor-mediated endocytosis. This resulted in enhanced extravasation of NDP-MSH-PEG-HAuNS from tumor blood vessels and their dispersion into tumor matrix compared with nonspecific PEGylated HAuNS. Successful selective photothermal ablation of B16/F10 melanoma with targeted HAuNS was confirmed by histologic and [18F]fluorodeoxyglucose positron emission tomography evaluation at 24 hours post near IR-region laser irradiation at a low-dose energy of 30 J/cm2. CONCLUSION: NDP-MSH-PEG-HAuNS have the potentials to mediate targeted photothermal ablation of melanoma.</abstract><notes>Lu, Wei&#xD;Xiong, Chiyi&#xD;Zhang, Guodong&#xD;Huang, Qian&#xD;Zhang, Rui&#xD;Zhang, Jin Z&#xD;Li, Chun&#xD;CA16672/CA/NCI NIH HHS/United States&#xD;R01 CA119387/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2009 Feb 1;15(3):876-86.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19188158</url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom4>6.646</custom4><electronic-resource-num>15/3/876 [pii]&#xD;10.1158/1078-0432.CCR-08-1480</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2391</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2391</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hayashi, T.</author><author>Gray, C. S.</author><author>Chan, M.</author><author>Tawatao, R. I.</author><author>Ronacher, L.</author><author>McGargill, M. A.</author><author>Datta, S. K.</author><author>Carson, D. A.</author><author>Corr, M.</author></authors></contributors><auth-address>Moores Cancer Center, and Department Medicine, University California at San Diego, La Jolla, CA 92093, USA.</auth-address><titles><title>Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>2764-9</pages><volume>106</volume><number>8</number><edition>2009/02/04</edition><keywords><keyword>Adenine/analogs &amp; derivatives/pharmacology</keyword><keyword>Animals</keyword><keyword>Autoimmune Diseases/ prevention &amp; control</keyword><keyword>Encephalomyelitis, Autoimmune, Experimental/immunology</keyword><keyword>Immune Tolerance</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Toll-Like Receptor 7/agonists/ immunology</keyword></keywords><dates><year>2009</year><pub-dates><date>Feb 24</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>19188597</accession-num><abstract>Activation of Toll-like receptors (TLR) contributes to the initiation and maintenance of chronic inflammation in autoimmune diseases, yet repeated exposure to a TLR agonist can induce hyporesponsiveness to subsequent TLR stimulation. Here, we used a synthetic TLR7 agonist, 9-benzyl-8-hydroxy-2-(2-methoxyethoxy) adenine (SM360320, 1V136) to study TLR7 induced attenuation of inflammatory responses and its application to autoimmune diseases. Repeated low dose administration of this TLR7 agonist induced hyporesponsiveness or tolerance to TLR2, -7, and -9 activators and limited the course of neural inflammation in an experimental allergic encephalomyelitis model. The hyporesponsiveness did not depend on T or B lymphocytes, but did require bone marrow derived cells. In addition, TLR7 tolerance reduced inflammation in a passive antibody mediated arthritis model. TLR7 tolerance did not cause global immunosuppression, because susceptibility to Listeria monocytogenes infection was not altered. The mechanism of TLR7 tolerance involved the up-regulation of 2 inhibitors of TLR signaling: Interleukin 1 Receptor Associated Kinase (IRAK) M, and Src homology 2 domain-containing inositol polyphosphate phosphatase (SHIP)-1. These findings suggest that induction of TLR7 tolerance might be a new therapeutic approach to subdue inflammation in autoimmune diseases.</abstract><notes>Hayashi, Tomoko&#xD;Gray, Christine S&#xD;Chan, Michael&#xD;Tawatao, Rommel I&#xD;Ronacher, Lisa&#xD;McGargill, Maureen A&#xD;Datta, Sandip K&#xD;Carson, Dennis A&#xD;Corr, Maripat&#xD;5 U01 AI056453/AI/NIAID NIH HHS/United States&#xD;CA119335/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, N.I.H., Intramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2764-9. Epub 2009 Feb 2.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom2>2634806</custom2><custom4>10.228</custom4><electronic-resource-num>0813037106 [pii]&#xD;10.1073/pnas.0813037106 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2028</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2028</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kaneda, M. M.</author><author>Caruthers, S.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Washington University, St Louis, MO, USA.</auth-address><titles><title>Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics</title><secondary-title>Ann Biomed Eng</secondary-title></titles><periodical><full-title>Ann Biomed Eng</full-title></periodical><pages>1922-33</pages><volume>37</volume><number>10</number><edition>2009/02/03</edition><dates><year>2009</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1521-6047 (Electronic)</isbn><accession-num>19184435</accession-num><abstract>A broad array of nanomaterials is available for use as contrast agents for molecular imaging and drug delivery. Due to the lack of endogenous background signal in vivo and the high NMR sensitivity of the (19)F atom, liquid perfluorocarbon nanoemulsions make ideal agents for cellular and magnetic resonance molecular imaging. The perfluorocarbon core material is surrounded by a lipid monolayer which can be functionalized with a variety of agents including targeting ligands, imaging agents and drugs either individually or in combination. Multiple copies of targeting ligands (approximately 20-40 monoclonal antibodies or 200-400 small molecule ligands) serve to enhance avidity through multivalent interactions while the composition of the particle&apos;s perfluorocarbon core results in high local concentrations of (19)F. Additionally, lipophilic drugs contained within molecularly targeted nanoemulsions can result in contact facilitated drug delivery to target cells. Ultimately, the dual use of perfluorocarbon nanoparticles for both site targeted drug delivery and molecular imaging may provide both imaging of disease states as well as conclusive evidence that drug delivery is localized to the area of interest. This review will focus on liquid perfluorocarbon nanoparticles as (19)F molecular imaging agents and for targeted drug delivery in cancer and cardiovascular disease.</abstract><notes>Kaneda, Megan M&#xD;Caruthers, Shelton&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;CA119342/CA/NCI NIH HHS/United States&#xD;HL073646/HL/NHLBI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Annals of biomedical engineering&#xD;Ann Biomed Eng. 2009 Oct;37(10):1922-33. Epub 2009 Jan 30.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom4>2.999</custom4><electronic-resource-num>10.1007/s10439-009-9643-z [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1876</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1876</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hoover, D. K.</author><author>Lee, E. J.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry, Carolina Center for Genome Science, University of North Carolina, Chapel Hill, North Carolina 27599-3290.</auth-address><titles><title>Total Internal Reflection Fluorescence Microscopy of Cell Adhesion on Patterned Self-Assembled Monolayers on Gold</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><edition>2009/02/03</edition><dates><year>2009</year><pub-dates><date>Jan 30</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>19182992</accession-num><abstract>We report the use of total internal reflection fluorescence microscopy (TIRFM) to study cell adhesion on patterned self-assembled monolayers (SAMs) on gold surfaces. Microcontact printing was used to pattern hydrophobic features to which the extracellular protein fibronectin was adsorbed, while dip-pen nanolithography was used to produce electroactive nanoarrays of hydroquinone-terminated alkanethiol on gold-coated quartz substrates. The hydroquinone was electrochemically oxidized to the corresponding quinone, and an oxyamine-tethered linear Arg-Gly-Asp (RGD) peptide was chemoselectively immobilized. A prism-based method of TIRFM was used to examine adhered cells on both the microscale and nanoscale features. We also demonstrate that, following imaging with TIRFM, the substrates can be visualized using conventional fluorescence microscopy.</abstract><notes>Journal article&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2009 Jan 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19182992</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>4.347</custom4><electronic-resource-num>10.1021/la803927k&#xD;10.1021/la803927k [pii]</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1894</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1894</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hu, R.</author><author>Yong, K. T.</author><author>Roy, I.</author><author>Ding, H.</author><author>He, S.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>[Hu, Rui] SUNY Buffalo, Inst Lasers Photon &amp; Biophoton, Buffalo, NY 14260 USA. Zhejiang Univ, Ctr Opt &amp; Electromagnet Res, Hangzhou 310058, Zhejiang, Peoples R China.&#xD;Hu, R, SUNY Buffalo, Inst Lasers Photon &amp; Biophoton, Buffalo, NY 14260 USA.</auth-address><titles><title>Metallic Nanostructures as Localized Plasmon Resonance Enhanced Scattering Probes for Multiplex Dark-Field Targeted Imaging of Cancer Cells</title><secondary-title>Journal of Physical Chemistry C</secondary-title><alt-title>J. Phys. Chem. C</alt-title></titles><periodical><full-title>Journal of Physical Chemistry C</full-title></periodical><alt-periodical><full-title>J. Phys. Chem. C</full-title></alt-periodical><pages>2676-2684</pages><volume>113</volume><number>7</number><edition>2009/02</edition><keywords><keyword>OPTICAL COHERENCE TOMOGRAPHY</keyword><keyword>SHAPE-CONTROLLED SYNTHESIS</keyword><keyword>HIGH-YIELD</keyword><keyword>SYNTHESIS</keyword><keyword>GOLD NANORODS</keyword><keyword>SILVER NANOPARTICLES</keyword><keyword>QUANTUM DOTS</keyword><keyword>AQUEOUS-SOLUTION</keyword><keyword>CONTRAST AGENTS</keyword><keyword>COUPLED PROBE</keyword><keyword>ASPECT-RATIO</keyword></keywords><dates><year>2009</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1932-7447</isbn><accession-num>ISI:000263299600005</accession-num><abstract>In this paper, we report the use of bioconjugated gold nanorods and silver nanoparticles as targeted localized surface plasmon resonance enhanced scattering probes for dark-field multiplex and transmission electron microscopy (TEM) imaging of pancreatic cancer cells. We take advantage of the spectrally widely separated localized plasmon resonance of the gold nanorods and silver nanoparticles which produce wavelength selective plasmon resonance scattering to allow multiplex imaging with high contrast. When the surfaces are functionalized, aqueous dispersions of bioconjugated gold nanorods and silver nanoparticles are prepared. We demonstrate receptor-mediated delivery of bioconjugated gold nanorods and silver nanoparticles simultaneously into pancreatic cancer cells, using multiplexed dark-field microscopy technique. We also show that the bioconjugated metallic nanostructures can be used for high-contrast TEM imaging as well.</abstract><notes>ISI Document Delivery No.: 406MM&#xD;Times Cited: 1&#xD;Cited Reference Count: 67&#xD;Hu, Rui Yong, Ken-Tye Roy, Indrajit Ding, Hong He, Sailing Prasad, Paras N.&#xD;AMER CHEMICAL SOC</notes><work-type>Article</work-type><urls><related-urls><url>&lt;Go to ISI&gt;://000263299600005</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom4>3.398</custom4><electronic-resource-num>10.1021/jp8076672</electronic-resource-num><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2460</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2460</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Barick, K. C.</author><author>Aslam, M.</author><author>Prasad, Pottumarthi V.</author><author>Dravid, Vinayak P.</author><author>Bahadur, Dhirendra</author></authors></contributors><titles><title>Nanoscale assembly of amine-functionalized colloidal iron oxide</title><secondary-title>Journal of Magnetism and Magnetic Materials</secondary-title></titles><periodical><full-title>Journal of Magnetism and Magnetic Materials</full-title></periodical><pages>1529-1532</pages><volume>321</volume><number>10</number><edition>2009/02</edition><keywords><keyword>Nanoparticle</keyword><keyword>Nanoassembly</keyword><keyword>MR contrast agent</keyword><keyword>Surface functionalization</keyword><keyword>Iron oxide</keyword></keywords><dates><year>2009</year></dates><isbn>0304-8853</isbn><notes>doi: DOI: 10.1016/j.jmmm.2009.02.080</notes><urls><related-urls><url>http://www.sciencedirect.com/science/article/B6TJJ-4VNKGYC-9/2/2b7a7136253a5c9fad9ad276e839064c</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>1.342</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2199</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2199</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kowalczyk, B.</author><author>Byrska, M.</author><author>Mahmud, G.</author><author>Huda, S.</author><author>Kandere-Grzybowska, K.</author><author>Grzybowski, B. A.</author></authors></contributors><auth-address>Department of Chemical and Biological Engineering, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, USA.</auth-address><titles><title>Nanoparticle-based solution deposition of gold films supporting bioresistant SAMs</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>1905-7</pages><volume>25</volume><number>4</number><edition>2009/01/28</edition><keywords><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line</keyword><keyword>Gold/ chemistry</keyword><keyword>Hot Temperature</keyword><keyword>Metal Nanoparticles/ chemistry/ ultrastructure</keyword><keyword>Mice</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Molecular Structure</keyword><keyword>Solutions</keyword></keywords><dates><year>2009</year><pub-dates><date>Feb 17</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>19170541</accession-num><abstract>Thin films of gold on glass are prepared by solution deposition of functionalized gold nanoparticles followed by thermal treatment. The processed films adhere strongly to glass without any adhesion layers and can be micropatterned/microetched without delamination from the substrate. The formation of self-assembled monolayers (SAMs) of oligo(ethylene glycol) alkane thiols (EG SAMs) renders the films resistant to cell adhesion and allows for cell patterning.</abstract><notes>Kowalczyk, Bartlomiej&#xD;Byrska, Marta&#xD;Mahmud, Goher&#xD;Huda, Sabil&#xD;Kandere-Grzybowska, Kristiana&#xD;Grzybowski, Bartosz A&#xD;U54CA119341/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2009 Feb 17;25(4):1905-7.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.347</custom4><electronic-resource-num>10.1021/la803287u [doi]&#xD;10.1021/la803287u [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2264</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2264</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Salvador-Morales, C.</author><author>Zhang, L.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Laboratory of Nanomedicine and Biomaterials, Department of Anesthesia, Brigham and Women&apos;s Hospital-Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.</auth-address><titles><title>Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups</title><secondary-title>Biomaterials</secondary-title></titles><periodical><full-title>Biomaterials</full-title></periodical><pages>2231-40</pages><volume>30</volume><number>12</number><edition>2009/01/27</edition><keywords><keyword>Biocompatible Materials/ metabolism</keyword><keyword>Complement System Proteins/immunology/metabolism</keyword><keyword>Humans</keyword><keyword>Lipids/ chemistry/ immunology</keyword><keyword>Nanoparticles/ chemistry</keyword><keyword>Polymers/ chemistry/pharmacology</keyword><keyword>Protein Binding</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1878-5905 (Electronic)</isbn><accession-num>19167749</accession-num><abstract>Here we report the immunological characterization of lipid-polymer hybrid nanoparticles (NPs) and propose a method to control the levels of complement activation induced by these NPs. This method consists of the highly specific modification of the NP surface with methoxyl, carboxyl, and amine groups. Hybrid NPs with methoxyl surface groups induced the lowest complement activation, whereas the NPs with amine surface groups induced the highest activation. All possible combinations among carboxyl, amine, and methoxyl groups also activated the complement system to a certain extent. All types of NPs activated the complement system primarily via the alternative pathway rather than the lectin pathway. The classical pathway was activated to a very small extent by the NPs with carboxyl and amine surface groups. Human serum and plasma protein binding studies showed that these NPs had different protein binding patterns. Studies of both complement activation and coagulation activation suggested that NPs with methoxyl surface groups might be an ideal candidate for drug delivery applications, since they are not likely to cause any immunological adverse reaction in the human body.</abstract><notes>Salvador-Morales, Carolina&#xD;Zhang, Liangfang&#xD;Langer, Robert&#xD;Farokhzad, Omid C&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;EB003647/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Biomaterials&#xD;Biomaterials. 2009 Apr;30(12):2231-40. Epub 2009 Jan 23.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2699891</custom2><custom3>NIHMS102713</custom3><custom4>7.325</custom4><electronic-resource-num>S0142-9612(09)00011-8 [pii]&#xD;10.1016/j.biomaterials.2009.01.005 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2347</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2347</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sharma, Y.</author><author>Raza, S. H.</author><author>Kong, K. Y.</author><author>Chaudry, Q.</author><author>Muller, S.</author><author>Young, A. N.</author><author>Chen, Z. G.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Georgia Institute of Technology, Atlanta, GA 30332 USA. ysharma3@gatech.edu</auth-address><titles><title>PASuite: a preprocessing algorithm suite for cellular and molecular image classification in cancer diagnosis and treatment</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>3114-7</pages><volume>2008</volume><edition>2009/01/24</edition><keywords><keyword>Algorithms</keyword><keyword>Carcinoma, Renal Cell/ diagnosis/ therapy</keyword><keyword>Cell Nucleolus/metabolism</keyword><keyword>Cell Nucleus/metabolism</keyword><keyword>Computer Graphics</keyword><keyword>Diagnosis, Computer-Assisted/ methods</keyword><keyword>Head and Neck Neoplasms/ diagnosis/ therapy</keyword><keyword>Humans</keyword><keyword>Image Processing, Computer-Assisted/ methods</keyword><keyword>Kidney Neoplasms/ diagnosis/ therapy</keyword><keyword>Medical Oncology/methods</keyword><keyword>Models, Theoretical</keyword><keyword>Reproducibility of Results</keyword><keyword>Software</keyword><keyword>User-Computer Interface</keyword></keywords><dates><year>2008</year></dates><isbn>1557-170X (Print)</isbn><accession-num>19163366</accession-num><abstract>We present a generalized tool to mark and preprocess cancerous regions in an image. Currently, tissue biopsies are analyzed and graded manually by expert pathologists and thus can be time consuming and challenging due to variations in tissue morphology, inconsistencies in preparation of tissue specimen and errors in the image acquisition process. Our tool is designed to automatically standardize the variations in different images due to changing illumination and experimental conditions. Segregating cancerous regions from non-cancerous areas is a mandatory step before extracting relevant information from cancer images such as the number and size of nuclei and subsequently using it for classification and quantitative analysis. We tested our tool for two completely different cancers: Head and Neck Cancer (HNC) and Renal Cell Carcinoma (RCC). The tool enables the user to successfully segment the cancerous areas for both types of cancers and our results match with the manual validation by a pathologist.</abstract><notes>Sharma, Yachna&#xD;Raza, S Hussain&#xD;Kong, Koon Y&#xD;Chaudry, Qaiser&#xD;Muller, Susan&#xD;Young, Andrew N&#xD;Chen, Zhuo Georgia&#xD;Wang, May D&#xD;P20GM072069/GM/NIGMS NIH HHS/United States&#xD;R01CA108468/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2008;2008:3114-7.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2008.4649863 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2346</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2346</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kapoor, S.</author><author>Quo, C. F.</author><author>Merrill, A. H., Jr.</author><author>Wang, M. D.</author></authors></contributors><auth-address>College of Computing, Georgia Institute of Technology, Atlanta, GA 30332, USA. skapoor6@mail.gatech.edu</auth-address><titles><title>An interactive visualization tool and data model for experimental design in systems biology</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>2423-6</pages><volume>2008</volume><edition>2009/01/24</edition><keywords><keyword>Algorithms</keyword><keyword>Computational Biology/methods</keyword><keyword>Computer Graphics</keyword><keyword>Computer Simulation</keyword><keyword>Database Management Systems</keyword><keyword>Databases, Factual</keyword><keyword>Gene Expression Profiling/ methods</keyword><keyword>Humans</keyword><keyword>Lipids/chemistry</keyword><keyword>Metabolic Networks and Pathways</keyword><keyword>Reproducibility of Results</keyword><keyword>Sphingolipids/ chemistry</keyword><keyword>Systems Biology/ methods</keyword><keyword>Systems Integration</keyword><keyword>User-Computer Interface</keyword></keywords><dates><year>2008</year></dates><isbn>1557-170X (Print)</isbn><accession-num>19163191</accession-num><abstract>Experimental design is important, but is often under-supported, in systems biology research. To improve experimental design, we extend the visualization of complex sphingolipid pathways to study biosynthetic origin in SphinGOMAP. We use the ganglio-series sphingolipid dataset as a test bed and the Java Universal Network / Graph Framework (JUNG) visualization toolkit. The result is an interactive visualization tool and data model for experimental design in lipid systems biology research. We improve the current SphinGOMAP in terms of interactive visualization by allowing (i) choice of four different network layouts, (ii) dynamic addition / deletion of on-screen molecules and (iii) mouse-over to reveal detailed molecule data. Future work will focus on integrating various lipid-relevant data systematically i.e. SphinGOMAP biosynthetic data, Lipid Bank molecular data (Japan) and Lipid MAPS metabolic pathway data (USA). We aim to build a comprehensive and interactive communication platform to improve experimental design for scientists globally in high-throughput lipid systems biology research.</abstract><notes>Kapoor, Shray&#xD;Quo, Chang Feng&#xD;Merrill, Alfred H Jr&#xD;Wang, May D&#xD;R01CA108468/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2008;2008:2423-6.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2008.4649688 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2348</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2348</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kaddi, C.</author><author>Quo, C. F.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, 30332 USA. gtg538v@mail.gatech.edu</auth-address><titles><title>Quantitative metrics for bio-modeling algorithm selection</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>4613-6</pages><volume>2008</volume><edition>2009/01/24</edition><keywords><keyword>Algorithms</keyword><keyword>Animals</keyword><keyword>Biochemistry/methods</keyword><keyword>Catalysis</keyword><keyword>Computer Simulation</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword><keyword>Models, Biological</keyword><keyword>Models, Statistical</keyword><keyword>Models, Theoretical</keyword><keyword>Systems Biology</keyword></keywords><dates><year>2008</year></dates><isbn>1557-170X (Print)</isbn><accession-num>19163744</accession-num><abstract>In this paper, we report our efforts in developing guidelines that are capable of helping researchers to select algorithms in systems biology modeling. We propose a set of metrics based on discrete observable units in terms of key bio-modeling considerations. We accomplish this by (i) reviewing classical metric definitions, (ii) implementing widely used modeling algorithms on a specific case study, and (iii) testing metrics that are a hybrid of classical metrics and key bio-modeling considerations. The modeling algorithms implemented are Michaelis-Menten kinetics, generalized mass action, flux balance analysis, and metabolic control analysis. This work extends our previous work in developing qualitative guidelines to select bio-modeling algorithms. Our results impact systems biology modeling specifically by increasing the level of confidence for users to select bio-modeling algorithms by using quantitative metrics appropriately.</abstract><notes>Kaddi, Chanchala&#xD;Quo, Chang Feng&#xD;Wang, May D&#xD;R01 CA108468/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2008;2008:4613-6.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2008.4650241 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2349</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2349</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fox, B. M.</author><author>Moffitt, R. A.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Georgia Institute of Technology, Atlanta, GA 30318, USA. bfox3@gatech.edu</auth-address><titles><title>An agent-based stochastic tumor model for predicting mitotic arrest drug response</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>5458-61</pages><volume>2008</volume><edition>2009/01/24</edition><keywords><keyword>Antimitotic Agents/administration &amp; dosage</keyword><keyword>Antineoplastic Agents/ administration &amp; dosage</keyword><keyword>Cell Size/drug effects</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Computer Simulation</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Drug Therapy, Computer-Assisted/ methods</keyword><keyword>Humans</keyword><keyword>Maximum Tolerated Dose</keyword><keyword>Mitosis/drug effects</keyword><keyword>Models, Biological</keyword><keyword>Models, Statistical</keyword><keyword>Neoplasms/drug therapy/ pathology/ physiopathology</keyword><keyword>Stochastic Processes</keyword></keywords><dates><year>2008</year></dates><isbn>1557-170X (Print)</isbn><accession-num>19163952</accession-num><abstract>We present a 2D agent-based stochastic solid tumor model which incorporates cellular response to a chemotherapeutic drug such as paclitaxel (Taxol). First, we show that our model not only reproduces the findings of past mathematical models but also agrees qualitatively with previously observed experimental findings in vitro. Then, the model is used to study two contrasting methods of chemotherapeutic dosing: (1) maximum tolerated dose (MTD) and (2) metronomic dosing. Results of our simulations confirm the typical clinical observation that a single front-loaded dosing to MTD leads to a period of remission followed by recurrence, while metronomic dosing maintains or reduces the tumor size. These results suggest patient treatment strategies should favor the more recently proposed metronomic dosing paradigm over the traditionally used MTD therapy. The model proposed here is adaptable to different solid tumor types as well as different chemotherapeutic drug pharmacokinetic and pharmacodynamic properties, making it ideal for similar studies on different clinical problems.</abstract><notes>Fox, Brandon M&#xD;Moffitt, Richard A&#xD;Wang, May D&#xD;P20GM072069/GM/NIGMS NIH HHS/United States&#xD;R01CA108468/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2008;2008:5458-61.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2008.4650449 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2345</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2345</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Caldwell, M. L.</author><author>Moffitt, R. A.</author><author>Liu, J.</author><author>Parry, R. M.</author><author>Sharma, Y.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Georgia Institute of Technology, Atlanta, GA 30318 USA. mcaldwell@gatech.edu</auth-address><titles><title>Simple quantification of multiplexed quantum dot staining in clinical tissue samples</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>1907-10</pages><volume>2008</volume><edition>2009/01/24</edition><keywords><keyword>Biomedical Engineering</keyword><keyword>Carcinoma, Renal Cell/classification/diagnosis/metabolism</keyword><keyword>Diagnosis, Computer-Assisted</keyword><keyword>Discriminant Analysis</keyword><keyword>Humans</keyword><keyword>Image Interpretation, Computer-Assisted</keyword><keyword>Kidney Neoplasms/classification/diagnosis/metabolism</keyword><keyword>Quantum Dots</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Staining and Labeling</keyword></keywords><dates><year>2008</year></dates><isbn>1557-170X (Print)</isbn><accession-num>19163062</accession-num><abstract>In this paper, we present a simple method for the processing and quantification of multiplexed Quantum Dot (QD) labeled images of clinical cancer tissue samples. QDs provide several features which make them ideal for reliable quantification, including long-term signal stability, high signal-to-noise ratios, as well as narrow emission bandwidths. Deconvolution of QD spectra is accomplished in a batch mode in which unmixing parameters are preserved across samples to allow for quantitative and reproducible comparisons. After unmixing the QD images, we segment each one to exclude acellular regions. We use a simple average intensity to quantify the level of QD staining for each image. We illustrate the viability of this approach by testing it on 28 tissue samples using a tissue microarray. We show that using as few as two QD protein targets (MDM-2, and B-actin), the Renal Cell Carcinoma (RCC) samples are distinguishable from adjacent normal tissue samples. A simple linear discriminant results in 100% classification of 25 RCC samples and 3 normal samples. This suggests that multiplexed QDs can be used to properly diagnose RCC from otherwise healthy tissue. We expect to apply this work to larger panels of more robust QD biomarker targets to aid in clinical decision-making for the diagnosis and prognosis of diseases, such as cancer.</abstract><notes>Caldwell, Matthew L&#xD;Moffitt, Richard A&#xD;Liu, Jian&#xD;Parry, R Mitchell&#xD;Sharma, Yachna&#xD;Wang, May D&#xD;P20GM072069/GM/NIGMS NIH HHS/United States&#xD;R01CA108468/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2008;2008:1907-10.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2008.4649559 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2350</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2350</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Barrett, A. B.</author><author>Phan, J. H.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Department of Biomedical Engineering at the Georgia Institute of Technology, Atlanta, 30318 USA. andreabarrett@gatech.edu</auth-address><titles><title>Combining multiple microarray studies using bootstrap meta-analysis</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>5660-3</pages><volume>2008</volume><edition>2009/01/24</edition><keywords><keyword>Algorithms</keyword><keyword>Artificial Intelligence</keyword><keyword>Database Management Systems</keyword><keyword>Databases, Genetic</keyword><keyword>Gene Expression Profiling/ methods</keyword><keyword>Information Storage and Retrieval/ methods</keyword><keyword>Meta-Analysis as Topic</keyword><keyword>Oligonucleotide Array Sequence Analysis/ methods</keyword><keyword>Pattern Recognition, Automated/methods</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2008</year></dates><isbn>1557-170X (Print)</isbn><accession-num>19164001</accession-num><abstract>Microarray technology has enabled us to simultaneously measure the expression of thousands of genes. Using this high-throughput data collection, we can examine subtle genetic changes between biological samples and build predictive models for clinical applications. Although microarrays have dramatically increased the rate of data collection, sample size is still a major issue in feature selection. Previous methods show that microarray data combination is successful in improving selection when using z-scores and fold change. We propose a wrapper based gene selection technique that combines bootstrap estimated classification errors for individual genes across multiple datasets. The bootstrap is an unbiased estimator of classification error and has been shown to be effective for small sample data. Coupled with data combination across multiple data sets, we show that this meta-analytic approach improves gene selection.</abstract><notes>Barrett, Andrea B&#xD;Phan, John H&#xD;Wang, May D&#xD;R01CA108468/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2008;2008:5660-3.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom3>2009</custom3><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2008.4650498 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2113</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2113</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Niu, G.</author><author>Shi, J.</author><author>Liu, S.</author><author>Wang, F.</author><author>Chen, X.</author></authors></contributors><auth-address>Department of Radiology, Biophysics &amp; Bio-X, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>(68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging</title><secondary-title>Eur J Nucl Med Mol Imaging</secondary-title></titles><periodical><full-title>Eur J Nucl Med Mol Imaging</full-title></periodical><pages>947-57</pages><volume>36</volume><number>6</number><edition>2009/01/23</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Dimerization</keyword><keyword>Female</keyword><keyword>Gallium Radioisotopes/chemistry</keyword><keyword>Glycine/ chemistry</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/analysis/ metabolism</keyword><keyword>Mice</keyword><keyword>Neoplasms/ metabolism/ radionuclide imaging</keyword><keyword>Peptides, Cyclic/ chemistry/metabolism/pharmacokinetics</keyword><keyword>Polyethylene Glycols/ chemistry</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Radiochemistry</keyword><keyword>Staining and Labeling</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1619-7089 (Electronic)</isbn><accession-num>19159928</accession-num><abstract>PURPOSE: Radiolabeled cyclic RGD (Arg-Gly-Asp) peptides have great potential for the early tumor detection and noninvasive monitoring of tumor metastasis and therapeutic response. (18)F-labeled RGD analogs ([(18)F]-AH111585 and [(18)F]Galacto-RGD) have been investigated in clinical trials for positron emission tomography (PET) imaging of integrin expression in cancer patients. To develop new RGD radiotracers with higher tumor accumulation, improved in vivo kinetics, easy availability and low cost, we developed two new RGD peptides and labeled them with generator-eluted (68)Ga (t(1/2) = 68 min) for PET imaging of integrin alpha(v)beta(3) expression in tumor xenograft models. MATERIALS AND METHODS: The two new cyclic RGD dimers, E[PEG(4)-c(RGDfK)](2) (P(4)-RGD2, PEG(4) = 15-amino-4,7,10,13-tetraoxapentadecanoic acid) and E[Gly(3)-c(RGDfK)](2) (G(3)-RGD2, G(3) = Gly-Gly-Gly) were designed, synthesized and conjugated with 1,4,7-triazacyclononanetriacetic acid (NOTA) for (68)Ga labeling. The microPET imaging and biodistribution of the (68)Ga labeled RGD tracers were investigated in integrin alpha(v)beta(3)-positive tumor xenografts. RESULTS: The new RGD dimers with the Gly(3) and PEG(4) linkers showed higher integrin alpha(v)beta(3) binding affinity than no-linker RGD dimer (RGD2). NOTA-G(3)-RGD2 and NOTA-P(4)-RGD2 could be labeled with (68)Ga within 30 min with higher purity (&gt;98%) and specific activity (8.88-11.84 MBq/nmol). Both (68)Ga-NOTA-P(4)-RGD2 and (68)Ga-NOTA-G(3)-RGD2 exhibited significantly higher tumor uptake and tumor-to-normal tissue ratios than (68)Ga-NOTA-RGD2. CONCLUSION: Because of their high affinity, high specificity and excellent pharmacokinetic properties, further investigation of the two novel RGD dimers for clinical PET imaging of integrin alpha(v)beta(3) expression in cancer patients is warranted.</abstract><notes>Liu, Zhaofei&#xD;Niu, Gang&#xD;Shi, Jiyun&#xD;Liu, Shuanglong&#xD;Wang, Fan&#xD;Liu, Shuang&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21CA121842/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;European journal of nuclear medicine and molecular imaging&#xD;Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):947-57. Epub 2009 Jan 22.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.625</custom4><electronic-resource-num>10.1007/s00259-008-1045-1 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2198</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2198</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Goluch, E. D.</author><author>Stoeva, S. I.</author><author>Lee, J. S.</author><author>Shaikh, K. A.</author><author>Mirkin, C. A.</author><author>Liu, C.</author></authors></contributors><auth-address>Department of Bioengineering, University of Illinois at Urbana-Champaign, 208 North Wright Street, Urbana, IL 61801, United States.</auth-address><titles><title>A microfluidic detection system based upon a surface immobilized biobarcode assay</title><secondary-title>Biosens Bioelectron</secondary-title></titles><periodical><full-title>Biosens Bioelectron</full-title></periodical><pages>2397-403</pages><volume>24</volume><number>8</number><edition>2009/01/23</edition><keywords><keyword>Biosensing Techniques/ instrumentation</keyword><keyword>Blood Chemical Analysis/ instrumentation</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Immunoassay/ instrumentation</keyword><keyword>Microfluidic Analytical Techniques/ instrumentation</keyword><keyword>Prostate-Specific Antigen/ blood</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>1873-4235 (Electronic)</isbn><accession-num>19157846</accession-num><abstract>The biobarcode assay (BCA) is capable of achieving low detection limits and high specificity for both protein and DNA targets. The realization of a BCA in a microfluidic format presents unique opportunities and challenges. In this work, we describe a modified form of the BCA called the surface immobilized biobarcode assay (SI-BCA). The SI-BCA employs microchannel walls functionalized with antibodies that bind with the intended targets. Compared with the conventional BCA, it reduces the system complexity and results in shortened process time, which is attributed to significantly reduced diffusion times in the micro-scale channels. Raw serum samples, without any pretreatment, were evaluated with this technique. Prostate specific antigen in the samples was detected at concentrations ranging from 40 pM to 40 fM. The detection limit of the assay using buffer samples is 10 fM. The entire assay, from sample injection to final data analysis was completed in 80 min.</abstract><notes>Goluch, Edgar D&#xD;Stoeva, Savka I&#xD;Lee, Jae-Seung&#xD;Shaikh, Kashan A&#xD;Mirkin, Chad A&#xD;Liu, Chang&#xD;U54CA119341/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Biosensors &amp; bioelectronics&#xD;Biosens Bioelectron. 2009 Apr 15;24(8):2397-403. Epub 2008 Dec 24.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>5.330</custom4><electronic-resource-num>S0956-5663(08)00660-X [pii]&#xD;10.1016/j.bios.2008.12.017 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2112</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2112</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fu, A.</author><author>Hu, W.</author><author>Xu, L.</author><author>Wilson, R. J.</author><author>Yu, H.</author><author>Osterfeld, S. J.</author><author>Gambhir, S. S.</author><author>Wang, S. X.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, Stanford University, Stanford, CA 94305, USA. aihuafu@stanford.edu</auth-address><titles><title>Protein-functionalized synthetic antiferromagnetic nanoparticles for biomolecule detection and magnetic manipulation</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>1620-4</pages><volume>48</volume><number>9</number><edition>2009/01/22</edition><keywords><keyword>Aptamers, Nucleotide/chemistry</keyword><keyword>Biosensing Techniques</keyword><keyword>Magnetics</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Nanoparticles/ chemistry</keyword><keyword>Proteins/chemical synthesis/ chemistry</keyword></keywords><dates><year>2009</year></dates><isbn>1521-3773 (Electronic)</isbn><accession-num>19156803</accession-num><abstract>Direct protein functionalization provides synthetic antiferromagnetic nanoparticles with high chemical specificity and multifunctionality. These nanoparticle-protein conjugates function as improved magnetic labels for biological detection experiments, and exhibit tunable responses to a small external magnetic field gradient, thus allowing the observation of distinctive single nanoparticle motion.</abstract><notes>Fu, Aihua&#xD;Hu, Wei&#xD;Xu, Liang&#xD;Wilson, Robert J&#xD;Yu, Heng&#xD;Osterfeld, Sebastian J&#xD;Gambhir, Sanjiv S&#xD;Wang, Shan X&#xD;1K99 EB008558-01/EB/NIBIB NIH HHS/United States&#xD;1U54 CA119367-01/CA/NCI NIH HHS/United States&#xD;K99 EB008558-01/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2009;48(9):1620-4.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom2>2665302</custom2><custom3>NIHMS97300</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200803994 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2263</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2263</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Devaraj, N. K.</author><author>Keliher, E. J.</author><author>Thurber, G. M.</author><author>Nahrendorf, M.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Simches Research Building, 185 Cambridge Street, Boston, Massachusetts 02114, USA.</auth-address><titles><title>18F labeled nanoparticles for in vivo PET-CT imaging</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>397-401</pages><volume>20</volume><number>2</number><edition>2009/01/14</edition><keywords><keyword>Animals</keyword><keyword>Cross-Linking Reagents/chemistry</keyword><keyword>Dextrans/chemistry</keyword><keyword>Ferric Compounds/chemistry</keyword><keyword>Fluorine Radioisotopes/ chemistry</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Nanoparticles/ chemistry/ diagnostic use</keyword><keyword>Phantoms, Imaging</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Staining and Labeling</keyword><keyword>Tissue Distribution</keyword><keyword>Tomography, X-Ray Computed</keyword></keywords><dates><year>2009</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1520-4812 (Electronic)</isbn><accession-num>19138113</accession-num><abstract>We report the synthesis and in vivo characterization of an 18F modified trimodal nanoparticle (18F-CLIO). This particle consists of cross-linked dextran held together in core-shell formation by a superparamagnetic iron oxide core and functionalized with the radionuclide 18F in high yield via &quot;click&quot; chemistry. The particle can be detected with positron emission tomography, fluorescence molecular tomography, and magnetic resonance imaging. The presence of 18F dramatically lowers the detection threshold of the nanoparticles, while the facile conjugation chemistry provides a simple platform for rapid and efficient nanoparticle labeling.</abstract><notes>Devaraj, Neal K&#xD;Keliher, Edmund J&#xD;Thurber, Greg M&#xD;Nahrendorf, Matthias&#xD;Weissleder, Ralph&#xD;T32 CA079443-06A1/CA/NCI NIH HHS/United States&#xD;T32-CA79443/CA/NCI NIH HHS/United States&#xD;U01 HL080731-03/HL/NHLBI NIH HHS/United States&#xD;U01-HL080731/HL/NHLBI NIH HHS/United States&#xD;U54 CA119349-040003/CA/NCI NIH HHS/United States&#xD;U54-CA119349/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2009 Feb;20(2):397-401.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2644737</custom2><custom3>NIHMS89653</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/bc8004649 [doi]&#xD;10.1021/bc8004649 [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2390</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2390</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cortes-Mateos, M. J.</author><author>Martin, D.</author><author>Sandoval, S.</author><author>Ruidiaz, M. E.</author><author>Messmer, D.</author><author>Wang-Rodriguez, J.</author><author>Trogler, W.</author><author>Kummel, A. C.</author><author>Blair, S. L.</author></authors></contributors><auth-address>Moores Cancer Center, University of California San Diego, San Diego, CA 92093-0987, USA.</auth-address><titles><title>Automated microscopy to evaluate surgical specimens via touch prep in breast cancer</title><secondary-title>Ann Surg Oncol</secondary-title></titles><periodical><full-title>Ann Surg Oncol</full-title></periodical><pages>709-20</pages><volume>16</volume><number>3</number><edition>2009/01/13</edition><keywords><keyword>Adolescent</keyword><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Aged, 80 and over</keyword><keyword>Breast Neoplasms/ diagnosis/surgery</keyword><keyword>Carcinoma, Ductal, Breast/diagnosis/surgery</keyword><keyword>Carcinoma, Intraductal, Noninfiltrating/diagnosis/surgery</keyword><keyword>Carcinoma, Lobular/diagnosis/surgery</keyword><keyword>Combined Modality Therapy</keyword><keyword>Cytological Techniques</keyword><keyword>Female</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Humans</keyword><keyword>Lymph Nodes/pathology/surgery</keyword><keyword>Lymphatic Metastasis</keyword><keyword>Mastectomy</keyword><keyword>Microscopy/ methods</keyword><keyword>Middle Aged</keyword><keyword>Neoplasm Staging</keyword><keyword>Neoplasm, Residual/ diagnosis/surgery</keyword><keyword>Pattern Recognition, Automated/ methods</keyword><keyword>Prognosis</keyword><keyword>Survival Rate</keyword><keyword>Treatment Outcome</keyword><keyword>Young Adult</keyword></keywords><dates><year>2009</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1534-4681 (Electronic)</isbn><accession-num>19137376</accession-num><abstract>BACKGROUND: Breast conservation therapy is the standard treatment for breast cancer; however, 20-50% of operations have a positive margin leading to secondary procedures. The standard of care to evaluate surgical margins is based on permanent section. Imprint cytology (touch prep) has been used to evaluate surgical samples, but conventional techniques require an experienced cytopathologist for correct interpretation. An automated image screening process has been developed to discern cancer cells from normal epithelial cells. This technique is based on cellularity of the imprint specimen and does not require expertise in cytopathology. METHODS: A rapid immunofluorescent staining technique coupled with automated microscopy was used to classify specimens as cancer vs. noncancer based on the density of epithelial cells captured on touch prep of tumor cross-sections. The results of the automated analysis vs. a manual screen of ten 20x fields were compared to the pathology interpretation on permanent section. RESULTS: A total of 34 consecutive cases were analyzed: 10 normal cases, and 24 cancer cases. The cross-section specimens for invasive cancer were correctly classified in at least 65% of the cases by using manual microscopy and at least 83% by using automated microscopy. The manual and automated microscopy correlated well for measurements of epithelial cell density (R(2)=0.64); however, the automated microscopy was more accurate. CONCLUSIONS: This preliminary study using an automated system for intraoperative interpretation does not require a cytopathologist and shows that rapid, low-resolution imaging can correctly identify cancer cells for invasive carcinoma in surgical specimens. Therefore, automated determination of cellularity in touch prep is a promising technique for future margin interpretation of breast conservation therapy.</abstract><notes>Cortes-Mateos, Maria Jose&#xD;Martin, David&#xD;Sandoval, Sergio&#xD;Ruidiaz, Manuel E&#xD;Messmer, Davorka&#xD;Wang-Rodriguez, Jessica&#xD;Trogler, William&#xD;Kummel, Andrew C&#xD;Blair, Sarah L&#xD;5 U54 CA119335-03/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Annals of surgical oncology&#xD;Ann Surg Oncol. 2009 Mar;16(3):709-20. Epub 2009 Jan 10.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom4>4.507</custom4><electronic-resource-num>10.1245/s10434-008-0274-7 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1776</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1776</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, G.</author><author>Yang, Z.</author><author>Lu, W.</author><author>Zhang, R.</author><author>Huang, Q.</author><author>Tian, M.</author><author>Li, L.</author><author>Liang, D.</author><author>Li, C.</author></authors></contributors><auth-address>Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.</auth-address><titles><title>Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice</title><secondary-title>Biomaterials</secondary-title></titles><periodical><full-title>Biomaterials</full-title></periodical><pages>1928-36</pages><volume>30</volume><number>10</number><edition>2009/01/10</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Gold/*chemistry</keyword><keyword>Humans</keyword><keyword>Indium/chemistry</keyword><keyword>Magnetic Resonance Spectroscopy</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Transplantation/*methods</keyword><keyword>*Particle Size</keyword><keyword>Polyethylene Glycols/*chemistry/pharmacology</keyword><keyword>Random Allocation</keyword><keyword>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</keyword><keyword>Thioctic Acid/chemistry</keyword><keyword>Tissue Distribution/drug effects</keyword><keyword>Transplantation, Heterologous/*methods</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1878-5905 (Electronic)</isbn><accession-num>19131103</accession-num><abstract>Polyethylene glycol (PEG)-coated (pegylated) gold nanoparticles (AuNPs) have been proposed as drug carriers and diagnostic contrast agents. However, the impact of particle characteristics on the biodistribution and pharmacokinetics of pegylated AuNPs is not clear. We investigated the effects of PEG molecular weight, type of anchoring ligand, and particle size on the assembly properties and colloidal stability of PEG-coated AuNPs. The pharmacokinetics and biodistribution of the most stable PEG-coated AuNPs in nude mice bearing subcutaneous A431 squamous tumors were further studied using (111)In-labeled AuNPs. AuNPs coated with thioctic acid (TA)-anchored PEG exhibited higher colloidal stability in phosphate-buffered saline in the presence of dithiothreitol than did AuNPs coated with monothiol-anchored PEG. AuNPs coated with high-molecular-weight (5000 Da) PEG were more stable than AuNPs coated with low-molecular-weight (2000 Da) PEG. Of the 20-nm, 40-nm, and 80-nm AuNPs coated with TA-terminated PEG(5000), the 20-nm AuNPs exhibited the lowest uptake by reticuloendothelial cells and the slowest clearance from the body. Moreover, the 20-nm AuNPs coated with TA-terminated PEG(5000) showed significantly higher tumor uptake and extravasation from the tumor blood vessels than did the 40- and 80-nm AuNPs. Thus, 20-nm AuNPs coated with TA-terminated PEG(5000) are promising potential drug delivery vehicles and diagnostic imaging agents.</abstract><notes>Zhang, Guodong&#xD;Yang, Zhi&#xD;Lu, Wei&#xD;Zhang, Rui&#xD;Huang, Qian&#xD;Tian, Mei&#xD;Li, Li&#xD;Liang, Dong&#xD;Li, Chun&#xD;R01 CA119387/CA/NCI NIH HHS/United States&#xD;U24 CA126577/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Biomaterials&#xD;Biomaterials. 2009 Apr;30(10):1928-36. Epub 2009 Jan 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19131103</url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom4>7.325</custom4><electronic-resource-num>S0142-9612(08)01022-3 [pii]&#xD;10.1016/j.biomaterials.2008.12.038</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1772</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1772</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yu, Z. T.</author><author>Kamei, K.</author><author>Takahashi, H.</author><author>Shu, C. J.</author><author>Wang, X.</author><author>He, G. W.</author><author>Silverman, R.</author><author>Radu, C. G.</author><author>Witte, O. N.</author><author>Lee, K. B.</author><author>Tseng, H. R.</author></authors></contributors><auth-address>Department of Mechanical and Aerospace Engineering, University of California, Los Angeles, CA 90095, USA.</auth-address><titles><title>Integrated microfluidic devices for combinatorial cell-based assays</title><secondary-title>Biomed Microdevices</secondary-title></titles><periodical><full-title>Biomed Microdevices</full-title></periodical><pages>547-55</pages><volume>11</volume><number>3</number><edition>2009/01/09</edition><keywords><keyword>Animals</keyword><keyword>Annexin A5/metabolism</keyword><keyword>Antibiotics, Antineoplastic/pharmacology</keyword><keyword>Apoptosis/drug effects</keyword><keyword>Bioreactors</keyword><keyword>Cell Culture Techniques/*instrumentation/methods</keyword><keyword>Cell Proliferation</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Cyclooxygenase 2/metabolism</keyword><keyword>Dactinomycin/pharmacology</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Enzyme Inhibitors/pharmacology</keyword><keyword>Equipment Design</keyword><keyword>Fibroblasts/metabolism</keyword><keyword>Fibronectins/analysis/immunology</keyword><keyword>Genes, Reporter</keyword><keyword>Green Fluorescent Proteins/genetics</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Melanoma, Experimental/metabolism/pathology</keyword><keyword>Mice</keyword><keyword>Microfluidic Analytical Techniques/*instrumentation/methods</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Staurosporine/pharmacology</keyword><keyword>Transcriptional Activation</keyword><keyword>Transfection</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1572-8781 (Electronic)</isbn><accession-num>19130244</accession-num><abstract>The development of miniaturized cell culture platforms for performing parallel cultures and combinatorial assays is important in cell biology from the single-cell level to the system level. In this paper we developed an integrated microfluidic cell-culture platform, Cell-microChip (Cell-microChip), for parallel analyses of the effects of microenvironmental cues (i.e., culture scaffolds) on different mammalian cells and their cellular responses to external stimuli. As a model study, we demonstrated the ability of culturing and assaying several mammalian cells, such as NIH 3T3 fibroblast, B16 melanoma and HeLa cell lines, in a parallel way. For functional assays, first we tested drug-induced apoptotic responses from different cell lines. As a second functional assay, we performed &quot;on-chip&quot; transfection of a reporter gene encoding an enhanced green fluorescent protein (EGFP) followed by live-cell imaging of transcriptional activation of cyclooxygenase 2 (Cox-2) expression. Collectively, our Cell-microChip approach demonstrated the capability to carry out parallel operations and the potential to further integrate advanced functions and applications in the broader space of combinatorial chemistry and biology.</abstract><notes>Yu, Zeta Tak For&#xD;Kamei, Ken-ichiro&#xD;Takahashi, Hiroko&#xD;Shu, Chengyi Jenny&#xD;Wang, Xiaopu&#xD;He, George Wenfu&#xD;Silverman, Robert&#xD;Radu, Caius G&#xD;Witte, Owen N&#xD;Lee, Ki-Bum&#xD;Tseng, Hsian-Rong&#xD;CA08630/CA/NCI NIH HHS/United States&#xD;T32 CM008652/CM/NCI NIH HHS/United States&#xD;Howard Hughes Medical Institute/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Biomedical microdevices&#xD;Biomed Microdevices. 2009 Jun;11(3):547-55.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19130244</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom4>3.368</custom4><electronic-resource-num>10.1007/s10544-008-9260-x</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2111</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2111</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xing, Y.</author><author>Rao, J.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology, Stanford University School of Medicine Stanford, CA 94305, USA. jrao@stanford.edu</auth-address><titles><title>Quantum dot bioconjugates for in vitro diagnostics &amp; in vivo imaging</title><secondary-title>Cancer Biomark</secondary-title></titles><periodical><full-title>Cancer Biomark</full-title></periodical><pages>307-19</pages><volume>4</volume><number>6</number><edition>2009/01/08</edition><keywords><keyword>Animals</keyword><keyword>Biocompatible Materials</keyword><keyword>Diagnostic Imaging</keyword><keyword>Humans</keyword><keyword>Neoplasms/ diagnosis</keyword><keyword>Quantum Dots</keyword><keyword>Tissue Distribution</keyword><keyword>Tumor Markers, Biological</keyword></keywords><dates><year>2008</year></dates><isbn>1574-0153 (Print)</isbn><accession-num>19126959</accession-num><abstract>Semiconductor quantum dots are tiny light-emitting nanocrystals (2-10 nm) that have captivated researchers in the biomedical field in the last decade. Compared to organic dyes and fluorescent proteins, quantum dots (QDs) have unique optical properties such as tunable emission spectra, improved brightness, superior photostability, and simultaneous excitation of multiple fluorescence colors. Since the first successful reports on biological use of QDs a decade ago, QDs and their bioconjugates have been successfully applied in various imaging applications including fixed cell labeling, imaging of live cell dynamics, in situ tissue profiling, fluorescence detection, sensing and in vivo animal imaging. In this review, we will cover the optical properties of QDs, the biofunctionization strategies, their in vitro diagnostic applications and in vivo imaging applications. In addition, we will discuss the making of a new class of QDs--the self-illuminating QDs and their in vivo imaging and sensing applications. We will conclude with the issues and perspectives on QDs as in vivo imaging probes.</abstract><notes>Xing, Yun&#xD;Rao, Jianghong&#xD;1U54CA119367-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;Netherlands&#xD;Cancer biomarkers : section A of Disease markers&#xD;Cancer Biomark. 2008;4(6):307-19.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>3.118</custom4><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2343</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2343</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, A. M.</author><author>Mohs, A. M.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, 101 Woodruff Circle, Suite 2001, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Tuning the optical and electronic properties of colloidal nanocrystals by lattice strain</title><secondary-title>Nat Nanotechnol</secondary-title></titles><periodical><full-title>Nat Nanotechnol</full-title></periodical><pages>56-63</pages><volume>4</volume><number>1</number><edition>2009/01/03</edition><keywords><keyword>Crystallization/methods</keyword><keyword>Electrons</keyword><keyword>Nanoparticles/ chemistry</keyword><keyword>Optical Phenomena</keyword><keyword>Particle Size</keyword><keyword>Quantum Dots</keyword><keyword>Semiconductors</keyword></keywords><dates><year>2009</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1748-3395 (Electronic)</isbn><accession-num>19119284</accession-num><abstract>Strain can have a large influence on the properties of materials at the nanoscale. The effect of lattice strain on semiconductor devices has been widely studied, but its influence on colloidal semiconductor nanocrystals is still poorly understood. Here we show that the epitaxial deposition of a compressive shell (ZnS, ZnSe, ZnTe, CdS or CdSe) onto a soft nanocrystalline core (CdTe) to form a lattice-mismatched quantum dot can dramatically change the conduction and valence band energies of both the core and the shell. In particular, standard type-I quantum-dot behaviour is replaced by type-II behaviour, which is characterized by spatial separation of electrons and holes, extended excited-state lifetimes and giant spectral shifts. Moreover, the strain induced by the lattice mismatch can be used to tune the light emission--which displays narrow linewidths and high quantum yields--across the visible and near-infrared part of the spectrum (500-1,050 nm). Lattice-mismatched core-shell quantum dots are expected to have applications in solar energy conversion, multicolour biomedical imaging and super-resolution optical microscopy.</abstract><notes>Smith, Andrew M&#xD;Mohs, Aaron M&#xD;Nie, Shuming&#xD;P20 GM072069/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-01/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-02/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-03/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-04/GM/NIGMS NIH HHS/United States&#xD;PN2EY018244/EY/NEI NIH HHS/United States&#xD;R01 CA108468/CA/NCI NIH HHS/United States&#xD;R01 CA108468-01/CA/NCI NIH HHS/United States&#xD;R01 CA108468-02/CA/NCI NIH HHS/United States&#xD;R01 CA108468-03/CA/NCI NIH HHS/United States&#xD;R01 CA108468-04/CA/NCI NIH HHS/United States&#xD;R01 CA108468-05/CA/NCI NIH HHS/United States&#xD;U01HL080711/HL/NHLBI NIH HHS/United States&#xD;U54 CA119338-01/CA/NCI NIH HHS/United States&#xD;U54 CA119338-02/CA/NCI NIH HHS/United States&#xD;U54 CA119338-03/CA/NCI NIH HHS/United States&#xD;U54 CA119338-04/CA/NCI NIH HHS/United States&#xD;U54 CA119338-040001/CA/NCI NIH HHS/United States&#xD;U54 CA119338-049005/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Nature nanotechnology&#xD;Nat Nanotechnol. 2009 Jan;4(1):56-63. Epub 2008 Dec 7.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom2>2711767</custom2><custom3>NIHMS117811</custom3><custom4>20.588</custom4><electronic-resource-num>nnano.2008.360 [pii]&#xD;10.1038/nnano.2008.360 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2517</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2517</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, Z.</author><author>Mascheri, N.</author><author>Dharmakumar, R.</author><author>Fan, Z.</author><author>Paunesku, T.</author><author>Woloschak, G.</author><author>Li, D.</author></authors></contributors><titles><title>Superparamagnetic iron oxide nanoparticle-labeled cells as an effective vehicle for tracking the GFP gene marker using magnetic resonance imaging</title><secondary-title>Cytotherapy</secondary-title></titles><periodical><full-title>Cytotherapy</full-title></periodical><pages>43 - 51</pages><volume>11</volume><number>1</number><edition>2009/01</edition><dates><year>2009</year></dates><isbn>1465-3249</isbn><urls><related-urls><url>http://www.informaworld.com/10.1080/14653240802420243</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>3.259</custom4><access-date>September 28, 2009</access-date></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2535</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2535</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yu Zhang</author><author>Mo Yang</author><author>Ji-Ho Park</author><author>Jennifer Singelyn</author><author>Huiqing Ma</author><author>Michael J. Sailor</author><author>Erkki Ruoslahti</author><author>Mihrimah Ozkan</author><author>Cengiz Ozkan</author></authors></contributors><auth-address>Department of Mechanical Engineering University of California at Riverside Riverside, CA 92521 (USA); Department of Health Technology and Informatics The Hong Kong Polytechnic University Kowloon, Hong Kong (P.R. China); Department of Chemistry and Biochemistry Materials Science and Engineering Program University of California at San Diego La Jolla, CA 92093 (USA); Department of Bioengineering University of California at San Diego La Jolla, CA 92093 (USA); Department of Bioengineering University of California at Riverside Riverside, CA 92521 (USA); Burnham Institute for Medical Research at UCSB University of California, Santa Barbara Santa Barbara, CA 93106 (USA); Department of Electrical Engineering University of California at Riverside Riverside, CA 92521 (USA)</auth-address><titles><title>A Surface-Charge Study on Cellular-Uptake Behavior of F3-Peptide-Conjugated Iron Oxide Nanoparticles</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>1990-1996</pages><volume>5</volume><number>17</number><edition>2009/01</edition><dates><year>2009</year></dates><isbn>1613-6829</isbn><notes>10.1002/smll.200900520</notes><urls><related-urls><url>http://dx.doi.org/10.1002/smll.200900520</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>7.292</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2533</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2533</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yu Zhang</author><author>Mo Yang</author><author>Mihrimah Ozkan</author><author>Cengiz S. Ozkan</author></authors></contributors><auth-address>Dept. of Mechanical Engineering, University of California Riverside, Riverside, CA 92521; Dept. of Health Technology and Informatics, the Hong Kong Polytechnic University, Hong Kong, China; Dept. of Electrical Engineering, University of California Riverside, Riverside, CA 92521</auth-address><titles><title>Magnetic force microscopy of iron oxide nanoparticles and their cellular uptake</title><secondary-title>Biotechnology Progress</secondary-title></titles><periodical><full-title>Biotechnology Progress</full-title></periodical><pages>923-928</pages><volume>25</volume><number>4</number><edition>2009/01</edition><dates><year>2009</year></dates><isbn>1520-6033</isbn><notes>10.1002/btpr.215</notes><urls><related-urls><url>http://dx.doi.org/10.1002/btpr.215</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>2.499</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2516</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2516</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>You, Eun-Ah</author><author>Ahn, Richard W.</author><author>Lee, Min Hyung</author><author>Raja, Meera R.</author><author>O&apos;Halloran, Thomas V.</author><author>Odom, Teri W.</author></authors></contributors><titles><title>Size Control of Arsenic Trioxide Nanocrystals Grown in Nanowells</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>10863-10865</pages><volume>131</volume><number>31</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>0002-7863</isbn><notes>doi: 10.1021/ja902117b</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ja902117b</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja902117b</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2442</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2442</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, Sheng</author><author>Ding, Yong</author><author>Wei, Yaguang</author><author>Fang, Hao</author><author>Shen, Yue</author><author>Sood, Ashok K.</author><author>Polla, Dennis L.</author><author>Wang, Zhong Lin</author></authors></contributors><titles><title>Patterned Growth of Horizontal ZnO Nanowire Arrays</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>6670-6671</pages><volume>131</volume><number>19</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>0002-7863</isbn><notes>doi: 10.1021/ja902119h</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ja902119h</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja902119h</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2506</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2506</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thaxton, C. Shad</author><author>Daniel, Weston L.</author><author>Giljohann, David A.</author><author>Thomas, Audrey D.</author><author>Mirkin, Chad A.</author></authors></contributors><titles><title>Templated Spherical High Density Lipoprotein Nanoparticles</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>1384-1385</pages><volume>131</volume><number>4</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>0002-7863</isbn><notes>doi: 10.1021/ja808856z</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ja808856z</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja808856z</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2503</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2503</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sweeney, Christina M.</author><author>Hasan, Warefta</author><author>Nehl, Colleen L.</author><author>Odom, Teri W.</author></authors></contributors><titles><title>Optical Properties of Anisotropic CoreShell Pyramidal Particles</title><secondary-title>The Journal of Physical Chemistry A</secondary-title></titles><periodical><full-title>The Journal of Physical Chemistry A</full-title></periodical><pages>4265-4268</pages><volume>113</volume><number>16</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>1089-5639</isbn><notes>doi: 10.1021/jp810837u</notes><urls><related-urls><url>http://dx.doi.org/10.1021/jp810837u</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>2.889</custom4><electronic-resource-num>10.1021/jp810837u</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2500</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2500</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, DeeDee</author><author>Clark, Sandra H.</author><author>Bertin, Paul A.</author><author>Mirkin, Bernard L.</author><author>Nguyen, SonBinh T.</author></authors></contributors><titles><title>Synthesis and in vitro activity of ROMP-based polymer nanoparticles</title><secondary-title>Journal of Materials Chemistry</secondary-title></titles><periodical><full-title>Journal of Materials Chemistry</full-title></periodical><pages>2159-2165</pages><volume>19</volume><number>15</number><edition>2009/01</edition><dates><year>2009</year></dates><abstract>A new type of polymer nanoparticle (PNP) containing a high density of covalently linked doxorubicin, attached via a non-cleavable amine linkage (amine-linked Dox-PNP) was prepared. Together with a previously reported cleavable carbamate-linked Dox-PNP, this new amine-linked Dox-PNP was subsequently evaluated against free doxorubicin for its cytotoxicity and inhibitory effects on SKNSH wild-type and SKrDOX6 doxorubicin-resistant human neuroblastoma cell lines. Analogous cholesterol-containing PNPs (Chol-PNPs) and indomethacin-containing PNPs (IND-PNPs) were also synthesized and used as the non-cytotoxic controls. While neither cell line was affected by Chol-PNPs or IND-PNPs, SKrDOX6 doxorubicin-resistant cells exhibited similar cytotoxic responses to free doxorubicin and both amine- and carbamate-linked Dox-PNPs, suggesting that doxorubicin or the doxorubicin-containing polymer must be the active agent in the latter case. SKNSH wild-type cells also responded to both Dox-PNPs, albeit at a higher apparent concentration than free doxorubicin alone. The growth of SKNSH wild-type cells was significantly inhibited upon incubation with carbamate-linked Dox-PNPs, as with free doxorubicin, over a 7 day period. In comparison to free doxorubicin, carbamate-linked Dox-PNPs produced a longer (72 h) period of initial inhibition in SKrDOX6 doxorubicin-resistant cells.</abstract><notes>10.1039/b817511j</notes><urls><related-urls><url>http://dx.doi.org/10.1039/b817511j</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>1.342</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2438</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2438</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, Chunmeng</author><author>Zhu, Ying</author><author>Xie, Zhihui</author><author>Qian, Weiping</author><author>Hsieh, Chia-Ling</author><author>Nie, Shuming</author><author>Su, Yongping</author><author>Zhau, Haiyen E.</author><author>Chung, Leland W. K.</author></authors></contributors><titles><title>Visualizing Human Prostate Cancer Cells in Mouse Skeleton Using Bioconjugated Near-infrared Fluorescent Quantum Dots</title><secondary-title>Urology</secondary-title></titles><periodical><full-title>Urology</full-title></periodical><pages>446-451</pages><volume>74</volume><number>2</number><edition>2009/01</edition><dates><year>2009</year></dates><isbn>0090-4295</isbn><notes>doi: DOI: 10.1016/j.urology.2009.01.023</notes><urls><related-urls><url>http://www.sciencedirect.com/science/article/B6VJW-4W84GR9-1/2/45ede613191460983f2cbb780ece0b54</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>2.604</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2402</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2402</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, X. M.</author><author>Li, J.</author><author>Nie, S. M.</author></authors></contributors><auth-address>[Qian, Ximei; Li, Jun; Nie, Shuming] Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA. [Qian, Ximei; Li, Jun; Nie, Shuming] Emory Univ, Dept Chem, Atlanta, GA 30322 USA. [Qian, Ximei; Li, Jun; Nie, Shuming] Georgia Inst Technol, Atlanta, GA 30322 USA. [Li, Jun] Hunan Univ, Biomed Engn Ctr, State Key Lab Chemobiosensing &amp; Chemometr, Changsha 410082, Hunan, Peoples R China.&#xD;Nie, SM, Emory Univ, Dept Biomed Engn, 101 Woodruff Circle,Suite 2001, Atlanta, GA 30322 USA.&#xD;snie@emory.edu</auth-address><titles><title>Stimuli-Responsive SERS Nanoparticles: Conformational Control of Plasmonic Coupling and Surface Raman Enhancement</title><secondary-title>Journal of the American Chemical Society</secondary-title><alt-title>J. Am. Chem. Soc.</alt-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>7540-+</pages><volume>131</volume><number>22</number><edition>2009/01</edition><keywords><keyword>GOLD NANOPARTICLES</keyword><keyword>MOLECULAR RULER</keyword><keyword>SPECTROSCOPY</keyword><keyword>SCATTERING</keyword><keyword>NANOCRYSTALS</keyword><keyword>NANOSENSORS</keyword><keyword>PROTEINS</keyword><keyword>COLLOIDS</keyword></keywords><dates><year>2009</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0002-7863</isbn><accession-num>ISI:000267177900031</accession-num><abstract>Stimuli-responsive surface-enhanced Raman scattering (SERS) nanoparticles have been developed by using colloidal gold nanocrystals and a class of thiolated block copolymers consisting of a pH-responsive polymer segment, an amphiphilic polyethylene glycol segment, and a lipoic acid anchoring group. The results demonstrate that SERS signals can be switched on and off by molecular conformations in response to pH. An important finding is that neutralized polymethacrylic acid (PMAA) molecules are able to interact with amphiphilic polyethylene glycol (PEG) chains, leading to highly compact and intermingled copolymer structures on the surface of nanoparticles. This type of molecular conformation change provides a new strategy for controlling plasmonic coupling and electromagnetic Raman enhancement and raises the possibility of using SERS nanoparticle tags for biomolecular binding and enzymatic cleavage studies.</abstract><notes>ISI Document Delivery No.: 460HD&#xD;Times Cited: 0&#xD;Cited Reference Count: 26&#xD;Qian, Ximei Li, Jun Nie, Shuming&#xD;AMER CHEMICAL SOC</notes><work-type>Article</work-type><urls><related-urls><url>&lt;Go to ISI&gt;://000267177900031</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja902226z</electronic-resource-num><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2495</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2495</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Prigodich, Andrew E.</author><author>Seferos, Dwight S.</author><author>Massich, Matthew D.</author><author>Giljohann, David A.</author><author>Lane, Brandon C.</author><author>Mirkin, Chad A.</author></authors></contributors><titles><title>Nano-flares for mRNA Regulation and Detection</title><secondary-title>ACS Nano</secondary-title></titles><periodical><full-title>ACS Nano</full-title></periodical><pages>2147-2152</pages><volume>3</volume><number>8</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>1936-0851</isbn><notes>doi: 10.1021/nn9003814</notes><urls><related-urls><url>http://dx.doi.org/10.1021/nn9003814</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>5.472</custom4><electronic-resource-num>10.1021/nn9003814</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2527</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2527</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ji-Ho Park</author><author>Geoffrey von Maltzahn</author><author>Lianglin Zhang</author><author>Austin M. Derfus</author><author>Dmitri Simberg</author><author>Todd J. Harris</author><author>Erkki Ruoslahti</author><author>Sangeeta N. Bhatia</author><author>Michael J. Sailor</author></authors></contributors><auth-address>Materials Science and Engineering Program Department of Chemistry and Biochemistry University of California, San Diego 9500 Gilman, La Jolla, CA 92093 (USA); Department of Bioengineering University of California, San Diego 9500 Gilman, La Jolla, CA 92093 (USA); Harvard-MIT Division of Health Sciences and Technology Massachusetts Institute of Technology 77 Massachusetts Avenue, Cambridge, MA 02139 (USA); Cancer Research Center Burnham Institute for Medical Research 10901 N. Torrey Pines Rd., La Jolla, CA 92037 (USA); Vascular Mapping Center Burnham Institute for Medical Research (at UCSB) Bio II Rm. #3119, University of California, Santa Barbara Santa Barbara, CA 93106 (USA); Current address: Biosite, Inc. 9975 Summers Ridge Road San Diego, CA 92121 (USA); Current address: Pfizer Inc., PGRD-La Jolla 10777 Science Center Dr. San Diego, CA 92121 (USA)</auth-address><titles><title>Systematic Surface Engineering of Magnetic Nanoworms for In vivo Tumor Targeting</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>694-700</pages><volume>5</volume><number>6</number><edition>2009/01</edition><dates><year>2009</year></dates><isbn>1613-6829</isbn><notes>10.1002/smll.200801789</notes><urls><related-urls><url>http://dx.doi.org/10.1002/smll.200801789</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>7.292</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2528</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2528</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, Ji-Ho</author><author>Gu, Luo</author><author>von Maltzahn, Geoffrey</author><author>Ruoslahti, Erkki</author><author>Bhatia, Sangeeta N.</author><author>Sailor, Michael J.</author></authors></contributors><titles><title>Biodegradable luminescent porous silicon nanoparticles for in vivo applications</title><secondary-title>Nat Mater</secondary-title></titles><periodical><full-title>Nat Mater</full-title></periodical><pages>331-336</pages><volume>8</volume><number>4</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>Nature Publishing Group</publisher><isbn>1476-1122</isbn><notes>10.1038/nmat2398</notes><urls><related-urls><url>http://dx.doi.org/10.1038/nmat2398</url><url>http://www.nature.com/nmat/journal/v8/n4/suppinfo/nmat2398_S1.html</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>25.759</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2534</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2534</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bifeng Pan</author><author>Daxiang Cui</author><author>Ping Xu</author><author>Cengiz Ozkan</author><author>Gao Feng</author><author>Mihri Ozkan</author><author>Tuo Huang</author><author>Bingfeng Chu</author><author>Qing Li</author><author>Rong He</author><author>Guohan Hu</author></authors></contributors><titles><title>Synthesis and characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes and their application in gene delivery systems</title><secondary-title>Nanotechnology</secondary-title></titles><periodical><full-title>Nanotechnology</full-title></periodical><pages>125101</pages><number>12</number><edition>2009/01</edition><dates><year>2009</year></dates><isbn>0957-4484</isbn><abstract>With the aim of improving the amount and delivery efficiency of genes taken by carbon nanotubes into human cancer cells, different generations of polyamidoamine dendrimer modified multi-walled carbon nanotubes (dMNTs) were fabricated, and characterized by high-resolution transmission electron microscopy, atomic force microscopy, x-ray photoelectron spectroscopy, Raman spectroscopy, Fourier transform infrared spectroscopy and thermogravimetric analysis, revealing the presence of dendrimer capped on the surface of carbon nanotubes. The dMNTs fully conjugated with FITC-labeled antisense c-myc oligonucleotides (asODN), those resultant asODN-dMNTs composites were incubated with human breast cancer cell line MCF-7 cells and MDA-MB-435 cells, and liver cancer cell line HepG2 cells, and confirmed to enter into tumor cells within 15 min by laser confocal microscopy. These composites inhibited the cell growth in time- and dose-dependent means, and down-regulated the expression of the c-myc gene and C-Myc protein. Compared with the composites of CNT-NH2-asODN and dendrimer-asODN, no. 5 generation of dendrimer-modified MNT-asODN composites exhibit maximal transfection efficiencies and inhibition effects on tumor cells. The intracellular gene transport and uptake via dMNTs should be generic for the mammalian cell lines. The dMNTs have potentials in applications such as gene or drug delivery for cancer therapy and molecular imaging.</abstract><urls><related-urls><url>http://stacks.iop.org/0957-4484/20/125101</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>3.727</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2445</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2445</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Osunkoya, Adeboye O.</author><author>Yin-Goen, Qiqin</author><author>Phan, John H.</author><author>Moffitt, Richard A.</author><author>Stokes, Todd H.</author><author>Wang, May D.</author><author>Young, Andrew N.</author></authors></contributors><titles><title>Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis</title><secondary-title>Human Pathology</secondary-title></titles><periodical><full-title>Human Pathology</full-title></periodical><volume>In Press, Corrected Proof</volume><edition>2009/01</edition><keywords><keyword>Renal cell carcinoma</keyword><keyword>Microarrays</keyword><keyword>Quantitative RT-PCR</keyword><keyword>Immunohistochemistry</keyword><keyword>Bioinformatics</keyword></keywords><dates><year>2009</year><pub-dates><date>2009</date></pub-dates></dates><isbn>0046-8177</isbn><notes>doi: DOI: 10.1016/j.humpath.2009.05.006</notes><urls><related-urls><url>http://www.sciencedirect.com/science/article/B6WGD-4X1R2R8-7/2/98046b37ded11ac475f9592a04c02888</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>3.177</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2446</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2446</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nyadong, Leonard</author><author>Harris, Glenn A.</author><author>Balayssac, Stephane</author><author>Galhena, Asiri S.</author><author>Malet-Martino, Myriam</author><author>Martino, Robert</author><author>Parry, R. Mitchell</author><author>Wang, May Dongmei</author><author>Fernandez, Facundo M.</author><author>Gilard, Veronique</author></authors></contributors><titles><title>Combining Two-Dimensional Diffusion-Ordered Nuclear Magnetic Resonance Spectroscopy, Imaging Desorption Electrospray Ionization Mass Spectrometry, and Direct Analysis in Real-Time Mass Spectrometry for the Integral Investigation of Counterfeit Pharmaceuticals</title><secondary-title>Analytical Chemistry</secondary-title></titles><periodical><full-title>Analytical Chemistry</full-title></periodical><pages>4803-4812</pages><volume>81</volume><number>12</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>0003-2700</isbn><notes>doi: 10.1021/ac900384j</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ac900384j</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>5.918</custom4><electronic-resource-num>10.1021/ac900384j</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2523</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2523</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>A. K. M. Newaz</author><author>Yun Wang</author><author>Jian Wu</author><author>S. A. Solin</author><author>V. R. Kavasseri</author><author>I. S. Ahmad</author><author>I. Adesida</author></authors></contributors><titles><title>Transport measurements and analytical modeling of extraordinary electrical conductance in Ti-GaAs metal-semiconductor hybrid structures</title><secondary-title>Physical Review B (Condensed Matter and Materials Physics)</secondary-title></titles><periodical><full-title>Physical Review B (Condensed Matter and Materials Physics)</full-title></periodical><pages>195308</pages><volume>79</volume><number>19</number><edition>2009/01</edition><keywords><keyword>electric sensing devices</keyword><keyword>enhanced magnetoresistance</keyword><keyword>gallium arsenide</keyword><keyword>III-V semiconductors</keyword><keyword>semiconductor epitaxial layers</keyword><keyword>semiconductor-metal boundaries</keyword><keyword>titanium</keyword></keywords><dates><year>2009</year></dates><urls><related-urls><url>http://link.aps.org/abstract/PRB/v79/e195308</url><url>http://dx.doi.org/10.1103/PhysRevB.79.195308</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom4>3.284</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2489</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2489</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mrksich, Milan</author></authors></contributors><titles><title>Using self-assembled monolayers to model the extracellular matrix</title><secondary-title>Acta Biomaterialia</secondary-title></titles><periodical><full-title>Acta Biomaterialia</full-title></periodical><pages>832-841</pages><volume>5</volume><number>3</number><edition>2009/01</edition><keywords><keyword>Cell-matrix interactions</keyword><keyword>Self-assembled monolayers</keyword><keyword>Modelling</keyword></keywords><dates><year>2009</year></dates><isbn>1742-7061</isbn><notes>doi: DOI: 10.1016/j.actbio.2009.01.016</notes><urls><related-urls><url>http://www.sciencedirect.com/science/article/B7GHW-4VG7MSV-1/2/e6cacbfb415ff63dd48ed3ae15917a66</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.255</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2525</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2525</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Missirlis, Dimitris</author><author>Khant, Htet</author><author>Tirrell, Matthew</author></authors></contributors><titles><title>Mechanisms of Peptide Amphiphile Internalization by SJSA-1 Cells in Vitro</title><secondary-title>Biochemistry</secondary-title></titles><periodical><full-title>Biochemistry</full-title></periodical><pages>3304-3314</pages><volume>48</volume><number>15</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>0006-2960</isbn><notes>doi: 10.1021/bi802356k</notes><urls><related-urls><url>http://dx.doi.org/10.1021/bi802356k</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>3.402</custom4><electronic-resource-num>10.1021/bi802356k</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2529</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2529</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Geoffrey von Maltzahn</author><author>Andrea Centrone</author><author>Ji-Ho Park</author><author>Renuka Ramanathan</author><author>Michael J. Sailor</author><author>T. Alan Hatton</author><author>Sangeeta N. Bhatia</author></authors></contributors><auth-address>Harvard-MIT Division of Health Sciences and Technology Massachusetts Institute of Technology 77 Massachusetts Avenue, Cambridge, MA 02139 (USA); Electrical Engineering and Computer Science, MIT David H. Koch Institute for Integrative Cancer Research Department of Medicine, Brigham and Women&apos;s Hospital, and Howard Hughes Medical Institute Boston, MA (USA); Department of Chemical Engineering Massachusetts Institute of Technology 77 Massachusetts Avenue, Cambridge, MA 02139 (USA); Materials Science and Engineering Program Department of Chemistry and Biochemistry University of California, San Diego 9500 Gilman, La Jolla, CA 92093 (USA); Departments of Bioengineering and Nanoengineering University of California, San Diego 9500 Gilman, La Jolla, CA 92093 (USA)</auth-address><titles><title>SERS-Coded Gold Nanorods as a Multifunctional Platform for Densely Multiplexed Near-Infrared Imaging and Photothermal Heating</title><secondary-title>Advanced Materials</secondary-title></titles><periodical><full-title>Advanced Materials</full-title></periodical><pages>3175-3180</pages><volume>21</volume><number>31</number><edition>2009/01</edition><dates><year>2009</year></dates><isbn>1521-4095</isbn><notes>10.1002/adma.200803464</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200803464</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>10.231</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2484</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2484</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Major, Jody L.</author><author>Meade, Thomas J.</author></authors></contributors><titles><title>Bioresponsive, Cell-Penetrating, and Multimeric MR Contrast Agents</title><secondary-title>Accounts of Chemical Research</secondary-title></titles><periodical><full-title>Accounts of Chemical Research</full-title></periodical><pages>893-903</pages><volume>42</volume><number>7</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>0001-4842</isbn><notes>doi: 10.1021/ar800245h</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ar800245h</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>15.403</custom4><electronic-resource-num>10.1021/ar800245h</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2454</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2454</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mahmud, Goher</author><author>Campbell, Christopher J.</author><author>Bishop, Kyle J. M.</author><author>Komarova, Yulia A.</author><author>Chaga, Oleg</author><author>Soh, Siowling</author><author>Huda, Sabil</author><author>Kandere-Grzybowska, Kristiana</author><author>Grzybowski, Bartosz A.</author></authors></contributors><titles><title>Directing cell motions on micropatterned ratchets</title><secondary-title>Nat Phys</secondary-title></titles><periodical><full-title>Nat Phys</full-title></periodical><pages>606-612</pages><volume>5</volume><number>8</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>Nature Publishing Group</publisher><isbn>1745-2473</isbn><notes>10.1038/nphys1306</notes><urls><related-urls><url>http://dx.doi.org/10.1038/nphys1306</url><url>http://www.nature.com/nphys/journal/v5/n8/suppinfo/nphys1306_S1.html</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>17.189</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2480</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2480</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Abigail K. R. Lytton-Jean</author><author>Julianne M. Gibbs-Davis</author><author>Hai Long</author><author>George C. Schatz</author><author>Chad A. Mirkin</author><author>SonBinh T. Nguyen</author></authors></contributors><auth-address>Department of Chemistry and The International Institute for Nanotechnology Northwestern University, Evanston, IL 60208 (USA); Present address: David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MS 02139 (USA); Present address: Department of Chemistry, University of Alberta, Edmonton, AB T6G 2G2 (Canada); Present address: Scientific Computing Division, National Renewable Energy Laboratory, Golden, CO 80401 (USA)</auth-address><titles><title>Highly Cooperative Behavior of Peptide Nucleic Acid-Linked DNA-Modified Gold-Nanoparticle and Comb-Polymer Aggregates</title><secondary-title>Advanced Materials</secondary-title></titles><periodical><full-title>Advanced Materials</full-title></periodical><pages>706-709</pages><volume>21</volume><number>6</number><edition>2009/01</edition><dates><year>2009</year></dates><isbn>1521-4095</isbn><notes>10.1002/adma.200801724</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200801724</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>10.231</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2540</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2540</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lu, James J.</author><author>Langer, Robert</author><author>Chen, Jianzhu</author></authors></contributors><titles><title>A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery</title><secondary-title>Molecular Pharmaceutics</secondary-title></titles><periodical><full-title>Molecular Pharmaceutics</full-title></periodical><pages>763-771</pages><volume>6</volume><number>3</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>1543-8384</isbn><notes>doi: 10.1021/mp900023v</notes><urls><related-urls><url>http://dx.doi.org/10.1021/mp900023v</url></related-urls></urls><custom1>CCNE - MIT</custom1><custom4>4.388</custom4><electronic-resource-num>10.1021/mp900023v</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2479</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2479</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, Sang-Min</author><author>Chen, Haimei</author><author>OHalloran, Thomas V.</author><author>Nguyen, SonBinh T.</author></authors></contributors><titles><title>Polymer-Caged Nanobins as a Modular Drug Delivery Platform</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>9311-9320</pages><volume>131</volume><number>26</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>0002-7863</isbn><notes>doi: 10.1021/ja9017336</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ja9017336</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja9017336</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2477</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2477</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jae-Hyun Lee</author><author>Kyuri Lee</author><author>SeungHo Moon</author><author>Yuhan Lee</author><author>TaeGwan Park</author><author>Jinwoo Cheon</author></authors></contributors><auth-address>Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701 (Korea), Fax: (+82)42-869-2610; Department of Chemistry, Yonsei University, Seoul 120-749 (Korea), Fax: (+82)2-364-7050</auth-address><titles><title>All-in-One Target-Cell-Specific Magnetic Nanoparticles for Simultaneous Molecular Imaging and siRNA Delivery13</title><secondary-title>Angewandte Chemie International Edition</secondary-title></titles><periodical><full-title>Angewandte Chemie International Edition</full-title></periodical><pages>4174-4179</pages><volume>48</volume><number>23</number><edition>2009/01</edition><dates><year>2009</year></dates><isbn>1521-3773</isbn><notes>10.1002/anie.200805998</notes><urls><related-urls><url>http://dx.doi.org/10.1002/anie.200805998</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>11.025</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2478</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2478</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, Jeunghoon</author><author>Hasan, Warefta</author><author>Odom, Teri W.</author></authors></contributors><titles><title>Tuning the Thickness and Orientation of Single Au Pyramids for Improved Refractive Index Sensitivities</title><secondary-title>The Journal of Physical Chemistry C</secondary-title></titles><periodical><full-title>The Journal of Physical Chemistry C</full-title></periodical><pages>2205-2207</pages><volume>113</volume><number>6</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>1932-7447</isbn><notes>doi: 10.1021/jp8111155</notes><urls><related-urls><url>http://dx.doi.org/10.1021/jp8111155</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>3.398</custom4><electronic-resource-num>10.1021/jp8111155</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2475</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2475</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koynova, Rumiana</author><author>Tenchov, Boris</author><author>Wang, Li</author><author>MacDonald, Robert C.</author></authors></contributors><titles><title>Hydrophobic Moiety of Cationic Lipids Strongly Modulates Their Transfection Activity</title><secondary-title>Molecular Pharmaceutics</secondary-title></titles><periodical><full-title>Molecular Pharmaceutics</full-title></periodical><pages>951-958</pages><volume>6</volume><number>3</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>1543-8384</isbn><notes>doi: 10.1021/mp8002573</notes><urls><related-urls><url>http://dx.doi.org/10.1021/mp8002573</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.388</custom4><electronic-resource-num>10.1021/mp8002573</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2474</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2474</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koynova, Rumiana</author><author>Tenchov, Boris</author></authors></contributors><titles><title>Cationic phospholipids: structure-transfection activity relationships</title><secondary-title>Soft Matter</secondary-title></titles><periodical><full-title>Soft Matter</full-title></periodical><pages>3187-3200</pages><volume>5</volume><number>17</number><edition>2009/01</edition><dates><year>2009</year></dates><abstract>Synthetic cationic lipids are presently the most widely used non-viral gene carriers. Examined here is a particularly attractive cationic lipid class, triester phosphatidylcholines (PCs) exhibiting low toxicities and good transfection efficiency. Similarly to other cationic lipids, they form stable complexes (lipoplexes) with the polyanionic nucleic acids. A summary of studies on a set of [similar]30 cationic PCs reveals the existence of a strong, systematic dependence of their transfection efficiency on the lipid hydrocarbon chain structure: transfection activity increases with increase of chain unsaturation from 0 to 2 double bonds per lipid and decreases with increase of chain length in the range [similar]30-50 total number of chain carbon atoms. Maximum transfection was observed for ethyl phosphate PCs (EPCs) with monounsaturated 14:1 chains (total of 2 double bonds and 30 chain carbon atoms). Lipid phase behavior is known to depend strongly on the chain molecular structure and the above relationships thus substantiate a view that cationic PC phase propensities are an important determinant of their activity. Indeed, X-ray structural studies show that the rate of DNA release from lipoplexes as well as transfection activity well correlate with non-lamellar phase progressions observed in cationic PC mixtures with membrane lipids. These findings appear to be of considerable interest because, according to current views, key processes in lipid-mediated transfection such as lipoplex disassembly and DNA release within the cells are believed to take place upon cationic lipid mixing with cellular lipids.</abstract><notes>10.1039/b902027f</notes><urls><related-urls><url>http://dx.doi.org/10.1039/b902027f</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.890</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2547</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2547</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kelly, Kimberly A.</author><author>Shaw, Stanley Y.</author><author>Nahrendorf, Matthias</author><author>Kristoff, Kelly</author><author>Aikawa, Elena</author><author>Schreiber, Stuart L.</author><author>Clemons, Paul A.</author><author>Weissleder, Ralph</author></authors></contributors><titles><title>Unbiased discovery of in vivo imaging probes through in vitro profiling of nanoparticle libraries</title><secondary-title>Integrative Biology</secondary-title></titles><periodical><full-title>Integrative Biology</full-title></periodical><pages>311-317</pages><volume>1</volume><number>4</number><edition>2009/01</edition><dates><year>2009</year></dates><abstract>In vivo imaging reveals how proteins and cells function as part of complex regulatory networks in intact organisms, and thereby contributes to a systems-level understanding of biological processes. However, the development of novel in vivo imaging probes remains challenging. Most probes are directed against a limited number of pre-specified protein targets; cell-based screens for imaging probes have shown promise, but raise concerns over whether in vitro surrogate cell models recapitulate in vivo phenotypes. Here, we rapidly profile the in vitro binding of nanoparticle imaging probes in multiple samples of defined target vs. background cell types, using primary cell isolates. This approach selects for nanoparticles that show desired targeting effects across all tested members of a class of cells, and decreases the likelihood that an idiosyncratic cell line will unduly skew screening results. To adjust for multiple hypothesis testing, we use permutation methods to identify nanoparticles that best differentiate between the target and background cell classes. (This approach is conceptually analogous to one used for high-dimensionality datasets of genome-wide gene expression, e.g. to identify gene expression signatures that discriminate subclasses of cancer.) We apply this approach to the identification of nanoparticle imaging probes that bind endothelial cells, and validate our in vitro findings in human arterial samples, and by in vivo intravital microscopy in mice. Overall, this work presents a generalizable approach to the unbiased discovery of in vivo imaging probes, and may guide the further development of novel endothelial imaging probes.</abstract><notes>10.1039/b821775k</notes><urls><related-urls><url>http://dx.doi.org/10.1039/b821775k</url></related-urls></urls><custom1>CCNE - MIT</custom1><custom4>3.167</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2472</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2472</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jung-tak Jang</author><author>Hyunsoo Nah</author><author>Jae-Hyun Lee</author><author>SeungHo Moon</author><author>MinGyu Kim</author><author>Jinwoo Cheon</author></authors></contributors><auth-address>Department of Chemistry, Yonsei University, Seoul 120-749 (Korea), Fax: (+82)2-364-7050; Pohang Accelerator Laboratory (PAL), Pohang 790-784 (Korea)</auth-address><titles><title>Critical Enhancements of MRI Contrast and Hyperthermic Effects by Dopant-Controlled Magnetic Nanoparticles13</title><secondary-title>Angewandte Chemie International Edition</secondary-title></titles><periodical><full-title>Angewandte Chemie International Edition</full-title></periodical><pages>1234-1238</pages><volume>48</volume><number>7</number><edition>2009/01</edition><dates><year>2009</year></dates><isbn>1521-3773</isbn><notes>10.1002/anie.200805149</notes><urls><related-urls><url>http://dx.doi.org/10.1002/anie.200805149</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>11.025</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2549</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2549</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Issadore, D.</author><author>Humphry, K. J.</author><author>Brown, K. A.</author><author>Sandberg, L.</author><author>Weitz, D. A.</author><author>Westervelt, R. M.</author></authors></contributors><titles><title>Microwave dielectric heating of drops in microfluidic devices</title><secondary-title>Lab Chip</secondary-title></titles><periodical><full-title>Lab Chip</full-title></periodical><pages>1701-1706</pages><volume>9</volume><number>12</number><edition>2009/01</edition><dates><year>2009</year></dates><isbn>1473-0197</isbn><accession-num>ISI:000266616000009</accession-num><abstract>We present a technique to locally and rapidly heat water drops in microfluidic devices with microwave dielectric heating. Water absorbs microwave power more efficiently than polymers, glass, and oils due to its permanent molecular dipole moment that has large dielectric loss at GHz frequencies. The relevant heat capacity of the system is a single thermally isolated picolitre-scale drop of water, enabling very fast thermal cycling. We demonstrate microwave dielectric heating in a microfluidic device that integrates a flow-focusing drop maker, drop splitters, and metal electrodes to locally deliver microwave power from an inexpensive, commercially available 3.0 GHz source and amplifier. The temperature change of the drops is measured by observing the temperature dependent fluorescence intensity of cadmium selenide nanocrystals suspended in the water drops. We demonstrate characteristic heating times as short as 15 ms to steady-state temperature changes as large as 30 degrees C above the base temperature of the microfluidic device. Many common biological and chemical applications require rapid and local control of temperature and can benefit from this new technique.</abstract><notes>Issadore, David Humphry, Katherine J. Brown, Keith A. Sandberg, Lori Weitz, David A. Westervelt, Robert M.</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000266616000009</url></related-urls></urls><custom1>CCNE - MIT</custom1><custom4>7.000</custom4><electronic-resource-num>10.1039/b822357b</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2522</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2522</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>M. S. Hughes</author><author>J. N. Marsh</author><author>J. M. Arbeit</author><author>R. G. Neumann</author><author>R. W. Fuhrhop</author><author>K. D. Wallace</author><author>L. Thomas</author><author>J. Smith</author><author>K. Agyem</author><author>G. M. Lanza</author><author>S. A. Wickline</author><author>J. E. McCarthy</author></authors></contributors><titles><title>Application of Renyi entropy for ultrasonic molecular imaging</title><secondary-title>The Journal of the Acoustical Society of America</secondary-title></titles><periodical><full-title>The Journal of the Acoustical Society of America</full-title></periodical><pages>3141-3145</pages><volume>125</volume><number>5</number><edition>2009/01</edition><keywords><keyword>acoustic signal processing</keyword><keyword>biomedical ultrasonics</keyword><keyword>entropy</keyword><keyword>ultrasonic imaging</keyword><keyword>ultrasonic scattering</keyword></keywords><dates><year>2009</year></dates><urls><related-urls><url>http://link.aip.org/link/?JAS/125/3141/1</url><url>http://dx.doi.org/10.1121/1.3097489</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom4>na</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2470</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2470</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hill, Haley D.</author><author>Millstone, Jill E.</author><author>Banholzer, Matthew J.</author><author>Mirkin, Chad A.</author></authors></contributors><titles><title>The Role Radius of Curvature Plays in Thiolated Oligonucleotide Loading on Gold Nanoparticles</title><secondary-title>ACS Nano</secondary-title></titles><periodical><full-title>ACS Nano</full-title></periodical><pages>418-424</pages><volume>3</volume><number>2</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>1936-0851</isbn><notes>doi: 10.1021/nn800726e</notes><urls><related-urls><url>http://dx.doi.org/10.1021/nn800726e</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>5.472</custom4><electronic-resource-num>10.1021/nn800726e</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2463</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2463</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Giljohann, David A.</author><author>Seferos, Dwight S.</author><author>Prigodich, Andrew E.</author><author>Patel, Pinal C.</author><author>Mirkin, Chad A.</author></authors></contributors><titles><title>Gene Regulation with Polyvalent siRNANanoparticle Conjugates</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>2072-2073</pages><volume>131</volume><number>6</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>0002-7863</isbn><notes>doi: 10.1021/ja808719p</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ja808719p</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja808719p</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2532</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2532</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cortes-Mateos, Maria</author><author>Martin, David</author><author>Sandoval, Sergio</author><author>Ruidiaz, Manuel</author><author>Messmer, Davorka</author><author>Wang-Rodriguez, Jessica</author><author>Trogler, William</author><author>Kummel, Andrew</author><author>Blair, Sarah</author></authors></contributors><titles><title>Automated Microscopy to Evaluate Surgical Specimens Via Touch Prep in Breast Cancer</title><secondary-title>Annals of Surgical Oncology</secondary-title></titles><periodical><full-title>Annals of Surgical Oncology</full-title></periodical><pages>709-720</pages><volume>16</volume><number>3</number><edition>2009/01</edition><dates><year>2009</year></dates><abstract>Abstract Background&amp;nbsp;&amp;nbsp;Breast conservation therapy is the standard treatment for breast cancer; however, 2050% of operations have a positive margin leading to secondary procedures. The standard of care to evaluate surgical margins is based on permanent section. Imprint cytology (touch prep) has been used to evaluate surgical samples, but conventional techniques require an experienced cytopathologist for correct interpretation. An automated image screening process has been developed to discern cancer cells from normal epithelial cells. This technique is based on cellularity of the imprint specimen and does not require expertise in cytopathology. Methods&amp;nbsp;&amp;nbsp;A rapid immunofluorescent staining technique coupled with automated microscopy was used to classify specimens as cancer vs. noncancer based on the density of epithelial cells captured on touch prep of tumor cross-sections. The results of the automated analysis vs. a manual screen of ten 20 fields were compared to the pathology interpretation on permanent section. Results&amp;nbsp;&amp;nbsp;A total of 34 consecutive cases were analyzed: 10 normal cases, and 24 cancer cases. The cross-section specimens for invasive cancer were correctly classified in at least 65% of the cases by using manual microscopy and at least 83% by using automated microscopy. The manual and automated microscopy correlated well for measurements of epithelial cell density (R 2&amp;nbsp;=&amp;nbsp;0.64); however, the automated microscopy was more accurate. Conclusions&amp;nbsp;&amp;nbsp;This preliminary study using an automated system for intraoperative interpretation does not require a cytopathologist and shows that rapid, low-resolution imaging can correctly identify cancer cells for invasive carcinoma in surgical specimens. Therefore, automated determination of cellularity in touch prep is a promising technique for future margin interpretation of breast conservation therapy.</abstract><notes>10.1245/s10434-008-0274-7</notes><urls><related-urls><url>http://dx.doi.org/10.1245/s10434-008-0274-7</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>4.507</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2452</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2452</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Braunschweig, Adam B.</author><author>Senesi, Andrew J.</author><author>Mirkin, Chad A.</author></authors></contributors><titles><title>Redox-Activating Dip-Pen Nanolithography (RA-DPN)</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>922-923</pages><volume>131</volume><number>3</number><edition>2009/01</edition><dates><year>2009</year></dates><publisher>American Chemical Society</publisher><isbn>0002-7863</isbn><notes>doi: 10.1021/ja809107n</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ja809107n</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja809107n</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2110</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2110</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Yan, Y.</author><author>Chin, F. T.</author><author>Wang, F.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford, Department of Radiology, Biophysics, Stanford University School of Medicine, Stanford, California 94305, USA.</auth-address><titles><title>Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN</title><secondary-title>J Med Chem</secondary-title></titles><periodical><full-title>J Med Chem</full-title><abbr-1>Journal of medicinal chemistry</abbr-1></periodical><pages>425-32</pages><volume>52</volume><number>2</number><edition>2008/12/31</edition><keywords><keyword>Animals</keyword><keyword>Bombesin/chemistry/ pharmacokinetics</keyword><keyword>Dimerization</keyword><keyword>Fluorine Radioisotopes</keyword><keyword>Integrin alphaVbeta3/ metabolism</keyword><keyword>Neoplasms, Experimental/metabolism/ radionuclide imaging</keyword><keyword>Oligopeptides/chemistry/ pharmacokinetics</keyword><keyword>Receptors, Bombesin/ metabolism</keyword></keywords><dates><year>2009</year><pub-dates><date>Jan 22</date></pub-dates></dates><isbn>1520-4804 (Electronic)</isbn><accession-num>19113865</accession-num><abstract>Radiolabeled RGD and bombesin peptides have been extensively investigated for tumor integrin alpha(v)beta(3) and GRPR imaging, respectively. Due to the fact that many tumors are both integrin and GRPR positive, we designed and synthesized a heterodimeric peptide Glu-RGD-BBN, which is expected to be advantageous over the monomeric peptides for dual-receptor targeting. A PEG(3) spacer was attached to the glutamate alpha-amino group of Glu-RGD-BBN to enhance the (18)F labeling yield and to improve the in vivo kinetics. PEG(3)-Glu-RGD-BBN possesses the comparable GRPR and integrin alpha(v)beta(3) receptor-binding affinities as the corresponding monomers, respectively. The dual-receptor targeting properties of (18)F-FB-PEG(3)-Glu-RGD-BBN were observed in PC-3 tumor model. (18)F-FB-PEG(3)-Glu-RGD-BBN with high tumor contrast and favorable pharmacokinetics is a promising PET tracer for dual integrin and GRPR positive tumor imaging. This heterodimer strategy may also be an applicable method to develop other molecules with improved in vitro and in vivo characterizations for tumor diagnosis and therapy.</abstract><notes>Liu, Zhaofei&#xD;Yan, Yongjun&#xD;Chin, Frederic T&#xD;Wang, Fan&#xD;Chen, Xiaoyuan&#xD;P50CA114747/CA/NCI NIH HHS/United States&#xD;R01 120188/PHS HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21CA102123/CA/NCI NIH HHS/United States&#xD;R21CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of medicinal chemistry&#xD;J Med Chem. 2009 Jan 22;52(2):425-32.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>5.079</custom4><electronic-resource-num>10.1021/jm801285t [doi]&#xD;10.1021/jm801285t [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2262</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2262</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chan, J. M.</author><author>Zhang, L.</author><author>Yuet, K. P.</author><author>Liao, G.</author><author>Rhee, J. W.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery</title><secondary-title>Biomaterials</secondary-title></titles><periodical><full-title>Biomaterials</full-title></periodical><pages>1627-34</pages><volume>30</volume><number>8</number><edition>2008/12/30</edition><keywords><keyword>Cell Death/drug effects</keyword><keyword>Chemistry, Pharmaceutical</keyword><keyword>Delayed-Action Preparations/pharmacology</keyword><keyword>Drug Delivery Systems/ methods</keyword><keyword>Drug Stability</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword><keyword>Lactic Acid/ chemical synthesis/chemistry/pharmacology</keyword><keyword>Lecithins/ chemical synthesis/chemistry/pharmacology</keyword><keyword>Lipids/chemistry</keyword><keyword>Nanoparticles/ chemistry</keyword><keyword>Particle Size</keyword><keyword>Polyethylene Glycols/ chemical synthesis/chemistry/pharmacology</keyword><keyword>Polyglycolic Acid/ chemical synthesis/chemistry/pharmacology</keyword><keyword>Taxoids/ administration &amp; dosage/pharmacology</keyword></keywords><dates><year>2009</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1878-5905 (Electronic)</isbn><accession-num>19111339</accession-num><abstract>Current approaches to encapsulate and deliver therapeutic compounds have focused on developing liposomal and biodegradable polymeric nanoparticles (NPs), resulting in clinically approved therapeutics such as Doxil/Caelyx and Genexol-PM, respectively. Our group recently reported the development of biodegradable core-shell NP systems that combined the beneficial properties of liposomal and polymeric NPs for controlled drug delivery. Herein we report the parameters that alter the biological and physicochemical characteristics, stability, drug release properties and cytotoxicity of these core-shell NPs. We further define scalable processes for the formulation of these NPs in a reproducible manner. These core-shell NPs consist of (i) a poly(D,L-lactide-co-glycolide) hydrophobic core, (ii) a soybean lecithin monolayer, and (iii) a poly(ethylene glycol) shell, and were synthesized by a modified nanoprecipitation method combined with self-assembly. Preparation of the NPs showed that various formulation parameters such as the lipid/polymer mass ratio and lipid/lipid-PEG molar ratio controlled NP physical stability and size. We encapsulated a model chemotherapy drug, docetaxel, in the NPs and showed that the amount of lipid coverage affected its drug release kinetics. Next, we demonstrated a potentially scalable process for the formulation, purification, and storage of NPs. Finally, we tested the cytotoxicity using MTT assays on two model human cell lines, HeLa and HepG2, and demonstrated the biocompatibility of these particles in vitro. Our data suggest that the PLGA-lecithin-PEG core-shell NPs may be a useful new controlled release drug delivery system.</abstract><notes>Chan, Juliana M&#xD;Zhang, Liangfang&#xD;Yuet, Kai P&#xD;Liao, Grace&#xD;Rhee, June-Wha&#xD;Langer, Robert&#xD;Farokhzad, Omid C&#xD;CA 119349/CA/NCI NIH HHS/United States&#xD;EB 003647/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Biomaterials&#xD;Biomaterials. 2009 Mar;30(8):1627-34. Epub 2008 Dec 25.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>7.325</custom4><electronic-resource-num>S0142-9612(08)00976-9 [pii]&#xD;10.1016/j.biomaterials.2008.12.013 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2109</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2109</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, H.</author><author>Chen, K.</author><author>Niu, G.</author><author>Chen, X.</author></authors></contributors><auth-address>Department of Radiology, Stanford University School of Medicine, Stanford, California 94305-5484, USA.</auth-address><titles><title>Site-specifically biotinylated VEGF(121) for near-infrared fluorescence imaging of tumor angiogenesis</title><secondary-title>Mol Pharm</secondary-title></titles><periodical><full-title>Mol Pharm</full-title></periodical><pages>285-94</pages><volume>6</volume><number>1</number><edition>2008/12/23</edition><keywords><keyword>Animals</keyword><keyword>Biotin/ chemistry</keyword><keyword>Cell Line</keyword><keyword>Humans</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Neoplasms/ blood supply/chemistry/ metabolism</keyword><keyword>Neovascularization, Pathologic/ metabolism</keyword><keyword>Spectrophotometry, Infrared</keyword><keyword>Substrate Specificity</keyword><keyword>Swine</keyword><keyword>Vascular Endothelial Growth Factor A/ chemistry/ metabolism</keyword></keywords><dates><year>2009</year><pub-dates><date>Jan-Feb</date></pub-dates></dates><isbn>1543-8384 (Print)</isbn><accession-num>19099493</accession-num><abstract>The vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) pathway is considered to be one of the most important regulators of angiogenesis and a key target in anticancer treatment. Imaging VEGFR expression can serve as a new paradigm for assessing the efficacy of antiangiogenic cancer therapy, improving cancer management, and elucidating the role and modulation of VEGF/VEGFR signaling during cancer development and intervention. In this study we developed an Avi-tagged VEGF(121) protein, which is site-specifically biotinylated in the presence of bacterial BirA biotin ligase. BirA biotinylated VEGF(121)-Avi (VEGF(121)-Avib) forms a stable complex with streptavidin-IRDye800 (SA800) that retains high affinity for VEGFR in vitro and allows receptor specific targeting in vivo in a 67NR murine xenograft model. In contrast, chemical coupling of IRDye800 abrogated the VEGFR binding ability of the modified protein both in vitro and in vivo. The VEGF(121)-Avib/SA800 complex (VEGF-Avib/SA800) may be used for quantitative and repetitive near-infrared fluorescence imaging of VEGFR expression and translated into clinic for evaluating cancer and other angiogenesis related diseases.</abstract><notes>Wang, Hui&#xD;Chen, Kai&#xD;Niu, Gang&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular pharmaceutics&#xD;Mol Pharm. 2009 Jan-Feb;6(1):285-94.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.388</custom4><electronic-resource-num>10.1021/mp800185h [doi]&#xD;10.1021/mp800185h [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2342</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2342</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yezhelyev, M.</author><author>Yacoub, R.</author><author>O&apos;Regan, R.</author></authors></contributors><auth-address>Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.</auth-address><titles><title>Inorganic nanoparticles for predictive oncology of breast cancer</title><secondary-title>Nanomed</secondary-title></titles><periodical><full-title>Nanomed</full-title></periodical><pages>83-103</pages><volume>4</volume><number>1</number><edition>2008/12/20</edition><keywords><keyword>Animals</keyword><keyword>Breast Neoplasms/ diagnosis/ therapy</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Inorganic Chemicals/chemistry</keyword><keyword>Metal Nanoparticles/chemistry</keyword><keyword>Nanomedicine/methods</keyword><keyword>Nanoparticles/chemistry/ diagnostic use/ therapeutic use/toxicity</keyword><keyword>Quantum Dots</keyword></keywords><dates><year>2009</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>19093898</accession-num><abstract>Nanoparticles (NPs) and nanosized objects are being incorporated rapidly into clinical medicine and particularly into the field of medical oncology, including breast cancer. A number of novel methods for breast cancer diagnosis and treatment, which are based on NPs and other nanodevices, are now available for translation into clinical practice. Computer tomography and MRI with iron-based magnetic NPs are promising methods for radiological detection of cancers. Semiconductor fluorescent NPs (quantum dots) are being developed for simultaneous detection and localization of multiple breast cancer biomarkers, enabling the personalization of therapeutic regimens for each patient. Additionally, inorganic NPs can be conjugated with tumor-specific ligands and used for tumor-selective delivery of chemotherapeutic or hormonal agents. NPs bearing tumor-targeted antibodies and oligonucleotides for anticancer gene therapy are a novel and rapidly developing therapeutic approach in oncology. Nab-paclitaxel and liposomal anthracyclines are US FDA-approved NP-based drug-delivery systems that have demonstrated at least equivalent efficacy and decreased toxicity compared with conventional chemotherapeutic agents used in the treatment of breast cancer. This review focuses on recent applications of NPs into predictive oncology of breast cancer with an emphasis placed on the role of inorganic nanosized objects in the diagnosis and treatment of this malignancy.</abstract><notes>Yezhelyev, Maksym&#xD;Yacoub, Rami&#xD;O&apos;Regan, Ruth&#xD;U54 CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2009 Jan;4(1):83-103.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>6.093</custom4><electronic-resource-num>10.2217/17435889.4.1.83 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1822</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1822</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Veiseh, O.</author><author>Gunn, J. W.</author><author>Kievit, F. M.</author><author>Sun, C.</author><author>Fang, C.</author><author>Lee, J. S.</author><author>Zhang, M.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, University of Washington Seattle, WA 98195, USA.</auth-address><titles><title>Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>256-64</pages><volume>5</volume><number>2</number><edition>2008/12/18</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/*administration &amp; dosage</keyword><keyword>DNA/chemistry</keyword><keyword>Drug Delivery Systems/methods</keyword><keyword>Endocytosis</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Matrix Metalloproteinase 2/metabolism</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Neoplasms/*metabolism</keyword><keyword>Peptides/chemistry</keyword><keyword>RNA, Small Interfering/metabolism</keyword><keyword>Scorpion Venoms/*chemistry</keyword></keywords><dates><year>2009</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>19089837</accession-num><abstract>Nanoparticles have been investigated as drug delivery vehicles, contrast agents, and multifunctional devices for patient care. Current nanoparticle-based therapeutic strategies for cancer treatment are mainly based on delivery of chemotherapeutic agents to induce apoptosis or DNA/siRNA to regulate oncogene expression. Here, a nanoparticle system that demonstrates an alternative approach to the treatment of cancers through the inhibition of cell invasion, while serving as a magnetic resonance and optical imaging contrast agent, is presented. The nanoparticle comprises an iron oxide nanoparticle core conjugated with an amine-functionalized poly(ethylene glycol) silane and a small peptide, chlorotoxin (CTX), which enables the tumor cell-specific binding of the nanoparticle. It is shown that the nanoparticle exhibits substantially enhanced cellular uptake and an invasion inhibition rate of approximately 98% compared to unbound CTX ( approximately 45%). Significantly, the investigation from flow cytometry analysis, transmission electron microscopy, and fluorescent imaging reveals that the CTX-enabled nanoparticles deactivated the membrane-bound matrix metalloproteinase 2 (MMP-2) and induced increased internalization of lipid rafts that contain surface-expressed MMP-2 and volume-regulating ion channels through receptor-mediated endocytosis, leading to enhanced prohibitory effects. Since upregulation and activity of MMP-2 have been observed in tumors of neuroectodermal origin, and in cancers of the breast, colon, skin, lung, prostate, ovaries, and a host of others, this nanoparticle system can be potentially used for non-invasive diagnosis and treatment of a variety of cancer types.</abstract><notes>Veiseh, Omid&#xD;Gunn, Jonathan W&#xD;Kievit, Forrest M&#xD;Sun, Conroy&#xD;Fang, Chen&#xD;Lee, Jerry S H&#xD;Zhang, Miqin&#xD;5R01CA11235/CA/NCI NIH HHS/United States&#xD;5R01CA9408/CA/NCI NIH HHS/United States&#xD;R01EB006043/EB/NIBIB NIH HHS/United States&#xD;T32GM065098/GM/NIGMS NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2009 Feb;5(2):256-64.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19089837</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom2>2692352</custom2><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200800646</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2261</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2261</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jeong, J. H.</author><author>Wang, Z.</author><author>Guimaraes, A. S.</author><author>Ouyang, X.</author><author>Figueiredo, J. L.</author><author>Ding, Z.</author><author>Jiang, S.</author><author>Guney, I.</author><author>Kang, G. H.</author><author>Shin, E.</author><author>Hahn, W. C.</author><author>Loda, M. F.</author><author>Abate-Shen, C.</author><author>Weissleder, R.</author><author>Chin, L.</author></authors></contributors><auth-address>Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.</auth-address><titles><title>BRAF activation initiates but does not maintain invasive prostate adenocarcinoma</title><secondary-title>PLoS ONE</secondary-title></titles><periodical><full-title>PLoS ONE</full-title></periodical><pages>e3949</pages><volume>3</volume><number>12</number><edition>2008/12/17</edition><keywords><keyword>Androgens</keyword><keyword>Animals</keyword><keyword>Castration</keyword><keyword>Cell Lineage</keyword><keyword>Cell Proliferation</keyword><keyword>Epithelial Cells/enzymology/pathology</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Hyperplasia</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Phosphoproteins/metabolism</keyword><keyword>Prostate/enzymology/pathology</keyword><keyword>Prostatic Neoplasms/enzymology/genetics/ pathology</keyword><keyword>Proto-Oncogene Proteins B-raf/genetics/ metabolism</keyword><keyword>Proto-Oncogene Proteins c-akt/metabolism</keyword><keyword>Rats</keyword><keyword>Trans-Activators/metabolism</keyword><keyword>Transgenes</keyword><keyword>Tumor Markers, Biological/metabolism</keyword><keyword>Urothelium/embryology/pathology</keyword></keywords><dates><year>2008</year></dates><isbn>1932-6203 (Electronic)</isbn><accession-num>19079609</accession-num><abstract>Prostate cancer is the second leading cause of cancer-related deaths in men. Activation of MAP kinase signaling pathway has been implicated in advanced and androgen-independent prostate cancers, although formal genetic proof has been lacking. In the course of modeling malignant melanoma in a tyrosinase promoter transgenic system, we developed a genetically-engineered mouse (GEM) model of invasive prostate cancers, whereby an activating mutation of BRAF(V600E)--a mutation found in approximately 10% of human prostate tumors--was targeted to the epithelial compartment of the prostate gland on the background of Ink4a/Arf deficiency. These GEM mice developed prostate gland hyperplasia with progression to rapidly growing invasive adenocarcinoma without evidence of AKT activation, providing genetic proof that activation of MAP kinase signaling is sufficient to drive prostate tumorigenesis. Importantly, genetic extinction of BRAF(V600E) in established prostate tumors did not lead to tumor regression, indicating that while sufficient to initiate development of invasive prostate adenocarcinoma, BRAF(V600E) is not required for its maintenance.</abstract><notes>Jeong, Joseph H&#xD;Wang, Zhenxiong&#xD;Guimaraes, Alexander S&#xD;Ouyang, Xuesong&#xD;Figueiredo, Jose L&#xD;Ding, Zhihu&#xD;Jiang, Shan&#xD;Guney, Isil&#xD;Kang, Gyeong Hoon&#xD;Shin, Eyoung&#xD;Hahn, William C&#xD;Loda, Massimo F&#xD;Abate-Shen, Cory&#xD;Weissleder, Ralph&#xD;Chin, Lynda&#xD;P01 CA089021/CA/NCI NIH HHS/United States&#xD;P50 CA86355/CA/NCI NIH HHS/United States&#xD;R01 CA076501/CA/NCI NIH HHS/United States&#xD;R01 CA093947-07/CA/NCI NIH HHS/United States&#xD;R01 CA109038/CA/NCI NIH HHS/United States&#xD;R01 CA93947/CA/NCI NIH HHS/United States&#xD;R24 CA92782/CA/NCI NIH HHS/United States&#xD;U01 CA084294/CA/NCI NIH HHS/United States&#xD;U01 CA84313/CA/NCI NIH HHS/United States&#xD;U54 CA119349/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;PloS one&#xD;PLoS One. 2008;3(12):e3949. Epub 2008 Dec 16.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2597248</custom2><custom4>14.662</custom4><electronic-resource-num>10.1371/journal.pone.0003949 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2108</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2108</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Goodwin, A. P.</author><author>Tabakman, S. M.</author><author>Welsher, K.</author><author>Sherlock, S. P.</author><author>Prencipe, G.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry, Stanford University, Stanford, California 94305, USA.</auth-address><titles><title>Phospholipid-dextran with a single coupling point: a useful amphiphile for functionalization of nanomaterials</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>289-96</pages><volume>131</volume><number>1</number><edition>2008/12/09</edition><keywords><keyword>Coated Materials, Biocompatible/ chemical synthesis/chemistry</keyword><keyword>Dextrans/ chemistry</keyword><keyword>Drug Stability</keyword><keyword>Luminescent Measurements</keyword><keyword>Metal Nanoparticles/ chemistry</keyword><keyword>Micelles</keyword><keyword>Nanotubes/chemistry</keyword><keyword>Nanotubes, Carbon/ chemistry</keyword><keyword>Phosphatidylethanolamines/ chemistry</keyword><keyword>Polyethylene Glycols/ chemistry</keyword><keyword>Spectrometry, Fluorescence</keyword></keywords><dates><year>2009</year><pub-dates><date>Jan 14</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>19061329</accession-num><abstract>Nanomaterials hold much promise for biological applications, but they require appropriate functionalization to provide biocompatibility in biological environments. For noncovalent functionalization with biocompatible polymers, the polymer must also remain attached to the nanomaterial after removal of its excess to mimic the high-dilution conditions of administration in vivo. Reported here are the synthesis and utilization of singly substituted conjugates of dextran and a phospholipid (dextran-DSPE) as stable coatings for nanomaterials. Suspensions of single-walled carbon nanotubes were found not only to be stable to phosphate buffered saline (PBS), serum, and a variety of pH&apos;s after excess polymer removal, but also to provide brighter photoluminescence than carbon nanotubes suspended by poly(ethylene glycol)-DSPE. In addition, both gold nanoparticles (AuNPs) and gold nanorods (AuNRs) were found to maintain their dispersion and characteristic optical absorbance after transfer into dextran-DSPE and were obtained in much better yield than similar suspensions with PEG-phospholipid and commonly used thiol-PEG. These suspensions were also stable to PBS, serum, and a variety of pH&apos;s after removal of excess polymer. dextran-DSPE thus shows great promise as a general surfactant material for the functionalization of a variety of nanomaterials, which could facilitate future biological applications.</abstract><notes>Goodwin, Andrew P&#xD;Tabakman, Scott M&#xD;Welsher, Kevin&#xD;Sherlock, Sarah P&#xD;Prencipe, Giuseppe&#xD;Dai, Hongjie&#xD;1U54-CA119367/CA/NCI NIH HHS/United States&#xD;R01-CA135109/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2009 Jan 14;131(1):289-96.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja807307e [doi]&#xD;10.1021/ja807307e [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1946</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1946</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shu, C.</author><author>Slebodnick, C.</author><author>Xu, L.</author><author>Champion, H.</author><author>Fuhrer, T.</author><author>Cai, T.</author><author>Reid, J. E.</author><author>Fu, W.</author><author>Harich, K.</author><author>Dorn, H. C.</author><author>Gibson, H. W.</author></authors></contributors><auth-address>Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24060-0212, USA.</auth-address><titles><title>Highly regioselective derivatization of trimetallic nitride templated endohedral metallofullerenes via a facile photochemical reaction</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>17755-60</pages><volume>130</volume><number>52</number><edition>2008/12/06</edition><keywords><keyword>Crystallography, X-Ray</keyword><keyword>Fullerenes/ chemistry</keyword><keyword>Lutetium/ chemistry</keyword><keyword>Magnetic Resonance Spectroscopy</keyword><keyword>Models, Molecular</keyword><keyword>Nitrogen Compounds/ chemistry</keyword><keyword>Organometallic Compounds/ chemistry</keyword><keyword>Photochemical Processes</keyword><keyword>Scandium/ chemistry</keyword><keyword>Spectrophotometry, Ultraviolet</keyword><keyword>Substrate Specificity</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec 31</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>19055362</accession-num><abstract>Photochemically generated benzyl radicals react with Sc(3)N@C(80)-I(h) to produce a dibenzyl adduct [Sc(3)N@C(80)(CH(2)C(6)H(5))(2)] in 82% yield and high regioselectivity. The adduct&apos;s (1)H spectrum revealed high symmetry: only one AB pattern was observed for the methylene protons. The (13)C NMR spectrum suggested a C(2)-symmetrical structure. DFT calculations reveal that a 1,4-adduct is more favorable than a 1,2-adduct by &gt;10 kcal/mol. The 1,4-structure on [566] ring junctions was unambiguously confirmed by X-ray crystallographic analysis. UV-vis spectra revealed that the removal of two p orbitals from the pi system of the cage together with the benzylic substituents change the electronic properties of the metallofullerene in a manner similar to those reported for disilirane and trifluoromethyl moieties. Under the same conditions from Lu(3)N@C(80)-I(h) we prepared (63% yield) Lu(3)N@C(80)(CH(2)C(6)H(5))(2), which demonstrated properties similar to the 1,4-dibenzyl adduct of Sc(3)N@C(80)-I(h).</abstract><notes>Shu, Chunying&#xD;Slebodnick, Carla&#xD;Xu, Liaosa&#xD;Champion, Hunter&#xD;Fuhrer, Tim&#xD;Cai, Ting&#xD;Reid, Jonathan E&#xD;Fu, Wujun&#xD;Harich, Kim&#xD;Dorn, Harry C&#xD;Gibson, Harry W&#xD;1R01-CA119371-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Dec 31;130(52):17755-60.</notes><urls></urls><custom1>CNPP - V.C.U.</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja804909t [doi]&#xD;10.1021/ja804909t [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2107</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2107</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sirk, S. J.</author><author>Olafsen, T.</author><author>Barat, B.</author><author>Bauer, K. B.</author><author>Wu, A. M.</author></authors></contributors><auth-address>Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA. ssirk@mednet.ucla.edu</auth-address><titles><title>Site-specific, thiol-mediated conjugation of fluorescent probes to cysteine-modified diabodies targeting CD20 or HER2</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>2527-34</pages><volume>19</volume><number>12</number><edition>2008/12/05</edition><keywords><keyword>Animals</keyword><keyword>Antigens, CD20/ immunology</keyword><keyword>Binding Sites</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chromatography, Gel</keyword><keyword>Cysteine/ metabolism</keyword><keyword>Electrophoresis, Polyacrylamide Gel</keyword><keyword>Flow Cytometry</keyword><keyword>Fluorescent Dyes/ chemistry</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Immunoglobulin Fragments/ immunology/ metabolism</keyword><keyword>Receptor, erbB-2/ immunology</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Sulfhydryl Compounds/ chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1520-4812 (Electronic)</isbn><accession-num>19053310</accession-num><abstract>Small, engineered antibody fragments such as diabodies (50 kDa noncovalent dimers of single-chain Fv fragments) are useful alternatives to their larger antibody counterparts. However, due to their size, they are more susceptible to disruption of their antigen binding sites when modified using random conjugation techniques. Previous work has demonstrated the utility of a C-terminal cysteine modification for site-specific radiolabeling of an anti-CEA diabody, resulting in the creation of a cys-diabody (CysDb). In the present work, the adaptability of the CysDb system was explored by creating two additional CysDbs: one specific for CD20 and one for HER2. Purified CysDbs of both specificities demonstrated behavior consistent with stable, covalent dimers harboring a readily reducible disulfide bond. Each CysDb was site-specifically conjugated to three different fluorophores for optical detection: the large fluorescent proteins phycoerythrin (PE) and allophycocyanin (APC), and the small fluorescent molecule Alexa Fluor488. Fluorophore-conjugated CysDbs bound specifically to their targets in both antigen systems and with each different fluorescent tag as determined by flow cytometry. In vitro specific antigen binding was observed in the presence of a mixture of specific and nonspecifically conjugated CysDbs. Conjugates retained both specificity and fluorescence, demonstrating the successful expansion of the CysDb repertoire to new targets and to new site-specific conjugation possibilities.</abstract><notes>Sirk, Shannon J&#xD;Olafsen, Tove&#xD;Barat, Bhaswati&#xD;Bauer, Karl B&#xD;Wu, Anna M&#xD;AI28697/AI/NIAID NIH HHS/United States&#xD;CA119367/CA/NCI NIH HHS/United States&#xD;CA16042/CA/NCI NIH HHS/United States&#xD;P50 CA107399/CA/NCI NIH HHS/United States&#xD;P50086306/PHS HHS/United States&#xD;R01 EB000312/EB/NIBIB NIH HHS/United States&#xD;T32 GM008652/GM/NIGMS NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2008 Dec;19(12):2527-34.</notes><urls></urls><custom1>CCNE - Caltech</custom1><custom2>2668938</custom2><custom3>NIHMS91453</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/bc800113v [doi]&#xD;10.1021/bc800113v [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2545</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2545</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Devaraj, N. K.</author><author>Weissleder, R.</author><author>Hilderbrand, S. A.</author></authors></contributors><auth-address>Center for Systems Biology, Massachusetts General Hospital/Harvard Medical School Boston, Massachusetts 02114, USA.</auth-address><titles><title>Tetrazine-based cycloadditions: application to pretargeted live cell imaging</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>2297-9</pages><volume>19</volume><number>12</number><edition>2008/12/05</edition><keywords><keyword>Alkenes/chemistry</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Survival</keyword><keyword>Heterocyclic Compounds, 1-Ring/*chemistry/*metabolism</keyword><keyword>Humans</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Pyrazines/*chemistry/*metabolism</keyword><keyword>Receptor, erbB-2/metabolism</keyword><keyword>Staining and Labeling</keyword><keyword>Substrate Specificity</keyword><keyword>Time Factors</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1520-4812 (Electronic)</isbn><accession-num>19053305</accession-num><abstract>Bioorthogonal tetrazine cycloadditions have been applied to live cell labeling. Tetrazines react irreversibly with the strained dienophile norbornene forming dihydropyrazine products and dinitrogen. The reaction is high yielding, selective, and fast in aqueous media. Her2/neu receptors on live human breast cancer cells were targeted with a monoclonal antibody modified with a norbornene. Tetrazines conjugated to a near-infrared fluorochrome selectively and rapidly label the pretargeted antibody in the presence of serum. These findings indicate that this chemistry is suitable for in vitro labeling experiments, and suggests that it may prove a useful strategy for in vivo pretargeted imaging under numerous modalities.</abstract><notes>Devaraj, Neal K&#xD;Weissleder, Ralph&#xD;Hilderbrand, Scott A&#xD;T32 CA079443-04/CA/NCI NIH HHS/United States&#xD;T32 CA079443-06A1/CA/NCI NIH HHS/United States&#xD;T32-CA 79443/CA/NCI NIH HHS/United States&#xD;U01 HL080731-04/HL/NHLBI NIH HHS/United States&#xD;U01-HL080731/HL/NHLBI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2008 Dec;19(12):2297-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19053305</url></related-urls></urls><custom1>CCNE - MIT</custom1><custom2>2677645</custom2><custom4>4.802</custom4><electronic-resource-num>10.1021/bc8004446&#xD;10.1021/bc8004446 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2405</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2405</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yang, L. L.</author><author>Cao, Z. H.</author><author>Sajja, H. K.</author><author>Mao, H.</author><author>Wang, L. Y.</author><author>Geng, H. Y.</author><author>Xu, H. Y.</author><author>Jiang, T. S.</author><author>Wood, W. C.</author><author>Nie, S. M.</author><author>Wang, Y. A.</author></authors></contributors><auth-address>[Yang, Lily; Cao, Zehong; Sajja, Hari Krishna; Wood, William C.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA. [Yang, Lily; Mao, Hui; Wang, Liya] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA. [Nie, Shuming] Emory Univ, Sch Med, Dept Biomed Engn, Atlanta, GA 30322 USA. [Geng, Huaying; Xu, Hengyi; Jiang, Tieshan; Wang, Y. Andrew] Ocean Nanotech LLC, Fayetteville, AR 72701 USA.&#xD;Yang, LL, Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA.</auth-address><titles><title>Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging</title><secondary-title>Journal of Biomedical Nanotechnology</secondary-title><alt-title>J. Biomed. Nanotechnol.</alt-title></titles><periodical><full-title>Journal of Biomedical Nanotechnology</full-title><abbr-1>J. Biomed. Nanotechnol.</abbr-1></periodical><alt-periodical><full-title>Journal of Biomedical Nanotechnology</full-title><abbr-1>J. Biomed. Nanotechnol.</abbr-1></alt-periodical><pages>439-449</pages><volume>4</volume><number>4</number><edition>2008/12</edition><keywords><keyword>Magnetic Iron Oxide Nanoparticles</keyword><keyword>uPAR</keyword><keyword>Targeted Nanoparticle</keyword><keyword>Breast</keyword><keyword>Cancer</keyword><keyword>Drug Delivery Nanoparticle</keyword><keyword>Doxorubicin</keyword><keyword>UROKINASE PLASMINOGEN-ACTIVATOR</keyword><keyword>NORMAL BREAST-TISSUE</keyword><keyword>CARCINOMA</keyword><keyword>IN-SITU</keyword><keyword>SUPERPARAMAGNETIC NANOPARTICLES</keyword><keyword>EPITHELIAL-CELLS</keyword><keyword>CANCER</keyword><keyword>DOXORUBICIN</keyword><keyword>EXPRESSION</keyword><keyword>MRI</keyword><keyword>AGENTS</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1550-7033</isbn><accession-num>ISI:000262544200008</accession-num><abstract>The development of multifunctional nanoparticles that have dual capabilities of tumor imaging and delivering therapeutic agents into tumor cells holds great promises for novel approaches for tumor imaging and therapy We have engineered urokinase plasminogen activator receptor (uPAR) targeted biodegradable nanoparticles using a size uniform and amphiphilic polymer-coated magnetic iron oxide (10) nanoparticle conjugated with the amino-terminal fragment (ATF) of urokinase plasminogen activator (uPA), which is a high affinity natural ligand for uPAR. We further developed methods to encapsulate hydrophobic chemotherapeutic drugs into the polymer layer on the 10 nanoparticles, making these targeted magnetic resonance imaging (MRI) sensitive nanoparticles drug delivery vehicles. Using a fluorescent drug doxorubicin (Dox) as a model system, we showed that this hydrophobic drug can be efficiently encapsulated into the uPAR-targeted 10 nanoparticles. This class of Dox-loaded nanoparticles has a compact size and is stable in pH 7.4 buffer. However, encapsulated Dox can be released from the nanoparticles at pH 4.0 to 5.0 within 2 hrs. In comparison with the effect of equivalent dosage of free drug or non-targeted 10-Dox nanoparticles, uPAR-targeted 10-Dox nanoparticles deliver higher levels of Dox into breast cancer cells and produce a stronger inhibitory effect on tumor cell growth. Importantly, Dox-loaded 10 nanoparticles maintain their T2 MRI contrast effect after being internalized into the tumor cells due to their significant susceptibility effect in the cells, indicating that this drug delivery nanoparticle has the potential to be used as targeted therapeutic imaging probes for monitoring the drug delivery using MRI.</abstract><notes>ISI Document Delivery No.: 395SQ&#xD;Times Cited: 1&#xD;Cited Reference Count: 49&#xD;Yang, Lily Cao, Zehong Sajja, Hari Krishna Mao, Hui Wang, Liya Geng, Huaying Xu, Hengyi Jiang, Tieshan Wood, William C. Nie, Shuming Wang, Y. Andrew&#xD;AMER SCIENTIFIC PUBLISHERS</notes><work-type>Article</work-type><urls><related-urls><url>&lt;Go to ISI&gt;://000262544200008</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>1.201</custom4><electronic-resource-num>10.1166/jbn.2008.007</electronic-resource-num><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2498</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2498</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Seferos, Dwight S.</author><author>Prigodich, Andrew E.</author><author>Giljohann, David A.</author><author>Patel, Pinal C.</author><author>Mirkin, Chad A.</author></authors></contributors><titles><title>Polyvalent DNA Nanoparticle Conjugates Stabilize Nucleic Acids</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>308-311</pages><volume>9</volume><number>1</number><edition>2008/12</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>1530-6984</isbn><notes>doi: 10.1021/nl802958f</notes><urls><related-urls><url>http://dx.doi.org/10.1021/nl802958f</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>12.189</custom4><electronic-resource-num>10.1021/nl802958f</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1555</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1555</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schmieder, A. H.</author><author>Caruthers, S. D.</author><author>Zhang, H.</author><author>Williams, T. A.</author><author>Robertson, J. D.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Lanza, GM&#xD;Washington Univ, Sch Med, Campus Box 8215,4320 Forest Pk Ave, St Louis, MO 63108 USA&#xD;Washington Univ, Sch Med, St Louis, MO 63108 USA&#xD;Philips Healthcare, Andover, MA USA&#xD;Univ Missouri Res Reactor, Columbia, MO USA</auth-address><titles><title>Three-dimensional MR mapping of angiogenesis with alpha(5)beta(1)(alpha(v)beta(3))-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model</title><secondary-title>Faseb Journal</secondary-title></titles><periodical><full-title>Faseb Journal</full-title></periodical><pages>4179-4189</pages><volume>22</volume><number>12</number><edition>2008/12</edition><keywords><keyword>magnetic resonance imaging</keyword><keyword>fumagillin</keyword><keyword>cancer</keyword><keyword>molecular imaging</keyword><keyword>antiangiogenic</keyword><keyword>vx-2 rabbit tumors</keyword><keyword>in-vivo</keyword><keyword>breast-cancer</keyword><keyword>inhibitor tnp-470</keyword><keyword>phase-i</keyword><keyword>integrin alpha(5)beta(1)</keyword><keyword>contrast agent</keyword><keyword>alpha(v)beta(3)</keyword><keyword>ag-013736</keyword><keyword>antibody</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0892-6638</isbn><accession-num>ISI:000261254800017</accession-num><abstract>Our objectives were 1) to characterize angiogenesis in the MDA-MB-435 xenograft mouse model with three-dimensional (3D) MR molecular imaging using alpha(5)beta(1)(RGD)- or irrelevant RGS-targeted paramagnetic nanoparticles and 2) to use MR molecular imaging to assess the antiangiogenic effectiveness of alpha(5)beta(1)(alpha(v)beta(3))- vs. alpha(v)beta(3)-targeted fumagillin (50 mu g/kg) nanoparticles. Tumor-bearing mice were imaged with MR before and after administration of either alpha(5)beta(1)(RGD) or irrelevant RGS-paramagnetic nanoparticles. In experiment 2, mice received saline or alpha(5)beta(1)(alpha(v)beta(3))- or alpha(v)beta(3)-targeted fumagillin nanoparticles on days 7, 11, 15, and 19 posttumor implant. On day 22, MRI was performed using alpha(5)beta(1)(alpha(v)beta(3))-targeted paramagnetic nanoparticles to monitor the antiangiogenic response. 3D reconstructions of alpha(5)beta(1)(RGD)-signal enhancement revealed a sparse, asymmetrical pattern of angiogenesis along the tumor periphery, which occupied &lt; 2.0% tumor surface area. alpha(5)beta(1)-targeted rhodamine nanoparticles colocalized with FITC-lectin corroborated the peripheral neovascular signal. alpha(5)beta(1)(alpha(v)beta(3))-fumagillin nanoparticles decreased neovasculature to negligible levels relative to control; alpha(v)beta(3)-targeted fumagillin nanoparticles were less effective (P &gt; 0.05). Reduction of angiogenesis in MDA-MB-435 tumors from low to negligible levels did not decrease tumor volume. MR molecular imaging may be useful for characterizing tumors with sparse neovasculature that are unlikely to have a reduced growth response to targeted antiangiogenic therapy.</abstract><notes>377MH&#xD;Times Cited:0&#xD;Cited References Count:49</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000261254800017</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom4>7.128</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1483</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1483</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Osterfeld, S. J.</author><author>Yu, H.</author><author>Gaster, R. S.</author><author>Caramuta, S.</author><author>Xu, L.</author><author>Han, S. J.</author><author>Hall, D. A.</author><author>Wilson, R. J.</author><author>Sun, S. H.</author><author>White, R. L.</author><author>Davis, R. W.</author><author>Pourmand, N.</author><author>Wang, S. X.</author></authors></contributors><auth-address>Davis, RW&#xD;Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA&#xD;Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA&#xD;Stanford Univ, Dept Mat Sci &amp; Engn, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA&#xD;Brown Univ, Dept Chem, Providence, RI 02912 USA&#xD;Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA</auth-address><titles><title>Multiplex protein assays based on real-time magnetic nanotag sensing</title><secondary-title>Proceedings of the National Academy of Sciences of the United States of America</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>20637-20640</pages><volume>105</volume><number>52</number><edition>2008/12</edition><keywords><keyword>giant magnetoresistive sensors</keyword><keyword>gmr</keyword><keyword>magnetic nanotags</keyword><keyword>multiplex protein detection</keyword><keyword>biochip</keyword><keyword>spin-valve sensors</keyword><keyword>human chorionic-gonadotropin</keyword><keyword>superparamagnetic nanoparticles</keyword><keyword>biological applications</keyword><keyword>DNA detection</keyword><keyword>biosensor</keyword><keyword>magnetoresistance</keyword><keyword>arrays</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec 30</date></pub-dates></dates><isbn>0027-8424</isbn><accession-num>ISI:000262092800015</accession-num><abstract>Magnetic nanotags (MNTs) are a promising alternative to fluorescent labels in biomolecular detection assays, because minute quantities of MNTs can be detected with inexpensive giant magnetoresistive (GMR) sensors, such as spin valve (SV) sensors. However, translating this promise into easy to use and multilplexed protein assays, which are highly sought after in molecular diagnostics such as cancer diagnosis and treatment monitoring, has been challenging. Here, we demonstrate multiplex protein detection of potential cancer markers at subpicomolar concentration levels and with a dynamic range of more than four decades. With the addition of nanotag amplification, the analytic sensitivity extends into the low fM concentration range. The multianalyte ability, sensitivity, scalability, and ease of use of the MNT-based protein assay technology make it a strong contender for versatile and portable molecular diagnostics in both research and clinical settings.</abstract><notes>389LB&#xD;Times Cited:0&#xD;Cited References Count:27</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000262092800015</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom4>10.228</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1471</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1471</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Neubauer, A. M.</author><author>Sim, H.</author><author>Winter, P. M.</author><author>Caruthers, S. D.</author><author>Williams, T. A.</author><author>Robertson, J. D.</author><author>Sept, D.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Wickline, SA&#xD;Washington Univ, C TRAIN Grp, Consortium Translat Res Adv Imaging &amp; Nanomed, Campus Box 8215,Cortex Bldg,Suite 101,4320 Forest, St Louis, MO 63108 USA&#xD;Washington Univ, C TRAIN Grp, Consortium Translat Res Adv Imaging &amp; Nanomed, St Louis, MO 63108 USA&#xD;Washington Univ, Dept Biomed Engn, St Louis, MO USA&#xD;Philips Med Syst, Andover, MA USA&#xD;Univ Missouri Res Reactor, Analyt Chem Grp, Columbia, MO USA</auth-address><titles><title>Nanoparticle Pharmacokinetic Profiling In Vivo Using Magnetic Resonance Imaging</title><secondary-title>Magnetic Resonance in Medicine</secondary-title></titles><periodical><full-title>Magnetic Resonance in Medicine</full-title></periodical><pages>1353-1361</pages><volume>60</volume><number>6</number><edition>2008/12</edition><keywords><keyword>nanoparticles</keyword><keyword>alpha(nu)beta(3)-integrin</keyword><keyword>pharmacokinetic</keyword><keyword>binding</keyword><keyword>adventitial vasa vasorum</keyword><keyword>contrast agent</keyword><keyword>phase-i</keyword><keyword>mri</keyword><keyword>atherosclerosis</keyword><keyword>angiogenesis</keyword><keyword>hypercholesterolemia</keyword><keyword>expression</keyword><keyword>liver</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0740-3194</isbn><accession-num>ISI:000261225100012</accession-num><abstract>Contrast agents targeted to molecular markers of disease are currently being developed with the goal of identifying disease early and evaluating treatment effectiveness using noninvasive imaging modalities such as MRI. Pharmacokinetic profiling of the binding of targeted contrast agents, while theoretically possible with MRI, has thus far only been demonstrated with more sensitive imaging techniques. Paramagnetic liquid perfluorocarbon nanoparticles were formulated to target alpha(nu)beta(3)-integrins associated with early atherosclerosis in cholesterol-fed rabbits to produce a measurable signal increase on magnetic resonance images after binding. In this work, we combine quantitative information of the in vivo binding of this agent over time obtained by means of MRI with blood sampling to derive pharmacokinetic parameters using simultaneous and individual fitting of the data to a three compartment model. A doubling of tissue exposure (or area under the curve) is obtained with targeted as compared to control nanoparticles, and key parameter differences are discovered that may aid in development of models for targeted drug delivery. Magn Reson Med 60:11353-11361,2008. (C) 2008 Wiley-Liss, Inc.</abstract><notes>377AW&#xD;Times Cited:0&#xD;Cited References Count:30</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000261225100012</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom4>4.163</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2468</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2468</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hill, Haley D.</author><author>Hurst, Sarah J.</author><author>Mirkin, Chad A.</author></authors></contributors><titles><title>Curvature-Induced Base Pair Slipping Effects in DNA-Nanoparticle Hybridization</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>317-321</pages><volume>9</volume><number>1</number><edition>2008/12</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>1530-6984</isbn><notes>doi: 10.1021/nl8030482</notes><urls><related-urls><url>http://dx.doi.org/10.1021/nl8030482</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>12.189</custom4><electronic-resource-num>10.1021/nl8030482</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1218</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1218</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gratton, S. E.</author><author>Williams, S. S.</author><author>Napier, M. E.</author><author>Pohlhaus, P. D.</author><author>Zhou, Z.</author><author>Wiles, K. B.</author><author>Maynor, B. W.</author><author>Shen, C.</author><author>Olafsen, T.</author><author>Samulski, E. T.</author><author>Desimone, J. M.</author></authors></contributors><auth-address>section sign Carolina Center of Cancer Nanotechnology Excellence double dagger Institute for Advanced Materials dagger Department of Chemistry desimone@unc.edu.</auth-address><titles><title>The Pursuit of a Scalable Nanofabrication Platform for Use in Material and Life Science Applications</title><secondary-title>Acc Chem Res</secondary-title><alt-title>Accounts of chemical research</alt-title></titles><periodical><full-title>Acc Chem Res</full-title></periodical><alt-periodical><full-title>Accounts of Chemical Research</full-title></alt-periodical><edition>2008/12</edition><dates><year>2008</year><pub-dates><date>Aug 23</date></pub-dates></dates><isbn>1520-4898 (Electronic)</isbn><accession-num>18720952</accession-num><abstract>In this Account, we describe the use of perfluoropolyether (PFPE)-based materials that are able to accurately mold and replicate micro- and nanosized features using traditional techniques such as embossing as well as new techniques that we developed to exploit the exceptional surface characteristics of fluorinated substrates. Because of the unique partial wetting and nonwetting characteristics of PFPEs, we were able to go beyond the usual molding and imprint lithography approaches and have created a technique called PRINT (Particle [or Pattern] Replication In Nonwetting Templates). PRINT is a distinctive &quot;top-down&quot; fabrication technique capable of generating isolated particles, arrays of particles, and arrays of patterned features for a plethora of applications in both nanomedicine and materials science. A particular strength of the PRINT technology is the high-resolution molding of well-defined particles with precise control over size, shape, deformability, and surface chemistry. The level of replication obtained showcases some of the unique characteristics of PFPE molding materials. In particular, these materials arise from very low surface energy precursors with positive spreading coefficients, can be photocured at ambient temperature, and are minimally adhesive, nonswelling, and conformable. These distinctive features enable the molding of materials with unique attributes and nanometer resolution that have unprecedented scientific and technological value. For example, in nanomedicine, the use of PFPE materials with the PRINT technique allows us to design particles in which we can tailor key therapeutic parameters such as bioavailability, biodistribution, target-specific cell penetration, and controlled cargo release. Similarly, in materials science, we can fabricate optical films and lens arrays, replicate complex, naturally occurring objects such as adenovirus particles, and create 2D patterned arrays of inorganic oxides.</abstract><notes>Journal article</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18720952 </url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>15.403</custom4><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2464</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2464</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Goluch, Edgar D.</author><author>Stoeva, Savka I.</author><author>Lee, Jae-Seung</author><author>Shaikh, Kashan A.</author><author>Mirkin, Chad A.</author><author>Liu, Chang</author></authors></contributors><titles><title>A microfluidic detection system based upon a surface immobilized biobarcode assay</title><secondary-title>Biosensors and Bioelectronics</secondary-title></titles><periodical><full-title>Biosensors and Bioelectronics</full-title></periodical><pages>2397-2403</pages><volume>24</volume><number>8</number><edition>2008/12</edition><reprint-edition>2008/12</reprint-edition><keywords><keyword>Biobarcode assay (BCA)</keyword><keyword>Microfluidic</keyword><keyword>Surface immobilized</keyword><keyword>Nanoparticle</keyword><keyword>Prostate specific antigen (PSA)</keyword><keyword>Serum</keyword></keywords><dates><year>2009</year></dates><isbn>0956-5663</isbn><notes>doi: DOI: 10.1016/j.bios.2008.12.017</notes><urls><related-urls><url>http://www.sciencedirect.com/science/article/B6TFC-4V74VB2-4/2/303e1c3d62c6b3c3ae0b7c1abaa8ce31</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>5.330</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2542</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2542</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Garanger, Elisabeth</author><author>Weissleder, Ralph</author><author>Josephson, Lee</author></authors></contributors><titles><title>A Multifunctional Single-Attachment-Point Reagent for Controlled Protein Biotinylation</title><secondary-title>Bioconjugate Chemistry</secondary-title></titles><periodical><full-title>Bioconjugate Chemistry</full-title></periodical><pages>170-173</pages><volume>20</volume><number>1</number><edition>2008/12</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>1043-1802</isbn><notes>doi: 10.1021/bc800392t</notes><urls><related-urls><url>http://dx.doi.org/10.1021/bc800392t</url></related-urls></urls><custom1>CCNE - MIT</custom1><custom4>4.802</custom4><electronic-resource-num>10.1021/bc800392t</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1210</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1210</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gao, H.</author><author>Henzie, J.</author><author>Lee, M. H.</author><author>Odom, T. W.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Screening plasmonic materials using pyramidal gratings</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title><alt-title>Proceedings of the National Academy of Sciences of the United States of America</alt-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><alt-periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></alt-periodical><pages>20146-51</pages><volume>105</volume><number>51</number><edition>2008/12</edition><keywords><keyword>Biosensing Techniques/*instrumentation</keyword><keyword>Metals, Heavy/*chemistry</keyword><keyword>*Proteins</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec 23</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>19074259</accession-num><abstract>Surface plasmon polaritons (SPPs) are responsible for exotic optical phenomena, including negative refraction, surface enhanced Raman scattering, and nanoscale focusing of light. Although many materials support SPPs, the choice of metal for most applications has been based on traditional plasmonic materials (Ag, Au) because there have been no side-by-side comparisons of the different materials on well-defined, nanostructured surfaces. Here, we report a platform that not only enabled rapid screening of a wide range of metals under different excitation conditions and dielectric environments, but also identified new and unexpected materials for biosensing applications. Nanopyramidal gratings were used to generate plasmon dispersion diagrams for Al, Ag, Au, Cu, and Pd. Surprisingly, the SPP coupling efficiencies of Cu and Al exceeded widely used plasmonic materials under certain excitation conditions. Furthermore, grazing angle excitation led to the highest refractive index sensitivities (figure of merit &gt;85) reported at optical frequencies because of extremely narrow SPP resonances (full-width-at-half-minimum &lt;6 nm or 7 meV). Finally, our screening process revealed that Ag, with the highest sensitivity, was not necessarily the preferred material for detecting molecules. We discovered that Au and even Pd, a weak plasmonic material, showed comparable index shifts on formation of a protein monolayer.</abstract><notes>Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19074259 </url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>10.228</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1198</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1198</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fan, R.</author><author>Vermesh, O.</author><author>Srivastava, A.</author><author>Yen, B. K. H.</author><author>Qin, L. D.</author><author>Ahmad, H.</author><author>Kwong, G. A.</author><author>Liu, C. C.</author><author>Gould, J.</author><author>Hood, L.</author><author>Heath, J. R.</author></authors></contributors><auth-address>Heath, JR&#xD;CALTECH, NanoSyst Biol Canc Ctr, MC 127-72,1200 E Calif Blvd, Pasadena, CA 91125 USA&#xD;CALTECH, NanoSyst Biol Canc Ctr, Pasadena, CA 91125 USA&#xD;CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA&#xD;CALTECH, Div Chem &amp; Chem Engn, Pasadena, CA 91125 USA&#xD;Inst Syst Biol, Seattle, WA 98103 USA</auth-address><titles><title>Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood</title><secondary-title>Nature Biotechnology</secondary-title></titles><periodical><full-title>Nature Biotechnology</full-title></periodical><pages>1373-1378</pages><volume>26</volume><number>12</number><edition>2008/12</edition><keywords><keyword>human plasma proteome</keyword><keyword>ovarian-cancer</keyword><keyword>inflammation</keyword><keyword>DNA</keyword><keyword>sensitivity</keyword><keyword>separation</keyword><keyword>devices</keyword><keyword>cell</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1087-0156</isbn><accession-num>ISI:000261591300023</accession-num><abstract>As the tissue that contains the largest representation of the human proteome(1), blood is the most important fluid for clinical diagnostics(2-4). However, although changes of plasma protein profiles reflect physiological or pathological conditions associated with many human diseases, only a handful of plasma proteins are routinely used in clinical tests. Reasons for this include the intrinsic complexity of the plasma proteome(1), the heterogeneity of human diseases and the rapid degradation of proteins in sampled blood(5). We report an integrated microfluidic system, the integrated blood barcode chip that can sensitively sample a large panel of protein biomarkers over broad concentration ranges and within 10 min of sample collection. It enables on-chip blood separation and rapid measurement of a panel of plasma proteins from quantities of whole blood as small as those obtained by a finger prick. Our device holds potential for inexpensive, noninvasive and informative clinical diagnoses, particularly in point-of-care settings.</abstract><notes>382FR&#xD;Times Cited:1&#xD;Cited References Count:33</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000261591300023</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom4>25.329</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1111</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1111</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, T.</author><author>Xu, L. S.</author><author>Shu, C. Y.</author><author>Reid, J. E.</author><author>Gibson, H. W.</author><author>Dorn, H. C.</author></authors></contributors><auth-address>Gibson, HW&#xD;Virginia Polytech Inst &amp; State Univ, Dept Chem, Blacksburg, VA 24060 USA&#xD;Virginia Polytech Inst &amp; State Univ, Dept Chem, Blacksburg, VA 24060 USA</auth-address><titles><title>Synthesis and Characterization of a Non-IPR Fullerene Derivative: Sc3N@C-68[C(COOC2H5)(2)]</title><secondary-title>Journal of Physical Chemistry C</secondary-title></titles><periodical><full-title>Journal of Physical Chemistry C</full-title></periodical><pages>19203-19208</pages><volume>112</volume><number>49</number><edition>2008/12</edition><keywords><keyword>isolated pentagon rule</keyword><keyword>trimetallic nitride cluster</keyword><keyword>endohedral metallofullerenes</keyword><keyword>materials science</keyword><keyword>carbon cage</keyword><keyword>c-60</keyword><keyword>sc3n-at-c-80</keyword><keyword>density</keyword><keyword>purification</keyword><keyword>la-at-c-82</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec 11</date></pub-dates></dates><isbn>1932-7447</isbn><accession-num>ISI:000261426600007</accession-num><abstract>A non-IPR (isolated pentagon rule) trimetallic nitride endohedral metallofullerene derivative, a diethyl malonate adduct of Sc3N@C-68, was synthesized, isolated, and characterized by mass spectrometry and NMR spectroscopy. The proposed addition site Of Sc3N@C-68 monoadduct was in good agreement with the experimental and calculated C-13 NMR spectra, LUMO electron density study, and UV-vis spectroscopy.</abstract><notes>379WJ&#xD;Times Cited:0&#xD;Cited References Count:43</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000261426600007</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom4>3.398</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1100</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1100</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Brown, E. M.</author><author>Paunesku, T.</author><author>Wu, A.</author><author>Thurn, K. T.</author><author>Haley, B.</author><author>Clark, J.</author><author>Priester, T.</author><author>Woloschak, G. E.</author></authors></contributors><auth-address>Department of Radiation Oncology, Northwestern University, Feinberg School of Medicine, 303 E. Chicago Avenue, Ward-13-002, Chicago, IL 60611, USA.</auth-address><titles><title>Methods for assessing DNA hybridization of peptide nucleic acid-titanium dioxide nanoconjugates</title><secondary-title>Anal Biochem</secondary-title><alt-title>Analytical biochemistry</alt-title></titles><periodical><full-title>Anal Biochem</full-title><abbr-1>Analytical biochemistry</abbr-1></periodical><alt-periodical><full-title>Anal Biochem</full-title><abbr-1>Analytical biochemistry</abbr-1></alt-periodical><pages>226-35</pages><volume>383</volume><number>2</number><edition>2008/12</edition><keywords><keyword>Absorption</keyword><keyword>Base Sequence</keyword><keyword>Nanoparticles/analysis/*chemistry</keyword><keyword>*Nucleic Acid Hybridization</keyword><keyword>Peptide Nucleic Acids/analysis/*chemistry/genetics</keyword><keyword>Peptides/metabolism</keyword><keyword>Plasmids/genetics</keyword><keyword>Surface Properties</keyword><keyword>Temperature</keyword><keyword>Titanium/analysis/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec 15</date></pub-dates></dates><isbn>1096-0309 (Electronic)</isbn><accession-num>18786502</accession-num><abstract>We describe the synthesis of peptide nucleic acid (PNA)-titanium dioxide (TiO(2)) nanoconjugates and several novel methods developed to investigate the DNA hybridization behaviors of these constructs. PNAs are synthetic DNA analogs resistant to degradation by cellular enzymes that hybridize to single-stranded DNA (ssDNA) with higher affinity than DNA oligonucleotides, invade double-stranded DNA (dsDNA), and form different PNA/DNA complexes. Previously, we developed a DNA-TiO(2) nanoconjugate capable of hybridizing to target DNA intracellularly in a sequence-specific manner with the ability to cleave DNA when excited by electromagnetic radiation but susceptible to degradation that may lower its intracellular targeting efficiency and retention time. PNA-TiO(2) nanoconjugates described in the current article hybridize to target ssDNA, oligonucleotide dsDNA, and supercoiled plasmid DNA under physiological-like ionic and temperature conditions, enabling rapid, inexpensive, sequence-specific concentration of nucleic acids in vitro. When modified by the addition of imaging agents or peptides, hybridization capabilities of PNA-TiO(2) nanoconjugates are enhanced, providing essential benefits for numerous in vitro and in vivo applications. The series of experiments shown here could not be done with either TiO(2)-DNA nanoconjugates or PNAs alone, and the novel methods developed will benefit studies of numerous other nanoconjugate systems.</abstract><notes>CA107467/CA/NCI NIH HHS/United States&#xD;EB002100/EB/NIBIB NIH HHS/United States&#xD;P50 CA89018/CA/NCI NIH HHS/United States&#xD;U54 CA119341/CA/NCI NIH HHS/United States&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18786502 </url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>3.145</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1074</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1074</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Barrett, D. G.</author><author>Lamb, B. M.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Yousaf, MN&#xD;Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA</auth-address><titles><title>Microfluidic etching and oxime-based tailoring of biodegradable polyketoesters</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>9861-9867</pages><volume>24</volume><number>17</number><edition>2008/12</edition><keywords><keyword>ring-opening polymerization</keyword><keyword>chemoselective immobilization</keyword><keyword>soft lithography</keyword><keyword>click chemistry</keyword><keyword>fabrication</keyword><keyword>polyesters</keyword><keyword>scaffolds</keyword><keyword>polymers</keyword><keyword>ligands</keyword><keyword>systems</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep 2</date></pub-dates></dates><isbn>0743-7463</isbn><accession-num>ISI:000258722100099</accession-num><abstract>A straightforward, flexible, and inexpensive method to etch biodegradable poly(1,2,6-hexanetriol alpha-ketoglutarate) films is reported. Microfluidic delivery of the etchant, a solution of NaOH, can create micron-scale channels through local hydrolysis of the polyester film. In addition, the presence of a ketone in the repeat unit allows for prior or post chemoselective modifications, enabling the design Of functionalized microchannels. Delivery of oxyamine tethered ligands react with ketone groups on the polyketoester to generate covalent oxime linkages. By thermally sealing an etched film to a second flat surface, poly(1,2,6-hexanetriol alpha-ketoglutarate) can be used to create biodegradable microfluidic devices. In order to determine the versatility of the microfluidic etch technique, poly(epsilon-caprolactone) was etched with acetone. This strategy provides a facile method for the direct patterning of biodegradable materials, both through etching and chemoselective ligand immobilization.</abstract><notes>341NV&#xD;Times Cited:0&#xD;Cited References Count:28</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258722100099</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2009</custom3><custom4>4.347</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2339</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2339</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Merrill, A. H., Jr.</author><author>Stokes, T. H.</author><author>Momin, A.</author><author>Park, H.</author><author>Portz, B. J.</author><author>Kelly, S.</author><author>Wang, E.</author><author>Sullards, M. C.</author><author>Wang, M. D.</author></authors></contributors><auth-address>School of Biology, Georgia Institute of Technology, Atlanta, GA 30332, USA. al.merrill@biology.gatech.edu</auth-address><titles><title>Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease</title><secondary-title>J Lipid Res</secondary-title></titles><periodical><full-title>J Lipid Res</full-title></periodical><pages>S97-102</pages><volume>50 Suppl</volume><edition>2008/11/26</edition><keywords><keyword>Animals</keyword><keyword>Biological Phenomena</keyword><keyword>Disease</keyword><keyword>Humans</keyword><keyword>Lipid Metabolism</keyword><keyword>Sphingolipids/ analysis/chemistry/ metabolism</keyword><keyword>Systems Biology</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0022-2275 (Print)</isbn><accession-num>19029065</accession-num><abstract>The sphingolipidome is the portion of the lipidome that encompasses all sphingoid bases and their derivatives. Whereas the most studied sphingoid base is sphingosine [(2S,3R,4E)-2-aminooctadecene-1,3-diol], mammals have dozens of structural variants, and hundreds of additional types have been found in other eukaryotic organisms and some bacteria and viruses. Multiplying these figures by the N-acyl-derivatives (&quot;ceramides&quot;) and the more than 500 phospho- and glyco- headgroups places the number of discrete molecular species in the tens of thousands or higher. Structure-specific, quantitative information about a growing fraction of the sphingolipidome can now be obtained using various types of chromatography coupled with tandem mass spectrometry, and application of these methods is producing many surprises regarding sphingolipid structure, metabolism, and function. Such large data sets can be difficult to interpret, but the development of tools that display results from genomic and lipidomic studies in a pathway relational, nodal, context can make it easier for investigators to deal with this complexity.</abstract><notes>Merrill, Alfred H Jr&#xD;Stokes, Todd H&#xD;Momin, Amin&#xD;Park, Hyejung&#xD;Portz, Brent J&#xD;Kelly, Samuel&#xD;Wang, Elaine&#xD;Sullards, M Cameron&#xD;Wang, May Dongmei&#xD;GM069338/GM/NIGMS NIH HHS/United States&#xD;P20GM072069/GM/NIGMS NIH HHS/United States&#xD;R01CA108468/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of lipid research&#xD;J Lipid Res. 2009 Apr;50 Suppl:S97-102. Epub 2008 Nov 21.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom2>2674747</custom2><custom4>4.361</custom4><electronic-resource-num>R800073-JLR200 [pii]&#xD;10.1194/jlr.R800073-JLR200 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2338</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2338</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, A. M.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Bioengineering, Emory University, Atlanta, GA 30322, USA.</auth-address><titles><title>Nanocrystal synthesis in an amphibious bath: spontaneous generation of hydrophilic and hydrophobic surface coatings</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>9916-21</pages><volume>47</volume><number>51</number><edition>2008/11/19</edition><keywords><keyword>Hydrophobicity</keyword><keyword>Nanoparticles/ chemistry</keyword><keyword>Surface Properties</keyword><keyword>Water/chemistry</keyword></keywords><dates><year>2008</year></dates><isbn>1521-3773 (Electronic)</isbn><accession-num>19016290</accession-num><notes>Smith, Andrew M&#xD;Nie, Shuming&#xD;P20 GM072069/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-01/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-02/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-03/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-04/GM/NIGMS NIH HHS/United States&#xD;R01 CA108468/CA/NCI NIH HHS/United States&#xD;R01 CA108468-01/CA/NCI NIH HHS/United States&#xD;R01 CA108468-02/CA/NCI NIH HHS/United States&#xD;R01 CA108468-03/CA/NCI NIH HHS/United States&#xD;R01 CA108468-04/CA/NCI NIH HHS/United States&#xD;R01 CA108468-05/CA/NCI NIH HHS/United States&#xD;U01L080711/PHS HHS/United States&#xD;U54 CA119338-01/CA/NCI NIH HHS/United States&#xD;U54 CA119338-02/CA/NCI NIH HHS/United States&#xD;U54 CA119338-03/CA/NCI NIH HHS/United States&#xD;U54 CA119338-04/CA/NCI NIH HHS/United States&#xD;U54 CA119338-040001/CA/NCI NIH HHS/United States&#xD;U54 CA119338-049005/CA/NCI NIH HHS/United States&#xD;U54A119338/PHS HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2008;47(51):9916-21.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom2>2702705</custom2><custom3>NIHMS117806</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200804179 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2104</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2104</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Veeravagu, A.</author><author>Liu, Z.</author><author>Niu, G.</author><author>Chen, K.</author><author>Jia, B.</author><author>Cai, W.</author><author>Jin, C.</author><author>Hsu, A. R.</author><author>Connolly, A. J.</author><author>Tse, V.</author><author>Wang, F.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, California 94305-5484, USA.</auth-address><titles><title>Integrin alphavbeta3-targeted radioimmunotherapy of glioblastoma multiforme</title><secondary-title>Clin Cancer Res</secondary-title></titles><periodical><full-title>Clin Cancer Res</full-title></periodical><pages>7330-9</pages><volume>14</volume><number>22</number><edition>2008/11/18</edition><keywords><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/ pharmacology</keyword><keyword>Antineoplastic Agents/ pharmacology</keyword><keyword>Brain Neoplasms/ drug therapy/radionuclide imaging</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Glioblastoma/ drug therapy/radionuclide imaging</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>In Situ Nick-End Labeling</keyword><keyword>Integrin alphaVbeta3/ drug effects/immunology</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Radioimmunotherapy/ methods</keyword><keyword>Tissue Distribution</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov 15</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>19010848</accession-num><abstract>PURPOSE: Abegrin is a monoclonal antibody to human integrin alphavbeta3, a cell adhesion molecule highly expressed on actively angiogenic endothelium and glioblastoma multiforme tumor cells. The purpose of this study was to evaluate the efficacy of a novel 90Y-Abegrin radioimmunotherapeutic agent in murine xenograft glioblastoma models with noninvasive in vivo molecular imaging modalities. EXPERIMENTAL DESIGN: A s.c. U87MG human glioblastoma xenograft model was used to determine maximum tolerated dose (MTD), biodistribution, dose response, and efficacy of 90Y-Abegrin. Antitumor efficacy was also characterized in an orthotopic U87MG and in a HT-29 colorectal cancer model, a low integrin-expressing carcinoma. Small-animal positron emission tomography imaging was used to correlate histologic findings of treatment efficacy. RESULTS: MTD and dose response analysis revealed 200 microCi per mouse as appropriate treatment dose with hepatic clearance and no organ toxicity. 90Y-Abegrin-treated U87MG tumor mice showed partial regression of tumor volume, with increased tumor volumes in 90Y-IgG, Abegrin, and saline groups. 18F-FDG imaging revealed a reduction of cell proliferation and metabolic activity whereas 18F-FLT reflected decreased DNA synthesis in the 90Y-Abegrin group. Ki67 analysis showed reduced proliferative index and quantitative terminal deoxynucleotidyl transferase dUTP nick-end labeling-positive analysis revealed increased DNA fragmentation and apoptosis in 90Y-Abegrin animals. CD31 and 4&apos;,6-diamidino-2-phenylindole staining showed increased vascular fragmentation and dysmorphic vessel structure in 90Y-Abegrin animals only. Orthotopic U87MG tumors treated with 90Y-Abegrin displayed reduced tumor volume. HT-29 tumors showed no significant difference among the various groups. CONCLUSION: Radioimmunotherapy with 90Y-labeled Abegrin may prove promising in the treatment of highly vascular, invasive, and heterogeneous malignant brain tumors.</abstract><notes>Veeravagu, Anand&#xD;Liu, Zhaofei&#xD;Niu, Gang&#xD;Chen, Kai&#xD;Jia, Bing&#xD;Cai, Weibo&#xD;Jin, Cunjing&#xD;Hsu, Andrew R&#xD;Connolly, Andrew J&#xD;Tse, Victor&#xD;Wang, Fan&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 Nov 15;14(22):7330-9.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.646</custom4><electronic-resource-num>14/22/7330 [pii]&#xD;10.1158/1078-0432.CCR-08-0797 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2103</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2103</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koh, A. L.</author><author>Shachaf, C. M.</author><author>Elchuri, S.</author><author>Nolan, G. P.</author><author>Sinclair, R.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, Stanford University, Durand Building Room 139, 496 Lomita Mall, Stanford, CA 94305, USA. alkoh@stanford.edu</auth-address><titles><title>Electron microscopy localization and characterization of functionalized composite organic-inorganic SERS nanoparticles on leukemia cells</title><secondary-title>Ultramicroscopy</secondary-title></titles><periodical><full-title>Ultramicroscopy</full-title></periodical><pages>111-21</pages><volume>109</volume><number>1</number><edition>2008/11/11</edition><keywords><keyword>Humans</keyword><keyword>Immunoconjugates/chemistry/ultrastructure</keyword><keyword>Intercellular Adhesion Molecule-1/chemistry</keyword><keyword>Metal Nanoparticles/chemistry/ ultrastructure</keyword><keyword>Microscopy, Electron, Scanning/ methods</keyword><keyword>Microscopy, Electron, Transmission/ methods</keyword><keyword>Silver/chemistry</keyword><keyword>Spectrum Analysis, Raman/methods</keyword><keyword>U937 Cells/ ultrastructure</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0304-3991 (Print)</isbn><accession-num>18995965</accession-num><abstract>We demonstrate the use of electron microscopy as a powerful characterization tool to identify and locate antibody-conjugated composite organic-inorganic nanoparticle (COINs) surface enhanced Raman scattering (SERS) nanoparticles on cells. U937 leukemia cells labeled with antibody CD54-conjugated COINs were characterized in their native, hydrated state using wet scanning electron microscopy (SEM) and in their dehydrated state using high-resolution SEM. In both cases, the backscattered electron (BSE) detector was used to detect and identify the silver constituents in COINs due to its high sensitivity to atomic number variations within a specimen. The imaging and analytical capabilities in the SEM were further complemented by higher resolution transmission electron microscopy (TEM) images and scanning Auger electron spectroscopy (AES) data to give reliable and high-resolution information about nanoparticles and their binding to cell surface antigens.</abstract><notes>Koh, Ai Leen&#xD;Shachaf, Catherine M&#xD;Elchuri, Sailaja&#xD;Nolan, Garry P&#xD;Sinclair, Robert&#xD;U54/PHS HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Netherlands&#xD;Ultramicroscopy&#xD;Ultramicroscopy. 2008 Dec;109(1):111-21. Epub 2008 Oct 2.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom2>2650478</custom2><custom3>NIHMS81717</custom3><custom4>2.629</custom4><electronic-resource-num>S0304-3991(08)00232-5 [pii]&#xD;10.1016/j.ultramic.2008.09.004 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2102</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2102</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Niu, G.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, California, USA. wcai@uwhealth.org</auth-address><titles><title>Imaging of integrins as biomarkers for tumor angiogenesis</title><secondary-title>Curr Pharm Des</secondary-title></titles><periodical><full-title>Curr Pharm Des</full-title></periodical><pages>2943-73</pages><volume>14</volume><number>28</number><edition>2008/11/11</edition><keywords><keyword>Animals</keyword><keyword>Clinical Trials as Topic</keyword><keyword>Gene Expression</keyword><keyword>Humans</keyword><keyword>Integrins/ metabolism</keyword><keyword>Neoplasms/ blood supply/radionuclide imaging</keyword><keyword>Neovascularization, Pathologic/ radionuclide imaging</keyword><keyword>Radiopharmaceuticals/diagnostic use</keyword><keyword>Tumor Markers, Biological/metabolism</keyword></keywords><dates><year>2008</year></dates><isbn>1873-4286 (Electronic)</isbn><accession-num>18991712</accession-num><abstract>The integrin family plays important roles during tumor angiogenesis, the formation of new blood vessels from pre-existing vasculature. Traditional structural and functional imaging techniques are not sufficient for early lesion detection, patient stratification, or monitoring the therapeutic efficacy against cancer. Molecular imaging, the visualization, characterization and measurement of biological processes at the molecular and cellular levels in humans and other living systems, can fulfill these goals. In this review article, we will summarize the current state-of-the-art of imaging integrin (alpha(2)beta(1), alpha(3)beta(1), alpha(4)beta(1), alpha(v)beta(3), and alpha(v)beta(6)) expression using either single molecular imaging modality (magnetic resonance imaging, ultrasound, optical, single photon emission computed tomography, and positron emission tomography) or a combination of different modalities. For clinical translation, radionuclide-based imaging will have broad potential applications in cancer patients and the currently available clinical data (exclusively on integrin alpha(v)beta(3) so far) will be discussed in detail. The design, optimization, and characterization of imaging agents targeting integrins will be presented and areas needing extensive future research effort will be discussed. In the new era of personalized medicine, fast clinical translation and incorporation of integrin imaging into anti-cancer clinical trials will be critical for the maximum benefit of cancer patients.</abstract><notes>Cai, Weibo&#xD;Niu, Gang&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;Netherlands&#xD;Current pharmaceutical design&#xD;Curr Pharm Des. 2008;14(28):2943-73.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>na</custom4><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1823</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1823</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Veiseh, O.</author><author>Kievit, F. M.</author><author>Gunn, J. W.</author><author>Ratner, B. D.</author><author>Zhang, M.</author></authors></contributors><auth-address>Department of Materials Science &amp; Engineering, University of Washington, Seattle, WA 98195, USA.</auth-address><titles><title>A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells</title><secondary-title>Biomaterials</secondary-title></titles><periodical><full-title>Biomaterials</full-title></periodical><pages>649-57</pages><volume>30</volume><number>4</number><edition>2008/11/08</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Survival</keyword><keyword>Cyclic AMP/analogs &amp; derivatives/metabolism</keyword><keyword>Electrophoresis, Agar Gel</keyword><keyword>Endocytosis</keyword><keyword>Flow Cytometry</keyword><keyword>Gene Expression Regulation</keyword><keyword>*Gene Transfer Techniques</keyword><keyword>Genetic Vectors/*genetics</keyword><keyword>Green Fluorescent Proteins/metabolism</keyword><keyword>Ligands</keyword><keyword>Magnetic Resonance Spectroscopy</keyword><keyword>Mice</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Neoplasms/*genetics</keyword><keyword>Polyethylene Glycols/metabolism</keyword><keyword>Rats</keyword><keyword>Receptors, Cell Surface/metabolism</keyword><keyword>Scorpion Venoms/metabolism</keyword><keyword>*Transfection</keyword><keyword>Transgenes</keyword></keywords><dates><year>2009</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1878-5905 (Electronic)</isbn><accession-num>18990439</accession-num><abstract>As conventional cancer therapies struggle with toxicity issues and irregular remedial efficacy, the preparation of novel gene therapy vectors could offer clinicians the tools for addressing the genetic errors of diseased tissue. The transfer of gene therapy to the clinic has proven difficult due to safety, target specificity, and transfection efficiency concerns. Polyethylenimine (PEI) nanoparticles have been identified as promising gene carriers that induce gene transfection with high efficiency. However, the inherent toxicity of the material and non-selective delivery are the major concerns in applying these particles clinically. Here, a non-viral nanovector has been developed by PEGylation of DNA-complexing PEI in nanoparticles functionalized with an Alexa Fluor 647 near infrared fluorophore, and the chlorotoxin (CTX) peptide which binds specifically to many forms of cancer. With this nanovector, the potential toxicity to healthy cells is minimized by both the reduction of the toxicity of PEI with the biocompatible copolymer and the targeted delivery of the nanovector to cancer cells, as evaluated by viability studies. The nanovector demonstrated high levels of targeting specificity and gene transfection efficiency with both C6 glioma and DAOY medulloblastoma tumor cells. Significantly, with the CTX as the targeting ligand, the nanovector may serve as a widely applicable gene delivery system for a broad array of cancer types.</abstract><notes>Veiseh, Omid&#xD;Kievit, Forrest M&#xD;Gunn, Jonathan W&#xD;Ratner, Buddy D&#xD;Zhang, Miqin&#xD;R01CA119408/CA/NCI NIH HHS/United States&#xD;R01CA134213/CA/NCI NIH HHS/United States&#xD;R01EB006043/EB/NIBIB NIH HHS/United States&#xD;T32GM065098/GM/NIGMS NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Biomaterials&#xD;Biomaterials. 2009 Feb;30(4):649-57. Epub 2008 Nov 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18990439</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom4>7.325</custom4><electronic-resource-num>S0142-9612(08)00777-1 [pii]&#xD;10.1016/j.biomaterials.2008.10.003</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2101</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2101</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Niu, G.</author><author>Chen, X.</author></authors></contributors><auth-address>Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, California, USA.</auth-address><titles><title>Has molecular and cellular imaging enhanced drug discovery and drug development?</title><secondary-title>Drugs R D</secondary-title></titles><periodical><full-title>Drugs R D</full-title></periodical><pages>351-68</pages><volume>9</volume><number>6</number><edition>2008/11/08</edition><keywords><keyword>Animals</keyword><keyword>Diagnostic Imaging/ methods</keyword><keyword>Drug Design</keyword><keyword>Drug Discovery/ methods</keyword><keyword>Gene Expression</keyword><keyword>Gene Therapy/methods</keyword><keyword>Humans</keyword></keywords><dates><year>2008</year></dates><isbn>1174-5886 (Print)</isbn><accession-num>18989988</accession-num><abstract>A great many efforts have been made to accelerate the drug discovery and development process, which is extremely time and money consuming. Recently developed molecular imaging has many significant advantages over conventional methods for examining molecular pathways and obtaining pharmacokinetic, pharmacodynamic and mechanistic information. This review briefly summarizes various molecular and cellular imaging techniques and discusses several important applications of molecular and cellular imaging in drug discovery and development, which include: (i) measurement of pharmacodynamic endpoints by imaging metabolism and proliferation, imaging angiogenic parameters, and imaging a particular pathway or downstream target; (ii) evaluation of pharmacokinetics; and (iii) imaging therapeutic gene expression with relevance to gene therapy. Molecular imaging is becoming more widely used as a non-invasive tool for drug discovery and drug screening. Further refinements in imaging techniques, optimization of imaging probes and collaborative efforts will be needed to fully realise the vast potential of molecular imaging techniques in discovering and developing new drugs.</abstract><notes>Niu, Gang&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;New Zealand&#xD;Drugs in R&amp;D&#xD;Drugs R D. 2008;9(6):351-68. doi: 10.2165/0126839-200809060-00002.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>1.00</custom4><electronic-resource-num>962 [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2148</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2148</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kay, B. K.</author><author>Thai, S.</author><author>Volgina, V. V.</author></authors></contributors><auth-address>Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL, USA.</auth-address><titles><title>High-throughput biotinylation of proteins</title><secondary-title>Methods Mol Biol</secondary-title></titles><periodical><full-title>Methods Mol Biol</full-title></periodical><pages>185-96</pages><volume>498</volume><edition>2008/11/07</edition><keywords><keyword>Animals</keyword><keyword>Biotin/metabolism</keyword><keyword>Biotinylation/ methods</keyword><keyword>Carbon-Nitrogen Ligases/metabolism</keyword><keyword>Escherichia coli/genetics/metabolism</keyword><keyword>Escherichia coli Proteins/metabolism</keyword><keyword>Microspheres</keyword><keyword>Proteins/ metabolism</keyword><keyword>Recombinant Proteins/ metabolism</keyword><keyword>Repressor Proteins/metabolism</keyword><keyword>Streptavidin/metabolism</keyword></keywords><dates><year>2009</year></dates><isbn>1064-3745 (Print)</isbn><accession-num>18988027</accession-num><abstract>One of the more useful tags for a protein in biochemical experiments is biotin, because of its femtomolar dissociation constant with streptavidin or avidin. Robust methodologies have been developed for other the in vivo addition of a single biotin to recombinant protein or the in vitro enzymatic or chemical addition of biotin to a protein. Such modified proteins can be used in a variety of experiments, such as affinity selection of phage-displayed peptides or antibodies, pull-down of interacting proteins from cell lysates, or displaying proteins on arrays. We present three complementary approaches for biotinylating proteins in vivo in Escherichia coli or in vitro using chemical or enzymatical reactions all of which can be scaled up to tag large numbers of proteins in parallel.</abstract><notes>Kay, Brian K&#xD;Thai, Sang&#xD;Volgina, Veronica V&#xD;1R01 GM079096/GM/NIGMS NIH HHS/United States&#xD;1U54 CA119343/CA/NCI NIH HHS/United States&#xD;P01 GM075913/GM/NIGMS NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Methods in molecular biology (Clifton, N.J.)&#xD;Methods Mol Biol. 2009;498:185-96.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>na</custom4><electronic-resource-num>10.1007/978-1-59745-196-3_13 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2260</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2260</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dhar, S.</author><author>Gu, F. X.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author><author>Lippard, S. J.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>17356-61</pages><volume>105</volume><number>45</number><edition>2008/11/04</edition><keywords><keyword>Aptamers, Nucleotide/genetics/therapeutic use</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cisplatin/administration &amp; dosage/ therapeutic use</keyword><keyword>Drug Delivery Systems/ methods</keyword><keyword>Endocytosis/physiology</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Molecular Structure</keyword><keyword>Nanoparticles/ therapeutic use</keyword><keyword>Nanotechnology/ methods</keyword><keyword>Platinum Compounds</keyword><keyword>Polyethylene Glycols/ metabolism</keyword><keyword>Polyglactin 910/ metabolism</keyword><keyword>Prodrugs/ therapeutic use</keyword><keyword>Prostatic Neoplasms/ drug therapy</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov 11</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18978032</accession-num><abstract>Cisplatin is used to treat a variety of tumors, but dose limiting toxicities or intrinsic and acquired resistance limit its application in many types of cancer including prostate. We report a unique strategy to deliver cisplatin to prostate cancer cells by constructing Pt(IV)-encapsulated prostate-specific membrane antigen (PSMA) targeted nanoparticles (NPs) of poly(D,L-lactic-co-glycolic acid) (PLGA)-poly(ethylene glycol) (PEG)-functionalized controlled release polymers. By using PLGA-b-PEG nanoparticles with PSMA targeting aptamers (Apt) on the surface as a vehicle for the platinum(IV) compound c,t,c-[Pt(NH(3))(2)(O(2)CCH(2)CH(2)CH(2)CH(2)CH(3))(2)Cl(2)] (1), a lethal dose of cisplatin was delivered specifically to prostate cancer cells. PSMA aptamer targeted delivery of Pt(IV) cargos to PSMA(+) LNCaP prostate cancer cells by endocytosis of the nanoparticle vehicles was demonstrated using fluorescence microscopy by colocalization of green fluorescent labeled cholesterol-encapsulated NPs and early endosome marker EEA-1. The choice of linear hexyl chains in 1 was the result of a systematic study to optimize encapsulation and controlled release from the polymer without compromising either feature. Release of cisplatin from the polymeric nanoparticles after reduction of 1 and formation of cisplatin 1,2-intrastrand d(GpG) cross-links on nuclear DNA was confirmed by using a monoclonal antibody for the adduct. A comparison between the cytotoxic activities of Pt(IV)-encapsulated PLGA-b-PEG NPs with the PSMA aptamer on the surface (Pt-NP-Apt), cisplatin, and the nontargeted Pt(IV)-encapsulated NPs (Pt-NP) against human prostate PSMA-overexpressing LNCaP and PSMA(-) PC3 cancer cells revealed significant differences. The effectiveness of PSMA targeted Pt-NP-Apt nanoparticles against the PSMA(+) LNCaP cells is approximately an order of magnitude greater than that of free cisplatin.</abstract><notes>Dhar, Shanta&#xD;Gu, Frank X&#xD;Langer, Robert&#xD;Farokhzad, Omid C&#xD;Lippard, Stephen J&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;CA34992/CA/NCI NIH HHS/United States&#xD;EB003647/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17356-61. Epub 2008 Oct 31.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2582270</custom2><custom4>10.228</custom4><electronic-resource-num>0809154105 [pii]&#xD;10.1073/pnas.0809154105 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1791</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1791</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhou, J.</author><author>Fei, P.</author><author>Gu, Y. D.</author><author>Mai, W. J.</author><author>Gao, Y. F.</author><author>Yang, R.</author><author>Bao, G.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>Wang, ZL&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA 30332 USA&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA 30332 USA&#xD;Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA&#xD;Emory Univ, Atlanta, GA 30332 USA&#xD;Peking Univ, Coll Engn, Dept Adv Mat &amp; Nanotechnol, Beijing 100084, Peoples R China</auth-address><titles><title>Piezoelectric-Potential-Control led Polarity-Reversible Schottky Diodes and Switches of ZnO Wires</title><secondary-title>Nano Letters</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>3973-3977</pages><volume>8</volume><number>11</number><edition>2008/11</edition><keywords><keyword>nanowire</keyword><keyword>sensor</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1530-6984</isbn><accession-num>ISI:000260888600074</accession-num><abstract>Using a two-end bonded ZnO piezoelectric-fine-wire (PFW) (nanowire, microwire) on a flexible polymer substrate, the strain-induced change in I-V transport characteristic from symmetric to diode-type has been observed. This phenomenon is attributed to the asymmetric change in Schottky-barrier heights at both source and drain electrodes as caused by the strain-induced piezoelectric potential-drop along the PFW, which have been quantified using the thermionic emission-diffusion theory. A new piezotronic switch device with an &quot;on&quot; and &quot;off&quot; ratio of similar to 120 has been demonstrated. This work demonstrates a novel approach for fabricating diodes and switches that rely on a strain governed piezoelectric-semiconductor coupling process.</abstract><notes>372FX&#xD;Times Cited:0&#xD;Cited References Count:26</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000260888600074</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>12.189</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1714</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1714</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Waters, E. A.</author><author>Chen, J. J.</author><author>Yang, X. X.</author><author>Zhang, H. Y.</author><author>Neumann, R.</author><author>Santeford, A.</author><author>Arbeit, J.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Wickline, SA&#xD;Washington Univ, Sch Med, Div Cardiol, Dept Med,C TRAIN Grp, Campus Box 8215,Cortex Bldg,Suite 101,4320 Forest, St Louis, MO 63108 USA&#xD;Washington Univ, Sch Med, Div Cardiol, Dept Med,C TRAIN Grp, St Louis, MO 63108 USA&#xD;Washington Univ, Dept Biomed Engn, St Louis, MO USA&#xD;Washington Univ, Sch Med, Dept Surg, Div Urol, St Louis, MO 63110 USA</auth-address><titles><title>Detection of Targeted Perfluorocarbon Nanoparticle Binding Using F-19 Diffusion Weighted MR Spectroscopy</title><secondary-title>Magnetic Resonance in Medicine</secondary-title></titles><periodical><full-title>Magnetic Resonance in Medicine</full-title></periodical><pages>1232-1236</pages><volume>60</volume><number>5</number><edition>2008/11</edition><keywords><keyword>diffusion</keyword><keyword>magnetic resonance spectroscopy</keyword><keyword>fluorine</keyword><keyword>angiogenesis</keyword><keyword>k14-hpv16 transgenic mice</keyword><keyword>rat-brain</keyword><keyword>angiogenesis</keyword><keyword>carcinogenesis</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>0740-3194</isbn><accession-num>ISI:000260341700023</accession-num><abstract>Real-time detection of targeted contrast agent binding is challenging due to background signal from unbound agent. F-19 diffusion weighted MR spectroscopy (DWS) could selectively detect binding of angiogenesis-targeted perfluorocarbon nanoparticles in vivo. Transgenic K14-HPV16 mice with epidermal squamous carcinomas exhibiting up-regulated neovasculature were used, with nontransgenic littermates as controls. Mice were treated with alpha(v)beta(3)-integrin targeted perfluorocarbon nanoparticles. 19F DWS (b-values from 0 to 16,000 S/mm(2)) was performed on mouse ears in vivo at 11.74 Tesla. Progressive decay of 19F signal with increased diffusion weighting at low b-values I(&lt; 1500 s/mm(2) was observed in ears of both K14-HPV16 and control mice, demonstrating suppression of background 19F signal from unbound nanoparticles in the blood. Much of the 19F signal from ears of K14-HPV16 mice persisted at high b-values, indicating a stationary signal source, reflecting abundant nanoparticle binding to angiogenesis. 19F signal in controls decayed completely at high b-values (&gt; 1500 s/mm(2)), reflecting a moving signal source due to absence of angiogenesis (no binding sites). Estimated ADCs of nanoparticles in K14-HPV16 and control mice were 33.1 +/- 12.9 mu m(2)/S and 19563 +/- 5858 mu m(2)/S (p &lt; 0.01). In vivo 19F DWS can be used for specific detection of bound perfluorocarbon nanoparticles by selectively suppressing background 19F signal from nanoparticles flowing in blood. Magn Reson Med 60:1232-1236, 2008. (C) 2008 WileyLiss, Inc.</abstract><notes>364NF&#xD;Times Cited:0&#xD;Cited References Count:16</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000260341700023</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom4>4.163</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1709</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1709</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, Y.</author><author>Wei, W.</author><author>Maspoch, D.</author><author>Wu, J.</author><author>Dravid, V. P.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Superparamagnetic sub-5 nm Fe@C nanoparticles: isolation, structure, magnetic properties, and directed assembly</title><secondary-title>Nano Lett</secondary-title><alt-title>Nano letters</alt-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><alt-periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></alt-periodical><pages>3761-5</pages><volume>8</volume><number>11</number><edition>2008/11</edition><dates><year>2008</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18942880</accession-num><abstract>A method for isolating single crystalline sub-5 nm carbon coated iron nanoparticles (Fe@C NPs) from a carbon nanotube matrix has been developed. The isolation of such particles allows for their characterization by high resolution electron microscopy methods and SQUID magnetometry. While the NPs are superparamagnetic at room temperature, at 10 K they exhibit a coercivity nearly 30 times greater than that of commercial Fe3O4 NPs of comparable size. A novel nanotemplate directed assembly method for manipulating the particles at the individual particle level is also reported.</abstract><notes>Journal Article&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18942880 </url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>12.189</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2508</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2508</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tu, Chun</author><author>Ortega-Cava, Cesar F.</author><author>Chen, Gengsheng</author><author>Fernandes, Norvin D.</author><author>Cavallo-Medved, Dora</author><author>Sloane, Bonnie F.</author><author>Band, Vimla</author><author>Band, Hamid</author></authors></contributors><titles><title>Lysosomal Cathepsin B Participates in the Podosome-Mediated Extracellular Matrix Degradation and Invasion via Secreted Lysosomes in v-Src Fibroblasts</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>9147-9156</pages><volume>68</volume><number>22</number><edition>2008/11</edition><dates><year>2008</year><pub-dates><date>November 15, 2008</date></pub-dates></dates><abstract>Podosomes mediate cell migration and invasion by coordinating the reorganization of actin cytoskeleton and focal matrix degradation. MMP and serine proteases have been found to function at podosomes. The lysosomal cysteine cathepsins, a third major class of matrix-degrading enzymes involved in tumor invasion and tissue remodeling, have yet to be linked to podosomes with the exception of cathepsin K in osteoclasts. Using inhibitors and shRNA-mediated depletion, we show that cathepsin B participates in podosomes-mediated focal matrix degradation and invasion in v-Src-transformed fibroblasts. We observed that lysosomal marker LAMP-1 localized at the center of podosome rosettes protruding into extracellular matrix using confocal microscopy. Time-lapse live-cell imaging revealed that lysosomal vesicles moved to and fused with podosomes. Disruption of lysosomal pH gradient with Bafilomycin A1, chloroquine, or ammonium chloride greatly enhanced the formation of podosomes and increased the matrix degradation. Live-cell imaging showed that actin structures, induced shortly after Bafilomycin A1 treatment, were closely associated with lysosomes. Overall, our results suggest that cathepsin B, delivered by lysosomal vesicles, is involved in the matrix degradtion of podosomes. [Cancer Res 2008;68(22):9147-56]</abstract><urls><related-urls><url>http://cancerres.aacrjournals.org/cgi/content/abstract/68/22/9147</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>7.980</custom4><electronic-resource-num>10.1158/0008-5472.can-07-5127</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1496</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1496</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Patel, P. C.</author><author>Giljohann, D. A.</author><author>Seferos, D. S.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Peptide antisense nanoparticles</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title><alt-title>Proceedings of the National Academy of Sciences of the United States of America</alt-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><alt-periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></alt-periodical><pages>17222-6</pages><volume>105</volume><number>45</number><edition>2008/11</edition><keywords><keyword>Blotting, Western</keyword><keyword>*Gene Expression Regulation</keyword><keyword>Gold/*chemistry</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Mass Spectrometry</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Oligonucleotides, Antisense/*chemistry</keyword><keyword>Peptides/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov 11, 2008</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>19004812</accession-num><abstract>We have designed a heterofunctionalized nanoparticle conjugate consisting of a 13-nm gold nanoparticle (Au NP) containing both antisense oligonucleotides and synthetic peptides. The synthesis of this conjugate is accomplished by mixing thiolated oligonucleotides and cysteine-terminated peptides with gold nanoparticles in the presence of salt, which screens interactions between biomolecules, yielding a densely functionalized nanomaterial. By controlling the stoichiometry of the components in solution, we can control the surface loading of each biomolecule. The conjugates are prepared easily and show perinuclear localization and an enhanced gene regulation activity when tested in a cellular model. This heterofunctionalized structure represents a new strategy for preparing nanomaterials with potential therapeutic applications.</abstract><notes>Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=19004812 </url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>10.228</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1430</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1430</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Majoros, I. J.</author><author>Williams, C. R.</author><author>Tomalia, D. A.</author><author>Baker, J. R.</author></authors></contributors><auth-address>Majoros, IJ&#xD;Univ Michigan, Dept Internal Med, Div Allergy, Michigan Nanotechnol Inst Med &amp; Biol Sci, Ann Arbor, MI 48109 USA&#xD;Univ Michigan, Dept Internal Med, Div Allergy, Michigan Nanotechnol Inst Med &amp; Biol Sci, Ann Arbor, MI 48109 USA</auth-address><titles><title>New Dendrimers: Synthesis and Characterization of POPAM-PAMAM Hybrid Dendrimers</title><secondary-title>Macromolecules</secondary-title></titles><periodical><full-title>Macromolecules</full-title></periodical><pages>8372-8379</pages><volume>41</volume><number>22</number><edition>2008/11</edition><keywords><keyword>starburst dendrimers</keyword><keyword>cancer-therapy</keyword><keyword>shape</keyword><keyword>architecture</keyword><keyword>nanodevice</keyword><keyword>chemistry</keyword><keyword>topology</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov 25</date></pub-dates></dates><isbn>0024-9297</isbn><accession-num>ISI:000261003700018</accession-num><abstract>Recently developed multifunctional cancer therapeutic nanodevice production is based on poly(amidoamine) PAMAM generation 5 (G5) dendrimer as a carrier. Scale-up synthesis of this nanodevice is limited because of long reaction sequence (12 reaction steps) and long and not easy work-up of the products after each reaction step. Combination of poly(propylenimine) and poly(amidoamine) synthesis can improve the production of the drug carrier. In this paper we give a general overview of the synthesis and characterization of a series of novel hybrid dendrimers which we coined as novel POMAM hybrid dendrimers, constructed from poly(propylenimine) (PPI or POPAM) core and poly(amidoamine) PAMAM shells. The synthesis was accomplished by a divergent reiterating method involving repeating subsequent Michael addition and amidation reactions. Each generation of the newly synthesized dendrimer was characterized by using HPLC, GPC, NMR, and AFM.</abstract><notes>373WH&#xD;Times Cited:0&#xD;Cited References Count:22</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000261003700018</url></related-urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom4>4.431</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1425</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1425</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Major, J. L.</author><author>Boiteau, R. M.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Meade, TJ&#xD;Northwestern Univ, Dept Chem Biochem &amp; Mol Cell Biol, 2145 Sheridan Rd, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Chem Biochem &amp; Mol Cell Biol, Evanston, IL 60208 USA</auth-address><titles><title>Mechanisms of Zn-II-Activated Magnetic Resonance Imaging Agents</title><secondary-title>Inorganic Chemistry</secondary-title></titles><periodical><full-title>Inorganic Chemistry</full-title></periodical><pages>10788-10795</pages><volume>47</volume><number>22</number><edition>2008/11</edition><keywords><keyword>mri contrast agent</keyword><keyword>beta-galactosidase</keyword><keyword>zinc</keyword><keyword>luminescence</keyword><keyword>relaxation</keyword><keyword>complexes</keyword><keyword>disease</keyword><keyword>brain</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov 17</date></pub-dates></dates><isbn>0020-1669</isbn><accession-num>ISI:000260791100078</accession-num><abstract>We report on the mechanism of a series of Zn-II-activated magnetic resonance contrast agents that modulate the access of water to a paramagnetic Gd-III ion to create an increase in relaxivity upon binding of Zn-II, In the absence and presence of Zn-II, the coordination at the Gd-III center is modulated by appended Zn-II binding groups. These groups were systematically varied to optimize the change in coordination upon Zn-II binding. We observe that at least one appended aminoacetate must be present as a coordinating group to bind Gd-III and effectively inhibit access of water. At least two binding groups are required to efficiently bind Zn-II, creating an unsaturated complex and allowing access of water. C-13 isotopic labeling of the acetate binding groups for NMR spectroscopy provides evidence of a change in the metal coordination of these groups upon the addition of Zn-II supporting our proposed mechanism of activation as presented.</abstract><notes>370VL&#xD;Times Cited:0&#xD;Cited References Count:25</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000260791100078</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.215</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1421</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1421</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Luo, W.</author><author>Westcott, N. P.</author><author>Pulsipher, A.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Yousaf, MN&#xD;Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA</auth-address><titles><title>Renewable and Optically Transparent Electroactive Indium Tin Oxide Surfaces for Chemoselective Ligand Immobilization and Biospecific Cell Adhesion</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>13096-13101</pages><volume>24</volume><number>22</number><edition>2008/11</edition><keywords><keyword>self-assembled monolayers</keyword><keyword>ito electrodes</keyword><keyword>chemistry</keyword><keyword>proteins</keyword><keyword>devices</keyword><keyword>functionalization</keyword><keyword>polarization</keyword><keyword>microarrays</keyword><keyword>cocultures</keyword><keyword>gradients</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov 18</date></pub-dates></dates><isbn>0743-7463</isbn><accession-num>ISI:000260874800053</accession-num><abstract>In this report, we show the successful transfer of a sophisticated electroactive immobilization and release strategy to an indium tin oxide (ITO) surface to generate (1) optically transparent, robust. and renewable surfaces, (2) inert surfaces that resist nonspecific protein adsorption and cell attachment, and (3) tailored biospecific surfaces for live-cell high-resolution fluorescence microscopy of cell culture. By comparing the surface chemistry properties on both ITO and gold surfaces, we demonstrate the ITO surfaces are superior to gold as a renewable surface, in robustness (durability), and as an optically transparent material for live-cell fluorescence microscopy studies of cell behavior. These advantages will make ITO surfaces a desired platform for numerous biosensor and microarray applications and as model substrates for various cell biological studies.</abstract><notes>372AW&#xD;Times Cited:0&#xD;Cited References Count:32</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000260874800053</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>4.347</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1420</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1420</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Luo, W.</author><author>Jones, S. R.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Yousaf, MN&#xD;Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA</auth-address><titles><title>Geometric Control of Stem Cell Differentiation Rate on Surfaces</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>12129-12133</pages><volume>24</volume><number>21</number><edition>2008/11</edition><keywords><keyword>polarization</keyword><keyword>shape</keyword><keyword>bone</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov 4</date></pub-dates></dates><isbn>0743-7463</isbn><accession-num>ISI:000260508800010</accession-num><abstract>We develop a general methodology to create a patterned surface array that allows for the study of how the cell population, surface adhesion area, and pattern geometry combine to influence stem cell differentiation. We use a simple microfabrication technique to pattern human mesenchymal stem cells (hMSC&apos;s) on transparent surfaces and develop a new method to quantitate adipogenic differentiation. We found that the pattern geometry and therefore the cell population, rather than the cell adhesive area, influence the rate of adipogenic differentiation from hMSC&apos;s. Furthermore, the cells within the pattern behave more characteristically of a tissue than do individual cells because a certain critical threshold cell density is required to induce differentiation.</abstract><notes>366UL&#xD;Times Cited:0&#xD;Cited References Count:25</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000260508800010</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>4.347</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2537</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2537</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lu, Qing</author><author>Nunez, Esperanza</author><author>Lin, Chunrun</author><author>Christensen, Kimberly</author><author>Downs, Tracy</author><author>Carson, Dennis A.</author><author>Wang-Rodriguez, Jessica</author><author>Liu, Yu-Tsueng</author></authors></contributors><titles><title>A sensitive array-based assay for identifying multiple TMPRSS2:ERG fusion gene variants</title><secondary-title>Nucl. Acids Res.</secondary-title></titles><periodical><full-title>Nucl. Acids Res.</full-title></periodical><pages>e130-</pages><volume>36</volume><number>20</number><edition>2008/11</edition><dates><year>2008</year><pub-dates><date>November 1, 2008</date></pub-dates></dates><abstract>Studies of gene fusions in solid tumors are not as extensive as in hematological malignancies due to several technical and analytical problems associated with tumor heterogeneity. Nevertheless, there is a growing interest in the role of fusion genes in common epithelial tumors after the discovery of recurrent TMPRSS2:ETS fusions in prostate cancer. Among all of the reported fusion partners in the ETS gene family, TMPRSS2:ERG is the most prevalent one. Here, we present a simple and sensitive microarray-based assay that is able to simultaneously determine multiple fusion variants with a single RT-PCR in impure RNA specimens. The assay detected TMPRSS2:ERG fusion transcripts with a detection sensitivity of &lt;10 cells in the presence of more than 3000 times excess normal RNA, and in primary prostate tumors having no &gt;1% of cancer cells. The ability to detect multiple transcript variants in a single assay is critically dependent on both the primer and probe designs. The assay should facilitate clinical and basic studies for fusion gene screening in clinical specimens, as it can be readily adapted to include multiple gene loci.</abstract><urls><related-urls><url>http://nar.oxfordjournals.org/cgi/content/abstract/36/20/e130</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>6.968</custom4><electronic-resource-num>10.1093/nar/gkn585</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1386</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1386</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, S. S.</author><author>Lim, J.</author><author>Cha, J.</author><author>Tan, S.</author><author>Heath, J. R.</author></authors></contributors><auth-address>Heath, JR&#xD;Inst Bioengn &amp; Nanotechnol, 31 Biopolis Way, The Nanos 138669, Singapore&#xD;Inst Bioengn &amp; Nanotechnol, The Nanos 138669, Singapore&#xD;CALTECH, Div Chem &amp; Chem Engn, Pasadena, CA USA</auth-address><titles><title>Rapid Microwave-Assisted CNBr Cleavage of Bead-Bound Peptides</title><secondary-title>Journal of Combinatorial Chemistry</secondary-title></titles><periodical><full-title>Journal of Combinatorial Chemistry</full-title></periodical><pages>807-809</pages><volume>10</volume><number>6</number><edition>2008/11</edition><keywords><keyword>organic-synthesis</keyword><keyword>combinatorial libraries</keyword><keyword>cyanogen-bromide</keyword><keyword>ladder-synthesis</keyword><keyword>chemistry</keyword><keyword>spectrometry</keyword><keyword>irradiation</keyword><keyword>efficiency</keyword><keyword>catalysis</keyword><keyword>proteins</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov-Dec</date></pub-dates></dates><isbn>1520-4766</isbn><accession-num>ISI:000260851400003</accession-num><notes>371SK&#xD;Times Cited:0&#xD;Cited References Count:34</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000260851400003</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom4>2.489</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1365</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1365</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lamb, B. M.</author><author>Westcott, N. P.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Yousaf, MN&#xD;Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA</auth-address><titles><title>Microfluidic Lithography to Create Dynamic Gradient SAM Surfaces for Spatio-temporal Control of Directed Cell Migration</title><secondary-title>Chembiochem</secondary-title></titles><periodical><full-title>Chembiochem</full-title></periodical><pages>2628-2632</pages><volume>9</volume><number>16</number><edition>2008/11</edition><keywords><keyword>cell migration</keyword><keyword>cell patterning</keyword><keyword>microfluidics</keyword><keyword>monolayers</keyword><keyword>redox chemistry</keyword><keyword>self-assembled monolayers</keyword><keyword>ligands</keyword><keyword>immobilization</keyword><keyword>polarization</keyword><keyword>gold</keyword><keyword>attachment</keyword><keyword>generation</keyword><keyword>cocultures</keyword><keyword>chemistry</keyword><keyword>substrate</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov 3</date></pub-dates></dates><isbn>1439-4227</isbn><accession-num>ISI:000261001900013</accession-num><notes>373VP&#xD;Times Cited:0&#xD;Cited References Count:40</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000261001900013</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>3.684</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1180</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1180</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dhar, S.</author><author>Liu, Z.</author><author>Thomale, J.</author><author>Dai, H. J.</author><author>Lippard, S. J.</author></authors></contributors><auth-address>Dai, HJ&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA&#xD;Stanford Univ, Adv Mat Lab, Stanford, CA 94305 USA&#xD;MIT, Dept Chem, Cambridge, MA 02139 USA&#xD;Univ Duisburg Essen, Inst Cell Biol, D-45122 Essen, Germany</auth-address><titles><title>Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>11467-11476</pages><volume>130</volume><number>34</number><edition>2008/11</edition><keywords><keyword>disulfide bonds</keyword><keyword>drug-delivery</keyword><keyword>in-vivo</keyword><keyword>platinum(iv) complexes</keyword><keyword>mammalian-cells</keyword><keyword>cancer-cells</keyword><keyword>functionalization</keyword><keyword>transporters</keyword><keyword>receptor</keyword><keyword>DNA</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 27</date></pub-dates></dates><isbn>0002-7863</isbn><accession-num>ISI:000258660600046</accession-num><abstract>Most low-molecular-weight platinum anticancer drugs have short blood circulation times that are reflected in their reduced tumor uptake and intracellular DNA binding. A platinum(IV) complex of the formula c,c,t-[Pt(NH3)(2)Cl-2(O2CCH2CH2CO2H)(O2CCH2CH2CONH-PEG-FA)] (1), containing a folate derivative (FA) at an axial position, was prepared and characterized. Folic acid offers a means of targeting human cells that highly overexpress the folate receptor (FR). Compound 1 was attached to the surface of an amine-functionalized single-walled carbon nanotube (SWNT-PL-PEG-NH2) through multiple amide linkages to use the SWNTs as a &quot;longboat delivery system&quot; for the platinum warhead, carrying it to the tumor cell and releasing cisplatin upon intracellular reduction of Pt(IV) to Pt(II). The ability of SWNT tethered 1 to destroy selectively FR(+) vs FR(-) cells demonstrated its ability to target tumor cells that overexpress the FR on their surface. That the SWNTs deliver the folate-bearing Pt(IV) cargos into FR(+) cancer cells by endocytosis was demonstrated by the localization of fluorophore-labeled SWNTs using fluorescence microscopy. Once inside the cell, cisplatin, formed upon reductive release from the longboat oars, enters the nucleus and reacts with its target nuclear DNA, as determined by platinum atomic absorption spectroscopy of cell extracts. Formation of the major cisplatin 1,2-intrastrand d(GpG) cross-links on the nuclear DNA was demonstrated by use of a monoclonal antibody specific for this adduct. The SWNT-tethered compound 1 is the first construct in which both the targeting and delivery moieties have been incorporated into the same molecule; it is also the first demonstration that intracellular reduction of a Pt(IV) prodrug leads to the cis-{Pt((NH3)(2)} 1,2-intrastrand d(GpG) cross-link in nuclear DNA.</abstract><notes>340QR&#xD;Times Cited:1&#xD;Cited References Count:59</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258660600046</url></related-urls></urls><custom1>CCNE - MIT</custom1><custom4>8.256</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1119</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1119</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cao, P. G.</author><author>Xu, K.</author><author>Heath, J. R.</author></authors></contributors><auth-address>Heath, JR&#xD;CALTECH, Kavli Nanosci Inst, Noyes Lab, Div Chem &amp; Chem Engn, Pasadena, CA 91125 USA&#xD;CALTECH, Kavli Nanosci Inst, Noyes Lab, Div Chem &amp; Chem Engn, Pasadena, CA 91125 USA</auth-address><titles><title>Azidation of Silicon(111) Surfaces</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>14910-+</pages><volume>130</volume><number>45</number><edition>2008/11</edition><keywords><keyword>scanning-tunneling-microscopy</keyword><keyword>si(111) surfaces</keyword><keyword>chemical-stability</keyword><keyword>alkyl monolayers</keyword><keyword>click chemistry</keyword><keyword>chlorination/alkylation process</keyword><keyword>terminated monolayers</keyword><keyword>unsaturated grignards</keyword><keyword>crystalline si(111)</keyword><keyword>electrode surfaces</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov 12</date></pub-dates></dates><isbn>0002-7863</isbn><accession-num>ISI:000260682300004</accession-num><abstract>A two-step chlorination/azidation process was reported to prepare azide-modified silicon(111) surfaces. XPS and IR analyses show the covalent bonding of azide with silicon. In combination with scanning tunneling microscopy and spectroscopy analyses, different kinetic rates, azide coverages, and surface-area distributions were derived depending on the azidation solvent.</abstract><notes>369GK&#xD;Times Cited:0&#xD;Cited References Count:34</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000260682300004</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom4>8.256</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2025</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2025</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Neubauer, A. M.</author><author>Myerson, J.</author><author>Caruthers, S. D.</author><author>Hockett, F. D.</author><author>Winter, P. M.</author><author>Chen, J.</author><author>Gaffney, P. J.</author><author>Robertson, J. D.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>C-TRAIN Group, Washington University, St Louis, Missouri 63108, USA.</auth-address><titles><title>Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><pages>1066-72</pages><volume>60</volume><number>5</number><edition>2008/10/29</edition><keywords><keyword>Contrast Media/chemistry</keyword><keyword>Fluorine Radioisotopes/ chemistry/ diagnostic use</keyword><keyword>Fluorocarbons/chemistry</keyword><keyword>Gadolinium/ chemistry/ diagnostic use</keyword><keyword>Image Enhancement/methods</keyword><keyword>Magnetic Resonance Imaging/ methods</keyword><keyword>Molecular Probe Techniques</keyword><keyword>Nanoparticles/ chemistry/ diagnostic use</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1522-2594 (Electronic)</isbn><accession-num>18956457</accession-num><abstract>Recent advances in the design of fluorinated nanoparticles for molecular magnetic resonance imaging (MRI) have enabled specific detection of (19)F nuclei, providing unique and quantifiable spectral signatures. However, a pressing need for signal enhancement exists because the total (19)F in imaging voxels is often limited. By directly incorporating a relaxation agent, gadolinium (Gd), into the lipid monolayer that surrounds the perfluorocarbon (PFC), a marked augmentation of the (19)F signal from 200-nm nanoparticles was achieved. This design increases the magnetic relaxation rate of the (19)F nuclei fourfold at 1.5 T and effects a 125% increase in signal--an effect that is maintained when they are targeted to human plasma clots. By varying the surface concentration of Gd, the relaxation effect can be quantitatively modulated to tailor particle properties. This novel strategy dramatically improves the sensitivity and range of (19)F MRI/MRS and forms the basis for designing contrast agents capable of sensing their surface chemistry.</abstract><notes>Neubauer, Anne M&#xD;Myerson, Jacob&#xD;Caruthers, Shelton D&#xD;Hockett, Franklin D&#xD;Winter, Patrick M&#xD;Chen, Junjie&#xD;Gaffney, Patrick J&#xD;Robertson, J David&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;R01 HL073646-03/HL/NHLBI NIH HHS/United States&#xD;U54 CA119342-02/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine&#xD;Magn Reson Med. 2008 Nov;60(5):1066-72.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom2>2597646</custom2><custom3>NIHMS65223</custom3><custom4>4.163</custom4><electronic-resource-num>10.1002/mrm.21750 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2100</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2100</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chen, Z.</author><author>Tabakman, S. M.</author><author>Goodwin, A. P.</author><author>Kattah, M. G.</author><author>Daranciang, D.</author><author>Wang, X.</author><author>Zhang, G.</author><author>Li, X.</author><author>Liu, Z.</author><author>Utz, P. J.</author><author>Jiang, K.</author><author>Fan, S.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry and Laboratory for Advanced Materials, Stanford University, 333 Campus Drive, Mudd Building, Room 121, Stanford, California 94305, USA.</auth-address><titles><title>Protein microarrays with carbon nanotubes as multicolor Raman labels</title><secondary-title>Nat Biotechnol</secondary-title></titles><periodical><full-title>Nat Biotechnol</full-title></periodical><pages>1285-92</pages><volume>26</volume><number>11</number><edition>2008/10/28</edition><keywords><keyword>Animals</keyword><keyword>Autoantibodies/ blood</keyword><keyword>Carbon Isotopes/chemistry</keyword><keyword>Carbon Radioisotopes/chemistry</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Myeloblastin/immunology</keyword><keyword>Nanotubes, Carbon/ chemistry</keyword><keyword>Protein Array Analysis/ methods</keyword><keyword>Spectrum Analysis, Raman/ methods</keyword><keyword>Wegener Granulomatosis/ diagnosis/immunology</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1546-1696 (Electronic)</isbn><accession-num>18953353</accession-num><abstract>The current sensitivity of standard fluorescence-based protein detection limits the use of protein arrays in research and clinical diagnosis. Here, we use functionalized, macromolecular single-walled carbon nanotubes (SWNTs) as multicolor Raman labels for highly sensitive, multiplexed protein detection in an arrayed format. Unlike fluorescence methods, Raman detection benefits from the sharp scattering peaks of SWNTs with minimal background interference, affording a high signal-to-noise ratio needed for ultra-sensitive detection. When combined with surface-enhanced Raman scattering substrates, the strong Raman intensity of SWNT tags affords protein detection sensitivity in sandwich assays down to 1 fM--a three-order-of-magnitude improvement over most reports of fluorescence-based detection. We use SWNT Raman tags to detect human autoantibodies against proteinase 3, a biomarker for the autoimmune disease Wegener&apos;s granulomatosis, diluted up to 10(7)-fold in 1% human serum. SWNT Raman tags are not subject to photobleaching or quenching. By conjugating different antibodies to pure (12)C and (13)C SWNT isotopes, we demonstrate multiplexed two-color SWNT Raman-based protein detection.</abstract><notes>Chen, Zhuo&#xD;Tabakman, Scott M&#xD;Goodwin, Andrew P&#xD;Kattah, Michael G&#xD;Daranciang, Dan&#xD;Wang, Xinran&#xD;Zhang, Guangyu&#xD;Li, Xiaolin&#xD;Liu, Zhuang&#xD;Utz, Paul J&#xD;Jiang, Kaili&#xD;Fan, Shoushan&#xD;Dai, Hongjie&#xD;R01 CA135109-01/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Nature biotechnology&#xD;Nat Biotechnol. 2008 Nov;26(11):1285-92. Epub 2008 Oct 26.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>25.329</custom4><electronic-resource-num>nbt.1501 [pii]&#xD;10.1038/nbt.1501 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2099</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2099</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Guzman, R.</author><author>Hsu, A. R.</author><author>Wang, H.</author><author>Chen, K.</author><author>Sun, G.</author><author>Gera, A.</author><author>Choi, R.</author><author>Bliss, T.</author><author>He, L.</author><author>Li, Z. B.</author><author>Maag, A. L.</author><author>Hori, N.</author><author>Zhao, H.</author><author>Moseley, M.</author><author>Steinberg, G. K.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford, Department of Radiology, Stanford University, Stanford, CA, USA.</auth-address><titles><title>Positron emission tomography imaging of poststroke angiogenesis</title><secondary-title>Stroke</secondary-title></titles><periodical><full-title>Stroke</full-title></periodical><pages>270-7</pages><volume>40</volume><number>1</number><edition>2008/10/25</edition><keywords><keyword>Animals</keyword><keyword>Biological Markers/analysis/metabolism</keyword><keyword>Bromodeoxyuridine</keyword><keyword>Cell Proliferation</keyword><keyword>Cerebral Arteries/metabolism/ radionuclide imaging</keyword><keyword>Copper Radioisotopes/diagnostic use</keyword><keyword>Disease Models, Animal</keyword><keyword>Female</keyword><keyword>Fluorodeoxyglucose F18/diagnostic use</keyword><keyword>Infarction, Middle Cerebral Artery/physiopathology/ radionuclide imaging</keyword><keyword>Kinetics</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Neovascularization, Physiologic/ physiology</keyword><keyword>Positron-Emission Tomography/ methods</keyword><keyword>Rats</keyword><keyword>Rats, Sprague-Dawley</keyword><keyword>Receptors, Vascular Endothelial Growth Factor/ analysis/metabolism</keyword><keyword>Recovery of Function/physiology</keyword><keyword>Stroke/physiopathology/ radionuclide imaging</keyword><keyword>Vascular Endothelial Growth Factor A/analysis/metabolism</keyword></keywords><dates><year>2009</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1524-4628 (Electronic)</isbn><accession-num>18948613</accession-num><abstract>BACKGROUND AND PURPOSE: Vascular endothelial growth factor (VEGF) and VEGF receptors (VEGFRs) play important roles during neurovascular repair after stroke. In this study, we imaged VEGFR expression with positron emission tomography (PET) to noninvasively analyze poststroke angiogenesis. METHODS: Female Sprague-Dawley rats after distal middle cerebral artery occlusion surgery were subjected to weekly MRI, (18)F-FDG PET, and (64)Cu-DOTA-VEGF(121) PET scans. Several control experiments were performed to confirm the VEGFR specificity of (64)Cu-DOTA-VEGF(121) uptake in the stroke border zone. VEGFR, BrdU, lectin staining, and (125)I-VEGF(165) autoradiography on stroke brain tissue slices were performed to validate the in vivo findings. RESULTS: T2-weighed MRI correlated with the &quot;cold spot&quot; on (18)F-FDG PET for rats undergoing distal middle cerebral artery occlusion surgery. The (64)Cu-DOTA-VEGF(121) uptake in the stroke border zone peaked at approximately 10 days after surgery, indicating neovascularization as confirmed by histology (VEGFR-2, BrdU, and lectin staining). VEGFR specificity of (64)Cu-DOTA-VEGF(121) uptake was confirmed by significantly lower uptake of (64)Cu-DOTA-VEGF(mutant) in vivo and intense (125)I-VEGF(165) uptake ex vivo in the stroke border zone. No appreciable uptake of (64)Cu-DOTA-VEGF(121) was observed in the brain of sham-operated rats. CONCLUSIONS: For the first time to our knowledge, we successfully evaluated the VEGFR expression kinetics noninvasively in a rat stroke model. In vivo imaging of VEGFR expression could become a significant clinical tool to plan and monitor therapies aimed at improving poststroke angiogenesis.</abstract><notes>Cai, Weibo&#xD;Guzman, Raphael&#xD;Hsu, Andrew R&#xD;Wang, Hui&#xD;Chen, Kai&#xD;Sun, Guohua&#xD;Gera, Atul&#xD;Choi, Raymond&#xD;Bliss, Tonya&#xD;He, Lina&#xD;Li, Zi-Bo&#xD;Maag, Anne-Lise D&#xD;Hori, Nobutaka&#xD;Zhao, Heng&#xD;Moseley, Michael&#xD;Steinberg, Gary K&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Stroke; a journal of cerebral circulation&#xD;Stroke. 2009 Jan;40(1):270-7. Epub 2008 Oct 23.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.872</custom4><electronic-resource-num>STROKEAHA.108.517474 [pii]&#xD;10.1161/STROKEAHA.108.517474 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2337</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2337</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, X.</author><author>Zhou, X.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Surface-enhanced Raman nanoparticle beacons based on bioconjugated gold nanocrystals and long range plasmonic coupling</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>14934-5</pages><volume>130</volume><number>45</number><edition>2008/10/22</edition><keywords><keyword>Biocompatible Materials/chemistry</keyword><keyword>DNA/analysis/chemistry</keyword><keyword>DNA Probes/ chemistry</keyword><keyword>Gold/ chemistry</keyword><keyword>Metal Nanoparticles/ chemistry</keyword><keyword>Nucleic Acid Hybridization</keyword><keyword>Oligonucleotides/chemistry</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Rosaniline Dyes/chemistry</keyword><keyword>Spectrum Analysis, Raman/ methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov 12</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18937463</accession-num><abstract>We have developed a new class of surface-enhanced Raman scattering beacons (SERS beacons) that can be turned on and off by long-range plasmonic coupling, induced by biomolecular recognition and binding events. The beacons are based on colloidal gold nanocrystals in two sizes (40 and 60 nm) and are prepared by spectral encoding with a Raman reporter molecule, functionalized with thiolated DNA probes, and stabilized and protected by low molecular weight poly(ethylene glycol)s (PEGs). The results show the SERS signal intensities increase by 40-200-fold when the nanoparticle beacons are activated by plasmonic coupling, much higher than the bright-to-dark intensity ratios reported for traditional molecular beacons. Multivalent gold nanoparticles also have exquisite specificity and are able to recognize single-base mismatches or mutations. This class of SERS nanoparticle beacons has novel mechanisms for molecular detection and signal amplification, and its long-range coupling nature raises new opportunities in developing plasmonic probes to detect proteins, cells, and intact viruses.</abstract><notes>Qian, Ximei&#xD;Zhou, Xi&#xD;Nie, Shuming&#xD;P20 GM072069/GM/NIGMS NIH HHS/United States&#xD;R01 CA108468/CA/NCI NIH HHS/United States&#xD;U01HL080711/HL/NHLBI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Nov 12;130(45):14934-5. Epub 2008 Oct 21.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja8062502 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1928</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1928</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nyk, M.</author><author>Kumar, R.</author><author>Ohulchanskyy, T. Y.</author><author>Bergey, E. J.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, Department of Chemistry, University at Buffalo, State University of New York, Buffalo, New York 14260-3000, USA.</auth-address><titles><title>High contrast in vitro and in vivo photoluminescence bioimaging using near infrared to near infrared up-conversion in Tm3+ and Yb3+ doped fluoride nanophosphors</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>3834-8</pages><volume>8</volume><number>11</number><edition>2008/10/22</edition><keywords><keyword>Animals</keyword><keyword>Biosensing Techniques/ methods</keyword><keyword>Cations/chemistry</keyword><keyword>Cell Line</keyword><keyword>Cell Survival</keyword><keyword>Fluorides/ chemistry</keyword><keyword>Luminescent Measurements</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanoparticles/ chemistry/ ultrastructure</keyword><keyword>Photochemistry</keyword><keyword>Thulium/ chemistry</keyword><keyword>X-Ray Diffraction</keyword><keyword>Ytterbium/ chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18928324</accession-num><abstract>A new approach for photoluminescence imaging in vitro and in vivo has been shown utilizing near infrared to near infrared (NIR-to-NIR) up-conversion in nanophosphors. This NIR-to-NIR up-conversion process provides deeper light penetration into biological specimen and results in high contrast optical imaging due to absence of an autofluorescence background and decreased light scattering. Aqueous dispersible fluoride (NaYF4) nanocrystals (20-30 nm size) co-doped with the rare earth ions, Tm(3+) and Yb(3+), were synthesized and characterized by TEM, XRD, and photoluminescence (PL) spectroscopy. In vitro cellular uptake was shown by the PL microscopy visualizing the characteristic emission of Tm(3+) at approximately 800 nm excited with 975 nm. No apparent cytotoxicity was observed. Subsequent animal imaging studies were performed using Balb-c mice injected intravenously with up-converting nanophosphors, demonstrating the high contrast PL imaging in vivo.</abstract><notes>Nyk, Marcin&#xD;Kumar, Rajiv&#xD;Ohulchanskyy, Tymish Y&#xD;Bergey, Earl J&#xD;Prasad, Paras N&#xD;R01CA104492/CA/NCI NIH HHS/United States&#xD;R01CA119358/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2008 Nov;8(11):3834-8. Epub 2008 Oct 18.</notes><urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom4>12.189</custom4><electronic-resource-num>10.1021/nl802223f [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2098</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2098</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xia, Z.</author><author>Xing, Y.</author><author>So, M. K.</author><author>Koh, A. L.</author><author>Sinclair, R.</author><author>Rao, J.</author></authors></contributors><auth-address>Biophysics Program, Department of Radiology, Stanford University School of Medicine, 1201 Welch Road, Stanford, California 94305-5484, USA.</auth-address><titles><title>Multiplex detection of protease activity with quantum dot nanosensors prepared by intein-mediated specific bioconjugation</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>8649-55</pages><volume>80</volume><number>22</number><edition>2008/10/17</edition><keywords><keyword>Animals</keyword><keyword>Biosensing Techniques/ methods</keyword><keyword>Buffers</keyword><keyword>Cell Line, Tumor</keyword><keyword>Energy Transfer</keyword><keyword>Humans</keyword><keyword>Inteins</keyword><keyword>Luciferases, Renilla/chemistry/metabolism</keyword><keyword>Luminescence</keyword><keyword>Matrix Metalloproteinase 2/analysis/blood/metabolism/secretion</keyword><keyword>Matrix Metalloproteinase 7/analysis/metabolism</keyword><keyword>Mice</keyword><keyword>Peptide Hydrolases/analysis/ metabolism</keyword><keyword>Quantum Dots</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Substrate Specificity</keyword><keyword>Urokinase-Type Plasminogen Activator/analysis/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov 15</date></pub-dates></dates><isbn>1520-6882 (Electronic)</isbn><accession-num>18922019</accession-num><abstract>We report here a protease sensing nanoplatform based on semiconductor nanocrystals or quantum dots (QDs) and bioluminescence resonance energy transfer (QD-BRET) to detect the protease activity in complex biological samples. These nanosensors consist of bioluminescent proteins as the BRET donor, quantum dots as the BRET acceptor, and protease substrates sandwiched between the two as a sensing group. An intein-mediated conjugation strategy was developed for site-specific conjugation of proteins to QDs in preparing these QD nanosensors. In this traceless ligation, the intein itself is spliced out and excluded from the final conjugation product. With this method, we have synthesized a series of QD nanosensors for highly sensitive detection of an important class of protease matrix metalloproteinase (MMP) activity. We demonstrated that these nanosensors can detect the MMP activity in buffers and in mouse serum with the sensitivity to a few nanograms per milliliter and secreted proteases by tumor cells. The suitability of these nanosensors for a multiplex protease assay has also been shown.</abstract><notes>Xia, Zuyong&#xD;Xing, Yun&#xD;So, Min-Kyung&#xD;Koh, Ai Leen&#xD;Sinclair, Robert&#xD;Rao, Jianghong&#xD;1R01CA135294-01/CA/NCI NIH HHS/United States&#xD;1U54CA119367-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2008 Nov 15;80(22):8649-55. Epub 2008 Oct 16.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom2>2677517</custom2><custom3>NIHMS91097</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac801562f [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2146</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2146</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Taylor, K. M.</author><author>Rieter, W. J.</author><author>Lin, W.</author></authors></contributors><auth-address>Department of Chemistry, CB#3290, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>14358-9</pages><volume>130</volume><number>44</number><edition>2008/10/11</edition><keywords><keyword>Animals</keyword><keyword>HT29 Cells</keyword><keyword>Humans</keyword><keyword>Ligands</keyword><keyword>Magnetic Resonance Imaging/ methods</keyword><keyword>Manganese/ chemistry</keyword><keyword>Metal Nanoparticles/ chemistry</keyword><keyword>Mice</keyword><keyword>Microwaves</keyword><keyword>Oligopeptides/chemistry</keyword><keyword>Organometallic Compounds/chemistry</keyword><keyword>Rhodamines/chemistry</keyword><keyword>Silicon Dioxide/chemistry</keyword><keyword>Surface-Active Agents/chemistry</keyword><keyword>Tricarboxylic Acids/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov 5</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18844356</accession-num><abstract>Manganese-containing nanoscale metal-organic frameworks (NMOFs) with controllable morphologies were synthesized using reverse-phase microemulsion techniques at room temperature and a surfactant-assisted procedure at 120 degrees C with microwave heating. The nanoparticles were characterized using a variety of methods including SEM, TEM, TGA, PXRD, and ICP-MS. Although the nanoparticles gave a modest longitudinal relaxivity (r1) on a per Mn basis, they provided an efficient vehicle for the delivery of large doses of Mn2+ ions which exhibited very high in vitro and in vivo r1 values and afforded excellent MR contrast enhancement. The particle surface was also modified with a silica shell to allow covalent attachment of a cyclic RGD peptide and an organic fluorophore. The cell-targeting molecules on the Mn NMOFs enhanced their delivery to cancer cells to allow for target-specific MR imaging in vitro. The MR contrast enhancement was also demonstrated in vivo using a mouse model. Such core-shell hybrid nanostructures provide an ideal platform for targeted delivery of other imaging and therapeutic agents to diseased tissues.</abstract><notes>Taylor, Kathryn M L&#xD;Rieter, William J&#xD;Lin, Wenbin&#xD;U54-CA119343/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Nov 5;130(44):14358-9. Epub 2008 Oct 10.</notes><urls></urls><custom1>CCNE - UNC</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja803777x [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2389</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2389</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Alvarez, S. D.</author><author>Derfus, A. M.</author><author>Schwartz, M. P.</author><author>Bhatia, S. N.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0358, USA.</auth-address><titles><title>The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors</title><secondary-title>Biomaterials</secondary-title></titles><periodical><full-title>Biomaterials</full-title></periodical><edition>2008/10/11</edition><dates><year>2008</year><pub-dates><date>Oct 7</date></pub-dates></dates><isbn>1878-5905 (Electronic)</isbn><accession-num>18845334</accession-num><abstract>Porous Si is a nanostructured material that is of interest for molecular and cell-based biosensing, drug delivery, and tissue engineering applications. Surface chemistry is an important factor determining the stability of porous Si in aqueous media, its affinity for various biomolecular species, and its compatibility with tissues. In this study, the attachment and viability of a primary cell type to porous Si samples containing various surface chemistries is reported, and the ability of the porous Si films to retain their optical reflectivity properties relevant to molecular biosensing is assessed. Four chemical species grafted to the porous Si surface are studied: silicon oxide (via ozone oxidation), dodecyl (via hydrosilylation with dodecene), undecanoic acid (via hydrosilylation with undecylenic acid), and oligo(ethylene) glycol (via hydrosilylation with undecylenic acid followed by an oligo(ethylene) glycol coupling reaction). Fourier Transform Infrared (FTIR) spectroscopy and contact angle measurements are used to characterize the surface. Adhesion and short-term viability of primary rat hepatocytes on these surfaces, with and without pre-adsorption of collagen type I, are assessed using vital dyes (calcein-AM and ethidium homodimer I). Cell viability on undecanoic acid-terminated porous Si, oxide-terminated porous Si, and oxide-terminated flat (non-porous) Si are monitored by quantification of albumin production over the course of 8 days. The stability of porous Si thin films after 8 days in cell culture is probed by measuring the optical interferometric reflectance spectra. Results show that hepatocytes adhere better to surfaces coated with collagen, and that chemical modification does not exert a deleterious effect on primary rat hepatocytes. The hydrosilylation chemistry greatly improves the stability of porous Si in contact with cultured primary cells while allowing cell coverage levels comparable to standard culture preparations on tissue culture polystyrene.</abstract><notes>Biomaterials&#xD;Biomaterials. 2008 Oct 7.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom3>2008</custom3><custom4>7.325</custom4><electronic-resource-num>S0142-9612(08)00676-5 [pii]&#xD;10.1016/j.biomaterials.2008.09.005 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1840</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1840</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yu-Su, S. Y.</author><author>Thomas, D. R.</author><author>Alford, J. E.</author><author>LaRue, I.</author><author>Pitsikalis, M.</author><author>Hadjichristidis, N.</author><author>DeSimone, J. M.</author><author>Dobrynin, A. V.</author><author>Sheiko, S. S.</author></authors></contributors><auth-address>Department of Chemistry, Caudill and Kenan Laboratories, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Molding block copolymer micelles: a framework for molding of discrete objects on surfaces</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>12671-9</pages><volume>24</volume><number>21</number><edition>2008/10/10</edition><dates><year>2008</year><pub-dates><date>Nov 4</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>18841925</accession-num><abstract>Soft lithography based on photocurable perfluoropolyether (PFPE) was used to mold and replicate poly(styrene-b-isoprene) block-copolymer micelles within a broad range of shapes and sizes including spheres, cylinders, and torroids. These physically assembled nanoparticles were first formed in a selective solvent for one block then deposited onto substrates having various surface energies in an effort to minimize the deformation of the micelles due to attractive surface forces. The successful molding of these delicate nanoparticles underscores two advantages of PFPE as a molding material. First, it allows one to minimize particle deformation due to adsorption by using low energy substrates. Second, PFPE is not miscible with the organic micelles and thus prevents their dissociation. For spherical PS-b-PI micelles, a threshold value of the substrate surface energy for the mold to lift-off cleanly, that is, the particles remain adhered to the substrate after mold removal was determined to be around gamma congruent with 54 mJ/m2. For substrates with higher surface energies (&gt;54 mJ/m2), the micelles undergo flattening which increase the contact area and thus facilitate molding, although at the expense of particle deformation. The results are consistent with theoretical predictions of a molding range for substrate surface energies, which depends on the size, shape, and mechanical properties of the particles. In a similar fashion, cylindrical PS-b-PI micelles remain on the substrate at surface energies gamma&gt;or=54 mJ/m2 after a mold removal. However, cylindrical micelles behaved differently at lower surface energies. These micelles ruptured due to their inability to slide on the surfaces during mold lift-off. Thus, the successful molding of extended objects is attainable only when the particle is adsorbed on higher energy substrates where deformation can still be kept at a minimum by using stronger materials such as carbon nanotubes for the master.</abstract><notes>Yu-Su, Sherryl Y&#xD;Thomas, David R&#xD;Alford, Jonathan E&#xD;LaRue, Isaac&#xD;Pitsikalis, Marinos&#xD;Hadjichristidis, Nikos&#xD;DeSimone, Joseph M&#xD;Dobrynin, Andrey V&#xD;Sheiko, Sergei S&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2008 Nov 4;24(21):12671-9. Epub 2008 Oct 8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18841925</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>4.347</custom4><electronic-resource-num>10.1021/la802549s</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2023</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2023</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lijowski, M.</author><author>Caruthers, S.</author><author>Hu, G.</author><author>Zhang, H.</author><author>Scott, M. J.</author><author>Williams, T.</author><author>Erpelding, T.</author><author>Schmieder, A. H.</author><author>Kiefer, G.</author><author>Gulyas, G.</author><author>Athey, P. S.</author><author>Gaffney, P. J.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Washington University Medical School, St Louis, MO 63108, USA.</auth-address><titles><title>High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model</title><secondary-title>Invest Radiol</secondary-title></titles><periodical><full-title>Invest Radiol</full-title></periodical><pages>15-22</pages><volume>44</volume><number>1</number><edition>2008/10/07</edition><keywords><keyword>Animals</keyword><keyword>Disease Models, Animal</keyword><keyword>Humans</keyword><keyword>Image Enhancement/methods</keyword><keyword>Integrin alphaVbeta3/metabolism</keyword><keyword>Magnetic Resonance Imaging/ methods</keyword><keyword>Molecular Probe Techniques</keyword><keyword>Nanoparticles/diagnostic use</keyword><keyword>Neoplasms, Experimental/blood supply/ diagnosis/ metabolism</keyword><keyword>Neovascularization, Pathologic/ diagnosis/ metabolism</keyword><keyword>Rabbits</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Tomography, Emission-Computed, Single-Photon/ methods</keyword><keyword>Tomography, X-Ray Computed/ methods</keyword></keywords><dates><year>2009</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1536-0210 (Electronic)</isbn><accession-num>18836386</accession-num><abstract>OBJECTIVES: The use of antiangiogenic therapy in conjunction with traditional chemotherapy is becoming increasingly in cancer management, but the optimal benefit of these targeted pharmaceuticals has been limited to a subset of the population treated. Improved imaging probes that permit sensitive detection and high-resolution characterization of tumor angiogenesis could improve patient risk-benefit stratification. The overarching objective of these experiments was to develop a dual modality alpha(nu)beta3-targeted nanoparticle molecular imaging agent that affords sensitive nuclear detection in conjunction with high-resolution MR characterization of tumor angiogenesis. MATERIALS AND METHODS: In part 1, New Zealand white rabbits (n = 21) bearing 14d Vx2 tumor received either alpha(nu)beta3-targeted 99mTc nanoparticles at doses of 11, 22, or 44 MBq/kg, nontargeted 99mTc nanoparticles at 22 MBq/kg, or alpha(nu)beta3-targeted 99mTc nanoparticles (22 MBq/kg) competitively inhibited with unlabeled alpha(nu)beta3-nanoparticles. All animals were imaged dynamically over 2 hours with a planar camera using a pinhole collimator. In part 2, the effectiveness of alpha(nu)beta3-targeted 99mTc nanoparticles in the Vx2 rabbit model was demonstrated using clinical SPECT-CT imaging techniques. Next, MR functionality was incorporated into alpha(nu)beta3-targeted 99mTc nanoparticles by inclusion of lipophilic gadolinium chelates into the outer phospholipid layer, and the concept of high sensitivity - high-resolution detection and characterization of tumor angiogenesis was shown using sequential SPECT-CT and MR molecular imaging with 3D neovascular mapping. RESULTS: alpha(nu)beta3-Targeted 99mTc nanoparticles at 22 MBq/kg produced the highest tumor-to-muscle contrast ratio (8.56 +/- 0.13, TMR) versus the 11 MBq/kg (7.32 +/- 0.12) and 44 MBq/kg (6.55 +/- 0.07) doses, (P &lt; 0.05). TMR of nontargeted particles at 22.2 MBq/kg (5.48 +/- 0.09) was less (P &lt; 0.05) than the equivalent dosage of alpha(nu)beta3-targeted 99mTc nanoparticles. Competitively inhibition of 99mTc alpha(nu)beta3-integrin-targeted nanoparticles at 22.2 MBq/kg reduced (P &lt; 0.05) TMR (5.31 +/- 0.06) to the nontargeted control contrast level. Multislice CT imaging could not distinguish the presence of Vx2 tumor implanted in the popliteal fossa from lymph nodes in the same fossa or in the contralateral leg. However, the use of 99mTc alpha(nu)beta3-nanoparticles with SPECT-CT produced a clear neovasculature signal from the tumor that was absent in the nonimplanted hind leg. Using alpha(nu)beta3-targeted 99mTc-gadolinium nanoparticles, the sensitive detection of the Vx2 tumor was extended to allow MR molecular imaging and 3D mapping of angiogenesis in the small tumor, revealing an asymmetrically distributed, patchy neovasculature along the periphery of the cancer. CONCLUSION: Dual modality molecular imaging with alpha(nu)beta3-targeted 99mTc-gadolinium nanoparticles can afford highly sensitive and specific localization of tumor angiogenesis, which can be further characterized with high-resolution MR neovascular mapping, which may predict responsiveness to antiangiogenic therapy.</abstract><notes>Lijowski, Michal&#xD;Caruthers, Shelton&#xD;Hu, Grace&#xD;Zhang, Huiying&#xD;Scott, Michael J&#xD;Williams, Todd&#xD;Erpelding, Todd&#xD;Schmieder, Anne H&#xD;Kiefer, Garry&#xD;Gulyas, Gyongyi&#xD;Athey, Phillip S&#xD;Gaffney, Patrick J&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;EB-01704/EB/NIBIB NIH HHS/United States&#xD;HL-73646/HL/NHLBI NIH HHS/United States&#xD;HL-78631/HL/NHLBI NIH HHS/United States&#xD;N01-CO-27031-16/CO/NCI NIH HHS/United States&#xD;N01-CO-37007/CO/NCI NIH HHS/United States&#xD;R01 HL078631-01/HL/NHLBI NIH HHS/United States&#xD;R01 HL078631-02/HL/NHLBI NIH HHS/United States&#xD;R01 HL078631-03/HL/NHLBI NIH HHS/United States&#xD;R01 HL078631-04/HL/NHLBI NIH HHS/United States&#xD;R01 NS059302-01/NS/NINDS NIH HHS/United States&#xD;R01 NS059302-02/NS/NINDS NIH HHS/United States&#xD;U54 CA119342-040001/CA/NCI NIH HHS/United States&#xD;U54 CA136398-010003/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Investigative radiology&#xD;Invest Radiol. 2009 Jan;44(1):15-22.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom2>2703786</custom2><custom3>NIHMS118914</custom3><custom4>4.115</custom4><electronic-resource-num>10.1097/RLI.0b013e31818935eb [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1841</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1841</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hu, Z.</author><author>Chen, L.</author><author>Betts, D. E.</author><author>Pandya, A.</author><author>Hillmyer, M. A.</author><author>DeSimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Optically transparent, amphiphilic networks based on blends of perfluoropolyethers and poly(ethylene glycol)</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>14244-52</pages><volume>130</volume><number>43</number><edition>2008/10/07</edition><dates><year>2008</year><pub-dates><date>Oct 29</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18834196</accession-num><abstract>Amphiphilic networks of perfluoropolyethers (PFPE) and poly(ethylene glycol) (PEG) have been achieved to yield optically transparent, mechanically robust films over a wide range of compositions. Telechelic diols of these oligomers were transformed to a photocurable dimethacryloxy form (DMA) and free radically cured at various composition weight ratios to yield free-standing films. Clear and colorless amphiphilic networks could be achieved when low molar mass versions of both the PFPE-DMA (1 kg/mol) and the PEG-DMA (550 g/mol) were used. The bulk morphologies of the samples were extensively characterized by a variety of techniques including ultraviolet-visible spectroscopy, differential scanning calorimetry, dynamic mechanic thermal analysis, small-angle X-ray scattering, atomic force microscopy, X-ray photoelectron spectroscopy, and optical microscopy, which strongly suggest that nanoscopic to macroscopic phase-separated materials could be achieved. By incorporating a threshold amount of PFPEs into PEG-based hydrogel networks, water swelling could be significantly reduced, which may offer a new strategy for a number of medical device applications. Along these lines, strong inhibition of nonspecific protein adsorption could be achieved with these amphiphilic network materials compared with an oligo(ethylene glycol)-based self-assembled monolayer coated surface.</abstract><notes>Hu, Zhaokang&#xD;Chen, Liang&#xD;Betts, Douglas E&#xD;Pandya, Ashish&#xD;Hillmyer, Marc A&#xD;DeSimone, Joseph M&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Oct 29;130(43):14244-52. Epub 2008 Oct 4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18834196</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja803991n</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1311</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1311</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Karmali, P. P.</author><author>Kotamraju, V. R.</author><author>Kastantin, M.</author><author>Black, M.</author><author>Missirlis, D.</author><author>Tirrell, M.</author><author>Ruoslahti, E.</author></authors></contributors><auth-address>Vascular Mapping Center, Burnham Institute for Medical Research at UCSB, University of California, Santa Barbara, California 93106-9610, USA.</auth-address><titles><title>Targeting of albumin-embedded paclitaxel nanoparticles to tumors</title><secondary-title>Nanomedicine</secondary-title></titles><periodical><full-title>Nanomedicine</full-title></periodical><pages>73-82</pages><volume>5</volume><number>1</number><edition>2008/10/03</edition><keywords><keyword>Albumins/administration &amp; dosage/therapeutic use</keyword><keyword>Animals</keyword><keyword>Breast Neoplasms/*drug therapy/pathology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Drug Carriers/administration &amp; dosage/chemistry</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Nanoparticles/*administration &amp; dosage/*therapeutic use</keyword><keyword>Paclitaxel/*administration &amp; dosage/*therapeutic use</keyword><keyword>Peptides/administration &amp; dosage/chemistry</keyword></keywords><dates><year>2009</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1549-9642 (Electronic)</isbn><accession-num>18829396</accession-num><abstract>We have used tumor-homing peptides to target abraxane, a clinically approved paclitaxel-albumin nanoparticle, to tumors in mice. The targeting was accomplished with two peptides, CREKA and LyP-1 (CGNKRTRGC). Fluorescein (FAM)-labeled CREKA-abraxane, when injected intravenously into mice bearing MDA-MB-435 human cancer xenografts, accumulated in tumor blood vessels, forming aggregates that contained red blood cells and fibrin. FAM-LyP-1-abraxane co-localized with extravascular islands expressing its receptor, p32. Self-assembled mixed micelles carrying the homing peptide and the label on different subunits accumulated in the same areas of tumors as LyP-1-abraxane, showing that Lyp-1 can deliver intact nanoparticles into extravascular sites. Untargeted, FAM-abraxane was detected in the form of a faint meshwork in tumor interstitium. LyP-1-abraxane produced a statistically highly significant inhibition of tumor growth compared with untargeted abraxane. These results show that nanoparticles can be effectively targeted into extravascular tumor tissue and that targeting can enhance the activity of a therapeutic nanoparticle.</abstract><notes>Karmali, Priya Prakash&#xD;Kotamraju, Venkata Ramana&#xD;Kastantin, Mark&#xD;Black, Matthew&#xD;Missirlis, Dimitris&#xD;Tirrell, Matthew&#xD;Ruoslahti, Erkki&#xD;CA104898/CA/NCI NIH HHS/United States&#xD;CA115410/CA/NCI NIH HHS/United States&#xD;CA124427/CA/NCI NIH HHS/United States&#xD;CA19335/CA/NCI NIH HHS/United States&#xD;HL080718/HL/NHLBI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nanomedicine : nanotechnology, biology, and medicine&#xD;Nanomedicine. 2009 Mar;5(1):73-82. Epub 2008 Oct 1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18829396</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>6.093</custom4><electronic-resource-num>S1549-9634(08)00124-X [pii]&#xD;10.1016/j.nano.2008.07.007</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2096</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2096</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cao, Q.</author><author>Cai, W.</author><author>Niu, G.</author><author>He, L.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA 94305, USA.</auth-address><titles><title>Multimodality imaging of IL-18--binding protein-Fc therapy of experimental lung metastasis</title><secondary-title>Clin Cancer Res</secondary-title></titles><periodical><full-title>Clin Cancer Res</full-title></periodical><pages>6137-45</pages><volume>14</volume><number>19</number><edition>2008/10/03</edition><keywords><keyword>Animals</keyword><keyword>Breast Neoplasms</keyword><keyword>Cell Line, Tumor</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Female</keyword><keyword>Immunoglobulin Fc Fragments/ chemistry/metabolism</keyword><keyword>Immunotherapy/ methods</keyword><keyword>Intercellular Signaling Peptides and Proteins/ chemistry/metabolism</keyword><keyword>Interleukin-18/ chemistry/metabolism</keyword><keyword>Lung Neoplasms/ pathology/ therapy</keyword><keyword>Melanoma, Experimental</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Positron-Emission Tomography/methods</keyword><keyword>Tomography, X-Ray Computed/methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Oct 1</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>18829492</accession-num><abstract>PURPOSE: Interleukin (IL)-18 plays important roles in cancer progression and metastasis. The goal of this study is to identify cell lines that are most sensitive to stand alone IL-18-binding protein (IL-18bp)-Fc treatment, to study the pharmacokinetics and tumor targeting efficiency of IL-18bp-Fc, and to evaluate the efficacy of IL-18bp-Fc in treating breast cancer experimental lung metastasis by multimodality imaging. EXPERIMENTAL DESIGN: Reverse transcription-PCR, ELISA, and other cell-based assays were done on murine 4T1, CT-26, and B16F10 cells. The most IL-18bp-Fc-sensitive 4T1 cells were stably transfected with firefly luciferase (fLuc) and injected i.v. into female BALB/C mice to establish the experimental lung metastasis model. Tumor targeting efficiency and pharmacokinetics of IL-18bp-Fc was assessed by (64)Cu-DOTA-IL-18bp-Fc positron emission tomography (PET) and biodistribution studies. Two groups of fLuc-4T1 experimental lung metastasis tumor-bearing mice were each given saline or IL-18bp-Fc (1 mg/kg) daily i.p. Bioluminescence imaging, (18)F-FDG PET, and computed tomography scans were done to evaluate the treatment efficacy. Ex vivo experiments were also carried out to validate the imaging results. RESULTS: IL-18bp-Fc had high and specific accumulation in the fLuc-4T1 lung metastasis tumor as evidenced by both PET and biodistribution studies. Bioluminescence imaging, (18)F-FDG PET, and computed tomography scans all revealed that IL-18bp-Fc treatment was effective in inhibiting the lung metastasis tumor progression, validated by ex vivo examination of the lung. CONCLUSIONS: IL-18bp-Fc therapy can inhibit 4T1 breast cancer experimental lung metastasis. Noninvasive multimodality molecular imaging is a powerful tool for evaluating the tumor targeting efficiency/pharmacokinetics of the drug and effective monitoring of the therapeutic response.</abstract><notes>Cao, Qizhen&#xD;Cai, Weibo&#xD;Niu, Gang&#xD;He, Lina&#xD;Chen, Xiaoyuan&#xD;P50 CA 114747/CA/NCI NIH HHS/United States&#xD;R01 CA 119053/CA/NCI NIH HHS/United States&#xD;R21 CA 102123/CA/NCI NIH HHS/United States&#xD;R21 CA 121842/CA/NCI NIH HHS/United States&#xD;R24 CA 93862/CA/NCI NIH HHS/United States&#xD;U54 CA 119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 Oct 1;14(19):6137-45.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.646</custom4><electronic-resource-num>14/19/6137 [pii]&#xD;10.1158/1078-0432.CCR-08-0049 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2440</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2440</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, Sheng</author><author>Wei, Yaguang</author><author>Liu, Jin</author><author>Yang, Rusen</author><author>Wang, Zhong Lin</author></authors></contributors><titles><title>Integrated Multilayer Nanogenerator Fabricated Using Paired Nanotip-to-Nanowire Brushes</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>4027-4032</pages><volume>8</volume><number>11</number><edition>2008/10</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>1530-6984</isbn><notes>doi: 10.1021/nl8027813</notes><urls><related-urls><url>http://dx.doi.org/10.1021/nl8027813</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>12.189</custom4><electronic-resource-num>10.1021/nl8027813</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2441</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2441</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, Sheng</author><author>Wei, Yaguang</author><author>Kirkham, Melanie</author><author>Liu, Jin</author><author>Mai, Wenjie</author><author>Davidovic, Dragomir</author><author>Snyder, Robert L.</author><author>Wang, Zhong Lin</author></authors></contributors><titles><title>Patterned Growth of Vertically Aligned ZnO Nanowire Arrays on Inorganic Substrates at Low Temperature without Catalyst</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>14958-14959</pages><volume>130</volume><number>45</number><edition>2008/10</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>0002-7863</isbn><notes>doi: 10.1021/ja806952j</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ja806952j</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja806952j</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1707</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1707</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, Y.</author><author>Giam, L. R.</author><author>Park, M.</author><author>Lenhert, S.</author><author>Fuchs, H.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>A self-correcting inking strategy for cantilever arrays addressed by an inkjet printer and used for dip-pen nanolithography</title><secondary-title>Small</secondary-title><alt-title>Small (Weinheim an der Bergstrasse, Germany)</alt-title></titles><periodical><full-title>Small</full-title></periodical><pages>1666-70</pages><volume>4</volume><number>10</number><edition>2008/10</edition><keywords><keyword>Anisotropy</keyword><keyword>Fluorescence</keyword><keyword>Hydrophobicity</keyword><keyword>*Ink</keyword><keyword>Nanotechnology/*instrumentation</keyword><keyword>Phospholipids/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>18654990</accession-num><notes>Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18654990 </url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>7.292</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2511</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2511</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dingxin Wang</author><author>Sumeet Virmani</author><author>Richard Tang</author><author>Barbara Szolc-Kowalska</author><author>Gayle Woloschak</author><author>Reed A. Omary</author><author>Andrew C. Larson</author></authors></contributors><auth-address>Department of Radiology, Northwestern University, Chicago, Illinois, USA; Department of Biomedical Engineering, Northwestern University, Chicago, Illinois, USA; Department of Radiation Oncology, Northwestern University, Chicago, Illinois, USA; Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA</auth-address><titles><title>Four-dimensional transcatheter intraarterial perfusion (TRIP)-MRI for monitoring liver tumor embolization in VX2 rabbits</title><secondary-title>Magnetic Resonance in Medicine</secondary-title></titles><periodical><full-title>Magnetic Resonance in Medicine</full-title></periodical><pages>970-975</pages><volume>60</volume><number>4</number><edition>2008/10</edition><dates><year>2008</year></dates><isbn>1522-2594</isbn><notes>10.1002/mrm.21678</notes><urls><related-urls><url>http://dx.doi.org/10.1002/mrm.21678</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.163</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2510</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2510</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Virmani, Sumeet</author><author>Rhee, Thomas K.</author><author>Ryu, Robert K.</author><author>Sato, Kent T.</author><author>Lewandowski, Robert J.</author><author>Mulcahy, Mary F.</author><author>Kulik, Laura M.</author><author>Szolc-Kowalska, Barbara</author><author>Woloschak, Gayle E.</author><author>Yang, Guang-Yu</author><author>Salem, Riad</author><author>Larson, Andrew C.</author><author>Omary, Reed A.</author></authors></contributors><titles><title>Comparison of Hypoxia-inducible Factor-1[alpha] Expression before and after Transcatheter Arterial Embolization in Rabbit VX2 Liver Tumors</title><secondary-title>Journal of Vascular and Interventional Radiology</secondary-title></titles><periodical><full-title>Journal of Vascular and Interventional Radiology</full-title></periodical><pages>1483-1489</pages><volume>19</volume><number>10</number><edition>2008/10</edition><dates><year>2008</year></dates><isbn>1051-0443</isbn><notes>doi: DOI: 10.1016/j.jvir.2008.06.017</notes><urls><related-urls><url>http://www.sciencedirect.com/science/article/B8CX3-4THST16-7/2/94caecb00d04e939564ddb97755783b0</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>2.956</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2502</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2502</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stepp, Brian R.</author><author>Gibbs-Davis, Julianne M.</author><author>Koh, Dorothea L. F.</author><author>Nguyen, SonBinh T.</author></authors></contributors><titles><title>Cooperative Melting in Caged Dimers of Rigid Small Molecule-DNA Hybrids</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>9628-9629</pages><volume>130</volume><number>30</number><edition>2008/10</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>0002-7863</isbn><notes>doi: 10.1021/ja801572n</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ja801572n</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja801572n</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1503</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1503</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Peng, X. H.</author><author>Qian, X. M.</author><author>Mao, H.</author><author>Wang, A. Y.</author><author>Chen, Z.</author><author>Nie, S. M.</author><author>Shin, D. M.</author></authors></contributors><auth-address>Shin, DM&#xD;Emory Univ, Winship Canc Inst, Sch Med, Room 3090,1365-C Clifton Rd, Atlanta, GA 30322 USA&#xD;Emory Univ, Winship Canc Inst, Sch Med, Atlanta, GA 30322 USA&#xD;Emory Univ, Sch Med, Dept Med Hematol Oncol, Atlanta, GA 30322 USA&#xD;Emory Univ, Sch Med, Dept Biomed Engn, Atlanta, GA 30322 USA&#xD;Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA</auth-address><titles><title>Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy</title><secondary-title>International Journal of Nanomedicine</secondary-title></titles><periodical><full-title>International Journal of Nanomedicine</full-title></periodical><pages>311-321</pages><volume>3</volume><number>3</number><edition>2008/10</edition><keywords><keyword>iron oxide nanoparticles</keyword><keyword>tumor imaging</keyword><keyword>mri</keyword><keyword>therapy</keyword><keyword>resonance contrast agents</keyword><keyword>in-vivo</keyword><keyword>intracellular uptake</keyword><keyword>cancer-therapy</keyword><keyword>drug-delivery</keyword><keyword>breast-cancer</keyword><keyword>superparamagnetic nanoparticles</keyword><keyword>biomedical applications</keyword><keyword>surface modification</keyword><keyword>polymeric micelles</keyword></keywords><dates><year>2008</year></dates><isbn>1176-9114</isbn><accession-num>ISI:000260478900003</accession-num><abstract>Magnetic iron oxide (IO) nanoparticles with a long blood retention time, biodegradability and low toxicity have emerged as one of the primary nanomaterials for biomedical applications in vitro and in vivo. IO nanoparticles have a large surface area and can be engineered to provide a large number of functional groups for cross-linking to tumor-targeting ligands such as monoclonal antibodies, peptides, or small molecules for diagnostic imaging or delivery of therapeutic agents. IO nanoparticles possess unique paramagnetic properties, which generate significant susceptibility effects resulting in strong T-2 and T-2* contrast, as well as T-1 effects at very low concentrations for magnetic resonance imaging (MRI), which is widely used for clinical oncology imaging. We review recent advances in the development of targeted IO nanoparticles for tumor imaging and therapy.</abstract><notes>366KE&#xD;Times Cited:0&#xD;Cited References Count:87</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000260478900003</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>1.649</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2486</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2486</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Major, Jody L.</author><author>Boiteau, Rene M.</author><author>Meade, Thomas J.</author></authors></contributors><titles><title>Mechanisms of ZnII-Activated Magnetic Resonance Imaging Agents</title><secondary-title>Inorganic Chemistry</secondary-title></titles><periodical><full-title>Inorganic Chemistry</full-title></periodical><pages>10788-10795</pages><volume>47</volume><number>22</number><edition>2008/10</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>0020-1669</isbn><notes>doi: 10.1021/ic801458u</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ic801458u</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.215</custom4><electronic-resource-num>10.1021/ic801458u</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1412</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1412</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z. A.</author><author>Li, X. L.</author><author>Tabakman, S. M.</author><author>Jiang, K. L.</author><author>Fan, S. S.</author><author>Dai, H. J.</author></authors></contributors><auth-address>Dai, HJ&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA&#xD;Tsinghua Univ, Dept Phys, Beijing 100084, Peoples R China&#xD;Stanford Univ, Tsinghua Foxconn Nanotechnol Res Ctr, Stanford, CA 94305 USA</auth-address><titles><title>Multiplexed multicolor Raman imaging of live cells with isotopically modified single walled carbon nanotubes</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>13540-+</pages><volume>130</volume><number>41</number><edition>2008/10</edition><keywords><keyword>spectroscopy</keyword><keyword>transporters</keyword><keyword>cancer</keyword><keyword>mice</keyword><keyword>delivery</keyword><keyword>targets</keyword></keywords><dates><year>2008</year><pub-dates><date>Oct 15</date></pub-dates></dates><isbn>0002-7863</isbn><accession-num>ISI:000259924000017</accession-num><abstract>We show that single walled carbon nanotubes (SWNTs) with different isotope compositions exhibit distinct Raman G-band peaks and can be used for multiplexed multicolor Raman imaging of biological systems. Cancer cells with specific receptors are selectively labeled with three differently &quot;colored&quot; SWNTs conjugated with various targeting ligands including Herceptin (anti-Her2), Erbitux (anti-Her1), and RGD peptide, allowing for multicolor Raman imaging of cells in a multiplexed manner. SWNT Raman signals are highly robust against photobleaching, allowing long-term imaging and tracking. With narrow peak features, SWNT Raman signals are easily differentiated from the autofluorescence background. The SWNT Raman excitation and scattering photons are in the near-infrared region, which is the most transparent optical window for biological systems in vitro and in vivo. Thus, SWNTs are novel Raman tags promising for multiplexed biological detection and imaging.</abstract><notes>358NK&#xD;Times Cited:1&#xD;Cited References Count:23</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000259924000017</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom4>8.256</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1305</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1305</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kairdolf, B. A.</author><author>Smith, A. M.</author><author>Nie, S.</author></authors></contributors><auth-address>Nie, S&#xD;Emory Univ, Dept Biomed Engn, 101 Woodruff Circle,Suite 2001, Atlanta, GA 30322 USA&#xD;Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA&#xD;Emory Univ, Dept Chem, Atlanta, GA 30322 USA&#xD;Georgia Inst Technol, Atlanta, GA 30322 USA</auth-address><titles><title>One-pot synthesis, encapsulation, and solubilization of size-tuned quantum dots with amphiphilic multidentate ligands</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>12866-+</pages><volume>130</volume><number>39</number><edition>2008/10</edition><keywords><keyword>high-quality cdte</keyword><keyword>semiconductor nanocrystals</keyword><keyword>microwave irradiation</keyword><keyword>shell</keyword><keyword>cdse</keyword></keywords><dates><year>2008</year><pub-dates><date>Oct 1</date></pub-dates></dates><isbn>0002-7863</isbn><accession-num>ISI:000259553700015</accession-num><abstract>We report one-pot synthesis, encapsulation, and solubilization of high-quality quantum dots (QDs) based on the use of amphiphilic and multidentate polymer ligands. In this &quot;all-in-one&quot; procedure, the resulting QDs are first capped by the multidentate ligand and are then spontaneously encapsulated and solubilized by a second layer of the same multidentate polymer upon exposure to water. In addition to providing better control of nanocrystal nucleation and growth kinetics (including resistance to Ostwald ripening), this procedure allows for in situ growth of an inorganic passivating shell on the nanocrystal core, enabling one-pot synthesis of both type-I and type-II core-shell QDs with tunable light emission from visible to near-infrared wavelengths.</abstract><notes>353GI&#xD;Times Cited:0&#xD;Cited References Count:24</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000259553700015</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>8.256</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1283</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1283</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Il Seo, S.</author><author>Gera, L.</author><author>Zhau, H. E.</author><author>Qian, W. P.</author><author>Iqbal, S.</author><author>Johnson, N. A.</author><author>Zhang, S. M.</author><author>Zayzafoon, M.</author><author>Stewart, J.</author><author>Wang, R. X.</author><author>Chung, L. W. K.</author><author>Wu, D. Q.</author></authors></contributors><auth-address>Wu, Dq&#xD;Emory Univ, Sch Med, Mol Urol &amp; Therapeut Program, Dept Urol, 1365-B Clifton Rd,Suite 5100, Atlanta, GA 30322 USA&#xD;Emory Univ, Sch Med, Mol Urol &amp; Therapeut Program, Dept Urol, Atlanta, GA 30322 USA&#xD;Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA&#xD;Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea&#xD;Univ Colorado, Hlth Sci Ctr, Dept Biochem &amp; Mol Genet, Denver, CO USA&#xD;Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA</auth-address><titles><title>BKM1740, an Acyl-Tyrosine Bisphosphonate Amide Derivative, Inhibits the Bone Metastatic Growth of Human Prostate Cancer Cells by Inducing Apoptosis</title><secondary-title>Clinical Cancer Research</secondary-title></titles><periodical><full-title>Clinical Cancer Research</full-title></periodical><pages>6198-6206</pages><volume>14</volume><number>19</number><edition>2008/10</edition><keywords><keyword>bradykinin antagonist dimer</keyword><keyword>survivin expression</keyword><keyword>mesenchymal transition</keyword><keyword>zoledronic acid</keyword><keyword>in-vitro</keyword><keyword>microenvironment</keyword><keyword>progression</keyword><keyword>agents</keyword><keyword>lncap</keyword><keyword>chemotherapy</keyword></keywords><dates><year>2008</year><pub-dates><date>Oct 1</date></pub-dates></dates><isbn>1078-0432</isbn><accession-num>ISI:000260142500033</accession-num><abstract>Purpose: Survivin overexpression has been associated with an unfavorable outcome in human PCa; however, its role in metastasis remains elusive. We aim to (a) evaluate the clinical implications of survivin expression in PCa bone metastasis; (b) determine in vivo efficacy of BKM1740, a small-molecule compound, against PCa skeletal growth and survival; and (c) investigate molecular mechanism by which BKM1740 augments apoptosis in bone metastatic PCa cells.&#xD;Experimental Design: Survivin expression was analyzed in PCa specimens and experimental models. Bone metastatic C4-2 and ARCaP(M) cell lines were used to evaluate the in vitro effects of BKM1740 and molecular mechanism for the induction of apoptosis. C4-2 cells were grown intratibially in athymic nude mice to evaluate the in vivo efficacy of BKM1740. Tumor growth in mouse bone was assessed by serum prostate-specific antigen and radiography and confirmed by immunohistochemical analyses.&#xD;Results: Survivin expression is positively associated with clinical PCa bone metastasis. BKM1740 induced apoptosis in PCa cells by repressing survivin. Mice with established C4-2 tumors in tibia showed a marked decrease in serum prostate-specific antigen and much improved bone architecture radiographically after treatment with BKM1740. Immunohistochemical assays of mouse tumor samples confirmed that the in vivo effects were mediated by inhibition of survivin and induction of apoptosis.&#xD;Conclusions: Survivin expression is associated with PCa bone metastasis. BKM1740 treatment specifically inhibited survivin and induced apoptosis in vitro and was efficacious in retarding PCa skeletal growth in a mouse model. BKM1740 is a promising small-molecule compound that could be used to treat PCa bone metastasis.</abstract><notes>361QP&#xD;Times Cited:0&#xD;Cited References Count:48</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000260142500033</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>6.646</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2471</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2471</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hwang, Hyonseok</author><author>Schatz, George C.</author><author>Ratner, Mark A.</author></authors></contributors><titles><title>Coarse-Grained Molecular Dynamics Study of Cyclic Peptide Nanotube Insertion into a Lipid Bilayer</title><secondary-title>The Journal of Physical Chemistry A</secondary-title></titles><periodical><full-title>The Journal of Physical Chemistry A</full-title></periodical><pages>4780-4787</pages><volume>113</volume><number>16</number><edition>2008/10</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>1089-5639</isbn><notes>doi: 10.1021/jp8080657</notes><urls><related-urls><url>http://dx.doi.org/10.1021/jp8080657</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>2.889</custom4><electronic-resource-num>10.1021/jp8080657</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2521</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2521</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hughes, M.</author><author>Caruthers, S.</author><author>Trung, Tran</author><author>Marsh, J.</author><author>Wallace, K.</author><author>Cyrus, T.</author><author>Partlow, K.</author><author>Scott, M.</author><author>Lijowski, M.</author><author>Neubauer, A.</author><author>Winter, P.</author><author>Hu, G.</author><author>Zhang, Hyuing</author><author>McCarthy, J.</author><author>Maurizi, B.</author><author>Allen, J.</author><author>Caradine, C.</author><author>Neumann, R.</author><author>Arbeit, J.</author><author>Lanza, G.</author><author>Wickline, S.</author></authors></contributors><titles><title>Perfluorocarbon Nanoparticles for Molecular Imaging and Targeted Therapeutics</title><secondary-title>Proceedings of the Ieee</secondary-title></titles><periodical><full-title>Proceedings of the Ieee</full-title></periodical><pages>397-415</pages><volume>96</volume><number>3</number><edition>2008/10</edition><keywords><keyword>biomedical MRI</keyword><keyword>biomedical ultrasonics</keyword><keyword>cellular biophysics</keyword><keyword>drugs</keyword><keyword>molecular biophysics</keyword><keyword>nanoparticles</keyword><keyword>nanotechnology</keyword><keyword>organic compounds</keyword><keyword>patient treatment</keyword><keyword>single photon emission computed tomography</keyword><keyword>tumours</keyword><keyword>MRI</keyword><keyword>PET</keyword><keyword>SPECT</keyword><keyword>biological processes</keyword><keyword>drug delivery</keyword><keyword>gross anatomical description</keyword><keyword>magnetic resonance imaging</keyword><keyword>molecular imaging</keyword><keyword>noninvasive diagnostic imaging</keyword><keyword>nuclear imaging</keyword><keyword>perfluorocarbon nanoparticles</keyword><keyword>positron emission tomography</keyword><keyword>targeted therapeutics</keyword><keyword>tissue epitopes</keyword><keyword>ultrasound imaging</keyword><keyword>Contrast agent</keyword><keyword>multiplatform contrast agent</keyword><keyword>targeted contrast</keyword><keyword>tumor imaging</keyword></keywords><dates><year>2008</year></dates><isbn>0018-9219</isbn><urls></urls><custom1>CCNE - Siteman</custom1><custom4>10.228</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1251</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1251</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Henzie, J.</author><author>Lee, J.</author><author>Lee, M. H.</author><author>Hasan, W.</author><author>Odom, T. W.</author></authors></contributors><auth-address>Department of Chemistry and Materials Science and Engineering, Northwestern University, Evanston, Illinois 60208.</auth-address><titles><title>Nanofabrication of Plasmonic Structures</title><secondary-title>Annu Rev Phys Chem</secondary-title><alt-title>Annual review of physical chemistry</alt-title></titles><periodical><full-title>Annu Rev Phys Chem</full-title><abbr-1>Annual review of physical chemistry</abbr-1></periodical><alt-periodical><full-title>Annu Rev Phys Chem</full-title><abbr-1>Annual review of physical chemistry</abbr-1></alt-periodical><edition>2008/10</edition><dates><year>2008</year><pub-dates><date>Oct 17</date></pub-dates></dates><isbn>0066-426X (Print)</isbn><accession-num>18928404</accession-num><abstract>This review focuses on nanofabrication tools, based on soft lithography, which can generate a wide range of noble-metal structures with exceptional optical properties. These techniques offer a scalable and practical approach for producing arrays of complementary plasmonic structures (nanoholes and nanoparticles) and, in addition, expand the possible architectures of plasmonic materials because the metal building blocks can be organized over multiple length scales. We describe the preparation and characterization of five different systems: subwavelength nanohole arrays, finite arrays of nanoholes, microscale arrays of nanoholes, multiscale arrays of nanoparticles, and pyramidal particles. We also discuss how the surface plasmon resonances of these structures can be tuned across visible and near-infrared wavelengths by varying different parameters. Applications and future prospects of these nanostructured metals are addressed. Expected final online publication date for the Annual Review of Physical Chemistry Volume 60 is March 31, 2009. Please see http://www.annualreviews.org/catalog/pubdates.aspx for revised estimates.</abstract><notes>Journal article</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18928404 </url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>13.679</custom4><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2541</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2541</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Garanger, Elisabeth</author><author>Aikawa, Elena</author><author>Reynolds, Fred</author><author>Weissleder, Ralph</author><author>Josephson, Lee</author></authors></contributors><titles><title>Simplified syntheses of complex multifunctional nanomaterials</title><secondary-title>Chemical Communications</secondary-title></titles><periodical><full-title>Chemical Communications</full-title></periodical><pages>4792-4794</pages><number>39</number><edition>2008/10</edition><dates><year>2008</year></dates><abstract>Multifunctional probes are synthesized in a single step using peptide scaffold-based multifunctional single-attachment-point (MSAP) reagents.</abstract><notes>10.1039/b809537j</notes><urls><related-urls><url>http://dx.doi.org/10.1039/b809537j</url></related-urls></urls><custom1>CCNE - MIT</custom1><custom4>3.684</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1192</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1192</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Endres, P. J.</author><author>MacRenaris, K. W.</author><author>Vogt, S.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Meade, TJ&#xD;Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Chem, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Biochem, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Mol &amp; Cell Biol, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Neurobiol &amp; Physiol, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Radiol, Evanston, IL 60208 USA&#xD;Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA</auth-address><titles><title>Cell-Permeable MR Contrast Agents with Increased Intracellular Retention</title><secondary-title>Bioconjugate Chemistry</secondary-title></titles><periodical><full-title>Bioconjugate Chemistry</full-title></periodical><pages>2049-2059</pages><volume>19</volume><number>10</number><edition>2008/10</edition><keywords><keyword>x-ray-fluorescence</keyword><keyword>arginine-rich peptides</keyword><keyword>gd(iii) complexes</keyword><keyword>nmr</keyword><keyword>glutathione</keyword><keyword>visualization</keyword><keyword>liposomes</keyword><keyword>delivery</keyword><keyword>luminescence</keyword><keyword>mechanisms</keyword></keywords><dates><year>2008</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1043-1802</isbn><accession-num>ISI:000260108400014</accession-num><abstract>Magnetic resonance imaging (MRI) is a technique used in both clinical and experimental settings to produce hi.-h-resolution images of opaque organisms without ionizing radiation. Currently, MR imaging is augmented by contrast agents, and the vast majority these small molecule Gd(III) chelates are confined to the extracellular regions. As a result, contrast agents are confined to vascular regions reducing their ability to provide information about cell physiology or molecular pathology. We have shown that polypeptides of arginine have the capacity to transport Gd(III) contrast agents across cell membranes. However, this transport is not unidirectional, and once inside the cell, the arginine-modified contrast agents efflux rapidly, decreasing the intracellular Gd(III) concentration and corresponding MR image intensity. By exploiting the inherent disulfide reducing environment of cells, thiol compounds. Gd(III)-DOTA-SS-Arg(8) and Gd(III)-DTPA-SS-Arg(8), are cleaved from their cell-penetrating peptide transduction domains upon cell internalization. This reaction prolongs the cell-associated lifetime of the chelated Gd(III) by cleaving it from the cell transduction domain.</abstract><notes>361DT&#xD;Times Cited:0&#xD;Cited References Count:50</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000260108400014</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.802</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1077</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1077</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Barrett, D. G.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Yousaf, MN&#xD;Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA</auth-address><titles><title>Poly(triol alpha-ketoglutarate) as biodegradable, chemoselective, and mechanically tunable elastomers</title><secondary-title>Macromolecules</secondary-title></titles><periodical><full-title>Macromolecules</full-title></periodical><pages>6347-6352</pages><volume>41</volume><number>17</number><edition>2008/10</edition><keywords><keyword>ring-opening polymerization</keyword><keyword>aliphatic polyesters</keyword><keyword>surfaces</keyword><keyword>ligands</keyword><keyword>biosynthesis</keyword><keyword>copolymers</keyword><keyword>scaffolds</keyword><keyword>chemistry</keyword><keyword>strategy</keyword><keyword>delivery</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep 9</date></pub-dates></dates><isbn>0024-9297</isbn><accession-num>ISI:000258909000015</accession-num><abstract>We report the design of several elastomers based on the thermal polycondensation of alpha-ketoglutaric acid and one of three triols: glycerol, 1,2,4-butanetriol, or 1,2,6-hexanetriol. By varying the curing temperature and the duration of the curing process, a wide range of mechanical properties was achieved. The values of the Young&apos;s modulus (0.1 - 657.4 MPa), ultimate stress (0.2 - 30.8 MPa), and ultimate strain (22 - 583%) encompass the mechanical properties of many biological materials, increasing the probability of success for the use of poly(triol alpha-ketoglutarate) as a biomaterial. Furthermore, the poly(triol alpha-ketoglutarate) series hydrolytically degraded in as fast as 2 days and as long as 28 days in phosphate-buffered saline solutions. For postpolymerization modifications, the repeat units contain ketones, which are capable of reacting with a variety of oxyamine--terminated molecules to generate stable oxime linkages. Finally, the versatility and utility of these elastomers were demonstrated by creating micropatterned structures and films for biospecific cell scaffold supports.</abstract><notes>344EL&#xD;Times Cited:0&#xD;Cited References Count:35</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258909000015</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2009</custom3><custom4>4.431</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2258</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2258</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Perez, J. M.</author><author>Grimm, J.</author><author>Josephson, L.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Nanoscience Technology Center, Department of Chemistry, University of Central Florida, Orlando, FL, USA.</auth-address><titles><title>Integrated nanosensors to determine levels and functional activity of human telomerase</title><secondary-title>Neoplasia</secondary-title></titles><periodical><full-title>Neoplasia</full-title></periodical><pages>1066-72</pages><volume>10</volume><number>10</number><edition>2008/09/25</edition><keywords><keyword>Biosensing Techniques/ methods</keyword><keyword>Drug Screening Assays, Antitumor/ methods</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Inhibitors/ analysis/therapeutic use</keyword><keyword>Humans</keyword><keyword>Image Interpretation, Computer-Assisted</keyword><keyword>Magnetics</keyword><keyword>Models, Biological</keyword><keyword>Nanostructures/diagnostic use</keyword><keyword>Neoplasms/diagnosis/drug therapy/enzymology/metabolism</keyword><keyword>Telomerase/ analysis/antagonists &amp; inhibitors/ metabolism</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2008</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1476-5586 (Electronic)</isbn><accession-num>18813356</accession-num><abstract>Telomerase is a key oncogenic enzyme, and a number of novel telomerase inhibitors are currently under development. Because inhibition can be achieved either at the protein or at the enzymatic activity level, independent measurements of these parameters are important in the development of effective therapeutic agents. In the current study, we have developed a set of functional magnetic nanosensors capable of measuring the concentration of telomerase, as well as its enzymatic activity in parallel. The method is based on a magnetic relaxation switch assay, which can be performed in crude tissue samples and is fast and extremely sensitive. Using this method, we were able to detect different amounts of telomerase protein and activity in various cancer and normal cell lines. Furthermore, we were able to study the effect of phosphorylation on telomerase activity. This system not only could provide a rapid assay for the evaluation of antitelomerase therapies but could also be implemented to the study of other cancer markers.</abstract><notes>Perez, J Manuel&#xD;Grimm, Jan&#xD;Josephson, Lee&#xD;Weissleder, Ralph&#xD;KO1 CA101781/CA/NCI NIH HHS/United States&#xD;P50-CA86355/CA/NCI NIH HHS/United States&#xD;R21/R33 CA91807/CA/NCI NIH HHS/United States&#xD;R24-CA92782/CA/NCI NIH HHS/United States&#xD;R25CA096945-05/CA/NCI NIH HHS/United States&#xD;U54 CA126515/CA/NCI NIH HHS/United States&#xD;U54-CA119349/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Validation Studies&#xD;Canada&#xD;Neoplasia (New York, N.Y.)&#xD;Neoplasia. 2008 Oct;10(10):1066-72.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2546593</custom2><custom4>5.124</custom4><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2022</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2022</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Du, W.</author><author>Nystrom, A. M.</author><author>Zhang, L.</author><author>Powell, K. T.</author><author>Li, Y.</author><author>Cheng, C.</author><author>Wickline, S. A.</author><author>Wooley, K. L.</author></authors></contributors><auth-address>Department of Chemistry, Washington University in Saint Louis, Saint Louis, Missouri 63130, USA.</auth-address><titles><title>Amphiphilic hyperbranched fluoropolymers as nanoscopic 19F magnetic resonance imaging agent assemblies</title><secondary-title>Biomacromolecules</secondary-title></titles><periodical><full-title>Biomacromolecules</full-title></periodical><pages>2826-33</pages><volume>9</volume><number>10</number><edition>2008/09/18</edition><keywords><keyword>Acetates/chemistry</keyword><keyword>Calorimetry, Differential Scanning/methods</keyword><keyword>Contrast Media/pharmacology</keyword><keyword>Fluorine Radioisotopes/ chemistry</keyword><keyword>Lauric Acids/chemistry</keyword><keyword>Magnetic Resonance Imaging/ methods</keyword><keyword>Magnetic Resonance Spectroscopy</keyword><keyword>Methacrylates/chemistry</keyword><keyword>Micelles</keyword><keyword>Microscopy, Atomic Force/methods</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Molecular Weight</keyword><keyword>Polyhydroxyalkanoates/chemistry</keyword><keyword>Polymers/ chemistry</keyword><keyword>Polystyrenes/chemistry</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1526-4602 (Electronic)</isbn><accession-num>18795785</accession-num><abstract>Three hyperbranched fluoropolymers were synthesized and their micelles were constructed as potential (19)F MRI agents. A hyperbranched star-like core was first synthesized via atom transfer radical self-condensing vinyl (co)polymerization (ATR-SCVCP) of 4-chloromethyl styrene (CMS), lauryl acrylate (LA), and 1,1,1-tris(4&apos;-(2&apos;&apos;-bromoisobutyryloxy)phenyl)ethane (TBBPE). The polymerization gave a small core with M n of 5.5 kDa with PDI of 1.6, which served as a macroinitiator. Trifluoroethyl methacrylate (TFEMA) and tert-butyl acrylate (tBA) in different ratios were then &quot;grafted&quot; from the core to give three polymers with M(n) of about 120 kDa and PDI values of about 1.6-1.8. After acidolysis of the tert-butyl ester groups, amphiphilic, hyperbranched star-like polymers with M(n) of about 100 kDa were obtained. These structures were subjected to micelle formation in aqueous solution to give micelles having TEM-measured diameters ranging from 3-8 nm and DLS-measured hydrodynamic diameters from 20-30 nm. These micelles gave a narrow, single resonance by (19)F NMR spectroscopy, with a half-width of approximately 130 Hz. The T1/T2 parameters were about 500 and 50 ms, respectively, and were not significantly affected by the composition and sizes of the micelles. (19)F MRI phantom images of these fluorinated micelles were acquired, which demonstrated that these fluorinated micelles maybe useful as novel (19)F MRI agents for a variety of biomedical studies.</abstract><notes>Du, Wenjun&#xD;Nystrom, Andreas M&#xD;Zhang, Lei&#xD;Powell, Kenya T&#xD;Li, Yali&#xD;Cheng, Chong&#xD;Wickline, Samuel A&#xD;Wooley, Karen L&#xD;HL080729/HL/NHLBI NIH HHS/United States&#xD;P20 RR020643/RR/NCRR NIH HHS/United States&#xD;R24-CA83060/CA/NCI NIH HHS/United States&#xD;U54CA119342/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Biomacromolecules&#xD;Biomacromolecules. 2008 Oct;9(10):2826-33. Epub 2008 Sep 17.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom2>2744969</custom2><custom3>NIHMS121109</custom3><custom4>4.658</custom4><electronic-resource-num>10.1021/bm800595b [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2095</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2095</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chen, K.</author><author>Cai, W.</author><author>Li, Z. B.</author><author>Wang, H.</author><author>Chen, X.</author></authors></contributors><auth-address>Department of Radiology and Bio-X Program, Stanford University School of Medicine, CA 94305-5484, USA.</auth-address><titles><title>Quantitative PET imaging of VEGF receptor expression</title><secondary-title>Mol Imaging Biol</secondary-title></titles><periodical><full-title>Mol Imaging Biol</full-title></periodical><pages>15-22</pages><volume>11</volume><number>1</number><edition>2008/09/12</edition><keywords><keyword>Animals</keyword><keyword>Antigens, CD31/metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Copper Radioisotopes/diagnostic use</keyword><keyword>Fluorescent Antibody Technique, Direct</keyword><keyword>Glioblastoma/blood supply/metabolism/pathology</keyword><keyword>Heterocyclic Compounds, 1-Ring/metabolism</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Neoplasms/diagnosis/radionuclide imaging</keyword><keyword>Neovascularization, Pathologic/metabolism/radionuclide imaging</keyword><keyword>Positron-Emission Tomography/ methods</keyword><keyword>Receptors, Vascular Endothelial Growth Factor/ metabolism</keyword><keyword>Tumor Burden</keyword><keyword>Vascular Endothelial Growth Factor A/metabolism</keyword><keyword>Vascular Endothelial Growth Factor Receptor-1/metabolism</keyword><keyword>Vascular Endothelial Growth Factor Receptor-2/metabolism</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2009</year><pub-dates><date>Jan-Feb</date></pub-dates></dates><isbn>1536-1632 (Print)</isbn><accession-num>18784964</accession-num><abstract>PURPOSE: Vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) signaling pathway plays pivotal roles in regulating tumor angiogenesis. Quantitative positron emission tomography (PET) imaging of VEGFR will facilitate the planning of whether, and when, to start anti-angiogenic treatment and enable more robust and effective monitoring of such treatment. MATERIALS AND METHODS: VEGF(121) was conjugated with DOTA (1,4,7,10-tetra-azacylododecane N,N&apos;,N&apos;&apos;,N&apos;&apos;&apos;-tetraacetic acid) and then labeled with (64)Cu for PET imaging of mice bearing different-sized human glioblastoma U87MG tumors (n = 15). Western blotting and immunofluorescence staining of tumor tissue was carried out to correlate with/validate the imaging results. RESULTS: The specific activity of (64)Cu-DOTA-VEGF(121) was 3.2 GBq/mg. The uptake of (64)Cu-DOTA-VEGF(121) in the tumor peaked when the tumor size was about 100-250 mm(3). Both small and large tumors had lower tracer uptake indicating a narrow range of tumor size with high VEGFR-2 expression. All tumors had similarly low VEGFR-1 expression. Most importantly, the tumor uptake value obtained from PET imaging had good linear correlation with the relative tumor tissue VEGFR-2 expression as measured by Western blot, where r (2) equals 0.68 based on the PET uptake at 4 h post-injection. Histology of the frozen tumor tissue corroborates well with the imaging results. CONCLUSION: The tumor uptake of (64)Cu-DOTA-VEGF(121) measured by small-animal PET imaging reflects tumor VEGFR-2 expression level in vivo. Such correlation may facilitate future treatment planning and treatment monitoring of cancer and potentially other angiogenesis-related diseases.</abstract><notes>Chen, Kai&#xD;Cai, Weibo&#xD;Li, Zi-Bo&#xD;Wang, Hui&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging&#xD;Mol Imaging Biol. 2009 Jan-Feb;11(1):15-22. Epub 2008 Sep 11.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>3.372</custom4><electronic-resource-num>10.1007/s11307-008-0172-1 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2388</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2388</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Marciniak, J.</author><author>Kummel, A.</author><author>Esener, S.</author><author>Heller, M.</author><author>Messmer, B.</author></authors></contributors><auth-address>Department of Bioengineering, University of California-San Diego, La Jolla, CA, USA.</auth-address><titles><title>Coupled rolling circle amplification loop-mediated amplification for rapid detection of short DNA sequences</title><secondary-title>Biotechniques</secondary-title></titles><periodical><full-title>Biotechniques</full-title></periodical><pages>275-80</pages><volume>45</volume><number>3</number><edition>2008/09/10</edition><keywords><keyword>Base Sequence</keyword><keyword>DNA Ligases/metabolism</keyword><keyword>DNA Probes/genetics</keyword><keyword>DNA, Circular/chemistry/ genetics</keyword><keyword>DNA, Single-Stranded/ genetics</keyword><keyword>Molecular Probe Techniques</keyword><keyword>Molecular Sequence Data</keyword><keyword>Nucleic Acid Amplification Techniques/ methods</keyword><keyword>Oligonucleotide Probes/chemistry/genetics/metabolism</keyword><keyword>Time Factors</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0736-6205 (Print)</isbn><accession-num>18778251</accession-num><abstract>Circularizable oligonucleotide probes can detect short DNA sequences with single-base resolution at the site of ligation and can be amplified by rolling circle amplification (RCA) using strand displacing polymerases. A secondary amplification scheme was developed that uses the loop-mediated amplification reaction concurrent with RCA to achieve rapid signal development from the starting circular molecules. This isothermal reaction was found to be significantly faster than the comparable hyperbranching amplification method and could detect 100 circular copies in less than 1 h.</abstract><notes>Marciniak, Jennifer&#xD;Kummel, Andrew&#xD;Esener, Sadik&#xD;Heller, Michael&#xD;Messmer, Bradley&#xD;U54 CA 119335/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;BioTechniques&#xD;Biotechniques. 2008 Sep;45(3):275-80.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom4>2.499</custom4><electronic-resource-num>000112910 [pii]&#xD;10.2144/000112910 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1945</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1945</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zuo, T.</author><author>Xu, L.</author><author>Beavers, C. M.</author><author>Olmstead, M. M.</author><author>Fu, W.</author><author>Crawford, T. D.</author><author>Balch, A. L.</author><author>Dorn, H. C.</author></authors></contributors><auth-address>Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA.</auth-address><titles><title>M2@C79N (M = Y, Tb): isolation and characterization of stable endohedral metallofullerenes exhibiting M-M bonding interactions inside aza[80]fullerene cages</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>12992-7</pages><volume>130</volume><number>39</number><edition>2008/09/09</edition><keywords><keyword>Aza Compounds/ chemical synthesis/isolation &amp; purification</keyword><keyword>Crystallography, X-Ray</keyword><keyword>Electron Spin Resonance Spectroscopy</keyword><keyword>Fullerenes/ chemistry/isolation &amp; purification</keyword><keyword>Models, Chemical</keyword><keyword>Models, Molecular</keyword><keyword>Organometallic Compounds/ chemical synthesis/isolation &amp; purification</keyword><keyword>Terbium/ chemistry</keyword><keyword>Thermodynamics</keyword><keyword>Yttrium/ chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Oct 1</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18774804</accession-num><abstract>Y2@C79N and Tb2@C79N have been prepared by conducting the Kratschmer-Huffman electric-arc process under 20 Torr of N2 and 280 Torr of He with metal oxide-doped graphite rods. These new heterofullerenes were separated from the resulting mixture of empty cage fullerenes and endohedral fullerenes by chemical separation and a two-stage chromatographic process. Crystallographic data for Tb2@C79N x Ni(OEP) x 2 C6H6 demonstrate the presence of an 80-atom cage with idealized I(h) symmetry and two, widely separated Tb atoms inside with a Tb-Tb separation of 3.9020(10) A for the major terbium sites. The EPR spectrum of the odd-electron Y2@C79N indicates that the spin density largely resides on the two equivalent yttrium ions. Computational studies on Y2@C79N suggest that the nitrogen atom resides at a 665 ring junction in the equator on the fullerene cage and that the unpaired electron is localized in a bonding orbital between the two yttrium ions of this stable radical. Thus, the Tb-Tb bond length of the single-electron bond is an exceedingly long metal-metal bond.</abstract><notes>Zuo, Tianming&#xD;Xu, Liaosa&#xD;Beavers, Christine M&#xD;Olmstead, Marilyn M&#xD;Fu, Wujun&#xD;Crawford, T Daniel&#xD;Balch, Alan L&#xD;Dorn, Harry C&#xD;1R01-CA119371-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Oct 1;130(39):12992-7. Epub 2008 Sep 6.</notes><urls></urls><custom1>CNPP - V.C.U.</custom1><custom2>2696175</custom2><custom3>NIHMS90933</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja802417d [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2094</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2094</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>De la Zerda, A.</author><author>Zavaleta, C.</author><author>Keren, S.</author><author>Vaithilingam, S.</author><author>Bodapati, S.</author><author>Liu, Z.</author><author>Levi, J.</author><author>Smith, B. R.</author><author>Ma, T. J.</author><author>Oralkan, O.</author><author>Cheng, Z.</author><author>Chen, X.</author><author>Dai, H.</author><author>Khuri-Yakub, B. T.</author><author>Gambhir, S. S.</author></authors></contributors><titles><title>Carbon nanotubes as photoacoustic molecular imaging agents in living mice</title><secondary-title>Nat Nanotechnol</secondary-title></titles><periodical><full-title>Nat Nanotechnol</full-title></periodical><pages>557-62</pages><volume>3</volume><number>9</number><edition>2008/09/06</edition><keywords><keyword>Acoustics/instrumentation</keyword><keyword>Animals</keyword><keyword>Contrast Media/ administration &amp; dosage</keyword><keyword>Diagnostic Imaging/instrumentation/ methods</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Nanotubes, Carbon</keyword><keyword>Neoplasms, Experimental/ pathology</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Spectrum Analysis, Raman/methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1748-3395 (Electronic)</isbn><accession-num>18772918</accession-num><abstract>Photoacoustic imaging of living subjects offers higher spatial resolution and allows deeper tissues to be imaged compared with most optical imaging techniques. As many diseases do not exhibit a natural photoacoustic contrast, especially in their early stages, it is necessary to administer a photoacoustic contrast agent. A number of contrast agents for photoacoustic imaging have been suggested previously, but most were not shown to target a diseased site in living subjects. Here we show that single-walled carbon nanotubes conjugated with cyclic Arg-Gly-Asp (RGD) peptides can be used as a contrast agent for photoacoustic imaging of tumours. Intravenous administration of these targeted nanotubes to mice bearing tumours showed eight times greater photoacoustic signal in the tumour than mice injected with non-targeted nanotubes. These results were verified ex vivo using Raman microscopy. Photoacoustic imaging of targeted single-walled carbon nanotubes may contribute to non-invasive cancer imaging and monitoring of nanotherapeutics in living subjects.</abstract><notes>De la Zerda, Adam&#xD;Zavaleta, Cristina&#xD;Keren, Shay&#xD;Vaithilingam, Srikant&#xD;Bodapati, Sunil&#xD;Liu, Zhuang&#xD;Levi, Jelena&#xD;Smith, Bryan R&#xD;Ma, Te-Jen&#xD;Oralkan, Omer&#xD;Cheng, Zhen&#xD;Chen, Xiaoyuan&#xD;Dai, Hongjie&#xD;Khuri-Yakub, Butrus T&#xD;Gambhir, Sanjiv S&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;P50 CA114747-01/CA/NCI NIH HHS/United States&#xD;U54 CA119367-01/CA/NCI NIH HHS/United States&#xD;U54 CA119367-02/CA/NCI NIH HHS/United States&#xD;U54 CA119367-03/CA/NCI NIH HHS/United States&#xD;Letter&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Nature nanotechnology&#xD;Nat Nanotechnol. 2008 Sep;3(9):557-62. Epub 2008 Aug 17.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom2>2562547</custom2><custom3>NIHMS67924</custom3><custom4>20.588</custom4><electronic-resource-num>nnano.2008.231 [pii]&#xD;10.1038/nnano.2008.231 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2496</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2496</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Raja, S. M.</author><author>Clubb, R. J.</author><author>Bhattacharyya, M.</author><author>Dimri, M.</author><author>Cheng, H.</author><author>Pan, W.</author><author>Ortega-Cava, C.</author><author>Lakku-Reddi, A.</author><author>Naramura, M.</author><author>Band, V.</author><author>Band, H.</author></authors></contributors><auth-address>Eppley Institute for Research in Cancer and Allied Diseases, UNMC-Eppley Cancer Center, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198-6805, USA. sraja@unmc.edu</auth-address><titles><title>A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells</title><secondary-title>Cancer Biol Ther</secondary-title></titles><periodical><full-title>Cancer Biol Ther</full-title><abbr-1>Cancer biology &amp; therapy</abbr-1></periodical><pages>1630-40</pages><volume>7</volume><number>10</number><edition>2008/09/05</edition><keywords><keyword>Antibodies, Monoclonal/*administration &amp; dosage</keyword><keyword>Antineoplastic Combined Chemotherapy Protocols/therapeutic use</keyword><keyword>Benzoquinones/*administration &amp; dosage</keyword><keyword>Breast Neoplasms/*metabolism</keyword><keyword>Cell Death</keyword><keyword>Cell Line, Tumor</keyword><keyword>Flow Cytometry</keyword><keyword>HSP90 Heat-Shock Proteins/metabolism</keyword><keyword>Humans</keyword><keyword>Lactams, Macrocyclic/*administration &amp; dosage</keyword><keyword>Lysosomes/*metabolism</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Models, Biological</keyword><keyword>Protein Structure, Tertiary</keyword><keyword>Receptor, erbB-2/*metabolism</keyword><keyword>Ubiquitin/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1555-8576 (Electronic)</isbn><accession-num>18769124</accession-num><abstract>ErbB2 (or Her2/Neu) overexpression in breast cancer signifies poorer prognosis, yet it has provided an avenue for targeted therapy as demonstrated by the success of the humanized monoclonal antibody Trastuzumab (Herceptin). Resistance to Trastuzumab and eventual failure in most cases, however, necessitate alternate ErbB2-targeted therapies. HSP90 inhibitors such as 17-allylaminodemethoxygeldanamycin (17-AAG), potently downregulate the cell surface ErbB2. While the precise mechanisms of Trastuzumab or 17-AAG action remain unclear, ubiquitinylation-dependent proteasomal or lysosomal degradation of ErbB2 appears to play a substantial role. As Trastuzumab and 17-AAG induce the recruitment of distinct E3 ubiquitin ligases, Cbl and CHIP respectively, to ErbB2, we hypothesized that 17-AAG and Trastuzumab combination could induce a higher level of ubiquitinylation and downregulation of ErbB2 as compared to single drug treatments. We present biochemical and cell biological evidence that combined 17-AAG and Trastuzumab treatment of ErbB2-overexpressing breast cancer cell lines leads to enhanced ubiquitinylation, downregulation from the cell surface and lysosomal degradation of ErbB2. Importantly, combined 17-AAG and Trastuzumab treatment induced synergistic growth arrest and cell death specifically in ErbB2-overexpressing but not in ErbB2-low breast cancer cells. Our results suggest the 17-AAG and Trastuzumab combination as a mechanism-based combinatorial targeted therapy for ErbB2-overexpressing breast cancer patients.</abstract><notes>Raja, Srikumar M&#xD;Clubb, Robert J&#xD;Bhattacharyya, Mitra&#xD;Dimri, Manjari&#xD;Cheng, Hao&#xD;Pan, Wei&#xD;Ortega-Cava, Cesar&#xD;Lakku-Reddi, Alagarsamy&#xD;Naramura, Mayumi&#xD;Band, Vimla&#xD;Band, Hamid&#xD;1U54 CA119341-01/CA/NCI NIH HHS/United States&#xD;CA116552/CA/NCI NIH HHS/United States&#xD;CA76118/CA/NCI NIH HHS/United States&#xD;CA81076/CA/NCI NIH HHS/United States&#xD;CA87986/CA/NCI NIH HHS/United States&#xD;CA94143/CA/NCI NIH HHS/United States&#xD;CA96844/CA/NCI NIH HHS/United States&#xD;CA99163/CA/NCI NIH HHS/United States&#xD;CA99900/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer biology &amp; therapy&#xD;Cancer Biol Ther. 2008 Oct;7(10):1630-40. Epub 2008 Oct 9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18769124</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom2>2727620</custom2><custom4>3.118</custom4><electronic-resource-num>6585 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2335</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2335</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huang, W. C.</author><author>Havel, J. J.</author><author>Zhau, H. E.</author><author>Qian, W. P.</author><author>Lue, H. W.</author><author>Chu, C. Y.</author><author>Nomura, T.</author><author>Chung, L. W.</author></authors></contributors><auth-address>Molecular Urology and Therapeutics Program, Department of Urology and Winship Cancer Institute, Emory University School of Medicine, GA 30322, USA. whuang3@emory.edu</auth-address><titles><title>Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells</title><secondary-title>Clin Cancer Res</secondary-title></titles><periodical><full-title>Clin Cancer Res</full-title></periodical><pages>5341-7</pages><volume>14</volume><number>17</number><edition>2008/09/04</edition><keywords><keyword>Antibodies/pharmacology</keyword><keyword>Apoptosis</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Neoplasms, Hormone-Dependent/metabolism</keyword><keyword>Prostate-Specific Antigen/metabolism</keyword><keyword>Prostatic Neoplasms/ metabolism</keyword><keyword>Receptors, Androgen/ metabolism</keyword><keyword>Signal Transduction</keyword><keyword>beta 2-Microglobulin/immunology/ metabolism/pharmacology</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep 1</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>18765525</accession-num><abstract>PURPOSE: beta2-Microglobulin (beta2M) has been shown to promote osteomimicry and the proliferation of human prostate cancer cells. The objective of this study is to determine the mechanism by which targeting beta2M using anti-beta2M antibody inhibited growth and induced apoptosis in prostate cancer cells. EXPERIMENTAL DESIGN: Polyclonal and monoclonal beta2M antibodies were used to interrupt beta2M signaling in human prostate cancer cell lines and the growth of prostate tumors in mice. The effects of the beta2M antibody on a survival factor, androgen receptor (AR), and its target gene, prostate-specific antigen (PSA) expression, were investigated in cultured cells and in tumor xenografts. RESULTS: The beta2M antibody inhibited growth and promoted apoptosis in both AR-positive and PSA-positive, and AR-negative and PSA-negative, prostate cancer cells via the down-regulation of the AR in AR-positive prostate cancer cells and directly caused apoptosis in AR-negative prostate cancer cells in vitro and in tumor xenografts. The beta2M antibody had no effect on AR expression or the growth of normal prostate cells. CONCLUSIONS: beta2M downstream signaling regulates AR and PSA expression directly in AR-positive prostate cancer cells. In both AR-positive and AR-negative prostate cancer cells, interrupting beta2M signaling with the beta2M antibody inhibited cancer cell growth and induced its apoptosis. The beta2M antibody is a novel and promising therapeutic agent for the treatment of human prostate cancers.</abstract><notes>Huang, Wen-Chin&#xD;Havel, Jonathan J&#xD;Zhau, Haiyen E&#xD;Qian, Wei Ping&#xD;Lue, Hui-Wen&#xD;Chu, Chia-Yi&#xD;Nomura, Takeo&#xD;Chung, Leland W K&#xD;P01 CA98912/CA/NCI NIH HHS/United States&#xD;U54 CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 Sep 1;14(17):5341-7.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>6.646</custom4><electronic-resource-num>14/17/5341 [pii]&#xD;10.1158/1078-0432.CCR-08-0793 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1792</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1792</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhou, J.</author><author>Gu, Y. D.</author><author>Fei, P.</author><author>Mai, W. J.</author><author>Gao, Y. F.</author><author>Yang, R. S.</author><author>Bao, G.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>Wang, ZL&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA 30332 USA&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA 30332 USA&#xD;Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA&#xD;Emory Univ, Atlanta, GA 30332 USA&#xD;Peking Univ, Coll Engn, Dept Adv Mat &amp; Nanotechnol, Beijing 100084, Peoples R China</auth-address><titles><title>Flexible piezotronic strain sensor</title><secondary-title>Nano Letters</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>3035-3040</pages><volume>8</volume><number>9</number><edition>2008/09</edition><keywords><keyword>pressure-dependence</keyword><keyword>silicon nanowires</keyword><keyword>barrier height</keyword><keyword>zno nanowire</keyword><keyword>nanobelts</keyword><keyword>arrays</keyword><keyword>gan</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1530-6984</isbn><accession-num>ISI:000259140200076</accession-num><abstract>Strain sensors based on individual ZnO piezoelectric fine-wires (PFWs; nanowires, microwires) have been fabricated by a simple, reliable, and cost-effective technique. The electromechanical sensor device consists of a single electrically connected PFW that is placed on the outer surface of a flexible polystyrene (PS) substrate and bonded at its two ends. The entire device is fully packaged by a polydimethylsiloxane (PDMS) thin layer. The PFW has Schottky contacts at its two ends but with distinctly different barrier heights. The I-V characteristic is highly sensitive to strain mainly due to the change in Schottky barrier height (SBH), which scales linear with strain. The change in SBH is suggested owing to the strain induced band structure change and piezoelectric effect. The experimental data can be well-described by the thermionic emission-diffusion model. A gauge factor of as high as 1250 has been demonstrated, which is 25% higher than the best gauge factor demonstrated for carbon nanotubes. The strain sensor developed here has applications in strain and stress measurements in cell biology, biomedical sciences, MEMS devices, structure monitoring, and more.</abstract><notes>347KQ&#xD;Times Cited:2&#xD;Cited References Count:34</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000259140200076</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>12.189</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1790</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1790</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhou, J.</author><author>Fei, P.</author><author>Gao, Y. F.</author><author>Gu, Y. D.</author><author>Liu, J.</author><author>Bao, G.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>Wang, ZL&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA 30332 USA&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA 30332 USA&#xD;Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA&#xD;Emory Univ, Atlanta, GA 30322 USA&#xD;Peking Univ, Coll Engn, Dept Adv Mat &amp; Nanotechnol, Beijing 100084, Peoples R China</auth-address><titles><title>Mechanical-electrical triggers and sensors using piezoelectric micowires/nanowires</title><secondary-title>Nano Letters</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>2725-2730</pages><volume>8</volume><number>9</number><edition>2008/09</edition><keywords><keyword>carbon nanotube</keyword><keyword>silicon nanowires</keyword><keyword>zno films</keyword><keyword>nanogenerator</keyword><keyword>transistor</keyword><keyword>nanosensors</keyword><keyword>performance</keyword><keyword>barrier</keyword><keyword>density</keyword><keyword>driven</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1530-6984</isbn><accession-num>ISI:000259140200022</accession-num><abstract>We demonstrate a mechanical-electrical trigger using a ZnO piezoelectric fine-wire (PFW) (microwire, nanowire). Once subjected to mechanical impact, a bent PFW creates a voltage drop across its width, with the tensile and compressive surfaces showing positive and negative voltages, respectively. The voltage and current created by the piezoelectric effect could trigger an external electronic system, thus, the impact force/pressure can be detected. The response time of the trigger/sensor is similar to 10 ms. The piezoelectric potential across the PFW has a lifetime of similar to 100 s, which is long enough for effectively &quot;gating&quot; the transport current along the wire; thus a piezoelectric field effect transistor is possible based on the piezotronic effect.</abstract><notes>347KQ&#xD;Times Cited:1&#xD;Cited References Count:26</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000259140200022</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>12.189</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1774</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1774</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zavaleta, C.</author><author>de la Zerda, A.</author><author>Liu, Z.</author><author>Keren, S.</author><author>Cheng, Z.</author><author>Schipper, M.</author><author>Chen, X.</author><author>Dai, H.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Gambhir, SS&#xD;Stanford Univ, Mol Imaging Program Stanford, Dept Radiol, 1201 Welch Rd, Stanford, CA 94305 USA&#xD;Stanford Univ, Mol Imaging Program Stanford, Dept Radiol, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Bioengn, BioX Program, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA</auth-address><titles><title>Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes</title><secondary-title>Nano Letters</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>2800-2805</pages><volume>8</volume><number>9</number><edition>2008/09</edition><keywords><keyword>integrin alpha(v)beta(3) expression</keyword><keyword>organic-inorganic nanoparticles</keyword><keyword>in-vivo</keyword><keyword>drug-delivery</keyword><keyword>cancer</keyword><keyword>angiogenesis</keyword><keyword>scattering</keyword><keyword>complexes</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1530-6984</isbn><accession-num>ISI:000259140200034</accession-num><abstract>An optimized noninvasive Raman microscope was used to evaluate tumor targeting and localization of single walled carbon nanotubes (SWNTs) in mice. Raman images were acquired in two groups of tumor-bearing mice. The control group received plain-SWNTs, whereas the experimental group received tumor targeting RGD-SWNTs intravenously. Raman imaging commenced over the next 72 h and revealed increased accumulation of RGD-SWNTs in tumor (p &lt; 0.05) as opposed to plain-SWNTs. These results support the development of a new preclinical Raman imager.</abstract><notes>347KQ&#xD;Times Cited:2&#xD;Cited References Count:33</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000259140200034</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom4>12.189</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1721</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1721</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Westcott, N. P.</author><author>Pulsipher, A.</author><author>Lamb, B. M.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Yousaf, MN&#xD;Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA</auth-address><titles><title>Expedient generation of patterned surface aldehydes by microfluidic oxidation for chemoselective immobilization of ligands and cells</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>9237-9240</pages><volume>24</volume><number>17</number><edition>2008/09</edition><keywords><keyword>self-assembled monolayers</keyword><keyword>strategy</keyword><keyword>protein</keyword><keyword>polarization</keyword><keyword>attachment</keyword><keyword>gradients</keyword><keyword>peptide</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep 2</date></pub-dates></dates><isbn>0743-7463</isbn><accession-num>ISI:000258722100014</accession-num><abstract>An expedient and inexpensive method to generate patterned aldehydes on self-assembled monolayers (SAMs) of alkanethiolates on gold with control of density for subsequent chemoselective immobilization from commercially available starting materials has been developed. Utilizing microfluidic cassettes, primary alcohol oxidation of tetra(ethylene glycol) undecane thiol and 11-mercapto-1-undecanol SAMs was performed directly on the surface generating patterned aldehyde groups with pyridinium chlorochromate. The precise density of surface aldehydes generated can be controlled and characterized by electrochemistry. For biological applications, fibroblast cells were seeded on patterned surfaces presenting biospecifc cell adhesive (Arg-Glyc-Asp) RGD peptides.</abstract><notes>341NV&#xD;Times Cited:1&#xD;Cited References Count:22</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258722100014</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>4.347</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1611</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1611</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>So, M. K.</author><author>Yao, H. Q.</author><author>Rao, J. H.</author></authors></contributors><auth-address>Rao, JH&#xD;Stanford Univ, Sch Med, Dept Radiol, Biophys Canc Biol &amp; Mol Imaging Programs, 1201 Welch Rd,P093,Mail Code 5484, Stanford, CA 94305 USA&#xD;Stanford Univ, Sch Med, Dept Radiol, Biophys Canc Biol &amp; Mol Imaging Programs, Stanford, CA 94305 USA</auth-address><titles><title>HaloTag protein-mediated specific labeling of living cells with quantum dots</title><secondary-title>Biochemical and Biophysical Research Communications</secondary-title></titles><periodical><full-title>Biochemical and Biophysical Research Communications</full-title></periodical><pages>419-423</pages><volume>374</volume><number>3</number><edition>2008/09</edition><keywords><keyword>quantum dots</keyword><keyword>halotag protein</keyword><keyword>live cell labeling</keyword><keyword>fluorescence imaging</keyword><keyword>in-vivo</keyword><keyword>live cells</keyword><keyword>nanocrystallites</keyword><keyword>probes</keyword><keyword>tools</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep 26</date></pub-dates></dates><isbn>0006-291X</isbn><accession-num>ISI:000259108800004</accession-num><abstract>Quantum dots emerge as an attractive alternative to small molecule fluorophores as fluorescent tags for in vivo cell labeling and imaging. This communication presents a method for specific labeling of live cells using quantum dots. The labeling is mediated by HaloTag protein expressed at the cell surface which forms a stable covalent adduct with its ligand (HaloTag ligand). The labeling can be performed in one single step with quantum dot conjugates that are functionalized with HaloTag ligand, or in two steps with biotinylated HaloTag ligand first and followed by streptavidin coated quantum dots. Live cell fluorescence imaging indicates that the labeling is specific and takes place at the cell surface. This HaloTag protein-mediated cell labeling method should facilitate the application of quantum dots for live cell imaging. (C) 2008 Elsevier Inc. All rights reserved.</abstract><notes>346ZT&#xD;Times Cited:0&#xD;Cited References Count:28</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000259108800004</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom4>2.823</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1543</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1543</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rieter, W. J.</author><author>Pott, K. M.</author><author>Taylor, K. M. L.</author><author>Lin, W. B.</author></authors></contributors><auth-address>Lin, WB&#xD;Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA</auth-address><titles><title>Nanoscale coordination polymers for platinum-based anticancer drug delivery</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>11584-+</pages><volume>130</volume><number>35</number><edition>2008/09</edition><keywords><keyword>metal-organic frameworks</keyword><keyword>cancer-chemotherapy</keyword><keyword>carbon nanotubes</keyword><keyword>nanoparticles</keyword><keyword>agent</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep 3</date></pub-dates></dates><isbn>0002-7863</isbn><accession-num>ISI:000258792000011</accession-num><abstract>Pt-containing nanoscale coordination polymer (NCP) particles with the formula of Tb-2(DSCP)(3)(H2O)(12) (where DSCP represents disuccinatocisplatin), NCP-1, were precipitated from an aqueous solution of Tb3+ ions and DSCP bridging ligands via the addition of a poor solvent. SEM and TEM images showed that as-synthesized NCP-1 exhibited a spherical morphology with a DLS diameter of 58.3 +/- 11.3 nm. NCP-1 particles were stabilized against rapid dissolution in water by encapsulation in shells of amorphous silica. The resulting silica-coated particles NCP-1 exhibited significantly longer half-lives for DSCP release from the particles (a t(1/2) of similar to 9 h for NCP-1&apos; with 7 nm silica coating vs t(1/2) of similar to 1 h for as-synthesized NCP-1). In vitro cancer cell cytotoxicity assays with the human colon carcinoma cell line (HT-29) showed that internalized NCP-1&apos; particles readily released the DSCP moieties which were presumably reduced to cytotoxic Pt(II) species to give the Pt-containing NCPs anticancer efficacy superior to the cisplatin standard. The generality of this degradable nanoparticle formulation should allow for the design of NCPs as effective delivery vehicles for a variety of biologically and medically important cargoes such as therapeutic and imaging agents.</abstract><notes>342NY&#xD;Times Cited:2&#xD;Cited References Count:16</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258792000011</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>8.256</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1525</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1525</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, X. M.</author><author>Nie, S. M.</author></authors></contributors><auth-address>Nie, SM&#xD;Emory Univ, Dept Biomed Engn, 101 Woodruff Circle,Suite 2001, Atlanta, GA 30322 USA&#xD;Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA&#xD;Georgia Inst Technol, Atlanta, GA 30322 USA</auth-address><titles><title>Single-molecule and single-nanoparticle SERS: from fundamental mechanisms to biomedical applications</title><secondary-title>Chemical Society Reviews</secondary-title></titles><periodical><full-title>Chemical Society Reviews</full-title></periodical><pages>912-920</pages><volume>37</volume><number>5</number><edition>2008/09</edition><keywords><keyword>surface-enhanced raman</keyword><keyword>rhodamine 6g molecules</keyword><keyword>gold nanoparticles</keyword><keyword>metal nanoparticles</keyword><keyword>optical-properties</keyword><keyword>active-sites</keyword><keyword>lung-cancer</keyword><keyword>scattering</keyword><keyword>spectroscopy</keyword><keyword>nanocrystals</keyword></keywords><dates><year>2008</year></dates><isbn>0306-0012</isbn><accession-num>ISI:000255444700004</accession-num><abstract>This tutorial review discusses a new class of colloidal metal nanoparticles that is able to enhance the efficiencies of surface-enhanced Raman scattering (SERS) by as much as 10(14)-10(15) fold. This enormous enhancement allows spectroscopic detection and identification of single molecules located on the nanoparticle surface or at the junction of two particles under ambient conditions. Considerable progress has been made in understanding the enhancement mechanisms, including definitive evidence for the single-molecule origin of fluctuating SERS signals. For applications, SERS nanoparticle tags have been developed based on the use of embedded reporter molecules and a silica or polymer encapsulation layer. The SERS nanoparticle tags are capable of providing detailed spectroscopic information and are much brighter than semiconductor quantum dots in the near-infrared spectral window. These properties have raised new opportunities for multiplexed molecular diagnosis and in vivo Raman spectroscopy and imaging.</abstract><notes>294ZL&#xD;Times Cited:7&#xD;Cited References Count:54</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000255444700004</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>3.684</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1429</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1429</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Majoros, I. J.</author><author>Williams, C. R.</author><author>Baker, J. R.</author></authors></contributors><auth-address>Majoros, IJ&#xD;Univ Michigan, Michigan Nanotechnol Inst Med &amp; Biol Sci, Ann Arbor, MI 48109 USA&#xD;Univ Michigan, Michigan Nanotechnol Inst Med &amp; Biol Sci, Ann Arbor, MI 48109 USA</auth-address><titles><title>Current dendrimer applications in cancer diagnosis and therapy</title><secondary-title>Current Topics in Medicinal Chemistry</secondary-title></titles><periodical><full-title>Current Topics in Medicinal Chemistry</full-title></periodical><pages>1165-1179</pages><volume>8</volume><number>14</number><edition>2008/09</edition><keywords><keyword>pamam dendrimer</keyword><keyword>drug delivery</keyword><keyword>cancer diagnosis</keyword><keyword>cancer therapy</keyword><keyword>chemotherapy</keyword><keyword>photodynamic therapy</keyword><keyword>mri</keyword><keyword>apoptosis</keyword><keyword>neutron-capture therapy</keyword><keyword>imaging contrast agents</keyword><keyword>drug-delivery</keyword><keyword>polyamidoamine dendrimers</keyword><keyword>photodynamic therapy</keyword><keyword>gene delivery</keyword><keyword>in-vitro</keyword><keyword>encapsulating photosensitizers</keyword><keyword>folate receptor</keyword><keyword>energy-transfer</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1568-0266</isbn><accession-num>ISI:000259501400003</accession-num><abstract>In recent years, medicinal chemists have begun to realize that dendrimers may be a keystone in the future of medicine. The field of oncology will soon be revolutionized by novel strategies for diagnosis and therapy employing dendrimer-based nanodevices. In the near future, cancer diagnosis via MRI will be improved by the incorporation of dendrimers as advanced contrast agents. Novel dendrimer-based contrast agents can not only be targeted specifically to cancer cells but may also incorporate a cytotoxic function to induce apoptosis on said cells as well. Dendrimers are being applied to a variety of cancer therapies to improve the safety and effectiveness of many common therapeutics. Investigations into the applicability of dendrimers in photodynamic therapy, boron neutron capture therapy, and gene transfection are also being undertaken. This review will cover the fundamentals of cutting-edge research utilizing dendrimers for cancer diagnosis and therapy. An objective review of these new technologies will detail how dendrimer-based nanodevices are advantageous over conventional medicine.</abstract><notes>352MN&#xD;Times Cited:0&#xD;Cited References Count:72</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000259501400003</url></related-urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom4>4.464</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1378</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1378</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J.</author><author>Hasan, W.</author><author>Stender, C. L.</author><author>Odom, T. W.</author></authors></contributors><auth-address>dagger Department of Chemistry todom@northwestern.edu.</auth-address><titles><title>Pyramids: A Platform for Designing Multifunctional Plasmonic Particles</title><secondary-title>Acc Chem Res</secondary-title><alt-title>Accounts of chemical research</alt-title></titles><periodical><full-title>Acc Chem Res</full-title></periodical><alt-periodical><full-title>Accounts of Chemical Research</full-title></alt-periodical><edition>2008/09</edition><dates><year>2008</year><pub-dates><date>Sep 20</date></pub-dates></dates><isbn>1520-4898 (Electronic)</isbn><accession-num>18803410</accession-num><abstract>This Account explores nanofabricated pyramids, a new class of nanoparticles with tunable optical properties at visible and near-infrared wavelengths. This system is ideally suited for designing multifunctional plasmonic materials for use in diagnostics, imaging, sensing, and therapeutics. The nanofabrication scheme that we developed (called PEEL) for these asymmetric metal particles is extremely versatile and offers several advantages over synthetic methodologies. The PEEL approach yields pyramids with variable sizes, thicknesses, and multimetal compositions, as well as blunt or ultrasharp tips or no tips. In addition, we have prepared pyramids with site-specific chemical and biological functionality on different portions of the pyramids. This is an important design feature for biological applications, as suggested by the generation of amphiphilic gold pyramids functionalized with alkanethiols on the hydrophobic portions and DNA on the hydrophilic portions. The optical characteristics of these pyramids depend on particle orientation, wavevector direction, and polarization direction and can be tuned. Using the multipolar surface plasmon resonances of large (&gt;250 nm) pyramids, imaging and spectral identification of pyramid orientation in condensed media was possible. We were also able to direct pyramids to assemble into one- and two-dimensional arrays with interesting optical properties. Furthermore, modification of the PEEL fabrication scheme allowed the production of multimaterial pyramidal structures with complex attributes, highlighting the power of this platform for exacting nanometer-scale control over particle structure and composition.</abstract><notes>Journal article</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18803410 </url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>15.403</custom4><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1364</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1364</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lamb, B. M.</author><author>Westcott, N. P.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Yousaf, MN&#xD;Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA</auth-address><titles><title>Live-Cell Fluorescence Microscopy of Directed Cell Migration on Partially Etched Electroactive SAM Gold Surfaces</title><secondary-title>Chembiochem</secondary-title></titles><periodical><full-title>Chembiochem</full-title></periodical><pages>2220-2224</pages><volume>9</volume><number>14</number><edition>2008/09</edition><keywords><keyword>cell migration</keyword><keyword>cells electrochemistry</keyword><keyword>microfluidic lithography</keyword><keyword>self assembled monolayers (sams)</keyword><keyword>self-assembled monolayers</keyword><keyword>ligands</keyword><keyword>polarization</keyword><keyword>immobilization</keyword><keyword>patterns</keyword><keyword>polarity</keyword><keyword>cdc42</keyword><keyword>activation</keyword><keyword>gradients</keyword><keyword>chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep 22</date></pub-dates></dates><isbn>1439-4227</isbn><accession-num>ISI:000260086000008</accession-num><notes>360VJ&#xD;Times Cited:1&#xD;Cited References Count:28</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000260086000008</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>3.684</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1292</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1292</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jacobson, K.</author><author>Rajfur, Z.</author><author>Vitriol, E.</author><author>Hahn, K.</author></authors></contributors><auth-address>Jacobson, K&#xD;Univ N Carolina, Dept Cell &amp; Dev Biol, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Cell &amp; Dev Biol, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA</auth-address><titles><title>Chromophore-assisted laser inactivation in cell biology</title><secondary-title>Trends in Cell Biology</secondary-title></titles><periodical><full-title>Trends in Cell Biology</full-title></periodical><pages>443-450</pages><volume>18</volume><number>9</number><edition>2008/09</edition><keywords><keyword>green fluorescent protein</keyword><keyword>egfp-fusion proteins</keyword><keyword>singlet-oxygen</keyword><keyword>light inactivation</keyword><keyword>correlation spectroscopy</keyword><keyword>fibroblast motility</keyword><keyword>ena/vasp proteins</keyword><keyword>capping protein</keyword><keyword>microscopy</keyword><keyword>actin</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0962-8924</isbn><accession-num>ISI:000259334100006</accession-num><abstract>Chromophore-assisted laser inactivation (CALI) is a technique whereby engineered proteins and dye molecules that produce substantial amounts of reactive oxygen species upon absorption of light are used to perturb biological systems in a spatially and temporally defined manner. CALI is an important complement to conventional genetic and pharmacological manipulations. In this review, we examine the applications of CALI to cell biology and discuss the underlying photochemical mechanisms that mediate this powerful technique.</abstract><notes>350DZ&#xD;Times Cited:0&#xD;Cited References Count:44</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000259334100006</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>12.503</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1281</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1281</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hurst, S. J.</author><author>Hill, H. D.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>&quot;Three-dimensional hybridization&quot; with polyvalent DNA-gold nanoparticle conjugates</title><secondary-title>J Am Chem Soc</secondary-title><alt-title>Journal of the American Chemical Society</alt-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><alt-periodical><full-title>Journal of the American Chemical Society</full-title></alt-periodical><pages>12192-200</pages><volume>130</volume><number>36</number><edition>2008/09</edition><keywords><keyword>Base Pairing</keyword><keyword>DNA/*chemistry</keyword><keyword>Gold/*chemistry</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Nucleic Acid Hybridization/*methods</keyword><keyword>Transition Temperature</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep 10</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18710229</accession-num><abstract>We have determined the minimum number of base pairings necessary to stabilize DNA-Au NP aggregates as a function of salt concentration for particles between 15 and 150 nm in diameter. Significantly, we find that sequences containing a single base pair interaction are capable of effecting hybridization between 150 nm DNA-Au NPs. While traditional DNA hybridization involves two strands interacting in one dimension (1D, Z), we propose that hybridization in the context of an aggregate of polyvalent DNA-Au NP conjugates occurs in three dimensions (many oligonucleotides oriented perpendicular to the X, Y plane engage in base pairing), making nanoparticle assembly possible with three or fewer base pairings per DNA strand. These studies enabled us to compare the stability of duplex DNA free in solution and bound to the nanoparticle surface. We estimate that 4-8, 6-19, or 8-33 additional DNA bases must be added to free duplex DNA to achieve melting temperatures equivalent to hybridized systems formed from 15, 60, or 150 nm DNA-Au NPs, respectively. In addition, we estimate that the equilibrium binding constant (K(eq)) for 15 nm DNA-Au NPs (3 base pairs) is approximately 3 orders of magnitude higher than the K(eq) for the corresponding nanoparticle free system.</abstract><notes>Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18710229 </url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>8.256</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2524</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2524</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fogal, Valentina</author><author>Zhang, Lianglin</author><author>Krajewski, Stan</author><author>Ruoslahti, Erkki</author></authors></contributors><titles><title>Mitochondrial/Cell-Surface Protein p32/gC1qR as a Molecular Target in Tumor Cells and Tumor Stroma</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>7210-7218</pages><volume>68</volume><number>17</number><edition>2008/09</edition><dates><year>2008</year><pub-dates><date>September 1, 2008</date></pub-dates></dates><abstract>A tumor homing peptide, LyP-1, selectively binds to tumor-associated lymphatic vessels and tumor cells in certain tumors and exhibits an antitumor effect. Here, we show that the protein known as p32 or gC1q receptor is the receptor for LyP-1. Various human tumor cell lines were positive for p32 expression in culture, and the expression was increased in xenograft tumors grown from the positive cell lines. Fluorescence-activated cell sorting analyses with anti-p32 antibodies showed that p32-positive cell lines expressed p32 at the cell surface. These cells bound and internalized LyP-1 peptide in proportion to the cell-surface expression level, which correlated with malignancy rather than total p32 expression in the cells. Like the LyP-1 peptide, p32 antibodies highlighted hypoxic areas in tumors, where they bound to both tumor cells and cells that expressed macrophage/myeloid cell markers and often seemed to be incorporated into the walls of tumor lymphatics. Significant p32 expression was common in human cancers and the p32 levels were often greatly elevated compared with the corresponding normal tissue. These results establish p32, particularly its cell-surface-expressed form, as a new marker of tumor cells and tumor-associated macrophages/myeloid cells in hypoxic/metabolically deprived areas of tumors. Its unique localization in tumors and its relative tumor specificity may make p32 a useful target in tumor diagnosis and therapy. [Cancer Res 2008;68(17):7210-8]</abstract><urls><related-urls><url>http://cancerres.aacrjournals.org/cgi/content/abstract/68/17/7210</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>7.980</custom4><electronic-resource-num>10.1158/0008-5472.can-07-6752</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2531</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2531</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Alvarez, Sara D.</author><author>Derfus, Austin M.</author><author>Schwartz, Michael P.</author><author>Bhatia, Sangeeta N.</author><author>Sailor, Michael J.</author></authors></contributors><titles><title>The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors</title><secondary-title>Biomaterials</secondary-title></titles><periodical><full-title>Biomaterials</full-title></periodical><pages>26-34</pages><volume>30</volume><number>1</number><edition>2008/09</edition><reprint-edition>2008/09</reprint-edition><keywords><keyword>Porous silicon</keyword><keyword>Surface modification</keyword><keyword>Hepatocyte</keyword><keyword>Cell adhesion</keyword><keyword>Cell viability</keyword><keyword>Sensor</keyword></keywords><dates><year>2009</year></dates><isbn>0142-9612</isbn><notes>doi: DOI: 10.1016/j.biomaterials.2008.09.005</notes><urls><related-urls><url>http://www.sciencedirect.com/science/article/B6TWB-4TMHKVR-2/2/1aefe9870a434156d4de638de015f96d</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>7.325</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2188</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2188</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Palmer, L. C.</author><author>Stupp, S. I.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, Illinois 60208, USA.</auth-address><titles><title>Molecular self-assembly into one-dimensional nanostructures</title><secondary-title>Acc Chem Res</secondary-title></titles><periodical><full-title>Acc Chem Res</full-title></periodical><pages>1674-84</pages><volume>41</volume><number>12</number><edition>2008/08/30</edition><keywords><keyword>Anthracenes/chemistry</keyword><keyword>Microscopy, Atomic Force</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanostructures/ chemistry/radiation effects</keyword><keyword>Peptides/chemistry</keyword><keyword>Stereoisomerism</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1520-4898 (Electronic)</isbn><accession-num>18754628</accession-num><abstract>Self-assembly of small molecules into one-dimensional nanostructures offers many potential applications in electronically and biologically active materials. The recent advances discussed in this Account demonstrate how researchers can use the fundamental principles of supramolecular chemistry to craft the size, shape, and internal structure of nanoscale objects. In each system described here, we used atomic force microscopy (AFM) and transmission electron microscopy (TEM) to study the assembly morphology. Circular dichroism, nuclear magnetic resonance, infrared, and optical spectroscopy provided additional information about the self-assembly behavior in solution at the molecular level. Dendron rod-coil molecules self-assemble into flat or helical ribbons. They can incorporate electronically conductive groups and can be mineralized with inorganic semiconductors. To understand the relative importance of each segment in forming the supramolecular structure, we synthetically modified the dendron, rod, and coil portions. The self-assembly depended on the generation number of the dendron, the number of hydrogen-bonding functions, and the length of the rod and coil segments. We formed chiral helices using a dendron-rod-coil molecule prepared from an enantiomerically enriched coil. Because helical nanostructures are important targets for use in biomaterials, nonlinear optics, and stereoselective catalysis, researchers would like to precisely control their shape and size. Tripeptide-containing peptide lipid molecules assemble into straight or twisted nanofibers in organic solvents. As seen by AFM, the sterics of bulky end groups can tune the helical pitch of these peptide lipid nanofibers in organic solvents. Furthermore, we demonstrated the potential for pitch control using trans-to-cis photoisomerization of a terminal azobenzene group. Other molecules called peptide amphiphiles (PAs) are known to assemble in water into cylindrical nanostructures that appear as nanofiber bundles. Surprisingly, TEM of a PA substituted by a nitrobenzyl group revealed assembly into quadruple helical fibers with a braided morphology. Upon photocleavage of this the nitrobenzyl group, the helices transform into single cylindrical nanofibers. Finally, inspired by the tobacco mosaic virus, we used a dumbbell-shaped, oligo(phenylene ethynylene) template to control the length of a PA nanofiber self-assembly (&lt;10 nm). AFM showed complete disappearance of long nanofibers in the presence of this rigid-rod template. Results from quick-freeze/deep-etch TEM and dynamic light scattering demonstrated the templating behavior in aqueous solution. This strategy could provide a general method to control size the length of nonspherical supramolecular nanostructures.</abstract><notes>Palmer, Liam C&#xD;Stupp, Samuel I&#xD;5 R01 DE015920-04/DE/NIDCR NIH HHS/United States&#xD;5 R01 EB003806-05/EB/NIBIB NIH HHS/United States&#xD;5 U54 CA119341-03/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Accounts of chemical research&#xD;Acc Chem Res. 2008 Dec;41(12):1674-84.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom2>2645948</custom2><custom3>NIHMS65642</custom3><custom4>15.403</custom4><electronic-resource-num>10.1021/ar8000926 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2186</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2186</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCullagh, M.</author><author>Zhang, L.</author><author>Karaba, A. H.</author><author>Zhu, H.</author><author>Schatz, G. C.</author><author>Lewis, F. D.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Effect of loop distortion on the stability and structural dynamics of DNA hairpin and dumbbell conjugates</title><secondary-title>J Phys Chem B</secondary-title></titles><periodical><full-title>J Phys Chem B</full-title></periodical><pages>11415-21</pages><volume>112</volume><number>36</number><edition>2008/08/19</edition><keywords><keyword>DNA/ chemistry</keyword><keyword>Models, Molecular</keyword><keyword>Nucleic Acid Conformation</keyword><keyword>Spectrophotometry, Ultraviolet</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep 11</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>18707160</accession-num><abstract>The thermal stability and conformational dynamics of DNA hairpin and dumbbell conjugates having short A-tract base pair domains connected by tri- or hexa(ethylene glycol) linkers is reported. The formation of stable base-paired A-tract hairpins having oligo(ethylene glycol) linkers requires a minimum of four or five A-T base pairs. The formation of base-paired dumbbells having oligo(ethylene glycol) linkers by means of chemical ligation of nicked dumbbells requires a minimum of two A-T base pairs on either side of the nick. Molecular modeling indicates that the hexa(ethylene glycol) linker is sufficiently long to permit formation of strain-free loop regions and B-DNA base pair domains. In contrast, the tri(ethylene glycol) is too short to permit Watson-Crick base pairing between the bases attached to the linker. The shorter linker distorts the duplex, resulting in fluxional behavior in which the base pairs adjacent to the linker and at the open end of the hairpin dissociate on the nanosecond time scale. The loss of interstrand binding energy caused by these fluctuations leads to a difference of approximately 5 degrees C in melting temperature between EG3 and EG6 hairpins. An analysis of the fluxional behavior of the EG3 adjacent base-pair has been used to study the pathways for base flipping and base stacking, including the identification of rotated base (partially flipped) intermediates that have not been described previously for A-T base pairs.</abstract><notes>McCullagh, Martin&#xD;Zhang, Ligang&#xD;Karaba, Andrew H&#xD;Zhu, Huihe&#xD;Schatz, George C&#xD;Lewis, Frederick D&#xD;1 U54 CA119341-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2008 Sep 11;112(36):11415-21. Epub 2008 Aug 16.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.688</custom4><electronic-resource-num>10.1021/jp802378a [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2021</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2021</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schmieder, A. H.</author><author>Caruthers, S. D.</author><author>Zhang, H.</author><author>Williams, T. A.</author><author>Robertson, J. D.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Washington University Medical School, Campus Box 8215, 4320 Forest Park Ave., St. Louis, MO 63108, USA.</auth-address><titles><title>Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model</title><secondary-title>FASEB J</secondary-title></titles><periodical><full-title>FASEB J</full-title></periodical><pages>4179-89</pages><volume>22</volume><number>12</number><edition>2008/08/14</edition><keywords><keyword>Angiogenesis Inhibitors/administration &amp; dosage</keyword><keyword>Animals</keyword><keyword>Breast Neoplasms/drug therapy/ pathology</keyword><keyword>Cell Adhesion</keyword><keyword>Contrast Media/diagnostic use</keyword><keyword>Cyclohexanes/therapeutic use</keyword><keyword>Fatty Acids, Unsaturated/therapeutic use</keyword><keyword>Fibronectins/metabolism</keyword><keyword>Flow Cytometry</keyword><keyword>Integrin alphaVbeta3/ administration &amp; dosage</keyword><keyword>Magnetic Resonance Angiography</keyword><keyword>Mice</keyword><keyword>Microscopy, Confocal</keyword><keyword>Nanoparticles/diagnostic use</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neovascularization, Pathologic/diagnosis/ pathology</keyword><keyword>Oligopeptides</keyword><keyword>Particle Size</keyword><keyword>Receptors, Vitronectin/antagonists &amp; inhibitors/biosynthesis</keyword><keyword>Sesquiterpenes/therapeutic use</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-6860 (Electronic)</isbn><accession-num>18697838</accession-num><abstract>Our objectives were 1) to characterize angiogenesis in the MDA-MB-435 xenograft mouse model with three-dimensional (3D) MR molecular imaging using alpha(5)beta(1)(RGD)- or irrelevant RGS-targeted paramagnetic nanoparticles and 2) to use MR molecular imaging to assess the antiangiogenic effectiveness of alpha(5)beta(1)(alpha(nu)beta(3))- vs. alpha(nu)beta(3)-targeted fumagillin (50 mug/kg) nanoparticles. Tumor-bearing mice were imaged with MR before and after administration of either alpha(5)beta(1)(RGD) or irrelevant RGS-paramagnetic nanoparticles. In experiment 2, mice received saline or alpha(5)beta(1)(alpha(nu)beta(3))- or alpha(nu)beta(3)-targeted fumagillin nanoparticles on days 7, 11, 15, and 19 posttumor implant. On day 22, MRI was performed using alpha(5)beta(1)(alpha(nu)beta(3))-targeted paramagnetic nanoparticles to monitor the antiangiogenic response. 3D reconstructions of alpha(5)beta(1)(RGD)-signal enhancement revealed a sparse, asymmetrical pattern of angiogenesis along the tumor periphery, which occupied &lt;2.0% tumor surface area. alpha(5)beta(1)-targeted rhodamine nanoparticles colocalized with FITC-lectin corroborated the peripheral neovascular signal. alpha(5)beta(1)(alpha(nu)beta(3))-fumagillin nanoparticles decreased neovasculature to negligible levels relative to control; alpha(nu)beta(3)-targeted fumagillin nanoparticles were less effective (P&gt;0.05). Reduction of angiogenesis in MDA-MB-435 tumors from low to negligible levels did not decrease tumor volume. MR molecular imaging may be useful for characterizing tumors with sparse neovasculature that are unlikely to have a reduced growth response to targeted antiangiogenic therapy.</abstract><notes>Schmieder, Anne H&#xD;Caruthers, Shelton D&#xD;Zhang, Huiying&#xD;Williams, Todd A&#xD;Robertson, J David&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;CA-119342/CA/NCI NIH HHS/United States&#xD;HL-73646/HL/NHLBI NIH HHS/United States&#xD;HL-78631/HL/NHLBI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;The FASEB journal : official publication of the Federation of American Societies for Experimental Biology&#xD;FASEB J. 2008 Dec;22(12):4179-89. Epub 2008 Aug 12.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom2>2614609</custom2><custom4>7.128</custom4><electronic-resource-num>fj.08-112060 [pii]&#xD;10.1096/fj.08-112060 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1843</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1843</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gratton, S. E.</author><author>Ropp, P. A.</author><author>Pohlhaus, P. D.</author><author>Luft, J. C.</author><author>Madden, V. J.</author><author>Napier, M. E.</author><author>DeSimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina, Chapel Hill, NC 27599, USA.</auth-address><titles><title>The effect of particle design on cellular internalization pathways</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>11613-8</pages><volume>105</volume><number>33</number><edition>2008/08/14</edition><keywords><keyword>Cell Membrane/*metabolism</keyword><keyword>Endocytosis</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>*Nanoparticles/ultrastructure</keyword><keyword>Particle Size</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 19</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18697944</accession-num><abstract>The interaction of particles with cells is known to be strongly influenced by particle size, but little is known about the interdependent role that size, shape, and surface chemistry have on cellular internalization and intracellular trafficking. We report on the internalization of specially designed, monodisperse hydrogel particles into HeLa cells as a function of size, shape, and surface charge. We employ a top-down particle fabrication technique called PRINT that is able to generate uniform populations of organic micro- and nanoparticles with complete control of size, shape, and surface chemistry. Evidence of particle internalization was obtained by using conventional biological techniques and transmission electron microscopy. These findings suggest that HeLa cells readily internalize nonspherical particles with dimensions as large as 3 mum by using several different mechanisms of endocytosis. Moreover, it was found that rod-like particles enjoy an appreciable advantage when it comes to internalization rates, reminiscent of the advantage that many rod-like bacteria have for internalization in nonphagocytic cells.</abstract><notes>Gratton, Stephanie E A&#xD;Ropp, Patricia A&#xD;Pohlhaus, Patrick D&#xD;Luft, J Christopher&#xD;Madden, Victoria J&#xD;Napier, Mary E&#xD;DeSimone, Joseph M&#xD;P01-GM059299/GM/NIGMS NIH HHS/United States&#xD;U54-CA119343/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11613-8. Epub 2008 Aug 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18697944</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom2>2575324</custom2><custom4>10.228</custom4><electronic-resource-num>0801763105 [pii]&#xD;10.1073/pnas.0801763105</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2387</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2387</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, J. H.</author><author>von Maltzahn, G.</author><author>Ruoslahti, E.</author><author>Bhatia, S. N.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Materials Science and Engineering Program, Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman, La Jolla, CA 92093, USA.</auth-address><titles><title>Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>7284-8</pages><volume>47</volume><number>38</number><edition>2008/08/13</edition><keywords><keyword>Antineoplastic Agents/ analysis/pharmacokinetics</keyword><keyword>Biological Transport</keyword><keyword>Cell Line, Tumor</keyword><keyword>Doxorubicin/analysis/pharmacokinetics</keyword><keyword>Drug Delivery Systems</keyword><keyword>Ferric Compounds/analysis/chemistry/metabolism</keyword><keyword>Fluorescence</keyword><keyword>Humans</keyword><keyword>Magnetics</keyword><keyword>Micelles</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Quantum Dots</keyword><keyword>Spectrometry, Fluorescence</keyword></keywords><dates><year>2008</year></dates><isbn>1521-3773 (Electronic)</isbn><accession-num>18696519</accession-num><notes>Park, Ji-Ho&#xD;von Maltzahn, Geoffrey&#xD;Ruoslahti, Erkki&#xD;Bhatia, Sangeeta N&#xD;Sailor, Michael J&#xD;R01A124427-02/PHS HHS/United States&#xD;U01 HL 080718/HL/NHLBI NIH HHS/United States&#xD;U54 CA 119335/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2008;47(38):7284-8.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200801810 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2256</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2256</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Harris, T. J.</author><author>von Maltzahn, G.</author><author>Lord, M. E.</author><author>Park, J. H.</author><author>Agrawal, A.</author><author>Min, D. H.</author><author>Sailor, M. J.</author><author>Bhatia, S. N.</author></authors></contributors><auth-address>Harvard-MIT Division of Health Sciences and Technology Massachusetts Institute of Technology E19-502D Cambridge, MA 02139, USA.</auth-address><titles><title>Protease-triggered unveiling of bioactive nanoparticles</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>1307-12</pages><volume>4</volume><number>9</number><edition>2008/08/12</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Drug Carriers/chemistry/pharmacology</keyword><keyword>Humans</keyword><keyword>Matrix Metalloproteinase 2/ chemistry/ metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Nanoparticles/ chemistry</keyword><keyword>Neoplasms/pathology</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>18690639</accession-num><notes>Harris, Todd J&#xD;von Maltzahn, Geoffrey&#xD;Lord, Matthew E&#xD;Park, Ji-Ho&#xD;Agrawal, Amit&#xD;Min, Dal-Hee&#xD;Sailor, Michael J&#xD;Bhatia, Sangeeta N&#xD;EB 006324/EB/NIBIB NIH HHS/United States&#xD;R01CA124427-01/CA/NCI NIH HHS/United States&#xD;U54 CA119335/CA/NCI NIH HHS/United States&#xD;U54 CA119349/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2008 Sep;4(9):1307-12.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200701319 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1642</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1642</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Swanson, S. D.</author><author>Kukowska-Latallo, J. F.</author><author>Patri, A. K.</author><author>Chen, C.</author><author>Ge, S.</author><author>Cao, Z.</author><author>Kotlyar, A.</author><author>East, A. T.</author><author>Baker, J. R.</author></authors></contributors><auth-address>Department of Radiology,The University of Michigan Medical School, The University of Michigan, USA.</auth-address><titles><title>Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement</title><secondary-title>Int J Nanomedicine</secondary-title></titles><periodical><full-title>Int J Nanomedicine</full-title></periodical><pages>201-10</pages><volume>3</volume><number>2</number><edition>2008/08/09</edition><dates><year>2008</year></dates><isbn>1176-9114 (Print)</isbn><accession-num>18686779</accession-num><abstract>A target-specific MRI contrast agent for tumor cells expressing high affinity folate receptor was synthesized using generation five (G5) ofpolyamidoamine (PAMAM) dendrimer. Surface modified dendrimer was functionalized for targeting with folic acid (FA) and the remaining terminal primary amines of the dendrimer were conjugated with the bifunctional NCS-DOTA chelator that forms stable complexes with gadolinium (Gd III). Dendrimer-DOTA conjugates were then complexed with GdCl3 followed by ICP-OES as well as MRI measurement of their longitudinal relaxivity (T1 s(-1) mM(-1)) of water. In xenograft tumors established in immunodeficient (SCID) mice with KB human epithelial cancer cells expressing folate receptor (FAR), the 3D MRI results showed specific and statistically significant signal enhancement in tumors generated with targeted Gd(III)-DOTA-G5-FA compared with signal generated by non-targeted Gd(III)-DOTA-G5 contrast nanoparticle. The targeted dendrimer contrast nanoparticles infiltrated tumor and were retained in tumor cells up to 48 hours post-injection of targeted contrast nanoparticle. The presence of folic acid on the dendrimer resulted in specific delivery of the nanoparticle to tissues and xenograft tumor cells expressing folate receptor in vivo. We present the specificity of the dendrimer nanoparticles for targeted cancer imaging with the prolonged clearance time compared with the current clinically approved gadodiamide (Omniscan) contrast agent. Potential application of this approach may include determination of the folate receptor status of tumors and monitoring of drug therapy.</abstract><notes>Swanson, Scott D&#xD;Kukowska-Latallo, Jolanta F&#xD;Patri, Anil K&#xD;Chen, Chunyan&#xD;Ge, Song&#xD;Cao, Zhengyi&#xD;Kotlyar, Alina&#xD;East, Andrea T&#xD;Baker, James R&#xD;1 R01 EB002657/EB/United States NIBIB&#xD;N01-CO-97111/CO/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;New Zealand&#xD;International journal of nanomedicine&#xD;Int J Nanomedicine. 2008;3(2):201-10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18686779</url></related-urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom3>2008</custom3><custom4>1.649</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2143</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2143</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rieter, W. J.</author><author>Pott, K. M.</author><author>Taylor, K. M.</author><author>Lin, W.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Nanoscale coordination polymers for platinum-based anticancer drug delivery</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>11584-5</pages><volume>130</volume><number>35</number><edition>2008/08/09</edition><keywords><keyword>Antineoplastic Agents/ administration &amp; dosage/chemistry</keyword><keyword>Cisplatin/administration &amp; dosage/ analogs &amp; derivatives</keyword><keyword>Colorectal Neoplasms/drug therapy</keyword><keyword>Delayed-Action Preparations</keyword><keyword>Drug Delivery Systems/ methods</keyword><keyword>HT29 Cells</keyword><keyword>Humans</keyword><keyword>Models, Molecular</keyword><keyword>Nanostructures/ chemistry</keyword><keyword>Silicon Dioxide/administration &amp; dosage/chemistry</keyword><keyword>Terbium/chemistry</keyword><keyword>X-Ray Diffraction</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep 3</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18686947</accession-num><abstract>Pt-containing nanoscale coordination polymer (NCP) particles with the formula of Tb2(DSCP)3(H2O)12 (where DSCP represents disuccinatocisplatin), NCP-1, were precipitated from an aqueous solution of Tb3+ ions and DSCP bridging ligands via the addition of a poor solvent. SEM and TEM images showed that as-synthesized NCP-1 exhibited a spherical morphology with a DLS diameter of 58.3 +/- 11.3 nm. NCP-1 particles were stabilized against rapid dissolution in water by encapsulation in shells of amorphous silica. The resulting silica-coated particles NCP-1&apos; exhibited significantly longer half-lives for DSCP release from the particles (a t1/2 of 9 h for NCP-1&apos; with 7 nm silica coating vs t1/2 of 1 h for as-synthesized NCP-1). In vitro cancer cell cytotoxicity assays with the human colon carcinoma cell line (HT-29) showed that internalized NCP-1&apos; particles readily released the DSCP moieties which were presumably reduced to cytotoxic Pt(II) species to give the Pt-containing NCPs anticancer efficacy superior to the cisplatin standard. The generality of this degradable nanoparticle formulation should allow for the design of NCPs as effective delivery vehicles for a variety of biologically and medically important cargoes such as therapeutic and imaging agents.</abstract><notes>Rieter, William J&#xD;Pott, Kimberly M&#xD;Taylor, Kathryn M L&#xD;Lin, Wenbin&#xD;U54-CA119343/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Sep 3;130(35):11584-5. Epub 2008 Aug 8.</notes><urls></urls><custom1>CCNE - UNC</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja803383k [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2333</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2333</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, A. M.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 101 Woodruff Circle, Suite 2001, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Minimizing the hydrodynamic size of quantum dots with multifunctional multidentate polymer ligands</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>11278-9</pages><volume>130</volume><number>34</number><edition>2008/08/06</edition><keywords><keyword>Amines/chemistry</keyword><keyword>Cadmium Compounds/ chemistry</keyword><keyword>Fluorescence</keyword><keyword>Image Enhancement/ methods</keyword><keyword>Ligands</keyword><keyword>Nanotechnology/ methods</keyword><keyword>Polymers/ chemistry</keyword><keyword>Quantum Dots</keyword><keyword>Spectrometry, Fluorescence/methods</keyword><keyword>Sulfhydryl Compounds/chemistry</keyword><keyword>Tellurium/ chemistry</keyword><keyword>Thermodynamics</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 27</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18680294</accession-num><abstract>We report a new strategy to minimize the hydrodynamic size of quantum dots (QDs) and to overcome their colloidal stability and photobleaching problems based on the use of multifunctional and multidentate polymer ligands. A novel finding is that a balanced composition of thiol (-SH) and amine (-NH 2) coordinating groups grafted to a linear polymer chain leads to highly compact nanocrystals with exceptional colloidal stability, a strong resistance to photobleaching, and high fluorescence quantum yields. In contrast to the standing brushlike conformation of PEGylated dihydrolipoic acid molecules, mutlidentate polymer ligands can wrap around the QDs in a closed &quot;loops-and-trains&quot; conformation. This structure is highly stable thermodynamically and is responsible for the excellent colloidal and optical properties. We have optimized this process for the preparation of ultrastable CdTe nanocrystals and have found the strategy to be broadly applicable to a wide range of nanocrystalline materials and heterostructures. This work has led to a new generation of bright and stable QDs with small hydrodynamic diameters between 5.6 and 9.7 nm with tunable fluorescence emission from the visible (515 nm) to the near-infrared (720 nm). These QDs are well suited for molecular and cellular imaging applications in which the nanoparticle hydrodynamic size must be minimized.</abstract><notes>Smith, Andrew M&#xD;Nie, Shuming&#xD;P20 GM072069/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-01/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-02/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-03/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-04/GM/NIGMS NIH HHS/United States&#xD;R01 CA108468/CA/NCI NIH HHS/United States&#xD;R01 CA108468-01/CA/NCI NIH HHS/United States&#xD;R01 CA108468-02/CA/NCI NIH HHS/United States&#xD;R01 CA108468-03/CA/NCI NIH HHS/United States&#xD;R01 CA108468-04/CA/NCI NIH HHS/United States&#xD;R01 CA108468-05/CA/NCI NIH HHS/United States&#xD;U01HL080711/HL/NHLBI NIH HHS/United States&#xD;U54 CA119338-01/CA/NCI NIH HHS/United States&#xD;U54 CA119338-02/CA/NCI NIH HHS/United States&#xD;U54 CA119338-03/CA/NCI NIH HHS/United States&#xD;U54 CA119338-04/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Aug 27;130(34):11278-9. Epub 2008 Aug 5.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom2>2703485</custom2><custom3>NIHMS118256</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja804306c [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1830</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1830</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Y.</author><author>Zhou, C.</author><author>Xu, Y.</author><author>Fang, C.</author><author>Zhang, M.</author></authors></contributors><auth-address>Reproductive Medical Center, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People&apos;s Republic of China.</auth-address><titles><title>Pregnancy outcome in preimplantation genetic diagnosis cycle by blastomere biopsy is related to both quality and quantity of embryos on day 3</title><secondary-title>Fertil Steril</secondary-title></titles><periodical><full-title>Fertil Steril</full-title></periodical><pages>1355-7</pages><volume>91</volume><number>4 Suppl</number><edition>2008/08/05</edition><keywords><keyword>Adult</keyword><keyword>Biopsy</keyword><keyword>Blastomeres/*pathology</keyword><keyword>Embryo Transfer/*methods</keyword><keyword>Embryonic Development/*physiology</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Pregnancy</keyword><keyword>*Pregnancy Outcome</keyword><keyword>Pregnancy Rate</keyword><keyword>Preimplantation Diagnosis/*methods</keyword><keyword>Reproductive Techniques, Assisted</keyword><keyword>Retrospective Studies</keyword><keyword>Time Factors</keyword></keywords><dates><year>2009</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1556-5653 (Electronic)</isbn><accession-num>18675415</accession-num><abstract>The aim of this study was to determine the impact of day 3 embryo quality and quantity on subsequent embryonic development and pregnancy outcome following embryo biopsy. The findings demonstrate that a significantly lower proportion of poor/fair-quality embryos develop further after biopsy, and that patients with &lt;4 good embryos on day 3 may have poor outcome. Therefore, appropriate counseling needs to be given to them before therapy is initiated.</abstract><notes>Liu, Ying&#xD;Zhou, Canquan&#xD;Xu, Yanwen&#xD;Fang, Cong&#xD;Zhang, Minfang&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Fertility and sterility&#xD;Fertil Steril. 2009 Apr;91(4 Suppl):1355-7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18675415</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom4>3.782</custom4><electronic-resource-num>S0015-0282(08)00721-8 [pii]&#xD;10.1016/j.fertnstert.2008.03.054</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2092</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2092</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, Z. B.</author><author>Niu, G.</author><author>Wang, H.</author><author>He, L.</author><author>Yang, L.</author><author>Ploug, M.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, California 94305-5484, USA.</auth-address><titles><title>Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPET</title><secondary-title>Clin Cancer Res</secondary-title></titles><periodical><full-title>Clin Cancer Res</full-title></periodical><pages>4758-66</pages><volume>14</volume><number>15</number><edition>2008/08/05</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Copper Radioisotopes/chemistry</keyword><keyword>Female</keyword><keyword>Heterocyclic Compounds, 1-Ring/pharmacology</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Peptides/chemistry</keyword><keyword>Positron-Emission Tomography/instrumentation/ methods</keyword><keyword>Receptors, Cell Surface/ biosynthesis</keyword><keyword>Receptors, Urokinase Plasminogen Activator</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Surface Plasmon Resonance</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>18676745</accession-num><abstract>PURPOSE: Malignant tumors are capable of degrading the surrounding extracellular matrix, resulting in local invasion or metastasis. Urokinase-type plasminogen activator (uPA) and its cell surface receptor (uPAR) are central molecules in one of the major protease systems involved in extracellular matrix degradation. Noninvasive imaging of this receptor in vivo with radiolabeled peptides that specifically target uPAR may therefore be useful to decipher the potential invasiveness of malignant lesions. EXPERIMENTAL DESIGN: In this study, we developed a (64)Cu-labeled uPAR-binding peptide for positron emission tomography (PET) imaging. A linear, high-affinity uPAR-binding peptide antagonist AE105 was conjugated with 1,4,7,10-tetraazadodecane-N,N&apos;,N&apos;&apos;,N&apos;&apos;&apos;-tetraacetic acid (DOTA) and labeled with (64)Cu for microPET imaging of mice bearing U87MG human glioblastoma (uPAR positive) and MDA-MB-435 human breast cancer (uPAR negative). RESULTS: Surface plasmon resonance measurements show that AE105 with DOTA conjugated at the alpha-amino group (DOTA-AE105) has high affinity toward uPAR. microPET imaging reveals a rapid and high accumulation of (64)Cu-DOTA-AE105 in uPAR-positive U87MG tumors (10.8 +/- 1.5%ID/g at 4.5 hours, n = 3) but not in uPAR-negative MDA-MB-435 tumors (1.2 +/- 0.6%ID/g at 4.5 hours, n = 3). Specificity of this peptide-based imaging of uPAR was validated by further control experiments. First, a nonbinding variant of AE105 carrying a single amino acid replacement (Trp--&gt;Glu) does not target U87MG tumors in vivo. Second, targeting of U87MG tumors by (64)Cu-DOTA-AE105 is specifically inhibited by a nonlabeled antagonist. CONCLUSION: The successful demonstration of the ability of a (64)Cu labeled uPAR-specific probe to visualize uPAR expression in vivo may allow clinical translation of this class of radiopharmaceuticals for uPAR-positive cancer detection and patient stratification for uPA/uPAR system-based cancer therapy.</abstract><notes>Li, Zi-Bo&#xD;Niu, Gang&#xD;Wang, Hui&#xD;He, Lina&#xD;Yang, Lily&#xD;Ploug, Michael&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 Aug 1;14(15):4758-66.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.646</custom4><electronic-resource-num>14/15/4758 [pii]&#xD;10.1158/1078-0432.CCR-07-4434 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2185</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2185</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>James, J.</author><author>Goluch, E. D.</author><author>Hu, H.</author><author>Liu, C.</author><author>Mrksich, M.</author></authors></contributors><auth-address>Department of Cell and Molecular Biology, Northwestern University, Chicago, Illinois, USA.</auth-address><titles><title>Subcellular curvature at the perimeter of micropatterned cells influences lamellipodial distribution and cell polarity</title><secondary-title>Cell Motil Cytoskeleton</secondary-title></titles><periodical><full-title>Cell Motil Cytoskeleton</full-title></periodical><pages>841-52</pages><volume>65</volume><number>11</number><edition>2008/08/05</edition><keywords><keyword>Actins/metabolism</keyword><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Polarity</keyword><keyword>Cell Shape</keyword><keyword>Cells, Cultured</keyword><keyword>Cytoskeleton/metabolism</keyword><keyword>Melanoma/metabolism</keyword><keyword>Microtubules/metabolism</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Pseudopodia/ metabolism</keyword><keyword>Rats</keyword><keyword>Stress Fibers/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1097-0169 (Electronic)</isbn><accession-num>18677773</accession-num><abstract>This paper employs substrates that are patterned with shapes having well-defined geometric cues to characterize the influence of curvature on the polarization of highly metastatic B16F10 rat melanoma cells. Substrates were patterned using microcontact printing to define adhesive islands of defined shape and size on a background that otherwise prevents cell adhesion. Cells adherent to these surfaces responded to local curvature at the perimeter of the adhesive islands; convex features promoted the assembly of lamellipodia and concave features promoted the assembly of stress filaments. Cells adherent to rectangular shapes displayed a polarized cytoskeleton that increased with the aspect ratio of the shapes. Shapes that combined local geometric cues, by way of concave or convex edges, with aspect ratio were used to understand the additive effects of shape on polarization. The dependence of cell polarity on shape was determined in the presence of small molecules that alter actomyosin contractility and revealed a stronger dependence on contractility for shapes having straight edges, in contrast to those having curved edges. This study demonstrates that the cytoskeleton modulates cell polarity in response to multiple geometric cues in the extracellular environment.</abstract><notes>James, Jane&#xD;Goluch, Edgar D&#xD;Hu, Huan&#xD;Liu, Chang&#xD;Mrksich, Milan&#xD;U54 CA119341-04/CA/NCI NIH HHS/United States&#xD;Howard Hughes Medical Institute/United States&#xD;United States&#xD;Cell motility and the cytoskeleton&#xD;Cell Motil Cytoskeleton. 2008 Nov;65(11):841-52.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom2>2652852</custom2><custom3>NIHMS88771</custom3><custom4>na</custom4><electronic-resource-num>10.1002/cm.20305 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2255</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2255</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Alexis, F.</author><author>Pridgen, E.</author><author>Molnar, L. K.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women&apos;s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. falexis@zeus.bwh.harvard.edu</auth-address><titles><title>Factors affecting the clearance and biodistribution of polymeric nanoparticles</title><secondary-title>Mol Pharm</secondary-title></titles><periodical><full-title>Mol Pharm</full-title></periodical><pages>505-15</pages><volume>5</volume><number>4</number><edition>2008/08/05</edition><keywords><keyword>Animals</keyword><keyword>Clinical Trials as Topic</keyword><keyword>Humans</keyword><keyword>Micelles</keyword><keyword>Nanoparticles</keyword><keyword>Particle Size</keyword><keyword>Surface Properties</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2008</year><pub-dates><date>Jul-Aug</date></pub-dates></dates><isbn>1543-8384 (Print)</isbn><accession-num>18672949</accession-num><abstract>Nanoparticle (NP) drug delivery systems (5-250 nm) have the potential to improve current disease therapies because of their ability to overcome multiple biological barriers and releasing a therapeutic load in the optimal dosage range. Rapid clearance of circulating nanoparticles during systemic delivery is a critical issue for these systems and has made it necessary to understand the factors affecting particle biodistribution and blood circulation half-life. In this review, we discuss the factors which can influence nanoparticle blood residence time and organ specific accumulation. These factors include interactions with biological barriers and tunable nanoparticle parameters, such as composition, size, core properties, surface modifications (pegylation and surface charge), and finally, targeting ligand functionalization. All these factors have been shown to substantially affect the biodistribution and blood circulation half-life of circulating nanoparticles by reducing the level of nonspecific uptake, delaying opsonization, and increasing the extent of tissue specific accumulation.</abstract><notes>Alexis, Frank&#xD;Pridgen, Eric&#xD;Molnar, Linda K&#xD;Farokhzad, Omid C&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;EB003647/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Molecular pharmaceutics&#xD;Mol Pharm. 2008 Jul-Aug;5(4):505-15. Epub 2008 Aug 4.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2663893</custom2><custom3>2008</custom3><custom4>4.388</custom4><electronic-resource-num>10.1021/mp800051m [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2091</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2091</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koh, A. L.</author><author>Hu, W.</author><author>Wilson, R. J.</author><author>Wang, S. X.</author><author>Sinclair, R.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, Stanford University, Stanford, CA 94305, USA. alkoh@stanford.edu</auth-address><titles><title>TEM analyses of synthetic anti-ferromagnetic (SAF) nanoparticles fabricated using different release layers</title><secondary-title>Ultramicroscopy</secondary-title></titles><periodical><full-title>Ultramicroscopy</full-title></periodical><pages>1490-4</pages><volume>108</volume><number>11</number><edition>2008/08/02</edition><dates><year>2008</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0304-3991 (Print)</isbn><accession-num>18672328</accession-num><abstract>This paper investigates the structural characteristics of templated synthetic anti-ferromagnetic (SAF) magnetic nanoparticles fabricated on two different release layers. When copper was used as the latter, the layered structure of the SAFs was found to be disrupted with wavy multi-layers due to the formation of copper grains from the release layer. By introducing oxygen into the copper release layer before the deposition of the film, the topography of the oxidized copper grains was effectively controlled. This led to the fabrication of SAF nanoparticles with flat multi-layers.</abstract><notes>Koh, Ai Leen&#xD;Hu, Wei&#xD;Wilson, Robert John&#xD;Wang, Shan Xiang&#xD;Sinclair, Robert&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Netherlands&#xD;Ultramicroscopy&#xD;Ultramicroscopy. 2008 Oct;108(11):1490-4. Epub 2008 Jun 25.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom2>2582063</custom2><custom3>NIHMS73760</custom3><custom4>2.629</custom4><electronic-resource-num>S0304-3991(08)00186-1 [pii]&#xD;10.1016/j.ultramic.2008.03.012 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2254</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2254</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hilderbrand, S. A.</author><author>Kelly, K. A.</author><author>Niedre, M.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research and Center for Systems Biology, Massachusetts General Hospital/Harvard Medical School, USA. Scott_Hilderbrand@hms.harvard.edu</auth-address><titles><title>Near infrared fluorescence-based bacteriophage particles for ratiometric pH imaging</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>1635-9</pages><volume>19</volume><number>8</number><edition>2008/08/01</edition><keywords><keyword>Bacteriophages/ metabolism</keyword><keyword>Carbocyanines/chemical synthesis/chemistry/metabolism</keyword><keyword>Fluorescence</keyword><keyword>Fluorescent Dyes/chemical synthesis/chemistry/metabolism</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Intracellular Space/metabolism</keyword><keyword>Phantoms, Imaging</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1520-4812 (Electronic)</isbn><accession-num>18666791</accession-num><abstract>Fluorogenic imaging agents emitting in the near-infrared are becoming important research tools for disease investigation in vivo. Often pathophysiological states such as cancer and cystic fibrosis are associated with disruptions in acid/base homeostasis. The development of optical sensors for pH imaging would facilitate the investigation of these diseased conditions. In this report, the design and synthesis of a ratiometric near-infrared emitting probe for pH quantification is detailed. The pH-responsive probe is prepared by covalent attachment of pH-sensitive and pH-insensitive fluorophores to a bacteriophage particle scaffold. The pH-responsive cyanine dye, HCyC-646, used to construct the probe, has a fluorogenic pKa of 6.2, which is optimized for visualization of acidic pH often associated with tumor hypoxia and other diseased states. Incorporation of pH-insensitive reference dyes enables the ratiometric determination of pH independent of the probe concentration. With the pH-responsive construct, measurement of intracellular pH and accurate determination of pH through optically diffuse biological tissue is demonstrated.</abstract><notes>Hilderbrand, Scott A&#xD;Kelly, Kimberly A&#xD;Niedre, Mark&#xD;Weissleder, Ralph&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;CA92782/CA/NCI NIH HHS/United States&#xD;HL080731/HL/NHLBI NIH HHS/United States&#xD;R24 CA092782-05/CA/NCI NIH HHS/United States&#xD;U01 HL080731-03/HL/NHLBI NIH HHS/United States&#xD;U54 CA119349-040003/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2008 Aug;19(8):1635-9. Epub 2008 Jul 31.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2705288</custom2><custom3>NIHMS104515</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/bc800188p [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1784</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1784</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhao, J.</author><author>Das, A.</author><author>Schatz, G. C.</author><author>Sligar, S. G.</author><author>Van Duyne, R. P.</author></authors></contributors><auth-address>Schatz, GC&#xD;Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Chem, Evanston, IL 60208 USA&#xD;Univ Illinois, Beckman Inst Adv Sci &amp; Technol, Dept Biochem &amp; Chem, Urbana, IL 61801 USA</auth-address><titles><title>Resonance localized surface plasmon spectroscopy: Sensing substrate and inhibitor binding to cytochrome P450</title><secondary-title>Journal of Physical Chemistry C</secondary-title></titles><periodical><full-title>Journal of Physical Chemistry C</full-title></periodical><pages>13084-13088</pages><volume>112</volume><number>34</number><edition>2008/08</edition><keywords><keyword>nanoscale optical biosensor</keyword><keyword>silver nanoparticles</keyword><keyword>nanosphere lithography</keyword><keyword>molecular resonances</keyword><keyword>solar-cells</keyword><keyword>spectra</keyword><keyword>sensors</keyword><keyword>p450</keyword><keyword>sensitivity</keyword><keyword>complexes</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 28</date></pub-dates></dates><isbn>1932-7447</isbn><accession-num>ISI:000258633600007</accession-num><abstract>A sensing method based on resonance localized surface plasmon spectroscopy was developed for low molecular weight substrate and inhibitor molecules binding to heme proteins. Cytochrome P450 proteins have Soret and Q absorption bands in the visible wavelength region. The coupling between the molecular resonance of P450 and the localized surface plasmon resonance (LSPR) of functionalized silver nanoparticles leads to a highly wavelength-dependent LSPR response. Binding of substrate (e.g., camphor) or inhibitor (e.g., imidazole) molecules to a cytochrome P450 causes the absorption band of cytochrome P450 shift to shorter or longer wavelengths, respectively. By monitoring the localized surface plasmon resonance (LSPR) of the nanosensors, the binding of camphor/imidazole to a nanoparticle whose surface is modified with cytochrome P450 protein leads to a wavelength-dependent blue/red shift in the LSPR. The magnitude of the LSPR shift induced by camphor or imidazole is consistent with the Soret band wavelength shift observed in P450 in solution.</abstract><notes>340GH&#xD;Times Cited:0&#xD;Cited References Count:44</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258633600007</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>3.398</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1737</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1737</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wu, J.</author><author>Aslam, M.</author><author>Dravid, V. P.</author></authors></contributors><auth-address>Wu, J&#xD;Northwestern Univ, Dept Mat Sci &amp; Engn, Int Inst Nanotechnol, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Mat Sci &amp; Engn, Int Inst Nanotechnol, Evanston, IL 60208 USA&#xD;Indian Inst Technol, Dept Phys, Bombay 400076, Maharashtra, India</auth-address><titles><title>Imaging of magnetic colloids under the influence of magnetic field by cryogenic transmission electron microscopy</title><secondary-title>Applied Physics Letters</secondary-title></titles><periodical><full-title>Applied Physics Letters</full-title></periodical><pages>-</pages><volume>93</volume><number>8</number><edition>2008/08</edition><keywords><keyword>cobalt nanoparticle rings</keyword><keyword>dipolar chains</keyword><keyword>flux-closure</keyword><keyword>zero-field</keyword><keyword>nanocrystals</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 25</date></pub-dates></dates><isbn>0003-6951</isbn><accession-num>ISI:000259011900057</accession-num><abstract>The application of superparamagnetic nanoparticles for in vivo magnetic resonance imaging (MRI) under external ac magnetic field has attracted considerable research efforts in recent years. However, it is unclear how superparamagnetic nanostructures arrange themselves in fluidic environment under external magnetic field. Here, we report direct visualization of the effect of applied magnetic field to the ferrofluids (about 6 nm superparamagnetic magnetite (Fe3O4) nanoparticle &quot;colloidal&quot; suspension) using the cryogenic transmission electron microscopy (cryo-TEM). While long dipole chains (up to millimeter range) of the magnetite along the magnetic lines are found in samples dried inside the magnetic field, only short dipole chains (within tens of nanometer scale) with random orientations are observed in the wet sample observed by cryo-TEM. In the wet sample, aggregations of medium-length dipole chains (up to hundreds of nanometer) can be observed at the areas where the nanoparticles are &quot;solidified&quot; when phase separation occurs. In situ formation of flux-closure rings is observed at the edge where vitreous ice sublimes due to high-energy electron radiation that leaves magnetite nanoparticles isolated in the vacuum. Such observations may help elucidate the nature of magnetic field-induced assembly in fluidic environment as in the physiological aqueous conditions in MRI and related applications. (C) 2008 American Institute of Physics.</abstract><notes>345QR&#xD;Times Cited:0&#xD;Cited References Count:18</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000259011900057</url></related-urls></urls><custom1>CNPP - Roswell Park Cancer Institute</custom1><custom4>4.096</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1675</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1675</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>van Vlerken, L. E.</author><author>Duan, Z.</author><author>Little, S. R.</author><author>Seiden, M. V.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Amiji, MM&#xD;Northeastern Univ, Dept Pharmaceut Sci, 110 Mugar Life Sci Bldg,360 Huntington Ave, Boston, MA 02115 USA&#xD;Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA&#xD;Massachusetts Gen Hosp, Boston, MA 02114 USA&#xD;Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA&#xD;Fox Chase Canc Ctr, Philadelphia, PA 19111 USA</auth-address><titles><title>Biodistribution and pharmacokinetic analysis of paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model</title><secondary-title>Molecular Pharmaceutics</secondary-title></titles><periodical><full-title>Molecular Pharmaceutics</full-title></periodical><pages>516-526</pages><volume>5</volume><number>4</number><edition>2008/08</edition><keywords><keyword>multidrug resistant tumors</keyword><keyword>polymer-blend nanoparticles</keyword><keyword>paclitaxel</keyword><keyword>ceramide</keyword><keyword>biodistribution</keyword><keyword>noncompartmental pharmacokinetics</keyword><keyword>multidrug-resistance</keyword><keyword>glycosphingolipid metabolism</keyword><keyword>targeted delivery</keyword><keyword>tamoxifen</keyword><keyword>cells</keyword><keyword>system</keyword><keyword>ph</keyword></keywords><dates><year>2008</year><pub-dates><date>Jul-Aug</date></pub-dates></dates><isbn>1543-8384</isbn><accession-num>ISI:000258226300006</accession-num><abstract>In this study, we have investigated the biodistribution and pharmacokinetic analysis of paclitaxel (PTX) and the apoptotic signaling molecule, C-6-ceramide (CER), when administered in a multifunctional polymer-blend nanoparticle formulation to female nude mice bearing an orthotopic drug sensitive MCF7 and multidrug resistant MCF7(TR) (MDR-1 positive) human breast adenocarcinoma. A polymer-blend nanoparticle system was engineered to incorporate temporally controlled sequential release of the combination drug payload. Hereby, PTX was encapsulated in the pH-responsive rapid releasing polymer, poly(beta-amino ester) (PbAE), while CER was present in the slow releasing polymer, poly(D,L-lactide-co-glycolide) (PLGA) with n these blend nanoparticles. When particle formulations were administered intravenously to MCF7 and MCF7TR tumor bearing mice, higher concentrations of PTX were found in the blood due to longer retention time and an enhanced tumor accumulation relative to administration of free drug. In addition, the PLGA/PbAE blend nanoparticles were effective in enhancing the residence time of both drugs at the tumor site by reducing systemic clearance. Overall, these results are highly encouraging for development of multifunctional polymer-blend nanoparticle formulations that can be used for temporal -controlled administration of two drugs from a single formulation.</abstract><notes>334MQ&#xD;Times Cited:0&#xD;Cited References Count:23</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258226300006</url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom4>4.388</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2505</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2505</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tetard, Laurene</author><author>Passian, Ali</author><author>Venmar, Katherine T.</author><author>Lynch, Rachel M.</author><author>Voy, Brynn H.</author><author>Shekhawat, Gajendra</author><author>Dravid, Vinayak P.</author><author>Thundat, Thomas</author></authors></contributors><titles><title>Imaging nanoparticles in cells by nanomechanical holography</title><secondary-title>Nat Nano</secondary-title></titles><periodical><full-title>Nat Nano</full-title></periodical><pages>501-505</pages><volume>3</volume><number>8</number><edition>2008/08</edition><dates><year>2008</year></dates><publisher>Nature Publishing Group</publisher><isbn>1748-3387</isbn><notes>10.1038/nnano.2008.162</notes><urls><related-urls><url>http://dx.doi.org/10.1038/nnano.2008.162</url><url>http://www.nature.com/nnano/journal/v3/n8/suppinfo/nnano.2008.162_S1.html</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>20.588</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2504</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2504</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tenchov, Boris G.</author><author>Wang, Li</author><author>Koynova, Rumiana</author><author>MacDonald, Robert C.</author></authors></contributors><titles><title>Modulation of a membrane lipid lamellar-nonlamellar phase transition by cationic lipids: A measure for transfection efficiency</title><secondary-title>Biochimica et Biophysica Acta (BBA) - Biomembranes</secondary-title></titles><periodical><full-title>Biochimica et Biophysica Acta (BBA) - Biomembranes</full-title></periodical><pages>2405-2412</pages><volume>1778</volume><number>10</number><edition>2008/08</edition><keywords><keyword>Cationic lipid</keyword><keyword>Lipofection</keyword><keyword>Lipoplex</keyword><keyword>Phase transition</keyword><keyword>Inverted hexagonal phase</keyword><keyword>Cubic phase</keyword></keywords><dates><year>2008</year></dates><isbn>0005-2736</isbn><notes>doi: DOI: 10.1016/j.bbamem.2008.07.022</notes><urls><related-urls><url>http://www.sciencedirect.com/science/article/B6T1T-4T4XRCS-2/2/21eb390ac4499e9750d1de06f9348949</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>3.640</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1634</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1634</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, C.</author><author>Fang, C.</author><author>Stephen, Z.</author><author>Veiseh, O.</author><author>Hansen, S.</author><author>Lee, D.</author><author>Ellenbogen, R. G.</author><author>Olson, J.</author><author>Zhang, M. Q.</author></authors></contributors><auth-address>Zhang, MQ&#xD;Univ Washington, Dept Mat Sci &amp; Engn, Seattle, WA 98195 USA&#xD;Univ Washington, Dept Mat Sci &amp; Engn, Seattle, WA 98195 USA&#xD;Univ Washington, Dept Biochem, Seattle, WA 98195 USA&#xD;Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA&#xD;Univ Washington, Dept Radiol, Seattle, WA 98195 USA&#xD;Univ Washington, Dept Neurol, Seattle, WA 98195 USA</auth-address><titles><title>Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles</title><secondary-title>Nanomedicine</secondary-title></titles><periodical><full-title>Nanomedicine</full-title></periodical><pages>495-505</pages><volume>3</volume><number>4</number><edition>2008/08</edition><keywords><keyword>chlorotoxin</keyword><keyword>drug delivery</keyword><keyword>iron oxide</keyword><keyword>magnetic resonance imaging</keyword><keyword>methotrexate</keyword><keyword>nanoparticle tumor</keyword><keyword>cancer-cells</keyword><keyword>magnetic nanoparticles</keyword><keyword>superparamagnetic nanoparticles</keyword><keyword>biomedical applications</keyword><keyword>intracellular uptake</keyword><keyword>her-2/neu receptor</keyword><keyword>prostate-cancer</keyword><keyword>brain-tumors</keyword><keyword>gliomas</keyword><keyword>nanotechnology</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1743-5889</isbn><accession-num>ISI:000258612700015</accession-num><abstract>Aims: This study examines the capabilities of an actively targeting superparamagnetic nanoparticle to specifically deliver therapeutic and MRI contrast agents to cancer cells. Materials &amp; methods: Iron oxide nanoparticles were synthesized and conjugated to both a chemotherapeutic agent, methotrexate, and a targeting ligand, chlorotoxin, through a poly(ethylene glycol) linker. Cytotoxicity of this nanoparticle conjugate was evaluated by Alamar Blue cell viability assays, while tumor-cell specificity was examined in vitro and in vivo by MRI. Results &amp; discussion: Characterization of these multifunctional nanoparticles confirms the successful attachment of both drug and targeting ligands. The targeting nanoparticle demonstrated preferential accumulation and increased cytotoxicity in tumor cells. Furthermore, prolonged retention of these nanoparticles was observed within tumors in vivo. Conclusion: The improved specificity, extended particle retention and increased cytotoxicity toward tumor cells demonstrated by this multifunctional nanoparticle system suggest that it possesses potential for applications in cancer diagnosis and treatment.</abstract><notes>339YH&#xD;Times Cited:1&#xD;Cited References Count:35</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258612700015</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom4>6.093</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2400</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2400</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, C. M.</author><author>Zhu, Y.</author><author>Xie, Z. H.</author><author>Qian, W. P.</author><author>Hsieh, C. L.</author><author>Nie, S. M.</author><author>Su, Y. P.</author><author>Zhau, H. E.</author><author>Chung, L. W. K.</author></authors></contributors><auth-address>[Chung, Leland W. K.] Emory Univ, Dept Urol, Mol Urol &amp; Therapeut Program, Winship Canc Inst,Sch Med, Atlanta, GA 30322 USA. Emory Univ, Winship Canc Inst, Sch Med, Dept Biomed Engn, Atlanta, GA 30322 USA. Third Mil Med Univ, Chongqing Engn &amp; Technol Ctr Nanomed, Int Cooperat Ctr Excellence Nanomed,Inst Combined, State Key Lab Trauma Burns &amp; Combined Injury, Chongqing, Peoples R China.&#xD;Chung, LWK, Emory Univ, Dept Urol, Mol Urol &amp; Therapeut Program, Winship Canc Inst,Sch Med, 1365B Clifton Rd NE, Atlanta, GA 30322 USA.&#xD;lwchung@emory.edu</auth-address><titles><title>Visualizing Human Prostate Cancer Cells in Mouse Skeleton Using Bioconjugated Near-infrared Fluorescent Quantum Dots</title><secondary-title>Urology</secondary-title><alt-title>Urology</alt-title></titles><periodical><full-title>Urology</full-title></periodical><alt-periodical><full-title>Urology</full-title></alt-periodical><pages>446-451</pages><volume>74</volume><number>2</number><edition>2008/08</edition><keywords><keyword>IN-VIVO</keyword><keyword>LIVE CELLS</keyword><keyword>NANOCRYSTALS</keyword><keyword>PROBES</keyword></keywords><dates><year>2009</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0090-4295</isbn><accession-num>ISI:000268930600068</accession-num><abstract>OBJECTIVES To visualize human prostate cancer cells in mouse bone with bioconjugated near-infrared quantum dot (QD) probes. Near-infrared fluorescent probes using QDs can visualize tumors in deep tissues in vivo. METHODS Human prostate cancer C4-2B xenografts grown in mouse tibia were detected by prostate-specific membrane antigen antibody conjugated with QDs emitting tight at the near-infrared range of 800 nm (QD800). Images in culture and in vivo were acquired using the IVIS Imaging System. RESULTS As few as 5000 cells can be detected subcutaneously when tagged with QD800 conjugate and injected directly into mice. QD800 conjugate injected intravenously in mice harboring C4-2B tumors in tibia detected signals from a minimum of 500 000 cells. The maximal light emission was detected 30 minutes after intravenous injection of QD800 conjugate in mice with established C4-2B tumors. CONCLUSIONS Bioconjugated near-infrared QD probes are highly sensitive molecular imaging tools for human prostate cancer micrometastases in mice. UROLOGY 74: 446-451, 2009. (C) 2009 Published by Elsevier Inc.</abstract><notes>ISI Document Delivery No.: 482ZK&#xD;Times Cited: 0&#xD;Cited Reference Count: 27&#xD;Shi, Chunmeng Zhu, Ying Xie, Zhihui Qian, Weiping Hsieh, Chia-Ling Nie, Shuming Su, Yongping Zhau, Haiyen E. Chung, Leland W. K.&#xD;ELSEVIER SCIENCE INC</notes><work-type>Article</work-type><urls><related-urls><url>&lt;Go to ISI&gt;://000268930600068</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>2.604</custom4><electronic-resource-num>10.1016/j.urology.2009.01.023</electronic-resource-num><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1498</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1498</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Paunesku, D.</author><author>Paunesku, T.</author><author>Wahl, A.</author><author>Kataoka, Y.</author><author>Murley, J.</author><author>Grdina, D. J.</author><author>Woloschak, G. E.</author></authors></contributors><auth-address>Department of Radiation Oncology, University of Chicago, Chicago, Illinois, USA.</auth-address><titles><title>Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine</title><secondary-title>Int J Radiat Biol</secondary-title><alt-title>International journal of radiation biology</alt-title></titles><periodical><full-title>Int J Radiat Biol</full-title><abbr-1>International journal of radiation biology</abbr-1></periodical><alt-periodical><full-title>Int J Radiat Biol</full-title><abbr-1>International journal of radiation biology</abbr-1></alt-periodical><pages>623-34</pages><volume>84</volume><number>8</number><edition>2008/08</edition><keywords><keyword>Amifostine/*pharmacology</keyword><keyword>Animals</keyword><keyword>Female</keyword><keyword>Gamma Rays/*adverse effects</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Neutrons/*adverse effects</keyword><keyword>Organothiophosphorus Compounds/pharmacology</keyword><keyword>Radiation-Protective Agents/*pharmacology</keyword><keyword>Whole-Body Irradiation</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0955-3002 (Print)</isbn><accession-num>18661379</accession-num><abstract>PURPOSE: To determine the effects of Amifostine or WR-151,327 on the incidence of lethal and non-lethal toxicities in a large cohort of mice exposed to gamma-ray or fission-spectrum neutron radiation. METHODS: To analyze data from 4000 B6CF1 mice which received a single whole body irradiation (WBI) with 206 cGy or 417 cGy cobalt-60 gamma rays or 10 cGy or 40 cGy of fission-spectrum neutrons (average energy 0.85 MeV) produced by the Janus reactor at Argonne National Laboratory. In the neutron cohort, Amifostine, WR-151,327, saline or nothing was injected once, intraperitoneally, 30 minutes before irradiation. In the cobalt-60 cohort, WR-151327 was omitted from the same protocol. At the time of natural death, tissue toxicities found in these mice were recorded, and these records were analyzed. While all previous studies focused on the modulation of life shortening effects of WBI by Amifostine, in this study we calculated changes in the frequencies of 59 tissue toxicities and changes in the total number of toxicities per animal. RESULTS: Amifostine protected against specific non-tumor pathological complications (67% of the non-tumor toxicities induced by gamma irradiation, 31% of the neutron induced specific toxicities), as well as specific tumors (56% of the tumor toxicities induced by gamma irradiation, 25% of the neutron induced tumors). Amifostine also reduced the total number of toxicities per animal for both genders in the gamma ray exposed mice and in males in the neutron exposed mice. CONCLUSIONS: Amifostine was protective against many, but not all, tissue toxicities caused by WBI gamma and neutron irradiation.</abstract><notes>Journal Article&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18661379 </url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>2.112</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1477</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1477</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Odero-Marah, V. A.</author><author>Wang, R. X.</author><author>Chu, G.</author><author>Zayzafoon, M.</author><author>Xu, J. C.</author><author>Shi, C. M.</author><author>Marshall, F. F.</author><author>Zhau, H. E.</author><author>Chung, L. W. K.</author></authors></contributors><auth-address>Zhau, HE&#xD;Emory Univ, Sch Med, Mol Urol &amp; Therapeut Program, Dept Urol, 1365B Clifton Rd NE, Atlanta, GA 30322 USA&#xD;Emory Univ, Sch Med, Mol Urol &amp; Therapeut Program, Dept Urol, Atlanta, GA 30322 USA&#xD;Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA&#xD;Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA</auth-address><titles><title>Receptor activator of NF-kappa B Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells</title><secondary-title>Cell Research</secondary-title></titles><periodical><full-title>Cell Research</full-title></periodical><pages>858-870</pages><volume>18</volume><number>8</number><edition>2008/08</edition><keywords><keyword>emt</keyword><keyword>bone microenvironment</keyword><keyword>rankl</keyword><keyword>prostate cancer</keyword><keyword>bone metastasis</keyword><keyword>egf</keyword><keyword>tgf beta 1</keyword><keyword>snail</keyword><keyword>matrix metalloproteinase-2 expression</keyword><keyword>transcription factor</keyword><keyword>tumor progression</keyword><keyword>multiple-myeloma</keyword><keyword>carcinoma-cells</keyword><keyword>bone metastasis</keyword><keyword>breast-cancer</keyword><keyword>snail</keyword><keyword>osteoprotegerin</keyword><keyword>disease</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1001-0602</isbn><accession-num>ISI:000258851700008</accession-num><abstract>Epithelial-mesenchymal transition (EMT) in cancer describes the phenotypic and behavioral changes of cancer cells from indolent to virulent forms with increased migratory, invasive and metastatic potential. EMT can be induced by soluble proteins like transforming growth factor beta 1 (TGF beta 1) and transcription factors including Snail and Slug. We utilized the ARCaP(E)/ARCaP(M) prostate cancer progression model and LNCaP clones stably overexpressing Snail to identify novel markers associated with EMT. Compared to ARCaP(E) cells, the highly tumorigenic mesenchymal ARCaP(M) and ARCaP(M1) variant cells displayed a higher incidence of bone metastasis after intracardiac administration in SCID mice. ARCaP(M) and ARCaP(M1) expressed mesenchymal stromal markers of vimentin and N-cadherin in addition to elevated levels of Receptor Activator of NF-kappa B Ligand (RANKL). We observed that both epidermal growth factor (EGF) plus TGF beta 1 treatment and Snail overexpression induced EMT in ARCaP(E) and LNCaP cells, and EMT was associated with increased expression of RANKL protein. Finally, we determined that the RANKL protein was functionally active, promoting osteoclastogenesis in vitro. Our results indicate that RANKL is a novel marker for EMT during prostate cancer progression. RANKL may function as a link between EMT, bone turnover, and prostate cancer skeletal metastasis.</abstract><notes>343KH&#xD;Times Cited:0&#xD;Cited References Count:56</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258851700008</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>4.087</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1433</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1433</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mancini, M. C.</author><author>Kairdolf, B. A.</author><author>Smith, A. M.</author><author>Nie, S. M.</author></authors></contributors><auth-address>Nie, SM&#xD;Emory Univ, Dept Biomed Engn, 101 Woodruff Circle,WMB Suite 2007, Atlanta, GA 30322 USA&#xD;Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA&#xD;Emory Univ, Dept Chem, Atlanta, GA 30322 USA&#xD;Emory Univ, Dept Hematol Oncol, Atlanta, GA 30322 USA&#xD;Georgia Inst Technol, Atlanta, GA 30322 USA</auth-address><titles><title>Oxidative quenching and degradation of polymer-encapsulated quantum dots: New insights into the long-term fate and toxicity of nanocrystals in vivo</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>10836-+</pages><volume>130</volume><number>33</number><edition>2008/08</edition><keywords><keyword>semiconductor nanocrystals</keyword><keyword>oxygen</keyword><keyword>dynamics</keyword><keyword>death</keyword><keyword>cells</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 20</date></pub-dates></dates><isbn>0002-7863</isbn><accession-num>ISI:000258415900003</accession-num><abstract>We report quenching and chemical degradation of polymer-coated quantum dots by reactive oxygen species (ROS), a group of oxygen-containing molecules that are produced by cellular metabolism and are involved in both normal physiological and disease processes such as oxidative signaling, cancer, and atherosclerosis. A major new finding is that hypochlorous acid (HOCl) in its neutral form is especially potent in degrading encapsulated QDs, due to its small size, neutral charge, long half-life, and fast reaction kinetics under physiologic conditions. Thus, small and neutral molecules such as HOCl and hydrogen peroxide (H2O2) are believed to diffuse across the polymer coating layer, leading to chemical oxidation of sulfur or selenium atoms on the OD surface. This &quot;etching&quot; process first generates lattice structural defects (which cause fluorescence quenching) and then produces soluble metal</abstract><notes>337DO&#xD;Times Cited:0&#xD;Cited References Count:22</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258415900003</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>8.256</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1409</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1409</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Robinson, J. T.</author><author>Sun, X. M.</author><author>Dai, H. J.</author></authors></contributors><auth-address>Dai, HJ&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA</auth-address><titles><title>PEGylated nanographene oxide for delivery of water-insoluble cancer drugs</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>10876-+</pages><volume>130</volume><number>33</number><edition>2008/08</edition><keywords><keyword>walled carbon nanotubes</keyword><keyword>transporters</keyword><keyword>graphene</keyword><keyword>pharmacokinetics</keyword><keyword>cpt-11</keyword><keyword>mice</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 20</date></pub-dates></dates><isbn>0002-7863</isbn><accession-num>ISI:000258415900023</accession-num><abstract>It is known that many potent, often aromatic drugs are water insoluble, which has hampered their use for disease treatment. In this work, we functionalized nanographene oxide (NGO), a novel graphitic material, with branched polyethylene glycol (PEG) to obtain a biocompatible NGO-PEG conjugate stable in various biological solutions, and used them for attaching hydrophobic aromatic molecules including a camptothecin (CPT) analogue, SN38, noncovalently via Pi-Pi stacking. The resulting NGO-PEG-SN38 complex exhibited excellent water solubility while maintaining its high cancer cell killing potency similar to that of the free SN38 molecules in organic solvents. The efficacy of NGO-PEG-SN38 was far higher than that of irinotecan (CPT-11), a FDA-approved water soluble SN38 prodrug used for the treatment of colon cancer. Our results showed that graphene is a novel class of material promising for biological applications including future in vivo cancer treatment with various aromatic, low-solubility drugs.</abstract><notes>337DO&#xD;Times Cited:2&#xD;Cited References Count:18</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258415900023</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom4>8.256</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1407</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1407</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Chen, K.</author><author>Davis, C.</author><author>Sherlock, S.</author><author>Cao, Q. Z.</author><author>Chen, X. Y.</author><author>Dai, H. J.</author></authors></contributors><auth-address>Dai, HJ&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA&#xD;Stanford Univ, Sch Med, Mol Imaging Program Stanford, Dept Radiol,Biophys &amp; BioX Program, Stanford, CA 94305 USA&#xD;Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA</auth-address><titles><title>Drug delivery with carbon nanotubes for in vivo cancer treatment</title><secondary-title>Cancer Research</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>6652-6660</pages><volume>68</volume><number>16</number><edition>2008/08</edition><keywords><keyword>cremophor-el</keyword><keyword>paclitaxel conjugate</keyword><keyword>systemic paclitaxel</keyword><keyword>tissue distribution</keyword><keyword>quantum dots</keyword><keyword>gene-therapy</keyword><keyword>rat-liver</keyword><keyword>mice</keyword><keyword>transporters</keyword><keyword>pharmacokinetics</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 15</date></pub-dates></dates><isbn>0008-5472</isbn><accession-num>ISI:000258548200022</accession-num><abstract>Chemically functionalized single-walled carbon nanotubes (SWNT) have shown promise in tumor-targeted accumulation in mice and exhibit biocompatibility, excretion, and little toxicity. Here, we show in vivo SWNT drug delivery for tumor suppression in mice. We conjugate paclitaxel (PTX), a widely used cancer chemotherapy drug, to branched polyethylene glycol chains on SWNTs via a cleavable ester bond to obtain a water-soluble SWNT-PTX conjugate. SWNT-PTX affords higher efficacy in suppressing tumor growth than clinical Taxol in a murine 4T1 breast cancer model, owing to prolonged blood circulation and 10-fold higher tumor PTX uptake by SWNT delivery likely through enhanced permeability and retention. Drug molecules carried into the reticuloendothelial. path-system are released from SWNTs and excreted via biliary way without causing obvious toxic effects to normal organs. Thus, nanotube drug delivery, is promising for high treatment efficacy and minimum side effects for future cancer therapy with low drug doses.</abstract><notes>338ZP&#xD;Times Cited:1&#xD;Cited References Count:48</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258548200022</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom4>7.980</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1363</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1363</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lamb, B. M.</author><author>Barrett, D. G.</author><author>Westeott, N. P.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Yousaf, MN&#xD;Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA</auth-address><titles><title>Microfluidic lithography of SAMs on gold to create dynamic surfaces for directed cell migration and contiguous cell cocultures</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>8885-8889</pages><volume>24</volume><number>16</number><edition>2008/08</edition><keywords><keyword>self-assembled monolayers</keyword><keyword>proteins</keyword><keyword>ligands</keyword><keyword>immobilization</keyword><keyword>fibroblasts</keyword><keyword>adhesion</keyword><keyword>density</keyword><keyword>films</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 19</date></pub-dates></dates><isbn>0743-7463</isbn><accession-num>ISI:000258377900073</accession-num><abstract>A straightforward, flexible, and inexpensive method to create patterned self-assembled monolayers (SAMs) on gold using microfluidics-microfluidic lithography-has been developed. Using a microfluidic cassette, alkanethiols were rapidly patterned on gold surfaces to generate monolayers and mixed monolayers. The patterning methodology is flexible and, by controlling the solvent conditions and thiol concentration, permeation of alkanethiols into the surrounding PDMS microfluidic cassette can be advantageously used to create different patterned feature sizes and to generate well-defined SAM surface gradients with a single microfluidic chip.,To demonstrate the utility of microfluidic lithography, multiple cell experiments were conducted. By patterning cell adhesive regions in an inert background, a combination of selective masking of the surface and centrifugation achieved spatial and temporal control of patterned cells, enabling the design of both dynamic surfaces for directed cell migration and contiguous cocultures. Cellular division and motility resulted in directed, dynamic migration, while the centrifugation-aided seeding of a second cell line produced contiguous cocultures with multiple sites for heterogeneous cell-cell interactions.</abstract><notes>336PU&#xD;Times Cited:2&#xD;Cited References Count:27</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258377900073</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>4.347</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1237</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1237</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hamad, I.</author><author>Hunter, A. C.</author><author>Rutt, K. J.</author><author>Liu, Z.</author><author>Dai, H.</author><author>Moghimi, S. M.</author></authors></contributors><auth-address>Moghimi, SM&#xD;Univ Copenhagen, Fac Pharmaceut Sci, Dept Pharmaceut &amp; Analyt Chem, Univ Parken 2, DK-2100 Copenhagen O, Denmark&#xD;Univ Copenhagen, Fac Pharmaceut Sci, Dept Pharmaceut &amp; Analyt Chem, DK-2100 Copenhagen O, Denmark&#xD;Univ Brighton, Sch Pharm, Mol Targeting &amp; Polymer Toxicol Grp, Brighton BN2 4GJ, E Sussex, England&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA</auth-address><titles><title>Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover</title><secondary-title>Molecular Immunology</secondary-title></titles><periodical><full-title>Molecular Immunology</full-title></periodical><pages>3797-3803</pages><volume>45</volume><number>14</number><edition>2008/08</edition><keywords><keyword>biomaterials</keyword><keyword>carbon nanotubes</keyword><keyword>complement system</keyword><keyword>c4</keyword><keyword>drug delivery system</keyword><keyword>nanomedicine</keyword><keyword>sc5b-9</keyword><keyword>liposome-encapsulated hemoglobin</keyword><keyword>in-vitro</keyword><keyword>protein-binding</keyword><keyword>surface</keyword><keyword>hypersensitivity</keyword><keyword>pharmacokinetics</keyword><keyword>nanoparticles</keyword><keyword>circulation</keyword><keyword>antibodies</keyword><keyword>mechanism</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0161-5890</isbn><accession-num>ISI:000259473900013</accession-num><abstract>We have investigated the interaction between long circulating poly(ethylene glycol)-stabilized single-walled carbon nanotubes (SWNTs) and the complement system. Aminopoly(ethylene glycol)(5000)-distearoylphosphatidylethanolamine (aminoPEG(5000)-DSPE) and methoxyPEG(5000)-DSPE coated as-grown HIPco SWNTs activated complement in undiluted normal human serum as reflected in significant rises in C4d and SC5b-9 levels, but not the alternative pathway split-product Bb, thus indicating activation exclusively through C4 cleavage. Studies in C2-depleted serum confirmed that PEGylated nanotube-mediated elevation of SC5b-9 was C4b2a convertase-dependent. With the aid of monoclonal antibodies against C1s and human serum depleted from C1q, nanotube-mediated complement activation in C1q-depleted serum was also shown to be independent of classical pathway. Nanotube-mediated C4d elevation in C1q-depleted serum, however, was inhibited by N-acetylglucosamine, Futhan (a broad-spectrum serine protease inhibitor capable of preventing complement activation through all three pathways) and anti-MASP-2 antibodies; this strongly suggests a role for activation of MASP-2 in subsequent C4 cleavage and assembly of C4b2a covertases. Intravenous injection of PEGylated nanotubes in some rats was associated with a significant rise in plasma thromboxane B2 levels, indicative of in vivo nanotube-mediated complement activation. The clinical implications of these observations are discussed. (C) 2008 Elsevier Ltd. All rights reserved.</abstract><notes>352CX&#xD;Times Cited:2&#xD;Cited References Count:27</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000259473900013</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom4>3.583</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2457</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2457</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cheon, Jinwoo</author><author>Lee, Jae-Hyun</author></authors></contributors><titles><title>Synergistically Integrated Nanoparticles as Multimodal Probes for Nanobiotechnology</title><secondary-title>Accounts of Chemical Research</secondary-title></titles><periodical><full-title>Accounts of Chemical Research</full-title></periodical><pages>1630-1640</pages><volume>41</volume><number>12</number><edition>2008/08</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>0001-4842</isbn><notes>doi: 10.1021/ar800045c</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ar800045c</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>15.403</custom4><electronic-resource-num>10.1021/ar800045c</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1105</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1105</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Burton, J. B.</author><author>Johnson, M.</author><author>Sato, M.</author><author>Koh, S. B. S.</author><author>Mulholland, D. J.</author><author>Stout, D.</author><author>Chatziioannou, A. F.</author><author>Phelps, M. E.</author><author>Wu, H.</author><author>Wu, L.</author></authors></contributors><auth-address>Wu, L&#xD;Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Mol &amp; Med Pharmacol, Los Angeles, CA 90095 USA&#xD;Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Mol &amp; Med Pharmacol, Los Angeles, CA 90095 USA&#xD;Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Urol, Los Angeles, CA 90095 USA&#xD;Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Bioengn, Los Angeles, CA 90095 USA&#xD;Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA</auth-address><titles><title>Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer</title><secondary-title>Nature Medicine</secondary-title></titles><periodical><full-title>Nature Medicine</full-title></periodical><pages>882-888</pages><volume>14</volume><number>8</number><edition>2008/08</edition><keywords><keyword>radical prostatectomy</keyword><keyword>pelvic lymphadenectomy</keyword><keyword>in-vivo</keyword><keyword>vector</keyword><keyword>progression</keyword><keyword>survival</keyword><keyword>cells</keyword><keyword>leads</keyword><keyword>mice</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1078-8956</isbn><accession-num>ISI:000258237500037</accession-num><abstract>The accurate assessment of nodal involvement in prostate cancer is crucial to planning treatment, yet there is a shortage of noninvasive imaging techniques capable of visualizing nodal lesions directly. This study demonstrates the feasibility of using recombinant human adenoviral vectors to detect nodal metastases in a human prostate cancer model. This was achieved by the prostate-restricted expression of optical and positron emission tomography (PET) imaging reporter genes by the viral vector coupled with the innate lymphotropic properties of adenovirus. We show that peritumoral administration of these vectors results in the direct detection of reporter gene expression in metastatic lesions within sentinel lymph nodes. Notably, this approach parallels the current lymphoscintigraphy method but enables the direct PET visualization of sentinel lymph node metastases, eliminating the need for invasive lymphadenectomy. These findings may lead to more effective diagnostic and therapeutic strategies for individuals with advanced-stage prostate cancer.</abstract><notes>334QY&#xD;Times Cited:2&#xD;Cited References Count:33</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258237500037</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom4>28.965</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1086</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1086</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bertin, P. A.</author><author>Georganopoulou, D.</author><author>Liang, T. Y.</author><author>Eckermann, A. L.</author><author>Wunder, M.</author><author>Ahrens, M. J.</author><author>Blackburn, G. F.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Bertin, PA&#xD;Ohmx Corp, 1801 Maple Ave,Suite 6143, Evanston, IL 60201 USA&#xD;Ohmx Corp, Evanston, IL 60201 USA&#xD;Northwestern Univ, Dept Chem, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Biochem &amp; Mol &amp; Cell Biol, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Physiol &amp; Neurobiol, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Radiol, Evanston, IL 60208 USA</auth-address><titles><title>Electroactive self-assembled monolayers on gold via bipodal dithiazepane anchoring groups</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>9096-9101</pages><volume>24</volume><number>16</number><edition>2008/08</edition><keywords><keyword>electrochemical characteristics</keyword><keyword>voltammetric response</keyword><keyword>molecular electronics</keyword><keyword>transfer kinetics</keyword><keyword>ferrocene</keyword><keyword>redox</keyword><keyword>surfaces</keyword><keyword>bridges</keyword><keyword>thiol</keyword><keyword>desorption</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 19</date></pub-dates></dates><isbn>0743-7463</isbn><accession-num>ISI:000258377900106</accession-num><abstract>Novel dithiazepane-functionalized ferrocenyl-phenylethynyl oligomers 1 and 2 have been synthesized. Self-assembled monolayers (SAMs) of these ferrocene derivatives have been studied by X-ray photoelectron spectroscopy, ellipsometry, and cyclic voltammetry. It has been shown by XPS that monolayers of the dithiazepane-anchored molecules on gold electrodes contain gold-thiolate species. Cyclic voltammetry of the SAMs were characteristic of stable electroactive monolayers even for single-component SAMs of 1 and 2, with the more ideal responses recorded for the two-component SAMs diluted with undecanethiol. The small variation in peak splittings at progressively higher scan rates in these SAMs makes dithiazepane-bridged redox species promising candidates for further studies on molecular wires with bipodal anchoring.</abstract><notes>336PU&#xD;Times Cited:0&#xD;Cited References Count:64</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000258377900106</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.347</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1683</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1683</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Verma, S.</author><author>Sallum, U. W.</author><author>Athar, H.</author><author>Rosenblum, L.</author><author>Foley, J. W.</author><author>Hasan, T.</author></authors></contributors><auth-address>Wellman Center for Photomedicine, Massachusetts General Hospital; and Department of Dermatology, Harvard Medical School, Boston, MA, USA.</auth-address><titles><title>Antimicrobial Photodynamic Efficacy of Side-chain Functionalized Benzo[a]phenothiazinium Dyes</title><secondary-title>Photochem Photobiol</secondary-title></titles><periodical><full-title>Photochem Photobiol</full-title></periodical><edition>2008/07/29</edition><dates><year>2008</year><pub-dates><date>Jul 23</date></pub-dates></dates><isbn>0031-8655 (Print)</isbn><accession-num>18657053</accession-num><abstract>5-(Ethylamino)-9-diethylaminobenzo[a]phenothiazinium chloride (EtNBS) is a photosensitizer (PS) with broad antimicrobial photodynamic activity. The objective of this study was to determine the antimicrobial photodynamic effect of side chain/end group modifications of EtNBS on two representative bacterial Gram-type-specific strains. Two EtNBS derivatives were synthesized, each functionalized with a different side-chain end-group, alcohol or carboxylic acid. In solution, both exhibited photochemical properties consistent with those of the EtNBS parent molecule. In vitro photodynamic therapy experiments revealed an initial Gram-type-specificity with two representative strains; both derivatives were phototoxic to Staphylococcus aureus 29213 but the carboxylic acid derivative was nontoxic to Escherichia coli 25922. This difference in photodynamic efficacy was not due to a difference in the binding of the two molecules to the bacteria as the amount of both derivatives bound by bacteria was identical. Interestingly, the carboxylic acid derivative produced no fluorescence emission when observed in cultures of E. coli via fluorescence microscopy. These early findings suggest that the addition of small functional groups could achieve Gram-type-specific phototoxicity through altering the photodynamic activity of PSs and deserve further exploration in a larger number of representative strains of each Gram type.</abstract><notes>Journal article&#xD;Photochemistry and photobiology&#xD;Photochem Photobiol. 2008 Jul 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18657053</url></related-urls></urls><custom1>CNPP - Harvard</custom1><custom3>2008</custom3><custom4>2.473</custom4><electronic-resource-num>PHP403 [pii]&#xD;10.1111/j.1751-1097.2008.00403.x</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2253</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2253</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Karnik, R.</author><author>Gu, F.</author><author>Basto, P.</author><author>Cannizzaro, C.</author><author>Dean, L.</author><author>Kyei-Manu, W.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Microfluidic platform for controlled synthesis of polymeric nanoparticles</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>2906-12</pages><volume>8</volume><number>9</number><edition>2008/07/29</edition><keywords><keyword>Microfluidics</keyword><keyword>Nanoparticles</keyword><keyword>Particle Size</keyword><keyword>Polymers/ chemical synthesis</keyword><keyword>Precipitation</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18656990</accession-num><abstract>A central challenge in the development of drug-encapsulated polymeric nanoparticles is the inability to control the mixing processes required for their synthesis resulting in variable nanoparticle physicochemical properties. Nanoparticles may be developed by mixing and nanoprecipitation of polymers and drugs dissolved in organic solvents with nonsolvents. We used rapid and tunable mixing through hydrodynamic flow focusing in microfluidic channels to control nanoprecipitation of poly(lactic- co-glycolic acid)- b-poly(ethylene glycol) diblock copolymers as a model polymeric biomaterial for drug delivery. We demonstrate that by varying (1) flow rates, (2) polymer composition, and (3) polymer concentration we can optimize the size, improve polydispersity, and control drug loading and release of the resulting nanoparticles. This work suggests that microfluidics may find applications for the development and optimization of polymeric nanoparticles in the newly emerging field of nanomedicine.</abstract><notes>Karnik, Rohit&#xD;Gu, Frank&#xD;Basto, Pamela&#xD;Cannizzaro, Christopher&#xD;Dean, Lindsey&#xD;Kyei-Manu, William&#xD;Langer, Robert&#xD;Farokhzad, Omid C&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;EB003647/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2008 Sep;8(9):2906-12. Epub 2008 Jul 26.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>12.189</custom4><electronic-resource-num>10.1021/nl801736q [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1554</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1554</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schipper, M. L.</author><author>Nakayama-Ratchford, N.</author><author>Davis, C. R.</author><author>Kam, N. W.</author><author>Chu, P.</author><author>Liu, Z.</author><author>Sun, X.</author><author>Dai, H.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Palo Alto, California 94305-5427, USA.</auth-address><titles><title>A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice</title><secondary-title>Nat Nanotechnol</secondary-title></titles><periodical><full-title>Nat Nanotechnol</full-title></periodical><pages>216-21</pages><volume>3</volume><number>4</number><edition>2008/07/26</edition><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1748-3395 (Electronic)</isbn><accession-num>18654506</accession-num><abstract>Single-walled carbon nanotubes are currently under evaluation in biomedical applications, including in vivo delivery of drugs, proteins, peptides and nucleic acids (for gene transfer or gene silencing), in vivo tumour imaging and tumour targeting of single-walled carbon nanotubes as an anti-neoplastic treatment. However, concerns about the potential toxicity of single-walled carbon nanotubes have been raised. Here we examine the acute and chronic toxicity of functionalized single-walled carbon nanotubes when injected into the bloodstream of mice. Survival, clinical and laboratory parameters reveal no evidence of toxicity over 4 months. Upon killing, careful necropsy and tissue histology show age-related changes only. Histology and Raman microscopic mapping demonstrate that functionalized single-walled carbon nanotubes persisted within liver and spleen macrophages for 4 months without apparent toxicity. Although this is a preliminary study with a small group of animals, our results encourage further confirmation studies with larger groups of animals.</abstract><notes>Schipper, Meike L&#xD;Nakayama-Ratchford, Nozomi&#xD;Davis, Corrine R&#xD;Kam, Nadine Wong Shi&#xD;Chu, Pauline&#xD;Liu, Zhuang&#xD;Sun, Xiaoming&#xD;Dai, Hongjie&#xD;Gambhir, Sanjiv S&#xD;P50 CA114747/CA/United States NCI&#xD;U54 CA119367/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Nature nanotechnology&#xD;Nat Nanotechnol. 2008 Apr;3(4):216-21. Epub 2008 Mar 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18654506</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>20.588</custom4><electronic-resource-num>nnano.2008.68 [pii]&#xD;10.1038/nnano.2008.68</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2252</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2252</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Peer, D.</author><author>Karp, J. M.</author><author>Hong, S.</author><author>Farokhzad, O. C.</author><author>Margalit, R.</author><author>Langer, R.</author></authors></contributors><auth-address>Department of Anesthesia, Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.</auth-address><titles><title>Nanocarriers as an emerging platform for cancer therapy</title><secondary-title>Nat Nanotechnol</secondary-title></titles><periodical><full-title>Nat Nanotechnol</full-title></periodical><pages>751-60</pages><volume>2</volume><number>12</number><edition>2008/07/26</edition><keywords><keyword>Antineoplastic Agents/ administration &amp; dosage/ chemistry</keyword><keyword>Drug Carriers/ chemistry</keyword><keyword>Drug Compounding/ trends</keyword><keyword>Nanomedicine/ trends</keyword><keyword>Nanostructures/ chemistry/ultrastructure</keyword><keyword>Neoplasms/ drug therapy</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1748-3395 (Electronic)</isbn><accession-num>18654426</accession-num><abstract>Nanotechnology has the potential to revolutionize cancer diagnosis and therapy. Advances in protein engineering and materials science have contributed to novel nanoscale targeting approaches that may bring new hope to cancer patients. Several therapeutic nanocarriers have been approved for clinical use. However, to date, there are only a few clinically approved nanocarriers that incorporate molecules to selectively bind and target cancer cells. This review examines some of the approved formulations and discusses the challenges in translating basic research to the clinic. We detail the arsenal of nanocarriers and molecules available for selective tumour targeting, and emphasize the challenges in cancer treatment.</abstract><notes>Peer, Dan&#xD;Karp, Jeffrey M&#xD;Hong, Seungpyo&#xD;Farokhzad, Omid C&#xD;Margalit, Rimona&#xD;Langer, Robert&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;EB 003647/EB/NIBIB NIH HHS/United States&#xD;R01-EB000244/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;England&#xD;Nature nanotechnology&#xD;Nat Nanotechnol. 2007 Dec;2(12):751-60.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>20.588</custom4><electronic-resource-num>nnano.2007.387 [pii]&#xD;10.1038/nnano.2007.387 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2088</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2088</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Cai, W.</author><author>He, L.</author><author>Nakayama, N.</author><author>Chen, K.</author><author>Sun, X.</author><author>Chen, X.</author><author>Dai, H.</author></authors></contributors><titles><title>In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice</title><secondary-title>Nat Nanotechnol</secondary-title></titles><periodical><full-title>Nat Nanotechnol</full-title></periodical><pages>47-52</pages><volume>2</volume><number>1</number><edition>2008/07/26</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Drug Carriers/ chemistry</keyword><keyword>Glioblastoma/drug therapy/ metabolism/pathology</keyword><keyword>Humans</keyword><keyword>Materials Testing</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Mice</keyword><keyword>Nanomedicine/ methods</keyword><keyword>Nanotubes, Carbon/ chemistry/ultrastructure</keyword><keyword>Polyethylene Glycols/ chemistry</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1748-3395 (Electronic)</isbn><accession-num>18654207</accession-num><notes>Liu, Zhuang&#xD;Cai, Weibo&#xD;He, Lina&#xD;Nakayama, Nozomi&#xD;Chen, Kai&#xD;Sun, Xiaoming&#xD;Chen, Xiaoyuan&#xD;Dai, Hongjie&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Letter&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Nature nanotechnology&#xD;Nat Nanotechnol. 2007 Jan;2(1):47-52. Epub 2006 Dec 17.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>20.588</custom4><electronic-resource-num>nnano.2006.170 [pii]&#xD;10.1038/nnano.2006.170 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1252</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1252</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Herlihy, K. P.</author><author>Nunes, J.</author><author>Desimone, J. M.</author></authors></contributors><auth-address>desimone@unc.edu.</auth-address><titles><title>Electrically Driven Alignment and Crystallization of Unique Anisotropic Polymer Particles</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><edition>2008/07/24</edition><dates><year>2008</year><pub-dates><date>Jul 23</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>18646784</accession-num><abstract>Micrometer-sized monodisperse anisotropic polymer particles, with disk, rod, fenestrated hexagon (hexnut), and boomerang shapes, were synthesized using the particle replication in nonwetting templates (PRINT) process, and investigations were conducted on aqueous suspensions of these particles when subjected to alternating electric fields. A coplanar electrode configuration, with 1 to 2 mm electrode gaps (20-50 V ac, 0.5-5.0 kHz) was used, and the experiments were monitored with fluorescence microscopy. For all particle suspensions, the field brought about significant changes in the packing and orientation. Extensive particle chaining and packing were observed for the disk, rod, and hexnut suspensions. Because of the size and geometry of the boomerang particles, limited chaining was observed; however, the field triggered a change from random to a more ordered packing arrangement.</abstract><notes>Journal article&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2008 Jul 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18646784</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>4.347</custom4><electronic-resource-num>10.1021/la801250g</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1598</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1598</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shukla, R.</author><author>Nune, S. K.</author><author>Chanda, N.</author><author>Katti, K.</author><author>Mekapothula, S.</author><author>Kulkarni, R. R.</author><author>Welshons, W. V.</author><author>Kannan, R.</author><author>Katti, K. V.</author></authors></contributors><auth-address>Department of Radiology, 301, Business Loop 70W University of Missouri-Columbia Columbia, MO 65212 (USA).</auth-address><titles><title>Soybeans as a Phytochemical Reservoir for the Production and Stabilization of Biocompatible Gold Nanoparticles</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><edition>2008/07/22</edition><dates><year>2008</year><pub-dates><date>Jul 18</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>18642250</accession-num><abstract>The present study demonstrates an unprecedented green process for the production of gold nanoparticles by simple treatment of gold salts with soybean extracts. Reduction capabilities of antioxidant phytochemicals present in soybean and their ability to reduce gold salts chemically to nanoparticles with subsequent coating of proteins and a host of other phytochemicals present in soybean on the freshly generated gold nanoparticles are discussed. The new genre of green nanoparticles exhibit remarkable in vitro stability in various buffers including saline, histidine, HSA, and cysteine solutions. MTT assays reveal that the green gold nanoparticles are nontoxic and thus provide excellent opportunities for their applications in nanomedicine for molecular imaging and therapy. The overall strategy described herein for the generation of gold nanoparticles meets all 12 principles of green chemistry, as no &quot;man-made&quot; chemicals, other than the gold salts, are used in the green nanotechnological process.</abstract><notes>Journal article&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2008 Jul 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18642250</url></related-urls></urls><custom1>CNPP - U. of Miss.</custom1><custom3>2008</custom3><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200800525</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1443</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1443</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCullagh, M.</author><author>Prytkova, T.</author><author>Tonzani, S.</author><author>Winter, N. D.</author><author>Schatz, G. C.</author></authors></contributors><titles><title>Modeling Self-Assembly Processes Driven by Nonbonded Interactions in Soft Materials</title><secondary-title>J Phys Chem B</secondary-title></titles><periodical><full-title>J Phys Chem B</full-title></periodical><edition>2008/07/19</edition><dates><year>2008</year><pub-dates><date>Jul 18</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>18636770</accession-num><abstract>This Centennial Feature Article provides an overview of research in the general area of self-assembly modeling, with particular emphasis on the self-assembly of molecules into soft nanoscale structures where the driving force for assembly is provided by nonbonded interactions (hydrogen bonds and electrostatics). The models have been developed at many different levels of theory, going all the way from simple analytical models of packing effects to atomistic descriptions using molecular dynamics methods. In between these limits are mean-field and coarse-grained models, including models for DNA, peptides, and lipids that can be used to describe the assembly of hybrid (amphiphilic) materials. Several recent applications to specific systems are discussed, including the description of peptide amphiphile assembly to make cylindrical micelles, the assembly and melting of DNA hairpins, the use of DNA tethers to assemble nanoparticles into aggregates and crystalline structures, and the use of coarse-grained lipid models to make lamellar and high-curvature phases. These examples demonstrate the difficulties associated with brute force atomistic methods, and they also show the opportunities (but uncertainties and ambiguities) associated with simpler models such as coarse-grained models. The examples also demonstrate the usefulness of successful modeling methods in the design of new materials, including an understanding of the relationship between structure and function.</abstract><notes>Journal article&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2008 Jul 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18636770</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.688</custom4><electronic-resource-num>10.1021/jp803192u</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2087</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2087</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, H. Y.</author><author>Li, Z.</author><author>Chen, K.</author><author>Hsu, A. R.</author><author>Xu, C.</author><author>Xie, J.</author><author>Sun, S.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, California 94305-5484, USA.</auth-address><titles><title>PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles</title><secondary-title>J Nucl Med</secondary-title></titles><periodical><full-title>J Nucl Med</full-title></periodical><pages>1371-9</pages><volume>49</volume><number>8</number><edition>2008/07/18</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chelating Agents/chemistry</keyword><keyword>Copper Radioisotopes</keyword><keyword>Female</keyword><keyword>Ferric Compounds/ chemistry</keyword><keyword>Glioblastoma/radionuclide imaging</keyword><keyword>Heterocyclic Compounds, 1-Ring/chemistry</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/metabolism</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Nanoparticles</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Oligopeptides/ chemistry</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Radiopharmaceuticals/ chemical synthesis/diagnostic use/pharmacokinetics</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>18632815</accession-num><abstract>The purpose of this study was to develop a bifunctional iron oxide (IO) nanoparticle probe for PET and MRI scans of tumor integrin alphavbeta3 expression. METHODS: Polyaspartic acid (PASP)-coated IO (PASP-IO) nanoparticles were synthesized using a coprecipitation method, and particle size and magnetic properties were measured. A phantom study was used to assess the efficacy of PASP-IO as a T2-weighted MRI contrast agent. PASP-IO nanoparticles with surface amino groups were coupled to cyclic arginine-glycine-aspartic (RGD) peptides for integrin alphavbeta3 targeting and macrocyclic 1,4,7,10-tetraazacyclododecane-N,N&apos;,N&apos;&apos;,N&apos;&apos;&apos;,-tetraacetic acid (DOTA) chelators for PET after labeling with 64Cu. IO nanoparticle conjugates were further tested in vitro and in vivo to determine receptor targeting efficacy and feasibility for dual PET/MRI. RESULTS: PASP-IO nanoparticles made by single-step reaction have a core size of 5 nm with a hydrodynamic diameter of 45 +/- 10 nm. The saturation magnetization of PASP-IO nanoparticles is about 117 emu/g of iron, and the measured r2 and r2* are 105.5 and 165.5 (s.mM)(-1), respectively. A displacement competitive binding assay indicates that DOTA-IO-RGD conjugates bound specifically to integrin alphavbeta3 in vitro. Both small-animal PET and T2-weighted MRI show integrin-specific delivery of conjugated RGD-PASP-IO nanoparticles and prominent reticuloendothelial system uptake. CONCLUSION: We have successfully developed an IO-based nanoprobe for simultaneous dual PET and MRI of tumor integrin expression. The success of this bifunctional imaging approach may allow for earlier tumor detection with a high degree of accuracy and provide further insight into the molecular mechanisms of cancer.</abstract><notes>Lee, Ha-Young&#xD;Li, Zibo&#xD;Chen, Kai&#xD;Hsu, Andrew R&#xD;Xu, Chenjie&#xD;Xie, Jin&#xD;Sun, Shouheng&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2008 Aug;49(8):1371-9. Epub 2008 Jul 16.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.282</custom4><electronic-resource-num>jnumed.108.051243 [pii]&#xD;10.2967/jnumed.108.051243 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1155</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1155</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Coti, K. K.</author><author>Wang, Y.</author><author>Lin, W. Y.</author><author>Chen, C. C.</author><author>Tak For Yu, Z.</author><author>Liu, K.</author><author>Shen, C. K.</author><author>Selke, M.</author><author>Yeh, A.</author><author>Lu, W.</author><author>Tseng, H. R.</author></authors></contributors><auth-address>Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, 700 Westwood Plaza, Los Angeles, CA 90095, USA. hrtseng@mednet.ucla.edu wlu@mednet.ucla.edu.</auth-address><titles><title>A dynamic micromixer for arbitrary control of disguised chemical selectivity</title><secondary-title>Chem Commun (Camb)</secondary-title></titles><periodical><full-title>Chem Commun (Camb)</full-title></periodical><pages>3426-8</pages><number>29</number><edition>2008/07/18</edition><dates><year>2008</year><pub-dates><date>Aug 7</date></pub-dates></dates><isbn>1359-7345 (Print)</isbn><accession-num>18633511</accession-num><abstract>A new type of dynamic micromixer combining the concepts of parallel multi-lamination and hydrodynamic focusing was developed for arbitrary control of disguised chemical selectivity.</abstract><notes>Coti, Karla K&#xD;Wang, Yanju&#xD;Lin, Wei-Yu&#xD;Chen, Chia-Chun&#xD;Tak For Yu, Zeta&#xD;Liu, Kan&#xD;Shen, Clifton K-F&#xD;Selke, Matthias&#xD;Yeh, Anchi&#xD;Lu, Weixing&#xD;Tseng, Hsian-Rong&#xD;England&#xD;Chemical communications (Cambridge, England)&#xD;Chem Commun (Camb). 2008 Aug 7;(29):3426-8. Epub 2008 May 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18633511</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>4.997</custom4><electronic-resource-num>10.1039/b804530e</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1156</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1156</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cottrell, W. J.</author><author>Paquette, A. D.</author><author>Keymel, K. R.</author><author>Foster, T. H.</author><author>Oseroff, A. R.</author></authors></contributors><auth-address>Department of Imaging Sciences, University of Rochester, Rochester, New York, USA.</auth-address><titles><title>Irradiance-Genetic risk factors of suicidal behaviour acid-photodynamic therapy of superficial basal cell carcinomas</title><secondary-title>Clin Cancer Res</secondary-title></titles><periodical><full-title>Clin Cancer Res</full-title></periodical><pages>4475-83</pages><volume>14</volume><number>14</number><edition>2008/07/17</edition><dates><year>2008</year><pub-dates><date>Jul 15</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>18628462</accession-num><abstract>PURPOSE: In superficial basal cell carcinomas treated with photodynamic therapy with topical delta-aminolevulinic acid, we examined effects of light irradiance on photodynamic efficiency and pain. The rate of singlet-oxygen production depends on the product of irradiance and photosensitizer and oxygen concentrations. High irradiance and/or photosensitizer levels cause inefficient treatment from oxygen depletion in preclinical models. EXPERIMENTAL DESIGN: Self-sensitized photobleaching of protoporphyrin IX (PpIX) fluorescence was used as a surrogate metric for photodynamic dose. We developed instrumentation measuring fluorescence and reflectance from lesions and margins during treatment at 633 nm with various irradiances. When PpIX was 90% bleached, irradiance was increased to 150 mW/cm(2) until 200 J/cm(2) were delivered. Pain was monitored. RESULTS: In 33 superficial basal cell carcinomas in 26 patients, photobleaching efficiency decreased with increasing irradiance above 20 mW/cm(2), consistent with oxygen depletion. Fluences bleaching PpIX fluorescence 80% (D80) were 5.7 +/- 1.6, 4.5 +/- 0.3, 7.5 +/- 0.8, 7.4 +/- 0.3, 12.4 +/- 0.3, and 28.7 +/- 7.1 J/cm(2), respectively, at 10, 20, 40, 50, 60 and 150 mW/cm(2). At 20-150 mW/cm(2), D80 doses required 2.5-3.5 min; times for the total 200 J/cm(2) were 22.2-25.3 min. No significant pain occurred up to 50 mW/cm(2); pain was not significant when irradiance then increased. Clinical responses were comparable to continuous 150 mW/cm(2) treatment. CONCLUSIONS: Photodynamic therapy with topical delta-aminolevulinic acid using approximately 40 mW/cm(2) at 633 nm is photodynamically efficient with minimum pain. Once PpIX is largely photobleached, higher irradiances allow efficient, rapid delivery of additional light. Optimal fluence at a single low irradiance is yet to be determined.</abstract><notes>Cottrell, William J&#xD;Paquette, Anne D&#xD;Keymel, Kenneth R&#xD;Foster, Thomas H&#xD;Oseroff, Allan R&#xD;CA16056/CA/United States NCI&#xD;P01 CA55719/CA/United States NCI&#xD;T32 HL66988/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 Jul 15;14(14):4475-83.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18628462</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2008</custom3><custom4>6.646</custom4><electronic-resource-num>14/14/4475 [pii]&#xD;10.1158/1078-0432.CCR-07-5199</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2086</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2086</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>So, M. K.</author><author>Yao, H.</author><author>Rao, J.</author></authors></contributors><auth-address>Department of Radiology, Stanford University School of Medicine, 1201 Welch Road, P093, Mail code 5484, Stanford, CA 94305, USA.</auth-address><titles><title>HaloTag protein-mediated specific labeling of living cells with quantum dots</title><secondary-title>Biochem Biophys Res Commun</secondary-title></titles><periodical><full-title>Biochem Biophys Res Commun</full-title></periodical><pages>419-23</pages><volume>374</volume><number>3</number><edition>2008/07/16</edition><keywords><keyword>Animals</keyword><keyword>Biotin/chemistry</keyword><keyword>Biotinylation</keyword><keyword>COS Cells</keyword><keyword>Cell Membrane/chemistry</keyword><keyword>Cercopithecus aethiops</keyword><keyword>Fluorescent Dyes/ chemistry</keyword><keyword>Ligands</keyword><keyword>Membrane Proteins/ chemistry</keyword><keyword>Quantum Dots</keyword><keyword>Staining and Labeling/ methods</keyword><keyword>Streptavidin/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep 26</date></pub-dates></dates><isbn>1090-2104 (Electronic)</isbn><accession-num>18621022</accession-num><abstract>Quantum dots emerge as an attractive alternative to small molecule fluorophores as fluorescent tags for in vivo cell labeling and imaging. This communication presents a method for specific labeling of live cells using quantum dots. The labeling is mediated by HaloTag protein expressed at the cell surface which forms a stable covalent adduct with its ligand (HaloTag ligand). The labeling can be performed in one single step with quantum dot conjugates that are functionalized with HaloTag ligand, or in two steps with biotinylated HaloTag ligand first and followed by streptavidin coated quantum dots. Live cell fluorescence imaging indicates that the labeling is specific and takes place at the cell surface. This HaloTag protein-mediated cell labeling method should facilitate the application of quantum dots for live cell imaging.</abstract><notes>So, Min-kyung&#xD;Yao, Hequan&#xD;Rao, Jianghong&#xD;1U54CA119367-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Biochemical and biophysical research communications&#xD;Biochem Biophys Res Commun. 2008 Sep 26;374(3):419-23. Epub 2008 Jul 11.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom2>2553894</custom2><custom3>NIHMS66521</custom3><custom4>2.823</custom4><electronic-resource-num>S0006-291X(08)01298-9 [pii]&#xD;10.1016/j.bbrc.2008.07.004 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1749</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1749</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yadav, S.</author><author>van Vlerken, L. E.</author><author>Little, S. R.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, USA.</auth-address><titles><title>Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells</title><secondary-title>Cancer Chemother Pharmacol</secondary-title></titles><periodical><full-title>Cancer Chemother Pharmacol</full-title></periodical><pages>711-22</pages><volume>63</volume><number>4</number><edition>2008/07/12</edition><keywords><keyword>Antineoplastic Agents, Phytogenic/administration &amp; dosage</keyword><keyword>Apoptosis/drug effects/physiology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Combined Modality Therapy</keyword><keyword>Drug Delivery Systems</keyword><keyword>*Drug Resistance, Multiple</keyword><keyword>Drug Resistance, Neoplasm</keyword><keyword>Female</keyword><keyword>*Gene Silencing</keyword><keyword>Gene Therapy</keyword><keyword>Humans</keyword><keyword>*Nanoparticles</keyword><keyword>Ovarian Neoplasms/genetics/metabolism/*therapy</keyword><keyword>P-Glycoprotein/*genetics</keyword><keyword>Paclitaxel/*administration &amp; dosage</keyword><keyword>Polyesters/*administration &amp; dosage</keyword><keyword>RNA, Small Interfering/pharmacology</keyword></keywords><dates><year>2009</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1432-0843 (Electronic)</isbn><accession-num>18618115</accession-num><abstract>In this study, the effect of MDR-1 gene silencing, using small interfering RNA (siRNA), and paclitaxel (PTX) co-therapy in overcoming tumor multidrug resistance was examined. Poly(ethylene oxide)-modified poly(beta-amino ester) (PEO-PbAE) and PEO-modified poly(epsilon-caprolactone) (PEO-PCL) nanoparticles were formulated to efficiently encapsulate MDR-1 silencing siRNA and PTX, respectively. Upon administration in multidrug resistant SKOV3(TR) human ovarian adenocarcinoma cells, siRNA-mediated MDR-1 gene silencing was evident at 100 nM dose. Combination of MDR-1 gene silencing and nanoparticle-mediated delivery significantly influenced the cytotoxic activity of PTX in SKOV3(TR) cells similar to what was observed in drug sensitive SKOV3 cells. We speculate that the enhancement in cytotoxicity was due to an increase in intracellular drug accumulation upon MDR-1 gene silencing leading to an apoptotic cell-kill effect. Taken together, these preliminary results are highly encouraging for the development of combination nano-therapeutic strategies that combine gene silencing and drug delivery to provide more potent therapeutic effect, especially in refractory tumors.</abstract><notes>Yadav, Sunita&#xD;van Vlerken, Lilian E&#xD;Little, Steven R&#xD;Amiji, Mansoor M&#xD;R01-CA119617/CA/NCI NIH HHS/United States&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Cancer chemotherapy and pharmacology&#xD;Cancer Chemother Pharmacol. 2009 Mar;63(4):711-22. Epub 2008 Jul 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18618115</url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom4>2.477</custom4><electronic-resource-num>10.1007/s00280-008-0790-y</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2251</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2251</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, A. Z.</author><author>Gu, F.</author><author>Zhang, L.</author><author>Chan, J. M.</author><author>Radovic-Moreno, A.</author><author>Shaikh, M. R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Department of Anesthesiology, Harvard Medical School, Brigham and Women&apos;s Hospital, Boston, MA 02115, USA.</auth-address><titles><title>Biofunctionalized targeted nanoparticles for therapeutic applications</title><secondary-title>Expert Opin Biol Ther</secondary-title></titles><periodical><full-title>Expert Opin Biol Ther</full-title></periodical><pages>1063-70</pages><volume>8</volume><number>8</number><edition>2008/07/11</edition><keywords><keyword>Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Ligands</keyword><keyword>Nanoparticles</keyword><keyword>Therapeutics</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1744-7682 (Electronic)</isbn><accession-num>18613759</accession-num><abstract>BACKGROUND: The development of nanoparticles for the delivery of therapeutic agents has introduced new opportunities for the improvement of medical treatment. Recent efforts have focused on developing targeted nanoparticles, which are formulated by (for therapeutic delivery) functionalizing nanoparticle surfaces with targeting molecules, such as antibodies, peptides, small molecules and oligonucleotides. OBJECTIVES: To review the state of targeted nanoparticles development. METHODS: The authors discuss the nanoparticle platforms for therapeutic delivery, targeting molecules and the biofunctionalized targeted nanoparticles currently in development. RESULTS/CONCLUSIONS: Biofunctionalized targeted nanoparticles have demonstrated exciting results in preclinical studies. With continued improvements, they may fulfill their potential as therapeutics carriers that can deliver the maximum dose to diseased tissue while minimizing effects on normal cells.</abstract><notes>Wang, Andrew Z&#xD;Gu, Frank&#xD;Zhang, Liangfang&#xD;Chan, Juliana M&#xD;Radovic-Moreno, Aleksander&#xD;Shaikh, Mariam R&#xD;Farokhzad, Omid C&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;EB003647/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;England&#xD;Expert opinion on biological therapy&#xD;Expert Opin Biol Ther. 2008 Aug;8(8):1063-70.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>1.424</custom4><electronic-resource-num>10.1517/14712598.8.8.1063 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2250</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2250</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Adams, D. R.</author><author>Toner, M.</author><author>Langer, R.</author></authors></contributors><auth-address>Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Microflow and crack formation patterns in drying sessile droplets of liposomes suspended in trehalose solutions</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>7688-97</pages><volume>24</volume><number>15</number><edition>2008/07/11</edition><keywords><keyword>Kinetics</keyword><keyword>Liposomes/ chemistry</keyword><keyword>Solutions</keyword><keyword>Surface Properties</keyword><keyword>Trehalose/ chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 5</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>18613701</accession-num><abstract>Anhydrobiotic preservation potentially provides a means of long-term storage of mammalian cells in carbohydrate glasses under ambient conditions. During desiccation, sessile droplets of glass-forming carbohydrate solutions exhibit complex phenomena, including fluid flow, droplet deformation, and crack formation, all of which may alter the cell preservation efficacy. Cell-sized liposomes were employed as a model system to explore these phenomena in diffusively dried sessile droplets of trehalose solutions. Two factors were identified that strongly influenced the features of the desiccated droplets: the underlying surface and the liposomes themselves. In particular, the surface altered the droplet shape as well as the microflow pattern and, in turn, the moisture conditions encountered by the liposomes during desiccation. A ring deposit formed when the droplets were dried on polystyrene, as would be expected owing to the capillary flow that generally occurs in pinned droplets. In contrast, when dried on the more hydrophilic glass slide, the resulting droplets were thinner, and the liposomes accumulated near their centers, which was an unexpected result likely owing to the glass-forming nature of trehalose solutions. As might be anticipated given the variations in liposome distribution, the choice of surface also influenced crack formation upon continued drying. In addition to providing a preferential path for drying, such cracks are relevant because they could inflict mechanical damage on cells. The liposomes themselves had an even more profound effect on crack formation; indeed, whereas cracks were found in all droplets containing liposomes, in their absence few of the droplets cracked at all, regardless of the surface type. These complex drying dynamics merit further investigation in the development of anhydrobiotic preservation protocols, particularly with regard to the role therein of surface hydrophobicity and the cells themselves.</abstract><notes>Adams, Dana R&#xD;Toner, Mehmet&#xD;Langer, Robert&#xD;DK46270/DK/NIDDK NIH HHS/United States&#xD;U54-CA119349/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2008 Aug 5;24(15):7688-97. Epub 2008 Jul 10.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom3>2008</custom3><custom4>4.347</custom4><electronic-resource-num>10.1021/la703835w [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2249</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2249</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, A. Z.</author><author>Bagalkot, V.</author><author>Vasilliou, C. C.</author><author>Gu, F.</author><author>Alexis, F.</author><author>Zhang, L.</author><author>Shaikh, M.</author><author>Yuet, K.</author><author>Cima, M. J.</author><author>Langer, R.</author><author>Kantoff, P. W.</author><author>Bander, N. H.</author><author>Jon, S.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Laboratory of Nanomedicine and Biomaterials, Department of Anesthesia, Brigham and Women&apos;s Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.</auth-address><titles><title>Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy</title><secondary-title>ChemMedChem</secondary-title></titles><periodical><full-title>ChemMedChem</full-title></periodical><pages>1311-5</pages><volume>3</volume><number>9</number><edition>2008/07/10</edition><keywords><keyword>Antineoplastic Agents/ chemical synthesis/diagnostic use/pharmacology</keyword><keyword>Aptamers, Nucleotide/ chemistry/diagnostic use/pharmacology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation/drug effects</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Drug Delivery Systems/methods</keyword><keyword>Drug Design</keyword><keyword>Drug Screening Assays, Antitumor</keyword><keyword>Ferrosoferric Oxide/ chemistry/diagnostic use/pharmacology</keyword><keyword>Humans</keyword><keyword>Magnetics</keyword><keyword>Male</keyword><keyword>Nanoparticles/ chemistry</keyword><keyword>Prostatic Neoplasms/ diagnosis/ drug therapy</keyword><keyword>Structure-Activity Relationship</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1860-7187 (Electronic)</isbn><accession-num>18613203</accession-num><notes>Wang, Andrew Z&#xD;Bagalkot, Vaishali&#xD;Vasilliou, Christophoros C&#xD;Gu, Frank&#xD;Alexis, Frank&#xD;Zhang, Liangfang&#xD;Shaikh, Mariam&#xD;Yuet, Kai&#xD;Cima, Michael J&#xD;Langer, Robert&#xD;Kantoff, Philip W&#xD;Bander, Neil H&#xD;Jon, Sangyong&#xD;Farokhzad, Omid C&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;EB003647/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;ChemMedChem&#xD;ChemMedChem. 2008 Sep;3(9):1311-5.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>3.150</custom4><electronic-resource-num>10.1002/cmdc.200800091 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1687</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1687</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>von Maltzahn, Geoffrey</author><author>Ren, Yin</author><author>Park, Ji-Ho</author><author>Min, Dal-Hee</author><author>Kotamraju, Venkata Ramana</author><author>Jayakumar, Jayanthi</author><author>Fogal, Valentina</author><author>Sailor, Michael J.</author><author>Ruoslahti, Erkki</author><author>Bhatia, Sangeeta N.</author></authors></contributors><auth-address>Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts, Cancer Research Center, Burnham Institute for Medical Research, La Jolla, California, Vascular Mapping Center, Burnham Institute for Medical Research at University of California Santa Barbara, Santa Barbara, California, Materials Science and Engineering Program, Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, and Electrical Engineering and Computer Science, MIT/Brigham &amp; Women s Hospital, Boston, Massachusetts</auth-address><titles><title>In Vivo Tumor Cell Targeting with Click Nanoparticles</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><volume>accepted</volume><edition>2008/07/09 </edition><dates><year>2008</year></dates><isbn>1043-1802</isbn><abstract>Abstract: The in vivo fate of nanomaterials strongly determines their biomedical efficacy. Accordingly, much effort has been invested into the development of library screening methods to select targeting ligands for a diversity of sites in vivo. Still, broad application of chemical and biological screens to the in vivo targeting of nanomaterials requires ligand attachment chemistries that are generalizable, efficient, covalent, orthogonal to diverse biochemical libraries, applicable under aqueous conditions, and stable in in vivo environments. To date, the copper(I)-catalyzed Huisgen 1,3-dipolar cycloaddition or  click  reaction has shown considerable promise as a method for developing targeted nanomaterials in vitro. Here, we investigate the utility of  click  chemistry for the in vivo targeting of inorganic nanoparticles to tumors. We find that  click  chemistry allows cyclic LyP-1 targeting peptides to be specifically linked to azido-nanoparticles and to direct their binding to p32-expressing tumor cells in vitro. Moreover,  click  nanoparticles are able to stably circulate for hours in vivo following intravenous administration (&gt;5 h circulation time), extravasate into tumors, and penetrate the tumor interstitium to specifically bind p32-expressing cells in tumors. In the future, in vivo use of  click  nanomaterials should expedite the progression from ligand discovery to in vivo evaluation and diversify approaches toward multifunctional nanoparticle development.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/bc800077y</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>UCSD/ MIT</custom2><custom3>2008</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/bc800077y </electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2142</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2142</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, S.</author><author>Liu, Z.</author><author>Sultana, S.</author><author>Schreiber, E.</author><author>Zhou, O.</author><author>Chang, S.</author></authors></contributors><auth-address>Department of Radiation Oncology, University of North Carolina at Chapel Hill, NC 27599, USA. sgwang@email.unc.edu</auth-address><titles><title>A novel high resolution micro-radiotherapy system for small animal irradiation for cancer research</title><secondary-title>Biofactors</secondary-title></titles><periodical><full-title>Biofactors</full-title></periodical><pages>265-70</pages><volume>30</volume><number>4</number><edition>2008/07/09</edition><keywords><keyword>Animals</keyword><keyword>Nanotubes, Carbon/ chemistry</keyword><keyword>Radiotherapy/ instrumentation</keyword><keyword>Tumor Cells, Cultured/radiation effects</keyword></keywords><dates><year>2007</year></dates><isbn>0951-6433 (Print)</isbn><accession-num>18607076</accession-num><abstract>Micro-radiotherapy (micro-RT) system is specially designed for small animal (cancer cell) irradiation for basic and translational cancer research. We use carbon nanotube (CNT) field emission technology to develop a novel micro-RT system for image-guided high precision irradiation that is similar to the state of the art radiotherapy which our cancer patients receive today at mouse scale. Through the field emission control of its individually addressable x-ray pixel beams the micro-RT system electronically shapes the radiation field and forms intensity modulation pattern. In this paper, we present the development of a carbon nanotube field emission cathode array chip--a key component for our novel micro-RT system. The prototype micro-RT CNT field emission cathode array chip has 5 x 5 individually addressable cathode pixels that are 1 mm in diameter and 2 mm in pitch. An individual CNT cathode pixel is predicted to generate a dose rate in the order of 100 cGy/min at the center of the irradiated mouse based on our Monte Carlo simulation. The temporal and spatial resolutions of the micro-RT system are expected to be approximately ms level and &lt; 2 mm respectively.</abstract><notes>Wang, Sigen&#xD;Liu, Zhijun&#xD;Sultana, Shabana&#xD;Schreiber, Eric&#xD;Zhou, Otto&#xD;Chang, Sha&#xD;U54 CA 119343-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Netherlands&#xD;BioFactors (Oxford, England)&#xD;Biofactors. 2007;30(4):265-70.</notes><urls></urls><custom1>CCNE - UNC</custom1><custom4>1.806</custom4><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1459</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1459</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Murphy, E. A.</author><author>Majeti, B. K.</author><author>Barnes, L. A.</author><author>Makale, M.</author><author>Weis, S. M.</author><author>Lutu-Fuga, K.</author><author>Wrasidlo, W.</author><author>Cheresh, D. A.</author></authors></contributors><auth-address>Department of Pathology, Moores Cancer Center, University of California at San Diego, 3855 Health Sciences Drive, La Jolla, CA 92093, USA.</auth-address><titles><title>Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>9343-8</pages><volume>105</volume><number>27</number><edition>2008/07/09</edition><keywords><keyword>Angiogenesis Inhibitors/pharmacology</keyword><keyword>Animals</keyword><keyword>Carcinoma, Renal Cell/pathology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Disease Models, Animal</keyword><keyword>Doxorubicin/*administration &amp; dosage/pharmacology/*therapeutic use</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Endothelium/drug effects/pathology</keyword><keyword>Integrin alphaVbeta3/metabolism</keyword><keyword>Kidney Neoplasms/pathology</keyword><keyword>Mice</keyword><keyword>*Nanoparticles</keyword><keyword>Neoplasm Metastasis/*drug therapy</keyword><keyword>Neoplasms/*blood supply/*pathology</keyword><keyword>Neovascularization, Pathologic/pathology</keyword><keyword>Oligopeptides/pharmacology</keyword><keyword>Pancreatic Neoplasms/blood supply/pathology</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2008</year><pub-dates><date>Jul 8</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18607000</accession-num><abstract>Integrin alphanubeta3 is found on a subset of tumor blood vessels where it is associated with angiogenesis and malignant tumor growth. We designed an alphanubeta3-targeted nanoparticle (NP) encapsulating the cytotoxic drug doxorubicin (Dox) for targeted drug delivery to the alphanubeta3-expressing tumor vasculature. We observed real-time targeting of this NP to tumor vessels and noted selective apoptosis in regions of the alphanubeta3-expressing tumor vasculature. In clinically relevant pancreatic and renal cell orthotopic models of spontaneous metastasis, targeted delivery of Dox produced an antimetastatic effect. In fact, alphanubeta3-mediated delivery of this drug to the tumor vasculature resulted in a 15-fold increase in antimetastatic activity without producing drug-associated weight loss as observed with systemic administration of the free drug. These findings reveal that NP-based delivery of cytotoxic drugs to the alphanubeta3-positive tumor vasculature represents an approach for treating metastatic disease.</abstract><notes>Murphy, Eric A&#xD;Majeti, Bharat K&#xD;Barnes, Leo A&#xD;Makale, Milan&#xD;Weis, Sara M&#xD;Lutu-Fuga, Kimberly&#xD;Wrasidlo, Wolfgang&#xD;Cheresh, David A&#xD;P01-CA078045/CA/United States NCI&#xD;P01-CA104898/CA/United States NCI&#xD;U54-CA119335/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9343-8. Epub 2008 Jul 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18607000</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>10.228</custom4><electronic-resource-num>0803728105 [pii]&#xD;10.1073/pnas.0803728105</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1517</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1517</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pogue, B. W.</author><author>Sheng, C.</author><author>Benevides, J.</author><author>Forcione, D.</author><author>Puricelli, B.</author><author>Nishioka, N.</author><author>Hasan, T.</author></authors></contributors><auth-address>Dartmouth College, Thayer School of Engineering, Hanover, New Hampshire 03755, USA. pogue@dartmouth.edu</auth-address><titles><title>Protoporphyrin IX fluorescence photobleaching increases with the use of fractionated irradiation in the esophagus</title><secondary-title>J Biomed Opt</secondary-title></titles><periodical><full-title>J Biomed Opt</full-title></periodical><pages>034009</pages><volume>13</volume><number>3</number><edition>2008/07/08</edition><dates><year>2008</year><pub-dates><date>May-Jun</date></pub-dates></dates><isbn>1083-3668 (Print)</isbn><accession-num>18601554</accession-num><abstract>Fluorescence measurements have been used to track the dosimetry of photodynamic therapy (PDT) for many years, and this approach can be especially important for treatments with aminolevulinic-acid-induced protoporphyrin IX (ALA-PpIX). PpIX photobleaches rapidly, and the bleaching is known to be oxygen dependent, and at the same time, fractionation or reduced irradiance treatments have been shown to significantly increase efficacy. Thus, in vivo measurement of either the bleaching rate and/or the total bleaching yield could be used to track the deposited dose in tissue and determine the optimal treatment plans. Fluorescence in rat esophagus and human Barrett&apos;s esophagus are measured during PDT in both continuous and fractionated light delivery treatment, and the bleaching is quantified. Reducing the optical irradiance from 50 to 25 mWcm did not significantly alter photobleaching in rat esophagus, but fractionation of the light at 1-min on and off intervals did increase photobleaching up to 10% more (p value=0.02) and up to 25% more in the human Barrett&apos;s tissue (p value&lt;0.001). While two different tissues and two different dosimetry systems are used, the data support the overall hypothesis that light fractionation in ALA-PpIX PDT esophageal treatments should have a beneficial effect on the total treatment effect.</abstract><notes>Pogue, Brian W&#xD;Sheng, Chao&#xD;Benevides, Juan&#xD;Forcione, David&#xD;Puricelli, Bill&#xD;Nishioka, Norm&#xD;Hasan, Tayyaba&#xD;P01CA84203/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of biomedical optics&#xD;J Biomed Opt. 2008 May-Jun;13(3):034009.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18601554</url></related-urls></urls><custom1>CNPP - Harvard</custom1><custom3>2008</custom3><custom4>3.371</custom4><electronic-resource-num>10.1117/1.2937476</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1384</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1384</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, S.</author><author>Zhu, L.</author><author>Minhaj, A. M.</author><author>Hinds, M. F.</author><author>Vu, D. H.</author><author>Rosen, D. I.</author><author>Davis, S. J.</author><author>Hasan, T.</author></authors></contributors><auth-address>Physical Sciences Inc., 20 New England Business Center, Andover, Massachusetts 01810-1077, USA. lee@psicorp.com</auth-address><titles><title>Pulsed diode laser-based monitor for singlet molecular oxygen</title><secondary-title>J Biomed Opt</secondary-title></titles><periodical><full-title>J Biomed Opt</full-title></periodical><pages>034010</pages><volume>13</volume><number>3</number><edition>2008/07/08</edition><dates><year>2008</year><pub-dates><date>May-Jun</date></pub-dates></dates><isbn>1083-3668 (Print)</isbn><accession-num>18601555</accession-num><abstract>Photodynamic therapy (PDT) is a promising cancer treatment. PDT uses the affinity of photosensitizers to be selectively retained in malignant tumors. When tumors, pretreated with the photosensitizer, are irradiated with visible light, a photochemical reaction occurs and tumor cells are destroyed. Oxygen molecules in the metastable singlet delta state O2(1Delta) are believed to be the species that destroys cancerous cells during PDT. Monitoring singlet oxygen produced by PDT may lead to more precise and effective PDT treatments. Our approach uses a pulsed diode laser-based monitor with optical fibers and a fast data acquisition system to monitor singlet oxygen during PDT. We present results of in vitro singlet oxygen detection in solutions and in a rat prostate cancer cell line as well as PDT mechanism modeling.</abstract><notes>Lee, Seonkyung&#xD;Zhu, Leyun&#xD;Minhaj, Ahmed M&#xD;Hinds, Michael F&#xD;Vu, Danthu H&#xD;Rosen, David I&#xD;Davis, Steven J&#xD;Hasan, Tayyaba&#xD;1R43CA96243-01/CA/United States NCI&#xD;P01 CA484203/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of biomedical optics&#xD;J Biomed Opt. 2008 May-Jun;13(3):034010.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18601555</url></related-urls></urls><custom1>CNPP - Harvard</custom1><custom3>2008</custom3><custom4>3.371</custom4><electronic-resource-num>10.1117/1.2927465</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1845</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1845</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Katsumata, T.</author><author>Nakakuki, H.</author><author>Tokunaga, C.</author><author>Fujii, N.</author><author>Egi, M.</author><author>Phan, T. H.</author><author>Mummalaneni, S.</author><author>DeSimone, J. A.</author><author>Lyall, V.</author></authors></contributors><auth-address>Food Creation Center, Kyowa Hakko Food Specialties Co., Ltd, Ibaraki, Japan.</auth-address><titles><title>Effect of Maillard reacted peptides on human salt taste and the amiloride-insensitive salt taste receptor (TRPV1t)</title><secondary-title>Chem Senses</secondary-title></titles><periodical><full-title>Chem Senses</full-title></periodical><pages>665-80</pages><volume>33</volume><number>7</number><edition>2008/07/08</edition><keywords><keyword>Algorithms</keyword><keyword>Amiloride/analogs &amp; derivatives/antagonists &amp;</keyword><keyword>inhibitors/chemistry/pharmacology</keyword><keyword>Animals</keyword><keyword>Chorda Tympani Nerve/*physiology</keyword><keyword>Epithelial Sodium Channel/drug effects/physiology</keyword><keyword>Maillard Reaction</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Peptides/*chemistry</keyword><keyword>Rats</keyword><keyword>Rats, Sprague-Dawley</keyword><keyword>Sodium Channel Blockers/pharmacology</keyword><keyword>Sodium Chloride/chemistry</keyword><keyword>TRPV Cation Channels/chemistry/genetics/*physiology</keyword><keyword>Taste/*physiology</keyword></keywords><dates><year>2008</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1464-3553 (Electronic)</isbn><accession-num>18603652</accession-num><abstract>Maillard reacted peptides (MRPs) were synthesized by conjugating a peptide fraction (1000-5000 Da) purified from soy protein hydrolyzate with galacturonic acid, glucosamine, xylose, fructose, or glucose. The effect of MRPs was investigated on human salt taste and on the chorda tympani (CT) taste nerve responses to NaCl in Sprague-Dawley rats, wild-type, and transient receptor potential vanilloid 1 (TRPV1) knockout mice. MRPs produced a biphasic effect on human salt taste perception and on the CT responses in rats and wild-type mice in the presence of NaCl + benzamil (Bz, a blocker of epithelial Na+ channels), enhancing the NaCl response at low concentrations and suppressing it at high concentrations. The effectiveness of MRPs as salt taste enhancers varied with the conjugated sugar moiety: galacturonic acid = glucosamine &gt; xylose &gt; fructose &gt; glucose. The concentrations at which MRPs enhanced human salt taste were significantly lower than the concentrations of MRPs that produced increase in the NaCl CT response. Elevated temperature, resiniferatoxin, capsaicin, and ethanol produced additive effects on the NaCl CT responses in the presence of MRPs. Elevated temperature and ethanol also enhanced human salt taste perception. N-(3-methoxyphenyl)-4-chlorocinnamid (a blocker of TRPV1t) inhibited the Bz-insensitive NaCl CT responses in the absence and presence of MRPs. TRPV1 knockout mice demonstrated no Bz-insensitive NaCl CT response in the absence or presence of MRPs. The results suggest that MRPs modulate human salt taste and the NaCl + Bz CT responses by interacting with TRPV1t.</abstract><notes>Katsumata, Tadayoshi&#xD;Nakakuki, Hiroko&#xD;Tokunaga, Chikara&#xD;Fujii, Noboru&#xD;Egi, Makoto&#xD;Phan, Tam-Hao T&#xD;Mummalaneni, Shobha&#xD;DeSimone, John A&#xD;Lyall, Vijay&#xD;DC-00122/DC/NIDCD NIH HHS/United States&#xD;DC-005981/DC/NIDCD NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Chemical senses&#xD;Chem Senses. 2008 Sep;33(7):665-80. Epub 2008 Jul 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18603652</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom2>2533421</custom2><custom4>2.436</custom4><electronic-resource-num>bjn033 [pii]&#xD;10.1093/chemse/bjn033</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1623</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1623</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stepp, B. R.</author><author>Gibbs-Davis, J. M.</author><author>Koh, D. L.</author><author>Nguyen, S. T.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Cooperative melting in caged dimers of rigid small molecule-DNA hybrids</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9628-9</pages><volume>130</volume><number>30</number><edition>2008/07/04</edition><dates><year>2008</year><pub-dates><date>Jul 30</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18597465</accession-num><notes>Stepp, Brian R&#xD;Gibbs-Davis, Julianne M&#xD;Koh, Dorothea L F&#xD;Nguyen, SonBinh T&#xD;1U54CA11934-01/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Jul 30;130(30):9628-9. Epub 2008 Jul 3.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18597465</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja801572n</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1394</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1394</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, S.</author><author>Szegedi, S.</author><author>Goluch, E.</author><author>Liu, C.</author></authors></contributors><auth-address>Micro and Nanotechnology Laboratory, University of Illinois at Urbana-Champaign 208 North Wright Street, Urbana, Illinois 61801, USA.</auth-address><titles><title>Dip pen nanolithography functionalized electrical gaps for multiplexed DNA detection</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>5899-904</pages><volume>80</volume><number>15</number><edition>2008/07/03</edition><dates><year>2008</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>1520-6882 (Electronic)</isbn><accession-num>18593193</accession-num><abstract>Nanoparticle-based, silver-enhanced DNA electrical detection shows great promise for point-of-care diagnostics. In this paper, we demonstrate that the dip pen nanolithography (DPN) method can be used to precisely functionalize multiple electrical gaps for multiplexed DNA detection. With the use of the DPN technique, capture ssDNAs are written inside 5 microm x 10 microm electrical gaps on substrates. The DPN functionalized electrical gaps can specifically hybridize to target ssDNAs in solution. Successful hybridization of the capture-target DNA complex is detected by the use of gold nanoparticles carrying ssDNA, which also hybridize to the target ssDNA, followed by silver enhancement. The drop of resistance across the gaps due to the formation of metal nanoparticle-DNA complexes is measured over time and compared against characteristics of control gaps, which are either left unfunctionalized or functionalized with noncomplementary capture ssDNA. This technique has potential for high-density multiplexed DNA assay chips. Multiplex detection of two different target ssDNAs in solution using DPN functionalized electrical gaps on the same chip is demonstrated. The lowest detection limit is 10 pM.</abstract><notes>Li, Shifeng&#xD;Szegedi, Sandra&#xD;Goluch, Edgar&#xD;Liu, Chang&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2008 Aug 1;80(15):5899-904. Epub 2008 Jul 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18593193</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac800445p</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1129</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1129</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chang, S. K.</author><author>Rizvi, I.</author><author>Solban, N.</author><author>Hasan, T.</author></authors></contributors><auth-address>Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.</auth-address><titles><title>In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment</title><secondary-title>Clin Cancer Res</secondary-title></titles><periodical><full-title>Clin Cancer Res</full-title></periodical><pages>4146-53</pages><volume>14</volume><number>13</number><edition>2008/07/03</edition><keywords><keyword>Animals</keyword><keyword>Calibration</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cytokines/metabolism</keyword><keyword>Fluorescent Dyes/pharmacology</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence/*instrumentation/*methods</keyword><keyword>Models, Biological</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neoplasms/*metabolism</keyword><keyword>Photochemotherapy/methods</keyword><keyword>Time Factors</keyword><keyword>Up-Regulation</keyword><keyword>Vascular Endothelial Growth Factor A/*metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Jul 1</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>18593993</accession-num><abstract>PURPOSE: Vascular endothelial growth factor (VEGF) expression is a critical component in tumor growth and metastasis. Capabilities to monitor VEGF expression in vivo can potentially serve as a useful tool for diagnosis, prognosis, treatment planning, monitoring, and research. Here, we present the first report of in vivo hyperspectral molecular imaging strategy capable of monitoring treatment-induced changes in VEGF expression. EXPERIMENTAL DESIGN: VEGF was targeted with an anti-VEGF antibody conjugated with a fluorescent dye and was imaged in vivo using a hyperspectral imaging system. The strategy was validated by quantitatively monitoring VEGF levels in three different tumors as well as following photodynamic treatment. Specificity of the molecular imaging strategy was tested using in vivo competition experiments and mathematically using a quantitative pharmacokinetic model. RESULTS: The molecular imaging strategy successfully imaged VEGF levels quantitatively in three different tumors and showed concordance with results from standard ELISA. Changes in tumoral VEGF concentration following photodynamic treatment and Avastin treatment were shown. Immunohistochemistry shows that (a) the VEGF-specific contrast agent labels both proteoglycan-bound and unbound VEGF in the extracellular space and (b) the bound VEGF is released from the extracellular matrix in response to photodynamic therapy. In vivo competition experiments and quantitative pharmacokinetic model-based analysis confirmed the high specificity of the imaging strategy. CONCLUSION: This first report of in vivo quantitative optical molecular imaging-based monitoring of a secreted cytokine in tumors may have implications in providing tools for mechanistic investigations as well as for improved treatment design and merits further investigation.</abstract><notes>Chang, Sung K&#xD;Rizvi, Imran&#xD;Solban, Nicolas&#xD;Hasan, Tayyaba&#xD;P01 CA84203/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 Jul 1;14(13):4146-53.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18593993</url></related-urls></urls><custom1>CNPP - Harvard</custom1><custom3>2008</custom3><custom4>6.646</custom4><electronic-resource-num>14/13/4146 [pii]&#xD;10.1158/1078-0432.CCR-07-4536</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1576</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1576</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, C.</author><author>Zhou, G.</author><author>Zhu, Y.</author><author>Su, Y.</author><author>Cheng, T.</author><author>Zhau, H. E.</author><author>Chung, L. W.</author></authors></contributors><auth-address>Molecular Urology and Therapeutics Program, Department of Urology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA. shicm1010@yahoo.com.cn</auth-address><titles><title>Quantum dots-based multiplexed immunohistochemistry of protein expression in human prostate cancer cells</title><secondary-title>Eur J Histochem</secondary-title></titles><periodical><full-title>Eur J Histochem</full-title></periodical><pages>127-34</pages><volume>52</volume><number>2</number><edition>2008/07/02</edition><dates><year>2008</year><pub-dates><date>Apr-Jun</date></pub-dates></dates><isbn>1121-760X (Print)</isbn><accession-num>18591159</accession-num><abstract>Semiconductor quantum dots (QDs) are bright fluorescent nanoparticles that have been successfully used for the detection of biomarker expression in cells. The objective of the present study is to use this technology in a multiplexing manner to determine at a single cell level the expression of a cell-specific bio-marker, prostate-specific antigen (PSA) expressed by human prostate cancer LNCaP and ARCaP cell lines. Here we compared the sensitivity of immunohistochemistry (IHC) and QD-based detection of AR and PSA expression in these cell lines. Further, we conducted multiplexing QD-based detection of PSA and androgen receptor (AR) expression in LNCaP cells subjecting to androgen (R1881) stimulation. The involvement of AR in PSA regulation in LNCaP cells, at a single cell level, was confirmed by the co-incubation of LNCaP cells in the presence of both R1881 and its receptor antagonist, bicalutamide (Casodex). We showed here the superior quality of QDs, in comparison to IHC, for the detection of AR and PSA in cultured LNCaP and ARCaP cells. Multiplexing QDs technique can be used to detect simultaneously AR and PSA expression induced by R1881 which promoted AR translocation from its cytosolic to the nuclear compartment. We observed AR antagonist, bicalutamide, inhibited AR nuclear translocation and PSA, but not AR expression in LNCaP cells.</abstract><notes>Shi, C&#xD;Zhou, G&#xD;Zhu, Y&#xD;Su, Y&#xD;Cheng, T&#xD;Zhau, H E&#xD;Chung, L W K&#xD;CA108468/CA/United States NCI&#xD;P01 CA098912/CA/United States NCI&#xD;R01 GM60652/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Italy&#xD;European journal of histochemistry : EJH&#xD;Eur J Histochem. 2008 Apr-Jun;52(2):127-34.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18591159</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>4.217</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1216</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1216</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gratton, S. E.</author><author>Napier, M. E.</author><author>Ropp, P. A.</author><author>Tian, S.</author><author>Desimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry and Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, USA.</auth-address><titles><title>Microfabricated Particles for Engineered Drug Therapies: Elucidation into the Mechanisms of Cellular Internalization of PRINT Particles</title><secondary-title>Pharm Res</secondary-title></titles><periodical><full-title>Pharm Res</full-title></periodical><volume>accepted</volume><edition>2008/07/02</edition><dates><year>2008</year></dates><isbn>0724-8741 (Print)</isbn><accession-num>18592353</accession-num><abstract>PURPOSE: To investigate the cellular internalization pathways of shape- and size-specific particles as a function of zeta potential in different cell types. METHODS: A top-down particle fabrication technique called PRINT was utilized to fabricate monodisperse 1 mum cylindrical particles. Cellular internalization of these PRINT particles was monitored using confocal microscopy, flow cytometry, and transmission electron microscopy. The endocytic pathway used by 1 mum cationic PRINT particles was evaluated using different inhibitory strategies. Cytotoxicity assays were used to determine the toxicity of both cationic and anionic PRINT particles in multiple cell types. RESULTS: Particle internalization was confirmed using confocal microscopy, flow cytometry and transmission electron microscopy. The mechanism of internalization of positively charged PRINT particles was found to be predominantly clathrin-mediated endocytosis and macropinocytosis with very few particles utilizing a caveolae-mediated endocytic pathway. The exposed charge on the surface of the particles had a significant effect on the rate of endocytosis in all cell types tested, except for the macrophage cells. No significant cytotoxicity was observed for all PRINT particles used in the present study. CONCLUSIONS: Cylindrical 1 mum PRINT particles were readily internalized into HeLa, NIH 3T3, OVCAR-3, MCF-7, and RAW 264.7 cells. Particles with a positive zeta potential exhibited an enhanced rate of endocytosis compared to negatively charged particles with identical sizes and shapes. It was found that PRINT particles with a positive zeta potential were endocytosed into HeLa cells using predominantely clathrin-mediated and macropinocytotic pathways.</abstract><notes>Journal article&#xD;Pharmaceutical research&#xD;Pharm Res. 2008 Jul 1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18592353</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>3.831</custom4><electronic-resource-num>10.1007/s11095-008-9654-8</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2083</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2083</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Chen, X.</author></authors></contributors><auth-address>Department of Radiology and Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin 53792-3252, USA. wcai@uwhealth.org</auth-address><titles><title>Multimodality molecular imaging of tumor angiogenesis</title><secondary-title>J Nucl Med</secondary-title></titles><periodical><full-title>J Nucl Med</full-title></periodical><pages>113S-28S</pages><volume>49 Suppl 2</volume><edition>2008/07/01</edition><keywords><keyword>Animals</keyword><keyword>Fluorometry</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/metabolism</keyword><keyword>Liposomes</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>Nanoparticles</keyword><keyword>Nanotubes</keyword><keyword>Neoplasms/ blood supply</keyword><keyword>Neovascularization, Pathologic/ diagnosis/metabolism/radionuclide</keyword><keyword>imaging/ultrasonography</keyword><keyword>Positron-Emission Tomography/methods</keyword><keyword>Quantum Dots</keyword><keyword>Radiopharmaceuticals/diagnostic use</keyword><keyword>Receptors, Vascular Endothelial Growth Factor/metabolism</keyword><keyword>Vascular Endothelial Growth Factor A/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>18523069</accession-num><abstract>Molecular imaging is a key component of 21st-century cancer management. The vascular endothelial growth factor (VEGF)/VEGF receptor signaling pathway and integrin alpha v beta 3, a cell adhesion molecule, play pivotal roles in regulating tumor angiogenesis, the growth of new blood vessels. This review summarizes the current status of tumor angiogenesis imaging with SPECT, PET, molecular MRI, targeted ultrasound, and optical techniques. For integrin alpha v beta 3 imaging, only nanoparticle-based probes, which truly target the tumor vasculature rather than tumor cells because of poor extravasation, are discussed. Once improvements in the in vivo stability, tumor-targeting efficacy, and pharmacokinetics of tumor angiogenesis imaging probes are made, translation to clinical applications will be critical for the maximum benefit of these novel agents. The future of tumor angiogenesis imaging lies in multimodality and nanoparticle-based approaches, imaging of protein-protein interactions, and quantitative molecular imaging. Combinations of multiple modalities can yield complementary information and offer synergistic advantages over any modality alone. Nanoparticles, possessing multifunctionality and enormous flexibility, can allow for the integration of therapeutic components, targeting ligands, and multimodality imaging labels into one entity, termed &quot;nanomedicine,&quot; for which the ideal target is tumor neovasculature. Quantitative imaging of tumor angiogenesis and protein-protein interactions that modulate angiogenesis will lead to more robust and effective monitoring of personalized molecular cancer therapy. Multidisciplinary approaches and cooperative efforts from many individuals, institutions, industries, and organizations are needed to quickly translate multimodality tumor angiogenesis imaging into multiple facets of cancer management. Not limited to cancer, these novel agents can also have broad applications for many other angiogenesis-related diseases.</abstract><notes>Cai, Weibo&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 120188/PHS HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2008 Jun;49 Suppl 2:113S-28S.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.282</custom4><electronic-resource-num>49/Suppl_2/113S [pii]&#xD;10.2967/jnumed.107.045922 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1754</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1754</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yang, Jian</author><author>Lind, Johan U.</author><author>Trogler, William C.</author></authors></contributors><auth-address>Department of Chemistry &amp; Biochemistry and CalIT2 Nanomedicine Laboratory, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0358</auth-address><titles><title>Synthesis of Hollow Silica and Titania Nanospheres</title><secondary-title>Chem. Mater.</secondary-title></titles><periodical><full-title>Chem. Mater.</full-title></periodical><pages>2875-2877</pages><volume>20</volume><number>9</number><edition>2008/07</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0897-4756</isbn><abstract>no abstract</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/cm703264y</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>5.932</custom4><electronic-resource-num>10.1021/cm703264y</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1734</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1734</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wu, A.</author><author>Paunesku, T.</author><author>Brown, E.M.B.</author><author>Babbo, A.</author><author>Cruz, C.</author><author>Aslam, M.</author><author>Dravid, V.</author><author>Woloschak, G.E</author></authors></contributors><titles><title>Titanium Dioxide Nanoparticles Assembled by DNA Molecules Hybridization and Loading of DNA Interacting Proteins</title><secondary-title>Nano</secondary-title></titles><periodical><full-title>Nano</full-title></periodical><pages>27-36</pages><volume>3</volume><number>1</number><edition>2008/07</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>1.110</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1713</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1713</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Waters, E.A.</author><author>Chen, J.</author><author>Zhang, H.</author><author>Lanza, G.M.</author><author>Wickline, S.A.</author></authors></contributors><titles><title>Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS</title><secondary-title>J Cardiovasc Magn Reson</secondary-title></titles><periodical><full-title>J Cardiovasc Magn Reson</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Siteman</custom1><custom4>2.327</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1708</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1708</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, Y.</author><author>Newaz, A. K. M.</author><author>Wu, J.</author><author>Solin, S. A.</author><author>Kavasseri, V. R.</author><author>Jin, N.</author><author>Ahmed, I. S.</author><author>Adesida, I.</author></authors></contributors><titles><title>Extraordinary electroconductance in metal-semiconductor hybrid structures</title><secondary-title>Applied Physics Letters</secondary-title></titles><periodical><full-title>Applied Physics Letters</full-title></periodical><pages>262106</pages><volume>92</volume><number>26</number><edition>2008/07</edition><keywords><keyword>electrical conductivity</keyword><keyword>electron field emission</keyword><keyword>gallium arsenide</keyword><keyword>III-V semiconductors</keyword><keyword>junction gate field effect transistors</keyword><keyword>metallic thin films</keyword><keyword>Schottky gate field effect transistors</keyword><keyword>semiconductor epitaxial layers</keyword><keyword>semiconductor-metal boundaries</keyword><keyword>thermionic electron emission</keyword><keyword>titanium</keyword></keywords><dates><year>2008</year><pub-dates><date>Jul 2</date></pub-dates></dates><abstract>We report the phenomenon of extraordinary electroconductance in microscopic metal-semiconductor hybrid structures fabricated from GaAs epitaxial layer and a Ti thin film shunt. Four-lead Van der Pauw structures show a gain of 5.2% in electroconductance under +2.5  kV/cm with zero shunt bias. The increase in the sample conductance results from the thermionic field emission of electrons and the geometrical amplification. A model provides good agreement with the experimental data and clearly demonstrates the geometry dependence of the field effect in extraordinary electroconductance (EEC). The differences between EEC devices and field effect transistors, such as junction field effect transistor (FET) and Schottky barrier gate FET, are discussed. </abstract><urls><related-urls><url>http://link.aip.org/link/?APL/92/262106/1</url><url>http://dx.doi.org/10.1063/1.2955503</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>4.096</custom4><electronic-resource-num>DOI:10.1063/1.2955503</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1689</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1689</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, D.</author><author>Bangash, A.</author><author>Rhee, T.</author><author>Woloschak, G.</author><author>Paunesku, T.</author><author>Salem, R.</author><author>Omary, R.</author><author>Larson, A</author></authors></contributors><titles><title>Fourdimensional Transcatheter Intra-arterial Perfusion (TRIP)-MRI for Monitoring Liver Tumor Embolization in VX2 Rabbits</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.163</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1662</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1662</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tong, R.</author><author>Cheng, J</author></authors></contributors><titles><title>Formulation of Conjugated Polylactide-Doxorubicin Nanoparticles through Ring-Opening Polymerization</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Siteman</custom1><custom4>8.256</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1649</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1649</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tenchov, B.G.</author><author>Wang, L.</author><author>Koynova, R.D.</author><author>MacDonald R.C.</author></authors></contributors><titles><title>Modulation of a Membrane Lipid Phase Transition: A Predictive Measure for Lipofection Efficiency</title><secondary-title>Biochim Biophys Acta-Biomembranes</secondary-title></titles><periodical><full-title>Biochim Biophys Acta-Biomembranes</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>3.640</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1579</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1579</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, C.</author><author>Zhu, Y.</author><author>Xie, Z. </author><author>Qian, W.</author><author>Hsieh, C.L.</author><author>Nie, S.</author><author>Su, Y.</author><author>Zhau, H.E.</author><author>Chung, L.W.K.</author></authors></contributors><titles><title>Visualizing human prostate cancer cells in mouse skeleton using bioconjugated near-infrared fluorescent quantum dots</title><secondary-title>Urology</secondary-title></titles><periodical><full-title>Urology</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Emory/GT</custom1><custom4>2.604</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1566</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1566</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Seo, S.I.</author><author>Gera, L.</author><author>Zhau, H.E.</author><author>Qian, W.P.</author><author>Iqbal, S.</author><author>Johnson, N.A.</author><author>Zhang, S.</author><author>Zayzafoon, M.</author><author>Stewart, J.</author><author>Chung, L.W.K.</author><author>Wu, D.</author></authors></contributors><titles><title>BKM1740, an acyl-tyrosine bisphosphonate amide derivative, inhibits the bone metastatic growth of human prostate cancer cells through the inhibition of survivin expression</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Emory/GT</custom1><custom4>4.163</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1556</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1556</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schreiber, E. C.</author><author>Chang, S. X. </author></authors></contributors><titles><title>Monte Carlo simulation of x-ray pixel beam array micro-RT dosimetry</title><secondary-title>Radiation Research</secondary-title></titles><periodical><full-title>Radiation Research</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - UNC</custom1><custom4>2.599</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1550</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1550</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ruiz-Cabello, J.</author><author>Walczak P, </author><author>Kedziorek DA, </author><author>Chacko VP, </author><author>Schmieder AH, </author><author>Wickline SA, </author><author>Lanza GM, </author><author>Bulte JWM</author></authors></contributors><titles><title>In Vivo Hot Spot MR Imaging of Neural Stem Cells using Fluorinated Nanoparticles</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Siteman</custom1><custom4>4.163</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1489</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1489</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, J.H.</author><author>von Maltzahn, G.</author><author>Zhang, L.</author><author>Schwartz, M.P.</author><author>Ruoslahti, E.</author><author>Bhatia, S.N.</author><author>Sailor, M.J.</author></authors></contributors><auth-address>Materials Science and Engineering Program Department of Chemistry and Biochemistry University of California, San Diego 9500 Gilman, La Jolla, CA 92093 (USA); Harvard-MIT Division of Health Sciences and Technology Massachusetts Institute of Technology 77 Massachusetts Avenue, Cambridge, MA 02139 (USA); Burnham Institute for Medical Research at UCSB University of California, Santa Barbara 1105 Life Sciences Technology Bldg., Santa Barbara, CA 93106 (USA)</auth-address><titles><title>Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging</title><secondary-title>Advanced Materials</secondary-title></titles><periodical><full-title>Advanced Materials</full-title></periodical><pages>1589</pages><volume>20</volume><number>9</number><edition>2008/07</edition><keywords><keyword>Bionanotechnology</keyword><keyword>Iron oxide</keyword><keyword>Nanoparticles</keyword><keyword>Cells</keyword><keyword>Drug delivery</keyword></keywords><dates><year>2008</year></dates><isbn>1521-4095</isbn><abstract>No Abstract.</abstract><notes>10.1002/adma.200890033</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200890033</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>UCSD/ MIT</custom2><custom3>2008</custom3><custom4>10.231</custom4><electronic-resource-num>10.1002/adma.200890033</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1485</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1485</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pan, D.</author><author>Caruthers, S. D.</author><author>Hu, G.</author><author>Senpan, A.</author><author>Scott, M. J.</author><author>Gaffney, P. J.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Pan, D&#xD;Washington Univ, Sch Med, C TRAIN, 4320 Forest Pk Ave, St Louis, MO 63108 USA&#xD;Washington Univ, Sch Med, C TRAIN, St Louis, MO 63108 USA&#xD;Washington Univ, Sch Med, Div Cardiol, St Louis, MO 63108 USA&#xD;Philips HealthCare, Andover, MA USA&#xD;St Thomas Hosp, Dept Surg, London SE1 7EH, England</auth-address><titles><title>Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance Imaging of vascular targets</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>9186-+</pages><volume>130</volume><number>29</number><edition>2008/07</edition><keywords><keyword>contrast agents</keyword><keyword>nanoparticles</keyword><keyword>micelles</keyword></keywords><dates><year>2008</year><pub-dates><date>Jul 23</date></pub-dates></dates><isbn>0002-7863</isbn><accession-num>ISI:000257796500004</accession-num><abstract>Although gadolinium has been the dominant paramagnetic metal for MR paramagnetic contrast agents, the recent association of this lanthanice with nephrogenic systemic fibrosis, an untreatable disease, has spawned renewed interest in alternative metals for MR molecular imaging. We have developed a self-assembled, manganese(III)-labeled nanobialys (1), a toroidal-shaped MR theranostic nanoparticle. In this report, Mn(III) nanobialys are characterized as MR molecular imaging agents for targeted detection of fibrin, a major biochemical feature of thrombus. A complementary ability of nanobialys to incorporate chemotherapeutic compounds with greater than 98% efficiency and to retain more than 80% of these drugs after infinite sink dissolution, point to the theranostic potential of this platform technology.</abstract><notes>328KE&#xD;Times Cited:0&#xD;Cited References Count:29</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000257796500004</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom4>8.256</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1472</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1472</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Neubauer, M.</author><author>Caruthers, S.D.</author><author>Hockett, F.D.</author><author>Winter, P.M.</author><author>Chen J, </author><author>Gaffney PJ, </author><author>Robertson JD, </author><author>Lanza GM, </author><author>Wickline SA. </author></authors></contributors><titles><title>Tunable perfluorocarbon nanoparticles for molecular imaging using gadolinium-modulated 19F signals</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Siteman</custom1><custom4>4.163</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1456</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1456</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Moore, D.</author><author>Morber, J. R.</author><author>Snyder, R. L.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245</auth-address><titles><title>Growth of Ultralong ZnS/SiO2 Core-Shell Nanowires by Volume and Surface Diffusion VLS Process</title><secondary-title>J. Phys. Chem. C</secondary-title></titles><periodical><full-title>J. Phys. Chem. C</full-title></periodical><pages>2895-2903</pages><volume>112</volume><number>8</number><edition>2008/07</edition><dates><year>2008</year></dates><isbn>1932-7447</isbn><abstract>Abstract: Nanowires of up to 1 cm in length and approximately 30 nm in diameter were synthesized through a simple chemical vapor deposition process. Scanning electron microscopy (SEM) data showed that these nanowires were well-aligned and grew in the direction along the flow of the carrier gas. Through transmission electron microscopy (TEM) and X-ray diffraction (XRD) analysis, the nanowires were found to be composed of a single-crystalline ZnS core and amorphous SiO2 shell. Gold catalyst particles were found at the tips of the nanowires and completely encased by a silica shell. Photoluminescence (PL) measurements were performed on nanowire samples in which the synthesis time was systematically varied to provide information regarding growth dynamics. After a systematic study on the structure, we propose that the core-shell nanowires were formed via a distinct volume and surface diffusion process occurring simultaneously for different chemical species in and on the gold catalyst particle.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/jp709903b</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>3.398</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1439</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1439</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McAlpine, M. C.</author><author>Agnew, H. D.</author><author>Rohde, R. D.</author><author>Blanco, M.</author><author>Ahmad, H.</author><author>Stuparu, A. D.</author><author>Goddard, W. A.</author><author>Heath, J. R.</author></authors></contributors><auth-address>Heath, JR&#xD;CALTECH, Kavli NanoSci Inst, Pasadena, CA 91125 USA&#xD;CALTECH, Kavli NanoSci Inst, Pasadena, CA 91125 USA&#xD;CALTECH, Div Chem &amp; Chem Engn, Pasadena, CA 91125 USA&#xD;CALTECH, Mat &amp; Proc Simulat Ctr, Beckman Inst 139 74, Pasadena, CA 91125 USA</auth-address><titles><title>Peptide-nanowire hybrid materials for selective sensing of small molecules</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>9583-9589</pages><volume>130</volume><number>29</number><edition>2008/07</edition><keywords><keyword>electronic nose</keyword><keyword>chemical sensors</keyword><keyword>real-time</keyword><keyword>breath</keyword><keyword>arrays</keyword><keyword>spectroscopy</keyword><keyword>surfaces</keyword><keyword>hydrogen</keyword><keyword>aptamers</keyword><keyword>inhibit</keyword></keywords><dates><year>2008</year><pub-dates><date>Jul 23</date></pub-dates></dates><isbn>0002-7863</isbn><accession-num>ISI:000257796500074</accession-num><abstract>The development of a miniaturized sensing platform for the selective detection of chemical odorants could stimulate exciting scientific and technological opportunities. Oligopeptides are robust substrates for the selective recognition of a variety of chemical and biological species. Likewise, semiconducting nanowires are extremely sensitive gas sensors. Here we explore the possibilities and chemistries of linking peptides to silicon nanowire sensors for the selective detection of small molecules. The silica surface of the nanowires is passivated with peptides using amide coupling chemistry. The peptide/ nanowire sensors can be designed, through the peptide sequence, to exhibit orthogonal responses to acetic acid and ammonia vapors, and can detect traces of these gases from &quot;chemically camouflaged&quot; mixtures. Through both theory and experiment, we find that this sensing selectivity arises from both acid/base reactivity and from molecular structure. These results provide a model platform for what can be achieved in terms of selective and sensitive &quot;electronic noses.&quot;.</abstract><notes>328KE&#xD;Times Cited:0&#xD;Cited References Count:50</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000257796500074</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom4>8.256</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1415</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1415</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lu, H.</author><author>Cheng, J</author></authors></contributors><titles><title>Controlled Ring-Opening Polymerization of Amino Acid N-Carboxyanhydrides and Facile End Group Functionalization of Polypeptides</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Siteman</custom1><custom4>8.256</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1284</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1284</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Insin, Numpon</author><author>Tracy, Joseph B.</author><author>Lee, Hakho</author><author>Zimmer, John P.</author><author>Westervelt, Robert M.</author><author>Bawendi, Moungi G.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and ! Division of Engineering and Applied Sciences and Department of Physics, Harvard University, Cambridge, Massachusetts 02138</auth-address><titles><title>Incorporation of Iron Oxide Nanoparticles and Quantum Dots into Silica Microspheres</title><secondary-title>ACS Nano</secondary-title></titles><periodical><full-title>ACS Nano</full-title></periodical><pages>197-202</pages><volume>2</volume><number>2</number><edition>2008/07</edition><dates><year>2008</year><pub-dates><date>2008/07</date></pub-dates></dates><isbn>1936-0851</isbn><abstract>ABSTRACT We describe the synthesis of magnetic and fluorescent silica microspheres fabricated by incorporating maghemite (-Fe2O3) nanoparticles (MPs) and CdSe/CdZnS core/shell quantum dots (QDs) into a silica shell around preformed silica microspheres. The resultant &lt;500 nm microspheres have a narrow size distribution and show uniform incorporation of QDs and MPs into the shell. We have demonstrated manipulation of these microspheres using an external magnetic field with real-time fluorescence microscopy imaging.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/nn700344x</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>5.472</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1271</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1271</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huang, W.C.</author><author>Havel, J.J.</author><author>Zhau, H.E.</author><author>Qian, W.P.</author><author>Lue, H.W.</author><author>Chu, C.Y.</author><author>Nomura, T.</author><author>Chung, L.W.K.</author></authors></contributors><titles><title>Microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells</title><secondary-title>Clinical Cancer Res</secondary-title></titles><periodical><full-title>Clinical Cancer Res</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Emory/GT</custom1><custom4>6.646</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1242</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1242</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Harris, T.</author><author>von Maltzhahn, G </author><author>Lord, M.E.</author><author>Park, J.</author><author>Agarwal, A.</author><author>Min, D.</author><author>Sailor, M.J. </author><author>Bhatia, S.N.</author></authors></contributors><titles><title>Protease-Triggered Unveiling of Bioactive Nanoparticles</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>internal</custom2><custom4>7.292</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1232</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1232</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hadjipanayis, C.G.</author><author>Bonder, M.J.</author><author>Balakrishnan, S.</author><author>Wang, X.</author><author>Mao, H.</author><author>Hadjipanayis, G.C.</author></authors></contributors><titles><title>Metallic iron nanoparticles for MRI contrast enhancement and local hyperthermia</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Emory/GT</custom1><custom4>7.292</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1231</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1231</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gurard-Levin, Zachary A.</author><author>Mrksich, Milan</author></authors></contributors><auth-address>Department of Chemistry and Howard Hughes Medical Institute, The University of Chicago, 929 East 57th Street, Chicago, Illinois 60521</auth-address><titles><title>The Activity of HDAC8 Depends on Local and Distal Sequences of Its Peptide Substrates</title><secondary-title>Biochemistry</secondary-title></titles><periodical><full-title>Biochemistry</full-title></periodical><pages>6242-6250</pages><volume>47</volume><number>23</number><edition>2008/07</edition><dates><year>2008</year></dates><isbn>0006-2960</isbn><abstract>Abstract: This paper introduces a flexible assay for characterizing the activities of the histone deacetylase enzymes. The approach combines mass spectrometry with self-assembled monolayers that present acetylated peptides and enables a label-free and one-step assay of this biochemical activity. The assay was used to characterize the activity of HDAC8 toward peptides taken from the N-terminal tail of the H4 histone and reveals that a distal region of the peptide substrate interacts with the deacetylase at an exosite and contributes to the activity of the substrate. Specifically, a peptide corresponding to residues 8 19 of H4 and having lysine 12 acetylated is an active substrate, but removal of the KRHR (residues 16 19) sequence abolishes activity. Mutation of glycine 11 to arginine in the peptide lacking the KRHR sequence restores activity, demonstrating that both local and distal sequences act synergistically to regulate the activity of the HDAC. Assays with peptides bearing multiply acetylated residues, but in which each acetyl group is isotopically labeled, permit studies of the processive deacetylation of peptides. Peptide substrates having an extended sequence that includes K20 were used to demonstrate that methylation of this residue directly affects HDAC8 activity at K12. This work provides a mechanistic basis for the regulation of HDAC activities by distal sequences and may contribute to studies aimed at evaluating the role of the histone code in regulating gene expression.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/bi800053v</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>3.402</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1230</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1230</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gurard-Levin, Zachary A.</author><author>Mrksich, Milan</author></authors></contributors><titles><title>Combining Self-Assembled Monolayers and Mass Spectrometry for Applications in Biochips</title><secondary-title>Annual Review of Analytical Chemistry</secondary-title></titles><periodical><full-title>Annual Review of Analytical Chemistry</full-title></periodical><pages>767-800</pages><volume>1</volume><number>1</number><edition>2008/07</edition><dates><year>2008</year></dates><abstract>Biochip arrays have enabled the massively parallel analysis of genomic DNA and hold great promise for application to the analysis of proteins, carbohydrates, and small molecules. Surface chemistry plays an intrinsic role in the preparation and analysis of biochips by providing functional groups for immobilization of ligands, providing an environment that maintains activity of the immobilized molecules, controlling nonspecific interactions of analytes with the surface, and enabling detection methods. This review describes recent advances in surface chemistry that enable quantitative assays of a broad range of biochemical activities. The discussion emphasizes the use of self-assembled monolayers of alkanethiolates on gold as a structurally well-defined and synthetically flexible platform for controlling the immobilization and activity of molecules in an array. The review also surveys recent methods of performing label-free assays, and emphasizes the use of matrix-assisted laser desorption/ionization mass spectrometry to directly observe molecules attached to the self-assembled monolayers.</abstract><urls><related-urls><url>http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.anchem.1.031207.112903</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>na</custom4><electronic-resource-num>doi:10.1146/annurev.anchem.1.031207.112903</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1229</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1229</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gupta, T.</author><author>Virmani, S.</author><author>Neidt, T.M.</author><author>Szolc-Kowalska, B.</author><author>Woloschak, G.E.</author><author>Ryu, R.K.</author><author>Sato, K.T.</author><author>Gates, V.</author><author>Lewandowski, R.J.</author><author>Salem, R.</author><author>Omary, R.A.</author><author>Larson, A.C</author></authors></contributors><titles><title>MRI Tracking of Iron-labeled Glass Radioembolization Microspheres During Transcatheter Intra-arterial Delivery to Liver Tumors in VX2 Rabbits</title><secondary-title>Radiology</secondary-title></titles><periodical><full-title>Radiology</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>6.634</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1225</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1225</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Guimaraes, A.</author><author>Rakhlin, E.</author><author>Long, D.</author><author>Weissleder, R.</author><author>Thayer S</author></authors></contributors><titles><title>MRI monitors physiologic changes with anti-hedgehog therapy in pancreatic adenocarcinoma xenograft model</title><secondary-title>Pancreas</secondary-title></titles><periodical><full-title>Pancreas</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom4>2.807</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1220</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1220</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gratton, S.E.A</author><author>Williams, S.  </author><author>Napier M.E.</author><author>et al.</author></authors></contributors><titles><title>The Pursuit of a Scalable Nano-Fabrication Platform for Use in Material and Life Science Applications</title><secondary-title>Accounts of Chemical Research</secondary-title></titles><periodical><full-title>Accounts of Chemical Research</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - UNC</custom1><custom4>15.403</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1219</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1219</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gratton, S.E.A.</author><author>Ropp, P.A. </author><author>Pohlhaus, P.D. </author><author>Luft, J.C. </author><author>Madden, V.J. </author><author>Napier, M.E. </author><author>DeSimone J.M. </author></authors></contributors><titles><title>The Effect of Particle Design on Cellular Internalization Pathways</title><secondary-title>PNAS</secondary-title></titles><periodical><full-title>PNAS</full-title></periodical><volume>accepted</volume><edition>2008/07</edition><dates><year>2008</year></dates><urls></urls><custom1>CCNE - UNC</custom1><custom4>9.598</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1185</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1185</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Duan, Hongwei</author><author>Kuang, Min</author><author>Wang, Xiaoxia</author><author>Wang, Y. Andrew</author><author>Mao, Hui</author><author>Nie, Shuming</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, 101 Woodruff Circle Suite 2001, Atlanta, Georgia 30322, Department of Radiology and Center for MR Research, Emory University School of Medicine, 1364 Clifton Road, Atlanta, Georgia 30322, and Ocean Nanotech, LLC, 700 Research Center Blvd., Fayetteville, Arkansas 72701</auth-address><titles><title>Reexamining the Effects of Particle Size and Surface Chemistry on the Magnetic Properties of Iron Oxide Nanocrystals: New Insights into Spin Disorder and Proton Relaxivity</title><secondary-title>J. Phys. Chem. C</secondary-title></titles><periodical><full-title>J. Phys. Chem. C</full-title></periodical><pages>8127-8131</pages><volume>112</volume><number>22</number><edition>2008/07</edition><dates><year>2008</year></dates><isbn>1932-7447</isbn><abstract>Abstract: Superparamagnetic iron oxide nanocrystals are a class of nontoxic and biodegradable nanomaterials with broad applications in science, engineering, and medicine, but there is still considerable debate on how crystalline domain size and surface chemistry influence their properties for magnetic resonance imaging (MRI). Here we examine the effects of particle size and surface chemistry by comparing proton relaxivity data for two particle sizes and three surface coatings (6 combinations). These combinations are achieved by using both direct ligand exchange and indirect encapsulation methods to solubilize oleic-acid capped iron oxide nanocrystals. The results indicate that proton relaxivity depends on the particle size, the surface coating thickness and hydrophilicity, and the coordination chemistry of inner capping ligands. Nanocrystals coated with the hydrophilic ligand polyethylenimine (PEI) yield the highest proton relaxivity, whereas nanocrystals capped with oleic acid and amphiphilic polymers exhibit the strongest dependence on particle size. These effects arise from intrinsic surface spin disorders as well as from rapid exchange (diffusion) of water molecules between the bulk phase and the adjacent layer surrounding the particle surface.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/jp8029083</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>3.398</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2451</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2451</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bertin, Paul A.</author><author>Georganopoulou, Dimitra</author><author>Liang, Taiyang</author><author>Eckermann, Amanda L.</author><author>Wunder, Markus</author><author>Ahrens, Michael J.</author><author>Blackburn, Gary F.</author><author>Meade, Thomas J.</author></authors></contributors><titles><title>Electroactive Self-Assembled Monolayers on Gold via Bipodal Dithiazepane Anchoring Groups</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>9096-9101</pages><volume>24</volume><number>16</number><edition>2008/07</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>0743-7463</isbn><notes>doi: 10.1021/la801165b</notes><urls><related-urls><url>http://dx.doi.org/10.1021/la801165b</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.347</custom4><electronic-resource-num>10.1021/la801165b</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1061</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1061</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Angeli, Clairette D.</author><author>Cai, Ting</author><author>Duchamp, James C.</author><author>Reid, Jonathan E.</author><author>Singer, Eric S.</author><author>Gibson, Harry W.</author><author>Dorn, Harry C.</author></authors></contributors><auth-address>Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0212, and Department of Chemistry, Emory and Henry College, Emory, Virginia 24327</auth-address><titles><title>Purification of Trimetallic Nitride Templated Endohedral Metallofullerenes by a Chemical Reaction of Congeners with Eutectic 9-Methylanthracene</title><secondary-title>Chem. Mater.</secondary-title></titles><periodical><full-title>Chem. Mater.</full-title></periodical><pages>4993-4997</pages><volume>20</volume><number>15</number><edition>2008/06/28</edition><dates><year>2008</year></dates><isbn>0897-4756</isbn><abstract>Abstract: The availability of pure samples is a major hurdle in the study of trimetallic nitride templated endohedral metallofullerenes (TNT EMFs). Current HPLC methods of purification are costly, nonrecyclable, and take considerable time. Reported herein is a solvent-free reaction of crude soot extract (empty-cage and Sc or Lu TNT EMFs) in molten 9-methylanthracene that affords almost complete conversion of empty-cage fullerenes to 9-methylanthracene adducts, while leaving TNT EMFs unreacted. After the recovered extract is washed with diethyl ether, the washed extract can then be applied to a silica gel column and subsequently flushed with toluene. To illustrate for Sc3N@C80, the sample was purified to ~60% in a time period of &lt;24 h. Final one-step HPLC purification provided high-purity TNT EMF samples (&gt;99%) in an expeditious and less costly manner.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/cm800795q</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>5.932</custom4><electronic-resource-num>10.1021/cm800795q</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2247</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2247</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Allen, P. M.</author><author>Bawendi, M. G.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Ternary I-III-VI quantum dots luminescent in the red to near-infrared</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9240-1</pages><volume>130</volume><number>29</number><edition>2008/06/28</edition><keywords><keyword>Copper/ chemistry</keyword><keyword>Indium/ chemistry</keyword><keyword>Luminescent Measurements/methods</keyword><keyword>Quantum Dots</keyword><keyword>Selenium/ chemistry</keyword><keyword>Semiconductors</keyword><keyword>Spectroscopy, Near-Infrared/ methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Jul 23</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18582061</accession-num><abstract>We report the synthesis of a size series of copper indium selenide quantum dots (QDs) of various stoichiometries exhibiting photoluminescence (PL) from the red to near-infrared (NIR). The synthetic method is modular, and we have extended it to the synthesis of luminescent silver indium diselenide QDs. Previous reports on QDs luminescent in the NIR region have been primarily restricted to binary semiconductor systems, such as InAs, PbS, and CdTe. This work seeks to expand the availability of luminescent QD materials to ternary I-III-VI semiconductor systems.</abstract><notes>Allen, Peter M&#xD;Bawendi, Moungi G&#xD;1U54-CA119349/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Jul 23;130(29):9240-1. Epub 2008 Jun 27.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja8036349 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1628</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1628</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stokes, T. H.</author><author>Torrance, J. T.</author><author>Li, H.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Department of Electrical and Computer Engineering, Georgia Institute of Technology, Van Leer Building, 777 Atlantic Drive NW, Atlanta, GA 30332, USA. todd.stokes@bme.gatech.edu</auth-address><titles><title>ArrayWiki: an enabling technology for sharing public microarray data repositories and meta-analyses</title><secondary-title>BMC Bioinformatics</secondary-title></titles><periodical><full-title>BMC Bioinformatics</full-title></periodical><pages>S18</pages><volume>9 Suppl 6</volume><edition>2008/06/27</edition><keywords><keyword>*Artificial Intelligence</keyword><keyword>Biotechnology/*methods</keyword><keyword>*Database Management Systems</keyword><keyword>*Databases, Genetic</keyword><keyword>Information Dissemination/*methods</keyword><keyword>Internet</keyword><keyword>*Meta-Analysis as Topic</keyword><keyword>Oligonucleotide Array Sequence Analysis/*methods</keyword></keywords><dates><year>2008</year></dates><isbn>1471-2105 (Electronic)</isbn><accession-num>18541053</accession-num><abstract>BACKGROUND: A survey of microarray databases reveals that most of the repository contents and data models are heterogeneous (i.e., data obtained from different chip manufacturers), and that the repositories provide only basic biological keywords linking to PubMed. As a result, it is difficult to find datasets using research context or analysis parameters information beyond a few keywords. For example, to reduce the &quot;curse-of-dimension&quot; problem in microarray analysis, the number of samples is often increased by merging array data from different datasets. Knowing chip data parameters such as pre-processing steps (e.g., normalization, artefact removal, etc), and knowing any previous biological validation of the dataset is essential due to the heterogeneity of the data. However, most of the microarray repositories do not have meta-data information in the first place, and do not have a a mechanism to add or insert this information. Thus, there is a critical need to create &quot;intelligent&quot; microarray repositories that (1) enable update of meta-data with the raw array data, and (2) provide standardized archiving protocols to minimize bias from the raw data sources. RESULTS: To address the problems discussed, we have developed a community maintained system called ArrayWiki that unites disparate meta-data of microarray meta-experiments from multiple primary sources with four key features. First, ArrayWiki provides a user-friendly knowledge management interface in addition to a programmable interface using standards developed by Wikipedia. Second, ArrayWiki includes automated quality control processes (caCORRECT) and novel visualization methods (BioPNG, Gel Plots), which provide extra information about data quality unavailable in other microarray repositories. Third, it provides a user-curation capability through the familiar Wiki interface. Fourth, ArrayWiki provides users with simple text-based searches across all experiment meta-data, and exposes data to search engine crawlers (Semantic Agents) such as Google to further enhance data discovery. CONCLUSIONS: Microarray data and meta information in ArrayWiki are distributed and visualized using a novel and compact data storage format, BioPNG. Also, they are open to the research community for curation, modification, and contribution. By making a small investment of time to learn the syntax and structure common to all sites running MediaWiki software, domain scientists and practioners can all contribute to make better use of microarray technologies in research and medical practices. ArrayWiki is available at http://www.bio-miblab.org/arraywiki.</abstract><notes>Stokes, Todd H&#xD;Torrance, J T&#xD;Li, Henry&#xD;Wang, May D&#xD;R01CA108468/CA/United States NCI&#xD;U54CA119338/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;BMC bioinformatics&#xD;BMC Bioinformatics. 2008 May 28;9 Suppl 6:S18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18541053</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>4.246</custom4><electronic-resource-num>1471-2105-9-S6-S18 [pii]&#xD;10.1186/1471-2105-9-S6-S18</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1528</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1528</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Quo, C. F.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Wallace H, Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA. gtg801f@mail.gatech.edu</auth-address><titles><title>Quantitative analysis of numerical solvers for oscillatory biomolecular system models</title><secondary-title>BMC Bioinformatics</secondary-title></titles><periodical><full-title>BMC Bioinformatics</full-title></periodical><pages>S17</pages><volume>9 Suppl 6</volume><edition>2008/06/27</edition><keywords><keyword>*Algorithms</keyword><keyword>Biological Clocks/*physiology</keyword><keyword>Computer Simulation</keyword><keyword>*Models, Biological</keyword><keyword>Numerical Analysis, Computer-Assisted</keyword><keyword>Oscillometry/*methods</keyword><keyword>Proteome/*metabolism</keyword><keyword>Signal Transduction/*physiology</keyword></keywords><dates><year>2008</year></dates><isbn>1471-2105 (Electronic)</isbn><accession-num>18541052</accession-num><abstract>BACKGROUND: This article provides guidelines for selecting optimal numerical solvers for biomolecular system models. Because various parameters of the same system could have drastically different ranges from 10(-15) to 10(10), the ODEs can be stiff and ill-conditioned, resulting in non-unique, non-existing, or non-reproducible modeling solutions. Previous studies have not examined in depth how to best select numerical solvers for biomolecular system models, which makes it difficult to experimentally validate the modeling results. To address this problem, we have chosen one of the well-known stiff initial value problems with limit cycle behavior as a test-bed system model. Solving this model, we have illustrated that different answers may result from different numerical solvers. We use MATLAB numerical solvers because they are optimized and widely used by the modeling community. We have also conducted a systematic study of numerical solver performances by using qualitative and quantitative measures such as convergence, accuracy, and computational cost (i.e. in terms of function evaluation, partial derivative, LU decomposition, and &quot;take-off&quot; points). The results show that the modeling solutions can be drastically different using different numerical solvers. Thus, it is important to intelligently select numerical solvers when solving biomolecular system models. RESULTS: The classic Belousov-Zhabotinskii (BZ) reaction is described by the Oregonator model and is used as a case study. We report two guidelines in selecting optimal numerical solver(s) for stiff, complex oscillatory systems: (i) for problems with unknown parameters, ode45 is the optimal choice regardless of the relative error tolerance; (ii) for known stiff problems, both ode113 and ode15s are good choices under strict relative tolerance conditions. CONCLUSIONS: For any given biomolecular model, by building a library of numerical solvers with quantitative performance assessment metric, we show that it is possible to improve reliability of the analytical modeling, which in turn can improve the efficiency and effectiveness of experimental validations of these models. Also, our study can be extended to study a variety of molecular-level system models for human disease diagnosis and therapeutic treatment.</abstract><notes>Quo, Chang F&#xD;Wang, May D&#xD;R01CA108468/CA/United States NCI&#xD;U54CA119338/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;BMC bioinformatics&#xD;BMC Bioinformatics. 2008 May 28;9 Suppl 6:S17.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18541052</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>4.246</custom4><electronic-resource-num>1471-2105-9-S6-S17 [pii]&#xD;10.1186/1471-2105-9-S6-S17</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1253</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1253</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hill, H. D.</author><author>Macfarlane, R. J.</author><author>Senesi, A. J.</author><author>Lee, B.</author><author>Park, S. Y.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>chadnano@northwestern.edu.</auth-address><titles><title>Controlling the Lattice Parameters of Gold Nanoparticle FCC Crystals with Duplex DNA Linkers</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><edition>2008/06/25</edition><dates><year>2008</year><pub-dates><date>Jun 24</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18572967</accession-num><abstract>DNA-functionalized gold nanoparticles can be used to induce the formation and control the unit cell parameters of highly ordered face-centered cubic crystal lattices. Nanoparticle spacing increases linearly with longer DNA interconnect length, yielding maximum unit cell parameters of 77 nm and 0.52% inorganic-filled space for the DNA constructs studied. In general, we show that longer DNA connections result in a decrease in the overall crystallinity and order of the lattice due to greater conformational flexibility.</abstract><notes>Journal article&#xD;Nano letters&#xD;Nano Lett. 2008 Jun 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18572967</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl8011787</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2385</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2385</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cato, M. H.</author><author>D&apos;Annibale, F.</author><author>Mills, D. M.</author><author>Cerignoli, F.</author><author>Dawson, M. I.</author><author>Bergamaschi, E.</author><author>Bottini, N.</author><author>Magrini, A.</author><author>Bergamaschi, A.</author><author>Rosato, N.</author><author>Rickert, R. C.</author><author>Mustelin, T.</author><author>Bottini, M.</author></authors></contributors><auth-address>Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.</auth-address><titles><title>Cell-type specific and cytoplasmic targeting of PEGylated carbon nanotube-based nanoassemblies</title><secondary-title>J Nanosci Nanotechnol</secondary-title></titles><periodical><full-title>J Nanosci Nanotechnol</full-title></periodical><pages>2259-69</pages><volume>8</volume><number>5</number><edition>2008/06/25</edition><keywords><keyword>Animals</keyword><keyword>Cytoplasm/ metabolism</keyword><keyword>Endocytosis</keyword><keyword>Flow Cytometry</keyword><keyword>Mice</keyword><keyword>Microscopy, Atomic Force</keyword><keyword>Microscopy, Confocal</keyword><keyword>Nanotubes, Carbon</keyword><keyword>Polyethylene Glycols/ chemistry</keyword><keyword>Spectrophotometry, Ultraviolet</keyword><keyword>T-Lymphocytes/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1533-4880 (Print)</isbn><accession-num>18572636</accession-num><abstract>In this paper we report the fabrication of a multivalent, cell-type specific and cytoplasmic delivery system based on single-walled carbon nanotubes. The latter were functionalized through adsorption of phospholipids terminated by biotinylated PEG chains functionalized with fluorochrome-coupled neutravidin, and subsequently with antibodies (anti-CD3epsilon and anti-CD28) for T cell receptor post-signaling endocytosis and a synthetic fusogenic polymer for disruption of lysosomal compartments. The biomimetic nanoassemblies were composed by PEGylated individual/very small bundles of carbon nanotubes having an average length and a standard deviation of 176 nm and 77 nm, respectively. The nanoassemblies were stably dispersed under physiological conditions, visible by conventional optical and confocal microscopy and specifically targeted to T cells both in vitro and in living animals. The addition of a fusogenic polymer to the nanoassemblies did not affect the cellular uptake and allowed the release into the cytosol of the targeted cells both in vitro and in the animals. The present manuscript is the first report about the cytoplasmic delivery of carbon nanotubes in a specific cell type in intact animals and paves the way for their use as in vivo intracellular delivery systems.</abstract><notes>Cato, Matthew H&#xD;D&apos;Annibale, Federica&#xD;Mills, David M&#xD;Cerignoli, Fabio&#xD;Dawson, Marcia I&#xD;Bergamaschi, Enrico&#xD;Bottini, Nunzio&#xD;Magrini, Andrea&#xD;Bergamaschi, Antonio&#xD;Rosato, Nicola&#xD;Rickert, Robert C&#xD;Mustelin, Tomas&#xD;Bottini, Massimo&#xD;U54 CA119335-02/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of nanoscience and nanotechnology&#xD;J Nanosci Nanotechnol. 2008 May;8(5):2259-69.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom4>2.100</custom4><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2330</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2330</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yezhelyev, M. V.</author><author>Qi, L.</author><author>O&apos;Regan, R. M.</author><author>Nie, S.</author><author>Gao, X.</author></authors></contributors><auth-address>Winship Cancer Institute, Emory University, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9006-12</pages><volume>130</volume><number>28</number><edition>2008/06/24</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cyclophilins/antagonists &amp; inhibitors/genetics</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Models, Molecular</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Nanoparticles/ chemistry</keyword><keyword>Peptidylprolyl Isomerase/antagonists &amp; inhibitors/genetics</keyword><keyword>Protons</keyword><keyword>Quantum Dots</keyword><keyword>RNA, Small Interfering/ administration &amp; dosage/ chemistry/genetics</keyword><keyword>Transfection/ methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Jul 16</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18570415</accession-num><abstract>We report the rational design of multifunctional nanoparticles for short-interfering RNA (siRNA) delivery and imaging based on the use of semiconductor quantum dots (QDs) and proton-absorbing polymeric coatings (proton sponges). With a balanced composition of tertiary amine and carboxylic acid groups, these nanoparticles are specifically designed to address longstanding barriers in siRNA delivery such as cellular penetration, endosomal release, carrier unpacking, and intracellular transport. The results demonstrate dramatic improvement in gene silencing efficiency by 10-20-fold and simultaneous reduction in cellular toxicity by 5-6-fold, when compared directly with existing transfection agents for MDA-MB-231 cells. The QD-siRNA nanoparticles are also dual-modality optical and electron-microscopy probes, allowing real-time tracking and ultrastructural localization of QDs during delivery and transfection. These new insights and capabilities represent a major step toward nanoparticle engineering for imaging and therapeutic applications.</abstract><notes>Yezhelyev, Maksym V&#xD;Qi, Lifeng&#xD;O&apos;Regan, Ruth M&#xD;Nie, Shuming&#xD;Gao, Xiaohu&#xD;P20 GM072069/GM/NIGMS NIH HHS/United States&#xD;R01 CA108468/CA/NCI NIH HHS/United States&#xD;R01 CA131797/CA/NCI NIH HHS/United States&#xD;R01 CA131797-02/CA/NCI NIH HHS/United States&#xD;U01HL080711/HL/NHLBI NIH HHS/United States&#xD;U54 CA119338-03/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Jul 16;130(28):9006-12. Epub 2008 Jun 21.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom2>2621273</custom2><custom3>NIHMS85530</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja800086u [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1499</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1499</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Paunesku, T.</author><author>Ke, T.</author><author>Dharmakumar, R.</author><author>Mascheri, N.</author><author>Wu, A.</author><author>Lai, B.</author><author>Vogt, S.</author><author>Maser, J.</author><author>Thurn, K.</author><author>Szolc-Kowalska, B.</author><author>Larson, A.</author><author>Bergan, R. C.</author><author>Omary, R.</author><author>Li, D.</author><author>Lu, Z. R.</author><author>Woloschak, G. E.</author></authors></contributors><auth-address>Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA; Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.</auth-address><titles><title>Gadolinium-conjugated TiO(2)-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images</title><secondary-title>Nanomedicine</secondary-title></titles><periodical><full-title>Nanomedicine</full-title></periodical><edition>2008/06/24</edition><dates><year>2008</year><pub-dates><date>Jun 20</date></pub-dates></dates><isbn>1549-9642 (Electronic)</isbn><accession-num>18567541</accession-num><abstract>Nanoconjugates composed of titanium dioxide (TiO(2)) nanoparticles, DNA oligonucleotides, and a gadolinium (Gd) contrast agent were synthesized for use in magnetic resonance imaging. Transfection of cultured cancer cells with these nanoconjugates showed them to be superior to the free contrast agent of the same formulation with regard to intracellular accumulation, retention, and subcellular localization. Our results have shown that 48 hours after treatment, the concentration of Gd in nanoconjugate-treated cells was 1000-fold higher than in cells treated with contrast agent alone. Consequently, T1-weighted contrast enhancements were observed in cells treated with nanoconjugates but not in cells treated by the contrast agent alone. This type of nanoconjugate with increased retention time, Gd accumulation, and intracellular delivery may find its use in Gd neutron-capture cancer therapy.</abstract><notes>Journal article&#xD;Nanomedicine : nanotechnology, biology, and medicine&#xD;Nanomedicine. 2008 Jun 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18567541</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>6.093</custom4><electronic-resource-num>S1549-9634(08)00046-4 [pii]&#xD;10.1016/j.nano.2008.04.004</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2246</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2246</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Levy-Nissenbaum, E.</author><author>Radovic-Moreno, A. F.</author><author>Wang, A. Z.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women&apos;s Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA.</auth-address><titles><title>Nanotechnology and aptamers: applications in drug delivery</title><secondary-title>Trends Biotechnol</secondary-title></titles><periodical><full-title>Trends Biotechnol</full-title></periodical><pages>442-9</pages><volume>26</volume><number>8</number><edition>2008/06/24</edition><keywords><keyword>Aptamers, Nucleotide/ chemistry/diagnostic use/therapeutic use</keyword><keyword>Drug Delivery Systems</keyword><keyword>Nanoparticles/ chemistry</keyword><keyword>Nanotechnology/methods</keyword><keyword>Nucleic Acid Conformation</keyword><keyword>Oligonucleotides/ chemistry/diagnostic use/therapeutic use</keyword><keyword>SELEX Aptamer Technique/methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0167-7799 (Print)</isbn><accession-num>18571753</accession-num><abstract>Nucleic acid ligands, also known as aptamers, are a class of macromolecules that are being used in several novel nanobiomedical applications. Aptamers are characterized by high affinity and specificity for their target, a versatile selection process, ease of chemical synthesis and a small physical size, which collectively make them attractive molecules for targeting diseases or as therapeutics. These properties will enable aptamers to facilitate innovative new nanotechnologies with applications in medicine. In this review, we will highlight recent developments in using aptamers in nanotechnology solutions for treating and diagnosing disease.</abstract><notes>Levy-Nissenbaum, Etgar&#xD;Radovic-Moreno, Aleksandar F&#xD;Wang, Andrew Z&#xD;Langer, Robert&#xD;Farokhzad, Omid C&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;EB003647/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;England&#xD;Trends in biotechnology&#xD;Trends Biotechnol. 2008 Aug;26(8):442-9. Epub 2008 Jun 19.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>8.212</custom4><electronic-resource-num>S0167-7799(08)00153-4 [pii]&#xD;10.1016/j.tibtech.2008.04.006 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1445</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1445</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Melancon, M. P.</author><author>Lu, W.</author><author>Yang, Z.</author><author>Zhang, R.</author><author>Cheng, Z.</author><author>Elliot, A. M.</author><author>Stafford, J.</author><author>Olson, T.</author><author>Zhang, J. Z.</author><author>Li, C.</author></authors></contributors><auth-address>Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.</auth-address><titles><title>In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy</title><secondary-title>Mol Cancer Ther</secondary-title></titles><periodical><full-title>Mol Cancer Ther</full-title></periodical><pages>1730-9</pages><volume>7</volume><number>6</number><edition>2008/06/21</edition><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1535-7163 (Print)</isbn><accession-num>18566244</accession-num><abstract>Laser-induced phototherapy is a new therapeutic use of electromagnetic radiation for cancer treatment. The use of targeted plasmonic gold nanoparticles can reduce the laser energy necessary for selective tumor cell destruction. However, the ability for targeted delivery of the currently used gold nanoparticles to tumor cells is limited. Here, we describe a new class of molecular specific photothermal coupling agents based on hollow gold nanoshells (HAuNS; average diameter, approximately 30 nm) covalently attached to monoclonal antibody directed at epidermal growth factor receptor (EGFR). The resulting anti-EGFR-HAuNS exhibited excellent colloidal stability and efficient photothermal effect in the near-infrared region. EGFR-mediated selective uptake of anti-EGFR-HAuNS in EGFR-positive A431 tumor cells but not IgG-HAuNS control was shown in vitro by imaging scattered light from the nanoshells. Irradiation of A431 cells treated with anti-EGFR-HAuNS with near-infrared laser resulted in selective destruction of these cells. In contrast, cells treated with anti-EGFR-HAuNS alone, laser alone, or IgG-HAuNS plus laser did not show observable effect on cell viability. Using 111In-labeled HAuNS, we showed that anti-EGFR-HAuNS could be delivered to EGFR-positive tumors at 6.8% ID/g, and the microscopic image of excised tumor with scattering signal from nanoshells confirmed preferential delivery to A431 tumor of anti-EGFR-HAuNS compared with IgG-HAuNS. The absence of silica core, the relatively small particle size and high tumor uptake, and the absence of cytotoxic surfactant required to stabilize other gold nanoparticles suggest that immuno-HAuNS have the potential to extend to in vivo molecular therapy.</abstract><notes>Melancon, Marites P&#xD;Lu, Wei&#xD;Yang, Zhi&#xD;Zhang, Rui&#xD;Cheng, Zhi&#xD;Elliot, Andrew M&#xD;Stafford, Jason&#xD;Olson, Tammy&#xD;Zhang, Jin Z&#xD;Li, Chun&#xD;CA16672/CA/United States NCI&#xD;R01 CA119387/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Molecular cancer therapeutics&#xD;Mol Cancer Ther. 2008 Jun;7(6):1730-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18566244</url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom3>2008</custom3><custom4>5.428</custom4><electronic-resource-num>7/6/1730 [pii]&#xD;10.1158/1535-7163.MCT-08-0016</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2084</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2084</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chen, K.</author><author>Li, Z. B.</author><author>Wang, H.</author><author>Cai, W.</author><author>Chen, X.</author></authors></contributors><auth-address>Department of Radiology and Bio-X Program, School of Medicine, Stanford University, Stanford, CA 94305-5484, USA.</auth-address><titles><title>Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots</title><secondary-title>Eur J Nucl Med Mol Imaging</secondary-title></titles><periodical><full-title>Eur J Nucl Med Mol Imaging</full-title></periodical><pages>2235-44</pages><volume>35</volume><number>12</number><edition>2008/06/21</edition><keywords><keyword>Amines/chemistry</keyword><keyword>Animals</keyword><keyword>Chelating Agents/chemistry</keyword><keyword>Copper Radioisotopes/chemistry</keyword><keyword>Fluorescence</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Fluorescent Dyes/chemical synthesis/chemistry</keyword><keyword>Frozen Sections</keyword><keyword>Heterocyclic Compounds, 1-Ring/chemistry</keyword><keyword>Humans</keyword><keyword>Infrared Rays</keyword><keyword>Mice</keyword><keyword>Neoplasms/ blood supply/pathology/ radionuclide imaging</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Quantum Dots</keyword><keyword>Rats</keyword><keyword>Receptors, Vascular Endothelial Growth Factor/ metabolism</keyword><keyword>Staining and Labeling</keyword><keyword>Tomography, Optical</keyword><keyword>Vascular Endothelial Growth Factor A/chemistry/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1619-7089 (Electronic)</isbn><accession-num>18566815</accession-num><abstract>PURPOSE: To date, the in vivo imaging of quantum dots (QDs) has been mostly qualitative or semiquantitative. The development of a dual-function positron emission tomography (PET)/near-infrared fluorescence (NIRF) probe might allow the accurate assessment of the tumor-targeting efficacy of QDs. MATERIALS AND METHODS: An amine-functionalized QD was conjugated with VEGF protein and DOTA chelator for VEGFR-targeted PET/NIRF imaging after (64)Cu-labeling. The targeting efficacy of this dual functional probe was evaluated in vitro and in vivo through cell-binding assay, cell staining, in vivo optical/PET imaging, ex vivo optical/PET imaging, and histology. RESULTS: The DOTA-QD-VEGF exhibited VEGFR-specific binding in both cell-binding assay and cell staining experiment. Both NIR fluorescence imaging and microPET showed VEGFR-specific delivery of conjugated DOTA-QD-VEGF nanoparticle and prominent reticuloendothelial system uptake. The U87MG tumor uptake of (64)Cu-labeled DOTA-QD was less than one percentage injected dose per gram (%ID/g), significantly lower than that of (64)Cu-labeled DOTA-QD-VEGF (1.52 +/- 0.6%ID/g, 2.81 +/- 0.3%ID/g, 3.84 +/- 0.4%ID/g, and 4.16 +/- 0.5%ID/g at 1, 4, 16, and 24 h post injection, respectively; n = 3). Good correlation was also observed between the results measured by ex vivo PET and NIRF organ imaging. Histologic examination revealed that DOTA-QD-VEGF primarily targets the tumor vasculature through a VEGF-VEGFR interaction. CONCLUSION: We have successfully developed a QD-based nanoprobe for dual PET and NIRF imaging of tumor VEGFR expression. The success of this bifunctional imaging approach may render higher degree of accuracy for the quantitative targeted NIRF imaging in deep tissue.</abstract><notes>Chen, Kai&#xD;Li, Zi-Bo&#xD;Wang, Hui&#xD;Cai, Weibo&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;European journal of nuclear medicine and molecular imaging&#xD;Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2235-44. Epub 2008 Jun 20.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.625</custom4><electronic-resource-num>10.1007/s00259-008-0860-8 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1123</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1123</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chan, E. W.</author><author>Park, S.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and The Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3290, USA.</auth-address><titles><title>An electroactive catalytic dynamic substrate that immobilizes and releases patterned ligands, proteins, and cells</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>6267-71</pages><volume>47</volume><number>33</number><edition>2008/06/21</edition><dates><year>2008</year></dates><isbn>1521-3773 (Electronic)</isbn><accession-num>18567039</accession-num><notes>Chan, Eugene W L&#xD;Park, Sungjin&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2008;47(33):6267-71.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18567039</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200800166</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1551</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1551</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sanedrin, R. G.</author><author>Huang, L.</author><author>Jang, J. W.</author><author>Kakkassery, J.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Polyethylene glycol as a novel resist and sacrificial material for generating positive and negative nanostructures</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>920-4</pages><volume>4</volume><number>7</number><edition>2008/06/20</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>18563746</accession-num><notes>Sanedrin, Raymond G&#xD;Huang, Ling&#xD;Jang, Jae-Won&#xD;Kakkassery, Joseph&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2008 Jul;4(7):920-4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18563746</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200701089</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1350</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1350</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koynova, R.</author><author>Wang, L.</author><author>Macdonald, R. C.</author></authors></contributors><auth-address>rkoynova@gmail.com.</auth-address><titles><title>Cationic Phospholipids Forming Cubic Phases: Lipoplex Structure and Transfection Efficiency</title><secondary-title>Mol Pharm</secondary-title></titles><periodical><full-title>Mol Pharm</full-title></periodical><edition>2008/06/20</edition><dates><year>2008</year><pub-dates><date>Jun 19</date></pub-dates></dates><isbn>1543-8384 (Print)</isbn><accession-num>18563910</accession-num><abstract>The transfection activity and the phase behavior of two novel cationic O-alkyl-phosphatidylcholines, 1,2-dioleoyl- sn-glycero-3-hexylphosphocholine (C6-DOPC) and 1,2-dierucoyl- sn-glycero-3-ethylphosphocholine (di22:1-EPC), have been examined with the aim of more completely understanding the mechanism of lipid-mediated DNA delivery. Both lipids form cubic phases: C6-DOPC in the entire temperature range from -10 to 90 degrees C, while di22:1-EPC exhibits an irreversible lamellar-cubic transition between 50 and 70 degrees C on heating. The lipoplexes formed by C6-DOPC arrange into hexagonal phase, while the lipoplexes of di22:1-EPC are lamellar. Both lipids exhibit lower transfection activity than the lamellar-forming 1,2-dioleoyl- sn-glycero-3-ethylphosphocholine (EDOPC). Thus, for the studied cationic phospholipid-DNA systems, the lipoplex phase state is a factor that does not seem to correlate with transfection activity. The parameter that exhibits better correlation with the transfection activity within the present data set is the phase state of the lipid dispersion prior to the addition of DNA. Thus, the lamellar lipid dispersion (EDOPC) produces more efficient lipoplexes than the dispersion with coexisting lamellar and cubic aggregates (diC22:1-EPC), which is even more efficient than the purely cubic dispersions (C6-DOPC; diC22:1-EPC after heating). It could be inferred from these data and from previous research that cubic phase lipid aggregates are unlikely to be beneficial to transfection. The lack of correlation between the phase state of lipoplexes and their transfection activity observed within the present data set does not mean that lipid phase state is generally unimportant for lipofection: a viewpoint now emerging from our previous studies is that the critical factor in lipid-mediated transfection is the structural evolution of lipoplexes within the cell, upon interacting and mixing with cellular lipids.</abstract><notes>Journal article&#xD;Molecular pharmaceutics&#xD;Mol Pharm. 2008 Jun 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18563910</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.388</custom4><electronic-resource-num>10.1021/mp800011e</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1127</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1127</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chan, E. W.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and the Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3290, USA.</auth-address><titles><title>A photo-electroactive surface strategy for immobilizing ligands in patterns and gradients for studies of cell polarization</title><secondary-title>Mol Biosyst</secondary-title></titles><periodical><full-title>Mol Biosyst</full-title></periodical><pages>746-53</pages><volume>4</volume><number>7</number><edition>2008/06/20</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1742-2051 (Electronic)</isbn><accession-num>18563249</accession-num><abstract>We report a combined photochemical and electrochemical method to pattern ligands and cells in complex geometries and gradients on inert surfaces. This work demonstrates: (1) the control of density of immobilized ligands within overlapping photopatterns, and (2) the attached cell culture patterned onto ligand defined gradients for studies of directional cell polarity. Our approach is based on the photochemical activation of benzoquinonealkanethiols. Immobilization of aminooxy terminated ligands in selected region of the quinone monolayer resulted in patterns on the surface. This approach is unique in that the extent of photochemical deprotection, as well as ligand immobilization can be monitored and quantified by cyclic voltammetry in situ. Furthermore, complex photochemical patterns of single or multiple ligands can be routinely generated using photolithographic masks. Finally, this methodology is completely compatible with attached cell culture and we show how the subtle interplay between cell-cell interactions and underlying peptide gradient influences cell polarization. The combined use of photochemistry, electrochemistry and well defined surface chemistry provides molecular level control of patterned ligands and gradients on surfaces.</abstract><notes>Chan, Eugene W L&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Molecular bioSystems&#xD;Mol Biosyst. 2008 Jul;4(7):746-53. Epub 2008 May 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18563249</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>4.121</custom4><electronic-resource-num>10.1039/b801394b</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1635</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1635</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, C.</author><author>Lee, J. S.</author><author>Zhang, M.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA.</auth-address><titles><title>Magnetic nanoparticles in MR imaging and drug delivery</title><secondary-title>Adv Drug Deliv Rev</secondary-title></titles><periodical><full-title>Adv Drug Deliv Rev</full-title></periodical><pages>1252-65</pages><volume>60</volume><number>11</number><edition>2008/06/19</edition><dates><year>2008</year><pub-dates><date>Aug 17</date></pub-dates></dates><isbn>0169-409X (Print)</isbn><accession-num>18558452</accession-num><abstract>Magnetic nanoparticles (MNPs) possess unique magnetic properties and the ability to function at the cellular and molecular level of biological interactions making them an attractive platform as contrast agents for magnetic resonance imaging (MRI) and as carriers for drug delivery. Recent advances in nanotechnology have improved the ability to specifically tailor the features and properties of MNPs for these biomedical applications. To better address specific clinical needs, MNPs with higher magnetic moments, non-fouling surfaces, and increased functionalities are now being developed for applications in the detection, diagnosis, and treatment of malignant tumors, cardiovascular disease, and neurological disease. Through the incorporation of highly specific targeting agents and other functional ligands, such as fluorophores and permeation enhancers, the applicability and efficacy of these MNPs have greatly increased. This review provides a background on applications of MNPs as MR imaging contrast agents and as carriers for drug delivery and an overview of the recent developments in this area of research.</abstract><notes>Sun, Conroy&#xD;Lee, Jerry S H&#xD;Zhang, Miqin&#xD;Netherlands&#xD;Advanced drug delivery reviews&#xD;Adv Drug Deliv Rev. 2008 Aug 17;60(11):1252-65. Epub 2008 Apr 10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18558452</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2008</custom3><custom4>10.625</custom4><electronic-resource-num>S0169-409X(08)00101-4 [pii]&#xD;10.1016/j.addr.2008.03.018</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1775</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1775</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, A. P.</author><author>Burzynski, R.</author><author>Yoon, Y. K.</author><author>Prasad, P. N.</author><author>He, S.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, State University of New York at Buffalo, Buffalo, NY 14260, USA.</auth-address><titles><title>Double-layer fabrication scheme for large-area polymeric photonic crystal membrane on silicon surface by multibeam interference lithography</title><secondary-title>Opt Lett</secondary-title></titles><periodical><full-title>Opt Lett</full-title></periodical><pages>1303-5</pages><volume>33</volume><number>12</number><edition>2008/06/17</edition><dates><year>2008</year><pub-dates><date>Jun 15</date></pub-dates></dates><isbn>0146-9592 (Print)</isbn><accession-num>18552939</accession-num><abstract>We report on the fabrication of two-dimensional polymeric photonic crystal membranes on the surface of silicon using visible-light multibeam interference lithography. The structures are created by the interference of three beams of a green laser. A polymer buffer layer doped with a Rhodamine B laser dye, interlaid between the lithography layer and the silicon substrate, suppresses the effects of strong reflection and nonradiative absorption of silicon on the interference pattern. Large-area defect-free photonic crystal membranes are experimentally realized on silicon surface.</abstract><notes>Zhang, A Ping&#xD;Burzynski, Ryszard&#xD;Yoon, Yong-Kyu&#xD;Prasad, Paras N&#xD;He, Sailing&#xD;United States&#xD;Optics letters&#xD;Opt Lett. 2008 Jun 15;33(12):1303-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18552939</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2008</custom3><custom4>3.803</custom4><electronic-resource-num>163298 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1530</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1530</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Radu, C. G.</author><author>Shu, C. J.</author><author>Nair-Gill, E.</author><author>Shelly, S. M.</author><author>Barrio, J. R.</author><author>Satyamurthy, N.</author><author>Phelps, M. E.</author><author>Witte, O. N.</author></authors></contributors><auth-address>Department of Molecular and Medical Pharmacology, 23-120 Center for Health Sciences, Los Angeles, California 90095, USA.</auth-address><titles><title>Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2&apos;-deoxycytidine analog</title><secondary-title>Nat Med</secondary-title></titles><periodical><full-title>Nat Med</full-title></periodical><pages>783-8</pages><volume>14</volume><number>7</number><edition>2008/06/11</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1546-170X (Electronic)</isbn><accession-num>18542051</accession-num><abstract>Monitoring immune function with molecular imaging could have a considerable impact on the diagnosis and treatment evaluation of immunological disorders and therapeutic immune responses. Positron emission tomography (PET) is a molecular imaging modality with applications in cancer and other diseases. PET studies of immune function have been limited by a lack of specialized probes. We identified [(18)F]FAC (1-(2&apos;-deoxy-2&apos;-[(18)F]fluoroarabinofuranosyl) cytosine) by differential screening as a new PET probe for the deoxyribonucleotide salvage pathway. [(18)F]FAC enabled visualization of lymphoid organs and was sensitive to localized immune activation in a mouse model of antitumor immunity. [(18)F]FAC microPET also detected early changes in lymphoid mass in systemic autoimmunity and allowed evaluation of immunosuppressive therapy. These data support the use of [(18)F]FAC PET for immune monitoring and suggest a wide range of clinical applications in immune disorders and in certain types of cancer.</abstract><notes>Radu, Caius G&#xD;Shu, Chengyi J&#xD;Nair-Gill, Evan&#xD;Shelly, Stephanie M&#xD;Barrio, Jorge R&#xD;Satyamurthy, Nagichettiar&#xD;Phelps, Michael E&#xD;Witte, Owen N&#xD;5U54 CA119347/CA/United States NCI&#xD;P50 CA86306/CA/United States NCI&#xD;R24 CA92865/CA/United States NCI&#xD;T32 GM08042/GM/United States NIGMS&#xD;United States Howard Hughes Medical Institute&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nature medicine&#xD;Nat Med. 2008 Jul;14(7):783-8. Epub 2008 Jun 8.</notes><reviewed-item>internal</reviewed-item><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18542051</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>28.965</custom4><electronic-resource-num>nm1724 [pii]&#xD;10.1038/nm1724</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1181</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1181</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dickerson, E. B.</author><author>Dreaden, E. C.</author><author>Huang, X.</author><author>El-Sayed, I. H.</author><author>Chu, H.</author><author>Pushpanketh, S.</author><author>McDonald, J. F.</author><author>El-Sayed, M. A.</author></authors></contributors><auth-address>School of Biology, Ovarian Cancer Institute, Georgia Institute of Technology, Atlanta, GA 30332-0400, USA.</auth-address><titles><title>Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice</title><secondary-title>Cancer Lett</secondary-title></titles><periodical><full-title>Cancer Lett</full-title></periodical><edition>2008/06/11</edition><dates><year>2008</year><pub-dates><date>Jun 7</date></pub-dates></dates><isbn>0304-3835 (Print)</isbn><accession-num>18541363</accession-num><abstract>Plasmonic photothermal therapy (PPTT) is a minimally-invasive oncological treatment strategy in which photon energy is selectively administered and converted into heat sufficient to induce cellular hyperthermia. The present work demonstrates the feasibility of in vivo PPTT treatment of deep-tissue malignancies using easily-prepared plasmonic gold nanorods and a small, portable, inexpensive near-infrared (NIR) laser. Dramatic size decreases in squamous cell carcinoma xenografts were observed for direct (P&lt;0.0001) and intravenous (P&lt;0.0008) administration of pegylated gold nanorods in nu/nu mice. Inhibition of average tumor growth for both delivery methods was observed over a 13-day period, with resorption of &gt;57% of the directly-injected tumors and 25% of the intravenously-treated tumors.</abstract><notes>Journal article&#xD;Cancer letters&#xD;Cancer Lett. 2008 Jun 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18541363</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>3.398</custom4><electronic-resource-num>S0304-3835(08)00325-X [pii]&#xD;10.1016/j.canlet.2008.04.026</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1786</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1786</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhau, H. E.</author><author>Odero-Marah, V.</author><author>Lue, H. W.</author><author>Nomura, T.</author><author>Wang, R.</author><author>Chu, G.</author><author>Liu, Z. R.</author><author>Zhou, B. P.</author><author>Huang, W. C.</author><author>Chung, L. W.</author></authors></contributors><auth-address>Molecular Urology &amp; Therapeutics Program, Department of Urology, Emory University School of Medicine, 1365B Clifton Road, Suite 5107, Atlanta, GA, 30322, USA, hzhau@emory.edu.</auth-address><titles><title>Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model</title><secondary-title>Clin Exp Metastasis</secondary-title></titles><periodical><full-title>Clin Exp Metastasis</full-title></periodical><pages>601-10</pages><volume>25</volume><number>6</number><edition>2008/06/07</edition><dates><year>2008</year><pub-dates><date>Jun 07</date></pub-dates></dates><isbn>0262-0898 (Print)</isbn><accession-num>18535913</accession-num><abstract>Androgen refractory cancer of the prostate (ARCaP) cells contain androgen receptor (AR) and synthesize and secrete prostate specific antigen (PSA). We isolated epithelia-like ARCaP(E) from parental ARCaP cells and induced them to undergo epithelial-mesenchymal transition (EMT) by exposing these cells to soluble factors including TGFbeta1 plus EGF, IGF-1, beta2-microglobulin (beta2-m), or a bone microenvironment. The molecular and behavioral characteristics of the resultant ARCaP(M) were characterized extensively in comparison to the parental ARCaP(E) cells. In addition to expressing mesenchymal biomarkers, ARCaP(M) gained 100% incidence of bone metastasis. ARCaP(M) cells express receptor activator of NF-kappaB ligand (RANKL), which was shown to increase tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts in culture, and when metastatic to bone in vivo. We provide evidence that RANKL expression was promoted by increased cell signaling mediated by the activation of Stat3-Snail-LIV-1. RANKL expressed by ARCaP(M) cells is functional both in vitro and in vivo. The lesson we learned from the ARCaP model of EMT is that activation of a specific cell signaling pathway by soluble factors can lead to increased bone turnover, mediated by enhanced RANKL expression by tumor cells, which is implicated in the high incidence of prostate cancer bone colonization. The ARCaP EMT model is highly attractive for developing new therapeutic agents to treat prostate cancer bone metastasis.</abstract><notes>Zhau, Haiyen E&#xD;Odero-Marah, Valerie&#xD;Lue, Hui-Wen&#xD;Nomura, Takeo&#xD;Wang, Ruoxiang&#xD;Chu, Gina&#xD;Liu, Zhi-Ren&#xD;Zhou, Binhua P&#xD;Huang, Wen-Chin&#xD;Chung, Leland W K&#xD;Netherlands&#xD;Clinical &amp; experimental metastasis&#xD;Clin Exp Metastasis. 2008;25(6):601-10. Epub 2008 Jun 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18535913</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>3.222</custom4><electronic-resource-num>10.1007/s10585-008-9183-1</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1702</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1702</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, S.X.</author><author>Li, G.   </author></authors></contributors><auth-address>Dept. of Mater. Sci. &amp; Eng., Stanford Univ., Stanford, CA</auth-address><titles><title>Advances in Giant Magnetoresistance Biosensors With Magnetic Nanoparticle Tags: Review and Outlook</title><secondary-title>IEEE Transactions on Magnetics</secondary-title></titles><periodical><full-title>Ieee Transactions on Magnetics</full-title></periodical><pages>1687-1702</pages><volume>44</volume><number>7</number><edition>2008/06</edition><dates><year>2008</year><pub-dates><date>Jun 17</date></pub-dates></dates><isbn>0018-9464</isbn><accession-num>10058865</accession-num><abstract>We present a review of giant magnetoresistance (GMR) spin valve sensors designed for detection of magnetic nanoparticles as biomolecular labels (nanotags) in magneto-nano biodetection technology. We discuss the intricacy of magneto-nano biosensor design and show that as few as approximately 14 monodisperse 16-nm superparamagnetic nanoparticles can be detected by submicron spin valve sensors at room temperature without resorting to lock-in (narrow band) detection. GMR biosensors and biochips have been successfully applied to the detection of biological events in the form of both protein and DNA assays with great speed, sensitivity, selectivity, and economy. The limit of molecular detection is well below 10 pM in concentration, and the protein or DNA assay time can be under two hours. The technology is highly scalable to deep multiplex detection of biomarkers in a complex disease, and amenable to integration of microfluidics and CMOS electronics for portable applications. On-chip CMOS circuitry makes a sensor density of 0.1-1 million sensors per square centimeter feasible and affordable. The theoretical and experimental results thus far suggest that magneto-nano biochip-based GMR sensor arrays and nanotags hold great promise in biomedicine, particularly for point-of-care molecular diagnostics of cancer, infectious diseases, radiation injury, cardiac diseases, and other diseases.</abstract><urls><related-urls><url>http://ieeexplore.ieee.org/xpl/freeabs_all.jsp?arnumber=4544935</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>0.953</custom4><electronic-resource-num>10.1109/TMAG.2008.920962</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2497</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2497</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Raymond G. Sanedrin</author><author>Ling Huang</author><author>Jae-Won Jang</author><author>Joseph Kakkassery</author><author>Chad A. Mirkin</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology Northwestern University 2145 Sheridan Road, Evanston, IL 60208-3113 (USA)</auth-address><titles><title>Polyethylene Glycol as a Novel Resist and Sacrificial Material for Generating Positive and Negative Nanostructures</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>920-924</pages><volume>4</volume><number>7</number><edition>2008/06</edition><dates><year>2008</year></dates><isbn>1613-6829</isbn><notes>10.1002/smll.200701089</notes><urls><related-urls><url>http://dx.doi.org/10.1002/smll.200701089</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>7.292</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2487</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2487</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCullagh, Martin</author><author>Prytkova, Tatiana</author><author>Tonzani, Stefano</author><author>Winter, Nicolas D.</author><author>Schatz, George C.</author></authors></contributors><titles><title>Modeling Self-Assembly Processes Driven by Nonbonded Interactions in Soft Materials</title><secondary-title>The Journal of Physical Chemistry B</secondary-title></titles><periodical><full-title>The Journal of Physical Chemistry B</full-title></periodical><pages>10388-10398</pages><volume>112</volume><number>34</number><edition>2008/06</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>1520-6106</isbn><notes>doi: 10.1021/jp803192u</notes><urls><related-urls><url>http://dx.doi.org/10.1021/jp803192u</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>2.889</custom4><electronic-resource-num>10.1021/jp803192u</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2538</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2538</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kaushal, Sharmeela</author><author>McElroy, Michele</author><author>Luiken, George</author><author>Talamini, Mark</author><author>Moossa, A.</author><author>Hoffman, Robert</author><author>Bouvet, Michael</author></authors></contributors><titles><title>Fluorophore-conjugated anti-CEA Antibody for the Intraoperative Imaging of Pancreatic and Colorectal Cancer</title><secondary-title>Journal of Gastrointestinal Surgery</secondary-title></titles><periodical><full-title>Journal of Gastrointestinal Surgery</full-title></periodical><pages>1938-1950</pages><volume>12</volume><number>11</number><edition>2008/06</edition><dates><year>2008</year></dates><abstract>Abstract Introduction&amp;nbsp;&amp;nbsp;Colorectal and pancreatic cancers together comprise the third and fourth most common causes of cancer-related death in the United States. In both of these cancers, complete detection of primary and metastatic lesions at the time of surgery is critical to optimal surgical resection and appropriate patient treatment. Materials and Methods&amp;nbsp;&amp;nbsp;We have investigated the use of fluorophore-labeled anti-carcinoembryonic antigen (CEA) monoclonal antibody to aid in cancer visualization in nude mouse models of human colorectal and pancreatic cancer. Anti-CEA was conjugated with a green fluorophore. Subcutaneous, orthotopic primary and metastatic human pancreatic and colorectal tumors were easily visualized with fluorescence imaging after administration of conjugated anti-CEA. The fluorescence signal was detectable 30&amp;nbsp;min after systemic antibody delivery and remained present for 2&amp;nbsp;weeks, with minimal in vivo photobleaching after exposure to standard operating room lighting. Tumor resection techniques revealed improved ability to resect labeled tumor tissue under fluorescence guidance. Comparison of two different fluorophores revealed differences in doseresponse and photobleaching in vivo. Conclusion&amp;nbsp;&amp;nbsp;These results indicate that fluorophore-labeled anti-CEA offers a novel intraoperative imaging technique for enhanced visualization of tumors in colorectal and pancreatic cancer when CEA expression is present, and that the choice of fluorophore significantly affects the signal intensity in the labeled tumor.</abstract><notes>10.1007/s11605-008-0581-0</notes><urls><related-urls><url>http://dx.doi.org/10.1007/s11605-008-0581-0</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>2.939</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1227</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1227</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gunn, J.</author><author>Wallen, H.</author><author>Veiseh, O.</author><author>Sun, C.</author><author>Fang, C.</author><author>Cao, J. H.</author><author>Yee, C.</author><author>Zhang, M. Q.</author></authors></contributors><auth-address>Yee, C&#xD;Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA&#xD;Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA&#xD;Univ Washington, Dept Mat Sci &amp; Engn, Seattle, WA 98195 USA</auth-address><titles><title>A multimodal targeting nanoparticle for selectively labeling T cells</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>712-715</pages><volume>4</volume><number>6</number><edition>2008/06</edition><keywords><keyword>cell labeling</keyword><keyword>labeling efficacy</keyword><keyword>magnetic nanoparticles</keyword><keyword>magnetic resonance imaging specific targeting</keyword><keyword>in-vivo tracking</keyword><keyword>cancer-immunotherapy</keyword><keyword>metastatic melanoma</keyword><keyword>tumor</keyword><keyword>mri</keyword><keyword>immunity</keyword><keyword>agent</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1613-6810</isbn><accession-num>ISI:000257549100002</accession-num><notes>324WC&#xD;Times Cited:0&#xD;Cited References Count:22</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000257549100002</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom4>7.292</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1188</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1188</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Duan, H. W.</author><author>Kuang, M.</author><author>Wang, X. X.</author><author>Wang, Y. A.</author><author>Mao, H.</author><author>Nie, S. M.</author></authors></contributors><auth-address>Mao, H&#xD;Emory Univ, Dept Biomed Engn, 101 Woodruff Circle,Suite 2001, Atlanta, GA 30322 USA&#xD;Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA&#xD;Georgia Inst Technol, Atlanta, GA 30322 USA&#xD;Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA&#xD;Emory Univ, Sch Med, Ctr MR Res, Atlanta, GA 30322 USA&#xD;Ocean Nanotech LLC, Fayetteville, AR 72701 USA</auth-address><titles><title>Reexamining the effects of particle size and surface chemistry on the magnetic properties of iron oxide nanocrystals: New insights into spin disorder and proton relaxivity</title><secondary-title>Journal of Physical Chemistry C</secondary-title></titles><periodical><full-title>Journal of Physical Chemistry C</full-title></periodical><pages>8127-8131</pages><volume>112</volume><number>22</number><edition>2008/06</edition><keywords><keyword>uniform magnetite</keyword><keyword>contrast agents</keyword><keyword>water diffusion</keyword><keyword>nanoparticles</keyword><keyword>exchange</keyword><keyword>cells</keyword><keyword>fluorescence</keyword><keyword>enhancement</keyword><keyword>model</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun 5</date></pub-dates></dates><isbn>1932-7447</isbn><accession-num>ISI:000256265100006</accession-num><abstract>Superparamagnetic iron oxide nanocrystals are a class of nontoxic and biodegradable nanomaterials with broad applications in science, engineering, and medicine, but there is still considerable debate on how crystalline domain size and surface chemistry influence their properties for magnetic resonance imaging (MRI). Here we examine the effects of particle size and surface chemistry by comparing proton relaxivity data for two particle sizes and three surface coatings (6 combinations). These combinations are achieved by using both direct ligand exchange and indirect encapsulation methods to solubilize oleic-acid capped iron oxide nanocrystals. The results indicate that proton relaxivity depends on the particle size, the surface coating thickness and hydrophilicity, and the coordination chemistry of inner capping ligands. Nanocrystals coated with the hydrophilic ligand polyethylenimine (PEI) yield the highest proton relaxivity, whereas nanocrystals capped with oleic acid and amphiphilic polymers exhibit the strongest dependence on particle size. These effects arise from intrinsic surface spin disorders as well as from rapid exchange (diffusion) of water molecules between the bulk phase and the adjacent layer surrounding the particle surface.</abstract><notes>306RI&#xD;Times Cited:0&#xD;Cited References Count:25</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000256265100006</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>3.398</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2453</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2453</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Brown, Eric M. B.</author><author>Paunesku, Tatjana</author><author>Wu, AiGuo</author><author>Thurn, K. Ted</author><author>Haley, Benjamin</author><author>Clark, Jimmy</author><author>Priester, Taisa</author><author>Woloschak, Gayle E.</author></authors></contributors><titles><title>Methods for assessing DNA hybridization of peptide nucleic acid-titanium dioxide nanoconjugates</title><secondary-title>Anal Biochem</secondary-title></titles><periodical><full-title>Anal Biochem</full-title><abbr-1>Analytical biochemistry</abbr-1></periodical><pages>226-235</pages><volume>383</volume><number>2</number><edition>2008/06</edition><keywords><keyword>Titanium dioxide</keyword><keyword>Peptide nucleic acid</keyword><keyword>Nanoparticle</keyword><keyword>DNA</keyword><keyword>Hybridization</keyword></keywords><dates><year>2008</year></dates><isbn>0003-2697</isbn><notes>doi: DOI: 10.1016/j.ab.2008.08.020</notes><urls><related-urls><url>http://www.sciencedirect.com/science/article/B6W9V-4T9CCX5-1/2/2a06239a64c8a6d5a998cb6bdcd609fb</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>3.145</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2550</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2550</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bleszynski-Jayich, A. C.</author><author>Froberg, L. E.</author><author>Bjork, M. T.</author><author>Trodahl, H. J.</author><author>Samuelson, L.</author><author>Westervelt, R. M.</author></authors></contributors><titles><title>Imaging a one-electron InAs quantum dot in an InAs/InP nanowire</title><secondary-title>Physical Review B</secondary-title></titles><periodical><full-title>Physical Review B</full-title></periodical><volume>77</volume><number>24</number><edition>2008/06</edition><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1098-0121</isbn><accession-num>ISI:000257289700086</accession-num><abstract>Nanowire heterostructures define high-quality few-electron quantum dots for nanoelectronics, spintronics, and quantum information processing. We use a cooled scanning probe microscope (SPM) to image and control an InAs quantum dot in an InAs/InP nanowire using the tip as a movable gate. Images of dot conductance vs tip position at T=4.2 K show concentric rings as electrons are added, starting with the first electron. The SPM can locate a dot along a nanowire and individually tune its charge, abilities that will be very useful for the control of coupled nanowire dots.</abstract><notes>Bleszynski-Jayich, Ania C. Froberg, Linus E. Bjork, Mikael T. Trodahl, H. J. Samuelson, Lars Westervelt, R. M.</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000257289700086</url></related-urls></urls><custom1>CCNE - MIT</custom1><custom4>3.284</custom4><electronic-resource-num>245327&#xD;10.1103/PhysRevB.77.245327</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2245</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2245</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCarthy, J. R.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Harvard Medical School and Massachusetts General Hospital, Charlestown, MA 02129, USA. jason_mccarthy@hms.harvard.edu</auth-address><titles><title>Multifunctional magnetic nanoparticles for targeted imaging and therapy</title><secondary-title>Adv Drug Deliv Rev</secondary-title></titles><periodical><full-title>Adv Drug Deliv Rev</full-title></periodical><pages>1241-51</pages><volume>60</volume><number>11</number><edition>2008/05/30</edition><keywords><keyword>Animals</keyword><keyword>Atherosclerosis/diagnosis</keyword><keyword>Biocompatible Materials/diagnostic use/therapeutic use</keyword><keyword>Diagnostic Imaging/methods</keyword><keyword>Drug Delivery Systems/ methods</keyword><keyword>Ferric Compounds/chemistry</keyword><keyword>Humans</keyword><keyword>Magnetics</keyword><keyword>Nanoparticles/chemistry/diagnostic use/therapeutic use</keyword><keyword>Neoplasms/diagnosis</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 17</date></pub-dates></dates><isbn>0169-409X (Print)</isbn><accession-num>18508157</accession-num><abstract>Magnetic nanoparticles have become important tools for the imaging of prevalent diseases, such as cancer, atherosclerosis, diabetes, and others. While first generation nanoparticles were fairly nonspecific, newer generations have been targeted to specific cell types and molecular targets via affinity ligands. Commonly, these ligands emerge from phage or small molecule screens, or are based on antibodies or aptamers. Secondary reporters and combined therapeutic molecules have further opened potential clinical applications of these materials. This review summarizes some of the recent biomedical applications of these newer magnetic nanomaterials.</abstract><notes>McCarthy, Jason R&#xD;Weissleder, Ralph&#xD;U01 HL080731-01/HL/NHLBI NIH HHS/United States&#xD;U01 HL080731-02/HL/NHLBI NIH HHS/United States&#xD;U01 HL080731-03/HL/NHLBI NIH HHS/United States&#xD;U01 HL080731-04/HL/NHLBI NIH HHS/United States&#xD;U01-HL080731/HL/NHLBI NIH HHS/United States&#xD;U54 CA126515-010002/CA/NCI NIH HHS/United States&#xD;U54 CA126515-020002/CA/NCI NIH HHS/United States&#xD;U54-CA119349/CA/NCI NIH HHS/United States&#xD;U54-CA126515/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;Netherlands&#xD;Advanced drug delivery reviews&#xD;Adv Drug Deliv Rev. 2008 Aug 17;60(11):1241-51. Epub 2008 Apr 10.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2583936</custom2><custom3>NIHMS62164</custom3><custom4>10.625</custom4><electronic-resource-num>S0169-409X(08)00096-3 [pii]&#xD;10.1016/j.addr.2008.03.014 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2384</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2384</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Anglin, E. J.</author><author>Cheng, L.</author><author>Freeman, W. R.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093-0358, USA.</auth-address><titles><title>Porous silicon in drug delivery devices and materials</title><secondary-title>Adv Drug Deliv Rev</secondary-title></titles><periodical><full-title>Adv Drug Deliv Rev</full-title></periodical><pages>1266-77</pages><volume>60</volume><number>11</number><edition>2008/05/30</edition><keywords><keyword>Animals</keyword><keyword>Biocompatible Materials</keyword><keyword>Delayed-Action Preparations</keyword><keyword>Drug Delivery Systems/ methods</keyword><keyword>Electrochemistry</keyword><keyword>Humans</keyword><keyword>Neoplasms/therapy</keyword><keyword>Porosity</keyword><keyword>Silicon/ chemistry</keyword><keyword>Silicon Dioxide/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 17</date></pub-dates></dates><isbn>0169-409X (Print)</isbn><accession-num>18508154</accession-num><abstract>Porous Si exhibits a number of properties that make it an attractive material for controlled drug delivery applications: The electrochemical synthesis allows construction of tailored pore sizes and volumes that are controllable from the scale of microns to nanometers; a number of convenient chemistries exist for the modification of porous Si surfaces that can be used to control the amount, identity, and in vivo release rate of drug payloads and the resorption rate of the porous host matrix; the material can be used as a template for organic and biopolymers, to prepare composites with a designed nanostructure; and finally, the optical properties of photonic structures prepared from this material provide a self-reporting feature that can be monitored in vivo. This paper reviews the preparation, chemistry, and properties of electrochemically prepared porous Si or SiO2 hosts relevant to drug delivery applications.</abstract><notes>Anglin, Emily J&#xD;Cheng, Lingyun&#xD;Freeman, William R&#xD;Sailor, Michael J&#xD;EYO-7366/PHS HHS/United States&#xD;R01 EY007366-21/EY/NEI NIH HHS/United States&#xD;U54 CA 119335/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;Netherlands&#xD;Advanced drug delivery reviews&#xD;Adv Drug Deliv Rev. 2008 Aug 17;60(11):1266-77. Epub 2008 Apr 10.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom2>2710886</custom2><custom3>NIHMS102528</custom3><custom4>10.625</custom4><electronic-resource-num>S0169-409X(08)00100-2 [pii]&#xD;10.1016/j.addr.2008.03.017 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1684</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1684</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Virmani, S.</author><author>Harris, K. R.</author><author>Szolc-Kowalska, B.</author><author>Paunesku, T.</author><author>Woloschak, G. E.</author><author>Lee, F. T.</author><author>Lewandowski, R. J.</author><author>Sato, K. T.</author><author>Ryu, R. K.</author><author>Salem, R.</author><author>Larson, A. C.</author><author>Omary, R. A.</author></authors></contributors><auth-address>Department of Radiology, Northwestern University, 737 N Michigan Ave, Ste 1600, Chicago, IL 60611, USA.</auth-address><titles><title>Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs</title><secondary-title>J Vasc Interv Radiol</secondary-title></titles><periodical><full-title>J Vasc Interv Radiol</full-title></periodical><pages>931-6</pages><volume>19</volume><number>6</number><edition>2008/05/28</edition><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1051-0443 (Print)</isbn><accession-num>18503910</accession-num><abstract>PURPOSE: To compare two methods to (a) propagate VX2 cell strain in rabbit hind limbs and (b) inoculate liver parenchymal tumors in rabbits. MATERIALS AND METHODS: One hundred forty-two New Zealand white rabbits were used for this study (60 with hind limb tumor [donors] and 82 with liver tumors [recipients]). In the donor group, nine rabbits received frozen VX2 cell suspension and 51 were injected with freshly prepared VX2 cell suspension. In the recipient group, 32 rabbits were injected with VX2 tumor cells and 50 were implanted with a small tumor fragment in the liver parenchyma. Success rates in terms of tumor growth were compared by using chi(2) or Fisher exact tests, with alpha = .05. RESULTS: Hind limb and liver tumors were successfully grown in 48 of the 60 rabbits in the donor group (80%) and 57 of the 82 rabbits in the recipient group (70%). The success rate of growing hind limb tumors increased from 33% (three of nine rabbits) to 88% (45 of 51 rabbits) when fresh VX2 cells instead of frozen were injected percutaneously (P &lt; .0011). Similarly, the success rate for VX2 liver tumors almost doubled from 47% (15 of 32 rabbits) to 84% (42 of 50 rabbits) when a tumor fragment instead of VX2 cell suspension was used (P &lt; .00036). This also significantly reduced the frequency of metastasis (P &lt; .005). CONCLUSIONS: The authors recommend (a) the use of fresh VX2 cell suspension for percutaneous injection in the hind limbs of rabbits to maintain the VX2 cell strain and (b) the surgical implantation of freshly harvested VX2 tumor fragment into the liver parenchyma to establish liver tumors.</abstract><notes>Virmani, Sumeet&#xD;Harris, Kathleen R&#xD;Szolc-Kowalska, Barbara&#xD;Paunesku, Tatjana&#xD;Woloschak, Gayle E&#xD;Lee, Fred T&#xD;Lewandowski, Robert J&#xD;Sato, Kent T&#xD;Ryu, Robert K&#xD;Salem, Riad&#xD;Larson, Andrew C&#xD;Omary, Reed A&#xD;CA107467/CA/United States NCI&#xD;EB002100/EB/United States NIBIB&#xD;P50 CA89018/CA/United States NCI&#xD;U54 CA119341/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of vascular and interventional radiology : JVIR&#xD;J Vasc Interv Radiol. 2008 Jun;19(6):931-6. Epub 2008 Apr 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18503910</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>2.956</custom4><electronic-resource-num>S1051-0443(08)00231-5 [pii]&#xD;10.1016/j.jvir.2008.02.019</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1748</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1748</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, X.</author><author>Zhao, Z.</author><author>Qin, L.</author><author>Wei, W.</author><author>Levine, J. E.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Fluorescence recovery assay for the detection of protein-DNA binding</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>5616-21</pages><volume>80</volume><number>14</number><edition>2008/05/24</edition><dates><year>2008</year><pub-dates><date>Jul 15</date></pub-dates></dates><isbn>1520-6882 (Electronic)</isbn><accession-num>18498181</accession-num><abstract>We report a novel and straightforward fluorescence recovery assay which enables the detection of protein-DNA interactions and simultaneously determines relative binding affinities of sequence-specific DNA-binding proteins for a variety of DNA sequences in a multiplexed format. The detection of protein-DNA binding is accomplished by monitoring fluorescence recovery during exonuclease digestion of DNA sequences that are modified with fluorophore-quencher pairs. Retardation of fluorescence recovery occurs with binding of the protein to the putative DNA binding element, which arrests exonuclease digestion. The assay detects protein-DNA binding in a homogeneous solution simply, quickly, and reliably without using radioisotopes. Multiplexing is possible by labeling different DNA sequences with spectrally distinct dyes, allowing simultaneous analysis of experimental and control binding reactions in the same mixture.</abstract><notes>Xu, Xiaoyang&#xD;Zhao, Zhen&#xD;Qin, Lidong&#xD;Wei, Wei&#xD;Levine, Jon E&#xD;Mirkin, Chad A&#xD;R01 HD20677/HD/United States NICHD&#xD;U54 HD041859/HD/United States NICHD&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2008 Jul 15;80(14):5616-21. Epub 2008 May 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18498181</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac8007016</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1221</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1221</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Grover, W. H.</author><author>von Muhlen, M. G.</author><author>Manalis, S. R.</author></authors></contributors><auth-address>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Teflon films for chemically-inert microfluidic valves and pumps</title><secondary-title>Lab Chip</secondary-title></titles><periodical><full-title>Lab Chip</full-title></periodical><pages>913-8</pages><volume>8</volume><number>6</number><edition>2008/05/24</edition><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>18497911</accession-num><abstract>We present a simple method for fabricating chemically-inert Teflon microfluidic valves and pumps in glass microfluidic devices. These structures are modeled after monolithic membrane valves and pumps that utilize a featureless polydimethylsiloxane (PDMS) membrane bonded between two etched glass wafers. The limited chemical compatibility of PDMS has necessitated research into alternative materials for microfluidic devices. Previous work has shown that spin-coated amorphous fluoropolymers and Teflon-fluoropolymer laminates can be fabricated and substituted for PDMS in monolithic membrane valves and pumps for space flight applications. However, the complex process for fabricating these spin-coated Teflon films and laminates may preclude their use in many research and manufacturing contexts. As an alternative, we show that commercially-available fluorinated ethylene-propylene (FEP) Teflon films can be used to fabricate chemically-inert monolithic membrane valves and pumps in glass microfluidic devices. The FEP Teflon valves and pumps presented here are simple to fabricate, function similarly to their PDMS counterparts, maintain their performance over extended use, and are resistant to virtually all chemicals. These structures should facilitate lab-on-a-chip research involving a vast array of chemistries that are incompatible with native PDMS microfluidic devices.</abstract><notes>Grover, William H&#xD;von Muhlen, Marcio G&#xD;Manalis, Scott R&#xD;P50-GM68762/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Lab on a chip&#xD;Lab Chip. 2008 Jun;8(6):913-8. Epub 2008 Apr 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18497911</url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2008</custom3><custom4>7.000</custom4><electronic-resource-num>10.1039/b800600h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1063</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1063</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Anker, J. N.</author><author>Hall, W. P.</author><author>Lyandres, O.</author><author>Shah, N. C.</author><author>Zhao, J.</author><author>Van Duyne, R. P.</author></authors></contributors><auth-address>Chemistry Department, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Biosensing with plasmonic nanosensors</title><secondary-title>Nat Mater</secondary-title></titles><periodical><full-title>Nat Mater</full-title></periodical><pages>442-53</pages><volume>7</volume><number>6</number><edition>2008/05/24</edition><keywords><keyword>*Biosensing Techniques</keyword><keyword>*Metal Nanoparticles</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Surface Plasmon Resonance/*instrumentation</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1476-1122 (Print)</isbn><accession-num>18497851</accession-num><abstract>Recent developments have greatly improved the sensitivity of optical sensors based on metal nanoparticle arrays and single nanoparticles. We introduce the localized surface plasmon resonance (LSPR) sensor and describe how its exquisite sensitivity to size, shape and environment can be harnessed to detect molecular binding events and changes in molecular conformation. We then describe recent progress in three areas representing the most significant challenges: pushing sensitivity towards the single-molecule detection limit, combining LSPR with complementary molecular identification techniques such as surface-enhanced Raman spectroscopy, and practical development of sensors and instrumentation for routine use and high-throughput detection. This review highlights several exceptionally promising research directions and discusses how diverse applications of plasmonic nanoparticles can be integrated in the near future.</abstract><notes>Anker, Jeffrey N&#xD;Hall, W Paige&#xD;Lyandres, Olga&#xD;Shah, Nilam C&#xD;Zhao, Jing&#xD;Van Duyne, Richard P&#xD;1 U54 CA119341-01/CA/United States NCI&#xD;5 F32 GM077020/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;England&#xD;Nature materials&#xD;Nat Mater. 2008 Jun;7(6):442-53.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18497851</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>25.759</custom4><electronic-resource-num>nmat2162 [pii]&#xD;10.1038/nmat2162</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2325</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2325</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, A. M.</author><author>Duan, H.</author><author>Mohs, A. M.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, Atlanta, GA 30322, USA.</auth-address><titles><title>Bioconjugated quantum dots for in vivo molecular and cellular imaging</title><secondary-title>Adv Drug Deliv Rev</secondary-title></titles><periodical><full-title>Adv Drug Deliv Rev</full-title></periodical><pages>1226-40</pages><volume>60</volume><number>11</number><edition>2008/05/23</edition><keywords><keyword>Animals</keyword><keyword>Biocompatible Materials/ pharmacokinetics/toxicity</keyword><keyword>Diagnostic Imaging/ methods</keyword><keyword>Drug Delivery Systems/methods</keyword><keyword>Humans</keyword><keyword>Nanotechnology/methods</keyword><keyword>Neoplasms/diagnosis</keyword><keyword>Quantum Dots</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 17</date></pub-dates></dates><isbn>0169-409X (Print)</isbn><accession-num>18495291</accession-num><abstract>Semiconductor quantum dots (QDs) are tiny light-emitting particles on the nanometer scale, and are emerging as a new class of fluorescent labels for biology and medicine. In comparison with organic dyes and fluorescent proteins, they have unique optical and electronic properties, with size-tunable light emission, superior signal brightness, resistance to photobleaching, and broad absorption spectra for simultaneous excitation of multiple fluorescence colors. QDs also provide a versatile nanoscale scaffold for designing multifunctional nanoparticles with both imaging and therapeutic functions. When linked with targeting ligands such as antibodies, peptides or small molecules, QDs can be used to target tumor biomarkers as well as tumor vasculatures with high affinity and specificity. Here we discuss the synthesis and development of state-of-the-art QD probes and their use for molecular and cellular imaging. We also examine key issues for in vivo imaging and therapy, such as nanoparticle biodistribution, pharmacokinetics, and toxicology.</abstract><notes>Smith, Andrew M&#xD;Duan, Hongwei&#xD;Mohs, Aaron M&#xD;Nie, Shuming&#xD;P20 GM072069/GM/NIGMS NIH HHS/United States&#xD;P20 GM072069-03/GM/NIGMS NIH HHS/United States&#xD;PN2 EY018244-02/EY/NEI NIH HHS/United States&#xD;R01 CA108468/CA/NCI NIH HHS/United States&#xD;R01 CA108468-04/CA/NCI NIH HHS/United States&#xD;U01 HL080711-03/HL/NHLBI NIH HHS/United States&#xD;U01HL080711/HL/NHLBI NIH HHS/United States&#xD;U54 CA119338-03/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;Netherlands&#xD;Advanced drug delivery reviews&#xD;Adv Drug Deliv Rev. 2008 Aug 17;60(11):1226-40. Epub 2008 Apr 10.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom2>2649798</custom2><custom3>NIHMS62165</custom3><custom4>10.625</custom4><electronic-resource-num>S0169-409X(08)00098-7 [pii]&#xD;10.1016/j.addr.2008.03.015 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1571</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1571</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shaw, S. Y.</author><author>Westly, E. C.</author><author>Pittet, M. J.</author><author>Subramanian, A.</author><author>Schreiber, S. L.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Broad Institute of Harvard and MIT, 7 Cambridge Center, Cambridge, MA 02142, USA.</auth-address><titles><title>Perturbational profiling of nanomaterial biologic activity</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>7387-92</pages><volume>105</volume><number>21</number><edition>2008/05/22</edition><keywords><keyword>Animals</keyword><keyword>Biological Assay</keyword><keyword>Cell Line</keyword><keyword>Cluster Analysis</keyword><keyword>Humans</keyword><keyword>Materials Testing/*methods</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Nanoparticles/chemistry/*toxicity</keyword><keyword>Structure-Activity Relationship</keyword></keywords><dates><year>2008</year><pub-dates><date>May 27</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18492802</accession-num><abstract>Our understanding of the biologic effects (including toxicity) of nanomaterials is incomplete. In vivo animal studies remain the gold standard; however, widespread testing remains impractical, and the development of in vitro assays that correlate with in vivo activity has proven challenging. Here, we demonstrate the feasibility of analyzing in vitro nanomaterial activity in a generalizable, systematic fashion. We assessed nanoparticle effects in a multidimensional manner, using multiple cell types and multiple assays that reflect different aspects of cellular physiology. Hierarchical clustering of these data identifies nanomaterials with similar patterns of biologic activity across a broad sampling of cellular contexts, as opposed to extrapolating from results of a single in vitro assay. We show that this approach yields robust and detailed structure-activity relationships. Furthermore, a subset of nanoparticles were tested in mice, and nanoparticles with similar activity profiles in vitro exert similar effects on monocyte number in vivo. These data suggest a strategy of multidimensional characterization of nanomaterials in vitro that can inform the design of novel nanomaterials and guide studies of in vivo activity.</abstract><notes>Shaw, Stanley Y&#xD;Westly, Elizabeth C&#xD;Pittet, Mikael J&#xD;Subramanian, Aravind&#xD;Schreiber, Stuart L&#xD;Weissleder, Ralph&#xD;K08HL077186/HL/United States NHLBI&#xD;N01-CO-12400/CO/United States NCI&#xD;P50CA086355/CA/United States NCI&#xD;U01HL080731/HL/United States NHLBI&#xD;U54CA119349/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 May 27;105(21):7387-92. Epub 2008 May 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18492802</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>10.228</custom4><electronic-resource-num>0802878105 [pii]&#xD;10.1073/pnas.0802878105</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1661</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1661</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tong, R.</author><author>Cheng, J.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.</auth-address><titles><title>Paclitaxel-initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>4830-4</pages><volume>47</volume><number>26</number><edition>2008/05/21</edition><keywords><keyword>Antineoplastic Agents, Phytogenic/chemistry</keyword><keyword>Drug Carriers/*chemical synthesis</keyword><keyword>Models, Chemical</keyword><keyword>Molecular Structure</keyword><keyword>*Nanoparticles</keyword><keyword>Paclitaxel/*chemistry</keyword><keyword>Polyesters/*chemistry</keyword><keyword>Polymers/*chemistry</keyword></keywords><dates><year>2008</year></dates><isbn>1521-3773 (Electronic)</isbn><accession-num>18491339</accession-num><notes>Tong, Rong&#xD;Cheng, Jianjun&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2008;47(26):4830-4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18491339</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>10.031</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200800491</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1616</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1616</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Son, S.</author><author>Grover, W. H.</author><author>Burg, T. P.</author><author>Manalis, S. R.</author></authors></contributors><auth-address>Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Suspended microchannel resonators for ultralow volume universal detection</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>4757-60</pages><volume>80</volume><number>12</number><edition>2008/05/21</edition><keywords><keyword>Chemistry, Analytical/*instrumentation/*methods</keyword><keyword>Computers</keyword><keyword>Solutions</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun 15</date></pub-dates></dates><isbn>1520-6882 (Electronic)</isbn><accession-num>18489125</accession-num><abstract>Universal detectors that maintain high sensitivity as the detection volume is reduced to the subnanoliter scale can enhance the utility of miniaturized total analysis systems (mu-TAS). Here the unique scaling properties of the suspended microchannel resonator (SMR) are exploited to show universal detection in a 10 pL analysis volume with a density detection limit of approximately 1 microg/cm (3) (10 Hz bandwidth) and a dynamic range of 6 decades. Analytes with low UV extinction coefficients such as polyethylene glycol (PEG) 8 kDa, glucose, and glycine are measured with molar detection limits of 0.66, 13.5, and 31.6 microM, respectively. To demonstrate the potential for real-time monitoring, gel filtration chromatography was used to separate different molecular weights of PEG as the SMR acquired a chromatogram by measuring the eluate density. This work suggests that the SMR could offer a simple and sensitive universal detector for various separation systems from liquid chromatography to capillary electrophoresis. Moreover, since the SMR is itself a microfluidic channel, it can be directly integrated into mu-TAS without compromising overall performance.</abstract><notes>Son, Sungmin&#xD;Grover, William H&#xD;Burg, Thomas P&#xD;Manalis, Scott R&#xD;EB003403/EB/United States NIBIB&#xD;P50-GM68762/GM/United States NIGMS&#xD;R21 EB003403-02/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2008 Jun 15;80(12):4757-60. Epub 2008 May 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18489125</url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2008</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac800307a</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1495</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1495</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Partlow, K. C.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Department of Medicine, Washington University in St. Louis, School of Medicine, Campus Box 8215, 660 South Euclid Avenue, St. Louis, MO 63110, USA.</auth-address><titles><title>Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery</title><secondary-title>Biomaterials</secondary-title></titles><periodical><full-title>Biomaterials</full-title></periodical><pages>3367-75</pages><volume>29</volume><number>23</number><edition>2008/05/20</edition><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0142-9612 (Print)</isbn><accession-num>18485474</accession-num><abstract>The ability to specifically deliver therapeutic agents to selected cell types while minimizing systemic toxicity is a principal goal of nanoparticle-based drug delivery approaches. Numerous cellular portals exist for cargo uptake and transport, but after targeting, intact nanoparticles typically are internalized via endocytosis prior to drug release. However, in this work, we show that certain classes of nanoparticles, namely lipid-coated liquid perfluorocarbon emulsions, undergo unique interactions with cells to deliver lipophilic substances to target cells without the need for entire nanoparticle internalization. To define the delivery mechanisms, fluorescently-labeled nanoparticles complexed with alphav beta 3-integrin targeting ligands were incubated with alphav beta 3-integrin expressing cells (C32 melanoma) under selected inhibitory conditions that revealed specific nanoparticle-to-cell interactions. We observed that the predominant mechanism of lipophilic delivery entailed direct delivery of lipophilic substances to the target cell plasma membrane via lipid mixing and subsequent intracellular trafficking through lipid raft-dependent processes. We suggest that local drug delivery to selected cell types could be facilitated by employing targeted nanoparticles designed specifically to utilize alternative membrane transport mechanisms.</abstract><notes>Partlow, Kathryn C&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;CO-37007/CO/United States NCI&#xD;HL-073646/HL/United States NHLBI&#xD;HL-078631/HL/United States NHLBI&#xD;U54-CA-119342/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Biomaterials&#xD;Biomaterials. 2008 Aug;29(23):3367-75. Epub 2008 May 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18485474</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>7.325</custom4><electronic-resource-num>S0142-9612(08)00265-2 [pii]&#xD;10.1016/j.biomaterials.2008.04.030</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2081</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2081</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, H.</author><author>Chen, K.</author><author>Cai, W.</author><author>Li, Z.</author><author>He, L.</author><author>Kashefi, A.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, 1201 Welch Road, P095, Stanford, CA 94305-5484, USA.</auth-address><titles><title>Integrin-targeted imaging and therapy with RGD4C-TNF fusion protein</title><secondary-title>Mol Cancer Ther</secondary-title></titles><periodical><full-title>Mol Cancer Ther</full-title></periodical><pages>1044-53</pages><volume>7</volume><number>5</number><edition>2008/05/17</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/ pharmacology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chelating Agents/pharmacology</keyword><keyword>Copper Radioisotopes/pharmacokinetics</keyword><keyword>Female</keyword><keyword>Heterocyclic Compounds, 1-Ring/pharmacokinetics/pharmacology</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/ antagonists &amp; inhibitors/genetics</keyword><keyword>Mice</keyword><keyword>Organometallic Compounds/pharmacokinetics/pharmacology</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Recombinant Fusion Proteins/pharmacokinetics/ pharmacology</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Tissue Distribution</keyword><keyword>Tumor Necrosis Factor-alpha/pharmacokinetics/pharmacology</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1535-7163 (Print)</isbn><accession-num>18483294</accession-num><abstract>This study used integrin alpha v beta3 as a target for tumor-specific delivery of tumor necrosis factor-alpha (TNF). The fusion protein RGD4C-TNF bound specifically to alpha v beta3 as evidenced by cell receptor binding assay and noninvasive micro-positron emission tomography imaging. 64Cu-DOTA-RGD4C-TNF had significantly higher activity accumulation in integrin-positive tumors (U87MG and MDA-MB-435) but not in integrin-negative tumors (C6) compared with 64Cu-DOTA-TNF. The magnitude of tumor uptake of 64Cu-DOTA-RGD4C-TNF correlated well with the alpha v beta3 level (U87MG &gt; MDA-MB-435 &gt; C6). Tumor accumulation of 64Cu-DOTA-RGD4C-TNF could be effectively blocked by c(RGDyK) peptide in alpha v beta3-positive tumor models, suggesting alpha v beta3 specificity of RGD4C-TNF fusion protein in vivo. Furthermore, although the fusion of RGD4C moiety to TNF had little effect on the bioactivity and cytotoxicity of RGD4C-TNF compared with TNF in cell culture, RGD4C-TNF was significantly more potent than TNF in inhibiting orthotopic MDA-MB-435 tumor growth. Ex vivo tissue staining confirmed specific cytotoxicity of RGD4C-TNF against integrin-positive tumor cells and tumor vasculature.</abstract><notes>Wang, Hui&#xD;Chen, Kai&#xD;Cai, Weibo&#xD;Li, Zibo&#xD;He, Lina&#xD;Kashefi, Amir&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Molecular cancer therapeutics&#xD;Mol Cancer Ther. 2008 May;7(5):1044-53.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>5.428</custom4><electronic-resource-num>7/5/1044 [pii]&#xD;10.1158/1535-7163.MCT-07-2084 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1177</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1177</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Devalapally, H.</author><author>Duan, Z.</author><author>Seiden, M. V.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, USA.</auth-address><titles><title>Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles</title><secondary-title>Clin Cancer Res</secondary-title></titles><periodical><full-title>Clin Cancer Res</full-title></periodical><pages>3193-203</pages><volume>14</volume><number>10</number><edition>2008/05/17</edition><dates><year>2008</year><pub-dates><date>May 15</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>18483388</accession-num><abstract>PURPOSE: To modulate intracellular ceramide levels and lower the apoptotic threshold in multidrug-resistant ovarian adenocarcinoma, we have examined the efficacy and preliminary safety of tamoxifen coadministration with paclitaxel in biodegradable poly(ethylene oxide)-modified poly(epsilon-caprolactone) (PEO-PCL) nanoparticles. EXPERIMENTAL DESIGN: In vitro cytotoxicity and proapoptotic activity of paclitaxel and tamoxifen, either as single agent or in combination, was examined in wild-type (SKOV3) and MDR-1-positive (SKOV3TR) human ovarian adenocarcinoma cells. Subcutaneous SKOV3 and SKOV3TR xenografts were established in female nu/nu mice, and this model was used to evaluate the antitumor efficacy and preliminary safety. Paclitaxel (20 mg/kg) and tamoxifen (70 mg/kg) were administered i.v. either as a single agent or in combination in aqueous solution and in PEO-PCL nanoparticles. RESULTS: In vitro cytotoxicity results showed that administration of paclitaxel and tamoxifen in combination lowered the IC50 of paclitaxel by 10-fold in SKOV3 cells and by &gt;3-fold in SKOV3TR cells. The combination paclitaxel/tamoxifen co-therapy showed even more pronounced effect when administered in nanoparticle formulations. Upon i.v. administration of paclitaxel/tamoxifen combination in PEO-PCL nanoparticle formulations, significant enhancement in antitumor efficacy was observed. Furthermore, the combination paclitaxel/tamoxifen therapy did not induce any acute toxicity as measured by body weight changes, blood cell counts, and hepatotoxicity. CONCLUSIONS: The results of this study show that combination of paclitaxel and tamoxifen in biodegradable PEO-PCL nanoparticles can serve as an effective clinically translatable strategy to overcome multidrug resistance in ovarian cancer.</abstract><notes>Devalapally, Harikrishna&#xD;Duan, Zhenfeng&#xD;Seiden, Michael V&#xD;Amiji, Mansoor M&#xD;R01-CA119617/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 May 15;14(10):3193-203.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18483388</url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2008</custom3><custom4>6.646</custom4><electronic-resource-num>14/10/3193 [pii]&#xD;10.1158/1078-0432.CCR-07-4973</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1404</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1404</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Y.</author><author>Boukhelifa, M.</author><author>Tribble, E.</author><author>Morin-Kensicki, E.</author><author>Uetrecht, A.</author><author>Bear, J. E.</author><author>Bankaitis, V. A.</author></authors></contributors><auth-address>Department of Cell and Developmental Biology, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7090.</auth-address><titles><title>The sac1 phosphoinositide phosphatase regulates Golgi membrane morphology and mitotic spindle organization in mammals</title><secondary-title>Mol Biol Cell</secondary-title></titles><periodical><full-title>Mol Biol Cell</full-title></periodical><pages>3080-96</pages><volume>19</volume><number>7</number><edition>2008/05/16</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1059-1524 (Print)</isbn><accession-num>18480408</accession-num><abstract>Phosphoinositides (PIPs) are ubiquitous regulators of signal transduction events in eukaryotic cells. PIPs are degraded by various enzymes, including PIP phosphatases. The integral membrane Sac1 phosphatases represent a major class of such enzymes. The central role of lipid phosphatases in regulating PIP homeostasis notwithstanding, the biological functions of Sac1-phosphatases remain poorly characterized. Herein, we demonstrate that functional ablation of the single murine Sac1 results in preimplantation lethality in the mouse and that Sac1 insufficiencies result in disorganization of mammalian Golgi membranes and mitotic defects characterized by multiple mechanically active spindles. Complementation experiments demonstrate mutant mammalian Sac1 proteins individually defective in either phosphoinositide phosphatase activity, or in recycling of the enzyme from the Golgi system back to the endoplasmic reticulum, are nonfunctional proteins in vivo. The data indicate Sac1 executes an essential household function in mammals that involves organization of both Golgi membranes and mitotic spindles and that both enzymatic activity and endoplasmic reticulum localization are important Sac1 functional properties.</abstract><notes>Liu, Yang&#xD;Boukhelifa, Malika&#xD;Tribble, Emily&#xD;Morin-Kensicki, Elizabeth&#xD;Uetrecht, Andrea&#xD;Bear, James E&#xD;Bankaitis, Vytas A&#xD;United States&#xD;Molecular biology of the cell&#xD;Mol Biol Cell. 2008 Jul;19(7):3080-96. Epub 2008 May 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18480408</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>6.017</custom4><electronic-resource-num>E07-12-1290 [pii]&#xD;10.1091/mbc.E07-12-1290</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2383</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2383</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hayashi, T.</author><author>Cottam, H. B.</author><author>Chan, M.</author><author>Jin, G.</author><author>Tawatao, R. I.</author><author>Crain, B.</author><author>Ronacher, L.</author><author>Messer, K.</author><author>Carson, D. A.</author><author>Corr, M.</author></authors></contributors><auth-address>Rebecca and John Moores Cancer Center, University of California, San Diego, La Jolla, California , CA, USA.</auth-address><titles><title>Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7</title><secondary-title>Am J Physiol Regul Integr Comp Physiol</secondary-title></titles><periodical><full-title>Am J Physiol Regul Integr Comp Physiol</full-title></periodical><pages>R123-32</pages><volume>295</volume><number>1</number><edition>2008/05/16</edition><keywords><keyword>Adenine/administration &amp; dosage/analogs &amp; derivatives/pharmacology</keyword><keyword>Administration, Intranasal</keyword><keyword>Animals</keyword><keyword>Anorexia/ etiology</keyword><keyword>Appetite Depressants/administration &amp; dosage/pharmacology</keyword><keyword>Cytokines/genetics/metabolism</keyword><keyword>Drug Administration Routes</keyword><keyword>Female</keyword><keyword>Gene Deletion</keyword><keyword>Gene Expression Regulation/drug effects</keyword><keyword>Hypothermia/ etiology</keyword><keyword>Ligands</keyword><keyword>Mast Cells/ metabolism</keyword><keyword>Membrane Glycoproteins/genetics/ metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mucous Membrane</keyword><keyword>Myeloid Differentiation Factor 88/genetics/metabolism</keyword><keyword>Random Allocation</keyword><keyword>Time Factors</keyword><keyword>Toll-Like Receptor 7/genetics/ metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0363-6119 (Print)</isbn><accession-num>18480244</accession-num><abstract>Systemic viral infections produce a highly regulated set of responses in sickness behavior, such as fever, anorexia, and adipsia. Toll-like receptor (TLR)7, activated by viral RNA during infection, potently stimulates the innate and adaptive immune responses that aid in viral clearance. However, the physiological consequences of TLR7 activation have not been thoroughly studied. In these experiments, we used a potent synthetic TLR7 ligand, 9-benzyl-8-hydroxy-2-(2-methoxyethoxy)adenine (SM360320; 1V136), to investigate the consequences of TLR7 activation in genetically defined strains of mice. Administration of the drug by the nasal, intragastric, or intraperitoneal routes caused transient hypophagia, hypodypsia, and hypothermia. Analyses of mutant mouse strains indicated that these effects were dependent on the expression of TLR7, its adaptor protein MyD88, and TNF-alpha, and independent of IL-1beta, IL-6 and cyclo-oxygenase-1 (COX1). Partial roles were also implied for mast cells and COX2. Although plasma TNF-alpha levels were significantly higher after systemic drug delivery, the behavioral effects were maximal when the agent was administered to the mucosa. Tissue and mucosal mast cells are known to express high levels of TLR7 and to rapidly release TNF-alpha upon TLR7 ligation. Mice deficient in tissue mast cells, W/W(v), had significantly less anorexia after TLR7 activation, and this response was restored with mast cell reconstitution. Our results thus suggest that tissue mast cells may play a role in the anorexia induced by mucosal activation of TLR7.</abstract><notes>Hayashi, Tomoko&#xD;Cottam, Howard B&#xD;Chan, Michael&#xD;Jin, Guangyi&#xD;Tawatao, Rommel I&#xD;Crain, Brian&#xD;Ronacher, Lisa&#xD;Messer, Karen&#xD;Carson, Dennis A&#xD;Corr, Maripat&#xD;5 U01 AI056453/AI/NIAID NIH HHS/United States&#xD;AI40682/AI/NIAID NIH HHS/United States&#xD;CA119335/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;American journal of physiology. Regulatory, integrative and comparative physiology&#xD;Am J Physiol Regul Integr Comp Physiol. 2008 Jul;295(1):R123-32. Epub 2008 May 14.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom2>2494819</custom2><custom4>3.556</custom4><electronic-resource-num>00527.2007 [pii]&#xD;10.1152/ajpregu.00527.2007 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1172</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1172</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Deshpande, D.</author><author>Devalapally, H.</author><author>Amiji, M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 110 Mugar Life Sciences Building, Boston, MA, 02115, USA.</auth-address><titles><title>Enhancement in Anti-proliferative Effects of Paclitaxel in Aortic Smooth Muscle Cells upon Co-administration with Ceramide using Biodegradable Polymeric Nanoparticles</title><secondary-title>Pharm Res</secondary-title></titles><periodical><full-title>Pharm Res</full-title></periodical><pages>1936-47</pages><volume>25</volume><number>8</number><edition>2008/05/16</edition><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0724-8741 (Print)</isbn><accession-num>18480968</accession-num><abstract>PURPOSE: Using a combination of paclitaxel (PTX), and the apoptotic signaling molecule, C(6)-ceramide (CER), the enhancement in anti-proliferative effect of human aortic smooth muscle cells (SMC) was examined by administering in polymeric nanoparticles. METHODS: PTX- and CER-loaded poly(ethylene oxide)-modified poly(epsilon caprolactone) (PEO-PCL) nanoparticles were formulated by solvent displacement and characterized. The uptake and intracellular localization of the nanoparticle in SMC was examined using Z-stack fluorescent confocal microscopy. Anti-proliferative and pro-apoptotic effects of SMC were determined upon administration of PTX and CER, either as single agent or in combination, in aqueous solution and in PEO-PCL nanoparticle formulations. RESULTS: High encapsulation efficiencies (i.e., &gt;95%) of PTX and CER at 10% (w/w) loading were attained in the PEO-PCL nanoparticles of around 270 nm in diameter. Fluorescence confocal analysis showed that nanoparticle delivery did facilitate cellular uptake and internalization. Additionally, combination of PTX and CER delivery in PEO-PCL nanoparticles was significantly more effective in decreasing the proliferation of SMC, probably by enhancing the apoptotic response. CONCLUSIONS: The results of this study show that combination of PTX and CER when administered in PEO-PCL nanoparticles can significantly augment the anti-proliferative effect in SMC. This strategy may potentially be useful in the treatment of coronary restenosis.</abstract><notes>Deshpande, Dipti&#xD;Devalapally, Harikrishna&#xD;Amiji, Mansoor&#xD;United States&#xD;Pharmaceutical research&#xD;Pharm Res. 2008 Aug;25(8):1936-47. Epub 2008 May 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18480968</url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2008</custom3><custom4>3.831</custom4><electronic-resource-num>10.1007/s11095-008-9614-3</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1744</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1744</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, G.</author><author>Yong, K. T.</author><author>Roy, I.</author><author>Mahajan, S. D.</author><author>Ding, H.</author><author>Schwartz, S. A.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute For Lasers, Photonics And Biophotonics, The State University of New York, Buffalo, New York 14260-3000, USA.</auth-address><titles><title>Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>1179-85</pages><volume>19</volume><number>6</number><edition>2008/05/14</edition><keywords><keyword>Biosensing Techniques/*instrumentation</keyword><keyword>Blood-Brain Barrier/*metabolism</keyword><keyword>Fluorescence</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Time Factors</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1520-4812 (Electronic)</isbn><accession-num>18473444</accession-num><abstract>We report here, what we believe to be the first time, the successful transport of bioconjugated quantum rods (QRs) across an in vitro blood-brain barrier (BBB) model via a receptor-mediated transport, as well as the use of QR multiplexing technique to compare simultaneously the transmigration efficiency of different biomolecules across the BBB. The migration rate of bioconjugated QRs crossing the in vitro BBB was found to be concentration- and time-dependent. This work illustrates a nanoparticle-based platform that will not only allow a direct visualization of the transmigration ability of various kinds of biomolecules across the BBB, but also facilitate the development of novel diagnostic and therapeutic nanoprobes for early diagnosis and therapy of various disorders of the brain following systemic administration.</abstract><notes>Xu, Gaixia&#xD;Yong, Ken-Tye&#xD;Roy, Indrajit&#xD;Mahajan, Supriya D&#xD;Ding, Hong&#xD;Schwartz, Stanley A&#xD;Prasad, Paras N&#xD;R01CA119397/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2008 Jun;19(6):1179-85. Epub 2008 May 13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18473444</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2008</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/bc700477u</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2080</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2080</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xing, Y.</author><author>So, M. K.</author><author>Koh, A. L.</author><author>Sinclair, R.</author><author>Rao, J.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS), Department of Radiology, School of Medicine, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>Improved QD-BRET conjugates for detection and imaging</title><secondary-title>Biochem Biophys Res Commun</secondary-title></titles><periodical><full-title>Biochem Biophys Res Commun</full-title></periodical><pages>388-94</pages><volume>372</volume><number>3</number><edition>2008/05/13</edition><keywords><keyword>Animals</keyword><keyword>Diagnostic Imaging</keyword><keyword>Enzymes, Immobilized/chemistry</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Luciferases, Renilla/chemistry</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Molecular Probes/ chemistry</keyword><keyword>Oxidation-Reduction</keyword><keyword>Quantum Dots</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>1090-2104 (Electronic)</isbn><accession-num>18468518</accession-num><abstract>Self-illuminating quantum dots, also known as QD-BRET conjugates, are a new class of quantum dot bioconjugates which do not need external light for excitation. Instead, light emission relies on the bioluminescence resonance energy transfer from the attached Renilla luciferase enzyme, which emits light upon the oxidation of its substrate. QD-BRET combines the advantages of the QDs (such as superior brightness and photostability, tunable emission, multiplexing) as well as the high sensitivity of bioluminescence imaging, thus holding the promise for improved deep tissue in vivo imaging. Although studies have demonstrated the superior sensitivity and deep tissue imaging potential, the stability of the QD-BRET conjugates in biological environment needs to be improved for long-term imaging studies such as in vivo cell tracking. In this study, we seek to improve the stability of QD-BRET probes through polymeric encapsulation with a polyacrylamide gel. Results show that encapsulation caused some activity loss, but significantly improved both the in vitro serum stability and in vivo stability when subcutaneously injected into the animal. Stable QD-BRET probes should further facilitate their applications for both in vitro testing as well as in vivo cell tracking studies.</abstract><notes>Xing, Yun&#xD;So, Min-Kyung&#xD;Koh, Ai Leen&#xD;Sinclair, Robert&#xD;Rao, Jianghong&#xD;1U54CA119367-01/CA/NCI NIH HHS/United States&#xD;U54 CA119367-010005/CA/NCI NIH HHS/United States&#xD;U54 CA119367-020005/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Biochemical and biophysical research communications&#xD;Biochem Biophys Res Commun. 2008 Aug 1;372(3):388-94. Epub 2008 May 9.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom2>2529157</custom2><custom3>NIHMS56253</custom3><custom4>2.823</custom4><electronic-resource-num>S0006-291X(08)00835-8 [pii]&#xD;10.1016/j.bbrc.2008.04.159 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1143</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1143</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Choi, J. S.</author><author>Choi, H. J.</author><author>Jung, D. C.</author><author>Lee, J. H.</author><author>Cheon, J.</author></authors></contributors><auth-address>Department of Chemistry, Yonsei University, Seoul, 120-749, Korea.</auth-address><titles><title>Nanoparticle assisted magnetic resonance imaging of the early reversible stages of amyloid beta self-assembly</title><secondary-title>Chem Commun (Camb)</secondary-title></titles><periodical><full-title>Chem Commun (Camb)</full-title></periodical><pages>2197-9</pages><number>19</number><edition>2008/05/09</edition><keywords><keyword>Amyloid beta-Protein/*chemistry/metabolism</keyword><keyword>Cobalt/*chemistry</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Magnetics</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Peptide Fragments/*chemistry/metabolism</keyword><keyword>Platinum/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>May 21</date></pub-dates></dates><isbn>1359-7345 (Print)</isbn><accession-num>18463738</accession-num><abstract>Co@Pt-Au nanoparticles, which have enhanced magnetism and high stability in aqueous media, are utilized in conjunction with MRI to monitor the structural evolution of Abeta assemblies, especially Abeta protofibrils in the early reversible stages.</abstract><notes>Choi, Jin-Sil&#xD;Choi, Hyuck Jae&#xD;Jung, Dae Chul&#xD;Lee, Joo-Hyuk&#xD;Cheon, Jinwoo&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Chemical communications (Cambridge, England)&#xD;Chem Commun (Camb). 2008 May 21;(19):2197-9. Epub 2008 Apr 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18463738</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.997</custom4><electronic-resource-num>10.1039/b803294g</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1745</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1745</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, L.</author><author>Yu, H.</author><author>Akhras, M. S.</author><author>Han, S. J.</author><author>Osterfeld, S.</author><author>White, R. L.</author><author>Pourmand, N.</author><author>Wang, S. X.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, Stanford University, Stanford, CA 94305-4045, USA.</auth-address><titles><title>Giant magnetoresistive biochip for DNA detection and HPV genotyping</title><secondary-title>Biosens Bioelectron</secondary-title></titles><periodical><full-title>Biosens Bioelectron</full-title></periodical><edition>2008/05/07</edition><dates><year>2008</year><pub-dates><date>Apr 8</date></pub-dates></dates><isbn>0956-5663 (Print)</isbn><accession-num>18457945</accession-num><abstract>A giant magnetoresistive (GMR) biochip based on spin valve sensor array and magnetic nanoparticle labels was developed for inexpensive, sensitive and reliable DNA detection. The DNA targets detected in this experiment were PCR products amplified from Human Papillomavirus (HPV) plasmids. The concentrations of the target DNA after PCR were around 10nM in most cases, but concentrations of 10pM were also detectable, which is demonstrated by experiments with synthetic DNA samples. A mild but highly specific surface chemistry was used for probe oligonucleotide immobilization. Double modulation technique was used for signal detection in order to reduce the 1/f noise in the sensor. Twelve assays were performed with an accuracy of approximately 90%. Magnetic signals were consistent with particle coverage data measured with Scanning Electron Microscopy (SEM). More recent research on microfluidics showed the potential of reducing the assay time below one hour. This is the first demonstration of magnetic DNA detection using plasmid-derived samples. This study provides a direct proof that GMR sensors can be used for biomedical applications.</abstract><notes>Journal article&#xD;Biosensors &amp; bioelectronics&#xD;Biosens Bioelectron. 2008 Apr 8;.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18457945</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>5.330</custom4><electronic-resource-num>S0956-5663(08)00148-6 [pii]&#xD;10.1016/j.bios.2008.03.030</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1618</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1618</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Song, Y.</author><author>Kohlmeir, E. K.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Departments of Chemistry, Biochemistry and Molecular and Cell Biology, Neurobiology and Physiology, Radiology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Synthesis of multimeric MR contrast agents for cellular imaging</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>6662-3</pages><volume>130</volume><number>21</number><edition>2008/05/03</edition><keywords><keyword>Animals</keyword><keyword>Biocompatible Materials/chemical synthesis/pharmacology</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Contrast Media/*chemical synthesis/pharmacology</keyword><keyword>Gadolinium/*chemistry/pharmacology</keyword><keyword>Heterocyclic Compounds/chemistry/pharmacology</keyword><keyword>Magnetic Resonance Imaging/methods</keyword><keyword>Mice</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Organometallic Compounds/*chemical synthesis/chemistry/pharmacology</keyword></keywords><dates><year>2008</year><pub-dates><date>May 28</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18452288</accession-num><abstract>We have prepared a series of molecular multimeric MR contrast agents for cell labeling that are easy to synthesize, relatively low molecular weight, and biocompatible. The relaxivities of the agents range from 17 to 85 mM(-1) s(-1). Cellular uptake is concentration dependent and viability is excellent. MR images of cell pellets reveal a marked increase in observed signal intensity.</abstract><notes>Song, Ying&#xD;Kohlmeir, Ellen K&#xD;Meade, Thomas J&#xD;1P50 NS054287-01/NS/United States NINDS&#xD;1R01 EB005866-01/EB/United States NIBIB&#xD;S10 RR15685-01/RR/United States NCRR&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 May 28;130(21):6662-3. Epub 2008 May 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18452288</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja0777990</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1437</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1437</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Matson, J. B.</author><author>Grubbs, R. H.</author></authors></contributors><auth-address>NanoSystems Biology Cancer Center, Division of Chemistry and Chemical Engineering, MC 127-72, California Institute of Technology, Pasadena, California 91125, USA.</auth-address><titles><title>Synthesis of fluorine-18 functionalized nanoparticles for use as in vivo molecular imaging agents</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>6731-3</pages><volume>130</volume><number>21</number><edition>2008/05/03</edition><keywords><keyword>Bicyclo Compounds/*chemistry</keyword><keyword>Catalysis</keyword><keyword>Diagnostic Imaging/methods</keyword><keyword>Electron Spin Resonance Spectroscopy</keyword><keyword>Fluorine Radioisotopes/*chemistry</keyword><keyword>Heptanes/*chemistry</keyword><keyword>Hydrophobicity</keyword><keyword>Imides/chemical synthesis/chemistry</keyword><keyword>Isotope Labeling/methods</keyword><keyword>Mesylates/chemistry</keyword><keyword>Micelles</keyword><keyword>Microscopy, Atomic Force</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Polyethylene Glycols/*chemistry</keyword><keyword>Radiopharmaceuticals/*chemical synthesis/chemistry</keyword><keyword>Ruthenium/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>May 28</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18452296</accession-num><abstract>Nanoparticles containing fluorine-18 were prepared from block copolymers made by ring opening metathesis polymerization (ROMP). Using the fast initiating ruthenium metathesis catalyst (H2IMes)(pyr)2(Cl)2Ru=CHPh, low polydispersity amphiphilic block copolymers were prepared from a cinnamoyl-containing hydrophobic norbornene monomer and a mesyl-terminated PEG-containing hydrophilic norbornene monomer. Self-assembly into micelles and subsequent cross-linking of the micelle cores by light-activated dimerization of the cinnamoyl groups yielded stable nanoparticles. Incorporation of fluorine-18 was achieved by nucleophilic displacement of the mesylates by the radioactive fluoride ion with 31% incorporation of radioactivity. The resulting positron-emitting nanoparticles are to be used as in vivo molecular imaging agents for use in tumor imaging.</abstract><notes>Matson, John B&#xD;Grubbs, Robert H&#xD;5U54 CA119347/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 May 28;130(21):6731-3. Epub 2008 May 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18452296</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja802010d</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1795</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1795</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zuo, T.</author><author>Olmstead, M. M.</author><author>Beavers, C. M.</author><author>Balch, A. L.</author><author>Wang, G.</author><author>Yee, G. T.</author><author>Shu, C.</author><author>Xu, L.</author><author>Elliott, B.</author><author>Echegoyen, L.</author><author>Duchamp, J. C.</author><author>Dorn, H. C.</author></authors></contributors><auth-address>Chemistry Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA.</auth-address><titles><title>Preparation and structural characterization of the Ih and the D5h isomers of the endohedral fullerenes Tm3N@C80: icosahedral C80 cage encapsulation of a trimetallic nitride magnetic cluster with three uncoupled Tm3+ ions</title><secondary-title>Inorg Chem</secondary-title></titles><periodical><full-title>Inorg Chem</full-title></periodical><pages>5234-44</pages><volume>47</volume><number>12</number><edition>2008/05/02</edition><dates><year>2008</year><pub-dates><date>Jun 16</date></pub-dates></dates><isbn>0020-1669 (Print)</isbn><accession-num>18447327</accession-num><abstract>We report an efficient method for the preparation and purification of the Ih and the D5h isomers of Tm3N@C80. Following preparation in a Kratschmer-Huffman electric-arc generator, the Tm3N@C80 isomers were obtained by a chemical separation process followed by a one-stage isomer selective chromatographic high-performance liquid chromatography (HPLC) separation (pyrenyl, 5PYE column). The HPLC chromatographic retention behavior on a pentabromobenzyl (5PBB) column suggests a charge transfer of approximately 6 electrons; [M3N] 6+@C80(6-) and the chromatographic retention mechanisms of the Ih and the D5h isomers of Tm3N@C80 on both 5PBB and 5PYE columns are discussed. Single-crystal X-ray diffraction data demonstrate that the Tm3N cluster has a planar structure but represents a tight fit for trapping the Tm3N cluster inside the I h - and the D 5h -C 80 cages. Specifically, the Tm atoms punch out the cage carbon atoms adjacent to them. The &quot;punched out&quot; effect can be demonstrated by cage radii and pyramidal angles at cage carbon atoms near the Tm atoms. The magnetic susceptibility (chiT) for Tm3N@ Ih -C80 was found to exhibit Curie-Weiss behavior with C = 23.4 emu.K/mol, which is consistent with the calculated value for three uncoupled Tm3+ ions by considering the spin and orbital contributions with no quenching of the orbital angular momentum ( L = 5, S = 1, and J = 6; Ccalcd = 23.3 emu.K/mol). The electrochemical measurements demonstrate that both the Ih and the D5h isomers of Tm3N@C80 have a large electrochemical gap.</abstract><notes>Zuo, Tianming&#xD;Olmstead, Marilyn M&#xD;Beavers, Christine M&#xD;Balch, Alan L&#xD;Wang, Guangbin&#xD;Yee, Gordon T&#xD;Shu, Chunying&#xD;Xu, Liaosa&#xD;Elliott, Bevan&#xD;Echegoyen, Luis&#xD;Duchamp, James C&#xD;Dorn, Harry C&#xD;1R01-CA119371-01/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Inorganic chemistry&#xD;Inorg Chem. 2008 Jun 16;47(12):5234-44. Epub 2008 Apr 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18447327</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>4.215</custom4><electronic-resource-num>10.1021/ic800227x</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2515</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2515</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, Xiaoyang</author><author>Zhao, Zhen</author><author>Qin, Lidong</author><author>Wei, Wei</author><author>Levine, Jon E.</author><author>Mirkin, Chad A.</author></authors></contributors><titles><title>Fluorescence Recovery Assay for the Detection of ProteinDNA Binding</title><secondary-title>Analytical Chemistry</secondary-title></titles><periodical><full-title>Analytical Chemistry</full-title></periodical><pages>5616-5621</pages><volume>80</volume><number>14</number><edition>2008/05</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>0003-2700</isbn><notes>doi: 10.1021/ac8007016</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ac8007016</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>5.918</custom4><electronic-resource-num>10.1021/ac8007016</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1641</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1641</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, X.</author><author>Zaric, S.</author><author>Daranciang, D.</author><author>Welsher, K.</author><author>Lu, Y.</author><author>Li, X.</author><author>Dai, H.</author></authors></contributors><auth-address>Dai, H&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA&#xD;Stanford Univ, Adv Mat Lab, Stanford, CA 94305 USA&#xD;Beijing Univ Chem Technol, Dept Chem, Beijing 100029, Peoples R China</auth-address><titles><title>Optical properties of ultrashort semiconducting single-walled carbon nanotube capsules down to sub-10 nm</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>6551-6555</pages><volume>130</volume><number>20</number><edition>2008/05</edition><keywords><keyword>electronic-structure</keyword><keyword>length</keyword><keyword>separation</keyword><keyword>enrichment</keyword><keyword>diameter</keyword></keywords><dates><year>2008</year><pub-dates><date>May 21</date></pub-dates></dates><isbn>0002-7863</isbn><accession-num>ISI:000255854100049</accession-num><abstract>Single-walled carbon nanotubes (SWNTs) are typically long (greater than or similar to 100 nm) and have been well established as novel quasi one-dimensional systems with interesting electrical, mechanical, and optical properties. Here, quasi zero-dimensional SWNTs with finite lengths down to the molecular scale (7.5 nm in average) were obtained by length separation using a density gradient ultracentrifugation method. Different sedimentation rates of nanotubes with different lengths in a density gradient were taken advantage of to sort SWNTs according to length. Optical experiments on the SWNT fractions revealed that the UV-vis-NIR absorption and photoluminescence peaks of the ultrashort SWNTs blue-shift up to similar to 30 meV compared to long nanotubes, owing to quantum confinement effects along the length of ultrashort SWNTs. These nanotube capsules essentially correspond to SWNT quantum dots.</abstract><notes>300VU&#xD;Times Cited:5&#xD;Cited References Count:31</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000255854100049</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom4>8.256</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2499</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2499</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Siegel, D. P.</author><author>Tenchov, B. G.</author></authors></contributors><titles><title>Influence of the Lamellar Phase Unbinding Energy on the Relative Stability of Lamellar and Inverted Cubic Phases</title></titles><pages>3987-3995</pages><volume>94</volume><number>10</number><edition>2008/05</edition><dates><year>2008</year></dates><isbn>0006-3495</isbn><urls><related-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0006349508703990</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>na</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1490</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1490</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, J. H.</author><author>von Maltzahn, G.</author><author>Zhang, L.</author><author>Schwartz, M. P.</author><author>Ruoslahti, E.</author><author>Bhatia, S. N.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Materials Science and Engineering Program Department of Chemistry and Biochemistry University of California, San Diego 9500 Gilman, La Jolla, CA 92093 (USA); Harvard-MIT Division of Health Sciences and Technology Massachusetts Institute of Technology 77 Massachusetts Avenue, Cambridge, MA 02139 (USA); Burnham Institute for Medical Research at UCSB University of California, Santa Barbara 1105 Life Sciences Technology Bldg., Santa Barbara, CA 93106 (USA)</auth-address><titles><title>Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging (Adv. Mater. 9/2008)</title><secondary-title>Advanced Materials</secondary-title></titles><periodical><full-title>Advanced Materials</full-title></periodical><pages>1589</pages><volume>20</volume><number>9</number><edition>2008/05</edition><keywords><keyword>Bionanotechnology</keyword><keyword>Iron oxide</keyword><keyword>Nanoparticles</keyword><keyword>Cells</keyword><keyword>Drug delivery</keyword></keywords><dates><year>2008</year><pub-dates><date>May 5, 2008</date></pub-dates></dates><isbn>1521-4095</isbn><abstract>No Abstract.</abstract><notes>10.1002/adma.200890033</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200890033</url></related-urls></urls><custom1>CNPP - U.C.S.F.</custom1><custom3>2008</custom3><custom4>10.231</custom4><electronic-resource-num>10.1002/adma.200890033</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1228</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1228</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Guo, W.</author><author>Lasky, J. L.</author><author>Chang, C. J.</author><author>Mosessian, S.</author><author>Lewis, X.</author><author>Xiao, Y.</author><author>Yeh, J. E.</author><author>Chen, J. Y.</author><author>Iruela-Arispe, M. L.</author><author>Varella-Garcia, M.</author><author>Wu, H.</author></authors></contributors><auth-address>Wu, H&#xD;Univ Calif Los Angeles, Dept Mol &amp; Med Pharmacol, Los Angeles, CA 90095 USA&#xD;Univ Calif Los Angeles, Dept Mol &amp; Med Pharmacol, Los Angeles, CA 90095 USA&#xD;Univ Calif Los Angeles, Dept Pediat Hematol Oncol, Los Angeles, CA 90095 USA&#xD;Univ Calif Los Angeles, Dept Mol Cellular &amp; Dev Biol, Los Angeles, CA 90095 USA&#xD;Univ Calif Los Angeles, Eli &amp; Edythe Broad Ctr Regenerat Med &amp; Stem Cell, Los Angeles, CA 90095 USA&#xD;Univ Colorado, Hlth Sci Ctr, Dept Med, Div Med Oncol,Univ Colorado Canc Ctr, Denver, CO 80262 USA&#xD;MIT, Dept Chem Engn, Cambridge, MA 02139 USA</auth-address><titles><title>Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title></periodical><pages>529-U7</pages><volume>453</volume><number>7194</number><edition>2008/05</edition><keywords><keyword>acute lymphoblastic-leukemia</keyword><keyword>c-myc</keyword><keyword>notch1</keyword><keyword>cancer</keyword><keyword>mouse</keyword><keyword>leukemia/lymphoma</keyword><keyword>translocations</keyword><keyword>inactivation</keyword><keyword>expression</keyword><keyword>deletion</keyword></keywords><dates><year>2008</year><pub-dates><date>May 22</date></pub-dates></dates><isbn>0028-0836</isbn><accession-num>ISI:000256023700044</accession-num><abstract>Cancer stem cells, which share many common properties and regulatory machineries with normal stem cells, have recently been proposed to be responsible for tumorigenesis and to contribute to cancer resistance(1). The main challenges in cancer biology are to identify cancer stem cells and to define the molecular events required for transforming normal cells to cancer stem cells. Here we show that Pten deletion in mouse haematopoietic stem cells leads to a myeloproliferative disorder, followed by acute T-lymphoblastic leukaemia (T-ALL). Self- renewable leukaemia stem cells (LSCs) are enriched in the c-Kit(mid)CD3(+)Lin(-) compartment, where unphosphorylated beta-catenin is significantly increased. Conditional ablation of one allele of the beta-catenin gene substantially decreases the incidence and delays the occurrence of T-ALL caused by Pten loss, indicating that activation of the beta-catenin pathway may contribute to the formation or expansion of the LSC population. Moreover, a recurring chromosomal translocation, T(14;15), results in aberrant overexpression of the c-myc oncogene in c-Kit mid CD3(+)Lin(-) LSCs and CD3(+) leukaemic blasts, recapitulating a subset of human T-ALL. No alterations in Notch1 signalling are detected in this model, suggesting that Pten inactivation and c-myc overexpression may substitute functionally for Notch1 abnormalities(2,3), leading to T-ALL development. Our study indicates that multiple genetic or molecular alterations contribute cooperatively to LSC transformation.</abstract><notes>303EL&#xD;Times Cited:3&#xD;Cited References Count:27</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000256023700044</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom4>31.210</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1128</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1128</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chang, C. J.</author><author>Mulholland, D. J.</author><author>Valamehr, B.</author><author>Mosessian, S.</author><author>Sellers, W. R.</author><author>Wu, H.</author></authors></contributors><auth-address>Wu, H&#xD;Univ Calif Los Angeles, Sch Med, Dept Mol &amp; Med Pharmacol, Los Angeles, CA 90095 USA&#xD;Univ Calif Los Angeles, Sch Med, Dept Mol &amp; Med Pharmacol, Los Angeles, CA 90095 USA&#xD;Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA</auth-address><titles><title>PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression</title><secondary-title>Molecular and Cellular Biology</secondary-title></titles><periodical><full-title>Molecular and Cellular Biology</full-title></periodical><pages>3281-3289</pages><volume>28</volume><number>10</number><edition>2008/05</edition><keywords><keyword>lipid phosphatase-activity</keyword><keyword>cyclin d1</keyword><keyword>protein</keyword><keyword>p53</keyword><keyword>phosphorylation</keyword><keyword>cells</keyword><keyword>expression</keyword><keyword>pathway</keyword><keyword>cancer</keyword><keyword>gene</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>0270-7306</isbn><accession-num>ISI:000255600800017</accession-num><abstract>The tumor suppressor gene PTEN (phosphatase and tensin homologue deleted on chromosome 10) is frequently mutated or deleted in various human cancers. PTEN localizes predominantly to the cytoplasm and functions as a lipid phosphatase, thereby negatively regulating the phosphatidylinositol 3-kinase-AKT signaling pathway. PTEN can also localize to the nucleus, where it binds and regulates p53 protein level and transcription activity. However, the precise function of nuclear PTEN and the factors that control PTEN nuclear localization are still largely unknown. In this study, we identified oxidative stress as one of the physiological stimuli that regulate the accumulation of nuclear PTEN. Specifically, oxidative stress inhibits PTEN nuclear export, a process depending on phosphorylation of its amino acid residue Ser-380. Nuclear PTEN, independent of its phosphatase activity, leads to p53-mediated G(1) growth arrest, cell death, and reduction of reactive oxygen species production. Using xenografts propagated from human prostate cancer cell lines, we reveal that nuclear PTEN is sufficient to reduce tumor progression in vivo in a p53-dependent manner. The data outlined in this study suggest a unique role of nuclear PTEN to arrest and protect cells upon oxidative damage and to regulate tumorigenesis. Since tumor cells are constantly exposed to oxidative stress, our study elucidates the cooperative roles of nuclear PTEN with p53 in tumor suppression.</abstract><notes>297EV&#xD;Times Cited:3&#xD;Cited References Count:40</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000255600800017</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom4>6.426</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1071</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1071</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Banholzer, M. J.</author><author>Millstone, J. E.</author><author>Qin, L.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Rationally designed nanostructures for surface-enhanced Raman spectroscopy</title><secondary-title>Chem Soc Rev</secondary-title></titles><periodical><full-title>Chem Soc Rev</full-title></periodical><pages>885-97</pages><volume>37</volume><number>5</number><edition>2008/04/30</edition><keywords><keyword>Anisotropy</keyword><keyword>Nanostructures/*analysis/*chemistry</keyword><keyword>Nanotechnology/*trends</keyword><keyword>Particle Size</keyword><keyword>Spectrum Analysis, Raman/*methods</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>0306-0012 (Print)</isbn><accession-num>18443674</accession-num><abstract>Research on surface-enhanced Raman spectroscopy (SERS) is an area of intense interest because the technique allows one to probe small collections of, and in certain cases, individual molecules using relatively straightforward spectroscopic techniques and nanostructured substrates. Researchers in this area have attempted to develop many new technological innovations including high sensitivity chemical and biological detection systems, labeling schemes for authentication and tracking purposes, and dual scanning-probe/spectroscopic techniques that simultaneously provide topographical and spectroscopic information about an underlying surface or nanostructure. However, progress has been hampered by the inability of researchers to fabricate substrates with the high sensitivity, tunability, robustness, and reproducibility necessary for truly practical and successful SERS-based systems. These limitations have been due in part to a relative lack of control over the nanoscale features of Raman substrates that are responsible for the enhancement. With the advent of nanotechnology, new approaches are being developed to overcome these issues and produce substrates with higher sensitivity, stability, and reproducibility. This tutorial review focuses on recent progress in the design and fabrication of substrates for surface-enhanced Raman spectroscopy, with an emphasis on the influence of nanotechnology.</abstract><notes>Banholzer, Matthew J&#xD;Millstone, Jill E&#xD;Qin, Lidong&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;England&#xD;Chemical Society reviews&#xD;Chem Soc Rev. 2008 May;37(5):885-97. Epub 2008 Mar 26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18443674</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>17.730</custom4><electronic-resource-num>10.1039/b710915f</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2323</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2323</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Singhal, S.</author><author>Miller, D.</author><author>Ramalingam, S.</author><author>Sun, S. Y.</author></authors></contributors><auth-address>General Thoracic Surgery, Emory University School of Medicine, 1365 Clifton Road, NE, Building A, Suite 2100, CT Section, Room A-2212, Atlanta, GA 30322, United States. Sunil.Singhal@emoryhealthcare.org</auth-address><titles><title>Gene expression profiling of non-small cell lung cancer</title><secondary-title>Lung Cancer</secondary-title></titles><periodical><full-title>Lung Cancer</full-title></periodical><pages>313-24</pages><volume>60</volume><number>3</number><edition>2008/04/29</edition><keywords><keyword>Animals</keyword><keyword>Apoptosis/genetics</keyword><keyword>Carcinoma, Non-Small-Cell Lung/diagnosis/ genetics/pathology</keyword><keyword>Gene Expression Profiling</keyword><keyword>Gene Expression Regulation, Neoplastic/ genetics</keyword><keyword>Gene Therapy</keyword><keyword>Humans</keyword><keyword>Lung Neoplasms/diagnosis/ genetics/pathology</keyword><keyword>Neoplasm Staging</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Predictive Value of Tests</keyword><keyword>Prognosis</keyword><keyword>Signal Transduction/genetics</keyword><keyword>Tumor Markers, Biological/ genetics</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0169-5002 (Print)</isbn><accession-num>18440087</accession-num><abstract>Functional genomics has emerged over the past 10 years as a novel technology to study genetic alterations. Gene expression arrays are one genomic technique employed to discover changes in the DNA expression that occur in neoplastic transformation. Microarrays have been applied to investigating lung cancer. Specific applications include discovering novel genetic changes that occur in lung tumors. Microarrays can also be applied to improve diagnosis, staging and discover prognostic markers. The eventual goal of this technology is to discover new markers for therapy and to customize therapy based on an individual tumor genetic composition. In this review, we present the current state of gene expression array technology in its application to lung cancer.</abstract><notes>Singhal, Sunil&#xD;Miller, Daniel&#xD;Ramalingam, Suresh&#xD;Sun, Shi-Yong&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;Ireland&#xD;Lung cancer (Amsterdam, Netherlands)&#xD;Lung Cancer. 2008 Jun;60(3):313-24. Epub 2008 Apr 25.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom2>2517078</custom2><custom3>NIHMS56514</custom3><custom4>3.004</custom4><electronic-resource-num>S0169-5002(08)00119-0 [pii]&#xD;10.1016/j.lungcan.2008.03.007 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1137</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1137</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cheng, L.</author><author>Anglin, E.</author><author>Cunin, F.</author><author>Kim, D.</author><author>Sailor, M. J.</author><author>Falkenstein, I.</author><author>Tammewar, A.</author><author>Freeman, W. R.</author></authors></contributors><auth-address>Jacobs Retina Center at Shiley Eye Center, UCSD, 9415 Campus Point Drive, La Jolla, CA 92037-0946, USA. cheng@eyecenter.ucsd.edu</auth-address><titles><title>Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle</title><secondary-title>Br J Ophthalmol</secondary-title></titles><periodical><full-title>Br J Ophthalmol</full-title></periodical><pages>705-11</pages><volume>92</volume><number>5</number><edition>2008/04/29</edition><keywords><keyword>Animals</keyword><keyword>Biocompatible Materials</keyword><keyword>*Drug Carriers</keyword><keyword>Electroretinography</keyword><keyword>Fundus Oculi</keyword><keyword>Half-Life</keyword><keyword>Injections</keyword><keyword>Materials Testing</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>*Nanoparticles</keyword><keyword>Ophthalmoscopy</keyword><keyword>Oxidation-Reduction</keyword><keyword>Porosity</keyword><keyword>Rabbits</keyword><keyword>Silicon</keyword><keyword>*Vitreous Body</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1468-2079 (Electronic)</isbn><accession-num>18441177</accession-num><abstract>AIM: To determine the suitability of porous silicon photonic crystals for intraocular drug-delivery. METHODS: A rugate structure was electrochemically etched into a highly doped p-type silicon substrate to create a porous silicon film that was subsequently removed and ultrasonically fractured into particles. To stabilise the particles in aqueous media, the silicon particles were modified by surface alkylation (using thermal hydrosilylation) or by thermal oxidation. Unmodified particles, hydrosilylated particles and oxidised particles were injected into rabbit vitreous. The stability and toxicity of each type of particle were studied by indirect ophthalmoscopy, biomicroscopy, tonometry, electroretinography (ERG) and histology. RESULTS: No toxicity was observed with any type of the particles during a period of &gt;4 months. Surface alkylation led to dramatically increased intravitreal stability and slow degradation. The estimated vitreous half-life increased from 1 week (fresh particles) to 5 weeks (oxidised particles) and to 16 weeks (hydrosilylated particles). CONCLUSION: The porous silicon photonic crystals showed good biocompatibility and may be used as an intraocular drug-delivery system. The intravitreal injectable porous silicon photonic crystals may be engineered to host a variety of therapeutics and achieve controlled drug release over long periods of time to treat chronic vitreoretinal diseases.</abstract><notes>Cheng, L&#xD;Anglin, E&#xD;Cunin, F&#xD;Kim, D&#xD;Sailor, M J&#xD;Falkenstein, I&#xD;Tammewar, A&#xD;Freeman, W R&#xD;U54 CA 119335/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;The British journal of ophthalmology&#xD;Br J Ophthalmol. 2008 May;92(5):705-11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18441177</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>2.689</custom4><electronic-resource-num>92/5/705 [pii]&#xD;10.1136/bjo.2007.133587</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1759</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1759</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yao, C.</author><author>Qin, Z.</author><author>Works, K. N.</author><author>Austin, G. E.</author><author>Young, A. N.</author></authors></contributors><auth-address>Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, Decatur, GA 30033, USA.</auth-address><titles><title>C/EBP and C-Myb sites are important for the functional activity of the human myeloperoxidase upstream enhancer</title><secondary-title>Biochem Biophys Res Commun</secondary-title></titles><periodical><full-title>Biochem Biophys Res Commun</full-title></periodical><pages>309-14</pages><volume>371</volume><number>2</number><edition>2008/04/26</edition><keywords><keyword>Binding Sites</keyword><keyword>CCAAT-Enhancer-Binding Proteins/chemistry/genetics/*metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Deoxyribonuclease I/chemistry</keyword><keyword>*Enhancer Elements (Genetics)</keyword><keyword>*Gene Expression Regulation</keyword><keyword>Genes, Reporter</keyword><keyword>Humans</keyword><keyword>Peroxidase/*genetics</keyword><keyword>Protein Footprinting</keyword><keyword>Proto-Oncogene Proteins c-myb/chemistry/genetics/*metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun 27</date></pub-dates></dates><isbn>1090-2104 (Electronic)</isbn><accession-num>18435917</accession-num><abstract>Myeloperoxidase (MPO), an enzyme active against bacterial and fungal infections, is expressed specifically in myeloblasts and promyelocytes and minimal in other cell types. We recently identified and partially characterized an upstream enhancer located between -4100 and -3844 bp of the MPO gene. We showed that an AML1 site contributes to enhancer activity and specificity. We now demonstrate three additional footprints within the MPO enhancer and provide evidence that C/EBP and c-Myb sites contribute to its functional, tissue-specific activity. This distal enhancer appears to play an important role in the control of MPO transcription during differentiation of myeloid cells.</abstract><notes>Yao, Congjun&#xD;Qin, Zhenyu&#xD;Works, Kimberly N&#xD;Austin, Garth E&#xD;Young, Andrew N&#xD;United States&#xD;Biochemical and biophysical research communications&#xD;Biochem Biophys Res Commun. 2008 Jun 27;371(2):309-14. Epub 2008 Apr 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18435917</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>2.823</custom4><electronic-resource-num>S0006-291X(08)00744-4 [pii]&#xD;10.1016/j.bbrc.2008.04.065</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1557</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1557</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schulz, K. R.</author><author>Danna, E. A.</author><author>Krutzik, P. O.</author><author>Nolan, G. P.</author></authors></contributors><auth-address>Stanford University, Stanford, California, USA.</auth-address><titles><title>Single-cell phospho-protein analysis by flow cytometry</title><secondary-title>Curr Protoc Immunol</secondary-title></titles><periodical><full-title>Curr Protoc Immunol</full-title></periodical><pages>Unit 8 17</pages><volume>Chapter 8</volume><edition>2008/04/25</edition><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1934-368X (Electronic)</isbn><accession-num>18432997</accession-num><abstract>This protocol describes methods for monitoring intracellular phosphorylation-dependent signaling events on a single-cell basis. This approach measures cell signaling by treating cells with exogenous stimuli, fixing cells with formaldehyde, permeabilizing with methanol, and then staining with phospho-specific antibodies. Thus, cell signaling states can be determined as a measure of how cells interact with their environment. This method has applications in clinical research as well as mechanistic studies of basic biology. In clinical research, diagnostic or drug efficacy information can be retrieved by discovering how a disease affects the ability of cells to respond to growth factors. Basic scientists can use this technique to analyze signaling events in cell lines and human or murine primary cells, including rare populations, like B1 cells or stem cells. This technique has broad applications to take standard biochemical analysis into primary cells to garner valuable information about signaling events in physiologic settings.</abstract><notes>Schulz, Kenneth R&#xD;Danna, Erika A&#xD;Krutzik, Peter O&#xD;Nolan, Garry P&#xD;United States&#xD;Current protocols in immunology / edited by John E. Coligan ... [et al.]&#xD;Curr Protoc Immunol. 2007 Aug;Chapter 8:Unit 8.17.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18432997</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>na</custom4><electronic-resource-num>10.1002/0471142735.im0817s78</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1339</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1339</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koh, I.</author><author>Hong, R.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Building 149, 13th Street, Boston, MA 02129, USA.</auth-address><titles><title>Sensitive NMR sensors detect antibodies to influenza</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>4119-21</pages><volume>47</volume><number>22</number><edition>2008/04/23</edition><keywords><keyword>Antibodies, Viral/*analysis/chemistry</keyword><keyword>Antigen-Antibody Reactions</keyword><keyword>Hemagglutinin Glycoproteins, Influenza Virus/immunology</keyword><keyword>Humans</keyword><keyword>*Magnetics</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Nuclear Magnetic Resonance, Biomolecular/*methods</keyword><keyword>Oligopeptides/immunology</keyword><keyword>Orthomyxoviridae/*immunology</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2008</year></dates><isbn>1521-3773 (Electronic)</isbn><accession-num>18428168</accession-num><notes>Koh, Isaac&#xD;Hong, Rui&#xD;Weissleder, Ralph&#xD;Josephson, Lee&#xD;R01EB0004626/EB/United States NIBIB&#xD;U54A119349/United States PHS&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2008;47(22):4119-21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18428168</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200800069</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1263</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1263</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Howarth, M.</author><author>Liu, W.</author><author>Puthenveetil, S.</author><author>Zheng, Y.</author><author>Marshall, L. F.</author><author>Schmidt, M. M.</author><author>Wittrup, K. D.</author><author>Bawendi, M. G.</author><author>Ting, A. Y.</author></authors></contributors><auth-address>Department of Chemistry, 77 Massachusetts Avenue, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Monovalent, reduced-size quantum dots for imaging receptors on living cells</title><secondary-title>Nat Methods</secondary-title></titles><periodical><full-title>Nat Methods</full-title></periodical><pages>397-9</pages><volume>5</volume><number>5</number><edition>2008/04/22</edition><keywords><keyword>Animals</keyword><keyword>Carcinoembryonic Antigen</keyword><keyword>Cell Survival</keyword><keyword>Cells/*cytology/*metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Electrophoresis, Agar Gel</keyword><keyword>Fluorescent Dyes</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>Ligands</keyword><keyword>Nanotechnology/methods</keyword><keyword>Polyethylene Glycols</keyword><keyword>*Quantum Dots</keyword><keyword>Rats</keyword><keyword>Receptors, Cell Surface/*analysis</keyword><keyword>Receptors, Glutamate/metabolism</keyword><keyword>Staining and Labeling/methods</keyword><keyword>Streptavidin</keyword><keyword>Synapses/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1548-7105 (Electronic)</isbn><accession-num>18425138</accession-num><abstract>We describe a method to generate monovalent quantum dots (QDs) using agarose gel electrophoresis. We passivated QDs with a carboxy-terminated polyethylene-glycol ligand, yielding particles with half the diameter of commercial QDs, which we conjugated to a single copy of a high-affinity targeting moiety (monovalent streptavidin or antibody to carcinoembryonic antigen) to label cell-surface proteins. The small size improved access of QD-labeled glutamate receptors to neuronal synapses, and monovalency prevented EphA3 tyrosine kinase activation.</abstract><notes>Howarth, Mark&#xD;Liu, Wenhao&#xD;Puthenveetil, Sujiet&#xD;Zheng, Yi&#xD;Marshall, Lisa F&#xD;Schmidt, Michael M&#xD;Wittrup, K Dane&#xD;Bawendi, Moungi G&#xD;Ting, Alice Y&#xD;CA101830/CA/United States NCI&#xD;P20GM072029-01/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nature methods&#xD;Nat Methods. 2008 May;5(5):397-9. Epub 2008 Apr 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18425138</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>15.011</custom4><electronic-resource-num>nmeth.1206 [pii]&#xD;10.1038/nmeth.1206</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1318</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1318</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kelly, K. A.</author><author>Bardeesy, N.</author><author>Anbazhagan, R.</author><author>Gurumurthy, S.</author><author>Berger, J.</author><author>Alencar, H.</author><author>Depinho, R. A.</author><author>Mahmood, U.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America. kkelly9@partners.org</auth-address><titles><title>Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma</title><secondary-title>PLoS Med</secondary-title></titles><periodical><full-title>PLoS Med</full-title></periodical><pages>e85</pages><volume>5</volume><number>4</number><edition>2008/04/18</edition><keywords><keyword>Adenocarcinoma/*diagnosis</keyword><keyword>Animals</keyword><keyword>Carcinoma, Pancreatic Ductal/*diagnosis</keyword><keyword>Cell Line, Tumor</keyword><keyword>Disease Models, Animal</keyword><keyword>Humans</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>Microscopy, Confocal</keyword><keyword>Nanoparticles/*diagnostic use</keyword><keyword>Pancreatic Neoplasms/*diagnosis</keyword><keyword>Peptide Library</keyword><keyword>Peptides/*metabolism</keyword><keyword>Plectin/*metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>1549-1676 (Electronic)</isbn><accession-num>18416599</accession-num><abstract>BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) carries an extremely poor prognosis, typically presenting with metastasis at the time of diagnosis and exhibiting profound resistance to existing therapies. The development of molecular markers and imaging probes for incipient PDAC would enable earlier detection and guide the development of interventive therapies. Here we sought to identify novel molecular markers and to test their potential as targeted imaging agents. METHODS AND FINDINGS: Here, a phage display approach was used in a mouse model of PDAC to screen for peptides that specifically bind to cell surface antigens on PDAC cells. These screens yielded a motif that distinguishes PDAC cells from normal pancreatic duct cells in vitro, which, upon proteomics analysis, identified plectin-1 as a novel biomarker of PDAC. To assess their utility for in vivo imaging, the plectin-1 targeted peptides (PTP) were conjugated to magnetofluorescent nanoparticles. In conjunction with intravital confocal microscopy and MRI, these nanoparticles enabled detection of small PDAC and precursor lesions in engineered mouse models. CONCLUSIONS: Our approach exploited a well-defined model of PDAC, enabling rapid identification and validation of PTP. The developed specific imaging probe, along with the discovery of plectin-1 as a novel biomarker, may have clinical utility in the diagnosis and management of PDAC in humans.</abstract><notes>Kelly, Kimberly A&#xD;Bardeesy, Nabeel&#xD;Anbazhagan, Rajesh&#xD;Gurumurthy, Sushma&#xD;Berger, Justin&#xD;Alencar, Herlen&#xD;Depinho, Ronald A&#xD;Mahmood, Umar&#xD;Weissleder, Ralph&#xD;K01 CA10464703/CA/United States NCI&#xD;P01-CA11796901/CA/United States NCI&#xD;P50-CA86355/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;PLoS medicine&#xD;PLoS Med. 2008 Apr 15;5(4):e85.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18416599</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>13.180</custom4><electronic-resource-num>07-PLME-RA-1015 [pii]&#xD;10.1371/journal.pmed.0050085</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1169</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1169</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dennis, A. M.</author><author>Bao, G.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 313 Ferst Drive, Atlanta, Georgia 30332, USA.</auth-address><titles><title>Quantum dot-fluorescent protein pairs as novel fluorescence resonance energy transfer probes</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>1439-45</pages><volume>8</volume><number>5</number><edition>2008/04/17</edition><keywords><keyword>Crystallization/*methods</keyword><keyword>Fluorescence Resonance Energy Transfer/*methods</keyword><keyword>Histidine/*chemistry</keyword><keyword>Materials Testing</keyword><keyword>Molecular Conformation</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Particle Size</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18412403</accession-num><abstract>Fluorescence resonance energy transfer (FRET) characteristics, including the efficiency, donor-acceptor distance, and binding strength of six fluorescent protein (FP)-quantum dot (QD) pairs were quantified, demonstrating that FPs are efficient acceptors for QD donors with up to 90% quenching of QD fluorescence and that polyhistidine coordination to QD core-shell surface is a straightforward and effective means of conjugating proteins to commercially available QDs. This provides a novel approach to developing QD-based FRET probes for biomedical applications.</abstract><notes>Dennis, Allison M&#xD;Bao, Gang&#xD;CA119338/CA/United States NCI&#xD;HL-80711/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2008 May;8(5):1439-45. Epub 2008 Apr 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18412403</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl080358+</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1236</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1236</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hall, W. P.</author><author>Anker, J. N.</author><author>Lin, Y.</author><author>Modica, J.</author><author>Mrksich, M.</author><author>Van Duyne, R. P.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, USA.</auth-address><titles><title>A calcium-modulated plasmonic switch</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>5836-7</pages><volume>130</volume><number>18</number><edition>2008/04/12</edition><keywords><keyword>Calcium/*chemistry/metabolism</keyword><keyword>Calmodulin/*chemistry/metabolism</keyword><keyword>Carboxylic Ester Hydrolases/chemistry</keyword><keyword>Metal Nanoparticles/chemistry</keyword><keyword>Nanotechnology</keyword><keyword>Protein Conformation</keyword><keyword>Protein Structure, Tertiary</keyword><keyword>Silver/chemistry</keyword><keyword>Surface Plasmon Resonance/methods</keyword></keywords><dates><year>2008</year><pub-dates><date>May 7</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18402443</accession-num><notes>Hall, W Paige&#xD;Anker, Jeffrey N&#xD;Lin, Yao&#xD;Modica, Justin&#xD;Mrksich, Milan&#xD;Van Duyne, Richard P&#xD;1 U54 CA119341-01/CA/United States NCI&#xD;5 F32 GM077020/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 May 7;130(18):5836-7. Epub 2008 Apr 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18402443</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja7109037</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1081</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1081</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bashir, A.</author><author>Volik, S.</author><author>Collins, C.</author><author>Bafna, V.</author><author>Raphael, B. J.</author></authors></contributors><auth-address>Bioinformatics Graduate Program, University of California San Diego, San Diego, California, United States of America. abashir@ucsd.edu</auth-address><titles><title>Evaluation of paired-end sequencing strategies for detection of genome rearrangements in cancer</title><secondary-title>PLoS Comput Biol</secondary-title></titles><periodical><full-title>PLoS Comput Biol</full-title></periodical><pages>e1000051</pages><volume>4</volume><number>4</number><edition>2008/04/12</edition><keywords><keyword>*Algorithms</keyword><keyword>Base Sequence</keyword><keyword>Breast Neoplasms/*genetics</keyword><keyword>Chromosome Mapping/*methods</keyword><keyword>Female</keyword><keyword>Gene Rearrangement/*genetics</keyword><keyword>Humans</keyword><keyword>Molecular Sequence Data</keyword><keyword>Sequence Analysis, DNA/*methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1553-7358 (Electronic)</isbn><accession-num>18404202</accession-num><abstract>Paired-end sequencing is emerging as a key technique for assessing genome rearrangements and structural variation on a genome-wide scale. This technique is particularly useful for detecting copy-neutral rearrangements, such as inversions and translocations, which are common in cancer and can produce novel fusion genes. We address the question of how much sequencing is required to detect rearrangement breakpoints and to localize them precisely using both theoretical models and simulation. We derive a formula for the probability that a fusion gene exists in a cancer genome given a collection of paired-end sequences from this genome. We use this formula to compute fusion gene probabilities in several breast cancer samples, and we find that we are able to accurately predict fusion genes in these samples with a relatively small number of fragments of large size. We further demonstrate how the ability to detect fusion genes depends on the distribution of gene lengths, and we evaluate how different parameters of a sequencing strategy impact breakpoint detection, breakpoint localization, and fusion gene detection, even in the presence of errors that suggest false rearrangements. These results will be useful in calibrating future cancer sequencing efforts, particularly large-scale studies of many cancer genomes that are enabled by next-generation sequencing technologies.</abstract><notes>Bashir, Ali&#xD;Volik, Stanislav&#xD;Collins, Colin&#xD;Bafna, Vineet&#xD;Raphael, Benjamin J&#xD;5 U54 CA119335-02/CA/United States NCI&#xD;CA58207/CA/United States NCI&#xD;R33 CA103068/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;PLoS computational biology&#xD;PLoS Comput Biol. 2008 Apr 25;4(4):e1000051.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18404202</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>6.144</custom4><electronic-resource-num>10.1371/journal.pcbi.1000051</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1583</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1583</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, X.</author><author>Wang, S. H.</author><author>Swanson, S. D.</author><author>Ge, S.</author><author>Cao, Z.</author><author>Van Antwerp, M. E.</author><author>Landmark, K. J.</author><author>Baker, Jr., J. R.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109 (USA); Department of Radiology, University of Michigan, Ann Arbor, MI 48109 (USA); Department of Physics, University of Michigan, Ann Arbor, MI 48109 (USA)</auth-address><titles><title>Dendrimer-Functionalized Shell-crosslinked Iron Oxide Nanoparticles for In-Vivo Magnetic Resonance Imaging of Tumors</title><secondary-title>Advanced Materials</secondary-title></titles><periodical><full-title>Advanced Materials</full-title></periodical><pages>1671-1678</pages><volume>20</volume><number>9</number><edition>2008/04/11</edition><keywords><keyword>dendrimers</keyword><keyword>functionalization</keyword><keyword>iron oxide</keyword><keyword>magnetic resonance imaging</keyword><keyword>metal nanoparticles</keyword></keywords><dates><year>2008</year></dates><isbn>1521-4095</isbn><abstract>No Abstract.</abstract><notes>10.1002/adma.200702770</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200702770</url></related-urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom3>2008</custom3><custom4>10.231</custom4><electronic-resource-num>10.1002/adma.200702770</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1622</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1622</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Squires, T. M.</author><author>Messinger, R. J.</author><author>Manalis, S. R.</author></authors></contributors><auth-address>Department of Chemical Engineering, University of California, Santa Barbara, California 93106, USA. squires@engineering.ucsb.edu</auth-address><titles><title>Making it stick: convection, reaction and diffusion in surface-based biosensors</title><secondary-title>Nat Biotechnol</secondary-title></titles><periodical><full-title>Nat Biotechnol</full-title></periodical><pages>417-26</pages><volume>26</volume><number>4</number><edition>2008/04/09</edition><keywords><keyword>Adhesiveness</keyword><keyword>Biosensing Techniques/*instrumentation/*methods</keyword><keyword>Computer Simulation</keyword><keyword>Diffusion</keyword><keyword>*Equipment Failure Analysis</keyword><keyword>Microfluidics/*methods</keyword><keyword>*Models, Chemical</keyword><keyword>*Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1546-1696 (Electronic)</isbn><accession-num>18392027</accession-num><abstract>The past decade has seen researchers develop and apply novel technologies for biomolecular detection, at times approaching hard limits imposed by physics and chemistry. In nearly all sensors, the transport of target molecules to the sensor can play as critical a role as the chemical reaction itself in governing binding kinetics, and ultimately performance. Yet rarely does an analysis of the interplay between diffusion, convection and reaction motivate experimental design or interpretation. Here we develop a physically intuitive and practical understanding of analyte transport for researchers who develop and employ biosensors based on surface capture. We explore the qualitatively distinct behaviors that result, develop rules of thumb to quickly determine how a given system will behave, and derive order-of-magnitude estimates for fundamental quantities of interest, such as fluxes, collection rates and equilibration times. We pay particular attention to collection limits for micro- and nanoscale sensors, and highlight unexplained discrepancies between reported values and theoretical limits.</abstract><notes>Squires, Todd M&#xD;Messinger, Robert J&#xD;Manalis, Scott R&#xD;P50-GM68762/GM/United States NIGMS&#xD;R01-CA119402/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nature biotechnology&#xD;Nat Biotechnol. 2008 Apr;26(4):417-26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18392027</url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2008</custom3><custom4>25.329</custom4><electronic-resource-num>nbt1388 [pii]&#xD;10.1038/nbt1388</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1505</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1505</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Perelman, L. A.</author><author>Pacholski, C.</author><author>Li, Y. Y.</author><author>Vannieuwenhz, M. S.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Nitto Denko Technical Corp, Carlsbad, CA, USA. loren.perelman@gmail.com</auth-address><titles><title>pH-triggered release of vancomycin from protein-capped porous silicon films</title><secondary-title>Nanomed</secondary-title></titles><periodical><full-title>Nanomed</full-title></periodical><pages>31-43</pages><volume>3</volume><number>1</number><edition>2008/04/09</edition><keywords><keyword>Absorption</keyword><keyword>Coated Materials, Biocompatible/*chemistry</keyword><keyword>Diffusion</keyword><keyword>Drug Carriers/*chemistry</keyword><keyword>*Hydrogen-Ion Concentration</keyword><keyword>Materials Testing</keyword><keyword>*Membranes, Artificial</keyword><keyword>Protein Binding</keyword><keyword>Serum Albumin, Bovine/*chemistry</keyword><keyword>Silicon/*chemistry</keyword><keyword>Vancomycin/administration &amp; dosage/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>18393665</accession-num><abstract>OBJECTIVE: An in vitro model system for pH-triggered release of the antibiotic vancomycin from porous Si films is studied. METHOD: Vancomycin is infused into a mesoporous Si film from a mixed aqueous/acetonitrile solution and trapped by a capping layer containing the protein bovine serum albumin (BSA). The protein effectively traps vancomycin in the porous nanostructure at pH 4.0; the protein dissolves and vancomycin is released into solution when the pH increases to 7.4. The surface chemistry of porous Si exerts a substantial effect on the efficacy of drug loading. The amount of drug loading is larger in freshly-etched (hydrophobic, hydrogen-terminated) porous Si and smaller in methyl-modified, undecylenic acid-modified and thermally oxidized samples. The quantity of drug loaded in a freshly etched porous Si chip is proportional to the thickness of the porous layer, which exhibits a constant volume loading efficiency of 31% (v/v). Flow-cell experiments designed to mimic the transition from pH 4 to 7 that occurs when material moves from the stomach to the upper intestinal tract were performed on the freshly etched films and vancomycin- and BSA-release rates were quantified from the effluent of the flow cell by high-pressure liquid chromatography analysis. RESULTS &amp; CONCLUSION: There is a small, constant rate of vancomycin release at pH 4 that is independent of the amount of drug loaded in the pores. This is attributed to diffusion of vancomycin from the BSA-capping layer. The release rate increases five- to tenfold when the pH of the solution in the flow cell increases to 7.4; 100% of the drug is released within 3 h of this increase.</abstract><notes>Perelman, Loren A&#xD;Pacholski, Claudia&#xD;Li, Yang Yang&#xD;Vannieuwenhz, Michael S&#xD;Sailor, Michael J&#xD;U54 CA 119335/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2008 Feb;3(1):31-43.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18393665</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>6.093</custom4><electronic-resource-num>10.2217/17435889.3.1.31</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1353</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1353</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Krishnan, R.</author><author>Sullivan, B. D.</author><author>Mifflin, R. L.</author><author>Esener, S. C.</author><author>Heller, M. J.</author></authors></contributors><auth-address>University of California, San Diego, Department of Bioengineering, La Jolla, CA 92093-0412, USA.</auth-address><titles><title>Alternating current electrokinetic separation and detection of DNA nanoparticles in high-conductance solutions</title><secondary-title>Electrophoresis</secondary-title></titles><periodical><full-title>Electrophoresis</full-title></periodical><pages>1765-74</pages><volume>29</volume><number>9</number><edition>2008/04/09</edition><keywords><keyword>Buffers</keyword><keyword>DNA, Single-Stranded/*analysis/chemistry</keyword><keyword>Electric Conductivity</keyword><keyword>Electrophoresis, Microchip/instrumentation/*methods</keyword><keyword>Fluorescent Dyes</keyword><keyword>Microelectrodes</keyword><keyword>Nanoparticles</keyword><keyword>Oligonucleotide Array Sequence Analysis/instrumentation/*methods</keyword><keyword>Oligonucleotides/chemistry</keyword><keyword>Polystyrenes/chemistry</keyword><keyword>Solutions</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>0173-0835 (Print)</isbn><accession-num>18393345</accession-num><abstract>In biomedical research and diagnostics, it is a significant challenge to directly isolate and identify rare cells and potential biomarkers in blood, plasma and other clinical samples. Additionally, the advent of bionanotechnology is leading to numerous drug delivery approaches that involve encapsulation of drugs and imaging agents within nanoparticles, which now will also have to be identified and separated from blood and plasma. Alternating current (AC) electrokinetic techniques such as dielectrophoresis (DEP) offer a particularly attractive mechanism for the separation of cells and nanoparticles. Unfortunately, present DEP techniques require the dilution of blood/plasma, thus making the technology less suitable for clinical sample preparation. Using array devices with microelectrodes over-coated with porous hydrogel layers, AC electric field conditions have been found which allow the separation of DNA nanoparticles to be achieved under high-conductance (ionic strength) conditions. At AC frequencies in the 3000 Hz to 10,000 Hz range and 10 volts peak-to-peak, the separation of 10-microm polystyrene particles into low field regions, and 60-nm DNA-derivatized nanoparticles and 200-nm nanoparticles into high-field regions was carried out in 149 mM 1xPBS buffer (1.68 S/m). These results may allow AC electrokinetic systems to be developed that can be used with clinically relevant samples under physiological conditions.</abstract><notes>Krishnan, Rajaram&#xD;Sullivan, Benjamin D&#xD;Mifflin, Robert L&#xD;Esener, Sadik C&#xD;Heller, Michael J&#xD;U54-CA119335/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Electrophoresis&#xD;Electrophoresis. 2008 May;29(9):1765-74.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18393345</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>3.576</custom4><electronic-resource-num>10.1002/elps.200800037</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1597</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1597</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shuford, K. L.</author><author>Lee, J.</author><author>Odom, T. W.</author><author>Schatz, G. C.</author></authors></contributors><auth-address>Chemical Sciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831-6142, Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, and Department of Materials Science and Engineering, Northwestern University, Evanston, Illinois 60208-3113</auth-address><titles><title>Optical Properties of Gold Pyramidal Shells</title><secondary-title>J. Phys. Chem. C</secondary-title></titles><periodical><full-title>J. Phys. Chem. C</full-title></periodical><pages>6662-6666</pages><volume>112</volume><number>17</number><edition>2008/04/08</edition><dates><year>2008</year></dates><isbn>1932-7447</isbn><abstract>Abstract: We present an investigation of the optical properties of gold pyramidal shell nanoparticles. Theory shows a multiresonance spectrum at near-infrared wavelengths that is consistent with the measured extinction spectra of particles that are fabricated using a soft-lithography technique. In addition to electric dipole and electric quadrupole resonances, the calculations identify an unusual plasmon mode, which involves oscillation of the polarization perpendicular to the direction of both the incident polarization and wave vector. We show that this TE-like resonance can be suppressed by truncating the tip of the pyramid or by increasing the shell thickness without adversely affecting the in-plane dipole and quadrupole resonances.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/jp8004844</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>3.398</custom4><electronic-resource-num>10.1021/jp8004844 </electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1606</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1606</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, B. R.</author><author>Cheng, Z.</author><author>De, A.</author><author>Koh, A. L.</author><author>Sinclair, R.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, and Department of Materials Science and Engineering, Stanford University, Stanford, California 94305, and Department of Bioengineering, Stanford University School of Medicine, Stanford, California 94305 sgambhir@stanford.edu.</auth-address><titles><title>Real-Time Intravital Imaging of RGD-Quantum Dot Binding to Luminal Endothelium in Mouse Tumor Neovasculature</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><edition>2008/04/05</edition><dates><year>2008</year><pub-dates><date>Apr 4</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18386933</accession-num><abstract>Nanoscale materials have increasingly become subject to intense investigation for use in cancer diagnosis and therapy. However, there is a fundamental dearth in cellular-level understanding of how nanoparticles interact within the tumor environment in living subjects. Adopting quantum dots (qdots) for their excellent brightness, photostability, monodispersity, and fluorescent yield, we link arginine-glycine-aspartic acid (RGD) peptides to target qdots specifically to newly formed/forming blood vessels expressing alpha vbeta 3 integrins. Using this model nanoparticle system, we exploit intravital microscopy with subcellular ( approximately 0.5 microm) resolution to directly observe and record, for the first time, the binding of nanoparticle conjugates to tumor blood vessels in living subjects. This generalizable method enabled us to show that in this model qdots do not extravasate and, unexpectedly, that they only bind as aggregates rather than individually. This level of understanding is critical on the path toward ensuring regulatory approval of nanoparticles in humans for disease diagnostics and therapeutics. Equally vital, the work provides a platform by which to design and optimize molecularly targeted nanoparticles including quantum dots for applications in living subjects.</abstract><notes>Journal article&#xD;Nano letters&#xD;Nano Lett. 2008 Apr 4;.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18386933</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl080141f</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1719</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1719</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Weissleder, R.</author><author>Pittet, M. J.</author></authors></contributors><auth-address>Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5206, Boston, Massachusetts 02114, USA.</auth-address><titles><title>Imaging in the era of molecular oncology</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title></periodical><pages>580-9</pages><volume>452</volume><number>7187</number><edition>2008/04/04</edition><keywords><keyword>Diagnostic Imaging/methods/*trends</keyword><keyword>Fluorescence</keyword><keyword>Genes, Reporter</keyword><keyword>Humans</keyword><keyword>Microscopy</keyword><keyword>Molecular Diagnostic Techniques/methods/*trends</keyword><keyword>Neoplasms/*diagnosis/genetics/*metabolism/pathology</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 3</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>18385732</accession-num><abstract>New technologies for imaging molecules, particularly optical technologies, are increasingly being used to understand the complexity, diversity and in vivo behaviour of cancers. &apos;Omic&apos; approaches are providing comprehensive &apos;snapshots&apos; of biological indicators, or biomarkers, of cancer, but imaging can take this information a step further, showing the activity of these markers in vivo and how their location changes over time. Advances in experimental and clinical imaging are likely to improve how cancer is understood at a systems level and, ultimately, should enable doctors not only to locate tumours but also to assess the activity of the biological processes within these tumours and to provide &apos;on the spot&apos; treatment.</abstract><notes>Weissleder, Ralph&#xD;Pittet, Mikael J&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;England&#xD;Nature&#xD;Nature. 2008 Apr 3;452(7187):580-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18385732</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>31.210</custom4><electronic-resource-num>nature06917 [pii]&#xD;10.1038/nature06917</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1240</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1240</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hanash, S. M.</author><author>Pitteri, S. J.</author><author>Faca, V. M.</author></authors></contributors><auth-address>Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, Washington 98109, USA.</auth-address><titles><title>Mining the plasma proteome for cancer biomarkers</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title></periodical><pages>571-9</pages><volume>452</volume><number>7187</number><edition>2008/04/04</edition><keywords><keyword>Body Fluids/metabolism</keyword><keyword>Humans</keyword><keyword>Neoplasms/*blood/diagnosis/pathology</keyword><keyword>Plasma/*metabolism</keyword><keyword>Proteome/*metabolism</keyword><keyword>*Proteomics</keyword><keyword>Tumor Markers, Biological/analysis/*blood</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 3</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>18385731</accession-num><abstract>Systematic searches for plasma proteins that are biological indicators, or biomarkers, for cancer are underway. The difficulties caused by the complexity of biological-fluid proteomes and tissue proteomes (which contribute proteins to plasma) and by the extensive heterogeneity among diseases, subjects and levels of sample procurement are gradually being overcome. This is being achieved through rigorous experimental design and in-depth quantitative studies. The expected outcome is the development of panels of biomarkers that will allow early detection of cancer and prediction of the probable response to therapy. Achieving these objectives requires high-quality specimens with well-matched controls, reagent resources, and an efficient process to confirm discoveries through independent validation studies.</abstract><notes>Hanash, Samir M&#xD;Pitteri, Sharon J&#xD;Faca, Vitor M&#xD;Review&#xD;England&#xD;Nature&#xD;Nature. 2008 Apr 3;452(7187):571-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18385731</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>31.210</custom4><electronic-resource-num>nature06916 [pii]&#xD;10.1038/nature06916</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1266</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1266</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hu, W.</author><author>Wilson, R. J.</author><author>Koh, A.</author><author>Fu, A.</author><author>Faranesh, A. Z.</author><author>Earhart, C. M.</author><author>Osterfeld, S. J.</author><author>Han, S. J.</author><author>Xu, L.</author><author>Guccione, S.</author><author>Sinclair, R.</author><author>Wang, S. X.</author></authors></contributors><auth-address>Department of Materials Science and Engineering Stanford University Stanford, CA 94305 (USA); Department of Electrical Engineering Stanford University Stanford, CA 94305 (USA); Department of Mechanical Engineering Stanford University Stanford, CA 94305 (USA); Department of Radiology Stanford University Stanford, CA 94305 (USA)</auth-address><titles><title>High-Moment Antiferromagnetic Nanoparticles with Tunable Magnetic Properties</title><secondary-title>Advanced Materials</secondary-title></titles><periodical><full-title>Advanced Materials</full-title></periodical><pages>1479-1483</pages><volume>20</volume><number>8</number><edition>2008/04/4</edition><keywords><keyword>magnetic nanoparticles</keyword><keyword>nanoimprint lithography</keyword><keyword>ferromagnetic materials</keyword></keywords><dates><year>2008</year></dates><isbn>1521-4095</isbn><abstract>No Abstract.</abstract><notes>10.1002/adma.200703077</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200703077</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>10.231</custom4><electronic-resource-num>10.1002/adma.200703077</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1334</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1334</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, S. J.</author><author>Han, J.</author></authors></contributors><auth-address>Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Self-sealed vertical polymeric nanoporous-junctions for high-throughput nanofluidic applications</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>3507-11</pages><volume>80</volume><number>9</number><edition>2008/04/03</edition><keywords><keyword>Dimethylpolysiloxanes/*chemistry</keyword><keyword>Fluorocarbon Polymers/chemistry</keyword><keyword>Microfluidic Analytical Techniques/instrumentation/*methods</keyword><keyword>Nanotechnology/instrumentation/*methods</keyword><keyword>Proteins/chemistry</keyword><keyword>Silicones/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>1520-6882 (Electronic)</isbn><accession-num>18380489</accession-num><abstract>We developed a reliable but simple integration method of polymeric nanostructure in a poly(dimethylsiloxane) (PDMS)-based microfluidic channel, for nanofluidic applications. The Nafion polymer junction was creased by infiltrating polymer solution between the gaps created by mechanical cutting, without any photolithography or etching processes. The PDMS can seal itself with the heterogeneous polymeric nanoporous material between the PDMS/PDMS gap due to its flexibility without any (covalent) bonding between PDMS and the polymer materials. Thus, one can easily integrate the nanoporous-junction into a PDMS microchip in a leak-free manner with excellent repeatability. We demonstrated nanofluidic preconcentration of proteins (beta-phycoerythrin) using the device. Because the polymeric junction spans across the entire microchannel height, the preconcentration was achieved with high-pressure field or even in large channels, with the dimensions of 1000 microm width x 100 microm depth.</abstract><notes>Kim, Sung Jae&#xD;Han, Jongyoon&#xD;CA119402/CA/United States NCI&#xD;EB005743/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2008 May 1;80(9):3507-11. Epub 2008 Apr 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18380489</url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2008</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac800157q</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1320</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1320</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kelly, K. A.</author><author>Setlur, S. R.</author><author>Ross, R.</author><author>Anbazhagan, R.</author><author>Waterman, P.</author><author>Rubin, M. A.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA. kkelly9@partners.org</auth-address><titles><title>Detection of early prostate cancer using a hepsin-targeted imaging agent</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>2286-91</pages><volume>68</volume><number>7</number><edition>2008/04/03</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Peptide Library</keyword><keyword>Prostatic Neoplasms/*diagnosis/*enzymology/genetics</keyword><keyword>RNA, Messenger/biosynthesis/genetics</keyword><keyword>Serine Endopeptidases/*analysis/biosynthesis/genetics</keyword><keyword>Transfection</keyword><keyword>Tumor Markers, Biological/*analysis/biosynthesis/genetics</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 1</date></pub-dates></dates><isbn>1538-7445 (Electronic)</isbn><accession-num>18381435</accession-num><abstract>Early detection and diagnosis of prostate cancer is key to designing effective treatment strategies. Microarrays have resulted in the discovery of hepsin (HPN) as a biomarker for detection of prostate cancer. In this study, we explore the development of HPN imaging probes for detection of prostate cancer. We used phage display to isolate HPN binding peptides with 190 + 2.2 nmol/L affinity in monomeric form and high specificity. The identified peptides were able to detect human prostate cancer on tissue microarrays and in cell-based assays. HPN-targeted imaging agents were synthesized by conjugating multiple peptides to fluorescent nanoparticles to further improve avidity through multivalency and to improve pharmacokinetics. When injected into mouse xenograft models, HPN-targeted nanoparticles bound specifically to HPN-expressing LNCaP xenografts compared with non-HPN-expressing PC3 xenografts. HPN imaging may provide a new method for detection of prostate cancer.</abstract><notes>Kelly, Kimberly A&#xD;Setlur, Sunita R&#xD;Ross, Robert&#xD;Anbazhagan, Rajesh&#xD;Waterman, Peter&#xD;Rubin, Mark A&#xD;Weissleder, Ralph&#xD;P50-CA090381/CA/United States NCI&#xD;P50-CA86355/CA/United States NCI&#xD;R01AG21404/AG/United States NIA&#xD;R24-CA92782/CA/United States NCI&#xD;U54-CA119349/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2008 Apr 1;68(7):2286-91.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18381435</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.980</custom4><electronic-resource-num>68/7/2286 [pii]&#xD;10.1158/0008-5472.CAN-07-1349</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2321</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2321</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Graham, T. R.</author><author>Zhau, H. E.</author><author>Odero-Marah, V. A.</author><author>Osunkoya, A. O.</author><author>Kimbro, K. S.</author><author>Tighiouart, M.</author><author>Liu, T.</author><author>Simons, J. W.</author><author>O&apos;Regan, R. M.</author></authors></contributors><auth-address>Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.</auth-address><titles><title>Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>2479-88</pages><volume>68</volume><number>7</number><edition>2008/04/03</edition><keywords><keyword>Cadherins/metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Movement/physiology</keyword><keyword>DNA, Complementary/genetics</keyword><keyword>Epithelial Cells/pathology</keyword><keyword>Homeodomain Proteins/biosynthesis/genetics/ metabolism</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Insulin-Like Growth Factor I/ metabolism</keyword><keyword>Male</keyword><keyword>Mesoderm/pathology</keyword><keyword>Mitogen-Activated Protein Kinases/metabolism</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Prostatic Neoplasms/genetics/ metabolism/ pathology</keyword><keyword>RNA, Messenger/biosynthesis/genetics</keyword><keyword>Signal Transduction</keyword><keyword>Transcription Factors/biosynthesis/genetics/ metabolism</keyword><keyword>Transfection</keyword><keyword>Up-Regulation</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 1</date></pub-dates></dates><isbn>1538-7445 (Electronic)</isbn><accession-num>18381457</accession-num><abstract>The epithelial-to-mesenchymal transition (EMT) is crucial for the migration and invasion of many epithelial tumors, including prostate cancer. Although it is known that ZEB1 overexpression promotes EMT primarily through down-regulation of E-cadherin in a variety of cancers, the soluble ligands responsible for the activation of ZEB1 have yet to be identified. In the present study, we investigated the role of insulin-like growth factor-I (IGF-I) in the regulation of ZEB1 during EMT associated with prostate tumor cell migration. We found that ZEB1 is expressed in highly aggressive prostate cancer cells and that its expression correlates directly with Gleason grade in human prostate tumors (P &lt; 0.001). IGF-I up-regulates ZEB1 expression in prostate cancer cells exhibiting an epithelial phenotype. In prostate cancer cells displaying a mesenchymal phenotype, ZEB1 inhibition reverses the suppression of E-cadherin protein and down-regulates the expression of the mesenchymal markers N-cadherin and fibronectin. Furthermore, ZEB1 blockade decreases migratory and invasive potential in ARCaP(M) compared with the control. These results identify ZEB1 as a key transcriptional regulator of EMT in prostate cancer and suggest that the aberrant expression of ZEB1 in prostate cancer cells occurs in part in response to IGF-I stimulation.</abstract><notes>Graham, Tisheeka R&#xD;Zhau, Haiyen E&#xD;Odero-Marah, Valerie A&#xD;Osunkoya, Adeboye O&#xD;Kimbro, K Sean&#xD;Tighiouart, Mourad&#xD;Liu, Tongrui&#xD;Simons, Jonathan W&#xD;O&apos;Regan, Ruth M&#xD;CA119338/CA/NCI NIH HHS/United States&#xD;P01 CA098912/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2008 Apr 1;68(7):2479-88.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>7.980</custom4><electronic-resource-num>68/7/2479 [pii]&#xD;10.1158/0008-5472.CAN-07-2559 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1150</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1150</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cilliers, R.</author><author>Song, Y.</author><author>Kohlmeir, E. K.</author><author>Larson, A. C.</author><author>Omary, R. A.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois, USA.</auth-address><titles><title>Modification of embolic-PVA particles with MR contrast agents</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><pages>898-902</pages><volume>59</volume><number>4</number><edition>2008/04/03</edition><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0740-3194 (Print)</isbn><accession-num>18383280</accession-num><abstract>We report the synthesis and characterization of polyvinyl alcohol (PVA) embolic particles modified with a clinically approved magnetic resonance (MR) contrast agent. PVA particles are used during transcatheter arterial embolization (TAE) procedures and this minimally invasive technique is a widely employed treatment for inoperable tumors. The PVA particles are injected into tumor vessels and prevent blood flow which results in tumor attenuation. An accurate assessment of the endpoint of embolization is critical to successful TAE procedures. Recent reports suggest that 20% of endpoint determination of TAE procedures by angiographic techniques are erroneous. Real time, in vivo imaging of the embolic particles would overcome this limitation. The contrast-modified PVA particles described here show an 80% decrease in T(1) relaxation times compared to unmodified particles. Images of particles in capillary tubes of similar size to catheters used in TAE procedures are clearly visible by MRI.</abstract><notes>Cilliers, Renee&#xD;Song, Ying&#xD;Kohlmeir, Ellen K&#xD;Larson, Andrew C&#xD;Omary, Reed A&#xD;Meade, Thomas J&#xD;CA119341/CA/United States NCI&#xD;R01 EB005866/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine&#xD;Magn Reson Med. 2008 Apr;59(4):898-902.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18383280</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.163</custom4><electronic-resource-num>10.1002/mrm.21518</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1134</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1134</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chen, J.</author><author>Wang, Q.</author><author>Zhang, H.</author><author>Yang, X.</author><author>Wang, J.</author><author>Berkowitz, B. A.</author><author>Wickline, S. A.</author><author>Song, S. K.</author></authors></contributors><auth-address>Department of Medicine, Washington University, St. Louis, Missouri, USA.</auth-address><titles><title>In vivo quantification of T1, T2, and apparent diffusion coefficient in the mouse retina at 11.74T</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><pages>731-8</pages><volume>59</volume><number>4</number><edition>2008/04/03</edition><keywords><keyword>*Algorithms</keyword><keyword>Animals</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Image Interpretation, Computer-Assisted/*methods</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Reproducibility of Results</keyword><keyword>Retina/*cytology</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0740-3194 (Print)</isbn><accession-num>18383302</accession-num><abstract>MRI has recently been used for noninvasive examination of retinal structure and function in rats and cats. However, the advantages of quantitative high-resolution MRI of retina from mice have not yet been explored. In the present study, T(1) and T(2) relaxation time constants and the directional apparent diffusion coefficient (ADC) in the retina of C57/BL6 mice were measured. Three MR-detected retina layers and a MR-detected choroid layer were observed on both T(1)- and T(2)-weighted images at an image resolution of 47 x 47 x 400 microm(3). The significantly higher ADC parallel to than that perpendicular to the optic nerve in the MR-detected outer retina layer at the central retina reflects the known cellular organization of the photoreceptor cells. This study establishes, for the first time, normative metrics of T(1), T(2), and ADC of the mouse retina. These MR parameters are expected to be useful in future evaluation of developmental and pathological alterations of retinal cell layers in mice.</abstract><notes>Chen, Junjie&#xD;Wang, Qing&#xD;Zhang, Huiying&#xD;Yang, Xiaoxia&#xD;Wang, Jian&#xD;Berkowitz, Bruce A&#xD;Wickline, Samuel A&#xD;Song, Sheng-Kwei&#xD;CA 119342/CA/United States NCI&#xD;EY018109/EY/United States NEI&#xD;HL073646/HL/United States NHLBI&#xD;R24-CA83060/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine&#xD;Magn Reson Med. 2008 Apr;59(4):731-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18383302</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>4.163</custom4><electronic-resource-num>10.1002/mrm.21570</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1323</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1323</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Keren, S.</author><author>Zavaleta, C.</author><author>Cheng, Z.</author><author>de la Zerda, A.</author><author>Gheysens, O.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Departments of Radiology and Bioengineering, Bio-X Program, Stanford University, 1201 Welch Road, Stanford, CA 94305-5484, USA.</auth-address><titles><title>Noninvasive molecular imaging of small living subjects using Raman spectroscopy</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>5844-9</pages><volume>105</volume><number>15</number><edition>2008/04/02</edition><dates><year>2008</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18378895</accession-num><abstract>Molecular imaging of living subjects continues to rapidly evolve with bioluminescence and fluorescence strategies, in particular being frequently used for small-animal models. This article presents noninvasive deep-tissue molecular images in a living subject with the use of Raman spectroscopy. We describe a strategy for small-animal optical imaging based on Raman spectroscopy and Raman nanoparticles. Surface-enhanced Raman scattering nanoparticles and single-wall carbon nanotubes were used to demonstrate whole-body Raman imaging, nanoparticle pharmacokinetics, multiplexing, and in vivo tumor targeting, using an imaging system adapted for small-animal Raman imaging. The imaging modality reported here holds significant potential as a strategy for biomedical imaging of living subjects.</abstract><notes>Keren, S&#xD;Zavaleta, C&#xD;Cheng, Z&#xD;de la Zerda, A&#xD;Gheysens, O&#xD;Gambhir, S S&#xD;5-RO1-EBB000312/United States PHS&#xD;P50 CA114747/CA/United States NCI&#xD;T32 CA09695-15/CA/United States NCI&#xD;U54 CA119367/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5844-9. Epub 2008 Mar 31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18378895</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>10.228</custom4><electronic-resource-num>0710575105 [pii]&#xD;10.1073/pnas.0710575105</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1317</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1317</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kelly, J. Y.</author><author>DeSimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry and Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Shape-specific, monodisperse nano-molding of protein particles</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>5438-9</pages><volume>130</volume><number>16</number><edition>2008/04/02</edition><keywords><keyword>Adhesiveness</keyword><keyword>Albumins/*chemistry</keyword><keyword>Antineoplastic Combined Chemotherapy Protocols/*therapeutic use</keyword><keyword>Breast Neoplasms/*drug therapy</keyword><keyword>*Electronics</keyword><keyword>Female</keyword><keyword>Gold/chemistry</keyword><keyword>Humans</keyword><keyword>Industry</keyword><keyword>Microscopy, Electron, Scanning/methods</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Nanoparticles/*chemistry/ultrastructure</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Particle Size</keyword><keyword>RNA, Small Interfering/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 23</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18376832</accession-num><notes>Kelly, Jennifer Y&#xD;DeSimone, Joseph M&#xD;5-654-CA119373-02/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Apr 23;130(16):5438-9. Epub 2008 Apr 1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18376832</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja8014428</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1615</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1615</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Soman, N.R.</author><author>Marsh, J.N.</author><author>Lanza, G.M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Washington University School of Medicine, Consortium for Translational Research in Advanced Imaging and Nanomedicine, CTRAIN, Campus Box 8215, St Louis, MO 63110, USA</auth-address><titles><title>New mechanisms for non-porative ultrasound stimulation of cargo delivery to cell cytosol with targeted perfluorocarbon nanoparticles</title><secondary-title>Nanotechnology</secondary-title></titles><periodical><full-title>Nanotechnology</full-title></periodical><pages>185102-185109</pages><volume>19</volume><number>18</number><edition>2008/04/01</edition><section>185102</section><dates><year>2008</year><pub-dates><date>7 May 2008</date></pub-dates></dates><abstract>The cell membrane constitutes a major barrier for non-endocytotic intracellular delivery of therapeutic molecules from drug delivery vehicles. Existing approaches to breaching the cell membrane include cavitational ultrasound (with microbubbles), electroporation and cell-penetrating peptides. We report the use of diagnostic ultrasound for intracellular delivery of therapeutic bulky cargo with the use of molecularly targeted liquid perfluorocarbon (PFC) nanoparticles. To demonstrate the concept, we used a lipid with a surrogate polar head group, nanogold-DPPE, incorporated into the nanoparticle lipid monolayer. Melanoma cells were incubated with nanogold particles and this was followed by insonication with continuous wave ultrasound (2.25 MHz, 5 min, 0.6 MPa). Cells not exposed to ultrasound showed gold particles partitioned only in the outer bilayer of the cell membrane with no evidence of the intracellular transit of nanogold. However, the cells exposed to ultrasound exhibited numerous nanogold-DPPE components inside the cell that appeared polarized inside intracellular vesicles demonstrating cellular uptake and trafficking. Further, ultrasound-exposed cells manifested no incorporation of calcein or the release of lactate dehydrogenase. These observations are consistent with a mechanism that suggests that ultrasound is capable of stimulating the intracellular delivery of therapeutic molecules via non-porative mechanisms. Therefore, non-cavitational adjunctive ultrasound offers a novel paradigm in intracellular cargo delivery from PFC nanoparticles.</abstract><urls><related-urls><url>http://www.iop.org/EJ/abstract/0957-4484/19/18/185102</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>3.727</custom4><electronic-resource-num>10.1088/0957-4484/19/18/185102</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2076</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2076</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cao, Q.</author><author>Li, Z. B.</author><author>Chen, K.</author><author>Wu, Z.</author><author>He, L.</author><author>Neamati, N.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology, Biophysics, and Bio-X Program, Stanford University School of Medicine, 1201 Welch Rd, Stanford P095, CA 94305-5484, USA.</auth-address><titles><title>Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide-paclitaxel conjugate in mice with breast cancer</title><secondary-title>Eur J Nucl Med Mol Imaging</secondary-title></titles><periodical><full-title>Eur J Nucl Med Mol Imaging</full-title></periodical><pages>1489-98</pages><volume>35</volume><number>8</number><edition>2008/04/01</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/administration &amp; dosage/pharmacokinetics</keyword><keyword>Breast Neoplasms/ drug therapy/ metabolism/radionuclide imaging</keyword><keyword>Drug Delivery Systems/methods</keyword><keyword>Female</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Oligopeptides/ administration &amp; dosage/ pharmacokinetics</keyword><keyword>Organ Specificity</keyword><keyword>Paclitaxel/ administration &amp; dosage/ pharmacokinetics</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1619-7070 (Print)</isbn><accession-num>18373091</accession-num><abstract>PURPOSE: Targeting drugs to receptors involved in tumor angiogenesis has been demonstrated as a novel and promising approach to improve cancer treatment. In this study, we evaluated the anti-tumor efficacy of a dimeric RGD peptide-paclitaxel conjugate (RGD2-PTX) in an orthotopic MDA-MB-435 breast cancer model. METHODS: To assess the effect of conjugation and the presence of drug moiety on the MDA-MB-435 tumor and normal tissue uptake, the biodistribution of (3)H-RGD2-PTX was compared with that of (3)H-PTX. The treatment effect of RGD2-PTX and RGD2+PTX was measured by tumor size, (18)F-FDG/PET, (18)F-FLT/PET, and postmortem histopathology. RESULTS: By comparing the biodistribution of (3)H-RGD2-PTX and (3)H-PTX, we found that (3)H-RGD2-PTX had higher initial tumor exposure dose and prolonged tumor retention than (3)H-PTX. Metronomic low-dose treatment of breast cancer indicated that RGD2-PTX is significantly more effective than PTX+RGD2 combination and solvent control. Although in vivo (18)F-FLT/PET imaging and ex vivo Ki67 staining indicated little effect of the PTX-based drug on cell proliferation, (18)F-FDG/PET imaging showed significantly reduced tumor metabolism in the RGD2-PTX-treated mice versus those treated with RGD2+PTX and solvent control. Terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining also showed that RGD2-PTX treatment also had significantly higher cell apoptosis ratio than the other two groups. Moreover, the microvessel density was significantly reduced after RGD2-PTX treatment as determined by CD31 staining. CONCLUSION: Our results demonstrate that integrin-targeted delivery of paclitaxel allows preferential cytotoxicity to integrin-expressing tumor cells and tumor vasculature. The targeted delivery strategies developed in this study may also be applied to other chemotherapeutics for selective tumor killing.</abstract><notes>Cao, Qizhen&#xD;Li, Zi-Bo&#xD;Chen, Kai&#xD;Wu, Zhanhong&#xD;He, Lina&#xD;Neamati, Nouri&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 120188/PHS HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;European journal of nuclear medicine and molecular imaging&#xD;Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1489-98. Epub 2008 Mar 29.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.625</custom4><electronic-resource-num>10.1007/s00259-008-0744-y [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2493</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2493</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Paunesku, Tatjana</author><author>Ke, Tianyi</author><author>Dharmakumar, Rohan</author><author>Mascheri, Nicole</author><author>Wu, Aiguo</author><author>Lai, Barry</author><author>Vogt, Stefan</author><author>Maser, Jrg</author><author>Thurn, Kenneth</author><author>Szolc-Kowalska, Barbara</author><author>Larson, Andrew</author><author>Bergan, Raymond C.</author><author>Omary, Reed</author><author>Li, Debiao</author><author>Lu, Zheng-Rong</author><author>Woloschak, Gayle E.</author></authors></contributors><titles><title>Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images</title><secondary-title>Nanomedicine: Nanotechnology, Biology and Medicine</secondary-title></titles><periodical><full-title>Nanomedicine: Nanotechnology, Biology and Medicine</full-title></periodical><pages>201-207</pages><volume>4</volume><number>3</number><edition>2008/04</edition><keywords><keyword>Nanoconjugates</keyword><keyword>Magnetic resonance imaging</keyword><keyword>Subcellular targeting</keyword></keywords><dates><year>2008</year></dates><isbn>1549-9634</isbn><notes>doi: DOI: 10.1016/j.nano.2008.04.004</notes><urls><related-urls><url>http://www.sciencedirect.com/science/article/B7MDB-4SV0SWH-1/2/7a3ec5dfac096c6b1109754c82be00a4</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>na</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1375</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1375</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, H.Y.</author><author>Lee, S.H.</author><author>Chenjie, X.</author><author>Xie, J.</author><author>Lee, J.H.</author><author>Wu, B.</author><author>Koh, A.L.</author><author>Wang, X.</author><author>Sinclair, R.</author><author>Wang, S.X.</author><author>Nishimura, D.G.</author><author>Biswal, S.</author><author>Sun, S.</author><author>Cho, S.H.</author><author>Chen, X.</author></authors></contributors><titles><title>Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent</title><secondary-title>Nanotechnology</secondary-title></titles><periodical><full-title>Nanotechnology</full-title></periodical><volume>19</volume><edition>2008/04</edition><section>165101</section><dates><year>2008</year><pub-dates><date>23 April 2008</date></pub-dates></dates><abstract>The purpose of this study was to synthesize biocompatible polyvinylpyrrolidone (PVP)-coated iron oxide (PVP-IO) nanoparticles and to evaluate their efficacy as a magnetic resonance imaging (MRI) contrast agent. The PVP-IO nanoparticles were synthesized by a thermal decomposition method and characterized by x-ray diffraction (XRD), transmission electron microscopy (TEM), dynamic light scattering (DLS), and a superconducting quantum interface device (SQUID). The core size of the particles is about 810 nm and the overall size is around 2030 nm. The measured r2 (reciprocal of T2 relaxation time) and r2* (reciprocal of T2* relaxation time) are 141.2 and 338.1 (s mM)-1, respectively. The particles are highly soluble and stable in various buffers and in serum. The macrophage uptake of PVP-IO is comparable to that of Feridex as measured by a Prussian blue iron stain and phantom study. The signal intensity of a rabbit liver was effectively reduced after intravenous administration of PVP-IO. Therefore PVP-IO nanoparticles are potentially useful for T2-weighted MR imaging.</abstract><urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>3.727</custom4><electronic-resource-num>10.1088/0957-4484/19/16/165101</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1304</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1304</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kairdolf, B. A.</author><author>Mancini, M. C.</author><author>Smith, A. M.</author><author>Nie, S. M.</author></authors></contributors><auth-address>Nie, SM&#xD;Emory Clin, Dept Biomed Engn &amp; Chem, 101 Woodruff Circle,Suite 2001, Atlanta, GA 30322 USA&#xD;Emory Clin, Dept Biomed Engn &amp; Chem, Atlanta, GA 30322 USA&#xD;Georgia Inst Technol, Atlanta, GA 30332 USA</auth-address><titles><title>Minimizing nonspecific cellular binding of quantum dots with hydroxyl-derivatizied surface coatings</title><secondary-title>Analytical Chemistry</secondary-title></titles><periodical><full-title>Analytical Chemistry</full-title></periodical><pages>3029-3034</pages><volume>80</volume><number>8</number><edition>2008/04</edition><keywords><keyword>breast-cancer</keyword><keyword>nanocrystals</keyword><keyword>nanoparticles</keyword><keyword>micelles</keyword><keyword>growth</keyword><keyword>cells</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>0003-2700</isbn><accession-num>ISI:000254969100051</accession-num><abstract>Quantum-dot (QD) nanocrystals are promising fluorescent probes for multiplexed staining assays in biological applications. However, nonspecific QD binding to cellular membranes and proteins remains a limiting factor in detection sensitivity and specificity. Here we report a new class of hydroxyl (-OH)-coated QDs,for minimizing nonspecific cellular binding and for overcoming the bulky size problems encountered with previous surface coatings. The hydroxylated QDs are prepared from carboxylated (-COOH) dots via a hydroxylation and cross-linking process. With a compact hydrodynamic size of 13-14 nm (diameter), they are highly fluorescent (&gt; 60% quantum yields) and stable under both basic and acidic conditions. By using human cancer cells, we have evaluated their superior nonspecific binding properties against that of carboxylated, protein-coated, and poly(ethylene glycol) (PEG)-coated QDs. Quantitative cellular staining data indicate that the hydroxylated QDs result in a dramatic 140-fold reduction in nonspecific binding relative to that of carboxylated dots and-a still significant 10-20-fold reduction relative to that of PEG- and protein-coated dots.</abstract><notes>288EN&#xD;Times Cited:2&#xD;Cited References Count:36</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000254969100051</url></related-urls></urls><custom1>CCNE - Emory</custom1><custom4>5.918</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1887</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1887</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jonathan Gunn</author><author>Herschel Wallen</author><author>Omid Veiseh</author><author>Conroy Sun</author><author>Chen Fang</author><author>Jianhong Cao</author><author>Cassian Yee</author><author>Miqin Zhang</author></authors></contributors><auth-address>Department of Materials Science &amp; Engineering University of Washington 302L Roberts Hall Seattle, WA 98195 (USA); Clinical Research Division Fred Hutchinson Cancer Research Center Seattle, WA 98109 (USA)</auth-address><titles><title>A Multimodal Targeting Nanoparticle for Selectively Labeling T Cells</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>712-715</pages><volume>4</volume><number>6</number><edition>2008/04</edition><dates><year>2008</year></dates><isbn>1613-6829</isbn><notes>10.1002/smll.200701103</notes><urls><related-urls><url>http://dx.doi.org/10.1002/smll.200701103</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom4>7.292</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1382</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1382</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J. S.</author><author>Seferos, D. S.</author><author>Giljohann, D. A.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Thermodynamically controlled separation of polyvalent 2-nm gold nanoparticle-oligonucleotide conjugates</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>5430-1</pages><volume>130</volume><number>16</number><edition>2008/03/29</edition><keywords><keyword>DNA Probes/*chemical synthesis</keyword><keyword>Gold/*chemistry</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Oligonucleotides/*chemistry</keyword><keyword>Organometallic Compounds/*chemistry</keyword><keyword>Thermodynamics</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 23</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18370386</accession-num><notes>Lee, Jae-Seung&#xD;Seferos, Dwight S&#xD;Giljohann, David A&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Apr 23;130(16):5430-1. Epub 2008 Mar 28.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18370386</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja800797h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2239</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2239</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chen, J.</author><author>Chen, S. C.</author><author>Stern, P.</author><author>Scott, B. B.</author><author>Lois, C.</author></authors></contributors><auth-address>Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. jchen@mit.edu</auth-address><titles><title>Genetic strategy to prevent influenza virus infections in animals</title><secondary-title>J Infect Dis</secondary-title></titles><periodical><full-title>J Infect Dis</full-title></periodical><pages>S25-8</pages><volume>197 Suppl 1</volume><edition>2008/03/28</edition><keywords><keyword>Animals</keyword><keyword>Animals, Genetically Modified/immunology</keyword><keyword>Birds</keyword><keyword>Chickens/genetics/immunology</keyword><keyword>Ducks/genetics/immunology</keyword><keyword>Humans</keyword><keyword>Immunity, Innate/ genetics</keyword><keyword>Influenza in Birds/genetics/ prevention &amp; control</keyword><keyword>Poultry/ genetics/immunology</keyword><keyword>Poultry Diseases/genetics/ prevention &amp; control</keyword><keyword>RNA Interference/ immunology</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 15</date></pub-dates></dates><isbn>0022-1899 (Print)</isbn><accession-num>18269324</accession-num><abstract>The natural reservoirs of influenza viruses are aquatic birds. After adaptation, avian viruses can acquire the ability to infect humans and cause severe disease. Because domestic poultry serves as a key link between the natural reservoir of influenza viruses and epidemics and pandemics in human populations, an effective measure to control influenza would be to eliminate or reduce influenza virus infection in domestic poultry. The development and distribution of influenza-resistant poultry represents a proactive strategy for controlling the origin of influenza epidemics and pandemics in both poultry and human populations. Recent developments in RNA interference and transgenesis in birds should facilitate the development of influenza-resistant poultry.</abstract><notes>Chen, Jianzhu&#xD;Chen, Steve C-Y&#xD;Stern, Patrick&#xD;Scott, Benjamin B&#xD;Lois, Carlos&#xD;AI 56267/AI/NIAID NIH HHS/United States&#xD;CA 112967/CA/NCI NIH HHS/United States&#xD;CA 119349/CA/NCI NIH HHS/United States&#xD;R01 AI056267-01/AI/NIAID NIH HHS/United States&#xD;R01 AI056267-02/AI/NIAID NIH HHS/United States&#xD;R01 AI056267-03/AI/NIAID NIH HHS/United States&#xD;R01 AI056267-04/AI/NIAID NIH HHS/United States&#xD;U54 CA112967-019003/CA/NCI NIH HHS/United States&#xD;U54 CA112967-029003/CA/NCI NIH HHS/United States&#xD;U54 CA112967-039003/CA/NCI NIH HHS/United States&#xD;U54 CA112967-049003/CA/NCI NIH HHS/United States&#xD;U54 CA112967-059003/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;The Journal of infectious diseases&#xD;J Infect Dis. 2008 Feb 15;197 Suppl 1:S25-8.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2694447</custom2><custom3>NIHMS108206</custom3><custom4>5.375</custom4><electronic-resource-num>10.1086/524987 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2075</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2075</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Alam, M. R.</author><author>Dixit, V.</author><author>Kang, H.</author><author>Li, Z. B.</author><author>Chen, X.</author><author>Trejo, J.</author><author>Fisher, M.</author><author>Juliano, R. L.</author></authors></contributors><auth-address>Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill NC 27599, USA.</auth-address><titles><title>Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis</title><secondary-title>Nucleic Acids Res</secondary-title></titles><periodical><full-title>Nucleic Acids Res</full-title></periodical><pages>2764-76</pages><volume>36</volume><number>8</number><edition>2008/03/28</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Endocytosis</keyword><keyword>Genes, Reporter</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/ metabolism</keyword><keyword>Kinetics</keyword><keyword>Luciferases, Firefly/analysis/genetics</keyword><keyword>Oligonucleotides, Antisense/ administration &amp; dosage/analysis/chemistry</keyword><keyword>Oligopeptides/ chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1362-4962 (Electronic)</isbn><accession-num>18367474</accession-num><abstract>We describe the synthesis and characterization of a 5&apos; conjugate between a 2&apos;-O-Me phosphorothioate antisense oligonucleotide and a bivalent RGD (arginine-glycine-aspartic acid) peptide that is a high-affinity ligand for the alphavbeta3 integrin. We used alphavbeta3-positive melanoma cells transfected with a reporter comprised of the firefly luciferase gene interrupted by an abnormally spliced intron. Intranuclear delivery of a specific antisense oligonucleotide (termed 623) corrects splicing and allows luciferase expression in these cells. The RGD-623 conjugate or a cationic lipid-623 complex produced significant increases in luciferase expression, while &apos;free&apos; 623 did not. However, the kinetics of luciferase expression was distinct; the RGD-623 conjugate produced a gradual increase followed by a gradual decline, while the cationic lipid-623 complex caused a rapid increase followed by a monotonic decline. The subcellular distribution of the oligonucleotide delivered using cationic lipids included both cytoplasmic vesicles and the nucleus, while the RGD-623 conjugate was primarily found in cytoplasmic vesicles that partially co-localized with a marker for caveolae. Both the cellular uptake and the biological effect of the RGD-623 conjugate were blocked by excess RGD peptide. These observations suggest that the bivalent RGD peptide-oligonucleotide conjugate enters cells via a process of receptor-mediated endocytosis mediated by the alphavbeta3 integrin.</abstract><notes>Alam, Md Rowshon&#xD;Dixit, Vidula&#xD;Kang, Hyunmin&#xD;Li, Zi-Bo&#xD;Chen, Xiaoyuan&#xD;Trejo, Joann&#xD;Fisher, Michael&#xD;Juliano, Rudy L&#xD;P01 GM59299/GM/NIGMS NIH HHS/United States&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;U54CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Nucleic acids research&#xD;Nucleic Acids Res. 2008 May;36(8):2764-76. Epub 2008 Mar 26.</notes><urls></urls><custom1>CCNE - UNC</custom1><custom2>2377441</custom2><custom3>2008</custom3><custom4>6.968</custom4><electronic-resource-num>gkn115 [pii]&#xD;10.1093/nar/gkn115 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2017</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2017</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Winter, P. M.</author><author>Schmieder, A. H.</author><author>Caruthers, S. D.</author><author>Keene, J. L.</author><author>Zhang, H.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Washington University Medical School, Campus Box 8215, 4320 Forest Park Ave., St. Louis, MO 63108, USA. patrick@cvu.wustl.edu</auth-address><titles><title>Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits</title><secondary-title>FASEB J</secondary-title></titles><periodical><full-title>FASEB J</full-title></periodical><pages>2758-67</pages><volume>22</volume><number>8</number><edition>2008/03/26</edition><keywords><keyword>Adenocarcinoma/ blood supply/ drug therapy/metabolism/pathology</keyword><keyword>Aminopeptidases/antagonists &amp; inhibitors</keyword><keyword>Angiogenesis Inhibitors/ administration &amp; dosage</keyword><keyword>Animals</keyword><keyword>Cyclohexanes/ administration &amp; dosage</keyword><keyword>Fatty Acids, Unsaturated/ administration &amp; dosage</keyword><keyword>Integrin alphaVbeta3/ antagonists &amp; inhibitors</keyword><keyword>Male</keyword><keyword>Nanoparticles</keyword><keyword>Neovascularization, Pathologic/pathology/ prevention &amp; control</keyword><keyword>Rabbits</keyword><keyword>Sesquiterpenes/administration &amp; dosage</keyword></keywords><dates><year>2008</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1530-6860 (Electronic)</isbn><accession-num>18362202</accession-num><abstract>Fumagillin suppresses angiogenesis in cancer models and clinical trials, but it is associated with neurotoxicity at systemic doses. In this study, alpha(nu)beta(3)-targeted fumagillin nanoparticles were used to suppress the neovasculature and inhibit Vx-2 adenocarcinoma development using minute drug doses. Tumor-bearing rabbits were treated on days 6, 9, and 12 postimplantation with alpha(nu)beta(3)-targeted fumagillin nanoparticles (30 microg/kg), alpha(nu)beta(3)-targeted nanoparticles without drug, nontargeted fumagillin nanoparticles (30 microg/kg) or saline. On day 16, MRI was performed with alpha(nu)beta(3)-targeted paramagnetic nanoparticles to quantify tumor size and assess neovascularity. Tumor volume was reduced among rabbits receiving alpha(nu)beta(3)-targeted fumagillin nanoparticles (470+/-120 mm(3)) compared with the three control groups: nontargeted fumagillin nanoparticles (1370+/-300 mm(3), P&lt;0.05), alpha(nu)beta(3)-targeted nanoparticles without drug (1080+/-180 mm(3), P&lt;0.05) and saline (980+/-80 mm(3), P&lt;0.05). MR molecular imaging of control rabbits (no fumagillin) revealed a predominant peripheral distribution of neovascularity representing 7.2% of the tumor rim volume, which decreased to 2.8% (P&lt;0.05) with alpha(nu)beta(3)-targeted fumagillin nanoparticle treatment. Microscopically, the tumor parenchyma tended to show T-cell infiltration after targeted fumagillin treatment, which was not appreciated in control animals. These results suggest that alpha(nu)beta(3)-targeted fumagillin nanoparticles could provide a safe and effective means to deliver MetAP2 inhibitors alone or in combination with cytotoxic or immunotherapy.</abstract><notes>Winter, Patrick M&#xD;Schmieder, Anne H&#xD;Caruthers, Shelton D&#xD;Keene, Jeffery L&#xD;Zhang, Huiying&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;CA-119342/CA/NCI NIH HHS/United States&#xD;EB-01704/EB/NIBIB NIH HHS/United States&#xD;HL-73646/HL/NHLBI NIH HHS/United States&#xD;HL-78631/HL/NHLBI NIH HHS/United States&#xD;N01-CO-27031-16/CO/NCI NIH HHS/United States&#xD;N01-CO-37007/CO/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The FASEB journal : official publication of the Federation of American Societies for Experimental Biology&#xD;FASEB J. 2008 Aug;22(8):2758-67. Epub 2008 Mar 24.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom2>2493462</custom2><custom4>7.128</custom4><electronic-resource-num>fj.07-103929 [pii]&#xD;10.1096/fj.07-103929 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1512</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1512</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Petros, R. A.</author><author>Ropp, P. A.</author><author>DeSimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Caudill Laboratories CB 3290, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Reductively labile PRINT particles for the delivery of doxorubicin to HeLa cells</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>5008-9</pages><volume>130</volume><number>15</number><edition>2008/03/22</edition><keywords><keyword>Cell Survival/drug effects</keyword><keyword>Doxorubicin/*pharmacology</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Molecular Structure</keyword><keyword>Polymers/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 16</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18355010</accession-num><notes>Petros, Robby A&#xD;Ropp, Patricia A&#xD;DeSimone, Joseph M&#xD;U54-CA119343/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Apr 16;130(15):5008-9. Epub 2008 Mar 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18355010</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja801436j</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1361</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1361</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lakshman, M.</author><author>Xu, L.</author><author>Ananthanarayanan, V.</author><author>Cooper, J.</author><author>Takimoto, C. H.</author><author>Helenowski, I.</author><author>Pelling, J. C.</author><author>Bergan, R. C.</author></authors></contributors><auth-address>Division of Hematology/Oncology, Department of Medicine, Northwestern University Medical School and Robert H. Lurie Cancer Center of Northwestern University, Chicago, Illinois, USA.</auth-address><titles><title>Dietary genistein inhibits metastasis of human prostate cancer in mice</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>2024-32</pages><volume>68</volume><number>6</number><edition>2008/03/15</edition><keywords><keyword>Animals</keyword><keyword>Anticarcinogenic Agents/administration &amp; dosage/blood</keyword><keyword>Cell Growth Processes/drug effects</keyword><keyword>Cell Line, Tumor</keyword><keyword>Diet</keyword><keyword>Enzyme Activation/drug effects</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases/antagonists &amp;</keyword><keyword>inhibitors/biosynthesis</keyword><keyword>Genistein/*administration &amp; dosage/blood</keyword><keyword>Heat-Shock Proteins/antagonists &amp; inhibitors/biosynthesis</keyword><keyword>Humans</keyword><keyword>Lung Neoplasms/*prevention &amp; control/*secondary</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Neoplasm Proteins/antagonists &amp; inhibitors/biosynthesis</keyword><keyword>Prostatic Neoplasms/*drug therapy/metabolism/*pathology</keyword><keyword>Xenograft Model Antitumor Assays</keyword><keyword>p38 Mitogen-Activated Protein Kinases/antagonists &amp;</keyword><keyword>inhibitors/biosynthesis</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 15</date></pub-dates></dates><isbn>1538-7445 (Electronic)</isbn><accession-num>18339885</accession-num><abstract>Dietary genistein has been linked to lower prostate cancer (PCa) mortality. Metastasis is the ultimate cause of death from PCa. Cell detachment and invasion represent early steps in the metastatic cascade. We had shown that genistein inhibits PCa cell detachment and cell invasion in vitro. Genistein-mediated inhibition of activation of focal adhesion kinase (FAK) and of the p38 mitogen-activated protein kinase (MAPK)-heat shock protein 27 (HSP27) pathway has been shown by us to regulate PCa cell detachment and invasion effects, respectively. To evaluate the antimetastatic potential of genistein, we developed an animal model suited to evaluating antimetastatic drug efficacy. Orthotopically implanted human PC3-M PCa cells formed lung micrometastasis by 4 weeks in &gt;80% of inbred athymic mice. Feeding mice dietary genistein before implantation led to blood concentrations similar to those measured in genistein-consuming men. Genistein decreased metastases by 96%, induced nuclear morphometric changes in PC3-M cells indicative of increased adhesion (i.e., decreased detachment) but did not alter tumor growth. Genistein increased tumor levels of FAK, p38 MAPK, and HSP27 &quot;promotility&quot; proteins. However, the ratio of phosphorylated to total protein trended downward, indicating a failure to increase relative amounts of activated protein. This study describes a murine model of human PCa metastasis well suited for testing antimetastatic drugs. It shows for the first time that dietary concentrations of genistein can inhibit PCa cell metastasis. Increases in promotility proteins support the notion of cellular compensatory responses to antimotility effects induced by therapy. Studies of antimetastatic efficacy in man are warranted and are under way.</abstract><notes>Lakshman, Minalini&#xD;Xu, Li&#xD;Ananthanarayanan, Vijayalakshmi&#xD;Cooper, Joshua&#xD;Takimoto, Chris H&#xD;Helenowski, Irene&#xD;Pelling, Jill C&#xD;Bergan, Raymond C&#xD;CA119341/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2008 Mar 15;68(6):2024-32.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18339885</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>7.980</custom4><electronic-resource-num>68/6/2024 [pii]&#xD;10.1158/0008-5472.CAN-07-1246</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1145</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1145</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chong, H. S.</author><author>Song, H. A.</author><author>Lim, S.</author><author>Macrenaris, K.</author><author>Ma, X.</author><author>Lee, H.</author><author>Bui, P.</author><author>Meade, T.</author></authors></contributors><auth-address>Chemistry Division, Biological, Chemical, and Physical Sciences Department, Illinois Institute of Technology, 3101 S. Dearborn St., LS 182, Chicago, IL 60616, USA. chong@iit.edu</auth-address><titles><title>A novel cholic acid-based contrast enhancement agent for targeted MRI</title><secondary-title>Bioorg Med Chem Lett</secondary-title></titles><periodical><full-title>Bioorg Med Chem Lett</full-title></periodical><pages>2505-8</pages><volume>18</volume><number>7</number><edition>2008/03/14</edition><keywords><keyword>Chelating Agents/*chemical synthesis</keyword><keyword>Cholic Acid/*chemistry</keyword><keyword>Contrast Media/*chemistry</keyword><keyword>Gadolinium/*chemistry</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Ligands</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Microscopy, Electron, Transmission/methods</keyword><keyword>Nanoparticles/chemistry</keyword><keyword>Organometallic Compounds/*chemical synthesis</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 1</date></pub-dates></dates><isbn>1464-3405 (Electronic)</isbn><accession-num>18337094</accession-num><abstract>The novel Gd(III) complexes of heptadentate ligands NE3TA and NE3TA-Bn were prepared, and their relaxivities were measured and favorably compared to the commercially available MRI contrast enhancement agent Gd(DOTA). NE3TA was conjugated with cholic acid (CA) to produce CA-NE3TA. TEM images of Gd(CA-NE3TA) indicate that the complex self-assembles forming nano-sized micelles and displays an over threefold increased relaxivity compared to Gd(DOTA). The new cholic acid-conjugated nanoparticle MR contrast enhancement agent, Gd(CA-NE3TA) possesses great promise for use in targeted MRI.</abstract><notes>Chong, Hyun-Soon&#xD;Song, Hyun A&#xD;Lim, Sooyoun&#xD;Macrenaris, Keith&#xD;Ma, Xiang&#xD;Lee, Haisung&#xD;Bui, Phuong&#xD;Meade, Thomas&#xD;1R01-EB00-5866/EB/United States NIBIB&#xD;K22CA102637/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Bioorganic &amp; medicinal chemistry letters&#xD;Bioorg Med Chem Lett. 2008 Apr 1;18(7):2505-8. Epub 2008 Jan 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18337094</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>2.419</custom4><electronic-resource-num>S0960-894X(08)00059-0 [pii]&#xD;10.1016/j.bmcl.2008.01.044</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1612</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1612</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Solomon, A.</author><author>Mian, Y.</author><author>Ortega-Cava, C.</author><author>Liu, V. W.</author><author>Gurumurthy, C. B.</author><author>Naramura, M.</author><author>Band, V.</author><author>Band, H.</author></authors></contributors><auth-address>Division of Molecular Oncology, Evanston Northwestern Healthcare Research Institute, Department of Medicine, Feinberg School of Medicine, USA.</auth-address><titles><title>Upregulation of the let-7 microRNA with precocious development in lin-12/Notch hypermorphic Caenorhabditis elegans mutants</title><secondary-title>Dev Biol</secondary-title></titles><periodical><full-title>Dev Biol</full-title></periodical><pages>191-9</pages><volume>316</volume><number>2</number><edition>2008/03/13</edition><keywords><keyword>Animals</keyword><keyword>Animals, Genetically Modified</keyword><keyword>Blotting, Northern</keyword><keyword>Caenorhabditis elegans/*genetics/growth &amp; development</keyword><keyword>Gene Expression Regulation, Developmental</keyword><keyword>Green Fluorescent Proteins/genetics</keyword><keyword>Larva</keyword><keyword>MicroRNAs/*genetics</keyword><keyword>*Mutation</keyword><keyword>Phenotype</keyword><keyword>Receptors, Notch/genetics</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>1095-564X (Electronic)</isbn><accession-num>18334253</accession-num><abstract>The lin-12/Notch signaling pathway is conserved from worms to humans and is a master regulator of metazoan development. Here, we demonstrate that lin-12/Notch gain-of-function (gf) animals display precocious alae at the L4 larval stage with a significant increase in let-7 expression levels. Furthermore, lin-12(gf) animals display a precocious and higher level of let-7 gfp transgene expression in seam cells at L3 stage. Interestingly, lin-12(gf) mutant rescued the lethal phenotype of let-7 mutants similar to other known heterochronic mutants. We propose that lin-12/Notch signaling pathway functions in late developmental timing, upstream of or in parallel to the let-7 heterochronic pathway. Importantly, the human microRNA let-7a was also upregulated in various human cell lines in response to Notch 1 activation, suggesting an evolutionarily conserved cross-talk between let-7 and the canonical lin-12/Notch signaling pathway.</abstract><notes>Solomon, Aharon&#xD;Mian, Yousaf&#xD;Ortega-Cava, Cesar&#xD;Liu, Victor Won Tat&#xD;Gurumurthy, Channabasavaiah Basavaraju&#xD;Naramura, Mayumi&#xD;Band, Vimla&#xD;Band, Hamid&#xD;1U54 CA119341-01/CA/United States NCI&#xD;CA116552/CA/United States NCI&#xD;CA76118/CA/United States NCI&#xD;CA81076/CA/United States NCI&#xD;CA87986/CA/United States NCI&#xD;CA94143/CA/United States NCI&#xD;CA96844/CA/United States NCI&#xD;CA99163/CA/United States NCI&#xD;CA99900/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Developmental biology&#xD;Dev Biol. 2008 Apr 15;316(2):191-9. Epub 2008 Jan 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18334253</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.714</custom4><electronic-resource-num>S0012-1606(08)00006-7 [pii]&#xD;10.1016/j.ydbio.2007.12.046</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1715</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1715</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Waters, E. A.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Dept. of Cardiology, Washington University Medical School, Campus Box 8215, Cortex Building, Suite 101, 4320 Forest Park Ave., Saint Louis, MO, 63108, USA.</auth-address><titles><title>Contrast agents for MRI</title><secondary-title>Basic Res Cardiol</secondary-title></titles><periodical><full-title>Basic Res Cardiol</full-title></periodical><pages>114-21</pages><volume>103</volume><number>2</number><edition>2008/03/08</edition><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0300-8428 (Print)</isbn><accession-num>18324367</accession-num><abstract>Molecular imaging is a rapidly growing field with the potential to revolutionize cardiovascular medicine by shifting diagnostic focus from functional abnormalities which occur late in a disease process to the biochemical events which precipitate the earliest stages of disease. MRI is a modality well suited to this task as it allows a variety of contrast mechanisms for detection of epitopes of interest, as well as high-resolution anatomical localization and functional information. In this review, we discuss the widerange of available molecular MRI contrast agents and their application to diseases such as atherosclerosis, thrombus imaging, and stem cell tracking, along with opportunities for molecularly targeted drug delivery.</abstract><notes>Waters, Emily A&#xD;Wickline, Samuel A&#xD;Germany&#xD;Basic research in cardiology&#xD;Basic Res Cardiol. 2008 Mar;103(2):114-21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18324367</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>4.333</custom4><electronic-resource-num>10.1007/s00395-008-0711-6</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1672</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1672</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Urbanczyk-Pearson, L. M.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Department of Biochemistry and Molecular and Cell Biology, Department of Neurobiology and Physiology, Department of Radiology, Northwestern University, Evanston, Illinois 60201, USA.</auth-address><titles><title>Preparation of magnetic resonance contrast agents activated by beta-galactosidase</title><secondary-title>Nat Protoc</secondary-title></titles><periodical><full-title>Nat Protoc</full-title></periodical><pages>341-50</pages><volume>3</volume><number>3</number><edition>2008/03/08</edition><dates><year>2008</year></dates><isbn>1750-2799 (Electronic)</isbn><accession-num>18323804</accession-num><abstract>The preparation of beta-EgadMe and alpha-EgadMe, magnetic resonance (MR) contrast agents that can be used for in vivo detection of beta-galactosidase, is described. Diastereomerically pure beta-EgadMe can be synthesized by kinetically resolving the starting material as described in Step 1. The total time for the preparation of the racemic mixture of beta-EgadMe is about 8 d, and the total time for an diastereomerically resolved agent is about 9 d. The final metallated agent is stable at room temperature as a solid or in aqueous buffer (pH 5.5-10) indefinitely. Diastereomerically pure alpha-EgadMe can be prepared by beginning the synthesis with enantiomerically pure bromopropionic acid. The total time for the preparation of racemic alpha-EgadMe or diastereomerically pure alpha-EgadMe is about 8 d. The final metallated agent is stable at room temperature as a solid or in aqueous buffer (pH 5.5-10) indefinitely.</abstract><notes>Urbanczyk-Pearson, Lauren M&#xD;Meade, Thomas J&#xD;England&#xD;Nature protocols&#xD;Nat Protoc. 2008;3(3):341-50. Epub 2008 Feb 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18323804</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.175</custom4><electronic-resource-num>nprot.2007.529 [pii]&#xD;10.1038/nprot.2007.529</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1850</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1850</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Saunthararajah, Y.</author><author>Molokie, R.</author><author>Saraf, S.</author><author>Sidhwani, S.</author><author>Gowhari, M.</author><author>Vara, S.</author><author>Lavelle, D.</author><author>DeSimone, J.</author></authors></contributors><titles><title>Clinical effectiveness of decitabine in severe sickle cell disease</title><secondary-title>Br J Haematol</secondary-title></titles><periodical><full-title>Br J Haematol</full-title></periodical><pages>126-9</pages><volume>141</volume><number>1</number><edition>2008/03/08</edition><keywords><keyword>Adult</keyword><keyword>Anemia, Sickle Cell/*drug therapy</keyword><keyword>Azacitidine/*analogs &amp; derivatives/therapeutic use</keyword><keyword>DNA Modification Methylases/antagonists &amp; inhibitors</keyword><keyword>Enzyme Inhibitors/*therapeutic use</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Middle Aged</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1365-2141 (Electronic)</isbn><accession-num>18324975</accession-num><notes>Saunthararajah, Yogen&#xD;Molokie, Robert&#xD;Saraf, Santosh&#xD;Sidhwani, Seema&#xD;Gowhari, Michel&#xD;Vara, Steven&#xD;Lavelle, Donald&#xD;DeSimone, Joseph&#xD;Letter&#xD;England&#xD;British journal of haematology&#xD;Br J Haematol. 2008 Apr;141(1):126-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18324975</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>na</custom4><electronic-resource-num>BJH7027 [pii]&#xD;10.1111/j.1365-2141.2008.07027.x</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1393</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1393</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, R.</author><author>Guo, Y.</author><author>Han, B.M.</author><author>Yan, X.</author><author>Utleg, A.G.</author><author>Li, W.</author><author>Tu, L.C.</author><author>Wang, J.</author><author>Hood, L.</author><author>Xia, S.</author><author>Lin, B.</author></authors></contributors><auth-address>Shanghai Institute of Planned Parenthood Research, Shanghai, China; Systems Biomedicine Center, Shanghai Jiaotong University, Shanghai, China; Department of Urology, Shanghai 1st People&apos;s Hospital, Shanghai, China; The Institute for Systems Biology, Seattle, WA, USA</auth-address><titles><title>Proteomics cataloging analysis of human expressed prostatic secretions reveals rich source of biomarker candidates</title><secondary-title>PROTEOMICS - CLINICAL APPLICATIONS</secondary-title></titles><periodical><full-title>PROTEOMICS - CLINICAL APPLICATIONS</full-title></periodical><pages>543-555</pages><volume>2</volume><number>4</number><edition>2008/03/7</edition><keywords><keyword>Biomarker</keyword><keyword>Expressed prostatic secretions</keyword><keyword>Mass spectrometry</keyword><keyword>Prostate cancer</keyword></keywords><dates><year>2008</year></dates><isbn>1862-8354</isbn><abstract>Expressed prostatic secretions (EPS) contain proteins of prostate origin that may reflect the health status of the prostate and be used as diagnostic markers for prostate diseases including prostatitis, benign prostatic hyperplasia, and prostate cancer. Despite their importance and potential applications, a complete catalog of EPS proteins is not yet available. We, therefore, undertook a comprehensive analysis of the EPS proteome using 2-D micro-LC combined with MS/MS. Using stringent filtering criteria, we identified a list of 114 proteins with at least two unique-peptide hits and an additional 75 proteins with only a single unique-peptide hit. The proteins identified include kallikrein 2 (KLK2), KLK3 (prostate-specific antigen), KLK11, and nine cluster of differentiation (CD) molecules including CD10, CD13, CD14, CD26, CD66a, CD66c, CD 143, CD177, and CD224. To our knowledge, this list represents the first comprehensive characterization of the EPS proteome, and it provides a candidate biomarker list for targeted quantitative proteomics analysis using a multiple reaction monitoring (MRM) approach. To help prioritize candidate biomarkers, we constructed a protein-protein interaction network of the EPS proteins using Cytoscape (www.cytoscape.org), and overlaid the expression level changes from the Oncomine database onto the network.</abstract><notes>10.1002/prca.200780159</notes><urls><related-urls><url>http://dx.doi.org/10.1002/prca.200780159</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>na</custom4><electronic-resource-num>10.1002/prca.200780159 </electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1358</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1358</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kumar, R.</author><author>Roy, I. </author><author>Ohulchanskyy, T. Y.</author><author>Goswami, L. N.</author><author>Bonoiu, A. C.</author><author>Bergey, E. J.</author><author>Tramposch, K. M.</author><author>Maitra, A. </author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics, and Biophotonics, University at Buffalo, State University of New York, Buffalo, New York 14260-3000, and ! Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland 21231</auth-address><titles><title>Covalently Dye-Linked, Surface-Controlled, and Bioconjugated Organically Modified Silica Nanoparticles as Targeted Probes for Optical Imaging</title><secondary-title>ACS Nano</secondary-title></titles><periodical><full-title>ACS Nano</full-title></periodical><pages>449-456</pages><volume>2</volume><number>3</number><edition>2008/03/7</edition><dates><year>2008</year></dates><isbn>1936-0851</isbn><abstract>ABSTRACT In this paper we report the synthesis and characterization of organically modified silica (ORMOSIL) nanoparticles, covalently incorporating the fluorophore rhodamine-B, and surface-functionalized with a variety of active groups. The synthesized nanoparticles are of ultralow size (diameter ~20 nm), highly monodispersed, stable in aqueous suspension, and retain the optical properties of the incorporated fluorophore. The surface of the nanoparticles can be functionalized with a variety of active groups such as hydroxyl, thiol, amine, and carboxyl. The carboxyl groups on the surface were used to conjugate with various bioactive molecules such as transferrin, as well as monoclonal antibodies such as anti-claudin 4 and anti-mesothelin, for targeted delivery to pancreatic cancer cell lines. In vitro experiments have revealed that the cellular uptake of these bioconjugated (targeted) nanoparticles is significantly higher than that of the nonconjugated ones. The ease of surface functionalization and incorporation of a variety of biotargeting molecules, combined with their observed noncytotoxicity, makes these fluorescent ORMOSIL nanoparticles potential candidates as efficient probes for optical bioimaging, both in vitro and in vivo.</abstract><work-type>Journal Article</work-type><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/nn700370b</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2008</custom3><custom4>5.472</custom4><electronic-resource-num>10.1021/nn700370b</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1397</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1397</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lin, B.</author><author>Utleg, A. G.</author><author>Gravdal, K.</author><author>White, J. T.</author><author>Halvorsen, O. J.</author><author>Lu, W.</author><author>True, L. D.</author><author>Vessella, R.</author><author>Lange, P. H.</author><author>Nelson, P. S.</author><author>Hood, L.</author><author>Kalland, K. H.</author><author>Akslen, L. A.</author></authors></contributors><auth-address>Zhejiang-California International Nanosystems Institute, Hangzhou, China. bylin@u.washington.edu</auth-address><titles><title>WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence</title><secondary-title>Clin Cancer Res</secondary-title></titles><periodical><full-title>Clin Cancer Res</full-title></periodical><pages>1397-406</pages><volume>14</volume><number>5</number><edition>2008/03/05</edition><keywords><keyword>Adenocarcinoma/genetics/metabolism/pathology</keyword><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/immunology/metabolism</keyword><keyword>Blotting, Western</keyword><keyword>Follow-Up Studies</keyword><keyword>Gene Expression Profiling</keyword><keyword>Gene Expression Regulation, Neoplastic/*physiology</keyword><keyword>Humans</keyword><keyword>Immunoenzyme Techniques</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Neoplasm Recurrence, Local/*pathology</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Prognosis</keyword><keyword>Prostate-Specific Antigen/metabolism</keyword><keyword>Prostatic Hyperplasia/genetics/metabolism/pathology</keyword><keyword>Prostatic Neoplasms/*genetics/metabolism/pathology</keyword><keyword>Proteins/*genetics</keyword><keyword>RNA, Messenger/genetics/metabolism</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Survival Rate</keyword><keyword>Time Factors</keyword><keyword>Tumor Markers, Biological/genetics/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>18316561</accession-num><abstract>PURPOSE: Prostate cancer is the third leading cause of cancer death in the United States, following lung and colorectal cancer. We previously identified WDR19 as a prostate-specific, androgen-regulated gene. Here, we evaluate its utility as a prostate cancer tissue marker for diagnosis and prognostic evaluation. EXPERIMENTAL DESIGN: Real-time quantitative PCR was done on a panel of prostate tissue isolated by laser capture microdissection. After generating antibodies against WDR19, tissue microarrays (TMA) were employed to compare WDR19 expression between normal, benign prostatic hyperplasia, and prostate cancer tissue. RESULTS: Using microarrays and real-time quantitative PCR, we showed that WDR19 mRNA expression was increased in cancer. We further showed that WDR19 protein is localized to cytoplasmic subcellular granules and is expressed exclusively in prostate epithelia. Large-scale immunohistochemical staining using TMAs reveals a significant percentage of increase in intensely staining tissue cores in cancer tissue when compared with normal or benign prostatic hyperplastic tissue. Based on the analysis of a separate TMA for which clinical follow-up information was available, low-intensity WDR19 staining was significantly associated with decreased time to biochemical failure (P = 0.006) and with decreased time to locoregional recurrence (P = 0.050). CONCLUSIONS: WDR19 should be added to the list of prostate cancer tissue markers. The continued expansion of a multiple-marker panel will conceivably increase the sensitivity and specificity of prostate cancer diagnosis and prognosis.</abstract><notes>Lin, Biaoyang&#xD;Utleg, Angelita G&#xD;Gravdal, Karsten&#xD;White, James T&#xD;Halvorsen, Ole J&#xD;Lu, Wei&#xD;True, Lawrence D&#xD;Vessella, Robert&#xD;Lange, Paul H&#xD;Nelson, Peter S&#xD;Hood, Leroy&#xD;Kalland, Karl-Henning&#xD;Akslen, Lars A&#xD;5P50GM076547/GM/United States NIGMS&#xD;5U54CA119347/CA/United States NCI&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 Mar 1;14(5):1397-406.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18316561</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>6.646</custom4><electronic-resource-num>14/5/1397 [pii]&#xD;10.1158/1078-0432.CCR-07-1535</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1141</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1141</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cho, K.</author><author>Wang, X.</author><author>Nie, S.</author><author>Chen, Z. G.</author><author>Shin, D. M.</author></authors></contributors><auth-address>Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Therapeutic nanoparticles for drug delivery in cancer</title><secondary-title>Clin Cancer Res</secondary-title></titles><periodical><full-title>Clin Cancer Res</full-title></periodical><pages>1310-6</pages><volume>14</volume><number>5</number><edition>2008/03/05</edition><keywords><keyword>Antineoplastic Agents/*administration &amp; dosage</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Nanomedicine</keyword><keyword>Nanoparticles/*administration &amp; dosage</keyword><keyword>Neoplasms/*drug therapy</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>18316549</accession-num><abstract>Cancer nanotherapeutics are rapidly progressing and are being implemented to solve several limitations of conventional drug delivery systems such as nonspecific biodistribution and targeting, lack of water solubility, poor oral bioavailability, and low therapeutic indices. To improve the biodistribution of cancer drugs, nanoparticles have been designed for optimal size and surface characteristics to increase their circulation time in the bloodstream. They are also able to carry their loaded active drugs to cancer cells by selectively using the unique pathophysiology of tumors, such as their enhanced permeability and retention effect and the tumor microenvironment. In addition to this passive targeting mechanism, active targeting strategies using ligands or antibodies directed against selected tumor targets amplify the specificity of these therapeutic nanoparticles. Drug resistance, another obstacle that impedes the efficacy of both molecularly targeted and conventional chemotherapeutic agents, might also be overcome, or at least reduced, using nanoparticles. Nanoparticles have the ability to accumulate in cells without being recognized by P-glycoprotein, one of the main mediators of multidrug resistance, resulting in the increased intracellular concentration of drugs. Multifunctional and multiplex nanoparticles are now being actively investigated and are on the horizon as the next generation of nanoparticles, facilitating personalized and tailored cancer treatment.</abstract><notes>Cho, Kwangjae&#xD;Wang, Xu&#xD;Nie, Shuming&#xD;Chen, Zhuo Georgia&#xD;Shin, Dong M&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2008 Mar 1;14(5):1310-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18316549</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>6.646</custom4><electronic-resource-num>14/5/1310 [pii]&#xD;10.1158/1078-0432.CCR-07-1441</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2378</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2378</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Magrini, A.</author><author>Dawson, M. I.</author><author>Rosato, N.</author><author>Bergamaschi, A.</author><author>Mustelin, T.</author></authors></contributors><auth-address>Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.</auth-address><titles><title>Noncovalently silylated carbon nanotubes decorated with quantum dots</title><secondary-title>Carbon N Y</secondary-title></titles><periodical><full-title>Carbon N Y</full-title></periodical><pages>673-676</pages><volume>45</volume><number>3</number><edition>2008/03/04</edition><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0008-6223 (Print)</isbn><accession-num>18311318</accession-num><abstract>A nanoassembly of single-walled carbon nanotubes coated by a thin layer of silica followed by quantum dots was prepared. That the quantum dots retained their photoluminescent properties after deposition onto the silylated carbon nanotubes suggests that the thin layer of silica prevented the quenching of the fluorescence by the nanotubes. This fluorescent nanoassembly represents an excellent building block for photoelectric and optical devices and biological nanoprobes.</abstract><notes>U54 CA119335-02/NCI NIH HHS/United States&#xD;Carbon&#xD;Carbon N Y. 2007 Mar;45(3):673-676.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom2>1920329</custom2><custom3>NIHMS20541</custom3><custom4>4.812</custom4><electronic-resource-num>10.1016/j.carbon.2006.11.027 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1374</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1374</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, Hyung-Kun</author><author>Soukasene, Stephen</author><author>Jiang, Hongzhou</author><author>Zhang, Shuming</author><author>Feng, Wenchun</author><author>Stupp, Samuel I.</author></authors></contributors><titles><title>Light-induced self-assembly of nanofibers inside liposomes</title><secondary-title>Soft Matter</secondary-title></titles><periodical><full-title>Soft Matter</full-title></periodical><pages>962-964</pages><volume>4</volume><number>5</number><edition>2008/03/4</edition><dates><year>2008</year></dates><abstract>Spatially confined self-assembly of peptide amphiphile nanofibers inside liposomes is triggered by light.</abstract><notes>10.1039/b719486b</notes><urls><related-urls><url>http://dx.doi.org/10.1039/b719486b</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.890</custom4><electronic-resource-num>10.1039/b719486b</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2465</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2465</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Grozema, Ferdinand C.</author><author>Tonzani, Stefano</author><author>Berlin, Yuri A.</author><author>Schatz, George C.</author><author>Siebbeles, Laurens D. A.</author><author>Ratner, Mark A.</author></authors></contributors><titles><title>Effect of Structural Dynamics on Charge Transfer in DNA Hairpins</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>5157-5166</pages><volume>130</volume><number>15</number><edition>2008/03</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>0002-7863</isbn><notes>doi: 10.1021/ja078162j</notes><urls><related-urls><url>http://dx.doi.org/10.1021/ja078162j</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja078162j</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1710</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1710</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, Y. C.</author><author>Han, J.</author></authors></contributors><auth-address>Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Pre-binding dynamic range and sensitivity enhancement for immuno-sensors using nanofluidic preconcentrator</title><secondary-title>Lab Chip</secondary-title></titles><periodical><full-title>Lab Chip</full-title></periodical><pages>392-4</pages><volume>8</volume><number>3</number><edition>2008/02/29</edition><keywords><keyword>Binding Sites</keyword><keyword>Immunoassay/*instrumentation</keyword><keyword>Kinetics</keyword><keyword>Microfluidics/*instrumentation</keyword><keyword>*Nanotechnology</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>18305855</accession-num><abstract>Almost all immuno-biosensors are inherently limited by the quality of antibodies available for the target molecule, and obtaining a highly sensitive antibody for a given target molecule is a challenge. We describe a highly efficient and flexible way to enhance immunoassay detection sensitivity and binding kinetics using a nanofluidic based electrokinetic preconcentrator. The device is a microfluidic integration of charge-based biomolecule concentrator and a bead-based immunoassay. Because the preconcentrator can increase the local biomolecule concentration by many orders of magnitude, it gives the immuno-sensor better sensitivity and faster binding kinetics. With a 30 min preconcentration, we were able to enhance the immunoassay sensitivity (with molecular background) by more than 500 fold from higher 50 pM to the sub 100 fM range. Moreover, by adjusting the preconcentration time, we can switch the detection range of the given bead-based assay (from 10-10 000 ng ml(-1) to 0.01-10 000 ng ml(-1)) to have a broader dynamic range of detection. As the system can enhance both detection sensitivity and dynamic range, it can be used to address the most critical detection issues in the detection of common disease biomarkers.</abstract><notes>Wang, Ying-Chih&#xD;Han, Jongyoon&#xD;CA119402/CA/United States NCI&#xD;EB005743/EB/United States NIBIB&#xD;GM68762/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Lab on a chip&#xD;Lab Chip. 2008 Mar;8(3):392-4. Epub 2008 Jan 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18305855</url></related-urls></urls><custom1>CNPP - U. of Miss.</custom1><custom3>2008</custom3><custom4>7.000</custom4><electronic-resource-num>10.1039/b717220f</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1258</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1258</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hong, R.</author><author>Cima, M. J.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Harvard Medical School, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.</auth-address><titles><title>Magnetic microparticle aggregation for viscosity determination by MR</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><pages>515-20</pages><volume>59</volume><number>3</number><edition>2008/02/29</edition><keywords><keyword>Contrast Media/chemistry</keyword><keyword>Ferrosoferric Oxide/chemistry</keyword><keyword>Iron/*chemistry</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Oxides/*chemistry</keyword><keyword>Particle Size</keyword><keyword>Viscosity</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0740-3194 (Print)</isbn><accession-num>18306403</accession-num><abstract>Micron-sized magnetic particles were induced to aggregate when placed in homogeneous magnetic fields, like those of MR imagers and relaxometers, and then spontaneously returned to their dispersed state when removed from the field. Associated with the aggregation and dispersion of the magnetic particles were time-dependent increases and decreases in the spin-spin relaxation time (T2) of the water. Magnetic nanoparticles, with far smaller magnetic moments per particle, did not undergo magnetically induced aggregation and exhibited time-independent values of T2. The rate of T2 change associated with magnetic microparticle aggregation was used to determine the viscosity of liquid samples, providing a method that can be of particular advantage for determining the viscosity of small volumes of potentially biohazardous samples of blood or blood plasma.</abstract><notes>Hong, Rui&#xD;Cima, Michael J&#xD;Weissleder, Ralph&#xD;Josephson, Lee&#xD;R01-EB004626/EB/United States NIBIB&#xD;R01-EB00662/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine&#xD;Magn Reson Med. 2008 Mar;59(3):515-20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18306403</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>4.163</custom4><electronic-resource-num>10.1002/mrm.21526</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1049</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1049</key></foreign-keys><ref-type name="Hearing">14</ref-type><contributors><authors><author>Agrawal, A.</author><author>Deo, R.</author><author>Wang, G. D.</author><author>Wang, M. D.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, 101 Woodruff Circle, Suite 2001, Atlanta, GA 30322, USA.</auth-address><titles><title>Nanometer-scale mapping and single-molecule detection with color-coded nanoparticle probes</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>3298-303</pages><volume>105</volume><number>9</number><edition>2008/02/29</edition><keywords><keyword>Algorithms</keyword><keyword>Color</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>Molecular Probes/*chemistry/diagnostic use</keyword><keyword>Nanoparticles/*chemistry/diagnostic use</keyword><keyword>Nanotechnology/methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 4</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18305159</accession-num><abstract>We report a method for single-molecule detection and biomolecular structural mapping based on dual-color imaging and automated colocalization of bioconjugated nanoparticle probes at nanometer precision. In comparison with organic dyes and fluorescent proteins, nanoparticle probes such as fluorescence energy-transfer nanobeads and quantum dots provide significant advantages in signal brightness, photostability, and multicolor-light emission. As a result, we have achieved routine two-color superresolution imaging and single-molecule detection with standard fluorescence microscopes and inexpensive digital color cameras. By using green and red nanoparticles to simultaneously recognize two binding sites on a single target, individual biomolecules such as nucleic acids are detected and identified without target amplification or probe/target separation. We also demonstrate that a powerful astrophysical method (originally developed to analyze crowded stellar fields) can be used for automated and rapid statistical analysis of nanoparticle colocalization signals. The ability to rapidly localize bright nanoparticle probes at nanometer precision has implications not only for ultrasensitive medical detection but also for structural mapping of molecular complexes in which individual components are tagged with color-coded nanoparticles.</abstract><notes>Agrawal, Amit&#xD;Deo, Rajesh&#xD;Wang, Geoffrey D&#xD;Wang, May D&#xD;Nie, Shuming&#xD;P20 GM072069/GM/United States NIGMS&#xD;R01 CA108468/CA/United States NCI&#xD;R01 GM60562/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3298-303. Epub 2008 Feb 27.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18305159</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>10.228</custom4><electronic-resource-num>0712351105 [pii]&#xD;10.1073/pnas.0712351105</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1613</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1613</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Soman, N. R.</author><author>Lanza, G. M.</author><author>Heuser, J. M.</author><author>Schlesinger, P. H.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Washington University School of Medicine, St. Louis, MI 63110, USA.</auth-address><titles><title>Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>1131-6</pages><volume>8</volume><number>4</number><edition>2008/02/28</edition><keywords><keyword>Antineoplastic Agents/*administration &amp; dosage/pharmacology</keyword><keyword>Circular Dichroism</keyword><keyword>*Drug Carriers</keyword><keyword>Fluorescence</keyword><keyword>Fluorocarbons/*chemistry</keyword><keyword>Melitten/*administration &amp; dosage/pharmacology</keyword><keyword>*Nanostructures</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18302330</accession-num><abstract>The therapeutic potential of cytolytic peptides is plagued by nonspecificity and enzymatic degradation. We report the first stable incorporation of melittin (a 26 amino acid amphipathic peptide) into an outer lipid monolayer of perfluorocarbon nanoparticles. Melittin binds avidly to the nanoparticles (dissociation constant approximately 3.27 nM) and retains its pore-forming activity after contact-mediated delivery to model bilayer membrane (liposomes) thereby demonstrating the effectiveness of perfluorocarbon nanoparticles as unique nanocarriers for cytolytic peptides.</abstract><notes>Soman, Neelesh R&#xD;Lanza, Gregory M&#xD;Heuser, John M&#xD;Schlesinger, Paul H&#xD;Wickline, Samuel A&#xD;R01 HL 073646/HL/United States NHLBI&#xD;U54 CA119342/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2008 Apr;8(4):1131-6. Epub 2008 Feb 27.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18302330</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl073290r</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1796</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1796</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zuo, T.</author><author>Walker, K.</author><author>Olmstead, M. M.</author><author>Melin, F.</author><author>Holloway, B. C.</author><author>Echegoyen, L.</author><author>Dorn, H. C.</author><author>Chaur, M. N.</author><author>Chancellor, C. J.</author><author>Beavers, C. M.</author><author>Balch, A. L.</author><author>Athans, A. J.</author></authors></contributors><auth-address>Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.</auth-address><titles><title>New egg-shaped fullerenes: non-isolated pentagon structures of Tm3N@C(s)(51 365)-C84 and Gd3N@C(s)(51 365)-C84</title><secondary-title>Chem Commun (Camb)</secondary-title></titles><periodical><full-title>Chem Commun (Camb)</full-title></periodical><pages>1067-9</pages><number>9</number><edition>2008/02/23</edition><keywords><keyword>Crystallography, X-Ray</keyword><keyword>Fullerenes/*chemistry</keyword><keyword>Gadolinium/*chemistry</keyword><keyword>Models, Molecular</keyword><keyword>Nitrogen/*chemistry</keyword><keyword>Thulium/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 7</date></pub-dates></dates><isbn>1359-7345 (Print)</isbn><accession-num>18292892</accession-num><abstract>Although there are 51 568 non-IPR and 24 IPR structures for C84, the egg-shaped endohedral fullerenes Tm3N@C(s)(51 365)-C84 and Gd3N@C(s)(51 365)-C84 utilize the same non-IPR cage structure as found initially for Tb3N@C(s)(51 365)-C84.</abstract><notes>Zuo, Tianming&#xD;Walker, Kenneth&#xD;Olmstead, Marilyn M&#xD;Melin, Frederic&#xD;Holloway, Brian C&#xD;Echegoyen, Luis&#xD;Dorn, Harry C&#xD;Chaur, Manuel N&#xD;Chancellor, Christopher J&#xD;Beavers, Christine M&#xD;Balch, Alan L&#xD;Athans, Andreas J&#xD;1R01-CA119371-01/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Chemical communications (Cambridge, England)&#xD;Chem Commun (Camb). 2008 Mar 7;(9):1067-9. Epub 2008 Jan 31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18292892</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>4.997</custom4><electronic-resource-num>10.1039/b716037b</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1260</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1260</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hoover, D. K.</author><author>Chan, E. W.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and the Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Asymmetric peptide nanoarray surfaces for studies of single cell polarization</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>3280-1</pages><volume>130</volume><number>11</number><edition>2008/02/23</edition><keywords><keyword>3T3 Cells</keyword><keyword>Adsorption</keyword><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Polarity</keyword><keyword>Fibroblasts/*chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Hydroquinones/chemistry</keyword><keyword>Ligands</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Molecular Structure</keyword><keyword>Nanotechnology/methods</keyword><keyword>Organelles/chemistry</keyword><keyword>*Protein Array Analysis</keyword><keyword>Sulfhydryl Compounds/chemistry</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 19</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18290651</accession-num><notes>Hoover, Diana K&#xD;Chan, Eugene W L&#xD;Yousaf, Muhammad N&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Mar 19;130(11):3280-1. Epub 2008 Feb 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18290651</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja711016m</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1159</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1159</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cyrus, T.</author><author>Zhang, H.</author><author>Allen, J. S.</author><author>Williams, T. A.</author><author>Hu, G.</author><author>Caruthers, S. D.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Division of Cardiology, Washington University School of Medicine, Saint Louis, Mo. 63108, USA. tcyrus@im.wustl.edu</auth-address><titles><title>Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury</title><secondary-title>Arterioscler Thromb Vasc Biol</secondary-title></titles><periodical><full-title>Arterioscler Thromb Vasc Biol</full-title></periodical><pages>820-6</pages><volume>28</volume><number>5</number><edition>2008/02/23</edition><keywords><keyword>Angioplasty, Balloon/*adverse effects</keyword><keyword>Animals</keyword><keyword>Anti-Bacterial Agents/*administration &amp; dosage/pharmacology</keyword><keyword>Constriction, Pathologic/drug therapy/pathology/*prevention &amp; control</keyword><keyword>Drug-Eluting Stents</keyword><keyword>Endothelium, Vascular/drug effects/pathology</keyword><keyword>Femoral Artery/drug effects/pathology</keyword><keyword>Integrin alphaVbeta3/*administration &amp; dosage</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Male</keyword><keyword>Nanomedicine/methods</keyword><keyword>Nanoparticles/administration &amp; dosage/*therapeutic use</keyword><keyword>Rabbits</keyword><keyword>Sirolimus/*administration &amp; dosage/pharmacology</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1524-4636 (Electronic)</isbn><accession-num>18292395</accession-num><abstract>BACKGROUND: Drug eluting stents prevent vascular restenosis but can delay endothelial healing. A rabbit femoral artery model of stenosis formation after vascular injury was used to study the effect of intramural delivery of alpha(v)beta(3)-integrin-targeted rapamycin nanoparticles on vascular stenosis and endothelial healing responses. METHODS AND RESULTS: Femoral arteries of 48 atherosclerotic rabbits underwent balloon stretch injury and were locally treated with either (1) alpha(v)beta(3)-targeted rapamycin nanoparticles, (2) alpha(v)beta(3)-targeted nanoparticles without rapamycin, (3) nontargeted rapamycin nanoparticles, or (4) saline. Intramural binding of integrin-targeted paramagnetic nanoparticles was confirmed with MR molecular imaging (1.5 T). MR angiograms were indistinguishable between targeted and control arteries at baseline, but 2 weeks later they showed qualitatively less luminal plaque in the targeted rapamycin treated segments compared with contralateral control vessels. In a first cohort of 19 animals (38 vessel segments), microscopic morphometric analysis of the rapamycin-treated segments revealed a 52% decrease in the neointima/media ratio (P&lt;0.05) compared to control. No differences (P&gt;0.05) were observed among balloon injured vessel segments treated with alpha(v)beta(3)-targeted nanoparticles without rapamycin, nontargeted nanoparticles with rapamycin, or saline. In a second cohort of 29 animals, endothelial healing followed a parallel pattern over 4 weeks in the vessels treated with alpha(v)beta(3)-targeted rapamycin nanoparticles and the 3 control groups. CONCLUSIONS: Local intramural delivery of alpha(v)beta(3)-targeted rapamycin nanoparticles inhibited stenosis without delaying endothelial healing after balloon injury.</abstract><notes>Cyrus, Tillmann&#xD;Zhang, Huiying&#xD;Allen, John S&#xD;Williams, Todd A&#xD;Hu, Grace&#xD;Caruthers, Shelton D&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;EB-01704/EB/United States NIBIB&#xD;HL-73646/HL/United States NHLBI&#xD;HL-78631/HL/United States NHLBI&#xD;N01-CO-37007/CO/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Arteriosclerosis, thrombosis, and vascular biology&#xD;Arterioscler Thromb Vasc Biol. 2008 May;28(5):820-6. Epub 2008 Feb 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18292395</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>7.221</custom4><electronic-resource-num>ATVBAHA.107.156281 [pii]&#xD;10.1161/ATVBAHA.107.156281</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2074</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2074</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, Z. B.</author><author>Wu, Z.</author><author>Chen, K.</author><author>Ryu, E. K.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology, Biophysics, and Bio-X Program, Stanford University School of Medicine, Stanford, California 94305-5484, USA.</auth-address><titles><title>18F-labeled BBN-RGD heterodimer for prostate cancer imaging</title><secondary-title>J Nucl Med</secondary-title></titles><periodical><full-title>J Nucl Med</full-title></periodical><pages>453-61</pages><volume>49</volume><number>3</number><edition>2008/02/22</edition><keywords><keyword>Animals</keyword><keyword>Bombesin/ analogs &amp; derivatives/chemistry/diagnostic use/pharmacokinetics</keyword><keyword>Cell Line, Tumor</keyword><keyword>Dimerization</keyword><keyword>Humans</keyword><keyword>Isotope Labeling</keyword><keyword>Male</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Oligopeptides/chemistry/ diagnostic use/ pharmacokinetics</keyword><keyword>Organ Specificity</keyword><keyword>Prostatic Neoplasms/ metabolism/ radionuclide imaging</keyword><keyword>Radiopharmaceuticals/chemical synthesis/diagnostic use/pharmacokinetics</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>18287274</accession-num><abstract>Both bombesin (BBN) analogs and cyclic RGD peptides have been suitably radiolabeled for prostate cancer imaging. However, the limited expression of gastrin-releasing peptide receptor (GRPR) and integrin alpha(v)beta(3) as well as unfavorable in vivo kinetics limited further applications of these imaging agents. We hypothesize that a peptide ligand recognizing both GRPR and integrin will be advantageous because of its dual-receptor-targeting ability. METHODS: A BBN-RGD heterodimer was synthesized from bombesin(7-14) and c(RGDyK) through a glutamate linker and then labeled with (18)F via the N-succinimidyl-4-(18)F-fluorobenzoate ((18)F-SFB) prosthetic group. The receptor-binding characteristics and tumor-targeting efficacy of (18)F-FB-BBN-RGD were tested in vitro and in vivo. RESULTS: FB-BBN-RGD had comparable integrin alpha(v)beta(3)-binding affinity with c(RGDyK) and comparable GRPR-binding affinity with BBN(7-14). (18)F-FB-BBN-RGD had significantly higher tumor uptake compared with monomeric RGD and monomeric BBN peptide tracer analogs at all time points examined. The PC-3 tumor uptake of (18)F-FB-BBN-RGD was inhibited only partially in the presence of an excess amount of unlabeled BBN(7-14) or c(RGDyK) but was blocked completely in the presence of both BBN(7-14) and c(RGDyK). Compared with (18)F-FB-BBN and (18)F-FB-RGD, (18)F-FB-BBN-RGD also had improved pharmacokinetics, resulting in a significantly higher imaging quality. CONCLUSION: Dual integrin alpha(v)beta(3) and GRPR recognition showed significantly improved tumor-targeting efficacy and pharmacokinetics compared with (18)F-labeled RGD and BBN analogs. The same heterodimeric ligand design may also be applicable to other receptor system combinations and other imaging modalities.</abstract><notes>Li, Zi-Bo&#xD;Wu, Zhanhong&#xD;Chen, Kai&#xD;Ryu, Eun Kyoung&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2008 Mar;49(3):453-61. Epub 2008 Feb 20.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.282</custom4><electronic-resource-num>jnumed.107.048009 [pii]&#xD;10.2967/jnumed.107.048009 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1596</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1596</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shu, Chun-Ying</author><author>Wang, Chun-Ru</author><author>Zhang, Jian-Fei</author><author>Gibson, Harry W.</author><author>Dorn, Harry C.</author><author>Corwin, Frank D.</author><author>Fatouros, Panos P.</author><author>Dennis, T. John S.</author></authors></contributors><auth-address>Institute of Chemistry, Chinese Academy of Sciences, Beijing 100080, China, Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24060, Department of Radiology, Virginia Commonwealth University, Richmond, Virginia 23298, and Centre for Materials Research, Queen Mary, University of London, London E1 4NS, U.K.</auth-address><titles><title>Organophosphonate Functionalized Gd@C82 as a Magnetic Resonance Imaging Contrast Agent</title><secondary-title>Chem. Mater.</secondary-title></titles><periodical><full-title>Chem. Mater.</full-title></periodical><pages>2106-2109</pages><volume>20</volume><number>6</number><edition>2008/02/21 </edition><dates><year>2008</year></dates><isbn>0897-4756</isbn><abstract>Abstract: A new magnetic resonance imaging contrast agent containing organophosphonate functional groups was synthesized in high yield by a simple synthesis procedure. This molecule exhibits much higher longitudinal water proton relaxivity (37.0 mM 1 s 1) than commercial Omniscan (Gd-DTPA BMA, 5.7 mM 1 s 1) at 0.35 T. Notably, the relaxivity is larger than that of carboxylated Gd@C82 (16.0 mM 1 s 1) under the same conditions, indicating that the functional groups have an important role on the image contrast enhancement. In addition, the introduction of phosphonate substituents may provide bone-targeting MRI contrast agents.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/cm7023982</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>5.932</custom4><electronic-resource-num>10.1021/cm7023982 </electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1787</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1787</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zheng, Q.</author><author>Bonoiu, A.</author><author>Ohulchanskyy, T. Y.</author><author>He, G. S.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Department of Chemistry, Institute for Lasers, Photonics, and Biophotonics, State University of New York at Buffalo, Buffalo, New York 14260, USA.</auth-address><titles><title>Water-soluble two-photon absorbing nitrosyl complex for light-activated therapy through nitric oxide release</title><secondary-title>Mol Pharm</secondary-title></titles><periodical><full-title>Mol Pharm</full-title></periodical><pages>389-98</pages><volume>5</volume><number>3</number><edition>2008/02/20</edition><dates><year>2008</year><pub-dates><date>May-Jun</date></pub-dates></dates><isbn>1543-8384 (Print)</isbn><accession-num>18281943</accession-num><abstract>A water-soluble nitrosyl complex with large two-photon absorption was synthesized by incorporating a two-photon absorbing chromophore with tetra(ethylene glycol) units, into the Roussin&apos;s red salt. The nitrosyl complex exhibits quenched emission due to energy transfer from the two-photon chromophore to the Roussin&apos;s red salt. The nitric oxide (NO) release induced by one- or two-photon irradiation was detected by EPR spectroscopy with a chemical probe, the Fe(II)- N-(dithiocarbamoyl)- N-methyl- d-glucamine (Fe-MGD) complex. Increased one- or two-photon excited fluorescence, with a concomitant photochemical release of NO, was observed upon one- or two-photon light irradiation. With the observed light-dependent cytotoxicity against cancer cells of the water-soluble nitrosyl complex, it was demonstrated that two-photon-functionalized nitrosyl complexes can be effective NO donors for light-activated treatment.</abstract><notes>Zheng, Qingdong&#xD;Bonoiu, Adela&#xD;Ohulchanskyy, Tymish Y&#xD;He, Guang S&#xD;Prasad, Paras N&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Molecular pharmaceutics&#xD;Mol Pharm. 2008 May-Jun;5(3):389-98. Epub 2008 Feb 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18281943</url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2008</custom3><custom4>4.388</custom4><electronic-resource-num>10.1021/mp700117s</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1722</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1722</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Westcott, N. P.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Synergistic microfluidic and electrochemical strategy to activate and pattern surfaces selectively with ligands and cells</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>2261-5</pages><volume>24</volume><number>6</number><edition>2008/02/19</edition><keywords><keyword>3T3 Cells</keyword><keyword>Amines/chemical synthesis/*chemistry</keyword><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Movement</keyword><keyword>Cells, Cultured</keyword><keyword>Electrochemistry</keyword><keyword>Electrolytes/chemistry</keyword><keyword>Fibroblasts/*chemistry</keyword><keyword>Hydroquinones/chemical synthesis/*chemistry</keyword><keyword>Ligands</keyword><keyword>Mice</keyword><keyword>Microfluidics/instrumentation/*methods</keyword><keyword>Particle Size</keyword><keyword>Quinones/*chemistry</keyword><keyword>Solutions/chemistry</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 18</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>18278968</accession-num><abstract>We show a straightforward, flexible synergistic approach that combines microfluidics, electrochemistry, and a general immobilization strategy to activate regions of a substrate selectively for the precise immobilization of ligands and cells in patterns for a variety of cell-based assays and cell migration and cell adhesion studies. We develop microfluidic microchips to control the delivery of electrolyte solution to select regions of an electroactive hydroquinone SAM. Once an electrical potential is applied to the substrate, only the hydroquinone exposed to electrolyte solution within the microfluidic channels oxidizes to the corresponding quinone. The quinone form can then react chemoselectively with oxyamine-tethered ligands to pattern the surface. Therefore, this microfluidic/electrochemistry strategy selectively activates the surface for ligand patterning that exactly matches the channel design of the microfluidic channel. We demonstrate the ease of this system by first quantitatively characterizing the electrochemical activation and immobilization of ligands on the surface. Second, we immobilize a fluorescent dye to show the fidelity of the methodology, and third, we show the immobilization of biospecific cell adhesive peptide ligands to pattern cells. This is the first report that combines microfluidics/electrochemistry and a general electroactive immobilization strategy to pattern ligands and cells. We believe that this strategy will be of broad utility for applications ranging from fundamental studies of cell behavior to patterning molecules on a variety of materials for molecular electronic devices.</abstract><notes>Westcott, Nathan P&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2008 Mar 18;24(6):2261-5. Epub 2008 Feb 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18278968</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>4.347</custom4><electronic-resource-num>10.1021/la703744v</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1540</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1540</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rhee, W. J.</author><author>Santangelo, P. J.</author><author>Jo, H.</author><author>Bao, G.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.</auth-address><titles><title>Target accessibility and signal specificity in live-cell detection of BMP-4 mRNA using molecular beacons</title><secondary-title>Nucleic Acids Res</secondary-title></titles><periodical><full-title>Nucleic Acids Res</full-title></periodical><pages>e30</pages><volume>36</volume><number>5</number><edition>2008/02/16</edition><keywords><keyword>Animals</keyword><keyword>Base Sequence</keyword><keyword>Bone Morphogenetic Proteins/*genetics/metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Humans</keyword><keyword>In Situ Hybridization, Fluorescence</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Molecular Sequence Data</keyword><keyword>Oligonucleotide Probes/*chemistry</keyword><keyword>RNA, Messenger/*analysis/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1362-4962 (Electronic)</isbn><accession-num>18276638</accession-num><abstract>The ability to visualize mRNA in single living cells and monitor in real-time the changes of mRNA level and localization can provide unprecedented opportunities for biological and disease studies. However, the mRNA detection specificity and sensitivity are critically dependent on the selection of target sequences and their accessibility. We carried out an extensive study of the target accessibility of BMP-4 mRNA using 10 different designs of molecular beacons (MBs), and identified the optimal beacon design. Specifically, for MB design 1 and 8 (MB1 and MB8), the fluorescent intensities from BMP-4 mRNA correlated well with the GFP signal after upregulating BMP-4 and co-expressing GFP using adenovirus, and the knockdown of BMP-4 mRNA using siRNA significantly reduced the beacon signals, demonstrating detection specificity. The beacon specificity was further confirmed using blocking RNA and in situ hybridization. We found that fluorescence signal from MBs depends critically on target sequences; the target sequences corresponding to siRNA sites may not be good sites for beacon-based mRNA detection, and vice versa. Possible beacon design rules are identified and approaches for enhancing target accessibility are discussed. This has significant implications to MB design for live cell mRNA detection.</abstract><notes>Rhee, Won Jong&#xD;Santangelo, Philip J&#xD;Jo, Hanjoong&#xD;Bao, Gang&#xD;CA119338/CA/United States NCI&#xD;HL70531/HL/United States NHLBI&#xD;HL80711/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Nucleic acids research&#xD;Nucleic Acids Res. 2008 Mar;36(5):e30. Epub 2008 Feb 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18276638</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>6.968</custom4><electronic-resource-num>gkn039 [pii]&#xD;10.1093/nar/gkn039</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1526</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1526</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qin, Y.</author><author>Wang, X.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245, USA.</auth-address><titles><title>Microfibre-nanowire hybrid structure for energy scavenging</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title></periodical><pages>809-13</pages><volume>451</volume><number>7180</number><edition>2008/02/15</edition><dates><year>2008</year><pub-dates><date>Feb 14</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>18273015</accession-num><abstract>A self-powering nanosystem that harvests its operating energy from the environment is an attractive proposition for sensing, personal electronics and defence technologies. This is in principle feasible for nanodevices owing to their extremely low power consumption. Solar, thermal and mechanical (wind, friction, body movement) energies are common and may be scavenged from the environment, but the type of energy source to be chosen has to be decided on the basis of specific applications. Military sensing/surveillance node placement, for example, may involve difficult-to-reach locations, may need to be hidden, and may be in environments that are dusty, rainy, dark and/or in deep forest. In a moving vehicle or aeroplane, harvesting energy from a rotating tyre or wind blowing on the body is a possible choice to power wireless devices implanted in the surface of the vehicle. Nanowire nanogenerators built on hard substrates were demonstrated for harvesting local mechanical energy produced by high-frequency ultrasonic waves. To harvest the energy from vibration or disturbance originating from footsteps, heartbeats, ambient noise and air flow, it is important to explore innovative technologies that work at low frequencies (such as &lt;10 Hz) and that are based on flexible soft materials. Here we present a simple, low-cost approach that converts low-frequency vibration/friction energy into electricity using piezoelectric zinc oxide nanowires grown radially around textile fibres. By entangling two fibres and brushing the nanowires rooted on them with respect to each other, mechanical energy is converted into electricity owing to a coupled piezoelectric-semiconductor process. This work establishes a methodology for scavenging light-wind energy and body-movement energy using fabrics.</abstract><notes>Qin, Yong&#xD;Wang, Xudong&#xD;Wang, Zhong Lin&#xD;England&#xD;Nature&#xD;Nature. 2008 Feb 14;451(7180):809-13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18273015</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>31.210</custom4><electronic-resource-num>nature06601 [pii]&#xD;10.1038/nature06601</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1223</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1223</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gu, F.</author><author>Zhang, L.</author><author>Teply, B. A.</author><author>Mann, N.</author><author>Wang, A.</author><author>Radovic-Moreno, A. F.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Department of Chemical Engineering, Harvard-MIT Center of Cancer Nanotechnology Excellence, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.</auth-address><titles><title>Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>2586-91</pages><volume>105</volume><number>7</number><edition>2008/02/15</edition><keywords><keyword>Animals</keyword><keyword>Benzeneacetamides/chemistry</keyword><keyword>Biophysics</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chemistry, Physical</keyword><keyword>Endocytosis</keyword><keyword>Glycolates/*chemistry</keyword><keyword>Humans</keyword><keyword>Ligands</keyword><keyword>Magnetic Resonance Spectroscopy</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Mice, Nude</keyword><keyword>Molecular Structure</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Piperidones/chemistry</keyword><keyword>Polyethylene Glycols/*chemistry</keyword><keyword>Prostate-Specific Antigen/*chemistry</keyword><keyword>Surface Properties</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 19</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18272481</accession-num><abstract>There has been progressively heightened interest in the development of targeted nanoparticles (NPs) for differential delivery and controlled release of drugs. Despite nearly three decades of research, approaches to reproducibly formulate targeted NPs with the optimal biophysicochemical properties have remained elusive. A central challenge has been defining the optimal interplay of parameters that confer molecular targeting, immune evasion, and drug release to overcome the physiological barriers in vivo. Here, we report a strategy for narrowly changing the biophysicochemical properties of NPs in a reproducible manner, thereby enabling systematic screening of optimally formulated drug-encapsulated targeted NPs. NPs were formulated by the self-assembly of an amphiphilic triblock copolymer composed of end-to-end linkage of poly(lactic-co-glycolic-acid) (PLGA), polyethyleneglycol (PEG), and the A10 aptamer (Apt), which binds to the prostate-specific membrane antigen (PSMA) on the surface of prostate cancer (PCa) cells, enabling, respectively, controlled drug release, &quot;stealth&quot; properties for immune evasion, and cell-specific targeting. Fine-tuning of NP size and drug release kinetics was further accomplished by controlling the copolymer composition. By using distinct ratios of PLGA-b-PEG-b-Apt triblock copolymer with PLGA-b-PEG diblock copolymer lacking the A10 Apt, we developed a series of targeted NPs with increasing Apt densities that inversely affected the amount of PEG exposure on NP surface and identified the narrow range of Apt density when the NPs were maximally targeted and maximally stealth, resulting in most efficient PCa cell uptake in vitro and in vivo. This approach may contribute to further development of targeted NPs as highly selective and effective therapeutic modalities.</abstract><notes>Gu, Frank&#xD;Zhang, Liangfang&#xD;Teply, Benjamin A&#xD;Mann, Nina&#xD;Wang, Andrew&#xD;Radovic-Moreno, Aleksandar F&#xD;Langer, Robert&#xD;Farokhzad, Omid C&#xD;CA119349/CA/United States NCI&#xD;EB003647/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2586-91. Epub 2008 Feb 13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18272481</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>10.228</custom4><electronic-resource-num>0711714105 [pii]&#xD;10.1073/pnas.0711714105</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1322</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1322</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Keren, S.</author><author>Gheysens, O.</author><author>Levin, C. S.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Radiology Department, Stanford University, Standford, CA 94305, USA. shayk@stanford.edu</auth-address><titles><title>A comparison between a time domain and continuous wave small animal optical imaging system</title><secondary-title>IEEE Trans Med Imaging</secondary-title></titles><periodical><full-title>IEEE Trans Med Imaging</full-title></periodical><pages>58-63</pages><volume>27</volume><number>1</number><edition>2008/02/14</edition><keywords><keyword>Animals</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Image Enhancement/*instrumentation/methods</keyword><keyword>Image Interpretation, Computer-Assisted/*methods</keyword><keyword>Imaging, Three-Dimensional/*methods</keyword><keyword>Microscopy, Fluorescence/*instrumentation/methods/*veterinary</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Tomography, Optical/*instrumentation/methods/*veterinary</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0278-0062 (Print)</isbn><accession-num>18270062</accession-num><abstract>We present a phantom study to evaluate the performance of the eXplore Optix (Advanced Research Technologies-GE Healthcare), the first commercially available time-domain tomography system for small animal fluorescence imaging, and compare its capabilities with the widely used IVIS 200 (Xenogen Corporation-Caliper) continuous wave planar imaging system. The eXplore Optix, based on point-wise illumination and collection scheme, is found to be a log order more sensitive with significantly higher detection depth and spatial resolution as compared with the wide-area illumination IVIS 200 under the conditions tested. A time-resolved detection system allows the eXplore Optix to measure the arrival time distribution of fluorescence photons. This enables fluorescence lifetime measurement, absorption mapping, and estimation of fluorescent inclusion depth, which in turn is used by a reconstruction algorithm to calculate the volumetric distribution of the fluorophore concentration. An increased acquisition time and lack of ability to image multiple animals simultaneously are the main drawbacks of the eXplore Optix as compared with the IVIS 200.</abstract><notes>Keren, S&#xD;Gheysens, O&#xD;Levin, C S&#xD;Gambhir, S S&#xD;P50 CA114747/CA/United States NCI&#xD;U54 CA119367/CA/United States NCI&#xD;Comparative Study&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;IEEE transactions on medical imaging&#xD;IEEE Trans Med Imaging. 2008 Jan;27(1):58-63.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18270062</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>3.275</custom4><electronic-resource-num>10.1109/TMI.2007.902800</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1101</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1101</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bull, S. R.</author><author>Palmer, L. C.</author><author>Fry, N. J.</author><author>Greenfield, M. A.</author><author>Messmore, B. W.</author><author>Meade, T. J.</author><author>Stupp, S. I.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, Illinois 60208, USA.</auth-address><titles><title>A templating approach for monodisperse self-assembled organic nanostructures</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>2742-3</pages><volume>130</volume><number>9</number><edition>2008/02/13</edition><keywords><keyword>Aluminum Silicates/chemistry</keyword><keyword>Hydrophobicity</keyword><keyword>Microscopy, Atomic Force</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Models, Molecular</keyword><keyword>Molecular Structure</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Particle Size</keyword><keyword>Peptides/*chemical synthesis/chemistry</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Polymers/*chemical synthesis/chemistry</keyword><keyword>Protein Conformation</keyword><keyword>Protein Structure, Secondary</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar 5</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18266371</accession-num><abstract>The precise structural control is known for self-assembly into closed spherical structures (e.g., micelles), but similar control of open structures is much more challenging. Inspired by natural tobacco mosaic virus, we present the use of a rigid-rod template to control the size of a one-dimensional self-assembly. We believe that this strategy is novel for organic self-assembly and should provide a general approach to controlling size and dimension.</abstract><notes>Bull, Steve R&#xD;Palmer, Liam C&#xD;Fry, Nathaniel J&#xD;Greenfield, Megan A&#xD;Messmore, Benjamin W&#xD;Meade, Thomas J&#xD;Stupp, Samuel I&#xD;5R01EB005866-02/EB/United States NIBIB&#xD;CA119341-02/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Mar 5;130(9):2742-3. Epub 2008 Feb 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18266371</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja710749q</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1851</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1851</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lavelle, D.</author><author>Saunthararajah, Y.</author><author>Desimone, J.</author></authors></contributors><titles><title>DNA methylation and mechanism of action of 5-azacytidine</title><secondary-title>Blood</secondary-title></titles><periodical><full-title>Blood</full-title></periodical><pages>2485; author reply 2486</pages><volume>111</volume><number>4</number><edition>2008/02/12</edition><keywords><keyword>Azacitidine/*pharmacology</keyword><keyword>DNA Methylation/*drug effects</keyword><keyword>Fetal Hemoglobin/*genetics</keyword><keyword>Gene Expression Regulation/drug effects</keyword><keyword>Globins/genetics</keyword><keyword>Humans</keyword><keyword>RNA, Messenger/genetics</keyword><keyword>RNA, Small Interfering/genetics</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 15</date></pub-dates></dates><isbn>0006-4971 (Print)</isbn><accession-num>18263785</accession-num><notes>Lavelle, Donald&#xD;Saunthararajah, Yogen&#xD;Desimone, Joseph&#xD;Comment&#xD;Letter&#xD;United States&#xD;Blood&#xD;Blood. 2008 Feb 15;111(4):2485; author reply 2486.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18263785</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom4>9.691</custom4><electronic-resource-num>111/4/2485 [pii]&#xD;10.1182/blood-2007-10-119867</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1725</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1725</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wieland, K.A.</author><author>Solin, S.A.</author></authors></contributors><auth-address>Department of Physics and Center for Materials Innovation, Washington University in St. Louis, CB 1105, 1 Brookings Drive, St. Louis, MO 63130, United States</auth-address><titles><title>Analytical modeling of symmetry breaking in extraordinary optoconductance</title><secondary-title>Solid State Commun</secondary-title></titles><periodical><full-title>Solid State Commun</full-title></periodical><pages>1-6</pages><volume>146</volume><number>1-2</number><edition>2008/02/9</edition><keywords><keyword>Semiconductors</keyword><keyword>Metal</keyword><keyword>Photoconductivity and photovoltaics</keyword><keyword>Electronic transport</keyword></keywords><dates><year>2008</year><pub-dates><date>April</date></pub-dates></dates><abstract>Extraordinary optoconductance (EOC) devices with symmetric leads have been shown to have a symmetric positional dependence when exposed to focused illumination. While advantageous for a position sensitive detector (PSD), this symmetric positional dependence, when the device is uniformly illuminated, leads to a minimization of the output voltage. Here, with the aid of a previously employed point charge model, we address two ways to break the symmetry and recover the output signal. The first is to impose uniform illumination but only on half the sample. This method has practical limitations as the device is miniaturized to the nanoscale. The second is via asymmetric placement of the voltage probes in a four-probe measurement. Crucial to the discussion is the effect of the surface charge density. Several ways of modeling the induced surface charge density are presented. Utilizing the above-described approach, optimal asymmetric lead positions are found.</abstract><urls><related-urls><url>http://www.sciencedirect.com/science?_ob=ArticleURL&amp;_udi=B6TVW-4RSYCBV-3&amp;_user=10&amp;_rdoc=1&amp;_fmt=&amp;_orig=search&amp;_sort=d&amp;view=c&amp;_version=1&amp;_urlVersion=0&amp;_userid=10&amp;md5=2fcc089df58dcf8ee6b66b14fb01f338</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>1.632</custom4><electronic-resource-num>doi:10.1016/j.ssc.2008.02.002</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1595</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1595</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shu, C. Y.</author><author>Ma, X. Y.</author><author>Zhang, J. F.</author><author>Corwin, F. D.</author><author>Sim, J. H.</author><author>Zhang, E. Y.</author><author>Dorn, H. C.</author><author>Gibson, H. W.</author><author>Fatouros, P. P.</author><author>Wang, C. R.</author><author>Fang, X. H.</author></authors></contributors><auth-address>Beijing National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100080, China.</auth-address><titles><title>Conjugation of a water-soluble gadolinium endohedral fulleride with an antibody as a magnetic resonance imaging contrast agent</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>651-5</pages><volume>19</volume><number>3</number><edition>2008/02/08</edition><keywords><keyword>Antibodies/*chemistry</keyword><keyword>Biotin/chemistry</keyword><keyword>Chemistry, Physical</keyword><keyword>Contrast Media/*chemical synthesis</keyword><keyword>Gadolinium/*chemistry</keyword><keyword>Green Fluorescent Proteins/immunology</keyword><keyword>Indicators and Reagents</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Molecular Conformation</keyword><keyword>Molecular Weight</keyword><keyword>Serum Albumin, Bovine/chemistry</keyword><keyword>Solubility</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Streptavidin/chemistry</keyword><keyword>Water</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>18254583</accession-num><abstract>Water-soluble gadofullerides exhibited high efficiency as magnetic resonance imaging (MRI) contrast agents. In this paper, we report the conjugation of the newly synthesized gadofulleride, Gd@C82O6(OH) 16(-)(NHCH2CH2COOH)8, with the antibody of green fluorescence protein (anti-GFP), as a model for &quot;tumor targeted&quot; imaging agents based on endohedral metallofullerenes. In this model system, the activity of the anti-GFP conjugate can be conveniently detected by green fluorescence protein (GFP), leading to in vitro experiments more direct and facile than those of tumor antibodies. Objective-type total internal reflection fluorescence microscopy revealed that each gadofulleride aggregate conjugated on average five anti-GFPs, and the activity of anti-GFPs was preserved after conjugation. In addition, the gadofulleride/antibody conjugate exhibited higher water proton relaxivity (12.0 mM (-1) s (-1)) than the parent gadofulleride aggregate (8.1 mM (-1) s (-1)) in phosphate buffered saline at 0.35 T, as also confirmed by T1-weighted images of phantoms. These observations clearly indicate that the synthesized gadofulleride/antibody conjugate not only has targeting potential, but also exhibits higher efficiency as an MRI contrast agent.</abstract><notes>Shu, Chun-Ying&#xD;Ma, Xin-Yong&#xD;Zhang, Jian-Fei&#xD;Corwin, Frank D&#xD;Sim, Jae Hyun&#xD;Zhang, Er-Yun&#xD;Dorn, Harry C&#xD;Gibson, Harry W&#xD;Fatouros, Panos P&#xD;Wang, Chun-Ru&#xD;Fang, Xiao-Hong&#xD;1 RO1 CA119371/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2008 Mar;19(3):651-5. Epub 2008 Feb 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18254583</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/bc7002742</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1680</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1680</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Velichko, Y. S.</author><author>Stupp, S. I.</author><author>de la Cruz, M. O.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, Northwestern University, Evanston, Illinois 60208, USA.</auth-address><titles><title>Molecular simulation study of peptide amphiphile self-assembly</title><secondary-title>J Phys Chem B</secondary-title></titles><periodical><full-title>J Phys Chem B</full-title></periodical><pages>2326-34</pages><volume>112</volume><number>8</number><edition>2008/02/07</edition><keywords><keyword>Hydrogen Bonding</keyword><keyword>Hydrophobicity</keyword><keyword>Micelles</keyword><keyword>*Models, Chemical</keyword><keyword>Models, Molecular</keyword><keyword>Peptides/*chemistry/*metabolism</keyword><keyword>Polymers/chemistry</keyword><keyword>Protein Structure, Secondary</keyword><keyword>Thermodynamics</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 28</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>18251531</accession-num><abstract>We study the self-assembly of peptide amphiphile (PA) molecules, which is governed by hydrophobic interactions between alkyl tails and a network of hydrogen bonds between peptide blocks. We demonstrate that the interplay between these two interactions results in the formation of assemblies of different morphology, in particular, single beta-sheets connected laterally by hydrogen bonds, stacks of parallel beta-sheets, spherical micelles, micelles with beta-sheets in the corona, and long cylindrical fibers. We characterize the size distribution of the aggregates as a function of the molecular interactions. Our results suggest that the formation of nanofibers of peptide amphiphiles obeys an open association model, which resembles living polymerization.</abstract><notes>Velichko, Yuri S&#xD;Stupp, Samuel I&#xD;de la Cruz, Monica Olvera&#xD;5-R01-DE015920/DE/United States NIDCR&#xD;5-R01-EB003806/EB/United States NIBIB&#xD;5-U54-CA119341/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2008 Feb 28;112(8):2326-34. Epub 2008 Feb 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18251531</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.688</custom4><electronic-resource-num>10.1021/jp074420n</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1183</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1183</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dorvee, J. R.</author><author>Sailor, M. J.</author><author>Miskelly, G. M.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California, San Diego 9500 Gilman Drive, Dept. 0358, La Jolla, CA 92093-0358, USA.</auth-address><titles><title>Digital microfluidics and delivery of molecular payloads with magnetic porous silicon chaperones</title><secondary-title>Dalton Trans</secondary-title></titles><periodical><full-title>Dalton Trans</full-title></periodical><pages>721-30</pages><number>6</number><edition>2008/02/02</edition><keywords><keyword>Electromagnetic Fields</keyword><keyword>Ferric Compounds/*chemistry</keyword><keyword>Magnetics/*instrumentation</keyword><keyword>Microfluidics/*instrumentation/methods</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Particle Size</keyword><keyword>Porosity</keyword><keyword>Silicon/*chemistry</keyword><keyword>Surface Properties</keyword><keyword>Time Factors</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 14</date></pub-dates></dates><isbn>1477-9226 (Print)</isbn><accession-num>18239825</accession-num><abstract>Digital microfluidics involves the manipulation of molecules and materials in discrete packages. This paper reviews our work using amphiphilic magnetic microparticles constructed from porous silicon. An individual porous particle can be used to carry a nanomole or smaller quantities of a reagent, and assemblies of the particles can encapsulate and transport microliter droplets of liquid containing inorganic, organic, or biological molecules. The tracking and identification of each particle can be accomplished with spectral labels that are encoded into the particles during their synthesis. When used to chaperone liquid droplets, the labels can identify the separate droplets prior to mixing and also the combined droplets after mixing. Magnetic iron oxide nanoparticles encapsulated in the porous matrix allow the manipulation of the particles or whole droplet assemblies with a magnetic field, and they also allow heating of the particle&apos;s payload by means of an externally applied RF field. Examples of organic, inorganic, and biomolecular addition reactions, catalytic reactions, and thermolysis reactions are described.</abstract><notes>Dorvee, Jason R&#xD;Sailor, Michael J&#xD;Miskelly, Gordon M&#xD;U54 CA 119335/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Dalton transactions (Cambridge, England : 2003)&#xD;Dalton Trans. 2008 Feb 14;(6):721-30. Epub 2007 Nov 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18239825</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>3.212</custom4><electronic-resource-num>10.1039/b714594b</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1424</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1424</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mahmud, G.</author><author>Bishop, K. J. M.</author><author>Chegel, Y.</author><author>Smoukov, S. K.</author><author>Grzybowski, B. A.</author></authors></contributors><auth-address>Grzybowski, BA&#xD;Northwestern Univ, Dept Chem &amp; Biol Engn, 2145 Sheridan Rd, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Chem &amp; Biol Engn, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Chem, Evanston, IL 60208 USA</auth-address><titles><title>Wet-stamped precipitant gradients control the growth of protein microcrystals in an array of nanoliter wells</title><secondary-title>Journal of the American Chemical Society</secondary-title></titles><periodical><full-title>Journal of the American Chemical Society</full-title></periodical><pages>2146-+</pages><volume>130</volume><number>7</number><edition>2008/02</edition><keywords><keyword>crystallization</keyword><keyword>microfluidics</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 20</date></pub-dates></dates><isbn>0002-7863</isbn><accession-num>ISI:000253173300015</accession-num><abstract>Wet stamping initiated from a hydrogel reservoir soaked in a salt precipitant sets-up multiple conditions for the growth of protein crystals over an array of nanoliter wells. Diffusive delivery of the precipitant translates into time- and space-varying fluxes of the precipitant in the wells. These fluxes, in turn, control the numbers of seeded crystals as well as their dimensions. Reaction-diffusion equations with a nucleation term are developed to model the process of crystal growth and to relate the &apos;schedules&apos; of precipitant delivery to the dimensions and habits of the protein microcrystals in the array.</abstract><notes>262UK&#xD;Times Cited:1&#xD;Cited References Count:17</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000253173300015</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>8.256</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1637</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1637</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, C.</author><author>Veiseh, O.</author><author>Gunn, J.</author><author>Fang, C.</author><author>Hansen, S.</author><author>Lee, D.</author><author>Sze, R.</author><author>Ellenbogen, R. G.</author><author>Olson, J.</author><author>Zhang, M.</author></authors></contributors><auth-address>Department of Materials Science &amp; Engineering, University of Washington, Seattle, WA 98195, USA.</auth-address><titles><title>In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>372-9</pages><volume>4</volume><number>3</number><edition>2008/01/31</edition><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>18232053</accession-num><abstract>Converging advances in the development of nanoparticle-based imaging probes and improved understanding of the molecular biology of brain tumors offer the potential to provide physicians with new tools for the diagnosis and treatment of these deadly diseases. However, the effectiveness of promising nanoparticle technologies is currently limited by insufficient accumulation of these contrast agents within tumors. Here a biocompatible nanoprobe composed of a poly(ethylene glycol) (PEG) coated iron oxide nanoparticle that is capable of specifically targeting glioma tumors via the surface-bound targeting peptide, chlorotoxin (CTX), is presented. The preferential accumulation of the nanoprobe within gliomas and subsequent magnetic resonance imaging (MRI) contrast enhancement are demonstrated in vitro in 9L cells and in vivo in tumors of a xenograft mouse model. TEM imaging reveals that the nanoprobes are internalized into the cytoplasm of 9L cells and histological analysis of selected tissues indicates that there are no acute toxic effects of these nanoprobes. High targeting specificity and benign biological response establish this nanoprobe as a potential platform to aid in the diagnosis and treatment of gliomas and other tumors of neuroectodermal origin.</abstract><notes>Sun, Conroy&#xD;Veiseh, Omid&#xD;Gunn, Jonathan&#xD;Fang, Chen&#xD;Hansen, Stacey&#xD;Lee, Donghoon&#xD;Sze, Raymond&#xD;Ellenbogen, Richard G&#xD;Olson, Jim&#xD;Zhang, Miqin&#xD;N01CO37122/CO/United States NCI&#xD;R01CA119408/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2008 Mar;4(3):372-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18232053</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2008</custom3><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200700784</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1408</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1408</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Davis, C.</author><author>Cai, W.</author><author>He, L.</author><author>Chen, X.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>1410-5</pages><volume>105</volume><number>5</number><edition>2008/01/31</edition><keywords><keyword>Animals</keyword><keyword>Biocompatible Materials/analysis/*pharmacokinetics/*toxicity</keyword><keyword>Blood Circulation</keyword><keyword>Injections, Intravenous</keyword><keyword>Materials Testing</keyword><keyword>Mice</keyword><keyword>Mice, Inbred Strains</keyword><keyword>Nanotubes, Carbon/analysis/*toxicity</keyword><keyword>Polyethylene Glycols/chemistry/pharmacokinetics/toxicity</keyword><keyword>Spectrum Analysis, Raman</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 5</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18230737</accession-num><abstract>Carbon nanotubes are promising new materials for molecular delivery in biological systems. The long-term fate of nanotubes intravenously injected into animals in vivo is currently unknown, an issue critical to potential clinical applications of these materials. Here, using the intrinsic Raman spectroscopic signatures of single-walled carbon nanotubes (SWNTs), we measured the blood circulation of intravenously injected SWNTs and detect SWNTs in various organs and tissues of mice ex vivo over a period of three months. Functionalization of SWNTs by branched polyethylene-glycol (PEG) chains was developed, enabling thus far the longest SWNT blood circulation up to 1 day, relatively low uptake in the reticuloendothelial system (RES), and near-complete clearance from the main organs in approximately 2 months. Raman spectroscopy detected SWNT in the intestine, feces, kidney, and bladder of mice, suggesting excretion and clearance of SWNTs from mice via the biliary and renal pathways. No toxic side effect of SWNTs to mice was observed in necropsy, histology, and blood chemistry measurements. These findings pave the way to future biomedical applications of carbon nanotubes.</abstract><notes>Liu, Zhuang&#xD;Davis, Corrine&#xD;Cai, Weibo&#xD;He, Lina&#xD;Chen, Xiaoyuan&#xD;Dai, Hongjie&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1410-5. Epub 2008 Jan 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18230737</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>10.228</custom4><electronic-resource-num>0707654105 [pii]&#xD;10.1073/pnas.0707654105</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1753</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1753</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yang, J.</author><author>Gunn, J.</author><author>Dave, S. R.</author><author>Zhang, M.</author><author>Wang, Y. A.</author><author>Gao, X.</author></authors></contributors><auth-address>Department of Bioengineering, University of Washington, Seattle, WA 98195, USA.</auth-address><titles><title>Ultrasensitive detection and molecular imaging with magnetic nanoparticles</title><secondary-title>Analyst</secondary-title></titles><periodical><full-title>Analyst</full-title></periodical><pages>154-60</pages><volume>133</volume><number>2</number><edition>2008/01/30</edition><keywords><keyword>*Contrast Media</keyword><keyword>*Ferric Compounds</keyword><keyword>Forecasting</keyword><keyword>Humans</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>*Metal Nanoparticles</keyword><keyword>Nanocomposites</keyword><keyword>Nanotechnology</keyword><keyword>Research Design</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0003-2654 (Print)</isbn><accession-num>18227935</accession-num><abstract>Recent advances in nanotechnology have produced a variety of nanoparticles ranging from semiconductor quantum dots (QDs), magnetic nanoparticles (MNPs), metallic nanoparticles, to polymeric nanoparticles. Their unique electronic, magnetic, and optical properties have enabled a broad spectrum of biomedical applications such as ultrasensitive detection, medical imaging, and specific therapeutics. MNPs made from iron oxide, in particular, have attracted extensive interest and have already been used in clinical studies owing to their capability of deep-tissue imaging, non-immunogenesis, and low toxicity. In this Research Highlight article, we attempt to highlight the recent breakthroughs in MNP synthesis based on a non-hydrolytic approach, nanoparticle (NP) surface engineering, their unique structural and magnetic properties, and current applications in ultrasensitive detection and imaging with a special focus on innovative bioassays. We will also discuss our perspectives on future research directions.</abstract><notes>Yang, Jian&#xD;Gunn, Jonathan&#xD;Dave, Shivang R&#xD;Zhang, Miqin&#xD;Wang, Y Andrew&#xD;Gao, Xiaohu&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;The Analyst&#xD;Analyst. 2008 Feb;133(2):154-60. Epub 2007 Sep 10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18227935</url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2008</custom3><custom4>3.472</custom4><electronic-resource-num>10.1039/b700091j</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1705</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1705</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, X.</author><author>Yang, L.</author><author>Chen, Z. G.</author><author>Shin, D. M.</author></authors></contributors><auth-address>Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.</auth-address><titles><title>Application of nanotechnology in cancer therapy and imaging</title><secondary-title>CA Cancer J Clin</secondary-title></titles><periodical><full-title>CA Cancer J Clin</full-title></periodical><pages>97-110</pages><volume>58</volume><number>2</number><edition>2008/01/30</edition><dates><year>2008</year><pub-dates><date>Mar-Apr</date></pub-dates></dates><isbn>0007-9235 (Print)</isbn><accession-num>18227410</accession-num><abstract>Recent developments in nanotechnology have provided researchers with new tools for cancer imaging and treatment. This technology has enabled the development of nanoscale devices that can be conjugated with several functional molecules simultaneously, including tumor-specific ligands, antibodies, anticancer drugs, and imaging probes. Since these nanodevices are 100 to 1,000-fold smaller than cancer cells, they can be easily transferred through leaky blood vessels and interact with targeted tumor-specific proteins both on the surface of and inside cancer cells. Therefore, their application as cancer cell-specific delivery vehicles will be a significant addition to the currently available armory for cancer therapeutics and imaging.</abstract><notes>Wang, Xu&#xD;Yang, Lily&#xD;Chen, Zhuo Georgia&#xD;Shin, Dong M&#xD;P50 CA128613/CA/United States NCI&#xD;R01 CA 112643/CA/United States NCI&#xD;U01 CA 101244/CA/United States NCI&#xD;U54 CA 119338/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;CA: a cancer journal for clinicians&#xD;CA Cancer J Clin. 2008 Mar-Apr;58(2):97-110. Epub 2008 Jan 28.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18227410</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>69.026</custom4><electronic-resource-num>CA.2007.0003 [pii]&#xD;10.3322/CA.2007.0003</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1647</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1647</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Taylor, K. M.</author><author>Kim, J. S.</author><author>Rieter, W. J.</author><author>An, H.</author><author>Lin, W.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Mesoporous silica nanospheres as highly efficient MRI contrast agents</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>2154-5</pages><volume>130</volume><number>7</number><edition>2008/01/26</edition><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Contrast Media/*chemistry</keyword><keyword>Gadolinium/*chemistry</keyword><keyword>Magnetic Resonance Imaging/methods</keyword><keyword>Mice</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Monocytes/chemistry/cytology</keyword><keyword>Nanospheres/*chemistry</keyword><keyword>Pentetic Acid/analogs &amp; derivatives/chemistry</keyword><keyword>Silicon Dioxide/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 20</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18217764</accession-num><notes>Taylor, Kathryn M L&#xD;Kim, Jason S&#xD;Rieter, William J&#xD;An, Hongyu&#xD;Lin, Weili&#xD;Lin, Wenbin&#xD;P20 RR020764/RR/United States NCRR&#xD;U54-CA119343/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Feb 20;130(7):2154-5. Epub 2008 Jan 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18217764</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja710193c</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1110</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1110</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, T.</author><author>Xu, L.</author><author>Shu, C.</author><author>Champion, H. A.</author><author>Reid, J. E.</author><author>Anklin, C.</author><author>Anderson, M. R.</author><author>Gibson, H. W.</author><author>Dorn, H. C.</author></authors></contributors><auth-address>Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24060-0212, USA.</auth-address><titles><title>Selective formation of a symmetric Sc3N@C78 bisadduct: adduct docking controlled by an internal trimetallic nitride cluster</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>2136-7</pages><volume>130</volume><number>7</number><edition>2008/01/26</edition><keywords><keyword>Cyclopropanes/chemistry</keyword><keyword>Fullerenes/*chemistry</keyword><keyword>Hydrocarbons, Cyclic/*chemical synthesis/chemistry</keyword><keyword>Magnetic Resonance Imaging/methods</keyword><keyword>Malonates/chemistry</keyword><keyword>Models, Molecular</keyword><keyword>Nitrogen Compounds/*chemical synthesis/chemistry</keyword><keyword>Organometallic Compounds/chemical synthesis/chemistry</keyword><keyword>Scandium/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 20</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18217757</accession-num><notes>Cai, Ting&#xD;Xu, Liaosa&#xD;Shu, Chunying&#xD;Champion, Hunter A&#xD;Reid, Jonathan E&#xD;Anklin, Clemens&#xD;Anderson, Mark R&#xD;Gibson, Harry W&#xD;Dorn, Harry C&#xD;1R01-CA119371-01/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Feb 20;130(7):2136-7. Epub 2008 Jan 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18217757</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja077630m</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1370</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1370</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, A. W.</author><author>Sharp, E. R.</author><author>O&apos;Mahony, A.</author><author>Rosenberg, M. G.</author><author>Israelski, D. M.</author><author>Nolan, G. P.</author><author>Nixon, D. F.</author></authors></contributors><auth-address>Division of Experimental Medicine, University of California at San Francisco, 1001 Potrero Ave., Bldg. 3, UCSF Box 1234, San Francisco, CA 94143-1234, USA.</auth-address><titles><title>Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection</title><secondary-title>J Virol</secondary-title></titles><periodical><full-title>J Virol</full-title></periodical><pages>3702-12</pages><volume>82</volume><number>7</number><edition>2008/01/25</edition><keywords><keyword>Adolescent</keyword><keyword>Antigens, Surface/analysis</keyword><keyword>CD4 Lymphocyte Count</keyword><keyword>Cells, Cultured</keyword><keyword>Child</keyword><keyword>Child, Preschool</keyword><keyword>*Extracellular Signal-Regulated MAP Kinases</keyword><keyword>Female</keyword><keyword>Flow Cytometry</keyword><keyword>HIV Infections/*immunology/metabolism</keyword><keyword>HIV-1/*immunology</keyword><keyword>Humans</keyword><keyword>Infant</keyword><keyword>Male</keyword><keyword>Monocytes/chemistry</keyword><keyword>Phosphorylation</keyword><keyword>Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/analysis</keyword><keyword>STAT5 Transcription Factor/*metabolism</keyword><keyword>*Signal Transduction</keyword><keyword>Viral Load</keyword></keywords><dates><year>2008</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1098-5514 (Electronic)</isbn><accession-num>18216116</accession-num><abstract>Despite extensive evidence of cell signaling alterations induced by human immunodeficiency virus type 1 (HIV-1) in vitro, the relevance of these changes to the clinical and/or immunologic status of HIV-1-infected individuals is often unclear. As such, mapping the details of cell type-specific degradation of immune function as a consequence of changes to signaling network responses has not been readily accessible. We used a flow cytometric-based assay of signaling to determine Janus kinase/signal transducers and activators of transcription (Jak/STAT) signaling changes at the single-cell level within distinct cell subsets from the primary immune cells of HIV-1-infected donors. We identified a specific defect in granulocyte-macrophage colony-stimulating factor (GM-CSF)-driven Stat5 phosphorylation in the monocytes of HIV-1+ donors. This inhibition was statistically significant in a cohort of treated and untreated individuals. Ex vivo Stat5 phosphorylation levels varied among HIV-1+ donors but did not correlate with CD4(+) T-cell counts or HIV-1 plasma viral load. Low Stat5 activation occurred in HIV-1-infected donors despite normal GM-CSF receptor levels. Investigation of mitogen-activated protein kinase (MAPK) pathways, also stimulated by GM-CSF, led to the observation that lipopolysaccharide-stimulated extracellular signal-regulated kinase phosphorylation is enhanced in monocytes. Thus, we have identified a specific, imbalanced monocyte signaling profile, with inhibition of STAT and enhancement of MAPK signaling, associated with HIV-1 infection. This understanding of altered monocyte signaling responses that contribute to defective antigen presentation during HIV-1 infection could lead to immunotherapeutic approaches that compensate for the deficiency.</abstract><notes>Lee, Andrew W&#xD;Sharp, Elizabeth R&#xD;O&apos;Mahony, Alison&#xD;Rosenberg, Michael G&#xD;Israelski, Dennis M&#xD;Nolan, Garry P&#xD;Nixon, Douglas F&#xD;AI060379/AI/United States NIAID&#xD;K08 AI067064/AI/United States NIAID&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of virology&#xD;J Virol. 2008 Apr;82(7):3702-12. Epub 2008 Jan 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18216116</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>5.332</custom4><electronic-resource-num>JVI.01582-07 [pii]&#xD;10.1128/JVI.01582-07</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1664</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1664</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tran, T. D.</author><author>Caruthers, S. D.</author><author>Hughes, M.</author><author>Marsh, J. N.</author><author>Cyrus, T.</author><author>Winter, P. M.</author><author>Neubauer, A. M.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Division of Cardiology, Washington University Medical School, 660 South Euclid Blvd, St Louis, Missouri 63110, USA.</auth-address><titles><title>Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics</title><secondary-title>Int J Nanomedicine</secondary-title></titles><periodical><full-title>Int J Nanomedicine</full-title></periodical><pages>515-26</pages><volume>2</volume><number>4</number><edition>2008/01/22</edition><keywords><keyword>Clinical Medicine/trends</keyword><keyword>Contrast Media</keyword><keyword>Diagnostic Imaging/*trends</keyword><keyword>Drug Carriers/chemistry</keyword><keyword>Drug Delivery Systems/*trends</keyword><keyword>Fluorocarbons/*chemistry</keyword><keyword>Molecular Probe Techniques/*trends</keyword><keyword>Nanomedicine/trends</keyword><keyword>Nanoparticles/*diagnostic use/*therapeutic use</keyword></keywords><dates><year>2008</year></dates><isbn>1176-9114 (Print)</isbn><accession-num>18203420</accession-num><abstract>Molecular imaging is a novel tool that has allowed non-invasive diagnostic imaging to transition from gross anatomical description to identification of specific tissue epitopes and observation of biological processes at the cellular level. This technique has been confined to the field of nuclear imaging; however, recent advances in nanotechnology have extended this research to include ultrasound (US) and magnetic resonance (MR) imaging. The exploitation of nanotechnology for MR and US molecular imaging has generated several candidate contrast agents. One multimodality platform, targeted perfluorocarbon (PFC) nanoparticles, is useful for noninvasive detection with US and MR, targeted drug delivery, and quantification.</abstract><notes>Tran, Trung D&#xD;Caruthers, Shelton D&#xD;Hughes, Michael&#xD;Marsh, John N&#xD;Cyrus, Tillmann&#xD;Winter, Patrick M&#xD;Neubauer, Anne M&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Review&#xD;New Zealand&#xD;International journal of nanomedicine&#xD;Int J Nanomedicine. 2007;2(4):515-26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18203420</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>1.649</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2072</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2072</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, Z. B.</author><author>Chen, K.</author><author>Chen, X.</author></authors></contributors><auth-address>Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305-5484, USA.</auth-address><titles><title>(68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression</title><secondary-title>Eur J Nucl Med Mol Imaging</secondary-title></titles><periodical><full-title>Eur J Nucl Med Mol Imaging</full-title></periodical><pages>1100-8</pages><volume>35</volume><number>6</number><edition>2008/01/22</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Dimerization</keyword><keyword>Female</keyword><keyword>Gallium Radioisotopes/diagnostic use/pharmacokinetics</keyword><keyword>Glioblastoma/ metabolism/ radionuclide imaging</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/ metabolism</keyword><keyword>Isotope Labeling</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Oligopeptides/chemistry/ diagnostic use/ pharmacokinetics</keyword><keyword>Organ Specificity</keyword><keyword>Positron-Emission Tomography/ methods/ veterinary</keyword><keyword>Radiopharmaceuticals/chemistry/diagnostic use/pharmacokinetics</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1619-7070 (Print)</isbn><accession-num>18204838</accession-num><abstract>PURPOSE: We and others have reported that (18)F- and (64)Cu-labeled arginine-glycine-aspartate (RGD) peptides allow positron emission tomography (PET) quantification of integrin alpha(v)beta(3) expression in vivo. However, clinical translation of these radiotracers is partially hindered by the necessity of cyclotron facility to produce the PET isotopes. Generator-based PET isotope (68)Ga, with a half-life of 68 min and 89% positron emission, deserves special attention because of its independence of an onsite cyclotron. The goal of this study was to investigate the feasibility of (68)Ga-labeled RGD peptides for tumor imaging. METHODS: Three cyclic RGD peptides, c(RGDyK) (RGD1), E[c(RGDyK)](2) (RGD2), and E{E[c(RGDyK)](2)}(2) (RGD4), were conjugated with macrocyclic chelator 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) and labeled with (68)Ga. Integrin affinity and specificity of the peptide conjugates were assessed by cell-based receptor binding assay, and the tumor targeting efficacy of (68)Ga-labeled RGD peptides was evaluated in a subcutaneous U87MG glioblastoma xenograft model. RESULTS: U87MG cell-based receptor binding assay using (125)I-echistatin as radioligand showed that integrin affinity followed the order of NOTA-RGD4 &gt; NOTA-RGD2 &gt; NOTA-RGD1. All three NOTA conjugates allowed nearly quantitative (68)Ga-labeling within 10 min (12-17 MBq/nmol). Quantitative microPET imaging studies showed that (68)Ga-NOTA-RGD4 had the highest tumor uptake but also prominent activity accumulation in the kidneys. (68)Ga-NOTA-RGD2 had higher tumor uptake (e.g., 2.8 +/- 0.1%ID/g at 1 h postinjection) and similar pharmacokinetics (4.4 +/- 0.4 tumor/muscle ratio, 2.0 +/- 0.1 tumor/liver ratio, and 1.1 +/- 0.1 tumor/kidney ratio) compared with (68)Ga-NOTA-RGD1. CONCLUSIONS: The dimeric RGD peptide tracer (68)Ga-NOTA-RGD2 with good tumor uptake and favorable pharmacokinetics warrants further investigation for potential clinical translation to image integrin alpha(v)beta(3).</abstract><notes>Li, Zi-Bo&#xD;Chen, Kai&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;European journal of nuclear medicine and molecular imaging&#xD;Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1100-8. Epub 2008 Jan 19.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.625</custom4><electronic-resource-num>10.1007/s00259-007-0692-y [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1720</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1720</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Welsher, K.</author><author>Liu, Z.</author><author>Daranciang, D.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry, Stanford University, Stanford, California 94305, USA.</auth-address><titles><title>Selective probing and imaging of cells with single walled carbon nanotubes as near-infrared fluorescent molecules</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>586-90</pages><volume>8</volume><number>2</number><edition>2008/01/17</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Contrast Media/chemistry</keyword><keyword>Humans</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Lymphoma/*pathology</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Nanotubes, Carbon/*analysis</keyword><keyword>Spectrophotometry, Infrared/*methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18197719</accession-num><abstract>Fluorescent molecules emitting in the near-infrared (NIR, wavelength approximately 0.8-2 microm) are relatively scarce and have been actively sought for biological applications because cells and tissues exhibit little auto-fluorescence in this region. Here, we report the use of semiconducting single-walled carbon nanotubes (SWNTs) as near-infrared fluorescent tags for selective probing of cell surface receptors and cell imaging. Biologically inert SWNTs with polyethyleneglycol functionalization are conjugated to antibodies such as Rituxan to selectively recognize CD20 cell surface receptor on B-cells with little nonspecific binding to negative T-cells and Herceptin to recognize HER2/neu positive breast cancer cells. We image selective SWNT-antibody binding to cells by detecting the intrinsic NIR photoluminescence of nanotubes. We observe ultralow NIR autofluorescence for various cells, an advantageous feature over high autofluorescence and large variations between cells lines in the visible. This establishes SWNTs as novel NIR fluorophors for sensitive and selective biological detections and imaging in vitro and potentially in vivo. Further, our results clearly show that the interactions between carbon nanotubes and living cells are strongly dependent on surface functionalization of nanotubes.</abstract><notes>Welsher, Kevin&#xD;Liu, Zhuang&#xD;Daranciang, Dan&#xD;Dai, Hongjie&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2008 Feb;8(2):586-90. Epub 2008 Jan 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18197719</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl072949q</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1953</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1953</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thomas, T. P.</author><author>Shukla, R.</author><author>Kotlyar, A.</author><author>Liang, B.</author><author>Ye, J. Y.</author><author>Norris, T. B.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, Division of Allergy, University of Michigan, 9220 MSRB III, Box 0648, Ann Arbor, Michigan 48109, USA.</auth-address><titles><title>Dendrimer-epidermal growth factor conjugate displays superagonist activity</title><secondary-title>Biomacromolecules</secondary-title></titles><periodical><full-title>Biomacromolecules</full-title></periodical><pages>603-9</pages><volume>9</volume><number>2</number><edition>2008/01/16</edition><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Cell Line, Tumor</keyword><keyword>Dendrimers/ chemistry/metabolism/pharmacology</keyword><keyword>Epidermal Growth Factor/ analogs &amp; derivatives/metabolism</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Protein Binding/physiology</keyword><keyword>Receptor, Epidermal Growth Factor/ agonists/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1526-4602 (Electronic)</isbn><accession-num>18193839</accession-num><abstract>Binding of ligands on to epidermal growth factor receptor (EGFR) can stimulate cell growth; therefore, any application employing EGF as a targeting ligand for a &quot;drug carrier&quot; must evaluate the effect of the conjugate on cell growth. We report the synthesis and in vitro biological activity of EGF molecules coupled to a fluorescein-labeled polyamidoamine dendrimer. The conjugate bound and internalized into several EGFR-expressing cell lines in a receptor-specific fashion. The conjugate effectively induced EGFR phosphorylation and acted as a superagonist by stimulating cell growth to a greater degree than free EGF. Concomitant administration of the chemotherapeutic drug methotrexate completely inhibited cell growth to a degree similar to its effect in the absence of the conjugate. Thus, dendrimer-EGF conjugates serve as EGFR superagonists, but this activity can be overcome by chemotherapeutic drugs. The agonist activity of these materials must be taken into consideration when using EGF conjugates for imaging applications.</abstract><notes>Thomas, Thommey P&#xD;Shukla, Rameshwer&#xD;Kotlyar, Alina&#xD;Liang, Bradley&#xD;Ye, Jing Yong&#xD;Norris, Theodore B&#xD;Baker, James R Jr&#xD;1 R01 CA119409/CA/NCI NIH HHS/United States&#xD;1 R21 RR021893/RR/NCRR NIH HHS/United States&#xD;1 R33 CA112141/CA/NCI NIH HHS/United States&#xD;5P60 DK20572/DK/NIDDK NIH HHS/United States&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Biomacromolecules&#xD;Biomacromolecules. 2008 Feb;9(2):603-9. Epub 2008 Jan 15.</notes><urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom4>4.658</custom4><electronic-resource-num>10.1021/bm701185p [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1733</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1733</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wood, K. C.</author><author>Azarin, S. M.</author><author>Arap, W.</author><author>Pasqualini, R.</author><author>Langer, R.</author><author>Hammond, P. T.</author></authors></contributors><auth-address>Department of Chemical Engineering, Biological Engineering Division, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Tumor-targeted gene delivery using molecularly engineered hybrid polymers functionalized with a tumor-homing peptide</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>403-5</pages><volume>19</volume><number>2</number><edition>2008/01/15</edition><keywords><keyword>*Gene Transfer Techniques</keyword><keyword>Peptides/*administration &amp; dosage</keyword><keyword>Polymers/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>18189340</accession-num><abstract>Before gene therapy can be used in clinical settings, safe and efficient DNA delivery systems must be developed to overcome a range of extra- and intracellular transport barriers. As a step toward the development of a modular, multifunctional gene delivery system to overcome these diverse barriers, we have developed a family of linear-dendritic &quot;hybrid&quot; polymers which contain functionalities for tissue targeting, minimization of nonspecific interactions, endosomal buffering, and DNA binding. Here, we demonstrate the rapid three-step, room-temperature, aqueous synthesis of hybrid polymers, as well as the functionalization of these polymers with a peptide targeting ligand that specifically binds to glucose-regulated protein-78 kDa (GRP-78), a clinically relevant tumor antigen identified in human cancer patients. These polymer systems can condense plasmid DNA into small nanoparticle structures (&lt;210 nm) and transfect cells expressing GRP-78 with efficiencies that exceed that of branched polyethylenimine (bPEI), one of the best commercially available polymers for in vitro transfections. The synthetic approach described here may be useful for the rapid synthesis and optimization of polymer gene delivery systems bearing a range of diverse functional domains, and the specific GRP-78-targeted systems developed in this study may potentially have clinical applications in cancer gene therapy.</abstract><notes>Wood, Kris C&#xD;Azarin, Samira M&#xD;Arap, Wadih&#xD;Pasqualini, Renata&#xD;Langer, Robert&#xD;Hammond, Paula T&#xD;R01-EB00244/EB/United States NIBIB&#xD;R21-EB004122/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2008 Feb;19(2):403-5. Epub 2008 Jan 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18189340</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/bc700408r</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1578</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1578</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, C.</author><author>Zhu, Y.</author><author>Cerwinka, W. H.</author><author>Zhau, H. E.</author><author>Marshall, F. F.</author><author>Simons, J. W.</author><author>Nie, S.</author><author>Chung, L. W.</author></authors></contributors><auth-address>Molecular Urology and Therapeutics Program, Department of Urology, Emory University School of Medicine, Atlanta, GA 30322, USA.</auth-address><titles><title>Quantum dots: emerging applications in urologic oncology</title><secondary-title>Urol Oncol</secondary-title></titles><periodical><full-title>Urol Oncol</full-title></periodical><pages>86-92</pages><volume>26</volume><number>1</number><edition>2008/01/15</edition><keywords><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Nanoparticles/*diagnostic use</keyword><keyword>Prognosis</keyword><keyword>Prostatic Neoplasms/diagnosis/genetics</keyword><keyword>Quantum Theory</keyword><keyword>Tumor Markers, Biological/analysis</keyword><keyword>Urologic Neoplasms/*diagnosis/therapy</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan-Feb</date></pub-dates></dates><isbn>1078-1439 (Print)</isbn><accession-num>18190836</accession-num><abstract>Quantum dots (QDs), nanometer-sized fluorescent probes with unique optical and electronic properties, offer a promising and powerful tool for cancer imaging and diagnostics. For the past few years, QDs were actively developed for biomolecular profiling of cancer biomarkers, in vivo tumor imaging, and even targeted drug delivery. These emerging applications are currently being improved and integrated into clinical practice. In this article, we describe the development of multifunctional QDs and their potential applications in oncology, with a particular emphasis on the diagnosis, prognosis, and treatment of urologic cancers.</abstract><notes>Shi, Chunmeng&#xD;Zhu, Ying&#xD;Cerwinka, Wolfgang H&#xD;Zhau, Haiyen E&#xD;Marshall, Fray F&#xD;Simons, Jonathan W&#xD;Nie, Shuming&#xD;Chung, Leland W K&#xD;P01 CA098912/CA/United States NCI&#xD;R01 CA 108468/CA/United States NCI&#xD;R01 GM60562/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Urologic oncology&#xD;Urol Oncol. 2008 Jan-Feb;26(1):86-92.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18190836</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>1.962</custom4><electronic-resource-num>S1078-1439(07)00093-2 [pii]&#xD;10.1016/j.urolonc.2007.03.018</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1113</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1113</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, California 94305, USA.</auth-address><titles><title>Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging</title><secondary-title>Nat Protoc</secondary-title></titles><periodical><full-title>Nat Protoc</full-title></periodical><pages>89-96</pages><volume>3</volume><number>1</number><edition>2008/01/15</edition><keywords><keyword>Biological Markers/analysis/chemistry</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chromatography, High Pressure Liquid</keyword><keyword>Humans</keyword><keyword>Iodine Radioisotopes</keyword><keyword>Neoplasms/*blood supply/pathology</keyword><keyword>Oligopeptides/*analysis/chemistry</keyword><keyword>*Quantum Dots</keyword><keyword>Spectrometry, Fluorescence/*methods</keyword><keyword>Spectroscopy, Near-Infrared/*methods</keyword></keywords><dates><year>2008</year></dates><isbn>1750-2799 (Electronic)</isbn><accession-num>18193025</accession-num><abstract>To take full advantage of the unique optical properties of quantum dots (QDs) and expedite future near-infrared fluorescence (NIRF) imaging applications, QDs need to be effectively, specifically and reliably directed to a specific organ or disease site after systemic administration. Recently, we reported the use of peptide-conjugated QDs for non-invasive NIRF imaging of tumor vasculature markers in small animal models. In this protocol, we describe the detailed procedure for the preparation of such peptide-conjugated QDs using commercially available PEG-coated QDs and arginine-glycine-aspartic acid (RGD) peptides. Conjugation of the thiolated RGD peptide to the QDs was achieved through a heterobifunctional linker, 4-maleimidobutyric acid N-succinimidyl ester. Competitive cell binding assay, using (125)I-echistatin as the radioligand, and live cell staining were carried out to confirm the successful attachment of the RGD peptides to the QD surface before in vivo imaging of tumor-bearing mice. In general, QD conjugation and in vitro validation of the peptide-conjugated QDs can be accomplished within 1-2 d; in vivo imaging will take another 1-2 d depending on the experimental design.</abstract><notes>Cai, Weibo&#xD;Chen, Xiaoyuan&#xD;R21 CA121842/CA/United States NCI&#xD;U54CA119367/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Nature protocols&#xD;Nat Protoc. 2008;3(1):89-96.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18193025</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>4.175</custom4><electronic-resource-num>nprot.2007.478 [pii]&#xD;10.1038/nprot.2007.478</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1055</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1055</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Alexis, F.</author><author>Rhee, J. W.</author><author>Richie, J. P.</author><author>Radovic-Moreno, A. F.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Department of Anesthesiology, Brigham and Women&apos;s Hospital and Harvard Medical School, Boston, MA 02115, USA.</auth-address><titles><title>New frontiers in nanotechnology for cancer treatment</title><secondary-title>Urol Oncol</secondary-title></titles><periodical><full-title>Urol Oncol</full-title></periodical><pages>74-85</pages><volume>26</volume><number>1</number><edition>2008/01/15</edition><keywords><keyword>Dendrimers/diagnostic use</keyword><keyword>Drug Delivery Systems/methods</keyword><keyword>Drug Design</keyword><keyword>Humans</keyword><keyword>Nanotechnology/*trends</keyword><keyword>Urologic Neoplasms/*diagnosis/*pathology</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan-Feb</date></pub-dates></dates><isbn>1078-1439 (Print)</isbn><accession-num>18190835</accession-num><abstract>Nanotechnology is a field of research at the crossroads of biology, chemistry, physics, engineering, and medicine. Design of multifunctional nanoparticles capable of targeting cancer cells, delivering and releasing drugs in a regulated manner, and detecting cancer cells with enormous specificity and sensitivity are just some examples of the potential application of nanotechnology to oncological diseases. In this review we discuss the recent advances of cancer nanotechnology with particular attention to nanoparticle systems that are in clinical practice or in various stages of development for cancer imaging and therapy.</abstract><notes>Alexis, Frank&#xD;Rhee, June-Wha&#xD;Richie, Jerome P&#xD;Radovic-Moreno, Aleksandar F&#xD;Langer, Robert&#xD;Farokhzad, Omid C&#xD;CA119349/CA/United States NCI&#xD;EB003647/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Urologic oncology&#xD;Urol Oncol. 2008 Jan-Feb;26(1):74-85.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18190835</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>1.962</custom4><electronic-resource-num>S1078-1439(07)00092-0 [pii]&#xD;10.1016/j.urolonc.2007.03.017</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1738</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1738</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xia, N.</author><author>Thodeti, C. K.</author><author>Hunt, T. P.</author><author>Xu, Q.</author><author>Ho, M.</author><author>Whitesides, G. M.</author><author>Westervelt, R.</author><author>Ingber, D. E.</author></authors></contributors><auth-address>Vascular Biology Program, Department of Pathology, Children&apos;s Hospital and Harvard Medical School, Boston, MA 02115, USA.</auth-address><titles><title>Directional control of cell motility through focal adhesion positioning and spatial control of Rac activation</title><secondary-title>FASEB J</secondary-title></titles><periodical><full-title>FASEB J</full-title></periodical><pages>1649-59</pages><volume>22</volume><number>6</number><edition>2008/01/09</edition><keywords><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>*Cell Movement</keyword><keyword>Cell Surface Extensions/metabolism</keyword><keyword>Extracellular Matrix/metabolism/ultrastructure</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>*Focal Adhesions</keyword><keyword>Mice</keyword><keyword>NIH 3T3 Cells</keyword><keyword>rac GTP-Binding Proteins/*metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1530-6860 (Electronic)</isbn><accession-num>18180334</accession-num><abstract>Local physical interactions between cells and extracellular matrix (ECM) influence directional cell motility that is critical for tissue development, wound repair, and cancer metastasis. Here we test the possibility that the precise spatial positioning of focal adhesions governs the direction in which cells spread and move. NIH 3T3 cells were cultured on circular or linear ECM islands, which were created using a microcontact printing technique and were 1 microm wide and of various lengths (1 to 8 microm) and separated by 1 to 4.5 microm wide nonadhesive barrier regions. Cells could be driven proactively to spread and move in particular directions by altering either the interisland spacing or the shape of similar-sized ECM islands. Immunofluorescence microscopy confirmed that focal adhesions assembled preferentially above the ECM islands, with the greatest staining intensity being observed at adhesion sites along the cell periphery. Rac-FRET analysis of living cells revealed that Rac became activated within 2 min after peripheral membrane extensions adhered to new ECM islands, and this activation wave propagated outward in an oriented manner as the cells spread from island to island. A computational model, which incorporates that cells preferentially protrude membrane processes from regions near newly formed focal adhesion contacts, could predict with high accuracy the effects of six different arrangements of micropatterned ECM islands on directional cell spreading. Taken together, these results suggest that physical properties of the ECM may influence directional cell movement by dictating where cells will form new focal adhesions and activate Rac and, hence, govern where new membrane protrusions will form.</abstract><notes>Xia, Nan&#xD;Thodeti, Charles K&#xD;Hunt, Tom P&#xD;Xu, Qiaobing&#xD;Ho, Madelyn&#xD;Whitesides, George M&#xD;Westervelt, Robert&#xD;Ingber, Donald E&#xD;CA45548/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The FASEB journal : official publication of the Federation of American Societies for Experimental Biology&#xD;FASEB J. 2008 Jun;22(6):1649-59. Epub 2008 Jan 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18180334</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.128</custom4><electronic-resource-num>fj.07-090571 [pii]&#xD;10.1096/fj.07-090571</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1460</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1460</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Myc, A.</author><author>Douce, T. B.</author><author>Ahuja, N.</author><author>Kotlyar, A.</author><author>Kukowska-Latallo, J.</author><author>Thomas, T. P.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, BSRB, Ann Arbor, Michigan 48109, USA. myca@umich.edu</auth-address><titles><title>Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates</title><secondary-title>Anticancer Drugs</secondary-title></titles><periodical><full-title>Anticancer Drugs</full-title></periodical><pages>143-9</pages><volume>19</volume><number>2</number><edition>2008/01/08</edition><keywords><keyword>Antimetabolites, Antineoplastic/chemistry/*pharmacology</keyword><keyword>Carrier Proteins/genetics/metabolism</keyword><keyword>Cell Proliferation/*drug effects</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Coculture Techniques</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Drug Screening Assays, Antitumor/methods</keyword><keyword>Flow Cytometry</keyword><keyword>Folic Acid/chemistry/metabolism</keyword><keyword>Green Fluorescent Proteins/genetics/metabolism</keyword><keyword>Humans</keyword><keyword>KB Cells</keyword><keyword>Luminescent Proteins/genetics/metabolism</keyword><keyword>Methotrexate/chemistry/*pharmacology</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Plasmids/chemistry/genetics</keyword><keyword>Polyamines/*chemistry/metabolism</keyword><keyword>Receptors, Cell Surface/genetics/metabolism</keyword><keyword>Transfection</keyword><keyword>Tumor Stem Cell Assay/methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0959-4973 (Print)</isbn><accession-num>18176110</accession-num><abstract>Our previous studies have demonstrated the in-vitro and in-vivo targeting of a generation-5 (G5) dendrimer-based multifunctional conjugate, which used folic acid (FA) as the targeting agent and methotrexate (MTX) as the chemotherapeutic drug. For the synthesized G5-FA-MTX nanodevice conjugate to be clinically applicable as a cancer therapeutic drug, it is important that the compound elicits cytotoxicity specifically and consistently. The aim of this work was to evaluate four independently synthesized batches of G5-FA-MTX conjugates for their cytotoxic potential and specificity. For determination of specificity, we have used a unique &apos;coculture&apos; assay in which FA receptor-positive and FA receptor-negative cells were cultured together and have examined the preferential killing of the former. The results of our study show the batch-to-batch consistency and specificity of the G5-FA-MTX nanodevice in the preferential killing of FA receptor-positive cells. The coculture assay shows the consistency of the four different G5-FA-MTX conjugate lots in the specific killing of targeted cells. Further in-vivo studies are, however, necessary to prove the clinical potential of this targeted therapeutic nanodevice.</abstract><notes>Myc, Andrzej&#xD;Douce, Thomas B&#xD;Ahuja, Niharika&#xD;Kotlyar, Alina&#xD;Kukowska-Latallo, Jolanta&#xD;Thomas, Thommey P&#xD;Baker, James R Jr&#xD;1 R01 CA119409/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Anti-cancer drugs&#xD;Anticancer Drugs. 2008 Feb;19(2):143-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18176110</url></related-urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom3>2008</custom3><custom4>2.316</custom4><electronic-resource-num>10.1097/CAD.0b013e3282f28842&#xD;00001813-200802000-00005 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1403</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1403</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, W.</author><author>Howarth, M.</author><author>Greytak, A. B.</author><author>Zheng, Y.</author><author>Nocera, D. G.</author><author>Ting, A. Y.</author><author>Bawendi, M. G.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139-4307, USA.</auth-address><titles><title>Compact biocompatible quantum dots functionalized for cellular imaging</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>1274-84</pages><volume>130</volume><number>4</number><edition>2008/01/08</edition><keywords><keyword>Biocompatible Materials/*chemistry</keyword><keyword>Cell Adhesion</keyword><keyword>Epidermal Growth Factor/chemistry</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Hela Cells</keyword><keyword>Histidine/chemistry</keyword><keyword>Humans</keyword><keyword>Ligands</keyword><keyword>Micelles</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Protein Structure, Tertiary</keyword><keyword>*Quantum Dots</keyword><keyword>Receptor, Epidermal Growth Factor/chemistry</keyword><keyword>Streptavidin/chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 30</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18177042</accession-num><abstract>We present a family of water-soluble quantum dots (QDs) that exhibit low nonspecific binding to cells, small hydrodynamic diameter, tunable surface charge, high quantum yield, and good solution stability across a wide pH range. These QDs are amenable to covalent modification via simple carbodiimide coupling chemistry, which is achieved by functionalizing the surface of QDs with a new class of heterobifunctional ligands incorporating dihydrolipoic acid, a short poly(ethylene glycol) (PEG) spacer, and an amine or carboxylate terminus. The covalent attachment of molecules is demonstrated by appending a rhodamine dye to form a QD-dye conjugate exhibiting fluorescence resonance energy transfer (FRET). High-affinity labeling is demonstrated by covalent attachment of streptavidin, thus enabling the tracking of biotinylated epidermal growth factor (EGF) bound to EGF receptor on live cells. In addition, QDs solubilized with the heterobifunctional ligands retain their metal-affinity driven conjugation chemistry with polyhistidine-tagged proteins. This dual functionality is demonstrated by simultaneous covalent attachment of a rhodamine FRET acceptor and binding of polyhistidine-tagged streptavidin on the same nanocrystal to create a targeted QD, which exhibits dual-wavelength emission. Such emission properties could serve as the basis for ratiometric sensing of the cellular receptor&apos;s local chemical environment.</abstract><notes>Liu, Wenhao&#xD;Howarth, Mark&#xD;Greytak, Andrew B&#xD;Zheng, Yi&#xD;Nocera, Daniel G&#xD;Ting, Alice Y&#xD;Bawendi, Moungi G&#xD;1 P20GM072029-01/GM/United States NIGMS&#xD;1U54-CA119349/CA/United States NCI&#xD;GM68762/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Jan 30;130(4):1274-84. Epub 2008 Jan 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18177042</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja076069p</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1335</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1335</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kircher, M. F.</author><author>Grimm, J.</author><author>Swirski, F. K.</author><author>Libby, P.</author><author>Gerszten, R. E.</author><author>Allport, J. R.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Mass, USA.</auth-address><titles><title>Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions</title><secondary-title>Circulation</secondary-title></titles><periodical><full-title>Circulation</full-title></periodical><pages>388-95</pages><volume>117</volume><number>3</number><edition>2008/01/04</edition><keywords><keyword>Adoptive Transfer</keyword><keyword>Animals</keyword><keyword>Apolipoproteins E/deficiency</keyword><keyword>Atherosclerosis/*pathology</keyword><keyword>*Chemotaxis, Leukocyte</keyword><keyword>Green Fluorescent Proteins/genetics</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Mice, Transgenic</keyword><keyword>Monocytes/*physiology/transplantation</keyword><keyword>Organometallic Compounds/diagnostic use</keyword><keyword>Oxyquinoline/analogs &amp; derivatives/diagnostic use</keyword><keyword>Tomography, Emission-Computed, Single-Photon/*methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 22</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>18172031</accession-num><abstract>BACKGROUND: Monocytes play a key role in atherogenesis, but their participation has been discerned largely via ex vivo analyses of atherosclerotic lesions. We sought to establish a noninvasive technique to determine monocyte trafficking to atherosclerotic lesions in live animals. METHODS AND RESULTS: Using a micro-single-photon emission computed tomography small-animal imaging system and a Food and Drug Administration-approved radiotracer ([indium 111] oxyquinoline, (111)In-oxine), we demonstrate here that monocyte recruitment to atherosclerotic lesions can be visualized in a noninvasive, dynamic, and 3-dimensional fashion in live animals. We show in vivo that monocytes are recruited avidly to plaques within days of adoptive transfer. Using micro-single-photon emission computed tomography imaging as a screening tool, we were able to investigate modulatory effects on monocyte recruitment in live animals. We found that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors rapidly and substantially reduce monocyte recruitment to existing atherosclerotic lesions, as imaged here in vivo. CONCLUSIONS: This novel approach to track monocytes to atherosclerotic plaques in vivo should have broad applications and create new insights into the pathogenesis of atherosclerosis and other inflammatory diseases.</abstract><notes>Kircher, Moritz F&#xD;Grimm, Jan&#xD;Swirski, Filip K&#xD;Libby, Peter&#xD;Gerszten, Robert E&#xD;Allport, Jennifer R&#xD;Weissleder, Ralph&#xD;R24 CA92782/CA/United States NCI&#xD;U01 HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Circulation&#xD;Circulation. 2008 Jan 22;117(3):388-95. Epub 2008 Jan 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18172031</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>13.538</custom4><electronic-resource-num>CIRCULATIONAHA.107.719765 [pii]&#xD;10.1161/CIRCULATIONAHA.107.719765</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1768</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1768</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yoshimoto, K.</author><author>Dang, J.</author><author>Zhu, S.</author><author>Nathanson, D.</author><author>Huang, T.</author><author>Dumont, R.</author><author>Seligson, D. B.</author><author>Yong, W. H.</author><author>Xiong, Z.</author><author>Rao, N.</author><author>Winther, H.</author><author>Chakravarti, A.</author><author>Bigner, D. D.</author><author>Mellinghoff, I. K.</author><author>Horvath, S.</author><author>Cavenee, W. K.</author><author>Cloughesy, T. F.</author><author>Mischel, P. S.</author></authors></contributors><auth-address>Mischel, PS&#xD;Univ Calif Los Angeles, David Greffen Sch Med, Dept Pathol, 10833 Le Cone, Los Angeles, CA 90095 USA&#xD;Univ Calif Los Angeles, David Greffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA&#xD;Univ Calif Los Angeles, David Greffen Sch Med, Lab Med, Los Angeles, CA USA&#xD;Univ Calif Los Angeles, David Greffen Sch Med, Dept Mol &amp; Med Pharmacol, Los Angeles, CA USA&#xD;Univ Calif Los Angeles, David Greffen Sch Med, Dept Human Genet, Los Angeles, CA USA&#xD;Univ Calif Los Angeles, David Greffen Sch Med, Dept Biostat, Los Angeles, CA USA&#xD;Univ Calif Los Angeles, David Greffen Sch Med, Dept Neurol, Los Angeles, CA USA&#xD;Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, David Greffen Sch Med, Los Angeles, CA 90024 USA&#xD;Univ Calif Los Angeles, David Greffen Sch Med, Henry E Singleton Brain Tumor Program, Los Angeles, CA 90024 USA&#xD;DAKO A S, Glostrup, Denmark&#xD;Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA USA&#xD;Preston Robert Tisch Brain Tumor Ctr Duke, Dept Pathol, Durham, NC USA&#xD;Univ Calif San Diego, Ludwig Inst Canc Res, San Diego, CA 92103 USA</auth-address><titles><title>Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samples</title><secondary-title>Clinical Cancer Research</secondary-title></titles><periodical><full-title>Clinical Cancer Research</full-title></periodical><pages>488-493</pages><volume>14</volume><number>2</number><edition>2008/01</edition><keywords><keyword>growth-factor-receptor</keyword><keyword>kinase inhibitors</keyword><keyword>lung carcinomas</keyword><keyword>cancer</keyword><keyword>mutant</keyword><keyword>gliomas</keyword><keyword>variant</keyword><keyword>tumorigenicity</keyword><keyword>sensitivity</keyword><keyword>expression</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 15</date></pub-dates></dates><isbn>1078-0432</isbn><accession-num>ISI:000252725200022</accession-num><abstract>Purpose: Epidermal growth factor receptor variant III (EGFRvIII) is an oncogenic, constitutively active mutant form of the EGFR that is commonly expressed in glioblastoma and is also detected in a number of epithelial cancers. EGFRvIII presents a unique antigenic target for anti-EGFRvIII vaccines and it has been shown to modulate response to EGFR kinase inhibitor therapy. Thus, detection in clinical samples may be warranted. Existing patents preclude the use of anti-EGFRvIII antibodies for clinical detection. Further, frozen tissue is not routinely available, particularly for patients treated in the community. Thus, detection of EGFRvIII in formalin-fixed paraffin-embedded (FFPE) clinical samples is a major challenge.&#xD;Experimental Design: We developed a real-time reverse transcription-PCR (RT-PCR) assay for detecting EGFRvIII in FFPE samples and analyzed 59 FFPE glioblastoma clinical samples with paired frozen tissue from the same surgical resection. We assessed EGFRvIII protein expression by immunohistochemistry using two distinct specific anti-EGFRvIII antibodies and examined EGFR gene amplification by fluorescence in situ hybridization.&#xD;Results: The FFPE RT-PCR assay detected EGFRvIII in 16 of 59 (27%) samples, exclusively in cases with EGFR amplification, consistent with the expected frequency of this alteration. The FFPE RT-PCR assay was more sensitive and specific for detecting EGFRvIII than either of the two antibodies alone, or in combination, with a sensitivity of 93% (95% confidence interval, 0.78-1.00) and a specificity of 98% (95% confidence interval, 0.93-1.00).&#xD;Conclusion: This assay will facilitate accurate assessment of EGFRvIII in clinical samples and may aid in the development of strategies for stratifying patients for EGFRvIII-directed therapies.</abstract><notes>256JQ&#xD;Times Cited:1&#xD;Cited References Count:23</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000252725200022</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom4>6.646</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1656</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1656</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thomas, T. P.</author><author>Ye, J. Y.</author><author>Chang, Y. C.</author><author>Kotlyar, A.</author><author>Cao, Z.</author><author>Majoros, I. J.</author><author>Norris, T. B.</author><author>Baker, J. R.</author></authors></contributors><auth-address>Baker, JR&#xD;Univ Michigan, Michigan Nanotechnol Inst Med &amp; Biol Sci, Dept Internal Med, Div Allergy, 9220 MSRB 3,Box 0648, Ann Arbor, MI 48109 USA&#xD;Univ Michigan, Michigan Nanotechnol Inst Med &amp; Biol Sci, Dept Internal Med, Div Allergy, Ann Arbor, MI 48109 USA&#xD;Univ Michigan, Ctr Ultrafast Opt Sci, Ann Arbor, MI 48109 USA</auth-address><titles><title>Investigation of tumor cell targeting of a dendrimer nanoparticle using a double-clad optical fiber probe</title><secondary-title>Journal of Biomedical Optics</secondary-title></titles><periodical><full-title>Journal of Biomedical Optics</full-title></periodical><pages>-</pages><volume>13</volume><number>1</number><edition>2008/01</edition><keywords><keyword>dendrimer</keyword><keyword>nanotechnology</keyword><keyword>double-clad optical fiber</keyword><keyword>two-photon excitation</keyword><keyword>cancer targeting</keyword><keyword>cancer</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan-Feb</date></pub-dates></dates><isbn>1083-3668</isbn><accession-num>ISI:000254632300038</accession-num><abstract>Fluorescence quantification in tissues using conventional techniques can be difficult due to the absorption and scattering of light in tissues. Our previous studies have shown that a single-mode optical fiber (SMF)-based, two-photon optical fiber fluorescence (TPOFF) probe could be effective as a minimally invasive, real-time technique for quantifying fluorescence in solid tumors. We report improved results with this technique using a solid, double-clad optical fiber (DCF). The DCF can maintain a high excitation rate by propagating ultrashort laser pulses down an inner single-mode core, while demonstrating improved collection efficiency by using a high numerical aperture multimode outer core confined with a second clad. We have compared the TPOFF detection efficiency of the DCF versus the SMF with standard solutions of the generation 5 poly (amidoamine) dendrimer (G5) nanoparticles G5-6TAMRA (G5-6T) and G5-6TAMRA-folic acid (G5-6T-FA). The DCF probe showed three-to five-fold increases in the detection efficiency of these conjugates, in comparison to the SMF. We also demonstrate the applicability of the DCF to quantify the targeted uptake of G5-6T-FA in mouse tumors expressing the FA receptor. These results indicate that the TPOFF technique using the DCF probe is an appropriate tool to quantify low nanomolar concentrations of targeted fluorescent probes from deep tissue. (C) 2008 Society of Photo-Optical Instrumentation Engineers.</abstract><notes>283JK&#xD;Times Cited:1&#xD;Cited References Count:15</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000254632300038</url></related-urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom4>1.201</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2481</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2481</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mrksich, Milan</author></authors></contributors><titles><title>Mass Spectrometry of Self-Assembled Monolayers: A New Tool for Molecular Surface Science</title><secondary-title>ACS Nano</secondary-title></titles><periodical><full-title>ACS Nano</full-title></periodical><pages>7-18</pages><volume>2</volume><number>1</number><edition>2008/01</edition><dates><year>2008</year></dates><publisher>American Chemical Society</publisher><isbn>1936-0851</isbn><notes>doi: 10.1021/nn7004156</notes><urls><related-urls><url>http://dx.doi.org/10.1021/nn7004156</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom4>5.472</custom4><electronic-resource-num>10.1021/nn7004156</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1226</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1226</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Guimaraes, A.R.</author><author>Tabatabei, S.</author><author>Dahl, D.</author><author>McDougal, W.S.</author><author>Weissleder, R.</author><author>Harisinghani, M.G.</author></authors></contributors><titles><title>Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer.</title><secondary-title>Urology</secondary-title></titles><periodical><full-title>Urology</full-title></periodical><pages>708-12</pages><volume>71</volume><number>4</number><edition>2008 Mar 4</edition><dates><year>2008</year></dates><abstract>OBJECTIVE: To assess lymphotrophic nanoparticle-enhanced magnetic resonance imaging (LNMRI) in identifying malignant nodal involvement in patients with renal neoplasms. METHODS: MRI was performed in 9 patients with renal masses. All patients were imaged on a GE 1.5T system with phased array body coil. Protocols included T2 and T2* weighted imaging before and after administration of ferumoxtran-10 (Combidex) for the evaluation of lymph node (LN) involvement. All 9 patients underwent nephrectomy. Lymph node dissection (LND) was performed in patients with stage 2 renal cell cancer (RCC), or transitional cell cancer (TCC), per routine clinical practice. Data analysis was performed by 2 radiologists, who were blinded to pathologic results. Nodes that lacked contrast uptake were deemed malignant, and those with homogeneous uptake were deemed benign. Quantitative, retrospective analysis was performed on primary tumors by quantifying T2* with a monoexponential fitting algorithm (Osirix). T2* was quantified before, immediately after, and 24 hours after the administration of ferumoxtran-10. RESULTS: MRI demonstrated 26 lymph nodes within the 9 patients imaged (24 benign and 2 malignant). Pathologic results allowed comparison in 22 of the 26 lymph nodes and demonstrated high sensitivity (100%) and specificity (95.7%). CONCLUSIONS: LNMRI demonstrated high sensitivity (100%) and specificity (95.7%) in patients with renal neoplasms. Although in a relatively small sample size, the results are encouraging and warrant a larger, prospective trial.</abstract><urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>2.604</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1362</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1362</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lalush, D.D.S.     </author></authors></contributors><titles><title>Binary Encoding of Multiplexed Images in Mixed Noise</title><secondary-title>IEEE Transactions on Medical Imaging</secondary-title></titles><periodical><full-title>IEEE Transactions on Medical Imaging</full-title></periodical><pages>1</pages><volume>PP</volume><number>99</number><edition>2008-06-10</edition><dates><year>2008</year></dates><abstract>Binary coding of multiplexed signals and images has been studied in the context of spectroscopy with models of either purely constant or purely proportional noise, and has been shown to result in improved noise performance under certain conditions. We consider the case of mixed noise in an imaging system consisting of multiple individually-controllable sources (x-ray or near-infrared, for example) shining on a single detector. We develop a mathematical model for the noise in such a system and show that the noise is dependent on the properties of the binary coding matrix and on the average number of sources used for each code. Each binary matrix has a characteristic linear relationship between the ratio of proportional-to-constant noise and the noise level in the decoded image. We introduce a criterion for noise level, which is minimized via a genetic algorithm search. The search procedure results in the discovery of matrices that outperform the Hadamard S-matrices at certain levels of mixed noise. Simulation of a seven-source radiography system demonstrates that the noise model predicts trends and rank order of performance in regions of nonuniform images and in a simple tomosynthesis reconstruction. We conclude that the model developed provides a simple framework for analysis, discovery, and optimization of binary coding patterns used in multiplexed imaging systems.</abstract><urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>3.275</custom4><electronic-resource-num>10.1109/TMI.2008.922697</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1465</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1465</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nahrendorf, M.</author><author>Zhang, H.</author><author>Hembrador, S.</author><author>Panizzi, P.</author><author>Sosnovik, D. E.</author><author>Aikawa, E.</author><author>Libby, P.</author><author>Swirski, F. K.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.</auth-address><titles><title>Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis</title><secondary-title>Circulation</secondary-title></titles><periodical><full-title>Circulation</full-title></periodical><pages>379-87</pages><volume>117</volume><number>3</number><edition>2007/12/26</edition><keywords><keyword>Animals</keyword><keyword>Antigens, CD/analysis</keyword><keyword>Antigens, Differentiation, Myelomonocytic/analysis</keyword><keyword>Apolipoproteins E/deficiency</keyword><keyword>Atherosclerosis/pathology</keyword><keyword>Biological Markers/analysis</keyword><keyword>Copper Radioisotopes/diagnostic use</keyword><keyword>Inflammation/pathology</keyword><keyword>Macrophages/*pathology</keyword><keyword>Mice</keyword><keyword>Microscopy</keyword><keyword>Nanoparticles/*diagnostic use</keyword><keyword>Positron-Emission Tomography/*methods/standards</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 22</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>18158358</accession-num><abstract>BACKGROUND: Macrophages participate centrally in atherosclerosis, and macrophage markers (eg, CD68, MAC-3) correlate well with lesion severity and therapeutic modulation. On the basis of the avidity of lesional macrophages for polysaccharide-containing supramolecular structures such as nanoparticles, we have developed a new positron emission tomography (PET) agent with optimized pharmacokinetics to allow in vivo imaging at tracer concentrations. METHODS AND RESULTS: A dextranated and DTPA-modified magnetofluorescent 20-nm nanoparticle was labeled with the PET tracer 64Cu (1 mCi/0.1 mg nanoparticles) to yield a PET, magnetic resonance, and optically detectable imaging agent. Peak PET activity 24 hours after intravenous injection into mice deficient in apolipoprotein E with experimental atherosclerosis mapped to areas of high plaque load identified by computed tomography such as the aortic root and arch and correlated with magnetic resonance and optical imaging. Accumulated dose in apolipoprotein E-deficient aortas determined by gamma counting was 260% and in carotids 392% of respective wild-type organs (P&lt;0.05 both). Autoradiography of aortas demonstrated uptake of the agent into macrophage-rich atheromata identified by Oil Red O staining of lipid deposits. The novel nanoagent accumulated predominantly in macrophages as determined by fluorescence microscopy and flow cytometry of cells dissociated from aortas. CONCLUSIONS: This report establishes the capability of a novel trimodality nanoparticle to directly detect macrophages in atherosclerotic plaques. Advantages include improved sensitivity; direct correlation of PET signal with an established biomarker (CD68); ability to readily quantify the PET signal, perform whole-body vascular surveys, and spatially localize and follow the trireporter by microscopy; and clinical translatability of the agent given similarities to magnetic resonance imaging probes in clinical trials.</abstract><notes>Nahrendorf, Matthias&#xD;Zhang, Hanwen&#xD;Hembrador, Sheena&#xD;Panizzi, Peter&#xD;Sosnovik, David E&#xD;Aikawa, Elena&#xD;Libby, Peter&#xD;Swirski, Filip K&#xD;Weissleder, Ralph&#xD;R01-HL078641/HL/United States NHLBI&#xD;R24-CA92782/CA/United States NCI&#xD;U01-HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Circulation&#xD;Circulation. 2008 Jan 22;117(3):379-87. Epub 2007 Dec 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18158358</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>13.538</custom4><electronic-resource-num>CIRCULATIONAHA.107.741181 [pii]&#xD;10.1161/CIRCULATIONAHA.107.741181</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1771</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1771</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Young, A. N.</author><author>Master, V. A.</author><author>Paner, G. P.</author><author>Wang, M. D.</author><author>Amin, M. B.</author></authors></contributors><auth-address>Department of Pathology and Laboratory Medicine, Emory University School of Medicine/Grady Memorial Hospital, 80 Jesse Hill Jr. Drive SE, Atlanta, GA 30303, USA. andrew.n.young@emory.edu</auth-address><titles><title>Renal epithelial neoplasms: diagnostic applications of gene expression profiling</title><secondary-title>Adv Anat Pathol</secondary-title></titles><periodical><full-title>Adv Anat Pathol</full-title></periodical><pages>28-38</pages><volume>15</volume><number>1</number><edition>2007/12/25</edition><keywords><keyword>Carcinoma, Renal Cell/*diagnosis/*genetics</keyword><keyword>DNA, Neoplasm/genetics</keyword><keyword>Gene Expression Profiling/*methods</keyword><keyword>Humans</keyword><keyword>Kidney Neoplasms/*diagnosis/*genetics</keyword><keyword>Neoplasm Staging/methods</keyword><keyword>Neoplasms, Glandular and Epithelial/classification/diagnosis/genetics</keyword><keyword>Prognosis</keyword><keyword>World Health Organization</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1072-4109 (Print)</isbn><accession-num>18156810</accession-num><abstract>Renal cell carcinoma (RCC) is the most common form of kidney cancer in adults. RCC is a significant challenge for pathologic diagnosis and clinical management. The primary approach to diagnosis is by light microscopy, using the World Health Organization (WHO) classification system, which defines histopathologic tumor subtypes with distinct clinical behavior and underlying genetic mutations. However, light microscopic diagnosis of RCC subtypes can be difficult due to variable histology, morphologic features shared by tumor subtypes, and a growing frequency of small tumor biopsies with limited morphologic information. In addition to these diagnostic problems, the clinical behavior of RCC is highly variable, and therapeutic response rates are poor. Few clinical assays are available to predict outcome in RCC or correlate behavior with histology. Therefore, novel RCC classification systems based on gene expression should be useful for diagnosis, prognosis, and treatment. Recent microarray studies have shown that renal tumors are characterized by distinct gene expression profiles, which can be used to discover novel diagnostic and prognostic biomarkers. Here, we review clinical features of kidney cancer, the WHO classification system, and the growing role of molecular classification for diagnosis, prognosis, and therapy of this disease.</abstract><notes>Young, Andrew N&#xD;Master, Viraj A&#xD;Paner, Gladell P&#xD;Wang, May D&#xD;Amin, Mahul B&#xD;1U54 CA 119338-02/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;United States&#xD;Advances in anatomic pathology&#xD;Adv Anat Pathol. 2008 Jan;15(1):28-38.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18156810</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>3.260</custom4><electronic-resource-num>10.1097/PAP.0b013e3181594720&#xD;00125480-200801000-00003 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2429</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2429</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, X.</author><author>Peng, X. H.</author><author>Ansari, D. O.</author><author>Yin-Goen, Q.</author><author>Chen, G. Z.</author><author>Shin, D. M.</author><author>Yang, L.</author><author>Young, A. N.</author><author>Wang, M. D.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, 101 Woodruff Circle, Suite 2001, Atlanta, Georgia 30322, USA.</auth-address><titles><title>In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags</title><secondary-title>Nat Biotechnol</secondary-title></titles><periodical><full-title>Nat Biotechnol</full-title></periodical><pages>83-90</pages><volume>26</volume><number>1</number><edition>2007/12/25</edition><keywords><keyword>Animals</keyword><keyword>Carcinoma, Squamous Cell/ diagnosis</keyword><keyword>Cell Line, Tumor</keyword><keyword>Drug Delivery Systems/ methods</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Nanoparticles/ diagnostic use</keyword><keyword>Particle Size</keyword><keyword>Spectrum Analysis, Raman/ methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1546-1696 (Electronic)</isbn><accession-num>18157119</accession-num><abstract>We describe biocompatible and nontoxic nanoparticles for in vivo tumor targeting and detection based on pegylated gold nanoparticles and surface-enhanced Raman scattering (SERS). Colloidal gold has been safely used to treat rheumatoid arthritis for 50 years, and has recently been found to amplify the efficiency of Raman scattering by 14-15 orders of magnitude. Here we show that large optical enhancements can be achieved under in vivo conditions for tumor detection in live animals. An important finding is that small-molecule Raman reporters such as organic dyes were not displaced but were stabilized by thiol-modified polyethylene glycols. These pegylated SERS nanoparticles were considerably brighter than semiconductor quantum dots with light emission in the near-infrared window. When conjugated to tumor-targeting ligands such as single-chain variable fragment (ScFv) antibodies, the conjugated nanoparticles were able to target tumor biomarkers such as epidermal growth factor receptors on human cancer cells and in xenograft tumor models.</abstract><notes>Qian, Ximei&#xD;Peng, Xiang-Hong&#xD;Ansari, Dominic O&#xD;Yin-Goen, Qiqin&#xD;Chen, Georgia Z&#xD;Shin, Dong M&#xD;Yang, Lily&#xD;Young, Andrew N&#xD;Wang, May D&#xD;Nie, Shuming&#xD;P50CA128613/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nature biotechnology&#xD;Nat Biotechnol. 2008 Jan;26(1):83-90. Epub 2007 Dec 23.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>25.329</custom4><electronic-resource-num>nbt1377 [pii]&#xD;10.1038/nbt1377 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2070</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2070</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Niu, G.</author><author>Cai, W.</author><author>Chen, K.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, 1201 Welch Rd, P095, Stanford, CA 94305-5484, USA.</auth-address><titles><title>Non-invasive PET imaging of EGFR degradation induced by a heat shock protein 90 inhibitor</title><secondary-title>Mol Imaging Biol</secondary-title></titles><periodical><full-title>Mol Imaging Biol</full-title></periodical><pages>99-106</pages><volume>10</volume><number>2</number><edition>2007/12/25</edition><keywords><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/pharmacokinetics/pharmacology</keyword><keyword>Antineoplastic Agents/pharmacokinetics/pharmacology</keyword><keyword>Benzoquinones/pharmacokinetics/ pharmacology</keyword><keyword>Cell Death/drug effects</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation/drug effects</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>HSP90 Heat-Shock Proteins/ antagonists &amp; inhibitors</keyword><keyword>Heterocyclic Compounds, 1-Ring/pharmacokinetics/pharmacology</keyword><keyword>Humans</keyword><keyword>Lactams, Macrocyclic/pharmacokinetics/ pharmacology</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Positron-Emission Tomography/ methods</keyword><keyword>Protein Processing, Post-Translational/ drug effects</keyword><keyword>Receptor, Epidermal Growth Factor/ metabolism</keyword><keyword>Tissue Distribution/drug effects</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar-Apr</date></pub-dates></dates><isbn>1536-1632 (Print)</isbn><accession-num>18157579</accession-num><abstract>PURPOSE: The aim of this study is to non-invasively monitor the epidermal growth factor receptor (EGFR) response to a Hsp90 inhibitor-17-AAG treatment in a PC-3 prostate cancer model. PROCEDURES: Nude mice bearing PC-3 tumor were injected intraperitoneally with 17-AAG and then imaged with micro positron emission tomography (microPET) using (64)Cu-DOTA-cetuximab. Biodistribution studies, immunofluorescence staining, and Western blot were performed to validate the microPET results. RESULTS: PC-3 cells are sensitive to 17-AAG treatment in a dose-dependent manner. Quantitative microPET showed that (64)Cu-DOTA-cetuximab has prominent tumor activity accumulation in untreated tumors (14.6 +/- 2.6%ID/g) but significantly lower uptake in 17-AAG-treated tumors (8.9 +/- 1.6% ID/g) at 24 h post-injection. Both immunofluorescence staining and Western blot confirmed the significantly lower EGFR expression level in the tumor tissue upon 17-AAG treatment. CONCLUSIONS: The early response to anti-Hsp90 therapy was successfully monitored by quantitative PET using (64)Cu-DOTA-cetuximab, which indicates that this approach may be valuable in monitoring the therapeutic response to Hsp90 inhibitor 17-AAG in EGFR-positive cancer patients.</abstract><notes>Niu, Gang&#xD;Cai, Weibo&#xD;Chen, Kai&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging&#xD;Mol Imaging Biol. 2008 Mar-Apr;10(2):99-106. Epub 2007 Dec 22.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>3.372</custom4><electronic-resource-num>10.1007/s11307-007-0123-2 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1354</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1354</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Krutzik, P. O.</author><author>Crane, J. M.</author><author>Clutter, M. R.</author><author>Nolan, G. P.</author></authors></contributors><auth-address>Department of Microbiology and Immunology, Baxter Laboratory in Genetic Pharmacology, Stanford University, 269 Campus Drive, Stanford, California 94305, USA.</auth-address><titles><title>High-content single-cell drug screening with phosphospecific flow cytometry</title><secondary-title>Nat Chem Biol</secondary-title></titles><periodical><full-title>Nat Chem Biol</full-title></periodical><pages>132-42</pages><volume>4</volume><number>2</number><edition>2007/12/25</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Drug Evaluation, Preclinical</keyword><keyword>Flow Cytometry/*methods</keyword><keyword>Humans</keyword><keyword>Janus Kinases/metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Mitogen-Activated Protein Kinases/metabolism</keyword><keyword>Phosphorus/*analysis</keyword><keyword>STAT Transcription Factors/metabolism</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1552-4469 (Electronic)</isbn><accession-num>18157122</accession-num><abstract>Drug screening is often limited to cell-free assays involving purified enzymes, but it is arguably best applied against systems that represent disease states or complex physiological cellular networks. Here, we describe a high-content, cell-based drug discovery platform based on phosphospecific flow cytometry, or phosphoflow, that enabled screening for inhibitors against multiple endogenous kinase signaling pathways in heterogeneous primary cell populations at the single-cell level. From a library of small-molecule natural products, we identified pathway-selective inhibitors of Jak-Stat and MAP kinase signaling. Dose-response experiments in primary cells confirmed pathway selectivity, but importantly also revealed differential inhibition of cell types and new druggability trends across multiple compounds. Lead compound selectivity was confirmed in vivo in mice. Phosphoflow therefore provides a unique platform that can be applied throughout the drug discovery process, from early compound screening to in vivo testing and clinical monitoring of drug efficacy.</abstract><notes>Krutzik, Peter O&#xD;Crane, Janelle M&#xD;Clutter, Matthew R&#xD;Nolan, Garry P&#xD;AI35304/AI/United States NIAID&#xD;N01-HV-28183/HV/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature chemical biology&#xD;Nat Chem Biol. 2008 Feb;4(2):132-42. Epub 2007 Dec 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18157122</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>15.235</custom4><electronic-resource-num>nchembio.2007.59 [pii]&#xD;10.1038/nchembio.2007.59</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1257</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1257</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hodgson, L.</author><author>Pertz, O.</author><author>Hahn, K. M.</author></authors></contributors><auth-address>Department of Pharmacology, Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Design and optimization of genetically encoded fluorescent biosensors: GTPase biosensors</title><secondary-title>Methods Cell Biol</secondary-title></titles><periodical><full-title>Methods Cell Biol</full-title></periodical><pages>63-81</pages><volume>85</volume><edition>2007/12/25</edition><keywords><keyword>Base Sequence</keyword><keyword>Biosensing Techniques/*methods</keyword><keyword>Cell Line</keyword><keyword>Fluorescence Resonance Energy Transfer/*methods</keyword><keyword>*GTP Phosphohydrolases</keyword><keyword>*Green Fluorescent Proteins</keyword><keyword>Humans</keyword><keyword>Molecular Sequence Data</keyword><keyword>Protein Engineering</keyword><keyword>Recombinant Fusion Proteins</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0091-679X (Print)</isbn><accession-num>18155459</accession-num><abstract>This chapter details the design and optimization of biosensors based on a design used successfully to study nucleotide loading of small GTPase proteins in living cells. This design can be generalized to study many other protein activities, using a single, genetically encoded chain incorporating the protein to be studied, an &quot;affinity reagent&quot; which binds only to the activated form of the targeted protein, and mutants of the green fluorescent protein (GFP) that undergo fluorescence resonance energy transfer (FRET). Specific topics include procedures and caveats in the design and cloning of single-chain FRET sensors, in vitro and in vivo validation, expression in living cell systems for biological studies, and some general considerations in quantitative fluorescence imaging.</abstract><notes>Hodgson, Louis&#xD;Pertz, Olivier&#xD;Hahn, Klaus M&#xD;United States&#xD;Methods in cell biology&#xD;Methods Cell Biol. 2008;85:63-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18155459</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>1.582</custom4><electronic-resource-num>S0091-679X(08)85004-2 [pii]&#xD;10.1016/S0091-679X(08)85004-2</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1212</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1212</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Garrett, S. C.</author><author>Hodgson, L.</author><author>Rybin, A.</author><author>Toutchkine, A.</author><author>Hahn, K. M.</author><author>Lawrence, D. S.</author><author>Bresnick, A. R.</author></authors></contributors><auth-address>Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA.</auth-address><titles><title>A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics</title><secondary-title>Biochemistry</secondary-title></titles><periodical><full-title>Biochemistry</full-title></periodical><pages>986-96</pages><volume>47</volume><number>3</number><edition>2007/12/25</edition><keywords><keyword>Animals</keyword><keyword>Biosensing Techniques/*methods</keyword><keyword>Calcium/chemistry/*metabolism/pharmacology</keyword><keyword>Cell Movement/drug effects</keyword><keyword>Cell-Free System</keyword><keyword>Circular Dichroism</keyword><keyword>Cysteine/chemistry</keyword><keyword>Egtazic Acid/chemistry</keyword><keyword>Fibroblasts/drug effects/*metabolism</keyword><keyword>Fluorescence Polarization</keyword><keyword>Humans</keyword><keyword>Iodoacetamide/chemistry</keyword><keyword>Lysophospholipids/pharmacology</keyword><keyword>Mice</keyword><keyword>Models, Molecular</keyword><keyword>Molecular Structure</keyword><keyword>Nonmuscle Myosin Type IIA/chemistry/metabolism</keyword><keyword>Phenothiazines/chemistry/pharmacology</keyword><keyword>Protein Binding/drug effects</keyword><keyword>Protein Conformation/drug effects</keyword><keyword>Pyrimidinones/chemistry</keyword><keyword>Recombinant Proteins/antagonists &amp; inhibitors/chemistry/metabolism</keyword><keyword>S100 Proteins/*antagonists &amp; inhibitors/chemistry/*metabolism</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Trifluoperazine/chemistry/pharmacology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 22</date></pub-dates></dates><isbn>0006-2960 (Print)</isbn><accession-num>18154362</accession-num><abstract>S100A4, a member of the S100 family of Ca2+-binding proteins, displays elevated expression in malignant human tumors compared with benign tumors, and increased expression correlates strongly with poor patient survival. S100A4 has a direct role in metastatic progression, likely due to the modulation of actomyosin cytoskeletal dynamics, which results in increased cellular motility. We developed a fluorescent biosensor (Mero-S100A4) that reports on the Ca2+-bound, activated form of S100A4. Direct attachment of a novel solvatochromatic reporter dye to S100A4 results in a sensor that, upon activation, undergoes a 3-fold enhancement in fluorescence, thus providing a sensitive assay for use in vitro and in vivo. In cells, localized activation of S100A4 at the cell periphery is observed during random migration and following stimulation with lysophosphatidic acid, a known activator of cell motility and proliferation. Additionally, a screen against a library of FDA-approved drugs with the biosensor identified an array of phenothiazines as inhibitors of myosin-II associated S100A4 function. These data demonstrate the utility of the new biosensor both for drug discovery and for probing the cellular dynamics controlled by the S100A4 metastasis factor.</abstract><notes>Garrett, Sarah C&#xD;Hodgson, Louis&#xD;Rybin, Andrew&#xD;Toutchkine, Alexei&#xD;Hahn, Klaus M&#xD;Lawrence, David S&#xD;Bresnick, Anne R&#xD;CA095019/CA/United States NCI&#xD;GM057464/GM/United States NIGMS&#xD;GM069945/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Biochemistry&#xD;Biochemistry. 2008 Jan 22;47(3):986-96. Epub 2007 Dec 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18154362</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>3.402</custom4><electronic-resource-num>10.1021/bi7021624</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2069</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2069</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, Z. B.</author><author>Wu, Z.</author><author>Cao, Q.</author><author>Dick, D. W.</author><author>Tseng, J. R.</author><author>Gambhir, S. S.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305-5484, USA.</auth-address><titles><title>The synthesis of 18F-FDS and its potential application in molecular imaging</title><secondary-title>Mol Imaging Biol</secondary-title></titles><periodical><full-title>Mol Imaging Biol</full-title></periodical><pages>92-8</pages><volume>10</volume><number>2</number><edition>2007/12/22</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Female</keyword><keyword>Fluorine Radioisotopes</keyword><keyword>Humans</keyword><keyword>Inflammation</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Positron-Emission Tomography/ methods</keyword><keyword>Sorbitol/ analogs &amp; derivatives/ chemical synthesis/chemistry/ diagnostic use</keyword><keyword>Whole Body Imaging</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar-Apr</date></pub-dates></dates><isbn>1536-1632 (Print)</isbn><accession-num>18097725</accession-num><abstract>PURPOSE: 2-deoxy-2-[(18)F]fluoro-D-glucose (FDG) is the most commonly used positron emission tomography (PET) tracer for oncological and neurological imaging, but it has limitations on detecting tumor or inflammation in brain gray matter. In this study, we describe the development of 2-deoxy-2-[(18)F]fluorosorbitol ((18)F-FDS) and its possible application in lesion detection around brain area. PROCEDURES: (18)F-FDS was obtained by reduction of FDG using NaBH(4) (81 +/- 4% yield in 30 min). Cell uptake/efflux experiments in cell culture and small animal PET imaging on tumor and inflammation models were performed. RESULTS: Despite the low accumulation in cell culture, (18)F-FDS had good tumor uptake and contrast in the subcutaneous U87MG tumor model (4.54%ID/g at 30 min post-injection). Minimal uptake in the normal mouse brain facilitated good tumor contrast in both U87MG and GL-26 orthotopic tumor models. (18)F-FDS also had increased uptake in the inflamed foci of the TPA-induced acute inflammation model. CONCLUSIONS: Because of the ease of synthesis and favorable in vivo kinetics, (18)F-FDS may have potential applications in certain cases where FDG is inadequate (e.g., brain tumor).</abstract><notes>Li, Zi-Bo&#xD;Wu, Zhanhong&#xD;Cao, Qizhen&#xD;Dick, David W&#xD;Tseng, Jeffrey R&#xD;Gambhir, Sanjiv S&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging&#xD;Mol Imaging Biol. 2008 Mar-Apr;10(2):92-8. Epub 2007 Dec 21.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>3.372</custom4><electronic-resource-num>10.1007/s11307-007-0125-0 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1279</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1279</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hunt, T. P.</author><author>Issadore, D.</author><author>Westervelt, R. M.</author></authors></contributors><auth-address>Department of Physics, Harvard University, 29 Oxford Street, Cambridge, MA 02138, USA.</auth-address><titles><title>Integrated circuit/microfluidic chip to programmably trap and move cells and droplets with dielectrophoresis</title><secondary-title>Lab Chip</secondary-title></titles><periodical><full-title>Lab Chip</full-title></periodical><pages>81-7</pages><volume>8</volume><number>1</number><edition>2007/12/21</edition><keywords><keyword>Animals</keyword><keyword>Computer Simulation</keyword><keyword>Electronics/instrumentation/*methods</keyword><keyword>Electrophoresis/instrumentation/*methods</keyword><keyword>Macrophages, Alveolar/chemistry</keyword><keyword>Microfluidics/instrumentation/*methods</keyword><keyword>Models, Chemical</keyword><keyword>Motion</keyword><keyword>Rats</keyword><keyword>*Software</keyword><keyword>Yeasts/*cytology</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>18094765</accession-num><abstract>We present an integrated circuit/microfluidic chip that traps and moves individual living biological cells and chemical droplets along programmable paths using dielectrophoresis (DEP). Our chip combines the biocompatibility of microfluidics with the programmability and complexity of integrated circuits (ICs). The chip is capable of simultaneously and independently controlling the location of thousands of dielectric objects, such as cells and chemical droplets. The chip consists of an array of 128 x 256 pixels, 11 x 11 microm(2) in size, controlled by built-in SRAM memory; each pixel can be energized by a radio frequency (RF) voltage of up to 5 V(pp). The IC was built in a commercial foundry and the microfluidic chamber was fabricated on its top surface at Harvard. Using this hybrid chip, we have moved yeast and mammalian cells through a microfluidic chamber at speeds up to 30 microm sec(-1). Thousands of cells can be individually trapped and simultaneously positioned in controlled patterns. The chip can trap and move pL droplets of water in oil, split one droplet into two, and mix two droplets into one. Our IC/microfluidic chip provides a versatile platform to trap and move large numbers of cells and fluid droplets individually for lab-on-a-chip applications.</abstract><notes>Hunt, Thomas P&#xD;Issadore, David&#xD;Westervelt, R M&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Lab on a chip&#xD;Lab Chip. 2008 Jan;8(1):81-7. Epub 2007 Nov 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18094765</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.000</custom4><electronic-resource-num>10.1039/b710928h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1650</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1650</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Teply, B. A.</author><author>Tong, R.</author><author>Jeong, S. Y.</author><author>Luther, G.</author><author>Sherifi, I.</author><author>Yim, C. H.</author><author>Khademhosseini, A.</author><author>Farokhzad, O. C.</author><author>Langer, R. S.</author><author>Cheng, J.</author></authors></contributors><auth-address>Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules</title><secondary-title>Biomaterials</secondary-title></titles><periodical><full-title>Biomaterials</full-title></periodical><pages>1216-23</pages><volume>29</volume><number>9</number><edition>2007/12/18</edition><keywords><keyword>Administration, Oral</keyword><keyword>Animals</keyword><keyword>*Biocompatible Materials</keyword><keyword>Biological Availability</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Insulin/administration &amp; dosage/pharmacokinetics</keyword><keyword>*Lactic Acid</keyword><keyword>*Magnetics</keyword><keyword>Materials Testing</keyword><keyword>Mice</keyword><keyword>Particle Size</keyword><keyword>*Polyglycolic Acid</keyword><keyword>*Polymers</keyword><keyword>Proteins/*administration &amp; dosage/*pharmacokinetics</keyword></keywords><dates><year>2008</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0142-9612 (Print)</isbn><accession-num>18082254</accession-num><abstract>Protein drugs have low bioavailability after oral administration, which is due in part to fast transit of the drugs or drug delivery vehicles through the gastrointestinal tract. Increasing the time that the drugs spend in the intestine after dosing would allow for greater absorption and increased bioavailability. We developed a formulation strategy that can be used to prolong intestinal retention of drug delivery vehicles without substantial alterations to current polymeric encapsulation strategies. A model drug, insulin, was encapsulated in negatively charged poly(lactic-co-glycolic acid) (PLGA) microparticles, and the microparticles were subsequently mixed with positively charged micromagnets, whose size will prevent them from being absorbed. Stable complexes formed through electrostatic interaction. The complexes were effectively immobilized in vitro in a model of the mouse small intestine by application of an external magnetic field. Mice that were gavaged with radio-labeled complexes and fitted with a magnetic belt retained 32.5% of the (125)I-insulin in the small intestine compared with 5.4% for the control group 6h after administration (p=0.005). Furthermore, mice similarly gavaged with complexes encapsulating insulin (120 Units/kg) exhibited long-term glucose reduction in the groups with magnetic belts. The corresponding bioavailability of insulin was 5.11% compared with 0.87% for the control group (p=0.007).</abstract><notes>Teply, Benjamin A&#xD;Tong, Rong&#xD;Jeong, Seok Y&#xD;Luther, Gaurav&#xD;Sherifi, Ines&#xD;Yim, Christopher H&#xD;Khademhosseini, Ali&#xD;Farokhzad, Omid C&#xD;Langer, Robert S&#xD;Cheng, Jianjun&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Biomaterials&#xD;Biomaterials. 2008 Mar;29(9):1216-23. Epub 2007 Dec 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18082254</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom2>MIT/ Siteman</custom2><custom3>2008</custom3><custom4>7.325</custom4><electronic-resource-num>S0142-9612(07)00953-2 [pii]&#xD;10.1016/j.biomaterials.2007.11.018</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1241</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1241</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Harisinghani, M.</author><author>Ross, R. W.</author><author>Guimaraes, A. R.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, MA 02129-2060, USA. mharisinghani@partners.org</auth-address><titles><title>Utility of a new bolus-injectable nanoparticle for clinical cancer staging</title><secondary-title>Neoplasia</secondary-title></titles><periodical><full-title>Neoplasia</full-title></periodical><pages>1160-5</pages><volume>9</volume><number>12</number><edition>2007/12/18</edition><keywords><keyword>Adenocarcinoma/diagnosis/pathology/*secondary</keyword><keyword>Contrast Media/*administration &amp; dosage/analysis</keyword><keyword>Dextrans/*administration &amp; dosage</keyword><keyword>Ferrosoferric Oxide/administration &amp; dosage/analysis/*diagnostic use</keyword><keyword>Humans</keyword><keyword>Imaging, Three-Dimensional</keyword><keyword>Injections, Intravenous</keyword><keyword>Lymph Node Excision</keyword><keyword>Lymphatic Metastasis/*diagnosis/pathology</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>Male</keyword><keyword>Nanoparticles/administration &amp; dosage/analysis/*diagnostic use</keyword><keyword>Neoplasm Staging/*methods</keyword><keyword>Pelvis</keyword><keyword>Pilot Projects</keyword><keyword>Prospective Studies</keyword><keyword>Prostatic Neoplasms/*pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1476-5586 (Electronic)</isbn><accession-num>18084623</accession-num><abstract>BACKGROUND: In this study, we report on the use of a new, bolus-injectable, carboxymethyl dextran-based magnetic nanoparticle (MNP), ferumoxytol, to improve detection in loco-regional lymph nodes by magnetic resonance imaging (MRI). METHODS: This preliminary study was performed as a prospective, single-center, open label pilot study to determine the magnitude of nodal MRI signal changes and to determine the optimal time points for imaging following intravenous (IV) bolus injection of the MNP. The study group consisted of 10 patients, all of whom were diagnosed with prostate cancer before any systemic therapy. RESULTS: All 10 patients had lymph nodes evaluated by histopathology. Of the evaluated 26 lymph nodes, 20 were benign and 6 were malignant. The mean short-axis diameter of benign lymph nodes was 6 mm and the mean short-axis diameter of malignant lymph nodes was 7 mm. Following IV administration, there was a significant change in mean signal-to-noise ratio (SNR) of benign lymph nodes (P &lt; .0001) whereas there was little change in the mean SNR of malignant nodes (P = .1624). No adverse events were encountered. CONCLUSION: Ferumoxytol is safe and, at the appropriate circulation interval, modulates nodal signal intensity, allowing for identification of malignant nodal involvement by MRI.</abstract><notes>Harisinghani, Mukesh&#xD;Ross, Robert W&#xD;Guimaraes, Alexander R&#xD;Weissleder, Ralph&#xD;N01-CO-12400/CO/United States NCI&#xD;Clinical Trial&#xD;Research Support, N.I.H., Extramural&#xD;Canada&#xD;Neoplasia (New York, N.Y.)&#xD;Neoplasia. 2007 Dec;9(12):1160-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18084623</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>5.124</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1951</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1951</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Desai, A.</author><author>Shi, X.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI, USA.</auth-address><titles><title>CE of poly(amidoamine) succinamic acid dendrimers using a poly(vinyl alcohol)-coated capillary</title><secondary-title>Electrophoresis</secondary-title></titles><periodical><full-title>Electrophoresis</full-title></periodical><pages>510-5</pages><volume>29</volume><number>2</number><edition>2007/12/15</edition><keywords><keyword>Dendrimers/chemistry/ isolation &amp; purification</keyword><keyword>Electrophoresis, Capillary/ instrumentation/ methods</keyword><keyword>Polyvinyl Alcohol</keyword><keyword>Reproducibility of Results</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0173-0835 (Print)</isbn><accession-num>18080252</accession-num><abstract>Various generations (G1-G8) of negatively charged poly(amidoamine) (PAMAM) succinamic acid dendrimers (PAMAM-SAH) were analyzed by CE using a poly(vinyl alcohol)-coated capillary. Due to its excellent stability and osmotic flow-shielding effect, highly reproducible migration times were achieved for all generations of dendrimer (e.g., RSD for the migration times of G5 dendrimer was 0.6%). We also observed a reverse trend in migration times for the PAMAM-SAH dendrimers (i.e., higher generations migrated faster than lower generation dendrimers) compared to amine-terminated PAMAM dendrimers reported in the literature. This reversal in migration times was attributed to the difference in counterion binding around these negatively charged dendrimers. This reverse trend allowed a generational separation for lower generation (G1-G3) dendrimers. However, a sufficient resolution for the migration peaks of higher generations (G4-G5) in a mixture could not be achieved. This could be due to their nearly identical charge/mass ratio and dense molecular conformations. In addition, we show that dye-functionalized PAMAM-SAH dendrimers can also be analyzed with high reproducibility using this method.</abstract><notes>Desai, Ankur&#xD;Shi, Xiangyang&#xD;Baker, James R Jr&#xD;1 R01 CA119409/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Electrophoresis&#xD;Electrophoresis. 2008 Jan;29(2):510-5.</notes><urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom4>3.576</custom4><electronic-resource-num>10.1002/elps.200700454 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1215</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1215</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gounaris, E.</author><author>Erdman, S. E.</author><author>Restaino, C.</author><author>Gurish, M. F.</author><author>Friend, D. S.</author><author>Gounari, F.</author><author>Lee, D. M.</author><author>Zhang, G.</author><author>Glickman, J. N.</author><author>Shin, K.</author><author>Rao, V. P.</author><author>Poutahidis, T.</author><author>Weissleder, R.</author><author>McNagny, K. M.</author><author>Khazaie, K.</author></authors></contributors><auth-address>Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Mast cells are an essential hematopoietic component for polyp development</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>19977-82</pages><volume>104</volume><number>50</number><edition>2007/12/14</edition><keywords><keyword>Adenomatous Polyposis Coli/genetics/metabolism/pathology</keyword><keyword>Animals</keyword><keyword>Cells, Cultured</keyword><keyword>Colorectal Neoplasms/genetics/*pathology</keyword><keyword>Hematopoietic System/*metabolism/*pathology</keyword><keyword>Humans</keyword><keyword>Mast Cells/metabolism/*pathology</keyword><keyword>Mastocytosis/genetics/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Mice, Mutant Strains</keyword><keyword>Mice, Transgenic</keyword><keyword>Neoplasm Recurrence, Local/genetics/pathology</keyword><keyword>Polyps/genetics/*pathology</keyword><keyword>Precancerous Conditions/genetics/pathology</keyword><keyword>Radiation Chimera</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 11</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18077429</accession-num><abstract>It is generally agreed that most colon cancers develop from adenomatous polyps, and it is this fact on which screening strategies are based. Although there is overwhelming evidence to link intrinsic genetic lesions with the formation of these preneoplastic lesions, recent data suggest that the tumor stromal environment also plays an essential role in this disease. In particular, it has been suggested that CD34(+) immature myeloid precursor cells are required for tumor development and invasion. Here we have used mice conditional for the stabilization of beta-catenin or defective for the adenomatous polyposis coli (APC) gene to reinvestigated the identity and importance of tumor-infiltrating hematopoietic cells in polyposis. We show that, from the onset, polyps are infiltrated with proinflammatory mast cells (MC) and their precursors. Depletion of MC either pharmacologically or through the generation of chimeric mice with genetic lesions in MC development leads to a profound remission of existing polyps. Our data suggest that MC are an essential hematopoietic component for preneoplastic polyp development and are a novel target for therapeutic intervention.</abstract><notes>Gounaris, Elias&#xD;Erdman, Susan E&#xD;Restaino, Clifford&#xD;Gurish, Michael F&#xD;Friend, Daniel S&#xD;Gounari, Fotini&#xD;Lee, David M&#xD;Zhang, Guoying&#xD;Glickman, Jonathan N&#xD;Shin, Kichul&#xD;Rao, Varada P&#xD;Poutahidis, Theofilos&#xD;Weissleder, Ralph&#xD;McNagny, Kelly M&#xD;Khazaie, Khashayarsha&#xD;R01-AI059676/AI/United States NIAID&#xD;R01-CA104547/CA/United States NCI&#xD;R01-CA108854/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Validation Studies&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19977-82. Epub 2007 Dec 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18077429</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>10.228</custom4><electronic-resource-num>0704620104 [pii]&#xD;10.1073/pnas.0704620104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1083</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1083</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Beroukhim, R.</author><author>Getz, G.</author><author>Nghiemphu, L.</author><author>Barretina, J.</author><author>Hsueh, T.</author><author>Linhart, D.</author><author>Vivanco, I.</author><author>Lee, J. C.</author><author>Huang, J. H.</author><author>Alexander, S.</author><author>Du, J.</author><author>Kau, T.</author><author>Thomas, R. K.</author><author>Shah, K.</author><author>Soto, H.</author><author>Perner, S.</author><author>Prensner, J.</author><author>Debiasi, R. M.</author><author>Demichelis, F.</author><author>Hatton, C.</author><author>Rubin, M. A.</author><author>Garraway, L. A.</author><author>Nelson, S. F.</author><author>Liau, L.</author><author>Mischel, P. S.</author><author>Cloughesy, T. F.</author><author>Meyerson, M.</author><author>Golub, T. A.</author><author>Lander, E. S.</author><author>Mellinghoff, I. K.</author><author>Sellers, W. R.</author></authors></contributors><auth-address>Broad Institute, Massachusetts Institute of Technology and Harvard University, 7 Cambridge Center, Cambridge, MA 02142, USA.</auth-address><titles><title>Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>20007-12</pages><volume>104</volume><number>50</number><edition>2007/12/14</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Chromosome Aberrations/*statistics &amp; numerical data</keyword><keyword>Data Interpretation, Statistical</keyword><keyword>Glioma/*genetics/pathology</keyword><keyword>Humans</keyword><keyword>Polymorphism, Single Nucleotide</keyword><keyword>Probability</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 11</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>18077431</accession-num><abstract>Comprehensive knowledge of the genomic alterations that underlie cancer is a critical foundation for diagnostics, prognostics, and targeted therapeutics. Systematic efforts to analyze cancer genomes are underway, but the analysis is hampered by the lack of a statistical framework to distinguish meaningful events from random background aberrations. Here we describe a systematic method, called Genomic Identification of Significant Targets in Cancer (GISTIC), designed for analyzing chromosomal aberrations in cancer. We use it to study chromosomal aberrations in 141 gliomas and compare the results with two prior studies. Traditional methods highlight hundreds of altered regions with little concordance between studies. The new approach reveals a highly concordant picture involving approximately 35 significant events, including 16-18 broad events near chromosome-arm size and 16-21 focal events. Approximately half of these events correspond to known cancer-related genes, only some of which have been previously tied to glioma. We also show that superimposed broad and focal events may have different biological consequences. Specifically, gliomas with broad amplification of chromosome 7 have properties different from those with overlapping focalEGFR amplification: the broad events act in part through effects on MET and its ligand HGF and correlate with MET dependence in vitro. Our results support the feasibility and utility of systematic characterization of the cancer genome.</abstract><notes>Beroukhim, Rameen&#xD;Getz, Gad&#xD;Nghiemphu, Leia&#xD;Barretina, Jordi&#xD;Hsueh, Teli&#xD;Linhart, David&#xD;Vivanco, Igor&#xD;Lee, Jeffrey C&#xD;Huang, Julie H&#xD;Alexander, Sethu&#xD;Du, Jinyan&#xD;Kau, Tweeny&#xD;Thomas, Roman K&#xD;Shah, Kinjal&#xD;Soto, Horacio&#xD;Perner, Sven&#xD;Prensner, John&#xD;Debiasi, Ralph M&#xD;Demichelis, Francesca&#xD;Hatton, Charlie&#xD;Rubin, Mark A&#xD;Garraway, Levi A&#xD;Nelson, Stan F&#xD;Liau, Linda&#xD;Mischel, Paul S&#xD;Cloughesy, Tim F&#xD;Meyerson, Matthew&#xD;Golub, Todd A&#xD;Lander, Eric S&#xD;Mellinghoff, Ingo K&#xD;Sellers, William R&#xD;CA109038/CA/United States NCI&#xD;CA126546/CA/United States NCI&#xD;K08 CA122833-01A1/CA/United States NCI&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20007-12. Epub 2007 Dec 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18077431</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>10.228</custom4><electronic-resource-num>0710052104 [pii]&#xD;10.1073/pnas.0710052104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1717</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1717</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Weiss, E. A.</author><author>Porter, V. J.</author><author>Chiechi, R. C.</author><author>Geyer, S. M.</author><author>Bell, D. C.</author><author>Bawendi, M. G.</author><author>Whitesides, G. M.</author></authors></contributors><auth-address>Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138, USA.</auth-address><titles><title>The use of size-selective excitation to study photocurrent through junctions containing single-size and multi-size arrays of colloidal CdSe quantum dots</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>83-92</pages><volume>130</volume><number>1</number><edition>2007/12/13</edition><dates><year>2008</year><pub-dates><date>Jan 9</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18072774</accession-num><abstract>This paper describes a study of the generation and flow of photocurrent through junctions containing three-dimensional arrays of colloidal CdSe quantum dots (QDs) of either a single size or multiple sizes. The electrodes were indium tin oxide (ITO) covered with a thin layer of poly(3,4-ethylenedioxy-thiophene):poly(styrenesulfonate) (PEDOT:PSS) and a eutectic alloy of Ga and In (EGaIn). We measured the current-voltage characteristics of the junctions in the dark and under illumination, with various sources and wavelengths of excitation, and their photocurrent action spectra. Size-selective photoexcitation of the arrays of multiple sizes of QDs helped to determine (i) the location of the interface at which photoinduced separation of charge occurred, (ii) whether the energy absorbed by the QDs was redistributed before separation of charge, and (iii) the dependence of the photovoltage on the locations of various sizes of QDs within the junction. This research is a step toward the use of QDs for harvesting light and for transporting energy and charge in devices-for example, solar cells and photodetectors-that operate at zero bias.</abstract><notes>Weiss, Emily A&#xD;Porter, Venda J&#xD;Chiechi, Ryan C&#xD;Geyer, Scott M&#xD;Bell, David C&#xD;Bawendi, Moungi G&#xD;Whitesides, George M&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Jan 9;130(1):83-92. Epub 2007 Dec 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18072774</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja076439+</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1716</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1716</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Weiss, E. A.</author><author>Chiechi, R. C.</author><author>Geyer, S. M.</author><author>Porter, V. J.</author><author>Bell, D. C.</author><author>Bawendi, M. G.</author><author>Whitesides, G. M.</author></authors></contributors><auth-address>Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138, USA.</auth-address><titles><title>Size-dependent charge collection in junctions containing single-size and multi-size arrays of colloidal CdSe quantum dots</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>74-82</pages><volume>130</volume><number>1</number><edition>2007/12/13</edition><dates><year>2008</year><pub-dates><date>Jan 9</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18072773</accession-num><abstract>This paper describes the electrical characteristics of junctions composed of three-dimensional arrays of colloidal CdSe quantum dots (QDs) with tin-doped indium oxide (ITO)/poly(3,4-ethylenedioxy-thiophene):poly(styrenesulfonate) (PEDOT:PSS) and eutectic Ga-In (EGaIn) electrodes. It focuses on a comparison of junctions containing QDs of one size to those of arrays containing QDs of multiple sizes. This comparison makes it possible to estimate the relative contributions of transport across various interfaces (e.g., between the QDs and between the QDs and the electrodes) to the observed electrical characteristics of the junction and to evaluate the dependence of these contributions on the locations of various sizes of QDs within the junction. The junctions were diodes, and their turn-on voltage depended on the size of the QDs next to the PEDOT:PSS. We describe this dependence using a Marcus model to estimate the barrier for charge transfer induced by the difference in energies between the orbitals of the QDs and the valence band of PEDOT:PSS.</abstract><notes>Weiss, Emily A&#xD;Chiechi, Ryan C&#xD;Geyer, Scott M&#xD;Porter, Venda J&#xD;Bell, David C&#xD;Bawendi, Moungi G&#xD;Whitesides, George M&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2008 Jan 9;130(1):74-82. Epub 2007 Dec 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18072773</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja076438h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1671</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1671</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Urbanczyk-Pearson, L. M.</author><author>Femia, F. J.</author><author>Smith, J.</author><author>Parigi, G.</author><author>Duimstra, J. A.</author><author>Eckermann, A. L.</author><author>Luchinat, C.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, IL 60201, USA.</auth-address><titles><title>Mechanistic investigation of beta-galactosidase-activated MR contrast agents</title><secondary-title>Inorg Chem</secondary-title></titles><periodical><full-title>Inorg Chem</full-title></periodical><pages>56-68</pages><volume>47</volume><number>1</number><edition>2007/12/13</edition><keywords><keyword>Contrast Media/*chemistry</keyword><keyword>Gadolinium/*chemistry</keyword><keyword>Lanthanoid Series Elements/*chemistry</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Molecular Structure</keyword><keyword>Organometallic Compounds/*chemical synthesis/chemistry</keyword><keyword>Stereoisomerism</keyword><keyword>beta-Galactosidase/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 7</date></pub-dates></dates><isbn>0020-1669 (Print)</isbn><accession-num>18072754</accession-num><abstract>We report a mechanistic investigation of an isomeric series of beta-galactosidase-activated magnetic resonance contrast agents. Our strategy focuses on the synthesis of macrocyclic caged-complexes that coordinatively saturate a chelated lanthanide. Enzyme cleavage of the complex results in an open coordination site available for water that creates a detectable MR contrast agent. The complexes consist of a DO3A Gd(III) chelator modified with a galactopyranose at the N-10 position of the macrocycle. We observed significant differences in relaxometric properties and coordination geometry that can be correlated to subtle variations of the linker between the macrocycle and the galactopyranose. After synthesis and purification of the R, S, and racemic mixtures of complexes 1 and 3 and measurement of the hydration number, water residence lifetime, and longitudinal relaxation rates, we propose mechanisms for water exclusion from the lanthanide in the precleavage state. While the stereochemistry of the linker does not influence the agents&apos; properties, the mechanism of water exclusion for each isomer is significantly influenced by the position of modification. Data for one series with a methyl group substituted on the sugar-macrocycle linker at the alpha-position suggests a steric mechanism where the galactopyranose sugar blocks water from the Gd(III) center. In contrast, our observations for a second series with methyl substitution at the beta position of the sugar-macrocycle linker are consistent with a mechanism in which a bidentate anion occupies two available coordination sites of Gd(III) in the precleavage state.</abstract><notes>Urbanczyk-Pearson, Lauren M&#xD;Femia, Frank J&#xD;Smith, Jeffrey&#xD;Parigi, Giacomo&#xD;Duimstra, Joseph A&#xD;Eckermann, Amanda L&#xD;Luchinat, Claudio&#xD;Meade, Thomas J&#xD;5 U54 CA90810/CA/United States NCI&#xD;R01 AI47003/AI/United States NIAID&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Inorganic chemistry&#xD;Inorg Chem. 2008 Jan 7;47(1):56-68. Epub 2007 Dec 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18072754</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.215</custom4><electronic-resource-num>10.1021/ic700888w</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1344</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1344</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Korngold, E. C.</author><author>Jaffer, F. A.</author><author>Weissleder, R.</author><author>Sosnovik, D. E.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, 149 13th St., 5th floor, Boston, MA 02129, USA.</auth-address><titles><title>Noninvasive imaging of apoptosis in cardiovascular disease</title><secondary-title>Heart Fail Rev</secondary-title></titles><periodical><full-title>Heart Fail Rev</full-title></periodical><pages>163-73</pages><volume>13</volume><number>2</number><edition>2007/12/13</edition><dates><year>2008</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1382-4147 (Print)</isbn><accession-num>18074226</accession-num><abstract>Recent advances in molecular imaging have permitted the noninvasive imaging of apoptosis, a critical process underlying the pathogenesis of many diseases of the cardiovascular system including atherosclerotic vascular disease, myocardial ischemia and reperfusion injury, chronic heart failure, myocarditis, and cardiac allograft rejection. Multiple molecular targets including phosphatidylserine, phosphatidylinositol 3-kinase, and caspases have been targeted by a variety of imaging agents and modalities such as nuclear scintigraphy, PET, MRI, and fluorescent and bioluminescent imaging. Translationally, methods utilizing radiolabeled annexin V have proven promising in several clinical trials of ischemia-reperfusion injury and cardiac allograft rejection. New approaches using novel molecular imaging agents show great potential for the ability to image apoptosis in the research and clinical setting. Ultimately the ability to detect apoptosis noninvasively would help to identify patients for emerging anti-apoptotic therapies and guide clinical management with the aim of maximal myocardial preservation.</abstract><notes>Korngold, Ethan Chauncey&#xD;Jaffer, Farouc Amin&#xD;Weissleder, Ralph&#xD;Sosnovik, David Edwin&#xD;K08 HL079984/HL/United States NHLBI&#xD;UO1-HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Heart failure reviews&#xD;Heart Fail Rev. 2008 Jun;13(2):163-73.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18074226</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>2.125</custom4><electronic-resource-num>10.1007/s10741-007-9068-4</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1377</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1377</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J.</author><author>Hasan, W.</author><author>Lee, M. H.</author><author>Odom, T. W.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, IL 60208 (USA); Department of Materials Science and Engineering, Northwestern University, Evanston, IL 60208 (USA)</auth-address><titles><title>Optical Properties and Magnetic Manipulation of Bimaterial Nanopyramids</title><secondary-title>Advanced Materials</secondary-title></titles><periodical><full-title>Advanced Materials</full-title></periodical><pages>4387-4391</pages><volume>19</volume><number>24</number><edition>2007/12/11</edition><dates><year>2007</year><pub-dates><date>December 2007</date></pub-dates></dates><isbn>1521-4095</isbn><abstract>No abstract.</abstract><notes>10.1002/adma.200701505</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200701505</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>10.231</custom4><electronic-resource-num>10.1002/adma.200701505 </electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1096</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1096</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bouffard, J.</author><author>Kim, Y.</author><author>Swager, T. M.</author><author>Weissleder, R.</author><author>Hilderbrand, S. A.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>A highly selective fluorescent probe for thiol bioimaging</title><secondary-title>Org Lett</secondary-title></titles><periodical><full-title>Org Lett</full-title><abbr-1>Organic letters</abbr-1></periodical><pages>37-40</pages><volume>10</volume><number>1</number><edition>2007/12/08</edition><keywords><keyword>Colorimetry/methods</keyword><keyword>Diagnostic Imaging/*methods</keyword><keyword>*Fluorescent Dyes</keyword><keyword>Molecular Structure</keyword><keyword>Nitrobenzenes/*chemistry</keyword><keyword>Nitrogen/chemistry</keyword><keyword>Oxygen/chemistry</keyword><keyword>Sulfhydryl Compounds/*analysis</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 3</date></pub-dates></dates><isbn>1523-7060 (Print)</isbn><accession-num>18062694</accession-num><abstract>A new fluorescent turn-on probe (3) for the selective sensing and bioimaging of thiols is reported. In aqueous buffer solutions at physiological pH, thiols cleave the 2,4-dinitrobenzenesulfonyl group to release the red-emissive donor-acceptor fluorophore (4). The probe displays excellent immunity to interference from nitrogen and oxygen nucleophiles and the imaging of thiols in living cells is demonstrated.</abstract><notes>Bouffard, Jean&#xD;Kim, Youngmi&#xD;Swager, Timothy M&#xD;Weissleder, Ralph&#xD;Hilderbrand, Scott A&#xD;1-U01-HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Organic letters&#xD;Org Lett. 2008 Jan 3;10(1):37-40. Epub 2007 Dec 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18062694</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>4.742</custom4><electronic-resource-num>10.1021/ol702539v</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1688</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1688</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wallace, K. D.</author><author>Marsh, J. N.</author><author>Baldwin, S. L.</author><author>Connolly, A. M.</author><author>Keeling, R.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author><author>Hughes, M. S.</author></authors></contributors><auth-address>Washington University School of Medicine, Washington University, St. Louis, MO, USA. kirk.wallace@wustl.edu</auth-address><titles><title>Sensitive ultrasonic delineation of steroid treatment in living dystrophic mice with energy-based and entropy-based radio frequency signal processing</title><secondary-title>IEEE Trans Ultrason Ferroelectr Freq Control</secondary-title></titles><periodical><full-title>IEEE Trans Ultrason Ferroelectr Freq Control</full-title></periodical><pages>2291-9</pages><volume>54</volume><number>11</number><edition>2007/12/07</edition><keywords><keyword>Algorithms</keyword><keyword>Animals</keyword><keyword>Anti-Inflammatory Agents/administration &amp; dosage</keyword><keyword>*Disease Models, Animal</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Image Interpretation, Computer-Assisted/methods</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Transgenic</keyword><keyword>Muscle, Skeletal/drug effects/ultrasonography</keyword><keyword>Muscular Dystrophy, Duchenne/*drug therapy/*ultrasonography</keyword><keyword>Prednisolone/*administration &amp; dosage</keyword><keyword>Prognosis</keyword><keyword>Radio Waves</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Signal Processing, Computer-Assisted</keyword><keyword>Treatment Outcome</keyword><keyword>Ultrasonography/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 2007</date></pub-dates></dates><isbn>0885-3010 (Print)</isbn><accession-num>18051163</accession-num><abstract>Duchenne muscular dystrophy is a severe wasting disease, involving replacement of necrotic muscle tissue by fibrous material and fatty infiltrates. One primary animal model of this human disease is the X chromosome-linked mdx strain of mice. The goals of the present work were to validate and quantify the capability of both energy and entropy metrics of radio-frequency ultrasonic backscatter to differentiate among normal, dystrophic, and steroid-treated skeletal muscle in the mdx model. Thirteen 12-month-old mice were blocked into three groups: 4 treated mdx-dystrophic that received daily subcutaneous steroid (prednisolone) treatment for 14 days, 4 positive-control mdx-dystrophic that received saline injections for 14 days, and 5 negative-control animals. Biceps muscle of each animal was imaged in vivo using a 40-MHz center frequency transducer in conjunction with a Vevo-660 ultrasound system. Radio-frequency data were acquired (1 GHz, 8 bits) corresponding to a sequence of transverse images, advancing the transducer from &quot;shoulder&quot; to &quot;elbow&quot; in 100-micron steps. Data were processed to generate both &quot;integrated backscatter&quot; (log energy), and &quot;entropy&quot; (information theoretic receiver, H(f)) representations. Analyses of the integrated-backscatter values delineated both treated-and untreated-mdx biceps from normal controls (p &lt; 0.01). Complementary analyses of the entropy images differentiated the steroid-treated and positive-control mdx groups (p &lt; 0.01). To our knowledge, this study represents the first reported use of quantitative ultrasonic characterization of skeletal muscle in mdx mice. Successful differentiation among dystrophic, steroid-treated, and normal tissues suggests the potential for local noninvasive monitoring of disease severity and therapeutic effects.</abstract><notes>Wallace, Kirk D&#xD;Marsh, Jon N&#xD;Baldwin, Steven L&#xD;Connolly, Anne M&#xD;Keeling, Richard&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Hughes, Michael S&#xD;R01-HL042950/HL/United States NHLBI&#xD;R01-HL073646/HL/United States NHLBI&#xD;U54-CA119342/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;IEEE transactions on ultrasonics, ferroelectrics, and frequency control&#xD;IEEE Trans Ultrason Ferroelectr Freq Control. 2007 Nov;54(11):2291-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18051163</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2008</custom3><custom4>1.654</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1076</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1076</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Barrett, D. G.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and the Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>A tunable, chemoselective, and moldable biodegradable polyester for cell scaffolds</title><secondary-title>Chembiochem</secondary-title></titles><periodical><full-title>Chembiochem</full-title></periodical><pages>62-6</pages><volume>9</volume><number>1</number><edition>2007/12/07</edition><keywords><keyword>Aminooxyacetic Acid/chemistry</keyword><keyword>Biocompatible Materials/*chemical synthesis/*metabolism</keyword><keyword>Biodegradation, Environmental</keyword><keyword>Cross-Linking Reagents/chemistry</keyword><keyword>Ligands</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Polyesters/*chemical synthesis/*metabolism</keyword><keyword>Tissue Scaffolds/*chemistry</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 4</date></pub-dates></dates><isbn>1439-7633 (Electronic)</isbn><accession-num>18058776</accession-num><notes>Barrett, Devin G&#xD;Yousaf, Muhammad N&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Chembiochem : a European journal of chemical biology&#xD;Chembiochem. 2008 Jan 4;9(1):62-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18058776</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>3.684</custom4><electronic-resource-num>10.1002/cbic.200700550</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1064</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1064</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Arnold, R. S.</author><author>He, J.</author><author>Remo, A.</author><author>Ritsick, D.</author><author>Yin-Goen, Q.</author><author>Lambeth, J. D.</author><author>Datta, M. W.</author><author>Young, A. N.</author><author>Petros, J. A.</author></authors></contributors><auth-address>Department of Urology, Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Rd., Building B, Atlanta, GA 30322, USA.</auth-address><titles><title>Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1</title><secondary-title>Am J Pathol</secondary-title></titles><periodical><full-title>Am J Pathol</full-title></periodical><pages>2021-32</pages><volume>171</volume><number>6</number><edition>2007/12/07</edition><keywords><keyword>Aged</keyword><keyword>Animals</keyword><keyword>Caveolin 1/genetics/metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation</keyword><keyword>Gene Expression</keyword><keyword>Humans</keyword><keyword>Interleukin-8/genetics/metabolism</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>NADH, NADPH Oxidoreductases/antagonists &amp; inhibitors/genetics/*metabolism</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Prostate/enzymology/*pathology</keyword><keyword>Prostatic Neoplasms/*enzymology/genetics/*pathology</keyword><keyword>Proto-Oncogene Proteins c-fos/genetics/metabolism</keyword><keyword>RNA, Small Interfering/genetics</keyword><keyword>Reactive Oxygen Species/*metabolism</keyword><keyword>Transfection</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0002-9440 (Print)</isbn><accession-num>18055552</accession-num><abstract>Increased cellular reactive oxygen species (ROS) can act as mitogenic signals in addition to damaging DNA and oxidizing lipids and proteins, implicating ROS in cancer development and progression. To analyze the effects of Nox1 expression and its relation to cellular ROS and signal transduction involved in cellular proliferation, Nox1RNAi constructs were transfected into DU145 prostate cancer cells overexpressing Nox1, causing decreased Nox1 message and protein levels in the Nox1RNAi cell lines. Increased ROS and tumor growth in the Nox1-overexpressing DU145 cells were reversed in the presence of the Nox1RNAi. Analysis and comparison of the message levels in the overexpression and RNAi cells demonstrated that Nox1 overexpression leads to changes in message levels of a variety of proteins including c-fos-induced growth factor, interleukin-8, and Cav-1. Finally, we found that Nox1 protein overexpression is an early event in the development of prostate cancer using a National Cancer Institute prostate cancer tissue microarray (CPCTR). Tumor (86%) was significantly more likely to have Nox1 staining than benign prostate tissue (62%) (P = 0.0001). These studies indicate that Nox1 overexpression may function as a reversible signal for cellular proliferation with relevance for a common human tumor.</abstract><notes>Arnold, Rebecca S&#xD;He, Ju&#xD;Remo, Andrea&#xD;Ritsick, Darren&#xD;Yin-Goen, Qiqin&#xD;Lambeth, J David&#xD;Datta, Milton W&#xD;Young, Andrew N&#xD;Petros, John A&#xD;CA098912/CA/United States NCI&#xD;CA96994/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;The American journal of pathology&#xD;Am J Pathol. 2007 Dec;171(6):2021-32. Epub 2007 Nov 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18055552</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>6.200</custom4><electronic-resource-num>ajpath.2007.061144 [pii]&#xD;10.2353/ajpath.2007.061144</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1270</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1270</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huang, J.</author><author>Wang, X.</author><author>Wang, Z.L.</author></authors></contributors><titles><title>Bio-inspired fabrication of antireflection nanostructures by replicating fly eyes</title><secondary-title>Nanotechnology</secondary-title></titles><periodical><full-title>Nanotechnology</full-title></periodical><pages>6 pp</pages><volume>19</volume><number>2</number><edition>2007/12/6 </edition><section>025602</section><dates><year>2008</year><pub-dates><date>16 January 2008</date></pub-dates></dates><abstract>In this study, we examined the fine structure of the compound eyes of a household fly and precisely replicated its entire structure using a low-temperature atomic layer deposition technique. The surface of the fly eye is found to be covered by highly packed protuberances, which potentially increases visual efficiency through increased photon capture for a given stimulus. The alumina replica was achieved by removing the fly compound eye template at high temperature, and the alumina coating was crystallized simultaneously. Besides the morphology, the unique antireflection property was also inherited by the alumina replica. By measuring the reflective spectra of the replica, we demonstrated that the alumina replica of a fly eye was an efficient antireflection structure of visible light at an incident angle up to 80. Such a grating would be particularly useful on a cured corneal surface since it could increase the transmission of incident light through the cornea compared with a smooth surface.</abstract><urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>3.727</custom4><electronic-resource-num> 10.1088/0957-4484/19/02/025602</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1777</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1777</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, G.</author><author>Zhang, R.</author><author>Wen, X.</author><author>Li, L.</author><author>Li, C.</author></authors></contributors><auth-address>Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.</auth-address><titles><title>Micelles based on biodegradable poly(L-glutamic acid)-b-polylactide with paramagnetic Gd ions chelated to the shell layer as a potential nanoscale MRI-visible delivery system</title><secondary-title>Biomacromolecules</secondary-title></titles><periodical><full-title>Biomacromolecules</full-title></periodical><pages>36-42</pages><volume>9</volume><number>1</number><edition>2007/12/01</edition><keywords><keyword>Animals</keyword><keyword>*Biocompatible Materials</keyword><keyword>Gadolinium/*chemistry</keyword><keyword>Lactic Acid/*chemistry</keyword><keyword>Magnetic Resonance Spectroscopy/*methods</keyword><keyword>Mice</keyword><keyword>*Micelles</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>NIH 3T3 Cells</keyword><keyword>*Nanotechnology</keyword><keyword>Polyglutamic Acid/*chemistry</keyword><keyword>Polymers/*chemistry</keyword><keyword>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</keyword><keyword>Spectrophotometry, Infrared</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1526-4602 (Electronic)</isbn><accession-num>18047289</accession-num><abstract>There is much interest in the development of a nanoscale drug delivery system with MRI visibility to optimize the delivery efficiency and therapeutic efficacy under image guidance. Here we report on the successful fabrication of nanoscale micelles based on biodegradable poly( L-glutamic acid)- b-polylactide (PG- b-PLA) block copolymer with paramagnetic Gd3+ ions chelated to their shell. PG- b-PLA was synthesized by sequential polymerization reactions: anionic polymerization of L-lactide followed by ring-opening polymerization of benzyl glutamate N-carboxylic anhydride. The metal chelator p-aminobenzyldiethylenetriaminepenta(acetic acid) (DTPA) was readily conjugated to the side chain carboxylic acids of poly( L-glutamic acid). The resulting copolymer formed spherical micelles in aqueous solution with an average diameter of 230 nm at pH 7.4. The size of PG(DTPA)- b-PLA micelles decreased with increasing pH value. DTPA-Gd chelated to the shell layer of the micelles exhibited significantly higher spin-lattice relaxivity (r1) than a small-molecular-weight MRI contrast agent, indicating that water molecules could readily access the Gd ions in the micelles. Because of the presence of multiple carboxylic acid functional groups in the shell layer, polymeric micelles based on biodegradable PG(DTPA-Gd)- b-PLA may be a suitable platform for the development of MRI-visible, targeted nanoscale drug delivery systems.</abstract><notes>Zhang, Guodong&#xD;Zhang, Rui&#xD;Wen, Xiaoxia&#xD;Li, Li&#xD;Li, Chun&#xD;R01 CA119387/CA/NCI NIH HHS/United States&#xD;R01 CA119387-01/CA/NCI NIH HHS/United States&#xD;R01 CA119387-02/CA/NCI NIH HHS/United States&#xD;R01 CA119387-03/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Biomacromolecules&#xD;Biomacromolecules. 2008 Jan;9(1):36-42. Epub 2007 Nov 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18047289</url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom2>2547341</custom2><custom4>4.658</custom4><electronic-resource-num>10.1021/bm700713p</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1193</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1193</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Endres, P. J.</author><author>Paunesku, T.</author><author>Vogt, S.</author><author>Meade, T. J.</author><author>Woloschak, G. E.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, USA.</auth-address><titles><title>DNA-TiO2 nanoconjugates labeled with magnetic resonance contrast agents</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>15760-1</pages><volume>129</volume><number>51</number><edition>2007/12/01</edition><keywords><keyword>Contrast Media/*chemistry</keyword><keyword>DNA/*chemistry</keyword><keyword>Gadolinium/chemistry</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>*Metal Nanoparticles</keyword><keyword>Nucleic Acid Hybridization</keyword><keyword>Titanium/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 26</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18047347</accession-num><abstract>Recent efforts have shown that nanoscale materials, specifically, metal-based nanoparticles, hold particular promise for the development of multifunctional imaging probes. These new materials provide the means to chaperone and concentrate both drugs and contrast agents in specific organs, tissues, and cells. Therefore, we have prepared a Gd(III)-modified DNA-TiO2 semiconducting nanoparticle that is detectable in cells by MR imaging. These labeled particles are retained at specific subcellular locations via DNA hybridization to intracellular targets, hence creating the first nanoparticle system capable of targeting specific DNA sequences while being simultaneously detected via MR imaging.</abstract><notes>Endres, Paul J&#xD;Paunesku, Tatjana&#xD;Vogt, Stefan&#xD;Meade, Thomas J&#xD;Woloschak, Gayle E&#xD;1 R01 EB005866-01/EB/United States NIBIB&#xD;1 S10 RR13880-01/RR/United States NCRR&#xD;5 U54 CA90810/CA/United States NCI&#xD;R01 CA107467/CA/United States NCI&#xD;R01 EB0021000/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Dec 26;129(51):15760-1. Epub 2007 Nov 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18047347</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja0772389</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1053</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1053</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Aikawa, E.</author><author>Nahrendorf, M.</author><author>Figueiredo, J. L.</author><author>Swirski, F. K.</author><author>Shtatland, T.</author><author>Kohler, R. H.</author><author>Jaffer, F. A.</author><author>Aikawa, M.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, 149 13th St, Room 5420, Charlestown, MA 02129, USA. eaikawa@mgh.harvard.edu</auth-address><titles><title>Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo</title><secondary-title>Circulation</secondary-title></titles><periodical><full-title>Circulation</full-title></periodical><pages>2841-50</pages><volume>116</volume><number>24</number><edition>2007/11/28</edition><keywords><keyword>Animals</keyword><keyword>Apolipoproteins E/*deficiency/genetics</keyword><keyword>Atherosclerosis/pathology/*physiopathology</keyword><keyword>Calcinosis/etiology/pathology</keyword><keyword>Disease Models, Animal</keyword><keyword>Humans</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>Inflammation/*etiology/prevention &amp; control</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Osteogenesis/*physiology</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 11</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>18040026</accession-num><abstract>BACKGROUND: Arterial calcification is associated with cardiovascular events; however, mechanisms of calcification in atherosclerosis remain obscure. METHODS AND RESULTS: We tested the hypothesis that inflammation promotes osteogenesis in atherosclerotic plaques using in vivo molecular imaging in apolipoprotein E-/- mice (20 to 30 weeks old, n=35). A bisphosphonate-derivatized near-infrared fluorescent imaging agent (excitation 750 nm) visualized osteogenic activity that was otherwise undetectable by x-ray computed tomography. Flow cytometry validated the target specifically in osteoblast-like cells. A spectrally distinct near-infrared fluorescent nanoparticle (excitation 680 nm) was coinjected to simultaneously image macrophages. Fluorescence reflectance mapping demonstrated an association between osteogenic activity and macrophages in aortas of apolipoprotein E-/- mice (R2=0.93). Intravital dual-channel fluorescence microscopy was used to further monitor osteogenic changes in inflamed carotid arteries at 20 and 30 weeks of age and revealed that macrophage burden and osteogenesis concomitantly increased during plaque progression (P&lt;0.01 and P&lt;0.001, respectively) and decreased after statin treatment (P&lt;0.0001 and P&lt;0.05, respectively). Fluorescence microscopy on cryosections colocalized near-infrared fluorescent osteogenic signals with alkaline phosphatase activity, bone-regulating protein expression, and hydroxyapatite nanocrystals as detected by electron microscopy, whereas von Kossa and alizarin red stains showed no evidence of calcification. Real-time reverse-transcription polymerase chain reaction revealed that macrophage-conditioned media increased alkaline phosphatase mRNA expression in vascular smooth muscle cells. CONCLUSIONS: This serial in vivo study demonstrates the real-time association of macrophage burden with osteogenic activity in early-stage atherosclerosis and offers a cellular-resolution tool to identify preclinical microcalcifications.</abstract><notes>Aikawa, Elena&#xD;Nahrendorf, Matthias&#xD;Figueiredo, Jose-Luiz&#xD;Swirski, Filip K&#xD;Shtatland, Timur&#xD;Kohler, Rainer H&#xD;Jaffer, Farouc A&#xD;Aikawa, Masanori&#xD;Weissleder, Ralph&#xD;R0I-HL078641/HL/United States NHLBI&#xD;U0I-HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Circulation&#xD;Circulation. 2007 Dec 11;116(24):2841-50. Epub 2007 Nov 26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18040026</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>13.538</custom4><electronic-resource-num>CIRCULATIONAHA.107.732867 [pii]&#xD;10.1161/CIRCULATIONAHA.107.732867</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1562</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1562</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Seferos, D. S.</author><author>Giljohann, D. A.</author><author>Hill, H. D.</author><author>Prigodich, A. E.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Nano-flares: probes for transfection and mRNA detection in living cells</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>15477-9</pages><volume>129</volume><number>50</number><edition>2007/11/24</edition><keywords><keyword>Base Sequence</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Survival</keyword><keyword>DNA Probes/*chemistry/genetics</keyword><keyword>Humans</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>RNA, Messenger/*analysis/chemistry/genetics</keyword><keyword>Transfection/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 19</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18034495</accession-num><notes>Seferos, Dwight S&#xD;Giljohann, David A&#xD;Hill, Haley D&#xD;Prigodich, Andrew E&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Dec 19;129(50):15477-9. Epub 2007 Nov 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18034495</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja0776529</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1269</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1269</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huang, H.</author><author>Dorn, A.</author><author>Nair, G. P.</author><author>Bulovic, V.</author><author>Bawendi, M. G.</author></authors></contributors><auth-address>Department of Chemistry, Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Bias-induced photoluminescence quenching of single colloidal quantum dots embedded in organic semiconductors</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>3781-6</pages><volume>7</volume><number>12</number><edition>2007/11/24</edition><keywords><keyword>Colloids/*chemistry</keyword><keyword>Diamines/chemistry</keyword><keyword>Luminescence</keyword><keyword>Organic Chemicals/*chemistry</keyword><keyword>Quantum Theory</keyword><keyword>*Semiconductors</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>18034504</accession-num><abstract>We demonstrate reversible quenching of the photoluminescence from single CdSe/ZnS colloidal quantum dots embedded in thin films of the molecular organic semiconductor N,N&apos;-diphenyl-N,N&apos;-bis(3-methylphenyl)-(1,1&apos;-biphenyl)-4,4&apos;-diamine (TPD) in a layered device structure. Our analysis, based on current and charge carrier density, points toward field ionization as the dominant photoluminescence quenching mechanism. Blinking traces from individual quantum dots reveal that the photoluminescence amplitude decreases continuously as a function of increasing forward bias even at the single quantum dot level. In addition, we show that quantum dot photoluminescence is quenched by aluminum tris(8-hydroxyquinoline) (Alq3) in chloroform solutions as well as in thin solid films of Alq3 whereas TPD has little effect. This highlights the importance of chemical compatibility between semiconductor nanocrystals and surrounding organic semiconductors. Our study helps elucidate elementary interactions between quantum dots and organic semiconductors, knowledge needed for designing efficient quantum dot organic optoelectronic devices.</abstract><notes>Huang, Hao&#xD;Dorn, August&#xD;Nair, Gautham P&#xD;Bulovic, Vladimir&#xD;Bawendi, Moungi G&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Dec;7(12):3781-6. Epub 2007 Nov 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18034504</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl072263y</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1985</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1985</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Price, N. D.</author><author>Foltz, G.</author><author>Madan, A.</author><author>Hood, L.</author><author>Tian, Q.</author></authors></contributors><auth-address>Institute for Systems Biology, Seattle, WA 98103, USA.</auth-address><titles><title>Systems biology and cancer stem cells</title><secondary-title>J Cell Mol Med</secondary-title></titles><periodical><full-title>J Cell Mol Med</full-title></periodical><pages>97-110</pages><volume>12</volume><number>1</number><edition>2007/11/23</edition><keywords><keyword>Animals</keyword><keyword>Humans</keyword><keyword>Neoplasms/ pathology</keyword><keyword>Neoplastic Stem Cells/ pathology</keyword><keyword>Systems Biology</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan-Feb</date></pub-dates></dates><isbn>1582-1838 (Print)</isbn><accession-num>18031300</accession-num><abstract>The identification, purification, and characterization of cancer stem cells holds tremendous promise for improving the treatment of cancer. Mounting evidence is demonstrating that only certain tumor cells (i.e. the cancer stem cells) can give rise to tumors when injected and that these purified cell populations generate heterogeneous tumors. While the cell of origin is still not determined definitively, specific molecular markers for populations containing these cancer stem cells have been found for leukemia, brain cancer, and breast cancer, among others. Systems approaches, particularly molecular profiling, have proven to be of great utility for cancer diagnosis and characterization. These approaches also hold significant promise for identifying distinctive properties of the cancer stem cells, and progress is already being made.</abstract><notes>Price, Nathan D&#xD;Foltz, Greg&#xD;Madan, Anup&#xD;Hood, Leroy&#xD;Tian, Qiang&#xD;P01DK53074/DK/NIDDK NIH HHS/United States&#xD;P50 CA083636/CA/NCI NIH HHS/United States&#xD;U54 CA119347/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;Romania&#xD;Journal of cellular and molecular medicine&#xD;J Cell Mol Med. 2008 Jan-Feb;12(1):97-110. Epub 2007 Nov 20.</notes><urls></urls><custom1>CCNE - Caltech</custom1><custom4>5.818</custom4><electronic-resource-num>JCMM151 [pii]&#xD;10.1111/j.1582-4934.2007.00151.x [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2068</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2068</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, Z. B.</author><author>Wu, Z.</author><author>Chen, K.</author><author>Chin, F. T.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, CA, USA.</auth-address><titles><title>Click chemistry for (18)F-labeling of RGD peptides and microPET imaging of tumor integrin alphavbeta3 expression</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>1987-94</pages><volume>18</volume><number>6</number><edition>2007/11/23</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Fluorine Radioisotopes/chemistry</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/ metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Molecular Structure</keyword><keyword>Neoplasms/ metabolism</keyword><keyword>Oligopeptides/ chemistry/ pharmacology</keyword><keyword>Organ Specificity</keyword><keyword>Positron-Emission Tomography/ methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov-Dec</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>18030991</accession-num><abstract>The cell adhesion molecule integrin alpha vbeta 3 plays a key role in tumor angiogenesis and metastasis. A series of (18)F-labeled RGD peptides have been developed for PET of integrin expression based on primary amine reactive prosthetic groups. In this study, we report the use of the Cu(I)-catalyzed Huisgen cycloaddition, also known as a click reaction, to label RGD peptides with (18)F by forming 1,2,3-triazoles. Nucleophilic fluorination of a toluenesulfonic alkyne provided (18)F-alkyne in high yield (nondecay-corrected yield: 65.0 +/- 1.9%, starting from the azeotropically dried (18)F-fluoride), which was then reacted with an RGD azide (nondecay-corrected yield: 52.0 +/- 8.3% within 45 min including HPLC purification). The (18)F-labeled peptide was subjected to microPET studies in murine xenograft models. Murine microPET experiments showed good tumor uptake (2.1 +/- 0.4%ID/g at 1 h postinjection (p.i.)) with rapid renal and hepatic clearance of (18)F-fluoro-PEG-triazoles-RGD 2 ( (18)F-FPTA-RGD2) in a subcutaneous U87MG glioblastoma xenograft model (kidney 2.7 +/- 0.8%ID/g; liver 1.9 +/- 0.4%ID/g at 1 h p.i.). Metabolic stability of the newly synthesized tracer was also analyzed (intact tracer ranging from 75% to 99% at 1 h p.i.). In brief, the new tracer (18)F-FPTA-RGD2 was synthesized with high radiochemical yield and high specific activity. This tracer exhibited good tumor-targeting efficacy and relatively good metabolic stability, as well as favorable in vivo pharmacokinetics. This new (18)F labeling method based on click reaction may also be useful for radiolabeling of other biomolecules with azide groups in high yield.</abstract><notes>Li, Zi-Bo&#xD;Wu, Zhanhong&#xD;Chen, Kai&#xD;Chin, Frederick T&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2007 Nov-Dec;18(6):1987-94. Epub 2007 Nov 21.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.802</custom4><electronic-resource-num>10.1021/bc700226v [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1584</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1584</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shu, C.</author><author>Cai, T.</author><author>Xu, L.</author><author>Zuo, T.</author><author>Reid, J.</author><author>Harich, K.</author><author>Dorn, H. C.</author><author>Gibson, H. W.</author></authors></contributors><auth-address>Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24060-0212, USA.</auth-address><titles><title>Manganese(III)-catalyzed free radical reactions on trimetallic nitride endohedral metallofullerenes</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>15710-7</pages><volume>129</volume><number>50</number><edition>2007/11/22</edition><keywords><keyword>Catalysis</keyword><keyword>Chromatography, High Pressure Liquid</keyword><keyword>Free Radicals/chemistry</keyword><keyword>Fullerenes/*chemistry</keyword><keyword>Magnetic Resonance Spectroscopy</keyword><keyword>Malonates/chemistry</keyword><keyword>Manganese/*chemistry</keyword><keyword>Models, Molecular</keyword><keyword>Molecular Structure</keyword><keyword>Nitrogen/chemistry</keyword><keyword>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</keyword><keyword>Thermodynamics</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 19</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18027949</accession-num><abstract>The first reactions of trimetallic nitride templated endohedral metallofullerenes (TNT EMFs) with carbon radicals generated from diethyl malonate catalyzed by manganese(III) acetate are reported. Two methano monoadducts, Sc3N@C80-A and Sc3N@C80-B, were isolated and characterized. Sc3N@C80-A contains two ester moieties, whereas Sc3N@C80-B contains only one ester group and a hydrogen atom on the central carbon of the addend. NMR spectroscopy of the two monoadducts suggests that the addition occurs regioselectively at a 6,6-ring juncture on the surface of the icosahedrally (Ih) symmetric Sc3N@C80, forming the first 6,6-ring-bridged methano Ih Sc3N@C80 derivatives. The measured 1J(C,H) = 147 Hz for the methano carbon with its hydrogen in monoadduct Sc3N@C80-B nearly perfectly matches the data for pi-homoaromatic systems, indicating an open [6,6]-methano structure. Geometry optimization also found that the &quot;closed&quot; [6,6]-methano structures were energetically unstable and always led to the open forms. Thus, an &quot;open&quot; [6,6]-methanofulleride structure is proposed, which was induced by the norcaradiene rearrangement, resulting in the cleavage of the cyclopropane ring and the formation of energetically stable open cage fullerene derivatives. These are the first examples of thermodynamically stable adducts of the &quot;open&quot; type at the 6,6-ring juncture of Ih Sc3N@C80, differing greatly from the &quot;closed&quot; 5,6-ring juncture adducts reported previously. In addition, bis-, tri-, and up to octaadducts of Sc3N@C80 were detected by matrix-assisted laser desorption ionization time-of-flight mass spectrometry; this synthetic method was also applied to Lu3N@C80, producing adducts with up to 10 substituents on the carbon cage. These are the highest levels of substitution of TNT metallofullerenes reported so far.</abstract><notes>Shu, Chunying&#xD;Cai, Ting&#xD;Xu, Liaosa&#xD;Zuo, Tianming&#xD;Reid, Jonathan&#xD;Harich, Kim&#xD;Dorn, Harry C&#xD;Gibson, Harry W&#xD;1R01-CA119371-01/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Dec 19;129(50):15710-7. Epub 2007 Nov 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18027949</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja0768439</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2170</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2170</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gibbs-Davis, J. M.</author><author>Schatz, G. C.</author><author>Nguyen, S. T.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Sharp melting transitions in DNA hybrids without aggregate dissolution: proof of neighboring-duplex cooperativity</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>15535-40</pages><volume>129</volume><number>50</number><edition>2007/11/22</edition><keywords><keyword>Base Sequence</keyword><keyword>DNA/ chemistry</keyword><keyword>Ions/chemistry</keyword><keyword>Models, Chemical</keyword><keyword>Nucleic Acid Conformation</keyword><keyword>Nucleic Acid Denaturation</keyword><keyword>Transition Temperature</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 19</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>18027938</accession-num><abstract>Similar to DNA-modified gold nanoparticles, comb polymer-DNA hybrids exhibit very sharp melting transitions that can be utilized in highly selective DNA detection systems. Current theories suggest that such sharp melting results from either a phase transition caused by the macroscopic dissolution of the aggregate or neighboring-duplex interactions in the close-packed environment between adjacent DNA duplexes. To delineate the contributions of each of these effects, an aggregate system based on polymer-DNA hybrids was designed to include both polymer-linked and partially untethered duplexes. When this hybridized system was subjected to thermal analysis, both types of duplexes exhibited sharp melting transitions. The very sharp melting transition displayed by the partially untethered DNA duplexes offers proof that neighboring-duplex interactions can indeed induce cooperativity. Contributions of this neighboring-duplex effect, as well as the enhanced stabilization observed in polymer-DNA:polymer-DNA aggregates, can be quantitatively assessed using a simple thermodynamic model. While neighboring-duplex interactions alone can lead to cooperative melting, the enhanced stabilization observed in polymer-DNA aggregates is a function of both neighboring-duplex interactions and multivalent or aggregate properties.</abstract><notes>Gibbs-Davis, Julianne M&#xD;Schatz, George C&#xD;Nguyen, SonBinh T&#xD;1U54 CA119341-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Dec 19;129(50):15535-40. Epub 2007 Nov 21.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja073034g [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2013</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2013</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Berezin, M. Y.</author><author>Lee, H.</author><author>Akers, W.</author><author>Nikiforovich, G.</author><author>Achilefu, S.</author></authors></contributors><auth-address>Department of Radiology, Washington University School of Medicine, St. Louis, MO, USA.</auth-address><titles><title>Ratiometric analysis of fluorescence lifetime for probing binding sites in albumin with near-infrared fluorescent molecular probes</title><secondary-title>Photochem Photobiol</secondary-title></titles><periodical><full-title>Photochem Photobiol</full-title></periodical><pages>1371-8</pages><volume>83</volume><number>6</number><edition>2007/11/22</edition><keywords><keyword>Animals</keyword><keyword>Binding Sites</keyword><keyword>Cattle</keyword><keyword>Fluorescent Dyes/ analysis/chemistry</keyword><keyword>Models, Molecular</keyword><keyword>Molecular Structure</keyword><keyword>Protein Folding</keyword><keyword>Serum Albumin, Bovine/ analysis/chemistry/metabolism</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Spectroscopy, Near-Infrared</keyword><keyword>Time Factors</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov-Dec</date></pub-dates></dates><isbn>0031-8655 (Print)</isbn><accession-num>18028211</accession-num><abstract>A number of diseases have been linked to abnormal conformation of albumin, a major extracellular protein in blood. Current protein structural analysis requires pure isolated samples, thereby limiting their use for albumin analysis in blood. In this study, we report a new approach for high-throughput structure-related analysis of albumin by using the fluorescence lifetime properties of near-infrared (NIR) polymethine dyes. Based on molecular modeling, polymethine dyes are bound to two binding sites with different polarities on albumin. As a result, an NIR molecular probe exhibits two distinct lifetimes with two corresponding fluorescent fractional contributions. The distribution of fractional contributions along with individual fluorescence lifetimes represents unique parameters for characterizing albumin architecture by ratiometric analysis. After screening a small library of NIR polymethine dyes, we identified and used a polymethine dye with optimal fluorescence lifetime properties to assess structure-related differences in commercially available bovine serum albumin as model systems. The results show that changes in the lifetime of NIR dyes reflect the perturbation of the tertiary structures of albumin and that albumin prepared by different methods has slightly altered tertiary structures. Because of the reduced absorption of light by blood in the NIR region, the method developed can be used to determine structural changes in albumin in whole blood without prior isolation of the pure protein.</abstract><notes>Berezin, Mikhail Y&#xD;Lee, Hyeran&#xD;Akers, Walter&#xD;Nikiforovich, Gregory&#xD;Achilefu, Samuel&#xD;1 U01 HL080729/HL/NHLBI NIH HHS/United States&#xD;R01 CA109754/CA/NCI NIH HHS/United States&#xD;R01 EB1430/EB/NIBIB NIH HHS/United States&#xD;U54 CA119342/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Photochemistry and photobiology&#xD;Photochem Photobiol. 2007 Nov-Dec;83(6):1371-8.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom4>2.473</custom4><electronic-resource-num>PHP173 [pii]&#xD;10.1111/j.1751-1097.2007.00173.x [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1464</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1464</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nahrendorf, M.</author><author>Swirski, F. K.</author><author>Aikawa, E.</author><author>Stangenberg, L.</author><author>Wurdinger, T.</author><author>Figueiredo, J. L.</author><author>Libby, P.</author><author>Weissleder, R.</author><author>Pittet, M. J.</author></authors></contributors><auth-address>Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.</auth-address><titles><title>The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions</title><secondary-title>J Exp Med</secondary-title></titles><periodical><full-title>J Exp Med</full-title></periodical><pages>3037-47</pages><volume>204</volume><number>12</number><edition>2007/11/21</edition><keywords><keyword>Animals</keyword><keyword>Flow Cytometry</keyword><keyword>Heart Injuries/*physiopathology</keyword><keyword>Kinetics</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Monocytes/classification/*physiology</keyword><keyword>Myocardial Infarction/*physiopathology</keyword><keyword>Neutrophils/*physiology</keyword><keyword>Time Factors</keyword><keyword>*Wound Healing</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 26</date></pub-dates></dates><isbn>1540-9538 (Electronic)</isbn><accession-num>18025128</accession-num><abstract>Healing of myocardial infarction (MI) requires monocytes/macrophages. These mononuclear phagocytes likely degrade released macromolecules and aid in scavenging of dead cardiomyocytes, while mediating aspects of granulation tissue formation and remodeling. The mechanisms that orchestrate such divergent functions remain unknown. In view of the heightened appreciation of the heterogeneity of circulating monocytes, we investigated whether distinct monocyte subsets contribute in specific ways to myocardial ischemic injury in mouse MI. We identify two distinct phases of monocyte participation after MI and propose a model that reconciles the divergent properties of these cells in healing. Infarcted hearts modulate their chemokine expression profile over time, and they sequentially and actively recruit Ly-6C(hi) and -6C(lo) monocytes via CCR2 and CX(3)CR1, respectively. Ly-6C(hi) monocytes dominate early (phase I) and exhibit phagocytic, proteolytic, and inflammatory functions. Ly-6C(lo) monocytes dominate later (phase II), have attenuated inflammatory properties, and express vascular-endothelial growth factor. Consequently, Ly-6C(hi) monocytes digest damaged tissue, whereas Ly-6C(lo) monocytes promote healing via myofibroblast accumulation, angiogenesis, and deposition of collagen. MI in atherosclerotic mice with chronic Ly-6C(hi) monocytosis results in impaired healing, underscoring the need for a balanced and coordinated response. These observations provide novel mechanistic insights into the cellular and molecular events that regulate the response to ischemic injury and identify new therapeutic targets that can influence healing and ventricular remodeling after MI.</abstract><notes>Nahrendorf, Matthias&#xD;Swirski, Filip K&#xD;Aikawa, Elena&#xD;Stangenberg, Lars&#xD;Wurdinger, Thomas&#xD;Figueiredo, Jose-Luiz&#xD;Libby, Peter&#xD;Weissleder, Ralph&#xD;Pittet, Mikael J&#xD;P01-A154904/United States PHS&#xD;R01HL34636/HL/United States NHLBI&#xD;R24 CA69246/CA/United States NCI&#xD;U01 HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of experimental medicine&#xD;J Exp Med. 2007 Nov 26;204(12):3037-47. Epub 2007 Nov 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18025128</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>15.504</custom4><electronic-resource-num>jem.20070885 [pii]&#xD;10.1084/jem.20070885</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1396</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1396</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lim, S. D.</author><author>Young, A. N.</author><author>Paner, G. P.</author><author>Amin, M. B.</author></authors></contributors><auth-address>Department of Pathology, Konkuk University School of Medicine, Gwangjin-Gu, Seoul, Republic of Korea.</auth-address><titles><title>Prognostic role of CD44 cell adhesion molecule expression in primary and metastatic renal cell carcinoma: a clinicopathologic study of 125 cases</title><secondary-title>Virchows Arch</secondary-title></titles><periodical><full-title>Virchows Arch</full-title></periodical><pages>49-55</pages><volume>452</volume><number>1</number><edition>2007/11/21</edition><keywords><keyword>Antigens, CD44/*metabolism</keyword><keyword>Carcinoma, Renal Cell/*metabolism/mortality/secondary</keyword><keyword>Disease-Free Survival</keyword><keyword>Female</keyword><keyword>Fluorescent Antibody Technique, Indirect</keyword><keyword>Humans</keyword><keyword>Immunoenzyme Techniques</keyword><keyword>Kidney Neoplasms/*metabolism/mortality/pathology</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Neoplasm Staging</keyword><keyword>Prognosis</keyword><keyword>Survival Rate</keyword><keyword>Tumor Markers, Biological/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0945-6317 (Print)</isbn><accession-num>18026989</accession-num><abstract>Possible prognostic utility of CD44 in renal cell carcinoma (RCC) prompted a comparison of its expression in primary and metastatic RCC. A total of 164 paraffin-embedded tissues of primary RCC and metastatic RCCs from 125 patients were immunostained with CD44 (standard form) antibody. It consisted of 86 primary RCCs (50 with subsequent metastasis [MET+] and 36 with no known metastasis [MET-]) during follow up and 78 metastatic RCCs (39 metastatic RCCs only and 39 with matched RCC primary from RCC MET + category). Immunoreactivity for CD44 was scored semiquantitatively as 0, 1, or 2 (0, &lt;5%; 1, 5-50%; 2, &gt; or =50%). Expression of CD44 was significantly higher in metastatic RCCs compared to primary RCCs (p = 0.036). CD44 immunoreactivity in the primary RCC (MET- and MET+) correlated with progression-free survival (p = 0.027). In metastatic RCCs, CD44 immunoreactivity also correlated with survival after detection of first metastasis (p = 0.011). In multivariate analysis, stage (p = 0.0001) and CD44 immunoreactivity (p = 0.03) in primary RCC were independent predictors of progression-free survival. Our study suggests that CD44 status in RCC provides useful prognostic information both in primary and metastatic RCCs and may have applicability in stratifying patients for therapeutic decisions.</abstract><notes>Lim, So Dug&#xD;Young, Andrew N&#xD;Paner, Gladell P&#xD;Amin, Mahul B&#xD;Comparative Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Virchows Archiv : an international journal of pathology&#xD;Virchows Arch. 2008 Jan;452(1):49-55. Epub 2007 Nov 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18026989</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>2.029</custom4><electronic-resource-num>10.1007/s00428-007-0530-4</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1510</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1510</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Petermann, K. B.</author><author>Rozenberg, G. I.</author><author>Zedek, D.</author><author>Groben, P.</author><author>McKinnon, K.</author><author>Buehler, C.</author><author>Kim, W. Y.</author><author>Shields, J. M.</author><author>Penland, S.</author><author>Bear, J. E.</author><author>Thomas, N. E.</author><author>Serody, J. S.</author><author>Sharpless, N. E.</author></authors></contributors><auth-address>Department of Genetics, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-7295, USA.</auth-address><titles><title>CD200 is induced by ERK and is a potential therapeutic target in melanoma</title><secondary-title>J Clin Invest</secondary-title></titles><periodical><full-title>J Clin Invest</full-title></periodical><pages>3922-9</pages><volume>117</volume><number>12</number><edition>2007/11/17</edition><keywords><keyword>Acute Disease</keyword><keyword>Antigens, CD/genetics/*immunology</keyword><keyword>Antigens, Surface/genetics/immunology</keyword><keyword>Cell Movement/genetics/immunology</keyword><keyword>Cell Survival/genetics/immunology</keyword><keyword>Dendritic Cells/immunology/pathology</keyword><keyword>Extracellular Signal-Regulated MAP Kinases/genetics/*immunology</keyword><keyword>Gene Expression Regulation, Neoplastic/genetics/*immunology</keyword><keyword>Humans</keyword><keyword>Leukemia/genetics/immunology/pathology</keyword><keyword>Lymphocyte Activation/genetics/immunology</keyword><keyword>Melanoma/genetics/*immunology/pathology/therapy</keyword><keyword>Mutation</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Proto-Oncogene Proteins B-raf/genetics/immunology</keyword><keyword>Proto-Oncogene Proteins p21(ras)/genetics/immunology</keyword><keyword>Receptors, Cell Surface/genetics/immunology</keyword><keyword>T-Lymphocytes/immunology/pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0021-9738 (Print)</isbn><accession-num>18008004</accession-num><abstract>Immune-mediated antitumor responses occur in patients with metastatic melanoma (MM), and therapies designed to augment such responses are clinically beneficial. Despite the immunogenicity of melanoma, immunomodulatory therapies fail in the majority of patients with MM. An inability of DCs to sufficiently activate effector cells may, in part, underlie this failure of the antitumor response seen in most patients. In this work, we show that mutation of N-RAS or B-RAF, signature genetic lesions present in most MMs, potently induced the expression of cell-surface CD200, a repressor of DC function. Employing 2 independent, genome-wide microarray analyses, we identified CD200 as a highly dynamic, downstream target of RAS/RAF/MEK/ERK activation in melanoma. CD200 protein was similarly overexpressed in human melanoma cell lines and primary tumors. CD200 mRNA expression correlated with progression and was higher in melanoma than in other solid tumors or acute leukemia. Melanoma cell lines expressing endogenous CD200 repressed primary T cell activation by DCs, while knockdown of CD200 by shRNA abrogated this immunosuppressive effect. These data indicate that in addition to its effects on growth, survival, and motility, ERK activation in MM attenuates a host antitumor immune response, implicating CD200 and its interaction with the CD200 receptor as a potential therapeutic target for MM.</abstract><notes>Petermann, Kimberly B&#xD;Rozenberg, Gabriela I&#xD;Zedek, Daniel&#xD;Groben, Pamela&#xD;McKinnon, Karen&#xD;Buehler, Christin&#xD;Kim, William Y&#xD;Shields, Janiel M&#xD;Penland, Shannon&#xD;Bear, James E&#xD;Thomas, Nancy E&#xD;Serody, Jonathan S&#xD;Sharpless, Norman E&#xD;CA105837/CA/United States NCI&#xD;CA106991/CA/United States NCI&#xD;CA90679/CA/United States NCI&#xD;ES14635/ES/United States NIEHS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of clinical investigation&#xD;J Clin Invest. 2007 Dec;117(12):3922-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18008004</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>17.089</custom4><electronic-resource-num>10.1172/JCI32163</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2315</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2315</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stokes, T. H.</author><author>Han, X.</author><author>Moffitt, R. A.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Electrical and Computer Engineering Department, Georgia Institute of Technology, Atlanta, GA 30332, USA.</auth-address><titles><title>Extending microarray quality control and analysis algorithms to Illumina chip platform</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>4637-40</pages><volume>2007</volume><edition>2007/11/16</edition><keywords><keyword>Computer Simulation</keyword><keyword>Gene Expression Profiling/ instrumentation/ methods</keyword><keyword>Gene Expression Regulation</keyword><keyword>Oligonucleotide Array Sequence Analysis/ instrumentation/ methods</keyword><keyword>Random Allocation</keyword><keyword>Selection Bias</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Software</keyword></keywords><dates><year>2007</year></dates><isbn>1557-170X (Print)</isbn><accession-num>18003039</accession-num><abstract>This paper presents a novel data quality control technique for a challenging new microarray platform supplied by Illumina, Inc. Microarray is a revolutionary biotechnology that enables the study of thousands of genes and proteins simultaneously. While the type of microarray chip platforms keeps increasing and the manufacture quality keeps improving, the array data quality control and analysis tools are still lagging behind. In this research, we design an adaptable microarray data quality control and analysis system capable of handling multiple microarray platforms. We demonstrate that the Illumina chips, even though the layouts are randomly assembled, still contain artifacts. We conclude that it is necessary for chip manufacturers to provide low-level bead location output as a standard feature for better data quality assurance.</abstract><notes>Stokes, Todd H&#xD;Han, Xiao&#xD;Moffitt, Richard A&#xD;Wang, May D&#xD;P20GM072069/GM/NIGMS NIH HHS/United States&#xD;R01CA108468/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2007;2007:4637-40.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2007.4353373 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2310</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2310</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shah, N. A.</author><author>Moffitt, R. A.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology, GA 30332 USA. neil.shah@gatech.edu</auth-address><titles><title>Modified genetic algorithm for parameter selection of compartmental models</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>143-6</pages><volume>2007</volume><edition>2007/11/16</edition><keywords><keyword>Algorithms</keyword><keyword>Computer Simulation</keyword><keyword>Humans</keyword><keyword>Life Style</keyword><keyword>Models, Genetic</keyword><keyword>Obesity/etiology/genetics</keyword><keyword>United States</keyword></keywords><dates><year>2007</year></dates><isbn>1557-170X (Print)</isbn><accession-num>18001909</accession-num><abstract>A Modified Genetic Algorithm has been developed for the task of optimal parameter selection for compartmental models. As a case study, a predictive model of the emerging health threat of obesity in America was developed which incorporated varying levels of three treatment strategies in an attempt to decrease the amount of overweight Americans over a ten-year period. The Genetic Algorithm was then applied to the task of minimizing the number of overweight persons while minimizing the costs associated with implementing the chosen treatment plans. Throughout repeated trials, the GA was able to converge to consistent, high-scoring treatment strategies after only a few minutes of computation on a desktop PC. This result demonstrates the ability of the modified Genetic Algorithm to effectively perform multivariate, nonlinear, simulation-based optimization routines in a short time.</abstract><notes>Shah, Neil A&#xD;Moffitt, Richard A&#xD;Wang, May D&#xD;P20GM072069/GM/NIGMS NIH HHS/United States&#xD;R01CA108468/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2007;2007:143-6.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2007.4352243 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2311</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2311</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kaddi, C.</author><author>Oden, E. D.</author><author>Quo, C. F.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Wallace H. Coulter, Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA. gtg538v@mail.gatech.edu</auth-address><titles><title>Exploration of quantitative scoring metrics to compare systems biology modeling approaches</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>1121-4</pages><volume>2007</volume><edition>2007/11/16</edition><keywords><keyword>Computer Simulation</keyword><keyword>Energy Metabolism/ physiology</keyword><keyword>Models, Biological</keyword><keyword>Proteins/ metabolism</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Signal Transduction/ physiology</keyword><keyword>Software</keyword><keyword>Software Validation</keyword><keyword>Systems Biology/ methods</keyword></keywords><dates><year>2007</year></dates><isbn>1557-170X (Print)</isbn><accession-num>18002159</accession-num><abstract>In this paper, we report a focused case study to assess whether quantitative metrics are useful to evaluate molecular-level system biology models on cellular metabolism. Ideally, the bio-modeling community shall be able assess systems biology models based on objective and quantitative metrics. This is because metric-based model design not only can accelerate the validation process, but also can improve the efficacy of model design. In addition, the metric will enable researchers to select models with any desired quality standards to study biological pathway. In this case study, we compare popular systems biology modeling approaches such as Michaelis-Menten kinetics and generalized mass action and flux balance analysis to examine the difficulties in developing quantitative metrics for bio-model assessment. We created a set of guidelines in evaluating the efficacy of various bio-modeling approaches and system analysis in several &quot;bio-systems of interest&quot;. We found that quantitative scoring metrics are essential aids for (i) model adopters and users to determine fundamental distinctions among bio-models, and (ii) model developers to improve key areas in bio-modeling. Eventually, we want to extend this evaluation practice to broad systems biology modeling.</abstract><notes>Kaddi, Chanchala&#xD;Oden, Erica D&#xD;Quo, Chang F&#xD;Wang, May D&#xD;P20GM072069/GM/NIGMS NIH HHS/United States&#xD;R01CA108468/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Comparative Study&#xD;Guideline&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2007;2007:1121-4.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2007.4352493 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2314</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2314</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huynh, K. N.</author><author>Phan, J. H.</author><author>Vo, T. M.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 313 Ferst Drive, Atlanta, GA 30332, USA.</auth-address><titles><title>Improved bolstering error estimation for gene ranking</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>4633-6</pages><volume>2007</volume><edition>2007/11/16</edition><keywords><keyword>Animals</keyword><keyword>Computer Simulation</keyword><keyword>Gene Expression Profiling/ methods</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Oligonucleotide Array Sequence Analysis/ methods</keyword><keyword>Selection Bias</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Software</keyword></keywords><dates><year>2007</year></dates><isbn>1557-170X (Print)</isbn><accession-num>18003038</accession-num><abstract>Many methods have been proposed to identify differentially expressed genes in diseased tissues. The performance of the method is closely related to the evaluation metric. We examine several error estimation algorithms (i.e., cross validation, bootstrap, resubstitution, and resubstitution with bolstering) for three classifiers (i.e., support vector machine, Fisher&apos;s discriminant, and signed distance function). To control the classifier&apos;s data-overfitting problem, usually caused by small sample size for many real datasets, we generate synthetic datasets based on real data. This way, we can monitor sample size impact when evaluating the metrics. We find that resubstitution with bolstering has the best result, especially with respect to computational efficiency. However, classical bolstering tends to bias in high dimensions. Thus, we further investigate ways to reduce bolstering estimation bias without increasing computational intensity. Results of our investigation indicate that the estimator tends to become unbiased as the sample size increases. We also find that modified bolstering is the best among all metrics in terms of estimation accuracy and computational efficiency.</abstract><notes>Huynh, Kiet N T&#xD;Phan, John H&#xD;Vo, Tan M&#xD;Wang, May D&#xD;P20GM072069/GM/NIGMS NIH HHS/United States&#xD;R01CA108468/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2007;2007:4633-6.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2007.4353372 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2312</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2312</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dhingra, S.</author><author>Freedenberg, M.</author><author>Quo, C. F.</author><author>Merrill, A. H., Jr.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA. gtg225q@mail.gatech.edu</auth-address><titles><title>Computational modeling of a metabolic pathway in ceramide de novo synthesis</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>1405-8</pages><volume>2007</volume><edition>2007/11/16</edition><keywords><keyword>Algorithms</keyword><keyword>Ceramides/ metabolism</keyword><keyword>Computer Simulation</keyword><keyword>Gene Expression Regulation/ physiology</keyword><keyword>Models, Biological</keyword><keyword>Multienzyme Complexes/ metabolism</keyword><keyword>Signal Transduction/ physiology</keyword></keywords><dates><year>2007</year></dates><isbn>1557-170X (Print)</isbn><accession-num>18002227</accession-num><abstract>Studies have implicated ceramide as a key molecular agent in regulating programmed cell death, or apoptosis. Consequently, there is significant potential in targeting intracellular ceramide as a cancer therapeutic agent. The cell&apos;s major ceramide source is the ceramide de novo synthesis pathway, which consists of a complex network of interdependent enzyme-catalyzed biochemical reactions. To understand how ceramide works, we have initiated the study of the ceramide de novo synthesis pathway using computational modeling based on fundamental principles of biochemical kinetics. Specifically, we designed and developed the model in MATLAB SIMULINK for the behavior of dihydroceramide desaturase. Dihydroceramide desaturase is one of three key enzymes in the ceramide de novo synthesis pathway, and it converts a relatively inert precursor molecule, dihydroceramide into biochemically reactive ceramide. A major issue in modeling is parameter estimation. We solved this problem by adopting a heuristic strategy based on a priori knowledge from literature and experimental data. We evaluated model accuracy by comparing the model prediction results with interpolated experimental data. Our future work includes more experimental validation of the model, dynamic rate constants assessment, and expansion of the model to include additional enzymes in the ceramide de novo synthesis pathway.</abstract><notes>Dhingra, Shobhika&#xD;Freedenberg, Melissa&#xD;Quo, Chang F&#xD;Merrill, Alfred H Jr&#xD;Wang, May D&#xD;R01CA108468/CA/NCI NIH HHS/United States&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2007;2007:1405-8.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2007.4352561 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1385</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1385</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, S. M.</author><author>Chen, H.</author><author>Dettmer, C. M.</author><author>O&apos;Halloran, T. V.</author><author>Nguyen, S. T.</author></authors></contributors><auth-address>Department of Chemistry and the Center for Cancer Nanotechnology Excellence, Northwestern University, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Polymer-caged lipsomes: a pH-responsive delivery system with high stability</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>15096-7</pages><volume>129</volume><number>49</number><edition>2007/11/15</edition><keywords><keyword>Acrylic Resins/*chemistry</keyword><keyword>Animals</keyword><keyword>Cattle</keyword><keyword>Cholesterol/analogs &amp; derivatives/chemistry</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Drug Stability</keyword><keyword>Fluoresceins/*chemistry</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Lipid Bilayers/chemistry</keyword><keyword>Liposomes/blood/chemical synthesis/*chemistry</keyword><keyword>Microscopy, Electron, Transmission</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 12</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>17999499</accession-num><notes>Lee, Sang-Min&#xD;Chen, Haimei&#xD;Dettmer, Christine M&#xD;O&apos;Halloran, Thomas V&#xD;Nguyen, SonBinh T&#xD;P30CA060553/CA/United States NCI&#xD;U54CA119341/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Dec 12;129(49):15096-7. Epub 2007 Nov 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17999499</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja070748i</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1213</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1213</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Giljohann, D. A.</author><author>Seferos, D. S.</author><author>Patel, P. C.</author><author>Millstone, J. E.</author><author>Rosi, N. L.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>3818-21</pages><volume>7</volume><number>12</number><edition>2007/11/14</edition><keywords><keyword>Biological Transport</keyword><keyword>DNA/*chemistry/pharmacokinetics</keyword><keyword>Gold/*chemistry</keyword><keyword>Hela Cells/metabolism</keyword><keyword>Humans</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Oligodeoxyribonucleotides/*chemistry/pharmacokinetics</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17997588</accession-num><abstract>The cellular internalization of oligonucleotide-modified nanoparticles is investigated. Uptake is dependent on the density of the oligonucleotide loading on the surface of the particles, where higher densities lead to greater uptake. Densely functionalized nanoparticles adsorb a large number of proteins on the nanoparticle surface. Nanoparticle uptake is greatest where a large number of proteins are associated with the particle.</abstract><notes>Giljohann, David A&#xD;Seferos, Dwight S&#xD;Patel, Pinal C&#xD;Millstone, Jill E&#xD;Rosi, Nathaniel L&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Dec;7(12):3818-21. Epub 2007 Nov 13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17997588</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl072471q</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1118</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1118</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Calabrese, J. M.</author><author>Seila, A. C.</author><author>Yeo, G. W.</author><author>Sharp, P. A.</author></authors></contributors><auth-address>Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>RNA sequence analysis defines Dicer&apos;s role in mouse embryonic stem cells</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>18097-102</pages><volume>104</volume><number>46</number><edition>2007/11/09</edition><keywords><keyword>Animals</keyword><keyword>Base Sequence</keyword><keyword>DNA, Complementary</keyword><keyword>Embryonic Stem Cells/*metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>MicroRNAs/*genetics</keyword><keyword>RNA Interference</keyword><keyword>Repetitive Sequences, Nucleic Acid</keyword><keyword>Ribonuclease III/genetics/*physiology</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 13</date></pub-dates></dates><isbn>1091-6490 (Electronic)</isbn><accession-num>17989215</accession-num><abstract>Short RNA expression was analyzed from Dicer-positive and Dicer-knockout mouse embryonic [corrected] stem (ES) cells, using high-throughput pyrosequencing. A correlation of miRNA quantification with sequencing frequency estimates that there are 110,000 miRNAs per ES cell, the majority of which can be accounted for by six distinct miRNA loci. Four of these miRNA loci or their human homologues have demonstrated roles in cell cycle regulation or oncogenesis, suggesting that a major function of the miRNA pathway in ES cells may be to shape their distinct cell cycle. Forty-six previously uncharacterized miRNAs were identified, most of which are expressed at low levels and are less conserved than the set of known miRNAs. Low-abundance short RNAs matching all classes of repetitive elements were present in cells lacking Dicer, although the production of some SINE- and simple repeat-associated short RNAs appeared to be Dicer-dependent. These and other Dicer-dependent sequences resembled miRNAs. At a depth of sequencing that approaches the total number of 5&apos; phosphorylated short RNAs per cell, miRNAs appeared to be Dicer&apos;s only substrate. The results presented suggest a model in which repeat-associated miRNAs serve as host defenses against repetitive elements, a function canonically ascribed to other classes of short RNA.</abstract><notes>Calabrese, J Mauro&#xD;Seila, Amy C&#xD;Yeo, Gene W&#xD;Sharp, Phillip A&#xD;5-F32-HD051190/HD/United States NICHD&#xD;P01-CA42063/CA/United States NCI&#xD;P30-CA14051/CA/United States NCI&#xD;R01-GM34277/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18097-102. Epub 2007 Nov 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17989215</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>10.228</custom4><electronic-resource-num>0709193104 [pii]&#xD;10.1073/pnas.0709193104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1644</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1644</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Taktak, S.</author><author>Sosnovik, D.</author><author>Cima, M. J.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><auth-address>Center for Molecular Imaging Research and Department of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129, USA.</auth-address><titles><title>Multiparameter magnetic relaxation switch assays</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>8863-9</pages><volume>79</volume><number>23</number><edition>2007/11/07</edition><keywords><keyword>Magnetic Resonance Imaging</keyword><keyword>Magnetic Resonance Spectroscopy</keyword><keyword>*Magnetics</keyword><keyword>*Nanoparticles</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 1</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>17983206</accession-num><abstract>Magnetic nanoparticles (NPs) can serve as magnetic relaxation switches (MRSw&apos;s), switching from a dispersed to a clustered state, or the reverse, due to the presence of molecular targets, with changes in the spin-spin relaxation time of water (T2). Biotinylated NP probes reacted with an avidin molecular target to form stable NP clusters, which permitted several NMR parameters to be measured as a function of cluster size. Associated with avidin-induced NP cluster formation was an increase in the spin-spin relation rate (1/T2), while the spin-lattice relaxation rate (1/T1)was unaffected. On the basis of the selective effects of NP cluster formation on T2, we developed a T1/T2 interrogation method where NP probe concentration and avidin analyte were unknown and both were determined. A third NMR parameter examined was the replication of T2 measurements, which were used to rapidly determine whether the ratio of avidin to biotinylated NP was optimal or whether additional biotinylated NP was needed. The T1/T2 and T2 replication interrogation methods illustrate how MRSw assays can employ multiple parameters, instead of relying only on T2, to obtain information about the reaction of NPs with molecular targets.</abstract><notes>Taktak, Sonia&#xD;Sosnovik, David&#xD;Cima, Michael J&#xD;Weissleder, Ralph&#xD;Josephson, Lee&#xD;R01-EB004626/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2007 Dec 1;79(23):8863-9. Epub 2007 Nov 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17983206</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac701976p</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1549</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1549</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ruan, G.</author><author>Agrawal, A.</author><author>Marcus, A. I.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, 101 Woodruff Circle, Suite 2001, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>14759-66</pages><volume>129</volume><number>47</number><edition>2007/11/07</edition><keywords><keyword>Biological Transport</keyword><keyword>Cell Survival</keyword><keyword>Gene Products, tat/*chemistry</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Intracellular Space/*metabolism</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Peptides/*chemistry/*metabolism</keyword><keyword>*Quantum Dots</keyword><keyword>Temperature</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 28</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>17983227</accession-num><abstract>We report the use of Tat peptide-conjugated quantum dots (Tat-QDs) to examine the complex behavior of nanoparticle probes in live cells, a topic that is of considerable current interest in developing advanced nanoparticle agents for molecular and cellular imaging. Dynamic confocal imaging studies indicate that the peptide-conjugated QDs are internalized by macropinocytosis, a fluid-phase endocytosis process triggered by Tat-QD binding to negatively charged cell membranes. The internalized Tat-QDs are tethered to the inner vesicle surfaces and are trapped in cytoplasmic organelles. The QD loaded vesicles are found to be actively transported by molecular machines (such as dyneins) along microtubule tracks. The destination of this active transport is an asymmetric perinuclear region (outside the cell nucleus) known as the microtubule organizing center (MTOC). We also find that Tat-QDs strongly bind to cellular membrane structures such as filopodia and that large QD-containing vesicles are released from the tips of filopodia by vesicle shedding. These results provide new insights into the mechanisms of Tat peptide-mediated delivery as well as toward the design of functionalized nanoparticles for molecular imaging and targeted therapy.</abstract><notes>Ruan, Gang&#xD;Agrawal, Amit&#xD;Marcus, Adam I&#xD;Nie, Shuming&#xD;P20GM072069/GM/United States NIGMS&#xD;PN2EY018244/EY/United States NEI&#xD;R01CA108468/CA/United States NCI&#xD;U01HL080711/HL/United States NHLBI&#xD;U54CA119338/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Nov 28;129(47):14759-66. Epub 2007 Nov 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17983227</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja074936k</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1402</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1402</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, W.</author><author>Choi, H. S.</author><author>Zimmer, J. P.</author><author>Tanaka, E.</author><author>Frangioni, J. V.</author><author>Bawendi, M.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Compact cysteine-coated CdSe(ZnCdS) quantum dots for in vivo applications</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>14530-1</pages><volume>129</volume><number>47</number><edition>2007/11/07</edition><keywords><keyword>Animals</keyword><keyword>Cadmium/*chemistry/*pharmacokinetics</keyword><keyword>Cadmium Compounds/*chemistry/*pharmacokinetics</keyword><keyword>Cysteine/*chemistry</keyword><keyword>Molecular Structure</keyword><keyword>*Quantum Dots</keyword><keyword>Rats</keyword><keyword>Selenium Compounds/*chemistry/*pharmacokinetics</keyword><keyword>Sulfides/*chemistry/*pharmacokinetics</keyword><keyword>Zinc/*chemistry/*pharmacokinetics</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 28</date></pub-dates></dates><isbn>1520-5126 (Electronic)</isbn><accession-num>17983223</accession-num><abstract>We have developed a versatile nanoparticle construct using a compact cysteine coating on a CdSe(ZnCdS) core(shell) nanocrystal (QD-Cys) that is biologically compatible, exceptionally compact, highly fluorescent, and easily functionalized. The small hydrodynamic diameter of QD-Cys ( approximately 6 nm) allows for renal clearance of these nanoparticles in rat models. Moreover, the ability to directly conjugate to QD-Cys opens up the possibility of functionalized nanocrystals for in vivo targeted imaging, in which small targeting molecules can be appended to QD-Cys, and unbound QDs can be rapidly cleared to achieve high signal/noise ratios and to reduce background toxicity.</abstract><notes>Liu, Wenhao&#xD;Choi, Hak Soo&#xD;Zimmer, John P&#xD;Tanaka, Eiichi&#xD;Frangioni, John V&#xD;Bawendi, Moungi&#xD;1U54-CA119349/CA/United States NCI&#xD;GM68762/GM/United States NIGMS&#xD;R01-CA-115296/CA/United States NCI&#xD;R33-EB-000673/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Nov 28;129(47):14530-1. Epub 2007 Nov 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17983223</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja073790m</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1089</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1089</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Blair, S. L.</author><author>Wang-Rodriguez, J.</author><author>Cortes-Mateos, M. J.</author><author>Messmer, D.</author><author>Sandoval, S.</author><author>Messmer, B.</author><author>Trogler, W.</author><author>Kummel, A.</author></authors></contributors><auth-address>Department of Surgery and Pathology, University of California San Diego, La Jolla, California 92093-0987, USA. slblair@ucsd.edu</auth-address><titles><title>Enhanced touch preps improve the ease of interpretation of intraoperative breast cancer margins</title><secondary-title>Am Surg</secondary-title></titles><periodical><full-title>Am Surg</full-title></periodical><pages>973-6</pages><volume>73</volume><number>10</number><edition>2007/11/07</edition><keywords><keyword>Antibodies, Monoclonal</keyword><keyword>Breast Neoplasms/*surgery</keyword><keyword>Cadherins/analysis</keyword><keyword>Carcinoma in Situ/pathology</keyword><keyword>Carcinoma, Ductal, Breast/*pathology</keyword><keyword>*Cytological Techniques</keyword><keyword>Female</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Humans</keyword><keyword>Intraoperative Period</keyword><keyword>Mastectomy, Segmental/*standards</keyword><keyword>Paraffin Embedding</keyword><keyword>Prospective Studies</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0003-1348 (Print)</isbn><accession-num>17983060</accession-num><abstract>Positive margins and the resulting multiple operations are a major problem for breast conservation therapy. Accurate assessment of intraoperative tumor margins can limit multiple re-excision procedures. Intraoperative touch preparations have been used in the past but can be difficult to interpret without an experienced cytopathologist. The objective of this study is to examine the reliability of enhanced intraoperative touch preps (EIOTP) compared with final pathologic margins. We prospectively performed EIOTP on 20 tumors in women undergoing breast conservation therapy. Six margins and the main tumor were touched onto poly-L-lysine coated slides. The slides were stained with anti MUC1 and anti-E-cadherin antibodies, and Hoechst nuclear stain. A parallel set of slides were stained with hematoxylin and eosin for comparison. The EIOTP results were compared with pathologic interpretation of paraffin embedded permanent sections. A total of 120 margins underwent EIOTP in 20 patients. We found a sensitivity equal to 80 per cent, specificity 100 per cent, positive predictive value 100 per cent, and negative predictive value 99 per cent. EIOTP in conjunction with MUC-1 and E-cadherin by immunofluorescence is a sensitive and highly specific mechanism to identify cancer cells at breast tissue margins. The immunofluorescence stains may help the pathologist to identify cancer cells in fresh breast tissue and limit breast re-excisions in the future.</abstract><notes>Blair, Sarah L&#xD;Wang-Rodriguez, Jessica&#xD;Cortes-Mateos, Maria Jose&#xD;Messmer, Davorka&#xD;Sandoval, Sergio&#xD;Messmer, Bradley&#xD;Trogler, William&#xD;Kummel, Andrew&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The American surgeon&#xD;Am Surg. 2007 Oct;73(10):973-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17983060</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>1.661</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2236</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2236</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Adams, D. R.</author><author>Toner, M.</author><author>Langer, R.</author></authors></contributors><auth-address>Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Role of trehalose in prevention of giant vesicle adsorption and encapsulated solute leakage in anhydrobiotic preservation</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>13013-23</pages><volume>23</volume><number>26</number><edition>2007/11/07</edition><keywords><keyword>Adsorption</keyword><keyword>Phosphatidylcholines/chemistry</keyword><keyword>Trehalose/ chemistry</keyword><keyword>Water/chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 18</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>17983248</accession-num><abstract>Anhydrobiotic preservation has the potential to allow the processing and storage of mammalian cells in a state of suspended animation at ambient conditions in trehalose glasses; however, stresses--particularly to the lipid bilayer--during desiccation and rehydration have thus far prevented the full realization of the promise of this technique. Giant gel-phase 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) and liquid-crystalline-phase 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC) vesicles provide a model cell system with which to elucidate the role of trehalose in surface-lipid bilayer interactions, as well as the part played by lipid phase. In the absence of trehalose, DSPC liposomes adsorbed to polystyrene, producing irreversible structural changes and apparent leakage of all intravesicular solute upon drying and rehydration. Addition of trehalose significantly reduced vesicle adsorption with only transient intravesicular solute leakage for the rehydrated vesicles; however, at very low moisture contents, the vesicles underwent permanent structural changes. In contrast to the results with DSPC vesicles, DLPC vesicles largely avoided adsorption and exhibited high intravesicular solute retention when dried and rehydrated even in the absence of trehalose, despite significant internal structural changes.</abstract><notes>Adams, Dana R&#xD;Toner, Mehmet&#xD;Langer, Robert&#xD;DK46270/DK/NIDDK NIH HHS/United States&#xD;U54-CA119349/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2007 Dec 18;23(26):13013-23. Epub 2007 Nov 6.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom3>2007</custom3><custom4>4.347</custom4><electronic-resource-num>10.1021/la700452k [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2067</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2067</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Niu, G.</author><author>Cai, W.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford, Department of Radiology, Stanford University School of Medicine, Stanford, California 94305, USA.</auth-address><titles><title>Molecular imaging of human epidermal growth factor receptor 2 (HER-2) expression</title><secondary-title>Front Biosci</secondary-title></titles><periodical><full-title>Front Biosci</full-title></periodical><pages>790-805</pages><volume>13</volume><edition>2007/11/06</edition><keywords><keyword>Animals</keyword><keyword>Antibodies/chemistry</keyword><keyword>Antibodies, Monoclonal/chemistry</keyword><keyword>Diagnostic Imaging/instrumentation/methods</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Immunoglobulin Fragments/chemistry</keyword><keyword>Immunotherapy/methods</keyword><keyword>Mice</keyword><keyword>Positron-Emission Tomography/instrumentation/ methods</keyword><keyword>Receptor, erbB-2/ biosynthesis/chemistry</keyword><keyword>Tomography, Emission-Computed, Single-Photon/instrumentation/ methods</keyword></keywords><dates><year>2008</year></dates><isbn>1093-4715 (Electronic)</isbn><accession-num>17981588</accession-num><abstract>The human epidermal growth factor receptor 2 (HER-2) is a key member of the HER family of receptor tyrosine kinases. Activation of HER-2 affects cell growth, proliferation, migration, adhesion, and survival. Due to its crucial role in carcinogenesis and tumor progression, HER-2 has been intensively investigated as a target for cancer therapy. The ability to quantitatively image HER-2 expression in a noninvasive manner can aid in lesion detection, patient stratification, new drug development/validation, dose optimization, and treatment monitoring. This review summarizes the current state of understanding in multimodality imaging of HER-2 using positron emission tomography (PET), single photon emission computed tomography (SPECT), optical, and magnetic resonance (MR) imaging with HER-2 specific antibodies, antibody derivatives and affibodies as targeting ligands. Successful development of new HER-2 targeted imaging agents with optimal in vivo stability, targeting efficacy, and desirable pharmacokinetics for clinical translation will enable maximum benefit in cancer patient management.</abstract><notes>Niu, Gang&#xD;Cai, Weibo&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Frontiers in bioscience : a journal and virtual library&#xD;Front Biosci. 2008 Jan 1;13:790-805.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>3.001</custom4><electronic-resource-num>2720 [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1568</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1568</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sha, M. Y.</author><author>Xu, H.</author><author>Penn, S. G.</author><author>Cromer, R.</author></authors></contributors><auth-address>Oxonica Inc, 665 Clyde Avenue, Suite A, Mountain View, CA 94043, USA.</auth-address><titles><title>SERS nanoparticles: a new optical detection modality for cancer diagnosis</title><secondary-title>Nanomed</secondary-title></titles><periodical><full-title>Nanomed</full-title></periodical><pages>725-34</pages><volume>2</volume><number>5</number><edition>2007/11/03</edition><keywords><keyword>Contrast Media</keyword><keyword>Humans</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Nanomedicine/*trends</keyword><keyword>Nanoparticles/*diagnostic use</keyword><keyword>Neoplasms/*diagnosis</keyword><keyword>Surface Plasmon Resonance/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>17976033</accession-num><abstract>Surface-enhanced Raman scattering (SERS) is an optical detection technique that offers advantages over traditional assay detection technologies, such as fluorescence and chemiluminescence. These advantages include sensitivity, high levels of multiplexing, robustness and ability to perform detection in blood and other biological matrices. Here, we report on the growing field of SERS-active nanoparticles as a novel method for detection, with special emphasis on their use in the field of oncology. We discuss examples of SERS-active nanoparticles used in an assay for PSA, BRCA1 and Her-2, along with examples of nucleic-acid detection. We present data on a novel homogeneous, single-tube, rapid assay for nucleic acid detection and show how it will benefit the oncology community.</abstract><notes>Sha, Michael Y&#xD;Xu, Hongxia&#xD;Penn, Sharron G&#xD;Cromer, Remy&#xD;U54 CA 119338/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2007 Oct;2(5):725-34.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17976033</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>6.093</custom4><electronic-resource-num>10.2217/17435889.2.5.725</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2234</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2234</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pridgen, E. M.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>MIT-Harvard Center for Cancer Nanotechnology Excellence, Department of Chemical Engineering, Cambridge, MA 02139, USA.</auth-address><titles><title>Biodegradable, polymeric nanoparticle delivery systems for cancer therapy</title><secondary-title>Nanomed</secondary-title></titles><periodical><full-title>Nanomed</full-title></periodical><pages>669-80</pages><volume>2</volume><number>5</number><edition>2007/11/03</edition><keywords><keyword>Absorbable Implants</keyword><keyword>Antineoplastic Agents/ administration &amp; dosage</keyword><keyword>Drug Delivery Systems/ methods</keyword><keyword>Humans</keyword><keyword>Nanomedicine/ methods</keyword><keyword>Nanoparticles/ therapeutic use</keyword><keyword>Neoplasms/ drug therapy</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>17976029</accession-num><abstract>Nanotechnology has the potential to impact the treatment of cancer significantly. This review will explore how this potential is beginning to be realized through the design of polymeric nanoparticle delivery systems. Current research is focused on developing biocompatible nanoparticles capable of targeting specific cancer markers and delivering imaging and therapeutic agents for the detection and treatment of cancer, resulting in a number of preclinical and clinical applications. More sophisticated nanoparticle designs are now in development, including particles able to release multiple drugs for enhanced treatment efficacy and targeted, multifunctional particles capable of combining imaging and drug release.</abstract><notes>Pridgen, Eric M&#xD;Langer, Robert&#xD;Farokhzad, Omid C&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;EB003647/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2007 Oct;2(5):669-80.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>6.093</custom4><electronic-resource-num>10.2217/17435889.2.5.669 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2307</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2307</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huang, X.</author><author>Jain, P. K.</author><author>El-Sayed, I. H.</author><author>El-Sayed, M. A.</author></authors></contributors><auth-address>Georgia Institute of Technology, Laser Dynamics Laboratory, School of Chemistry and Biochemistry, Atlanta, GA 30332, USA.</auth-address><titles><title>Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy</title><secondary-title>Nanomed</secondary-title></titles><periodical><full-title>Nanomed</full-title></periodical><pages>681-93</pages><volume>2</volume><number>5</number><edition>2007/11/03</edition><keywords><keyword>Drug Delivery Systems/ trends</keyword><keyword>Gold</keyword><keyword>Humans</keyword><keyword>Nanomedicine/ trends</keyword><keyword>Nanoparticles/ diagnostic use/ therapeutic use</keyword><keyword>Neoplasms/ diagnosis/ therapy</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>17976030</accession-num><abstract>Recent years have seen tremendous progress in the design and study of nanomaterials geared towards biological and biomedical applications, most notable among these being the noble metal nanoparticles. In this review, we outline the surface-plasmon resonance-enhanced optical properties of colloidal gold nanoparticles directed towards recent biomedical applications with an emphasis on cancer diagnostics and therapeutics. Methods of molecular-specific diagnostics/detection of cancer, including strongly enhanced surface plasmon resonance light-scattering, surface-enhanced emission of gold nanorods and surface-enhanced Raman scattering, are described. We also discuss the plasmonic photothermal therapy of cancer achieved by using the strongly enhanced surface-plasmon resonance absorption of gold nanospheres and nanorods.</abstract><notes>Huang, Xiaohua&#xD;Jain, Prashant K&#xD;El-Sayed, Ivan H&#xD;El-Sayed, Mostafa A&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2007 Oct;2(5):681-93.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>6.093</custom4><electronic-resource-num>10.2217/17435889.2.5.681 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1117</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1117</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, X.</author><author>Lietha, D.</author><author>Ceccarelli, D. F.</author><author>Karginov, A. V.</author><author>Rajfur, Z.</author><author>Jacobson, K.</author><author>Hahn, K. M.</author><author>Eck, M. J.</author><author>Schaller, M. D.</author></authors></contributors><auth-address>Department of Cell &amp; Developmental Biology, 534 Taylor Hall, CB 7090, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Spatial and temporal regulation of focal adhesion kinase activity in living cells</title><secondary-title>Mol Cell Biol</secondary-title></titles><periodical><full-title>Mol Cell Biol</full-title></periodical><pages>201-14</pages><volume>28</volume><number>1</number><edition>2007/10/31</edition><keywords><keyword>Acids</keyword><keyword>Amino Acid Motifs</keyword><keyword>Amino Acid Sequence</keyword><keyword>Biosensing Techniques</keyword><keyword>Cell Line</keyword><keyword>Cell Survival</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases/chemistry/genetics/*metabolism</keyword><keyword>Humans</keyword><keyword>Models, Molecular</keyword><keyword>Phosphatidylinositol 4,5-Diphosphate/metabolism</keyword><keyword>Phospholipids/metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Protein Binding</keyword><keyword>Protein Structure, Tertiary</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1098-5549 (Electronic)</isbn><accession-num>17967873</accession-num><abstract>Focal adhesion kinase (FAK) is an essential kinase that regulates developmental processes and functions in the pathology of human disease. An intramolecular autoinhibitory interaction between the FERM and catalytic domains is a major mechanism of regulation. Based upon structural studies, a fluorescence resonance energy transfer (FRET)-based FAK biosensor that discriminates between autoinhibited and active conformations of the kinase was developed. This biosensor was used to probe FAK conformational change in live cells and the mechanism of regulation. The biosensor demonstrates directly that FAK undergoes conformational change in vivo in response to activating stimuli. A conserved FERM domain basic patch is required for this conformational change and for interaction with a novel ligand for FAK, acidic phospholipids. Binding to phosphatidylinositol 4,5-bisphosphate (PIP2)-containing phospholipid vesicles activated and induced conformational change in FAK in vitro, and alteration of PIP2 levels in vivo changed the level of activation of the conformational biosensor. These findings provide direct evidence of conformational regulation of FAK in living cells and novel insight into the mechanism regulating FAK conformation.</abstract><notes>Cai, Xinming&#xD;Lietha, Daniel&#xD;Ceccarelli, Derek F&#xD;Karginov, Andrei V&#xD;Rajfur, Zenon&#xD;Jacobson, Ken&#xD;Hahn, Klaus M&#xD;Eck, Michael J&#xD;Schaller, Michael D&#xD;GM0064346/GM/United States NIGMS&#xD;HL45100/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular and cellular biology&#xD;Mol Cell Biol. 2008 Jan;28(1):201-14. Epub 2007 Oct 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17967873</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>6.426</custom4><electronic-resource-num>MCB.01324-07 [pii]&#xD;10.1128/MCB.01324-07</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2306</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2306</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huang, X.</author><author>Qian, W.</author><author>El-Sayed, I. H.</author><author>El-Sayed, M. A.</author></authors></contributors><auth-address>Laser Dynamics Laboratory, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.</auth-address><titles><title>The potential use of the enhanced nonlinear properties of gold nanospheres in photothermal cancer therapy</title><secondary-title>Lasers Surg Med</secondary-title></titles><periodical><full-title>Lasers Surg Med</full-title></periodical><pages>747-53</pages><volume>39</volume><number>9</number><edition>2007/10/27</edition><keywords><keyword>Antibodies, Monoclonal/chemistry/pharmacology</keyword><keyword>Carcinoma, Squamous Cell/metabolism/pathology/ therapy</keyword><keyword>Cell Line, Tumor</keyword><keyword>Contrast Media</keyword><keyword>Gold/chemistry/ diagnostic use/ therapeutic use</keyword><keyword>Humans</keyword><keyword>Hyperthermia, Induced/ methods</keyword><keyword>Mouth Neoplasms/metabolism/pathology/ therapy</keyword><keyword>Nanostructures/ chemistry</keyword><keyword>Receptor, Epidermal Growth Factor/biosynthesis</keyword><keyword>Scattering, Radiation</keyword><keyword>Spectroscopy, Near-Infrared</keyword><keyword>Surface Plasmon Resonance</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0196-8092 (Print)</isbn><accession-num>17960762</accession-num><abstract>BACKGROUND AND OBJECTIVE: Laser photothermal therapy (PTT) is practiced at the moment using short laser pulses. The use of plasmonic nanoparticles as contrast agents can decrease the laser energy by using the optical property of the nanoparticles and improve the tumor selectivity by the molecular probes on the particle surface. In this study, we aim at selective and efficient PTT by exploiting the nonlinear optical properties of aggregated spherical gold nanoparticles conjugated to anti-epidermal growth factor receptor (anti-EGFR) antibodies using short NIR laser pulses. STUDY DESIGN/MATERIALS AND METHODS: Spherical gold nanoparticles are synthesized and conjugated to anti-EGFR antibodies to specifically target HSC oral cancer cells. The nanoparticles are characterized by micro-absorption spectra and dark field light scattering imaging. Photothermal destructions of control and nanoparticle treated cancer cells are carried out with a femtosecond Ti:Sapphire laser at 800 nm with a pulse duration of 100 femtoseconds and repetition rate of 1 kHz. RESULTS: The laser power threshold for the photothermal destruction of cells after the nanoparticle treatment is found to be 20 times lower than that required to destroy the cells in the normal PTT, that is, without nanoparticles. The number of destroyed cells is quadratically dependent on the laser power. The number of dead cells shows a nonlinear dependence on the concentration of gold nanoparticles that are specifically targeted to cancer cells. CONCLUSIONS: The energy threshold and selectivity of PTT can greatly benefit from the use of the plasmonic enhanced nonlinear optical processes of spherical gold nanoparticles conjugated to anti-EGFR antibodies. The quadratic dependence of the photothermal efficiency on the pulsed NIR laser power indicates a second harmonic generation or a two photon absorption process. The observed nonlinear dependence on the gold nanoparticle concentration suggests that aggregated nanospheres are responsible for the observed enhanced photothermal destruction of the cells.</abstract><notes>Huang, Xiaohua&#xD;Qian, Wei&#xD;El-Sayed, Ivan H&#xD;El-Sayed, Mostafa A&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Lasers in surgery and medicine&#xD;Lasers Surg Med. 2007 Oct;39(9):747-53.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>3.059</custom4><electronic-resource-num>10.1002/lsm.20577 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1758</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1758</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yang, Z.</author><author>Zheng, S.</author><author>Harrison, W. J.</author><author>Harder, J.</author><author>Wen, X.</author><author>Gelovani, J. G.</author><author>Qiao, A.</author><author>Li, C.</author></authors></contributors><auth-address>Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.</auth-address><titles><title>Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging</title><secondary-title>Biomacromolecules</secondary-title></titles><periodical><full-title>Biomacromolecules</full-title></periodical><pages>3422-8</pages><volume>8</volume><number>11</number><edition>2007/10/26</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chelating Agents/chemistry</keyword><keyword>Cross-Linking Reagents/*chemistry</keyword><keyword>Female</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>*Micelles</keyword><keyword>Molecular Structure</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Pentetic Acid/chemistry</keyword><keyword>Polymers/*chemistry/pharmacology</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1525-7797 (Print)</isbn><accession-num>17958440</accession-num><abstract>We report the synthesis of PEG-coated, core-cross-linked polymeric micelles (CCPMs) derived from an amine-terminated amphiphilic block copolymer, poly(PEG-methacrylate)-b-poly(triethoxysilyl propylmethacrylate). The block copolymer self-assembled to form micellar nanoparticles, and a Cy-7-like near-infrared fluorescence (NIRF) dye was entrapped in the core bearing reactive ethoxysilane functional groups through a subsequent sol-gel process. The fluorescent signal of CCPMs on the molar basis was 16-fold brighter than that of Cy7. With an average diameter of 24 +/- 8.9 nm, CCPMs exhibited a prolonged blood half-life (t1/2,alpha = 1.25 h; t1/2,beta = 46.18 h) and moderate uptake by the mononuclear phagocytic system. Significant accumulation of CCPMs in human breast tumor xenografts allowed noninvasive monitoring of the uptake kinetics with both NIRF optical and gamma imaging techniques. Our data suggest that Cy7-entrapped CCPM nanoparticles are suitable for NIRF imaging of solid tumors and have potential applications in the imaging of tumor-associated molecular markers.</abstract><notes>Yang, Zhi&#xD;Zheng, Shiying&#xD;Harrison, William J&#xD;Harder, John&#xD;Wen, Xiaoxia&#xD;Gelovani, Juri G&#xD;Qiao, Alex&#xD;Li, Chun&#xD;CA 16672/CA/United States NCI&#xD;R01 CA 119387/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Biomacromolecules&#xD;Biomacromolecules. 2007 Nov;8(11):3422-8. Epub 2007 Oct 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17958440</url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom3>2008</custom3><custom4>4.658</custom4><electronic-resource-num>10.1021/bm7005399</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1581</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1581</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, X.</author><author>Thomas, T. P.</author><author>Myc, L. A.</author><author>Kotlyar, A.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109-0533, USA.</auth-address><titles><title>Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles</title><secondary-title>Phys Chem Chem Phys</secondary-title></titles><periodical><full-title>Phys Chem Chem Phys</full-title></periodical><pages>5712-20</pages><volume>9</volume><number>42</number><edition>2007/10/26</edition><keywords><keyword>Electrophoresis, Polyacrylamide Gel</keyword><keyword>Ferric Compounds/*chemical synthesis/chemistry</keyword><keyword>*Metal Nanoparticles</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Polyamines/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 14</date></pub-dates></dates><isbn>1463-9076 (Print)</isbn><accession-num>17960261</accession-num><abstract>We report the synthesis and characterization of a group of carboxyl-functionalized poly(amidoamine) (PAMAM) dendrimers of generation 3 (G3) that were used for the stabilization of superparamagnetic iron oxide (Fe(3)O(4)) nanoparticles (NPs). Folic acid (FA) molecules were conjugated onto the dendrimer surfaces in an attempt to achieve specific targeted imaging of tumor cells that overexpress FA receptors using dendrimer-stabilized Fe(3)O(4) NPs. Fe(3)O(4) NPs were synthesized using controlled co-precipitation of Fe(ii) and Fe(iii) ions and the formed dendrimer-stabilized Fe(3)O(4) NPs were characterized using transmission electron microscopy (TEM) and polyacrylamide gel electrophoresis (PAGE). The intracellular uptake of dendrimer-stabilized Fe(3)O(4) NPs was tested in vitro using KB cells (a human epithelial carcinoma cell line) that overexpress FA receptors. It appears that carboxyl-terminated PAMAM dendrimer-stabilized Fe(3)O(4) NPs can be uptaken by KB cells regardless of the repelling force between the negatively charged cells and the negatively charged particles. In the presence of a large amount of carboxyl terminal groups on the dendrimer surface, the receptor-mediated endocytosis of Fe(3)O(4) NPs stabilized by FA-modified dendrimers was not facilitated. It implies that the surface charge of dendrimer-stabilized magnetic iron oxide NPs in biological medium is an important factor influencing their biological performance.</abstract><notes>Shi, Xiangyang&#xD;Thomas, Thommey P&#xD;Myc, Lukasz A&#xD;Kotlyar, Alina&#xD;Baker, James R Jr&#xD;1 R01 CA119409/CA/United States NCI&#xD;1 RO1 EB002657/EB/United States NIBIB&#xD;N0I-CO-97111/CO/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Physical chemistry chemical physics : PCCP&#xD;Phys Chem Chem Phys. 2007 Nov 14;9(42):5712-20. Epub 2007 Sep 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17960261</url></related-urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom3>2008</custom3><custom4>3.139</custom4><electronic-resource-num>10.1039/b709147h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1244</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1244</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hasan, W.</author><author>Lee, J.</author><author>Henzie, J.</author><author>Odom, T. W.</author></authors></contributors><auth-address>Department of Chemistry and Department of Materials Science and Engineering, Northwestern University, 2145 Sheridan Rd., Evanston, Illinois 60208-3113</auth-address><titles><title>Selective Functionalization and Spectral Identification of Gold Nanopyramids</title><secondary-title>J. Phys. Chem. C</secondary-title></titles><periodical><full-title>J. Phys. Chem. C</full-title></periodical><pages>17176-17179</pages><volume>111</volume><number>46</number><edition>2007/10/25  </edition><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1932-7447</isbn><abstract>Abstract: This paper reports the selective functionalization of gold nanopyramids and spectral identification of their orientation on a surface. Facile asymmetric functionalization of the nanopyramids with different thiol-terminated ligands was achieved by controlling the etching conditions of the nanopyramidal template. We confirmed this differential modification by attaching gold colloids to either the inner or outer surfaces of the Au nanopyramids using hybridized DNA. Significantly, we have also demonstrated that the relative orientation of the nanopyramids can be identified by measuring their scattering spectra only. This unique capability of these three-dimensional, asymmetric particles enables their orientation to be determined in condensed media without the need for direct and destructive imaging tools.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/jp709607s</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>3.398</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1779</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1779</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, L.</author><author>Gu, F. X.</author><author>Chan, J. M.</author><author>Wang, A. Z.</author><author>Langer, R. S.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Department of Chemical Engineering and Division of Health Science and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</auth-address><titles><title>Nanoparticles in medicine: therapeutic applications and developments</title><secondary-title>Clin Pharmacol Ther</secondary-title></titles><periodical><full-title>Clin Pharmacol Ther</full-title></periodical><pages>761-9</pages><volume>83</volume><number>5</number><edition>2007/10/25</edition><keywords><keyword>Drug Delivery Systems/*methods</keyword><keyword>Humans</keyword><keyword>Nanoparticles/*chemistry/*therapeutic use</keyword><keyword>Nanotechnology/methods</keyword></keywords><dates><year>2008</year><pub-dates><date>May</date></pub-dates></dates><isbn>1532-6535 (Electronic)</isbn><accession-num>17957183</accession-num><abstract>Nanotechnology is the understanding and control of matter generally in the 1-100 nm dimension range. The application of nanotechnology to medicine, known as nanomedicine, concerns the use of precisely engineered materials at this length scale to develop novel therapeutic and diagnostic modalities. Nanomaterials have unique physicochemical properties, such as ultra small size, large surface area to mass ratio, and high reactivity, which are different from bulk materials of the same composition. These properties can be used to overcome some of the limitations found in traditional therapeutic and diagnostic agents.</abstract><notes>Zhang, L&#xD;Gu, F X&#xD;Chan, J M&#xD;Wang, A Z&#xD;Langer, R S&#xD;Farokhzad, O C&#xD;CA119349/CA/United States NCI&#xD;EB003647/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Clinical pharmacology and therapeutics&#xD;Clin Pharmacol Ther. 2008 May;83(5):761-9. Epub 2007 Oct 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17957183</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.843</custom4><electronic-resource-num>6100400 [pii]&#xD;10.1038/sj.clpt.6100400</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1699</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1699</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, P.</author><author>Miller, J. E.</author><author>Henling, L. M.</author><author>Stern, C. L.</author><author>Frank, N. L.</author><author>Eckermann, A. L.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, USA.</auth-address><titles><title>Synthesis and characterization of ruthenium and rhenium nucleosides</title><secondary-title>Inorg Chem</secondary-title></titles><periodical><full-title>Inorg Chem</full-title></periodical><pages>9853-62</pages><volume>46</volume><number>23</number><edition>2007/10/24</edition><keywords><keyword>Magnetic Resonance Spectroscopy</keyword><keyword>Models, Molecular</keyword><keyword>Nucleosides/*chemical synthesis/chemistry</keyword><keyword>Rhenium/*chemistry</keyword><keyword>Ruthenium/*chemistry</keyword><keyword>Spectrometry, Mass, Electrospray Ionization</keyword><keyword>Spectrophotometry, Ultraviolet</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 12</date></pub-dates></dates><isbn>0020-1669 (Print)</isbn><accession-num>17948987</accession-num><abstract>We report the synthesis and characterization of new ruthenium and rhenium nucleosides [Ru(tolyl-acac)2(IMPy)-T] (tolyl-acac=di(p-methylbenzonatemethane), IMPy=2&apos;-iminomethylpyridine, T=thymidine) (5) and [Re(CO)3(IMPy)-T]Cl (9), respectively. Structural analysis of 9 shows that the incorporation of this metal complex causes minimal perturbation to the sugar backbone and the nucleobase. Eletrochemical (5, E1/2=0.265 V vs NHE; 9, E1/2=1.67 V vs NHE), absorption (5, lambdamax=600, 486 nm; 9, lambdamax=388 nm), and emission (9, lambdamax=770 nm, pi=17 ns) data indicate that 5 and 9 are suitable probes for DNA-mediated ground-state electron-transfer studies. The separation and characterization of diastereoisomers of 5 and bipyridyl-based ruthenium nucleoside [Ru(bpy)2(IMPy)-T]2+ (7) are reported.</abstract><notes>Wang, Peijiao&#xD;Miller, Jeremiah E&#xD;Henling, Lawrence M&#xD;Stern, Charlotte L&#xD;Frank, Natia L&#xD;Eckermann, Amanda L&#xD;Meade, Thomas J&#xD;U54CA119341/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Inorganic chemistry&#xD;Inorg Chem. 2007 Nov 12;46(23):9853-62. Epub 2007 Oct 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17948987</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.215</custom4><electronic-resource-num>10.1021/ic701250r</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1088</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1088</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bhaviripudi, S.</author><author>Qi, J.</author><author>Hu, E. L.</author><author>Belcher, A. M.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Synthesis, characterization, and optical properties of ordered arrays of III-nitride nanocrystals</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>3512-7</pages><volume>7</volume><number>11</number><edition>2007/10/24</edition><keywords><keyword>Crystallization</keyword><keyword>Gallium/*chemistry</keyword><keyword>Luminescence</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Micelles</keyword><keyword>Microscopy, Atomic Force</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Models, Chemical</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Nitrogen/*chemistry</keyword><keyword>Oxygen/chemistry</keyword><keyword>Photochemistry/methods</keyword><keyword>Polymers/chemistry</keyword><keyword>Silicon/chemistry</keyword><keyword>Spectrophotometry/methods</keyword><keyword>X-Ray Diffraction</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17949047</accession-num><abstract>A new approach involving self-assembling block copolymer micellar templates and gas-phase reactions to synthesize arrays of monodisperse III-nitrides nanocrystals in the size range of 1-5 nm with uniform spacings between the nanoparticles is demonstrated. The photoluminescence emission spectra revealed the GaN nanocrystals are in the quantum-confined regime. This method not only offers great promise for the controlled synthesis of arrays of ternary III-nitride nanocrystals but may also enable doping in binary nitrides.</abstract><notes>Bhaviripudi, Sreekar&#xD;Qi, Jifa&#xD;Hu, Evelyn L&#xD;Belcher, Angela M&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Nov;7(11):3512-7. Epub 2007 Oct 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17949047</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl072129d</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2305</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2305</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stokes, T. H.</author><author>Phan, J.</author><author>Quo, C. F.</author><author>Nie, S.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Sch. of Electr. &amp; Comput. Eng., Georgia Inst. of Technol., Atlanta, GA 30332, USA.</auth-address><titles><title>Bio-nano-informatics: an integrated information management system for personalized oncology</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>3325-8</pages><volume>1</volume><edition>2007/10/20</edition><keywords><keyword>Biomedical Engineering</keyword><keyword>Clinical Laboratory Information Systems</keyword><keyword>Computational Biology</keyword><keyword>Humans</keyword><keyword>Integrated Advanced Information Management Systems</keyword><keyword>Management Information Systems</keyword><keyword>Medical Oncology/ statistics &amp; numerical data</keyword><keyword>Nanotechnology/ statistics &amp; numerical data</keyword></keywords><dates><year>2006</year></dates><isbn>1557-170X (Print)</isbn><accession-num>17947022</accession-num><abstract>The Emory-Georgia Tech Nanotechnology Center for Personalized and Predictive Oncology is one of the eight national centers funded by the National Cancer Institute (NCI). Its overall goal is to combine nanotechnology and biocomputing with clinical oncology for personalized detection, diagnosis and treatment of human cancer. Within this large-scale and multifaceted center, a key challenge is how to integrate and manage data and resources. Here we have developed an &quot;intelligent&quot; information system for data management, interpretation, and for translation of new results to clinical applications.</abstract><notes>Stokes, Todd H&#xD;Phan, John&#xD;Quo, C F&#xD;Nie, Shuming&#xD;Wang, May D&#xD;R01 CA108468/CA/NCI NIH HHS/United States&#xD;U54 CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2006;1:3325-8.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2006.259752 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2303</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2303</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Phan, J. H.</author><author>Young, A. N.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Dept. of Biomed. Eng., Georgia Inst. of Technol., Atlanta, GA 30332, USA.</auth-address><titles><title>Selecting clinically-driven biomarkers for cancer nanotechnology</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>3317-20</pages><volume>1</volume><edition>2007/10/20</edition><keywords><keyword>Biomedical Engineering</keyword><keyword>Databases, Genetic</keyword><keyword>Gene Expression Profiling</keyword><keyword>Genetic Markers</keyword><keyword>Humans</keyword><keyword>Kidney Neoplasms/chemistry/diagnosis/genetics</keyword><keyword>Nanotechnology/methods</keyword><keyword>Neoplasms/chemistry/ diagnosis/genetics</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Quantum Dots</keyword><keyword>Tumor Markers, Biological/ analysis/genetics</keyword></keywords><dates><year>2006</year></dates><isbn>1557-170X (Print)</isbn><accession-num>17947020</accession-num><abstract>The challenge of biomarker identification for bionanotechnology is that we need to find less than ten potential biomarkers from high throughput data so that quantum dot synthesis and imaging can be effective. Among all the extensive biomarker research, the novelty of our research is to reduce the number the biomarkers by studying the efficacy of several classifiers and error estimation methods. Specifically, we are using renal cancer expression data. The dataset consists of 31 microarray samples divided into four classes -- clear cell, oncocytoma/chromophobe, papillary, and angiomyolipoma. Each class is compared to all other classes using error estimation methods for support vector machines (SVM), Fisher&apos;s discriminant (FD), and signed distance function (SDF). Prior knowledge of significant biomarker from a previous study is used to score the effectiveness of each classifier in correctly identifying these biomarkers. We have achieved intelligent model selection for biomarker identification so that the total number of nano-imaging targets is small.</abstract><notes>Phan, John H&#xD;Young, Andrew N&#xD;Wang, May D&#xD;R01 CA108468/CA/NCI NIH HHS/United States&#xD;U54 CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2006;1:3317-20.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2006.259746 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2304</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2304</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kong, K. Y.</author><author>Marcus, A. I.</author><author>Hong, J. Y.</author><author>Giannakakou, P.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Sch. of Electr. &amp; Comput. Eng., Georgia Inst. of Technol., Atlanta, GA 30332, USA. kykong@gatech.edu</auth-address><titles><title>Automatic microtubule tracking for QD-based in vivo cell imaging and drug efficacy study</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>3321-4</pages><volume>1</volume><edition>2007/10/20</edition><keywords><keyword>Algorithms</keyword><keyword>Antineoplastic Agents, Phytogenic/pharmacology</keyword><keyword>Biomedical Engineering</keyword><keyword>Breast Neoplasms/drug therapy/ultrastructure</keyword><keyword>Cell Line, Tumor</keyword><keyword>Drug Resistance, Neoplasm</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>Microscopy, Confocal</keyword><keyword>Microtubules/drug effects/ ultrastructure</keyword><keyword>Paclitaxel/pharmacology</keyword><keyword>Quantum Dots</keyword></keywords><dates><year>2006</year></dates><isbn>1557-170X (Print)</isbn><accession-num>17947021</accession-num><abstract>Microtubules (MT) are dynamic polymers that rapidly transition between states of growth, shortening, and pause. These dynamic events are critical for many microtubule functions such as intracellular trafficking and signaling. In addition, cancer chemotherapy drugs that target microtubules, such as the taxanes and the vinca alkaloids, are known to suppress microtubule dynamics at low doses, leading to mitotic arrest and cell death. Quantification of microtubule dynamics can be used as a read-out of anticancer-drug activity and can be a surrogate marker of drug sensitivity/resistance. The emerging nanotechnology such as quantum dots has provided properties such as less photo bleaching, higher probe imaging intensity, better specificity and sensitivity, which finally makes visualizing subcellular events over long enough time a possibility. But it also results in big increase in data acquisition. The traditional way of annotating MT manually is becoming a daunting task. Thus, the goal is to research and develop an efficient, reliable, and rapid MT tracking. In this paper, we describe active contour-based tracking methods to automatically track MT. We redefine the internal energy terms specifically for open snake, and examine different external energy terms for locating the end tips of a microtubule. This algorithm has been validated using simulated images, images of untreated MCF-7 breast cancer cells, and image of cells treated with the microtubule-targeting chemotherapeutic agent, Taxol.</abstract><notes>Kong, Koon Yin&#xD;Marcus, Adam I&#xD;Hong, Jin Young&#xD;Giannakakou, Paraskevi&#xD;Wang, May D&#xD;1 P01 CA116676-01A1/CA/NCI NIH HHS/United States&#xD;P20 GM072069/GM/NIGMS NIH HHS/United States&#xD;R01 CA100202/CA/NCI NIH HHS/United States&#xD;R01 CA108468/CA/NCI NIH HHS/United States&#xD;R01 CA114335/CA/NCI NIH HHS/United States&#xD;U54 CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2006;1:3321-4.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2006.259750 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2302</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2302</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bostick, R. M.</author><author>Kong, K. Y.</author><author>Ahearn, T. U.</author><author>Chaudry, Q.</author><author>Cohen, V.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Dept. of Epidemiology, Emory Univ., Atlanta, GA 30332, USA. rmbosti@sph.emory.edu</auth-address><titles><title>Detecting and quantifying biomarkers of risk for colorectal cancer using quantum dots and novel image analysis algorithms</title><secondary-title>Conf Proc IEEE Eng Med Biol Soc</secondary-title></titles><periodical><full-title>Conf Proc IEEE Eng Med Biol Soc</full-title></periodical><pages>3313-6</pages><volume>1</volume><edition>2007/10/20</edition><keywords><keyword>Algorithms</keyword><keyword>Biomedical Engineering</keyword><keyword>Biopsy</keyword><keyword>Colorectal Neoplasms/chemistry/ diagnosis</keyword><keyword>Humans</keyword><keyword>Image Interpretation, Computer-Assisted</keyword><keyword>Immunohistochemistry</keyword><keyword>Quantum Dots</keyword><keyword>Risk Factors</keyword><keyword>Tumor Markers, Biological/ analysis</keyword></keywords><dates><year>2006</year></dates><isbn>1557-170X (Print)</isbn><accession-num>17947019</accession-num><abstract>Colorectal cancer, the second leading cause of cancer deaths in the United States, is a molecular disease that is largely lifestyle determined and preventable. While heart disease has been sharply declining, in large part from widespread use of biological measurements that indicate risk (&quot;biomarkers of risk&quot;), such as blood cholesterol, to motivate and guide preventive treatment, colorectal cancer is a disease for which mortality rates have changed little and for which there have been no biomarkers of risk. Based on new knowledge about the molecular basis of colorectal cancer we developed and validated a panel of treatable biomarkers of risk that can be measured in rectal biopsies using automated immunohistochemistry and semi-automated image analysis. The methodology is now being made practical for clinical application through the use of 1) quantum dots, so that all of the biomarkers can be detected simultaneously on the same histologic sections (i.e., multiplexed), and 2) novel, automated image analysis algorithms to measure the quantities and tissue distributions of the biomarkers. Herein we summarize our methods, results, current directions, and progress.</abstract><notes>Bostick, Roberd M&#xD;Kong, Koon Yin&#xD;Ahearn, Thomas U&#xD;Chaudry, Qaiser&#xD;Cohen, Vaunita&#xD;Wang, May D&#xD;CA104637/CA/NCI NIH HHS/United States&#xD;CA108468/CA/NCI NIH HHS/United States&#xD;CA119338/CA/NCI NIH HHS/United States&#xD;GM072069/GM/NIGMS NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference&#xD;Conf Proc IEEE Eng Med Biol Soc. 2006;1:3313-6.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>1.994</custom4><electronic-resource-num>10.1109/IEMBS.2006.259745 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1514</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1514</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pitteri, S. J.</author><author>Hanash, S. M.</author></authors></contributors><titles><title>Proteomic approaches for cancer biomarker discovery in plasma</title><secondary-title>Expert Rev Proteomics</secondary-title></titles><periodical><full-title>Expert Rev Proteomics</full-title></periodical><pages>589-90</pages><volume>4</volume><number>5</number><edition>2007/10/19</edition><keywords><keyword>Humans</keyword><keyword>Neoplasm Proteins/blood</keyword><keyword>Proteomics/*methods</keyword><keyword>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</keyword><keyword>Tumor Markers, Biological/*blood</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1744-8387 (Electronic)</isbn><accession-num>17941811</accession-num><notes>Pitteri, Sharon J&#xD;Hanash, Samir M&#xD;Editorial&#xD;England&#xD;Expert review of proteomics&#xD;Expert Rev Proteomics. 2007 Oct;4(5):589-90.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17941811</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>3.650</custom4><electronic-resource-num>10.1586/14789450.4.5.589</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1112</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1112</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>Nanoplatforms for targeted molecular imaging in living subjects</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>1840-54</pages><volume>3</volume><number>11</number><edition>2007/10/19</edition><keywords><keyword>*Contrast Media</keyword><keyword>Diagnostic Imaging/*trends</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Humans</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Molecular Probe Techniques/*trends</keyword><keyword>Nanomedicine/*trends</keyword><keyword>Nanostructures/*diagnostic use</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17943716</accession-num><abstract>Molecular or personalized medicine is the future of patient management and molecular imaging plays a key role towards this goal. Recently, nanoplatform-based molecular imaging has emerged as an interdisciplinary field, which involves chemistry, engineering, biology, and medicine. Possessing unprecedented potential for early detection, accurate diagnosis, and personalized treatment of diseases, nanoplatforms have been employed in every single biomedical imaging modality, namely, optical imaging, computed tomography, ultrasound, magnetic resonance imaging, single-photon-emission computed tomography, and positron emission tomography. Multifunctionality is the key advantage of nanoplatforms over traditional approaches. Targeting ligands, imaging labels, therapeutic drugs, and many other agents can all be integrated into the nanoplatform to allow for targeted molecular imaging and molecular therapy by encompassing many biological and biophysical barriers. In this Review, we will summarize the current state-of-the-art of nanoplatforms for targeted molecular imaging in living subjects.</abstract><notes>Cai, Weibo&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/United States NCI&#xD;R21 CA102123/CA/United States NCI&#xD;R21 EB001785/EB/United States NIBIB&#xD;R24 CA93862/CA/United States NCI&#xD;U54 CA119367/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2007 Nov;3(11):1840-54.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17943716</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200700351</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2065</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2065</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Chen, K.</author><author>Li, Z. B.</author><author>Gambhir, S. S.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS), Department of Radiology, and Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305-5484, USA.</auth-address><titles><title>Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature</title><secondary-title>J Nucl Med</secondary-title></titles><periodical><full-title>J Nucl Med</full-title></periodical><pages>1862-70</pages><volume>48</volume><number>11</number><edition>2007/10/19</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chelating Agents</keyword><keyword>Copper Radioisotopes</keyword><keyword>Heterocyclic Compounds, 1-Ring/ pharmacokinetics</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/ metabolism</keyword><keyword>Iodine Radioisotopes</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neoplasms, Experimental/ blood supply</keyword><keyword>Neovascularization, Pathologic/metabolism/radionuclide imaging</keyword><keyword>Oligopeptides/ pharmacokinetics</keyword><keyword>Peptides/pharmacokinetics</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Quantum Dots</keyword><keyword>Radiopharmaceuticals/ pharmacokinetics</keyword><keyword>Spectroscopy, Near-Infrared</keyword><keyword>Tissue Distribution</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>17942800</accession-num><abstract>To date, the in vivo imaging of quantum dots (QDs) has been mostly qualitative or semiquantitative. The development of a dual-function PET/near-infrared fluorescence (NIRF) probe can allow for accurate assessment of the pharmacokinetics and tumor-targeting efficacy of QDs. METHODS: A QD with an amine-functionalized surface was modified with RGD peptides and 1,4,7,10-tetraazacyclodocecane-N,N&apos;,N&apos;&apos;,N&apos;&apos;&apos;-tetraacetic acid (DOTA) chelators for integrin alpha(v)beta(3)-targeted PET/NIRF imaging. A cell-binding assay and fluorescence cell staining were performed with U87MG human glioblastoma cells (integrin alpha(v)beta(3)-positive). PET/NIRF imaging, tissue homogenate fluorescence measurement, and immunofluorescence staining were performed with U87MG tumor-bearing mice to quantify the probe uptake in the tumor and major organs. RESULTS: There are about 90 RGD peptides per QD particle, and DOTA-QD-RGD exhibited integrin alpha(v)beta(3)-specific binding in cell cultures. The U87MG tumor uptake of (64)Cu-labeled DOTA-QD was less than 1 percentage injected dose per gram (%ID/g), significantly lower than that of (64)Cu-labeled DOTA-QD-RGD (2.2 +/- 0.3 [mean +/- SD] and 4.0 +/- 1.0 %ID/g at 5 and 18 h after injection, respectively; n = 3). Taking into account all measurements, the liver-, spleen-, and kidney-to-muscle ratios for (64)Cu-labeled DOTA-QD-RGD were about 100:1, 40:1, and 1:1, respectively. On the basis of the PET results, the U87MG tumor-to-muscle ratios for DOTA-QD-RGD and DOTA-QD were about 4:1 and 1:1, respectively. Excellent linear correlation was obtained between the results measured by in vivo PET imaging and those measured by ex vivo NIRF imaging and tissue homogenate fluorescence (r(2) = 0.93). Histologic examination revealed that DOTA-QD-RGD targets primarily the tumor vasculature through an RGD-integrin alpha(v)beta(3) interaction, with little extravasation. CONCLUSION: We quantitatively evaluated the tumor-targeting efficacy of a dual-function QD-based probe with PET and NIRF imaging. This dual-function probe has significantly reduced potential toxicity and overcomes the tissue penetration limitation of optical imaging, allowing for quantitative targeted imaging in deep tissue.</abstract><notes>Cai, Weibo&#xD;Chen, Kai&#xD;Li, Zi-Bo&#xD;Gambhir, Sanjiv S&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R01 CA119053/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 CA121842/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2007 Nov;48(11):1862-70. Epub 2007 Oct 17.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.282</custom4><electronic-resource-num>jnumed.107.043216 [pii]&#xD;10.2967/jnumed.107.043216 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1278</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1278</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huh, Y.M.</author><author>Lee, E.S.</author><author>Lee, J.H.</author><author>Jun, J.W.</author><author>Kim, P.H.</author><author>Yun, C.O.</author><author>Kim, J.H.</author><author>Suh, J.S.</author><author>Cheon, J.</author></authors></contributors><auth-address>Department of Radiology, College of Medicine, Yonsei University, Seoul 120-752 (Korea); Department of Chemistry, Yonsei University, Seoul 120-749 (Korea); Brain Korea 21 Projects for Medical Science, Institute for Cancer Research, Yonsei Cancer Center, College of Medicine, Yonsei University, Seoul 120-752 (Korea)</auth-address><titles><title>Hybrid Nanoparticles for Magnetic Resonance Imaging of Target-Specific Viral Gene Delivery</title><secondary-title>Advanced Materials</secondary-title></titles><periodical><full-title>Advanced Materials</full-title></periodical><pages>3109-3112</pages><volume>19</volume><number>20</number><edition>2007/10/17</edition><keywords><keyword>Gene delivery</keyword><keyword>Hybrid materials</keyword><keyword>Magnetic nanoparticles</keyword><keyword>Viruses</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1521-4095</isbn><abstract>No abstract.</abstract><notes>10.1002/adma.200701952</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adma.200701952</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>10.231</custom4><electronic-resource-num>10.1002/adma.200701952</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1250</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1250</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Heath, J. R.</author><author>Davis, M. E.</author></authors></contributors><auth-address>Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA. heath@caltech.edu</auth-address><titles><title>Nanotechnology and cancer</title><secondary-title>Annu Rev Med</secondary-title></titles><periodical><full-title>Annu Rev Med</full-title></periodical><pages>251-65</pages><volume>59</volume><edition>2007/10/17</edition><keywords><keyword>Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Nanoparticles</keyword><keyword>*Nanotechnology</keyword><keyword>Neoplasms/*diagnosis/*therapy</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0066-4219 (Print)</isbn><accession-num>17937588</accession-num><abstract>The biological picture of cancer is rapidly advancing from models built from phenomenological descriptions to network models derived from systems biology, which can capture the evolving pathophysiology of the disease at the molecular level. The translation of this (still academic) picture into a clinically relevant framework can be enabling for the war on cancer, but it is a scientific and technological challenge. In this review, we discuss emerging in vitro diagnostic technologies and therapeutic approaches that are being developed to handle this challenge. Our discussion of in vitro diagnostics is guided by the theme of making large numbers of measurements accurately, sensitively, and at very low cost. We discuss diagnostic approaches based on microfluidics and nanotechnology. We then review the current state of the art of nanoparticle-based therapeutics that have reached the clinic. The goal of the presentation is to identify nanotherapeutic strategies that are designed to increase efficacy while simultaneously minimizing the toxic side effects commonly associated with cancer chemotherapies.</abstract><notes>Heath, James R&#xD;Davis, Mark E&#xD;Review&#xD;United States&#xD;Annual review of medicine&#xD;Annu Rev Med. 2008;59:251-65.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17937588</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>13.679</custom4><electronic-resource-num>10.1146/annurev.med.59.061506.185523</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1249</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1249</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Healy, K. D.</author><author>Hodgson, L.</author><author>Kim, T. Y.</author><author>Shutes, A.</author><author>Maddileti, S.</author><author>Juliano, R. L.</author><author>Hahn, K. M.</author><author>Harden, T. K.</author><author>Bang, Y. J.</author><author>Der, C. J.</author></authors></contributors><auth-address>Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC 27599-7295, USA.</auth-address><titles><title>DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms</title><secondary-title>Mol Carcinog</secondary-title></titles><periodical><full-title>Mol Carcinog</full-title></periodical><pages>326-37</pages><volume>47</volume><number>5</number><edition>2007/10/13</edition><keywords><keyword>Carcinoma, Non-Small-Cell Lung/metabolism/pathology/*prevention &amp; control</keyword><keyword>Cell Movement</keyword><keyword>Collagen/metabolism</keyword><keyword>DNA Primers</keyword><keyword>Drug Combinations</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Genes, Tumor Suppressor/physiology</keyword><keyword>Guanosine Triphosphate/metabolism</keyword><keyword>Humans</keyword><keyword>Hydrolysis</keyword><keyword>Laminin/metabolism</keyword><keyword>Lung Neoplasms/metabolism/pathology/*prevention &amp; control</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Phospholipase C delta/metabolism</keyword><keyword>Polymerase Chain Reaction</keyword><keyword>Proteoglycans/metabolism</keyword><keyword>Tumor Cells, Cultured</keyword><keyword>Tumor Stem Cell Assay</keyword><keyword>Tumor Suppressor Proteins/*physiology</keyword><keyword>rho GTP-Binding Proteins/genetics/*metabolism</keyword><keyword>rhoA GTP-Binding Protein/genetics/*metabolism</keyword><keyword>rhoB GTP-Binding Protein/genetics/*metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>1098-2744 (Electronic)</isbn><accession-num>17932950</accession-num><abstract>Expression of the tumor suppressor deleted in liver cancer-1 (DLC-1) is lost in non-small cell lung (NSCLC) and other human carcinomas, and ectopic DLC-1 expression dramatically reduces proliferation and tumorigenicity. DLC-1 is a multi-domain protein that includes a Rho GTPase activating protein (RhoGAP) domain which has been hypothesized to be the basis of its tumor suppressive actions. To address the importance of the RhoGAP function of DLC-1 in tumor suppression, we performed biochemical and biological studies evaluating DLC-1 in NSCLC. Full-length DLC-1 exhibited strong GAP activity for RhoA as well as RhoB and RhoC, but only very limited activity for Cdc42 in vitro. In contrast, the isolated RhoGAP domain showed 5- to 20-fold enhanced activity for RhoA, RhoB, RhoC, and Cdc42. DLC-1 protein expression was absent in six of nine NSCLC cell lines. Restoration of DLC-1 expression in DLC-1-deficient NSCLC cell lines reduced RhoA activity, and experiments with a RhoA biosensor demonstrated that DLC-1 dramatically reduces RhoA activity at the leading edge of cellular protrusions. Furthermore, DLC-1 expression in NSCLC cell lines impaired both anchorage-dependent and -independent growth, as well as invasion in vitro. Surprisingly, we found that the anti-tumor activity of DLC-1 was due to both RhoGAP-dependent and -independent activities. Unlike the rat homologue p122RhoGAP, DLC-1 was not capable of activating the phospholipid hydrolysis activity of phospholipase C-delta1. Combined, these studies provide information on the mechanism of DLC-1 function and regulation, and further support the role of DLC-1 tumor suppression in NSCLC.</abstract><notes>Healy, Kevin D&#xD;Hodgson, Louis&#xD;Kim, Tai-Young&#xD;Shutes, Adam&#xD;Maddileti, Savitri&#xD;Juliano, Rudolph L&#xD;Hahn, Klaus M&#xD;Harden, T Kendall&#xD;Bang, Yung-Jue&#xD;Der, Channing J&#xD;CA063071/CA/United States NCI&#xD;CA67771/CA/United States NCI&#xD;GM57391/GM/United States NIGMS&#xD;GM57464/GM/United States NIGMS&#xD;GM64346/GM/United States NIGMS&#xD;P01HL4500/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Molecular carcinogenesis&#xD;Mol Carcinog. 2008 May;47(5):326-37.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17932950</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>2.743</custom4><electronic-resource-num>10.1002/mc.20389</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1189</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1189</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Duan, J.</author><author>Wu, J.</author><author>Valencia, C. A.</author><author>Liu, R.</author></authors></contributors><auth-address>School of Pharmacy and Carolina Center for Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Fibronectin type III domain based monobody with high avidity</title><secondary-title>Biochemistry</secondary-title></titles><periodical><full-title>Biochemistry</full-title></periodical><pages>12656-64</pages><volume>46</volume><number>44</number><edition>2007/10/13</edition><keywords><keyword>Antibodies, Monoclonal/*chemistry/*isolation &amp; purification/metabolism</keyword><keyword>*Antibody Affinity</keyword><keyword>Dimerization</keyword><keyword>Fibronectins/*chemistry</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/genetics/*immunology</keyword><keyword>K562 Cells</keyword><keyword>Peptide Hydrolases/metabolism</keyword><keyword>Protein Binding</keyword><keyword>Protein Denaturation</keyword><keyword>Protein Structure, Tertiary</keyword><keyword>Recombinant Fusion Proteins/chemistry/isolation &amp; purification/metabolism</keyword><keyword>Substrate Specificity</keyword><keyword>Transfection</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 6</date></pub-dates></dates><isbn>0006-2960 (Print)</isbn><accession-num>17929945</accession-num><abstract>Significant efforts have been made to improve the target-binding strength of numerous affinity molecules that are widely used in biomedical research and clinical applications. While many antibody-like fragments have been successfully optimized through affinity maturation, the process is time-consuming and restricted by the stability, solubility, and expression level of the protein sequences. To generate a fibronectin type III domain (FN3) based monobody that binds to the tumor-related biomarkers with exceptional high strength and stability, we developed a multivalent strategy by fusing an alphavbeta3-binding FN3 monobody with a short COMP pentamerization domain through a linker that facilitates appropriate display of multivalent FN3 domains. The fusion protein was highly expressed in the soluble fraction of Escherichia coli and efficiently self-assembled into a pentameric molecule that could be readily purified. Compared to the monomeric form, the pentameric monobody bound to alphavbeta3 integrin much more tightly with significantly slower off-rate, while still maintaining its excellent specificity toward alphavbeta3 when tested by using purified integrins and integrin-expressing cell lines. The multivalent strategy we describe here could be applied to engineer other FN3 monobodies to acquire significantly improved targeting-binding strengths.</abstract><notes>Duan, Jinzhu&#xD;Wu, Jinsong&#xD;Valencia, C Alexander&#xD;Liu, Rihe&#xD;U54 CA119343/CA/United States NCI&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Biochemistry&#xD;Biochemistry. 2007 Nov 6;46(44):12656-64. Epub 2007 Oct 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17929945</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>3.402</custom4><electronic-resource-num>10.1021/bi701215e</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1449</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1449</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Merrill, A. H., Jr.</author><author>Wang, M. D.</author><author>Park, M.</author><author>Sullards, M. C.</author></authors></contributors><auth-address>School of Biology, Chemistry and Biochemistry, The Wallace H Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA. al.merrill@biology.gatech.edu</auth-address><titles><title>(Glyco)sphingolipidology: an amazing challenge and opportunity for systems biology</title><secondary-title>Trends Biochem Sci</secondary-title></titles><periodical><full-title>Trends Biochem Sci</full-title></periodical><pages>457-68</pages><volume>32</volume><number>10</number><edition>2007/10/12</edition><keywords><keyword>Eukaryotic Cells/chemistry/metabolism</keyword><keyword>Extracellular Matrix/*metabolism</keyword><keyword>Glycolipids/chemistry/metabolism</keyword><keyword>Mass Spectrometry</keyword><keyword>Molecular Structure</keyword><keyword>Phospholipids/chemistry/metabolism</keyword><keyword>Prokaryotic Cells/chemistry/metabolism</keyword><keyword>Sphingolipids/chemistry/*metabolism</keyword><keyword>Systems Biology/*methods/trends</keyword><keyword>Viruses/chemistry/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0968-0004 (Print)</isbn><accession-num>17928229</accession-num><abstract>Sphingolipids are found in essentially all eukaryotes and in some prokaryotes and viruses, where they influence cell structure, signaling and interactions with the extracellular environment. Because of the combinatorial nature of their biosynthesis, the sphingolipidome comprises untold thousands of species that encompass bioactive backbones and complex phospho- and glycolipids. Mass spectrometry is able to analyze a growing fraction of the sphingolipidome and is beginning to provide information about localization. Use of these structure specific, quantitative methods is producing insights, and surprises, regarding sphingolipid structure, metabolism, function and disease. Dealing with such large data sets poses special challenges for systems biology, but the intrinsic and elegant interrelationships among these compounds might provide a key to dealing with the complexity of the sphingolipidome.</abstract><notes>Merrill, Alfred H Jr&#xD;Wang, May Dongmei&#xD;Park, Meeyoung&#xD;Sullards, M Cameron&#xD;GM069338/GM/United States NIGMS&#xD;PA02132/United States PHS&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Trends in biochemical sciences&#xD;Trends Biochem Sci. 2007 Oct;32(10):457-68.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17928229</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>14.994</custom4><electronic-resource-num>S0968-0004(07)00214-9 [pii]&#xD;10.1016/j.tibs.2007.09.004</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1310</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1310</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Karfeld, L. S.</author><author>Bull, S. R.</author><author>Davis, N. E.</author><author>Meade, T. J.</author><author>Barron, A. E.</author></authors></contributors><auth-address>Department of Chemical and Biological Engineering and Feinberg School of Medicine, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Use of a genetically engineered protein for the design of a multivalent MRI contrast agent</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>1697-700</pages><volume>18</volume><number>6</number><edition>2007/10/12</edition><keywords><keyword>Chelating Agents/chemistry</keyword><keyword>Contrast Media/*chemistry/*metabolism/pharmacology</keyword><keyword>Gold/chemistry</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Molecular Sequence Data</keyword><keyword>Molecular Structure</keyword><keyword>Polymers/chemistry</keyword><keyword>*Protein Engineering</keyword><keyword>Water/chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov-Dec</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>17927227</accession-num><abstract>The majority of clinically used contrast agents (CAs) for magnetic resonance imaging have low relaxivities and thus require high concentrations for signal enhancement. Research has turned to multivalent, macromolecular CAs to increase CA efficiency. However, previously developed macromolecular CAs do not provide high relaxivities, have limited biocompatibility, and/or do not have a structure that is readily modifiable to tailor to particular applications. We report a new family of multivalent, biomacromolecular, genetically engineered protein polymer-based CAs; the protein backbone contains evenly spaced lysines that are derivatized with gadolinium (Gd(III)) chelators. The protein&apos;s length and repeating amino acid sequence are genetically specified. We reproducibly obtained conjugates with an average of 8-9 Gd(III) chelators per protein. These multivalent CAs reproducibly provide a high relaxivity of 7.3 mM (-1) s (-1) per Gd(III) and 62.6 mM (-1) s (-1) per molecule. Furthermore, they can be incorporated into biomaterial hydrogels via chemical cross-linking of the remaining free lysines, and provide a dramatic contrast enhancement. Thus, these protein polymer CAs could be a useful tool for following the evolution of tissue engineering scaffolds.</abstract><notes>Karfeld, Lindsay S&#xD;Bull, Steve R&#xD;Davis, Nicolynn E&#xD;Meade, Thomas J&#xD;Barron, Annelise E&#xD;1 R01 EB003806/EB/United States NIBIB&#xD;1 R01 EB005866/EB/United States NIBIB&#xD;2 T32 GM008449/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2007 Nov-Dec;18(6):1697-700. Epub 2007 Oct 10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17927227</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/bc700149u</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1254</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1254</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hill, H. D.</author><author>Vega, R. A.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Nonenzymatic detection of bacterial genomic DNA using the bio bar code assay</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>9218-23</pages><volume>79</volume><number>23</number><edition>2007/10/12</edition><keywords><keyword>*Automatic Data Processing</keyword><keyword>Bacillus subtilis/genetics</keyword><keyword>Base Sequence</keyword><keyword>DNA Probes</keyword><keyword>DNA, Bacterial/*analysis</keyword><keyword>*Genome, Bacterial</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec 1</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>17927207</accession-num><abstract>The detection of bacterial genomic DNA through a nonenzymatic nanomaterials-based amplification method, the bio bar code assay, is reported. The assay utilizes oligonucleotide-functionalized magnetic microparticles to capture the target of interest from the sample. A critical step in the new assay involves the use of blocking oligonucleotides during heat denaturation of the double-stranded DNA. These blockers bind to specific regions of the target DNA upon cooling and prevent the duplex DNA from rehybridizing, which allows the particle probes to bind. Following target isolation using the magnetic particles, oligonucleotide-functionalized gold nanoparticles act as target recognition agents. The oligonucleotides on the nanoparticle (bar codes) act as amplification surrogates. The bar codes are then detected using the Scanometric method. The limit of detection for this assay was determined to be 2.5 fM, and this is the first demonstration of a bar code-type assay for the detection of double-stranded, genomic DNA.</abstract><notes>Hill, Haley D&#xD;Vega, Rafael A&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2007 Dec 1;79(23):9218-23. Epub 2007 Oct 10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17927207</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac701626y</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1078</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1078</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bartlett, D. W.</author><author>Davis, M. E.</author></authors></contributors><auth-address>Chemical Engineering, California Institute of Technology, 1200 E. California Blvd., MC 210-41, Pasadena, California 91125, USA.</auth-address><titles><title>Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles</title><secondary-title>Biotechnol Bioeng</secondary-title></titles><periodical><full-title>Biotechnol Bioeng</full-title></periodical><pages>975-85</pages><volume>99</volume><number>4</number><edition>2007/10/12</edition><keywords><keyword>Animals</keyword><keyword>Cell Proliferation</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Female</keyword><keyword>Gene Targeting/*methods</keyword><keyword>Gene Therapy/*methods</keyword><keyword>Injections, Intravenous</keyword><keyword>Mice</keyword><keyword>Nanoparticles/*administration &amp; dosage</keyword><keyword>Neuroblastoma/*genetics/pathology/*therapy</keyword><keyword>RNA, Small Interfering/*administration &amp; dosage</keyword><keyword>Transferrin/*genetics</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>1097-0290 (Electronic)</isbn><accession-num>17929316</accession-num><abstract>This study addresses issues of relevance for siRNA nanoparticle delivery by investigating the functional impact of tumor-specific targeting and dosing schedule. The investigations are performed using an experimental system involving a syngeneic mouse cancer model and a theoretical system based on our previously described mathematical model of siRNA delivery and function. A/J mice bearing subcutaneous Neuro2A tumors approximately 100 mm(3) in size were treated by intravenous injection with siRNA-containing nanoparticles formed with cyclodextrin-containing polycations (CDP). Three consecutive daily doses of transferrin (Tf)-targeted nanoparticles carrying 2.5 mg/kg of two different siRNA sequences targeting ribonucleotide reductase subunit M2 (RRM2) slowed tumor growth, whereas non-targeted nanoparticles were significantly less effective when given at the same dose. Furthermore, administration of the three doses on consecutive days or every 3 days did not lead to statistically significant differences in tumor growth delay. Mathematical model calculations of siRNA-mediated target protein knockdown and tumor growth inhibition are used to elucidate possible mechanisms to explain the observed effects and to provide guidelines for designing more effective siRNA-based treatment regimens regardless of delivery methodology and tumor type.</abstract><notes>Bartlett, Derek W&#xD;Davis, Mark E&#xD;CA119347/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Biotechnology and bioengineering&#xD;Biotechnol Bioeng. 2008 Mar 1;99(4):975-85.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17929316</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>2.499</custom4><electronic-resource-num>10.1002/bit.21668</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1735</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1735</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wu, H.</author><author>Neilson, J. R.</author><author>Kumar, P.</author><author>Manocha, M.</author><author>Shankar, P.</author><author>Sharp, P. A.</author><author>Manjunath, N.</author></authors></contributors><auth-address>The CBR Institute for Biomedical Research and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America.</auth-address><titles><title>miRNA profiling of naive, effector and memory CD8 T cells</title><secondary-title>PLoS ONE</secondary-title></titles><periodical><full-title>PLoS ONE</full-title></periodical><pages>e1020</pages><volume>2</volume><number>10</number><edition>2007/10/11</edition><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1932-6203 (Electronic)</isbn><accession-num>17925868</accession-num><abstract>microRNAs have recently emerged as master regulators of gene expression during development and cell differentiation. Although profound changes in gene expression also occur during antigen-induced T cell differentiation, the role of miRNAs in the process is not known. We compared the miRNA expression profiles between antigen-specific naive, effector and memory CD8+ T cells using 3 different methods--small RNA cloning, miRNA microarray analysis and real-time PCR. Although many miRNAs were expressed in all the T cell subsets, the frequency of 7 miRNAs (miR-16, miR-21, miR-142-3p, miR-142-5p, miR-150, miR-15b and let-7f) alone accounted for approximately 60% of all miRNAs, and their expression was several fold higher than the other expressed miRNAs. Global downregulation of miRNAs (including 6/7 dominantly expressed miRNAs) was observed in effector T cells compared to naive cells and the miRNA expression levels tended to come back up in memory T cells. However, a few miRNAs, notably miR-21 were higher in effector and memory T cells compared to naive T cells. These results suggest that concomitant with profound changes in gene expression, miRNA profile also changes dynamically during T cell differentiation. Sequence analysis of the cloned mature miRNAs revealed an extensive degree of end polymorphism. While 3&apos;end polymorphisms dominated, heterogeneity at both ends, resembling drosha/dicer processing shift was also seen in miR-142, suggesting a possible novel mechanism to generate new miRNA and/or to diversify miRNA target selection. Overall, our results suggest that dynamic changes in the expression of miRNAs may be important for the regulation of gene expression during antigen-induced T cell differentiation. Our study also suggests possible novel mechanisms for miRNA biogenesis and function.</abstract><notes>Wu, Haoquan&#xD;Neilson, Joel R&#xD;Kumar, Priti&#xD;Manocha, Monika&#xD;Shankar, Premlata&#xD;Sharp, Phillip A&#xD;Manjunath, N&#xD;R21 AI 066197/AI/United States NIAID&#xD;U19 AI 056900/AI/United States NIAID&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;PLoS ONE&#xD;PLoS ONE. 2007 Oct 10;2(10):e1020.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17925868</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>14.662</custom4><electronic-resource-num>10.1371/journal.pone.0001020</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1398</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1398</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lin, S.</author><author>Xie, X.</author><author>Patel, M. R.</author><author>Yang, Y. H.</author><author>Li, Z.</author><author>Cao, F.</author><author>Gheysens, O.</author><author>Zhang, Y.</author><author>Gambhir, S. S.</author><author>Rao, J. H.</author><author>Wu, J. C.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS) and Bio-X Program, Department of Radiology, Stanford University, Stanford, CA 94305, USA. susans1018@gmail.com</auth-address><titles><title>Quantum dot imaging for embryonic stem cells</title><secondary-title>BMC Biotechnol</secondary-title></titles><periodical><full-title>BMC Biotechnol</full-title></periodical><pages>67</pages><volume>7</volume><edition>2007/10/11</edition><keywords><keyword>Animals</keyword><keyword>Cells, Cultured</keyword><keyword>Embryonic Stem Cells/*cytology</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1472-6750 (Electronic)</isbn><accession-num>17925032</accession-num><abstract>BACKGROUND: Semiconductor quantum dots (QDs) hold increasing potential for cellular imaging both in vitro and in vivo. In this report, we aimed to evaluate in vivo multiplex imaging of mouse embryonic stem (ES) cells labeled with Qtracker delivered quantum dots (QDs). RESULTS: Murine embryonic stem (ES) cells were labeled with six different QDs using Qtracker. ES cell viability, proliferation, and differentiation were not adversely affected by QDs compared with non-labeled control cells (P = NS). Afterward, labeled ES cells were injected subcutaneously onto the backs of athymic nude mice. These labeled ES cells could be imaged with good contrast with one single excitation wavelength. With the same excitation wavelength, the signal intensity, defined as (total signal-background)/exposure time in millisecond was 11 +/- 2 for cells labeled with QD 525, 12 +/- 9 for QD 565, 176 +/- 81 for QD 605, 176 +/- 136 for QD 655, 167 +/- 104 for QD 705, and 1,713 +/- 482 for QD 800. Finally, we have shown that QD 800 offers greater fluorescent intensity than the other QDs tested. CONCLUSION: In summary, this is the first demonstration of in vivo multiplex imaging of mouse ES cells labeled QDs. Upon further improvements, QDs will have a greater potential for tracking stem cells within deep tissues. These results provide a promising tool for imaging stem cell therapy non-invasively in vivo.</abstract><notes>Lin, Shuan&#xD;Xie, Xiaoyan&#xD;Patel, Manishkumar R&#xD;Yang, Yao-Hung&#xD;Li, Zongjin&#xD;Cao, Feng&#xD;Gheysens, Oliver&#xD;Zhang, Yan&#xD;Gambhir, Sanjiv S&#xD;Rao, Jiang Hong&#xD;Wu, Joseph C&#xD;HL074883/HL/United States NHLBI&#xD;HL089027/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;BMC biotechnology&#xD;BMC Biotechnol. 2007 Oct 9;7:67.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17925032</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>2.804</custom4><electronic-resource-num>1472-6750-7-67 [pii]&#xD;10.1186/1472-6750-7-67</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2301</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2301</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hornsby, C. D.</author><author>Cohen, C.</author><author>Amin, M. B.</author><author>Picken, M. M.</author><author>Lawson, D.</author><author>Yin-Goen, Q.</author><author>Young, A. N.</author></authors></contributors><auth-address>Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30303, USA.</auth-address><titles><title>Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling</title><secondary-title>Arch Pathol Lab Med</secondary-title></titles><periodical><full-title>Arch Pathol Lab Med</full-title></periodical><pages>1541-6</pages><volume>131</volume><number>10</number><edition>2007/10/10</edition><keywords><keyword>Adenoma, Oxyphilic/diagnosis</keyword><keyword>Carcinoma, Renal Cell/diagnosis/genetics/ metabolism</keyword><keyword>Diagnosis, Differential</keyword><keyword>Gene Expression</keyword><keyword>Gene Expression Profiling/ methods</keyword><keyword>Immunohistochemistry</keyword><keyword>Kidney Neoplasms/diagnosis/genetics/ metabolism</keyword><keyword>Membrane Proteins/genetics/ metabolism</keyword><keyword>RNA, Messenger/metabolism</keyword><keyword>RNA, Neoplasm/analysis</keyword><keyword>Tumor Markers, Biological/genetics/ metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1543-2165 (Electronic)</isbn><accession-num>17922590</accession-num><abstract>CONTEXT: The differential diagnosis of eosinophilic renal tumors can be difficult by light microscopy. In particular, chromophobe renal cell carcinoma (RCC) is difficult to distinguish from oncocytoma. This differential diagnosis is important because chromophobe RCC is malignant, whereas oncocytoma is benign. Furthermore, chromophobe RCC has distinct malignant potential and prognosis compared with eosinophilic variants of other RCC subtypes. Immunohistochemistry is useful for distinguishing chromophobe RCC from other subtypes of renal carcinoma, but no expression marker reliably separates chromophobe RCC from oncocytoma. OBJECTIVE: In a previous gene expression microarray analysis of renal tumor subtypes, we found the distal nephron markers claudin-7 and claudin-8 to be overexpressed in chromophobe RCC versus oncocytoma and other tumor subtypes. We have confirmed similar findings in independent microarray data and validated differential claudin-7 protein expression by immunohistochemistry. DESIGN: Immunohistochemical analysis of claudin-7 in 36 chromophobe RCCs, 43 oncocytomas, 42 clear cell RCCs, and 29 papillary RCCs. RESULTS: Membranous claudin-7 expression was detected in 67% chromophobe RCCs, compared with 0% clear cell RCCs, 28% papillary RCCs, and 26% oncocytomas (P &lt; .001). CONCLUSIONS: Based on microarray and immunohistochemical data, we propose claudin-7 to be a candidate expression marker for distinguishing chromophobe RCC from other renal tumor subtypes, including the morphologically similar oncocytoma. The clinical utility of claudin-7 should be validated in independent studies of renal tumors, possibly in combination with additional targets in a multiplex immunohistochemical panel.</abstract><notes>Hornsby, Christopher D&#xD;Cohen, Cynthia&#xD;Amin, Mahul B&#xD;Picken, Maria M&#xD;Lawson, Diane&#xD;Yin-Goen, Qiqin&#xD;Young, Andrew N&#xD;1 U54 CA119338-02/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Validation Studies&#xD;United States&#xD;Archives of pathology &amp; laboratory medicine&#xD;Arch Pathol Lab Med. 2007 Oct;131(10):1541-6.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>2.181</custom4><electronic-resource-num>2006-0687-OAR [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1261</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1261</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hoover, D. K.</author><author>Lee, E. J.</author><author>Chan, E. W.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry, Carolina Center for Genome Science, University of North Carolina, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Electroactive nanoarrays for biospecific ligand mediated studies of cell adhesion</title><secondary-title>Chembiochem</secondary-title></titles><periodical><full-title>Chembiochem</full-title></periodical><pages>1920-3</pages><volume>8</volume><number>16</number><edition>2007/10/10</edition><keywords><keyword>3T3 Cells</keyword><keyword>Adsorption</keyword><keyword>Animals</keyword><keyword>Cell Adhesion/drug effects</keyword><keyword>Electrochemistry</keyword><keyword>Fibroblasts/cytology/*drug effects</keyword><keyword>Gold/chemistry</keyword><keyword>Hydroquinones/chemistry</keyword><keyword>Ligands</keyword><keyword>Mice</keyword><keyword>Molecular Structure</keyword><keyword>Nanostructures/chemistry</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Oligopeptides/chemistry/*pharmacology</keyword><keyword>Oxidation-Reduction</keyword><keyword>Particle Size</keyword><keyword>Protein Array Analysis/*methods</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Structure-Activity Relationship</keyword><keyword>Sulfhydryl Compounds/chemistry</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 5</date></pub-dates></dates><isbn>1439-4227 (Print)</isbn><accession-num>17924378</accession-num><notes>Hoover, Diana K&#xD;Lee, Eun-ju&#xD;Chan, Eugene W L&#xD;Yousaf, Muhammad N&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Chembiochem : a European journal of chemical biology&#xD;Chembiochem. 2007 Nov 5;8(16):1920-3.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17924378</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>3.684</custom4><electronic-resource-num>10.1002/cbic.200700421</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1663</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1663</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Toutchkine, A.</author><author>Han, W. G.</author><author>Ullmann, M.</author><author>Liu, T.</author><author>Bashford, D.</author><author>Noodleman, L.</author><author>Hahn, K. M.</author></authors></contributors><auth-address>Department of Pharmacology and Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Experimental and DFT studies: novel structural modifications greatly enhance the solvent sensitivity of live cell imaging dyes</title><secondary-title>J Phys Chem A</secondary-title></titles><periodical><full-title>J Phys Chem A</full-title></periodical><pages>10849-60</pages><volume>111</volume><number>42</number><edition>2007/10/09</edition><keywords><keyword>Absorption</keyword><keyword>*Algorithms</keyword><keyword>Benzene/chemistry</keyword><keyword>Cells/cytology/*ultrastructure</keyword><keyword>Electron Transport</keyword><keyword>Energy Transfer</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Hydrogen Bonding</keyword><keyword>Isomerism</keyword><keyword>Methanol/chemistry</keyword><keyword>Models, Molecular</keyword><keyword>Photochemistry</keyword><keyword>Quantum Theory</keyword><keyword>Solvents/*chemistry</keyword><keyword>Spectrometry, Fluorescence</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct 25</date></pub-dates></dates><isbn>1089-5639 (Print)</isbn><accession-num>17918807</accession-num><abstract>Structural modifications of previously reported merocyanine dyes (Toutchkine, A.; Kraynov, V.; Hahn, K. J. Am. Chem. Soc. 2003, 125, 4132-4145) were found to greatly enhance the solvent dependence of their absorbance and fluorescence emission maxima. Density functional theory (DFT) calculations have been performed to understand the differences in optical properties between the new and previously synthesized dyes. Absorption and emission energies were calculated for several new dyes using DFT vertical self-consistent reaction field (VSCRF) methods. Geometries of ground and excited states were optimized with a conductor-like screening model (COSMO) and self-consistent field (SCF) methods. The new dyes have enhanced zwitterionic character in the ground state and much lower polarity in the excited state, as shown by the DFT-VSCRF calculations. Consistently, the position of the absorption bands are strongly blue-shifted in more polar solvent (methanol compared to benzene), as predicted by the DFT spectral calculations. Inclusion of explicit H-bonding solvent molecules within the quantum model further enhances the predicted shifts and is consistent with the observed spectral broadening. Smaller but significant spectral shifts in polar versus nonpolar solvent are predicted and observed for emission bands. The new dyes show large fluorescence quantum yields in polar hydrogen-bonding solvents; qualitatively, the longest bonds along the conjugated chain at the excited S1 state minimum are shorter in the more polar solvent, inhibiting photoisomerization. The loss of photostability of the dyes is a consequence of the reaction with and electron transfer to singlet oxygen, starting oxidative dye cleavage. The calculated vertical ionization potentials of three dyes I-SO, AI-SO(4), and AI-BA(4) in benzene and methanol are consistent with their relative photobleaching rates; the charge distributions along the conjugated chains for the three dyes are similarly predictive of higher reaction rates for AI-SO(4) and AI-BA(4) than for I-SO. Time-dependent DFT calculations were also performed on AI-BA(4); these were less accurate than the VSCRF method in predicting the absorption energy shift from benzene to methanol.</abstract><notes>Toutchkine, Alexei&#xD;Han, Wen-Ge&#xD;Ullmann, Matthias&#xD;Liu, Tiqing&#xD;Bashford, Donald&#xD;Noodleman, Louis&#xD;Hahn, Klaus M&#xD;GM057464/GM/United States NIGMS&#xD;GM064346/GM/United States NIGMS&#xD;GM43278/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The journal of physical chemistry. A&#xD;J Phys Chem A. 2007 Oct 25;111(42):10849-60. Epub 2007 Oct 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17918807</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2008</custom3><custom4>2.889</custom4><electronic-resource-num>10.1021/jp073197r</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1423</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1423</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Madoz-Gurpide, J.</author><author>Kuick, R.</author><author>Wang, H.</author><author>Misek, D. E.</author><author>Hanash, S. M.</author></authors></contributors><auth-address>Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA. juanmg@usal.es</auth-address><titles><title>Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response</title><secondary-title>Mol Cell Proteomics</secondary-title></titles><periodical><full-title>Mol Cell Proteomics</full-title></periodical><pages>268-81</pages><volume>7</volume><number>2</number><edition>2007/10/06</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Antibodies, Neoplasm/immunology</keyword><keyword>Antibody Formation/*immunology</keyword><keyword>Antigens, Neoplasm/*blood/chemistry/*immunology</keyword><keyword>Autoantibodies/blood</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chemical Fractionation</keyword><keyword>Chromatography, Liquid</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Lung Neoplasms/*blood/genetics/*immunology</keyword><keyword>Mass Spectrometry</keyword><keyword>Molecular Sequence Data</keyword><keyword>Protein Array Analysis/*methods</keyword><keyword>Ubiquitin Thiolesterase/chemistry/genetics/immunology/isolation &amp;</keyword><keyword>purification</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1535-9484 (Electronic)</isbn><accession-num>17916591</accession-num><abstract>The identification of biomarkers (both molecules and profiles) in patient sera offers enormous interest for the diagnosis of cancers. In this context, the detection of antibodies to tumor cell autologous antigens possesses great potential. The humoral immune response represents a form of biological amplification of signals that are otherwise weak because of very low concentrations of antigen, especially in the early stages of cancers. Herein we present the use of integral microarrays spotted with tumor-derived proteins to investigate the antibody repertoire in the sera of lung cancer patients and controls. The use of two-dimensional liquid chromatography allowed us to separate proteins from the lung adenocarcinoma cell line A549 into 1760 fractions, which were printed in duplicate, along with various controls, onto nitrocellulose coated slides. The sensitivity and specificity of the microarrays to detect singular antibodies in fluids were first validated through the recognition of fractions containing a lung marker antigen by antibody probing. Twenty fractions were initially selected as highly reactive against the anti-PGP9.5 antibody, and subsequent mass spectrometry analyses confirmed the identity of PGP9.5 protein in four of them. As a result, the importance of neighboring fractions in microarray detection was revealed due to the spreading of proteins during the separation process. Next, the microarrays were individually incubated with 14 serum samples from patients with lung cancer patients, 14 sera from colon cancer patients, and 14 control sera from normal subjects. The reactivity of the selected fractions was analyzed, and the level of immunoglobulin bound to each fraction by each serum sample was quantified. Eight of the 20 fractions offered p values &lt; 0.01 and were recognized by an average of four reacting patients, whereas no serum from normal individuals was positive for those fractions. Protein microarrays from tumor-derived fractions hold the diagnostic potential of uncovering antigens that induce an immune response in patients with certain types of cancers.</abstract><notes>Madoz-Gurpide, Juan&#xD;Kuick, Rork&#xD;Wang, Hong&#xD;Misek, David E&#xD;Hanash, Sam M&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Molecular &amp; cellular proteomics : MCP&#xD;Mol Cell Proteomics. 2008 Feb;7(2):268-81. Epub 2007 Oct 4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17916591</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>9.391</custom4><electronic-resource-num>M700366-MCP200 [pii]&#xD;10.1074/mcp.M700366-MCP200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1750</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1750</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yamauchi, K.</author><author>Yang, M.</author><author>Hayashi, K.</author><author>Jiang, P.</author><author>Yamamoto, N.</author><author>Tsuchiya, H.</author><author>Tomita, K.</author><author>Moossa, A. R.</author><author>Bouvet, M.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., San Diego, California 92111-3604, USA.</auth-address><titles><title>Imaging of nucleolar dynamics during the cell cycle of cancer cells in live mice</title><secondary-title>Cell Cycle</secondary-title></titles><periodical><full-title>Cell Cycle</full-title></periodical><pages>2706-8</pages><volume>6</volume><number>21</number><edition>2007/10/04</edition><keywords><keyword>Animals</keyword><keyword>Cell Cycle/*physiology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Nucleolus/*chemistry/*physiology</keyword><keyword>Gene Expression Regulation, Neoplastic/*physiology</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microscopy, Confocal/methods</keyword></keywords><dates><year>2007</year><pub-dates><date>1 November 2007</date></pub-dates></dates><isbn>1551-4005 (Electronic)</isbn><accession-num>17912040</accession-num><abstract>The synthesis and assembly of ribosomal subunits take place in the nucleolus. The nucleolus forms in the nucleus around the repeated ribosomal gene clusters and undergoes cyclic changes during the cell cycle. Although the nucleolus is easily visualized by light microscopy of cells in vitro, the nucleolus has not been imaged in cells in vivo. We report here development of a mouse model to visualize the nucleolus cycle of cancer cells in live mice. HT-1080 human fibrosarcoma cells were labeled in the nucleus with histone H2B-GFP and with retroviral RFP in the cytoplasm. The nucleolus was visualized by contrast to the fluorescence of GFP expressed in the nucleus. HT-1080 dual-color cells were seeded on the surface of a skin-flap of nude mice. The inside surface of the skin-flap was directly imaged with a laser scanning microscope 24 hours after seeding. The nucleoli of the cancer cells were clearly imaged in real-time. The appearance of the nucleoli changed dramatically during the cell cycle. During mitosis, the nucleolus disappeared. After mitosis, the nucleoli decreased in number and increased in size. The nucleolus appears to have a major role in cell cycle regulation. Nucleolar imaging could be used for more precise determination of cancer-cell position in the cell cycle in vivo.</abstract><notes>Yamauchi, Kensuke&#xD;Yang, Meng&#xD;Hayashi, Katsuhiro&#xD;Jiang, Ping&#xD;Yamamoto, Norio&#xD;Tsuchiya, Hiroyuki&#xD;Tomita, Katsuro&#xD;Moossa, A R&#xD;Bouvet, Michael&#xD;Hoffman, Robert M&#xD;Comparative Study&#xD;United States&#xD;Cell cycle (Georgetown, Tex.)&#xD;Cell Cycle. 2007 Aug;6(21):2706-8. Epub 2007 Aug 10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17912040</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>4.120</custom4><electronic-resource-num>4861 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1686</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1686</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Virmani, S.</author><author>Wang, D.</author><author>Harris, K. R.</author><author>Ryu, R. K.</author><author>Sato, K. T.</author><author>Lewandowski, R. J.</author><author>Nemcek, A. A., Jr.</author><author>Szolc-Kowalska, B.</author><author>Woloschak, G.</author><author>Salem, R.</author><author>Larson, A. C.</author><author>Omary, R. A.</author></authors></contributors><auth-address>Department of Radiology, Northwestern University, 448 E Ontario St, Suite 700, Chicago, Illinois 60611, USA.</auth-address><titles><title>Comparison of transcatheter intraarterial perfusion MR imaging and fluorescent microsphere perfusion measurements during transcatheter arterial embolization of rabbit liver tumors</title><secondary-title>J Vasc Interv Radiol</secondary-title></titles><periodical><full-title>J Vasc Interv Radiol</full-title></periodical><pages>1280-6</pages><volume>18</volume><number>10</number><edition>2007/10/04</edition><keywords><keyword>Angiography, Digital Subtraction</keyword><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Contrast Media/administration &amp; dosage</keyword><keyword>*Embolization, Therapeutic</keyword><keyword>Fluorescent Dyes/*administration &amp; dosage</keyword><keyword>Gadolinium DTPA/administration &amp; dosage</keyword><keyword>Hepatic Artery/radiography</keyword><keyword>Injections, Intra-Arterial</keyword><keyword>Linear Models</keyword><keyword>*Liver Circulation</keyword><keyword>Liver Neoplasms, Experimental/*blood supply/pathology/*therapy</keyword><keyword>*Magnetic Resonance Angiography</keyword><keyword>*Microspheres</keyword><keyword>Rabbits</keyword><keyword>Reproducibility of Results</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1051-0443 (Print)</isbn><accession-num>17911519</accession-num><abstract>PURPOSE: Transcatheter intraarterial perfusion (TRIP) magnetic resonance (MR) imaging is clinically used in the interventional MR imaging setting to verify distribution of injected embolic or chemoembolic material during liver-directed transcatheter therapies and to monitor reductions in perfusion. The accuracy of this technique remains unknown. In the present study, rabbit VX2 liver tumors were used to test the hypothesis that TRIP MR imaging accurately measures changes in tumor perfusion during transcatheter arterial embolization (TAE), with injection of fluorescent microspheres used as the gold-standard technique. MATERIALS AND METHODS: Five New Zealand White rabbits were used for this study (two donor rabbits and three with VX2 liver tumors). In three rabbits with implanted VX2 liver tumors, catheters were superselectively placed under digital subtraction angiographic guidance into the left hepatic artery supplying the targeted tumor. Fluorescent microspheres were injected into each rabbit&apos;s left ventricle before and after TAE. TRIP MR images were obtained at baseline and after embolizations for all rabbits with intraarterial injections of 2.5% gadopentetate dimeglumine solution. Linear regression was used to compare relative reductions in tumor perfusion between TRIP MR imaging and fluorescent microspheres. Results were considered statistically significant at a P value less than .05. RESULTS: There was good correlation between TRIP MR imaging and fluorescent microsphere measurements of reduction in tumor perfusion (r = 0.722, P &lt; .012). CONCLUSIONS: TRIP MR imaging provides accurate semiquantitative measurement of perfusion reduction during TAE in rabbit liver tumors.</abstract><notes>Virmani, Sumeet&#xD;Wang, Dingxin&#xD;Harris, Kathleen R&#xD;Ryu, Robert K&#xD;Sato, Kent T&#xD;Lewandowski, Robert J&#xD;Nemcek, Albert A Jr&#xD;Szolc-Kowalska, Barbara&#xD;Woloschak, Gayle&#xD;Salem, Riad&#xD;Larson, Andrew C&#xD;Omary, Reed A&#xD;CA81375/CA/United States NCI&#xD;EB002100/EB/United States NIBIB&#xD;U54 CA119341/CA/United States NCI&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Validation Studies&#xD;United States&#xD;Journal of vascular and interventional radiology : JVIR&#xD;J Vasc Interv Radiol. 2007 Oct;18(10):1280-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17911519</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>2.956</custom4><electronic-resource-num>18/10/1280 [pii]&#xD;10.1016/j.jvir.2007.07.008</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1208</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1208</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fulci, G.</author><author>Dmitrieva, N.</author><author>Gianni, D.</author><author>Fontana, E. J.</author><author>Pan, X.</author><author>Lu, Y.</author><author>Kaufman, C. S.</author><author>Kaur, B.</author><author>Lawler, S. E.</author><author>Lee, R. J.</author><author>Marsh, C. B.</author><author>Brat, D. J.</author><author>van Rooijen, N.</author><author>Stemmer-Rachamimov, A. O.</author><author>Hochberg, F. H.</author><author>Weissleder, R.</author><author>Martuza, R. L.</author><author>Chiocca, E. A.</author></authors></contributors><auth-address>Molecular Neuro-oncology Laboratories, Neurosurgery Service, and Center for Molecular Imaging, Massachusetts General Hospital, Charlestown, Massachusetts, USA. gfulci@partners.org</auth-address><titles><title>Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>9398-406</pages><volume>67</volume><number>19</number><edition>2007/10/03</edition><keywords><keyword>Animals</keyword><keyword>Brain Neoplasms/blood/pathology/therapy/*virology</keyword><keyword>Glioma/blood/pathology/therapy/*virology</keyword><keyword>Macrophages/*virology</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microglia/pathology</keyword><keyword>Oncolytic Virotherapy/*methods</keyword><keyword>Phagocytosis</keyword><keyword>Rats</keyword><keyword>Rats, Inbred F344</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17909049</accession-num><abstract>Clinical trials have proven oncolytic virotherapy to be safe but not effective. We have shown that oncolytic viruses (OV) injected into intracranial gliomas established in rodents are rapidly cleared, and this is associated with up-regulation of markers (CD68 and CD163) of cells of monocytic lineage (monocytes/microglia/macrophages). However, it is unclear whether these cells directly impede intratumoral persistence of OV through phagocytosis and whether they infiltrate the tumor from the blood or the brain parenchyma. To investigate this, we depleted phagocytes with clodronate liposomes (CL) in vivo through systemic delivery and ex vivo in brain slice models with gliomas. Interestingly, systemic CL depleted over 80% of peripheral CD163+ macrophages in animal spleen and peripheral blood, thereby decreasing intratumoral infiltration of these cells, but CD68+ cells were unchanged. Intratumoral viral titers increased 5-fold. In contrast, ex vivo CL depleted only CD68+ cells from brain slices, and intratumoral viral titers increased 10-fold. These data indicate that phagocytosis by both peripheral CD163+ and brain-resident CD68+ cells infiltrating tumor directly affects viral clearance from tumor. Thus, improved therapeutic efficacy may require modulation of these innate immune cells. In support of this new therapeutic paradigm, we observed intratumoral up-regulation of CD68+ and CD163+ cells following treatment with OV in a patient with glioblastoma.</abstract><notes>Fulci, Giulia&#xD;Dmitrieva, Nina&#xD;Gianni, Davide&#xD;Fontana, Elisabeth J&#xD;Pan, Xiaogang&#xD;Lu, Yanhui&#xD;Kaufman, Claire S&#xD;Kaur, Balveen&#xD;Lawler, Sean E&#xD;Lee, Robert J&#xD;Marsh, Clay B&#xD;Brat, Daniel J&#xD;van Rooijen, Nico&#xD;Stemmer-Rachamimov, Anat O&#xD;Hochberg, Fred H&#xD;Weissleder, Ralph&#xD;Martuza, Robert L&#xD;Chiocca, E Antonio&#xD;CA095673/CA/United States NCI&#xD;NS41571/NS/United States NINDS&#xD;P01 CA69246/CA/United States NCI&#xD;R01 CA85139/CA/United States NCI&#xD;R01 HL63800/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2007 Oct 1;67(19):9398-406.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17909049</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.980</custom4><electronic-resource-num>67/19/9398 [pii]&#xD;10.1158/0008-5472.CAN-07-1063</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1154</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1154</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Corsten, M. F.</author><author>Miranda, R.</author><author>Kasmieh, R.</author><author>Krichevsky, A. M.</author><author>Weissleder, R.</author><author>Shah, K.</author></authors></contributors><auth-address>Center for Molecular Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, USA.</auth-address><titles><title>MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>8994-9000</pages><volume>67</volume><number>19</number><edition>2007/10/03</edition><keywords><keyword>Animals</keyword><keyword>Brain Neoplasms/genetics/pathology/*therapy</keyword><keyword>Caspases/metabolism</keyword><keyword>Cell Growth Processes/physiology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Genetic Vectors/genetics</keyword><keyword>Glioblastoma/genetics/pathology/*therapy</keyword><keyword>Humans</keyword><keyword>Lentivirus/genetics</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>MicroRNAs/*antagonists &amp; inhibitors</keyword><keyword>Neurons/*physiology</keyword><keyword>Oligonucleotides, Antisense/administration &amp; dosage/*genetics</keyword><keyword>Stem Cells/*physiology</keyword><keyword>TNF-Related Apoptosis-Inducing Ligand/*genetics</keyword><keyword>Transfection</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17908999</accession-num><abstract>Despite the development of new glioma therapies that allow for tumor-targeted in situ delivery of cytotoxic drugs, tumor resistance to apoptosis remains a key impediment to effective treatment. Mounting evidence indicates that microRNAs (miRNA) might play a fundamental role in tumorigenesis, controlling cell proliferation and apoptosis. In gliomas, microRNA-21 (miR-21) levels have been reported to be elevated and their knockdown is associated with increased apoptotic activity. We hypothesized that suppression of miR-21 might sensitize gliomas for cytotoxic tumor therapy. With the use of locked nucleic acid (LNA)-antimiR-21 oligonucleotides, bimodal imaging vectors, and neural precursor cells (NPC) expressing a secretable variant of the cytotoxic agent tumor necrosis factor-related apoptosis inducing ligand (S-TRAIL), we show that the combined suppression of miR-21 and NPC-S-TRAIL leads to a synergistic increase in caspase activity and significantly decreased cell viability in human glioma cells in vitro. This phenomenon persists in vivo, as we observed complete eradication of LNA-antimiR-21-treated gliomas subjected to the presence of NPC-S-TRAIL in the murine brain. Our results reveal the efficacy of miR-21 antagonism in murine glioma models and implicate miR-21 as a target for therapeutic intervention. Furthermore, our findings provide the basis for developing combination therapies using miRNA modulation and cytotoxic tumor therapies.</abstract><notes>Corsten, Maarten F&#xD;Miranda, Rafael&#xD;Kasmieh, Randa&#xD;Krichevsky, Anna M&#xD;Weissleder, Ralph&#xD;Shah, Khalid&#xD;P01 CA69246/CA/United States NCI&#xD;P50 CA86355/CA/United States NCI&#xD;R21 CA116141/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2007 Oct 1;67(19):8994-9000.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17908999</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.980</custom4><electronic-resource-num>67/19/8994 [pii]&#xD;10.1158/0008-5472.CAN-07-1045</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1416</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1416</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lu, W.</author><author>Jiang, W.</author><author>Chen, J.</author><author>Yin, M.</author><author>Wang, Z.</author><author>Jiang, X.</author></authors></contributors><auth-address>Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 200032, People&apos;s Republic of China.</auth-address><titles><title>Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride</title><secondary-title>Int J Pharm</secondary-title></titles><periodical><full-title>Int J Pharm</full-title></periodical><pages>196-205</pages><volume>349</volume><number>1-2</number><edition>2007/10/02</edition><keywords><keyword>Administration, Intranasal</keyword><keyword>Animals</keyword><keyword>Apomorphine/*administration &amp; dosage/*pharmacology/toxicity</keyword><keyword>Brain/*metabolism</keyword><keyword>Chemistry, Pharmaceutical</keyword><keyword>Cilia/drug effects/pathology</keyword><keyword>Copulation/*drug effects</keyword><keyword>Dopamine Agonists/*administration &amp; dosage/*pharmacology/toxicity</keyword><keyword>Drug Delivery Systems</keyword><keyword>Ejaculation/drug effects</keyword><keyword>Estrus/physiology</keyword><keyword>Female</keyword><keyword>Injections, Subcutaneous</keyword><keyword>Male</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Nasal Mucosa/pathology</keyword><keyword>Rats</keyword><keyword>Rats, Sprague-Dawley</keyword></keywords><dates><year>2008</year><pub-dates><date>Feb 12</date></pub-dates></dates><isbn>0378-5173 (Print)</isbn><accession-num>17904315</accession-num><abstract>Clinical studies showed apomorphine (APO) nasal spray was well tolerated, with lower dose and less side effect in treatment of erectile dysfunction compared with its sublingual formulation. The aim of this paper was to find out whether there exists any direct drug transport from nasal cavity to brain following intranasal administration to rats. Pharmacokinetic results illustrated there were no significant differences of AUC0--&gt;120 values in most brain regions and cerebrospinal fluid (CSF) through intranasal delivery route compared with subcutaneous injection, while its plasma AUC0--&gt;120 was only one-half. APO brain and CSF profiles after intranasal administration displayed faster onset compared with subcutaneous delivery. About 35-50% of APO content at 2h, by calculating brain drug direct transport percentage, were transported to different brain regions via the olfactory pathway. In addition, the similar brain drug concentration-time profiles through intranasal delivery compared with subcutaneous route had good correlation with its equivalent sexual stimulant activity on copulatory behaviour in rats. Therefore, we could conclude a nose-to-brain pathway for APO intranasal delivery, which significantly increased brain accumulation of APO. Current experiments also explained the reason why the intranasal application of APO could be an effective alternative to subcutaneous and oral formulations.</abstract><notes>Lu, Wei&#xD;Jiang, Wenming&#xD;Chen, Jun&#xD;Yin, Ming&#xD;Wang, Zejian&#xD;Jiang, Xinguo&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Netherlands&#xD;International journal of pharmaceutics&#xD;Int J Pharm. 2008 Feb 12;349(1-2):196-205. Epub 2007 Aug 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17904315</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>3.431</custom4><electronic-resource-num>S0378-5173(07)00692-8 [pii]&#xD;10.1016/j.ijpharm.2007.08.012</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1176</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1176</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Devalapally, H.</author><author>Duan, Z.</author><author>Seiden, M. V.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA.</auth-address><titles><title>Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer</title><secondary-title>Int J Cancer</secondary-title><alt-title>International journal of cancer</alt-title></titles><periodical><full-title>Int J Cancer</full-title></periodical><alt-periodical><full-title>Int J Cancer</full-title><abbr-1>International journal of cancer</abbr-1></alt-periodical><pages>1830-8</pages><volume>121</volume><number>8</number><edition>2007/10</edition><dates><year>2007</year><pub-dates><date>Oct 15</date></pub-dates></dates><isbn>0020-7136 (Print)</isbn><accession-num>17557285</accession-num><abstract>The objective of this study was to overcome drug resistance upon systemic administration of combination paclitaxel (PTX) and the apoptotic signaling molecule C(6)-ceramide (CER) in biodegradable poly(ethylene oxide)-modified poly(epsilon-caprolactone (PEO-PCL) nanoparticles. Subcutaneous sensitive (wild-type) and multidrug resistant (MDR-1 positive) SKOV-3 human ovarian adenocarcinoma xenografts were established in female Nu/Nu mice. PTX and CER were administered intravenously either as a single agent or in combination in aqueous solution and in PEO-PCL nanoparticles to the tumor-bearing mice. There was significant (p&lt; 0.05) tumor growth suppression in both wild-type SKOV-3 and multidrug resistant SKOV-3(TR) models upon single dose co-administration of PTX (20 mg/kg) and CER (100 mg/kg) in nanoparticle formulations as compared to the individual agents and administration in aqueous solutions. For instance, in SKOV-3 wild-type model, more than 4.3-fold increase (p &lt; 0.05) in tumor growth delay and 3.6-fold (p &lt; 0.05) increase in tumor volume doubling time (DT) were observed with the combination treatment in nanoparticles as compared to untreated animals. Similarly, 3-fold increase (p &lt; 0.05) in tumor growth delay and tumor volume DT was observed in SKOV-3(TR) model. Body weight changes and blood cells counts were used as measures of safety and, except for an increase in platelet counts (p &lt; 0.05) in PTX + CER treated animals, there was no difference between various treatment strategies. The results of this study show that combination of PTX and CER in biodegradable polymeric nanoparticles can serve as a very effective therapeutic strategy to overcome drug resistance in ovarian cancer. (c) 2007 Wiley-Liss, Inc.</abstract><notes>Journal Article&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17557285 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2008</custom3><custom4>4.656</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1175</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1175</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Devalapally, H.</author><author>Chakilam, A.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 110 Mugar Life Sciences Building, Boston, Massachusetts 02115.</auth-address><titles><title>Role of nanotechnology in pharmaceutical product development</title><secondary-title>J Pharm Sci</secondary-title><alt-title>Journal of pharmaceutical sciences</alt-title></titles><periodical><full-title>J Pharm Sci</full-title></periodical><alt-periodical><full-title>Journal of Pharmaceutical Sciences</full-title></alt-periodical><pages>2547-65</pages><volume>96</volume><number>10</number><edition>2007/10</edition><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0022-3549 (Print)</isbn><accession-num>17688284</accession-num><abstract>A number of new molecular entities (NMEs) selected for full-scale development based on their safety and pharmacological data suffer from undesirable physicochemical and biopharmaceutical properties, which lead to poor pharmacokinetics and distribution after in vivo administration. An optimization of the preformulation studies to develop a dosage form with proper drug delivery system to achieve desirable pharmacokinetic and toxicological properties can aid in the accelerated development of these NMEs into therapies. Nanoparticulate drug delivery systems show a promising approach to obtain desirable druglike properties by altering the biopharmaceutics and pharmacokinetics properties of the molecule. Apart from the advantages of enhancing potential for systemic administration, nanoparticulate drug delivery systems can also be used for site-specific delivery, thus alleviating unwanted toxicity due to nonspecific distribution, improve patient compliance, and provide favorable clinical outcomes. This review summarizes some of the parameters and approaches that can be used to evaluate nanoparticulate drug delivery systems in early stages of formulation development. (c) 2007 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 96: 2547-2565, 2007.</abstract><notes>Journal Article&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17688284 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2008</custom3><custom4>3.144</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1450</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1450</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mirkin, C. A.</author></authors></contributors><auth-address>Chemistry Department and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208</auth-address><titles><title>The Power of the Pen: Development of Massively Parallel Dip-Pen Nanolithography</title><secondary-title>ACS Nano</secondary-title></titles><periodical><full-title>ACS Nano</full-title></periodical><pages>79-83</pages><volume>1</volume><number>2</number><edition>2007/09/27 </edition><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1936-0851</isbn><abstract>ABSTRACT If one had complete control of the architecture of a surface, in terms of composition and physical structure, one could ask and answer some of the most important scientific questions in a wide variety of fields, including surface science, catalysis, and cellular biology. Unfortunately, there are few tools that allow one to tailor surface architecture with such control, and of those that exist, such as electron- and ion-beam lithographies, most are limited in terms of the environment in which they can operate, the materials that can be patterned, cost, and throughput. Toward this end, important new scanning probe technologies have been developed that have impacted fields such as electronics, optics, and medicine.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/nn700228m</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.472</custom4><electronic-resource-num>10.1021/nn700228m</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1160</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1160</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Daniel, K. D.</author><author>Kim, G. Y.</author><author>Vassiliou, C. C.</author><author>Jalali-Yazdi, F.</author><author>Langer, R.</author><author>Cima, M. J.</author></authors></contributors><auth-address>Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.</auth-address><titles><title>Multi-reservoir device for detecting a soluble cancer biomarker</title><secondary-title>Lab Chip</secondary-title></titles><periodical><full-title>Lab Chip</full-title></periodical><pages>1288-93</pages><volume>7</volume><number>10</number><edition>2007/09/27</edition><keywords><keyword>Biosensing Techniques/*instrumentation/methods</keyword><keyword>Blood Chemical Analysis/*instrumentation/methods</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Flow Injection Analysis/*instrumentation/methods</keyword><keyword>Humans</keyword><keyword>Magnetics/diagnostic use/*instrumentation</keyword><keyword>Microfluidic Analytical Techniques/*instrumentation/methods</keyword><keyword>Neoplasms/*blood</keyword><keyword>Tumor Markers, Biological/*blood</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>17896012</accession-num><abstract>By combining the sensing capabilities of nanoscale magnetic relaxation switches (MRS) within multi-reservoir structures, a potentially powerful implantable multiplexed sensor has been developed. MRS are magnetic nanoparticles that decrease the transverse relaxation time (T(2)) of water in the presence of an analyte. The switches encased in polydimethylsiloxane (PDMS) devices with polycarbonate membranes (10 nm pores) have demonstrated in vitro sensing of the beta subunit of human chorionic gonadotrophin (hCG-beta), which is elevated in testicular and ovarian cancer. Devices showed transverse relaxation time (T(2)) shortening by magnetic resonance imaging (MRI) when incubated in analyte solutions of 0.5 to 5 microg hCG-beta mL(-1). The decrease in T(2) was between 9% and 27% (compared to control devices) after approximately 28 h. This prototype device is an important first step in developing an implantable sensor for detecting soluble cancer biomarkers in vivo.</abstract><notes>Daniel, Karen D&#xD;Kim, Grace Y&#xD;Vassiliou, Christophoros C&#xD;Jalali-Yazdi, Farzad&#xD;Langer, Robert&#xD;Cima, Michael J&#xD;5 U54 CA119349-12/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Lab on a chip&#xD;Lab Chip. 2007 Oct;7(10):1288-93. Epub 2007 Jul 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17896012</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>7.000</custom4><electronic-resource-num>10.1039/b705143c</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1327</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1327</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, G. Y.</author><author>Josephson, L.</author><author>Langer, R.</author><author>Cima, M. J.</author></authors></contributors><auth-address>Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Magnetic relaxation switch detection of human chorionic gonadotrophin</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>2024-8</pages><volume>18</volume><number>6</number><edition>2007/09/26</edition><keywords><keyword>Chorionic Gonadotropin/*analysis/*chemistry</keyword><keyword>Cross-Linking Reagents/chemistry</keyword><keyword>Ferric Compounds/chemistry</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword><keyword>*Magnetics</keyword><keyword>Nanoparticles/chemistry</keyword><keyword>Particle Size</keyword><keyword>Solutions</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov-Dec</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>17892270</accession-num><abstract>Functionalized nanoparticle contrast agents, also known as magnetic relaxation switches (MRS), were prepared to detect protein A and the beta subunit of human chorionic gonadotrophin (hCG-beta). Antibodies were attached to cross-linked iron oxide (CLIO) nanoparticles using standard peptide chemistry. Protein A was used as a simple model analyte, as it is naturally multivalent and can bind multiple CLIO-IgG simultaneously. The addition of PA to CLIO-IgG resulted in transverse relaxation time (T2) shortening compared to a blank control as seen by NMR relaxometry measurements. Analyte-induced aggregation was confirmed by light scattering particle size analysis. A two-particle system was designed to measure hCG-beta, as it is not multivalent and requires conjugation of a matched pair of monoclonal antibodies to CLIO (referred to as C95 and C97). Measurement of hCG-beta is important, as elevated serum levels are associated with malignancies including testicular and ovarian cancers. The addition of hCG-beta to C95 and C97 resulted in T2 shortening with a linear dynamic concentration range of 0.1 to 1 molecules of analyte per nanoparticle. Similar data were obtained for the hCG dimer. Observations with higher stoichiometric ratios of analyte to nanoparticle and increased nanoparticle valency were also made. This method can potentially be adapted to detect other biomarkers in solution.</abstract><notes>Kim, Grace Y&#xD;Josephson, Lee&#xD;Langer, Robert&#xD;Cima, Michael J&#xD;5 U54 CA119349-12/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2007 Nov-Dec;18(6):2024-8. Epub 2007 Sep 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17892270</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/bc070110w</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1142</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1142</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Choi, H. S.</author><author>Liu, W.</author><author>Misra, P.</author><author>Tanaka, E.</author><author>Zimmer, J. P.</author><author>Itty Ipe, B.</author><author>Bawendi, M. G.</author><author>Frangioni, J. V.</author></authors></contributors><auth-address>Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Room SL-B05, Boston, Massachusetts 02215, USA.</auth-address><titles><title>Renal clearance of quantum dots</title><secondary-title>Nat Biotechnol</secondary-title></titles><periodical><full-title>Nat Biotechnol</full-title></periodical><pages>1165-70</pages><volume>25</volume><number>10</number><edition>2007/09/25</edition><keywords><keyword>Animals</keyword><keyword>Contrast Media</keyword><keyword>Diagnostic Imaging</keyword><keyword>Drug Stability</keyword><keyword>Kidney/*metabolism</keyword><keyword>Male</keyword><keyword>Nanotechnology</keyword><keyword>Particle Size</keyword><keyword>*Quantum Dots</keyword><keyword>Rats</keyword><keyword>Rats, Sprague-Dawley</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1087-0156 (Print)</isbn><accession-num>17891134</accession-num><abstract>The field of nanotechnology holds great promise for the diagnosis and treatment of human disease. However, the size and charge of most nanoparticles preclude their efficient clearance from the body as intact nanoparticles. Without such clearance or their biodegradation into biologically benign components, toxicity is potentially amplified and radiological imaging is hindered. Using intravenously administered quantum dots in rodents as a model system, we have precisely defined the requirements for renal filtration and urinary excretion of inorganic, metal-containing nanoparticles. Zwitterionic or neutral organic coatings prevented adsorption of serum proteins, which otherwise increased hydrodynamic diameter by &gt;15 nm and prevented renal excretion. A final hydrodynamic diameter &lt;5.5 nm resulted in rapid and efficient urinary excretion and elimination of quantum dots from the body. This study provides a foundation for the design and development of biologically targeted nanoparticles for biomedical applications.</abstract><notes>Choi, Hak Soo&#xD;Liu, Wenhao&#xD;Misra, Preeti&#xD;Tanaka, Eiichi&#xD;Zimmer, John P&#xD;Itty Ipe, Binil&#xD;Bawendi, Moungi G&#xD;Frangioni, John V&#xD;1U54-CA119349/CA/United States NCI&#xD;GM68762/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nature biotechnology&#xD;Nat Biotechnol. 2007 Oct;25(10):1165-70. Epub 2007 Sep 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17891134</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>25.329</custom4><electronic-resource-num>nbt1340 [pii]&#xD;10.1038/nbt1340</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1690</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1690</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, D.</author><author>Bangash, A. K.</author><author>Rhee, T. K.</author><author>Woloschak, G. E.</author><author>Paunesku, T.</author><author>Salem, R.</author><author>Omary, R. A.</author><author>Larson, A. C.</author></authors></contributors><auth-address>Department of Radiology, Feinberg School of Medicine, and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 448 E Ontario St, Suite 700, Chicago, IL 60611, USA.</auth-address><titles><title>Liver tumors: monitoring embolization in rabbits with VX2 tumors--transcatheter intraarterial first-pass perfusion MR imaging</title><secondary-title>Radiology</secondary-title></titles><periodical><full-title>Radiology</full-title></periodical><pages>130-9</pages><volume>245</volume><number>1</number><edition>2007/09/22</edition><keywords><keyword>Angiography, Digital Subtraction</keyword><keyword>Animals</keyword><keyword>*Embolization, Therapeutic</keyword><keyword>Liver Neoplasms, Experimental/*therapy</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Rabbits</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0033-8419 (Print)</isbn><accession-num>17885186</accession-num><abstract>PURPOSE: To prospectively test the hypothesis that transcatheter intraarterial first-pass perfusion (TRIP) magnetic resonance (MR) imaging can depict serial reductions in rabbit liver tumor perfusion during transcatheter arterial embolization (TAE). MATERIALS AND METHODS: All experiments had institutional animal care and use committee approval. In four rabbits implanted with eight VX2 liver tumors, catheters were positioned in the hepatic arteries with conventional angiographic guidance. After transfer to the MR imaging suite, serial TAE was performed, with approximately 0.5 million 40-120-microm embolic particles injected at each embolic stage. TRIP MR imaging was performed at baseline and after each subsequent embolic stage (10 minutes between stages). Serial TAE and TRIP MR imaging were repeated until stasis. The first-pass time course of signal enhancement was measured in both tumors and hepatic arteries. Tumor area under the curve (AUC) and maximum upslope (MUS) values, each normalized by arterial input, were measured to assess iterative perfusion reduction. Perfusion measurements across TAE stages were compared with paired t tests and linear regression. RESULTS: AUC decreased from a pre-TAE baseline of 0.408 (95% confidence interval [CI]: 0.330, 0.486) to 0.065 (95% CI: 0.046, 0.085) (P&lt;.001) after TAE. MUS decreased from a pre-TAE baseline of 0.151 (95% CI: 0.121, 0.181) to 0.027 (95% CI: 0.022, 0.031) (P&lt;.001) after TAE. Reductions to AUC and MUS after each embolic stage were statistically significant (P&lt;.006 for each group of paired comparisons). AUC strongly correlated with MUS (r=0.966, P&lt;.001). CONCLUSION: TRIP MR imaging can depict serial reductions in liver tumor perfusion during TAE. TRIP MR imaging offers the potential to target functional embolic end points during TAE.</abstract><notes>Wang, Dingxin&#xD;Bangash, Affaan K&#xD;Rhee, Thomas K&#xD;Woloschak, Gayle E&#xD;Paunesku, Tatjana&#xD;Salem, Riad&#xD;Omary, Reed A&#xD;Larson, Andrew C&#xD;United States&#xD;Radiology&#xD;Radiology. 2007 Oct;245(1):130-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17885186</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>6.634</custom4><electronic-resource-num>245/1/130 [pii]&#xD;10.1148/radiol.2451061689</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1328</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1328</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, G. Y.</author><author>Tyler, B. M.</author><author>Tupper, M. M.</author><author>Karp, J. M.</author><author>Langer, R. S.</author><author>Brem, H.</author><author>Cima, M. J.</author></authors></contributors><auth-address>Division of Health Sciences and Technology, MIT/Harvard University, USA.</auth-address><titles><title>Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model</title><secondary-title>J Control Release</secondary-title></titles><periodical><full-title>J Control Release</full-title></periodical><pages>172-8</pages><volume>123</volume><number>2</number><edition>2007/09/22</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents,</keyword><keyword>Alkylating/chemistry/pharmacokinetics/*pharmacology/therapeutic use</keyword><keyword>*Biocompatible Materials</keyword><keyword>Carmustine/chemistry/pharmacokinetics/*pharmacology/therapeutic use</keyword><keyword>Chemistry, Pharmaceutical</keyword><keyword>Decanoic Acids/chemistry</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>*Drug Carriers</keyword><keyword>Drug Compounding</keyword><keyword>*Drug Implants</keyword><keyword>Drug Stability</keyword><keyword>Female</keyword><keyword>Gliosarcoma/pathology/*prevention &amp; control</keyword><keyword>Half-Life</keyword><keyword>Lactic Acid/chemistry</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Polyesters/chemistry</keyword><keyword>Polyglycolic Acid/chemistry</keyword><keyword>Polymers/*chemistry</keyword><keyword>Rats</keyword><keyword>Rats, Inbred F344</keyword><keyword>Reproducibility of Results</keyword><keyword>Solubility</keyword><keyword>Time Factors</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov 6</date></pub-dates></dates><isbn>1873-4995 (Electronic)</isbn><accession-num>17884232</accession-num><abstract>Sustained local delivery of single agents and controlled delivery of multiple chemotherapeutic agents are sought for the treatment of brain cancer. A resorbable, multi-reservoir polymer microchip drug delivery system has been tested against a tumor model. The microchip reservoirs were loaded with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). BCNU was more stable at 37 degrees C within the microchip compared to a uniformly impregnated polymeric wafer (70% intact drug vs. 38%, at 48 h). The half-life of the intact free drug in the microchip was 11 days, which is a marked enhancement compared to its half-life in normal saline and 10% ethanol (7 and 10 min, respectively) [P. Tepe, S.J. Hassenbusch, R. Benoit, J.H. Anderson, BCNU stability as a function of ethanol concentration and temperature, J. Neurooncol. 10 (1991) 121-127; P. Kari, W.R. McConnell, J.M. Finkel, D.L. Hill, Distribution of Bratton-Marshall-positive material in mice following intravenous injections of nitrosoureas, Cancer Chemother. Pharmacol. 4 (1980) 243-248]. A syngeneic Fischer 344 9L gliosarcoma rat model was used to study the tumoricidal efficacy of BCNU delivery from the microchip or homogeneous polymer wafer. A dose-dependent decrease in tumor size was found for 0.17, 0.67, and 1.24 mg BCNU-microchips. Tumors treated with 1.24 mg BCNU-microchips showed significant tumor reduction (p=0.001) compared to empty control microchips at two weeks. The treatment showed similar efficacy to a polymer wafer with the same dosage. The microchip reservoir array may enable delivery of multiple drugs with independent release kinetics and formulations.</abstract><notes>Kim, Grace Y&#xD;Tyler, Betty M&#xD;Tupper, Malinda M&#xD;Karp, Jeffrey M&#xD;Langer, Robert S&#xD;Brem, Henry&#xD;Cima, Michael J&#xD;1 R24 AI47739/AI/United States NIAID&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Netherlands&#xD;Journal of controlled release : official journal of the Controlled Release Society&#xD;J Control Release. 2007 Nov 6;123(2):172-8. Epub 2007 Aug 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17884232</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>4.756</custom4><electronic-resource-num>S0168-3659(07)00407-5 [pii]&#xD;10.1016/j.jconrel.2007.08.003</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1932</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1932</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Verma, S.</author><author>Watt, G. M.</author><author>Mai, Z.</author><author>Hasan, T.</author></authors></contributors><auth-address>Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</auth-address><titles><title>Strategies for enhanced photodynamic therapy effects</title><secondary-title>Photochem Photobiol</secondary-title></titles><periodical><full-title>Photochem Photobiol</full-title></periodical><pages>996-1005</pages><volume>83</volume><number>5</number><edition>2007/09/21</edition><keywords><keyword>Drug Therapy, Combination</keyword><keyword>Photochemotherapy</keyword><keyword>Photosensitizing Agents/administration &amp; dosage/ therapeutic use</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep-Oct</date></pub-dates></dates><isbn>0031-8655 (Print)</isbn><accession-num>17880492</accession-num><abstract>Photodynamic therapy (PDT) is a treatment modality for the selective destruction of cancerous and nonneoplastic pathologies that involves the simultaneous presence of light, oxygen and a light-activatable chemical called a photosensitizer (PS) to achieve a cytotoxic effect. The photophysics and mechanisms of cell killing by PDT have been extensively studied in recent years, and PDT has received regulatory approval for the treatment of a number of diseases worldwide. As the application of this treatment modality expands with regard to both anatomical sites and disease stages, it will be important to develop strategies for enhancing PDT outcomes. This article focuses on two broad approaches for PDT enhancement: (1) mechanism-based combination treatments in which PDT and a second modality can be designed to either increase the susceptibility of tumor cells to PDT or nullify the treatment outcome-mitigating molecular responses triggered by PDT of tumors, and (2) the more recent approaches of PS targeting, either by specific cellular function-sensitive linkages or via conjugation to macromolecules.</abstract><notes>Verma, Sarika&#xD;Watt, Gregory M&#xD;Mai, Zhiming&#xD;Hasan, Tayyaba&#xD;P01 CA084203/CA/NCI NIH HHS/United States&#xD;R01 AR040352/AR/NIAMS NIH HHS/United States&#xD;R01 CA119388/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Photochemistry and photobiology&#xD;Photochem Photobiol. 2007 Sep-Oct;83(5):996-1005.</notes><urls></urls><custom1>CNPP - Harvard</custom1><custom4>2.473</custom4><electronic-resource-num>PHP166 [pii]&#xD;10.1111/j.1751-1097.2007.00166.x [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1079</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1079</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bartlett, D. W.</author><author>Su, H.</author><author>Hildebrandt, I. J.</author><author>Weber, W. A.</author><author>Davis, M. E.</author></authors></contributors><auth-address>Chemical Engineering, California Institute of Technology, 1200 East California Boulevard, MC 210-41, Pasadena, CA 91125, USA.</auth-address><titles><title>Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>15549-54</pages><volume>104</volume><number>39</number><edition>2007/09/19</edition><keywords><keyword>Animals</keyword><keyword>Chemistry, Pharmaceutical/methods</keyword><keyword>Cyclodextrins/*administration &amp; dosage/chemistry</keyword><keyword>Drug Carriers</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Heterocyclic Compounds, 1-Ring/chemistry</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mice, SCID</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neoplasms/*therapy</keyword><keyword>Positron-Emission Tomography/methods</keyword><keyword>RNA, Small Interfering/*metabolism</keyword><keyword>Technology, Pharmaceutical/methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep 25</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17875985</accession-num><abstract>Targeted delivery represents a promising approach for the development of safer and more effective therapeutics for oncology applications. Although macromolecules accumulate nonspecifically in tumors through the enhanced permeability and retention (EPR) effect, previous studies using nanoparticles to deliver chemotherapeutics or siRNA demonstrated that attachment of cell-specific targeting ligands to the surface of nanoparticles leads to enhanced potency relative to nontargeted formulations. Here, we use positron emission tomography (PET) and bioluminescent imaging to quantify the in vivo biodistribution and function of nanoparticles formed with cyclodextrin-containing polycations and siRNA. Conjugation of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid to the 5&apos; end of the siRNA molecules allows labeling with (64)Cu for PET imaging. Bioluminescent imaging of mice bearing luciferase-expressing Neuro2A s.c. tumors before and after PET imaging enables correlation of functional efficacy with biodistribution data. Although both nontargeted and transferrin-targeted siRNA nanoparticles exhibit similar biodistribution and tumor localization by PET, transferrin-targeted siRNA nanoparticles reduce tumor luciferase activity by approximately 50% relative to nontargeted siRNA nanoparticles 1 d after injection. Compartmental modeling is used to show that the primary advantage of targeted nanoparticles is associated with processes involved in cellular uptake in tumor cells rather than overall tumor localization. Optimization of internalization may therefore be key for the development of effective nanoparticle-based targeted therapeutics.</abstract><notes>Bartlett, Derek W&#xD;Su, Helen&#xD;Hildebrandt, Isabel J&#xD;Weber, Wolfgang A&#xD;Davis, Mark E&#xD;CA119347/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15549-54. Epub 2007 Sep 17.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17875985</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>10.228</custom4><electronic-resource-num>0707461104 [pii]&#xD;10.1073/pnas.0707461104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1171</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1171</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Desai, A.</author><author>Vyas, T.</author><author>Amiji, M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 110 Mugar Life Sciences Building, Boston, Massachusetts 02115.</auth-address><titles><title>Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulations</title><secondary-title>J Pharm Sci</secondary-title></titles><periodical><full-title>J Pharm Sci</full-title></periodical><pages>2745-56</pages><volume>97</volume><number>7</number><edition>2007/09/15</edition><dates><year>2007</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0022-3549 (Print)</isbn><accession-num>17854074</accession-num><abstract>The objective of this study was to examine augmentation of therapeutic activity in human glioblastoma cells with combination of paclitaxel (PTX) and the apoptotic signaling molecule, C(6)-ceramide (CER), when administered in novel oil-in-water nanoemulsions. The nanoemulsions were formulated with pine-nut oil, which has high concentrations of essential polyunsaturated fatty acid (PUFA). Drug-containing nanoemulsions were characterized for particle size, surface charge, and the particle morphology was examined with transmission electron microscopy (TEM). Epi-fluorescent microscopy was used to analyze nanoemulsion-encapsulated rhodamine-labeled PTX and NBD-labeled CER uptake and distribution in U-118 human glioblastoma cells. Cell viability was assessed with the MTS (formazan) assay, while apoptotic activity of PTX and CER was evaluated with caspase-3/7 activation and flow cytometry. Nanoemulsion formulations with the oil droplet size of approximately 200 nm in diameter were prepared with PTX, CER, and combination of the two agents. When administered to U-118 cells, significant enhancement in cytotoxicity was observed with combination of PTX and CER as compared to administration of individual agents. The increase in cytotoxicity correlated with enhancement in apoptotic activity in cells treated with combination of PTX and CER. The results of these studies show that oil-in-water nanoemulsions can be designed with combination therapy for enhancement of cytotoxic effect in brain tumor cells. In addition, PTX and CER can be used together to augment therapeutic activity, especially in aggressive tumor models such as glioblastoma. (c) 2007 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 97:2745-2756, 2008.</abstract><notes>Desai, Ankita&#xD;Vyas, Tushar&#xD;Amiji, Mansoor&#xD;United States&#xD;Journal of pharmaceutical sciences&#xD;J Pharm Sci. 2008 Jul;97(7):2745-56.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17854074</url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2008</custom3><custom4>3.144</custom4><electronic-resource-num>10.1002/jps.21182</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2229</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2229</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bagalkot, V.</author><author>Zhang, L.</author><author>Levy-Nissenbaum, E.</author><author>Jon, S.</author><author>Kantoff, P. W.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Laboratory of Nanomedicine and Biomaterials, Department of Anesthesiology, Brigham and Women&apos;s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.</auth-address><titles><title>Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>3065-70</pages><volume>7</volume><number>10</number><edition>2007/09/15</edition><keywords><keyword>Antineoplastic Agents/administration &amp; dosage</keyword><keyword>Aptamers, Nucleotide/ administration &amp; dosage</keyword><keyword>Cell Line, Tumor</keyword><keyword>Doxorubicin/ administration &amp; dosage</keyword><keyword>Drug Delivery Systems/ methods</keyword><keyword>Fluorescence Resonance Energy Transfer/ methods</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Prostatic Neoplasms/ drug therapy/metabolism/ pathology</keyword><keyword>Quantum Dots</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17854227</accession-num><abstract>We report a novel quantum dot (QD)-aptamer(Apt)-doxorubicin (Dox) conjugate [QD-Apt(Dox)] as a targeted cancer imaging, therapy, and sensing system. By functionalizing the surface of fluorescent QD with the A10 RNA aptamer, which recognizes the extracellular domain of the prostate specific membrane antigen (PSMA), we developed a targeted QD imaging system (QD-Apt) that is capable of differential uptake and imaging of prostate cancer cells that express the PSMA protein. The intercalation of Dox, a widely used antineoplastic anthracycline drug with fluorescent properties, in the double-stranded stem of the A10 aptamer results in a targeted QD-Apt(Dox) conjugate with reversible self-quenching properties based on a Bi-FRET mechanism. A donor-acceptor model fluorescence resonance energy transfer (FRET) between QD and Dox and a donor-quencher model FRET between Dox and aptamer result when Dox intercalated within the A10 aptamer. This simple multifunctional nanoparticle system can deliver Dox to the targeted prostate cancer cells and sense the delivery of Dox by activating the fluorescence of QD, which concurrently images the cancer cells. We demonstrate the specificity and sensitivity of this nanoparticle conjugate as a cancer imaging, therapy and sensing system in vitro.</abstract><notes>Bagalkot, Vaishali&#xD;Zhang, Liangfang&#xD;Levy-Nissenbaum, Etgar&#xD;Jon, Sangyong&#xD;Kantoff, Philip W&#xD;Langer, Robert&#xD;Farokhzad, Omid C&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;EB003647/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Oct;7(10):3065-70. Epub 2007 Sep 14.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom3>2007</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl071546n [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2064</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2064</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Niu, G.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University School of Medicine, 1201 Welch Rd, P095, Stanford, CA 94305-5484, USA. shawchen@stanford.edu</auth-address><titles><title>Multimodality imaging of the HER-kinase axis in cancer</title><secondary-title>Eur J Nucl Med Mol Imaging</secondary-title></titles><periodical><full-title>Eur J Nucl Med Mol Imaging</full-title></periodical><pages>186-208</pages><volume>35</volume><number>1</number><edition>2007/09/12</edition><keywords><keyword>Animals</keyword><keyword>Diagnostic Imaging/ methods</keyword><keyword>Enzyme Inhibitors/pharmacology/therapeutic use</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Neoplasms/diagnosis/drug therapy/ enzymology/genetics</keyword><keyword>Receptor, Epidermal Growth Factor/ analysis/antagonists &amp; inhibitors/metabolism</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1619-7089 (Electronic)</isbn><accession-num>17846765</accession-num><abstract>The human epidermal growth factor receptor (HER) family of receptor tyrosine kinases controls critical pathways involved in epithelial cell differentiation, growth, division, and motility. Alterations and disruptions in the function of the HER-kinase axis can lead to malignancy. Many therapeutic agents targeting the HER-kinase axis are approved for clinical use or are in preclinical/clinical development. The ability to quantitatively image the HER-kinase axis in a noninvasive manner can aid in lesion detection, patient stratification, new drug development/validation, dose optimization, and treatment monitoring. This review summarizes the current status in multimodality imaging of the HER-kinase axis using PET, SPECT, optical, and MR imaging. The targeting ligands used include small-molecule tyrosine kinase inhibitors, peptides, proteins, antibodies, and engineered antibody fragments. EGFR and HER2 imaging have been well documented in the past, and imaging of HER3, HER4, HER heterodimers, and HER-kinase mutants deserves significant research effort in the future. Successful development of new HER-kinase-targeted imaging agents with optimal in vivo stability, targeting efficacy, and desirable pharmacokinetics for clinical translation will enable maximum benefit in cancer patient management.</abstract><notes>Cai, Weibo&#xD;Niu, Gang&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;Germany&#xD;European journal of nuclear medicine and molecular imaging&#xD;Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):186-208. Epub 2007 Sep 11.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.625</custom4><electronic-resource-num>10.1007/s00259-007-0560-9 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1245</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1245</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hayashi, K.</author><author>Jiang, P.</author><author>Yamauchi, K.</author><author>Yamamoto, N.</author><author>Tsuchiya, H.</author><author>Tomita, K.</author><author>Moossa, A. R.</author><author>Bouvet, M.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer Inc, San Diego, CA 92111-3604, USA.</auth-address><titles><title>Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>8223-8</pages><volume>67</volume><number>17</number><edition>2007/09/07</edition><dates><year>2007</year><pub-dates><date>Sep 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17804736</accession-num><abstract>In the present report, we show real-time imaging of cancer cell trafficking in lymphatic vessels. Cancer cells labeled with both green fluorescent protein (GFP) in the nucleus and red fluorescent protein (RFP) in the cytoplasm or with GFP only or RFP only were injected into the inguinal lymph node of nude mice. The labeled cancer cells trafficked through lymphatic vessels where they were imaged via a skin flap in real time at the cellular level until they entered the axillary lymph node. The bright fluorescence of the cancer cells and the real-time microscopic imaging capability of the Olympus OV100 small-animal imaging system enabled imaging of the trafficking cancer cells in the lymphatics. Using this imaging strategy, two different cancer cell lines, one expressing GFP and the other expressing RFP, were simultaneously injected in the inguinal lymph node. Fluorescence imaging readily distinguished the two color-coded cell lines and their different abilities to survive in the lymphatic system. Using this imaging technology, we also investigated the role of pressure on tumor-cell shedding into lymphatic vessels. Pressure was generated by placing 25- and 250-g weights for 10 s on the bottom surface of a tumor-bearing footpad. Tumor cell fragments, single cells, and emboli shed from the footpad tumor were easily distinguished with the labeled cells and OV100 imaging system. Increasing pressure on the tumor increased the numbers of shed cells, fragments, and emboli. Pressure also deformed the shed emboli, increasing their maximum major axis. Imaging lymphatic trafficking of cancer cells can reveal critical steps of lymph node metastasis.</abstract><notes>Hayashi, Katsuhiro&#xD;Jiang, Ping&#xD;Yamauchi, Kensuke&#xD;Yamamoto, Norio&#xD;Tsuchiya, Hiroyuki&#xD;Tomita, Katsuro&#xD;Moossa, A R&#xD;Bouvet, Michael&#xD;Hoffman, Robert M&#xD;Ca099258/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2007 Sep 1;67(17):8223-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17804736</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2008</custom3><custom4>7.980</custom4><electronic-resource-num>67/17/8223 [pii]&#xD;10.1158/0008-5472.CAN-07-1237</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1080</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1080</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bashir, A.</author><author>Liu, Y. T.</author><author>Raphael, B.</author><author>Carson, D.</author><author>Bafna, V.</author></authors></contributors><auth-address>Bioinformatics Program, University of California, San Dego, Department of Computer Science and Engineering, University of California, San Dego, Moores Cancer Center, University of California, San Diego, Department of Computer Science &amp; Center for Computational Molecular Biology, Brown University.</auth-address><titles><title>Optimization of primer design for the detection of variable genomic lesions in cancer</title><secondary-title>Bioinformatics</secondary-title></titles><periodical><full-title>Bioinformatics</full-title></periodical><edition>2007/09/04</edition><dates><year>2007</year><pub-dates><date>Aug 30</date></pub-dates></dates><isbn>1460-2059 (Electronic)</isbn><accession-num>17766270</accession-num><abstract>Primer approximation multiplex PCR (PAMP) is a new experimental protocol for efficiently assaying structural variation in genomes. PAMP is particularly suited to cancer genomes where the precise breakpoints of alterations such as deletions or translocations vary between patients. The design of PCR primer sets for PAMP is challenging because a large number of primer pairs are required to detect alterations in the hundreds of kilobases range that can occur in cancer. These sets of primers must achieve high coverage of the region of interest, while avoiding primer dimers and satisfying the physicochemical constraints of good PCR primers. We describe a natural formulation of these constraints as a combinatorial optimization problem. We show that the PAMP primer design problem is NP-hard, and design algorithms based on simulated annealing and integer programming, that provide good solutions to this problem in practice. The algorithms are applied to a test region around the known CDKN2A deletion, which show excellent results even in a 1:49 mixture of mutated:wild-type cells. We use these test results to help set design parameters for larger problems. We can achieve near-optimal designs for regions close to 1Mb.</abstract><notes>Journal article&#xD;Bioinformatics. 2007 Aug 30;.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17766270</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>5.039</custom4><electronic-resource-num>btm390 [pii]&#xD;10.1093/bioinformatics/btm390</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1173</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1173</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Deshpande, V.S.</author><author>Mrksichb, M.</author><author>McMeeking, R.M.</author><author>Evans, A.G.</author></authors></contributors><titles><title>A bio-mechanical model for coupling cell contractility with focal adhesion formation</title><secondary-title>Journal of the Mechanics and Physics of Solids</secondary-title></titles><periodical><full-title>Journal of the Mechanics and Physics of Solids</full-title></periodical><pages>1484-1510</pages><volume>56</volume><number>4</number><edition>2007/09/01</edition><keywords><keyword>Mechano-sensitivity</keyword><keyword>Self-assembly</keyword><keyword>Focal adhesions</keyword><keyword>Stress fibers</keyword><keyword>Myosin</keyword></keywords><dates><year>2008</year><pub-dates><date>04/2008</date></pub-dates></dates><abstract>Focal adhesions (FAs) are large, multi-protein complexes that provide a mechanical link between the cytoskeletal contractile machinery and the extracellular matrix. They exhibit mechanosensitive properties; they self-assemble upon application of pulling forces and dissociate when these forces are decreased. We rationalize this mechano-sensitivity from thermodynamic considerations and develop a continuum framework in which the cytoskeletal contractile forces generated by stress fibers drive the assembly of the FA multi-protein complexes. The FA model has three essential features: (i) the low and high affinity integrins co-exist in thermodynamic equilibrium, (ii) the low affinity integrins within the plasma membrane are mobile, and (iii) the contractile forces generated by the stress fibers are in mechanical equilibrium and change the free energies of the integrins. A general two-dimensional framework is presented and the essential features of the model illustrated using one-dimensional examples. Consistent with observations, the coupled stress fiber and FA model predict that (a) the FAs concentrate around the periphery of the cell; (b) the fraction of the cell covered by FAs increases with decreasing cell size while the total FA intensity increases with increasing cell size; and (c) the FA intensity decreases substantially when cell contractility is curtailed.</abstract><urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>3.542</custom4><electronic-resource-num>10.1016/j.jmps.2007.08.006</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1657</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1657</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thurn, K.</author><author>Brown, E.</author><author>Wu, A. </author><author>Vogt, S. </author><author>Lai, B. </author><author>Maser, J.</author><author>Paunesku, T.</author><author>Woloschak, G.</author></authors></contributors><titles><title>Nanoparticles for Applications in Cellular Imaging</title><secondary-title>Nanoscale Research Letters</secondary-title></titles><periodical><full-title>Nanoscale Research Letters</full-title></periodical><pages>430-441</pages><volume>2</volume><number>9</number><edition>2007/09</edition><keywords><keyword>Nanoparticle</keyword><keyword>Cellular uptake</keyword><keyword>Quantum dots</keyword><keyword>Titanium dioxide</keyword></keywords><dates><year>2007</year><pub-dates><date>September 2007</date></pub-dates></dates><abstract>In the following review we discuss several types of nanoparticles (such as TiO2, quantum dots, and gold nanoparticles) and their impact on the ability to image biological components in fixed cells. The review also discusses factors influencing nanoparticle imaging and uptake in live cells in vitro. Due to their unique size-dependent properties nanoparticles offer numerous advantages over traditional dyes and proteins. For example, the photostability, narrow emission peak, and ability to rationally modify both the size and surface chemistry of Quantum Dots allow for simultaneous analyses of multiple targets within the same cell. On the other hand, the surface characteristics of nanometer sized TiO2 allow efficient conjugation to nucleic acids which enables their retention in specific subcellular compartments. We discuss cellular uptake mechanisms for the internalization of nanoparticles and studies showing the influence of nanoparticle size and charge and the cell type targeted on nanoparticle uptake. The predominant nanoparticle uptake mechanisms include clathrin-dependent mechanisms, macropinocytosis, and phagocytosis.</abstract><notes>[1]&#xD;[2]&#xD;[3]&#xD;[4]&#xD;doi:10.1007/s11671-007-9081-5</notes><urls><related-urls><url>http://www.ingentaconnect.com/content/klu/11671/2007/00000002/00000009/00009081</url><url>http://dx.doi.org/10.1007/s11671-007-9081-5</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>na</custom4><electronic-resource-num>10.1007/s11671-007-9081-5</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1480</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1480</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ohulchanskyy, T. Y.</author><author>Roy, I.</author><author>Goswami, L. N.</author><author>Chen, Y.</author><author>Bergey, E. J.</author><author>Pandey, R. K.</author><author>Oseroff, A. R.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute of Lasers, Photonics and Biophotonics, Department of Chemistry, State University of New York, Buffalo, New York, and PDT Center, Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, New York.</auth-address><titles><title>Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer</title><secondary-title>Nano Lett</secondary-title><alt-title>Nano letters</alt-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><alt-periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></alt-periodical><pages>2835-42</pages><volume>7</volume><number>9</number><edition>2007/09</edition><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17718587</accession-num><abstract>We report a novel nanoformulation of a photosensitizer (PS), for photodynamic therapy (PDT) of cancer, where the PS molecules are covalently incorporated into organically modified silica (ORMOSIL) nanoparticles. We found that the covalently incorporated PS molecules retained their spectroscopic and functional properties and could robustly generate cytotoxic singlet oxygen molecules upon photoirradiation. The synthesized nanoparticles are of ultralow size ( approximately 20 nm) and are highly monodispersed and stable in aqueous suspension. The advantage offered by this covalently linked nanofabrication is that the drug is not released during systemic circulation, which is often a problem with physical encapsulation. These nanoparticles are also avidly uptaken by tumor cells in vitro and demonstrate phototoxic action, thereby highlighting their potential in diagnosis and PDT of cancer.</abstract><notes>Journal Article&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17718587 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom2>Yes- Prasad and Oseroff CNPPs</custom2><custom3>2007</custom3><custom4>12.189</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1379</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1379</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J. H.</author><author>Chung, S.</author><author>Kim, S. J.</author><author>Han, J.</author></authors></contributors><auth-address>Department of Electrical Engineering and Computer Science, and Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139.</auth-address><titles><title>Poly(dimethylsiloxane)-Based Protein Preconcentration Using a Nanogap Generated by Junction Gap Breakdown</title><secondary-title>Anal Chem</secondary-title><alt-title>Analytical chemistry</alt-title></titles><periodical><full-title>Anal Chem</full-title></periodical><alt-periodical><full-title>Analytical Chemistry</full-title></alt-periodical><pages>6868-73</pages><volume>79</volume><number>17</number><edition>2007/09</edition><dates><year>2007</year><pub-dates><date>Sep 1</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>17628080</accession-num><abstract>Simple and efficient sample concentration tools are the key to the application of proteomics in a biological system. In this paper, we developed a method to realize a nanofluidic preconcentrator on a poly(dimethylsiloxane) (PDMS)-based microfluidic channel. The originality of our preconcentration device is the simple nanogap formation using the junction gap breakdown phenomenon between two PDMS microchannels, without using any photolithography and etching techniques. From the dc current measurement, we confirm that the nanogap formed between two microchannel junctions with approximately 80 nm depth. Using this device, we achieve the concentration volume of beta-phycoerythrin protein as high as 70 pL, which is 120-fold larger than that from our previous reports, with a concentration factor as high as 104 within 1 h. Also we show the availability of protein preconcentration under several different buffers (phosphate, acetate) at several different pH values (pH 5 to pH 9).</abstract><notes>Journal Article&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17628080 </url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2008</custom3><custom4>5.918</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1338</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1338</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Klejbor, I.</author><author>Stachowiak, E. K.</author><author>Bharali, D. J.</author><author>Roy, I.</author><author>Spodnik, I.</author><author>Morys, J.</author><author>Bergey, E. J.</author><author>Prasad, P. N.</author><author>Stachowiak, M. K.</author></authors></contributors><auth-address>Institute of Lasers, Photonics and Biophotonics, Department of Chemistry, 458 NSC, State University of New York, Buffalo, NY 14260, USA; Molecular and Structural Neurobiology and Gene Therapy Program, Department of Pathology and Anatomical Sciences, State University of New York, Buffalo, NY 14214, USA; Department of Anatomy and Neurobiology, Gdansk Medical School, Poland.</auth-address><titles><title>ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology</title><secondary-title>J Neurosci Methods</secondary-title></titles><periodical><full-title>J Neurosci Methods</full-title></periodical><pages>230-243</pages><volume>165</volume><number>2</number><edition>2007/09</edition><dates><year>2007</year><pub-dates><date>Sep 30</date></pub-dates></dates><isbn>0165-0270 (Print)</isbn><accession-num>17655935</accession-num><abstract>Studies have shown the presence of expanded polyQ containing proteins in brain cells related to Huntington disease (HD) and other poly-glutamine disorders. We report the use of organically modified silica (ORMOSIL) nanoparticles as an efficient non-viral gene carrier in an effort to model brain pathology associated with those disorders induced by expanded polyQ peptides. In experiment 1, plasmids expressing Hemaglutinin-tagged polypeptides with 20 glutamine repeats (Q20) or with extended 127-glutamine repeats (Q127) were complexed with ORMOSIL nanoparticles and injected twice (2 weeks apart) into the lateral ventricle of the mouse brain. Fourteen days post-injection of Q127, immunocytochemistry revealed the presence of the characteristic nuclear and cytoplasmic Q127 aggregates in numerous striatal, septal and neocortical neuronal cells as well as ubiquitin-containing aggregates indicative of the neuronal pathology. The mice receiving Q127 showed a marked increase in the reactive GFAP (+) astrocytes in striatum, septum and brain cortex, further indicating the neurodegenerative changes, accompanied by motor impairments. In experiment 2, plasmids Q20 or Q127 were complexed with ORMOSIL and were injected into the brain lateral ventricle or directly into the striatum of adult rats. In both routes of transfection, Q127 induced the appearance of reactive GFAP (+) astrocytes and activated ED1 antigen expressing microglia. An increase in the size of the lateral ventricle was also observed in rats receiving Q127. In transgenic mouse polyQ models, extensive pathologies occur outside the nervous system and the observed brain pathologies could reflect developmental effects of the toxic polyQ proteins. Our experiments show that the nervous tissue restricted expression of poly Q-extended peptides in adult brain is sufficient to evoke neuropathologies associated with HD and other polyQ disorders. Thus, nanotechnology can be employed to model pathological and behavioral aspects of genetic brain diseases in mice as well as in other species, providing a novel research tool for in vivo testing of single or multi-gene therapies.</abstract><notes>Journal article</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17655935 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2008</custom3><custom4>2.372</custom4><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1701</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1701</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, S. H.</author><author>Shi, X.</author><author>VanAntwerp, M.</author><author>Cao, Z.</author><author>Swanson, S. D.</author><author>Bi, X.</author><author>Baker, Jr., J. R.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109 (USA); Department of Radiology, Medical School, University of Michigan, Ann Arbor, MI 48109 (USA)</auth-address><titles><title>Dendrimer-Functionalized Iron Oxide Nanoparticles for Specific Targeting and Imaging of Cancer Cells</title><secondary-title>Advanced Functional Materials</secondary-title></titles><periodical><full-title>Advanced Functional Materials</full-title></periodical><pages>3043-3050</pages><volume>17</volume><number>16</number><edition>2007/08/31</edition><keywords><keyword>Dendrimers</keyword><keyword>Iron oxides</keyword><keyword>Layer-by-layer assembly</keyword></keywords><dates><year>2007</year><pub-dates><date>November 2007</date></pub-dates></dates><isbn>1616-3028</isbn><abstract>We demonstrated a unique approach that combines a layer-by-layer (LbL) self-assembly method with dendrimer chemistry tofunctionalize Fe3O4 nanoparticles (NPs) for specific targeting and imaging of cancer cells. In this approach, positively charged Fe3O4 NPs (8.4nm in diameter) synthesized by controlled co-precipitation of FeII and FeIII ions were modified with a bilayer composed of polystyrene sulfonate sodium salt and folic acid (FA)- and fluorescein isothiocyanate (FI)-functionalized poly(amidoamine) dendrimers of generation 5 (G5.NH2-FI-FA) through electrostatic LbL assembly, followed by an acetylation reaction to neutralize the remaining surface amine groups of G5 dendrimers. Combined flow cytometry, confocal microscopy, transmission electron microscopy, and magnetic resonance imaging studies show that Fe3O4/PSS/G5.NHAc-FI-FA NPs can specifically target cancer cells overexpressing FA receptors. The present approach to functionalizing Fe3O4 NPs opens a new avenue to fabricating various NPs for numerous biological sensing and therapeutic applications.</abstract><notes>10.1002/adfm.200601139</notes><urls><related-urls><url>http://dx.doi.org/10.1002/adfm.200601139</url></related-urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom3>2008</custom3><custom4>8.203</custom4><electronic-resource-num>10.1002/adfm.200601139</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1570</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1570</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sharma, P. K.</author><author>Reilly, M. J.</author><author>Jones, D. N.</author><author>Robinson, P. M.</author><author>Bhatia, S. R.</author></authors></contributors><auth-address>Department of Chemical Engineering, 159 Goessmann Laboratory, University of Massachusetts, Amherst, MA 01003-9303, USA.</auth-address><titles><title>The effect of pharmaceuticals on the nanoscale structure of PEO-PPO-PEO micelles</title><secondary-title>Colloids Surf B Biointerfaces</secondary-title></titles><periodical><full-title>Colloids Surf B Biointerfaces</full-title></periodical><pages>53-60</pages><volume>61</volume><number>1</number><edition>2007/08/31</edition><keywords><keyword>Hydrophobicity</keyword><keyword>Light</keyword><keyword>*Micelles</keyword><keyword>Neutron Diffraction</keyword><keyword>*Pharmaceutical Preparations/administration &amp; dosage</keyword><keyword>Poloxamer/*chemistry</keyword><keyword>Research Design</keyword><keyword>Scattering, Radiation</keyword><keyword>Scattering, Small Angle</keyword><keyword>Solubility</keyword><keyword>Spectrophotometry, Ultraviolet</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 15</date></pub-dates></dates><isbn>0927-7765 (Print)</isbn><accession-num>17728116</accession-num><abstract>We present results on the effects of various hydrophobic drugs and additives on the micellar structure of Pluronic F127 solutions. Small-angle neutron scattering experiments on 5wt% F127 solutions were used to measure micelle core size (R(1)), micelle corona size (R(2)), intermicellar interaction distance (R(int)), polydispersity (sigma), and aggregation number (N(agg)); dynamic light scattering was used to measure critical micelle concentration (CMC); and ultraviolet spectroscopy was used to measure drug solubility and apparent micelle-water partition coefficient (K(mw)). The core and corona size were found to generally increase in the presence of the drugs, as did R(int). Both sigma and N(agg) were found to decrease in the presence of most of the drugs, and the CMC was found to vary considerably with no clear correlation. A design of experiments (DOE) approach was used to analyze the results and build empirical correlations. All of the parameters from the SANS experiments were found to depend strongly on drug solubility, with a weak dependence on K(mw) in most cases. The aggregation number, however, was found to depend strongly on both K(mw) and solubility. The correlations can be used to roughly predict the structural parameters of F127 micelles for other hydrophobic drugs.</abstract><notes>Sharma, Praveen K&#xD;Reilly, Meghan J&#xD;Jones, Deanna N&#xD;Robinson, Paul M&#xD;Bhatia, Surita R&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Netherlands&#xD;Colloids and surfaces. B, Biointerfaces&#xD;Colloids Surf B Biointerfaces. 2008 Jan 15;61(1):53-60. Epub 2007 Jul 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17728116</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>2.109</custom4><electronic-resource-num>S0927-7765(07)00282-2 [pii]&#xD;10.1016/j.colsurfb.2007.07.002</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1426</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1426</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Major, J. L.</author><author>Parigi, G.</author><author>Luchinat, C.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208, USA.</auth-address><titles><title>The synthesis and in vitro testing of a zinc-activated MRI contrast agent</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>13881-6</pages><volume>104</volume><number>35</number><edition>2007/08/29</edition><dates><year>2007</year><pub-dates><date>Aug 28</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17724345</accession-num><abstract>Zinc(II) plays a vital role in normal cellular function as an essential component of numerous enzymes, transcription factors, and synaptic vesicles. While zinc can be linked to a variety of physiological processes, the mechanisms of its cellular actions are less discernible. Here, we have synthesized and tested a Zn(II)-activated magnetic resonance imaging (MRI) contrast agent in which the coordination geometry of the complex rearranges upon binding of Zn(II). In the absence of Zn(II) water is restricted from binding to a chelated Gd(III) ion by coordinating acetate arms resulting in a low relaxivity of 2.33 mM(-1) x s(-1) at 60 MHz. Upon addition of Zn(II) the relaxivity of the Gd(III)-Zn(II) complex increases to 5.07 mM(-1) x s(-1) and is consistent with one water molecule bound to Gd(III). These results were confirmed by nuclear magnetic relaxation dispersion analysis. There was no observed change in relaxivity of the Gd(III) complex when physiologically competing cations Ca(II) and Mg(II) were added. A competitive binding assay gave a dissociation constant of 2.38 x 10(-4) M for the Gd(III)-Zn(II) complex. In vitro magnetic resonance images confirm that Zn(II) concentrations as low as 100 microM can be detected by using this contrast agent.</abstract><notes>Major, Jody L&#xD;Parigi, Giacomo&#xD;Luchinat, Claudio&#xD;Meade, Thomas J&#xD;1 r01 eb005866-01/eb/nibib&#xD;5 u54 ca90810/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):13881-6. Epub 2007 Aug 27.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17724345</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>10.228</custom4><electronic-resource-num>0706247104 [pii]&#xD;10.1073/pnas.0706247104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1294</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1294</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jaffer, F. A.</author><author>Libby, P.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. fjaffer@mgh.harvard.edu</auth-address><titles><title>Molecular imaging of cardiovascular disease</title><secondary-title>Circulation</secondary-title></titles><periodical><full-title>Circulation</full-title></periodical><pages>1052-61</pages><volume>116</volume><number>9</number><edition>2007/08/29</edition><keywords><keyword>Atherosclerosis/pathology/radionuclide imaging</keyword><keyword>Cardiovascular Diseases/pathology/*radionuclide imaging</keyword><keyword>Clinical Trials as Topic</keyword><keyword>Contrast Media/adverse effects</keyword><keyword>Coronary Disease/pathology/radionuclide imaging</keyword><keyword>Humans</keyword><keyword>Macrophages/pathology/radionuclide imaging</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Myocardial Infarction/chemically induced/pathology</keyword><keyword>Positron-Emission Tomography/adverse effects</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Thrombosis/pathology/radionuclide imaging</keyword><keyword>Tomography, Emission-Computed, Single-Photon/adverse effects</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 28</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>17724271</accession-num><notes>Jaffer, Farouc A&#xD;Libby, Peter&#xD;Weissleder, Ralph&#xD;R01-HL078641/HL/United States NHLBI&#xD;U01-HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Circulation&#xD;Circulation. 2007 Aug 28;116(9):1052-61.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17724271</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>13.538</custom4><electronic-resource-num>116/9/1052 [pii]&#xD;10.1161/CIRCULATIONAHA.106.647164</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2375</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2375</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>D&apos;Annibale, F.</author><author>Magrini, A.</author><author>Cerignoli, F.</author><author>Arimura, Y.</author><author>Dawson, M. I.</author><author>Bergamaschi, E.</author><author>Rosato, N.</author><author>Bergamaschi, A.</author><author>Mustelin, T.</author></authors></contributors><auth-address>Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA. mbottini@burnham.org</auth-address><titles><title>Quantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytes</title><secondary-title>Int J Nanomedicine</secondary-title></titles><periodical><full-title>Int J Nanomedicine</full-title></periodical><pages>227-33</pages><volume>2</volume><number>2</number><edition>2007/08/29</edition><keywords><keyword>Animals</keyword><keyword>Avidin/ chemistry/immunology</keyword><keyword>Cells, Cultured</keyword><keyword>Drug Delivery Systems/ methods</keyword><keyword>Endocytosis/ physiology</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence/ methods</keyword><keyword>Molecular Probe Techniques</keyword><keyword>Nanoparticles/chemistry/ultrastructure</keyword><keyword>Quantum Dots</keyword><keyword>Silicon Dioxide/chemistry</keyword><keyword>Spectrometry, Fluorescence/methods</keyword><keyword>T-Lymphocytes/cytology/ immunology</keyword></keywords><dates><year>2007</year></dates><isbn>1176-9114 (Print)</isbn><accession-num>17722550</accession-num><abstract>To enhance diagnostic or therapeutic efficacy, novel nanomaterials must be engineered to function in biologically relevant environments, be visible by conventional fluorescent microscopy, and have multivalent loading capacity for easy detection or effective drug delivery. Here we report the fabrication of silica nanoparticles doped with quantum dots and superficially functionalized with amino and phosphonate groups. The amino groups were acylated with a water-soluble biotin-labeling reagent. The biotinylated nanoparticles were subsequently decorated with neutravidin by exploiting the strong affinity between neutravidin and biotin. The resultant neutravidin-decorated fluorescent silica nanoparticles stably dispersed under physiological conditions, were visible by conventional optical and confocal fluorescent microscopy, and could be further functionalized with macromolecules, nucleic acids, and polymers. We also coated the surface of the nanoparticles with biotinylated mouse anti-human CD3 (alphaCD3). The resultant fluorescent nanoassembly was taken up by Jurkat T cells through receptor-mediated endocytosis and was partially released to lysosomes. Thus, quantum dot-doped silica nanoparticles decorated with neutravidin represent a potentially excellent scaffold for constructing specific intracellular nanoprobes and transporters.</abstract><notes>Bottini, Massimo&#xD;D&apos;Annibale, Federica&#xD;Magrini, Andrea&#xD;Cerignoli, Fabio&#xD;Arimura, Yutaka&#xD;Dawson, Marcia I&#xD;Bergamaschi, Enrico&#xD;Rosato, Nicola&#xD;Bergamaschi, Antonio&#xD;Mustelin, Tomas&#xD;U54 CA119335-02/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;New Zealand&#xD;International journal of nanomedicine&#xD;Int J Nanomedicine. 2007;2(2):227-33.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom2>2673975</custom2><custom4>1.649</custom4><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1741</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1741</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xing, Y.</author><author>Smith, A. M.</author><author>Agrawal, A.</author><author>Ruan, G.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical, Engineering and Chemistry, Emory University and Georgia Institute of Technology, Atlanta, GA 30322, USA.</auth-address><titles><title>Molecular profiling of single cancer cells and clinical tissue specimens with semiconductor quantum dots</title><secondary-title>Int J Nanomedicine</secondary-title></titles><periodical><full-title>Int J Nanomedicine</full-title></periodical><pages>473-81</pages><volume>1</volume><number>4</number><edition>2007/08/28</edition><keywords><keyword>Animals</keyword><keyword>Humans</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>Molecular Probe Techniques</keyword><keyword>Neoplasm Proteins/*metabolism</keyword><keyword>Neoplasms/*metabolism/*pathology</keyword><keyword>*Quantum Dots</keyword><keyword>Semiconductors</keyword><keyword>Spectrometry, Fluorescence/*methods</keyword><keyword>Tumor Markers, Biological/*metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1176-9114 (Print)</isbn><accession-num>17722280</accession-num><abstract>Semiconductor quantum dots (QDs) are a new class of fluorescent labels with broad applications in biomedical imaging, disease diagnostics, and molecular and cell biology. In comparison with organic dyes and fluorescent proteins, quantum dots have unique optical and electronic properties such as size-tunable light emission, improved signal brightness, resistance against photobleaching, and simultaneous excitation of multiple fluorescence colors. Recent advances have led to multifunctional nanoparticle probes that are highly bright and stable under complex in vitro and in vivo conditions. New designs involve encapsulating luminescent QDs with amphiphilic block copolymers, and linking the polymer coating to tumor-targeting ligands and drug-delivery functionalities. These improved QDs have opened new possibilities for real-time imaging and tracking of molecular targets in living cells, for multiplexed analysis of biomolecular markers in clinical tissue specimens, and for ultrasensitive imaging of malignant tumors in living animal models. In this article, we briefly discuss recent developments in bioaffinity QD probes and their applications in molecular profiling of individual cancer cells and clinical tissue specimens.</abstract><notes>Xing, Yun&#xD;Smith, Andrew M&#xD;Agrawal, Amit&#xD;Ruan, Gang&#xD;Nie, Shuming&#xD;P20 gm072069/gm/nigms&#xD;R01 ca108468-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;New Zealand&#xD;International journal of nanomedicine&#xD;Int J Nanomedicine. 2006;1(4):473-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17722280</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>1.649</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1467</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1467</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nakano, I.</author><author>Masterman-Smith, M.</author><author>Saigusa, K.</author><author>Paucar, A. A.</author><author>Horvath, S.</author><author>Shoemaker, L.</author><author>Watanabe, M.</author><author>Negro, A.</author><author>Bajpai, R.</author><author>Howes, A.</author><author>Lelievre, V.</author><author>Waschek, J. A.</author><author>Lazareff, J. A.</author><author>Freije, W. A.</author><author>Liau, L. M.</author><author>Gilbertson, R. J.</author><author>Cloughesy, T. F.</author><author>Geschwind, D. H.</author><author>Nelson, S. F.</author><author>Mischel, P. S.</author><author>Terskikh, A. V.</author><author>Kornblum, H. I.</author></authors></contributors><auth-address>Department of Neurosurgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.</auth-address><titles><title>Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells</title><secondary-title>J Neurosci Res</secondary-title></titles><periodical><full-title>J Neurosci Res</full-title></periodical><pages>48-60</pages><volume>86</volume><number>1</number><edition>2007/08/28</edition><keywords><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Animals</keyword><keyword>Brain Neoplasms/*pathology</keyword><keyword>*Cell Proliferation</keyword><keyword>Cells, Cultured</keyword><keyword>Female</keyword><keyword>Flow Cytometry/methods</keyword><keyword>Gene Expression Regulation, Neoplastic/drug effects</keyword><keyword>Glioblastoma/*pathology</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Mass Spectrometry/methods</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Middle Aged</keyword><keyword>Neoplastic Stem Cells/*physiology</keyword><keyword>Pituitary Adenylate Cyclase-Activating Polypeptide/deficiency</keyword><keyword>Protein-Serine-Threonine Kinases/*physiology</keyword><keyword>RNA, Small Interfering/pharmacology</keyword><keyword>Receptors, Cell Surface/deficiency</keyword><keyword>Transfection/methods</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0360-4012 (Print)</isbn><accession-num>17722061</accession-num><abstract>Emerging evidence suggests that neural stem cells and brain tumors regulate their proliferation via similar pathways. In a previous study, we demonstrated that maternal embryonic leucine zipper kinase (Melk) is highly expressed in murine neural stem cells and regulates their proliferation. Here we describe how MELK expression is correlated with pathologic grade of brain tumors, and its expression levels are significantly correlated with shorter survival, particularly in younger glioblastoma patients. In normal human astrocytes, MELK is only faintly expressed, and MELK knockdown does not significantly influence their growth, whereas Ras and Akt overexpressing astrocytes have up-regulated MELK expression, and the effect of MELK knockdown is more prominent in these transformed astrocytes. In primary cultures from human glioblastoma and medulloblastoma, MELK knockdown by siRNA results in inhibition of the proliferation and survival of these tumors. Furthermore, we show that MELK siRNA dramatically inhibits proliferation and, to some extent, survival of stem cells isolated from glioblastoma in vitro. These results demonstrate a critical role for MELK in the proliferation of brain tumors, including their stem cells, and suggest that MELK may be a compelling molecular target for treatment of high-grade brain tumors.</abstract><notes>Nakano, Ichiro&#xD;Masterman-Smith, Michael&#xD;Saigusa, Kuniyasu&#xD;Paucar, Andres A&#xD;Horvath, Steve&#xD;Shoemaker, Lorelei&#xD;Watanabe, Momoko&#xD;Negro, Alejandra&#xD;Bajpai, Ruchi&#xD;Howes, Amy&#xD;Lelievre, Vincent&#xD;Waschek, James A&#xD;Lazareff, Jorge A&#xD;Freije, William A&#xD;Liau, Linda M&#xD;Gilbertson, Richard J&#xD;Cloughesy, Timothy F&#xD;Geschwind, Daniel H&#xD;Nelson, Stanley F&#xD;Mischel, Paul S&#xD;Terskikh, Alexey V&#xD;Kornblum, Harley I&#xD;CA108633/CA/United States NCI&#xD;CA110384/CA/United States NCI&#xD;CA88173/CA/United States NCI&#xD;HD34475/HD/United States NICHD&#xD;NS050151/NS/United States NINDS&#xD;NS43147/NS/United States NINDS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of neuroscience research&#xD;J Neurosci Res. 2008 Jan;86(1):48-60.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17722061</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2008</custom3><custom4>3.403</custom4><electronic-resource-num>10.1002/jnr.21471</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1390</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1390</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Leung, A. K.</author><author>Sharp, P. A.</author></authors></contributors><auth-address>Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>microRNAs: a safeguard against turmoil?</title><secondary-title>Cell</secondary-title></titles><periodical><full-title>Cell</full-title></periodical><pages>581-5</pages><volume>130</volume><number>4</number><edition>2007/08/28</edition><keywords><keyword>Animals</keyword><keyword>Humans</keyword><keyword>MicroRNAs/*genetics</keyword><keyword>Models, Biological</keyword><keyword>*Stress</keyword><keyword>Transcription, Genetic</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 24</date></pub-dates></dates><isbn>0092-8674 (Print)</isbn><accession-num>17719533</accession-num><abstract>Emerging data suggest that microRNAs (miRNAs) are instrumental in a variety of stress responses in addition to their more recognized role in development. Surprisingly, miRNAs, which normally suppress expression of target transcripts, may become activators of expression during stress. This might be partially explained by new interactions of miRNA/Argonaute complexes with RNA-binding proteins that relocate from different subcellular compartments during stress.</abstract><notes>Leung, Anthony K L&#xD;Sharp, Phillip A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cell&#xD;Cell. 2007 Aug 24;130(4):581-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17719533</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>30.149</custom4><electronic-resource-num>S0092-8674(07)01032-X [pii]&#xD;10.1016/j.cell.2007.08.010</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1442</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1442</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCarthy, J. R.</author><author>Kelly, K. A.</author><author>Sun, E. Y.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Harvard Medical School and Massachusetts General Hospital, 149 13th St, Rm 5406, Charlestown, MA 02129, USA. jason_mccarthy@hms.harvard.edu</auth-address><titles><title>Targeted delivery of multifunctional magnetic nanoparticles</title><secondary-title>Nanomed</secondary-title></titles><periodical><full-title>Nanomed</full-title></periodical><pages>153-67</pages><volume>2</volume><number>2</number><edition>2007/08/25</edition><keywords><keyword>Contrast Media/*chemistry</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Magnetics/*diagnostic use/*therapeutic use</keyword><keyword>Nanomedicine/*trends</keyword><keyword>Nanoparticles/*chemistry/*diagnostic use/*therapeutic use</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>17716118</accession-num><abstract>Magnetic nanoparticles and their magnetofluorescent analogues have become important tools for in vivo imaging using magnetic resonance imaging and fluorescent optical methods. A number of monodisperse magnetic nanoparticle preparations have been developed over the last decade for angiogenesis imaging, cancer staging, tracking of immune cells (monocyte/macrophage, T cells) and for molecular and cellular targeting. Phage display and data mining have enabled the procurement of novel tissue- or receptor-specific peptides, while high-throughput screening of diversity-oriented synthesis libraries has identified small molecules that permit or prevent uptake by specific cell types. Next-generation magnetic nanoparticles are expected to be truly multifunctional, incorporating therapeutic functionalities and further enhancing an already diverse repertoire of capabilities.</abstract><notes>McCarthy, Jason R&#xD;Kelly, Kimberly A&#xD;Sun, Eric Y&#xD;Weissleder, Ralph&#xD;U54-ca119349/ca/nci&#xD;U54-ca126515/ca/nci&#xD;Uo1-hl080731/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2007 Apr;2(2):153-67.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17716118</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>6.093</custom4><electronic-resource-num>10.2217/17435889.2.2.153</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1436</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1436</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Marsh, J. N.</author><author>Senpan, A.</author><author>Hu, G.</author><author>Scott, M. J.</author><author>Gaffney, P. J.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Washington University School of Medicine, Cardiovascular Division, St Louis, MO 63108, USA. jnm@cvu.wustl.edu</auth-address><titles><title>Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis</title><secondary-title>Nanomed</secondary-title></titles><periodical><full-title>Nanomed</full-title></periodical><pages>533-43</pages><volume>2</volume><number>4</number><edition>2007/08/25</edition><keywords><keyword>Blood Coagulation/*drug effects/physiology</keyword><keyword>Drug Carriers/chemistry</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Fibrin/*drug effects</keyword><keyword>Fibrinolytic Agents/administration &amp; dosage/chemistry</keyword><keyword>Fluorocarbons/*chemistry</keyword><keyword>Humans</keyword><keyword>Nanoparticles/*chemistry/ultrastructure</keyword><keyword>Particle Size</keyword><keyword>Streptokinase/*administration &amp; dosage/chemistry</keyword><keyword>Thrombolytic Therapy/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>17716136</accession-num><abstract>BACKGROUND: Reperfusion of the ischemic brain is the most effective therapy for acute stroke, restoring blood flow to threatened tissues. Thrombolytics, such as recombinant tissue plasminogen activator, administered within 3 h of symptom onset can improve neurologic outcome, although the potential for adverse hemorrhagic events limits its use to less than 3% of acute ischemic stroke patients. Targeting of clot-dissolving therapeutics has the potential to decrease the frequency of complications while simultaneously increasing treatment effectiveness, by concentrating the available drug at the desired site and permitting a lower systemic dose. OBJECTIVES: We aimed to develop a fibrin-specific, liquid perfluorocarbon nanoparticle that is surface modified to deliver the plasminogen activator streptokinase. We also aimed to evaluate its effectiveness for targeted thrombolysis in vitro using quantitative acoustic microscopy. METHODS: Human plasma clots were formed in vitro and targeted with streptokinase-loaded nanoparticles, control nanoparticles or a mixture of both. Depending on the treatment group, clots were then exposed to either phosphate-buffered saline (PBS), PBS with plasminogen or PBS with plasminogen and free streptokinase. Spatially registered ultrasound scans were performed at 15-min intervals for 1 h to quantify changes in clot morphology and backscatter. RESULTS: Nanoparticles bound to the clot significantly increased the acoustic contrast of the targeted clot surface, permitting volumetric estimates. Profile plots of detected clot surfaces demonstrated that streptokinase-loaded, fibrin-targeted perfluoro-octylbromide nanoparticles in the presence of plasminogen induced rapid fibrinolysis (&lt;60 min) without concurrent microbubble production and cavitation. Streptokinase-loaded or fibrin-targeted control nanoparticles insonified in PBS did not induce clot lysis. Morphologic changes in the treated group were accompanied by temporal and spatial changes in backscatter. Ultrasound exposure had no effect on the digestion process. Effective concentrations of targeted streptokinase were orders of magnitude lower than equivalently efficacious levels of free drug. Moreover, increasing competitive inhibition of fibrin-bound streptokinase nanoparticles reduced clot lysis in a monotonic fashion. As little as 1% surface targeting of streptokinase nanoparticles produced significant decreases in clot volumes (approximately 30%) in 1 h. CONCLUSION: This new nanoparticle-based thrombolytic agent provides specific and rapid fibrinolysis in vitro and may have a clinical role in early reperfusion during acute ischemic stroke.</abstract><notes>Marsh, J N&#xD;Senpan, A&#xD;Hu, G&#xD;Scott, M J&#xD;Gaffney, P J&#xD;Wickline, S A&#xD;Lanza, G M&#xD;Eb-01704/eb/nibib&#xD;Hl-73646/hl/nhlbi&#xD;Hl-78631/hl/nhlbi&#xD;N01-co-27031/co/nci&#xD;N01-co-37007/co/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2007 Aug;2(4):533-43.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17716136</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>6.093</custom4><electronic-resource-num>10.2217/17435889.2.4.533</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1367</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1367</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lanza, G. M.</author><author>Winter, P. M.</author><author>Caruthers, S. D.</author><author>Hughes, M. S.</author><author>Cyrus, T.</author><author>Marsh, J. N.</author><author>Neubauer, A. M.</author><author>Partlow, K. C.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Division of Cardiology, Washington University Medical School, Cortex Building, St Louis, MO 63108, USA. greg@cvu.wustl.edu</auth-address><titles><title>Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles</title><secondary-title>Nanomed</secondary-title></titles><periodical><full-title>Nanomed</full-title></periodical><pages>321-9</pages><volume>1</volume><number>3</number><edition>2007/08/25</edition><dates><year>2006</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1748-6963 (Electronic)</isbn><accession-num>17716162</accession-num><abstract>Nanomedicine promises to enhance the ability of clinicians to address some of the serious challenges responsible for cardiovascular mortality, morbidity and numerous societal consequences. Targeted imaging and therapy applications with perfluorocarbon nanoparticles are relevant to a broad spectrum of cardiovascular diseases, ranging from asymptomatic atherosclerotic disease to acute myocardial infarction or stroke. As illustrated in this article, perfluorocarbon nanoparticles offer new tools to recognize and characterize pathology, to identify and segment high-risk patients and to treat chronic and acute disease.</abstract><notes>Lanza, Gregory M&#xD;Winter, Patrick M&#xD;Caruthers, Shelton D&#xD;Hughes, Michael S&#xD;Cyrus, Tillmann&#xD;Marsh, Jon N&#xD;Neubauer, Anne M&#xD;Partlow, Kathy C&#xD;Wickline, Samuel A&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Nanomedicine (London, England)&#xD;Nanomed. 2006 Oct;1(3):321-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17716162</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>6.093</custom4><electronic-resource-num>10.2217/17435889.1.3.321</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2063</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2063</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wu, Z.</author><author>Li, Z. B.</author><author>Chen, K.</author><author>Cai, W.</author><author>He, L.</author><author>Chin, F. T.</author><author>Li, F.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA 94305, USA.</auth-address><titles><title>microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4)</title><secondary-title>J Nucl Med</secondary-title></titles><periodical><full-title>J Nucl Med</full-title></periodical><pages>1536-44</pages><volume>48</volume><number>9</number><edition>2007/08/21</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Female</keyword><keyword>Fluorine Radioisotopes/ pharmacokinetics</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/ biosynthesis</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Oligopeptides/chemistry/ pharmacokinetics</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Positron-Emission Tomography/methods</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>17704249</accession-num><abstract>In vivo imaging of alpha(v)beta(3) expression has important diagnostic and therapeutic applications. Multimeric cyclic RGD peptides are capable of improving the integrin alpha(v)beta(3)-binding affinity due to the polyvalency effect. Here we report an example of (18)F-labeled tetrameric RGD peptide for PET of alpha(v)beta(3) expression in both xenograft and spontaneous tumor models. METHODS: The tetrameric RGD peptide E{E[c(RGDyK)](2)}(2) was derived with amino-3,6,9-trioxaundecanoic acid (mini-PEG; PEG is poly(ethylene glycol)) linker through the glutamate alpha-amino group. NH(2)-mini-PEG-E{E[c(RGDyK)](2)}(2) (PRGD4) was labeled with (18)F via the N-succinimidyl-4-(18)F-fluorobenzoate ((18)F-SFB) prosthetic group. The receptor-binding characteristics of the tetrameric RGD peptide tracer (18)F-FPRGD4 were evaluated in vitro by a cell-binding assay and in vivo by quantitative microPET imaging studies. RESULTS: The decay-corrected radiochemical yield for (18)F-FPRGD4 was about 15%, with a total reaction time of 180 min starting from (18)F-F(-). The PEGylation had minimal effect on integrin-binding affinity of the RGD peptide. (18)F-FPRGD4 has significantly higher tumor uptake compared with monomeric and dimeric RGD peptide tracer analogs. The receptor specificity of (18)F-FPRGD4 in vivo was confirmed by effective blocking of the uptake in both tumors and normal organs or tissues with excess c(RGDyK). CONCLUSION: The tetrameric RGD peptide tracer (18)F-FPRGD4 possessing high integrin-binding affinity and favorable biokinetics is a promising tracer for PET of integrin alpha(v)beta(3) expression in cancer and other angiogenesis related diseases.</abstract><notes>Wu, Zhanhong&#xD;Li, Zi-Bo&#xD;Chen, Kai&#xD;Cai, Weibo&#xD;He, Lina&#xD;Chin, Frederick T&#xD;Li, Fang&#xD;Chen, Xiaoyuan&#xD;P50 CA 114747/CA/NCI NIH HHS/United States&#xD;R21 CA 102123/CA/NCI NIH HHS/United States&#xD;R21 EB 001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA 93862/CA/NCI NIH HHS/United States&#xD;U54 CA 119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2007 Sep;48(9):1536-44. Epub 2007 Aug 17.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.282</custom4><electronic-resource-num>jnumed.107.040816 [pii]&#xD;10.2967/jnumed.107.040816 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1553</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1553</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schipper, M. L.</author><author>Cheng, Z.</author><author>Lee, S. W.</author><author>Bentolila, L. A.</author><author>Iyer, G.</author><author>Rao, J.</author><author>Chen, X.</author><author>Wu, A. M.</author><author>Weiss, S.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Departments of Radiology and Bioengineering, Bio-X Program, Molecular Imaging Program at Stanford (MIPS), Stanford University, East 150 Clark Center, Palo Alto, CA 94305, USA.</auth-address><titles><title>microPET-based biodistribution of quantum dots in living mice</title><secondary-title>J Nucl Med</secondary-title></titles><periodical><full-title>J Nucl Med</full-title></periodical><pages>1511-8</pages><volume>48</volume><number>9</number><edition>2007/08/21</edition><keywords><keyword>Animals</keyword><keyword>Bone and Bones/metabolism</keyword><keyword>Cadmium Compounds/chemistry/*pharmacokinetics</keyword><keyword>*Copper Radioisotopes</keyword><keyword>Liver/metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Positron-Emission Tomography/methods</keyword><keyword>*Quantum Dots</keyword><keyword>Selenium Compounds/chemistry/*pharmacokinetics</keyword><keyword>Spleen/metabolism</keyword><keyword>Tissue Distribution</keyword><keyword>Zinc Compounds/chemistry/pharmacokinetics</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>17704240</accession-num><abstract>This study evaluates the quantitative biodistribution of commercially available CdSe quantum dots (QD) in mice. METHODS: (64)Cu-Labeled 800- or 525-nm emission wavelength QD (21- or 12-nm diameter), with or without 2,000 MW (molecular weight) polyethylene glycol (PEG), were injected intravenously into mice (5.55 MBq/25 pmol QD) and studied using well counting or by serial microPET and region-of-interest analysis. RESULTS: Both methods show rapid uptake by the liver (27.4-38.9 %ID/g) (%ID/g is percentage injected dose per gram tissue) and spleen (8.0-12.4 %ID/g). Size has no influence on biodistribution within the range tested here. Pegylated QD have slightly slower uptake into liver and spleen (6 vs. 2 min) and show additional low-level bone uptake (6.5-6.9 %ID/g). No evidence of clearance from these organs was observed. CONCLUSION: Rapid reticuloendothelial system clearance of QD will require modification of QD for optimal utility in imaging living subjects. Formal quantitative biodistribution/imaging studies will be helpful in studying many types of nanoparticles, including quantum dots.</abstract><notes>Schipper, Meike L&#xD;Cheng, Zhen&#xD;Lee, Sheen-Woo&#xD;Bentolila, Laurent A&#xD;Iyer, Gopal&#xD;Rao, Jianghong&#xD;Chen, Xiaoyuan&#xD;Wu, Anna M&#xD;Weiss, Shimon&#xD;Gambhir, Sanjiv S&#xD;5R01 EB 000312/EB/United States NIBIB&#xD;P50 CA 114747/CA/United States NCI&#xD;U54 CA 119367/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2007 Sep;48(9):1511-8. Epub 2007 Aug 17.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17704240</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>6.282</custom4><electronic-resource-num>jnumed.107.040071 [pii]&#xD;10.2967/jnumed.107.040071</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1075</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1075</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Barrett, D. G.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and The Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3290, USA.</auth-address><titles><title>Rapid patterning of cells and cell co-cultures on surfaces with spatial and temporal control through centrifugation</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>7437-9</pages><volume>46</volume><number>39</number><edition>2007/08/21</edition><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Cell Separation/*methods</keyword><keyword>Centrifugation/*methods</keyword><keyword>Coculture Techniques</keyword><keyword>Drosophila melanogaster</keyword><keyword>Surface Properties</keyword><keyword>Time Factors</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>17705322</accession-num><notes>Barrett, Devin G&#xD;Yousaf, Muhammad N&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2007;46(39):7437-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17705322</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200701841</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2061</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2061</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, H.</author><author>Cai, W.</author><author>Chen, K.</author><author>Li, Z. B.</author><author>Kashefi, A.</author><author>He, L.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA 94305-5484, USA.</auth-address><titles><title>A new PET tracer specific for vascular endothelial growth factor receptor 2</title><secondary-title>Eur J Nucl Med Mol Imaging</secondary-title></titles><periodical><full-title>Eur J Nucl Med Mol Imaging</full-title></periodical><pages>2001-10</pages><volume>34</volume><number>12</number><edition>2007/08/19</edition><keywords><keyword>Animals</keyword><keyword>Breast Neoplasms/ metabolism/ radionuclide imaging</keyword><keyword>Cell Line, Tumor</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Mice</keyword><keyword>Organ Specificity</keyword><keyword>Organometallic Compounds/ diagnostic use/ pharmacokinetics</keyword><keyword>Positron-Emission Tomography/ methods</keyword><keyword>Radiopharmaceuticals/diagnostic use/pharmacokinetics</keyword><keyword>Tissue Distribution</keyword><keyword>Vascular Endothelial Growth Factor A/ diagnostic use/ pharmacokinetics</keyword><keyword>Vascular Endothelial Growth Factor Receptor-2/ metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1619-7070 (Print)</isbn><accession-num>17694307</accession-num><abstract>PURPOSE: Noninvasive positron emission tomography (PET) imaging of vascular endothelial growth factor receptor 2 (VEGFR-2) expression could be a valuable tool for evaluation of patients with a variety of malignancies, and particularly for monitoring those undergoing antiangiogenic therapies that block VEGF/VEGFR-2 function. The aim of this study was to develop a VEGFR-2-specific PET tracer. METHODS: The D63AE64AE67A mutant of VEGF(121) (VEGF(DEE)) was generated by recombinant DNA technology. VEGF(121) and VEGF(DEE) were purified and conjugated with DOTA for (64)Cu labeling. The DOTA conjugates were tested in vitro for VEGFR-2 specificity and functional activity. In vivo tumor targeting efficacy and pharmacokinetics of (64)Cu-labeled VEGF(121) and VEGF(DEE) were compared using an orthotopic 4T1 murine breast tumor model. Blocking experiments, biodistribution studies, and immunofluorescence staining were carried out to confirm the noninvasive imaging results. RESULTS: Cell binding assay demonstrated that VEGF(DEE) had about 20-fold lower VEGFR-1 binding affinity and only slightly lower VEGFR-2 binding affinity as compared with VEGF(121). MicroPET imaging studies revealed that both (64)Cu-DOTA-VEGF(121) and (64)Cu-DOTA-VEGF(DEE) had rapid and prominent activity accumulation in VEGFR-2-expressing 4T1 tumors. The renal uptake of (64)Cu-DOTA-VEGF(DEE) was significantly lower than that of (64)Cu-DOTA-VEGF(121) as rodent kidneys expressed high levels of VEGFR-1 based on immunofluorescence staining. Blocking experiments and biodistribution studies confirmed the VEGFR specificity of (64)Cu-DOTA-VEGF(DEE). CONCLUSION: We have developed a VEGFR-2-specific PET tracer, (64)Cu-DOTA-VEGF(DEE). It has comparable tumor targeting efficacy to (64)Cu-DOTA-VEGF(121) but much reduced renal toxicity. This tracer may be translated into the clinic for imaging tumor angiogenesis and monitoring antiangiogenic treatment efficacy.</abstract><notes>Wang, Hui&#xD;Cai, Weibo&#xD;Chen, Kai&#xD;Li, Zi-Bo&#xD;Kashefi, Amir&#xD;He, Lina&#xD;Chen, Xiaoyuan&#xD;P50 CA 114747/CA/NCI NIH HHS/United States&#xD;R21 CA 102123/CA/NCI NIH HHS/United States&#xD;R21 EB 001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA 93862/CA/NCI NIH HHS/United States&#xD;U54 CA 119367/CA/NCI NIH HHS/United States&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;European journal of nuclear medicine and molecular imaging&#xD;Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2001-10. Epub 2007 Aug 11.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.625</custom4><electronic-resource-num>10.1007/s00259-007-0524-0 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1678</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1678</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Vega, R. A.</author><author>Shen, C. K.</author><author>Maspoch, D.</author><author>Robach, J. G.</author><author>Lamb, R. A.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Monitoring single-cell infectivity from virus-particle nanoarrays fabricated by parallel dip-pen nanolithography</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>1482-5</pages><volume>3</volume><number>9</number><edition>2007/08/19</edition><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17694589</accession-num><notes>Vega, Rafael A&#xD;Shen, Clifton K-F&#xD;Maspoch, Daniel&#xD;Robach, Jessica G&#xD;Lamb, Robert A&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2007 Sep;3(9):1482-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17694589</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200700244</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1659</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1659</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tison, C. K.</author><author>Milam, V. T.</author></authors></contributors><auth-address>School of Materials Science &amp; Engineering, Georgia Institute of Technology, 771 Ferst Dr. NW, Atlanta, Georgia 30332-0245, USA.</auth-address><titles><title>Reversing DNA-mediated adhesion at a fixed temperature</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>9728-36</pages><volume>23</volume><number>19</number><edition>2007/08/19</edition><keywords><keyword>Colloids/*chemistry</keyword><keyword>DNA/*chemistry</keyword><keyword>Microscopy, Confocal</keyword><keyword>Microspheres</keyword><keyword>Models, Biological</keyword><keyword>Nucleic Acid Hybridization</keyword><keyword>*Particle Size</keyword><keyword>Surface Properties</keyword><keyword>Temperature</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep 11</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>17696456</accession-num><abstract>Recognition-based assembly of micron- to nano-sized colloidal particles functionalized with DNA has generated great interest in the past decade; however, reversing the assembly process is typically achieved by thermal denaturation of the oligonucleotide duplexes. Here, we report an alternative disassembly approach at a fixed temperature using competitive hybridization events between immobilized and soluble oligonucleotide strands. Microspheres are first aggregated via primary hybridization events between immobilized DNA strands with a weak, but sufficient, affinity for partner strands to link complementary surfaces together. To reverse the aggregation process, soluble oligonucleotides are then added to competitively displace the original hybridization partners through secondary hybridization events. Using flow cytometry to quantify hybridization events and microscopy to examine DNA-mediated aggregation and redispersion, we found that the efficiency of competitive displacement is based upon (1) the difference in base pair matches between the primary and secondary target for the same probe sequence and (2) the concentration of hybridizing oligonucleotides participating in microsphere aggregation. To the best of our knowledge, this study is the first to employ DNA hybridization events to mediate reversible adhesion between colloidal particles at a fixed temperature.</abstract><notes>Tison, Christopher K&#xD;Milam, Valeria T&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2007 Sep 11;23(19):9728-36. Epub 2007 Aug 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17696456</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>4.347</custom4><electronic-resource-num>10.1021/la700601j</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1280</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1280</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hurst, S. J.</author><author>Han, M. S.</author><author>Lytton-Jean, A. K.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Screening the sequence selectivity of DNA-binding molecules using a gold nanoparticle-based colorimetric approach</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>7201-5</pages><volume>79</volume><number>18</number><edition>2007/08/19</edition><keywords><keyword>Base Sequence</keyword><keyword>Binding Sites</keyword><keyword>Colorimetry</keyword><keyword>DNA/*analysis/chemistry/metabolism</keyword><keyword>Gold/*chemistry</keyword><keyword>Molecular Sequence Data</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Transition Temperature</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep 15</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>17696406</accession-num><abstract>We have developed a novel competition assay that uses a gold nanoparticle (Au NP)-based, high-throughput colorimetric approach to screen the sequence selectivity of DNA-binding molecules. This assay hinges on the observation that the melting behavior of DNA-functionalized Au NP aggregates is sensitive to the concentration of the DNA-binding molecule in solution. When short, oligomeric hairpin DNA sequences were added to a reaction solution consisting of DNA-functionalized Au NP aggregates and DNA-binding molecules, these molecules may either bind to the Au NP aggregate interconnects or the hairpin stems based on their relative affinity for each. This relative affinity can be measured as a change in the melting temperature (Tm) of the DNA-modified Au NP aggregates in solution. As a proof of concept, we evaluated the selectivity of 4&apos;,6-diamidino-2-phenylindone (an AT-specific binder), ethidium bromide (a nonspecific binder), and chromomycin A (a GC-specific binder) for six sequences of hairpin DNA having different numbers of AT pairs in a five-base pair variable stem region. Our assay accurately and easily confirmed the known trends in selectivity for the DNA binders in question without the use of complicated instrumentation. This novel assay will be useful in assessing large libraries of potential drug candidates that work by binding DNA to form a drug/DNA complex.</abstract><notes>Hurst, Sarah J&#xD;Han, Min Su&#xD;Lytton-Jean, Abigail K R&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2007 Sep 15;79(18):7201-5. Epub 2007 Aug 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17696406</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac071253e</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1197</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1197</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Faca, V.</author><author>Pitteri, S. J.</author><author>Newcomb, L.</author><author>Glukhova, V.</author><author>Phanstiel, D.</author><author>Krasnoselsky, A.</author><author>Zhang, Q.</author><author>Struthers, J.</author><author>Wang, H.</author><author>Eng, J.</author><author>Fitzgibbon, M.</author><author>McIntosh, M.</author><author>Hanash, S.</author></authors></contributors><auth-address>Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, Washington 98109, USA. vfaca@fhcrc.org</auth-address><titles><title>Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes</title><secondary-title>J Proteome Res</secondary-title></titles><periodical><full-title>J Proteome Res</full-title></periodical><pages>3558-65</pages><volume>6</volume><number>9</number><edition>2007/08/19</edition><keywords><keyword>Anions</keyword><keyword>Blood Proteins/*chemistry</keyword><keyword>Chromatography, Ion Exchange/methods</keyword><keyword>Chromatography, Liquid/methods</keyword><keyword>Electrophoresis, Polyacrylamide Gel</keyword><keyword>Humans</keyword><keyword>Lung Neoplasms/metabolism</keyword><keyword>Mass Spectrometry/methods</keyword><keyword>Protein Isoforms</keyword><keyword>Proteins/*chemistry</keyword><keyword>Proteome</keyword><keyword>Proteomics/*methods</keyword><keyword>Serum/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1535-3893 (Print)</isbn><accession-num>17696519</accession-num><abstract>In-depth analysis of the serum and plasma proteomes by mass spectrometry is challenged by the vast dynamic range of protein abundance and substantial complexity. There is merit in reducing complexity through fractionation to facilitate mass spectrometry analysis of low-abundance proteins. However, fractionation reduces throughput and has the potential of diluting individual proteins or inducing their loss. Here, we have investigated the contribution of extensive fractionation of intact proteins to depth of analysis. Pooled serum depleted of abundant proteins was fractionated by an orthogonal two-dimensional system consisting of anion-exchange and reversed-phase chromatography. The resulting protein fractions were aliquotted; one aliquot was analyzed by shotgun LC-MS/MS, and another was further resolved into protein bands in a third dimension using SDS-PAGE. Individual gel bands were excised and subjected to in situ digestion and mass spectrometry. We demonstrate that increased fractionation results in increased depth of analysis based on total number of proteins identified in serum and based on representation in individual fractions of specific proteins identified in gel bands following a third-dimension SDS gel analysis. An intact protein analysis system (IPAS) based on a two-dimensional plasma fractionation schema was implemented that resulted in identification of 1662 proteins with high confidence with representation of protein isoforms that differed in their chromatographic mobility. Further increase in depth of analysis was accomplished by repeat analysis of aliquots from the same set of two-dimensional fractions resulting in overall identification of 2254 proteins. We conclude that substantial depth of analysis of proteins from milliliter quantities of serum or plasma and detection of isoforms are achieved with depletion of abundant proteins followed by two-dimensional protein fractionation and MS analysis of individual fractions.</abstract><notes>Faca, Vitor&#xD;Pitteri, Sharon J&#xD;Newcomb, Lisa&#xD;Glukhova, Veronika&#xD;Phanstiel, Doug&#xD;Krasnoselsky, Alexei&#xD;Zhang, Qing&#xD;Struthers, Jason&#xD;Wang, Hong&#xD;Eng, Jimmy&#xD;Fitzgibbon, Matt&#xD;McIntosh, Martin&#xD;Hanash, Samir&#xD;United States&#xD;Journal of proteome research&#xD;J Proteome Res. 2007 Sep;6(9):3558-65. Epub 2007 Aug 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17696519</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>5.737</custom4><electronic-resource-num>10.1021/pr070233q</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1190</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1190</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ebert, M. S.</author><author>Neilson, J. R.</author><author>Sharp, P. A.</author></authors></contributors><auth-address>Center for Cancer Research, E17-529B Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells</title><secondary-title>Nat Methods</secondary-title></titles><periodical><full-title>Nat Methods</full-title></periodical><pages>721-6</pages><volume>4</volume><number>9</number><edition>2007/08/19</edition><keywords><keyword>3&apos; Untranslated Regions</keyword><keyword>Animals</keyword><keyword>Blotting, Northern</keyword><keyword>Blotting, Western</keyword><keyword>Genes, Reporter</keyword><keyword>*Genetic Vectors</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Luciferases, Firefly/genetics</keyword><keyword>MicroRNAs/*genetics</keyword><keyword>Oligonucleotides, Antisense/genetics</keyword><keyword>Plasmids</keyword><keyword>*RNA Interference</keyword><keyword>RNA Polymerase III/genetics</keyword><keyword>Transfection</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1548-7091 (Print)</isbn><accession-num>17694064</accession-num><abstract>MicroRNAs are predicted to regulate thousands of mammalian genes, but relatively few targets have been experimentally validated and few microRNA loss-of-function phenotypes have been assigned. As an alternative to chemically modified antisense oligonucleotides, we developed microRNA inhibitors that can be expressed in cells, as RNAs produced from transgenes. Termed &apos;microRNA sponges&apos;, these competitive inhibitors are transcripts expressed from strong promoters, containing multiple, tandem binding sites to a microRNA of interest. When vectors encoding these sponges are transiently transfected into cultured cells, sponges derepress microRNA targets at least as strongly as chemically modified antisense oligonucleotides. They specifically inhibit microRNAs with a complementary heptameric seed, such that a single sponge can be used to block an entire microRNA seed family. RNA polymerase II promoter (Pol II)-driven sponges contain a fluorescence reporter gene for identification and sorting of sponge-treated cells. We envision the use of stably expressed sponges in animal models of disease and development.</abstract><notes>Ebert, Margaret S&#xD;Neilson, Joel R&#xD;Sharp, Phillip A&#xD;P30-CA14051/CA/United States NCI&#xD;U19-AI056900/AI/United States NIAID&#xD;U54 CA112967/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature methods&#xD;Nat Methods. 2007 Sep;4(9):721-6. Epub 2007 Aug 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17694064</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>15.011</custom4><electronic-resource-num>nmeth1079 [pii]&#xD;10.1038/nmeth1079</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1090</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1090</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bleszynski, A. C.</author><author>Zwanenburg, F. A.</author><author>Westervelt, R. M.</author><author>Roest, A. L.</author><author>Bakkers, E. P.</author><author>Kouwenhoven, L. P.</author></authors></contributors><auth-address>Department of Physics and School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts 02138, USA.</auth-address><titles><title>Scanned probe imaging of quantum dots inside InAs nanowires</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>2559-62</pages><volume>7</volume><number>9</number><edition>2007/08/19</edition><keywords><keyword>Arsenicals/*chemistry</keyword><keyword>Electron Transport</keyword><keyword>Indium/*chemistry</keyword><keyword>Materials Testing</keyword><keyword>Microscopy, Scanning Probe/*methods</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Nanotubes/*chemistry/*ultrastructure</keyword><keyword>Particle Size</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17691848</accession-num><abstract>We show how a scanning probe microscope (SPM) can be used to image electron flow through InAs nanowires, elucidating the physics of nanowire devices on a local scale. A charged SPM tip is used as a movable gate. Images of nanowire conductance versus tip position spatially map the conductance of InAs nanowires at liquid-He temperatures. Plots of conductance versus backgate voltage without the tip present show complex patterns of Coulomb-blockade peaks. Images of nanowire conductance identify their source as multiple quantum dots formed by disorder along the nanowire--each dot is surrounded by a series of concentric rings corresponding to Coulomb blockade peaks. An SPM image locates the dots and provides information about their size. In this way, SPM images can be used to understand the features that control transport through nanowires. The nanowires were grown from metal catalyst particles and have diameters approximately 80 nm and lengths 2-3 microm.</abstract><notes>Bleszynski, Ania C&#xD;Zwanenburg, Floris A&#xD;Westervelt, R M&#xD;Roest, Aarnoud L&#xD;Bakkers, Erik P A M&#xD;Kouwenhoven, Leo P&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Sep;7(9):2559-62. Epub 2007 Aug 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17691848</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl0621037</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1410</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1410</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Sun, X.</author><author>Nakayama-Ratchford, N.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry, Stanford University, Stanford, California 94305</auth-address><titles><title>Supramolecular Chemistry on Water-Soluble Carbon Nanotubes for Drug Loading and Delivery</title><secondary-title>ACS Nano</secondary-title></titles><periodical><full-title>ACS Nano</full-title></periodical><pages>50-56</pages><volume>1</volume><number>1</number><edition>2007/08/14</edition><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1936-0851</isbn><abstract>ABSTRACT We show that large surface areas exist for supramolecular chemistry on single-walled carbon nanotubes (SWNTs) prefunctionalized noncovalently or covalently by common surfactant or acid-oxidation routes. Water-soluble SWNTs with poly(ethylene glycol) (PEG) functionalization via these routes allow for surprisingly high degrees of -stacking of aromatic molecules, including a cancer drug (doxorubicin) with ultrahigh loading capacity, a widely used fluorescence molecule (fluorescein), and combinations of molecules. Binding of molecules to nanotubes and their release can be controlled by varying the pH. The strength of -stacking of aromatic molecules is dependent on nanotube diameter, leading to a method for controlling the release rate of molecules from SWNTs by using nanotube materials with suitable diameter. This work introduces the concept of  functionalization partitioning  of SWNTs, i.e., imparting multiple chemical species, such as PEG, drugs, and fluorescent tags, with different functionalities onto the surface of the same nanotube. Such chemical partitioning should open up new opportunities in chemical, biological, and medical applications of novel nanomaterials.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/nn700040t</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>5.472</custom4><electronic-resource-num>10.1021/nn700040t</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1109</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1109</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, T.</author><author>Xu, L.</author><author>Gibson, H. W.</author><author>Dorn, H. C.</author><author>Chancellor, C. J.</author><author>Olmstead, M. M.</author><author>Balch, A. L.</author></authors></contributors><auth-address>Contribution from the Departments of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24060-0212, and University of California, Davis, California 95616.</auth-address><titles><title>Sc(3)N@C(78): encapsulated cluster regiocontrol of adduct docking on an ellipsoidal metallofullerene sphere</title><secondary-title>J Am Chem Soc</secondary-title><alt-title>Journal of the American Chemical Society</alt-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><alt-periodical><full-title>Journal of the American Chemical Society</full-title></alt-periodical><pages>10795-800</pages><volume>129</volume><number>35</number><edition>2007/08/10 </edition><dates><year>2007</year><pub-dates><date>Sep 5</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17691732</accession-num><abstract>The first N-tritylpyrrolidino derivatives of D3h (78:5) Sc3N@C78 were successfully synthesized and isolated. The addition sites for the two nearly equivalent kinetic monoadducts 1a and 1b are across two different 6,6 junction sites on the Sc3N@C78 cage that are offset from the horizontal plane defined by the Sc3N cluster. The adducts were characterized by NMR experiments, DFT calculations and X-ray crystallographic analysis of Sc3N@C78 derivative 1a. A unique finding of this study is the regiocontrol of adduct docking by the internal Sc3N cluster.</abstract><notes>Journal Article&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17691732 </url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2008</custom3><custom4>8.256</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1395</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1395</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, Z. B.</author><author>Cai, W.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>Semiconductor quantum dots for in vivo imaging</title><secondary-title>J Nanosci Nanotechnol</secondary-title></titles><periodical><full-title>J Nanosci Nanotechnol</full-title></periodical><pages>2567-81</pages><volume>7</volume><number>8</number><edition>2007/08/10</edition><keywords><keyword>Animals</keyword><keyword>Cadmium/chemistry</keyword><keyword>Diagnostic Imaging/*instrumentation/methods</keyword><keyword>Embryo, Mammalian/pathology</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Fluorescent Dyes/chemistry</keyword><keyword>Humans</keyword><keyword>In Situ Hybridization, Fluorescence</keyword><keyword>Lymph Nodes/pathology</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Models, Chemical</keyword><keyword>Nanotechnology/*methods</keyword><keyword>*Quantum Dots</keyword><keyword>*Semiconductors</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1533-4880 (Print)</isbn><accession-num>17685272</accession-num><abstract>Quantum dots play an important role in the in vitro, ex vivo, and in vivo optical imaging. Dramatic improvements have been achieved in the aspect of surface modification, biocompatibility, and targeting specificity, which had significant impact on the in vivo applications of quantum dots. This review summarizes the recent advances of quantum dots for in vivo imaging using both non-specific and targeted approaches. The toxicity of cadmium chalcogenide materials and alternative approaches such as the use of doped nanocrystal quantum dots were also discussed. The integration of quantum dots with other imaging techniques is also expected to give rise to a new generation of multifunctional probes for biomedical applications.</abstract><notes>Li, Zi-Bo&#xD;Cai, Weibo&#xD;Chen, Xiaoyuan&#xD;R21 CA102123/CA/United States NCI&#xD;R21 EB001785/EB/United States NIBIB&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Journal of nanoscience and nanotechnology&#xD;J Nanosci Nanotechnol. 2007 Aug;7(8):2567-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17685272</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>2.100</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1337</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1337</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kirsch, D. G.</author><author>Dinulescu, D. M.</author><author>Miller, J. B.</author><author>Grimm, J.</author><author>Santiago, P. M.</author><author>Young, N. P.</author><author>Nielsen, G. P.</author><author>Quade, B. J.</author><author>Chaber, C. J.</author><author>Schultz, C. P.</author><author>Takeuchi, O.</author><author>Bronson, R. T.</author><author>Crowley, D.</author><author>Korsmeyer, S. J.</author><author>Yoon, S. S.</author><author>Hornicek, F. J.</author><author>Weissleder, R.</author><author>Jacks, T.</author></authors></contributors><auth-address>Center for Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>A spatially and temporally restricted mouse model of soft tissue sarcoma</title><secondary-title>Nat Med</secondary-title></titles><periodical><full-title>Nat Med</full-title></periodical><pages>992-7</pages><volume>13</volume><number>8</number><edition>2007/08/07</edition><keywords><keyword>Animals</keyword><keyword>Cell Transformation, Neoplastic</keyword><keyword>Cyclin-Dependent Kinase Inhibitor p16/genetics</keyword><keyword>*Disease Models, Animal</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Lung Neoplasms/secondary</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Sarcoma/genetics/metabolism/*pathology</keyword><keyword>Time Factors</keyword><keyword>Tumor Suppressor Protein p14ARF/genetics</keyword><keyword>Tumor Suppressor Protein p53/deficiency/genetics/metabolism</keyword><keyword>Up-Regulation/genetics</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1078-8956 (Print)</isbn><accession-num>17676052</accession-num><abstract>Soft tissue sarcomas are mesenchymal tumors that are fatal in approximately one-third of patients. To explore mechanisms of sarcoma pathogenesis, we have generated a mouse model of soft tissue sarcoma. Intramuscular delivery of an adenovirus expressing Cre recombinase in mice with conditional mutations in Kras and Trp53 was sufficient to initiate high-grade sarcomas with myofibroblastic differentiation. Like human sarcomas, these tumors show a predilection for lung rather than lymph node metastasis. Using this model, we showed that a prototype handheld imaging device can identify residual tumor during intraoperative molecular imaging. Deletion of the Ink4a-Arf locus (Cdkn2a), but not Bak1 and Bax, could substitute for mutation of Trp53 in this model. Deletion of Bak1 and Bax, however, was able to substitute for mutation of Trp53 in the development of sinonasal adenocarcinoma. Therefore, the intrinsic pathway of apoptosis seems sufficient to mediate p53 tumor suppression in an epithelial cancer, but not in this model of soft tissue sarcoma.</abstract><notes>Kirsch, David G&#xD;Dinulescu, Daniela M&#xD;Miller, John B&#xD;Grimm, Jan&#xD;Santiago, Philip M&#xD;Young, Nathan P&#xD;Nielsen, G Petur&#xD;Quade, Bradley J&#xD;Chaber, Christopher J&#xD;Schultz, Christian P&#xD;Takeuchi, Osamu&#xD;Bronson, Roderick T&#xD;Crowley, Denise&#xD;Korsmeyer, Stanley J&#xD;Yoon, Sam S&#xD;Hornicek, Francis J&#xD;Weissleder, Ralph&#xD;Jacks, Tyler&#xD;K08 CA 114176/CA/United States NCI&#xD;P30-CA14051/CA/United States NCI&#xD;P50 CA86355/CA/United States NCI&#xD;R24 CA92782/CA/United States NCI&#xD;U54 CA119349/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature medicine&#xD;Nat Med. 2007 Aug;13(8):992-7. Epub 2007 Aug 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17676052</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>28.965</custom4><electronic-resource-num>nm1602 [pii]&#xD;10.1038/nm1602</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1920</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1920</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, S. J.</author><author>Wang, Y. C.</author><author>Lee, J. H.</author><author>Jang, H.</author><author>Han, J.</author></authors></contributors><auth-address>Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Concentration polarization and nonlinear electrokinetic flow near a nanofluidic channel</title><secondary-title>Phys Rev Lett</secondary-title></titles><periodical><full-title>Phys Rev Lett</full-title></periodical><pages>044501</pages><volume>99</volume><number>4</number><edition>2007/08/07</edition><dates><year>2007</year><pub-dates><date>Jul 27</date></pub-dates></dates><isbn>0031-9007 (Print)</isbn><accession-num>17678369</accession-num><abstract>A perm-selective nanochannel could initiate concentration polarization near the nanochannel, significantly decreasing (increasing) the ion concentration in the anodic (cathodic) end of the nanochannel. Such strong concentration polarization can be induced even at moderate buffer concentrations because of local ion depletion (therefore thicker local Debye layer) near the nanochannel. In addition, fast fluid vortices were generated at the anodic side of the nanochannel due to the nonequilibrium electro-osmotic flow (EOF), which was at least approximately 10x faster than predicted from any equilibrium EOF. This result corroborates the relation among induced EOF, concentration polarization, and limiting-current behavior.</abstract><notes>Kim, Sung Jae&#xD;Wang, Ying-Chih&#xD;Lee, Jeong Hoon&#xD;Jang, Hongchul&#xD;Han, Jongyoon&#xD;CA119402/CA/NCI NIH HHS/United States&#xD;EB005743/EB/NIBIB NIH HHS/United States&#xD;GM68762/GM/NIGMS NIH HHS/United States&#xD;P50 GM068762-05/GM/NIGMS NIH HHS/United States&#xD;R01 CA119402-03/CA/NCI NIH HHS/United States&#xD;R01 EB005743-02/EB/NIBIB NIH HHS/United States&#xD;R01 EB005743-03/EB/NIBIB NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Physical review letters&#xD;Phys Rev Lett. 2007 Jul 27;99(4):044501. Epub 2007 Jul 25.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>2504030</custom2><custom3>NIHMS46503</custom3><custom4>7.134</custom4><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2299</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2299</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jain, P. K.</author><author>El-Sayed, M. A.</author></authors></contributors><auth-address>Laser Dynamics Laboratory, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332-0400, USA.</auth-address><titles><title>Universal scaling of plasmon coupling in metal nanostructures: extension from particle pairs to nanoshells</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>2854-8</pages><volume>7</volume><number>9</number><edition>2007/08/07</edition><keywords><keyword>Algorithms</keyword><keyword>Computer Simulation</keyword><keyword>Crystallization/ methods</keyword><keyword>Macromolecular Substances/chemistry</keyword><keyword>Materials Testing</keyword><keyword>Models, Chemical</keyword><keyword>Models, Molecular</keyword><keyword>Molecular Conformation</keyword><keyword>Nanostructures/ chemistry/ ultrastructure</keyword><keyword>Nanotechnology/ methods</keyword><keyword>Particle Size</keyword><keyword>Surface Plasmon Resonance/ methods</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17676810</accession-num><abstract>It has been recently shown that the strength of plasmon coupling between a pair of plasmonic metal nanoparticles falls as a function of the interparticle gap scaled by the particle size with a near-exponential decay trend that is universally independent of nanoparticle size, shape, metal type, or medium dielectric constant. In this letter, we extend this universal scaling behavior to the dielectric core-metal shell nanostructure. By using extended Mie theory simulations of silica core-metal nanoshells, we show that when the shift of the nanoshell plasmon resonance wavelength scaled by the solid nanosphere resonance wavelength is plotted against the shell thickness scaled by the core radius, nanoshells with different dimensions (radii) exhibit the same near-exponential decay. Thus, the nanoshell system becomes physically analogous to the particle-pair system, i.e., the nanoshell plasmon resonance results from the coupling of the inner shell surface (cavity) and the outer shell surface (sphere) plasmons over a separation distance essentially given by the metal shell thickness, which is consistent with the plasmon hybridization model of Prodan, Halas, and Nordlander. By using the universal scaling behavior in the nanoshell system, we propose a simple expression for predicting the dipolar plasmon resonance of a silica-gold nanoshell of given dimensions.</abstract><notes>Jain, Prashant K&#xD;El-Sayed, Mostafa A&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Sep;7(9):2854-8. Epub 2007 Aug 3.</notes><urls></urls><custom1>CCNE - UNC</custom1><custom4>12.189</custom4><electronic-resource-num>10.1021/nl071496m [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1272</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1272</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huang, X.</author><author>Jain, P. K.</author><author>El-Sayed, I. H.</author><author>El-Sayed, M. A.</author></authors></contributors><auth-address>Laser Dynamics Laboratory, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA, 30332-0400, USA.</auth-address><titles><title>Plasmonic photothermal therapy (PPTT) using gold nanoparticles</title><secondary-title>Lasers Med Sci</secondary-title></titles><periodical><full-title>Lasers Med Sci</full-title></periodical><pages>217-28</pages><volume>23</volume><number>3</number><edition>2007/08/04</edition><dates><year>2008</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0268-8921 (Print)</isbn><accession-num>17674122</accession-num><abstract>The use of lasers, over the past few decades, has emerged to be highly promising for cancer therapy modalities, most commonly the photothermal therapy method, which employs light absorbing dyes for achieving the photothermal damage of tumors, and the photodynamic therapy, which employs chemical photosensitizers that generate singlet oxygen that is capable of tumor destruction. However, recent advances in the field of nanoscience have seen the emergence of noble metal nanostructures with unique photophysical properties, well suited for applications in cancer phototherapy. Noble metal nanoparticles, on account of the phenomenon of surface plasmon resonance, possess strongly enhanced visible and near-infrared light absorption, several orders of magnitude more intense compared to conventional laser phototherapy agents. The use of plasmonic nanoparticles as highly enhanced photoabsorbing agents has thus introduced a much more selective and efficient cancer therapy strategy, viz. plasmonic photothermal therapy (PPTT). The synthetic tunability of the optothermal properties and the bio-targeting abilities of the plasmonic gold nanostructures make the PPTT method furthermore promising. In this review, we discuss the development of the PPTT method with special emphasis on the recent in vitro and in vivo success using gold nanospheres coupled with visible lasers and gold nanorods and silica-gold nanoshells coupled with near-infrared lasers.</abstract><notes>Huang, Xiaohua&#xD;Jain, Prashant K&#xD;El-Sayed, Ivan H&#xD;El-Sayed, Mostafa A&#xD;England&#xD;Lasers in medical science&#xD;Lasers Med Sci. 2008 Jul;23(3):217-28. Epub 2007 Aug 3.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17674122</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2008</custom3><custom4>1.691</custom4><electronic-resource-num>10.1007/s10103-007-0470-x</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2060</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2060</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Ebrahimnejad, A.</author><author>Chen, K.</author><author>Cao, Q.</author><author>Li, Z. B.</author><author>Tice, D. A.</author><author>Chen, X.</author></authors></contributors><auth-address>Department of Radiology and Bio-X Program, The Molecular Imaging Program at Stanford, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA 94305-5484, USA.</auth-address><titles><title>Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice</title><secondary-title>Eur J Nucl Med Mol Imaging</secondary-title></titles><periodical><full-title>Eur J Nucl Med Mol Imaging</full-title></periodical><pages>2024-36</pages><volume>34</volume><number>12</number><edition>2007/08/04</edition><keywords><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/ diagnostic use/ pharmacokinetics</keyword><keyword>Cell Line, Tumor</keyword><keyword>Humans</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasms/ metabolism/ radionuclide imaging</keyword><keyword>Organ Specificity</keyword><keyword>Organometallic Compounds/ diagnostic use/ pharmacokinetics</keyword><keyword>Positron-Emission Tomography/ methods</keyword><keyword>Radioimmunodetection/ methods</keyword><keyword>Radiopharmaceuticals/diagnostic use/pharmacokinetics</keyword><keyword>Receptor, EphA2/ metabolism</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1619-7070 (Print)</isbn><accession-num>17673999</accession-num><abstract>PURPOSE: EphA2 receptor tyrosine kinase is significantly overexpressed in a wide variety of cancer types. High EphA2 expression has been correlated with increased metastatic potential and poor patient survival. Although many recent reports have focused on blocking the EphA2 signaling pathway in cancer, the in vivo imaging of EphA2 has not yet been investigated. METHODS: We labeled 1C1, a humanized monoclonal antibody against both human and murine EphA2, with (64)Cu through the chelating agent 1,4,7,10-tetraazacyclododecane N,N&apos;,N&apos;&apos;,N&apos;&apos;&apos;-tetraacetic acid (DOTA) and carried out positron emission tomography (PET) imaging of eight tumor models with different EphA2 expression levels. Western blotting of tumor tissue lysate was performed to correlate the EphA2 expression level with (64)Cu-DOTA-1C1 uptake in the tumors. Immunofluorescence staining and biodistribution studies were also carried out to validate the in vivo results. RESULTS: The radiolabeling yield was 88.9 +/- 9.5% (n = 7) and the specific activity of (64)Cu-DOTA-1C1 was 1.32 +/- 0.14 GBq/mg of 1C1 mAb. The antibody retained antigen-binding affinity/specificity after DOTA conjugation as measured by FACS analysis. The uptake of (64)Cu-DOTA-1C1 in CT-26 tumors was as high as 25.1 +/- 2.5 %ID/g (n = 3) at 18 h post injection. (64)Cu-DOTA-IgG, an isotype-matched control, exhibited minimal non-specific uptake in all eight tumor models. In vivo EphA2 specificity of (64)Cu-DOTA-1C1 was confirmed by successful blocking of CT-26 tumor uptake by unlabeled 1C1. Most importantly, the tumor uptake value obtained from PET imaging had excellent linear correlation with the relative tumor tissue EphA2 expression level measured by Western blot, where r (2) equals 0.90 and 0.92 at 18 h and 42 h post injection, respectively. CONCLUSION: The tumor uptake of (64)Cu-DOTA-1C1 measured by microPET imaging reflects tumor EphA2 expression level in vivo. This is, to our knowledge, the first report of quantitative radioimmunoPET imaging of EphA2 in living subjects. Future clinical investigation of (64)Cu-DOTA-1C1 is warranted.</abstract><notes>Cai, Weibo&#xD;Ebrahimnejad, Alireza&#xD;Chen, Kai&#xD;Cao, Qizhen&#xD;Li, Zi-Bo&#xD;Tice, David A&#xD;Chen, Xiaoyuan&#xD;P50 CA 114747/CA/NCI NIH HHS/United States&#xD;R21 CA 102123/CA/NCI NIH HHS/United States&#xD;R21 EB 001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA 93862/CA/NCI NIH HHS/United States&#xD;U54 CA 119367/CA/NCI NIH HHS/United States&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;European journal of nuclear medicine and molecular imaging&#xD;Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2024-36. Epub 2007 Aug 3.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.625</custom4><electronic-resource-num>10.1007/s00259-007-0503-5 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2059</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2059</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>De, A.</author><author>Loening, A. M.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford and Bio-X Program, Department of Radiology, School of Medicine, Stanford University, Stanford, California 94305, USA.</auth-address><titles><title>An improved bioluminescence resonance energy transfer strategy for imaging intracellular events in single cells and living subjects</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>7175-83</pages><volume>67</volume><number>15</number><edition>2007/08/03</edition><keywords><keyword>Animals</keyword><keyword>Blotting, Western</keyword><keyword>Energy Transfer</keyword><keyword>Fibrosarcoma/ metabolism/pathology</keyword><keyword>Green Fluorescent Proteins/ metabolism</keyword><keyword>Humans</keyword><keyword>Luciferases, Renilla/ metabolism</keyword><keyword>Luminescent Agents/ metabolism</keyword><keyword>Luminescent Measurements/ methods</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microscopy, Video</keyword><keyword>Photons</keyword><keyword>Protein Binding</keyword><keyword>Protein Kinases/genetics/metabolism</keyword><keyword>Recombinant Fusion Proteins/metabolism</keyword><keyword>Sirolimus/pharmacology</keyword><keyword>Tacrolimus Binding Protein 1A/genetics/metabolism</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17671185</accession-num><abstract>Bioluminescence resonance energy transfer (BRET) is currently used for monitoring various intracellular events, including protein-protein interactions, in normal and aberrant signal transduction pathways. However, the BRET vectors currently used lack adequate sensitivity for imaging events of interest from both single living cells and small living subjects. Taking advantage of the critical relationship of BRET efficiency and donor quantum efficiency, we report generation of a novel BRET vector by fusing a GFP(2) acceptor protein with a novel mutant Renilla luciferase donor selected for higher quantum yield. This new BRET vector shows an overall 5.5-fold improvement in the BRET ratio, thereby greatly enhancing the dynamic range of the BRET signal. This new BRET strategy provides a unique platform to assay protein functions from both single live cells and cells located deep within small living subjects. The imaging utility of the new BRET vector is shown by constructing a sensor using two mammalian target of rapamycin pathway proteins (FKBP12 and FRB) that dimerize only in the presence of rapamycin. This new BRET vector should facilitate high-throughput sensitive BRET assays, including studies in single live cells and small living subjects. Applications will include anticancer therapy screening in cell culture and in small living animals.</abstract><notes>De, Abhijit&#xD;Loening, Andreas Markus&#xD;Gambhir, Sanjiv Sam&#xD;5R01 CA82214/CA/NCI NIH HHS/United States&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2007 Aug 1;67(15):7175-83.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>7.980</custom4><electronic-resource-num>67/15/7175 [pii]&#xD;10.1158/0008-5472.CAN-06-4623 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1065</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1065</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Arwert, E.</author><author>Hingtgen, S.</author><author>Figueiredo, J. L.</author><author>Bergquist, H.</author><author>Mahmood, U.</author><author>Weissleder, R.</author><author>Shah, K.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129, USA.</auth-address><titles><title>Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>7335-42</pages><volume>67</volume><number>15</number><edition>2007/08/03</edition><keywords><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/therapeutic use</keyword><keyword>Blotting, Western</keyword><keyword>Brain Neoplasms/genetics/immunology/*therapy</keyword><keyword>Cell Proliferation</keyword><keyword>Combined Modality Therapy</keyword><keyword>Flow Cytometry</keyword><keyword>*Gene Therapy</keyword><keyword>Genetic Engineering</keyword><keyword>Glioma/genetics/immunology/*therapy</keyword><keyword>Humans</keyword><keyword>Lentivirus/genetics</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>*RNA Interference</keyword><keyword>RNA, Small Interfering/*therapeutic use</keyword><keyword>Receptor, Epidermal Growth Factor/antagonists &amp;</keyword><keyword>inhibitors/*genetics/immunology</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17671203</accession-num><abstract>Many altered pathways in cancer cells depend on growth factor receptors. In primary malignant gliomas, the amplification/alteration of the epidermal growth factor receptor (EGFR) has been shown to play a significant role in enhancing glioma burden. In an effort to dissect the role of EGFR expression in glioma progression in vivo and evaluate targeted therapies for gliomas, we have genetically engineered glioma cells to visualize the dynamics of EGFR and targeted therapies in real time in vivo. Using engineered lentiviral vectors bearing fusions between EGFR and its exon 2 to 7 deleted variant (EGFRvIII) with green fluorescent protein (GFP) and Renilla luciferase (Rluc), we show that there is a direct correlation between EGFR expression and glioma cell proliferation in the initial stages of glioma progression. To monitor and evaluate EGFR-targeted therapies, we have engineered (a) short hairpin RNAs (shRNA) and (b) clinically used monoclonal antibody, cetuximab. Using EGFR-GFP-Rluc/firefly luciferase (Fluc)-DsRed2 glioma model, we show that both shRNAs and cetuximab result in a considerable reduction in glioma cell proliferation in culture and glioma burden in vivo that can be monitored in real time at a cellular resolution. This study serves as a template to follow the role of growth factor receptor expression in tumor progression and to image therapeutic efficacy of targeted therapies in cancer.</abstract><notes>Arwert, Esther&#xD;Hingtgen, Shawn&#xD;Figueiredo, Jose-Luiz&#xD;Bergquist, Henry&#xD;Mahmood, Umar&#xD;Weissleder, Ralph&#xD;Shah, Khalid&#xD;CA86355/CA/United States NCI&#xD;P50CA86355/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2007 Aug 1;67(15):7335-42.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17671203</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>7.980</custom4><electronic-resource-num>67/15/7335 [pii]&#xD;10.1158/0008-5472.CAN-07-0077</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1746</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1746</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, X.</author><author>Georganopoulou, D. G.</author><author>Hill, H. D.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Homogeneous detection of nucleic acids based upon the light scattering properties of silver-coated nanoparticle probes</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>6650-4</pages><volume>79</volume><number>17</number><edition>2007/08/01</edition><keywords><keyword>DNA/analysis</keyword><keyword>*Light</keyword><keyword>Metal Nanoparticles/*chemistry/ultrastructure</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nucleic Acids/*analysis</keyword><keyword>Silver/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep 1</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>17663531</accession-num><abstract>Herein we report the development of a simple, rapid, homogeneous, and sensitive detection system for DNA based on the scattering properties of silver-amplified gold nanoparticle probes. The assay uses DNA-functionalized magnetic particle probes that act as scavengers for target DNA, which can be collected via a magnetic field. Once the DNA targets are isolated from the initial sample, they are sandwiched via hybridization by a second set of probes. The latter probes are 13-nm gold nanoparticles modified with a different target complementary DNA. Excess probes are removed through repetitive washing steps. The gold particles are dispersed in solution by dehybridization, corresponding to an assumed 1:1 ratio with the target DNA. Electroless deposition of silver on the surface of the gold probes results in particle growth, which increases their scattering efficiency with time. The scattering efficiency and the extinction signatures of the particle sizes are monitored as a function of time and correlated with target concentration. The limit of detection for this novel assay was determined to be 10 fM.</abstract><notes>Xu, Xiaoyang&#xD;Georganopoulou, Dimitra G&#xD;Hill, Haley D&#xD;Mirkin, Chad A&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2007 Sep 1;79(17):6650-4. Epub 2007 Jul 31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17663531</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac070867g</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1677</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1677</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>van Vlerken, L. E.</author><author>Vyas, T. K.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 110 Mugar Life Sciences Building, Boston, Massachusetts 02115, USA.</auth-address><titles><title>Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery</title><secondary-title>Pharm Res</secondary-title><alt-title>Pharmaceutical research</alt-title></titles><periodical><full-title>Pharm Res</full-title></periodical><alt-periodical><full-title>Pharmaceutical Research</full-title></alt-periodical><pages>1405-14</pages><volume>24</volume><number>8</number><edition>2007/08</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/administration &amp; dosage/therapeutic use</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Gene Therapy/*methods</keyword><keyword>Humans</keyword><keyword>Models, Biological</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Neoplasms/drug therapy/*therapy</keyword><keyword>Polyethylene Glycols/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0724-8741 (Print)</isbn><accession-num>17393074</accession-num><abstract>The success of anti-cancer therapies largely depends on the ability of the therapeutics to reach their designated cellular and intracellular target sites, while minimizing accumulation and action at non-specific sites. Surface modification of nanoparticulate carriers with poly(ethylene glycol) (PEG)/poly(ethylene oxide) (PEO) has emerged as a strategy to enhance solubility of hydrophobic drugs, prolong circulation time, minimize non-specific uptake, and allow for specific tumor-targeting through the enhanced permeability and retention effect. Furthermore, PEG/PEO modification has emerged as a platform for incorporation of active targeting ligands, thereby providing the drug and gene carriers with specific tumor-targeting properties through a flexible tether. This review focuses on the recent developments surrounding such PEG/PEO-surface modification of polymeric nanocarriers to promote tumor-targeting capabilities, thereby enhancing efficacy of anti-cancer therapeutic strategies.</abstract><notes>Journal Article&#xD;Review&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17393074 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>3.831</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1447</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1447</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Melancon, M. P.</author><author>Wang, Y.</author><author>Wen, X.</author><author>Bankson, J. A.</author><author>Stephens, L. C.</author><author>Jasser, S.</author><author>Gelovani, J. G.</author><author>Myers, J. N.</author><author>Li, C.</author></authors></contributors><auth-address>Departments of Experimental Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</auth-address><titles><title>Development of a macromolecular dual-modality MR-optical imaging for sentinel lymph node mapping</title><secondary-title>Invest Radiol</secondary-title><alt-title>Investigative radiology</alt-title></titles><periodical><full-title>Invest Radiol</full-title></periodical><alt-periodical><full-title>Invest Radiol</full-title><abbr-1>Investigative radiology</abbr-1></alt-periodical><pages>569-78</pages><volume>42</volume><number>8</number><edition>2007/08</edition><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0020-9996 (Print)</isbn><accession-num>17620940</accession-num><abstract>OBJECTIVE: To evaluate the effectiveness of a dual magnetic resonance-near infrared fluorescence optical imaging agent, poly(l-glutamic acid)-DTPA-Gd-NIR813, for both preoperative and intraoperative visualization and characterization of sentinel lymph nodes (SLN) in mice. MATERIALS AND METHODS: Poly(L-glutamic acid) was conjugated with DTPA-Gd and NIR813 dye to obtain PG-DTPA-Gd-NIR813. To confirm drainage into the SLNs, this agent was injected subcutaneously into the front paw of nude mice followed by isosulfan blue (n = 6). Furthermore, PG-DTPA-Gd-NIR813 was injected subcutaneously at doses of 0.002 mmol Gd/kg (4.8 nmol eq. NIR813) and 0.02 mmol Gd/kg (48 nmol eq. NIR813) (n = 3/dose). To differentiate metastatic from nonmetastatic lymph nodes, nude mice bearing human oral squamous cell carcinoma (DM14) were injected intralingually with 0.02 mmol Gd/kg PG-DTPA-Gd-NIR813 (n = 3). Pre- and postcontrast images were taken using 4.7 T Bruker MRI scanner and Xenogen optical imaging system. The status of lymph nodes resected under the guidance of optical imaging was confirmed by histologic examinations. RESULTS: PG-DTPA-Gd-NIR813 colocalized with isosulfan blue, indicating drainage to the SLN. After subcutaneous injection, axiliary and branchial lymph nodes were clearly visualized with both T1-weighted MR and optical imaging within 3 minutes of contrast injection, even at the lowest dose tested (0.002 mmol Gd/kg). After intralingual injection in tumor-bearing mice, MR imaging identified 4 of the 6 superficial cervical lymph nodes, whereas near-infrared fluorescence (NIRF) optical imaging identified all 6 cervical nodes. The pattern of contrast enhancement of SLN visualized in MR images showed a characteristic ring-shaped appearance with a central filling defect, possibly resulting from nodal infiltration of metastatic lesions. Histopathologic examination of the SLNs resected under NIRF imaging guidance revealed micrometastases in all 6 SLNs identified by NIRF imaging. CONCLUSIONS: The dual modality imaging method demonstrated in this study represents an effective technique for localization and characterization of SLN.</abstract><notes>R01 ca119387/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17620940 </url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom3>2007</custom3><custom4>4.115</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1441</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1441</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCarthy, J. R.</author><author>Jaffer, F. A.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Building 149, 13th Street, Room 5406, Charlestown, MA 02129, USA. jason_mccarthy@hms.harvard.edu</auth-address><titles><title>A macrophage-targeted theranostic nanoparticle for biomedical applications</title><secondary-title>Small</secondary-title><alt-title>Small (Weinheim an der Bergstrasse, Germany)</alt-title></titles><periodical><full-title>Small</full-title></periodical><pages>983-7</pages><volume>2</volume><number>8-9</number><edition>2007/08</edition><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17193154</accession-num><notes>P50 ca86355/ca/nci&#xD;R01 hl080731/hl/nhlbi&#xD;T32 ca79443/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Germany</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17193154 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>7.292</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1336</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1336</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kirkham, M.</author><author>Wang, X.</author><author>Wang, Z.L.</author><author>Snyder, R.L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, GA 30332-0245, USA</auth-address><titles><title>Solid Au nanoparticles as a catalyst for growing aligned ZnO nanowires: a new understanding of the vapourliquidsolid process</title><secondary-title>Nanotechnology</secondary-title></titles><periodical><full-title>Nanotechnology</full-title></periodical><pages>365304</pages><volume>18</volume><number>36</number><edition>2007/08</edition><dates><year>2007</year><pub-dates><date>14 August 2007</date></pub-dates></dates><abstract>X-ray diffraction techniques have been applied to characterize the Au-catalysed growth of aligned ZnO nanowire arrays on an AlGaN/AlN/Al2O3 substrate. The orientation relationships between the AlN layer, AlGaN layer, ZnO nanowires and Au particles were determined using x-ray texture analysis. Two orientations of the Au nanoparticles, related by a 30 rotation about the sample normal, were observed. The gold lattice parameter of the ZnO nanowire sample was determined to be the same as that of a control sample never exposed to vaporized ZnO, indicating the absence of Zn in the Au catalyst particles. Our results indicate that the Au catalyst particles were solid during growth, and that growth proceeded by a surface diffusion process, rather than a bulk diffusion process.</abstract><work-type>Journal Article</work-type><urls><related-urls><url>http://www.nanoscience.gatech.edu/zlwang/paper/2007/07_NT_3.pdf</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>3.727</custom4><electronic-resource-num>10.1088/0957-4484/18/36/365304</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1296</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1296</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jarvinen, T. A.</author><author>Ruoslahti, E.</author></authors></contributors><auth-address>Cancer Research Center, Burnham Institute for Medical Research, La Jolla, CA, USA.</auth-address><titles><title>Molecular changes in the vasculature of injured tissues</title><secondary-title>Am J Pathol</secondary-title><alt-title>The American journal of pathology</alt-title></titles><periodical><full-title>Am J Pathol</full-title></periodical><alt-periodical><full-title>Am J Pathol</full-title><abbr-1>The American journal of pathology</abbr-1></alt-periodical><pages>702-11</pages><volume>171</volume><number>2</number><edition>2007/08</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Bacteriophages/genetics</keyword><keyword>CHO Cells</keyword><keyword>Cricetinae</keyword><keyword>Cricetulus</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Neovascularization, Pathologic/metabolism/*physiopathology</keyword><keyword>Oligopeptides/genetics/metabolism/*physiology</keyword><keyword>*Peptide Library</keyword><keyword>Rats</keyword><keyword>Rats, Sprague-Dawley</keyword><keyword>Skin/injuries/metabolism/physiopathology</keyword><keyword>Tendon Injuries/metabolism/physiopathology</keyword><keyword>Transfection/methods</keyword><keyword>Wound Healing/physiology</keyword><keyword>Wounds and Injuries/metabolism/*physiopathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0002-9440 (Print)</isbn><accession-num>17600129</accession-num><abstract>We have explored molecular specialization of the vasculature of regenerating wound tissue in the skin and tendons to identify a different repertoire of markers from that obtained by studying tumor vasculature. We screened a phage-displayed peptide library for peptides that home to wounds in mice and identified two peptides that selectively target phage to skin and tendon wounds: CARSKNKDC (CAR) and CRKDKC (CRK). CAR is homologous to heparin-binding sites in various proteins and binds to cell surface heparan sulfate and heparin. CRK is similar to a segment in thrombospondin type 1 repeat. Intravenously injected CAR and CRK phage, as well as fluorescein-labeled CAR and CRK peptides, selectively accumulated at wound sites, where they partially co-localized with blood vessels. The CAR peptide showed a preference for early stages of wound healing, whereas the CRK favored wounds at later stages of healing. The CAR peptide was internalized into the target cells and delivered the fluorescent label into the cell nuclei. These results identify new molecular markers in wound tissues and show that the expression of these markers in wound vasculature changes as healing progresses. The peptides recognizing these markers may be useful in delivering treatments into regenerating tissues.</abstract><notes>Ca 119335/ca/nci&#xD;Ca 30199/ca/nci&#xD;Ca 82713/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17600129 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>6.200</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1206</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1206</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Frullano, L.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Biochemistry and Molecular and Cell Biology, Neurobiology and Physiology, Radiology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208, USA.</auth-address><titles><title>Multimodal MRI contrast agents</title><secondary-title>J Biol Inorg Chem</secondary-title></titles><periodical><full-title>J Biol Inorg Chem</full-title></periodical><pages>939-49</pages><volume>12</volume><number>7</number><edition>2007/07/31</edition><keywords><keyword>Contrast Media/*chemistry</keyword><keyword>Gadolinium/chemistry</keyword><keyword>Iron/chemistry</keyword><keyword>Lanthanoid Series Elements/chemistry</keyword><keyword>Ligands</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>Molecular Structure</keyword><keyword>Nanoparticles/chemistry</keyword><keyword>Neoplasms/*diagnosis</keyword><keyword>Porphyrins/chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0949-8257 (Print)</isbn><accession-num>17659368</accession-num><notes>Frullano, Luca&#xD;Meade, Thomas J&#xD;Review&#xD;Germany&#xD;Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry&#xD;J Biol Inorg Chem. 2007 Sep;12(7):939-49. Epub 2007 Jul 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17659368</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>3.325</custom4><electronic-resource-num>10.1007/s00775-007-0265-3</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1376</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1376</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J.</author><author>Burdette, J. E.</author><author>MacRenaris, K. W.</author><author>Mustafi, D.</author><author>Woodruff, T. K.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Departments of Chemistry, Biochemistry and Molecular, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Rational design, synthesis, and biological evaluation of progesterone-modified MRI contrast agents</title><secondary-title>Chem Biol</secondary-title></titles><periodical><full-title>Chem Biol</full-title></periodical><pages>824-34</pages><volume>14</volume><number>7</number><edition>2007/07/28</edition><dates><year>2007</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1074-5521 (Print)</isbn><accession-num>17656319</accession-num><abstract>A series of contrast agents for magnetic resonance imaging (MRI) aimed at noninvasively determining the hormone receptor status of cancer in vitro was developed. These MRI contrast agents were prepared by conjugating progesterone to clinically used Gd(III) chelates. These agents exhibited higher progesterone receptor binding affinities in the nanomolar range and intracellular accumulation. High logP values of the modified compounds suggested that the lipophilicity of the steroid conjugates may have contributed to membrane permeability. Synchrotron radiation X-ray fluorescence microscopy and magnetic resonance images revealed that the synthesized conjugates showed the greatest cellular accumulation and significant increase in relaxivity in vitro compared to the previously developed steroid-modified agent. Transcriptional assays using the progesterone response element linked to luciferase indicated that the contrast agents entered the cell, interacted with the biological target, and drove specific progesterone-mediated transcription.</abstract><notes>Lee, Jiyoun&#xD;Burdette, Joanna E&#xD;MacRenaris, Keith W&#xD;Mustafi, Devkumar&#xD;Woodruff, Teresa K&#xD;Meade, Thomas J&#xD;1 r01 eb005866-01/eb/nibib&#xD;5 u54 ca90810/ca/nci&#xD;R01 hd044464/hd/nichd&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Chemistry &amp; biology&#xD;Chem Biol. 2007 Jul;14(7):824-34.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17656319</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>5.743</custom4><electronic-resource-num>S1074-5521(07)00211-6 [pii]&#xD;10.1016/j.chembiol.2007.06.006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1247</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1247</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>He, J. H.</author><author>Zhang, Y. Y.</author><author>Liu, J.</author><author>Moore, D.</author><author>Bao, G.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>Graduate Institute of Electro-Optical Engineering and Department of Electrical Engineering, National Taiwan University, Taipei, 106 Taiwan, School of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332-0245, and School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245</auth-address><titles><title>ZnS/Silica Nanocable Field Effect Transistors as Biological and Chemical Nanosensors</title><secondary-title>J. Phys. Chem. C</secondary-title></titles><periodical><full-title>J. Phys. Chem. C</full-title></periodical><pages>12152-12156</pages><volume>111</volume><number>33</number><edition>2007/07/27 </edition><dates><year>2007</year><pub-dates><date>July </date></pub-dates></dates><isbn>1932-7447</isbn><abstract>Abstract: Compound semiconductor/isolator (ZnS/silica) core/shell nanocables have been used to fabricate single nanowire-based field effect transistors. Using the surface-adsorbed charged molecules as the gate, the nanocable-based devices show potential for label-free, real-time, and sensitive detection of biological species. After chemical modification, amine- and oxide-functionalized nanocables exhibit linear pH-dependent conductance, which could be elucidated in terms of the changes of surface charge during protonation and deprotonation. Selective biological recognition of nanocable sensors has been demonstrated using biotinylation.</abstract><urls><related-urls><url>http://pubs3.acs.org/acs/journals/doilookup?in_doi=10.1021/jp074772u</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>3.398</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1963</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1963</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Vyas, T. K.</author><author>Shahiwala, A.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 110 Mugar Life Sciences Building, Boston, MA 02115, USA.</auth-address><titles><title>Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations</title><secondary-title>Int J Pharm</secondary-title></titles><periodical><full-title>Int J Pharm</full-title></periodical><pages>93-101</pages><volume>347</volume><number>1-2</number><edition>2007/07/27</edition><keywords><keyword>Administration, Oral</keyword><keyword>Animals</keyword><keyword>Area Under Curve</keyword><keyword>Biological Availability</keyword><keyword>Brain/ metabolism</keyword><keyword>Deoxycholic Acid/chemistry</keyword><keyword>Emulsions</keyword><keyword>HIV Protease Inhibitors/administration &amp; dosage/chemistry/pharmacokinetics</keyword><keyword>Injections, Intravenous</keyword><keyword>Linseed Oil/chemistry</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanotechnology/ methods</keyword><keyword>Particle Size</keyword><keyword>Phosphatidylcholines/chemistry</keyword><keyword>Plant Oils/chemistry</keyword><keyword>Saquinavir/administration &amp; dosage/chemistry/ pharmacokinetics</keyword><keyword>Sonication</keyword><keyword>Static Electricity</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2008</year><pub-dates><date>Jan 22</date></pub-dates></dates><isbn>0378-5173 (Print)</isbn><accession-num>17651927</accession-num><abstract>The aim of this investigation was to develop novel oil-in-water (o/w) nanoemulsions containing Saquinavir (SQV), an anti-HIV protease inhibitor, for enhanced oral bioavailability and brain disposition. SQV was dissolved in different types of edible oils rich in essential polyunsaturated fatty acids (PUFA) to constitute the internal oil phase of the nanoemulsions. The external phase consisted of surfactants Lipoid-80 and deoxycholic acid dissolved in water. The nanoemulsions with an average oil droplet size of 100-200 nm, containing tritiated [(3)H]-SQV, were administered orally and intravenously to male Balb/c mice. The SQV bioavailability as well as distribution in different organ systems was examined. SQV concentrations in the systemic circulation administered in flax-seed oil nanoemulsions were threefold higher as compared to the control aqueous suspension. The oral bioavailability and distribution to the brain, a potential sanctuary site for HIV, were significantly enhanced with SQV delivered in nanoemulsion formulations. In comparing SQV in flax-seed oil nanoemulsion with aqueous suspension, the maximum concentration (C(max)) and the area-under-the-curve (AUC) values were found to be five- and threefold higher in the brain, respectively, suggesting enhanced rate and extent of SQV absorption following oral administration of nanoemulsions. The results of this study show that oil-in-water nanoemulsions made with PUFA-rich oils may be very promising for HIV/AIDS therapy, in particular, for reducing the viral load in important anatomical reservoir sites.</abstract><notes>Vyas, Tushar K&#xD;Shahiwala, Aliasgar&#xD;Amiji, Mansoor M&#xD;R01 CA119617-01/CA/NCI NIH HHS/United States&#xD;R01 CA119617-02/CA/NCI NIH HHS/United States&#xD;R01 CA119617-03/CA/NCI NIH HHS/United States&#xD;Netherlands&#xD;International journal of pharmaceutics&#xD;Int J Pharm. 2008 Jan 22;347(1-2):93-101. Epub 2007 Jun 19.</notes><urls></urls><custom1>CNPP - Northeastern</custom1><custom2>2213794</custom2><custom3>NIHMS37580</custom3><custom4>3.431</custom4><electronic-resource-num>S0378-5173(07)00516-9 [pii]&#xD;10.1016/j.ijpharm.2007.06.016 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1736</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1736</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wu, H. J.</author><author>Sawaya, H.</author><author>Binstadt, B.</author><author>Brickelmaier, M.</author><author>Blasius, A.</author><author>Gorelik, L.</author><author>Mahmood, U.</author><author>Weissleder, R.</author><author>Carulli, J.</author><author>Benoist, C.</author><author>Mathis, D.</author></authors></contributors><auth-address>Section on Immunology and Immunogenetics, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02115, USA.</auth-address><titles><title>Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk</title><secondary-title>J Exp Med</secondary-title></titles><periodical><full-title>J Exp Med</full-title></periodical><pages>1911-22</pages><volume>204</volume><number>8</number><edition>2007/07/25</edition><keywords><keyword>Animals</keyword><keyword>Anti-Inflammatory Agents/pharmacology</keyword><keyword>Arthritis/*therapy</keyword><keyword>*CpG Islands</keyword><keyword>Dendritic Cells/*cytology/immunology</keyword><keyword>Immunotherapy/*methods</keyword><keyword>Inflammation/*therapy</keyword><keyword>Interferon Type II/metabolism</keyword><keyword>Interleukin-12/metabolism</keyword><keyword>Killer Cells, Natural/*cytology/immunology</keyword><keyword>Mice</keyword><keyword>Models, Biological</keyword><keyword>Neutrophils/metabolism</keyword><keyword>Oligonucleotides/chemistry</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 6</date></pub-dates></dates><isbn>0022-1007 (Print)</isbn><accession-num>17646407</accession-num><abstract>Unmethylated CpG-oligodeoxynucleotides (ODNs) are generally thought of as potent adjuvants with considerable therapeutic potential to enhance immune responses against microbes and tumors. Surprisingly, certain so-called stimulatory CpG-ODNs strongly inhibited the effector phase of inflammatory arthritis in the K/BxN serum transfer system, either preventively or therapeutically. Also unexpected was that the inhibitory influence did not depend on the adaptive immune system cells mobilized in an immunostimulatory context. Instead, they relied on cells of the innate immune system, specifically on cross talk between CD8 alpha(+) dendritic cells and natural killer cells, resulting in suppression of neutrophil recruitment to the joint, orchestrated through interleukin-12 and interferon-gamma. These findings highlight potential applications of CpG-ODNs and downstream molecules as antiinflammatory agents.</abstract><notes>Wu, Hsin-Jung&#xD;Sawaya, Heloisa&#xD;Binstadt, Bryce&#xD;Brickelmaier, Margot&#xD;Blasius, Amanda&#xD;Gorelik, Leonid&#xD;Mahmood, Umar&#xD;Weissleder, Ralph&#xD;Carulli, John&#xD;Benoist, Christophe&#xD;Mathis, Diane&#xD;P01 AI54904/AI/United States NIAID&#xD;R24 CA 92782/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of experimental medicine&#xD;J Exp Med. 2007 Aug 6;204(8):1911-22. Epub 2007 Jul 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17646407</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>15.504</custom4><electronic-resource-num>jem.20070285 [pii]&#xD;10.1084/jem.20070285</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1545</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1545</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rieter, W. J.</author><author>Taylor, K. M.</author><author>Lin, W.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Surface modification and functionalization of nanoscale metal-organic frameworks for controlled release and luminescence sensing</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9852-3</pages><volume>129</volume><number>32</number><edition>2007/07/25</edition><keywords><keyword>Delayed-Action Preparations</keyword><keyword>Dicarboxylic Acids/chemistry</keyword><keyword>Lanthanoid Series Elements/*chemistry</keyword><keyword>Nanocomposites/*chemistry</keyword><keyword>Organometallic Compounds/chemical synthesis/chemistry</keyword><keyword>Povidone/chemistry</keyword><keyword>Silicon Dioxide/*chemistry</keyword><keyword>Surface Properties</keyword><keyword>X-Ray Diffraction</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 15</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17645339</accession-num><notes>Rieter, William J&#xD;Taylor, Kathryn M L&#xD;Lin, Wenbin&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Aug 15;129(32):9852-3. Epub 2007 Jul 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17645339</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja073506r</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1211</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1211</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gao, Y.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245, USA.</auth-address><titles><title>Electrostatic potential in a bent piezoelectric nanowire. The fundamental theory of nanogenerator and nanopiezotronics</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>2499-505</pages><volume>7</volume><number>8</number><edition>2007/07/25</edition><keywords><keyword>Computer Simulation</keyword><keyword>Elasticity</keyword><keyword>*Electric Power Supplies</keyword><keyword>Electromagnetic Fields</keyword><keyword>Electronics/*instrumentation</keyword><keyword>Electrostatics</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>*Models, Chemical</keyword><keyword>Nanotechnology/*instrumentation/methods</keyword><keyword>Nanotubes/*chemistry</keyword><keyword>*Transducers</keyword><keyword>Vibration</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17645367</accession-num><abstract>We have applied the perturbation theory for calculating the piezoelectric potential distribution in a nanowire (NW) as pushed by a lateral force at the tip. The analytical solution given under the first-order approximation produces a result that is within 6% from the full numerically calculated result using the finite element method. The calculation shows that the piezoelectric potential in the NW almost does not depend on the z-coordinate along the NW unless very close to the two ends, meaning that the NW can be approximately taken as a &quot;parallel plated capacitor&quot;. This is entirely consistent to the model established for nanopiezotronics, in which the potential drop across the nanowire serves as the gate voltage for the piezoelectric field effect transistor. The maximum potential at the surface of the NW is directly proportional to the lateral displacement of the NW and inversely proportional to the cube of its length-to-diameter aspect ratio. The magnitude of piezoelectric potential for a NW of diameter 50 nm and length 600 nm is approximately 0.3 V. This voltage is much larger than the thermal voltage ( approximately 25 mV) and is high enough to drive the metal-semiconductor Schottky diode at the interface between atomic force microscope tip and the ZnO NW, as assumed in our original mechanism for the nanogenerators.</abstract><notes>Gao, Yifan&#xD;Wang, Zhong Lin&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Aug;7(8):2499-505. Epub 2007 Jul 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17645367</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl071310j</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1217</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1217</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gratton, S. E.</author><author>Pohlhaus, P. D.</author><author>Lee, J.</author><author>Guo, J.</author><author>Cho, M. J.</author><author>Desimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles</title><secondary-title>J Control Release</secondary-title></titles><periodical><full-title>J Control Release</full-title></periodical><pages>10-8</pages><volume>121</volume><number>1-2</number><edition>2007/07/24</edition><dates><year>2007</year><pub-dates><date>Aug 16</date></pub-dates></dates><isbn>1873-4995 (Electronic)</isbn><accession-num>17643544</accession-num><abstract>A novel method for the fabrication of polymeric particles on the order of tens of nanometers to several microns is described. This imprint lithographic technique called PRINT (Particle Replication In Non-wetting Templates), takes advantage of the unique properties of elastomeric molds comprised of a low surface energy perfluoropolyether network, allowing the production of monodisperse, shape-specific nanoparticles from an extensive array of organic precursors. This engineered nature of particle production has a number of advantages over the construction of traditional nanoparticles such as liposomes, dendrimers, and colloidal precipitates. The gentle &quot;top down&quot; approach of PRINT enables the simultaneous and independent control over particle size and shape, composition, and surface functionality, and permits the loading of delicate cargos such as small organic therapeutics and biological macromolecules. Thus, this single tool serves as a comprehensive platform for the rational design and investigation of new nanocarriers in medicine, having applications ranging from therapeutics to advanced diagnostics. Preliminary in vitro and in vivo studies were conducted, demonstrating the future utility of PRINT particles as delivery vectors in nanomedicine. Monodisperse 200 nm poly(ethylene glycol)-based (PEG) particles were fabricated using PRINT methodology and characterized via scanning electron microscopy and dynamic light scattering. Incubation with HeLa cells showed very little cytotoxicity, even at high concentrations. The biodistribution and pharmacokinetics of [(125)I]-labeled particles were studied in healthy mice following bolus tail vein administration. The particles were distributed mainly to the liver and the spleen with an apparent distribution t(1/2) of approximately 17 min followed by slow redistribution with a t(1/2) of 3.3 h. The volume of distribution for the central and peripheral compartments was found to be approximately 3 mL and 5 mL, respectively.</abstract><notes>Gratton, Stephanie E A&#xD;Pohlhaus, Patrick D&#xD;Lee, Jin&#xD;Guo, Ji&#xD;Cho, Moo J&#xD;Desimone, Joseph M&#xD;P01-gm59299/gm/nigms&#xD;U54-ca119343/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Netherlands&#xD;Journal of controlled release : official journal of the Controlled Release Society&#xD;J Control Release. 2007 Aug 16;121(1-2):10-8. Epub 2007 Jun 2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17643544</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>4.756</custom4><electronic-resource-num>S0168-3659(07)00269-6 [pii]&#xD;10.1016/j.jconrel.2007.05.027</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1515</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1515</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pittet, M. J.</author><author>Grimm, J.</author><author>Berger, C. R.</author><author>Tamura, T.</author><author>Wojtkiewicz, G.</author><author>Nahrendorf, M.</author><author>Romero, P.</author><author>Swirski, F. K.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Simches Research Building, 185 Cambridge Street, Boston, MA 02114, USA. mpittet@mgh.harvard.edu</auth-address><titles><title>In vivo imaging of T cell delivery to tumors after adoptive transfer therapy</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>12457-61</pages><volume>104</volume><number>30</number><edition>2007/07/21</edition><keywords><keyword>*Adoptive Transfer</keyword><keyword>Animals</keyword><keyword>Antigens/immunology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Movement</keyword><keyword>*Immunotherapy, Adoptive</keyword><keyword>Lymphopenia/immunology/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Neoplasms/*immunology/*pathology/therapy</keyword><keyword>T-Lymphocytes/*cytology/*immunology</keyword><keyword>Tomography Scanners, X-Ray Computed</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 24</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17640914</accession-num><abstract>Adoptive transfer therapy of in vitro-expanded tumor-specific cytolytic T lymphocytes (CTLs) can mediate objective cancer regression in patients. Yet, technical limitations hamper precise monitoring of posttherapy T cell responses. Here we show in a mouse model that fused single photon emission computed tomography and x-ray computed tomography allows quantitative whole-body imaging of (111)In-oxine-labeled CTLs at tumor sites. Assessment of CTL localization is rapid, noninvasive, three-dimensional, and can be repeated for longitudinal analyses. We compared the effects of lymphodepletion before adoptive transfer on CTL recruitment and report that combined treatment increased intratumoral delivery of CTLs and improved antitumor efficacy. Because (111)In-oxine is a Food and Drug Administration-approved clinical agent, and human SPECT-CT systems are available, this approach should be clinically translatable, insofar as it may assess the efficacy of immunization procedures in individual patients and lead to development of more effective therapies.</abstract><notes>Pittet, Mikael J&#xD;Grimm, Jan&#xD;Berger, Cedric R&#xD;Tamura, Takahiko&#xD;Wojtkiewicz, Gregory&#xD;Nahrendorf, Matthias&#xD;Romero, Pedro&#xD;Swirski, Filip K&#xD;Weissleder, Ralph&#xD;P50-CA086355/CA/United States NCI&#xD;R24-CA92782/CA/United States NCI&#xD;U54-CA126515-01/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12457-61. Epub 2007 Jul 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17640914</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>10.228</custom4><electronic-resource-num>0704460104 [pii]&#xD;10.1073/pnas.0704460104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1476</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1476</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Norville, J. E.</author><author>Kelly, D. F.</author><author>Knight, T. F., Jr.</author><author>Belcher, A. M.</author><author>Walz, T.</author></authors></contributors><auth-address>MIT Computer Science and Artificial Intelligence Laboratory, 32 Vassar Street, Cambridge, MA 02139, USA.</auth-address><titles><title>7A projection map of the S-layer protein sbpA obtained with trehalose-embedded monolayer crystals</title><secondary-title>J Struct Biol</secondary-title></titles><periodical><full-title>J Struct Biol</full-title></periodical><pages>313-23</pages><volume>160</volume><number>3</number><edition>2007/07/20</edition><keywords><keyword>Bacillus/*chemistry</keyword><keyword>Bacterial Proteins/chemistry/isolation &amp; purification/*ultrastructure</keyword><keyword>Carbon</keyword><keyword>Cryoelectron Microscopy/instrumentation/*methods</keyword><keyword>Crystallization/*methods</keyword><keyword>Crystallography/instrumentation/*methods</keyword><keyword>Dimyristoylphosphatidylcholine</keyword><keyword>Ethane</keyword><keyword>Monosaccharide Transport Proteins/chemistry/isolation &amp;</keyword><keyword>purification/*ultrastructure</keyword><keyword>Negative Staining/methods</keyword><keyword>Porosity</keyword><keyword>Protein Conformation</keyword><keyword>Quaternary Ammonium Compounds</keyword><keyword>Specimen Handling/instrumentation/*methods</keyword><keyword>Trehalose</keyword></keywords><dates><year>2007</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1095-8657 (Electronic)</isbn><accession-num>17638580</accession-num><abstract>Two-dimensional crystallization on lipid monolayers is a versatile tool to obtain structural information of proteins by electron microscopy. An inherent problem with this approach is to prepare samples in a way that preserves the crystalline order of the protein array and produces specimens that are sufficiently flat for high-resolution data collection at high tilt angles. As a test specimen to optimize the preparation of lipid monolayer crystals for electron microscopy imaging, we used the S-layer protein sbpA, a protein with potential for designing arrays of both biological and inorganic materials with engineered properties for a variety of nanotechnology applications. Sugar embedding is currently considered the best method to prepare two-dimensional crystals of membrane proteins reconstituted into lipid bilayers. We found that using a loop to transfer lipid monolayer crystals to an electron microscopy grid followed by embedding in trehalose and quick-freezing in liquid ethane also yielded the highest resolution images for sbpA lipid monolayer crystals. Using images of specimens prepared in this way we could calculate a projection map of sbpA at 7A resolution, one of the highest resolution projection structures obtained with lipid monolayer crystals to date.</abstract><notes>Norville, Julie E&#xD;Kelly, Deborah F&#xD;Knight, Thomas F Jr&#xD;Belcher, Angela M&#xD;Walz, Thomas&#xD;GM62580/GM/United States NIGMS&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of structural biology&#xD;J Struct Biol. 2007 Dec;160(3):313-23. Epub 2007 Jun 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17638580</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2008</custom3><custom4>3.677</custom4><electronic-resource-num>S1047-8477(07)00140-2 [pii]&#xD;10.1016/j.jsb.2007.06.002</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2297</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2297</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Oyelere, A. K.</author><author>Chen, P. C.</author><author>Huang, X.</author><author>El-Sayed, I. H.</author><author>El-Sayed, M. A.</author></authors></contributors><auth-address>Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, 901 Atlantic Drive, Atlanta, Georgia 30332, USA. aoyelere@gatech.edu</auth-address><titles><title>Peptide-conjugated gold nanorods for nuclear targeting</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>1490-7</pages><volume>18</volume><number>5</number><edition>2007/07/17</edition><keywords><keyword>Absorption</keyword><keyword>Biosensing Techniques/ methods</keyword><keyword>Cell Line/ultrastructure</keyword><keyword>Diagnostic Imaging/ methods</keyword><keyword>Epithelial Cells/pathology</keyword><keyword>Gold/ chemistry</keyword><keyword>Humans</keyword><keyword>Mouth Neoplasms/pathology</keyword><keyword>Nanotubes/ chemistry</keyword><keyword>Peptides/ chemistry</keyword><keyword>Spectroscopy, Near-Infrared/methods</keyword><keyword>Spectrum Analysis, Raman/methods</keyword><keyword>Surface Plasmon Resonance/methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep-Oct</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>17630680</accession-num><abstract>Resonant electron oscillations on the surface of noble metal nanoparticles (Au, Ag, Cu) create the surface plasmon resonance (SPR) that greatly enhances the absorption and Rayleigh (Mie) scattering of light by these particles. By adjusting the size and shape of the particles from spheres to rods, the SPR absorption and scattering can be tuned from the visible to the near-infrared region (NIR) where biologic tissues are relatively transparent. Further, gold nanorods greatly enhance surface Raman scattering of adsorbed molecules. These unique properties make gold nanorods especially attractive as optical sensors for biological and medical applications. In the present work, gold nanorods are covalently conjugated with a nuclear localization signal peptide through a thioalkyl-triazole linker and incubated with an immortalized benign epithelial cell line and an oral cancer cell line. Dark field light SPR scattering images demonstrate that nanorods are located in both the cytoplasm and nucleus of both cell lines. Single cell micro-Raman spectra reveal enhanced Raman bands of the peptide as well as molecules in the cytoplasm and the nucleus. Further, the Raman spectra reveal a difference between benign and cancer cell lines. This work represents an important step toward both imaging and Raman-based intracellular biosensing with covalently linked ligand-nanorod probes.</abstract><notes>Oyelere, Adegboyega K&#xD;Chen, Po C&#xD;Huang, Xiaohua&#xD;El-Sayed, Ivan H&#xD;El-Sayed, Mostafa A&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2007 Sep-Oct;18(5):1490-7. Epub 2007 Jul 13.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>4.802</custom4><electronic-resource-num>10.1021/bc070132i [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1255</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1255</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hodgson, L.</author><author>Chan, E. W.</author><author>Hahn, K. M.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry, Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3290, USA.</auth-address><titles><title>Combining surface chemistry with a FRET-based biosensor to study the dynamics of RhoA GTPase activation in cells on patterned substrates</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9264-5</pages><volume>129</volume><number>30</number><edition>2007/07/13</edition><keywords><keyword>Animals</keyword><keyword>Biosensing Techniques/instrumentation/*methods</keyword><keyword>Cell Adhesion/drug effects/physiology</keyword><keyword>Cell Line</keyword><keyword>Fibronectins/chemistry</keyword><keyword>Fluorescence Resonance Energy Transfer/instrumentation/*methods</keyword><keyword>Glass/chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Hydrophobicity</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Sulfhydryl Compounds/chemistry</keyword><keyword>Surface Properties</keyword><keyword>rhoA GTP-Binding Protein/*analysis/chemistry/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17625860</accession-num><notes>Hodgson, Louis&#xD;Chan, Eugene W L&#xD;Hahn, Klaus M&#xD;Yousaf, Muhammad N&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Aug 1;129(30):9264-5. Epub 2007 Jul 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17625860</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja072900m</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1569</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1569</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shachaf, C. M.</author><author>Perez, O. D.</author><author>Youssef, S.</author><author>Fan, A. C.</author><author>Elchuri, S.</author><author>Goldstein, M. J.</author><author>Shirer, A. E.</author><author>Sharpe, O.</author><author>Chen, J.</author><author>Mitchell, D. J.</author><author>Chang, M.</author><author>Nolan, G. P.</author><author>Steinman, L.</author><author>Felsher, D. W.</author></authors></contributors><auth-address>Division of Medical Oncology, Department of Medicine, Stanford University, Stanford, CA 94305-5151, USA.</auth-address><titles><title>Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis</title><secondary-title>Blood</secondary-title></titles><periodical><full-title>Blood</full-title></periodical><pages>2674-84</pages><volume>110</volume><number>7</number><edition>2007/07/12</edition><keywords><keyword>Animals</keyword><keyword>Cell Survival</keyword><keyword>Cell Transformation, Neoplastic/genetics/metabolism/*pathology</keyword><keyword>Cells, Cultured</keyword><keyword>Flow Cytometry</keyword><keyword>Gene Expression Profiling</keyword><keyword>Glycine/genetics/metabolism</keyword><keyword>Heptanoic Acids/*pharmacology</keyword><keyword>Humans</keyword><keyword>Hydroxymethylglutaryl CoA Reductases/*metabolism</keyword><keyword>Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology</keyword><keyword>Lymphoma/*metabolism/pathology/*prevention &amp; control</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>Mutation/genetics</keyword><keyword>Oncogene Protein p55(v-myc)/genetics/*metabolism</keyword><keyword>Phosphoproteins/metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Precancerous Conditions/pathology</keyword><keyword>Pyrroles/*pharmacology</keyword><keyword>Signal Transduction</keyword><keyword>Survival Rate</keyword><keyword>ras Proteins/genetics/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct 1</date></pub-dates></dates><isbn>0006-4971 (Print)</isbn><accession-num>17622571</accession-num><abstract>Statins are a class of drugs that inhibit 3-hydroxy-3-methylglutaryl-coenzyme A (HMGcoA) reductase, a critical enzyme in the mevalonate pathway. Several reports document that statins may prevent different human cancers. However, whether or not statins can prevent cancer is controversial due to discordant results. One possible explanation for these conflicting conclusions is that only some tumors or specific statins may be effective. Here, we demonstrate in an in vivo transgenic model in which atorvastatin reverses and prevents the onset of MYC-induced lymphomagenesis, but fails to reverse or prevent tumorigenesis in the presence of constitutively activated K-Ras (G12D). Using phosphoprotein fluorescence-activated cell sorter (FACS) analysis, atorvastatin treatment was found to result in the inactivation of the Ras and ERK1/2 signaling pathways associated with the dephosphorylation and inactivation of MYC. Correspondingly, tumors with a constitutively activated K-Ras (G12D) did not exhibit dephosphorylation of ERK1/2 and MYC. Atorvastatin&apos;s effects on MYC were specific to the inhibition of HMGcoA reductase, as treatment with mevalonate, the product of HMG-CoA reductase activity, abrogated these effects and inhibited the ability of atorvastatin to reverse or suppress tumorigenesis. Also, RNAi directed at HMGcoA reductase was sufficient to abrogate the neoplastic properties of MYC-induced tumors. Thus, atorvastatin, by inhibiting HMGcoA reductase, induces changes in phosphoprotein signaling that in turn prevent MYC-induced lymphomagenesis.</abstract><notes>Shachaf, Catherine M&#xD;Perez, Omar D&#xD;Youssef, Sawsan&#xD;Fan, Alice C&#xD;Elchuri, Sailaja&#xD;Goldstein, Matthew J&#xD;Shirer, Amy E&#xD;Sharpe, Orr&#xD;Chen, Joy&#xD;Mitchell, Dennis J&#xD;Chang, Maria&#xD;Nolan, Garry P&#xD;Steinman, Lawrence&#xD;Felsher, Dean W&#xD;1 R01 CA105102/CA/United States NCI&#xD;1 R01 CA89305-01A1/CA/United States NCI&#xD;3 R01 CA89305-0351/CA/United States NCI&#xD;AI/GF41520-01/AI/United States NIAID&#xD;AI35304/AI/United States NIAID&#xD;AR44565/AR/United States NIAMS&#xD;N01 AR62227/AR/United States NIAMS&#xD;N01 HV281831/HV/United States NHLBI&#xD;P01 AI39646/AI/United States NIAID&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Blood&#xD;Blood. 2007 Oct 1;110(7):2674-84. Epub 2007 Jul 10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17622571</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>9.691</custom4><electronic-resource-num>blood-2006-09-048033 [pii]&#xD;10.1182/blood-2006-09-048033</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1770</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1770</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Young, A. N.</author><author>Master, V. A.</author><author>Amin, M. B.</author></authors></contributors><auth-address>Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA. andrew.n.young@emory.edu</auth-address><titles><title>Current trends in the molecular classification of renal neoplasms</title><secondary-title>ScientificWorldJournal</secondary-title><alt-title>TSW Urology</alt-title></titles><periodical><full-title>ScientificWorldJournal</full-title><abbr-1>TSW Urology</abbr-1></periodical><alt-periodical><full-title>ScientificWorldJournal</full-title><abbr-1>TSW Urology</abbr-1></alt-periodical><pages>2505-18</pages><volume>6</volume><edition>2007/07/11</edition><keywords><keyword>Carcinoma, Renal Cell/*diagnosis/*pathology</keyword><keyword>Computational Biology</keyword><keyword>Gene Expression Profiling</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Kidney Neoplasms/*diagnosis/*genetics/*pathology</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Prognosis</keyword><keyword>Software</keyword><keyword>Treatment Outcome</keyword><keyword>Tumor Markers, Biological</keyword></keywords><dates><year>2006</year><pub-dates><date>July</date></pub-dates></dates><isbn>1537-744X (Electronic)</isbn><accession-num>17619725</accession-num><abstract>Renal cell carcinoma (RCC) is the most common form of kidney cancer in adults. RCC is a significant challenge for pathologic diagnosis and clinical management. The primary approach to diagnosis is by light microscopy, using the World Health Organization (WHO) classification system, which defines histopathologic tumor subtypes with distinct clinical behavior and underlying genetic mutations. However, light microscopic diagnosis of RCC subtypes is often difficult due to variable histology. In addition, the clinical behavior of RCC is highly variable and therapeutic response rates are poor. Few clinical assays are available to predict outcome in RCC or correlate behavior with histology. Therefore, novel RCC classification systems based on gene expression should be useful for diagnosis, prognosis, and treatment. Recent microarray studies have shown that renal tumors are characterized by distinct gene expression profiles, which can be used to discover novel diagnostic and prognostic biomarkers. Here, we review clinical features of kidney cancer, the WHO classification system, and the growing role of molecular classification for diagnosis, prognosis, and therapy of this disease.</abstract><notes>Young, Andrew N&#xD;Master, Viraj A&#xD;Amin, Mahul B&#xD;1 u54 ca119338-02/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;England&#xD;TheScientificWorldJournal&#xD;ScientificWorldJournal. 2006 Dec 15;6:2505-18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17619725</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>0.877</custom4><electronic-resource-num>10.1100/tsw.2006.390</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1535</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1535</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Reddi, A. L.</author><author>Ying, G.</author><author>Duan, L.</author><author>Chen, G.</author><author>Dimri, M.</author><author>Douillard, P.</author><author>Druker, B. J.</author><author>Naramura, M.</author><author>Band, V.</author><author>Band, H.</author></authors></contributors><auth-address>Division of Molecular Oncology, Evanston Northwestern Healthcare Research Institute, Northwestern University, Evanston, Illinois 60201, USA.</auth-address><titles><title>Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation</title><secondary-title>J Biol Chem</secondary-title></titles><periodical><full-title>J Biol Chem</full-title></periodical><pages>29336-47</pages><volume>282</volume><number>40</number><edition>2007/07/11</edition><keywords><keyword>Animals</keyword><keyword>Binding Sites</keyword><keyword>Cell Line, Tumor</keyword><keyword>Enzyme Inhibitors/pharmacology</keyword><keyword>*Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Ligands</keyword><keyword>Mice</keyword><keyword>Phospholipase C gamma/*metabolism</keyword><keyword>Protein Binding</keyword><keyword>Proto-Oncogene Proteins c-cbl/metabolism/*physiology</keyword><keyword>Receptor, Platelet-Derived Growth Factor beta/*metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Ubiquitin/metabolism</keyword><keyword>Wound Healing</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct 5</date></pub-dates></dates><isbn>0021-9258 (Print)</isbn><accession-num>17620338</accession-num><abstract>Ubiquitin conjugation to receptor tyrosine kinases is a critical biochemical step in attenuating their signaling through lysosomal degradation. Our previous studies have established Cbl as an E3 ubiquitin ligase for ubiquitinylation and degradation of platelet-derived growth factor receptor (PDGFR) alpha and PDGFRbeta. However, the role of endogenous Cbl in PDGFR regulation and the molecular mechanisms of this regulation remain unclear. Here, we demonstrate that endogenous Cbl is essential for ligand-induced ubiquitinylation and degradation of PDGFRbeta; this involves the Cbl TKB domain binding to PDGFRbeta phosphotyrosine 1021, a known phospholipase C (PLC) gamma1 SH2 domain-binding site. Lack of Cbl or ablation of the Cbl-binding site on PDGFRbeta impedes receptor sorting to the lysosome. Cbl-deficient cells also show more PDGF-induced PLCgamma1 association with PDGFRbeta and enhanced PLC-mediated cell migration. Thus, Cbl-dependent negative regulation of PDGFRbeta involves a dual mechanism that concurrently promotes ubiquitin-dependent lysosomal sorting of the receptor and competitively reduces the recruitment of a positive mediator of receptor signaling.</abstract><notes>Reddi, Alagarsamy Lakku&#xD;Ying, GuoGuang&#xD;Duan, Lei&#xD;Chen, Gengsheng&#xD;Dimri, Manjari&#xD;Douillard, Patrice&#xD;Druker, Brian J&#xD;Naramura, Mayumi&#xD;Band, Vimla&#xD;Band, Hamid&#xD;1U54 CA119341-01/CA/United States NCI&#xD;CA 87986/CA/United States NCI&#xD;CA 99900/CA/United States NCI&#xD;CA76118/CA/United States NCI&#xD;CA81076/CA/United States NCI&#xD;CA94143/CA/United States NCI&#xD;CA96844/CA/United States NCI&#xD;CA99163/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The Journal of biological chemistry&#xD;J Biol Chem. 2007 Oct 5;282(40):29336-47. Epub 2007 Jul 9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17620338</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>5.808</custom4><electronic-resource-num>M701797200 [pii]&#xD;10.1074/jbc.M701797200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1492</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1492</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, S. Y.</author><author>Gibbs-Davis, J. M.</author><author>Nguyen, S. T.</author><author>Schatz, G. C.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, Illinois 60208, USA.</auth-address><titles><title>Sharp melting in DNA-linked nanostructure systems: thermodynamic models of DNA-linked polymers</title><secondary-title>J Phys Chem B</secondary-title></titles><periodical><full-title>J Phys Chem B</full-title></periodical><pages>8785-91</pages><volume>111</volume><number>30</number><edition>2007/07/10</edition><keywords><keyword>Base Sequence</keyword><keyword>Chemistry, Physical</keyword><keyword>DNA/*chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Models, Theoretical</keyword><keyword>Molecular Sequence Data</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Polymers/*chemistry</keyword><keyword>*Thermodynamics</keyword><keyword>Transition Temperature</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 2</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>17616117</accession-num><abstract>Sharp melting that has been found for DNA-linked nanostructure systems such as DNA-linked gold nanoparticles enhances the resolution of DNA sequence detection enough to distinguish between a perfect match and single base pair mismatches. One intriguing explanation of the sharp melting involves the cooperative dehybridization of DNA strands between the nanostructures. However, in the DNA-linked gold nanoparticle system, strong optical absorption by the gold nanoparticles hinders the direct observation of cooperativity. Here, with a combination of theory and experiment, we investigate a DNA-linked polymer system in which we can show that the optical profile of the system at 260 nm is directly related to the individual DNA dehybridization profile, providing a clear distinction from other possible mechanisms. We find that cooperativity plays a crucial role in determining both the value of the melting temperature and the shape of the melting profile well away from the melting temperature. Our analysis suggests that the dehybridization properties of DNA strands in confined or dense structures differ from DNA in solution.</abstract><notes>Park, Sung Yong&#xD;Gibbs-Davis, Julianne M&#xD;Nguyen, Sonbinh T&#xD;Schatz, George C&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2007 Aug 2;111(30):8785-91. Epub 2007 Jul 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17616117</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.688</custom4><electronic-resource-num>10.1021/jp071985a</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1414</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1414</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Loening, A. M.</author><author>Wu, A. M.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Departments of Radiology and Bioengineering, Bio-X Program, Stanford University, Stanford, California 94305, USA.</auth-address><titles><title>Red-shifted Renilla reniformis luciferase variants for imaging in living subjects</title><secondary-title>Nat Methods</secondary-title></titles><periodical><full-title>Nat Methods</full-title></periodical><pages>641-3</pages><volume>4</volume><number>8</number><edition>2007/07/10</edition><keywords><keyword>Animals</keyword><keyword>Humans</keyword><keyword>Luciferases, Renilla/genetics/*metabolism</keyword><keyword>Luminescence</keyword><keyword>Mice</keyword><keyword>Mutagenesis, Site-Directed</keyword><keyword>Renilla/*enzymology</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1548-7091 (Print)</isbn><accession-num>17618292</accession-num><abstract>The use of R. reniformis luciferase (RLuc) as a reporter gene in small-animal imaging has been hampered by its 481 nm peaked emission spectrum, as blue wavelengths are strongly attenuated in biological tissues. To overcome this, we generated variants of RLuc with bathochromic (red) shifts of up to 66 nm (547 nm peak) that also had greater stability and higher light emission than native RLuc.</abstract><notes>Loening, Andreas Markus&#xD;Wu, Anna M&#xD;Gambhir, Sanjiv Sam&#xD;CA114747 ICMIC P50/CA/United States NCI&#xD;CA119367 CCNE U54/CA/United States NCI&#xD;R01 CA082214/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature methods&#xD;Nat Methods. 2007 Aug;4(8):641-3. Epub 2007 Jul 8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17618292</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>15.011</custom4><electronic-resource-num>nmeth1070 [pii]&#xD;10.1038/nmeth1070</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1302</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1302</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jiao, J.</author><author>Wang, S.</author><author>Qiao, R.</author><author>Vivanco, I.</author><author>Watson, P. A.</author><author>Sawyers, C. L.</author><author>Wu, H.</author></authors></contributors><auth-address>Department of Molecular and Medical Pharmacology, University of California at Los Angeles, Los Angeles, California 90095-1735, USA.</auth-address><titles><title>Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>6083-91</pages><volume>67</volume><number>13</number><edition>2007/07/10</edition><keywords><keyword>Agar/chemistry</keyword><keyword>Alleles</keyword><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation</keyword><keyword>Chromosomes/ultrastructure</keyword><keyword>Female</keyword><keyword>*Gene Expression Regulation, Neoplastic</keyword><keyword>Karyotyping</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Mutation</keyword><keyword>PTEN Phosphohydrolase/genetics/*physiology</keyword><keyword>Prostatic Neoplasms/etiology/*metabolism/*pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17616663</accession-num><abstract>PTEN mutations are among the most frequent genetic alterations found in human prostate cancers. Our previous works suggest that although precancerous lesions were found in Pten heterozygous mice, cancer progression and metastasis only happened when both alleles of Pten were deleted. To understand the molecular mechanisms underlying the role of PTEN in prostate cancer control, we generated two pairs of isogenic, androgen receptor (AR)-positive prostate epithelial lines from intact conditional Pten knock-out mice that are either heterozygous (PTEN-P2 and -P8) or homozygous (PTEN-CaP2 and PTEN-CaP8) for Pten deletion. Further characterization of these cells showed that loss of the second allele of Pten leads to increased anchorage-independent growth in vitro and tumorigenesis in vivo without obvious structural or numerical chromosome changes based on SKY karyotyping analysis. Despite no prior exposure to hormone ablation therapy, Pten null cells are tumorigenic in both male and female severe combined immunodeficiency mice. Furthermore, knocking down PTEN can convert the androgen-dependent Myc-CaP cell into androgen independence, suggesting that PTEN intrinsically controls androgen responsiveness, a critical step in the development of hormone refractory prostate cancer. Importantly, knocking down AR by shRNA in Pten null cells reverses androgen-independent growth in vitro and partially inhibited tumorigenesis in vivo, indicating that PTEN-controlled prostate tumorigenesis is AR dependent. These cell lines will serve as useful tools for understanding signaling pathways controlled by PTEN and elucidating the molecular mechanisms involved in hormone refractory prostate cancer formation.</abstract><notes>Jiao, Jing&#xD;Wang, Shunyou&#xD;Qiao, Rong&#xD;Vivanco, Igor&#xD;Watson, Philip A&#xD;Sawyers, Charles L&#xD;Wu, Hong&#xD;P50 ca092131/ca/nci&#xD;R01 ca107166/ca/nci&#xD;U01 ca84128-06/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2007 Jul 1;67(13):6083-91.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17616663</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>7.980</custom4><electronic-resource-num>67/13/6083 [pii]&#xD;10.1158/0008-5472.CAN-06-4202</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1062</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1062</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Anikeeva, P. O.</author><author>Halpert, J. E.</author><author>Bawendi, M. G.</author><author>Bulovic, V.</author></authors></contributors><auth-address>Laboratory of Organic Optics and Electronics, Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Electroluminescence from a mixed red-green-blue colloidal quantum dot monolayer</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>2196-200</pages><volume>7</volume><number>8</number><edition>2007/07/10</edition><keywords><keyword>Colloids/chemistry</keyword><keyword>Color</keyword><keyword>Crystallization/*methods</keyword><keyword>Electrochemistry/*instrumentation/methods</keyword><keyword>Light</keyword><keyword>Lighting/instrumentation/*methods</keyword><keyword>Luminescent Measurements/*instrumentation/methods</keyword><keyword>Macromolecular Substances/chemistry</keyword><keyword>Materials Testing</keyword><keyword>Molecular Conformation</keyword><keyword>Nanostructures/*chemistry/radiation effects/ultrastructure</keyword><keyword>Nanotechnology/*instrumentation/methods</keyword><keyword>Particle Size</keyword><keyword>*Quantum Dots</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17616230</accession-num><abstract>We demonstrate light emitting devices (LEDs) with a broad spectral emission generated by electroluminescence from a mixed-monolayer of red, green, and blue emitting colloidal quantum dots (QDs) in a hybrid organic/inorganic structure. The colloidal QDs are reproducibly synthesized and yield high luminescence efficiency materials suitable for LED applications. Independent processing of the organic charge transport layers and the QD luminescent layer allows for precise tuning of the emission spectrum without changing the device structure, simply by changing the ratio of different color QDs in the active layer. Spectral tuning is demonstrated through fabrication of white QD-LEDs that exhibit external quantum efficiencies of 0.36% (Commission Internationale de l&apos;Eclairage) coordinates of (0.35, 0.41) at video brightness, and color rendering index of 86 as compared to a 5500 K blackbody reference.</abstract><notes>Anikeeva, Polina O&#xD;Halpert, Jonathan E&#xD;Bawendi, Moungi G&#xD;Bulovic, Vladimir&#xD;Evaluation Studies&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Aug;7(8):2196-200. Epub 2007 Jul 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17616230</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl0703424</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1422</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1422</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lytton-Jean, A. K.</author><author>Han, M. S.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Microarray detection of duplex and triplex DNA binders with DNA-modified gold nanoparticles</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>6037-41</pages><volume>79</volume><number>15</number><edition>2007/07/07</edition><dates><year>2007</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>17614366</accession-num><abstract>We have designed a chip-based assay, using microarray technology, for determining the relative binding affinities of duplex and triplex DNA binders. This assay combines the high discrimination capabilities afforded by DNA-modified Au nanoparticles with the high-throughput capabilities of DNA microarrays. The detection and screening of duplex DNA binders are important because these molecules, in many cases, are potential anticancer agents as well as toxins. Triplex DNA binders are also promising drug candidates. These molecules, in conjunction with triplex-forming oligonucleotides, could potentially be used to achieve control of gene expression by interfering with transcription factors that bind to DNA. Therefore, the ability to screen for these molecules in a high-throughput fashion could dramatically improve the drug screening process. The assay reported here provides excellent discrimination between strong, intermediate, and weak duplex and triplex DNA binders in a high-throughput fashion.</abstract><notes>Lytton-Jean, Abigail K R&#xD;Han, Min Su&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2007 Aug 1;79(15):6037-41. Epub 2007 Jul 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17614366</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac070635h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1703</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1703</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, X.</author><author>Liu, J.</author><author>Song, J.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245, USA.</auth-address><titles><title>Integrated nanogenerators in biofluid</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>2475-9</pages><volume>7</volume><number>8</number><edition>2007/07/03</edition><keywords><keyword>Body Fluids/*chemistry</keyword><keyword>*Electricity</keyword><keyword>Electrochemistry/*instrumentation/methods</keyword><keyword>Energy Transfer</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Microfluidic Analytical Techniques/*instrumentation</keyword><keyword>Nanotechnology/*instrumentation/methods</keyword><keyword>Systems Integration</keyword><keyword>*Transducers</keyword><keyword>Zinc Oxide/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17604406</accession-num><abstract>We have demonstrated a prototype ZnO nanowire based nanogenerator (NG) that can effectively generate electricity inside biofluid when stimulated by ultrasonic waves. The potential of increasing output current and voltage was illustrated by connecting multiple NGs in parallel and serial, respectively, clearly demonstrating the possibility of raising output power by three-dimensional integration and architecture. The output current was increased by 20-30 times and reached as high as 35 nA when a 2 mm2 size NG was placed at a region where the ultrasonic waves were focused. This work unambiguously shows the feasibility of NGs for power conversion inside biofluid. It sets a solid foundation for self-powering implantable and wireless nanodevices and nanosystems in biofluid and any other type of liquid.</abstract><notes>Wang, Xudong&#xD;Liu, Jin&#xD;Song, Jinhui&#xD;Wang, Zhong Lin&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Aug;7(8):2475-9. Epub 2007 Jun 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17604406</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl0712567</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1513</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1513</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Petty, R. T.</author><author>Li, H. W.</author><author>Maduram, J. H.</author><author>Ismagilov, R.</author><author>Mrksich, M.</author></authors></contributors><auth-address>Department of Chemistry and Howard Hughes Medical Institute, The University of Chicago, Chicago, Illinois 60637, USA.</auth-address><titles><title>Attachment of cells to islands presenting gradients of adhesion ligands</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>8966-7</pages><volume>129</volume><number>29</number><edition>2007/07/03</edition><keywords><keyword>Animals</keyword><keyword>Cell Adhesion/*drug effects</keyword><keyword>Coloring Agents/chemical synthesis/*chemistry</keyword><keyword>Cytological Techniques/*instrumentation</keyword><keyword>Electrochemistry</keyword><keyword>Indicators and Reagents</keyword><keyword>Ligands</keyword><keyword>Melanoma, Experimental/ultrastructure</keyword><keyword>Membranes, Artificial</keyword><keyword>Mice</keyword><keyword>Vinculin/chemistry/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 25</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17602634</accession-num><notes>Petty, Rafe T&#xD;Li, Hung-Wing&#xD;Maduram, Jane H&#xD;Ismagilov, Rustem&#xD;Mrksich, Milan&#xD;T32 gm008720/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Jul 25;129(29):8966-7. Epub 2007 Jun 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17602634</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja0735709</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1330</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1330</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, J. S.</author><author>Rieter, W. J.</author><author>Taylor, K. M.</author><author>An, H.</author><author>Lin, W.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Self-assembled hybrid nanoparticles for cancer-specific multimodal imaging</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>8962-3</pages><volume>129</volume><number>29</number><edition>2007/07/03</edition><keywords><keyword>HT29 Cells</keyword><keyword>Humans</keyword><keyword>Luminescence</keyword><keyword>Microscopy, Confocal</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanoparticles/*chemistry/*diagnostic use</keyword><keyword>Neoplasms/*diagnosis</keyword><keyword>Particle Size</keyword><keyword>Silicon Dioxide</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 25</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17602632</accession-num><notes>Kim, Jason S&#xD;Rieter, William J&#xD;Taylor, Kathryn M L&#xD;An, Hongyu&#xD;Lin, Weili&#xD;Lin, Wenbin&#xD;P20 rr020764/rr/ncrr&#xD;U54-ca119343/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Jul 25;129(29):8962-3. Epub 2007 Jun 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17602632</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja073062z</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1607</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1607</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, D. </author><author>Pentzer, E. B.</author><author>Nguyen, S. T.</author></authors></contributors><titles><title>Bioactive and Therapeutic ROMP Polymers</title><secondary-title>Polymer Reviews</secondary-title></titles><periodical><full-title>Polymer Reviews</full-title></periodical><pages>419 - 459</pages><volume>47</volume><number>3</number><edition>2007/07</edition><dates><year>2007</year><pub-dates><date>July 2007</date></pub-dates></dates><isbn>1558-3724</isbn><abstract>This review summarizes the developments in the area of ROMP-based polymer carriers as well as side-chain and main-chain polymer therapeutics during the period of 19932007. The promising emergence of ROMP-derived amphiphilic block copolymers containing therapeutic agents, their assembly into polymer nanoparticles, together with their modification for the targeting group attachment is outlined. Recent application of ROMP-based side-chain polymer therapeutics as multivalent scaffolds and the synthesis of DIVEMA-type main-chain polymers from ROMP-active monomers are also discussed. Finally, an outlook on the opportunities and the future directions in the use of ROMP towards the development of the next generation of polymer therapeutics is provided.</abstract><urls><related-urls><url>http://www.informaworld.com/10.1080/15583720701455186</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.854</custom4><electronic-resource-num>10.1080/15583720701455186</electronic-resource-num><access-date>June 09, 2008</access-date></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1582</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1582</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, X.</author><author>Wang, S.</author><author>Meshinchi, S.</author><author>Van Antwerp, M. E.</author><author>Bi, X.</author><author>Lee, I.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109, USA. xshi@umich.edu</auth-address><titles><title>Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging</title><secondary-title>Small</secondary-title><alt-title>Small (Weinheim an der Bergstrasse, Germany)</alt-title></titles><periodical><full-title>Small</full-title></periodical><pages>1245-52</pages><volume>3</volume><number>7</number><edition>2007/07</edition><dates><year>2007</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17523182</accession-num><abstract>We present a general approach for the targeting and imaging of cancer cells using dendrimer-entrapped gold nanoparticles (Au DENPs). Au DENPs were found to be able to covalently link with targeting and imaging ligands for subsequent cancer-cell targeting and imaging. The Au DENPs linked with defined numbers of folic acid (FA) and fluorescein isothiocyanate (FI) molecules are water soluble, stable, and biocompatible. In vitro studies show that the FA- and FI-modified Au DENPs can specifically bind to KB cells (a human epithelial carcinoma cell line) that overexpress high-affinity folate receptors and they are internalized dominantly into lysosomes of target cells within 2 h. These findings demonstrate that Au DENPs may serve as a general platform for cancer imaging and therapeutics.</abstract><notes>N0i-co-97111/co/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17523182 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2007</custom3><custom4>7.292</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1267</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1267</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hu, W.</author><author>Wilson, R. J.</author><author>Xu, L.</author><author>Han, S. J.</author><author>Wang, S. X.</author></authors></contributors><auth-address>Hu, W&#xD;Stanford Univ, Dept Mat Sci &amp; Engn, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Mat Sci &amp; Engn, Stanford, CA 94305 USA</auth-address><titles><title>Patterning of high density magnetic nanodot arrays by nanoimprint lithography</title><secondary-title>Journal of Vacuum Science &amp; Technology A</secondary-title></titles><periodical><full-title>Journal of Vacuum Science &amp; Technology A</full-title></periodical><pages>1294-1297</pages><volume>25</volume><number>4</number><edition>2007/07</edition><keywords><keyword>single-domain</keyword><keyword>fabrication</keyword><keyword>islands</keyword><keyword>media</keyword><keyword>mold</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul-Aug</date></pub-dates></dates><isbn>0734-2101</isbn><accession-num>ISI:000248491700112</accession-num><abstract>In this work the authors present results from thermal nanoimprint lithography patterning of high density arrays of circular holes with 100 nm diameters at 300 nm pitch, or with 50 nm diameters at 100 nm pitch, throughout an area of 1 cm(2). They demonstrate the fabrication of dense gigabit magnetic nanodot arrays using polymethyl methacrylate and polymethyl glutarimide resist bilayers and a lift-off process. The magnetic properties of these nanodot arrays are shown to be readily characterized by alternating gradient magnetometry. Several issues are addressed which arise during patterning and characterization, such as template damage induced by Au metallization, metal residue control, and nanodot diameter tuning by oxygen plasma etching. (c) 2007 American Vacuum Society.</abstract><notes>196OK&#xD;Times Cited:0&#xD;Cited References Count:18</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000248491700112</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>1.373</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1170</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1170</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Derfus, A. M.</author><author>Chen, A. A.</author><author>Min, D. H.</author><author>Ruoslahti, E.</author><author>Bhatia, S. N.</author></authors></contributors><auth-address>Department of Bioengineering, University of California at San Diego, La Jolla, California 92093, Burnham Institute for Medical Research, La Jolla, California 92037, Health Sciences and Technology/Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138.</auth-address><titles><title>Targeted Quantum Dot Conjugates for siRNA Delivery</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><edition>2007/07</edition><dates><year>2007</year><pub-dates><date>Jul 14</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>17630789</accession-num><abstract>Treatment of human diseases such as cancer generally involves the sequential use of diagnostic tools and therapeutic modalities. Multifunctional platforms combining therapeutic and diagnostic imaging functions in a single vehicle promise to change this paradigm. in particular, nanoparticle-based multifunctional platforms offer the potential to improve the pharmacokinetics of drug formulations, while providing attachment sites for diagnostic imaging and disease targeting features. We have applied these principles to the delivery of small interfering RNA (siRNA) therapeutics, where systemic delivery is hampered by rapid excretion and nontargeted tissue distribution. Using a PEGlyated quantum dot (QD) core as a scaffold, siRNA and tumor-homing peptides (F3) were conjugated to functional groups on the particle&apos;s surface. We found that the homing peptide was required for targeted internalization by tumor cells, and that siRNA cargo could be coattached without affecting the function of the peptide. Using an EGFP model system, the role of conjugation chemistry was investigated, with siRNA attached to the particle by disulfide cross-linkers showing greater silencing efficiency than when attached by a nonreducible thioether linkage. Since each particle contains a limited number of attachment sites, we further explored the tradeoff between number of F3 peptides and the number of siRNA per particle, leading to an optimized formulation. Delivery of these F3/siRNA-QDs to EGFP-transfected HeLa cells and release from their endosomal entrapment led to significant knockdown of EGFP signal. By designing the siRNA sequence against a therapeutic target (e.g., oncogene) instead of EGFP, this technology may be ultimately adapted to simultaneously treat and image metastatic cancer.</abstract><notes>Journal article</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17630789 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>Yes- UCSD and MIT</custom2><custom3>2007</custom3><custom4>4.802</custom4><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1780</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1780</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, L.</author><author>Radovic-Moreno, A. F.</author><author>Alexis, F.</author><author>Gu, F. X.</author><author>Basto, B. A.</author><author>Bagalkot, V.</author><author>Jon, S.</author><author>Langer, R. S.</author><author>Farokhzad, O. C.</author></authors></contributors><titles><title>Co-Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle-Aptamer Bioconjugates</title><secondary-title>ChemMedChem</secondary-title></titles><periodical><full-title>ChemMedChem</full-title></periodical><pages>1268-71</pages><volume>2</volume><number>9</number><edition>2007/06/28</edition><keywords><keyword>antitumor agents</keyword><keyword>conjugation</keyword><keyword>dual drug delivery</keyword><keyword>nanoparticles</keyword><keyword>targeted therapy</keyword></keywords><dates><year>2007</year></dates><abstract>No abstract</abstract><urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>3.150</custom4><electronic-resource-num>10.1002/cmdc.200700121 </electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1681</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1681</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Venisnik, K. M.</author><author>Olafsen, T.</author><author>Gambhir, S. S.</author><author>Wu, A. M.</author></authors></contributors><auth-address>Crump Institute for Molecular Imaging, Department of Molecular &amp; Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.</auth-address><titles><title>Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imaging</title><secondary-title>Mol Imaging Biol</secondary-title></titles><periodical><full-title>Mol Imaging Biol</full-title></periodical><pages>267-77</pages><volume>9</volume><number>5</number><edition>2007/06/20</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Antibodies, Neoplasm/*diagnostic use/genetics</keyword><keyword>Base Sequence</keyword><keyword>Carcinoembryonic Antigen/*immunology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Copepoda/enzymology/genetics</keyword><keyword>DNA Primers/genetics</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Immunoglobulin Fragments/diagnostic use/genetics</keyword><keyword>Iodine Radioisotopes/diagnostic use</keyword><keyword>Luciferases/*diagnostic use/genetics</keyword><keyword>Luminescent Measurements</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Molecular Sequence Data</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neoplasms, Experimental/*diagnosis/radionuclide imaging</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Protein Engineering</keyword><keyword>Radiopharmaceuticals/diagnostic use</keyword><keyword>Rats</keyword><keyword>Recombinant Fusion Proteins/diagnostic use/genetics</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2007</year><pub-dates><date>Sep-Oct</date></pub-dates></dates><isbn>1536-1632 (Print)</isbn><accession-num>17577599</accession-num><abstract>The bioluminescent protein Gaussia luciferase (GLuc) was fused to an anti-carcinoembryonic antigen (CEA) antibody fragment, the diabody, for in vivo optical tumor imaging. A 15-amino acid N-terminal truncation (GLDelta15) resulted in a brighter protein. Fusions of the anti-CEA diabody to full-length GLuc and GLDelta15 retained high affinity for the antigen, emitted light, and exhibited excellent enzymatic stability. In vivo optical imaging of tumor-bearing mice demonstrated specific targeting of diabody-GLDelta15 to CEA-positive xenografts, with a tumor/background ratio of 3.8 +/- 0.4 at four hours after tail-vein injection, compared to antigen-negative tumors at 1.3 +/- 0.1 (p = 0.001). MicroPET imaging using (124)I-diabody-GLDelta15 demonstrated specific uptake in the CEA-positive tumor (2.6% ID [injected dose]/g) compared to the CEA-negative tumor (0.4% ID/g) at 21 hours. Although further optimization of this fusion protein may be needed to improve in vivo performance, the diabody-GLDelta15 is a promising optical imaging probe for tumor detection in vivo.</abstract><notes>Venisnik, Katy M&#xD;Olafsen, Tove&#xD;Gambhir, Sanjiv S&#xD;Wu, Anna M&#xD;P01 CA43904/CA/United States NCI&#xD;P30 CA16042/CA/United States NCI&#xD;R01 CA082214/CA/United States NCI&#xD;R24 CA92865/CA/United States NCI&#xD;T32 GM08652/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging&#xD;Mol Imaging Biol. 2007 Sep-Oct;9(5):267-77.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17577599</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2008</custom3><custom4>3.372</custom4><electronic-resource-num>10.1007/s11307-007-0101-8</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2057</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2057</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, Z. B.</author><author>Cai, W.</author><author>Cao, Q.</author><author>Chen, K.</author><author>Wu, Z.</author><author>He, L.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, California 94305, USA.</auth-address><titles><title>(64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression</title><secondary-title>J Nucl Med</secondary-title></titles><periodical><full-title>J Nucl Med</full-title></periodical><pages>1162-71</pages><volume>48</volume><number>7</number><edition>2007/06/19</edition><keywords><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line, Tumor</keyword><keyword>Copper Radioisotopes/ pharmacokinetics</keyword><keyword>Female</keyword><keyword>Heterocyclic Compounds, 1-Ring/chemistry</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/ metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Oligopeptides/chemical synthesis/ pharmacokinetics</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Radiopharmaceuticals/chemical synthesis/ pharmacokinetics</keyword><keyword>Tissue Distribution</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>17574975</accession-num><abstract>Integrin alpha(v)beta(3) plays a critical role in tumor angiogenesis and metastasis. Suitably radiolabeled cyclic arginine-glycine-aspartic (RGD) peptides can be used for noninvasive imaging of alpha(v)beta(3) expression and targeted radionuclide therapy. In this study, we developed (64)Cu-labeled multimeric RGD peptides, E{E[c(RGDyK)](2)}(2) (RGD tetramer) and E(E{E[c(RGDyK)](2)}(2))(2) (RGD octamer), for PET imaging of tumor integrin alpha(v)beta(3) expression. METHODS: Both RGD tetramer and RGD octamer were synthesized with glutamate as the linker. After conjugation with 1,4,7,10-tetra-azacyclododecane-N,N&apos;,N&apos;&apos;,N&apos;&apos;&apos;-tetraacetic acid (DOTA), the peptides were labeled with (64)Cu for biodistribution and small-animal PET imaging studies (U87MG human glioblastoma xenograft model and c-neu oncomouse model). A cell adhesion assay, a cell-binding assay, receptor blocking experiments, and immunohistochemistry were also performed to evaluate the alpha(v)beta(3)-binding affinity/specificity of the RGD peptide-based conjugates in vitro and in vivo. RESULTS: RGD octamer had significantly higher integrin alpha(v)beta(3)-binding affinity and specificity than RGD tetramer analog (inhibitory concentration of 50% was 10 nM for octamer vs. 35 nM for tetramer). (64)Cu-DOTA-RGD octamer had higher tumor uptake and longer tumor retention than (64)Cu-DOTA-RGD tetramer in both tumor models tested. The integrin alpha(v)beta(3) specificity of both tracers was confirmed by successful receptor-blocking experiments. The high uptake and slow clearance of (64)Cu-DOTA-RGD octamer in the kidneys was attributed mainly to the integrin positivity of the kidneys, significantly higher integrin alpha(v)beta(3)-binding affinity, and the larger molecular size of the octamer, as compared with the other RGD analogs. CONCLUSION: Polyvalency has a profound effect on the receptor-binding affinity and in vivo kinetics of radiolabeled RGD multimers. The information obtained here may guide the future development of RGD peptide-based imaging and internal radiotherapeutic agents targeting integrin alpha(v)beta(3).</abstract><notes>Li, Zi-Bo&#xD;Cai, Weibo&#xD;Cao, Qizhen&#xD;Chen, Kai&#xD;Wu, Zhanhong&#xD;He, Lina&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2007 Jul;48(7):1162-71. Epub 2007 Jun 15.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.282</custom4><electronic-resource-num>jnumed.107.039859 [pii]&#xD;10.2967/jnumed.107.039859 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1381</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1381</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J. S.</author><author>Lytton-Jean, A. K.</author><author>Hurst, S. J.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, Illinois 60208, USA.</auth-address><titles><title>Silver nanoparticle-oligonucleotide conjugates based on DNA with triple cyclic disulfide moieties</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>2112-5</pages><volume>7</volume><number>7</number><edition>2007/06/19</edition><keywords><keyword>*Dna</keyword><keyword>*Disulfides</keyword><keyword>*Metal Nanoparticles</keyword><keyword>*Oligonucleotides</keyword><keyword>*Phosphoric Acid Esters</keyword><keyword>*Silver</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17571909</accession-num><abstract>We report a new strategy for preparing silver nanoparticle-oligonucleotide conjugates that are based upon DNA with cyclic disulfide-anchoring groups. These particles are extremely stable and can withstand NaCl concentrations up to 1.0 M. When silver nanoparticles functionalized with complementary sequences are combined, they assemble to form DNA-linked nanoparticle networks. This assembly process is reversible with heating and is associated with a red shifting of the particle surface plasmon resonance and a concomitant color change from yellow to pale red. Analogous to the oligonucleotide-functionalized gold nanoparticles, these particles also exhibit highly cooperative binding properties with extremely sharp melting transitions. This work is an important step toward using silver nanoparticle-oligonucleotide conjugates for a variety of purposes, including molecular diagnostic labels, synthons in programmable materials synthesis approaches, and functional components for nanoelectronic and plasmonic devices.</abstract><notes>Lee, Jae-Seung&#xD;Lytton-Jean, Abigail K R&#xD;Hurst, Sarah J&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Jul;7(7):2112-5. Epub 2007 Jun 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17571909</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl071108g</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1349</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1349</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koynova, R.</author><author>Wang, L.</author><author>MacDonald, R. C.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois 60208, USA. r-tenchova@northwestern.edu</auth-address><titles><title>Synergy in lipofection by cationic lipid mixtures: superior activity at the gel-liquid crystalline phase transition</title><secondary-title>J Phys Chem B</secondary-title></titles><periodical><full-title>J Phys Chem B</full-title></periodical><pages>7786-95</pages><volume>111</volume><number>27</number><edition>2007/06/19</edition><keywords><keyword>Calorimetry, Differential Scanning</keyword><keyword>Cations/chemistry</keyword><keyword>Cells, Cultured</keyword><keyword>Chemistry, Pharmaceutical</keyword><keyword>Crystallization</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Gels</keyword><keyword>Humans</keyword><keyword>Lipid Bilayers</keyword><keyword>Lipids/*chemistry</keyword><keyword>Liposomes</keyword><keyword>Solutions</keyword><keyword>Temperature</keyword><keyword>Transfection</keyword><keyword>X-Ray Diffraction</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 12</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>17571876</accession-num><abstract>Some mixtures of two cationic lipids including phospholipid compounds (O-ethylphosphatidylcholines) as well as common, commercially available cationic lipids, such as dimethylammonium bromides and trimethylammonium propanes, deliver therapeutic DNA considerably more efficiently than do the separate molecules. In an effort to rationalize this widespread &quot;mixture synergism&quot;, we examined the phase behavior of the cationic lipid mixtures and constructed their binary phase diagrams. Among a group of more than 50 formulations, the compositions with maximum delivery activity resided unambiguously in the solid-liquid crystalline two-phase region at physiological temperature. Thus, the transfection efficacy of formulations exhibiting solid-liquid crystalline phase coexistence is more than 5 times higher than that of formulations in the gel (solid) phase and over twice that of liquid crystalline formulations; phase coexistence occurring at physiological temperature thus appears to contribute significantly to mixture synergism. This relationship between delivery activity and physical property can be rationalized on the basis of the known consequences of lipid-phase transitions, namely, the accumulation of defects and increased disorder at solid-liquid crystalline phase boundaries. Packing defects at the borders of coexisting solid and liquid crystalline domains, as well as large local density fluctuations, could be responsible for the enhanced fusogenicity of mixtures. This study leads to the important conclusion that manipulating the composition of the lipid carriers so that their phase transition takes place at physiological temperature can enhance their delivery efficacy.</abstract><notes>Koynova, Rumiana&#xD;Wang, Li&#xD;MacDonald, Robert C&#xD;Gm52329/gm/nigms&#xD;Gm57305/gm/nigms&#xD;Rr08630/rr/ncrr&#xD;U54ca119341/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2007 Jul 12;111(27):7786-95. Epub 2007 Jun 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17571876</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.688</custom4><electronic-resource-num>10.1021/jp071286y</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2012</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2012</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Berezin, M. Y.</author><author>Lee, H.</author><author>Akers, W.</author><author>Achilefu, S.</author></authors></contributors><auth-address>Department of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.</auth-address><titles><title>Near infrared dyes as lifetime solvatochromic probes for micropolarity measurements of biological systems</title><secondary-title>Biophys J</secondary-title></titles><periodical><full-title>Biophys J</full-title></periodical><pages>2892-9</pages><volume>93</volume><number>8</number><edition>2007/06/19</edition><keywords><keyword>Biopolymers/ chemistry</keyword><keyword>Coloring Agents/ diagnostic use</keyword><keyword>Molecular Conformation</keyword><keyword>Molecular Probe Techniques</keyword><keyword>Solvents/ chemistry</keyword><keyword>Spectrophotometry, Infrared/ methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct 15</date></pub-dates></dates><isbn>0006-3495 (Print)</isbn><accession-num>17573433</accession-num><abstract>The polarity of biological mediums controls a host of physiological processes such as digestion, signaling, transportation, metabolism, and excretion. With the recent widespread use of near-infrared (NIR) fluorescent dyes for biological imaging of cells and living organisms, reporting medium polarity with these dyes would provide invaluable functional information in addition to conventional optical imaging parameters. Here, we report a new approach to determine polarities of macro- and microsystems for in vitro and potential in vivo applications using NIR polymethine molecular probes. Unlike the poor solvatochromic response of NIR dyes in solvents with diverse polarity, their fluorescence lifetimes are highly sensitive, increasing by a factor of up to 8 on moving from polar to nonpolar mediums. We also established a correlation between fluorescence lifetime and solvent orientation polarizability and developed a lifetime polarity index for determining the polarity of complex systems, including micelles and albumin binding sites. Because of the importance of medium polarity in molecular, cellular, and biochemical processes and the significance of reduced autofluorescence and deep tissue penetration of light in the NIR region, the findings reported herein represent an important advance toward using NIR molecular probes to measure the polarity of complex biological systems in vitro and in vivo.</abstract><notes>Berezin, Mikhail Y&#xD;Lee, Hyeran&#xD;Akers, Walter&#xD;Achilefu, Samuel&#xD;1 U01 HL080729/HL/NHLBI NIH HHS/United States&#xD;R01 CA109754/CA/NCI NIH HHS/United States&#xD;R01 EB1430/EB/NIBIB NIH HHS/United States&#xD;U54 CA119342/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Biophysical journal&#xD;Biophys J. 2007 Oct 15;93(8):2892-9. Epub 2007 Jun 15.</notes><urls></urls><custom1>CCNE - Siteman</custom1><custom2>1989699</custom2><custom3>2008</custom3><custom4>5.036</custom4><electronic-resource-num>S0006-3495(07)71542-4 [pii]&#xD;10.1529/biophysj.107.111609 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1563</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1563</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Seferos, D. S.</author><author>Giljohann, D. A.</author><author>Rosi, N. L.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Locked nucleic acid-nanoparticle conjugates</title><secondary-title>Chembiochem</secondary-title></titles><periodical><full-title>Chembiochem</full-title></periodical><pages>1230-2</pages><volume>8</volume><number>11</number><edition>2007/06/15</edition><keywords><keyword>Base Sequence</keyword><keyword>Cell Line, Tumor</keyword><keyword>Humans</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Oligonucleotides, Antisense/*chemistry</keyword><keyword>Proteins/chemistry</keyword><keyword>Transition Temperature</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 23</date></pub-dates></dates><isbn>1439-4227 (Print)</isbn><accession-num>17562553</accession-num><notes>Seferos, Dwight S&#xD;Giljohann, David A&#xD;Rosi, Nathaniel L&#xD;Mirkin, Chad A&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Chembiochem : a European journal of chemical biology&#xD;Chembiochem. 2007 Jul 23;8(11):1230-2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17562553</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>3.684</custom4><electronic-resource-num>10.1002/cbic.200700262</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1346</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1346</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koynova, R.</author><author>Macdonald, R. C.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, 2205 Tech Drive, Evanston, IL 60208, USA. r-tenchova@northwestern.edu</auth-address><titles><title>Natural lipid extracts and biomembrane-mimicking lipid compositions are disposed to form nonlamellar phases, and they release DNA from lipoplexes most efficiently</title><secondary-title>Biochim Biophys Acta-Biomembranes</secondary-title></titles><periodical><full-title>Biochim Biophys Acta-Biomembranes</full-title></periodical><pages>2373-82</pages><volume>1768</volume><number>10</number><edition>2007/06/15</edition><keywords><keyword>Animals</keyword><keyword>Cattle</keyword><keyword>DNA/*administration &amp; dosage/chemistry</keyword><keyword>Electrostatics</keyword><keyword>Fluorometry</keyword><keyword>Lipids/*chemistry</keyword><keyword>Liposomes/chemistry</keyword><keyword>Membrane Lipids/*chemistry</keyword><keyword>Transfection/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0006-3002 (Print)</isbn><accession-num>17559800</accession-num><abstract>A viewpoint now emerging is that a critical factor in lipid-mediated transfection (lipofection) is the structural evolution of lipoplexes upon interacting and mixing with cellular lipids. Here we report our finding that lipid mixtures mimicking biomembrane lipid compositions are superior to pure anionic liposomes in their ability to release DNA from lipoplexes (cationic lipid/DNA complexes), even though they have a much lower negative charge density (and thus lower capacity to neutralize the positive charge of the lipoplex lipids). Flow fluorometry revealed that the portion of DNA released after a 30-min incubation of the cationic O-ethylphosphatidylcholine lipoplexes with the anionic phosphatidylserine or phosphatidylglycerol was 19% and 37%, respectively, whereas a mixture mimicking biomembranes (MM: phosphatidylcholine/phosphatidylethanolamine/phosphatidylserine /cholesterol 45:20:20:15 w/w) and polar lipid extract from bovine liver released 62% and 74%, respectively, of the DNA content. A possible reason for this superior power in releasing DNA by the natural lipid mixtures was suggested by structural experiments: while pure anionic lipids typically form lamellae, the natural lipid mixtures exhibited a surprising predilection to form nonlamellar phases. Thus, the MM mixture arranged into lamellar arrays at physiological temperature, but began to convert to the hexagonal phase at a slightly higher temperature, approximately 40-45 degrees C. A propensity to form nonlamellar phases (hexagonal, cubic, micellar) at close to physiological temperatures was also found with the lipid extracts from natural tissues (from bovine liver, brain, and heart). This result reveals that electrostatic interactions are only one of the factors involved in lipid-mediated DNA delivery. The tendency of lipid bilayers to form nonlamellar phases has been described in terms of bilayer &quot;frustration&quot; which imposes a nonzero intrinsic curvature of the two opposing monolayers. Because the stored curvature elastic energy in a &quot;frustrated&quot; bilayer seems to be comparable to the binding energy between cationic lipid and DNA, the balance between these two energies could play a significant role in the lipoplex-membrane interactions and DNA release energetics.</abstract><notes>Koynova, Rumiana&#xD;Macdonald, Robert C&#xD;GM52329/GM/United States NIGMS&#xD;GM57305/GM/United States NIGMS&#xD;R01 GM052329-09/GM/United States NIGMS&#xD;R01 GM057305-05/GM/United States NIGMS&#xD;RR08630/RR/United States NCRR&#xD;U54CA119341/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Netherlands&#xD;Biochimica et biophysica acta&#xD;Biochim Biophys Acta. 2007 Oct;1768(10):2373-82. Epub 2007 May 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17559800</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2008</custom3><custom4>3.640</custom4><electronic-resource-num>S0005-2736(07)00157-5 [pii]&#xD;10.1016/j.bbamem.2007.04.026</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1697</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1697</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, M. D.</author><author>Shin, D. M.</author><author>Simons, J. W.</author><author>Nie, S.</author></authors></contributors><auth-address>Georgia Institute of Technology, Department of Biomedical Engineering, and Emory University, Atlanta, GA 30332, USA. maywang@bme.gatech.edu</auth-address><titles><title>Nanotechnology for targeted cancer therapy</title><secondary-title>Expert Rev Anticancer Ther</secondary-title></titles><periodical><full-title>Expert Rev Anticancer Ther</full-title></periodical><pages>833-7</pages><volume>7</volume><number>6</number><edition>2007/06/09</edition><keywords><keyword>Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Nanostructures</keyword><keyword>*Nanotechnology</keyword><keyword>Neoplasms/diagnosis/*therapy</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1473-7140 (Print)</isbn><accession-num>17555393</accession-num><abstract>Cancer nanotechnology is currently under intense development for applications in cancer imaging, molecular diagnosis and targeted therapy. The basic rationale is that nanometer-sized particles, such as biodegradable micelles, semiconductor quantum dots and iron oxide nanocrystals, have functional or structural properties that are not available from either molecular or macroscopic agents. When linked with biotargeting ligands, such as monoclonal antibodies, peptides or small molecules, these nanoparticles are used to target malignant tumors with high affinity and specificity. In the &apos;mesoscopic&apos; size range of 5-100 nm in diameter, nanoparticles also have large surface areas and functional groups for conjugating to multiple diagnostic (e.g., optical, radioisotopic or magnetic) and therapeutic (e.g., anticancer) agents. Recent advances have led to multifunctional nanoparticle probes for molecular and cellular imaging, nanoparticle drugs for targeted therapy, and integrated nanodevices for early cancer detection and screening. These developments have opened exciting opportunities for personalized oncology in which cancer detection, diagnosis and therapy are tailored to each individual&apos;s molecular profile, and also for predictive oncology, in which genetic/molecular information is used to predict tumor development, progression and clinical outcome.</abstract><notes>Wang, May D&#xD;Shin, Dong M&#xD;Simons, Jonathan W&#xD;Nie, Shuming&#xD;P20 gm072069/gm/nigms&#xD;R01 ca10846801/ca/nci&#xD;U54ca119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;England&#xD;Expert review of anticancer therapy&#xD;Expert Rev Anticancer Ther. 2007 Jun;7(6):833-7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17555393</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>1.988</custom4><electronic-resource-num>10.1586/14737140.7.6.833</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1126</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1126</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chan, E. W.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and the Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Site-selective immobilization of ligands with control of density on electroactive microelectrode arrays</title><secondary-title>Chemphyschem</secondary-title></titles><periodical><full-title>Chemphyschem</full-title></periodical><pages>1469-72</pages><volume>8</volume><number>10</number><edition>2007/06/09</edition><keywords><keyword>Chemistry, Physical</keyword><keyword>Electrochemistry</keyword><keyword>Ligands</keyword><keyword>*Microelectrodes</keyword><keyword>Oxidation-Reduction</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 16</date></pub-dates></dates><isbn>1439-4235 (Print)</isbn><accession-num>17557372</accession-num><notes>Chan, Eugene W L&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Chemphyschem : a European journal of chemical physics and physical chemistry&#xD;Chemphyschem. 2007 Jul 16;8(10):1469-72.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17557372</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>3.502</custom4><electronic-resource-num>10.1002/cphc.200700303</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1277</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1277</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hughes, M. S.</author><author>McCarthy, J. E.</author><author>Marsh, J. N.</author><author>Arbeit, J. M.</author><author>Neumann, R. G.</author><author>Fuhrhop, R. W.</author><author>Wallace, K. D.</author><author>Znidersic, D. R.</author><author>Maurizi, B. N.</author><author>Baldwin, S. L.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>School of Medicine, Washington University, St. Louis, Missouri 63108, USA. msh@cvu.wustl.edu</auth-address><titles><title>Properties of an entropy-based signal receiver with an application to ultrasonic molecular imaging</title><secondary-title>J Acoust Soc Am</secondary-title></titles><periodical><full-title>J Acoust Soc Am</full-title></periodical><pages>3542-57</pages><volume>121</volume><number>6</number><edition>2007/06/08</edition><keywords><keyword>Entropy</keyword><keyword>Humans</keyword><keyword>Mathematics</keyword><keyword>Models, Molecular</keyword><keyword>Nanoparticles</keyword><keyword>Neoplasms/blood supply/ultrasonography</keyword><keyword>Neovascularization, Pathologic/diagnosis</keyword><keyword>*Ultrasonography</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1520-8524 (Electronic)</isbn><accession-num>17552706</accession-num><abstract>Qualitative and quantitative properties of the finite part, H(f), of the Shannon entropy of a continuous waveform f(t) in the continuum limit are derived in order to illuminate its use for waveform characterization. Simple upper and lower bounds on H(f), based on features of f(t), are defined. Quantitative criteria for a priori estimation of the average-case variation of H(f) and log E(f), where E(f) is the signal energy of f(t) are also derived. These provide relative sensitivity estimates that could be used to prospectively choose optimal imaging strategies in real-time ultrasonic imaging machines, where system bandwidth is often pushed to its limits. To demonstrate the utility of these sensitivity relations for this application, a study designed to assess the feasibility of identification of angiogenic neovasculature targeted with perfluorocarbon nanoparticles that specifically bind to alpha(v)beta3-integrin expression in tumors was performed. The outcome of this study agrees with the prospective sensitivity estimates that were used for the two receivers. Moreover, these data demonstrate the ability of entropy-based signal receivers when used in conjunction with targeted nanoparticles to elucidate the presence of alpha(v)beta3 integrins in primordial neovasculature, particularly in acoustically unfavorable environments.</abstract><notes>Hughes, M S&#xD;McCarthy, J E&#xD;Marsh, J N&#xD;Arbeit, J M&#xD;Neumann, R G&#xD;Fuhrhop, R W&#xD;Wallace, K D&#xD;Znidersic, D R&#xD;Maurizi, B N&#xD;Baldwin, S L&#xD;Lanza, G M&#xD;Wickline, S A&#xD;Co-27031/co/nci&#xD;Eb002168/eb/nibib&#xD;Hl042950/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The Journal of the Acoustical Society of America&#xD;J Acoust Soc Am. 2007 Jun;121(6):3542-57.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17552706</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>2.018</custom4><electronic-resource-num>10.1121/1.2722050</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1740</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1740</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xing, Y.</author><author>Chaudry, Q.</author><author>Shen, C.</author><author>Kong, K. Y.</author><author>Zhau, H. E.</author><author>Chung, L. W.</author><author>Petros, J. A.</author><author>O&apos;Regan, R. M.</author><author>Yezhelyev, M. V.</author><author>Simons, J. W.</author><author>Wang, M. D.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, 101 Woodruff Circle Suite 1001, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry</title><secondary-title>Nat Protoc</secondary-title></titles><periodical><full-title>Nat Protoc</full-title></periodical><pages>1152-65</pages><volume>2</volume><number>5</number><edition>2007/06/05</edition><dates><year>2007</year></dates><isbn>1750-2799 (Electronic)</isbn><accession-num>17546006</accession-num><abstract>Bioconjugated quantum dots (QDs) provide a new class of biological labels for evaluating biomolecular signatures (biomarkers) on intact cells and tissue specimens. In particular, the use of multicolor QD probes in immunohistochemistry is considered one of the most important and clinically relevant applications. At present, however, clinical applications of QD-based immunohistochemistry have achieved only limited success. A major bottleneck is the lack of robust protocols to define the key parameters and steps. Here, we describe our recent experience, preliminary results and detailed protocols for QD-antibody conjugation, tissue specimen preparation, multicolor QD staining, image processing and biomarker quantification. The results demonstrate that bioconjugated QDs can be used for multiplexed profiling of molecular biomarkers, and ultimately for correlation with disease progression and response to therapy. In general, QD bioconjugation is completed within 1 day, and multiplexed molecular profiling takes 1-3 days depending on the number of biomarkers and QD probes used.</abstract><notes>Xing, Yun&#xD;Chaudry, Qaiser&#xD;Shen, Christopher&#xD;Kong, Koon Yin&#xD;Zhau, Haiyen E&#xD;Chung, Leland W&#xD;Petros, John A&#xD;O&apos;Regan, Ruth M&#xD;Yezhelyev, Maksym V&#xD;Simons, Jonathan W&#xD;Wang, May D&#xD;Nie, Shuming&#xD;R01 ca108468/ca/nci&#xD;U54ca119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nature protocols&#xD;Nat Protoc. 2007;2(5):1152-65.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17546006</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>4.175</custom4><electronic-resource-num>nprot.2007.107 [pii]&#xD;10.1038/nprot.2007.107</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2373</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2373</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Cerignoli, F.</author><author>Mills, D. M.</author><author>D&apos;Annibale, F.</author><author>Leone, M.</author><author>Rosato, N.</author><author>Magrini, A.</author><author>Pellecchia, M.</author><author>Bergamaschi, A.</author><author>Mustelin, T.</author></authors></contributors><auth-address>Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, California 92037, USA. mbottini@burnham.org</auth-address><titles><title>Luminescent silica nanobeads: characterization and evaluation as efficient cytoplasmatic transporters for T-lymphocytes</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>7814-23</pages><volume>129</volume><number>25</number><edition>2007/06/05</edition><keywords><keyword>Antibodies</keyword><keyword>Antigens, CD28/chemistry/metabolism</keyword><keyword>Antigens, CD3/chemistry/metabolism</keyword><keyword>Avidin/chemistry/metabolism</keyword><keyword>Biological Transport</keyword><keyword>Biotin/chemistry/metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cytoplasm/ metabolism</keyword><keyword>Humans</keyword><keyword>Luminescence</keyword><keyword>Nanoparticles/ chemistry</keyword><keyword>Silicon Dioxide/ chemistry</keyword><keyword>T-Lymphocytes/ metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun 27</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17542582</accession-num><abstract>We report the fabrication and characterization of neutravidin-conjugated silica nanobeads doped with a ruthenium-complex luminophore and functionalized with antihuman CD3, antihuman CD28, and an acid-sensitive polymer. We observed that the nanobeads were readily delivered into Jurkat T leukemia cells by endocytosis, transported into lysosomes and subsequently into the cytoplasm as revealed by pH-sensitive luminescence. Since signs of cytotoxicity were not observed, the reported nanobeads could be an excellent and nontoxic building block for efficient intracellular transporters.</abstract><notes>Bottini, Massimo&#xD;Cerignoli, Fabio&#xD;Mills, David M&#xD;D&apos;Annibale, Federica&#xD;Leone, Marilisa&#xD;Rosato, Nicola&#xD;Magrini, Andrea&#xD;Pellecchia, Maurizio&#xD;Bergamaschi, Antonio&#xD;Mustelin, Tomas&#xD;U54 CA119335-02/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Jun 27;129(25):7814-23. Epub 2007 Jun 2.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom2>2536570</custom2><custom3>NIHMS62451</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja070245c [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2056</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2056</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cao, Q.</author><author>Cai, W.</author><author>Li, Z. B.</author><author>Chen, K.</author><author>He, L.</author><author>Li, H. C.</author><author>Hui, M.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305-5484, USA.</auth-address><titles><title>PET imaging of acute and chronic inflammation in living mice</title><secondary-title>Eur J Nucl Med Mol Imaging</secondary-title></titles><periodical><full-title>Eur J Nucl Med Mol Imaging</full-title></periodical><pages>1832-42</pages><volume>34</volume><number>11</number><edition>2007/06/02</edition><keywords><keyword>Animals</keyword><keyword>Copper Radioisotopes/diagnostic use/pharmacokinetics</keyword><keyword>Immunoglobulin G/ diagnostic use/ metabolism</keyword><keyword>Inflammation/ metabolism/ radionuclide imaging</keyword><keyword>Integrin alphaVbeta3/ metabolism</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Organ Specificity</keyword><keyword>Positron-Emission Tomography/ methods</keyword><keyword>Radiopharmaceuticals/diagnostic use/pharmacokinetics</keyword><keyword>Receptors, Tumor Necrosis Factor/ metabolism</keyword><keyword>Tissue Distribution</keyword><keyword>Tumor Necrosis Factor-alpha/ metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1619-7070 (Print)</isbn><accession-num>17541586</accession-num><abstract>PURPOSE: In this study, we evaluated the 12-O-tetradecanoyl-phorbol-13-acetate (TPA)-induced acute and chronic inflammation in living mice by PET imaging of TNF-alpha and integrin alpha(v)beta(3) expression. METHODS: TPA was topically applied to the right ear of BALB/c mice every other day to create the inflammation model. (64)Cu-DOTA-etanercept and (64)Cu-DOTA-E{E[c(RGDyK)](2)}(2) were used for PET imaging of TNF-alpha and integrin alpha(v)beta(3) expression in both acute and chronic inflammation. Hematoxylin and eosin staining, ex vivo autoradiography, direct tissue sampling, and immunofluorescence staining were also performed to confirm the non-invasive PET imaging results. RESULTS: The ear thickness increased significantly and the TNF-alpha level more than tripled after a single TPA challenge. MicroPET imaging using (64)Cu-DOTA-etanercept revealed high activity accumulation in the inflamed ear, reaching 11.1 +/- 1.3, 13.0 +/- 2.0, 10.9 +/- 1.4, 10.2 +/- 2.2%ID/g at 1, 4, 16, and 24 h post injection, respectively (n = 3). Repeated TPA challenges caused TPA-specific chronic inflammation and reduced (64)Cu-DOTA-etanercept uptake due to lowered TNF-alpha expression. (64)Cu-DOTA-E{E[c(RGDyK)](2)}(2) uptake in the chronically inflamed ears (after four and eight TPA challenges) was significantly higher than in the control ears and those after one TPA challenge. Immunofluorescence staining revealed increased integrin beta(3) expression, consistent with the non-invasive PET imaging results using (64)Cu-DOTA-E{E[c(RGDyK)](2)}(2) as an integrin alpha(v)beta(3)-specific radiotracer. Biodistribution and autoradiography studies further confirmed the quantification capability of microPET imaging. CONCLUSION: Successful PET imaging of TNF-alpha expression in acute inflammation and integrin alpha(v)beta(3) expression in chronic inflammation provides the rationale for multiple target evaluation over time to fully understand the inflammation processes.</abstract><notes>Cao, Qizhen&#xD;Cai, Weibo&#xD;Li, Zi-Bo&#xD;Chen, Kai&#xD;He, Lina&#xD;Li, Hui-Cheng&#xD;Hui, Mizhou&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;European journal of nuclear medicine and molecular imaging&#xD;Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1832-42. Epub 2007 May 31.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.625</custom4><electronic-resource-num>10.1007/s00259-007-0451-0 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1679</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1679</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Veiseh, M.</author><author>Gabikian, P.</author><author>Bahrami, S. B.</author><author>Veiseh, O.</author><author>Zhang, M.</author><author>Hackman, R. C.</author><author>Ravanpay, A. C.</author><author>Stroud, M. R.</author><author>Kusuma, Y.</author><author>Hansen, S. J.</author><author>Kwok, D.</author><author>Munoz, N. M.</author><author>Sze, R. W.</author><author>Grady, W. M.</author><author>Greenberg, N. M.</author><author>Ellenbogen, R. G.</author><author>Olson, J. M.</author></authors></contributors><auth-address>Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, 1100 Fairview Avenue N., Seattle, WA 98109, USA.</auth-address><titles><title>Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><alt-periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></alt-periodical><pages>6882-8</pages><volume>67</volume><number>14</number><edition>2007/06</edition><keywords><keyword>Animals</keyword><keyword>Brain Neoplasms/metabolism</keyword><keyword>Carbocyanines/*chemistry</keyword><keyword>Fluorescent Dyes/chemistry</keyword><keyword>Glioma/metabolism</keyword><keyword>Humans</keyword><keyword>Matrix Metalloproteinase 2/metabolism</keyword><keyword>Mice</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Neoplasms/*metabolism</keyword><keyword>Neovascularization, Pathologic</keyword><keyword>Photons</keyword><keyword>Rats</keyword><keyword>Scorpion Venoms/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17638899</accession-num><abstract>Toward the goal of developing an optical imaging contrast agent that will enable surgeons to intraoperatively distinguish cancer foci from adjacent normal tissue, we developed a chlorotoxin:Cy5.5 (CTX:Cy5.5) bioconjugate that emits near-IR fluorescent signal. The probe delineates malignant glioma, medulloblastoma, prostate cancer, intestinal cancer, and sarcoma from adjacent non-neoplastic tissue in mouse models. Metastatic cancer foci as small as a few hundred cells were detected in lymph channels. Specific binding to cancer cells is facilitated by matrix metalloproteinase-2 (MMP-2) as evidenced by reduction of CTX:Cy5.5 binding in vitro and in vivo by a pharmacologic blocker of MMP-2 and induction of CTX:Cy5.5 binding in MCF-7 cells following transfection with a plasmid encoding MMP-2. Mouse studies revealed that CTX:Cy5.5 has favorable biodistribution and toxicity profiles. These studies show that CTX:Cy5.5 has the potential to fundamentally improve intraoperative detection and resection of malignancies.</abstract><notes>Cq 84296/phs&#xD;N01 c0 37007-16/phs&#xD;P30 ca 15704-31/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17638899 </url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2007</custom3><custom4>7.980</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1522</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1522</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, M. C.</author><author>Ong, S. V.</author><author>Khanna, S. N.</author><author>Knickelbein, M. B.</author></authors></contributors><titles><title>Magnetic endohedral metallofullerenes with floppy interiors (vol 75, art no 104424, 2007)</title><secondary-title>Physical Review B</secondary-title></titles><periodical><full-title>Physical Review B</full-title></periodical><pages>-</pages><volume>75</volume><number>22</number><edition>2007/06</edition><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1098-0121</isbn><accession-num>ISI:000247624800097</accession-num><notes>184EV&#xD;Times Cited:0&#xD;Cited References Count:1</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000247624800097</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2007</custom3><custom4>3.284</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1520</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1520</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, J.</author><author>Yong, K. T.</author><author>Roy, I.</author><author>Ohulchanskyy, T. Y.</author><author>Bergey, E. J.</author><author>Lee, H. H.</author><author>Tramposch, K. M.</author><author>He, S.</author><author>Maitra, A.</author><author>Prasad, P. N.</author></authors></contributors><titles><title>Imaging pancreatic cancer using surface-functionalized quantum dots</title><secondary-title>J Phys Chem B</secondary-title><alt-title>The journal of physical chemistry</alt-title></titles><periodical><full-title>J Phys Chem B</full-title></periodical><alt-periodical><full-title>J Phys Chem B</full-title><abbr-1>The journal of physical chemistry</abbr-1></alt-periodical><pages>6969-72</pages><volume>111</volume><number>25</number><edition>2007/06</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>*Contrast Media</keyword><keyword>Humans</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Pancreatic Neoplasms/*diagnosis/*pathology</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun 28</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>17552555</accession-num><abstract>In this study, CdSe/CdS/ZnS quantum dots (QDs) were used as optical contrast agent for imaging pancreatic cancer cells in vitro using transferrin and anti-Claudin-4 as targeting ligands. CdSe/CdS/ZnS was chosen because the CdSe/CdS/ZnS QDs have better photoluminescence (PL) efficiency and stability than those of CdSe/ZnS. The transferrin-mediated targeting is demonstrated in both a cell-free coprecipitation assay as well as using in vitro confocal microscopy. Pancreatic cancer specific uptake is also demonstrated using the monoclonal antibody anti-Claudin-4. This targeted QD platform will be further modified for the purpose of developing as an early detection imaging tool for pancreatic cancer.</abstract><notes>Ca104492/ca/nci&#xD;R01ca119397/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17552555 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2007</custom3><custom4>4.688</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1446</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1446</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Melancon, M. P.</author><author>Wang, W.</author><author>Wang, Y. T.</author><author>Shao, R. P.</author><author>Ji, X. J.</author><author>Gelovani, J. G.</author><author>Li, C.</author></authors></contributors><auth-address>Li, C&#xD;Univ Texas, MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Imaging Box 57,1515 Holcombe Blvd, Houston, TX 77030 USA&#xD;Univ Texas, MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA</auth-address><titles><title>A novel method for Imaging in vivo degradation of poly(L-glutamic acid), a biodegradable drug carrier</title><secondary-title>Pharmaceutical Research</secondary-title></titles><periodical><full-title>Pharmaceutical Research</full-title></periodical><pages>1217-1224</pages><volume>24</volume><number>6</number><edition>2007/06</edition><keywords><keyword>biodegradation</keyword><keyword>cathepsin b</keyword><keyword>molecular imaging</keyword><keyword>near-infrared optical imaging</keyword><keyword>poly(l-glutamic acid)</keyword><keyword>cathepsin-b</keyword><keyword>fluorescent</keyword><keyword>paclitaxel</keyword><keyword>assay</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0724-8741</isbn><accession-num>ISI:000246619700021</accession-num><abstract>Purpose. To develop an L-PG-based imaging probe suitable for assessing the degradation of L-PG in vivo.&#xD;Materials and Methods. Conjugates of L-PG and a near-infrared fluorescence (NIRF) dye, NIR813, were characterized with regard to quenching efficiency and degradability by cathepsin B (CB) and other proteases. The kinetics of L-PG-NIR813&apos;s degradation and its degradation in orthotopic human U87/TGL glioma in nude mice after intravenous injection was assessed using NIRF optical imaging (n = 3).&#xD;Results. The fluorescence signal from L-PG-NIR813 was efficiently quenched and activated at NIR813 loadings of 8-10%. Upon exposure to CB, the fluorescence intensity of L-PG-NIR813 increased 10-fold. L-PG-NIR813 was also degraded by another cysteine protease cathepsin L, but not by MMP-2, cathepsin E, cathepsin D, and plasmin. A selective CB inhibitor blocked the fluorescence activation. After intravenous injection, the degradation of L-PG-NIR813 was visualized primarily in the liver, which peaked at 4 h postinjection. Activation of L-PG-NIR813 but not D-PG-NIR813 was clearly seen in U87/TGL tumors.&#xD;Conclusion. Our results indicate that L-PG-NIR813 may be used to monitor the in vivo degradation of L-PG-based polymeric drugs, and that this agent may prove useful in noninvasive imaging of protease activity, particularly that of cysteine proteases.</abstract><notes>169VH&#xD;Times Cited:0&#xD;Cited References Count:24</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246619700021</url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom3>2007</custom3><custom4>3.831</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1224</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1224</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Gu, F. X.</author><author>Karnik, R.</author><author>Wang, A. Z.</author><author>Alexis, F.</author><author>Levy-Nissenbaum, E.</author><author>Hong, S.</author><author>Langer, R. S.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Gu, Fx&#xD;MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA&#xD;MIT, Dept Chem Engn, Cambridge, MA 02139 USA&#xD;Harvard MIT Ctr Canc Nanotechnol, Cambridge, MA 02139 USA&#xD;MIT, Dept Mech Engn, Cambridge, MA 02139 USA&#xD;Harvard Univ, Sch Med, Brigham &amp; Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA&#xD;Harvard Univ, Sch Med, Brigham &amp; Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA</auth-address><titles><title>Targeted nanoparticles for cancer therapy</title><secondary-title>Nano Today</secondary-title></titles><periodical><full-title>Nano Today</full-title></periodical><pages>14-21</pages><volume>2</volume><number>3</number><edition>2007/06</edition><keywords><keyword>chronic lymphocytic-leukemia</keyword><keyword>pegylated liposomal doxorubicin</keyword><keyword>her2-positive breast-cancer</keyword><keyword>consolidative 1st-line chemotherapy</keyword><keyword>monoclonal-antibody therapy</keyword><keyword>stem-cell transplantation</keyword><keyword>chemical-analysis systems</keyword><keyword>ph-sensitive liposomes</keyword><keyword>human tumor xenograft</keyword><keyword>non-hodgkins-lymphoma</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1748-0132</isbn><accession-num>ISI:000246853500014</accession-num><abstract>Over the past decade, there has been an increasing interest in using nanotechnology for cancer therapy. The development of smart targeted nanoparticles (NPs) that can deliver drugs at a sustained rate directly to cancer cells may provide better efficacy and lower toxicity for treating primary and advanced metastatic tumors. We highlight some of the promising classes of targeting molecules that are under development for the delivery of NPs. We also review the emerging technologies for the fabrication of targeted NPs using microfluidic devices.</abstract><notes>173DK&#xD;Times Cited:0&#xD;Cited References Count:139</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246853500014</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>9.231</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1487</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1487</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, H.</author><author>Cannizzaro, C.</author><author>Vunjak-Novakovic, G.</author><author>Langer, R.</author><author>Vacanti, C. A.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Division of Health Sciences and Technology, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. hpark@mit.edu</auth-address><titles><title>Nanofabrication and microfabrication of functional materials for tissue engineering</title><secondary-title>Tissue Eng</secondary-title></titles><periodical><full-title>Tissue Eng</full-title></periodical><pages>1867-77</pages><volume>13</volume><number>8</number><edition>2007/05/24</edition><keywords><keyword>Animals</keyword><keyword>Biocompatible Materials/*chemical synthesis</keyword><keyword>Humans</keyword><keyword>*Nanostructures</keyword><keyword>*Nanotechnology</keyword><keyword>Tissue Engineering/*instrumentation/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1076-3279 (Print)</isbn><accession-num>17518744</accession-num><abstract>The burgeoning field of regenerative medicine promises significant progress in the treatment of cardiac ischemia, liver disease, and spinal cord injury. Key to its success will be the ability to engineer tissue safely and reliably. Tissue functionality must be recapitulated in the laboratory and then integrated into surrounding tissue upon transfer to the patient. Scaffolding materials must be chosen such that the microenvironment surrounding the cells is a close analog of the native environment. In the early days of tissue engineering, these materials were largely borrowed from other fields, with much of the focus on biocompatibility and biodegradation. However, attention has shifted recently to cell-cell and cell-surface interactions, largely because of enabling technologies at the nanoscale and microscale. Studies on cellular behavior in response to various stimuli are now easily realized by using microfabrication techniques and devices (e.g., biomedical microelectromechanical systems). These experiments are reproducible and moderate in cost, and often can be accomplished at high throughput, providing the fundamental knowledge required to design biomaterials that closely mimic the biological system. It is our opinion that these novel materials and technologies will bring engineered tissues one step closer to practical application in the clinic. This review discusses their application to cardiac, liver, and nerve tissue engineering.</abstract><notes>Park, Hyoungshin&#xD;Cannizzaro, Christopher&#xD;Vunjak-Novakovic, Gordana&#xD;Langer, Robert&#xD;Vacanti, Charles A&#xD;Farokhzad, Omid C&#xD;CA119349/CA/United States NCI&#xD;DE13023/DE/United States NIDCR&#xD;DE16516/DE/United States NIDCR&#xD;EB002520-01/EB/United States NIBIB&#xD;EB003647/EB/United States NIBIB&#xD;HL060435/HL/United States NHLBI&#xD;HL076485-01/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;United States&#xD;Tissue engineering&#xD;Tissue Eng. 2007 Aug;13(8):1867-77.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17518744</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>4.876</custom4><electronic-resource-num>10.1089/ten.2006.0198</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1629</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1629</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Subramanian, H.</author><author>Pradhan, P.</author><author>Kim, Y. L.</author><author>Backman, V.</author></authors></contributors><auth-address>Biomedical Engineering Department, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Penetration depth of low-coherence enhanced backscattered light in subdiffusion regime</title><secondary-title>Phys Rev E Stat Nonlin Soft Matter Phys</secondary-title></titles><periodical><full-title>Phys Rev E Stat Nonlin Soft Matter Phys</full-title></periodical><pages>041914</pages><volume>75</volume><number>4 Pt 1</number><edition>2007/05/16</edition><keywords><keyword>Anisotropy</keyword><keyword>Biophysics/*methods</keyword><keyword>Computer Simulation</keyword><keyword>Diffusion</keyword><keyword>Light</keyword><keyword>Models, Statistical</keyword><keyword>Models, Theoretical</keyword><keyword>Monte Carlo Method</keyword><keyword>Photons</keyword><keyword>Refractometry</keyword><keyword>*Scattering, Radiation</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1539-3755 (Print)</isbn><accession-num>17500928</accession-num><abstract>The mechanisms of photon propagation in random media in the diffusive multiple scattering regime have been previously studied using diffusion approximation. However, similar understanding in the low-order (subdiffusion) scattering regime is not complete due to difficulties in tracking photons that undergo very few scatterings events. Recent developments in low-coherence enhanced backscattering (LEBS) overcome these difficulties and enable probing photons that travel very short distances and undergo only a few scattering events. In LEBS, enhanced backscattering is observed under illumination with spatial coherence length L{sc} less than the scattering mean free path l{s}. In order to understand the mechanisms of photon propagation in LEBS in the subdiffusion regime, it is imperative to develop analytical and numerical models that describe the statistical properties of photon trajectories. Here we derive the probability distribution of penetration depth of LEBS photons and report Monte Carlo numerical simulations to support our analytical results. Our results demonstrate that, surprisingly, the transport of photons that undergo low-order scattering events has only weak dependence on the optical properties of the medium (l{s} and anisotropy factor g) and strong dependence on the spatial coherence length of illumination, L{sc} relative to those in the diffusion regime. More importantly, these low-order scattering photons typically penetrate less than l{s} into the medium due to the low spatial coherence length of illumination and their penetration depth is proportional to the one-third power of the coherence volume (i.e., [l{s}piL{s}{2}]1/3) .</abstract><notes>Subramanian, Hariharan&#xD;Pradhan, Prabhakar&#xD;Kim, Young L&#xD;Backman, Vadim&#xD;R01 ca 112315/ca/nci&#xD;R01eb 003682/eb/nibib&#xD;R25 ca 100600-01a1/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Physical review. E, Statistical, nonlinear, and soft matter physics&#xD;Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Apr;75(4 Pt 1):041914. Epub 2007 Apr 26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17500928</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>2.566</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1539</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1539</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rhee, T. K.</author><author>Young, J. Y.</author><author>Larson, A. C.</author><author>Haines, G. K., 3rd</author><author>Sato, K. T.</author><author>Salem, R.</author><author>Mulcahy, M. F.</author><author>Kulik, L. M.</author><author>Paunesku, T.</author><author>Woloschak, G. E.</author><author>Omary, R. A.</author></authors></contributors><auth-address>Department of Radiology, Northwestern University Feinberg School of Medicine, 448 E Ontario St, Ste 700, Chicago, IL 60611, USA.</auth-address><titles><title>Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1alpha in rabbit VX2 liver tumors</title><secondary-title>J Vasc Interv Radiol</secondary-title></titles><periodical><full-title>J Vasc Interv Radiol</full-title></periodical><pages>639-45</pages><volume>18</volume><number>5</number><edition>2007/05/15</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>*Chemoembolization, Therapeutic</keyword><keyword>Disease Models, Animal</keyword><keyword>Feasibility Studies</keyword><keyword>Hypoxia-Inducible Factor 1, alpha Subunit/*biosynthesis</keyword><keyword>Liver Neoplasms, Experimental/*genetics/*therapy</keyword><keyword>Rabbits</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>1051-0443 (Print)</isbn><accession-num>17494846</accession-num><abstract>PURPOSE: To test the hypothesis that transcatheter arterial embolization (TAE) of VX2 rabbit liver tumors increases the expression of hypoxia-inducible factor-1alpha (HIF-1alpha), a transcription factor that regulates the expression of pro-angiogenic genes. MATERIALS AND METHODS: VX2 tumors were implanted in the livers of eight New Zealand white rabbits. Once tumor growth was seen at T2-weighted turbo spin-echo magnetic resonance (MR) imaging, four of the eight rabbits underwent TAE with 45-150-mum polyvinyl alcohol particles. The remaining four rabbits served as non-TAE controls. The TAE end point was stasis of antegrade blood flow. All rabbits were sacrificed for tumor harvest 2 hours after TAE. Tumor tissue and corresponding normal liver tissue in each rabbit liver were stained with anti-human HIF-1alpha monoclonal antibody and reviewed with light microscopy. Percentages of stained viable tumor and normal liver cells were compared by using the Mann-Whitney U test (alpha=0.05). RESULTS: In eight rabbits with 24 discrete liver tumors, the mean percentage (+/-standard deviation) of positive HIF-1alpha-stained cells in the TAE group was greater than that in the control group (19%+/-7.0 vs 12%+/-8.0, respectively) (P=.05). Normal liver tissue in both the TAE and control groups showed no HIF-1alpha staining. CONCLUSION: Although HIF-1alpha is not expressed in normal rabbit liver parenchyma-even after TAE-HIF-1alpha expression is present in implanted VX2 rabbit liver tumors and significantly increased in lesions that have undergone embolization.</abstract><notes>Rhee, Thomas K&#xD;Young, Joseph Y&#xD;Larson, Andrew C&#xD;Haines, G Kenneth 3rd&#xD;Sato, Kent T&#xD;Salem, Riad&#xD;Mulcahy, Mary F&#xD;Kulik, Laura M&#xD;Paunesku, Tatjana&#xD;Woloschak, Gayle E&#xD;Omary, Reed A&#xD;Ca73042/ca/nci&#xD;Ca81375/ca/nci&#xD;K08 dk60020/dk/niddk&#xD;Ns 21442/ns/ninds&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of vascular and interventional radiology : JVIR&#xD;J Vasc Interv Radiol. 2007 May;18(5):639-45.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17494846</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>2.956</custom4><electronic-resource-num>18/5/639 [pii]&#xD;10.1016/j.jvir.2007.02.031</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2055</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2055</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wu, Z.</author><author>Li, Z. B.</author><author>Cai, W.</author><author>He, L.</author><author>Chin, F. T.</author><author>Li, F.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305-5484, USA.</auth-address><titles><title>18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression</title><secondary-title>Eur J Nucl Med Mol Imaging</secondary-title></titles><periodical><full-title>Eur J Nucl Med Mol Imaging</full-title></periodical><pages>1823-31</pages><volume>34</volume><number>11</number><edition>2007/05/12</edition><keywords><keyword>Animals</keyword><keyword>Dimerization</keyword><keyword>Female</keyword><keyword>Fluorine Radioisotopes/chemistry/ diagnostic use/ pharmacokinetics</keyword><keyword>Gene Expression Profiling/methods</keyword><keyword>Glioblastoma/ metabolism/ radionuclide imaging</keyword><keyword>Integrin alphaVbeta3/ metabolism</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Oligopeptides/chemistry/ diagnostic use/ pharmacokinetics</keyword><keyword>Organ Specificity</keyword><keyword>Positron-Emission Tomography/methods</keyword><keyword>Radiopharmaceuticals/chemical synthesis/diagnostic use/pharmacokinetics</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2007</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1619-7070 (Print)</isbn><accession-num>17492285</accession-num><abstract>PURPOSE: We have previously reported that (18)F-FB-E[c(RGDyK)](2) ((18)F-FRGD2) allows quantitative PET imaging of integrin alpha(v)beta(3) expression. However, the potential clinical translation was hampered by the relatively low radiochemical yield. The goal of this study was to improve the radiolabeling yield, without compromising the tumor targeting efficiency and in vivo kinetics, by incorporating a hydrophilic bifunctional mini-PEG spacer. METHODS: (18)F-FB-mini-PEG-E[c(RGDyK)](2) ((18)F-FPRGD2) was synthesized by coupling N-succinimidyl-4-(18)F-fluorobenzoate ((18)F-SFB) with NH(2)-mini-PEG-E[c(RGDyK)](2) (denoted as PRGD2). In vitro receptor binding affinity, metabolic stability, and integrin alpha(v)beta(3) specificity of the new tracer (18)F-FPRGD2 were assessed. The diagnostic value of (18)F-FPRGD2 was evaluated in subcutaneous U87MG glioblastoma xenografted mice and in c-neu transgenic mice by quantitative microPET imaging studies. RESULTS: The decay-corrected radiochemical yield based on (18)F-SFB was more than 60% with radiochemical purity of &gt;99%. (18)F-FPRGD2 had high receptor binding affinity, metabolic stability, and integrin alpha(v)beta(3)-specific tumor uptake in the U87MG glioma xenograft model comparable to those of (18)F-FRGD2. The kidney uptake was appreciably lower for (18)F-FPRGD2 compared with (18)F-FRGD2 [2.0 +/- 0.2%ID/g for (18)F-FPRGD2 vs 3.0 +/- 0.2%ID/g for (18)F-FRGD2 at 1 h post injection (p.i.)]. The uptake in all the other organs except the urinary bladder was at background level. (18)F-FPRGD2 also exhibited excellent tumor uptake in c-neu oncomice (3.6 +/- 0.1%ID/g at 30 min p.i.). CONCLUSION: Incorporation of a mini-PEG spacer significantly improved the overall radiolabeling yield of (18)F-FPRGD2. (18)F-FPRGD2 also had reduced renal uptake and similar tumor targeting efficacy as compared with (18)F-FRGD2. Further testing and clinical translation of (18)F-FPRGD2 are warranted.</abstract><notes>Wu, Zhanhong&#xD;Li, Zi-Bo&#xD;Cai, Weibo&#xD;He, Lina&#xD;Chin, Frederick T&#xD;Li, Fang&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;European journal of nuclear medicine and molecular imaging&#xD;Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1823-31. Epub 2007 May 5.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.625</custom4><electronic-resource-num>10.1007/s00259-007-0427-0 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1182</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1182</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Dimri, M.</author><author>Naramura, M.</author><author>Duan, L.</author><author>Chen, J.</author><author>Ortega-Cava, C.</author><author>Chen, G.</author><author>Goswami, R.</author><author>Fernandes, N.</author><author>Gao, Q.</author><author>Dimri, G. P.</author><author>Band, V.</author><author>Band, H.</author></authors></contributors><auth-address>Division of Molecular Oncology, Evanston Northwestern Healthcare Research Institute, Evanston, IL 60201, USA.</auth-address><titles><title>Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>4164-72</pages><volume>67</volume><number>9</number><edition>2007/05/08</edition><keywords><keyword>Animals</keyword><keyword>Breast Neoplasms/*enzymology/pathology</keyword><keyword>Cell Adhesion/physiology</keyword><keyword>Cell Growth Processes/physiology</keyword><keyword>Cell Transformation, Neoplastic/*metabolism/pathology</keyword><keyword>Collagen</keyword><keyword>Drug Combinations</keyword><keyword>Epithelial Cells/enzymology/pathology</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Laminin</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Protein-Tyrosine Kinases/*biosynthesis</keyword><keyword>Proteoglycans</keyword><keyword>Receptor, Epidermal Growth Factor/*biosynthesis</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2007</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17483327</accession-num><abstract>Epidermal growth factor receptor (EGFR), a member of the ErbB family of receptor tyrosine kinases, is overexpressed in as many as 60% cases of breast and other cancers. EGFR overexpression is a characteristic of highly aggressive molecular subtypes of breast cancer with basal-like and BRCA1 mutant phenotypes distinct from ErbB2-overexpressing breast cancers. Yet, EGFR is substantially weaker compared with ErbB2 in promoting the oncogenic transformation of nontumorigenic human mammary epithelial cells (human MEC), suggesting a role for cooperating oncogenes. Here, we have modeled the co-overexpression of EGFR and a biologically and clinically relevant potential modifier c-Src in two distinct immortal but nontumorigenic human MECs. Using a combination of morphologic analysis and confocal imaging of polarity markers in three-dimensional Matrigel culture together with functional analyses of early oncogenic traits, we show for the first time that EGFR and c-Src co-overexpression but not EGFR or c-Src overexpression alone unleashes an oncogenic signaling program that leads to hyperproliferation and loss of polarity in three-dimensional acinar cultures, marked enhancement of migratory and invasive behavior, and anchorage-independent growth. Our results establish that EGFR overexpression in an appropriate context (modeled here using c-Src overexpression) can initiate oncogenic transformation of nontumorigenic human MECs and provide a suitable in vitro model to interrogate human breast cancer-relevant oncogenic signaling pathways initiated by overexpressed EGFR and to identify modifiers of EGFR-mediated breast oncogenesis.</abstract><notes>Dimri, Manjari&#xD;Naramura, Mayumi&#xD;Duan, Lei&#xD;Chen, Jing&#xD;Ortega-Cava, Cesar&#xD;Chen, Gengsheng&#xD;Goswami, Rasna&#xD;Fernandes, Norvin&#xD;Gao, Qingshen&#xD;Dimri, Goberdhan P&#xD;Band, Vimla&#xD;Band, Hamid&#xD;1U54 CA 119341-01/CA/United States NCI&#xD;CA 76118/CA/United States NCI&#xD;CA 81076/CA/United States NCI&#xD;CA 87986/CA/United States NCI&#xD;CA 94143/CA/United States NCI&#xD;CA 96844/CA/United States NCI&#xD;CA 99163/CA/United States NCI&#xD;CA 99900/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2007 May 1;67(9):4164-72.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17483327</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>7.980</custom4><electronic-resource-num>67/9/4164 [pii]&#xD;10.1158/0008-5472.CAN-06-2580</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2293</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2293</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Huang, X.</author><author>El-Sayed, I. H.</author><author>Qian, W.</author><author>El-Sayed, M. A.</author></authors></contributors><auth-address>Laser Dynamics Laboratory, School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.</auth-address><titles><title>Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>1591-7</pages><volume>7</volume><number>6</number><edition>2007/05/04</edition><keywords><keyword>Carcinoma, Squamous Cell/ immunology/ pathology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Contrast Media</keyword><keyword>Gold/chemistry/ diagnostic use</keyword><keyword>Humans</keyword><keyword>Immunoassay/methods</keyword><keyword>Molecular Probe Techniques</keyword><keyword>Nanotechnology/methods</keyword><keyword>Nanotubes/ chemistry/ultrastructure</keyword><keyword>Receptor, Epidermal Growth Factor/chemistry/ immunology</keyword><keyword>Refractometry/ methods</keyword><keyword>Spectrum Analysis, Raman/ methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17474783</accession-num><abstract>Human oral cancer cells are found to assemble and align gold nanorods conjugated to anti-epidermal growth factor receptor (anti-EGFR) antibodies. Immnoconjugated gold nanorods and nanospheres were shown previously to exhibit strong Rayleigh (Mie) scattering useful for imaging. In the present letter, molecules near the nanorods on the cancer cells are found to give a Raman spectrum that is greatly enhanced (due to the high surface plasmon field of the nanorod assembly in which their extended surface plasmon fields overlap), sharp (due to a homogeneous environment), and polarized (due to anisotropic alignments). These observed properties can be used as diagnostic signatures for cancer cells.</abstract><notes>Huang, Xiaohua&#xD;El-Sayed, Ivan H&#xD;Qian, Wei&#xD;El-Sayed, Mostafa A&#xD;U54CA119338/CA/NCI NIH HHS/United States&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Jun;7(6):1591-7. Epub 2007 May 3.</notes><urls></urls><custom1>CCNE - Emory</custom1><custom4>12.189</custom4><electronic-resource-num>10.1021/nl070472c [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1761</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1761</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yao, H.</author><author>Zhang, Y.</author><author>Xiao, F.</author><author>Xia, Z.</author><author>Rao, J.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology, Biophysics, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA 94305-5484, USA.</auth-address><titles><title>Quantum dot/bioluminescence resonance energy transfer based highly sensitive detection of proteases</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>4346-9</pages><volume>46</volume><number>23</number><edition>2007/05/01</edition><keywords><keyword>Enzyme Activation</keyword><keyword>Fluorescence Resonance Energy Transfer/*methods</keyword><keyword>Luminescent Measurements/*methods</keyword><keyword>Matrix Metalloproteinases/*analysis/*chemistry</keyword><keyword>*Quantum Dots</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2007</year></dates><isbn>1433-7851 (Print)</isbn><accession-num>17465433</accession-num><notes>Yao, Hequan&#xD;Zhang, Yan&#xD;Xiao, Fei&#xD;Xia, Zuyong&#xD;Rao, Jianghong&#xD;1u54ai19367-01/ai/niaid&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2007;46(23):4346-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17465433</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200700280</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1300</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1300</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ji, Y.</author><author>Hayashi, K.</author><author>Amoh, Y.</author><author>Tsuji, K.</author><author>Yamauchi, K.</author><author>Yamamoto, N.</author><author>Tsuchiya, H.</author><author>Tomita, K.</author><author>Bouvet, M.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., 7917 Ostrow Street, San Diego, CA 92111, USA.</auth-address><titles><title>The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer</title><secondary-title>Anticancer Res</secondary-title></titles><periodical><full-title>Anticancer Res</full-title></periodical><pages>713-8</pages><volume>27</volume><number>2</number><edition>2007/05/01</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents, Phytogenic/*pharmacology</keyword><keyword>Camptothecin/*analogs &amp; derivatives/pharmacology</keyword><keyword>Colonic Neoplasms/*blood supply/*drug therapy/genetics/metabolism</keyword><keyword>Female</keyword><keyword>Green Fluorescent Proteins/biosynthesis/genetics</keyword><keyword>HCT116 Cells</keyword><keyword>Humans</keyword><keyword>Intermediate Filament Proteins/biosynthesis/genetics</keyword><keyword>Luminescent Proteins/biosynthesis/genetics</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Nude</keyword><keyword>Mice, Transgenic</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Neovascularization, Pathologic/drug therapy/genetics/metabolism</keyword><keyword>Nerve Tissue Proteins/biosynthesis/genetics</keyword><keyword>Recombinant Fusion Proteins/biosynthesis/genetics</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar-Apr</date></pub-dates></dates><isbn>0250-7005 (Print)</isbn><accession-num>17465193</accession-num><abstract>Recent studies have shown the expression of a stem cell marker protein, nestin, in nascent blood vessels in nestin-driven green fluorescent protein (ND-GFP) transgenic nude mice. In the present study, we visualized tumor angiogenesis and evaluated the antiangiogenic efficacy of CPT-11 in ND-GFP nude mice using dual-color fluorescence imaging. We orthotopically implanted ND-GFP nude mice with the human cancer cell line HCT-116 expressing red fluorescent protein (RFP). The mice were treated with CPT-11 at 40 mg/kg on days 7, 10, 14. Tumor angiogenesis was imaged and visualized by dual-color fluorescence imaging on day 17, three days after the last CPT-11 treatment. Tumor volume and the mean nascent blood vessel density were determined and compared to the control mice. The growing tumor had high expressions of nestin in the nascent blood vessels. The nascent blood vessels showed co-localization of the endothelial-cell-specific marker CD-31 under immunohistochemical staining. The nascent blood vessels were highly visible and their density was determined. ND-GFP nude mice that were administered CPT-11 showed significant reduction in the mean nascent blood vessel density and tumor volume. The dual-color model of ND-GFP transgenic nude mice orthotopically implanted with HCT-116 expressing RFP proved to be effective in visualizing and quantitating tumor growth and tumor angiogenesis. The results showed that CPT-11 is an effective inhibitor of angiogenesis and provided strong implications for wider clinical application of CPT-11 for colon cancer.</abstract><notes>Ji, Yong&#xD;Hayashi, Katsuhiro&#xD;Amoh, Yasuyuki&#xD;Tsuji, Kazuhiko&#xD;Yamauchi, Kensuke&#xD;Yamamoto, Norio&#xD;Tsuchiya, Hiroyuki&#xD;Tomita, Katsuro&#xD;Bouvet, Michael&#xD;Hoffman, Robert M&#xD;Greece&#xD;Anticancer research&#xD;Anticancer Res. 2007 Mar-Apr;27(2):713-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17465193</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>2.316</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1275</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1275</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hughes, M. S.</author><author>Marsh, J. N.</author><author>Wallace, K. D.</author><author>Donahue, T. A.</author><author>Connolly, A. M.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Washington University, School of Medicine, St Louis, MO 63108, USA. msh@cvu.wust.edu</auth-address><titles><title>Sensitive ultrasonic detection of dystrophic skeletal muscle in patients with duchenne muscular dystrophy using an entropy-based signal receiver</title><secondary-title>Ultrasound Med Biol</secondary-title></titles><periodical><full-title>Ultrasound Med Biol</full-title></periodical><pages>1236-43</pages><volume>33</volume><number>8</number><edition>2007/05/01</edition><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0301-5629 (Print)</isbn><accession-num>17467153</accession-num><abstract>The dystrophinopathies comprise a group of X-linked genetic diseases that feature dystrophin deficiency. Duchenne and Becker muscular dystrophy are characterized by progressive weakness and wasting of skeletal, smooth, and/or cardiac muscle. Duchenne muscular dystrophy (DMD) is the most severe dystrophinopathy, with an incidence of 1:3500 male births. Despite understanding the structural and genetic basis for DMD, the pathogenesis and clinical basis for more severe involvement in specific skeletal muscle groups and the heart are poorly understood. Current techniques, such as strength testing for monitoring progress of disease and therapy in DMD patients, are imprecise and physically demanding for test subjects. Ultrasound is well-suited to detect changes in structure and organization in muscle tissue in a manner that makes low demands on the patient. Therefore, we investigated the use of ultrasound to quantitatively phenotype the remodeling process in patients with DMD. Beam-formed radio-frequency (RF) data were acquired from the skeletal muscles of nine DMD and five normal subjects imaged with a clinical imaging system (HDI5000 w/7 MHz probe applied above left biceps muscle). From these data, images were reconstructed using B-mode (log of analytic signal magnitude) and information-theoretic receivers (H(f)-receiver). H(f) images obtained from dystrophic muscle contained extensive &quot;mottled&quot; regions (i.e., areas with heterogeneous image contrast) that were not readily apparent from the B-Mode images. The 2-D autocorrelation of DMD H(f) images have broader peaks than those of normal subjects, which is indicative of larger scatterer sizes, consistent with pathologic changes of fibers, edema and fatty infiltration. Comparison of the relative peak widths (full width measured at 60% maximum) of the autocorrelation of the DMD and normal H(f) images shows a quantitative difference between the two groups (p &lt; 0.005, student two-tailed paired t-test). Consequently, these imaging techniques may prove useful for longitudinal monitoring of disease progression and therapy.</abstract><notes>Hughes, Michael S&#xD;Marsh, Jon N&#xD;Wallace, Kirk D&#xD;Donahue, Tamara A&#xD;Connolly, Anne M&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;5r01hl042950-17/hl/nhlbi&#xD;5r01hl073646-02/hl/nhlbi&#xD;Iu54ca119342-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Ultrasound in medicine &amp; biology&#xD;Ultrasound Med Biol. 2007 Aug;33(8):1236-43. Epub 2007 Apr 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17467153</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>2.884</custom4><electronic-resource-num>S0301-5629(07)00086-5 [pii]&#xD;10.1016/j.ultrasmedbio.2007.02.007</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1676</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1676</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>van Vlerken, L. E.</author><author>Duan, Z.</author><author>Seiden, M. V.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, Massachusetts, USA.</auth-address><titles><title>Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><alt-periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></alt-periodical><pages>4843-50</pages><volume>67</volume><number>10</number><edition>2007/05</edition><keywords><keyword>Antineoplastic Agents, Phytogenic/*administration &amp; dosage</keyword><keyword>Cell Line, Tumor</keyword><keyword>Ceramides/*administration &amp; dosage/*metabolism</keyword><keyword>Drug Resistance, Multiple</keyword><keyword>Drug Resistance, Neoplasm</keyword><keyword>Ethylene Oxide/administration &amp; dosage/chemistry</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Lactones/administration &amp; dosage/chemistry</keyword><keyword>Nanoparticles/*administration &amp; dosage/chemistry</keyword><keyword>Ovarian Neoplasms/*drug therapy/*metabolism</keyword><keyword>Paclitaxel/*administration &amp; dosage</keyword></keywords><dates><year>2007</year><pub-dates><date>May 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17510414</accession-num><abstract>Although multidrug resistance (MDR) is known to develop through a variety of molecular mechanisms within the tumor cell, many tend to converge toward the alteration of apoptotic signaling. The enzyme glucosylceramide synthase (GCS), responsible for bioactivation of the proapoptotic mediator ceramide to a nonfunctional moiety glucosylceramide, is overexpressed in many MDR tumor types and has been implicated in cell survival in the presence of chemotherapy. The purpose of this study was to investigate the therapeutic strategy of coadministering ceramide with paclitaxel, a commonly used chemotherapeutic agent, in an attempt to restore apoptotic signaling and overcome MDR in the human ovarian cancer cell line SKOV3. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) (PEO-PCL) nanoparticles were used to encapsulate and deliver the therapeutic agents for enhanced efficacy. Results show that indeed the cotherapy eradicates the complete population of MDR cancer cells when they are treated at their IC(50) dose of paclitaxel. More interestingly, when the cotherapy was combined with the properties of nanoparticle drug delivery, the MDR cells can be resensitized to a dose of paclitaxel near the IC(50) of non-MDR (drug sensitive) cells, indicating a 100-fold increase in chemosensitization via this approach. Molecular analysis of activity verified the hypothesis that the efficacy of this therapeutic approach is indeed due to a restoration in apoptotic signaling, although the beneficial properties of PEO-PCL nanoparticle delivery seemed to enhance the therapeutic success even further, showing the promising potential for the clinical use of this therapeutic strategy to overcome MDR.</abstract><notes>Ca-095522/ca/nci&#xD;Ca-119617/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17510414 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>7.980</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1564</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1564</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Segal, E.</author><author>Perelman, L. A.</author><author>Cunin, F.</author><author>Di Renzo, F.</author><author>Devoisselle, J. M.</author><author>Li, Y. Y.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Segal, E&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Mat Sci &amp; Engn Program, La Jolla, CA 92093 USA&#xD;Inst Charles Gerhardt, CNRS,UMR 5618, UMI, ENSCM, F-34296 Montpellier, France&#xD;Hitachi Chem Res Ctr Inc, Irvine, CA 92617 USA</auth-address><titles><title>Confinement of thermoresponsive hydrogels in nanostructured porous silicon dioxide templates</title><secondary-title>Advanced Functional Materials</secondary-title></titles><periodical><full-title>Advanced Functional Materials</full-title></periodical><pages>1153-1162</pages><volume>17</volume><number>7</number><edition>2007/05</edition><keywords><keyword>linkable pnipaam copolymers</keyword><keyword>volume phase-transition</keyword><keyword>drug-delivery</keyword><keyword>polymer gels</keyword><keyword>scanning microcalorimetry</keyword><keyword>mechanical-properties</keyword><keyword>optical-properties</keyword><keyword>photonic crystals</keyword><keyword>colloidal silica</keyword><keyword>layers</keyword></keywords><dates><year>2007</year><pub-dates><date>May 7</date></pub-dates></dates><isbn>1616-301X</isbn><accession-num>ISI:000246647500015</accession-num><abstract>A thermoresponsive hydrogel, poly(N-isopropylacrylamide) (poly(NIPAM)), is synthesized in situ within an oxidized porous Si template, and the nanocomposite material is characterized. Infiltration of the hydrogel into the interconnecting nanoscale pores of the porous SiO2 host is confirmed by scanning electron microscopy. The optical reflectivity spectrum of the nanocomposite hybrid displays Fabry-Perot fringes characteristic of thin film interference, enabling direct, real-time observation of the volume phase transition of the confined poly(NIPAM) hydrogel. Reversible optical reflectivity changes are observed to correlate with the temperature-dependent volume phase transition of the hydrogel, providing a new means of studying nanoscale confinement of responsive hydrogels. The confined hydrogel displays a swelling and shrinking response to changes in temperature that is significantly faster than that of the bulk hydrogel. The porosity and pore size of the SiO2 template, which are precisely controlled by the electrochemical synthesis parameters, strongly influence the extent and rate of changes in the reflectivity spectrum of the nanocomposite. The observed optical response is ascribed to changes in both the mechanical and the dielectric properties of the nanocomposite.</abstract><notes>170FH&#xD;Times Cited:0&#xD;Cited References Count:51</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246647500015</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>8.203</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1560</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1560</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schwartz, M. P.</author><author>Yu, C.</author><author>Alvarez, S. D.</author><author>Migliori, B.</author><author>Godin, D.</author><author>Chao, L.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Sailor, MJ&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA&#xD;NSERC, CRSNG, Ottawa, ON K1A 1H5, Canada</auth-address><titles><title>Using an oxidized porous silicon interferometer for determination of relative protein binding affinity through non-covalent capture probe immobilization</title><secondary-title>Physica Status Solidi a-Applications and Materials Science</secondary-title></titles><periodical><full-title>Physica Status Solidi a-Applications and Materials Science</full-title></periodical><pages>1444-1448</pages><volume>204</volume><number>5</number><edition>2007/05</edition><keywords><keyword>surface-plasmon resonance</keyword><keyword>grating couplers</keyword><keyword>microcavities</keyword><keyword>chemistry</keyword><keyword>biosensor</keyword><keyword>sensors</keyword><keyword>immunoassays</keyword><keyword>crystals</keyword><keyword>sera</keyword><keyword>size</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>0031-8965</isbn><accession-num>ISI:000246642300041</accession-num><abstract>An oxidized porous Si interferometer was used to measure binding of immunoglobulin G (IgG) to an immobilized protein A capture probe. Protein A was non-covalently immobilized on a thermally oxidized porous Si (PSiO2) sample and exposed to IgG originating from different species. The resulting order of IgG affinity toward the protein A-coated surface (human &gt; rabbit &gt;&gt; sheep IgG) agrees with previous inhibition studies for protein A/IgG binding. No signal change was observed when a protein A coated sample was exposed to bovine serum albumin (BSA), demonstrating that the adsorbed sensing layer sufficiently coats the PSiO2 surface to prevent non-specific binding. This strategy is excellent for qualitative measurements of protein binding affinity because it is label-free, requires minimal sample preparation, and can be implemented using an inexpensive CCD-based spectrometer coupled to a tungsten lamp. (c) 2007 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract><notes>170DN&#xD;Times Cited:1&#xD;Cited References Count:36</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246642300041</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>1.179</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1521</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1521</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, M. C.</author><author>Khanna, S. N.</author></authors></contributors><auth-address>Qian, MC&#xD;Virginia Commonwealth Univ, Dept Phys, Med Coll Virginia Campus, Richmond, VA 23284 USA&#xD;Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA</auth-address><titles><title>An ab initio investigation on the endohedral metallofullerene Gd3N-C-80</title><secondary-title>Journal of Applied Physics</secondary-title></titles><periodical><full-title>Journal of Applied Physics</full-title></periodical><pages>-</pages><volume>101</volume><number>9</number><edition>2007/05</edition><keywords><keyword>gd3n-at-c-80</keyword><keyword>gd3n</keyword></keywords><dates><year>2007</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>0021-8979</isbn><accession-num>ISI:000246567900217</accession-num><abstract>First-principles electronic structure studies on the ground state geometry and electronic and magnetic properties of bare and hydrogen coated metallofullerene Gd3N-C-80 have been carried out within a density functional formalism. The correlation effects are incorporated either through a generalized gradient corrected functional or through an on-site Coulomb interaction (LDA+U). It is shown that the bare Gd3N-C-80 possess a ferromagnetic ground state with a large spin moment of 21 mu(B) that is highly stable against spin fluctuations. The simulated Raman spectrum shows that the low-energy peaks are contributed by the floppy movement of N atom. As to the effect of addition of hydrogens, it is shown that the most favorable site for the hydrogen adsorption is an on-top site where the H atom is located above a five-member carbon ring with a binding energy of 1.92 eV, while the least stable site corresponds to an on-top absorption above a six-member ring. A study of the energetics upon multiple adsorption of H shows that the binding energy of the H to metallofullerene drops after 11 H atoms. This shows that it should be possible to attach multiple ligands offering the potential that the Gd3N-C-80 can be functionalized with ligands or assembled in cluster assemblies.</abstract><notes>169BO&#xD;Times Cited:0&#xD;Cited References Count:14</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246567900217</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2007</custom3><custom4>2.479</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1506</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1506</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Perelman, L. A.</author><author>Schwartz, M. P.</author><author>Wohlrab, A. M.</author><author>VanNieuwenhze, M. S.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Sailor, MJ&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Mat Sci &amp; Engn Program, La Jolla, CA 92093 USA</auth-address><titles><title>A simplified biomolecule attachment strategy for biosensing using a porous Si oxide interferometer</title><secondary-title>Physica Status Solidi a-Applications and Materials Science</secondary-title></titles><periodical><full-title>Physica Status Solidi a-Applications and Materials Science</full-title></periodical><pages>1394-1398</pages><volume>204</volume><number>5</number><edition>2007/05</edition><keywords><keyword>surface-plasmon resonance</keyword><keyword>fourier-transform spectroscopy</keyword><keyword>ala-d-ala</keyword><keyword>trivalent system</keyword><keyword>silicon</keyword><keyword>chemistry</keyword><keyword>vancomycin</keyword><keyword>affinity</keyword><keyword>sensors</keyword><keyword>layers</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>0031-8965</isbn><accession-num>ISI:000246642300031</accession-num><abstract>A simple strategy for linking biomolecules to porous Si surfaces and detecting peptide/drug binding is described. Porous Si is prepared using an electrochemical etch and then thermally oxidized by heating in ambient atmosphere. Bovine serum albumin (BSA) is then non-covalently adsorbed to the inner pore walls of the porous Si oxide (PSiO2) matrix. The BSA layer is used as a linker for covalent attachment of the peptide Ac-L-Lysine-D-Alanine-D-Alanine (KAA) using published bioconjugation chemistry. BSA-coated surfaces functionalized with KAA display specificity for the glycopeptide vancomycin while resisting adsorption of non-specific reagents. While the biomolecule attachment strategy reported here is used to bind peptides, the scheme can be generalized to the linking of any primary amine-containing molecule to PSiO2 surfaces. (c) 2007 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract><notes>170DN&#xD;Times Cited:0&#xD;Cited References Count:28</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246642300031</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>1.179</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1491</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1491</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, J. S.</author><author>Meade, S. O.</author><author>Segal, E.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Sailor, MJ&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Jacobs Sch Engn, Dept Bioengn, La Jolla, CA 92093 USA</auth-address><titles><title>Porous silicon-based polymer replicas formed by bead patterning</title><secondary-title>Physica Status Solidi a-Applications and Materials Science</secondary-title></titles><periodical><full-title>Physica Status Solidi a-Applications and Materials Science</full-title></periodical><pages>1383-1387</pages><volume>204</volume><number>5</number><edition>2007/05</edition><keywords><keyword>photonic crystals</keyword><keyword>smart dust</keyword><keyword>biosensor</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>0031-8965</isbn><accession-num>ISI:000246642300029</accession-num><abstract>Monodisperse, micrometer-sized polymer beads can be imparted with a porous nanostructure by softening them into a porous silicon photonic crystal template. Infiltration of the polymer and replication of the photonic spectral properties is verified by optical reflectivity measurements of the beads as they infuse into the nanostructure. The polymer beads can be removed from the porous Si template by dissolution of the template with a basic solution. This treatment destroys the photonic properties, although scanning electron microscopy (SEM) reveals that some nanotexturing remains in the polymer beads. This simple, solvent-free process provides a means to produce nanotextured particles of controllable size and shape. (c) 2007 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract><notes>170DN&#xD;Times Cited:0&#xD;Cited References Count:16</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246642300029</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>1.179</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1389</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1389</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Leroueil, P. R.</author><author>Hong, S.</author><author>Mecke, A.</author><author>Baker, J. R., Jr.</author><author>Orr, B. G.</author><author>Banaszak Holl, M. M.</author></authors></contributors><auth-address>Program in Macromolecular Science and Engineering, Department of Chemistry, University of Michigan, Ann Arbor, MI 48109, USA.</auth-address><titles><title>Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face?</title><secondary-title>Acc Chem Res</secondary-title><alt-title>Accounts of chemical research</alt-title></titles><periodical><full-title>Acc Chem Res</full-title></periodical><alt-periodical><full-title>Accounts of Chemical Research</full-title></alt-periodical><pages>335-42</pages><volume>40</volume><number>5</number><edition>2007/05</edition><keywords><keyword>Cell Membrane/chemistry/*metabolism</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cytosol/chemistry/metabolism</keyword><keyword>Diffusion</keyword><keyword>Dimyristoylphosphatidylcholine/chemistry/metabolism</keyword><keyword>Enzyme-Linked Immunosorbent Assay</keyword><keyword>Fluorescent Dyes/analysis/chemistry</keyword><keyword>Lipid Bilayers/*chemistry/metabolism</keyword><keyword>Microscopy, Atomic Force</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Models, Biological</keyword><keyword>Models, Molecular</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>*Nanotechnology</keyword><keyword>Particle Size</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>0001-4842 (Print)</isbn><accession-num>17474708</accession-num><abstract>Polycationic organic nanoparticles are shown to disrupt model biological membranes and living cell membranes at nanomolar concentrations. The degree of disruption is shown to be related to nanoparticle size and charge, as well as to the phase-fluid, liquid crystalline, or gel-of the biological membrane. Disruption events on model membranes have been directly imaged using scanning probe microscopy, whereas disruption events on living cells have been analyzed using cytosolic enzyme leakage assays, dye diffusion assays, and fluorescence microscopy.</abstract><notes>N01-c027173/phs&#xD;R01-eb005028/eb/nibib&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17474708 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2007</custom3><custom4>15.403</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1342</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1342</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kommareddy, S.</author><author>Amiji, M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115-5005, USA.</auth-address><titles><title>Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors</title><secondary-title>Cancer Gene Ther</secondary-title><alt-title>Cancer gene therapy</alt-title></titles><periodical><full-title>Cancer Gene Ther</full-title><abbr-1>Cancer gene therapy</abbr-1></periodical><alt-periodical><full-title>Cancer Gene Ther</full-title><abbr-1>Cancer gene therapy</abbr-1></alt-periodical><pages>488-98</pages><volume>14</volume><number>5</number><edition>2007/05</edition><keywords><keyword>Adenocarcinoma/blood supply/chemistry/therapy</keyword><keyword>Animals</keyword><keyword>Breast Neoplasms/blood supply/chemistry/therapy</keyword><keyword>Capsules/administration &amp; dosage/chemistry</keyword><keyword>Cell Line, Tumor</keyword><keyword>DNA/administration &amp; dosage/chemistry</keyword><keyword>Female</keyword><keyword>Gelatin/chemistry</keyword><keyword>*Gene Therapy</keyword><keyword>*Genetic Vectors/administration &amp; dosage/chemistry</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mice, Inbred Strains</keyword><keyword>*Nanoparticles/administration &amp; dosage/chemistry</keyword><keyword>Neovascularization, Pathologic/*therapy</keyword><keyword>Plasmids/administration &amp; dosage/chemistry</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Vascular Endothelial Growth Factor Receptor-1/analysis/*genetics</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>0929-1903 (Print)</isbn><accession-num>17363959</accession-num><abstract>This study examined the potential of engineered gelatin-based nanoparticulate vectors for systemic delivery of therapeutic genes to human solid tumor xenografts in vivo. Plasmid DNA encoding for the soluble form of the extracellular domain of vascular endothelial growth factor receptor-1 (VEGF-R1 or sFlt-1) was encapsulated in the control and poly(ethylene glycol) (PEG)-modified gelatin-based nanoparticles. When the plasmid DNA was delivered in PEG-modified thiolated gelatin nanoparticles, highest levels of sFlt-1 expression was observed in vitro in MDA-MB-435 human breast adenocarcinoma cell line. In addition, upon intravenous administration in female Nu/Nu mice bearing orthotopic MDA-MB-435 breast adenocarcinoma xenografts, efficient in vivo expression of sFlt-1 plasmid DNA was confirmed quantitatively by enzyme-linked immunosorbent assay and qualitatively by Western blot analysis. The expressed sFlt-1 was therapeutically active as shown by suppression of tumor growth and microvessel density measurements. The results of this study show that PEG-modified gelatin-based nanovectors can serve as a safe and effective systemically administered gene delivery vehicle for solid tumor.</abstract><notes>Eb-002027/eb/nibib&#xD;R01-ca095522/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17363959 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>3.889</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1299</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1299</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ji, X. J.</author><author>Shao, R. P.</author><author>Elliott, A. M.</author><author>Stafford, R. J.</author><author>Esparza-Coss, E.</author><author>Bankson, J. A.</author><author>Liang, G.</author><author>Luo, Z. P.</author><author>Park, K.</author><author>Markert, J. T.</author><author>Li, C.</author></authors></contributors><auth-address>Li, C&#xD;Univ Texas, MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Box 57,1515 Holcombe Blvd, Houston, TX 77030 USA&#xD;Univ Texas, MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA&#xD;Univ Texas, MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA&#xD;Sam Houston State Univ, Dept Phys, Huntsville, TX 77341 USA&#xD;Texas A&amp;M Univ, Coll Stn, Microscopy &amp; Imaging Ctr, College Stn, TX 77843 USA&#xD;Univ Texas, Dept Phys, Austin, TX 78712 USA</auth-address><titles><title>Bifunctional gold nanoshells with a superparamagnetic iron oxide-silica core suitable for both MR imaging and photothermal therapy</title><secondary-title>Journal of Physical Chemistry C</secondary-title></titles><periodical><full-title>Journal of Physical Chemistry C</full-title></periodical><pages>6245-6251</pages><volume>111</volume><number>17</number><edition>2007/05</edition><keywords><keyword>atherosclerotic plaques</keyword><keyword>surface modification</keyword><keyword>contrast agents</keyword><keyword>nanoparticles</keyword><keyword>particles</keyword><keyword>growth</keyword><keyword>cancer</keyword><keyword>scattering</keyword></keywords><dates><year>2007</year><pub-dates><date>May 3</date></pub-dates></dates><isbn>1932-7447</isbn><accession-num>ISI:000245954900016</accession-num><abstract>We describe the synthesis, characterization, and use of hybrid nanoparticles with a superparamagnetic iron oxide (SPIO)-silica core and a gold nanoshell. These multifunctional nanoparticles, designated SPIO-Au nanoshells, displayed superparamagnetic characteristics and a significant absorbance in the near-infrared (NIR) region of the electromagnetic spectrum. In addition, they exhibited high transverse relaxivities, R-2, and a large R-2/R-1 ratio, and therefore, they could be imaged by MRI to obtain T-2-weighted images. Moreover, the SPIO-Au nanoshells showed efficient photothermal effects when exposed to NIR light. The use of SPIO-Au nanoshells, with their combination of unique magnetic and optical properties, should enhance the efficacy of nanoshell-mediated photothermal therapy by making it possible to direct more nanoparticles to tumors through the application of external magnetic field and by permitting real-time in vivo MRI imaging of the distribution of the nanoparticles before, during, and after photothermal therapy.</abstract><notes>160PN&#xD;Times Cited:0&#xD;Cited References Count:27</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000245954900016</url></related-urls></urls><custom1>CNPP - U.T. M.D. Anderson</custom1><custom3>2007</custom3><custom4>3.398</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1194</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1194</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Etgar, L.</author><author>Lifshitz, E.</author><author>Tannenbaum, R.</author></authors></contributors><auth-address>Tannenbaum, R&#xD;Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel&#xD;Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel&#xD;Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel&#xD;Technion Israel Inst Technol, Schulich Fac Chem, Nanosci &amp; Nanotechnol Program, IL-32000 Haifa, Israel&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA USA</auth-address><titles><title>Hierarchical conjugate structure of gamma-Fe2O3 nanoparticles and PbSe quantum dots for biological applications</title><secondary-title>Journal of Physical Chemistry C</secondary-title></titles><periodical><full-title>Journal of Physical Chemistry C</full-title></periodical><pages>6238-6244</pages><volume>111</volume><number>17</number><edition>2007/05</edition><keywords><keyword>iron-oxide nanoparticles</keyword><keyword>magnetic nanoparticles</keyword><keyword>semiconductor nanocrystals</keyword><keyword>colloidal pbse</keyword><keyword>optical gain</keyword><keyword>biomolecules</keyword><keyword>superlattices</keyword><keyword>nanoclusters</keyword><keyword>separation</keyword><keyword>emission</keyword></keywords><dates><year>2007</year><pub-dates><date>May 3</date></pub-dates></dates><isbn>1932-7447</isbn><accession-num>ISI:000245954900015</accession-num><abstract>The development and characterization of a unique conjugated structure comprised of gamma-Fe2O3 nanoparticles (NPs) and PbSe nanocrystal quantum dots (NQDs), bonded via chemical functional groups, are discussed. Compatibility with an aqueous environment was rendered by exchanging the traditional organic surfactants (oleic acid) of the PbSe NQDs and gamma-Fe2O3 NPs with 2-aminoethanethiol and polyhedral silsesquioxane hydrate octakis ligands, respectively. Comparison of the transmission electron microscopy (TEM) images of the PbSe NQDs and gamma-Fe2O3 NPs capped with either organic or water-soluble ligands highlights the preservation of the morphology and size of both types of nanoclusters upon ligand exchange. Furthermore, the absorbance, photoluminescence (PL), and Fourier transform infrared spectra of the PbSe QDs revealed that the optical properties of the NQDs were retained during the surfactant exchange. High-resolution TEM images of the complete conjugated structure validate the presence of the coupling between the PbSe NQDs and the gamma-Fe2O3 NPs. This unique system has substantial advantages for biological applications such as bio-sensing, detection of cancer cells, and drug delivery.</abstract><notes>160PN&#xD;Times Cited:0&#xD;Cited References Count:54</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000245954900015</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>3.398</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1072</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1072</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Banyard, J.</author><author>Bao, L.</author><author>Hofer, M. D.</author><author>Zurakowski, D.</author><author>Spivey, K. A.</author><author>Feldman, A. S.</author><author>Hutchinson, L. M.</author><author>Kuefer, R.</author><author>Rubin, M. A.</author><author>Zetter, B. R.</author></authors></contributors><auth-address>Vascular Biology Program, Department of Surgery, Children&apos;s Hospital, Boston, MA 02115, USA.</auth-address><titles><title>Collagen XXIII expression is associated with prostate cancer recurrence and distant metastases</title><secondary-title>Clin Cancer Res</secondary-title></titles><periodical><full-title>Clin Cancer Res</full-title></periodical><pages>2634-42</pages><volume>13</volume><number>9</number><edition>2007/05</edition><keywords><keyword>Antibodies/immunology</keyword><keyword>Collagen/*analysis/metabolism</keyword><keyword>Disease Progression</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Male</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Neoplasm Recurrence, Local/*diagnosis</keyword><keyword>Neoplasm Staging</keyword><keyword>Prognosis</keyword><keyword>Prostatic Neoplasms/chemistry/*pathology</keyword><keyword>Tumor Markers, Biological/*analysis/metabolism</keyword><keyword>Up-Regulation</keyword></keywords><dates><year>2007</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>17473194</accession-num><abstract>PURPOSE: We had previously identified a new transmembrane collagen, type XXIII, in metastatic rat prostate carcinoma cells. The purpose of this study was to determine the expression of collagen XXIII in human prostate cancer and investigate its relationship with disease progression. EXPERIMENTAL DESIGN: We investigated collagen XXIII expression in prostate cancer tissue and did a retrospective analysis of association with prostate-specific antigen (PSA)-defined disease recurrence. The presence of collagen XXIII in prostate cancer patient urine was also assessed before and after prostatectomy. RESULTS: Collagen XXIII protein was detected at very low levels in benign prostate tissue and was significantly increased in prostate cancer. Distant metastases exhibited significantly higher collagen XXIII levels compared with either localized prostate cancer or regional (lymph node) metastases. Patients with high collagen XXIII levels had a 2.8-fold higher risk of PSA failure with median time to failure of 8.1 months, compared with low collagen XXIII patients with a median time to failure of 5 years. Multivariate Cox regression showed that the presence of collagen XXIII was significantly associated with time to PSA recurrence, independent of other clinical variables. Collagen XXIII was also detected in prostate cancer patient urine, with reduced levels after prostatectomy, indicating potential as a noninvasive fluid biomarker. CONCLUSIONS: We present the first report demonstrating increased collagen XXIII expression in prostate cancer tissue. We show that collagen XXIII level is a significant independent predictor of PSA-defined disease recurrence, suggesting a potential role as a molecular biomarker of prostate cancer progression and metastasis.</abstract><notes>Ca09381-03/ca/nci&#xD;Ca104973/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;an official journal of the American Association for Cancer Research</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17473194 </url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2007</custom3><custom4>6.646</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1067</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1067</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Aslam, M.</author><author>Schultz, E. A.</author><author>Sun, T.</author><author>Meade, T.</author><author>Dravid, V. P.</author></authors></contributors><auth-address>Dravid, VP&#xD;Northwestern Univ, Feinberg Sch Med, Dept Mat Sci &amp; Engn, 2145 Sheridan Rd, Evanston, IL 60208 USA&#xD;Northwestern Univ, Feinberg Sch Med, Dept Mat Sci &amp; Engn, Evanston, IL 60208 USA&#xD;Northwestern Univ, Int Inst Nanotechnol, Feinberg Sch Med, Evanston, IL 60208 USA&#xD;Northwestern Univ, Feinberg Sch Med, Dept Chem, Evanston, IL 60208 USA&#xD;Northwestern Univ, Feinberg Sch Med, Dept Biochem &amp; Mol &amp; Cell Biol, Evanston, IL 60208 USA</auth-address><titles><title>Synthesis of amine-stabilized aqueous colloidal iron oxide nanoparticles</title><secondary-title>Crystal Growth &amp; Design</secondary-title></titles><periodical><full-title>Crystal Growth &amp; Design</full-title></periodical><pages>471-475</pages><volume>7</volume><number>3</number><edition>2007/05</edition><keywords><keyword>magnetic nanocrystals</keyword><keyword>particles</keyword><keyword>size</keyword><keyword>surface</keyword><keyword>molecules</keyword><keyword>fe3o4</keyword><keyword>xps</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1528-7483</isbn><accession-num>ISI:000244701500002</accession-num><abstract>We demonstrate a simple one-step process for the synthesis of iron oxide nanoparticle aqueous colloids using the multifunctional molecule dodecylamine (DDA), which electrostatically complexes with aqueous iron ions (one precursor Fe2+ from FeCl2), reduces them, and subsequently caps the nanoparticles. The iron oxide particles thus synthesized are of the face-centered cubic (FCC) phase with a high degree of monodispersity and an appropriate concentration of the amine-capping molecular layer. The aqueous magnetic nanocrystalline colloids were characterized by TEM, XRD, XPS, TGA/DTA, and FTIR spectroscopy techniques. The relaxivity, stability, and hydrodynamic size of the nanoparticles were investigated for potential application in magnetic resonance imaging (MRI). The magnetic properties were also studied by using a superconducting quantum interference device (SQUID) magnetometer at room temperature. We believe that such a simple one-step synthesis of biocompatible aqueous nanomagnetic colloids will have viable applications in biomedical imaging, diagnostics, and therapeutics.</abstract><notes>143DZ&#xD;Times Cited:0&#xD;Cited References Count:36</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000244701500002</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.491</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1066</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1066</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Aslam, M.</author><author>Li, S.</author><author>Dravid, V.P.</author></authors></contributors><titles><title>Controlled synthesis and stability of Co@SiO2 aqueous colloids</title><secondary-title>J. Am. Ceram. Soc.</secondary-title></titles><periodical><full-title>J. Am. Ceram. Soc.</full-title></periodical><pages>950-956</pages><volume>90</volume><number>3</number><edition>2007/05</edition><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><urls><related-urls><url>http://vpd.ms.northwestern.edu/Publications_files/2007/Cobalt_silica_Published2007.pdf</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>na</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1056</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1056</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Alvarez, S. D.</author><author>Schwartz, M. P.</author><author>Migliori, B.</author><author>Rang, C. U.</author><author>Chao, L.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Sailor, MJ&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA</auth-address><titles><title>Using a porous silicon photonic crystal for bacterial cell-based biosensing</title><secondary-title>Physica Status Solidi a-Applications and Materials Science</secondary-title></titles><periodical><full-title>Physica Status Solidi a-Applications and Materials Science</full-title></periodical><pages>1439-1443</pages><volume>204</volume><number>5</number><edition>2007/05</edition><keywords><keyword>immobilization</keyword><keyword>microcavities</keyword><keyword>bacteriophage</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>0031-8965</isbn><accession-num>ISI:000246642300040</accession-num><abstract>This work demonstrates a method for non-invasively monitoring the growth and 06 virus infection of Pseudomonas syringae bacteria using a 1-D porous silicon photonic crystal and a white-light source coupled to a CCD spectrometer. Bacteria growth on porous Si leads to increased scattering efficiency that can be measured as a change in intensity of light reflected from a 1-D porous Si photonic crystal. A linear relationship between bacteria concentration and intensity of light at the photonic resonance is observed, and detection limits are similar to those obtained from optical density measurements. Upon infection with virus, decreases in scattered light intensity are observed at times that correlate with cell lysis caused by viral replication and subsequent bursting of bacteria cells. It is shown that measurements can be performed in real-time and in an incubator where cells remain in their ideal environment throughout the experiment. This method is well-suited for cell-based biosensing, because bacteria cells can be monitored remotely without the need for sampling cells for plating or optical density measurements. (c) 2007 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract><notes>170DN&#xD;Times Cited:0&#xD;Cited References Count:16</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246642300040</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>1.179</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1653</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1653</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thomas, M.</author><author>Lu, J. J.</author><author>Chen, J.</author><author>Klibanov, A. M.</author></authors></contributors><auth-address>Department of Chemistry and Division of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. mint@mit.edu</auth-address><titles><title>Non-viral siRNA delivery to the lung</title><secondary-title>Adv Drug Deliv Rev</secondary-title></titles><periodical><full-title>Adv Drug Deliv Rev</full-title></periodical><pages>124-33</pages><volume>59</volume><number>2-3</number><edition>2007/04/27</edition><keywords><keyword>Animals</keyword><keyword>Drug Delivery Systems/methods/*trends</keyword><keyword>Gene Silencing</keyword><keyword>Humans</keyword><keyword>Lung/metabolism/pathology</keyword><keyword>Lung Diseases/genetics/*therapy</keyword><keyword>RNA, Small Interfering/*administration &amp; dosage/genetics/pharmacokinetics</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 30</date></pub-dates></dates><isbn>0169-409X (Print)</isbn><accession-num>17459519</accession-num><abstract>SiRNAs exert their biological effect by guiding the degradation of their cognate mRNA sequence, thereby shutting down the corresponding protein production (gene silencing by RNA interference or RNAi). Due to this property, siRNAs are emerging as promising therapeutic agents for the treatment of inherited and acquired diseases, as well as research tools for the elucidation of gene function in both health and disease. Because of their lethality and prevalence, lung diseases have attracted particular attention as targets of siRNA-mediated cures. In addition, lung is accessible to therapeutic agents via multiple routes, e.g., through the nose and the mouth, thus obviating the need for targeting and making it an appealing target for RNAi-based therapeutic strategies. The clinical success of siRNA-mediated interventions critically depends upon the safety and efficacy of the delivery methods and agents. Delivery of siRNAs relevant to lung diseases has been attempted through multiple routes and using various carriers in animal models. This review focuses on the recent progress in non-viral delivery of siRNAs for the treatment of lung diseases, particularly infectious diseases. The rapid progress will put siRNA-based therapeutics on fast track to the clinic.</abstract><notes>Thomas, Mini&#xD;Lu, James J&#xD;Chen, Jianzhu&#xD;Klibanov, Alexander M&#xD;Ai56267/ai/niaid&#xD;Eb000244/eb/nibib&#xD;P50 ca112967/ca/nci&#xD;U54 ca119349/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;Netherlands&#xD;Advanced drug delivery reviews&#xD;Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):124-33. Epub 2007 Mar 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17459519</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>10.625</custom4><electronic-resource-num>S0169-409X(07)00020-8 [pii]&#xD;10.1016/j.addr.2007.03.003</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1627</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1627</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stokes, T. H.</author><author>Moffitt, R. A.</author><author>Phan, J. H.</author><author>Wang, M. D.</author></authors></contributors><auth-address>Department of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA 30332-0535, USA.</auth-address><titles><title>chip artifact CORRECTion (caCORRECT): a bioinformatics system for quality assurance of genomics and proteomics array data</title><secondary-title>Ann Biomed Eng</secondary-title></titles><periodical><full-title>Ann Biomed Eng</full-title></periodical><pages>1068-80</pages><volume>35</volume><number>6</number><edition>2007/04/27</edition><keywords><keyword>*Algorithms</keyword><keyword>*Artifacts</keyword><keyword>Computational Biology/*methods</keyword><keyword>Genomics/*methods</keyword><keyword>Oligonucleotide Array Sequence Analysis/*methods</keyword><keyword>Quality Control</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword><keyword>*Software</keyword><keyword>Software Design</keyword><keyword>*User-Computer Interface</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0090-6964 (Print)</isbn><accession-num>17458699</accession-num><abstract>Quality assurance of high throughput &quot;-omics&quot; data is a major concern for biomedical discovery and translational medicine, and is considered a top priority in bioinformatics and systems biology. Here, we report a web-based bioinformatics tool called caCORRECT for chip artifact detection, analysis, and CORRECTion, which removes systematic artifactual noises that are commonly observed in microarray gene expression data. Despite the development of major databases such as GEO arrayExpress, caArray, and the SMD to manage and distribute microarray data to the public, reproducibility has been questioned in many cases, including high-profile papers and datasets. Based on both archived and synthetic data, we have designed the caCORRECT to have several advanced features: (1) to uncover significant, correctable artifacts that affect reproducibility of experiments; (2) to improve the integrity and quality of public archives by removing artifacts; (3) to provide a universal quality score to aid users in their selection of suitable microarray data; and (4) to improve the true-positive rate of biomarker selection verified by test data. These features are expected to improve the reproducibility of Microarray study. caCORRECT is freely available at: http://caCORRECT.bme.gatech.edu.</abstract><notes>Stokes, Todd H&#xD;Moffitt, Richard A&#xD;Phan, John H&#xD;Wang, May D&#xD;P20gm072069/gm/nigms&#xD;R01ca108468/ca/nci&#xD;U54ca119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Annals of biomedical engineering&#xD;Ann Biomed Eng. 2007 Jun;35(6):1068-80. Epub 2007 Apr 26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17458699</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>2.999</custom4><electronic-resource-num>10.1007/s10439-007-9313-y</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1146</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1146</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chu, T.</author><author>Ebright, J.</author><author>Ellington, A. D.</author></authors></contributors><auth-address>University of Texas at Austin, Department of Chemistry and Biochemistry, Institute for Cell and Molecular Biology, Austin, TX 78712, USA.</auth-address><titles><title>Using aptamers to identify and enter cells</title><secondary-title>Curr Opin Mol Ther</secondary-title></titles><periodical><full-title>Curr Opin Mol Ther</full-title></periodical><pages>137-44</pages><volume>9</volume><number>2</number><edition>2007/04/27</edition><keywords><keyword>Animals</keyword><keyword>Antigens, Surface/metabolism</keyword><keyword>Aptamers, Nucleotide/*analysis/chemistry/*metabolism</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Humans</keyword><keyword>Nucleic Acid Conformation</keyword><keyword>RNA, Small Interfering/metabolism</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1464-8431 (Print)</isbn><accession-num>17458167</accession-num><abstract>While nucleic acid binding species (aptamers) have previously been selected against a variety of biomedically important protein targets, the selection of aptamers against complex targets, such as cell surfaces and organisms, is becoming increasingly feasible. A number of aptamers have now been generated that can target specific cell-surface antigens and cell types, including tumor biomarkers and tumor cells. The generation of anti-cell aptamers has important implications for identifying disease-specific biomarkers, generating diagnostics, and developing novel drug delivery strategies.</abstract><notes>Chu, Ted&#xD;Ebright, Jessica&#xD;Ellington, Andrew D&#xD;Review&#xD;England&#xD;Current opinion in molecular therapeutics&#xD;Curr Opin Mol Ther. 2007 Apr;9(2):137-44.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17458167</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>2.147</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1481</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1481</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Olafsen, T.</author><author>Gu, Z.</author><author>Sherman, M. A.</author><author>Leyton, J. V.</author><author>Witkosky, M. E.</author><author>Shively, J. E.</author><author>Raubitschek, A. A.</author><author>Morrison, S. L.</author><author>Wu, A. M.</author><author>Reiter, R. E.</author></authors></contributors><auth-address>Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, David Geffen School of Medicine at University of California, Los Angeles, CA 90095, USA. tolafsen@mednet.ucla.edu</auth-address><titles><title>Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody</title><secondary-title>J Immunother</secondary-title></titles><periodical><full-title>J Immunother</full-title></periodical><pages>396-405</pages><volume>30</volume><number>4</number><edition>2007/04/26</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/chemistry</keyword><keyword>Antineoplastic Agents/pharmacology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Humans</keyword><keyword>Hybridomas/metabolism</keyword><keyword>Immunotherapy/*methods</keyword><keyword>Kinetics</keyword><keyword>Male</keyword><keyword>Membrane Glycoproteins/*immunology</keyword><keyword>Mice</keyword><keyword>Molecular Sequence Data</keyword><keyword>Neoplasm Proteins/*immunology</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Prostatic Neoplasms/metabolism/*pathology</keyword><keyword>Sequence Homology, Amino Acid</keyword></keywords><dates><year>2007</year><pub-dates><date>May-Jun</date></pub-dates></dates><isbn>1524-9557 (Print)</isbn><accession-num>17457214</accession-num><abstract>The murine 1G8 (micro1G8) monoclonal antibody directed against prostate stem cell antigen (PSCA) prevents prostate tumor establishment, growth, and metastasis in murine models. To further delineate in vivo targeting properties, micro1G8 was radiolabeled with In-111 and evaluated in nude mice bearing PC3-PSCA xenografts. Tumor activity ranged from 11.8% to 17.1% injected dose per gram (ID/g) at 24 to 96 hours postinjection. To extend the clinical applicability of micro1G8, a chimeric 1G8 antibody was produced that exhibited specific binding to PSCA and significant antitumor effect over micro1G8 in established LAPC-9 prostate cancer xenografts (P=0.0014). However, low expression yields and instability prompted us to humanize 1G8 by grafting the complementary determining regions onto the stable, human Fv framework of anti-p185 4D5v8 (trastuzumab). Two humanized 1G8 (hu1G8) versions (A and B) that differed in the number of murine residues present in the C-terminal half of CDR-H2, were produced. Biacore binding studies demonstrated affinities of 1.47 nM for micro1G8 and 3.74 nM for hu2B3-B, representing a 2.5-fold reduction. Tumor targeting of version B radioiodinated with I was evaluated by serial microPET imaging. Specific tumor targeting of I-hu1G8-B to PC3-PSCA [12.7 (+/-1.6)% ID/g at 94 h] and LAPC-9 [6.6 (+/-0.9)% ID/g at 168 h) xenografts was observed. Inhibition of tumor growth by hu1G8-B was demonstrated in mice bearing low-expressing SW-780-PSCA bladder carcinoma xenografts. In this model, the micro1G8 was ineffective, whereas the hu1G8-B exhibited approximately 50% inhibitory effect. These data support further development of hu1G8 anti-PSCA antibody for targeted imaging and therapy for tumors of urogenital origin.</abstract><notes>Olafsen, Tove&#xD;Gu, Zhennan&#xD;Sherman, Mark A&#xD;Leyton, Jeffrey V&#xD;Witkosky, Michael E&#xD;Shively, John E&#xD;Raubitschek, Andrew A&#xD;Morrison, Sherie L&#xD;Wu, Anna M&#xD;Reiter, Robert E&#xD;CA 16042/CA/United States NCI&#xD;CA 33572/CA/United States NCI&#xD;P01 CA 43904/CA/United States NCI&#xD;P50 CA 92131/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Journal of immunotherapy (Hagerstown, Md. : 1997)&#xD;J Immunother. 2007 May-Jun;30(4):396-405.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17457214</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>3.797</custom4><electronic-resource-num>10.1097/CJI.0b013e318031b53b&#xD;00002371-200705000-00004 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1106</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1106</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, L.</author><author>Makhov, A. M.</author><author>Bear, J. E.</author></authors></contributors><auth-address>Lineberger Comprehensive Cancer Center, Department of Cell &amp; Developmental Biology, University of North Carolina at Chapel Hill, North Carolina 27599-7295, USA.</auth-address><titles><title>F-actin binding is essential for coronin 1B function in vivo</title><secondary-title>J Cell Sci</secondary-title></titles><periodical><full-title>J Cell Sci</full-title></periodical><pages>1779-90</pages><volume>120</volume><number>Pt 10</number><edition>2007/04/26</edition><keywords><keyword>Actins/*metabolism/ultrastructure</keyword><keyword>Adenosine Diphosphate/metabolism</keyword><keyword>Adenosine Triphosphate/metabolism</keyword><keyword>Amino Acid Sequence/physiology</keyword><keyword>Animals</keyword><keyword>Arginine/metabolism</keyword><keyword>Binding Sites/physiology</keyword><keyword>Cell Line</keyword><keyword>Cell Movement/physiology</keyword><keyword>Drosophila melanogaster</keyword><keyword>Fibroblasts/metabolism/ultrastructure</keyword><keyword>Humans</keyword><keyword>Microfilament Proteins/chemistry/*metabolism</keyword><keyword>Microfilaments/metabolism/ultrastructure</keyword><keyword>Microscopy, Electron</keyword><keyword>Models, Molecular</keyword><keyword>Protein Binding/physiology</keyword><keyword>Protein Structure, Tertiary/physiology</keyword><keyword>Pseudopodia/metabolism/ultrastructure</keyword><keyword>Rats</keyword></keywords><dates><year>2007</year><pub-dates><date>May 15</date></pub-dates></dates><isbn>0021-9533 (Print)</isbn><accession-num>17456547</accession-num><abstract>Coronins are conserved F-actin binding proteins that have been implicated in a variety of processes including fibroblast migration, phagocytosis, and chemotaxis. Recent data from our lab indicate that coronin 1B coordinates Arp2/3-dependent actin filament nucleation and cofilin-mediated filament turnover at the leading edge of migrating fibroblasts. Analysis of coronin function has been hampered by the lack of a clear understanding of how coronin interacts with F-actin. Here, we identify a surface-exposed conserved arginine residue at position 30 (R30), which is crucial for coronin 1B binding to F-actin both in vitro and in vivo. Using actin co-sedimentation, we demonstrate that coronin 1B binds with high affinity to ATP/ADP-P(i)-F-actin (170 nM) and with 47-fold lower affinity to ADP-F-actin (8 microM). In contrast to a previous study, we find no evidence for enhanced cofilin binding to F-actin in the presence of either coronin 1B or coronin 1A. Instead, we find that coronin 1B protects actin filaments from cofilin-induced depolymerization. Consistent with an important role for interactions between coronin 1B and F-actin in vivo, an R30D coronin mutant that does not bind F-actin localizes inefficiently to the leading edge. Furthermore, our analysis indicates that F-actin binding is absolutely required for coronin 1B to exert its effects on whole-cell motility and lamellipodial dynamics.</abstract><notes>Cai, Liang&#xD;Makhov, Alexander M&#xD;Bear, James E&#xD;1U54CA119343/CA/United States NCI&#xD;CA-16086/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Journal of cell science&#xD;J Cell Sci. 2007 May 15;120(Pt 10):1779-90. Epub 2007 Apr 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17456547</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>6.847</custom4><electronic-resource-num>jcs.007641 [pii]&#xD;10.1242/jcs.007641</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1050</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1050</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Agrawal, A.</author><author>Sathe, T.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, Suite 2001, 101 Woodruff Circle, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Single-bead immunoassays using magnetic microparticles and spectral-shifting quantum dots</title><secondary-title>J Agric Food Chem</secondary-title></titles><periodical><full-title>J Agric Food Chem</full-title></periodical><pages>3778-82</pages><volume>55</volume><number>10</number><edition>2007/04/26</edition><keywords><keyword>Fluorescent Dyes</keyword><keyword>Immunoassay/*methods</keyword><keyword>*Magnetics</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>*Microspheres</keyword><keyword>Tumor Necrosis Factor-alpha/analysis</keyword></keywords><dates><year>2007</year><pub-dates><date>May 16</date></pub-dates></dates><isbn>0021-8561 (Print)</isbn><accession-num>17455953</accession-num><abstract>This paper reports a single-bead immunoassay method based on the combined use of magnetic microparticles (MMPs) for target capturing/enrichment and antibody-conjugated semiconductor quantum dots (QDs) for fluorescence detection. In comparison with organic dyes and fluorescent proteins, QDs exhibit unique optical properties such as size-tunable fluorescence emission (spectral shifting), large absorption coefficients, improved brightness, and superior photostability. Magnetic beads, composed of iron oxide nanoparticles embedded in polymeric matrices, provide a platform for rapid capturing and enrichment of biomolecules and pathogens in dilute biological and environmental samples. However, a major problem in using magnetic beads for fluorescence immunoassays is that the bead&apos;s autofluorescence strongly interferes with the target detection signal. This spectral overlapping problem can be overcome by using semiconductor QDs as a new class of spectral-shifting labels. By shifting the QD emission signals away from the bead autofluorescence, it is possible to detect biomolecular antigens such as tumor necrosis factor (TNF-alpha) at femtomolar (10-15 M) concentrations when the target molecules are captured and enriched on the magnetic bead surface. This sensitivity is almost 1000 times higher that that of traditional immunoabsorbent assays and more than 100 times higher than immunofluorescent assays using organic dyes.</abstract><notes>Agrawal, Amit&#xD;Sathe, Tushar&#xD;Nie, Shuming&#xD;P20 GM072069/GM/United States NIGMS&#xD;R01 CA108468-01/CA/United States NCI&#xD;U54CA119338/CA/United States NCI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of agricultural and food chemistry&#xD;J Agric Food Chem. 2007 May 16;55(10):3778-82. Epub 2007 Apr 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17455953</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>3.165</custom4><electronic-resource-num>10.1021/jf0635006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2222</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2222</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>von Maltzahn, G.</author><author>Harris, T. J.</author><author>Park, J. H.</author><author>Min, D. H.</author><author>Schmidt, A. J.</author><author>Sailor, M. J.</author><author>Bhatia, S. N.</author></authors></contributors><auth-address>Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts, USA.</auth-address><titles><title>Nanoparticle self-assembly gated by logical proteolytic triggers</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>6064-5</pages><volume>129</volume><number>19</number><edition>2007/04/24</edition><keywords><keyword>Algorithms</keyword><keyword>Avidin/chemistry</keyword><keyword>Biosensing Techniques/ methods</keyword><keyword>Biotin/chemistry</keyword><keyword>Ligands</keyword><keyword>Matrix Metalloproteinase 2/analysis</keyword><keyword>Matrix Metalloproteinase 7/analysis</keyword><keyword>Nanoparticles/ chemistry</keyword><keyword>Oligopeptides/chemistry</keyword><keyword>Peptide Hydrolases/ analysis</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Substrate Specificity</keyword><keyword>Tumor Markers, Biological/ analysis</keyword></keywords><dates><year>2007</year><pub-dates><date>May 16</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17447766</accession-num><notes>von Maltzahn, Geoffrey&#xD;Harris, Todd J&#xD;Park, Ji-Ho&#xD;Min, Dal-Hee&#xD;Schmidt, Alexander J&#xD;Sailor, Michael J&#xD;Bhatia, Sangeeta N&#xD;R01 CA124427-01/CA/NCI NIH HHS/United States&#xD;U54 CA119335/CA/NCI NIH HHS/United States&#xD;U54 CA119349/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 May 16;129(19):6064-5. Epub 2007 Apr 21.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja070461l [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1440</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1440</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McAlpine, M. C.</author><author>Ahmad, H.</author><author>Wang, D.</author><author>Heath, J. R.</author></authors></contributors><auth-address>Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.</auth-address><titles><title>Highly ordered nanowire arrays on plastic substrates for ultrasensitive flexible chemical sensors</title><secondary-title>Nat Mater</secondary-title></titles><periodical><full-title>Nat Mater</full-title></periodical><pages>379-84</pages><volume>6</volume><number>5</number><edition>2007/04/24</edition><keywords><keyword>Biosensing Techniques/*instrumentation/*trends</keyword><keyword>Chemistry, Analytical/instrumentation/trends</keyword><keyword>*Nanowires/ultrastructure</keyword><keyword>*Plastics</keyword><keyword>Semiconductors/trends</keyword><keyword>Silicon</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>1476-1122 (Print)</isbn><accession-num>17450146</accession-num><abstract>The development of a robust method for integrating high-performance semiconductors on flexible plastics could enable exciting avenues in fundamental research and novel applications. One area of vital relevance is chemical and biological sensing, which if implemented on biocompatible substrates, could yield breakthroughs in implantable or wearable monitoring systems. Semiconducting nanowires (and nanotubes) are particularly sensitive chemical sensors because of their high surface-to-volume ratios. Here, we present a scalable and parallel process for transferring hundreds of pre-aligned silicon nanowires onto plastic to yield highly ordered films for low-power sensor chips. The nanowires are excellent field-effect transistors, and, as sensors, exhibit parts-per-billion sensitivity to NO2, a hazardous pollutant. We also use SiO2 surface chemistries to construct a &apos;nano-electronic nose&apos; library, which can distinguish acetone and hexane vapours via distributed responses. The excellent sensing performance coupled with bendable plastic could open up opportunities in portable, wearable or even implantable sensors.</abstract><notes>McAlpine, Michael C&#xD;Ahmad, Habib&#xD;Wang, Dunwei&#xD;Heath, James R&#xD;5u54 ca119347/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Nature materials&#xD;Nat Mater. 2007 May;6(5):379-84. Epub 2007 Apr 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17450146</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>25.759</custom4><electronic-resource-num>nmat1891 [pii]&#xD;10.1038/nmat1891</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1473</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1473</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nie, S.</author><author>Xing, Y.</author><author>Kim, G. J.</author><author>Simons, J. W.</author></authors></contributors><auth-address>Department of Biomedical Engineering and the Winship Cancer Institute, Emory University and Georgia Institute of Technology, Atlanta, Georgia 30322, USA. snie@emory.edu</auth-address><titles><title>Nanotechnology applications in cancer</title><secondary-title>Annu Rev Biomed Eng</secondary-title></titles><periodical><full-title>Annu Rev Biomed Eng</full-title></periodical><pages>257-88</pages><volume>9</volume><edition>2007/04/19</edition><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1523-9829 (Print)</isbn><accession-num>17439359</accession-num><abstract>Cancer nanotechnology is an interdisciplinary area of research in science, engineering, and medicine with broad applications for molecular imaging, molecular diagnosis, and targeted therapy. The basic rationale is that nanometer-sized particles, such as semiconductor quantum dots and iron oxide nanocrystals, have optical, magnetic, or structural properties that are not available from molecules or bulk solids. When linked with tumor targeting ligands such as monoclonal antibodies, peptides, or small molecules, these nanoparticles can be used to target tumor antigens (biomarkers) as well as tumor vasculatures with high affinity and specificity. In the mesoscopic size range of 5-100 nm diameter, nanoparticles also have large surface areas and functional groups for conjugating to multiple diagnostic (e.g., optical, radioisotopic, or magnetic) and therapeutic (e.g., anticancer) agents. Recent advances have led to bioaffinity nanoparticle probes for molecular and cellular imaging, targeted nanoparticle drugs for cancer therapy, and integrated nanodevices for early cancer detection and screening. These developments raise exciting opportunities for personalized oncology in which genetic and protein biomarkers are used to diagnose and treat cancer based on the molecular profiles of individual patients.</abstract><notes>Nie, Shuming&#xD;Xing, Yun&#xD;Kim, Gloria J&#xD;Simons, Jonathan W&#xD;P20gm072069/gm/nigms&#xD;R01 ca108468-01/ca/nci&#xD;U54ca119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Annual review of biomedical engineering&#xD;Annu Rev Biomed Eng. 2007;9:257-88.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17439359</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>13.679</custom4><electronic-resource-num>10.1146/annurev.bioeng.9.060906.152025</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1405</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1405</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Y. T.</author><author>Carson, D. A.</author></authors></contributors><auth-address>Moores UCSD Cancer Center, University of California San Diego, La Jolla, California, United States of America. ytliu@ucsd.edu</auth-address><titles><title>A novel approach for determining cancer genomic breakpoints in the presence of normal DNA</title><secondary-title>PLoS ONE</secondary-title></titles><periodical><full-title>PLoS ONE</full-title></periodical><pages>e380</pages><volume>2</volume><number>4</number><edition>2007/04/19</edition><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1932-6203 (Electronic)</isbn><accession-num>17440616</accession-num><abstract>CDKN2A (encodes p16(INK4A) and p14(ARF)) deletion, which results in both Rb and p53 inactivation, is the most common chromosomal anomaly in human cancers. To precisely map the deletion breakpoints is important to understanding the molecular mechanism of genomic rearrangement and may also be useful for clinical applications. However, current methods for determining the breakpoint are either of low resolution or require the isolation of relatively pure cancer cells, which can be difficult for clinical samples that are typically contaminated with various amounts of normal host cells. To overcome this hurdle, we have developed a novel approach, designated Primer Approximation Multiplex PCR (PAMP), for enriching breakpoint sequences followed by genomic tiling array hybridization to locate the breakpoints. In a series of proof-of-concept experiments, we were able to identify cancer-derived CDKN2A genomic breakpoints when more than 99.9% of wild type genome was present in a model system. This design can be scaled up with bioinformatics support and can be applied to validate other candidate cancer-associated loci that are revealed by other more systemic but lower throughput assays.</abstract><notes>Liu, Yu-Tsueng&#xD;Carson, Dennis A&#xD;United States&#xD;PLoS ONE&#xD;PLoS ONE. 2007 Apr 18;2(4):e380.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17440616</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>14.662</custom4><electronic-resource-num>10.1371/journal.pone.0000380</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1621</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1621</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sosnovik, D. E.</author><author>Nahrendorf, M.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, 149 13th St, Charlestown, MA 02129, USA. sosnovik@nmr.mgh.harvard.edu</auth-address><titles><title>Molecular magnetic resonance imaging in cardiovascular medicine</title><secondary-title>Circulation</secondary-title></titles><periodical><full-title>Circulation</full-title></periodical><pages>2076-86</pages><volume>115</volume><number>15</number><edition>2007/04/18</edition><keywords><keyword>Animals</keyword><keyword>Biological Markers/analysis</keyword><keyword>Biosensing Techniques</keyword><keyword>Cardiovascular Diseases/*diagnosis</keyword><keyword>Ferrosoferric Oxide/diagnostic use</keyword><keyword>Gadolinium/diagnostic use</keyword><keyword>Humans</keyword><keyword>*Magnetic Resonance Imaging/instrumentation/methods/trends</keyword><keyword>Nanoparticles/diagnostic use</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr 17</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>17438163</accession-num><notes>Sosnovik, David E&#xD;Nahrendorf, Matthias&#xD;Weissleder, Ralph&#xD;K08 HL079984/HL/United States NHLBI&#xD;P01CA117969-015904/CA/United States NCI&#xD;R01EB004626/EB/United States NIBIB&#xD;R01HL07864/HL/United States NHLBI&#xD;U01HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Circulation&#xD;Circulation. 2007 Apr 17;115(15):2076-86.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17438163</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>13.538</custom4><electronic-resource-num>115/15/2076 [pii]&#xD;10.1161/CIRCULATIONAHA.106.658930</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1435</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1435</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Marsh, J. N.</author><author>Partlow, K. C.</author><author>Abendschein, D. R.</author><author>Scott, M. J.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Center for Applied Nanomedicine, Department of Internal Medicine, Washington University, St. Louis, MO 63108, USA. jnm@cvu.wustl.edu</auth-address><titles><title>Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes</title><secondary-title>Ultrasound Med Biol</secondary-title></titles><periodical><full-title>Ultrasound Med Biol</full-title></periodical><pages>950-8</pages><volume>33</volume><number>6</number><edition>2007/04/17</edition><keywords><keyword>Animals</keyword><keyword>Cells, Cultured</keyword><keyword>*Contrast Media</keyword><keyword>Emulsions</keyword><keyword>*Epitopes</keyword><keyword>Female</keyword><keyword>Fluorocarbons/*diagnostic use</keyword><keyword>Image Enhancement/methods</keyword><keyword>Light</keyword><keyword>Microscopy, Acoustic/methods</keyword><keyword>Microscopy, Electron, Scanning/methods</keyword><keyword>Muscle, Smooth, Vascular/cytology/ultrasonography</keyword><keyword>Nanoparticles/*diagnostic use</keyword><keyword>Nanotechnology/methods</keyword><keyword>Scattering, Radiation</keyword><keyword>Swine</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0301-5629 (Print)</isbn><accession-num>17434667</accession-num><abstract>Targeted, liquid perfluorocarbon nanoparticles are effective agents for acoustic contrast enhancement of abundant cellular epitopes (e.g., fibrin in thrombi) and for lower prevalence binding sites, such as integrins associated with tumor neovasculature. In this study, we sought to delineate the quantitative relationship between the extent of contrast enhancement of targeted surfaces and the density (and concentration) of bound perfluorocarbon (PFC) nanoparticles. Two dramatically different substrates were utilized for targeting. In one set of experiments, the surfaces of smooth, flat, avidin-coated agar disks were exposed to biotinylated nanoparticles to yield a thin layer of targeted contrast. For the second set of measurements, we targeted PFC nanoparticles applied in thicker layers to cultured smooth muscle cells expressing the transmembrane glycoprotein &quot;tissue factor&quot; at the cell surface. An acoustic microscope was used to characterize reflectivity for all samples as a function of bound PFC (determined via gas chromatography). We utilized a formulation of low-scattering nanoparticles having oil-based cores to compete against high-scattering PFC nanoparticles for binding, to elucidate the dependence of contrast enhancement on PFC concentration. The relationship between reflectivity enhancement and bound PFC content varied in a curvilinear fashion and exhibited an apparent asymptote (approximately 16 dB and 9 dB enhancement for agar and cell samples, respectively) at the maximum concentrations (approximately 150 microg and approximately 1000 microg PFOB for agar and cell samples, respectively). Samples targeted with only oil-based nanoparticles exhibited mean backscatter values that were nearly identical to untreated samples (&lt;1 dB difference), confirming the oil particles&apos; low-scattering behavior. The results of this study indicate that substantial contrast enhancement with liquid perfluorocarbon nanoparticles can be realized even in cases of partial surface coverage (as might be encountered when targeting sparsely populated epitopes) or when targeting surfaces with locally irregular topography. Furthermore, it may be possible to assess the quantity of bound cellular epitopes through acoustic means.</abstract><notes>Marsh, Jon N&#xD;Partlow, Kathryn C&#xD;Abendschein, Dana R&#xD;Scott, Michael J&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Ca119342/ca/nci&#xD;Eb002168/eb/nibib&#xD;Hl042950/hl/nhlbi&#xD;R01 eb002168-06/eb/nibib&#xD;R01 hl042950-15/hl/nhlbi&#xD;R01 hl042950-16/hl/nhlbi&#xD;R01 hl042950-17/hl/nhlbi&#xD;U54 ca119342-01/ca/nci&#xD;U54 ca119342-02/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;England&#xD;Ultrasound in medicine &amp; biology&#xD;Ultrasound Med Biol. 2007 Jun;33(6):950-8. Epub 2007 Apr 16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17434667</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>2.884</custom4><electronic-resource-num>S0301-5629(07)00010-5 [pii]&#xD;10.1016/j.ultrasmedbio.2006.12.007</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1537</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1537</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Red-Horse, K.</author><author>Ferrara, N.</author></authors></contributors><titles><title>Vascular targeting via caveolae</title><secondary-title>Nat Biotechnol</secondary-title></titles><periodical><full-title>Nat Biotechnol</full-title></periodical><pages>431-2</pages><volume>25</volume><number>4</number><edition>2007/04/11</edition><keywords><keyword>Aminopeptidases/immunology</keyword><keyword>Animals</keyword><keyword>Antibodies/immunology</keyword><keyword>Biological Transport</keyword><keyword>Blood Vessels/*metabolism</keyword><keyword>Caveolae/*metabolism</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Neoplasms/therapy</keyword><keyword>Rats</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1087-0156 (Print)</isbn><accession-num>17420750</accession-num><notes>Red-Horse, Kristy&#xD;Ferrara, Napoleone&#xD;Comment&#xD;News&#xD;United States&#xD;Nature biotechnology&#xD;Nat Biotechnol. 2007 Apr;25(4):431-2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17420750</url></related-urls></urls><custom1>CNPP - S.K.C.C.</custom1><custom3>2007</custom3><custom4>25.329</custom4><electronic-resource-num>nbt0407-431 [pii]&#xD;10.1038/nbt0407-431</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1293</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1293</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jaffer, F. A.</author><author>Kim, D. E.</author><author>Quinti, L.</author><author>Tung, C. H.</author><author>Aikawa, E.</author><author>Pande, A. N.</author><author>Kohler, R. H.</author><author>Shi, G. P.</author><author>Libby, P.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, MA 02129, USA. fjaffer@partners.org</auth-address><titles><title>Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor</title><secondary-title>Circulation</secondary-title></titles><periodical><full-title>Circulation</full-title></periodical><pages>2292-8</pages><volume>115</volume><number>17</number><edition>2007/04/11</edition><keywords><keyword>Animals</keyword><keyword>Apolipoproteins E/genetics</keyword><keyword>Carotid Arteries/*enzymology/pathology</keyword><keyword>Carotid Artery Diseases/*metabolism/pathology</keyword><keyword>Cathepsins/*metabolism</keyword><keyword>Elastin/metabolism</keyword><keyword>Enzyme Activation</keyword><keyword>Fluorescein-5-isothiocyanate</keyword><keyword>Fluorescent Dyes</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Macrophages/enzymology/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Mutant Strains</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>Peptide Hydrolases</keyword><keyword>Spectroscopy, Near-Infrared/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>17420353</accession-num><abstract>BACKGROUND: Cathepsin K (CatK), a potent elastinolytic and collagenolytic cysteine protease, likely participates in the evolution and destabilization of atherosclerotic plaques. To assess better the biology of CatK activity in vivo, we developed a novel near-infrared fluorescence (NIRF) probe for imaging of CatK and evaluated it in mouse and human atherosclerosis. METHODS AND RESULTS: The NIRF imaging agent consists of the CatK peptide substrate GHPGGPQGKC-NH2 linked to an activatable fluorogenic polymer. In vitro, CatK produced a 2- to 14-fold activation of the agent over other cysteine and matrix metalloproteinases (P&lt;0.0001), as well as a &gt;8-fold activation over a control imaging agent (P&lt;0.001). Optical imaging of atheroma revealed &gt;100% NIRF signal increases in apolipoprotein E-/- mice in vivo (n=13; P&lt;0.05, CatK imaging agent versus control agent) and in human carotid endarterectomy specimens ex vivo (n=14; P&lt;0.05). Fluorescence microscopy of plaque sections demonstrated that enzymatically active CatK (positive NIRF signal) localized primarily in the vicinity of CatK-positive macrophages. Augmented NIRF signal (reflecting CatK activity) colocalized with disrupted elastin fibers within the media underlying plaques. CONCLUSIONS: Use of this novel protease-activatable NIRF agent for optical imaging in vivo demonstrated preferential localization of enzymatically active CatK to macrophages, consistent with their known greater elastinolytic capabilities compared with smooth muscle cells. Augmented CatK proteolysis in atheromata further links CatK to vascular remodeling and plaque vulnerability.</abstract><notes>Jaffer, Farouc A&#xD;Kim, Dong-Eog&#xD;Quinti, Luisa&#xD;Tung, Ching-Hsuan&#xD;Aikawa, Elena&#xD;Pande, Ashvin N&#xD;Kohler, Rainer H&#xD;Shi, Guo-Ping&#xD;Libby, Peter&#xD;Weissleder, Ralph&#xD;P50-CA86355/CA/United States NCI&#xD;R01-HL080472/HL/United States NHLBI&#xD;R24-CA92782/CA/United States NCI&#xD;U01 HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Circulation&#xD;Circulation. 2007 May 1;115(17):2292-8. Epub 2007 Apr 9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17420353</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>13.538</custom4><electronic-resource-num>CIRCULATIONAHA.106.660340 [pii]&#xD;10.1161/CIRCULATIONAHA.106.660340</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1246</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1246</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hayashi, K.</author><author>Yamauchi, K.</author><author>Yamamoto, N.</author><author>Tsuchiya, H.</author><author>Tomita, K.</author><author>Amoh, Y.</author><author>Hoffman, R. M.</author><author>Bouvet, M.</author></authors></contributors><auth-address>Department of Surgery, University of California San Diego, San Diego, California, USA.</auth-address><titles><title>Dual-color imaging of angiogenesis and its inhibition in bone and soft tissue sarcoma</title><secondary-title>J Surg Res</secondary-title></titles><periodical><full-title>J Surg Res</full-title></periodical><pages>165-70</pages><volume>140</volume><number>2</number><edition>2007/04/10</edition><keywords><keyword>Animals</keyword><keyword>Antibiotics, Antineoplastic/therapeutic use</keyword><keyword>Bone Neoplasms/*blood supply/drug therapy/metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation</keyword><keyword>Doxorubicin/therapeutic use</keyword><keyword>Endothelium, Vascular/metabolism/pathology</keyword><keyword>Fibrosarcoma/*blood supply/drug therapy/metabolism</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Green Fluorescent Proteins/metabolism</keyword><keyword>Humans</keyword><keyword>Intermediate Filament Proteins/genetics/metabolism</keyword><keyword>Luminescent Proteins/metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Mice, Transgenic</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>Neovascularization, Pathologic/metabolism/*pathology/*prevention &amp; control</keyword><keyword>Nerve Tissue Proteins/genetics/metabolism</keyword><keyword>Regional Blood Flow</keyword><keyword>Sarcoma/*blood supply/drug therapy/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun 15</date></pub-dates></dates><isbn>0022-4804 (Print)</isbn><accession-num>17418866</accession-num><abstract>BACKGROUND: Angiogenesis is a critical step in tumor growth, progression, and metastasis. Soft tissue and bone sarcoma are resistant to most therapeutic approaches. Angiogenesis of these tumors may be an effective target. We hypothesized that we could inhibit tumor growth by targeting angiogenesis in a mouse model of sarcoma. We demonstrate in this report, using powerful color-coded fluorescent imageable tumor-host models, the onset of angiogenesis of these sarcomas and its inhibition. MATERIALS AND METHODS: Transgenic mice were used as the host in which green fluorescent protein (GFP) is driven by a regulatory element of the stem cell marker nestin (ND-GFP). Nascent blood vessels express ND-GFP in this model. We visualized, by dual-color fluorescence imaging, angiogenesis of sarcoma formed by the HT-1080 human fibrosarcoma cell line expressing red fluorescent protein (RFP) in the ND-GFP mice. Tumor cells were injected into either the muscle or the bone. RESULTS: Nestin was highly expressed in proliferating endothelial cells and nascent blood vessels in the growing tumors, including the surrounding tissues. Immunohistochemical staining showed that CD31 colocalized in ND-GFP-expressing nascent blood vessels. The density of nascent blood vessels in the tumor was readily quantitated. The mice were given daily i.p. injections of 5 mg/kg of doxorubicin after implantation of tumor cells. Doxorubicin significantly decreased the mean nascent blood vessel density in the tumors as well as decreased tumor volume. CONCLUSION: The dual-color model of the ND-GFP nude mouse and RFP sarcoma cells is useful for the visualization and quantitation of bone and soft tissue tumor angiogenesis and evaluation of angiogenic inhibitors for such tumors. These data suggest targeting angiogenesis of sarcomas as a promising clinical approach.</abstract><notes>Hayashi, Katsuhiro&#xD;Yamauchi, Kensuke&#xD;Yamamoto, Norio&#xD;Tsuchiya, Hiroyuki&#xD;Tomita, Katsuro&#xD;Amoh, Yasuyuki&#xD;Hoffman, Robert M&#xD;Bouvet, Michael&#xD;Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of surgical research&#xD;J Surg Res. 2007 Jun 15;140(2):165-70. Epub 2007 Apr 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17418866</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>1.977</custom4><electronic-resource-num>S0022-4804(06)00611-1 [pii]&#xD;10.1016/j.jss.2006.11.018</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1704</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1704</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, X.</author><author>Song, J.</author><author>Liu, J.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, GA 30332-0245, USA.</auth-address><titles><title>Direct-current nanogenerator driven by ultrasonic waves</title><secondary-title>Science</secondary-title></titles><periodical><full-title>Science</full-title></periodical><pages>102-5</pages><volume>316</volume><number>5821</number><edition>2007/04/07</edition><keywords><keyword>Electric Conductivity</keyword><keyword>*Electricity</keyword><keyword>Microelectrodes</keyword><keyword>Nanotechnology</keyword><keyword>*Nanowires</keyword><keyword>*Ultrasonics</keyword><keyword>Zinc Oxide</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr 6</date></pub-dates></dates><isbn>1095-9203 (Electronic)</isbn><accession-num>17412957</accession-num><abstract>We have developed a nanowire nanogenerator that is driven by an ultrasonic wave to produce continuous direct-current output. The nanogenerator was fabricated with vertically aligned zinc oxide nanowire arrays that were placed beneath a zigzag metal electrode with a small gap. The wave drives the electrode up and down to bend and/or vibrate the nanowires. A piezoelectric-semiconducting coupling process converts mechanical energy into electricity. The zigzag electrode acts as an array of parallel integrated metal tips that simultaneously and continuously create, collect, and output electricity from all of the nanowires. The approach presents an adaptable, mobile, and cost-effective technology for harvesting energy from the environment, and it offers a potential solution for powering nanodevices and nanosystems.</abstract><notes>Wang, Xudong&#xD;Song, Jinhui&#xD;Liu, Jin&#xD;Wang, Zhong Lin&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Science (New York, N.Y.)&#xD;Science. 2007 Apr 6;316(5821):102-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17412957</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>30.268</custom4><electronic-resource-num>316/5821/102 [pii]&#xD;10.1126/science.1139366</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1542</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1542</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rieter, W. J.</author><author>Kim, J. S.</author><author>Taylor, K. M.</author><author>An, H.</author><author>Lin, W.</author><author>Tarrant, T.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Hybrid silica nanoparticles for multimodal imaging</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>3680-2</pages><volume>46</volume><number>20</number><edition>2007/04/07</edition><keywords><keyword>Gadolinium/chemistry</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Molecular Structure</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Organometallic Compounds/chemical synthesis/chemistry</keyword><keyword>Particle Size</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Silicon Dioxide/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>17415734</accession-num><notes>Rieter, William J&#xD;Kim, Jason S&#xD;Taylor, Kathryn M L&#xD;An, Hongyu&#xD;Lin, Weili&#xD;Tarrant, Teresa&#xD;Lin, Wenbin&#xD;P20 rr020764/rr/ncrr&#xD;U54-ca119343/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2007;46(20):3680-2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17415734</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200604738</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1125</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1125</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chan, E. W.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-3290, USA.</auth-address><titles><title>Surface-chemistry control to silence gene expression in Drosophila Schneider 2 cells through RNA interference</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>3881-4</pages><volume>46</volume><number>21</number><edition>2007/04/07</edition><keywords><keyword>Animals</keyword><keyword>Cells, Cultured</keyword><keyword>Drosophila/*cytology/*genetics</keyword><keyword>*Gene Expression Regulation</keyword><keyword>*Gene Silencing</keyword><keyword>Gold/chemistry</keyword><keyword>*RNA Interference</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>17415732</accession-num><notes>Chan, Eugene W L&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2007;46(21):3881-4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17415732</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200604079</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1695</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1695</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, L.</author><author>MacDonald, R. C.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois 60208, USA.</auth-address><titles><title>Synergistic effect between components of mixtures of cationic amphipaths in transfection of primary endothelial cells</title><secondary-title>Mol Pharm</secondary-title></titles><periodical><full-title>Mol Pharm</full-title></periodical><pages>615-23</pages><volume>4</volume><number>4</number><edition>2007/04/06</edition><keywords><keyword>Cations/chemistry</keyword><keyword>Cells, Cultured</keyword><keyword>Endothelial Cells/*metabolism</keyword><keyword>Endothelium, Vascular/cytology</keyword><keyword>Humans</keyword><keyword>Lipids/*chemistry</keyword><keyword>Membrane Fusion</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Models, Structural</keyword><keyword>Phosphatidylcholines/*chemistry</keyword><keyword>Solubility</keyword><keyword>*Transfection</keyword><keyword>Umbilical Arteries/cytology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jul-Aug</date></pub-dates></dates><isbn>1543-8384 (Print)</isbn><accession-num>17408283</accession-num><abstract>To date, the primary approach to improving the transfection properties of cationic lipids has been the synthesis of new kinds of cationic amphipaths. Recently, however, it was found that combining two cationic lipid derivatives having the same head group but tails of different chain lengths can provide another, and often superior, approach to higher transfection efficiency. For example, the combination of medium-chain and long-chain homologues of O-ethylphosphatidylcholine transfected DNA into primary human umbilical artery endothelial cells (HUAECs) more than 30-fold more efficiently than did either compound separately. Here it is reported that this synergism of mixtures is not limited to O-ethylphosphatidylcholine homologues, but is also exhibited by other common cationic amphipathic transfection reagents; for example, combining DC-Chol (3beta-[N&apos;,N&apos;-dimethylaminoethane)-carbamol] cholesterol), dimethylditetradecylammonium bromide, or DMTAP (1,2-dimyristoyl-3-trimethylammonium-propane) with EDOPC increased transfection significantly both in the absence and in the presence of serum. Furthermore, combining a poorer transfection agent-dimethyldioctadecylammonium bromide-with dimethylditetradecylammonium bromide increased transfection by about an order of magnitude with a maximum at an intermediate composition. Lack of synergy occurred with some mixtures, such as DMTAP and DOTAP (1,2-dioleoyl-3-trimethylammonium-propane), in which case transfection activity was a linear function of composition both in the absence and presence of serum. Although the mechanism of enhanced transfection by mixtures is not fully understood, the existence of a number of optimal mixtures with diverse cationic compounds indicates that attention to mixture formulations can lead to greatly improved transfection by cationic amphipathic carriers.</abstract><notes>Wang, Li&#xD;MacDonald, Robert C&#xD;GM074429/GM/United States NIGMS&#xD;GM52329/GM/United States NIGMS&#xD;GM57305/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular pharmaceutics&#xD;Mol Pharm. 2007 Jul-Aug;4(4):615-23. Epub 2007 Apr 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17408283</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.388</custom4><electronic-resource-num>10.1021/mp0601291</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1609</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1609</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>So, M. K.</author><author>Loening, A. M.</author><author>Gambhir, S. S.</author><author>Rao, J.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology, Stanford University School of Medicine, 1201 Welch Road, Stanford, California 94305-5484, USA.</auth-address><titles><title>Creating self-illuminating quantum dot conjugates</title><secondary-title>Nat Protoc</secondary-title></titles><periodical><full-title>Nat Protoc</full-title></periodical><pages>1160-4</pages><volume>1</volume><number>3</number><edition>2007/04/05</edition><keywords><keyword>Energy Transfer</keyword><keyword>Imidazoles</keyword><keyword>Luciferases, Renilla</keyword><keyword>*Luminescence</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Pyrazines</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1750-2799 (Electronic)</isbn><accession-num>17406398</accession-num><abstract>Semiconductor quantum dots are inorganic fluorescent nanocrystals that, because of their unique optical properties compared with those of organic fluorophores, have become popular as fluorescent imaging probes. Although external light excitation is typically required for imaging with quantum dots, a new type of quantum dot conjugate has been reported that can luminesce with no need for external excitation. These self-illuminating quantum dot conjugates can be prepared by coupling of commercially available carboxylate-presenting quantum dots to the light-emitting protein Renilla luciferase. When the conjugates are exposed to the luciferase&apos;s substrate coelenterazine, the energy released by substrate catabolism is transferred to the quantum dots through bioluminescence resonance energy transfer, leading to quantum dot light emission. This protocol describes step-by-step procedures for the preparation and characterization of these self-illuminating quantum dot conjugates. The preparation process is relatively simple and can be done in less than 2 hours. The availability of self-illuminating quantum dot conjugates will provide many new possibilities for in vivo imaging and detection, such as monitoring of in vivo cell trafficking, multiplex bioluminescence imaging and new quantum dot-based biosensors.</abstract><notes>So, Min-Kyung&#xD;Loening, Andreas M&#xD;Gambhir, Sanjiv S&#xD;Rao, Jianghong&#xD;1u54ca119367-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nature protocols&#xD;Nat Protoc. 2006;1(3):1160-4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17406398</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>4.175</custom4><electronic-resource-num>nprot.2006.162 [pii]&#xD;10.1038/nprot.2006.162</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1516</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1516</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pittet, M. J.</author><author>Swirski, F. K.</author><author>Reynolds, F.</author><author>Josephson, L.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA. mpittet@hms.harvard.edu</auth-address><titles><title>Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles</title><secondary-title>Nat Protoc</secondary-title></titles><periodical><full-title>Nat Protoc</full-title></periodical><pages>73-9</pages><volume>1</volume><number>1</number><edition>2007/04/05</edition><keywords><keyword>Animals</keyword><keyword>Ferric Compounds/chemistry</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Magnetics</keyword><keyword>Mice</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Staining and Labeling/*methods</keyword><keyword>T-Lymphocytes/*chemistry/cytology</keyword></keywords><dates><year>2006</year><pub-dates><date>June</date></pub-dates></dates><isbn>1750-2799 (Electronic)</isbn><accession-num>17406214</accession-num><abstract>Observation of immune and stem cells in their native microenvironments requires the development of imaging agents to allow their in vivo tracking. We describe here the synthesis of magnetofluorescent nanoparticles for cell labeling in vitro and for multimodality imaging of administered cells in vivo. MION-47, a prototype monocrystalline iron oxide nanoparticle, was first converted to an intermediate bearing a fluorochrome and amine groups, then reacted with either HIV-Tat peptide or protamine to yield a nanoparticle with membrane-translocating properties. We describe how to assess optimal cell labeling with tests of cell phenotype and function. Synthesis of magnetofluorescent nanoparticles and cell-labeling optimization can be realized in 48 h, whereas nanoparticle uptakes and retention studies may generally take up to 120 h. Labeled cells can be detected by magnetic resonance imaging, fluorescence reflectance imaging, fluorescence-mediated tomography, confocal microscopy and flow cytometry, and can be purified based on their fluorescent or magnetic properties. The present protocol focuses on T-cell labeling but can be used for labeling a variety of circulating cells.</abstract><notes>Pittet, Mikael J&#xD;Swirski, Filip K&#xD;Reynolds, Frederick&#xD;Josephson, Lee&#xD;Weissleder, Ralph&#xD;England&#xD;Nature protocols&#xD;Nat Protoc. 2006;1(1):73-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17406214</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>4.175</custom4><electronic-resource-num>nprot.2006.11 [pii]&#xD;10.1038/nprot.2006.11</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1632</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1632</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sullivan, B. D.</author><author>Dehlinger, D. A.</author><author>Zlatanovic, S.</author><author>Esener, S. A.</author><author>Heller, M. J.</author></authors></contributors><auth-address>Department of Bioengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, USA.</auth-address><titles><title>Low-frequency electrophoretic actuation of nanoscale optoentropic transduction mechanisms</title><secondary-title>Nano Lett</secondary-title><alt-title>Nano letters</alt-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><alt-periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></alt-periodical><pages>950-5</pages><volume>7</volume><number>4</number><edition>2007/04</edition><keywords><keyword>Biosensing Techniques/*methods</keyword><keyword>DNA/*chemistry</keyword><keyword>Electrophoresis/*methods</keyword><keyword>Fluorescence Resonance Energy Transfer/*methods</keyword><keyword>In Situ Hybridization/*methods</keyword><keyword>Nanostructures/*chemistry/ultrastructure</keyword><keyword>Sequence Analysis, DNA/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17355161</accession-num><abstract>Inherent bistabilities within DNA-assembled fluorescent resonant energy transfer systems demonstrated time-varying optical signals in response to an electrophoretic driving force. Frequency responses of electrophoretically driven FRET systems were shown to be sequence specific. Integration of these signals over time gave near single-molecule sensitivity within a high background of autofluorescence. This research suggests that externally driven nanoscale mechanical systems may help improve information flow within morphologically intact specimens.</abstract><notes>U54 ca119335/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17355161 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>12.189</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1161</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1161</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>David, K.</author><author>Dan, N.</author><author>Tannenbaum, R.</author></authors></contributors><auth-address>Tannenbaum, R&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, 771 Ferst Dr NW, Atlanta, GA 30332 USA&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA 30332 USA&#xD;Drexel Univ, Dept Chem &amp; Biol Engn, Philadelphia, PA 19104 USA&#xD;Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel</auth-address><titles><title>Competitive adsorption of polymers on metal nanoparticles</title><secondary-title>Surface Science</secondary-title></titles><periodical><full-title>Surface Science</full-title></periodical><pages>1781-1788</pages><volume>601</volume><number>8</number><edition>2007/04</edition><keywords><keyword>polymer adsorption</keyword><keyword>competitive adsorption</keyword><keyword>metal nanoparticles</keyword><keyword>thermal properties</keyword><keyword>diblock co-polymers</keyword><keyword>thermal-properties</keyword><keyword>colloidal particle</keyword><keyword>oxide nanoclusters</keyword><keyword>surfaces</keyword><keyword>polystyrene</keyword><keyword>matrix</keyword><keyword>kinetics</keyword><keyword>decomposition</keyword><keyword>interfaces</keyword><keyword>silica</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>0039-6028</isbn><accession-num>ISI:000246313900002</accession-num><abstract>We investigate the effect of system properties and adsorption sequence on competitive adsorption of poly(methyl methacrylate) (PMMA) and polystyrene (PS) on narrowly polydispersed cobalt (Co) nanoparticles (D similar to 27 nm). The adsorbed layer composition is studied using thermo-gravimetric analysis (TGA). We find that adsorbed layers of PS are completely displaced by PMMA when the solvent is a common good solvent. An adsorbed layer of only PMMA is also obtained through competitive adsorption from a common good solvent. However, in a selective solvent that is poor for PS, sequential adsorption leads to the formation of mixed layers. (c) 2007 Elsevier B.V. All rights reserved.</abstract><notes>165OD&#xD;Times Cited:0&#xD;Cited References Count:46</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246313900002</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>1.787</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1104</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1104</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Burg, T. P.</author><author>Godin, M.</author><author>Knudsen, S. M.</author><author>Shen, W.</author><author>Carlson, G.</author><author>Foster, J. S.</author><author>Babcock, K.</author><author>Manalis, S. R.</author></authors></contributors><auth-address>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Weighing of biomolecules, single cells and single nanoparticles in fluid</title><secondary-title>Nature</secondary-title><alt-title>Nature</alt-title></titles><periodical><full-title>Nature</full-title></periodical><alt-periodical><full-title>Nature</full-title></alt-periodical><pages>1066-9</pages><volume>446</volume><number>7139</number><edition>2007/04</edition><keywords><keyword>Bacteria/chemistry/isolation &amp; purification</keyword><keyword>Biological Products/analysis/*chemistry</keyword><keyword>Cells/*chemistry</keyword><keyword>Colloids/analysis/chemistry</keyword><keyword>Microfluidics/*instrumentation/*methods</keyword><keyword>Molecular Weight</keyword><keyword>Nanoparticles/analysis/*chemistry</keyword><keyword>Proteins/analysis/chemistry</keyword><keyword>Quartz</keyword><keyword>Solutions/chemistry</keyword><keyword>Vacuum</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr 26</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>17460669</accession-num><abstract>Nanomechanical resonators enable the measurement of mass with extraordinary sensitivity. Previously, samples as light as 7 zeptograms (1 zg = 10(-21) g) have been weighed in vacuum, and proton-level resolution seems to be within reach. Resolving small mass changes requires the resonator to be light and to ring at a very pure tone-that is, with a high quality factor. In solution, viscosity severely degrades both of these characteristics, thus preventing many applications in nanotechnology and the life sciences where fluid is required. Although the resonant structure can be designed to minimize viscous loss, resolution is still substantially degraded when compared to measurements made in air or vacuum. An entirely different approach eliminates viscous damping by placing the solution inside a hollow resonator that is surrounded by vacuum. Here we demonstrate that suspended microchannel resonators can weigh single nanoparticles, single bacterial cells and sub-monolayers of adsorbed proteins in water with sub-femtogram resolution (1 Hz bandwidth). Central to these results is our observation that viscous loss due to the fluid is negligible compared to the intrinsic damping of our silicon crystal resonator. The combination of the low resonator mass (100 ng) and high quality factor (15,000) enables an improvement in mass resolution of six orders of magnitude over a high-end commercial quartz crystal microbalance. This gives access to intriguing applications, such as mass-based flow cytometry, the direct detection of pathogens, or the non-optical sizing and mass density measurement of colloidal particles.</abstract><notes>Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17460669 </url></related-urls></urls><custom1>CNPP - MIT</custom1><custom3>2007</custom3><custom4>31.210</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1438</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1438</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Maynor, B. W.</author><author>LaRue, I.</author><author>Hu, Z.</author><author>Rolland, J. P.</author><author>Pandya, A.</author><author>Fu, Q.</author><author>Liu, J.</author><author>Spontak, R. J.</author><author>Sheiko, S. S.</author><author>Samulski, R. J.</author><author>Samulski, E. T.</author><author>DeSimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Supramolecular nanomimetics: replication of micelles, viruses, and other naturally occurring nanoscale objects</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>845-9</pages><volume>3</volume><number>5</number><edition>2007/03/30</edition><keywords><keyword>Biomimetic Materials/*chemistry</keyword><keyword>Biomimetics/*methods</keyword><keyword>Crystallization/*methods</keyword><keyword>Ethers/*chemistry</keyword><keyword>Fluorocarbons/*chemistry</keyword><keyword>Macromolecular Substances/chemistry</keyword><keyword>Materials Testing</keyword><keyword>Micelles</keyword><keyword>Molecular Conformation</keyword><keyword>Nanostructures/*chemistry/ultrastructure</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Particle Size</keyword><keyword>Surface Properties</keyword><keyword>Viruses/*chemistry/ultrastructure</keyword></keywords><dates><year>2007</year><pub-dates><date>May</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17393549</accession-num><notes>Maynor, Benjamin W&#xD;LaRue, Isaac&#xD;Hu, Zhaokang&#xD;Rolland, Jason P&#xD;Pandya, Ashish&#xD;Fu, Qiang&#xD;Liu, Jie&#xD;Spontak, Richard J&#xD;Sheiko, Sergei S&#xD;Samulski, Richard J&#xD;Samulski, Edward T&#xD;DeSimone, Joseph M&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2007 May;3(5):845-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17393549</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200600507</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1058</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1058</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Amoh, Y.</author><author>Li, L.</author><author>Katsuoka, K.</author><author>Bouvet, M.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., San Diego, CA 92111, USA.</auth-address><titles><title>GFP-expressing vascularization of Gelfoam as a rapid in vivo assay of angiogenesis stimulators and inhibitors</title><secondary-title>Biotechniques</secondary-title></titles><periodical><full-title>Biotechniques</full-title></periodical><pages>294, 296, 298</pages><volume>42</volume><number>3</number><edition>2007/03/30</edition><keywords><keyword>Angiogenesis Inducing Agents/*pharmacology</keyword><keyword>Angiogenesis Inhibitors/*pharmacology</keyword><keyword>Animals</keyword><keyword>Gelatin Sponge, Absorbable/*chemistry</keyword><keyword>Green Fluorescent Proteins/*metabolism</keyword><keyword>Humans</keyword><keyword>Liver Neoplasms/pathology/secondary</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Nude</keyword><keyword>Mice, Transgenic</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Neoplasm Transplantation</keyword><keyword>*Neovascularization, Pathologic</keyword><keyword>Pancreatic Neoplasms/pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0736-6205 (Print)</isbn><accession-num>17390535</accession-num><notes>Amoh, Yasuyuki&#xD;Li, Lingna&#xD;Katsuoka, Kensei&#xD;Bouvet, Michael&#xD;Hoffman, Robert M&#xD;Ca099258/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;BioTechniques&#xD;Biotechniques. 2007 Mar;42(3):294, 296, 298.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17390535</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>2.499</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1518</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1518</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pourmand, N.</author><author>Caramuta, S.</author><author>Villablanca, A.</author><author>Mori, S.</author><author>Karhanek, M.</author><author>Wang, S. X.</author><author>Davis, R. W.</author></authors></contributors><auth-address>Stanford Genome Technology Center, Palo Alto, CA 94304, USA. pourmand@stanford.edu</auth-address><titles><title>Branch migration displacement assay with automated heuristic analysis for discrete DNA length measurement using DNA microarrays</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>6146-51</pages><volume>104</volume><number>15</number><edition>2007/03/29</edition><dates><year>2007</year><pub-dates><date>Apr 10</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17389407</accession-num><abstract>The analysis of short tandem repeats (STRs) plays an important role in forensic science, human identification, genetic mapping, and disease diagnostics. Traditional STR analysis utilizes gel- or column-based approaches to analyze DNA repeats. Individual STR alleles are separated and distinguished according to fragment length; thus the assay is generally hampered by its low multiplex capacity. However, use of DNA microarray would employ a simple hybridization and detection for field forensics and biology. Here we demonstrate a rapid, highly sensitive method for STR analysis that utilizes DNA microarray technology. We describe two adaptations to accomplish this: the use of competitive hybridization to remove unpaired ssDNA from an array and the use of neural network classification to automate the analysis. The competitive displacement technique mimics the branch migration process that occurs during DNA recombination. Our technique will facilitate the rapid deduction of identity, length, and number of repeats for the multiple STRs in an unknown DNA sample.</abstract><notes>Pourmand, Nader&#xD;Caramuta, Stefano&#xD;Villablanca, Andrea&#xD;Mori, Silvia&#xD;Karhanek, Miloslav&#xD;Wang, Shan X&#xD;Davis, Ronald W&#xD;P01-hg000205/hg/nhgri&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6146-51. Epub 2007 Mar 27.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17389407</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>10.228</custom4><electronic-resource-num>0700921104 [pii]&#xD;10.1073/pnas.0700921104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1747</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1747</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, X.</author><author>Han, M. S.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113, USA.</auth-address><titles><title>A gold-nanoparticle-based real-time colorimetric screening method for endonuclease activity and inhibition</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>3468-70</pages><volume>46</volume><number>19</number><edition>2007/03/28</edition><keywords><keyword>Base Sequence</keyword><keyword>*Biosensing Techniques</keyword><keyword>Endonucleases/*analysis/antagonists &amp; inhibitors/metabolism</keyword><keyword>Gold/*chemistry/diagnostic use</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Oligonucleotide Probes/*chemistry</keyword><keyword>Spectrophotometry, Ultraviolet</keyword></keywords><dates><year>2007</year></dates><isbn>1433-7851 (Print)</isbn><accession-num>17385814</accession-num><notes>Xu, Xiaoyang&#xD;Han, Min Su&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2007;46(19):3468-70.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17385814</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200605249</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1654</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1654</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thomas, M.</author><author>Lu, J. J.</author><author>Zhang, C.</author><author>Chen, J.</author><author>Klibanov, A. M.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, Building 56-579, Cambridge, Massachusetts 02139, USA.</auth-address><titles><title>Identification of novel superior polycationic vectors for gene delivery by high-throughput synthesis and screening of a combinatorial library</title><secondary-title>Pharm Res</secondary-title></titles><periodical><full-title>Pharm Res</full-title></periodical><pages>1564-71</pages><volume>24</volume><number>8</number><edition>2007/03/27</edition><keywords><keyword>Acrylates/chemistry</keyword><keyword>Animals</keyword><keyword>COS Cells</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Survival</keyword><keyword>Cercopithecus aethiops</keyword><keyword>*Combinatorial Chemistry Techniques</keyword><keyword>Cross-Linking Reagents/chemistry</keyword><keyword>Genetic Vectors/*chemistry/genetics</keyword><keyword>Humans</keyword><keyword>Imines/*chemistry</keyword><keyword>Luciferases/genetics/metabolism</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Molecular Structure</keyword><keyword>Polyamines/*chemistry</keyword><keyword>Polyethylenes/*chemistry</keyword><keyword>Transfection/methods</keyword><keyword>beta-Galactosidase/genetics/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>0724-8741 (Print)</isbn><accession-num>17385014</accession-num><abstract>PURPOSE: Low efficiency and toxicity are two major drawbacks of current non-viral gene delivery vectors. Since DNA delivery to mammalian cells is a multi-step process, generating and searching combinatorial libraries of vectors employing high-throughput synthesis and screening methods is an attractive strategy for the development of new improved vectors because it increases the chance of identifying the most overall optimized vectors. MATERIALS AND METHODS: Based on the rationale that increasing the effective molecular weight of small PEIs, which are poor vectors compared to the higher molecular weight homologues but less toxic, raises their transfection efficiency due to better DNA binding, we synthesized a library of 144 biodegradable derivatives from two small PEIs and 24 bi- and oligo-acrylate esters. A 423-Da linear PEI and its 1:1 (w/w) mixture with a 1.8-kDa branched PEI were cross-linked with the acrylates at three molar ratios in DMSO. The resulting polymers were screened for their efficiency in delivering a beta-galactosidase expressing plasmid to COS-7 monkey kidney cells. Selected most potent polymers from the initial screen were tested for toxicity in A549 human lung cancer cells, and in vivo in a systemic gene delivery model in mice employing a firefly luciferase expressing plasmid. RESULTS: Several polycations that exhibited high potency and low toxicity in vitro were identified from the library. The most potent derivative of the linear 423-Da PEI was that cross-linked with tricycle-[5.2.1.0]-decane-dimethanol diacrylate (diacrylate 14), which exhibited an over 3,600-fold enhancement in efficiency over the parent. The most potent mixed PEI was that cross-linked with ethylene glycol diacrylate (diacrylate 4) which was over 850-fold more efficient than the physically mixed parent PEIs. The relative efficiencies of these polymers were even up to over twice as high as that of the linear 22-kDa PEI, considered the &quot;gold standard&quot; for in vitro and systemic gene delivery. The potent cross-linked polycations identified were also less toxic than the 22-kDa PEI. The optimal vector in vivo was the mixed PEI cross-linked with propylene glycol glycerolate diacrylate (diacrylate 7); it mediated the highest gene expression in the lungs, followed by the spleen, with the expression in the former being 53-fold higher compared to the latter. In contrast, the parent PEIs mediated no gene expression at all under similar conditions, and injection of the polyplexes of the 22-kDa PEI at its optimal N/P of 10 prepared under identical conditions killed half of the mice injected. CONCLUSIONS: High-throughput synthesis and transfection assay of a cross-linked library of biodegradable PEIs was proven effective in identifying highly transfecting vectors. The identified vectors exhibited dramatically superior efficiency compared to their parents both in vitro and in an in vivo systemic gene delivery model. The majority of these vectors mediated preferential gene delivery to the lung, and their in vivo toxicity paralleled that in vitro.</abstract><notes>Thomas, Mini&#xD;Lu, James J&#xD;Zhang, Chengcheng&#xD;Chen, Jianzhu&#xD;Klibanov, Alexander M&#xD;Ai56267/ai/niaid&#xD;Gm26698/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Pharmaceutical research&#xD;Pharm Res. 2007 Aug;24(8):1564-71. Epub 2007 Mar 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17385014</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>3.831</custom4><electronic-resource-num>10.1007/s11095-007-9279-3</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1463</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1463</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nahrendorf, M.</author><author>Sosnovik, D. E.</author><author>Waterman, P.</author><author>Swirski, F. K.</author><author>Pande, A. N.</author><author>Aikawa, E.</author><author>Figueiredo, J. L.</author><author>Pittet, M. J.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, USA.</auth-address><titles><title>Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct</title><secondary-title>Circ Res</secondary-title></titles><periodical><full-title>Circ Res</full-title></periodical><pages>1218-25</pages><volume>100</volume><number>8</number><edition>2007/03/24</edition><keywords><keyword>Animals</keyword><keyword>Enzyme Activation/physiology</keyword><keyword>Factor XIII/biosynthesis</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Image Interpretation, Computer-Assisted/methods</keyword><keyword>Leukocytes/cytology/enzymology/*radiography</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Inbred CBA</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Myocardial Infarction/enzymology/pathology/*radiography</keyword><keyword>Neutrophil Infiltration/physiology</keyword><keyword>Peptide Hydrolases/*metabolism</keyword><keyword>Tomography, Optical/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr 27</date></pub-dates></dates><isbn>1524-4571 (Electronic)</isbn><accession-num>17379832</accession-num><abstract>Inflammatory responses after myocardial infarction profoundly impact tissue repair. Yet, efficient tools to serially and noninvasively assess cellular and molecular functions in postinfarct inflammation are lacking. Here we use multichannel fluorescent molecular tomography (FMT) for spatiotemporal resolution of phagocytic and proteolytic activities mediated by macrophages and neutrophils in murine infarcts. We performed FMT imaging to compare the course of efficient and impaired healing in wild-type and FXIII-/- mice, respectively. Mice subjected to coronary ligation received simultaneous injections with Prosense-680, an activatable fluorescence sensor reporting on cathepsin activity, and CLIO-VT750, a magneto-fluorescent nanoparticle for imaging of phagocyte recruitment. On FMT, Prosense-680 infarct signal was 19-fold higher than background (P&lt;0.05). Protease activity was higher in the infarcted lateral wall than in the remote, uninjured septum on ex vivo fluorescence reflectance imaging (contrast to noise ratio 118+/-24). CLIO-VT750 FMT signal coregistered with contrast enhancement in the hypokinetic infarct on MRI. Microscopic fluorescence signal colocalized with immunoreactive staining for cathepsin, macrophages and neutrophils. Flow cytometry of digested infarcts revealed monocytes/macrophages and neutrophils as the source of the fluorescence signal. Phagocytic activity peaked on day 6, and proteolytic activity peaked on day 4 after myocardial infarction. FMT detected impaired recruitment of phagocytes and protease activity in FXIII-/- mice (P&lt;0.05). FMT is a promising noninvasive molecular imaging approach to characterize infarct healing. Spectrally resolved imaging agents allow for simultaneous assesment of key processes of in vivo cellular functions. Specifically, we show that in vivo FMT detects impaired healing in FXIII-/- mice.</abstract><notes>Nahrendorf, Matthias&#xD;Sosnovik, David E&#xD;Waterman, Peter&#xD;Swirski, Filip K&#xD;Pande, Ashvin N&#xD;Aikawa, Elena&#xD;Figueiredo, Jose-Luiz&#xD;Pittet, Mikael J&#xD;Weissleder, Ralph&#xD;K08 HL079984/HL/United States NHLBI&#xD;R01-HL078641/HL/United States NHLBI&#xD;R24-CA92782/CA/United States NCI&#xD;UO1-HL080731/HL/United States NHLBI&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Circulation research&#xD;Circ Res. 2007 Apr 27;100(8):1218-25. Epub 2007 Mar 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17379832</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>10.445</custom4><electronic-resource-num>01.RES.0000265064.46075.31 [pii]&#xD;10.1161/01.RES.0000265064.46075.31</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1073</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1073</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Barat, B.</author><author>Wu, A. M.</author></authors></contributors><auth-address>Crump Institute for Molecular Imaging, Department of Molecular &amp; Medical Pharmacology, David Geffen School of Medicine at UCLA, 700 Westwood Plaza, Los Angeles, CA 90095, USA.</auth-address><titles><title>Metabolic biotinylation of recombinant antibody by biotin ligase retained in the endoplasmic reticulum</title><secondary-title>Biomol Eng</secondary-title></titles><periodical><full-title>Biomol Eng</full-title></periodical><pages>283-91</pages><volume>24</volume><number>3</number><edition>2007/03/24</edition><dates><year>2007</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1389-0344 (Print)</isbn><accession-num>17379573</accession-num><abstract>Due to its strength and specificity, the interaction between avidin and biotin has been used in a variety of scientific and medical applications ranging from immunohistochemistry to drug targeting. The present study describes two methods for biotinylation of proteins secreted from eukaryotic cells using the Escherichia coli biotin protein ligase. In one system the biotin ligase was co-secreted from the cells along with substrate protein enabling extracellular biotinylation of the tagged protein. In the other system, biotin ligase was engineered to be retained in the endoplasmic reticulum (ER) and metabolically biotinylates the secretory protein as it passes through the ER. An engineered antibody fragment, a diabody with specificity for carcinoembryonic antigen (CEA) was fused to the biotin acceptor domain (123 amino acid) of Propionibacterium shermanii. Coexpression of the fusion protein with ER retained biotin ligase showed higher biotinylation efficiency than biotinylation by co-secreted ligase. Biotinylation of the anti-CEA diabody tagged with a short (15 amino acid, Biotin Avitagtrade mark) biotin acceptor peptide was also successful. Utilization of ER retained biotin ligase for biotinylation of protein is an attractive alternative for efficiently producing uniformly biotinylated recombinant proteins for a variety of avidin-biotin technologies.</abstract><notes>Barat, Bhaswati&#xD;Wu, Anna M&#xD;Netherlands&#xD;Biomolecular engineering&#xD;Biomol Eng. 2007 Sep;24(3):283-91. Epub 2007 Feb 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17379573</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2008</custom3><custom4>2.575</custom4><electronic-resource-num>S1389-0344(07)00020-2 [pii]&#xD;10.1016/j.bioeng.2007.02.003</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1538</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1538</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rhee, T. K.</author><author>Ryu, R. K.</author><author>Bangash, A. K.</author><author>Wang, D.</author><author>Szolc-Kowalska, B.</author><author>Harris, K. R.</author><author>Sato, K. T.</author><author>Chrisman, H. B.</author><author>Vogelzang, R. L.</author><author>Paunesku, T.</author><author>Woloschak, G. E.</author><author>Larson, A. C.</author><author>Omary, R. A.</author></authors></contributors><auth-address>aDepartment of Radiology, Northwestern University Feinberg School of Medicine, 676 North St Clair St, Ste 800, Chicago, IL 60611.</auth-address><titles><title>Rabbit VX2 Tumors as an Animal Model of Uterine Fibroids and for Uterine Artery Embolization</title><secondary-title>J Vasc Interv Radiol</secondary-title></titles><periodical><full-title>J Vasc Interv Radiol</full-title></periodical><pages>411-8</pages><volume>18</volume><number>3</number><edition>2007/03/23</edition><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1051-0443 (Print)</isbn><accession-num>17377188</accession-num><abstract>Purpose To determine the suitability of the rabbit VX2 tumor animal model for uterine fibroids and uterine artery embolization (UAE). Materials and Methods The authors implanted and grew one uterine VX2 tumor per rabbit in six rabbits. UAE was performed by using 100-300 mum embolic particles and confirmed with x-ray digital subtraction angiography, magnetic resonance (MR) imaging, and necropsy. Unenhanced and contrast medium-enhanced MR images of VX2 tumors were obtained before and after UAE. Relative MR signal-to noise-ratio (SNR) was measured in the uterine VX2 tumor and in normal uterine tissue before and after UAE and compared by using a paired t-test (P = .05). Results VX2 uterine tumors were successfully grown, and both VX2 tumor presence in the uterus and UAE were seen angiographically and confirmed with necropsy in all six rabbits. Statistically significant reductions in relative SNRs were measured in tumors (SNR before UAE, 15.3 +/- 5.15; SNR after UAE, 3.84 +/- 3.94; P &lt; .0001). No statistically significant decrease in SNR was measured in normal uterine tissue before and after UAE (P = .63 for the right uterine horn and P = .93 for the left uterine horn). Conclusion Rabbit VX2 uterine tumors may be a suitable animal model of uterine fibroids and UAE.</abstract><notes>Rhee, Thomas K&#xD;Ryu, Robert K&#xD;Bangash, Affaan K&#xD;Wang, Dingxin&#xD;Szolc-Kowalska, Barbara&#xD;Harris, Kathleen R&#xD;Sato, Kent T&#xD;Chrisman, Howard B&#xD;Vogelzang, Robert L&#xD;Paunesku, Tatjana&#xD;Woloschak, Gayle E&#xD;Larson, Andrew C&#xD;Omary, Reed A&#xD;United States&#xD;Journal of vascular and interventional radiology : JVIR&#xD;J Vasc Interv Radiol. 2007 Mar;18(3):411-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17377188</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>2.956</custom4><electronic-resource-num>18/3/411 [pii]&#xD;10.1016/j.jvir.2007.01.013</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1469</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1469</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Neubauer, A. M.</author><author>Caruthers, S. D.</author><author>Hockett, F. D.</author><author>Cyrus, T.</author><author>Robertson, J. D.</author><author>Allen, J. S.</author><author>Williams, T. D.</author><author>Fuhrhop, R. W.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Washington University, St. Louis, MO 63108, USA.</auth-address><titles><title>Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents</title><secondary-title>J Cardiovasc Magn Reson</secondary-title></titles><periodical><full-title>J Cardiovasc Magn Reson</full-title></periodical><pages>565-73</pages><volume>9</volume><number>3</number><edition>2007/03/17</edition><keywords><keyword>Animals</keyword><keyword>Contrast Media</keyword><keyword>Coronary Disease/*diagnosis</keyword><keyword>Emulsions</keyword><keyword>Fluorine Radioisotopes/*diagnostic use</keyword><keyword>Fluorocarbons/*diagnostic use</keyword><keyword>Gadolinium DTPA/*analogs &amp; derivatives/diagnostic use</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>Magnetic Resonance Angiography/*methods</keyword><keyword>Nanoparticles/*diagnostic use</keyword><keyword>Oleic Acids/*diagnostic use</keyword><keyword>Phantoms, Imaging</keyword><keyword>Rabbits</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1097-6647 (Print)</isbn><accession-num>17365236</accession-num><abstract>While the current gold standard for coronary imaging is X-ray angiography, evidence is accumulating that it may not be the most sensitive technique for detecting unstable plaque. Other imaging modalities, such as cardiovascular magnetic resonance (CMR), can be used for plaque characterization, but suffer from long scan and reconstruction times for determining regions of stenosis. We have developed an intravascular fluorinated contrast agent that can be used for angiography with cardiovascular magnetic resosnace at clinical field strengths (1.5 T). This liquid perfluorocarbon nanoparticle contains a high concentration of fluorine atoms that can be used to generate contrast on 19F MR images without any competing background signal from surrounding tissues. By using a perfluorocarbon with 20 equivalent fluorine molecules, custom-built RF coils, a modified clinical scanner, and an efficient steady-state free procession sequence, we demonstrate the use of this agent for angiography of small vessels in vitro, ex vivo, and in vivo. The surprisingly high signal generated with very short scan times and low doses of perfluorocarbon indicates that this technique may be useful in clinical settings when coupled with advanced imaging strategies.</abstract><notes>Neubauer, Anne M&#xD;Caruthers, Shelton D&#xD;Hockett, Franklin D&#xD;Cyrus, Tillman&#xD;Robertson, J David&#xD;Allen, J Stacy&#xD;Williams, Todd D&#xD;Fuhrhop, Ralph W&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;United States&#xD;Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance&#xD;J Cardiovasc Magn Reson. 2007;9(3):565-73.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17365236</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>2.327</custom4><electronic-resource-num>772835296 [pii]&#xD;10.1080/10976640600945481</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1728</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1728</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Winter, P. M.</author><author>Cai, K.</author><author>Caruthers, S. D.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Medicine and Biomedical Engineering, C-TRAIN Group, St. Louis, MO 63108, USA. patrick@cvu.wustl.edu</auth-address><titles><title>Emerging nanomedicine opportunities with perfluorocarbon nanoparticles</title><secondary-title>Expert Rev Med Devices</secondary-title></titles><periodical><full-title>Expert Rev Med Devices</full-title></periodical><pages>137-45</pages><volume>4</volume><number>2</number><edition>2007/03/16</edition><keywords><keyword>Contrast Media</keyword><keyword>Drug Carriers/*chemistry</keyword><keyword>Drug Delivery Systems/*trends</keyword><keyword>Fluorocarbons/*diagnostic use/*therapeutic use</keyword><keyword>Forecasting</keyword><keyword>Magnetic Resonance Imaging/methods</keyword><keyword>Nanomedicine/*trends</keyword><keyword>Nanoparticles/*diagnostic use/*therapeutic use</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1743-4440 (Print)</isbn><accession-num>17359221</accession-num><abstract>Perfluorocarbon (PFC) nanoparticles can serve as a platform technology for molecular imaging and targeted drug-delivery applications. These nanoparticles are approximately 250 nm in diameter and are encapsulated in a phospholipid shell, which provides an ideal surface for the incorporation of targeting ligands, imaging agents and drugs. For molecular imaging, PFC nanoparticles can carry very large payloads of gadolinium to detect pathological biomarkers with magnetic resonance imaging. A variety of different epitopes, including alpha(v)beta(3)-integrin, tissue factor and fibrin, have been imaged using nanoparticles formulated with appropriate antibodies or peptidomimentics as targeting ligands. Lipophilic drugs can also be incorporated into the outer lipid shell of nanoparticles for targeted delivery. Upon binding to the target cell, the drug is exchanged from the particle surfactant monolayer to the cell membrane through a novel process called &apos;contact facilitated drug delivery&apos;. By combining targeted molecular imaging and localized drug delivery, PFC nanoparticles provide diagnosis and therapy with a single agent.</abstract><notes>Winter, Patrick M&#xD;Cai, Kejia&#xD;Caruthers, Shelton D&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Co-07121/co/nci&#xD;Eb-01704/eb/nibib&#xD;Hl-42950/hl/nhlbi&#xD;Hl-59865/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;England&#xD;Expert review of medical devices&#xD;Expert Rev Med Devices. 2007 Mar;4(2):137-45.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17359221</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>1.519</custom4><electronic-resource-num>10.1586/17434440.4.2.137</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1519</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1519</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Price, N. D.</author><author>Trent, J.</author><author>El-Naggar, A. K.</author><author>Cogdell, D.</author><author>Taylor, E.</author><author>Hunt, K. K.</author><author>Pollock, R. E.</author><author>Hood, L.</author><author>Shmulevich, I.</author><author>Zhang, W.</author></authors></contributors><auth-address>Institute for Systems Biology, Seattle, WA 98103, USA.</auth-address><titles><title>Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>3414-9</pages><volume>104</volume><number>9</number><edition>2007/03/16</edition><keywords><keyword>Algorithms</keyword><keyword>Blotting, Western</keyword><keyword>Chromosomes, Human, Pair 9/*genetics</keyword><keyword>Computational Biology/methods</keyword><keyword>Diagnosis, Differential</keyword><keyword>Evaluation Studies</keyword><keyword>Gastrointestinal Stromal Tumors/classification/*genetics</keyword><keyword>Genetic Markers/genetics</keyword><keyword>Genomics/methods</keyword><keyword>Guanine Nucleotide Exchange Factors/*genetics</keyword><keyword>Humans</keyword><keyword>Leiomyosarcoma/classification/*genetics</keyword><keyword>Muscle Proteins/*genetics</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Open Reading Frames/*genetics</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb 27</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17360660</accession-num><abstract>Gastrointestinal stromal tumor (GIST) has emerged as a clinically distinct type of sarcoma with frequent overexpression and mutation of the c-Kit oncogene and a favorable response to imatinib mesylate [also known as STI571 (Gleevec)] therapy. However, a significant diagnostic challenge remains in the differentiation of GIST from leiomyosarcomas (LMSs). To improve on the diagnostic evaluation and to complement the immunohistochemical evaluation of these tumors, we performed a whole-genome gene expression study on 68 well characterized tumor samples. Using bioinformatic approaches, we devised a two-gene relative expression classifier that distinguishes between GIST and LMS with an accuracy of 99.3% on the microarray samples and an estimated accuracy of 97.8% on future cases. We validated this classifier by using RT-PCR on 20 samples in the microarray study and on an additional 19 independent samples, with 100% accuracy. Thus, our two-gene relative expression classifier is a highly accurate diagnostic method to distinguish between GIST and LMS and has the potential to be rapidly implemented in a clinical setting. The success of this classifier is likely due to two general traits, namely that the classifier is independent of data normalization and that it uses as simple an approach as possible to achieve this independence to avoid overfitting. We expect that the use of simple marker pairs that exhibit these traits will be of significant clinical use in a variety of contexts.</abstract><notes>Price, Nathan D&#xD;Trent, Jonathan&#xD;El-Naggar, Adel K&#xD;Cogdell, David&#xD;Taylor, Ellen&#xD;Hunt, Kelly K&#xD;Pollock, Raphael E&#xD;Hood, Leroy&#xD;Shmulevich, Ilya&#xD;Zhang, Wei&#xD;1k23ca109060-01/ca/nci&#xD;Ca-16672/ca/nci&#xD;P50 gm076547/gm/nigms&#xD;R01 ca098570-01/ca/nci&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3414-9. Epub 2007 Feb 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17360660</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>10.228</custom4><electronic-resource-num>0611373104 [pii]&#xD;10.1073/pnas.0611373104</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1773</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1773</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zabirnyk, O.</author><author>Yezhelyev, M.</author><author>Seleverstov, O.</author></authors></contributors><auth-address>Institute of Anatomy, University of Leipzig, Leipzig, Germany.</auth-address><titles><title>Nanoparticles as a novel class of autophagy activators</title><secondary-title>Autophagy</secondary-title></titles><periodical><full-title>Autophagy</full-title></periodical><pages>278-81</pages><volume>3</volume><number>3</number><edition>2007/03/14</edition><keywords><keyword>Animals</keyword><keyword>*Autophagy</keyword><keyword>Cell Line</keyword><keyword>Drug Delivery Systems</keyword><keyword>Environment</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>*Nanoparticles/administration &amp; dosage/chemistry</keyword><keyword>Quantum Dots</keyword></keywords><dates><year>2007</year><pub-dates><date>May-Jun</date></pub-dates></dates><isbn>1554-8627 (Print)</isbn><accession-num>17351332</accession-num><abstract>Nano-sized objects exist as engineered tools as well as natural or anthropogenic environmental factors. Recent progress in the field of nanotechnology allows for a deeper understanding of their impact on organisms. Recently, we showed that the size-dependent cell interaction with quantum dots is autophagy-mediated. The potential role of other endo- and exogenous nanoparticles in terms of autophagy is discussed here. Their physical properties should be taken into consideration while constructing delivery systems. Furthermore, we propose several models of targeted nanoparticles delivery. Autophagy can be considered as an additional mechanism providing intracellular selectivity for introduced nanoparticles.</abstract><notes>Zabirnyk, Olga&#xD;Yezhelyev, Maksym&#xD;Seleverstov, Oleksandr&#xD;United States&#xD;Autophagy&#xD;Autophagy. 2007 May-Jun;3(3):278-81. Epub 2007 May 31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17351332</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>4.657</custom4><electronic-resource-num>3916 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1108</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1108</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, L.</author><author>Marshall, T. W.</author><author>Uetrecht, A. C.</author><author>Schafer, D. A.</author><author>Bear, J. E.</author></authors></contributors><auth-address>Lineberger Comprehensive Cancer Center and Department of Cell and Developmental Biology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Coronin 1B coordinates Arp2/3 complex and cofilin activities at the leading edge</title><secondary-title>Cell</secondary-title></titles><periodical><full-title>Cell</full-title></periodical><pages>915-29</pages><volume>128</volume><number>5</number><edition>2007/03/14</edition><keywords><keyword>4-Butyrolactone/*analogs &amp; derivatives/genetics/metabolism</keyword><keyword>Actin Depolymerizing Factors/*metabolism</keyword><keyword>Actin-Related Protein 2-3 Complex/*metabolism</keyword><keyword>Actins/metabolism</keyword><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>*Cell Movement</keyword><keyword>Drosophila</keyword><keyword>Enzyme Inhibitors/pharmacology</keyword><keyword>Green Fluorescent Proteins/genetics/metabolism</keyword><keyword>Humans</keyword><keyword>Kymography</keyword><keyword>Okadaic Acid/pharmacology</keyword><keyword>Phosphoprotein Phosphatase/metabolism</keyword><keyword>Phosphorylation/drug effects</keyword><keyword>RNA Interference</keyword><keyword>Rats</keyword><keyword>Recombinant Proteins/genetics/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 9</date></pub-dates></dates><isbn>0092-8674 (Print)</isbn><accession-num>17350576</accession-num><abstract>Actin filament formation and turnover within the treadmilling actin filament array at the leading edge of migrating cells are interdependent and coupled, but the mechanisms coordinating these two activities are not understood. We report that Coronin 1B interacts simultaneously with Arp2/3 complex and Slingshot (SSH1L) phosphatase, two regulators of actin filament formation and turnover, respectively. Coronin 1B inhibits filament nucleation by Arp2/3 complex and this inhibition is attenuated by phosphorylation of Coronin 1B at Serine 2, a site targeted by SSH1L. Coronin 1B also directs SSH1L to lamellipodia where SSH1L likely regulates Cofilin activity via dephosphorylation. Accordingly, depleting Coronin 1B increases phospho-Cofilin levels, and alters lamellipodial dynamics and actin filament architecture at the leading edge. We conclude that Coronin 1B&apos;s coordination of filament formation by Arp2/3 complex and filament turnover by Cofilin is required for effective lamellipodial protrusion and cell migration.</abstract><notes>Cai, Liang&#xD;Marshall, Thomas W&#xD;Uetrecht, Andrea C&#xD;Schafer, Dorothy A&#xD;Bear, James E&#xD;1u54 ca 119343/ca/nci&#xD;Ca 16086/ca/nci&#xD;Gm 067222/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Cell&#xD;Cell. 2007 Mar 9;128(5):915-29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17350576</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>30.149</custom4><electronic-resource-num>S0092-8674(07)00132-8 [pii]&#xD;10.1016/j.cell.2007.01.031</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1724</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1724</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wickline, S. A.</author><author>Neubauer, A. M.</author><author>Winter, P. M.</author><author>Caruthers, S. D.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Department of Medicine, Washington University, St. Louis, Missouri 63110, USA. saw@wuphys.wustl.edu</auth-address><titles><title>Molecular imaging and therapy of atherosclerosis with targeted nanoparticles</title><secondary-title>J Magn Reson Imaging</secondary-title></titles><periodical><full-title>J Magn Reson Imaging</full-title></periodical><pages>667-80</pages><volume>25</volume><number>4</number><edition>2007/03/10</edition><keywords><keyword>*Atherosclerosis/diagnosis/therapy</keyword><keyword>*Contrast Media</keyword><keyword>Diagnostic Imaging/*methods</keyword><keyword>Humans</keyword><keyword>Nanomedicine/*methods</keyword><keyword>Nanoparticles/*diagnostic use/*therapeutic use</keyword><keyword>Neovascularization, Pathologic/diagnosis</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1053-1807 (Print)</isbn><accession-num>17347992</accession-num><abstract>Advances in bionanotechnology are poised to impact the field of cardiovascular diagnosis and therapy for decades to come. This review seeks to illustrate selected examples of newly developed diagnostic and therapeutic nanosystems that have been evaluated in experimental atherosclerosis, thrombosis, and vascular biology. We review a variety of nanotechnologies that are capable of detecting early cardiovascular pathology, as well as associated imaging approaches and conjunctive strategies for site-targeted treatment with nanoparticle delivery systems.</abstract><notes>Wickline, Samuel A&#xD;Neubauer, Anne M&#xD;Winter, Patrick M&#xD;Caruthers, Shelton D&#xD;Lanza, Gregory M&#xD;Eb-01704/eb/nibib&#xD;Hl-073646/hl/nhlbi&#xD;Hl-42950/hl/nhlbi&#xD;Hl-59865/hl/nhlbi&#xD;N01-co-07121/co/nci&#xD;U54-ca-119342/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Journal of magnetic resonance imaging : JMRI&#xD;J Magn Reson Imaging. 2007 Apr;25(4):667-80.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17347992</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>3.041</custom4><electronic-resource-num>10.1002/jmri.20866</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1264</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1264</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hsieh, C. L.</author><author>Xie, Z.</author><author>Yu, J.</author><author>Martin, W. D.</author><author>Datta, M. W.</author><author>Wu, G. J.</author><author>Chung, L. W.</author></authors></contributors><auth-address>Molecular Urology and Therapeutic Program, Department of Urology, Emory University School of Medicine, Atlanta, Georgia 30322, USA. chsieh2@emory.edu</auth-address><titles><title>Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model</title><secondary-title>Prostate</secondary-title></titles><periodical><full-title>Prostate</full-title></periodical><pages>685-91</pages><volume>67</volume><number>7</number><edition>2007/03/08</edition><keywords><keyword>Animals</keyword><keyword>Antigens, Viral, Tumor/genetics/metabolism</keyword><keyword>Bone Neoplasms/diagnosis/genetics/secondary</keyword><keyword>Disease Models, Animal</keyword><keyword>Disease Progression</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Luciferases/genetics/*metabolism</keyword><keyword>Luminescent Proteins/genetics/*metabolism</keyword><keyword>Lymphatic Metastasis/diagnosis/genetics/pathology</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>Neoplasm Metastasis/diagnosis/genetics/*pathology</keyword><keyword>Prostate-Specific Antigen/genetics/metabolism</keyword><keyword>Prostatic Neoplasms/genetics/*metabolism/pathology</keyword><keyword>Receptors, Androgen/genetics/*metabolism</keyword><keyword>Receptors, Tumor Necrosis Factor, Member 25/genetics/*metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>May 15</date></pub-dates></dates><isbn>0270-4137 (Print)</isbn><accession-num>17342752</accession-num><abstract>BACKGROUND: We previously established a bioluminescent transgenic mouse model, sPSA-Luc, with luciferase gene expression restricted to the prostate under the control of the supra prostate-specific antigen (sPSA) promoter. We now assess the feasibility of generating bigenic mice, TRAMP-Luc, with the sPSA-Luc as the founder strain crossbred with TRAMP (transgenic adenocarcinoma mouse prostate) mice, to evaluate non-invasively the metastatic potential of prostate tumors. METHODS: TRAMP-Luc mice were obtained as [C57BL/6 TRAMP x FVB sPSA-Luc] F1 offspring. Tumor development in 10 TRAMP-Luc males was followed by bioluminescence imaging from 8 to 24 weeks of age. Immunohistochemical (IHC) staining for T antigen (Tg), androgen receptor (AR), luciferase and/or pathological analysis verified the tumor distribution in the imaged tissues including prostate gland, lymph node and bone. RESULTS: Group I animals that presented with no grossly visible tumors showed prostate-confined bioluminescence with slightly increased signal intensity with age. Group II animals that developed large tumors displayed a widely distributed and biphasic bioluminescence pattern. The peak was reached between 10 and 14 weeks of age, then markedly decreased or even disappeared beyond week 16, except for one mouse that showed an increased bioluminescence signal at the jaw bone and hind limbs at week 22. These tumors were shown by IHC to contain Tg but lost AR and luciferase beyond week 16 in poorly differentiated prostate tumors. CONCLUSION: A direct correlation between bioluminescence emission and AR expression was found in TRAMP-Luc tumor progression model. This model allows non-invasive imaging of prostate cancer metastases to bone and soft tissues.</abstract><notes>Hsieh, Chia-Ling&#xD;Xie, Zhihui&#xD;Yu, Jie&#xD;Martin, W David&#xD;Datta, Milton W&#xD;Wu, Guang-Jer&#xD;Chung, Leland W K&#xD;1p01ca098912-01/ca/nci&#xD;1u54ca119338/ca/nci&#xD;5p20gm072069/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The Prostate&#xD;Prostate. 2007 May 15;67(7):685-91.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17342752</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>3.258</custom4><electronic-resource-num>10.1002/pros.20510</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1620</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1620</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sosnovik, D. E.</author><author>Nahrendorf, M.</author><author>Deliolanis, N.</author><author>Novikov, M.</author><author>Aikawa, E.</author><author>Josephson, L.</author><author>Rosenzweig, A.</author><author>Weissleder, R.</author><author>Ntziachristos, V.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. sosnovik@nmr.mgh.harvard.edu</auth-address><titles><title>Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo</title><secondary-title>Circulation</secondary-title></titles><periodical><full-title>Circulation</full-title></periodical><pages>1384-91</pages><volume>115</volume><number>11</number><edition>2007/03/07</edition><keywords><keyword>Animals</keyword><keyword>Carbocyanines</keyword><keyword>Disease Models, Animal</keyword><keyword>Macrophages/*pathology</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Myocardial Infarction/immunology/*pathology</keyword><keyword>Myocardium/immunology/*pathology</keyword><keyword>Tomography, Optical/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 20</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>17339546</accession-num><abstract>BACKGROUND: Fluorescence imaging of the heart is currently limited to invasive ex vivo or in vitro applications. We hypothesized that the adaptation of advanced transillumination and tomographic techniques would allow noninvasive fluorescence images of the heart to be acquired in vivo and be coregistered with in vivo cardiac magnetic resonance images. METHODS AND RESULTS: The uptake of the magnetofluorescent nanoparticle CLIO-Cy5.5 by macrophages in infarcted myocardium was studied. Ligation of the left coronary artery was performed in 12 mice and sham surgery in 7. The mice were injected, 48 hours after surgery, with 3 to 20 mg of iron per kilogram of CLIO-Cy5.5. Magnetic resonance imaging and fluorescence molecular tomography were performed 48 hours later. An increase in magnetic resonance imaging contrast-to-noise ratio, indicative of myocardial probe accumulation, was seen in the anterolateral walls of the infarcted mice but not in the sham-operated mice (23.0+/-2.7 versus 5.43+/-2.4; P&lt;0.01). Fluorescence intensity over the heart was also significantly greater in the fluorescence molecular tomography images of the infarcted mice (19.1+/-5.2 versus 5.3+/-1.4; P&lt;0.05). The uptake of CLIO-Cy5.5 by macrophages infiltrating the infarcted myocardium was confirmed by fluorescence microscopy and immunohistochemistry. CONCLUSIONS: Noninvasive imaging of myocardial macrophage infiltration has been shown to be possible by both fluorescence tomography and magnetic resonance imaging. This could be of significant value in both the research and clinical settings. The techniques developed could also be used to image other existing fluorescent and magnetofluorescent probes and could significantly expand the role of fluorescence imaging in the heart.</abstract><notes>Sosnovik, David E&#xD;Nahrendorf, Matthias&#xD;Deliolanis, Nikolaos&#xD;Novikov, Mikhail&#xD;Aikawa, Elena&#xD;Josephson, Lee&#xD;Rosenzweig, Anthony&#xD;Weissleder, Ralph&#xD;Ntziachristos, Vasilis&#xD;K08 HL079984/HL/United States NHLBI&#xD;R01EB000750/EB/United States NIBIB&#xD;U01 HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Circulation&#xD;Circulation. 2007 Mar 20;115(11):1384-91. Epub 2007 Mar 5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17339546</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>13.538</custom4><electronic-resource-num>CIRCULATIONAHA.106.663351 [pii]&#xD;10.1161/CIRCULATIONAHA.106.663351</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2052</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2052</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hsu, A. R.</author><author>Cai, W.</author><author>Veeravagu, A.</author><author>Mohamedali, K. A.</author><author>Chen, K.</author><author>Kim, S.</author><author>Vogel, H.</author><author>Hou, L. C.</author><author>Tse, V.</author><author>Rosenblum, M. G.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, California 94305-5484, USA.</auth-address><titles><title>Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel</title><secondary-title>J Nucl Med</secondary-title></titles><periodical><full-title>J Nucl Med</full-title></periodical><pages>445-54</pages><volume>48</volume><number>3</number><edition>2007/03/03</edition><keywords><keyword>Animals</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Copper Radioisotopes/diagnostic use</keyword><keyword>Dideoxynucleosides/diagnostic use</keyword><keyword>Glioblastoma/diagnosis/ drug therapy</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>Plant Proteins/metabolism/ therapeutic use</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Receptors, Vascular Endothelial Growth Factor/analysis</keyword><keyword>Recombinant Fusion Proteins/metabolism/ therapeutic use</keyword><keyword>Ribosome Inactivating Proteins, Type 1</keyword><keyword>Vascular Endothelial Growth Factor A/metabolism/ therapeutic use</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>17332623</accession-num><abstract>Vascular endothelial growth factor A (VEGF-A) and its receptors, Flt-1/FLT-1 (VEGFR-1) and Flk-1/KDR (VEGFR-2), are key regulators of tumor angiogenesis and tumor growth. The purpose of this study was to determine the antiangiogenic and antitumor efficacies of a vasculature-targeting fusion toxin (VEGF(121)/rGel) composed of the VEGF-A isoform VEGF(121) linked with a G(4)S tether to recombinant plant toxin gelonin (rGel) in an orthotopic glioblastoma mouse model by use of noninvasive in vivo bioluminescence imaging (BLI), MRI, and PET. METHODS: Tumor-bearing mice were randomized into 2 groups and balanced according to BLI and MRI signals. PET with (64)Cu-1,4,7,10-tetraazacyclododedane-N,N&apos;,N&apos;&apos;,N&apos;&apos;&apos;-tetraacetic acid (DOTA)-VEGF(121)/rGel was performed before VEGF(121)/rGel treatment. (18)F-Fluorothymidine ((18)F-FLT) scans were obtained before and after treatment to evaluate VEGF(121)/rGel therapeutic efficacy. In vivo results were confirmed with ex vivo histologic and immunohistochemical analyses. RESULTS: Logarithmic transformation of peak BLI tumor signal intensity revealed a strong correlation with MRI tumor volume (r = 0.89, n = 14). PET with (64)Cu-DOTA-VEGF(121)/rGel before treatment revealed a tumor accumulation (mean +/- SD) of 11.8 +/- 2.3 percentage injected dose per gram at 18 h after injection, and the receptor specificity of the tumor accumulation was confirmed by successful blocking of the uptake in the presence of an excess amount of VEGF(121). PET with (18)F-FLT revealed significant a decrease in tumor proliferation in VEGF(121)/rGel-treated mice compared with control mice. Histologic analysis revealed specific tumor neovasculature damage after treatment with 4 doses of VEGF(121)/rGel; this damage was accompanied by a significant decrease in peak BLI tumor signal intensity. CONCLUSION: The results of this study suggest that future clinical multimodality imaging and therapy with VEGF(121)/rGel may provide an effective means to prospectively identify patients who will benefit from VEGF(121)/rGel therapy and then stratify, personalize, and monitor treatment to obtain optimal survival outcomes.</abstract><notes>Hsu, Andrew R&#xD;Cai, Weibo&#xD;Veeravagu, Anand&#xD;Mohamedali, Khalid A&#xD;Chen, Kai&#xD;Kim, Sehoon&#xD;Vogel, Hannes&#xD;Hou, Lewis C&#xD;Tse, Victor&#xD;Rosenblum, Michael G&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2007 Mar;48(3):445-54.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.282</custom4><electronic-resource-num>48/3/445 [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2203</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2203</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Aslam, M.</author><author>Schultz, E. A.</author><author>Tao, S.</author><author>Meade, T.</author><author>Dravid, V. P.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, and the International Institute for Nanotechnology, Northwestern University, Evanston, Illinois 60208.</auth-address><titles><title>Synthesis of Amine-stabilized Aqueous Colloidal Iron Oxide Nanoparticles</title><secondary-title>Cryst Growth Des</secondary-title></titles><periodical><full-title>Cryst Growth Des</full-title></periodical><pages>471-475</pages><volume>7</volume><number>3</number><edition>2007/03/01</edition><dates><year>2007</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>1528-7483 (Print)</isbn><accession-num>19305647</accession-num><abstract>We demonstrate a simple one-step process for the synthesis of iron oxide nanoparticle aqueous colloids using the multifunctional molecule, dodecylamine (DDA), that electrostatically complexes with aqueous iron ions (one precursor Fe(2+) from FeCl(2)), reduces them, and subsequently caps the nanoparticles. The iron oxide particles thus synthesized are of the face-centered cubic (FCC) phase with high degree of monodispersity with appropriate concentration of amine capping molecular layer. The aqueous magnetic nanocrystalline colloids were characterized by TEM, XRD, XPS, TGA/DTA and FTIR spectroscopy techniques. The relaxivity, stability, and hydrodynamic size of the nanoparticles were investigated for potential application in magnetic resonance imaging (MRI). The magnetic properties were also studied by using a superconducting quantum interference device (SQUID) magnetometer at room temperature. We believe that such simple one-step synthesis of biocompatible aqueous nanomagnetic colloids will have viable applications in biomedical imaging, diagnostics and therapeutics.</abstract><notes>U54 CA119341-01/NCI NIH HHS/United States&#xD;U54 CA119341-02/NCI NIH HHS/United States&#xD;U54 CA119341-03/NCI NIH HHS/United States&#xD;Crystal growth &amp; design&#xD;Cryst Growth Des. 2007 Mar 1;7(3):471-475.</notes><urls></urls><custom1>CNPP - Roswell Park Cancer Institute</custom1><custom2>2659353</custom2><custom3>NIHMS63318</custom3><custom4>4.491</custom4><electronic-resource-num>10.1021/cg060656p [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1766</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1766</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yong, K. T.</author><author>Qian, J.</author><author>Roy, I.</author><author>Lee, H. H.</author><author>Bergey, E. J.</author><author>Tramposch, K. M.</author><author>He, S.</author><author>Swihart, M. T.</author><author>Maitra, A.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, University at Buffalo, The State University of New York, Buffalo, New York 14260-4200, USA.</auth-address><titles><title>Quantum rod bioconjugates as targeted probes for confocal and two-photon fluorescence imaging of cancer cells</title><secondary-title>Nano Lett</secondary-title><alt-title>Nano letters</alt-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><alt-periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></alt-periodical><pages>761-5</pages><volume>7</volume><number>3</number><edition>2007/03</edition><keywords><keyword>Fluorescent Dyes</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Microscopy, Confocal</keyword><keyword>Microscopy, Electron</keyword><keyword>Microscopy, Fluorescence, Multiphoton</keyword><keyword>Molecular Probes/chemistry</keyword><keyword>Nanotechnology</keyword><keyword>Nanotubes/*chemistry/ultrastructure</keyword><keyword>*Quantum Dots</keyword><keyword>Transferrin/pharmacokinetics</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17288490</accession-num><abstract>Live cell imaging using CdSe/CdS/ZnS quantum rods (QRs) as targeted optical probes is reported. The QRs, synthesized in organic media using a binary surfactant mixture, were dispersed in aqueous media using mercaptoundecanoic acid (MUA) and lysine. Transferrin (Tf) was linked to the QRs to produce QR-Tf bioconjugates that were used for targeted in vitro delivery to a human cancer cell line. Confocal and two-photon imaging were used to confirm receptor-mediated uptake of QR-Tf conjugates into the HeLa cells, which overexpress the transferrin receptor (TfR). Uptake was not observed with QRs that lacked Tf functionalization or with cells that were presaturated with free Tf and then treated with Tf-functionalized QRs.</abstract><notes>Ca104492/ca/nci&#xD;R01ca119397/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17288490 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2007</custom3><custom4>12.189</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1711</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1711</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, Z. L.</author></authors></contributors><auth-address>Wang, ZL&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA 30332 USA&#xD;Georgia Inst Technol, Sch Mat Sci &amp; Engn, Atlanta, GA 30332 USA</auth-address><titles><title>Nanopiezotronics</title><secondary-title>Advanced Materials</secondary-title></titles><periodical><full-title>Advanced Materials</full-title></periodical><pages>889-892</pages><volume>19</volume><number>6</number><edition>2007/03</edition><keywords><keyword>nanowire</keyword><keyword>arrays</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 19</date></pub-dates></dates><isbn>0935-9648</isbn><accession-num>ISI:000245382100023</accession-num><abstract>This article introduces the fundamental principal nanopiezotronics which utilizes the coupled piezoelectric and semiconducting properties of nanowires and nanobelts for designing and fabricating electronic devices and components, such as field effect transistors and diodes. The physics of nanopiezotronics is based on the principle of a nanowire nanogenerator that converts mechanical energy into electric energy. It is anticipated to have a wide range of applications in electromechanical coupled electronics, sensing, harvesting/recycling energy from the environment, and self-powered nanosystems.</abstract><notes>152SM&#xD;Times Cited:3&#xD;Cited References Count:10</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000245382100023</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>10.231</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1523</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1523</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Qian, M. C.</author><author>Ong, S. V.</author><author>Khanna, S. N.</author><author>Knickelbein, M. B.</author></authors></contributors><auth-address>Khanna, SN&#xD;Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA&#xD;Virginia Commonwealth Univ, Dept Phys, Richmond, VA 23284 USA&#xD;Argonne Natl Lab, Div Chem, Argonne, IL 60439 USA</auth-address><titles><title>Magnetic endohedral metallofullerenes with floppy interiors</title><secondary-title>Physical Review B</secondary-title></titles><periodical><full-title>Physical Review B</full-title></periodical><pages>-</pages><volume>75</volume><number>10</number><edition>2007/03</edition><keywords><keyword>mri contrast agents</keyword><keyword>nickel clusters</keyword><keyword>transition-metal</keyword><keyword>molecular-beam</keyword><keyword>gd3n-at-c-80</keyword><keyword>temperature</keyword><keyword>gd3n</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1098-0121</isbn><accession-num>ISI:000245329100069</accession-num><abstract>It is shown that Gd3N@C-80 is a highly magnetic and very stable motif that allows enhanced contrast magnetic resonance imaging and electric dipole moment with potential for cancer treatment. Using a synergistic approach combining Stern-Gerlach experiments in beams and first-principles electronic structure studies, it is demonstrated that an isolated Gd3N has a ground state spin moment of 23 mu(B) followed by a noncollinear state of 17.2 mu(B) only 88 meV above the ground state. The large moment is largely due to localized f electrons. As a Gd3N is embedded inside a C-80 cage, the localized f electrons maintain the magnetic character while the hybridization between the s, d states of isolated Gd3N and p states of C-80 leads to a strongly bound motif with an interaction energy of 13.63 eV and a large highest-occupied-molecular-orbital-lowest-unoccupied-molecular-orbital gap of 1.48 eV. Gd3N@C-80 is further shown to possess two isomers corresponding to the location of the N atom on either side of the Gd-3 triangle with an appreciable electric dipole moment and a low barrier of 91 meV for transition between them offering potential for a fluctuating dipole.</abstract><notes>151ZF&#xD;Times Cited:1&#xD;Cited References Count:40</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000245329100069</url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2007</custom3><custom4>3.284</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1479</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1479</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Oh, P.</author><author>Borgstrom, P.</author><author>Witkiewicz, H.</author><author>Li, Y.</author><author>Borgstrom, B. J.</author><author>Chrastina, A.</author><author>Iwata, K.</author><author>Zinn, K. R.</author><author>Baldwin, R.</author><author>Testa, J. E.</author><author>Schnitzer, J. E.</author></authors></contributors><auth-address>Sidney Kimmel Cancer Center, 10905 Road to the Cure, San Diego, California 92121, USA.</auth-address><titles><title>Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung</title><secondary-title>Nat Biotechnol</secondary-title><alt-title>Nature biotechnology</alt-title></titles><periodical><full-title>Nat Biotechnol</full-title></periodical><alt-periodical><full-title>Nature Biotechnology</full-title></alt-periodical><pages>327-37</pages><volume>25</volume><number>3</number><edition>2007/03</edition><keywords><keyword>Aminopeptidases/*immunology</keyword><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/biosynthesis/*pharmacokinetics</keyword><keyword>Caveolae/*immunology/physiology</keyword><keyword>Caveolin 1/metabolism</keyword><keyword>Drug Carriers</keyword><keyword>Drug Delivery Systems</keyword><keyword>*Endocytosis</keyword><keyword>Endothelium, Vascular/*immunology/physiology</keyword><keyword>Lung/blood supply/*immunology/physiology</keyword><keyword>Mice</keyword><keyword>Nanoparticles</keyword><keyword>Proteomics/methods</keyword><keyword>Radionuclide Imaging</keyword><keyword>Rats</keyword><keyword>Tomography, Emission-Computed, Single-Photon</keyword><keyword>*Video Recording</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1087-0156 (Print)</isbn><accession-num>17334358</accession-num><abstract>How effectively and quickly endothelial caveolae can transcytose in vivo is unknown, yet critical for understanding their function and potential clinical utility. Here we use quantitative proteomics to identify aminopeptidase P (APP) concentrated in caveolae of lung endothelium. Electron microscopy confirms this and shows that APP antibody targets nanoparticles to caveolae. Dynamic intravital fluorescence microscopy reveals that targeted caveolae operate effectively as pumps, moving antibody within seconds from blood across endothelium into lung tissue, even against a concentration gradient. This active transcytosis requires normal caveolin-1 expression. Whole body gamma-scintigraphic imaging shows rapid, specific delivery into lung well beyond that achieved by standard vascular targeting. This caveolar trafficking in vivo may underscore a key physiological mechanism for selective transvascular exchange and may provide an enhanced delivery system for imaging agents, drugs, gene-therapy vectors and nanomedicines. &apos;In vivo proteomic imaging&apos; as described here integrates organellar proteomics with multiple imaging techniques to identify an accessible target space that includes the transvascular pumping space of the caveola.</abstract><notes>R01 hl074063/hl/nhlbi&#xD;R01 hl52766/hl/nhlbi&#xD;R01 hl58216/hl/nhlbi&#xD;R01ca104898/ca/nci&#xD;R24ca95893/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17334358 </url></related-urls></urls><custom1>CNPP - S.K.C.C.</custom1><custom3>2007</custom3><custom4>25.329</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1461</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1461</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Myc, A.</author><author>Majoros, I. J.</author><author>Thomas, T. P.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, Michigan 48109, USA.</auth-address><titles><title>Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells</title><secondary-title>Biomacromolecules</secondary-title><alt-title>Biomacromolecules</alt-title></titles><periodical><full-title>Biomacromolecules</full-title></periodical><alt-periodical><full-title>Biomacromolecules</full-title></alt-periodical><pages>13-8</pages><volume>8</volume><number>1</number><edition>2007/03</edition><keywords><keyword>*Apoptosis</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chromatography, Gel</keyword><keyword>Chromatography, High Pressure Liquid</keyword><keyword>Dendrimers/*chemistry</keyword><keyword>Drug Delivery Systems</keyword><keyword>Electrochemistry</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Humans</keyword><keyword>Hydrolysis</keyword><keyword>Jurkat Cells</keyword><keyword>Models, Chemical</keyword><keyword>Nanoparticles/chemistry</keyword><keyword>Nanotechnology/methods</keyword><keyword>Neoplasms/metabolism/*pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1525-7797 (Print)</isbn><accession-num>17206782</accession-num><abstract>Our previous studies have demonstrated the applicability of poly(amidoamine) (PAMAM) dendrimers as a platform for the targeted delivery of chemotherapeutic drugs both in vitro and in vivo. To monitor the rate and extent of cell-killing caused by the delivered chemotherapeutic drug, we wished to analyze the degree of apoptosis in targeted cells on a real-time basis. As the apoptosis-regulating caspases are activated during the apoptotic process, several caspase-hydrolyzable, fluorescence resonance energy transfer (FRET)-based substrates have been marketed for the detection of apoptosis. However, the applicability of these agents is limited because of their nonspecificity and the consequent high background fluorescence in tissues. Here we show the synthesis, characterization, and in vitro targeting of an engineered PAMAM nanodevice in which folic acid (FA) is conjugated as the targeting molecule and a caspase-specific FRET-based agent (PhiPhiLux G1D2) is conjugated as the apoptosis-detecting agent. This conjugate specifically targets FA-receptor-positive, KB cells. In these cells, the apoptosis-inducing agent staurosporine caused a 5-fold increase in the cellular fluorescence. These results show, for the first time, the potential applicability of a targeted apoptosis-measuring nanodevice, which could be used for simultaneously monitoring the apoptotic potential of a delivered drug.</abstract><notes>N01-cm-97065-32/cm/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17206782 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2007</custom3><custom4>4.658</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1444</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1444</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Meade, S. O.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Sailor, MJ&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Chem &amp; Biochem, La Jolla, CA 92093 USA</auth-address><titles><title>Microfabrication of freestanding porous silicon particles containing spectral barcodes</title><secondary-title>Physica Status Solidi-Rapid Research Letters</secondary-title></titles><periodical><full-title>Physica Status Solidi-Rapid Research Letters</full-title></periodical><pages>R71-R73</pages><volume>1</volume><number>2</number><edition>2007/03</edition><keywords><keyword>photonic crystals</keyword><keyword>microcarriers</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1862-6254</isbn><accession-num>ISI:000244882400013</accession-num><abstract>A method to microfabricate micron-scale freestanding porous silicon photonic crystal particles is described. An electrochemically prepared film of porous silicon on a crystalline silicon substrate is patterned with an SU8-25 photoresist, and the unmasked porous silicon is removed with a chlorine plasma reactive ion etch. Porous microparticles are then removed from the substrate by electropolishing. Scanning electron microscopy and microscopic reflection spectroscopy are used to characterize the geometry and optical properties of the freestanding particles.</abstract><notes>145RO&#xD;Times Cited:0&#xD;Cited References Count:7</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000244882400013</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>1.179</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1372</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1372</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, H.</author><author>Liu, Y.</author><author>Ham, D.</author><author>Westervelt, R. M.</author></authors></contributors><auth-address>Department of Physics, Harvard University, Cambridge, MA 02138, USA.</auth-address><titles><title>Integrated cell manipulation system--CMOS/microfluidic hybrid</title><secondary-title>Lab Chip</secondary-title><alt-title>Lab on a chip</alt-title></titles><periodical><full-title>Lab Chip</full-title></periodical><alt-periodical><full-title>Lab Chip</full-title><abbr-1>Lab on a chip</abbr-1></alt-periodical><pages>331-7</pages><volume>7</volume><number>3</number><edition>2007/03</edition><keywords><keyword>Catalysis</keyword><keyword>Microfluidics/*instrumentation</keyword><keyword>Miniaturization</keyword><keyword>*Systems Integration</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>17330164</accession-num><abstract>Manipulation of biological cells using a CMOS/microfluidic hybrid system is demonstrated. The hybrid system starts with a custom-designed CMOS (complementary metal-oxide semiconductor) chip fabricated in a semiconductor foundry. A microfluidic channel is post-fabricated on top of the CMOS chip to provide biocompatible environments. The motion of individual biological cells that are tagged with magnetic beads is directly controlled by the CMOS chip that generates microscopic magnetic field patterns using an on-chip array of micro-electromagnets. Furthermore, the CMOS chip allows high-speed and programmable reconfiguration of the magnetic fields, substantially increasing the manipulation capability of the hybrid system. Extending from previous work that verified the concept of the hybrid system, this paper reports a set of manipulation experiments with biological cells, which further confirms the advantage of the hybrid approach. To enhance the biocompatibility of the system, the microfluidic channel is redesigned and the temperature of the device is monitored by on-chip sensors. Combining microelectronics and microfluidics, the CMOS/microfluidic hybrid system presents a new model for a cell manipulation platform in biological and biomedical applications.</abstract><notes>Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17330164 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>7.000</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1343</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1343</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kommareddy, S.</author><author>Amiji, M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, Massachusetts 02115, USA.</auth-address><titles><title>Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery</title><secondary-title>Nanomedicine</secondary-title></titles><periodical><full-title>Nanomedicine</full-title></periodical><pages>32-42</pages><volume>3</volume><number>1</number><edition>2007/03</edition><keywords><keyword>Animals</keyword><keyword>DNA/*metabolism</keyword><keyword>Disulfides/*chemistry/metabolism</keyword><keyword>Electrostatics</keyword><keyword>Gelatin/*chemistry/metabolism</keyword><keyword>Glutathione/*metabolism</keyword><keyword>Green Fluorescent Proteins/metabolism</keyword><keyword>Mice</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Particle Size</keyword><keyword>Plasmids/metabolism</keyword><keyword>Polyethylene Glycols/*chemistry</keyword><keyword>Transfection/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1549-9642 (Electronic)</isbn><accession-num>17379167</accession-num><abstract>Poly(ethylene glycol) (PEG)-modified thiolated gelatin (PEG-SHGel) anoparticles were developed as a long-circulating passively targeted delivery system that responds to intracellular glutathione concentrations to enhance DNA delivery and transfection. Reporter plasmid expressing enhanced green fluorescent protein (EGFP-N1) was encapsulated in the nanoparticles. DNA-containing gelatin (Gel) and thiolated gelatin (SHGel) nanoparticles were found to have a size range of 220 to 250 nm, whereas surface modification with PEG resulted in particles with a slightly larger size range of 310 to 350 nm. PEG modification was confirmed by electron spectroscopy for chemical analysis (ESCA), where an increase in the ether peak intensities of the C1s spectra corresponds to the surface presence of ethylene oxide residues. In addition, the PEG-SHGel nanoparticles released encapsulate plasmid DNA in response to varying concentrations of glutathione (up to 5.0 mM GSH in phosphate-buffered saline, or PBS). The stability of the encapsulated DNA was confirmed by agarose gel electrophoresis. Finally, from the qualitative and quantitative results of in vitro transfection studies in murine fibroblast cells (NIH3T3), PEG-Gel and PEG-SHGel nanoparticles afforded the highest transfection efficiency of the reporter plasmid. The results of these studies show that PEG-modified thiolated gelatin nanoparticles could serve as a very efficient nanoparticulate vector for systemic DNA delivery to solid tumors where the cells are known to have significantly higher intracellular GSH concentrations.</abstract><notes>Eb-002027/eb/nibib&#xD;R01-ca095522/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;nanotechnology, biology, and medicine</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17379167 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>6.093</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1332</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1332</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, S.</author><author>Ohulchanskyy, T. Y.</author><author>Pudavar, H. E.</author><author>Pandey, R. K.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, Department of Chemistry, State University of New York, Buffalo, NY 14260-3000, USA.</auth-address><titles><title>Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy</title><secondary-title>J Am Chem Soc</secondary-title><alt-title>Journal of the American Chemical Society</alt-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><alt-periodical><full-title>Journal of the American Chemical Society</full-title></alt-periodical><pages>2669-75</pages><volume>129</volume><number>9</number><edition>2007/03</edition><keywords><keyword>Absorption</keyword><keyword>Antineoplastic Agents/*chemistry/pharmacology</keyword><keyword>Chlorophyll/analogs &amp; derivatives/chemistry/pharmacology</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Hela Cells/drug effects/pathology</keyword><keyword>Humans</keyword><keyword>Intracellular Space/pathology</keyword><keyword>Micelles</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>*Photochemotherapy</keyword><keyword>*Photons</keyword><keyword>Photosensitizing Agents/*chemistry/pharmacology</keyword><keyword>Precipitation</keyword><keyword>Singlet Oxygen/chemistry</keyword><keyword>Spectrometry, Fluorescence</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 7</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17288423</accession-num><abstract>We report energy-transferring organically modified silica nanoparticles for two-photon photodynamic therapy. These nanoparticles co-encapsulate two-photon fluorescent dye nanoaggregates as an energy up-converting donor and a photosensitizing PDT drug as an acceptor. They combine two features: (i) aggregation-enhanced two-photon absorption and emission properties of a novel two-photon dye and (ii) nanoscopic fluorescence resonance energy transfer between this nanoaggregate and a photosensitizer, 2-devinyl-2-(1-hexyloxyethyl)pyropheophorbide. Stable aqueous dispersions of the co-encapsulating nanoparticles (diameter &lt; or = 30 nm) have been prepared in the nonpolar interior of micelles by coprecipitating an organically modified silica sol with the photosensitizer and an excess amount of the two-photon dye which forms fluorescent aggregates by phase separation from the particle matrix. Using a multidisciplinary nanophotonic approach, we show: (i) indirect excitation of the photosensitizer through efficient two-photon excited intraparticle energy transfer from the dye aggregates in the intracellular environment of tumor cells and (ii) generation of singlet oxygen and in vitro cytotoxic effect in tumor cells by photosensitization under two-photon irradiation.</abstract><notes>R01 ca 119358-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17288423 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2007</custom3><custom4>8.256</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1178</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1178</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Devalapally, H.</author><author>Shenoy, D.</author><author>Little, S.</author><author>Langer, R.</author><author>Amiji, M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, USA.</auth-address><titles><title>Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model</title><secondary-title>Cancer Chemother Pharmacol</secondary-title><alt-title>Cancer chemotherapy and pharmacology</alt-title></titles><periodical><full-title>Cancer Chemother Pharmacol</full-title></periodical><pages>477-84</pages><volume>59</volume><number>4</number><edition>2007/03</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chemistry, Pharmaceutical</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Mice</keyword><keyword>*Nanoparticles</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Ovarian Neoplasms/*drug therapy</keyword><keyword>Paclitaxel/*administration &amp; dosage/adverse effects</keyword><keyword>Polyesters/*administration &amp; dosage</keyword><keyword>Polyethylene Glycols</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0344-5704 (Print)</isbn><accession-num>16862429</accession-num><abstract>PURPOSE: The objective of this study was to evaluate the anti-tumor efficacy and lack of systemic toxicity of paclitaxel when administered in pH-sensitive poly(ethylene oxide) (PEO)-modified poly(beta-amino ester) (PbAE) nanoparticles in mice bearing human ovarian adenocarcinoma (SKOV-3) xenograft. METHODS: Paclitaxel-encapsulated PEO-modified PbAE (PEO-PbAE) nanoparticles were prepared by the solvent displacement method. PEO-modified poly(epsilon-caprolactone) (PCL) (PEO-PCL) nanoparticles were used as a non pH-responsive control formulation. Efficacy studies were conducted in SKOV-3 tumor-bearing athymic (Nu/Nu) mice at an equivalent paclitaxel dose of 20 mg/kg with the control and nanoparticle formulations. Safety of the drug when administered in the control and nanoparticle formulation was determined from blood cell counts and changes in body weight of the animals. RESULTS: The formulated paclitaxel-containing PEO-PbAE and PEO-PCL nanoparticles had a particle size in the range of 100-200 nm and a surface charge of + 39.0 and - 30.8 mV, respectively. After intravenous administration of paclitaxel in these formulations, the tumor growth was inhibited significantly. Both of the formulated nanoparticles tested have shown improved therapeutic efficacy as compared to the paclitaxel aqueous solution. Additionally, significantly lower toxicity profile of paclitaxel was observed with PEO-modified nanoparticles as compared to the aqueous solution formulation CONCLUSION: PEO-modified PbAE nanoparticles are a unique pH-sensitive drug delivery system that elicits enhanced efficacy and safety profile in solid tumor therapy.</abstract><notes>R01-ca095522/ca/nci&#xD;R01-ca119617/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Germany</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16862429 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>2.477</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1068</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1068</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Baba, K.</author><author>Pudavar, H. E.</author><author>Roy, I.</author><author>Ohulchanskyy, T. Y.</author><author>Chen, Y.</author><author>Pandey, R. K.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, SUNY at Buffalo, Buffalo, NY 14260, USA.</auth-address><titles><title>New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug</title><secondary-title>Mol Pharm</secondary-title><alt-title>Molecular pharmaceutics</alt-title></titles><periodical><full-title>Mol Pharm</full-title></periodical><alt-periodical><full-title>Molecular Pharmaceutics</full-title></alt-periodical><pages>289-97</pages><volume>4</volume><number>2</number><edition>2007/03</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Survival</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>*Hydrophobicity</keyword><keyword>Light</keyword><keyword>Mice</keyword><keyword>Microscopy, Confocal</keyword><keyword>Molecular Structure</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Photochemotherapy/*methods</keyword><keyword>Photosensitizing Agents/*administration &amp; dosage/pharmacokinetics</keyword><keyword>Solubility</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar-Apr</date></pub-dates></dates><isbn>1543-8384 (Print)</isbn><accession-num>17266331</accession-num><abstract>A carrier-free method for delivery of a hydrophobic drug in its pure form, using nanocrystals (nanosized crystals), is proposed. To demonstrate this technique, nanocrystals of a hydrophobic photosensitizing anticancer drug, 2-devinyl-2-(1-hexyloxyethyl)pyropheophorbide (HPPH), have been synthesized using the reprecipitation method. The resulting drug nanocrystals were monodispersed and stable in aqueous dispersion, without the necessity of an additional stabilizer (surfactant). As shown by confocal microscopy, these pure drug nanocrystals were taken up by the cancer cells with high avidity. Though the fluorescence and photodynamic activity of the drug were substantially quenched in the form of nanocrystals in aqueous suspension, both these characteristics were recovered under in vitro and in vivo conditions. This recovery of drug activity and fluorescence is possibly due to the interaction of nanocrystals with serum albumin, resulting in conversion of the drug nanocrystals into the molecular form. This was confirmed by demonstrating similar recovery in presence of fetal bovine serum (FBS) or bovine serum albumin (BSA). Under similar treatment conditions, the HPPH in nanocrystal form or in 1% Tween-80/water formulation showed comparable in vitro and in vivo efficacy.</abstract><notes>P30 ca16056/ca/nci&#xD;R01 ca119358/ca/nci&#xD;Evaluation Studies&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17266331 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2007</custom3><custom4>4.388</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1047</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1047</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Adair, C.</author><author>Woods, M.</author><author>Zhao, P.</author><author>Pasha, A.</author><author>Winter, P. M.</author><author>Lanza, G. M.</author><author>Athey, P.</author><author>Sherry, A. D.</author><author>Kiefer, G. E.</author></authors></contributors><auth-address>Macrocyclics, 2110 Research Row, STE 425, Dallas, TX 75235, USA.</auth-address><titles><title>Spectral properties of a bifunctional PARACEST europium chelate: an intermediate for targeted imaging applications</title><secondary-title>Contrast Media Mol Imaging</secondary-title></titles><periodical><full-title>Contrast Media Mol Imaging</full-title></periodical><pages>55-8</pages><volume>2</volume><number>1</number><edition>2007/02/28</edition><keywords><keyword>Chelating Agents/chemistry/diagnostic use</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Heterocyclic Compounds, 1-Ring/*chemistry/*diagnostic use</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Organometallic Compounds/*chemistry/*diagnostic use</keyword><keyword>Spectrum Analysis</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1555-4317 (Electronic)</isbn><accession-num>17326038</accession-num><abstract>This report describes a preliminary study to investigate the effect of structural variations in a bifunctional ligand being developed for targeted PARACEST applications. Utilizing Eu-DOTA-4AmCE as the functional PARACEST core, a nitro-aromatic functionality was incorporated to provide the point for conjugation. This intermediate possesses a coordinated water proton signal at 57 ppm which upon saturation produces a 22% decrease in bulk water signal intensity using 10 mM agent. Curve fitting analysis of the CEST spectrum to an exchange model based upon modified Bloch equations gave an estimate of 687 +/- 100 micros for the bound water lifetime (tau(m)). Although substantially longer than the 382 micros observed for the parent chelate structure, this water exchange rate remains in the necessary window to produce a significant CEST effect. These findings demonstrate the need to recognize the influence of bifunctional linkers on water exchange rates in lanthanide complexes of this type and the potential for using this functionality as a means of fine-tuning PARACEST performance.</abstract><notes>Adair, Christopher&#xD;Woods, Mark&#xD;Zhao, Piyu&#xD;Pasha, Azhar&#xD;Winter, Patrick M&#xD;Lanza, Gregory M&#xD;Athey, Phillip&#xD;Sherry, A Dean&#xD;Kiefer, Garry E&#xD;United States&#xD;Contrast media &amp; molecular imaging&#xD;Contrast Media Mol Imaging. 2007 Jan;2(1):55-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17326038</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>1.478</custom4><electronic-resource-num>10.1002/cmmi.125</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1357</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1357</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kuick, R.</author><author>Misek, D. E.</author><author>Monsma, D. J.</author><author>Webb, C. P.</author><author>Wang, H.</author><author>Peterson, K. J.</author><author>Pisano, M.</author><author>Omenn, G. S.</author><author>Hanash, S. M.</author></authors></contributors><auth-address>Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, MI, USA.</auth-address><titles><title>Discovery of cancer biomarkers through the use of mouse models</title><secondary-title>Cancer Lett</secondary-title></titles><periodical><full-title>Cancer Lett</full-title></periodical><pages>40-8</pages><volume>249</volume><number>1</number><edition>2007/02/27</edition><keywords><keyword>Animals</keyword><keyword>*Disease Models, Animal</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Neoplasm Proteins/metabolism</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neoplasms/*metabolism</keyword><keyword>Proteomics</keyword><keyword>RNA, Messenger/metabolism</keyword><keyword>*Tumor Markers, Biological</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr 28</date></pub-dates></dates><isbn>0304-3835 (Print)</isbn><accession-num>17320282</accession-num><abstract>Although our understanding of the molecular pathogenesis of common types of cancer has improved considerably, the development of effective strategies for cancer diagnosis and treatment have lagged behind. Mouse models of cancer potentially represent an efficient means for uncovering diagnostic markers as genetic alterations associated with human tumors can be engineered in mice. In addition, defined stages of tumor development, breeding conditions, and blood sampling can all be controlled and standardized to limit heterogeneity. Alternatively human cancer cells can be injected into mice and tumor development monitored in xenotransplants. Mouse-based studies promise to elucidate a repertoire of protein changes that occur in blood and biological fluids during tumor development. This is illustrated in a study in which we have applied a three-dimensional intact protein analysis system (IPAS) to elucidate detectable protein changes in serum from immunodeficient mice with lung xenografts from orthotopically implanted human A549 lung adenocarcinoma cells. With sufficiently detailed protein sequence identifications, the observed protein changes can be attributed to either the host mouse or the human tumor cells. It is noteworthy that the majority of increases identified have corresponded to relatively abundant serum proteins, some of which have previously been reported as increased in the sera of cancer patients. Proteomic studies of mouse models of cancer allow assessment of the range of changes in plasma proteins that occur with tumor development and may lead to the identification of potential cancer markers applicable to humans.</abstract><notes>Kuick, Rork&#xD;Misek, David E&#xD;Monsma, David J&#xD;Webb, Craig P&#xD;Wang, Hong&#xD;Peterson, Kelli J&#xD;Pisano, Michael&#xD;Omenn, Gilbert S&#xD;Hanash, Samir M&#xD;Review&#xD;Ireland&#xD;Cancer letters&#xD;Cancer Lett. 2007 Apr 28;249(1):40-8. Epub 2007 Feb 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17320282</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>3.398</custom4><electronic-resource-num>S0304-3835(06)00700-2 [pii]&#xD;10.1016/j.canlet.2006.12.032</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1186</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1186</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Duan, H.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Emory University, Atlanta, Georgia, USA.</auth-address><titles><title>Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>3333-8</pages><volume>129</volume><number>11</number><edition>2007/02/27</edition><keywords><keyword>Cadmium Compounds/chemistry</keyword><keyword>Cell Membrane/metabolism</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Coated Materials, Biocompatible/*chemistry/*pharmacokinetics/pharmacology</keyword><keyword>Endosomes/*metabolism</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Polyethylene Glycols/*chemistry/pharmacokinetics/pharmacology</keyword><keyword>Polyethyleneimine/*chemistry/pharmacokinetics/pharmacology</keyword><keyword>*Quantum Dots</keyword><keyword>Selenium Compounds/chemistry</keyword><keyword>Sulfides/chemistry</keyword><keyword>Surface Properties</keyword><keyword>Zinc Compounds/chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 21</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17319667</accession-num><abstract>We report the development of cell-penetrating quantum dots (QDs) based on the use of multivalent and endosome-disrupting (endosomolytic) surface coatings. Hyperbranched copolymer ligands such as polyethylene glycol (PEG) grafted polyethylenimine (PEI-g-PEG) are found to encapsulate and solubilize luminescent quantum dots through direct ligand-exchange reactions. Because of the positive charges and a &quot;proton sponge effect&quot; associated with multivalent amine groups, this class of ligand-exchanged QDs is able to penetrate cell membranes and is also able to disrupt endosomal organelles in living cells. The grafted PEG segment is essential for reducing the cytotoxicity of PEI as well as for improving the overall nanoparticle stability and biocompatibility. In comparison with previous QDs encapsulated with amphiphilic polymers, the cell-penetrating QDs are smaller in size and are considerably more stable in acidic environments. Cellular uptake and imaging studies reveal that the number of PEG grafts per PEI molecule has a pronounced effect on the intracellular pathways of internalized QDs. In particular, QDs coated with PEI-g-PEG2 are rapidly internalized by endocytosis, and are initially stored in vesicles, followed by slow endosomal escape and release into the cytoplasm. These insights are important toward the design and development of nanoparticle agents for intracellular imaging and therapeutic applications.</abstract><notes>Duan, Hongwei&#xD;Nie, Shuming&#xD;P20 gm072069/gm/nigms&#xD;R01 ca108468/ca/nci&#xD;U01hl080711/hl/nhlbi&#xD;U54ca119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Mar 21;129(11):3333-8. Epub 2007 Feb 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17319667</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja068158s</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1561</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1561</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schwartz, Z.</author><author>Bell, B. F.</author><author>Wang, L.</author><author>Zhao, G.</author><author>Olivares-Navarrete, R.</author><author>Boyan, B. D.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology, 315 Ferst Drive NW, Atlanta, GA 30332-0363, USA.</auth-address><titles><title>Beta-1 integrins mediate substrate dependent effects of 1alpha,25(OH)2D3 on osteoblasts</title><secondary-title>J Steroid Biochem Mol Biol</secondary-title></titles><periodical><full-title>J Steroid Biochem Mol Biol</full-title></periodical><pages>606-9</pages><volume>103</volume><number>3-5</number><edition>2007/02/24</edition><keywords><keyword>Calcitriol/*metabolism</keyword><keyword>Humans</keyword><keyword>Integrin beta Chains/genetics/*metabolism</keyword><keyword>Osteoblasts/*metabolism</keyword><keyword>Substrate Specificity</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0960-0760 (Print)</isbn><accession-num>17317155</accession-num><abstract>Surface micron-scale and submicron scale features increase osteoblast differentiation and enhance responses of osteoblasts to 1,25-dihydroxyvitamin D(3) [1alpha,25(OH)(2)D(3)]. beta(1) integrin expression is increased in osteoblasts grown on Ti substrates with rough microarchitecture, and it is regulated by 1alpha,25(OH)(2)D(3) in a surface-dependent manner. To determine if beta(1) has a role in mediating osteoblast response, we silenced beta(1) expression in MG63 human osteoblast-like cells using small interfering RNA (siRNA). In addition, MG63 cells were treated with two different monoclonal antibodies to human beta(1) to block ligand binding. beta(1)-silenced MG63 cells grown on a tissue culture plastic had reduced alkaline phosphatase activity and levels of osteocalcin, transforming growth factor beta(1), prostaglandin E(2), and osteoprotegerin in comparison with control cells. Moreover, beta(1)-silencing inhibited the effects of surface roughness on these parameters and partially inhibited effects of 1alpha,25(OH)(2)D(3). Anti beta(1) antibodies decreased alkaline phosphatase but increase osteocalcin; effects of 1alpha,25(OH)(2)D(3) on cell number and alkaline phosphatase were reduced and effects on osteocalcin were increased. These findings indicate that beta(1) plays a major and complex role in osteoblastic differentiation modulated by either surface microarchitecture or 1alpha,25(OH)(2)D(3). The results also show that beta(1) mediates, in part, the synergistic effects of surface roughness and 1alpha,25(OH)(2)D(3).</abstract><notes>Schwartz, Zvi&#xD;Bell, Bryan F&#xD;Wang, Liping&#xD;Zhao, Ge&#xD;Olivares-Navarrete, Rene&#xD;Boyan, Barbara D&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;The Journal of steroid biochemistry and molecular biology&#xD;J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):606-9. Epub 2006 Dec 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17317155</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>3.056</custom4><electronic-resource-num>S0960-0760(06)00449-3 [pii]&#xD;10.1016/j.jsbmb.2006.12.083</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1455</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1455</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Montet-Abou, K.</author><author>Montet, X.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><titles><title>Cell internalization of magnetic nanoparticles using transfection agents</title><secondary-title>Mol Imaging</secondary-title></titles><periodical><full-title>Mol Imaging</full-title></periodical><pages>1-9</pages><volume>6</volume><number>1</number><edition>2007/02/22</edition><dates><year>2007</year><pub-dates><date>Jan-Mar</date></pub-dates></dates><isbn>1535-3508 (Print)</isbn><accession-num>17311760</accession-num><abstract>Transfection agent (TFA)-induced magnetic cell labeling with Feridex IV is an attractive method of loading cells because it employs a pharmaceutical source of iron oxide. Although attractive, the method has two significant drawbacks. First, it requires mixing positively charged transfection agents and negatively charged magnetic nanoparticles, and the resulting loss of nanoparticle surface charge causes nanoparticle precipitation. Second, it can result in nanoparticle adsorption to the cell surface rather than internalization. Internalization of Feridex (and associated dextran) is important since dextran cell exterior can react with the antidextran antibodies, commonly present in human populations, and trigger an antibody-mediated cytotoxicity. Here we employed three assays for selecting Feridex/TFA mixtures to minimize nanoparticle precipitation and surface adsorption: (1) an assay for precipitation or stability (light scattering), (2) an assay for labeled cells (percentage of cells retained by a magnetic filter), and (3) an antidextran-based assay for nanoparticle internalization. Cells loaded with Feridex/protamine had internalized iron, whereas cells loaded with Feridex/Lipofectamine had surface-adsorbed iron. Optimal conditions for loading cells were 10 mug/Feridex and 3 mug/mL protamine sulfate. Conditions for loading cells with Feridex and a TFA need to be carefully selected to minimize nanoparticle precipitation and dextran adsorption to the cell surface.</abstract><notes>Montet-Abou, Karin&#xD;Montet, Xavier&#xD;Weissleder, Ralph&#xD;Josephson, Lee&#xD;United States&#xD;Molecular imaging : official journal of the Society for Molecular Imaging&#xD;Mol Imaging. 2007 Jan-Mar;6(1):1-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17311760</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>3.329</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1331</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1331</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, J. S.</author><author>Valencia, C. A.</author><author>Liu, R.</author><author>Lin, W.</author></authors></contributors><auth-address>Department of Chemistry and School of Pharmacy and Carolina Center for Genome Sciences, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Highly-efficient purification of native polyhistidine-tagged proteins by multivalent NTA-modified magnetic nanoparticles</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>333-41</pages><volume>18</volume><number>2</number><edition>2007/02/22</edition><keywords><keyword>Animals</keyword><keyword>Cells, Cultured</keyword><keyword>Chelating Agents</keyword><keyword>Chromatography, Affinity</keyword><keyword>Endostatins/chemistry/isolation &amp; purification</keyword><keyword>Histidine/*chemistry</keyword><keyword>Humans</keyword><keyword>Kidney/metabolism</keyword><keyword>*Magnetics</keyword><keyword>Mice</keyword><keyword>*Nanoparticles</keyword><keyword>Nickel/*chemistry</keyword><keyword>Nitrilotriacetic Acid/*chemistry</keyword><keyword>Nuclear Proteins/chemistry/isolation &amp; purification</keyword><keyword>Proteins/*chemistry/isolation &amp; purification</keyword><keyword>Ubiquitin/metabolism</keyword><keyword>Ubiquitin Thiolesterase/chemistry/isolation &amp; purification</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar-Apr</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>17311440</accession-num><abstract>A new bis-nitrilotriacetic acid (NTA) chelate with catechol anchor was synthesized and immobilized on superparamagnetic iron oxide nanoparticles. When loaded with Ni(II), these bis-NTA-immobilized nanoparticles were shown to bind polyhistidine (His x 6-tagged) fusion proteins in their native, folded conformations that commercial microbeads failed to bind under identical conditions. Control experiments with a mono-NTA chelate immobilized on iron oxide nanoparticles indicate a similarly high affinity for His x 6-tagged native proteins, suggesting that the high density of the mono-NTA chelate presented by the nanoparticles allows the binding of the His x 6-tag to more than one Ni-NTA moiety on the surface. This study shows that the multivalency strategy can be utilized to enhance the binding of His x 6-tagged proteins in their native, folded conformations. We further demonstrated the selective purification of His x 6-tagged proteins from crude cell lysates by using the Ni(II)-loaded iron oxide nanoparticles. The present platform is capable of efficient purification of His x 6-tagged proteins that are expressed at low levels in mammalian cells. This work thus presents a novel nanoparticle-based high-capacity protein purification system with shorter incubation times, proportionally large washes, and significantly smaller elution volumes compared to commercially available microbeads.</abstract><notes>Kim, Jason S&#xD;Valencia, C Alexander&#xD;Liu, Rihe&#xD;Lin, Wenbin&#xD;U54-ca119343/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2007 Mar-Apr;18(2):333-41. Epub 2007 Feb 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17311440</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/bc060195l</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1052</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1052</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Agus, D. B.</author><author>Sweeney, C. J.</author><author>Morris, M. J.</author><author>Mendelson, D. S.</author><author>McNeel, D. G.</author><author>Ahmann, F. R.</author><author>Wang, J.</author><author>Derynck, M. K.</author><author>Ng, K.</author><author>Lyons, B.</author><author>Allison, D. E.</author><author>Kattan, M. W.</author><author>Scher, H. I.</author></authors></contributors><auth-address>Cedars-Sinai Prostate Cancer Center, Los Angeles, CA 90048, USA. David.Agus@cshs.org</auth-address><titles><title>Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy</title><secondary-title>J Clin Oncol</secondary-title></titles><periodical><full-title>J Clin Oncol</full-title></periodical><pages>675-81</pages><volume>25</volume><number>6</number><edition>2007/02/20</edition><keywords><keyword>Aged</keyword><keyword>Antibodies, Monoclonal/*administration &amp; dosage</keyword><keyword>Bridged Compounds/adverse effects/*therapeutic use</keyword><keyword>Disease Progression</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Drug Administration Schedule</keyword><keyword>Drug Resistance, Neoplasm</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Neoplasm Recurrence, Local/*drug therapy/pathology</keyword><keyword>Orchiectomy</keyword><keyword>Probability</keyword><keyword>Prognosis</keyword><keyword>Prostatic Neoplasms/*drug therapy/mortality/pathology/surgery</keyword><keyword>Receptor, erbB-2/administration &amp; dosage/*antagonists &amp; inhibitors</keyword><keyword>Risk Assessment</keyword><keyword>Single-Blind Method</keyword><keyword>Survival Analysis</keyword><keyword>Taxoids/adverse effects/*therapeutic use</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb 20</date></pub-dates></dates><isbn>1527-7755 (Electronic)</isbn><accession-num>17308272</accession-num><abstract>PURPOSE: Pertuzumab represents a new class of targeted anticancer agents, human epidermal growth factor receptor (HER) dimerization inhibitors. The aim of this single-arm phase II clinical study was to assess the efficacy and safety of single-agent pertuzumab in castration-resistant prostate cancer (CRPC) patients who had experienced progression after prior chemotherapy. PATIENTS AND METHODS: Patients received pertuzumab every 3 weeks. All castration-resistant patients had experienced progression after at least one taxane-based regimen. Patients received a loading dose of 840 mg pertuzumab (cycle 1) followed by 420 mg for subsequent cycles. The primary end point was overall response and safety. A separate retrospective analysis of actual survival time versus predicted survival time for a patient population with comparable prognostic features was performed. RESULTS: Patients were enrolled (N = 42) and treated (n = 41). No patients had complete or partial response (as defined by Response Evaluation Criteria in Solid Tumors Group or 50% decline in prostate-specific antigen). Of 30 efficacy-assessable patients, five had stable disease (SD) for at least 23 weeks; one of five had SD for 36 weeks. Pertuzumab was well tolerated; diarrhea was the most common adverse effect (61.0%, grades 1 to 3). Retrospective analysis of survival using a validated nomogram suggested that survival was prolonged with pertuzumab treatment, compared with historic controls with similar baseline prognostic features. CONCLUSION: Pertuzumab was well tolerated and resulted in no objective responses, but several patients had SD more than 23 weeks from a heavily pretreated population. Retrospective analysis suggested prolonged median survival time with pertuzumab compared with historical controls. Thus, inhibition of HER dimerization may have clinical utility in CRPC patients.</abstract><notes>Agus, David B&#xD;Sweeney, Christopher J&#xD;Morris, Michael J&#xD;Mendelson, David S&#xD;McNeel, Douglas G&#xD;Ahmann, Frederick R&#xD;Wang, Jin&#xD;Derynck, Mika K&#xD;Ng, Kimmie&#xD;Lyons, Benjamin&#xD;Allison, David E&#xD;Kattan, Michael W&#xD;Scher, Howard I&#xD;Clinical Trial, Phase II&#xD;Multicenter Study&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of clinical oncology : official journal of the American Society of Clinical Oncology&#xD;J Clin Oncol. 2007 Feb 20;25(6):675-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17308272</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>15.556</custom4><electronic-resource-num>25/6/675 [pii]&#xD;10.1200/JCO.2006.07.0649</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2051</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2051</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Niu, G.</author><author>Xiong, Z.</author><author>Cheng, Z.</author><author>Cai, W.</author><author>Gambhir, S. S.</author><author>Xing, L.</author><author>Chen, X.</author></authors></contributors><auth-address>Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.</auth-address><titles><title>In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene</title><secondary-title>Mol Imaging Biol</secondary-title></titles><periodical><full-title>Mol Imaging Biol</full-title></periodical><pages>126-34</pages><volume>9</volume><number>3</number><edition>2007/02/14</edition><keywords><keyword>Adenoviruses, Human/ genetics</keyword><keyword>Animals</keyword><keyword>Base Sequence</keyword><keyword>Cell Line, Tumor</keyword><keyword>DNA Primers/genetics</keyword><keyword>Female</keyword><keyword>Gene Expression</keyword><keyword>Genes, Reporter</keyword><keyword>Genetic Vectors</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/genetics</keyword><keyword>Luciferases, Firefly/ genetics</keyword><keyword>Luminescent Measurements</keyword><keyword>Mammary Neoplasms, Experimental/diagnosis/genetics</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Oligopeptides/genetics</keyword><keyword>Polyethylene Glycols</keyword><keyword>Receptors, Virus/genetics</keyword><keyword>Recombinant Proteins/genetics</keyword><keyword>Transduction, Genetic</keyword></keywords><dates><year>2007</year><pub-dates><date>May-Jun</date></pub-dates></dates><isbn>1536-1632 (Print)</isbn><accession-num>17297551</accession-num><abstract>PURPOSE: The goal of this study is to demonstrate the feasibility of chemically modified human adenovirus (Ad) vectors for tumor retargeting. PROCEDURES: E1- and E3-deleted Ad vectors carrying firefly luciferase reporter gene under cytomegalovirus promoter (AdLuc) was surface-modified with cyclic arginine-glycine-aspartic acid (RGD) peptides through a bifunctional poly(ethyleneglycol) linker (RGD-PEG-AdLuc) for integrin alpha(v)beta(3) specific delivery. The Coxsackie and adenovirus viral receptor (CAR) and integrin alpha(v)beta(3) expression in various tumor cell lines was determined by reverse transcriptase PCR and fluorescence-activated cell sorting. Bioluminescence imaging was performed in vitro and in vivo to evaluate RGD-modified AdLuc infectivity. RESULTS: RGD-PEG-AdLuc abrogated the native CAR tropism and exhibited significantly enhanced transduction efficiency of integrin-positive tumors than AdLuc through intravenous administration. CONCLUSION: This approach provides a robust platform for site-specific gene delivery and noninvasive monitoring of the transgene delivery efficacy and homing.</abstract><notes>Niu, Gang&#xD;Xiong, Zhengming&#xD;Cheng, Zhen&#xD;Cai, Weibo&#xD;Gambhir, Sanjiv S&#xD;Xing, Lei&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging&#xD;Mol Imaging Biol. 2007 May-Jun;9(3):126-34.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>3.372</custom4><electronic-resource-num>10.1007/s11307-007-0079-2 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1187</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1187</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Duan, H.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, 101 Woodruff Circle, Atlanta, GA 30322, USA.</auth-address><titles><title>Etching colloidal gold nanocrystals with hyperbranched and multivalent polymers: a new route to fluorescent and water-soluble atomic clusters</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>2412-3</pages><volume>129</volume><number>9</number><edition>2007/02/14</edition><keywords><keyword>Gold Colloid/*chemistry</keyword><keyword>Luminescent Agents/*chemistry</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanoparticles</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Particle Size</keyword><keyword>Polymers/*chemistry</keyword><keyword>Solubility</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Water/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 7</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17295485</accession-num><notes>Duan, Hongwei&#xD;Nie, Shuming&#xD;P20 gm 072069/gm/nigms&#xD;R01 ca 108468-01/ca/nci&#xD;U01 hl 080711/hl/nhlbi&#xD;U54 ca 119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Mar 7;129(9):2412-3. Epub 2007 Feb 13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17295485</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja067727t</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1655</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1655</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thomas, R. K.</author><author>Baker, A. C.</author><author>Debiasi, R. M.</author><author>Winckler, W.</author><author>Laframboise, T.</author><author>Lin, W. M.</author><author>Wang, M.</author><author>Feng, W.</author><author>Zander, T.</author><author>MacConaill, L.</author><author>Lee, J. C.</author><author>Nicoletti, R.</author><author>Hatton, C.</author><author>Goyette, M.</author><author>Girard, L.</author><author>Majmudar, K.</author><author>Ziaugra, L.</author><author>Wong, K. K.</author><author>Gabriel, S.</author><author>Beroukhim, R.</author><author>Peyton, M.</author><author>Barretina, J.</author><author>Dutt, A.</author><author>Emery, C.</author><author>Greulich, H.</author><author>Shah, K.</author><author>Sasaki, H.</author><author>Gazdar, A.</author><author>Minna, J.</author><author>Armstrong, S. A.</author><author>Mellinghoff, I. K.</author><author>Hodi, F. S.</author><author>Dranoff, G.</author><author>Mischel, P. S.</author><author>Cloughesy, T. F.</author><author>Nelson, S. F.</author><author>Liau, L. M.</author><author>Mertz, K.</author><author>Rubin, M. A.</author><author>Moch, H.</author><author>Loda, M.</author><author>Catalona, W.</author><author>Fletcher, J.</author><author>Signoretti, S.</author><author>Kaye, F.</author><author>Anderson, K. C.</author><author>Demetri, G. D.</author><author>Dummer, R.</author><author>Wagner, S.</author><author>Herlyn, M.</author><author>Sellers, W. R.</author><author>Meyerson, M.</author><author>Garraway, L. A.</author></authors></contributors><auth-address>Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA.</auth-address><titles><title>High-throughput oncogene mutation profiling in human cancer</title><secondary-title>Nat Genet</secondary-title></titles><periodical><full-title>Nat Genet</full-title></periodical><pages>347-51</pages><volume>39</volume><number>3</number><edition>2007/02/13</edition><keywords><keyword>DNA Mutational Analysis/*methods</keyword><keyword>Gene Expression Profiling</keyword><keyword>Genome, Human</keyword><keyword>Genotype</keyword><keyword>Humans</keyword><keyword>*Mutation</keyword><keyword>Neoplasms/*genetics</keyword><keyword>*Oncogenes</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1061-4036 (Print)</isbn><accession-num>17293865</accession-num><abstract>Systematic efforts are underway to decipher the genetic changes associated with tumor initiation and progression. However, widespread clinical application of this information is hampered by an inability to identify critical genetic events across the spectrum of human tumors with adequate sensitivity and scalability. Here, we have adapted high-throughput genotyping to query 238 known oncogene mutations across 1,000 human tumor samples. This approach established robust mutation distributions spanning 17 cancer types. Of 17 oncogenes analyzed, we found 14 to be mutated at least once, and 298 (30%) samples carried at least one mutation. Moreover, we identified previously unrecognized oncogene mutations in several tumor types and observed an unexpectedly high number of co-occurring mutations. These results offer a new dimension in tumor genetics, where mutations involving multiple cancer genes may be interrogated simultaneously and in &apos;real time&apos; to guide cancer classification and rational therapeutic intervention.</abstract><notes>Thomas, Roman K&#xD;Baker, Alissa C&#xD;Debiasi, Ralph M&#xD;Winckler, Wendy&#xD;Laframboise, Thomas&#xD;Lin, William M&#xD;Wang, Meng&#xD;Feng, Whei&#xD;Zander, Thomas&#xD;MacConaill, Laura&#xD;Lee, Jeffrey C&#xD;Nicoletti, Rick&#xD;Hatton, Charlie&#xD;Goyette, Mary&#xD;Girard, Luc&#xD;Majmudar, Kuntal&#xD;Ziaugra, Liuda&#xD;Wong, Kwok-Kin&#xD;Gabriel, Stacey&#xD;Beroukhim, Rameen&#xD;Peyton, Michael&#xD;Barretina, Jordi&#xD;Dutt, Amit&#xD;Emery, Caroline&#xD;Greulich, Heidi&#xD;Shah, Kinjal&#xD;Sasaki, Hidefumi&#xD;Gazdar, Adi&#xD;Minna, John&#xD;Armstrong, Scott A&#xD;Mellinghoff, Ingo K&#xD;Hodi, F Stephen&#xD;Dranoff, Glenn&#xD;Mischel, Paul S&#xD;Cloughesy, Tim F&#xD;Nelson, Stan F&#xD;Liau, Linda M&#xD;Mertz, Kirsten&#xD;Rubin, Mark A&#xD;Moch, Holger&#xD;Loda, Massimo&#xD;Catalona, William&#xD;Fletcher, Jonathan&#xD;Signoretti, Sabina&#xD;Kaye, Frederic&#xD;Anderson, Kenneth C&#xD;Demetri, George D&#xD;Dummer, Reinhard&#xD;Wagner, Stephan&#xD;Herlyn, Meenhard&#xD;Sellers, William R&#xD;Meyerson, Matthew&#xD;Garraway, Levi A&#xD;P50ca70907/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature genetics&#xD;Nat Genet. 2007 Mar;39(3):347-51. Epub 2007 Feb 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17293865</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>26.446</custom4><electronic-resource-num>ng1975 [pii]&#xD;10.1038/ng1975</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1411</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1411</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Winters, M.</author><author>Holodniy, M.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>siRNA delivery into human T cells and primary cells with carbon-nanotube transporters</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>2023-7</pages><volume>46</volume><number>12</number><edition>2007/02/10</edition><keywords><keyword>Antigens, CD4/metabolism</keyword><keyword>*Biosensing Techniques</keyword><keyword>Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Leukemia, T-Cell, Acute/genetics</keyword><keyword>Nanotubes, Carbon/*chemistry</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>RNA, Small Interfering/*administration &amp; dosage/pharmacology</keyword><keyword>Receptors, CCR5/metabolism</keyword><keyword>Receptors, CXCR4/*antagonists &amp; inhibitors/genetics/metabolism</keyword><keyword>T-Lymphocytes/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>17290476</accession-num><notes>Liu, Zhuang&#xD;Winters, Mark&#xD;Holodniy, Mark&#xD;Dai, Hongjie&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2007;46(12):2023-7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17290476</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200604295</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1494</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1494</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Partlow, K. C.</author><author>Chen, J.</author><author>Brant, J. A.</author><author>Neubauer, A. M.</author><author>Meyerrose, T. E.</author><author>Creer, M. H.</author><author>Nolta, J. A.</author><author>Caruthers, S. D.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Department of Medicine, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO 63110, USA.</auth-address><titles><title>19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons</title><secondary-title>FASEB J</secondary-title></titles><periodical><full-title>FASEB J</full-title></periodical><pages>1647-54</pages><volume>21</volume><number>8</number><edition>2007/02/08</edition><keywords><keyword>Animals</keyword><keyword>Fetal Blood</keyword><keyword>Fluorine</keyword><keyword>Fluorocarbons/*diagnostic use/pharmacokinetics</keyword><keyword>Hematopoietic Stem Cell Transplantation</keyword><keyword>Hematopoietic Stem Cells/*cytology/metabolism</keyword><keyword>Humans</keyword><keyword>Isotopes</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Methods</keyword><keyword>Mice</keyword><keyword>Nanoparticles/diagnostic use</keyword><keyword>Neoplasms, Experimental</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1530-6860 (Electronic)</isbn><accession-num>17284484</accession-num><abstract>MRI has been employed to elucidate the migratory behavior of stem/progenitor cells noninvasively in vivo with traditional proton (1H) imaging of iron oxide nanoparticle-labeled cells. Alternatively, we demonstrate that fluorine (19F) MRI of cells labeled with different types of liquid perfluorocarbon (PFC) nanoparticles produces unique and sensitive cell markers distinct from any tissue background signal. To define the utility for cell tracking, mononuclear cells harvested from human umbilical cord blood were grown under proendothelial conditions and labeled with nanoparticles composed of two distinct PFC cores (perfluorooctylbromide and perfluoro-15-crown-5 ether). The sensitivity for detecting and imaging labeled cells was defined on 11.7T (research) and 1.5T (clinical) scanners. Stem/progenitor cells (CD34+ CD133+ CD31+) readily internalized PFC nanoparticles without aid of adjunctive labeling techniques, and cells remained functional in vivo. PFC-labeled cells exhibited distinct 19F signals and were readily detected after both local and intravenous injection. PFC nanoparticles provide an unequivocal and unique signature for stem/progenitor cells, enable spatial cell localization with 19F MRI, and permit quantification and detection of multiple fluorine signatures via 19F MR spectroscopy. This method should facilitate longitudinal investigation of cellular events in vivo for multiple cell types simultaneously.</abstract><notes>Partlow, Kathryn C&#xD;Chen, Junjie&#xD;Brant, Jason A&#xD;Neubauer, Anne M&#xD;Meyerrose, Todd E&#xD;Creer, Michael H&#xD;Nolta, Jan A&#xD;Caruthers, Shelton D&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Co-37007/co/nci&#xD;Hl-073646/hl/nhlbi&#xD;Hl-078631/hl/nhlbi&#xD;U54-ca-119342/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The FASEB journal : official publication of the Federation of American Societies for Experimental Biology&#xD;FASEB J. 2007 Jun;21(8):1647-54. Epub 2007 Feb 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17284484</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>7.128</custom4><electronic-resource-num>fj.06-6505com [pii]&#xD;10.1096/fj.06-6505com</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1468</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1468</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nakayama-Ratchford, N.</author><author>Bangsaruntip, S.</author><author>Sun, X.</author><author>Welsher, K.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>Noncovalent functionalization of carbon nanotubes by fluorescein-polyethylene glycol: supramolecular conjugates with pH-dependent absorbance and fluorescence</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>2448-9</pages><volume>129</volume><number>9</number><edition>2007/02/08</edition><keywords><keyword>Electrochemistry</keyword><keyword>Fluorescein/*chemistry</keyword><keyword>Fluorescence</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Microscopy, Atomic Force</keyword><keyword>*Nanotechnology</keyword><keyword>Nanotubes, Carbon/*chemistry</keyword><keyword>Polyethylene Glycols/*chemistry</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Surface Properties</keyword><keyword>Surface-Active Agents/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 7</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17284037</accession-num><notes>Nakayama-Ratchford, Nozomi&#xD;Bangsaruntip, Sarunya&#xD;Sun, Xiaoming&#xD;Welsher, Kevin&#xD;Dai, Hongjie&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Mar 7;129(9):2448-9. Epub 2007 Feb 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17284037</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja068684j</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1500</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1500</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Paunesku, T.</author><author>Vogt, S.</author><author>Lai, B.</author><author>Maser, J.</author><author>Stojicevic, N.</author><author>Thurn, K. T.</author><author>Osipo, C.</author><author>Liu, H.</author><author>Legnini, D.</author><author>Wang, Z.</author><author>Lee, C.</author><author>Woloschak, G. E.</author></authors></contributors><auth-address>Department of Radiation Oncology, Northwestern University, Chicago, Illinois 60611, USA.</auth-address><titles><title>Intracellular distribution of TiO2-DNA oligonucleotide nanoconjugates directed to nucleolus and mitochondria indicates sequence specificity</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>596-601</pages><volume>7</volume><number>3</number><edition>2007/02/06</edition><keywords><keyword>Animals</keyword><keyword>Base Sequence</keyword><keyword>Cell Line</keyword><keyword>Cell Nucleolus/*metabolism/ultrastructure</keyword><keyword>DNA, Mitochondrial/metabolism</keyword><keyword>Humans</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Microscopy, Electron</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Mitochondria/*metabolism/ultrastructure</keyword><keyword>Nanotechnology</keyword><keyword>Oligodeoxyribonucleotides/*chemistry/*metabolism</keyword><keyword>PC12 Cells</keyword><keyword>Rats</keyword><keyword>Titanium/*chemistry/*metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17274661</accession-num><abstract>Deoxyribonucleic acid (DNA) oligonucleotides hybridize to matching DNA sequences in cells, as established in the literature, depending on active transcription of the target sequence and local molarity of the oligonucleotide. We investigated the intracellular distribution of nanoconjugates composed of DNA oligonucleotides attached to TiO2 nanoparticles, thus creating a locally increased concentration of the oligonucleotide. Two types of nanoconjugates, with oligonucleotides matching mitochondrial or nucleolar DNA, were specifically retained in mitochondria or nucleoli.</abstract><notes>Paunesku, Tatjana&#xD;Vogt, Stefan&#xD;Lai, Barry&#xD;Maser, Jorg&#xD;Stojicevic, Natasa&#xD;Thurn, Kenneth T&#xD;Osipo, Clodia&#xD;Liu, Hong&#xD;Legnini, Daniel&#xD;Wang, Zhou&#xD;Lee, Chung&#xD;Woloschak, Gayle E&#xD;Ca107467/ca/nci&#xD;Eb002100/eb/nibib&#xD;P50 ca89018/ca/nci&#xD;U54ca119341/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2007 Mar;7(3):596-601. Epub 2007 Feb 3.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17274661</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl0624723</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1265</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1265</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hu, G.</author><author>Lijowski, M.</author><author>Zhang, H.</author><author>Partlow, K. C.</author><author>Caruthers, S. D.</author><author>Kiefer, G.</author><author>Gulyas, G.</author><author>Athey, P.</author><author>Scott, M. J.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Department of Medicine, Division of Cardiology, Washington University Medical School, St. Louis, MO, USA.</auth-address><titles><title>Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles</title><secondary-title>Int J Cancer</secondary-title></titles><periodical><full-title>Int J Cancer</full-title></periodical><pages>1951-7</pages><volume>120</volume><number>9</number><edition>2007/02/06</edition><keywords><keyword>Animals</keyword><keyword>Indium Radioisotopes/*diagnostic use</keyword><keyword>Integrin alphaVbeta3/*analysis</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Male</keyword><keyword>*Nanoparticles</keyword><keyword>Neoplasms, Experimental/*blood supply/radionuclide imaging</keyword><keyword>Neovascularization, Pathologic/*radionuclide imaging</keyword><keyword>Rabbits</keyword></keywords><dates><year>2007</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>0020-7136 (Print)</isbn><accession-num>17278104</accession-num><abstract>Earlier tumor detection can improve 5-year survival of patients, particularly among those presenting with cancers less than 1 cm in diameter. alpha(nu)beta(3)-Targeted (111)In nanoparticles (NP) were developed and studied for detection of tumor angiogenesis. Studies were conducted in New Zealand white rabbits implanted 12 days earlier with Vx-2 tumor. alpha(nu)beta(3)-Targeted (111)In/NP bearing approximately 10 (111)In/NP vs. approximately 1 (111)In/NP nuclide payloads were compared to nontargeted radiolabeled control particles. In vivo competitive binding studies were used to assess ligand-targeting specificity. alpha(nu)beta(3)-Integrin-targeted NP with approximately 10 (111)In/NP provided better (p &lt; 0.05) tumor-to-muscle ratio contrast (6.3 +/- 0.2) than approximately 1 (111)In/NP (5.1 +/- 0.1) or nontargeted particles with approximately 10 (111)In/NP (3.7 +/- 0.1) over the initial 2-hr postinjection. At 18 hr, mean tumor activity in rabbits receiving alpha(nu)beta(3)-integrin-targeted NP was 4-fold higher than the nontargeted control. Specificity of the NP for the tumor neovasculature was supported by in vivo competition studies and by fluorescence microscopy of alpha(nu)beta(3)-targeted fluorescent-labeled NP. Biodistribution studies revealed that the primary clearance organ in rabbits as a %ID/g tissue was the spleen. Circulatory half-life (t(1/2)beta) was estimated to be approximately 5 hr using a 2-compartment model. alpha(nu)beta(3)-Targeted (111)In perfluorocarbon NP may provide a clinically useful tool for sensitively detecting angiogenesis in nascent tumors, particularly in combination with secondary high-resolution imaging modalities, such as MRI.</abstract><notes>Hu, Grace&#xD;Lijowski, Michal&#xD;Zhang, Huiying&#xD;Partlow, Kathryn C&#xD;Caruthers, Shelton D&#xD;Kiefer, Garry&#xD;Gulyas, Gyongyi&#xD;Athey, Phillip&#xD;Scott, Michael J&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Eb-01704/eb/nibib&#xD;Hl-73646/hl/nhlbi&#xD;Hl-78631/hl/nhlbi&#xD;N01-co-27031-16/co/nci&#xD;N01-co-37007/co/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;International journal of cancer. Journal international du cancer&#xD;Int J Cancer. 2007 May 1;120(9):1951-7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17278104</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>4.656</custom4><electronic-resource-num>10.1002/ijc.22581</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1114</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1114</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Olafsen, T.</author><author>Zhang, X.</author><author>Cao, Q.</author><author>Gambhir, S. S.</author><author>Williams, L. E.</author><author>Wu, A. M.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology, Stanford University School of Medicine, Stanford, California 94305-5484, USA.</auth-address><titles><title>PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody</title><secondary-title>J Nucl Med</secondary-title></titles><periodical><full-title>J Nucl Med</full-title></periodical><pages>304-10</pages><volume>48</volume><number>2</number><edition>2007/02/03</edition><keywords><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/*diagnostic use</keyword><keyword>Carcinoembryonic Antigen/*immunology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Colorectal Neoplasms/*radionuclide imaging</keyword><keyword>Female</keyword><keyword>Fluorine Radioisotopes/diagnostic use</keyword><keyword>Half-Life</keyword><keyword>Humans</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>Immunoglobulin Fab Fragments/diagnostic use</keyword><keyword>Iodine Radioisotopes/diagnostic use</keyword><keyword>Isotope Labeling</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Radiopharmaceuticals/*diagnostic use</keyword><keyword>Rats</keyword><keyword>Tissue Distribution</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>17268029</accession-num><abstract>In this study, we investigated the 18F-labeled anti-carcinoembryonic antigen (CEA) T84.66 diabody, a genetically engineered noncovalent dimer of single-chain variable fragments, for small-animal PET imaging of CEA expression in xenograft-bearing mice. METHODS: 18F labeling of the anti-CEA T84.66 diabody (molecular mass, 55 kDa) was achieved with N-succinimidyl-4-18F-fluorobenzoate (18F-SFB). The biodistribution of the 18F-fluorobenzyl-T84.66 diabody (18F-FB-T84.66 diabody) was evaluated in athymic nude mice bearing subcutaneous LS 174T human colon carcinoma and C6 rat glioma tumors. Serial small-animal PET imaging studies were performed to further evaluate in vivo targeting efficacy and pharmacokinetics. RESULTS: Radiolabeling required 35 +/- 5 (mean +/- SD) min starting from 18F-SFB, and the tracer 18F-FB-T84.66 diabody was synthesized with a specific activity of 1.83 +/- 1.71 TBq/mmol. The decay-corrected radiochemical yield was 1.40% +/- 0.16% (n = 4), and the radiochemical purity was greater than 98%. The radioimmunoreactivity was 57.1% +/- 2.0%. The 18F-FB-T84.66 diabody showed rapid and high tumor uptake and fast clearance from the circulation in the LS 174T xenograft model, as evidenced by both small-animal PET imaging and biodistribution studies. High-contrast small-animal PET images were obtained as early as 1 h after injection of the 18F-FB-T84.66 diabody, and only a background level of activity accumulation was found in CEA-negative C6 tumors. The tracer exhibited predominantly renal clearance, with some activity in the liver and spleen at early time points. CONCLUSION: The 18F-labeled diabody represents a new class of tumor-specific probes for PET that are based on targeting cell surface antigen expression. The 18F-FB-T84.66 diabody can be used for high-contrast small-animal PET imaging of CEA-positive tumor xenografts. It may be translated to the clinic for PET of CEA-positive malignancies.</abstract><notes>Cai, Weibo&#xD;Olafsen, Tove&#xD;Zhang, Xianzhong&#xD;Cao, Qizhen&#xD;Gambhir, Sanjiv S&#xD;Williams, Lawrence E&#xD;Wu, Anna M&#xD;Chen, Xiaoyuan&#xD;Ca16042/ca/nci&#xD;P01 ca43904/ca/nci&#xD;P50 ca86306/ca/nci&#xD;P50 da114747/da/nida&#xD;R21 ca102123/ca/nci&#xD;R21 eb001785/eb/nibib&#xD;R24 ca93862/ca/nci&#xD;U54 ca119367/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2007 Feb;48(2):304-10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17268029</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>6.282</custom4><electronic-resource-num>48/2/304 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1203</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1203</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fisher, M.</author><author>Abramov, M.</author><author>Van Aerschot, A.</author><author>Xu, D.</author><author>Juliano, R. L.</author><author>Herdewijn, P.</author></authors></contributors><auth-address>Department of Pharmacology, School of Medicine, University of North Carolina Chapel Hill NC 27599, USA.</auth-address><titles><title>Inhibition of MDR1 expression with altritol-modified siRNAs</title><secondary-title>Nucleic Acids Res</secondary-title></titles><periodical><full-title>Nucleic Acids Res</full-title></periodical><pages>1064-74</pages><volume>35</volume><number>4</number><edition>2007/02/01</edition><keywords><keyword>Animals</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Mice</keyword><keyword>NIH 3T3 Cells</keyword><keyword>P-Glycoprotein/*genetics/metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Polymerase Chain Reaction</keyword><keyword>*RNA Interference</keyword><keyword>RNA, Messenger/metabolism</keyword><keyword>RNA, Small Interfering/*chemistry/pharmacology</keyword><keyword>Rhodamine 123/analysis</keyword><keyword>Sugar Alcohols/*chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1362-4962 (Electronic)</isbn><accession-num>17264131</accession-num><abstract>Altritol-modified nucleic acids (ANAs) support RNA-like A-form structures when included in oligonucleotide duplexes. Thus altritol residues seem suitable as candidates for the chemical modification of siRNAs. Here we report that ANA-modified siRNAs targeting the MDR1 gene can exhibit improved efficacy as compared to unmodified controls. This was particularly true of ANA modifications at or near the 3&apos; end of the sense or antisense strands, while modification at the 5&apos; end of the antisense strand resulted in complete loss of activity. Multiple ANA modifications within the sense strand were also well tolerated. Duplexes with ANA modifications at appropriate positions in both strands were generally more effective than duplexes with one modified and one unmodified strand. Initial evidence suggests that the loss of activity associated with ANA modification of the 5&apos;-antisense strand may be due to reduced phosphorylation at this site by cellular kinases. Treatment of drug resistant cells with MDR1-targeted siRNAs resulted in reduction of P-glycoprotein (Pgp) expression, parallel reduction in MDR1 message levels, increased accumulation of the Pgp substrate rhodamine 123, and reduced resistance to anti-tumor drugs. Interestingly, the duration of action of some of the ANA-modified siRNAs was substantially greater than that of unmodified controls. These observations suggest that altritol modifications may be helpful in developing siRNAs with enhanced pharmacological effectiveness.</abstract><notes>Fisher, Michael&#xD;Abramov, Mikhail&#xD;Van Aerschot, Arthur&#xD;Xu, Dong&#xD;Juliano, Rudolph L&#xD;Herdewijn, Piet&#xD;P01 gm59299/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nucleic acids research&#xD;Nucleic Acids Res. 2007;35(4):1064-74. Epub 2007 Jan 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17264131</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>6.968</custom4><custom7>Jan</custom7><electronic-resource-num>gkl1126 [pii]&#xD;10.1093/nar/gkl1126</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1341</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1341</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kommareddy, S.</author><author>Amiji, M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, 110 Mugar Life Sciences Building, Boston, MA 02115, USA.</auth-address><titles><title>Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice</title><secondary-title>J Pharm Sci</secondary-title><alt-title>Journal of pharmaceutical sciences</alt-title></titles><periodical><full-title>J Pharm Sci</full-title></periodical><alt-periodical><full-title>Journal of Pharmaceutical Sciences</full-title></alt-periodical><pages>397-407</pages><volume>96</volume><number>2</number><edition>2007/02</edition><keywords><keyword>Animals</keyword><keyword>Breast Neoplasms/*metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chemistry, Pharmaceutical</keyword><keyword>Female</keyword><keyword>Gelatin/*chemistry/pharmacokinetics</keyword><keyword>Humans</keyword><keyword>Indium Radioisotopes</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>*Nanoparticles/chemistry/ultrastructure</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Particle Size</keyword><keyword>Polyethylene Glycols/*chemistry/pharmacokinetics</keyword><keyword>Sulfhydryl Compounds/*chemistry/pharmacokinetics</keyword><keyword>Surface Properties</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0022-3549 (Print)</isbn><accession-num>17075865</accession-num><abstract>The objective of the present study was to modify thiolated gelatin nanoparticles with poly(ethylene glycol) (PEG) chains and examine their long circulating and tumor-targeting properties in vivo in an orthotopic a human breast adenocarcinoma xenograft model. The crosslinked nanoparticle systems were characterized to have a size of 150-250 nm with rapid payload release properties in a highly reducing environment. Upon PEG modification, the nanoparticle size increased to 300-350 nm in diameter. The presence of PEG chains on the surface was confirmed by characterization with electron spectroscopy for chemical analysis. The in vivo long-circulating potential, biodistribution and passive tumor targeting of the controls, and PEG-modified thiolated gelatin nanoparticles were evaluated by injecting indium-111 (111In)-labeled nanoparticles into breast tumor (MDA-MB-435)-bearing nude mice. Upon modification with PEG, the nanoparticles were found to have longer circulation times, with the plasma and tumor half-lives of 15.3 and 37.8 h, respectively. The results also showed preferential localization of thiolated nanoparticles in the tumor mass. The resulting nanoparticulate systems with long circulation properties could be used to target encapsulated drugs and genes to tumors passively by utilizing the enhanced permeability and retention effect of the tumor vasculature.</abstract><notes>Eb-002027/eb/nibib&#xD;R01-ca095522/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17075865 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>3.144</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1316</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1316</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kattumuri, V.</author><author>Katti, K.</author><author>Bhaskaran, S.</author><author>Boote, E. J.</author><author>Casteel, S. W.</author><author>Fent, G. M.</author><author>Robertson, D. J.</author><author>Chandrasekhar, M.</author><author>Kannan, R.</author><author>Katti, K. V.</author></authors></contributors><auth-address>Department of Physics, Alton Building Laboratories, University of Missouri-Columbia, Columbia, MO 65211 USA.</auth-address><titles><title>Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies</title><secondary-title>Small</secondary-title><alt-title>Small (Weinheim an der Bergstrasse, Germany)</alt-title></titles><periodical><full-title>Small</full-title></periodical><pages>333-41</pages><volume>3</volume><number>2</number><edition>2007/02</edition><keywords><keyword>Animals</keyword><keyword>Contrast Media</keyword><keyword>Crystallization/methods</keyword><keyword>Excipients/chemistry</keyword><keyword>Gold/*chemistry/*pharmacokinetics</keyword><keyword>Gum Arabic/*chemistry/*pharmacokinetics</keyword><keyword>Kinetics</keyword><keyword>Macromolecular Substances/chemistry</keyword><keyword>Materials Testing</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Molecular Conformation</keyword><keyword>Nanoparticles/*chemistry/*ultrastructure</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Particle Size</keyword><keyword>Surface Properties</keyword><keyword>Swine</keyword><keyword>Tissue Distribution</keyword><keyword>Tomography, X-Ray Computed</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17262759</accession-num><abstract>Gold nanoparticles (AuNPs) have exceptional stability against oxidation and therefore will play a significant role in the advancement of clinically useful diagnostic and therapeutic nanomedicines. Despite the huge potential for a new generation of AuNP-based nanomedicinal products, nontoxic AuNP constructs and formulations that can be readily administered site-specifically through the intravenous mode, for diagnostic imaging by computed tomography (CT) or for therapy via various modalities, are still rare. Herein, we report results encompassing: 1) the synthesis and stabilization of AuNPs within the nontoxic phytochemical gum-arabic matrix (GA-AuNPs); 2) detailed in vitro analysis and in vivo pharmacokinetics studies of GA-AuNPs in pigs to gain insight into the organ-specific localization of this new generation of AuNP vector, and 3) X-ray CT contrast measurements of GA-AuNP vectors for potential utility in molecular imaging. Our results demonstrate that naturally occurring GA can be used as a nontoxic phytochemical construct in the production of readily administrable biocompatible AuNPs for diagnostic and therapeutic applications in nanomedicine.</abstract><notes>1r01a119412-01/phs&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Germany</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17262759 </url></related-urls></urls><custom1>CNPP - U. of Miss.</custom1><custom3>2007</custom3><custom4>7.292</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1136</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1136</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cheng, J.</author><author>Teply, B. A.</author><author>Sherifi, I.</author><author>Sung, J.</author><author>Luther, G.</author><author>Gu, F. X.</author><author>Levy-Nissenbaum, E.</author><author>Radovic-Moreno, A. F.</author><author>Langer, R.</author><author>Farokhzad, O. C.</author></authors></contributors><auth-address>Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.</auth-address><titles><title>Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery</title><secondary-title>Biomaterials</secondary-title><alt-title>Biomaterials</alt-title></titles><periodical><full-title>Biomaterials</full-title></periodical><alt-periodical><full-title>Biomaterials</full-title></alt-periodical><pages>869-76</pages><volume>28</volume><number>5</number><edition>2007/02</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/administration &amp; dosage</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Lactic Acid/*chemistry</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Models, Chemical</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Polyethylene Glycols/*chemistry</keyword><keyword>Polyglycolic Acid/*chemistry</keyword><keyword>Polymers/*chemistry</keyword><keyword>Prostatic Neoplasms/drug therapy</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0142-9612 (Print)</isbn><accession-num>17055572</accession-num><abstract>Nanoparticle (NP) size has been shown to significantly affect the biodistribution of targeted and non-targeted NPs in an organ specific manner. Herein we have developed NPs from carboxy-terminated poly(d,L-lactide-co-glycolide)-block-poly(ethylene glycol) (PLGA-b-PEG-COOH) polymer and studied the effects of altering the following formulation parameters on the size of NPs: (1) polymer concentration, (2) drug loading, (3) water miscibility of solvent, and (4) the ratio of water to solvent. We found that NP mean volumetric size correlates linearly with polymer concentration for NPs between 70 and 250 nm in diameter (linear coefficient=0.99 for NPs formulated with solvents studied). NPs with desirable size, drug loading, and polydispersity were conjugated to the A10 RNA aptamer (Apt) that binds to the prostate specific membrane antigen (PSMA), and NP and NP-Apt biodistribution was evaluated in a LNCaP (PSMA+) xenograft mouse model of prostate cancer. The surface functionalization of NPs with the A10 PSMA Apt significantly enhanced delivery of NPs to tumors vs. equivalent NPs lacking the A10 PSMA Apt (a 3.77-fold increase at 24h; NP-Apt 0.83%+/-0.21% vs. NP 0.22%+/-0.07% of injected dose per gram of tissue; mean+/-SD, n=4, p=0.002). The ability to control NP size together with targeted delivery may result in favorable biodistribution and development of clinically relevant targeted therapies.</abstract><notes>Ca 119349/ca/nci&#xD;Eb 003647/eb/nibib&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17055572 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>7.325</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2049</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2049</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Chen, K.</author><author>He, L.</author><author>Cao, Q.</author><author>Koong, A.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University School of Medicine, 1201 Welch Rd P095, Stanford, CA 94305-5484, USA.</auth-address><titles><title>Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody</title><secondary-title>Eur J Nucl Med Mol Imaging</secondary-title></titles><periodical><full-title>Eur J Nucl Med Mol Imaging</full-title></periodical><pages>850-8</pages><volume>34</volume><number>6</number><edition>2007/01/31</edition><keywords><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/chemistry/ pharmacology</keyword><keyword>Antineoplastic Agents/ pharmacology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Copper Radioisotopes/ therapeutic use</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neoplasms/ radionuclide imaging</keyword><keyword>Positron-Emission Tomography/instrumentation/ methods</keyword><keyword>Radiometry</keyword><keyword>Receptor, Epidermal Growth Factor/ biosynthesis</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1619-7070 (Print)</isbn><accession-num>17262214</accession-num><abstract>PURPOSE: Cetuximab, a chimeric monoclonal antibody targeting epidermal growth factor receptor (EGFR) on the surface of cancer cells, was approved by the FDA to treat patients with metastatic colorectal cancer. It is currently also in advanced-stage development for the treatment of several other solid tumors. Here we report for the first time the quantitative positron emission tomography (PET) imaging of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab. METHODS: We conjugated cetuximab with macrocyclic chelating agent 1,4,7,10-tetraazadodecane-N,N&apos;,N&apos;&apos;,N&apos;&apos;&apos;-tetraacetic acid (DOTA), labeled with 64Cu, and tested the resulting 64Cu-DOTA-cetuximab in seven xenograft tumor models. The tracer uptake measured by PET was correlated with the EGFR expression quantified by western blotting. The estimated human dosimetry based on the PET data in Sprague-Dawley rats was also calculated. RESULTS: MicroPET imaging showed that 64Cu-DOTA-cetuximab had increasing tumor activity accumulation over time in EGFR-positive tumors but relatively low uptake in EGFR-negative tumors at all times examined (&lt;5%ID/g). There was a good correlation (R2=0.80) between the tracer uptake (measured by PET) and the EGFR expression level (measured by western blotting). Human dosimetry estimation indicated that the tracer may be safely administered to human patients for tumor diagnosis, with the dose-limiting organ being the liver. CONCLUSION: The success of EGFR-positive tumor imaging using 64Cu-DOTA-cetuximab can be translated into the clinic to characterize the pharmacokinetics, to select the right population of patients for EGFR-targeted therapy, to monitor the therapeutic efficacy of anti-EGFR treatment, and to optimize the dosage of either cetuximab alone or cetuximab in combination with other therapeutic agents.</abstract><notes>Cai, Weibo&#xD;Chen, Kai&#xD;He, Lina&#xD;Cao, Qizhen&#xD;Koong, Albert&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;European journal of nuclear medicine and molecular imaging&#xD;Eur J Nucl Med Mol Imaging. 2007 Jun;34(6):850-8. Epub 2007 Jan 30.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>4.625</custom4><electronic-resource-num>10.1007/s00259-006-0361-6 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1070</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1070</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bailey, R. C.</author><author>Kwong, G. A.</author><author>Radu, C. G.</author><author>Witte, O. N.</author><author>Heath, J. R.</author></authors></contributors><auth-address>NanoSystems Biology Cancer Center: Division of Chemistry and Chemical Engineering, MC 127-72, California Institute of Technology, Pasadena, California 91125, USA.</auth-address><titles><title>DNA-encoded antibody libraries: a unified platform for multiplexed cell sorting and detection of genes and proteins</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>1959-67</pages><volume>129</volume><number>7</number><edition>2007/01/31</edition><keywords><keyword>Animals</keyword><keyword>Antibodies/chemistry/*genetics/immunology</keyword><keyword>Cell Line</keyword><keyword>DNA/chemistry/genetics</keyword><keyword>Flow Cytometry</keyword><keyword>*Gene Library</keyword><keyword>Immunoconjugates/chemistry/genetics/immunology</keyword><keyword>Immunoglobulin G/chemistry/genetics</keyword><keyword>Mice</keyword><keyword>Microfluidic Analytical Techniques</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>*Peptide Library</keyword><keyword>T-Lymphocytes/immunology</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb 21</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17260987</accession-num><abstract>Whether for pathological examination or for fundamental biology studies, different classes of biomaterials and biomolecules are each measured from a different region of a typically heterogeneous tissue sample, thus introducing unavoidable sources of noise that are hard to quantitate. We describe the method of DNA-encoded antibody libraries (DEAL) for spatially multiplexed detection of ssDNAs and proteins as well as for cell sorting, all on the same diagnostic platform. DEAL is based upon the coupling of ssDNA oligomers onto antibodies which are then combined with the biological sample of interest. Spotted DNA arrays, which are found to inhibit biofouling, are utilized to spatially stratify the biomolecules or cells of interest. We demonstrate the DEAL technique for (1) the rapid detection of multiple proteins within a single microfluidic channel, and, with the additional step of electroless amplification of gold-nanoparticle labeled secondary antibodies, we establish a detection limit of 10 fM for the protein IL-2, 150 times more sensitive than the analogue ELISA; (2) the multiplexed, on-chip sorting of both immortalized cell lines and primary immune cells with an efficiency that exceeds surface-confined panning approaches; and (3) the co-detection of ssDNAs, proteins, and cell populations on the same platform.</abstract><notes>Bailey, Ryan C&#xD;Kwong, Gabriel A&#xD;Radu, Caius G&#xD;Witte, Owen N&#xD;Heath, James R&#xD;5u54 ca119347/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2007 Feb 21;129(7):1959-67. Epub 2007 Jan 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17260987</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja065930i</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1356</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1356</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kudlay, A.</author><author>Gibbs, J. M.</author><author>Schatz, G. C.</author><author>Nguyen, S. T.</author><author>de la Cruz, M. O.</author></authors></contributors><auth-address>Northwestern University, Department of Chemistry, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA. kudlay@umd.edu</auth-address><titles><title>Sharp melting of polymer-DNA hybrids: an associative phase separation approach</title><secondary-title>J Phys Chem B</secondary-title></titles><periodical><full-title>J Phys Chem B</full-title></periodical><pages>1610-9</pages><volume>111</volume><number>7</number><edition>2007/01/30</edition><keywords><keyword>*Algorithms</keyword><keyword>DNA/*chemistry</keyword><keyword>Nucleic Acid Conformation</keyword><keyword>Nucleic Acid Denaturation</keyword><keyword>*Nucleic Acid Hybridization</keyword><keyword>*Phase Transition</keyword><keyword>Solutions/chemistry</keyword><keyword>Temperature</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb 22</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>17256893</accession-num><abstract>An associative equilibrium theory describing the sharp melting behavior of polymer-DNA hybrids is developed. The theory considers linear polymers with attached DNAs on each polymer that serve as &quot;stickers&quot; and with a two-state model governing the DNA melting equilibrium. For three or more oligonucleotides on each polymer, solutions of polymer-DNA hybrids are found to undergo phase separation at sufficiently low temperatures. The dense phase dissolves as temperature increases, which leads to a sharp increase in the fraction of non-hybridized DNA near the phase transition temperature, in agreement with experimental absorbance profiles at 260 nm. The melting temperature is predicted to have the same dependence on salt concentration as a solution of unattached DNAs and be weakly sensitive to the concentration of DNA in solution. The melting temperature is predicted to be higher than that of unattached DNA in solution, with the magnitude of the increase sensitive to the DNA hybridization cooperativity. The theoretical predictions are generally in good quantitative agreement with new experimental data (also presented here), which show the effect of the polymer-DNA hybrid length and salt concentration on the melting profiles.</abstract><notes>Kudlay, Alexander&#xD;Gibbs, Julianne M&#xD;Schatz, George C&#xD;Nguyen, SonBinh T&#xD;de la Cruz, Monica Olvera&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2007 Feb 22;111(7):1610-9. Epub 2007 Jan 26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17256893</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.688</custom4><electronic-resource-num>10.1021/jp0664667</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2371</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2371</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Cerignoli, F.</author><author>Tautz, L.</author><author>Rosato, N.</author><author>Bergamaschi, A.</author><author>Mustelin, T.</author></authors></contributors><auth-address>Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.</auth-address><titles><title>Adsorption of streptavidin onto single-walled carbon nanotubes: application in fluorescent supramolecular nanoassemblies</title><secondary-title>J Nanosci Nanotechnol</secondary-title></titles><periodical><full-title>J Nanosci Nanotechnol</full-title></periodical><pages>3693-8</pages><volume>6</volume><number>12</number><edition>2007/01/30</edition><keywords><keyword>Adsorption</keyword><keyword>Binding Sites</keyword><keyword>Biosensing Techniques/methods</keyword><keyword>Crystallization/methods</keyword><keyword>Fluorescent Dyes/ chemistry</keyword><keyword>Macromolecular Substances/chemistry</keyword><keyword>Materials Testing</keyword><keyword>Microscopy, Fluorescence/ methods</keyword><keyword>Molecular Conformation</keyword><keyword>Nanostructures/ chemistry/ ultrastructure</keyword><keyword>Nanotechnology/ methods</keyword><keyword>Particle Size</keyword><keyword>Protein Binding</keyword><keyword>Streptavidin/ chemistry/ ultrastructure</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1533-4880 (Print)</isbn><accession-num>17256317</accession-num><abstract>We report the solubilization of full-length single-walled carbon nanotubes into a physiological buffer by sonication in presence of streptavidin. Transmission electron microscopy showed that the resultant dispersion was enriched of individual/small ropes of nanotubes. By the analysis of the crystal structure of tetrameric streptavidin and of the tryptophan emission of adsorbed proteins we hypothesized that proteins adsorbed onto SWNT sidewalls through their amine functionalities. Our results suggested using streptavidin as an interlinker between carbon nanotubes and semiconducting nanocrystals. We fabricated a supramolecular luminescent nanoassembly composed of individual or small ropes of full-length single-walled carbon nanotubes decorated with streptavidin-conjugated quantum dots. The luminescent nanoassembly was stably dispersed under physiological conditions and was readily visible by optical fluorescent microscopies.</abstract><notes>Bottini, Massimo&#xD;Cerignoli, Fabio&#xD;Tautz, Lutz&#xD;Rosato, Nicola&#xD;Bergamaschi, Antonio&#xD;Mustelin, Tomas&#xD;U54 CA119335/CA/NCI NIH HHS/United States&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Journal of nanoscience and nanotechnology&#xD;J Nanosci Nanotechnol. 2006 Dec;6(12):3693-8.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom4>2.100</custom4><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1448</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1448</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mellinghoff, I. K.</author><author>Cloughesy, T. F.</author><author>Mischel, P. S.</author></authors></contributors><auth-address>Departments of Molecular and Medical Pharmacology, Neurology, and Pathology and Henry E. Singleton Brain Tumor Program, David Geffen School of Medicine, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.</auth-address><titles><title>PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors</title><secondary-title>Clin Cancer Res</secondary-title></titles><periodical><full-title>Clin Cancer Res</full-title></periodical><pages>378-81</pages><volume>13</volume><number>2 Pt 1</number><edition>2007/01/27</edition><keywords><keyword>1-Phosphatidylinositol 3-Kinase/metabolism</keyword><keyword>Animals</keyword><keyword>Brain Neoplasms/*metabolism</keyword><keyword>Enzyme Inhibitors/*pharmacology</keyword><keyword>Glioblastoma/*metabolism</keyword><keyword>Humans</keyword><keyword>Models, Biological</keyword><keyword>Neoplasms/metabolism</keyword><keyword>PTEN Phosphohydrolase/*physiology</keyword><keyword>Receptor, Epidermal Growth Factor/*antagonists &amp; inhibitors/*physiology</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 15</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>17255257</accession-num><abstract>Molecularly targeted therapies are transforming the treatment of cancer. Elucidating the dynamic signaling networks that underlie sensitivity and resistance to these inhibitors is critical for successful clinical application. There is considerable evidence to suggest that constitutively activating mutations in kinases that regulate cellular growth may result in tumor cell &quot;addiction&quot; and favorable response to targeted inhibition. However, there is emerging evidence to suggest that clinical response may also be determined by other changes in the molecular circuitry of cancer cells, such as loss of key tumor-suppressor proteins. Here, we will discuss resistance to epidermal growth factor receptor tyrosine kinase inhibitors in glioblastoma patients that is mediated by loss of the PTEN tumor-suppressor protein.</abstract><notes>Mellinghoff, Ingo K&#xD;Cloughesy, Tim F&#xD;Mischel, Paul S&#xD;Ca 108633/ca/nci&#xD;Ca 119347/ca/nci&#xD;Ns 050151/ns/ninds&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):378-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17255257</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>6.646</custom4><electronic-resource-num>13/2/378 [pii]&#xD;10.1158/1078-0432.CCR-06-1992</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1121</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1121</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Caruthers, S. D.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Consortium for Translational Research in Advanced Imaging and Nanomedicine, Washington University School of Medicine, 4444 Forest Park Avenue, Campus Box 8215, St Louis, MO 63108-2212, USA. scaruthers@cmrl.wustl.edu &lt;scaruthers@cmrl.wustl.edu&gt;</auth-address><titles><title>Nanotechnological applications in medicine</title><secondary-title>Curr Opin Biotechnol</secondary-title></titles><periodical><full-title>Curr Opin Biotechnol</full-title></periodical><pages>26-30</pages><volume>18</volume><number>1</number><edition>2007/01/27</edition><keywords><keyword>Drug Carriers/chemistry</keyword><keyword>Humans</keyword><keyword>Medicine/*trends</keyword><keyword>Nanomedicine/*trends</keyword><keyword>Nanostructures/chemistry</keyword><keyword>Nanotechnology/methods/*trends</keyword><keyword>Pharmaceutical Preparations/chemistry</keyword><keyword>Quantum Dots</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0958-1669 (Print)</isbn><accession-num>17254762</accession-num><abstract>Nanotechnology-based tools and techniques are rapidly emerging in the fields of medical imaging and targeted drug delivery. Employing constructs such as dendrimers, liposomes, nanoshells, nanotubes, emulsions and quantum dots, these advances lead toward the concept of personalized medicine and the potential for very early, even pre-symptomatic, diagnoses coupled with highly-effective targeted therapy. Highlighting clinically available and preclinical applications, this review explores the opportunities and issues surrounding nanomedicine.</abstract><notes>Caruthers, Shelton D&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;England&#xD;Current opinion in biotechnology&#xD;Curr Opin Biotechnol. 2007 Feb;18(1):26-30. Epub 2007 Jan 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17254762</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2007</custom3><custom4>7.744</custom4><electronic-resource-num>S0958-1669(07)00007-9 [pii]&#xD;10.1016/j.copbio.2007.01.006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1682</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1682</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ventura, A.</author><author>Kirsch, D. G.</author><author>McLaughlin, M. E.</author><author>Tuveson, D. A.</author><author>Grimm, J.</author><author>Lintault, L.</author><author>Newman, J.</author><author>Reczek, E. E.</author><author>Weissleder, R.</author><author>Jacks, T.</author></authors></contributors><auth-address>Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA.</auth-address><titles><title>Restoration of p53 function leads to tumour regression in vivo</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title></periodical><pages>661-5</pages><volume>445</volume><number>7128</number><edition>2007/01/26</edition><keywords><keyword>Alleles</keyword><keyword>Animals</keyword><keyword>Apoptosis</keyword><keyword>Cell Aging</keyword><keyword>Cell Division</keyword><keyword>Disease Models, Animal</keyword><keyword>Humans</keyword><keyword>Lymphoma/metabolism/pathology</keyword><keyword>Mice</keyword><keyword>Neoplasms/drug therapy/*metabolism/*pathology</keyword><keyword>Organ Specificity</keyword><keyword>Sarcoma/metabolism/pathology</keyword><keyword>Tumor Suppressor Protein p53/deficiency/genetics/*metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb 8</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>17251932</accession-num><abstract>Tumorigenesis is a multi-step process that requires activation of oncogenes and inactivation of tumour suppressor genes. Mouse models of human cancers have recently demonstrated that continuous expression of a dominantly acting oncogene (for example, Hras, Kras and Myc) is often required for tumour maintenance; this phenotype is referred to as oncogene addiction. This concept has received clinical validation by the development of active anticancer drugs that specifically inhibit the function of oncoproteins such as BCR-ABL, c-KIT and EGFR. Identifying additional gene mutations that are required for tumour maintenance may therefore yield clinically useful targets for new cancer therapies. Although loss of p53 function is a common feature of human cancers, it is not known whether sustained inactivation of this or other tumour suppressor pathways is required for tumour maintenance. To explore this issue, we developed a Cre-loxP-based strategy to temporally control tumour suppressor gene expression in vivo. Here we show that restoring endogenous p53 expression leads to regression of autochthonous lymphomas and sarcomas in mice without affecting normal tissues. The mechanism responsible for tumour regression is dependent on the tumour type, with the main consequence of p53 restoration being apoptosis in lymphomas and suppression of cell growth with features of cellular senescence in sarcomas. These results support efforts to treat human cancers by way of pharmacological reactivation of p53.</abstract><notes>Ventura, Andrea&#xD;Kirsch, David G&#xD;McLaughlin, Margaret E&#xD;Tuveson, David A&#xD;Grimm, Jan&#xD;Lintault, Laura&#xD;Newman, Jamie&#xD;Reczek, Elizabeth E&#xD;Weissleder, Ralph&#xD;Jacks, Tyler&#xD;England&#xD;Nature&#xD;Nature. 2007 Feb 8;445(7128):661-5. Epub 2007 Jan 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17251932</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>31.210</custom4><electronic-resource-num>nature05541 [pii]&#xD;10.1038/nature05541</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1345</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1345</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kowalczyk, J.</author><author>Barski, P.</author><author>Witt, D.</author><author>Grzybowski, B. A.</author></authors></contributors><auth-address>ProChimia Surfaces, ul. Zacisze 2, 81-823 Sopot, Poland.</auth-address><titles><title>Versatile and efficient synthesis of omega-functionalized asymmetric disulfides via sulfenyl bromide adducts</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>2318-21</pages><volume>23</volume><number>5</number><edition>2007/01/26</edition><keywords><keyword>Bromides/*chemistry</keyword><keyword>Catalysis</keyword><keyword>Chemistry, Physical/*methods</keyword><keyword>Disulfides/*chemistry</keyword><keyword>Electrochemistry/methods</keyword><keyword>Models, Chemical</keyword><keyword>Molecular Structure</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb 27</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>17249705</accession-num><abstract>Various types of asymmetric disulfides can be synthesized under mild conditions and in excellent yields by a method involving dialkoxylthiophosphoranesulfenyl halide precursors. This straightforward, rapid procedure is used to prepare a series of disulfides bearing neutral, acidic, and basic terminal groups as well as groups commonly used in biospecific self-assembled monolayers.</abstract><notes>Kowalczyk, Janusz&#xD;Barski, Piotr&#xD;Witt, Dariusz&#xD;Grzybowski, Bartosz A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2007 Feb 27;23(5):2318-21. Epub 2007 Jan 24.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17249705</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.347</custom4><electronic-resource-num>10.1021/la063013k</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2221</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2221</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCarthy, J. R.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, 149 13th St., Rm 5406, Charlestown, MA 02129, USA. jason_mccarthy@hms.harvard.edu</auth-address><titles><title>Model systems for fluorescence and singlet oxygen quenching by metalloporphyrins</title><secondary-title>ChemMedChem</secondary-title></titles><periodical><full-title>ChemMedChem</full-title></periodical><pages>360-5</pages><volume>2</volume><number>3</number><edition>2007/01/25</edition><keywords><keyword>Algorithms</keyword><keyword>Cations</keyword><keyword>Copper/chemistry</keyword><keyword>Dimerization</keyword><keyword>Energy Transfer</keyword><keyword>Fluorescence</keyword><keyword>Metalloporphyrins/ chemistry</keyword><keyword>Metals/ chemistry</keyword><keyword>Nickel/chemistry</keyword><keyword>Palladium/chemistry</keyword><keyword>Photochemotherapy/ methods</keyword><keyword>Silver/chemistry</keyword><keyword>Singlet Oxygen/ chemistry</keyword><keyword>Spectrometry, Fluorescence/methods</keyword><keyword>Spectrophotometry, Ultraviolet/methods</keyword><keyword>Zinc/chemistry</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1860-7187 (Electronic)</isbn><accession-num>17245681</accession-num><abstract>Next-generation photodynamic therapy agents will minimize extraneous phototoxicity by being active only at the target site. To this end, we have developed a model system to systematically investigate the excited-state quenching ability of a number of metalloporphyrins. Central metal ions that prefer four-coordinate, square planar orientations (Ag(II), Cu(II), Ni(II), Pd(II), and Zn(II)) were used. Porphyrin dimers based on 5-(4-aminophenyl)-10,15,20-triphenylporphyrin and comprising both a free base porphyrin and a metalloporphyrin covalently linked through a five-carbon alkyl chain were synthesized. The fluorescence and singlet oxygen quantum yields for the dimers were probed at 630 and 650 nm, respectively, resulting in the excitation of only the free base porphyrin and allowing a comparison of the quenching efficacy of each central metal ion. These results demonstrate that metalloporphyrins can serve as efficient quenchers, and may be useful in the design of novel light-activated therapeutic agents.</abstract><notes>McCarthy, Jason R&#xD;Weissleder, Ralph&#xD;U54-CA119349-01/CA/NCI NIH HHS/United States&#xD;UO1-HL080731-02/HL/NHLBI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;ChemMedChem&#xD;ChemMedChem. 2007 Mar;2(3):360-5.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom4>3.150</custom4><electronic-resource-num>10.1002/cmdc.200600244 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1351</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1351</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Krauland, E. M.</author><author>Peelle, B. R.</author><author>Wittrup, K. D.</author><author>Belcher, A. M.</author></authors></contributors><auth-address>Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.</auth-address><titles><title>Peptide tags for enhanced cellular and protein adhesion to single-crystalline sapphire</title><secondary-title>Biotechnol Bioeng</secondary-title></titles><periodical><full-title>Biotechnol Bioeng</full-title></periodical><pages>1009-20</pages><volume>97</volume><number>5</number><edition>2007/01/24</edition><keywords><keyword>Affinity Labels/*chemistry</keyword><keyword>Aluminum Oxide/*chemistry</keyword><keyword>Binding Sites</keyword><keyword>Cell Adhesion/*physiology</keyword><keyword>Cell Culture Techniques/methods</keyword><keyword>Coated Materials, Biocompatible/*chemistry</keyword><keyword>Peptide Library</keyword><keyword>Peptides/*chemistry</keyword><keyword>Protein Binding</keyword><keyword>Saccharomyces cerevisiae/*physiology</keyword><keyword>Saccharomyces cerevisiae Proteins/chemistry/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0006-3592 (Print)</isbn><accession-num>17238208</accession-num><abstract>In order to facilitate a novel means for coupling proteins to metal oxides, peptides were identified from a dodecamer peptide yeast surface display library that bound a model metal oxide material, the C, A, and R crystalline faces of synthetic sapphire (alpha-Al(2)O(3)). Seven rounds of screening yielded peptides enriched in basic amino acids compared to the naive library. While the C-face had a high background of endogenous yeast cell binding, the A- and R faces displayed clear peptide-mediated cell adhesion. Cell detachment assays showed that cell adhesion strength correlated positively with increasing basicity of expressed peptides. Cell adhesion was also shown to be sensitive to buffer ionic strength as well as incubation with soluble peptide (with half maximal inhibition of cell binding at approximately 5 microM peptide). Next, dodecamer peptides cloned into yeast showed that lysine led to stronger interactions than arginine, and that charge distribution affected adhesion strength. We postulate binding to arise from peptide geometries that permit conformation alignment of the basic amino acids towards the surface so that the charged groups can undergo local electrostatic interactions with the surface oxide. Lastly, peptide K1 (-(GK)(6)) was cloned onto the c-terminus of maltose binding protein (MBP) and the resultant mutant protein showed a half-maximal binding at approximately 10(-7)-10(-6) M, which marked a approximately 500- to 1,000-fold binding improvement to sapphire&apos;s A-face as compared with wild-type MBP. Targeting proteins to metal oxide surfaces with peptide tags may provide a facile one-step alternative coupling chemistry for the formation of protein bioassays and biosensors.</abstract><notes>Krauland, Eric M&#xD;Peelle, Beau R&#xD;Wittrup, K Dane&#xD;Belcher, Angela M&#xD;T32 GM 008334/GM/United States NIGMS&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Biotechnology and bioengineering&#xD;Biotechnol Bioeng. 2007 Aug 1;97(5):1009-20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17238208</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>2.499</custom4><electronic-resource-num>10.1002/bit.21341</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1248</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1248</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>He, X. C.</author><author>Yin, T.</author><author>Grindley, J. C.</author><author>Tian, Q.</author><author>Sato, T.</author><author>Tao, W. A.</author><author>Dirisina, R.</author><author>Porter-Westpfahl, K. S.</author><author>Hembree, M.</author><author>Johnson, T.</author><author>Wiedemann, L. M.</author><author>Barrett, T. A.</author><author>Hood, L.</author><author>Wu, H.</author><author>Li, L.</author></authors></contributors><auth-address>Stowers Institute for Medical Research, Kansas City, Missouri 64110, USA.</auth-address><titles><title>PTEN-deficient intestinal stem cells initiate intestinal polyposis</title><secondary-title>Nat Genet</secondary-title></titles><periodical><full-title>Nat Genet</full-title></periodical><pages>189-98</pages><volume>39</volume><number>2</number><edition>2007/01/24</edition><keywords><keyword>Animals</keyword><keyword>Cell Count</keyword><keyword>Cell Cycle</keyword><keyword>Cell Nucleus/metabolism</keyword><keyword>Intestinal Polyps/*genetics</keyword><keyword>Intestines/*metabolism</keyword><keyword>Mice</keyword><keyword>PTEN Phosphohydrolase/genetics/metabolism/*physiology</keyword><keyword>Phosphorylation</keyword><keyword>Proto-Oncogene Proteins c-akt/metabolism</keyword><keyword>Stem Cells/*metabolism</keyword><keyword>beta Catenin/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1061-4036 (Print)</isbn><accession-num>17237784</accession-num><abstract>Intestinal polyposis, a precancerous neoplasia, results primarily from an abnormal increase in the number of crypts, which contain intestinal stem cells (ISCs). In mice, widespread deletion of the tumor suppressor Phosphatase and tensin homolog (PTEN) generates hamartomatous intestinal polyps with epithelial and stromal involvement. Using this model, we have established the relationship between stem cells and polyp and tumor formation. PTEN helps govern the proliferation rate and number of ISCs and loss of PTEN results in an excess of ISCs. In PTEN-deficient mice, excess ISCs initiate de novo crypt formation and crypt fission, recapitulating crypt production in fetal and neonatal intestine. The PTEN-Akt pathway probably governs stem cell activation by helping control nuclear localization of the Wnt pathway effector beta-catenin. Akt phosphorylates beta-catenin at Ser552, resulting in a nuclear-localized form in ISCs. Our observations show that intestinal polyposis is initiated by PTEN-deficient ISCs that undergo excessive proliferation driven by Akt activation and nuclear localization of beta-catenin.</abstract><notes>He, Xi C&#xD;Yin, Tong&#xD;Grindley, Justin C&#xD;Tian, Qiang&#xD;Sato, Toshiro&#xD;Tao, W Andy&#xD;Dirisina, Raminarao&#xD;Porter-Westpfahl, Kimberly S&#xD;Hembree, Mark&#xD;Johnson, Teri&#xD;Wiedemann, Leanne M&#xD;Barrett, Terrence A&#xD;Hood, Leroy&#xD;Wu, Hong&#xD;Li, Linheng&#xD;R01 dk070001/dk/niddk&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature genetics&#xD;Nat Genet. 2007 Feb;39(2):189-98. Epub 2007 Jan 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17237784</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>26.446</custom4><electronic-resource-num>ng1928 [pii]&#xD;10.1038/ng1928</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1533</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1533</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rao, J.</author><author>Dragulescu-Andrasi, A.</author><author>Yao, H.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology &amp; Bio-X Program, Cancer Biology Program, Stanford University School of Medicine, 1201 Welch Road, Stanford, California 94305-5484, USA. jrao@stanford.edu &lt;jrao@stanford.edu&gt;</auth-address><titles><title>Fluorescence imaging in vivo: recent advances</title><secondary-title>Curr Opin Biotechnol</secondary-title></titles><periodical><full-title>Curr Opin Biotechnol</full-title></periodical><pages>17-25</pages><volume>18</volume><number>1</number><edition>2007/01/20</edition><keywords><keyword>Animals</keyword><keyword>*Diagnostic Imaging</keyword><keyword>*Fluorescence</keyword><keyword>Fluorescent Dyes</keyword><keyword>Humans</keyword><keyword>Infrared Rays</keyword><keyword>Nanoparticles</keyword><keyword>Quantum Dots</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0958-1669 (Print)</isbn><accession-num>17234399</accession-num><abstract>In vivo fluorescence imaging uses a sensitive camera to detect fluorescence emission from fluorophores in whole-body living small animals. To overcome the photon attenuation in living tissue, fluorophores with long emission at the near-infrared (NIR) region are generally preferred, including widely used small indocarbocyanine dyes. The list of NIR probes continues to grow with the recent addition of fluorescent organic, inorganic and biological nanoparticles. Recent advances in imaging strategies and reporter techniques for in vivo fluorescence imaging include novel approaches to improve the specificity and affinity of the probes and to modulate and amplify the signal at target sites for enhanced sensitivity. Further emerging developments are aiming to achieve high-resolution, multimodality and lifetime-based in vivo fluorescence imaging.</abstract><notes>Rao, Jianghong&#xD;Dragulescu-Andrasi, Anca&#xD;Yao, Hequan&#xD;1u54ca119367-01/ca/nci&#xD;Eb3803/eb/nibib&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;England&#xD;Current opinion in biotechnology&#xD;Curr Opin Biotechnol. 2007 Feb;18(1):17-25. Epub 2007 Jan 17.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17234399</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>7.744</custom4><electronic-resource-num>S0958-1669(07)00004-3 [pii]&#xD;10.1016/j.copbio.2007.01.003</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1507</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1507</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Perez, O. D.</author><author>Mitchell, D.</author><author>Nolan, G. P.</author></authors></contributors><auth-address>The Baxter Laboratory for Genetic Pharmacology, Stanford University School of Medicine, Stanford, CA 94305, USA. Omar.Perez@nodalityinc.com</auth-address><titles><title>Differential role of ICAM ligands in determination of human memory T cell differentiation</title><secondary-title>BMC Immunol</secondary-title></titles><periodical><full-title>BMC Immunol</full-title></periodical><pages>2</pages><volume>8</volume><edition>2007/01/20</edition><keywords><keyword>Antigens, CD28/immunology/metabolism</keyword><keyword>Antigens, CD3/immunology/metabolism</keyword><keyword>Antigens, CD45/immunology/metabolism</keyword><keyword>Caspase 3/immunology/metabolism</keyword><keyword>Cell Adhesion Molecules/*immunology</keyword><keyword>Cell Differentiation/*immunology</keyword><keyword>Cells, Cultured</keyword><keyword>Flow Cytometry</keyword><keyword>Humans</keyword><keyword>*Immunologic Memory</keyword><keyword>Ligands</keyword><keyword>Lymphocyte Activation/immunology</keyword><keyword>Lymphocyte Function-Associated Antigen-1/immunology/metabolism</keyword><keyword>T-Lymphocytes/*cytology/*immunology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1471-2172 (Electronic)</isbn><accession-num>17233909</accession-num><abstract>BACKGROUND: Leukocyte Function Antigen-1 (LFA-1) is a primary adhesion molecule that plays important roles in T cell activation, leukocyte recirculation, and trans-endothelial migration. By applying a multivariate intracellular phospho-proteomic analysis, we demonstrate that LFA-1 differentially activates signaling molecules. RESULTS: Signal intensity was dependent on both ICAM ligand and LFA-1 concentration. In the presence of CD3 and CD28 stimulation, ICAM-2 and ICAM-3 decreased TGFbeta1 production more than ICAM-1. In long-term differentiation experiments, stimulation with ICAM-3, CD3, and CD28 generated IFNgamma producing CD4+CD45RO+CD62L-CD11aBrightCD27- cells that had increased expression of intracellular BCL2, displayed distinct chemokine receptor profiles, and exhibited distinct migratory characteristics. Only CD3/CD28 with ICAM-3 generated CD4+CD45RO+CD62L-CD11aBrightCD27- cells that were functionally responsive to chemotaxis and exhibited higher frequencies of cells that signaled to JNK and ERK1/2 upon stimulation with MIP3alpha. Furthermore, these reports identify that the LFA-1 receptor, when presented with multiple ligands, can result in distinct T cell differentiation states and suggest that the combinatorial integration of ICAM ligand interactions with LFA-1 have functional consequences for T cell biology. CONCLUSION: Thus, the ICAM ligands, differentially modulate LFA-1 signaling in T cells and potentiate the development of memory human T cells in vitro. These findings are of importance in a mechanistic understanding of memory cell differentiation and ex vivo generation of memory cell subsets for therapeutic applications.</abstract><notes>Perez, Omar D&#xD;Mitchell, Dennis&#xD;Nolan, Garry P&#xD;A1/GF41520-01/GF/United States NIH&#xD;AI35304/AI/United States NIAID&#xD;AR44565/AR/United States NIAMS&#xD;N01-AR-6-2227/AR/United States NIAMS&#xD;N01-HV-28183I/HV/United States NHLBI&#xD;P01-AI39646/AI/United States NIAID&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;BMC immunology&#xD;BMC Immunol. 2007 Jan 18;8:2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17233909</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>2.661</custom4><electronic-resource-num>1471-2172-8-2 [pii]&#xD;10.1186/1471-2172-8-2</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1054</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1054</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Aikawa, E.</author><author>Nahrendorf, M.</author><author>Sosnovik, D.</author><author>Lok, V. M.</author><author>Jaffer, F. A.</author><author>Aikawa, M.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass 02129, USA. eaikawa@partners.org</auth-address><titles><title>Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease</title><secondary-title>Circulation</secondary-title></titles><periodical><full-title>Circulation</full-title></periodical><pages>377-86</pages><volume>115</volume><number>3</number><edition>2007/01/17</edition><keywords><keyword>Animals</keyword><keyword>Aortic Valve Stenosis/pathology/*physiopathology</keyword><keyword>Apolipoproteins E/genetics/physiology</keyword><keyword>Atherosclerosis/pathology/*physiopathology</keyword><keyword>Calcinosis/pathology/physiopathology</keyword><keyword>Calcium/metabolism</keyword><keyword>Endothelium, Vascular/pathology/physiopathology</keyword><keyword>Enzyme Activation/physiology</keyword><keyword>Fibroblasts/pathology/physiology</keyword><keyword>Gene Expression Profiling</keyword><keyword>Hypercholesterolemia/pathology/physiopathology</keyword><keyword>Macrophage Activation/physiology</keyword><keyword>Macrophages/pathology/physiology</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Knockout</keyword><keyword>Osteoblasts/pathology/physiology</keyword><keyword>Osteogenesis/*physiology</keyword><keyword>Peptide Hydrolases/*physiology</keyword><keyword>Predictive Value of Tests</keyword><keyword>Spectroscopy, Near-Infrared/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 23</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>17224478</accession-num><abstract>BACKGROUND: Visualizing early changes in valvular cell functions in vivo may predict the future risk and identify therapeutic targets for prevention of aortic valve stenosis. METHODS AND RESULTS: To test the hypotheses that (1) aortic stenosis shares a similar pathogenesis to atherosclerosis and (2) molecular imaging can detect early changes in aortic valve disease, we used in vivo a panel of near-infrared fluorescence imaging agents to map endothelial cells, macrophages, proteolysis, and osteogenesis in aortic valves of hypercholesterolemic apolipoprotein E-deficient mice (30 weeks old, n=30). Apolipoprotein E-deficient mice with no probe injection (n=10) and wild-type mice (n=10) served as controls. Valves of apolipoprotein E-deficient mice contained macrophages, were thicker than wild-type mice (P&lt;0.001), and showed early dysfunction detected by MRI in vivo. Fluorescence imaging detected uptake of macrophage-targeted magnetofluorescent nanoparticles (24 hours after injection) in apolipoprotein E-deficient valves, which was negligible in controls (P&lt;0.01). Valvular macrophages showed proteolytic activity visualized by protease-activatable near-infrared fluorescence probes. Ex vivo magnetic resonance imaging enhanced with vascular cell adhesion molecule-1-targeted nanoparticles detected endothelial activation in valve commissures, the regions of highest mechanical stress. Osteogenic near-infrared fluorescence signals colocalized with alkaline phosphatase activity and expression of osteopontin, osteocalcin, Runx2/Cbfa1, Osterix, and Notch1 despite no evidence of calcium deposits, which suggests ongoing active processes of osteogenesis in inflamed valves. Notably, the aortic wall contained advanced calcification. Quantitative image analysis correlated near-infrared fluorescence signals with immunoreactive vascular cell adhesion molecule-1, macrophages, and cathepsin-B (P&lt;0.001). CONCLUSIONS: Molecular imaging can detect in vivo the key cellular events in early aortic valve disease, including endothelial cell and macrophage activation, proteolytic activity, and osteogenesis.</abstract><notes>Aikawa, Elena&#xD;Nahrendorf, Matthias&#xD;Sosnovik, David&#xD;Lok, Vincent M&#xD;Jaffer, Farouc A&#xD;Aikawa, Masanori&#xD;Weissleder, Ralph&#xD;R01-HL078641/HL/United States NHLBI&#xD;U01-HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Circulation&#xD;Circulation. 2007 Jan 23;115(3):377-86. Epub 2007 Jan 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17224478</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>13.538</custom4><electronic-resource-num>CIRCULATIONAHA.106.654913 [pii]&#xD;10.1161/CIRCULATIONAHA.106.654913</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1669</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1669</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tu, L. C.</author><author>Yan, X.</author><author>Hood, L.</author><author>Lin, B.</author></authors></contributors><auth-address>Institute for Systems Biology, Seattle, Washington 98103, USA.</auth-address><titles><title>Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells</title><secondary-title>Mol Cell Proteomics</secondary-title></titles><periodical><full-title>Mol Cell Proteomics</full-title></periodical><pages>575-88</pages><volume>6</volume><number>4</number><edition>2007/01/16</edition><keywords><keyword>Androgens/*metabolism/pharmacology</keyword><keyword>Cadherins/metabolism</keyword><keyword>Cell Cycle Proteins/chemistry/genetics/*metabolism</keyword><keyword>Cell Line, Tumor</keyword><keyword>Endoplasmic Reticulum/metabolism</keyword><keyword>Humans</keyword><keyword>Immunoprecipitation</keyword><keyword>Intracellular Signaling Peptides and</keyword><keyword>Proteins/chemistry/genetics/*metabolism</keyword><keyword>Male</keyword><keyword>Models, Biological</keyword><keyword>Neoplasms, Hormone-Dependent/etiology/genetics/metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Prostatic Neoplasms/etiology/genetics/*metabolism</keyword><keyword>Protein Binding</keyword><keyword>Protein Interaction Mapping</keyword><keyword>Proteomics</keyword><keyword>Tandem Mass Spectrometry</keyword><keyword>beta Catenin/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1535-9476 (Print)</isbn><accession-num>17220478</accession-num><abstract>NDRG1 is known to play important roles in both androgen-induced cell differentiation and inhibition of prostate cancer metastasis. However, the proteins associated with NDRG1 function are not fully enumerated. Using coimmunoprecipitation and mass spectrometry analysis, we identified 58 proteins that interact with NDRG1 in prostate cancer cells. These proteins include nuclear proteins, adhesion molecules, endoplasmic reticulum (ER) chaperons, proteasome subunits, and signaling proteins. Integration of our data with protein-protein interaction data from the Human Proteome Reference Database allowed us to build a comprehensive interactome map of NDRG1. This interactome map consists of several modules such as a nuclear module and a cell membrane module; these modules explain the reported versatile functions of NDRG1. We also determined that serine 330 and threonine 366 of NDRG1 were phosphorylated and demonstrated that the phosphorylation of NDRG1 was prominently mediated by protein kinase A (PKA). Further, we showed that NDRG1 directly binds to beta-catenin and E-cadherin. However, the phosphorylation of NDRG1 did not interrupt the binding of NDRG1 to E-cadherin and beta-catenin. Finally, we showed that the inhibition of NDRG1 expression by RNA interference decreased the ER inducible chaperon GRP94 expression, directly proving that NDRG1 is involved in the ER stress response. Intriguingly, we observed that many members of the NDRG1 interactome are androgen-regulated and that the NDRG1 interactome links to the androgen response network through common interactions with beta-catenin and heat shock protein 90. Therefore we overlaid the transcriptomic expression changes in the NDRG1 interactome in response to androgen treatment and built a dual dynamic picture of the NDRG1 interactome in response to androgen. This interactome map provides the first road map for understanding the functions of NDRG1 in cells and its roles in human diseases, such as prostate cancer, which can progress from androgen-dependent curable stages to androgen-independent incurable stages.</abstract><notes>Tu, Lan Chun&#xD;Yan, Xiaowei&#xD;Hood, Leroy&#xD;Lin, Biaoyang&#xD;1p50gm076547/gm/nigms&#xD;1u54ca119347/ca/nci&#xD;1u54da021519/da/nida&#xD;5p01ca085859/ca/nci&#xD;5p50ca097186/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular &amp; cellular proteomics : MCP&#xD;Mol Cell Proteomics. 2007 Apr;6(4):575-88. Epub 2007 Jan 12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17220478</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>9.391</custom4><electronic-resource-num>M600249-MCP200 [pii]&#xD;10.1074/mcp.M600249-MCP200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1575</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1575</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shen, W. H.</author><author>Balajee, A. S.</author><author>Wang, J.</author><author>Wu, H.</author><author>Eng, C.</author><author>Pandolfi, P. P.</author><author>Yin, Y.</author></authors></contributors><auth-address>Department of Radiation Oncology, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.</auth-address><titles><title>Essential role for nuclear PTEN in maintaining chromosomal integrity</title><secondary-title>Cell</secondary-title></titles><periodical><full-title>Cell</full-title></periodical><pages>157-70</pages><volume>128</volume><number>1</number><edition>2007/01/16</edition><keywords><keyword>Animals</keyword><keyword>Cell Nucleus/*metabolism</keyword><keyword>Centromere/metabolism</keyword><keyword>*Chromosomal Instability</keyword><keyword>Chromosomal Proteins, Non-Histone/metabolism</keyword><keyword>Chromosomes, Mammalian/*metabolism</keyword><keyword>DNA Breaks, Double-Stranded</keyword><keyword>DNA Repair</keyword><keyword>E2F1 Transcription Factor/metabolism</keyword><keyword>Fibroblasts/cytology</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mutant Proteins/metabolism</keyword><keyword>PTEN Phosphohydrolase/deficiency/*metabolism</keyword><keyword>Protein Binding</keyword><keyword>Protein Transport</keyword><keyword>Rad51 Recombinase/metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 12</date></pub-dates></dates><isbn>0092-8674 (Print)</isbn><accession-num>17218262</accession-num><abstract>A broad spectrum of mutations in PTEN, encoding a lipid phosphatase that inactivates the P13-K/AKT pathway, is found associated with primary tumors. Some of these mutations occur outside the phosphatase domain, suggesting that additional activities of PTEN function in tumor suppression. We report a nuclear function for PTEN in controlling chromosomal integrity. Disruption of Pten leads to extensive centromere breakage and chromosomal translocations. PTEN was found localized at centromeres and physically associated with CENP-C, an integral component of the kinetochore. C-terminal PTEN mutants disrupt the association of PTEN with centromeres and cause centromeric instability. Furthermore, Pten null cells exhibit spontaneous DNA double-strand breaks (DSBs). We show that PTEN acts on chromatin and regulates expression of Rad51, which reduces the incidence of spontaneous DSBs. Our results demonstrate that PTEN plays a fundamental role in the maintenance of chromosomal stability through the physical interaction with centromeres and control of DNA repair. We propose that PTEN acts as a guardian of genome integrity.</abstract><notes>Shen, Wen Hong&#xD;Balajee, Adayabalam S&#xD;Wang, Jianli&#xD;Wu, Hong&#xD;Eng, Charis&#xD;Pandolfi, Pier Paolo&#xD;Yin, Yuxin&#xD;R01 ca093677/ca/nci&#xD;R01 ca102447/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Cell&#xD;Cell. 2007 Jan 12;128(1):157-70.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17218262</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>30.149</custom4><electronic-resource-num>S0092-8674(06)01553-4 [pii]&#xD;10.1016/j.cell.2006.11.042</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1643</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1643</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Swirski, F. K.</author><author>Libby, P.</author><author>Aikawa, E.</author><author>Alcaide, P.</author><author>Luscinskas, F. W.</author><author>Weissleder, R.</author><author>Pittet, M. J.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA. mpittet@hms.harvard.edu</auth-address><titles><title>Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata</title><secondary-title>J Clin Invest</secondary-title></titles><periodical><full-title>J Clin Invest</full-title></periodical><pages>195-205</pages><volume>117</volume><number>1</number><edition>2007/01/04</edition><keywords><keyword>Animals</keyword><keyword>Antibodies, Monoclonal</keyword><keyword>Antigens, Ly/*immunology</keyword><keyword>Apolipoproteins E/blood/deficiency/genetics</keyword><keyword>Atherosclerosis/*blood/genetics</keyword><keyword>Disease Models, Animal</keyword><keyword>Flow Cytometry</keyword><keyword>Hypercholesterolemia/*blood</keyword><keyword>Macrophages/*cytology/*physiology</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Knockout</keyword><keyword>Monocytes/cytology/physiology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0021-9738 (Print)</isbn><accession-num>17200719</accession-num><abstract>Macrophage accumulation participates decisively in the development and exacerbation of atherosclerosis. Circulating monocytes, the precursors of macrophages, display heterogeneity in mice and humans, but their relative contribution to atherogenesis remains unknown. We report here that the Ly-6C(hi) monocyte subset increased dramatically in hypercholesterolemic apoE-deficient mice consuming a high-fat diet, with the number of Ly-6C(hi) cells doubling in the blood every month. Ly-6C(hi) monocytes adhered to activated endothelium, infiltrated lesions, and became lesional macrophages. Hypercholesterolemia-associated monocytosis (HAM) developed from increased survival, continued cell proliferation, and impaired Ly-6C(hi) to Ly-6C(lo) conversion and subsided upon statin-induced cholesterol reduction. Conversely, the number of Ly-6C(lo) cells remained unaffected. Thus, we believe that Ly-6C(hi) monocytes represent a newly recognized component of the inflammatory response in experimental atherosclerosis.</abstract><notes>Swirski, Filip K&#xD;Libby, Peter&#xD;Aikawa, Elena&#xD;Alcaide, Pilar&#xD;Luscinskas, F William&#xD;Weissleder, Ralph&#xD;Pittet, Mikael J&#xD;HL36028/HL/United States NHLBI&#xD;HL53393/HL/United States NHLBI&#xD;P01-A154904/United States PHS&#xD;R01HL034636/HL/United States NHLBI&#xD;R24 CA69246/CA/United States NCI&#xD;U01 HL080731/HL/United States NHLBI&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of clinical investigation&#xD;J Clin Invest. 2007 Jan;117(1):195-205.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17200719</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2007</custom3><custom4>17.089</custom4><electronic-resource-num>10.1172/JCI29950</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1432</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1432</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mallick, P.</author><author>Schirle, M.</author><author>Chen, S. S.</author><author>Flory, M. R.</author><author>Lee, H.</author><author>Martin, D.</author><author>Ranish, J.</author><author>Raught, B.</author><author>Schmitt, R.</author><author>Werner, T.</author><author>Kuster, B.</author><author>Aebersold, R.</author></authors></contributors><auth-address>Institute for Systems Biology, 1441 N. 34th Street, Seattle, Washington 98103, USA.</auth-address><titles><title>Computational prediction of proteotypic peptides for quantitative proteomics</title><secondary-title>Nat Biotechnol</secondary-title></titles><periodical><full-title>Nat Biotechnol</full-title></periodical><pages>125-31</pages><volume>25</volume><number>1</number><edition>2007/01/02</edition><keywords><keyword>*Algorithms</keyword><keyword>Gene Expression Profiling/*methods</keyword><keyword>Mass Spectrometry/*methods</keyword><keyword>Peptide Mapping/*methods</keyword><keyword>Peptides/analysis/*chemistry</keyword><keyword>Proteome/analysis/*chemistry</keyword><keyword>Sequence Analysis, Protein/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1087-0156 (Print)</isbn><accession-num>17195840</accession-num><abstract>Mass spectrometry-based quantitative proteomics has become an important component of biological and clinical research. Although such analyses typically assume that a protein&apos;s peptide fragments are observed with equal likelihood, only a few so-called &apos;proteotypic&apos; peptides are repeatedly and consistently identified for any given protein present in a mixture. Using &gt;600,000 peptide identifications generated by four proteomic platforms, we empirically identified &gt;16,000 proteotypic peptides for 4,030 distinct yeast proteins. Characteristic physicochemical properties of these peptides were used to develop a computational tool that can predict proteotypic peptides for any protein from any organism, for a given platform, with &gt;85% cumulative accuracy. Possible applications of proteotypic peptides include validation of protein identifications, absolute quantification of proteins, annotation of coding sequences in genomes, and characterization of the physical principles governing key elements of mass spectrometric workflows (e.g., digestion, chromatography, ionization and fragmentation).</abstract><notes>Mallick, Parag&#xD;Schirle, Markus&#xD;Chen, Sharon S&#xD;Flory, Mark R&#xD;Lee, Hookeun&#xD;Martin, Daniel&#xD;Ranish, Jeffrey&#xD;Raught, Brian&#xD;Schmitt, Robert&#xD;Werner, Thilo&#xD;Kuster, Bernhard&#xD;Aebersold, Ruedi&#xD;N01-hv-28179/hv/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Nature biotechnology&#xD;Nat Biotechnol. 2007 Jan;25(1):125-31. Epub 2006 Dec 31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17195840</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>25.329</custom4><electronic-resource-num>nbt1275 [pii]&#xD;10.1038/nbt1275</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1600</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1600</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Simberg, D.</author><author>Duza, T.</author><author>Park, J. H.</author><author>Essler, M.</author><author>Pilch, J.</author><author>Zhang, L.</author><author>Derfus, A. M.</author><author>Yang, M.</author><author>Hoffman, R. M.</author><author>Bhatia, S.</author><author>Sailor, M. J.</author><author>Ruoslahti, E.</author></authors></contributors><auth-address>Cancer Research Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.</auth-address><titles><title>Biomimetic amplification of nanoparticle homing to tumors</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title><alt-title>Proceedings of the National Academy of Sciences of the United States of America</alt-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><alt-periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></alt-periodical><pages>932-6</pages><volume>104</volume><number>3</number><edition>2007/01</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Biomimetics/*methods</keyword><keyword>Cell Line, Tumor</keyword><keyword>Liver/drug effects</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>*Nanoparticles/chemistry/diagnostic use</keyword><keyword>Neoplasms/blood supply/*diagnosis</keyword><keyword>Neovascularization, Pathologic</keyword><keyword>Peptides/chemistry/diagnostic use/pharmacology</keyword><keyword>Thrombosis/chemically induced/pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 16</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17215365</accession-num><abstract>Nanoparticle-based diagnostics and therapeutics hold great promise because multiple functions can be built into the particles. One such function is an ability to home to specific sites in the body. We describe here biomimetic particles that not only home to tumors, but also amplify their own homing. The system is based on a peptide that recognizes clotted plasma proteins and selectively homes to tumors, where it binds to vessel walls and tumor stroma. Iron oxide nanoparticles and liposomes coated with this tumor-homing peptide accumulate in tumor vessels, where they induce additional local clotting, thereby producing new binding sites for more particles. The system mimics platelets, which also circulate freely but accumulate at a diseased site and amplify their own accumulation at that site. The self-amplifying homing is a novel function for nanoparticles. The clotting-based amplification greatly enhances tumor imaging, and the addition of a drug carrier function to the particles is envisioned.</abstract><notes>Ca 099258/ca/nci&#xD;Ca 119335/ca/nci&#xD;N01 co 37117/co/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17215365 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom2>Yes- MIT and UCSD</custom2><custom3>2007</custom3><custom4>10.228</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1558</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1558</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schwartz, M. P.</author><author>Alvarez, S. D.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Sailor, MJ&#xD;Univ Calif San Diego, Dept Biochem &amp; Chem, 9500 Gilman Dr,Dept 0358, La Jolla, CA 92093 USA&#xD;Univ Calif San Diego, Dept Biochem &amp; Chem, La Jolla, CA 92093 USA</auth-address><titles><title>Porous SiO2 interferometric biosensor for quantitative determination of protein interactions: Binding of protein a to immunoglobulins derived from different species</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>327-334</pages><volume>79</volume><number>1</number><edition>2007/01</edition><keywords><keyword>surface-plasmon resonance</keyword><keyword>fourier-transform spectroscopy</keyword><keyword>optical biosensor</keyword><keyword>grating couplers</keyword><keyword>silicon microcavities</keyword><keyword>staphylococcus-aureus</keyword><keyword>ligand-binding</keyword><keyword>mass-transport</keyword><keyword>rate constants</keyword><keyword>acoustic-wave</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan 1</date></pub-dates></dates><isbn>0003-2700</isbn><accession-num>ISI:000243143300048</accession-num><abstract>Determination of kinetic and thermodynamic protein binding constants using interferometry from a porous Si Fabry-Perot layer is presented. A protein A capture probe is adsorbed within the pores of an oxidized porous Si matrix, and binding of immunoglobulin G (IgG) antibodies derived from different species is investigated. The relative protein A/IgG binding affinity is human &gt; rabbit &gt; goat, in agreement with literature values. The equilibrium binding constant (K-a) for human IgG binding to surface-immobilized protein A is determined to be (3.0 +/- 0.5) x 10(7) M-1 using an equilibrium Langmuir model. Kinetic rate constants are calculated to be k(d) = (2.1 +/- 0.2) x 10(-4) s(-1) and k(a) = (1.2 +/- 0.4) x 10(4) M-1 s(-1) using nonlinear least-squares analysis, yielding an equilibrium binding constant of K-a = (5.5 +/- 1.5) x 10(7) M-1. Both steady-state and time-dependent measurements yield equilibrium binding constants that are consistent with literature values. Kinetic rate constants determined through nonlinear least-squares analysis are also in agreement with protein A/IgG binding on a surface. Dosing with a high concentration of analyte leads to deviations from ideal binding behavior, interpreted in terms of restricted analyte diffusion within the porous SiO2 matrix. It is shown that the diffusion limitations can be minimized if the kinetic measurements are performed at low analyte concentrations or under conditions in which the protein A capture probe is not saturated with analyte. Potential limitations of the use of porous SiO2 interferometers for quantitative determination of protein binding constants are discussed.</abstract><notes>121FK&#xD;Times Cited:2&#xD;Cited References Count:57</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000243143300048</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>5.918</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1406</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1406</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Liu, Z.</author><author>Cai, W. B.</author><author>He, L. N.</author><author>Nakayama, N.</author><author>Chen, K.</author><author>Sun, X. M.</author><author>Chen, X. Y.</author><author>Dai, H. J.</author></authors></contributors><auth-address>Dai, HJ&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Chem, Stanford, CA 94305 USA&#xD;Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program Stanford MIPS, Stanford, CA 94305 USA&#xD;Stanford Univ, Sch Med, BioX Program, Stanford, CA 94305 USA</auth-address><titles><title>In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice</title><secondary-title>Nat Nanotechnol</secondary-title></titles><periodical><full-title>Nat Nanotechnol</full-title></periodical><pages>47-52</pages><volume>2</volume><number>1</number><edition>2007/01</edition><keywords><keyword>rgd peptide</keyword><keyword>cells</keyword><keyword>expression</keyword><keyword>functionalization</keyword><keyword>transporters</keyword><keyword>delivery</keyword><keyword>cancer</keyword><keyword>alpha(v)beta(3)</keyword><keyword>integrins</keyword><keyword>agents</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1748-3387</isbn><accession-num>ISI:000243902900015</accession-num><abstract>Single-walled carbon nanotubes (SWNTs) exhibit unique size, shape and physical properties(1-3) that make them promising candidates for biological applications. Here, we investigate the biodistribution of radio-labelled SWNTs in mice by in vivo positron emission tomography (PET), ex vivo biodistribution and Raman spectroscopy. It is found that SWNTs that are functionalized with phospholipids bearing polyethylene-glycol (PEG) are surprisingly stable in vivo. The effect of PEG chain length on the biodistribution and circulation of the SWNTs is studied. Effectively PEGylated SWNTs exhibit relatively long blood circulation times and low uptake by the reticuloendothelial system ( RES). Efficient targeting of integrin positive tumour in mice is achieved with SWNTs coated with PEG chains linked to an arginine-glycine-aspartic acid (RGD) peptide. A high tumour accumulation is attributed to the multivalent effect of the SWNTs. The Raman signatures of SWNTs are used to directly probe the presence of nanotubes in mice tissues and confirm the radio-label-based results.</abstract><notes>131WQ&#xD;Times Cited:4&#xD;Cited References Count:30</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000243902900015</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2007</custom3><custom4>20.588</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1259</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1259</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hong, S.</author><author>Leroueil, P. R.</author><author>Majoros, I. J.</author><author>Orr, B. G.</author><author>Baker, J. R., Jr.</author><author>Banaszak Holl, M. M.</author></authors></contributors><auth-address>Program in Macromolecular Science and Engineering, University of Michigan, Ann Arbor, MI 48109, USA.</auth-address><titles><title>The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform</title><secondary-title>Chem Biol</secondary-title><alt-title>Chemistry &amp; biology</alt-title></titles><periodical><full-title>Chem Biol</full-title></periodical><alt-periodical><full-title>Chem Biol</full-title><abbr-1>Chemistry &amp; biology</abbr-1></alt-periodical><pages>107-15</pages><volume>14</volume><number>1</number><edition>2007/01</edition><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1074-5521 (Print)</isbn><accession-num>17254956</accession-num><abstract>Dendrimer-based anticancer nanotherapeutics containing approximately 5 folate molecules have shown in vitro and in vivo efficacy in cancer cell targeting. Multivalent interactions have been inferred from observed targeting efficacy, but have not been experimentally proven. This study provides quantitative and systematic evidence for multivalent interactions between these nanodevices and folate-binding protein (FBP). A series of the nanodevices were synthesized by conjugation with different amounts of folate. Dissociation constants (K(D)) between the nanodevices and FBP measured by SPR are dramatically enhanced through multivalency ( approximately 2,500- to 170,000-fold). Qualitative evidence is also provided for a multivalent targeting effect to KB cells using flow cytometry. These data support the hypothesis that multivalent enhancement of K(D), not an enhanced rate of endocytosis, is the key factor resulting in the improved biological targeting by these drug delivery platforms.</abstract><notes>N01-co-27173/co/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17254956 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2007</custom3><custom4>5.743</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1428</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1428</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Majoros, I. J.</author><author>Thomas, T.P.</author><author>Candido, K. A.</author><author>Islam, M. T.</author><author>Woehler, S.</author><author>Mehta, C. B.</author><author>Kotlyar, A.</author><author>Cao, Z.</author><author>Kukowska-Latallo, J. F.</author><author>Baker, J.R. Jr. </author></authors></contributors><titles><title>Dendrimer-based nanomedicine: engineered nanodevice synthesis, characterization, and biological testing.</title><secondary-title>Biokmia</secondary-title></titles><periodical><full-title>Biokmia</full-title></periodical><pages>9-16</pages><volume>31</volume><edition>2007</edition><dates><year>2007</year></dates><work-type>Journal Article</work-type><urls></urls><custom1>CNPP - U. of Michigan Med.</custom1><custom3>2007</custom3><custom4>na</custom4></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1307</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1307</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kandere-Grzybowska, K.</author><author>Campbell, C. J.</author><author>Mahmud, G.</author><author>Komarova, Y.</author><author>Soh, S.</author><author>Grzybowski, B. A.</author></authors></contributors><auth-address>Grzybowski, BA&#xD;Northwestern Univ, Dept Biol &amp; Chem Engn, 2145 Sheridan Rd, Evanston, IL 60208 USA&#xD;Northwestern Univ, Dept Biol &amp; Chem Engn, Evanston, IL 60208 USA</auth-address><titles><title>Cell motility on micropatterned treadmills and tracks</title><secondary-title>Soft Matter</secondary-title></titles><periodical><full-title>Soft Matter</full-title></periodical><pages>672-679</pages><volume>3</volume><number>6</number><edition>2007</edition><keywords><keyword>drop shape-analysis</keyword><keyword>soft lithography</keyword><keyword>migration</keyword><keyword>surfaces</keyword><keyword>growth</keyword><keyword>fibroblasts</keyword><keyword>polarity</keyword><keyword>microtubules</keyword><keyword>orientation</keyword><keyword>monolayers</keyword></keywords><dates><year>2007</year></dates><isbn>1744-683X</isbn><accession-num>ISI:000246696700002</accession-num><abstract>Surfaces micropatterned with disjointed cell adhesive/non-adhesive regions allow for precise control of cell shape, internal organization and function. In particular, substrates prepared by the reaction - diffusion ASoMic ( Anisotropic So lid Microetching) method localize cells onto transparent micro-islands or tracks surrounded by an opaque, adhesion-resistant background. ASoMic is compatible with several important imaging modalities ( e. g. wide-field, fluorescent, TIRF and confocal microscopies), and can be used to study and quantify various intracellular and cellular processes related to cell motility. For cells constrained on the islands, the imposed geometry controls spatial organization of the cytoskeleton, while the transparency of the islands allows for real-time analysis of cytoskeletal dynamics. For cells on transparent, linear tracks, the high optical contrast between these adhesive regions and the surrounding non-adhesive background allows for straightforward quantification of the key parameters describing cell motility. Both types of systems provide analytical-quality data that can assist fundamental studies of cell locomotion and can provide a technological basis for cell motility microassays.</abstract><notes>170WK&#xD;Times Cited:0&#xD;Cited References Count:49</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000246696700002</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.890</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1630</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1630</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sui, G.</author><author>Lee, C. C.</author><author>Kamei, K.</author><author>Li, H. J.</author><author>Wang, J. Y.</author><author>Wang, J.</author><author>Herschman, H. R.</author><author>Tseng, H. R.</author></authors></contributors><auth-address>Department of Molecular Medical Pharmacology and Crump Institute for Molecular Imaging, University of California, Los Angeles, 700 Westwood Plaza, Los Angeles, CA 90095, USA.</auth-address><titles><title>A microfluidic platform for sequential ligand labeling and cell binding analysis</title><secondary-title>Biomed Microdevices</secondary-title></titles><periodical><full-title>Biomed Microdevices</full-title></periodical><pages>301-5</pages><volume>9</volume><number>3</number><edition>2006/12/30</edition><keywords><keyword>Animals</keyword><keyword>Cell Culture Techniques/*instrumentation/methods</keyword><keyword>Cell Membrane/*metabolism</keyword><keyword>Epidermal Growth Factor/*metabolism</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Flow Cytometry/*instrumentation/methods</keyword><keyword>Flow Injection Analysis/instrumentation/methods</keyword><keyword>Ligands</keyword><keyword>Mice</keyword><keyword>Microfluidic Analytical Techniques/*instrumentation/methods</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Protein Interaction Mapping/*methods</keyword><keyword>Receptor, Epidermal Growth Factor/*metabolism</keyword><keyword>Staining and Labeling/methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1387-2176 (Print)</isbn><accession-num>17195108</accession-num><abstract>Developing biochemical and cell biological assay for screening biomolecules, evaluating their characteristics in biological processes, and determining their pharmacological effects represents a key technology in biomedical research. A PDMS-based integrated microfluidic platform was fabricated and tested for facilitating the labeling of ligand on the nanogram scale and sequential cell binding analysis in a manner that saves both time and reagents. Within this microfluidic platform, ligand labeling, cell immobolization, and optical analysis are performed in a miniaturized, continuous and semi-automated manner. This microfluidic device for ligand labeling and cell analysis is composed of two functional modules: (i) a circular reaction loop for fluorophore-labeling of the ligand and (ii) four parallel-oriented incubation chambers for immobilization of cells, binding of ligand to different cell populations, and optical evaluation of interactions between the labeled ligand and its cell targets. Epidermal growth factor (EGF) as the ligand and different cell lines with various levels of EGF receptor expression have been utilized to test the feasiblity of this microfluidic platform. When compared to studies with traditional Petri dish handling of cells and tissues, or even microwell analyses, experiments with the microfluidic platform described here are much less time consuming, conserve reagents, and are programmable, which makes these platforms a very promising new tool for biological studies.</abstract><notes>Sui, Guodong&#xD;Lee, Cheng-Chung&#xD;Kamei, Ken-Ichiro&#xD;Li, Hua-Jung&#xD;Wang, Jin-Yi&#xD;Wang, Jun&#xD;Herschman, Harvey R&#xD;Tseng, Hsian-Rong&#xD;P50 ca086306:06/ca/nci&#xD;P50 ca092131:04/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Biomedical microdevices&#xD;Biomed Microdevices. 2007 Jun;9(3):301-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17195108</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>Caltech/ Stanford</custom2><custom3>2007</custom3><custom4>3.368</custom4><electronic-resource-num>10.1007/s10544-006-9033-3</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1673</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1673</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Van Meter, M. E.</author><author>Diaz-Flores, E.</author><author>Archard, J. A.</author><author>Passegue, E.</author><author>Irish, J. M.</author><author>Kotecha, N.</author><author>Nolan, G. P.</author><author>Shannon, K.</author><author>Braun, B. S.</author></authors></contributors><auth-address>Department of Pediatrics, University of California-San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA.</auth-address><titles><title>K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells</title><secondary-title>Blood</secondary-title></titles><periodical><full-title>Blood</full-title></periodical><pages>3945-52</pages><volume>109</volume><number>9</number><edition>2006/12/29</edition><keywords><keyword>Animals</keyword><keyword>*Cell Proliferation</keyword><keyword>Extracellular Signal-Regulated MAP Kinases/metabolism</keyword><keyword>Granulocyte-Macrophage Colony-Stimulating Factor/metabolism</keyword><keyword>Hematopoietic Stem Cells/*metabolism/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>Myeloproliferative Disorders/genetics/*metabolism/pathology</keyword><keyword>*Point Mutation</keyword><keyword>Proto-Oncogene Proteins p21(ras)/*biosynthesis/genetics</keyword><keyword>Ribosomal Protein S6 Kinases/metabolism</keyword><keyword>STAT5 Transcription Factor/metabolism</keyword><keyword>*Signal Transduction/genetics</keyword><keyword>Tumor Stem Cells/*metabolism/pathology</keyword></keywords><dates><year>2007</year><pub-dates><date>May 1</date></pub-dates></dates><isbn>0006-4971 (Print)</isbn><accession-num>17192389</accession-num><abstract>Defining how cancer-associated mutations perturb signaling networks in stem/progenitor populations that are integral to tumor formation and maintenance is a fundamental problem with biologic and clinical implications. Point mutations in RAS genes contribute to many cancers, including myeloid malignancies. We investigated the effects of an oncogenic Kras(G12D) allele on phosphorylated signaling molecules in primary c-kit(+) lin(-/low) hematopoietic stem/progenitor cells. Comparison of wild-type and Kras(G12D) c-kit(+) lin(-/low) cells shows that K-Ras(G12D) expression causes hyperproliferation in vivo and results in abnormal levels of phosphorylated STAT5, ERK, and S6 under basal and stimulated conditions. Whereas Kras(G12D) cells demonstrate hyperactive signaling after exposure to granulocyte-macrophage colony-stimulating factor, we unexpectedly observe a paradoxical attenuation of ERK and S6 phosphorylation in response to stem cell factor. These studies provide direct biochemical evidence that cancer stem/progenitor cells remodel signaling networks in response to oncogenic stress and demonstrate that multi-parameter flow cytometry can be used to monitor the effects of targeted therapeutics in vivo. This strategy has broad implications for defining the architecture of signaling networks in primary cancer cells and for implementing stem cell-targeted interventions.</abstract><notes>Van Meter, Margaret E M&#xD;Diaz-Flores, Ernesto&#xD;Archard, Joehleen A&#xD;Passegue, Emmanuelle&#xD;Irish, Jonathan M&#xD;Kotecha, Nikesh&#xD;Nolan, Garry P&#xD;Shannon, Kevin&#xD;Braun, Benjamin S&#xD;K08 ca 103868/ca/nci&#xD;N01 hv 28183/hv/nhlbi&#xD;R01 ca 72614/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Blood&#xD;Blood. 2007 May 1;109(9):3945-52. Epub 2006 Dec 27.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17192389</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>9.691</custom4><electronic-resource-num>blood-2006-09-047530 [pii]&#xD;10.1182/blood-2006-09-047530</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1640</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1640</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, E. Y.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Building 149, 13th St., Room 5410, Charlestown, MA 02129, USA.</auth-address><titles><title>Continuous analyte sensing with magnetic nanoswitches</title><secondary-title>Small</secondary-title></titles><periodical><full-title>Small</full-title></periodical><pages>1144-7</pages><volume>2</volume><number>10</number><edition>2006/12/29</edition><keywords><keyword>Biosensing Techniques</keyword><keyword>Fiber Optics</keyword><keyword>Glucose/chemistry</keyword><keyword>Immunoassay/instrumentation/methods</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Magnetic Resonance Spectroscopy/methods</keyword><keyword>Models, Chemical</keyword><keyword>Nanomedicine/*methods</keyword><keyword>Nanoparticles/chemistry</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Protein Binding</keyword><keyword>Surface Properties</keyword><keyword>Time Factors</keyword><keyword>Water</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17193579</accession-num><notes>Sun, Eric Yi&#xD;Weissleder, Ralph&#xD;Josephson, Lee&#xD;P50 ca86355/ca/nci&#xD;R01 00662/phs&#xD;R01 eb004626/eb/nibib&#xD;U01 hl 080731/hl/nhlbi&#xD;U54 ca119349/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Small (Weinheim an der Bergstrasse, Germany)&#xD;Small. 2006 Oct;2(10):1144-7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17193579</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>7.292</custom4><electronic-resource-num>10.1002/smll.200600204</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1475</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1475</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nomura, T.</author><author>Huang, W. C.</author><author>Zhau, H. E.</author><author>Wu, D.</author><author>Xie, Z.</author><author>Mimata, H.</author><author>Zayzafoon, M.</author><author>Young, A. N.</author><author>Marshall, F. F.</author><author>Weitzmann, M. N.</author><author>Chung, L. W.</author></authors></contributors><auth-address>Molecular Urology and Therapeutics Program, Department of Urology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Beta2-microglobulin promotes the growth of human renal cell carcinoma through the activation of the protein kinase A, cyclic AMP-responsive element-binding protein, and vascular endothelial growth factor axis</title><secondary-title>Clin Cancer Res</secondary-title></titles><periodical><full-title>Clin Cancer Res</full-title></periodical><pages>7294-305</pages><volume>12</volume><number>24</number><edition>2006/12/26</edition><keywords><keyword>1-Phosphatidylinositol 3-Kinase/metabolism</keyword><keyword>Animals</keyword><keyword>Apoptosis/drug effects</keyword><keyword>Carcinoma, Renal Cell/*metabolism/pathology</keyword><keyword>Cell Adhesion/physiology</keyword><keyword>Cell Movement/drug effects/physiology</keyword><keyword>Cell Proliferation/drug effects</keyword><keyword>Cyclic AMP Response Element-Binding Protein/*metabolism</keyword><keyword>Cyclic AMP-Dependent Protein Kinases/*metabolism</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Kidney/metabolism</keyword><keyword>Kidney Neoplasms/*metabolism/pathology</keyword><keyword>MAP Kinase Signaling System/physiology</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Mice, Nude</keyword><keyword>Models, Biological</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Oncogene Protein v-akt/metabolism</keyword><keyword>RNA, Small Interfering/pharmacology</keyword><keyword>Transfection</keyword><keyword>Tumor Cells, Cultured</keyword><keyword>Vascular Endothelial Growth Factor A/*metabolism</keyword><keyword>beta 2-Microglobulin/genetics/*physiology</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 15</date></pub-dates></dates><isbn>1078-0432 (Print)</isbn><accession-num>17189401</accession-num><abstract>PURPOSE: Beta(2)-microglobulin (beta2M), a soluble protein secreted by cancer and host inflammatory cells, has various biological functions, including antigen presentation. Because aberrant expression of beta2M has been reported in human renal cell carcinoma, we investigated the effects of beta2M overexpression on cancer cell growth and analyzed its molecular signaling pathway. EXPERIMENTAL DESIGN: We established clonal cell lines that overexpressed beta2M in human renal cell carcinoma (SN12C) cells and then examined cell growth in vitro and in vivo and studied the beta2M-mediated downstream cell signaling pathway. RESULTS: Our results showed that beta2M expression positively correlates with (a) in vitro growth on plastic dishes and as Matrigel colonies, (b) cell invasion and migration in Boyden chambers, and (c) vascular endothelial growth factor (VEGF) expression and secretion by cells. We found, in addition, that beta2M mediates its action through increased phosphorylation of cyclic AMP-responsive element-binding protein (CREB) via the protein kinase A-CREB axis, resulting in increased VEGF expression and secretion. In convergence with this signal axis, beta2M overexpression also activated both phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Beta2M overexpression induced accelerated growth of SN12C in mouse subcutis and bone. Interrupting the beta2M signaling pathway using small interfering RNA led to apoptosis with increased activation of caspase-3 and caspase-9 and cleaved poly(ADP-ribose) polymerase. CONCLUSIONS: Our results showed for the first time that the beta2M-protein kinase A-CREB-VEGF signaling axis plays a crucial role in support of renal cell carcinoma growth and progression and reveals a novel therapeutic target.</abstract><notes>Nomura, Takeo&#xD;Huang, Wen-Chin&#xD;Zhau, Haiyen E&#xD;Wu, Daqing&#xD;Xie, Zhihui&#xD;Mimata, Hiromitsu&#xD;Zayzafoon, Majd&#xD;Young, Andrew N&#xD;Marshall, Fray F&#xD;Weitzmann, M Neale&#xD;Chung, Leland W K&#xD;Gm-0702069/gm/nigms&#xD;P01-ca98912/ca/nci&#xD;R01-ca108468/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Clinical cancer research : an official journal of the American Association for Cancer Research&#xD;Clin Cancer Res. 2006 Dec 15;12(24):7294-305.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17189401</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>6.646</custom4><electronic-resource-num>12/24/7294 [pii]&#xD;10.1158/1078-0432.CCR-06-2060</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1162</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1162</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Davidson, E. A.</author><author>Ellington, A. D.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, Institute for Cell and Molecular Biology, 1 University Station/A4800, University of Texas at Austin, Austin, Texas 78712, USA.</auth-address><titles><title>Synthetic RNA circuits</title><secondary-title>Nat Chem Biol</secondary-title></titles><periodical><full-title>Nat Chem Biol</full-title></periodical><pages>23-8</pages><volume>3</volume><number>1</number><edition>2006/12/19</edition><keywords><keyword>Catalysis</keyword><keyword>Codon/genetics</keyword><keyword>*Gene Expression Regulation</keyword><keyword>*Genetic Engineering/methods</keyword><keyword>Models, Biological</keyword><keyword>RNA/chemistry/genetics/*physiology</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1552-4450 (Print)</isbn><accession-num>17173026</accession-num><abstract>Natural and engineered RNA &apos;parts&apos; can perform a variety of functions, including hybridizing to targets, binding ligands and undergoing programmed conformational changes, and catalyzing reactions. These RNA parts can in turn be assembled into synthetic genetic circuits that regulate gene expression by acting either in cis or in trans on mRNAs. As more parts are discovered and engineered, it should be increasingly possible to create synthetic RNA circuits that are able to carry out complex logical operations in cells, either superimposed on or autonomous to extant gene regulation.</abstract><notes>Davidson, Eric A&#xD;Ellington, Andrew D&#xD;Review&#xD;United States&#xD;Nature chemical biology&#xD;Nat Chem Biol. 2007 Jan;3(1):23-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17173026</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>15.235</custom4><electronic-resource-num>nchembio846 [pii]&#xD;10.1038/nchembio846</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1144</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1144</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Choi, J. S.</author><author>Jun, Y. W.</author><author>Yeon, S. I.</author><author>Kim, H. C.</author><author>Shin, J. S.</author><author>Cheon, J.</author></authors></contributors><auth-address>Department of Chemistry, Yonsei University, Seoul 120-749, Korea.</auth-address><titles><title>Biocompatible heterostructured nanoparticles for multimodal biological detection</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>15982-3</pages><volume>128</volume><number>50</number><edition>2006/12/15</edition><keywords><keyword>Biocompatible Materials/*chemistry</keyword><keyword>Biosensing Techniques/*methods</keyword><keyword>Dimerization</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanoparticles/*chemistry/*ultrastructure</keyword><keyword>Nanostructures/*chemistry/*ultrastructure</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 20</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17165720</accession-num><notes>Choi, Jin-sil&#xD;Jun, Young-wook&#xD;Yeon, Soo-In&#xD;Kim, Hyoung Chan&#xD;Shin, Jeon-Soo&#xD;Cheon, Jinwoo&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Dec 20;128(50):15982-3.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17165720</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja066547g</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1103</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1103</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bunimovich, Y. L.</author><author>Shin, Y. S.</author><author>Yeo, W. S.</author><author>Amori, M.</author><author>Kwong, G.</author><author>Heath, J. R.</author></authors></contributors><auth-address>Division of Chemistry and Chemical Engineering, MC 127-72, California Institute of Technology, Pasadena, California 91125, USA.</auth-address><titles><title>Quantitative real-time measurements of DNA hybridization with alkylated nonoxidized silicon nanowires in electrolyte solution</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>16323-31</pages><volume>128</volume><number>50</number><edition>2006/12/15</edition><keywords><keyword>Alkylation</keyword><keyword>Biosensing Techniques</keyword><keyword>DNA/*analysis</keyword><keyword>Electrolytes/*chemistry</keyword><keyword>Kinetics</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Molecular Structure</keyword><keyword>Nanowires/*chemistry/ultrastructure</keyword><keyword>Nucleic Acid Hybridization</keyword><keyword>Oxidation-Reduction</keyword><keyword>Silicon/*chemistry</keyword><keyword>Solutions</keyword><keyword>Spectrum Analysis</keyword><keyword>Time Factors</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 20</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17165787</accession-num><abstract>The quantitative, real-time detection of single-stranded oligonucleotides with silicon nanowires (SiNWs) in physiologically relevant electrolyte solution is demonstrated. Debye screening of the hybridization event is circumvented by utilizing electrostatically adsorbed primary DNA on an amine-terminated NW surface. Two surface functionalization chemistries are compared: an amine-terminated siloxane monolayer on the native SiO2 surface of the SiNW, and an amine-terminated alkyl monolayer grown directly on a hydrogen-terminated SiNW surface. The SiNWs without the native oxide exhibit improved solution-gated field-effect transistor characteristics and a significantly enhanced sensitivity to single-stranded DNA detection, with an accompanying 2 orders of magnitude improvement in the dynamic range of sensing. A model for the detection of analyte by SiNW sensors is developed and utilized to extract DNA-binding kinetic parameters. Those values are directly compared with values obtained by the standard method of surface plasmon resonance (SPR) and demonstrated to be similar. The nanowires, however, are characterized by higher detection sensitivity. The implication is that SiNWs can be utilized to quantitate the solution-phase concentration of biomolecules at low concentrations. This work also demonstrates the importance of surface chemistry for optimizing biomolecular sensing with silicon nanowires.</abstract><notes>Bunimovich, Yuri L&#xD;Shin, Young Shik&#xD;Yeo, Woon-Seok&#xD;Amori, Michael&#xD;Kwong, Gabriel&#xD;Heath, James R&#xD;5u54 ca119347/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Dec 20;128(50):16323-31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17165787</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja065923u</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1706</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1706</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, X.</author><author>Zhou, J.</author><author>Song, J.</author><author>Liu, J.</author><author>Xu, N.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245, USA.</auth-address><titles><title>Piezoelectric field effect transistor and nanoforce sensor based on a single ZnO nanowire</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>2768-72</pages><volume>6</volume><number>12</number><edition>2006/12/14</edition><keywords><keyword>Elasticity</keyword><keyword>Nanowires/*chemistry</keyword><keyword>Semiconductors</keyword><keyword>Stress, Mechanical</keyword><keyword>Surface Properties</keyword><keyword>Transistors</keyword><keyword>Zinc Oxide/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17163703</accession-num><abstract>Utilizing the coupled piezoelectric and semiconducting dual properties of ZnO, we demonstrate a piezoelectric field effect transistor (PE-FET) that is composed of a ZnO nanowire (NW) (or nanobelt) bridging across two Ohmic contacts, in which the source to drain current is controlled by the bending of the NW. A possible mechanism for the PE-FET is suggested to be associated with the carrier trapping effect and the creation of a charge depletion zone under elastic deformatioin. This PE-FET has been applied as a force/pressure sensor for measuring forces in the nanonewton range and even smaller with the use of smaller NWs. An almost linear relationship between the bending force and the conductance was found at small bending regions, demonstrating the principle of nanowire-based nanoforce and nanopressure sensors.</abstract><notes>Wang, Xudong&#xD;Zhou, Jun&#xD;Song, Jinhui&#xD;Liu, Jin&#xD;Xu, Ningsheng&#xD;Wang, Zhong L&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2006 Dec;6(12):2768-72.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17163703</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl061802g</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1565</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1565</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Seleverstov, O.</author><author>Zabirnyk, O.</author><author>Zscharnack, M.</author><author>Bulavina, L.</author><author>Nowicki, M.</author><author>Heinrich, J. M.</author><author>Yezhelyev, M.</author><author>Emmrich, F.</author><author>O&apos;Regan, R.</author><author>Bader, A.</author></authors></contributors><auth-address>Center for Biotechnology and Biomedicine (BBZ), University of Leipzig, D-04103 Leipzig, Germany. alex_seleverstov@yahoo.de</auth-address><titles><title>Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>2826-32</pages><volume>6</volume><number>12</number><edition>2006/12/14</edition><keywords><keyword>*Autophagy</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Membrane/metabolism/ultrastructure</keyword><keyword>Cell Survival</keyword><keyword>Cells, Cultured</keyword><keyword>Coculture Techniques</keyword><keyword>Fluorescence</keyword><keyword>Humans</keyword><keyword>Mesenchymal Stem Cells/metabolism/*physiology/ultrastructure</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Microtubule-Associated Proteins/metabolism</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>17163713</accession-num><abstract>Lately certain cytotoxicity of quantum dots (QDs) and some deleterious effects of labeling procedure on stem cells differentiation abilities were shown. In the present study we compared cytotoxicity and intracellular processing of two different-sized protein-conjugated QDs after labeling of the human mesenchymal stem cells (hMSC). An asymmetrical intracellular uptake of red (605 nm) and green (525 nm) quantum dots was observed. We describe for the first time a size-dependent activation of autophagy, caused by nanoparticles.</abstract><notes>Seleverstov, Oleksandr&#xD;Zabirnyk, Olga&#xD;Zscharnack, Matthias&#xD;Bulavina, Larysa&#xD;Nowicki, Marcin&#xD;Heinrich, Jan-Michael&#xD;Yezhelyev, Maksym&#xD;Emmrich, Frank&#xD;O&apos;Regan, Ruth&#xD;Bader, Augustinus&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2006 Dec;6(12):2826-32.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17163713</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl0619711</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1347</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1347</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koynova, R.</author><author>Tarahovsky, Y. S.</author><author>Wang, L.</author><author>MacDonald, R. C.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology and Cell Biology Northwestern University 2205 Tech Drive, Evanston, IL 60208, USA. r-tenchova@northwestern.edu</auth-address><titles><title>Lipoplex formulation of superior efficacy exhibits high surface activity and fusogenicity, and readily releases DNA</title><secondary-title>Biochim Biophys Acta-Biomembranes</secondary-title></titles><periodical><full-title>Biochim Biophys Acta-Biomembranes</full-title></periodical><pages>375-86</pages><volume>1768</volume><number>2</number><edition>2006/12/13</edition><keywords><keyword>Cell Membrane/*metabolism</keyword><keyword>Cell Nucleus/metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Cytoplasm/metabolism</keyword><keyword>DNA/chemistry/*metabolism</keyword><keyword>Endoplasmic Reticulum/metabolism</keyword><keyword>Endothelium, Vascular/cytology/*metabolism</keyword><keyword>Humans</keyword><keyword>*Liposomes</keyword><keyword>Microscopy, Electron</keyword><keyword>Mitochondria/metabolism</keyword><keyword>Oleic Acids/*metabolism</keyword><keyword>Phosphatidylcholines/*metabolism</keyword><keyword>Transfection</keyword><keyword>Umbilical Arteries/cytology/*metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0006-3002 (Print)</isbn><accession-num>17156744</accession-num><abstract>Lipoplexes containing a mixture of cationic phospholipids dioleoylethylphosphatidylcholine (EDOPC) and dilauroylethylphosphatidylcholine (EDLPC) are known to be far more efficient agents in transfection of cultured primary endothelial cells than are lipoplexes containing either lipid alone. The large magnitude of the synergy permits comparison of the physical and physico-chemical properties of lipoplexes that have very different transfection efficiencies, but minor chemical differences. Here we report that the superior transfection efficiency of the EDLPC/EDOPC lipoplexes correlates with higher surface activity, higher affinity to interact and mix with negatively charged membrane-mimicking liposomes, and with considerably more efficient DNA release relative to the EDOPC lipoplexes. Observations on cultured cells agree with the results obtained with model systems; confocal microscopy of transfected human umbilical artery endothelial cells (HUAEC) demonstrated more extensive DNA release into the cytoplasm and nucleoplasm for the EDLPC/EDOPC lipoplexes than for EDOPC lipoplexes; electron microscopy of cells fixed and embedded directly on the culture dish revealed contact of EDLPC/EDOPC lipoplexes with various cellular membranes, including those of the endoplasmic reticulum, mitochondria and nucleus. The sequence of events outlining efficient lipofection is discussed based on the presented data.</abstract><notes>Koynova, Rumiana&#xD;Tarahovsky, Yury S&#xD;Wang, Li&#xD;MacDonald, Robert C&#xD;Gm52329/gm/nigms&#xD;Gm57305/gm/nigms&#xD;R01 gm052329-06/gm/nigms&#xD;R01 gm057305-03a1/gm/nigms&#xD;Rr08630/rr/ncrr&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Netherlands&#xD;Biochimica et biophysica acta&#xD;Biochim Biophys Acta. 2007 Feb;1768(2):375-86. Epub 2006 Nov 1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17156744</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>3.640</custom4><electronic-resource-num>S0005-2736(06)00400-7 [pii]&#xD;10.1016/j.bbamem.2006.10.016</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1191</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1191</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Endres, P. J.</author><author>Macrenaris, K. W.</author><author>Vogt, S.</author><author>Allen, M. J.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Quantitative imaging of cell-permeable magnetic resonance contrast agents using x-ray fluorescence</title><secondary-title>Mol Imaging</secondary-title></titles><periodical><full-title>Mol Imaging</full-title></periodical><pages>485-97</pages><volume>5</volume><number>4</number><edition>2006/12/08</edition><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Chelating Agents/chemical synthesis/chemistry/pharmacokinetics</keyword><keyword>*Contrast Media/chemical synthesis/chemistry/pharmacokinetics</keyword><keyword>Dogs</keyword><keyword>Gadolinium DTPA/chemical synthesis/chemistry/pharmacokinetics</keyword><keyword>Heterocyclic Compounds/chemical synthesis/chemistry/pharmacokinetics</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Mice</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Organometallic Compounds/chemical synthesis/chemistry/pharmacokinetics</keyword><keyword>Spectrometry, X-Ray Emission</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct-Dec</date></pub-dates></dates><isbn>1535-3508 (Print)</isbn><accession-num>17150161</accession-num><abstract>The inability to transduce cellular membranes is a limitation of current magnetic resonance imaging probes used in biologic and clinical settings. This constraint confines contrast agents to extracellular and vascular regions of the body, drastically reducing their viability for investigating processes and cycles in developmental biology. Conversely, a contrast agent with the ability to permeate cell membranes could be used in visualizing cell patterning, cell fate mapping, gene therapy, and, eventually, noninvasive cancer diagnosis. Therefore, we describe the synthesis and quantitative imaging of four contrast agents with the capability to cross cell membranes in sufficient quantity for detection. Each agent is based on the conjugation of a Gd(III) chelator with a cellular transduction moiety. Specifically, we coupled Gd(III)-diethylenetriaminepentaacetic acid DTPA and Gd(III)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid with an 8-amino acid polyarginine oligomer and an amphipathic stilbene molecule, 4-amino-4&apos;-(N,N-dimethylamino)stilbene. The imaging modality that provided the best sensitivity and spatial resolution for direct detection of the contrast agents is synchrotron radiation x-ray fluorescence (SR-XRF). Unlike optical microscopy, SR-XRF provides two-dimensional images with resolution 10(3) better than (153)Gd gamma counting, without altering the agent by organic fluorophore conjugation. The transduction efficiency of the intracellular agents was evaluated by T(1) analysis and inductively coupled plasma mass spectrometry to determine the efficacy of each chelate-transporter combination.</abstract><notes>Endres, Paul J&#xD;Macrenaris, Keith W&#xD;Vogt, Stefan&#xD;Allen, Matthew J&#xD;Meade, Thomas J&#xD;1r01 eb005866-01/eb/nibib&#xD;5u54 ca90810/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Molecular imaging : official journal of the Society for Molecular Imaging&#xD;Mol Imaging. 2006 Oct-Dec;5(4):485-97.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17150161</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>3.329</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1179</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1179</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>deVera, I. E.</author><author>Katz, J. E.</author><author>Agus, D. B.</author></authors></contributors><auth-address>Center for Applied Molecular Medicine at Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.</auth-address><titles><title>Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery</title><secondary-title>Clin Adv Hematol Oncol</secondary-title></titles><periodical><full-title>Clin Adv Hematol Oncol</full-title></periodical><pages>541-9</pages><volume>4</volume><number>7</number><edition>2006/12/07</edition><keywords><keyword>Biological Markers/*analysis/blood</keyword><keyword>Human Genome Project</keyword><keyword>Humans</keyword><keyword>Mass Spectrometry/methods</keyword><keyword>Proteomics/*methods</keyword><keyword>Tumor Markers, Biological/analysis/blood</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>(Print)</isbn><accession-num>17147241</accession-num><abstract>The lack of effective surrogates or biomarkers for biologic and disease state is a major hindrance to effective cancer care. Many laboratories have been using mass spectrometry as the means to discover new biomarkers. The success of these efforts relies on effective collaboration between clinicians and mass spectroscopists. This review describes many of the common proteomic experimental methodologies and evaluates the current state of proteomics-based biomarker discovery--starting from sample collection through sample processing and ultimately sample measurement. Guidelines are given for the evaluation of experimental design and for the gauging of result significance. Particular emphasis is placed on those aspects strongly associated with reproducibility from both clinical and laboratory perspectives.</abstract><notes>deVera, Imelda E&#xD;Katz, Jonathan E&#xD;Agus, David B&#xD;United States&#xD;Clinical advances in hematology &amp; oncology : H&amp;O&#xD;Clin Adv Hematol Oncol. 2006 Jul;4(7):541-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17147241</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>na</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1303</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1303</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Juliano, R. L.</author></authors></contributors><auth-address>Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA. arjay@med.unc.edu</auth-address><titles><title>Intracellular delivery of oligonucleotide conjugates and dendrimer complexes</title><secondary-title>Ann N Y Acad Sci</secondary-title></titles><periodical><full-title>Ann N Y Acad Sci</full-title></periodical><pages>18-26</pages><volume>1082</volume><edition>2006/12/06</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Dendrimers/*pharmacokinetics/therapeutic use</keyword><keyword>Drug Carriers/*chemistry/pharmacokinetics</keyword><keyword>Gene Expression Regulation/drug effects</keyword><keyword>Humans</keyword><keyword>Macromolecular Substances/chemistry/pharmacokinetics/therapeutic use</keyword><keyword>Oligonucleotides/*administration &amp; dosage</keyword><keyword>Oligonucleotides, Antisense/administration &amp; dosage</keyword><keyword>Particle Size</keyword><keyword>Peptides/*pharmacokinetics/therapeutic use</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0077-8923 (Print)</isbn><accession-num>17145920</accession-num><abstract>Enhancing the delivery of antisense and siRNA molecules to cells and tissues is a key issue for oligonucleotide therapeutics. Cell-penetrating peptides (CPPs) have the ability to convey linked &quot;cargo&quot; molecules into the cytosol; thus we have explored the use of CPPs as delivery agents for oligonucleotides. We have extensively evaluated CPP-oligonucleotide conjugates, and have recently begun to explore the use of CPP-dendrimer-oligonucleotide complexes. We have found that CPP-antisense oligonucleotide conjugates can be taken up by cells and can effectively modify gene expression in cell culture and in tissues. Although not as potent in cell culture as cationic lipid delivery agents, CPP-oligonucleotide conjugates offer the advantage of being molecules rather than particles, and may have substantial advantages over particle-based delivery in the in vivo setting.</abstract><notes>Juliano, R L&#xD;United States&#xD;Annals of the New York Academy of Sciences&#xD;Ann N Y Acad Sci. 2006 Oct;1082:18-26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17145920</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>1.93</custom4><electronic-resource-num>1082/1/18 [pii]&#xD;10.1196/annals.1348.011</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1548</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1548</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rostad, K.</author><author>Mannelqvist, M.</author><author>Halvorsen, O. J.</author><author>Oyan, A. M.</author><author>Bo, T. H.</author><author>Stordrange, L.</author><author>Olsen, S.</author><author>Haukaas, S. A.</author><author>Lin, B.</author><author>Hood, L.</author><author>Jonassen, I.</author><author>Akslen, L. A.</author><author>Kalland, K. H.</author></authors></contributors><auth-address>Section for Microbiology and Immunology, The Gade Institute, Bergen, Norway.</auth-address><titles><title>ERG upregulation and related ETS transcription factors in prostate cancer</title><secondary-title>Int J Oncol</secondary-title></titles><periodical><full-title>Int J Oncol</full-title></periodical><pages>19-32</pages><volume>30</volume><number>1</number><edition>2006/12/05</edition><keywords><keyword>DNA Primers</keyword><keyword>DNA-Binding Proteins/*genetics</keyword><keyword>*Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>In Situ Hybridization</keyword><keyword>Male</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Polymerase Chain Reaction</keyword><keyword>Prostate/physiology</keyword><keyword>Prostatectomy</keyword><keyword>Prostatic Neoplasms/*genetics/surgery</keyword><keyword>Proto-Oncogene Proteins c-ets/*genetics</keyword><keyword>Trans-Activators/*genetics</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1019-6439 (Print)</isbn><accession-num>17143509</accession-num><abstract>The aim of this study was to identify and validate differentially expressed genes in matched pairs of benign and malignant prostate tissue. Samples included 29 histologically verified primary tumors and 23 benign controls. Microarray analysis was initially performed using a sequence verified set of 40,000 human cDNA clones. Among the genes most consistently and highly upregulated in prostate cancer was the ETS family transcription factor ERG (ETS related gene). This finding was validated in an expanded patient series (37 tumors and 38 benign samples) using DNA oligonucleotide microarray and real-time quantitative PCR assays. ERG was 20- to more than 100-fold overexpressed in prostate cancer compared with benign prostate tissue in more than 50% of patients according to quantitative PCR. Surprisingly, ERG mRNA levels were found to be significantly higher in the endothelial cell line, HUVEC, than in the prostate cell lines PC3, DU145 and LNCaP. In situ hybridization of prostate cancer tissue revealed that ERG was abundantly expressed in both prostate cancer cells and associated endothelial cells. The consistency and magnitude of ERG overexpression in prostate cancer appeared unique, but several related ETS transcription factors were also overexpressed in matched pairs of tumor and benign samples, whereas ETS2 was significantly underexpressed. Our findings support the hypothesis that ERG overexpression and related ETS transcription factors are important for early prostate carcinogenesis.</abstract><notes>Rostad, Kari&#xD;Mannelqvist, Monica&#xD;Halvorsen, Ole Johan&#xD;Oyan, Anne Margrete&#xD;Bo, Trond Hellem&#xD;Stordrange, Laila&#xD;Olsen, Sue&#xD;Haukaas, Svein Andreas&#xD;Lin, Biaoyang&#xD;Hood, Leroy&#xD;Jonassen, Inge&#xD;Akslen, Lars Andreas&#xD;Kalland, Karl-Henning&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Greece&#xD;International journal of oncology&#xD;Int J Oncol. 2007 Jan;30(1):19-32.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17143509</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>2.270</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2047</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2047</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Chen, K.</author><author>Mohamedali, K. A.</author><author>Cao, Q.</author><author>Gambhir, S. S.</author><author>Rosenblum, M. G.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS), Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305-5484, USA.</auth-address><titles><title>PET of vascular endothelial growth factor receptor expression</title><secondary-title>J Nucl Med</secondary-title></titles><periodical><full-title>J Nucl Med</full-title></periodical><pages>2048-56</pages><volume>47</volume><number>12</number><edition>2006/12/02</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Copper Radioisotopes/diagnostic use/pharmacokinetics</keyword><keyword>Gene Expression</keyword><keyword>Glioblastoma/blood supply/ metabolism/ radionuclide imaging</keyword><keyword>Humans</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Mice</keyword><keyword>Neovascularization, Pathologic/metabolism/radionuclide imaging</keyword><keyword>Organ Specificity</keyword><keyword>Positron-Emission Tomography/ methods</keyword><keyword>Receptors, Vascular Endothelial Growth Factor/ metabolism</keyword><keyword>Tissue Distribution</keyword><keyword>Vascular Endothelial Growth Factor A/ diagnostic use/ pharmacokinetics</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0161-5505 (Print)</isbn><accession-num>17138749</accession-num><abstract>For solid tumors and metastatic lesions, tumor vascularity is a critical factor in assessing response to therapy. Here we report the first example, to our knowledge, of (64)Cu-labeled vascular endothelial growth factor 121 (VEGF(121)) for PET of VEGF receptor (VEGFR) expression in vivo. METHODS: VEGF(121) was conjugated with 1,4,7,10-tetraazadodecane-N,N&apos;,N&apos;&apos;,N&apos;&apos;&apos;-tetraacetic acid (DOTA) and then labeled with (64)Cu for small-animal PET of mice bearing different sized U87MG human glioblastoma xenografts. Blocking experiments and ex vivo histopathology were performed to confirm the in vivo results. RESULTS: There were 4.3 +/- 0.2 DOTA molecules per VEGF(121), and the VEGFR2 binding affinity of DOTA-VEGF(121) was comparable to VEGF(121). (64)Cu labeling of DOTA-VEGF(121) was achieved in 90 +/- 10 min and the radiolabeling yield was 87.4% +/- 3.2%. The specific activity of (64)Cu-DOTA-VEGF(121) was 3.2 +/- 0.1 GBq/mg with a radiochemical purity of &gt;98%. Small-animal PET revealed rapid, specific, and prominent uptake of (64)Cu-DOTA-VEGF(121) in small U87MG tumors (high VEGFR2 expression) but significantly lower and sporadic uptake in large U87MG tumors (low VEGFR2 expression). No appreciable renal clearance of (64)Cu-DOTA-VEGF(121) was observed, although the kidney uptake was relatively high likely due to VEGFR1 expression. Blocking experiments, immunofluorescence staining, and western blot confirmed the VEGFR specificity of (64)Cu-DOTA-VEGF(121). CONCLUSION: Successful demonstration of the ability of (64)Cu-DOTA-VEGF(121) to visualize VEGFR expression in vivo may allow for clinical translation of this radiopharmaceutical for imaging tumor angiogenesis and guiding antiangiogenic treatment, especially patient selection and treatment monitoring of VEGFR-targeted cancer therapy.</abstract><notes>Cai, Weibo&#xD;Chen, Kai&#xD;Mohamedali, Khalid A&#xD;Cao, Qizhen&#xD;Gambhir, Sanjiv S&#xD;Rosenblum, Michael G&#xD;Chen, Xiaoyuan&#xD;1U54CA119367-01/CA/NCI NIH HHS/United States&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of nuclear medicine : official publication, Society of Nuclear Medicine&#xD;J Nucl Med. 2006 Dec;47(12):2048-56.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>6.282</custom4><electronic-resource-num>47/12/2048 [pii]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1201</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1201</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Farokhzad, O. C.</author><author>Langer, R.</author></authors></contributors><auth-address>Department of Anesthesiology, Peri-operative and Pain Medicine, Brigham and Women&apos;s Hospital and Harvard Medical School, Boston, MA 02115, USA. ofarokhzad@partners.org</auth-address><titles><title>Nanomedicine: developing smarter therapeutic and diagnostic modalities</title><secondary-title>Adv Drug Deliv Rev</secondary-title><alt-title>Advanced drug delivery reviews</alt-title></titles><periodical><full-title>Adv Drug Deliv Rev</full-title></periodical><alt-periodical><full-title>Advanced Drug Delivery Reviews</full-title></alt-periodical><pages>1456-9</pages><volume>58</volume><number>14</number><edition>2006/12</edition><keywords><keyword>Diagnostic Techniques and Procedures/*trends</keyword><keyword>Drug Delivery Systems/*trends</keyword><keyword>Humans</keyword><keyword>Nanomedicine/*trends</keyword><keyword>Therapeutics/*trends</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 1</date></pub-dates></dates><isbn>0169-409X (Print)</isbn><accession-num>17070960</accession-num><abstract>The early impact of nanotechnology on medicine is beginning to get realized, with novel nanoscale therapeutic and diagnostic modalities under development or in clinical practice today. In this commentary the field of &quot;nanomedicine&quot; is briefly reviewed form the perspective of where we were; where we are today; and where we are likely to go tomorrow.</abstract><notes>Journal Article&#xD;Review&#xD;Netherlands</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17070960 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>10.625</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1098</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1098</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bouvet, M.</author><author>Tsuji, K.</author><author>Yang, M.</author><author>Jiang, P.</author><author>Moossa, A. R.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>Department of Surgery, University of California, San Diego, USA.</auth-address><titles><title>In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><alt-periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></alt-periodical><pages>11293-7</pages><volume>66</volume><number>23</number><edition>2006/12</edition><keywords><keyword>Animals</keyword><keyword>Colonic Neoplasms/metabolism/*pathology</keyword><keyword>Female</keyword><keyword>Genetic Vectors/genetics</keyword><keyword>Green Fluorescent Proteins/genetics/*metabolism</keyword><keyword>HCT116 Cells</keyword><keyword>Humans</keyword><keyword>Liver Neoplasms/metabolism/*secondary</keyword><keyword>Luminescent Proteins/genetics/*metabolism</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Mice, Transgenic</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Neoplasms, Experimental/metabolism/pathology</keyword><keyword>Retroviridae/genetics</keyword><keyword>Spleen/metabolism/*pathology</keyword><keyword>Transfection</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>17145875</accession-num><abstract>The role of host cells in tumor progression and metastasis is critical. Intrasplenic injection of tumor cells has long been known as an effective method of developing liver metastases in nude mice, whereas portal vein (PV) injection of tumor cells can result in rapid death of the tumor cells. Host cells were thought to play a role in these phenomena. We report here that after splenic injection of tumor cells, splenocytes cotraffic with the tumor cells to the liver and facilitate metastatic colony formation. Human colon cancer cells that express green fluorescent protein (GFP) linked to histone H2B in the nucleus and red fluorescent protein (RFP) in the cytoplasm (HCT-116-GFP-RFP) were injected in either the PV or spleen of nude mice and imaged at the subcellular level in vivo. Extensive clasmocytosis (destruction of the cytoplasm) of the cancer cells occurred within 6 hours after PV injection and essentially all the cancer cells died. In contrast, splenic injection of these tumor cells resulted in the aggressive formation of liver and distant metastasis. GFP spleen cells were found in the liver metastases that resulted from intrasplenic injection of the tumor cells in transgenic nude mice ubiquitously expressing GFP. When GFP spleen cells and the RFP cancer cells were coinjected in the PV, liver metastasis resulted that contained GFP spleen cells. These results suggest a novel tumor-host interaction that enables efficient formation of liver metastasis via intrasplenic injection.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103568/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17145875 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>7.980</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1057</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1057</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Amoh, Y.</author><author>Bouvet, M.</author><author>Li, L.</author><author>Tsuji, K.</author><author>Moossa, A. R.</author><author>Katsuoka, K.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., 7917 Ostrow Street, San Diego, CA 92111, USA.</auth-address><titles><title>Visualization of nascent tumor angiogenesis in lung and liver metastasis by differential dual-color fluorescence imaging in nestin-linked-GFP mice</title><secondary-title>Clin Exp Metastasis</secondary-title><alt-title>Clinical &amp; experimental metastasis</alt-title></titles><periodical><full-title>Clin Exp Metastasis</full-title></periodical><alt-periodical><full-title>Clinical &amp; Experimental Metastasis</full-title></alt-periodical><pages>315-22</pages><volume>23</volume><number>7-8</number><edition>2006/12</edition><keywords><keyword>Animals</keyword><keyword>Antigens, CD31/analysis</keyword><keyword>Doxorubicin/pharmacology</keyword><keyword>Green Fluorescent Proteins</keyword><keyword>Immunohistochemistry</keyword><keyword>Intermediate Filament Proteins</keyword><keyword>Liver Neoplasms, Experimental/*blood supply/secondary</keyword><keyword>Lung Neoplasms/*blood supply/secondary</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>Neovascularization, Pathologic/*diagnosis</keyword><keyword>Nerve Tissue Proteins</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0262-0898 (Print)</isbn><accession-num>17136576</accession-num><abstract>Nestin regulatory-element-driven green fluorescent protein (ND-GFP) transgenic mice highly express GFP in proliferating endothelial cells and nascent blood vessels. In the present study, we visualized angiogenesis in experimental lung and liver metastases by GFP imaging in the ND-GFP transgenic mice. The murine melanoma cell line, B16F10 expressing red fluorescent protein (RFP), was injected i.v. in ND-GFP mice. ND-GFP was highly expressed in proliferating nascent blood vessels in the tumors that developed in the lung after tail vein injection, and in the tumors that developed in the liver after portal vein injection of RFP-expressing melanoma cells. Liver metastasis and angiogenesis were imaged intravitally. Doxorubicin significantly decreased metastatic angiogenesis in the liver. These results demonstrate a new imageable model of angiogenesis in metastasis in the liver and the lung. This new model should enable further understanding of the onset of angiogenesis in metastasis and its effect on metastatic growth. The model will serve as a unique screen for inhibitors of angiogenesis of metastatic tumors. The fact that liver-metastasis angiogenesis can be imaged in the live animal enables real-time studies of the effect of angiogenesis inhibitors.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Netherlands</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17136576 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>3.222</custom4><custom7>Dec</custom7><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1763</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1763</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yeo, W. S.</author><author>Mrksich, M.</author></authors></contributors><auth-address>Department of Chemistry and Howard Hughes Medical Institute, The University of Chicago, 929 East 57th Street, Chicago, Illinois 60637, USA.</auth-address><titles><title>Electroactive self-assembled monolayers that permit orthogonal control over the adhesion of cells to patterned substrates</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>10816-20</pages><volume>22</volume><number>25</number><edition>2006/11/30</edition><keywords><keyword>Animals</keyword><keyword>Cell Adhesion/physiology</keyword><keyword>Electrochemistry</keyword><keyword>Esters/chemical synthesis/*chemistry</keyword><keyword>Fibroblasts/*chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Ligands</keyword><keyword>*Membranes, Artificial</keyword><keyword>Mice</keyword><keyword>Molecular Structure</keyword><keyword>Particle Size</keyword><keyword>Quinones/chemical synthesis/*chemistry</keyword><keyword>Structure-Activity Relationship</keyword><keyword>Surface Properties</keyword><keyword>Swiss 3T3 Cells</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 5</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>17129065</accession-num><abstract>This article describes an electroactive substrate that displays two independent dynamic functions for controlling the adhesion of cells. The approach is based on self-assembled monolayers on gold that are patterned into regions presenting the Arg-Gly-Asp peptide cell adhesion ligand. The patterned regions differ in the electrochemical properties of the linkers that tether the peptides to the monolayer. In this work, three distinct chemistries are employed that provide for release of the ligand on application of a negative potential, release of the ligand on application of a positive potential, and no change in response to a potential. Cells were allowed to attach to a monolayer patterned into circular regions comprising the three chemistries. Treatment with electric potentials of 650 or -650 mV resulted in the selective release of adherent cells only from regions that display the relevant electroactive groups. This example establishes the preparation of dynamic substrates with multiple functions and will be important to preparing model cultures derived from multiple cell types, with control over the temporal interactions of each cell population.</abstract><notes>Yeo, Woon-Seok&#xD;Mrksich, Milan&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2006 Dec 5;22(25):10816-20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17129065</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>4.347</custom4><electronic-resource-num>10.1021/la061212y</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1324</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1324</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Keselowsky, B. G.</author><author>Wang, L.</author><author>Schwartz, Z.</author><author>Garcia, A. J.</author><author>Boyan, B. D.</author></authors></contributors><auth-address>Department of Biomedical Engineering, University of Florida, Gainesville, Florida, USA.</auth-address><titles><title>Integrin alpha(5) controls osteoblastic proliferation and differentiation responses to titanium substrates presenting different roughness characteristics in a roughness independent manner</title><secondary-title>J Biomed Mater Res A</secondary-title></titles><periodical><full-title>J Biomed Mater Res A</full-title></periodical><pages>700-10</pages><volume>80</volume><number>3</number><edition>2006/11/30</edition><keywords><keyword>Alkaline Phosphatase/metabolism</keyword><keyword>Biocompatible Materials/*pharmacology</keyword><keyword>Cell Cycle</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Line</keyword><keyword>Cell Proliferation</keyword><keyword>DNA/biosynthesis</keyword><keyword>Fibronectins/metabolism</keyword><keyword>Focal Adhesion Kinase 1/metabolism</keyword><keyword>Humans</keyword><keyword>Integrin alpha5beta1/metabolism</keyword><keyword>Integrin alphaV/metabolism/*physiology</keyword><keyword>Osteoblasts/*cytology/drug effects</keyword><keyword>Signal Transduction</keyword><keyword>Surface Properties</keyword><keyword>Titanium/*pharmacology</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>1549-3296 (Print)</isbn><accession-num>17133443</accession-num><abstract>Integrin alpha(5)beta(1) regulates osteoblast proliferation and differentiation on smooth synthetic surfaces presenting different chemistries, but it is not known whether this integrin controls osteoblast behavior on surfaces that have micron-scale rough topographies. We cultured MG63 human osteoblast-like cells on titanium substrates with three different roughness characteristics: chemically polished (PT), grit blasted and acid etched with a complex topography consisting of 20-100 mum craters and 0.5-2 mum micropits (SLA), and plasma-sprayed Ti with irregular projections (TPS). Cells spread well on PT but displayed a smaller footprint on SLA or TPS. Nuclei were larger on PT as well. alpha(5)beta(1) binding and FAK phosphorylation were greater on the rougher surfaces (TPS &gt; SLA &gt; PT). Antibodies against the alpha(5)beta(1) binding site on fibronectin had no effect on cell number at 3 days, but [(3)H]-thymidine incorporation was increased, suggesting that binding to fibronectin was necessary for cell cycle regulation. Antibodies to the alpha(5) subunit reduced cell number at 3 days on PT and TPS and reduced DNA synthesis on all substrates in a surface microstructure-independent manner. At 7 days, cell numbers were reduced on PT, and DNA synthesis was reduced by 50% on all surfaces. At 7 days, anti-alpha(5) antibodies caused a partial reduction in alkaline phosphatase enzyme activity on all surfaces, but this effect was independent of surface microstructure. These results indicate that surface micron-scale topography modulates alpha(5)beta(1) integrin binding and FAK activation. Signaling via alpha(5)-dependent mechanisms is required for DNA synthesis and regulation of alkaline phosphatase, but this effect is independent of surface microstructure.</abstract><notes>Keselowsky, B G&#xD;Wang, L&#xD;Schwartz, Z&#xD;Garcia, A J&#xD;Boyan, B D&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of biomedical materials research. Part A&#xD;J Biomed Mater Res A. 2007 Mar 1;80(3):700-10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17133443</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2007</custom3><custom4>3.371</custom4><electronic-resource-num>10.1002/jbm.a.30898</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1204</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1204</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Flory, M. R.</author><author>Lee, H.</author><author>Bonneau, R.</author><author>Mallick, P.</author><author>Serikawa, K.</author><author>Morris, D. R.</author><author>Aebersold, R.</author></authors></contributors><auth-address>Department of Molecular Biology and Biochemistry, Wesleyan University, Middletown, CT 06459, USA. mflory@wesleyan.edu</auth-address><titles><title>Quantitative proteomic analysis of the budding yeast cell cycle using acid-cleavable isotope-coded affinity tag reagents</title><secondary-title>Proteomics</secondary-title></titles><periodical><full-title>Proteomics</full-title></periodical><pages>6146-57</pages><volume>6</volume><number>23</number><edition>2006/11/30</edition><keywords><keyword>Carbon Isotopes</keyword><keyword>Cell Cycle/*physiology</keyword><keyword>Genes, Fungal/genetics</keyword><keyword>Isotope Labeling/*methods</keyword><keyword>Proteomics/*methods</keyword><keyword>Saccharomyces cerevisiae/*cytology</keyword><keyword>Saccharomyces cerevisiae Proteins/chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1615-9853 (Print)</isbn><accession-num>17133367</accession-num><abstract>Quantitative profiling of proteins, the direct effectors of nearly all biological functions, will undoubtedly complement technologies for the measurement of mRNA. Systematic proteomic measurement of the cell cycle is now possible by using stable isotopic labeling with isotope-coded affinity tag reagents and software tools for high-throughput analysis of LC-MS/MS data. We provide here the first such study achieving quantitative, global proteomic measurement of a time-course gene expression experiment in a model eukaryote, the budding yeast Saccharomyces cerevisiae, during the cell cycle. We sampled 48% of all predicted ORFs, and provide the data, including identifications, quantitations, and statistical measures of certainty, to the community in a sortable matrix. We do not detect significant concordance in the dynamics of the system over the time-course tested between our proteomic measurements and microarray measures collected from similarly treated yeast cultures. Our proteomic dataset therefore provides a necessary and complementary measure of eukaryotic gene expression, establishes a rich database for the functional analysis of S. cerevisiae proteins, and will enable further development of technologies for global proteomic analysis of higher eukaryotes.</abstract><notes>Flory, Mark R&#xD;Lee, Hookeun&#xD;Bonneau, Richard&#xD;Mallick, Parag&#xD;Serikawa, Kyle&#xD;Morris, David R&#xD;Aebersold, Ruedi&#xD;1r33-ca-93302/ca/nci&#xD;N01-hv-28179/hv/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Germany&#xD;Proteomics&#xD;Proteomics. 2006 Dec;6(23):6146-57.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17133367</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>5.191</custom4><electronic-resource-num>10.1002/pmic.200600159</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1124</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1124</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chan, E. W.</author><author>Yousaf, M. N.</author></authors></contributors><auth-address>Department of Chemistry and Carolina Center for Genome Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Immobilization of ligands with precise control of density to electroactive surfaces</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>15542-6</pages><volume>128</volume><number>48</number><edition>2006/11/30</edition><keywords><keyword>Aminooxyacetic Acid/*chemistry</keyword><keyword>Benzoquinones/*chemistry</keyword><keyword>Biosensing Techniques/*methods</keyword><keyword>Electrochemistry</keyword><keyword>Ligands</keyword><keyword>*Models, Chemical</keyword><keyword>Oxidation-Reduction</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 6</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17132022</accession-num><abstract>We report a broadly applicable surface chemistry methodology to immobilize ligands, proteins, and cells to an electroactive substrate with precise control of ligand density. This strategy is based on the coupling of soluble aminooxy terminated ligands with an electroactive quinone terminated monolayer. The surface chemistry product oxime is also redox active but at a different potential and therefore allows for real-time monitoring of the immobilization reaction. Only the quinone form of the immobilized redox pair is reactive with soluble aminooxy groups, which allows for the determination of the yield of reaction, the ability to immobilize multiple ligands at controlled densities, and the in-situ modulation of ligand activity. We demonstrate this methodology by using cyclic voltammetry to characterize the kinetics of a model interfacial reaction with aminooxy acetic acid. We also demonstrate the synthetic flexibility and utility of this method for biospecific interactions by installing aminooxy terminated FLAG peptides and characterizing their binding to soluble anti-FLAG with surface plasmon resonance spectroscopy. We further show this methodology is compatible with microarray technology by printing rhodamine-oxyamine in various size spots and characterizing the yield within the spots by cyclic voltammetry. We also show this methodology is compatible with cell culture conditions and fluorescent microscopy technology for cell biological studies. Arraying RGD-oxyamine peptides on these substrates allows for bio-specific adhesion of Swiss 3T3 Fibroblasts.</abstract><notes>Chan, Eugene W L&#xD;Yousaf, Muhammad N&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Dec 6;128(48):15542-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17132022</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja065828l</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1474</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1474</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nolan, G. P.</author></authors></contributors><auth-address>Stanford University School of Medicine, 300 Pasteur Drive, Palo Alto CA 94305, USA. gnolan@stanford.edu</auth-address><titles><title>Deeper insights into hematological oncology disorders via single-cell phospho-signaling analysis</title><secondary-title>Hematology Am Soc Hematol Educ Program</secondary-title></titles><periodical><full-title>Hematology Am Soc Hematol Educ Program</full-title></periodical><pages>123-7, 509</pages><edition>2006/11/25</edition><keywords><keyword>Animals</keyword><keyword>Flow Cytometry</keyword><keyword>Hematologic Neoplasms/*diagnosis/metabolism</keyword><keyword>Humans</keyword><keyword>Phosphorylation</keyword><keyword>Prognosis</keyword><keyword>*Signal Transduction</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1520-4391 (Print)</isbn><accession-num>17124050</accession-num><abstract>An understanding of hematological cancer cell signaling processes poses one of the most complex and intractable problems in modern biomedical inquiry. While we understand some of the fundamental players that contribute to oncogenic processes, significant effort is focused upon determining how these individual players relay information to each other to create the composite functions of a cancer cell. Efforts designed to understand these processes at the single cell level will undoubtedly allow for understanding of the heterogeneity of hematological tumors as well as, simultaneously, the function of the &apos;responding&apos; immune system. I will relate some of the insights our laboratory has developed over the last several years applying single-cell phospho-flow cytometry to the study of signaling in primary patient material and murine models. While it is clear that this analysis now allows us to accomplish phospho-signaling biochemistry at the single cell level with primary cell material, we are only beginning to develop some of the bioinformatics tools to appropriately display the vast amount of information collected by such approaches. These approaches, however, have already allowed us to develop approaches that prognosticate patient outcomes based on signaling status, prior to any treatment, as well as subgroup patient subtypes according to signaling states. The modest efforts to date presage a time where it should be possible to provide far more tailored therapies specific to the varied diseases represented by the hematological malignancies.</abstract><notes>Nolan, Garry P&#xD;Review&#xD;United States&#xD;Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program&#xD;Hematology Am Soc Hematol Educ Program. 2006;:123-7, 509.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17124050</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>na</custom4><electronic-resource-num>2006/1/123 [pii]&#xD;10.1182/asheducation-2006.1.123</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1115</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1115</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Rao, J.</author><author>Gambhir, S. S.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, 1201 Welch Road, P095, Stanford, CA 94305-5484, USA.</auth-address><titles><title>How molecular imaging is speeding up antiangiogenic drug development</title><secondary-title>Mol Cancer Ther</secondary-title></titles><periodical><full-title>Mol Cancer Ther</full-title></periodical><pages>2624-33</pages><volume>5</volume><number>11</number><edition>2006/11/24</edition><keywords><keyword>Angiogenesis Inhibitors/*therapeutic use</keyword><keyword>Animals</keyword><keyword>Antineoplastic Agents/*therapeutic use</keyword><keyword>Drug Design</keyword><keyword>Integrin alphaVbeta3/metabolism</keyword><keyword>Intracellular Signaling Peptides and Proteins/metabolism</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>Models, Biological</keyword><keyword>Neoplasms/*blood supply/metabolism/radionuclide imaging</keyword><keyword>Receptors, Vascular Endothelial Growth Factor/metabolism</keyword><keyword>*Tomography, Emission-Computed/trends</keyword><keyword>Vascular Endothelial Growth Factor A/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1535-7163 (Print)</isbn><accession-num>17121909</accession-num><abstract>Drug development is a long process that generally spans about 10 to 15 years. The shift in recent drug discovery to novel agents against specific molecular targets highlights the need for more robust molecular imaging platforms. Using molecular probes, molecular imaging can aid in many steps of the drug development process, such as providing whole body readout in an intact system, decreasing the workload and speeding up drug development/validation, and facilitating individualized anticancer treatment monitoring and dose optimization. The main focus of this review is the recent advances in tumor angiogenesis imaging, and the targets include vascular endothelial growth factor and vascular endothelial growth factor receptor, integrin alpha(v)beta(3), matrix metalloproteinase, endoglin (CD105), and E-selectin. Through tumor angiogenesis imaging, it is expected that a robust platform for understanding the mechanisms of tumor angiogenesis and evaluating the efficacy of novel antiangiogenic therapies will be developed, which can help antiangiogenic drug development in both the preclinical stage and the clinical settings. Molecular imaging has enormous potential in improving the efficiency of the drug development process, including the specific area of antiangiogenic drugs.</abstract><notes>Cai, Weibo&#xD;Rao, Jianghong&#xD;Gambhir, Sanjiv S&#xD;Chen, Xiaoyuan&#xD;P50 ca114747/ca/nci&#xD;R21 ca102123/ca/nci&#xD;R21 eb001785/eb/nibib&#xD;R24 ca93862/ca/nci&#xD;U54 ca119367/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Molecular cancer therapeutics&#xD;Mol Cancer Ther. 2006 Nov;5(11):2624-33.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17121909</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>5.428</custom4><electronic-resource-num>5/11/2624 [pii]&#xD;10.1158/1535-7163.MCT-06-0395</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1567</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1567</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Seo, W. S.</author><author>Lee, J. H.</author><author>Sun, X.</author><author>Suzuki, Y.</author><author>Mann, D.</author><author>Liu, Z.</author><author>Terashima, M.</author><author>Yang, P. C.</author><author>McConnell, M. V.</author><author>Nishimura, D. G.</author><author>Dai, H.</author></authors></contributors><auth-address>Department of Chemistry and Laboratory for Advanced Materials, Stanford University, Stanford, California 94305, USA.</auth-address><titles><title>FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents</title><secondary-title>Nat Mater</secondary-title></titles><periodical><full-title>Nat Mater</full-title></periodical><pages>971-6</pages><volume>5</volume><number>12</number><edition>2006/11/23</edition><keywords><keyword>Animals</keyword><keyword>Cobalt/*chemistry/*diagnostic use</keyword><keyword>Contrast Media/*chemistry</keyword><keyword>Crystallization/methods</keyword><keyword>Ferrous Compounds/*chemistry/*diagnostic use</keyword><keyword>Graphite/*chemistry</keyword><keyword>Image Enhancement/methods</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Materials Testing</keyword><keyword>Nanostructures/*chemistry/ultrastructure</keyword><keyword>Particle Size</keyword><keyword>Rabbits</keyword><keyword>Spectrophotometry, Infrared/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1476-1122 (Print)</isbn><accession-num>17115025</accession-num><abstract>Nanocrystals with advanced magnetic or optical properties have been actively pursued for potential biological applications, including integrated imaging, diagnosis and therapy. Among various magnetic nanocrystals, FeCo has superior magnetic properties, but it has yet to be explored owing to the problems of easy oxidation and potential toxicity. Previously, FeCo nanocrystals with multilayered graphitic carbon, pyrolytic carbon or inert metals have been obtained, but not in the single-shelled, discrete, chemically functionalized and water-soluble forms desired for biological applications. Here, we present a scalable chemical vapour deposition method to synthesize FeCo/single-graphitic-shell nanocrystals that are soluble and stable in water solutions. We explore the multiple functionalities of these core-shell materials by characterizing the magnetic properties of the FeCo core and near-infrared optical absorbance of the single-layered graphitic shell. The nanocrystals exhibit ultra-high saturation magnetization, r1 and r2 relaxivities and high optical absorbance in the near-infrared region. Mesenchymal stem cells are able to internalize these nanoparticles, showing high negative-contrast enhancement in magnetic-resonance imaging (MRI). Preliminary in vivo experiments achieve long-lasting positive-contrast enhancement for vascular MRI in rabbits. These results point to the potential of using these nanocrystals for integrated diagnosis and therapeutic (photothermal-ablation) applications.</abstract><notes>Seo, Won Seok&#xD;Lee, Jin Hyung&#xD;Sun, Xiaoming&#xD;Suzuki, Yoriyasu&#xD;Mann, David&#xD;Liu, Zhuang&#xD;Terashima, Masahiro&#xD;Yang, Philip C&#xD;McConnell, Michael V&#xD;Nishimura, Dwight G&#xD;Dai, Hongjie&#xD;1 u54 ca119367-01/ca/nci&#xD;R01 hlo78678/phs&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Nature materials&#xD;Nat Mater. 2006 Dec;5(12):971-6. Epub 2006 Nov 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17115025</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>25.759</custom4><electronic-resource-num>nmat1775 [pii]&#xD;10.1038/nmat1775</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1573</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1573</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shen, F.</author><author>Hodgson, L.</author><author>Hahn, K.</author></authors></contributors><auth-address>Department of Pharmacology, Linebarger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</auth-address><titles><title>Digital autofocus methods for automated microscopy</title><secondary-title>Methods Enzymol</secondary-title></titles><periodical><full-title>Methods Enzymol</full-title></periodical><pages>620-32</pages><volume>414</volume><edition>2006/11/18</edition><keywords><keyword>Algorithms</keyword><keyword>Automation</keyword><keyword>Computational Biology/methods</keyword><keyword>Computers</keyword><keyword>Image Processing, Computer-Assisted/instrumentation/*methods</keyword><keyword>Microscopy/methods</keyword><keyword>Microscopy, Fluorescence/*instrumentation/*methods</keyword><keyword>Models, Statistical</keyword><keyword>Programming Languages</keyword><keyword>Software</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>0076-6879 (Print)</isbn><accession-num>17110214</accession-num><abstract>Automatic focusing of microscope images is an essential part of modern high-throughput microscopy. This chapter describes implementation of a robust autofocus system appropriate for using either air or oil immersion objectives in robotic imaging. Both hardware and software algorithms are described, and caveats of using viscous immersion media with multifield scanning are detailed.</abstract><notes>Shen, Feimo&#xD;Hodgson, Louis&#xD;Hahn, Klaus&#xD;Review&#xD;United States&#xD;Methods in enzymology&#xD;Methods Enzymol. 2006;414:620-32.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17110214</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>2.126</custom4><electronic-resource-num>S0076-6879(06)14032-X [pii]&#xD;10.1016/S0076-6879(06)14032-X</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1285</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1285</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Irish, J. M.</author><author>Anensen, N.</author><author>Hovland, R.</author><author>Skavland, J.</author><author>Borresen-Dale, A. L.</author><author>Bruserud, O.</author><author>Nolan, G. P.</author><author>Gjertsen, B. T.</author></authors></contributors><auth-address>Department of Microbiology and Immunology, Baxter Laboratory of Genetic Pharmacology, Stanford University, Stanford, CA 94035, USA.</auth-address><titles><title>Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53</title><secondary-title>Blood</secondary-title></titles><periodical><full-title>Blood</full-title></periodical><pages>2589-96</pages><volume>109</volume><number>6</number><edition>2006/11/16</edition><keywords><keyword>Cells, Cultured</keyword><keyword>DNA Damage</keyword><keyword>Electrophoresis, Gel, Two-Dimensional</keyword><keyword>*Gene Expression</keyword><keyword>Gene Expression Profiling</keyword><keyword>*Gene Expression Regulation, Leukemic</keyword><keyword>Humans</keyword><keyword>Leukemia, Myelocytic, Acute/genetics/*metabolism/pathology</keyword><keyword>Mutation/genetics</keyword><keyword>Phosphorylation</keyword><keyword>Protein Isoforms/genetics/metabolism</keyword><keyword>Proto-Oncogene Proteins c-bcl-2/*metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Tumor Suppressor Protein p53/genetics/*metabolism</keyword><keyword>Tyrosine/genetics/*metabolism</keyword><keyword>fms-Like Tyrosine Kinase 3/genetics/*metabolism</keyword></keywords><dates><year>2007</year><pub-dates><date>Mar 15</date></pub-dates></dates><isbn>0006-4971 (Print)</isbn><accession-num>17105820</accession-num><abstract>Loss or mutation of the TP53 tumor suppressor gene is not commonly observed in acute myeloid leukemia (AML), suggesting that there is an alternate route for cell transformation. We investigated the hypothesis that previously observed Bcl-2 family member overexpression suppresses wild-type p53 activity in AML. We demonstrate that wild-type p53 protein is expressed in primary leukemic blasts from patients with de novo AML using 2-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and phospho-specific flow cytometry. We found that p53 was heterogeneously expressed and phosphorylated in AML patient samples and could accumulate following DNA damage. Overexpression of antiapoptosis protein Bcl-2 in AML cells was directly correlated with p53 expression and phosphorylation on serine residues 15, 46, and 392. Within those patients with the highest levels of Bcl-2 expression, we identified a mutation in FLT3 that duplicated phosphorylation site Y591. The presence of this mutation correlated with greater than normal Bcl-2 expression and with previously observed profiles of potentiated STAT and MAPK signaling. These results support the hypothesis that Flt3-mediated signaling in AML enables accumulation of Bcl-2 and maintains a downstream block to p53 pathway apoptosis. Bcl-2 inhibition might therefore improve the efficacy of existing AML therapies by inactivating this suppression of wild-type p53 activity.</abstract><notes>Irish, Jonathan M&#xD;Anensen, Nina&#xD;Hovland, Randi&#xD;Skavland, Jorn&#xD;Borresen-Dale, Anne-Lise&#xD;Bruserud, Oystein&#xD;Nolan, Garry P&#xD;Gjertsen, Bjorn T&#xD;N01-hv-281831/hv/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Blood&#xD;Blood. 2007 Mar 15;109(6):2589-96. Epub 2006 Nov 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17105820</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2007</custom3><custom4>9.691</custom4><electronic-resource-num>blood-2006-02-004234 [pii]&#xD;10.1182/blood-2006-02-004234</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1380</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1380</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, J. H.</author><author>Jun, Y. W.</author><author>Yeon, S. I.</author><author>Shin, J. S.</author><author>Cheon, J.</author></authors></contributors><auth-address>Department of Chemistry, Yonsei University, Seoul 120-749, Korea.</auth-address><titles><title>Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>8160-2</pages><volume>45</volume><number>48</number><edition>2006/11/15</edition><keywords><keyword>Cell Line</keyword><keyword>Fluorescent Dyes/*analysis/chemistry</keyword><keyword>Humans</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>Nanoparticles/*analysis/chemistry</keyword><keyword>Nanotechnology</keyword><keyword>Neuroblastoma/*diagnosis</keyword><keyword>Silicon Dioxide/chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 11</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>17103471</accession-num><notes>Lee, Jae-Hyun&#xD;Jun, Young-Wook&#xD;Yeon, Soo-In&#xD;Shin, Jeon-Soo&#xD;Cheon, Jinwoo&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2006 Dec 11;45(48):8160-2.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17103471</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200603052</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1214</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1214</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Goluch, E. D.</author><author>Nam, J. M.</author><author>Georganopoulou, D. G.</author><author>Chiesl, T. N.</author><author>Shaikh, K. A.</author><author>Ryu, K. S.</author><author>Barron, A. E.</author><author>Mirkin, C. A.</author><author>Liu, C.</author></authors></contributors><auth-address>Micro and Nanotechnology Laboratory, Bioengineering Department, University of Illinois at Urbana-Champaign, 208 N. Wright Street, Urbana, IL 61801, USA.</auth-address><titles><title>A bio-barcode assay for on-chip attomolar-sensitivity protein detection</title><secondary-title>Lab Chip</secondary-title></titles><periodical><full-title>Lab Chip</full-title></periodical><pages>1293-9</pages><volume>6</volume><number>10</number><edition>2006/11/15</edition><keywords><keyword>Animals</keyword><keyword>Enzyme-Linked Immunosorbent Assay</keyword><keyword>Goats</keyword><keyword>*Microfluidic Analytical Techniques</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Prostate-Specific Antigen/*blood</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>17102842</accession-num><abstract>Functionalized nanoparticles hold great promise in realizing highly sensitive and selective biodetection. We report a single disposable chip which is capable of carrying out a multi-step process that employs nanoparticles--a bio-barcode assay (BCA) for single protein marker detection. To illustrate the capability of the system, we tested for the presence of prostate specific antigen (PSA) in buffer solution and goat serum. Detection was accomplished at PSA concentrations as low as 500 aM. This corresponds to only 300 copies of protein analytes using 1 microL total sample volume. We established that the on-chip BCA for PSA detection offers four orders of magnitude higher sensitivity compared to commercially available ELISA-based PSA tests.</abstract><notes>Goluch, Edgar D&#xD;Nam, Jwa-Min&#xD;Georganopoulou, Dimitra G&#xD;Chiesl, Thomas N&#xD;Shaikh, Kashan A&#xD;Ryu, Kee S&#xD;Barron, Annelise E&#xD;Mirkin, Chad A&#xD;Liu, Chang&#xD;5 r01 hg-0197002s1/hg/nhgri&#xD;Ai-03-017/ai/niaid&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Lab on a chip&#xD;Lab Chip. 2006 Oct;6(10):1293-9. Epub 2006 Aug 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17102842</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>7.000</custom4><electronic-resource-num>10.1039/b606294f</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1069</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1069</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bagalkot, V.</author><author>Farokhzad, O. C.</author><author>Langer, R.</author><author>Jon, S.</author></authors></contributors><auth-address>Department of Life Science, Gwangju Institute of Science and Technology, 1 Oryoung-dong, Buk-gu, Gwangju 500712, South Korea.</auth-address><titles><title>An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>8149-52</pages><volume>45</volume><number>48</number><edition>2006/11/14</edition><keywords><keyword>Antineoplastic Agents/administration &amp; dosage/chemistry</keyword><keyword>Aptamers, Nucleotide/administration &amp; dosage/*chemistry</keyword><keyword>Doxorubicin/*administration &amp; dosage/*chemistry</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Humans</keyword><keyword>Leukemia, Plasmacytic/metabolism</keyword><keyword>Microscopy, Confocal</keyword><keyword>Molecular Structure</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 11</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>17099918</accession-num><notes>Bagalkot, Vaishali&#xD;Farokhzad, Omid C&#xD;Langer, Robert&#xD;Jon, Sangyong&#xD;Eb003647/eb/nibib&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2006 Dec 11;45(48):8149-52.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17099918</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200602251</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1262</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1262</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Horvath, S.</author><author>Zhang, B.</author><author>Carlson, M.</author><author>Lu, K. V.</author><author>Zhu, S.</author><author>Felciano, R. M.</author><author>Laurance, M. F.</author><author>Zhao, W.</author><author>Qi, S.</author><author>Chen, Z.</author><author>Lee, Y.</author><author>Scheck, A. C.</author><author>Liau, L. M.</author><author>Wu, H.</author><author>Geschwind, D. H.</author><author>Febbo, P. G.</author><author>Kornblum, H. I.</author><author>Cloughesy, T. F.</author><author>Nelson, S. F.</author><author>Mischel, P. S.</author></authors></contributors><auth-address>Department of Human Genetics, University of California, Los Angeles, CA 90095, USA. shorvath@mednet.ucla.edu</auth-address><titles><title>Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target.</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>17402-7</pages><volume>103,</volume><number>46</number><edition>2006/11/09</edition><keywords><keyword>Animals</keyword><keyword>Breast Neoplasms/genetics</keyword><keyword>Cells, Cultured</keyword><keyword>Gene Expression Profiling</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Glioblastoma/*genetics</keyword><keyword>Hu Paraneoplastic Encephalomyelitis Antigens/genetics</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Nerve Tissue Proteins/*genetics</keyword><keyword>Oncogene Proteins/*genetics</keyword><keyword>RNA Interference</keyword><keyword>*Signal Transduction</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov 14</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>17090670</accession-num><abstract>Glioblastoma is the most common primary malignant brain tumor of adults and one of the most lethal of all cancers. Patients with this disease have a median survival of 15 months from the time of diagnosis despite surgery, radiation, and chemotherapy. New treatment approaches are needed. Recent works suggest that glioblastoma patients may benefit from molecularly targeted therapies. Here, we address the compelling need for identification of new molecular targets. Leveraging global gene expression data from two independent sets of clinical tumor samples (n = 55 and n = 65), we identify a gene coexpression module in glioblastoma that is also present in breast cancer and significantly overlaps with the &quot;metasignature&quot; for undifferentiated cancer. Studies in an isogenic model system demonstrate that this module is downstream of the mutant epidermal growth factor receptor, EGFRvIII, and that it can be inhibited by the epidermal growth factor receptor tyrosine kinase inhibitor Erlotinib. We identify ASPM (abnormal spindle-like microcephaly associated) as a key gene within this module and demonstrate its overexpression in glioblastoma relative to normal brain (or body tissues). Finally, we show that ASPM inhibition by siRNA-mediated knockdown inhibits tumor cell proliferation and neural stem cell proliferation, supporting ASPM as a potential molecular target in glioblastoma. Our weighted gene coexpression network analysis provides a blueprint for leveraging genomic data to identify key control networks and molecular targets for glioblastoma, and the principle eluted from our work can be applied to other cancers.</abstract><notes>Horvath, S&#xD;Zhang, B&#xD;Carlson, M&#xD;Lu, K V&#xD;Zhu, S&#xD;Felciano, R M&#xD;Laurance, M F&#xD;Zhao, W&#xD;Qi, S&#xD;Chen, Z&#xD;Lee, Y&#xD;Scheck, A C&#xD;Liau, L M&#xD;Wu, H&#xD;Geschwind, D H&#xD;Febbo, P G&#xD;Kornblum, H I&#xD;Cloughesy, T F&#xD;Nelson, S F&#xD;Mischel, P S&#xD;Ca108633/ca/nci&#xD;Ca119347/ca/nci&#xD;Ns050151/ns/ninds&#xD;Ns43137/ns/ninds&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17402-7. Epub 2006 Nov 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17090670</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>10.228</custom4><electronic-resource-num>0608396103 [pii]&#xD;10.1073/pnas.0608396103</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1729</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1729</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Winter, P. M.</author><author>Cai, K.</author><author>Chen, J.</author><author>Adair, C. R.</author><author>Kiefer, G. E.</author><author>Athey, P. S.</author><author>Gaffney, P. J.</author><author>Buff, C. E.</author><author>Robertson, J. D.</author><author>Caruthers, S. D.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Department of Medicine, Cardiovascular Division, Washington University, St. Louis, Missouri 63108, USA. patrick@cvu.wustl.edu</auth-address><titles><title>Targeted PARACEST nanoparticle contrast agent for the detection of fibrin</title><secondary-title>Magn Reson Med</secondary-title></titles><periodical><full-title>Magn Reson Med</full-title></periodical><pages>1384-8</pages><volume>56</volume><number>6</number><edition>2006/11/08</edition><keywords><keyword>Contrast Media/analysis/*chemistry</keyword><keyword>Fibrin/*analysis/*chemistry</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Magnetic Resonance Spectroscopy/*methods</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Particle Size</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0740-3194 (Print)</isbn><accession-num>17089356</accession-num><abstract>A lipid-encapsulated perfluorocarbon nanoparticle molecular imaging contrast agent that utilizes a paramagnetic chemical exchange saturation transfer (PARACEST) chelate is presented. PARACEST agents are ideally suited for molecular imaging applications because one can switch the contrast on and off at will simply by adjusting the pulse sequence parameters. This obviates the need for pre- and postinjection images to define contrast agent binding. Spectroscopy (4.7T) of PARACEST nanoparticles revealed a bound water peak at 52 ppm, in agreement with results from the water-soluble chelate. Imaging of control nanoparticles showed no appreciable contrast, while PARACEST nanoparticles produced &gt;10% signal enhancement. PARACEST nanoparticles were targeted to clots via antifibrin antibodies and produced a contrast-to-noise ratio (CNR) of 10 at the clot surface.</abstract><notes>Winter, Patrick M&#xD;Cai, Kejia&#xD;Chen, Junjie&#xD;Adair, Christopher R&#xD;Kiefer, Garry E&#xD;Athey, Phillip S&#xD;Gaffney, Patrick J&#xD;Buff, Carolyn E&#xD;Robertson, J David&#xD;Caruthers, Shelton D&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Co-07121/co/nci&#xD;Eb-01704/eb/nibib&#xD;Hl-42950/hl/nhlbi&#xD;Hl-59865/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine&#xD;Magn Reson Med. 2006 Dec;56(6):1384-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17089356</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>4.163</custom4><electronic-resource-num>10.1002/mrm.21093</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2044</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2044</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cao, Q.</author><author>Cai, W.</author><author>Li, T.</author><author>Yang, Y.</author><author>Chen, K.</author><author>Xing, L.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford and Bio-X, Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA.</auth-address><titles><title>Combination of integrin siRNA and irradiation for breast cancer therapy</title><secondary-title>Biochem Biophys Res Commun</secondary-title></titles><periodical><full-title>Biochem Biophys Res Commun</full-title></periodical><pages>726-32</pages><volume>351</volume><number>3</number><edition>2006/11/08</edition><keywords><keyword>Breast Neoplasms/ drug therapy/genetics/pathology/ radiotherapy</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Survival/ drug effects/ radiation effects</keyword><keyword>Combined Modality Therapy</keyword><keyword>Gene Silencing</keyword><keyword>Gene Therapy/ methods</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/ genetics</keyword><keyword>RNA, Small Interfering/administration &amp; dosage/ genetics</keyword><keyword>Radiotherapy/methods</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 22</date></pub-dates></dates><isbn>0006-291X (Print)</isbn><accession-num>17087916</accession-num><abstract>Up-regulation of integrin alpha(v)beta(3) has been shown to play a key role in tumor angiogenesis and metastasis. In this study, we evaluated the role of integrin alpha(v)beta(3) in breast cancer cell resistance to ionizing irradiation (IR) and tested the anti-tumor efficacy of combining integrin alpha(v) siRNA and IR. Colonogenic survival assay, cell proliferation, apoptosis, and cell cycle analysis were carried out to determine the treatment effect of siRNA, IR, or combination of both on MDA-MB-435 cells (integrin alpha(v)beta(3)-positive). Integrin alpha(v)beta(3)-negative MCF-7 cells exert more radiosensitivity than MDA-MB-435 cells. IR up-regulates integrin alpha(v)beta(3) expression in MDA-MB-435 cells and integrin alpha(v) siRNA can effectively reduce both alpha(v) and alpha(v)beta(3) integrin expression, leading to increased radiosensitivity. Integrin alpha(v) siRNA also promotes IR-induced apoptosis and enhances IR-induced G2/M arrest in cell cycle progression. This study, with further optimization, may provide a simple and highly efficient treatment strategy for breast cancer as well as other integrin alpha(v)beta(3)-positive cancer types.</abstract><notes>Cao, Qizhen&#xD;Cai, Weibo&#xD;Li, Tianfang&#xD;Yang, Yong&#xD;Chen, Kai&#xD;Xing, Lei&#xD;Chen, Xiaoyuan&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;U54 CA119367/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Biochemical and biophysical research communications&#xD;Biochem Biophys Res Commun. 2006 Dec 22;351(3):726-32. Epub 2006 Oct 30.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>2.823</custom4><electronic-resource-num>S0006-291X(06)02360-6 [pii]&#xD;10.1016/j.bbrc.2006.10.100 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1532</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1532</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ramsey, M. R.</author><author>Sharpless, N. E.</author></authors></contributors><titles><title>ROS as a tumour suppressor?</title><secondary-title>Nat Cell Biol</secondary-title></titles><periodical><full-title>Nat Cell Biol</full-title></periodical><pages>1213-5</pages><volume>8</volume><number>11</number><edition>2006/11/02</edition><keywords><keyword>Cell Aging/*physiology</keyword><keyword>Cell Division/physiology</keyword><keyword>Cyclin-Dependent Kinase Inhibitor p16/metabolism/physiology</keyword><keyword>E2F Transcription Factors/metabolism/physiology</keyword><keyword>Humans</keyword><keyword>Models, Biological</keyword><keyword>Neoplasms/*metabolism/physiopathology</keyword><keyword>Reactive Oxygen Species/*metabolism</keyword><keyword>Retinoblastoma Protein/metabolism/physiology</keyword><keyword>Signal Transduction/physiology</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>1465-7392 (Print)</isbn><accession-num>17077852</accession-num><notes>Ramsey, Matthew R&#xD;Sharpless, Norman E&#xD;Comment&#xD;News&#xD;England&#xD;Nature cell biology&#xD;Nat Cell Biol. 2006 Nov;8(11):1213-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17077852</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>17.637</custom4><electronic-resource-num>ncb1106-1213 [pii]&#xD;10.1038/ncb1106-1213</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1633</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1633</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, B.</author><author>Ranish, J. A.</author><author>Utleg, A. G.</author><author>White, J. T.</author><author>Yan, X.</author><author>Lin, B.</author><author>Hood, L.</author></authors></contributors><auth-address>Institute for Systems Biology, Seattle, Washington 98103, USA.</auth-address><titles><title>Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics</title><secondary-title>Mol Cell Proteomics</secondary-title></titles><periodical><full-title>Mol Cell Proteomics</full-title></periodical><pages>141-9</pages><volume>6</volume><number>1</number><edition>2006/11/01</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Avidin/chemistry</keyword><keyword>Cattle</keyword><keyword>Chickens</keyword><keyword>Glycopeptides/*analysis/chemistry</keyword><keyword>Glycoproteins/chemistry</keyword><keyword>Glycosylation</keyword><keyword>Humans</keyword><keyword>Microsomes</keyword><keyword>Molecular Sequence Data</keyword><keyword>Neoplasm Proteins/chemistry</keyword><keyword>Proteomics/*methods</keyword><keyword>Spectrometry, Mass, Electrospray Ionization/*methods</keyword><keyword>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/*methods</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2007</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1535-9476 (Print)</isbn><accession-num>17074749</accession-num><abstract>We present a robust and general shotgun glycoproteomics approach to comprehensively profile glycoproteins in complex biological mixtures. In this approach, glycopeptides derived from glycoproteins are enriched by selective capture onto a solid support using hydrazide chemistry followed by enzymatic release of the peptides and subsequent analysis by tandem mass spectrometry. The approach was validated using standard protein mixtures that resulted in a close to 100% capture efficiency. Our capture approach was then applied to microsomal fractions of the cisplatin-resistant ovarian cancer cell line IGROV-1/CP. With a Protein Prophet probability value greater than 0.9, we identified a total of 302 proteins with an average protein identification rate of 136 +/- 19 (n = 4) in a single linear quadrupole ion trap (LTQ) mass spectrometer nano-LC-MS experiment and a selectivity of 91 +/- 1.6% (n = 4) for the N-linked glycoconsensus sequence. Our method has several advantages. 1) Digestion of proteins initially into peptides improves the solubility of large membrane proteins and exposes all of the glycosylation sites to ensure equal accessibility to capture reagents. 2) Capturing glycosylated peptides can effectively reduce sample complexity and at the same time increase the confidence of MS-based protein identifications (more potential peptide identifications per protein). 3) The utility of sodium sulfite as a quencher in our capture approach to replace the solid phase extraction step in an earlier glycoprotein chemical capture approach for removing excess sodium periodate allows the overall capture procedure to be completed in a single vessel. This improvement minimizes sample loss, increases sensitivity, and makes our protocol amenable for high throughput implementation, a feature that is essential for biomarker identification and validation of a large number of clinical samples. 4) The approach is demonstrated here on the analysis of N-linked glycopeptides; however, it can be applied equally well to O-glycoprotein analysis.</abstract><notes>Sun, Bingyun&#xD;Ranish, Jeffrey A&#xD;Utleg, Angelita G&#xD;White, James T&#xD;Yan, Xiaowei&#xD;Lin, Biaoyang&#xD;Hood, Leroy&#xD;1p50gm076547/gm/nigms&#xD;1u54ca119347/ca/nci&#xD;1u54da021519/da/nida&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular &amp; cellular proteomics : MCP&#xD;Mol Cell Proteomics. 2007 Jan;6(1):141-9. Epub 2006 Oct 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17074749</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2007</custom3><custom4>9.391</custom4><electronic-resource-num>T600046-MCP200 [pii]&#xD;10.1074/mcp.T600046-MCP200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1727</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1727</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Willets, K. A.</author><author>Van Duyne, R. P.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, IL 60208-3113, USA. kallie@northwestern.edu</auth-address><titles><title>Localized surface plasmon resonance spectroscopy and sensing</title><secondary-title>Annu Rev Phys Chem</secondary-title></titles><periodical><full-title>Annu Rev Phys Chem</full-title><abbr-1>Annual review of physical chemistry</abbr-1></periodical><pages>267-97</pages><volume>58</volume><edition>2006/10/28</edition><keywords><keyword>Nanostructures/chemistry/ultrastructure</keyword><keyword>Spectrum Analysis</keyword><keyword>Surface Plasmon Resonance/*instrumentation/*methods</keyword></keywords><dates><year>2007</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>0066-426X (Print)</isbn><accession-num>17067281</accession-num><abstract>Localized surface plasmon resonance (LSPR) spectroscopy of metallic nanoparticles is a powerful technique for chemical and biological sensing experiments. Moreover, the LSPR is responsible for the electromagnetic-field enhancement that leads to surface-enhanced Raman scattering (SERS) and other surface-enhanced spectroscopic processes. This review describes recent fundamental spectroscopic studies that reveal key relationships governing the LSPR spectral location and its sensitivity to the local environment, including nanoparticle shape and size. We also describe studies on the distance dependence of the enhanced electromagnetic field and the relationship between the plasmon resonance and the Raman excitation energy. Lastly, we introduce a new form of LSPR spectroscopy, involving the coupling between nanoparticle plasmon resonances and adsorbate molecular resonances. The results from these fundamental studies guide the design of new sensing experiments, illustrated through applications in which researchers use both LSPR wavelength-shift sensing and SERS to detect molecules of chemical and biological relevance.</abstract><notes>Willets, Katherine A&#xD;Van Duyne, Richard P&#xD;4r33 dk 066990-02/dk/niddk&#xD;U54 ca 119341/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Annual review of physical chemistry&#xD;Annu Rev Phys Chem. 2007;58:267-97.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17067281</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>13.679</custom4><electronic-resource-num>10.1146/annurev.physchem.58.032806.104607</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1195</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1195</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Euliss, L. E.</author><author>DuPont, J. A.</author><author>Gratton, S.</author><author>DeSimone, J.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Imparting size, shape, and composition control of materials for nanomedicine</title><secondary-title>Chem Soc Rev</secondary-title></titles><periodical><full-title>Chem Soc Rev</full-title></periodical><pages>1095-104</pages><volume>35</volume><number>11</number><edition>2006/10/24</edition><dates><year>2006</year><pub-dates><date>Nov</date></pub-dates></dates><isbn>0306-0012 (Print)</isbn><accession-num>17057838</accession-num><abstract>This tutorial review presents an overview of strategies for the synthesis and fabrication of organic nanomaterials, specifically those with potential for use in medical applications. Examples include liposomes, micelles, polymer-drug conjugates and dendrimers. Methods of driving shape via&quot;bottom-up&quot; synthetic approaches and thermodynamics and kinetics are discussed. Furthermore, methods of driving shape via&quot;top-down&quot; physical and engineering techniques are also explored. Finally, a novel method (referred to as PRINT) used to produce nanoparticles that are shape-specific, can contain any cargo, and can be easily modified is examined along with its potential future role in nanomedicine.</abstract><notes>Euliss, Larken E&#xD;DuPont, Julie A&#xD;Gratton, Stephanie&#xD;DeSimone, Joseph&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Chemical Society reviews&#xD;Chem Soc Rev. 2006 Nov;35(11):1095-104. Epub 2006 Sep 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17057838</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>17.730</custom4><electronic-resource-num>10.1039/b600913c</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2043</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2043</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hsu, A. R.</author><author>Hou, L. C.</author><author>Veeravagu, A.</author><author>Greve, J. M.</author><author>Vogel, H.</author><author>Tse, V.</author><author>Chen, X.</author></authors></contributors><auth-address>Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.</auth-address><titles><title>In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model</title><secondary-title>Mol Imaging Biol</secondary-title></titles><periodical><full-title>Mol Imaging Biol</full-title></periodical><pages>315-23</pages><volume>8</volume><number>6</number><edition>2006/10/21</edition><keywords><keyword>Animals</keyword><keyword>Brain Neoplasms/ diagnosis/metabolism/pathology</keyword><keyword>Disease Models, Animal</keyword><keyword>Female</keyword><keyword>Glioblastoma/ diagnosis/metabolism/pathology</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/ metabolism</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microscopy, Fluorescence/ methods</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Spectroscopy, Near-Infrared/ methods</keyword><keyword>Xenograft Model Antitumor Assays/ methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov-Dec</date></pub-dates></dates><isbn>1536-1632 (Print)</isbn><accession-num>17053862</accession-num><abstract>PURPOSE: Expression of cell adhesion molecule integrin alpha(v)beta(3) is significantly up-regulated during tumor growth, and sprouting of tumor vessels and correlates well with tumor aggressiveness. The purpose of this study was to visualize tumor integrin alpha(v)beta(3) expression in vivo by using near-infrared fluorescence (NIRF) imaging of Cy5.5-linked cyclic arginine-glycine-aspartic acid (RGD) peptide in an orthotopic brain tumor model. PROCEDURES: U87MG glioma cells transfected with the firefly luciferase gene were stereotactically injected into nude mice in the right frontal lobe. Bioluminescence imaging (BLI) using D: -luciferin substrate and small animal magnetic resonance imaging (MRI) using gadolinium contrast enhancement were conducted weekly after tumor cell inoculation to monitor intracranial tumor growth. Integrin alpha(v)beta(3) expression was assessed by using a three-dimensional optical imaging system (IVIS 200) 0-24 hours after administration of 1.5 nmol monomeric Cy5.5-RGD via the tail vein. Animals were injected intravenously with both Texas Red-tomato lectin and Cy5.5-RGD prior to sacrifice to visualize peptide localization to tumor vasculature using histology. RESULTS: Fluorescence microscopy demonstrated specific Cy5.5-RGD binding to both U87MG tumor vessels and tumor cells with no normal tissue binding. NIRF imaging showed highest tumor uptake and tumor to normal brain tissue ratio two hours postinjection (2.64 +/- 0.20). Tumor uptake of Cy5.5-RGD was effectively blocked by using unlabeled c(RGDyK), and injection of Cy5.5 dye alone showed nonspecific binding. CONCLUSIONS: Optical imaging via BLI and NIRF offer a simple, effective, and rapid technique for noninvasive in vivo monitoring and semiquantitative analysis of intracranial tumor growth and integrin alpha(v)beta(3) expression. This study suggests that NIRF via fluorescently labeled RGD peptides may provide enhanced surveillance of tumor angiogenesis and anti-integrin treatment efficacy in orthotopic brain tumor models.</abstract><notes>Hsu, Andrew R&#xD;Hou, Lewis C&#xD;Veeravagu, Anand&#xD;Greve, Joan M&#xD;Vogel, Hannes&#xD;Tse, Victor&#xD;Chen, Xiaoyuan&#xD;1U54CA119367-01/CA/NCI NIH HHS/United States&#xD;P50 CA119364/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;Evaluation Studies&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging&#xD;Mol Imaging Biol. 2006 Nov-Dec;8(6):315-23.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>3.372</custom4><electronic-resource-num>10.1007/s11307-006-0059-y [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1608</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1608</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Snee, P. T.</author><author>Somers, R. C.</author><author>Nair, G.</author><author>Zimmer, J. P.</author><author>Bawendi, M. G.</author><author>Nocera, D. G.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139-4306, USA.</auth-address><titles><title>A ratiometric CdSe/ZnS nanocrystal pH sensor</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>13320-1</pages><volume>128</volume><number>41</number><edition>2006/10/13</edition><keywords><keyword>Biosensing Techniques/instrumentation/*methods</keyword><keyword>Cadmium Compounds/*chemistry</keyword><keyword>Coloring Agents/chemistry</keyword><keyword>Crystallization</keyword><keyword>Cyclobutanes/chemistry</keyword><keyword>Equipment Design</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Ligands</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Oxides/chemistry</keyword><keyword>Phenols/chemistry</keyword><keyword>Phosphines/chemistry</keyword><keyword>Selenium Compounds/*chemistry</keyword><keyword>Solubility</keyword><keyword>Spectrum Analysis</keyword><keyword>Sulfides/*chemistry</keyword><keyword>Water/chemistry</keyword><keyword>Zinc Compounds/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 18</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17031920</accession-num><notes>Snee, Preston T&#xD;Somers, Rebecca C&#xD;Nair, Gautham&#xD;Zimmer, John P&#xD;Bawendi, Moungi G&#xD;Nocera, Daniel G&#xD;1u54-ca119349/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Oct 18;128(41):13320-1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17031920</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja0618999</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1482</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1482</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Olson, D. A.</author><author>Gratton, S. E.</author><author>DeSimone, J. M.</author><author>Sheares, V. V.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina at Chapel Hill, Venable Hall CB 3290, Chapel Hill, NC 27599-3290, USA.</auth-address><titles><title>Amorphous linear aliphatic polyesters for the facile preparation of tunable rapidly degrading elastomeric devices and delivery vectors</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>13625-33</pages><volume>128</volume><number>41</number><edition>2006/10/13</edition><keywords><keyword>Biocompatible Materials/*chemical synthesis</keyword><keyword>Cross-Linking Reagents/chemistry</keyword><keyword>Elastomers/*chemical synthesis</keyword><keyword>Materials Testing</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Models, Chemical</keyword><keyword>Molecular Weight</keyword><keyword>Polyesters/*chemistry</keyword><keyword>Temperature</keyword><keyword>Time Factors</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 18</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17031977</accession-num><abstract>A versatile method for preparing amorphous degradable elastomers with tunable properties that can be easily fabricated into a wide variety of shape-specific devices was investigated. Completely amorphous, liquid poly(ester ether) prepolymers with number-average molecular weights between 4 and 6 x 10(3) g/mol were prepared via condensation polymerization. These liquid prepolymers were then thermally cross-linked to form degradable elastomeric structures. The ability to vary the composition of these liquid prepolymers allows for easy control of the mechanical and degradation properties of the resulting elastomeric structures. Materials can be designed to completely degrade in vitro over a range of 30 days to 6 months, while the Young&apos;s modulus can be varied over 3 orders of magnitude (G = 0.02-20 MPa). Also, the liquid nature of these prepolymers makes them amenable to a wide variety of fabrication techniques. Using traditional and modified imprint lithography techniques, we have fabricated devices that demonstrate a wide variety of biologically applicable topologies, which could easily be extended to fabricate devices with more complex geometries. Until now, no method has combined this ease and speed of fabrication with the ability to control the mechanical and degradation properties of the resulting elastomers over such a broad range.</abstract><notes>Olson, David A&#xD;Gratton, Stephanie E A&#xD;DeSimone, Joseph M&#xD;Sheares, Valerie V&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Oct 18;128(41):13625-33.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17031977</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja063092m</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2157</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2157</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Frullano, L.</author><author>Tejerina, B.</author><author>Meade, T. J.</author></authors></contributors><auth-address>Department of Chemistry, Biochemistry and Molecular and Cell Biology, Neurobiology and Physiology, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Synthesis and characterization of a doxorubicin-Gd(III) contrast agent conjugate: a new approach toward prodrug-procontrast complexes</title><secondary-title>Inorg Chem</secondary-title></titles><periodical><full-title>Inorg Chem</full-title></periodical><pages>8489-91</pages><volume>45</volume><number>21</number><edition>2006/10/13</edition><keywords><keyword>Contrast Media/ chemical synthesis</keyword><keyword>Doxorubicin/ chemistry</keyword><keyword>Gadolinium</keyword><keyword>Gadolinium DTPA/ chemistry</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Models, Molecular</keyword><keyword>Molecular Conformation</keyword><keyword>Molecular Weight</keyword><keyword>Prodrugs</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 16</date></pub-dates></dates><isbn>0020-1669 (Print)</isbn><accession-num>17029358</accession-num><abstract>We have prepared the first MRI prodrug-procontrast complex by conjugating doxorubicin to a Gd(III) chelate using an acid-labile linker. The relaxometric properties of the adduct and pH activation are reported.</abstract><notes>Frullano, Luca&#xD;Tejerina, Baudilio&#xD;Meade, Thomas J&#xD;U54CA098010/CA/NCI NIH HHS/United States&#xD;U54CA119341/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Inorganic chemistry&#xD;Inorg Chem. 2006 Oct 16;45(21):8489-91.</notes><urls></urls><custom1>CCNE - Northwestern</custom1><custom4>4.215</custom4><electronic-resource-num>10.1021/ic0612045 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1133</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1133</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chen, H.</author><author>MacDonald, R. C.</author><author>Li, S.</author><author>Krett, N. L.</author><author>Rosen, S. T.</author><author>O&apos;Halloran, T. V.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>13348-9</pages><volume>128</volume><number>41</number><edition>2006/10/13</edition><keywords><keyword>Antineoplastic Agents/*administration &amp; dosage/pharmacology</keyword><keyword>Arsenicals/*administration &amp; dosage/pharmacology</keyword><keyword>Capsules/*chemistry</keyword><keyword>Chemistry, Pharmaceutical/*methods</keyword><keyword>Doxorubicin/pharmacology</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>Kinetics</keyword><keyword>Lipids/*chemistry</keyword><keyword>Liposomes/*chemistry</keyword><keyword>Lymphocytes/drug effects/pathology</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Oxides/*administration &amp; dosage/pharmacology</keyword><keyword>Temperature</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 18</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17031934</accession-num><notes>Chen, Haimei&#xD;MacDonald, Robert C&#xD;Li, Shuyou&#xD;Krett, Nancy L&#xD;Rosen, Steven T&#xD;O&apos;Halloran, Thomas V&#xD;Gm 054111/gm/nigms&#xD;P30 ca 060553/ca/nci&#xD;U54 ca 119341/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Oct 18;128(41):13348-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17031934</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja064864h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2042</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2042</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Wu, Y.</author><author>Chen, K.</author><author>Cao, Q.</author><author>Tice, D. A.</author><author>Chen, X.</author></authors></contributors><auth-address>The Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, Stanford, CA 94305-5484, USA.</auth-address><titles><title>In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>9673-81</pages><volume>66</volume><number>19</number><edition>2006/10/05</edition><keywords><keyword>Adenocarcinoma/chemistry/pathology/radionuclide imaging</keyword><keyword>Angiogenesis Inhibitors/analysis/immunology/ pharmacokinetics</keyword><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/analysis/immunology/ pharmacokinetics</keyword><keyword>Breast Neoplasms/chemistry/pathology/radionuclide imaging</keyword><keyword>Cell Line, Tumor/radionuclide imaging/transplantation</keyword><keyword>Chelating Agents/administration &amp; dosage/pharmacokinetics</keyword><keyword>Copper Radioisotopes/administration &amp; dosage/analysis/ pharmacokinetics</keyword><keyword>Female</keyword><keyword>Glioblastoma/chemistry/pathology/radionuclide imaging</keyword><keyword>Heterocyclic Compounds, 1-Ring/administration &amp; dosage/pharmacokinetics</keyword><keyword>Humans</keyword><keyword>Immunoconjugates/analysis/immunology/ pharmacokinetics</keyword><keyword>Integrin alphaVbeta3/analysis/ immunology</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Proteins/analysis/ immunology</keyword><keyword>Organometallic Compounds/analysis/immunology/ pharmacokinetics</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Prostatic Neoplasms/chemistry/radiography/radionuclide imaging</keyword><keyword>Radioimmunodetection</keyword><keyword>Radiometry</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 1</date></pub-dates></dates><isbn>1538-7445 (Electronic)</isbn><accession-num>17018625</accession-num><abstract>Abegrin (MEDI-522 or Vitaxin), a humanized monoclonal antibody against human integrin alpha(v)beta(3), is in clinical trials for cancer therapy. In vivo imaging using Abegrin-based probes is needed for better treatment monitoring and dose optimization. Here, we conjugated Abegrin with macrocyclic chelating agent 1,4,7,10-tetra-azacylododecane N,N&apos;,N&apos;&apos;,N&apos;&apos;&apos;-tetraacetic (DOTA) at five different DOTA/Abegrin ratios. The conjugates were labeled with (64)Cu (half-life = 12.7 hours) and tested in three human (U87MG, MDA-MB-435, and PC-3) and one mouse (GL-26) tumor models. The in vitro and in vivo effects of these (64)Cu-DOTA-Abegrin conjugates were evaluated. The number of DOTA per Abegrin varied from 1.65 +/- 0.32 to 38.53 +/- 5.71 and the radiolabeling yield varied from 5.20 +/- 3.16% to 88.12 +/- 6.98% (based on 2 mCi (64)Cu per 50 microg DOTA-Abegrin conjugate). No significant difference in radioimmunoreactivity was found among these conjugates (between 59.78 +/- 1.33 % and 71.13 +/- 2.58 %). Micro-positron emission tomography studies revealed that (64)Cu-DOTA-Abegrin (1,000:1) had the highest tumor activity accumulation (49.41 +/- 4.54% injected dose/g at 71-hour postinjection for U87MG tumor). The receptor specificity of (64)Cu-DOTA-Abegrin was confirmed by effective blocking of MDA-MB-435 tumor uptake with coadministration of nonradioactive Abegrin. (64)Cu-DOTA-IgG exhibited background level tumor uptake at all time points examined. Integrin alpha(v)beta(3)-specific tumor imaging using (64)Cu-DOTA-Abegrin may be translated into the clinic to characterize the pharmacokinetics, tumor targeting efficacy, dose optimization, and dose interval of Abegrin and/or Abegrin conjugates. Chemotherapeutics or radiotherapeutics using Abegrin as the delivering vehicle may also be effective in treating integrin alpha(v)beta(3)-positive tumors.</abstract><notes>Cai, Weibo&#xD;Wu, Yun&#xD;Chen, Kai&#xD;Cao, Qizhen&#xD;Tice, David A&#xD;Chen, Xiaoyuan&#xD;1U54CA119367-01/CA/NCI NIH HHS/United States&#xD;P50 CA114747/CA/NCI NIH HHS/United States&#xD;R21 CA102123/CA/NCI NIH HHS/United States&#xD;R21 EB001785/EB/NIBIB NIH HHS/United States&#xD;R24 CA93862/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2006 Oct 1;66(19):9673-81.</notes><urls></urls><custom1>CCNE - Stanford</custom1><custom4>7.980</custom4><electronic-resource-num>66/19/9673 [pii]&#xD;10.1158/0008-5472.CAN-06-1480 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2217</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2217</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Farokhzad, O. C.</author><author>Dimitrakov, J. D.</author><author>Karp, J. M.</author><author>Khademhosseini, A.</author><author>Freeman, M. R.</author><author>Langer, R.</author></authors></contributors><auth-address>Department of Anesthesiology, Brigham and Women&apos;s Hospital, Boston, Massachusetts, USA.</auth-address><titles><title>Drug delivery systems in urology--getting &quot;smarter&quot;</title><secondary-title>Urology</secondary-title></titles><periodical><full-title>Urology</full-title></periodical><pages>463-9</pages><volume>68</volume><number>3</number><edition>2006/10/03</edition><keywords><keyword>Drug Delivery Systems/instrumentation</keyword><keyword>Equipment Design</keyword><keyword>Humans</keyword><keyword>Miniaturization</keyword><keyword>Urologic Diseases/ drug therapy</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1527-9995 (Electronic)</isbn><accession-num>17010721</accession-num><notes>Farokhzad, Omid C&#xD;Dimitrakov, Jordan D&#xD;Karp, Jeffrey M&#xD;Khademhosseini, Ali&#xD;Freeman, Michael R&#xD;Langer, Robert&#xD;CA119349/CA/NCI NIH HHS/United States&#xD;EB003647/EB/NIBIB NIH HHS/United States&#xD;HL60435/HL/NHLBI NIH HHS/United States&#xD;R01 DK 065990/DK/NIDDK NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Urology&#xD;Urology. 2006 Sep;68(3):463-9.</notes><urls></urls><custom1>CCNE - MIT</custom1><custom2>1618825</custom2><custom3>NIHMS9248</custom3><custom4>2.604</custom4><electronic-resource-num>S0090-4295(06)00499-7 [pii]&#xD;10.1016/j.urology.2006.03.069 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1762</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1762</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yelin, D.</author><author>Rizvi, I.</author><author>White, W. M.</author><author>Motz, J. T.</author><author>Hasan, T.</author><author>Bouma, B. E.</author><author>Tearney, G. J.</author></authors></contributors><auth-address>Harvard Medical School and Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.</auth-address><titles><title>Three-dimensional miniature endoscopy</title><secondary-title>Nature</secondary-title><alt-title>Nature</alt-title></titles><periodical><full-title>Nature</full-title></periodical><alt-periodical><full-title>Nature</full-title></alt-periodical><pages>765</pages><volume>443</volume><number>7113</number><edition>2006/10</edition><keywords><keyword>Animals</keyword><keyword>Endoscopy/*methods</keyword><keyword>Female</keyword><keyword>Mice</keyword><keyword>Ovarian Neoplasms/pathology</keyword><keyword>Peritoneal Neoplasms/diagnosis/pathology/secondary</keyword><keyword>Peritoneum/pathology</keyword><keyword>Pliability</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 19</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>17051200</accession-num><notes>Journal Article&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17051200 </url></related-urls></urls><custom1>CNPP - Mass. Gen. Hosp.</custom1><custom3>2007</custom3><custom4>31.210</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1462</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1462</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nahrendorf, M.</author><author>Jaffer, F. A.</author><author>Kelly, K. A.</author><author>Sosnovik, D. E.</author><author>Aikawa, E.</author><author>Libby, P.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, USA.</auth-address><titles><title>Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis</title><secondary-title>Circulation</secondary-title><alt-title>Circulation</alt-title></titles><periodical><full-title>Circulation</full-title></periodical><alt-periodical><full-title>Circulation</full-title></alt-periodical><pages>1504-11</pages><volume>114</volume><number>14</number><edition>2006/10</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Apolipoproteins E/deficiency</keyword><keyword>Atherosclerosis/*drug therapy/*pathology</keyword><keyword>Diagnostic Imaging/methods</keyword><keyword>Down-Regulation/drug effects</keyword><keyword>Drug Monitoring/methods</keyword><keyword>Gene Expression Regulation/drug effects</keyword><keyword>Inflammation/*diagnosis</keyword><keyword>Ligands</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Peptides/administration &amp; dosage/pharmacology/therapeutic use</keyword><keyword>Vascular Cell Adhesion Molecule-1/*analysis/drug effects</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 3</date></pub-dates></dates><isbn>1524-4539 (Electronic)</isbn><accession-num>17000904</accession-num><abstract>BACKGROUND: Noninvasive imaging of adhesion molecules such as vascular cell adhesion molecule-1 (VCAM-1) may identify early stages of inflammation in atherosclerosis. We hypothesized that a novel, second-generation VCAM-1-targeted agent with enhanced affinity had sufficient sensitivity to enable real-time detection of VCAM-1 expression in experimental atherosclerosis in vivo, to quantify pharmacotherapy-induced reductions in VCAM-1 expression, and to identify activated cells in human plaques. METHODS AND RESULTS: In vivo phage display in apolipoprotein E-deficient mice identified a linear peptide affinity ligand, VHPKQHR, homologous to very late antigen-4, a known ligand for VCAM-1. This peptide was developed into a multivalent agent detectable by MRI and optical imaging (denoted VINP-28 for VCAM-1 internalizing nanoparticle 28, with 20 times higher affinity than previously reported for VNP). In vitro, VINP-28 targeted all cell types expressing VCAM-1. In vivo, MRI and optical imaging in apolipoprotein E-deficient mice (n=28) after injection with VINP-28 or saline revealed signal enhancement in the aortic root of mice receiving VINP-28 (P&lt;0.05). VINP-28 colocalized with endothelial cells and other VCAM-1-expressing cells, eg, macrophages, and was spatially distinct compared with untargeted control nanoparticles. Atheromata of atorvastatin-treated mice showed reduced VINP-28 deposition and VCAM-1 expression. VINP-28 enhanced early lesions in juvenile mice and resected human carotid artery plaques. CONCLUSIONS: VINP-28 allows noninvasive imaging of VCAM-1-expressing endothelial cells and macrophages in atherosclerosis and spatial monitoring of anti-VCAM-1 pharmacotherapy in vivo and identifies inflammatory cells in human atheromata. This clinically translatable agent could noninvasively detect inflammation in early, subclinical atherosclerosis.</abstract><notes>P01-ai054904/ai/niaid&#xD;R01-hl078641/hl/nhlbi&#xD;R01-hl36436/hl/nhlbi&#xD;U01-hl080731/hl/nhlbi&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17000904 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>13.538</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1453</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1453</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Montet, X.</author><author>Funovics, M.</author><author>Montet-Abou, K.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><auth-address>Department of Radiology, Geneva Hospital, Geneva, Switzerland, and Department of Angiography and Interventional Radiology, Vienna Medical University, Vienna, Austria.</auth-address><titles><title>Multivalent effects of RGD peptides obtained by nanoparticle display</title><secondary-title>J Med Chem</secondary-title><alt-title>Journal of medicinal chemistry</alt-title></titles><periodical><full-title>J Med Chem</full-title><abbr-1>Journal of medicinal chemistry</abbr-1></periodical><alt-periodical><full-title>J Med Chem</full-title><abbr-1>Journal of medicinal chemistry</abbr-1></alt-periodical><pages>6087-93</pages><volume>49</volume><number>20</number><edition>2006/10</edition><keywords><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line, Tumor</keyword><keyword>Endothelial Cells/metabolism</keyword><keyword>Endothelium, Vascular/cytology</keyword><keyword>Half-Life</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/*metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Nanostructures</keyword><keyword>Oligopeptides/blood/chemistry/*metabolism</keyword><keyword>Protein Binding</keyword><keyword>Protein Conformation</keyword></keywords><dates><year>2006</year><pub-dates><date>Oct 5</date></pub-dates></dates><isbn>0022-2623 (Print)</isbn><accession-num>17004722</accession-num><abstract>The binding of RGD peptides to integrins offers an excellent system to study the multivalent mediated changes in affinity that arise when peptides, displayed on the surface of a nanoparticle carrier, bind to integrins displayed on the cell membrane. The IC50 of an RGD nanoparticle for endothelial adhesion was 1.0 nM nanoparticle or 20 nM peptide (20 peptide/nanoparticle) and was associated with strong multivalent effects, defined as a multivalent enhancement factor (MVE) of 38 (MVE=IC50 (peptide)/IC50 (peptide when displayed by nanoparticle)). The attachment of RGD peptides to nanoparticles resulted in an extension of the peptide blood half-life from 13 to 180 min. Based on the multivalent enhancement of affinity and extension of blood half-life, multivalent RGD nanoparticle-sized materials should be potent inhibitors of the alpha(V)beta(3) function on endothelial cells in vivo.</abstract><notes>P50 ca86355/ca/nci&#xD;R01 eb00662/eb/nibib&#xD;R24 ca92782/ca/nci&#xD;In Vitro&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17004722 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>5.079</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1501</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1501</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Paunesku, T.</author><author>Vogt, S.</author><author>Maser, J.</author><author>Lai, B.</author><author>Woloschak, G.</author></authors></contributors><auth-address>Department of Radiation Oncology, Northwestern University, 303 E. Chicago Avenue, Chicago, IL 60611, USA.</auth-address><titles><title>X-ray fluorescence microprobe imaging in biology and medicine</title><secondary-title>J Cell Biochem</secondary-title></titles><periodical><full-title>J Cell Biochem</full-title></periodical><pages>1489-502</pages><volume>99</volume><number>6</number><edition>2006/09/29</edition><keywords><keyword>Animals</keyword><keyword>Homeostasis</keyword><keyword>Humans</keyword><keyword>Metals/metabolism</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>Nanotechnology</keyword><keyword>Therapeutics</keyword><keyword>Trace Elements/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec 15</date></pub-dates></dates><isbn>0730-2312 (Print)</isbn><accession-num>17006954</accession-num><abstract>Characteristic X-ray fluorescence is a technique that can be used to establish elemental concentrations for a large number of different chemical elements simultaneously in different locations in cell and tissue samples. Exposing the samples to an X-ray beam is the basis of X-ray fluorescence microscopy (XFM). This technique provides the excellent trace element sensitivity; and, due to the large penetration depth of hard X-rays, an opportunity to image whole cells and quantify elements on a per cell basis. Moreover, because specimens prepared for XFM do not require sectioning, they can be investigated close to their natural, hydrated state with cryogenic approaches. Until several years ago, XFM was not widely available to bio-medical communities, and rarely offered resolution better then several microns. This has changed drastically with the development of third-generation synchrotrons. Recent examples of elemental imaging of cells and tissues show the maturation of XFM imaging technique into an elegant and informative way to gain insight into cellular processes. Future developments of XFM-building of new XFM facilities with higher resolution, higher sensitivity or higher throughput will further advance studies of native elemental makeup of cells and provide the biological community including the budding area of bionanotechnology with a tool perfectly suited to monitor the distribution of metals including nanovectors and measure the results of interactions between the nanovectors and living cells and tissues.</abstract><notes>Paunesku, Tatjana&#xD;Vogt, Stefan&#xD;Maser, Jorg&#xD;Lai, Barry&#xD;Woloschak, Gayle&#xD;Ca 107467/ca/nci&#xD;Eb 002100/eb/nibib&#xD;P50 ca 89018/ca/nci&#xD;U54 ca 119341/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;United States&#xD;Journal of cellular biochemistry&#xD;J Cell Biochem. 2006 Dec 15;99(6):1489-502.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17006954</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>3.592</custom4><electronic-resource-num>10.1002/jcb.21047</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1793</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1793</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhou, Z.</author><author>Dominey, R. N.</author><author>Rolland, J. P.</author><author>Maynor, B. W.</author><author>Pandya, A. A.</author><author>DeSimone, J. M.</author></authors></contributors><auth-address>Department of Chemistry and the Institute for Advanced Materials, Nanoscience and Technology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Molded, high surface area polymer electrolyte membranes from cured liquid precursors</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>12963-72</pages><volume>128</volume><number>39</number><edition>2006/09/28</edition><dates><year>2006</year><pub-dates><date>Oct 4</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>17002393</accession-num><abstract>Polymer electrolyte membranes (PEMs) for fuel cells have been synthesized from easily processable, 100% curable, low molecular weight reactive liquid precursors that are photochemically cured into highly proton conductive solid membranes. The liquid precursors were directly cured into membranes of desired dimensions without the need for further processing steps such as melt extrusion or solvent casting. By employing chemical cross-linking, high proton conductivities can be achieved through the incorporation of significant levels of acidic groups without rendering the material water-soluble, which plagues commonly used non-cross-linked polymers. Fabrication of membrane electrode assemblies (MEAs) from these PEMs resulted in fuel cells that outperformed those based on commercial materials. Moreover, these liquid precursors enabled the formation of three-dimensional, patterned PEMs with high fidelity, micron-scale features by using soft lithographic/micromolding techniques. The patterned membranes provided a larger interfacial area between the membrane and catalyst layer than standard flat PEMs. MEAs composed of the patterned membranes demonstrated higher power densities over that of flat ones without an increase in the macroscopic area of the fuel cells. This can potentially miniaturize fuel cells and promote their application in portable devices.</abstract><notes>Zhou, Zhilian&#xD;Dominey, Raymond N&#xD;Rolland, Jason P&#xD;Maynor, Benjamin W&#xD;Pandya, Ashish A&#xD;DeSimone, Joseph M&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Oct 4;128(39):12963-72.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17002393</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja064391e</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1781</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1781</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, L.</author><author>Zhou, Z.</author><author>Cheng, B.</author><author>Desimone, J. M.</author><author>Samulski, E. T.</author></authors></contributors><auth-address>Curriculum in Applied and Materials Sciences and Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, USA.</auth-address><titles><title>Superhydrophobic behavior of a perfluoropolyether lotus-leaf-like topography</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>8576-80</pages><volume>22</volume><number>20</number><edition>2006/09/20</edition><keywords><keyword>Aluminum Oxide/*chemistry</keyword><keyword>Ethers/*chemistry</keyword><keyword>Fluorocarbons/*chemistry</keyword><keyword>Hydrophobicity</keyword><keyword>*Membranes, Artificial</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Nanostructures/*chemistry/ultrastructure</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 26</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>16981778</accession-num><abstract>We demonstrate the fabrication of 2-D arrays of nanopillars made from perfluoropolyether derivatives using a porous anodic aluminum oxide membrane as a template. Pretexturing the aluminum prior to anodization enables one to engineer multiple morphological length scales and thereby synthesize a lotus-leaf-like topography. Both nanopillars on a flat surface and on a lotus-leaf-like topology exhibit superhydrophobicity, low contact angle hysteresis, and self-cleaning.</abstract><notes>Zhang, Lei&#xD;Zhou, Zhilian&#xD;Cheng, Bin&#xD;Desimone, Joseph M&#xD;Samulski, Edward T&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Langmuir : the ACS journal of surfaces and colloids&#xD;Langmuir. 2006 Sep 26;22(20):8576-80.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16981778</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>4.347</custom4><electronic-resource-num>10.1021/la061400o</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1348</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1348</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Koynova, R.</author><author>Wang, L.</author><author>MacDonald, R. C.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology, and Cell Biology, Northwestern University, Evanston, IL 60208, USA. r-tenchova@northwestern.edu</auth-address><titles><title>An intracellular lamellar-nonlamellar phase transition rationalizes the superior performance of some cationic lipid transfection agents</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>14373-8</pages><volume>103</volume><number>39</number><edition>2006/09/20</edition><keywords><keyword>Animals</keyword><keyword>Cations/*metabolism</keyword><keyword>Cell Surface Extensions/*chemistry</keyword><keyword>Cells, Cultured</keyword><keyword>DNA/metabolism</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword><keyword>*Phase Transition</keyword><keyword>Phosphatidylcholines/chemistry/*metabolism</keyword><keyword>Phosphatidylglycerols/chemistry/metabolism</keyword><keyword>Transfection/*methods</keyword><keyword>X-Ray Diffraction</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 26</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16983097</accession-num><abstract>Two cationic phospholipid derivatives with asymmetric hydrocarbon chains were synthesized: ethyl esters of oleoyldecanoyl-ethylphosphatidylcholine (C18:1/C10-EPC) and stearoyldecanoyl-ethylphosphatidylcholine (C18:0/C10-EPC). The former was 50 times more effective as a DNA transfection agent (human umbilical artery endothelial cells) than the latter, despite their similar chemical structure and virtually identical lipoplex organization. A likely reason for the superior effectiveness of C18:1/C10-EPC relative to C18:0/C10-EPC (and to many other cationic lipoids) was suggested by the phases that evolved when these lipoids were mixed with negatively charged membrane lipid formulations. The saturated C18:0/C10-EPC remained lamellar in mixtures with biomembrane-mimicking lipid formulations [e.g., dioleoyl-phosphatidylcholine/dioleoyl-phosphatidylethanolamine/dioleoyl-ph osphatidylserine/cholesterol at 45:20:20:15 (wt/wt)]; in contrast, the unsaturated C18:1/C10-EPC exhibited a lamellar-nonlamellar phase transition in such mixtures, which took place at physiological temperatures, approximately 37 degrees C. As is well known, lipid vehicles exhibit maximum leakiness and contents release in the vicinity of phase transitions, especially those involving nonlamellar phase formation. Moreover, nonlamellar phase-forming compositions are frequently highly fusogenic. Indeed, FRET experiments showed that C18:1/C10-EPC exhibits lipid mixing with negatively charged membranes that is several times more extensive than that of C18:0/C10-EPC. Thus, C18:1/C10-EPC lipoplexes are likely to easily fuse with membranes, and, as a result of lipid mixing, the resultant aggregates should exhibit extensive phase coexistence and heterogeneity, thereby facilitating DNA release and leading to superior transfection efficiency. These results highlight the phase properties of the carrier lipid/cellular lipid mixtures as a decisive factor for transfection success and suggest a strategy for the rational design of superior cationic lipid carriers.</abstract><notes>Koynova, Rumiana&#xD;Wang, Li&#xD;MacDonald, Robert C&#xD;Gm 52329/gm/nigms&#xD;Gm 57305/gm/nigms&#xD;Gm 74429/gm/nigms&#xD;Rr 08630/rr/ncrr&#xD;U54 ca 119341/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14373-8. Epub 2006 Sep 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16983097</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>10.228</custom4><electronic-resource-num>0603085103 [pii]&#xD;10.1073/pnas.0603085103</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1783</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1783</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, Y.</author><author>So, M. K.</author><author>Rao, J.</author></authors></contributors><auth-address>Biophysics, Cancer Biology, and Molecular Imaging Programs, Department of Radiology, Stanford University School of Medicine, 1201 Welch Road, Stanford, California 94305-5484, USA.</auth-address><titles><title>Protease-modulated cellular uptake of quantum dots</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>1988-92</pages><volume>6</volume><number>9</number><edition>2006/09/14</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Coated Materials, Biocompatible/chemistry/*pharmacokinetics</keyword><keyword>Fibrosarcoma/*metabolism/*pathology</keyword><keyword>Humans</keyword><keyword>Materials Testing</keyword><keyword>Matrix Metalloproteinase 2/chemistry/*pharmacokinetics</keyword><keyword>Matrix Metalloproteinase 7/chemistry/*pharmacokinetics</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>16968013</accession-num><abstract>Quantum dots (QDs) are often cell-impermeable and require transporters to facilitate crossing over cell membranes. Here we present a simple and versatile method that utilizes enzymes, matrix metalloprotease 2 (MMP-2) and MMP-7, to modulate the cellular uptake of QDs. QD-peptide conjugates could be efficiently taken up into cells after the MMP treatment. This enzyme-modulated cellular uptake of QDs may be applied to other nanoparticles for biological imaging and selective drug delivery into tumor cells.</abstract><notes>Zhang, Yan&#xD;So, Min Kyung&#xD;Rao, Jianghong&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2006 Sep;6(9):1988-92.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16968013</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl0611586</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1298</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1298</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ji, H.</author><author>Sharpless, N. E.</author><author>Wong, K. K.</author></authors></contributors><auth-address>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.</auth-address><titles><title>EGFR targeted therapy: view from biological standpoint</title><secondary-title>Cell Cycle</secondary-title></titles><periodical><full-title>Cell Cycle</full-title></periodical><pages>2072-6</pages><volume>5</volume><number>18</number><edition>2006/09/14</edition><keywords><keyword>Adenocarcinoma/genetics/*metabolism/*therapy</keyword><keyword>Animals</keyword><keyword>Antineoplastic Agents/pharmacology</keyword><keyword>Carcinoma, Non-Small-Cell Lung/genetics/*metabolism/*therapy</keyword><keyword>Drug Resistance, Neoplasm/*physiology</keyword><keyword>Enzyme Inhibitors/pharmacology</keyword><keyword>Gene Therapy/methods/trends</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mutation/genetics</keyword><keyword>Receptor, Epidermal Growth Factor/*antagonists &amp;</keyword><keyword>inhibitors/genetics/*metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1551-4005 (Electronic)</isbn><accession-num>16969107</accession-num><abstract>Activating mutations in the kinase domain of the epidermal growth factor receptor (EGFR) in nonsmall cell lung cancers (NSCLCs) correlate with responsiveness to EGFR kinase inhibitors. In vitro cell culture studies have demonstrated that EGFR kinase domain mutants but not wild type (wt) EGFR are transforming and essential for cancer cell survival. We and others have recently demonstrated that the induction of EGFR kinase domain mutants specifically in murine lung epithelium in vivo led to development of adenocarcinoma with bronchioloalveolar carcinoma (BAC) features. These tumors depend completely on the sustained expression of EGFR kinase domain mutants for tumor maintenance. The murine tumors with EGFR kinase domain mutations are sensitive to EGFR targeted therapy similarly to NSCLC patients whose tumors harbor EGFR mutations. In contrast, initial results suggest that overexpression of wt EGFR in murine lungs does not seem to be transforming. We therefore divide EGFR targeted therapy in NSCLC patients into two parts: &quot;EGFR mutant targeted therapy&quot; and &quot;wt EGFR targeted therapy&quot;. The &quot;EGFR mutant targeted therapy&quot; targets the oncogene essential for tumor initiation and maintenance and is frequently correlated with effective clinical outcome. In contrast, &quot;wt EGFR targeted therapy&quot; likely targets the proto-oncogene product wt EGFR, which is not directly involved in tumor initiation and maintenance, and in these cases, the response has been considerably less dramatic.</abstract><notes>Ji, Hongbin&#xD;Sharpless, Norman E&#xD;Wong, Kwok-Kin&#xD;Ag24004/ag/nia&#xD;Ca90679/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Cell cycle (Georgetown, Tex.)&#xD;Cell Cycle. 2006 Sep;5(18):2072-6. Epub 2006 Sep 15.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16969107</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>4.120</custom4><electronic-resource-num>3277 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1276</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1276</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hughes, M. S.</author><author>Marsh, J. N.</author><author>Zhang, H.</author><author>Woodson, A. K.</author><author>Allen, J. S.</author><author>Lacy, E. K.</author><author>Carradine, C.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Washington University School of Medicine, St Louis, MO, USA. msh@cvu.wustl.edu</auth-address><titles><title>Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo</title><secondary-title>IEEE Trans Ultrason Ferroelectr Freq Control</secondary-title></titles><periodical><full-title>IEEE Trans Ultrason Ferroelectr Freq Control</full-title></periodical><pages>1609-16</pages><volume>53</volume><number>9</number><edition>2006/09/13</edition><keywords><keyword>*Algorithms</keyword><keyword>Animals</keyword><keyword>Breast Neoplasms/*ultrasonography</keyword><keyword>Cell Line, Tumor</keyword><keyword>Contrast Media</keyword><keyword>Drug Delivery Systems/methods</keyword><keyword>Humans</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Image Interpretation, Computer-Assisted/*methods</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>*Signal Processing, Computer-Assisted</keyword><keyword>Thermodynamics</keyword><keyword>Ultrasonography/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0885-3010 (Print)</isbn><accession-num>16964911</accession-num><abstract>We describe characterization of backscatter from tumor tissue targeted with a nanoparticle-based ultrasound contrast agent in vivo using analogs of thermodynamic quantities. We apply these waveform characteristics to detection of tumor neovasculature in tumors implanted in athymic nude mice, which were imaged using a research ultrasound scanner over a 2-hour period after injection of alpha upsilon beta3-targeted perfluorocarbon nanoparticles. Images were constructed from backscattered ultrasound using two different approaches: fundamental B-mode imaging and a signal receiver based on a thermodynamic analog (H(C)). The study shows that the thermodynamic analog is capable of detecting differences in backscattered signals that are not apparent with the B-mode approach.</abstract><notes>Hughes, Michael S&#xD;Marsh, Jon N&#xD;Zhang, Hyuing&#xD;Woodson, Adam K&#xD;Allen, John S&#xD;Lacy, Elizabeth K&#xD;Carradine, Cordelia&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Co-27031/co/nci&#xD;Hl042950/hl/nhlbi&#xD;Hl59865/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;IEEE transactions on ultrasonics, ferroelectrics, and frequency control&#xD;IEEE Trans Ultrason Ferroelectr Freq Control. 2006 Sep;53(9):1609-16.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16964911</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>1.654</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1452</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1452</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Molofsky, A. V.</author><author>Slutsky, S. G.</author><author>Joseph, N. M.</author><author>He, S.</author><author>Pardal, R.</author><author>Krishnamurthy, J.</author><author>Sharpless, N. E.</author><author>Morrison, S. J.</author></authors></contributors><auth-address>Howard Hughes Medical Institute, Department of Internal Medicine, and Center for Stem Cell Biology, University of Michigan, Ann Arbor, Michigan 48109-2216, USA.</auth-address><titles><title>Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title></periodical><pages>448-52</pages><volume>443</volume><number>7110</number><edition>2006/09/08</edition><keywords><keyword>Aging/*physiology</keyword><keyword>Animals</keyword><keyword>Cell Proliferation</keyword><keyword>Cyclin-Dependent Kinase Inhibitor</keyword><keyword>p16/biosynthesis/deficiency/genetics/*metabolism</keyword><keyword>Mice</keyword><keyword>Neurons/*cytology</keyword><keyword>Olfactory Bulb/cytology/physiology</keyword><keyword>Prosencephalon/*cytology/metabolism</keyword><keyword>Regeneration/*physiology</keyword><keyword>Stem Cells/cytology</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 28</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>16957738</accession-num><abstract>Mammalian ageing is associated with reduced regenerative capacity in tissues that contain stem cells. It has been proposed that this is at least partially caused by the senescence of progenitors with age; however, it has not yet been tested whether genes associated with senescence functionally contribute to physiological declines in progenitor activity. Here we show that progenitor proliferation in the subventricular zone and neurogenesis in the olfactory bulb, as well as multipotent progenitor frequency and self-renewal potential, all decline with age in the mouse forebrain. These declines in progenitor frequency and function correlate with increased expression of p16INK4a, which encodes a cyclin-dependent kinase inhibitor linked to senescence. Ageing p16INK4a-deficient mice showed a significantly smaller decline in subventricular zone proliferation, olfactory bulb neurogenesis, and the frequency and self-renewal potential of multipotent progenitors. p16INK4a deficiency did not detectably affect progenitor function in the dentate gyrus or enteric nervous system, indicating regional differences in the response of neural progenitors to increased p16INK4a expression during ageing. Declining subventricular zone progenitor function and olfactory bulb neurogenesis during ageing are thus caused partly by increasing p16INK4a expression.</abstract><notes>Molofsky, Anna V&#xD;Slutsky, Shalom G&#xD;Joseph, Nancy M&#xD;He, Shenghui&#xD;Pardal, Ricardo&#xD;Krishnamurthy, Janakiraman&#xD;Sharpless, Norman E&#xD;Morrison, Sean J&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nature&#xD;Nature. 2006 Sep 28;443(7110):448-52. Epub 2006 Sep 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16957738</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>31.210</custom4><electronic-resource-num>nature05091 [pii]&#xD;10.1038/nature05091</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1352</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1352</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Krishnamurthy, J.</author><author>Ramsey, M. R.</author><author>Ligon, K. L.</author><author>Torrice, C.</author><author>Koh, A.</author><author>Bonner-Weir, S.</author><author>Sharpless, N. E.</author></authors></contributors><auth-address>Department of Medicine, The Lineberger Comprehensive Cancer Center, The University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>p16INK4a induces an age-dependent decline in islet regenerative potential</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title></periodical><pages>453-7</pages><volume>443</volume><number>7110</number><edition>2006/09/08</edition><keywords><keyword>Aging/*physiology</keyword><keyword>Animals</keyword><keyword>Cell Proliferation</keyword><keyword>Cyclin-Dependent Kinase Inhibitor p16/genetics/*metabolism</keyword><keyword>Gene Expression Regulation</keyword><keyword>Islets of Langerhans/*cytology/drug effects/pathology</keyword><keyword>Mice</keyword><keyword>Regeneration/*physiology</keyword><keyword>Streptozocin/pharmacology</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 28</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>16957737</accession-num><abstract>The p16INK4a tumour suppressor accumulates in many tissues as a function of advancing age. p16INK4a is an effector of senescence and a potent inhibitor of the proliferative kinase Cdk4 (ref. 6), which is essential for pancreatic beta-cell proliferation in adult mammals. Here we show that p16INK4a constrains islet proliferation and regeneration in an age-dependent manner. Expression of the p16INK4a transcript is enriched in purified islets compared with the exocrine pancreas, and islet-specific expression of p16INK4a, but not other cyclin-dependent kinase inhibitors, increases markedly with ageing. To determine the physiological significance of p16INK4a accumulation on islet function, we assessed the impact of p16INK4a deficiency and overexpression with increasing age and in the regenerative response after exposure to a specific beta-cell toxin. Transgenic mice that overexpress p16INK4a to a degree seen with ageing demonstrated decreased islet proliferation. Similarly, islet proliferation was unaffected by p16INK4a deficiency in young mice, but was relatively increased in p16(INK4a)-deficient old mice. Survival after toxin-mediated ablation of beta-cells, which requires islet proliferation, declined with advancing age; however, mice lacking p16INK4a demonstrated enhanced islet proliferation and survival after beta-cell ablation. These genetic data support the view that an age-induced increase of p16INK4a expression limits the regenerative capacity of beta-cells with ageing.</abstract><notes>Krishnamurthy, Janakiraman&#xD;Ramsey, Matthew R&#xD;Ligon, Keith L&#xD;Torrice, Chad&#xD;Koh, Angela&#xD;Bonner-Weir, Susan&#xD;Sharpless, Norman E&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nature&#xD;Nature. 2006 Sep 28;443(7110):453-7. Epub 2006 Sep 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16957737</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>31.210</custom4><electronic-resource-num>nature05092 [pii]&#xD;10.1038/nature05092</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1295</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1295</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Janzen, V.</author><author>Forkert, R.</author><author>Fleming, H. E.</author><author>Saito, Y.</author><author>Waring, M. T.</author><author>Dombkowski, D. M.</author><author>Cheng, T.</author><author>DePinho, R. A.</author><author>Sharpless, N. E.</author><author>Scadden, D. T.</author></authors></contributors><auth-address>Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, 185 Cambridge Street, Boston, Massachusetts 02114, USA.</auth-address><titles><title>Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title></periodical><pages>421-6</pages><volume>443</volume><number>7110</number><edition>2006/09/08</edition><keywords><keyword>Aging</keyword><keyword>Animals</keyword><keyword>Apoptosis</keyword><keyword>Basic Helix-Loop-Helix Transcription Factors/genetics/metabolism</keyword><keyword>Bone Marrow Transplantation</keyword><keyword>*Cell Aging</keyword><keyword>Cell Count</keyword><keyword>Cell Proliferation</keyword><keyword>Cyclin-Dependent Kinase Inhibitor p16/genetics/*metabolism</keyword><keyword>Hematopoietic Stem Cells/*cytology/*metabolism</keyword><keyword>Homeodomain Proteins/genetics/metabolism</keyword><keyword>Mice</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 28</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>16957735</accession-num><abstract>Stem-cell ageing is thought to contribute to altered tissue maintenance and repair. Older humans experience increased bone marrow failure and poorer haematologic tolerance of cytotoxic injury. Haematopoietic stem cells (HSCs) in older mice have decreased per-cell repopulating activity, self-renewal and homing abilities, myeloid skewing of differentiation, and increased apoptosis with stress. Here we report that the cyclin-dependent kinase inhibitor p16INK4a, the level of which was previously noted to increase in other cell types with age, accumulates and modulates specific age-associated HSC functions. Notably, in the absence of p16INK4a, HSC repopulating defects and apoptosis were mitigated, improving the stress tolerance of cells and the survival of animals in successive transplants, a stem-cell-autonomous tissue regeneration model. Inhibition of p16INK4a may ameliorate the physiological impact of ageing on stem cells and thereby improve injury repair in aged tissue.</abstract><notes>Janzen, Viktor&#xD;Forkert, Randolf&#xD;Fleming, Heather E&#xD;Saito, Yoriko&#xD;Waring, Michael T&#xD;Dombkowski, David M&#xD;Cheng, Tao&#xD;DePinho, Ronald A&#xD;Sharpless, Norman E&#xD;Scadden, David T&#xD;England&#xD;Nature&#xD;Nature. 2006 Sep 28;443(7110):421-6. Epub 2006 Sep 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16957735</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>31.210</custom4><electronic-resource-num>nature05159 [pii]&#xD;10.1038/nature05159</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1639</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1639</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, E. Y.</author><author>Josephson, L.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Harvard Medical School, Charlestown, MA 02129, USA.</auth-address><titles><title>&quot;Clickable&quot; nanoparticles for targeted imaging</title><secondary-title>Mol Imaging</secondary-title></titles><periodical><full-title>Mol Imaging</full-title></periodical><pages>122-8</pages><volume>5</volume><number>2</number><edition>2006/09/07</edition><keywords><keyword>*Alkynes</keyword><keyword>Animals</keyword><keyword>*Azides</keyword><keyword>Cell Line</keyword><keyword>*Coated Materials, Biocompatible/administration &amp; dosage</keyword><keyword>*Drug Delivery Systems/methods</keyword><keyword>Fluorescein/administration &amp; dosage</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>Mice</keyword><keyword>*Nanostructures</keyword><keyword>Paclitaxel/administration &amp; dosage</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr-Jun</date></pub-dates></dates><isbn>1535-3508 (Print)</isbn><accession-num>16954026</accession-num><abstract>Nanomaterials functionalized with targeting ligands are increasingly recognized as useful materials for molecular imaging and drug delivery. Here we describe the development and validation of azide-alkyne reactions (&quot;click chemistry&quot;) for the rapid, site-specific modification of nanoparticles with small molecules. The facile preparation of stable nanoparticles bearing azido or alkyne groups capable of reaction with their corresponding counterpart functionalized small molecules is demonstrated. The Cu(I)-catalyzed cycloaddition of azides and alkynes is shown to be a highly efficient and selective method for point functionalization of magnetic nanoparticles. Derivatized nanoparticles bearing biotin, fluorochrome, or steroid moieties are stable for several months. Nanoparticle click chemistry will be useful for other nanomaterials, design of novel sensors, and drug delivery vehicles.</abstract><notes>Sun, Eric Yi&#xD;Josephson, Lee&#xD;Weissleder, Ralph&#xD;United States&#xD;Molecular imaging : official journal of the Society for Molecular Imaging&#xD;Mol Imaging. 2006 Apr-Jun;5(2):122-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16954026</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>3.329</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1478</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1478</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Oh, B. K.</author><author>Park, S.</author><author>Millstone, J. E.</author><author>Lee, S. W.</author><author>Lee, K. B.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Separation of tricomponent protein mixtures with triblock nanorods</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>11825-9</pages><volume>128</volume><number>36</number><edition>2006/09/07</edition><keywords><keyword>Acetic Acids/chemistry</keyword><keyword>Biotin/chemistry</keyword><keyword>Chromones/chemistry</keyword><keyword>Fluorescent Dyes/chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Histidine/chemistry</keyword><keyword>Hydrazines/chemistry</keyword><keyword>Magnetics</keyword><keyword>Nanotubes/*chemistry</keyword><keyword>Nickel/chemistry</keyword><keyword>Organic Chemicals/chemistry</keyword><keyword>Proteins/*isolation &amp; purification</keyword><keyword>Serum Albumin, Bovine/isolation &amp; purification</keyword><keyword>Staphylococcal Protein A/isolation &amp; purification</keyword><keyword>Ubiquitin/isolation &amp; purification</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 13</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16953622</accession-num><abstract>Two-component triblock magnetic nanorods with gold end blocks and nickel interior blocks have been synthesized and used as affinity templates for the simultaneous and efficient separation of a three-component protein mixture. The gold blocks were selectively functionalized with 11-amino-1-undecanethiol, and then glutaraldehyde was used to covalently attach nitrostreptavidin to them. His-tagged proteins bind to the nickel block and biotin-tagged proteins bind to the functionalized gold ends, allowing one to separate a mixture of three proteins with a single material. Each surface-bound protein can be released selectively using imidazole for the His-tagged protein and biotin for the biotinylated protein.</abstract><notes>Oh, Byung-Keun&#xD;Park, Sungho&#xD;Millstone, Jill E&#xD;Lee, Seung Woo&#xD;Lee, Ki-Bum&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Sep 13;128(36):11825-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16953622</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja057525h</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1099</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1099</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Brekke, C.</author><author>Morgan, S. C.</author><author>Lowe, A. S.</author><author>Meade, T. J.</author><author>Price, J.</author><author>Williams, S. C.</author><author>Modo, M.</author></authors></contributors><auth-address>NeuroImaging Research Group - Department of Neurology, Institute of Psychiatry, King&apos;s College London, UK.</auth-address><titles><title>The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry</title><secondary-title>NMR Biomed</secondary-title></titles><periodical><full-title>NMR Biomed</full-title></periodical><pages>77-89</pages><volume>20</volume><number>2</number><edition>2006/09/05</edition><keywords><keyword>Animals</keyword><keyword>Cell Differentiation/drug effects</keyword><keyword>Cell Line</keyword><keyword>Cell Movement/drug effects</keyword><keyword>Cell Proliferation/drug effects</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Contrast Media/*pharmacology</keyword><keyword>Dextrans/*pharmacology</keyword><keyword>Gadolinium/*pharmacology</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Mice</keyword><keyword>Neurons/cytology</keyword><keyword>Reactive Oxygen Species</keyword><keyword>Rhodamines/*pharmacology</keyword><keyword>Stem Cells/cytology</keyword></keywords><dates><year>2007</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0952-3480 (Print)</isbn><accession-num>16952123</accession-num><abstract>The in vivo monitoring of cell survival and migration will be essential to the translation of cell-based therapies from the laboratory to clinical studies. The pre-labeling of cells with magnetic resonance imaging (MRI) contrast agents renders them visible in vivo for serial cellular imaging. However, little is known about the impact of the presence of these metal particles inside transplanted cells. The use of the bimodal contrast agent GRID made it possible to demonstrate by means of fluorescent microscopy and inductively coupled plasma mass spectrometry (ICP-MS) that, after 16 h of incubation (without the use of a transfection agent), neural stem cells (NSCs) were saturated and no longer incorporated particles. With this maximal uptake, no significant effect on cell viability was observed. However, a significant decrease in proliferation was evident in cells that underwent 24 h of labeling. A significant increase in reactive oxygen species was observed for all GRID labeling, with a very significant increase with 24 h of labeling. GRID labeling did not affect cell motility in comparison with PKH26-labeled NSCs in a glioma-based migration assay and also allowed differentiation into all major cell types of the brain. GRID-labeled cells induced a signal change of 47% on T(2) measurements and allows a detection of cell clusters of approximately 220 cells/microl. Further in vivo testing will be required to ensure that cell labeling with gadolinium-based MRI contrast agents does not impair their ability to repair.</abstract><notes>Brekke, Cecilie&#xD;Morgan, Sarah C&#xD;Lowe, Andrew S&#xD;Meade, Thomas J&#xD;Price, Jack&#xD;Williams, Steve C R&#xD;Modo, Michel&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;NMR in biomedicine&#xD;NMR Biomed. 2007 Apr;20(2):77-89.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16952123</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2007</custom3><custom4>4.815</custom4><electronic-resource-num>10.1002/nbm.1077</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1434</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1434</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mannova, P.</author><author>Fang, R.</author><author>Wang, H.</author><author>Deng, B.</author><author>McIntosh, M. W.</author><author>Hanash, S. M.</author><author>Beretta, L.</author></authors></contributors><auth-address>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.</auth-address><titles><title>Modification of host lipid raft proteome upon hepatitis C virus replication</title><secondary-title>Mol Cell Proteomics</secondary-title></titles><periodical><full-title>Mol Cell Proteomics</full-title></periodical><pages>2319-25</pages><volume>5</volume><number>12</number><edition>2006/09/01</edition><keywords><keyword>Cell Extracts/chemistry</keyword><keyword>Cell Fractionation/methods</keyword><keyword>Electrophoresis, Gel, Two-Dimensional</keyword><keyword>Hepacivirus/*physiology</keyword><keyword>Host-Parasite Relations</keyword><keyword>Humans</keyword><keyword>Membrane Microdomains/*chemistry/metabolism/virology</keyword><keyword>Proteome/*analysis/metabolism</keyword><keyword>Proteomics/methods</keyword><keyword>Tumor Cells, Cultured</keyword><keyword>*Virus Replication</keyword></keywords><dates><year>2006</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1535-9476 (Print)</isbn><accession-num>16943187</accession-num><abstract>Hepatitis C virus (HCV) replication complex resides in detergent-insoluble subcellular domains or lipid rafts. We used two proteomics approaches to characterize the protein content of lipid rafts isolated from Huh7 cells and its modification upon HCV replication. Using two-dimensional electrophoresis and mass spectrometry, we identified approximately 100 protein spots in the isolated lipid rafts; among them, 39 were reproducibly modified in HCV replicon cell lines as compared with control cell lines. We also used stable isotope labeling by amino acids in cell culture (SILAC) combined with one-dimensional electrophoresis separation and mass spectrometry. Using this approach, we identified 1036 individual proteins based on peptides selected with at least 95% confidence; among them, 413 proteins were identified with at least two peptides. Quantification analysis identified 150 proteins modified by at least 2.5-fold (110 up-regulated and 40 down-regulated) in HCV-replicating cells compared with controls. Protein identifications and quantifications obtained by both proteomics approaches were largely concordant. Modulated proteins included a majority of proteins involved in vesicular and protein trafficking and in cell signaling. Remarkably for a large number of proteins, their up-regulation in lipid rafts of HCV replicon cells was due to their relocalization. By using small interfering RNAs directed to the modulated small GTPases Cdc42 and RhoA, we observed an increase in HCV replication, whereas reduction of syntaxin 7 expression resulted in decreased replication of HCV. Our findings indicate that protein subcellular relocalization occurs in HCV-containing cells that can directly affect HCV replication.</abstract><notes>Mannova, Petra&#xD;Fang, Ruihua&#xD;Wang, Hong&#xD;Deng, Bin&#xD;McIntosh, Martin W&#xD;Hanash, Samir M&#xD;Beretta, Laura&#xD;Comparative Study&#xD;United States&#xD;Molecular &amp; cellular proteomics : MCP&#xD;Mol Cell Proteomics. 2006 Dec;5(12):2319-25. Epub 2006 Aug 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16943187</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>9.391</custom4><electronic-resource-num>M600121-MCP200 [pii]&#xD;10.1074/mcp.M600121-MCP200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1660</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1660</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tiwari, S. B.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, USA.</auth-address><titles><title>Improved oral delivery of paclitaxel following administration in nanoemulsion formulations</title><secondary-title>J Nanosci Nanotechnol</secondary-title><alt-title>Journal of nanoscience and nanotechnology</alt-title></titles><periodical><full-title>J Nanosci Nanotechnol</full-title></periodical><alt-periodical><full-title>J Nanosci Nanotechnol</full-title><abbr-1>Journal of nanoscience and nanotechnology</abbr-1></alt-periodical><pages>3215-21</pages><volume>6</volume><number>9-10</number><edition>2006/09</edition><keywords><keyword>Administration, Oral</keyword><keyword>Animals</keyword><keyword>Antineoplastic Agents, Phytogenic/administration &amp;</keyword><keyword>dosage/blood/chemistry/pharmacokinetics</keyword><keyword>Drug Carriers/*chemistry</keyword><keyword>Drug Compounding/methods</keyword><keyword>Emulsions</keyword><keyword>Excipients/*chemistry</keyword><keyword>Female</keyword><keyword>Metabolic Clearance Rate</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Nanostructures/*chemistry/*ultrastructure</keyword><keyword>Organ Specificity</keyword><keyword>Paclitaxel/administration &amp; dosage/blood/*chemistry/*pharmacokinetics</keyword><keyword>Particle Size</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep-Oct</date></pub-dates></dates><isbn>1533-4880 (Print)</isbn><accession-num>17048539</accession-num><abstract>Nanoemulsion formulations were designed for enhancing the oral bioavailability of hydrophobic drugs. Paclitaxel was selected as a model hydrophobic drug, which is also a substrate for the P-glycoprotein efflux system. The oil-in-water (o/w) nanoemulsions were formulated with pine nut oil as the internal oil phase, egg lecithin as the primary emulsifier, and water as the external phase. Stearylamine and deoxycholic acid were used to impart positive and negative charge to the emulsions, respectively. Nanoemulsions were prepared by sonication method and characterized for particle size and surface charge. The control and nanoemulsion formulations with tritiated [3H]-paclitaxel were administered orally to female C57BL/6 mice and the distribution of the drug was examined. The formulated nanoemulsions had a particle size range of approximately 90-120 nm (laser diffraction method) and zeta potential values ranging from -56 mV to +34 mV. Following oral administration, a significantly higher concentration of paclitaxel was observed in the systemic circulation when administered in the nanoemulsion relative to control aqueous solution. The absorbed drug was found to be distributed in the liver, kidneys, and lungs. The results of this study suggest that nanoemulsions are promising novel formulations that can enhance the oral bioavailability of hydrophobic drugs, like paclitaxel.</abstract><notes>R01-ca-095522/ca/nci&#xD;R01-ca-119617/ca/nci&#xD;Comparative Study&#xD;Evaluation Studies&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17048539 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2007</custom3><custom4>2.100</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1636</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1636</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, C.</author><author>Sze, R.</author><author>Zhang, M.</author></authors></contributors><auth-address>Department of Materials Science and Engineering, University of Washington, Seattle, 98195, USA.</auth-address><titles><title>Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI</title><secondary-title>J Biomed Mater Res A</secondary-title><alt-title>Journal of biomedical materials research</alt-title></titles><periodical><full-title>J Biomed Mater Res A</full-title></periodical><alt-periodical><full-title>J Biomed Mater Res A</full-title><abbr-1>Journal of biomedical materials research</abbr-1></alt-periodical><pages>550-7</pages><volume>78</volume><number>3</number><edition>2006/09</edition><keywords><keyword>*Drug Delivery Systems</keyword><keyword>Ferric Compounds</keyword><keyword>*Folic Acid</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>Magnetics</keyword><keyword>*Nanostructures</keyword><keyword>*Polyethylene Glycols</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 1</date></pub-dates></dates><isbn>1549-3296 (Print)</isbn><accession-num>16736484</accession-num><abstract>We report the development and in vitro study of a nanoconjugate serving as a targeted magnetic resonance imaging (MRI) contrast enhancement agent for detection of cancer cells overexpressing the folate receptor. The nanoconjugate was synthesized by coating superparamagnetic iron oxide nanoparticles with covalently bound bifunctional poly(ethylene glycol) (PEG), followed by conjugation with folic acid (FA). The specificity of the nanoconjugate targeting cancerous cells was demonstrated by comparative intracellular uptake of the nanoconjugate and PEG-/dextran-coated nanoparticles by human adenocarcinoma HeLa cells. Preferential targeting to cancerous cells was studied by comparing the uptake of the nanoconjugate by HeLa cells and by non-FR expressing osteosarcoma MG-63 cells. Uptake of the nanoconjugate by HeLa cells after 4 h incubation was found to be a 12-fold higher than that of PEG- or dextran-coated nanoparticles as quantified by inductively coupled plasma spectroscopy. A significant negative contrast enhancement was observed with magnetic resonance (MR) phantom imaging for HeLa cells over MG-63 cells, when both were cultured with the nanoconjugate. Specificity of the nanoconjugate for folate receptors was also verified with a competitive inhibition assay, in which HeLa cells were incubated with both NP-PEG-FA and free FA. The bifunctional PEG used has amide linkages within the PEG chains that can form interchain hydrogen bonding, leading to improved stability of the PEG coating. Self-assembled PEG can be controlled at the molecular level and are suitable for nanoscale coatings.</abstract><notes>N01-co37122/co/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16736484 </url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2007</custom3><custom4>3.371</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1599</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1599</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shukla, R.</author><author>Thomas, T. P.</author><author>Peters, J. L.</author><author>Desai, A. M.</author><author>Kukowska-Latallo, J.</author><author>Patri, A. K.</author><author>Kotlyar, A.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, Division of Allergy, University of Michigan, 9220 MSRB III, Box 0648, Ann Arbor, 48109, USA.</auth-address><titles><title>HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb</title><secondary-title>Bioconjug Chem</secondary-title><alt-title>Bioconjugate chemistry</alt-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><alt-periodical><full-title>Bioconjugate Chemistry</full-title></alt-periodical><pages>1109-15</pages><volume>17</volume><number>5</number><edition>2006/09</edition><keywords><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/chemistry/*metabolism</keyword><keyword>Biocompatible Materials/chemistry/metabolism</keyword><keyword>Cell Line</keyword><keyword>Female</keyword><keyword>Fluorescent Dyes/chemistry/metabolism</keyword><keyword>Humans</keyword><keyword>Materials Testing</keyword><keyword>Mice</keyword><keyword>Mice, SCID</keyword><keyword>Molecular Structure</keyword><keyword>Neoplasms/*metabolism</keyword><keyword>Polyamines/chemistry/*metabolism</keyword><keyword>Receptor, erbB-2/chemistry/immunology/*metabolism</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep-Oct</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>16984117</accession-num><abstract>In the present study, we report the synthesis and human growth factor receptor-2 (HER2) specific tumor targeting properties of a dendrimer conjugated to anti-HER2 mAb (monoclonal antibody) conjugate. The polyamidoamine (PAMAM) dendrimer generation five (G5) was labeled with alexaFluor 488 and conjugated to anti-HER2 mAb. The binding and internalization of the antibody-conjugated dendrimer to HER2-expressing cells was evaluated by flow cytometry and confocal microscopy. Uniquely, the conjugate demonstrated cellular uptake and internalization in HER2-expressing cells as compared to free antibody. The time course of internalization and blocking experiments with free antibody suggest that the rapid and efficient cellular internalization of the dendrimer-antibody conjugate was achieved without alterations in specificity of targeting. Animal studies demonstrated that the conjugate targets HER2-expressing tumors.</abstract><notes>N01-cm-97065-32/cm/nci&#xD;Evaluation Studies&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16984117 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2007</custom3><custom4>4.802</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1309</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1309</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kannan, R.</author><author>Rahing, V.</author><author>Cutler, C.</author><author>Pandrapragada, R.</author><author>Katti, K. K.</author><author>Kattumuri, V.</author><author>Robertson, J. D.</author><author>Casteel, S. J.</author><author>Jurisson, S.</author><author>Smith, C.</author><author>Boote, E.</author><author>Katti, K. V.</author></authors></contributors><auth-address>Department of Radiology, University of Missouri-Columbia, Columbia, Missouri 65212, USA. kannanr@health.missouri.edu</auth-address><titles><title>Nanocompatible chemistry toward fabrication of target-specific gold nanoparticles</title><secondary-title>J Am Chem Soc</secondary-title><alt-title>Journal of the American Chemical Society</alt-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><alt-periodical><full-title>Journal of the American Chemical Society</full-title></alt-periodical><pages>11342-3</pages><volume>128</volume><number>35</number><edition>2006/09</edition><keywords><keyword>Animals</keyword><keyword>Biocompatible Materials/*chemistry/pharmacokinetics</keyword><keyword>Drug Stability</keyword><keyword>Gold/*chemistry/pharmacokinetics</keyword><keyword>Metal Nanoparticles/*chemistry</keyword><keyword>Mice</keyword><keyword>Mice, Inbred Strains</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>*Nanomedicine</keyword><keyword>Particle Size</keyword><keyword>Surface Properties</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 6</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16939243</accession-num><notes>1r01ca119412-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16939243 </url></related-urls></urls><custom1>CNPP - U. of Miss.</custom1><custom3>2007</custom3><custom4>8.256</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1202</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1202</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fatouros, P. P.</author><author>Corwin, F. D.</author><author>Chen, Z. J.</author><author>Broaddus, W. C.</author><author>Tatum, J. L.</author><author>Kettenmann, B.</author><author>Ge, Z.</author><author>Gibson, H. W.</author><author>Russ, J. L.</author><author>Leonard, A. P.</author><author>Duchamp, J. C.</author><author>Dorn, H. C.</author></authors></contributors><auth-address>Department of Radiology, Virginia Commonwealth University, Sanger Hall, B3-021, 1101 E Marshall St, PO Box 980072, Richmond, VA 23298-0072, USA. ppfatouros@vcu.edu</auth-address><titles><title>In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle</title><secondary-title>Radiology</secondary-title><alt-title>Radiology</alt-title></titles><periodical><full-title>Radiology</full-title></periodical><alt-periodical><full-title>Radiology</full-title></alt-periodical><pages>756-64</pages><volume>240</volume><number>3</number><edition>2006/09</edition><keywords><keyword>Animals</keyword><keyword>Brain/*anatomy &amp; histology</keyword><keyword>Female</keyword><keyword>Fullerenes/*diagnostic use</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>*Nanostructures</keyword><keyword>Rats</keyword><keyword>Rats, Inbred F344</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0033-8419 (Print)</isbn><accession-num>16837672</accession-num><abstract>PURPOSE: To evaluate the effectiveness of a functionalized trimetallic nitride endohedral metallofullerene nanoparticle as a magnetic resonance (MR) imaging proton relaxation agent and to follow its distribution for in vitro agarose gel infusions and in vivo infusions in rat brain. MATERIALS AND METHODS: The animal study was approved by the animal care and use committee. Gd(3)N@C(80) was functionalized with poly(ethylene glycol) units, and the carbon cage was hydroxylated to provide improved water solubility and biodistribution. Relaxation rate measurements (R1 = 1/T1 and R2 = 1/T2) of water solutions of this contrast agent were conducted at 0.35-, 2.4-, and 9.4-T MR imaging. Images of contrast agent distributions were produced following infusions in six agarose gel samples at 2.4 T and from direct brain infusions into normal and tumor-bearing rat brain at 2.4 T. The relaxivity of a control functionalized lutetium agent, Lu(3)N@C(80), was also determined. RESULTS: Water hydrogen MR imaging relaxivity (r1) for this metallofullerene nanoparticle was markedly higher than that for commercial agents (eg, gadodiamide); r1 values of 102, 143, and 32 L . mmol(-1) . sec(-1) were measured at 0.35, 2.4, and 9.4 T, respectively. In studies of in vitro agarose gel infusion, the use of functionalized Gd(3)N@C(80) at concentrations an order of magnitude lower resulted in equivalent visualization in comparison with commercial agents. Comparable contrast enhancement was obtained with direct infusions of 0.013 mmol/L of Gd(3)N@C(80) and 0.50 mmol/L of gadodiamide in live normal rat brain. Elapsed-time studies demonstrated lower diffusion rates for Gd(3)N@C(80) relative to gadodiamide in live normal rat brain tissue. Functionalized metallofullerenes directly infused into a tumor-bearing brain provided an improved tumor delineation in comparison with the intravenously injected conventional Gd(3+) chelate. A control lutetium functionalized Lu(3)N@C(80) nanoparticle exhibited very low MR imaging relaxivity. CONCLUSION: The new functionalized trimetallic nitride endohedral metallofullerene species Gd(3)N@C(80)[DiPEG5000(OH)(x)] is an effective proton relaxation agent, as demonstrated with in vitro relaxivity and MR imaging studies, in infusion experiments with agarose gel and in vivo rat brain studies simulating clinical conditions of direct intraparenchymal drug delivery for the treatment of brain tumors.</abstract><notes>R01 ca119371-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16837672 </url></related-urls></urls><custom1>CNPP - V.C.U.</custom1><custom3>2006</custom3><custom4>6.634</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1694</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1694</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, L.</author><author>Koynova, R.</author><author>Parikh, H.</author><author>MacDonald, R. C.</author></authors></contributors><auth-address>Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois, USA.</auth-address><titles><title>Transfection activity of binary mixtures of cationic o-substituted phosphatidylcholine derivatives: the hydrophobic core strongly modulates physical properties and DNA delivery efficacy</title><secondary-title>Biophys J</secondary-title></titles><periodical><full-title>Biophys J</full-title></periodical><pages>3692-706</pages><volume>91</volume><number>10</number><edition>2006/08/29</edition><keywords><keyword>Cations</keyword><keyword>Cell Membrane/chemistry/*metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Complex Mixtures/chemistry</keyword><keyword>DNA/administration &amp; dosage/*chemistry/genetics/*pharmacokinetics</keyword><keyword>Drug Carriers/*chemistry</keyword><keyword>Endothelial Cells/*metabolism</keyword><keyword>Humans</keyword><keyword>Hydrophobicity</keyword><keyword>Phosphatidylcholines/*chemistry</keyword><keyword>Transfection/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov 15</date></pub-dates></dates><isbn>0006-3495 (Print)</isbn><accession-num>16935955</accession-num><abstract>A combination of two cationic lipid derivatives having the same headgroup but tails of different chain lengths has been shown to have considerably different transfection activity than do the separate molecules. Such findings point to the importance of investigating the hydrophobic portions of cationic amphiphiles. Hence, we have synthesized a variety of cationic phosphatidylcholines with unusual hydrophobic moieties and have evaluated their transfection activity and that of their mixtures with the original molecule of this class, dioleoyl-O-ethylphosphatidylcholine (EDOPC). Four distinct relationships between transfection activity and composition of the mixture (plotted as percent of the new compound added to EDOPC) were found, namely: with a maximum or minimum; with a proportional change; or with essentially no change. Relevant physical properties of the lipoplexes were also examined; specifically, membrane fusion (by fluorescence resonance energy transfer between cationic and anionic lipids) and DNA unbinding (measured as accessibility of DNA to ethidium bromide by electrophoresis and by fluorescence resonance energy transfer between DNA and cationic lipid), both after the addition of negatively charged membrane lipids. Fusibility increased with increasing content of second cationic lipid, regardless of the transfection pattern. However, the extent of DNA unbinding after addition of negatively charged membrane lipids did correlate with extent of transfection. The phase behavior of cationic lipids per se as well as that of their mixtures with membrane lipids revealed structural differences that may account for and support the hypothesis that a membrane lipid-triggered, lamellar--&gt;nonlamellar phase transition that facilitates DNA release is critical to efficient transfection by cationic lipids.</abstract><notes>Wang, Li&#xD;Koynova, Rumiana&#xD;Parikh, Harsh&#xD;MacDonald, Robert C&#xD;Gm52329/gm/nigms&#xD;Gm57305/gm/nigms&#xD;Gm74429/gm/nigms&#xD;Rr08630/rr/ncrr&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Biophysical journal&#xD;Biophys J. 2006 Nov 15;91(10):3692-706. Epub 2006 Aug 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16935955</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>5.036</custom4><electronic-resource-num>biophysj.106.092700 [pii]&#xD;10.1529/biophysj.106.092700</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1451</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1451</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Mischel, P. S.</author><author>Cloughesy, T.</author></authors></contributors><auth-address>Pathology and Laboratory Medicine, David Geffen UCLA School of Medicine, Los Angeles, CA 90095-1732, USA. pmischel@mednet.ucla.edu</auth-address><titles><title>Using molecular information to guide brain tumor therapy</title><secondary-title>Nat Clin Pract Neurol</secondary-title></titles><periodical><full-title>Nat Clin Pract Neurol</full-title></periodical><pages>232-3</pages><volume>2</volume><number>5</number><edition>2006/08/26</edition><keywords><keyword>Brain Neoplasms/*genetics/*therapy</keyword><keyword>Glioma/*genetics/*therapy</keyword><keyword>Humans</keyword><keyword>Molecular Biology/*trends</keyword><keyword>Oncogenes/genetics</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1745-834X (Print)</isbn><accession-num>16932555</accession-num><notes>Mischel, Paul S&#xD;Cloughesy, Timothy&#xD;Review&#xD;England&#xD;Nature clinical practice. Neurology&#xD;Nat Clin Pract Neurol. 2006 May;2(5):232-3.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16932555</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>6.806</custom4><electronic-resource-num>ncpneuro0145 [pii]&#xD;10.1038/ncpneuro0145</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1602</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1602</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sinha, R.</author><author>Kim, G. J.</author><author>Nie, S.</author><author>Shin, D. M.</author></authors></contributors><auth-address>Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, 1365-C Clifton Road, Room 3090, Atlanta, GA 30322, USA.</auth-address><titles><title>Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery</title><secondary-title>Mol Cancer Ther</secondary-title></titles><periodical><full-title>Mol Cancer Ther</full-title></periodical><pages>1909-17</pages><volume>5</volume><number>8</number><edition>2006/08/25</edition><keywords><keyword>Animals</keyword><keyword>Antigens/drug effects/metabolism</keyword><keyword>Carbohydrates</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Humans</keyword><keyword>Nanostructures</keyword><keyword>Nanotechnology/*methods</keyword><keyword>Neoplasms/*drug therapy/therapy</keyword><keyword>Receptors, Cell Surface/drug effects/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1535-7163 (Print)</isbn><accession-num>16928810</accession-num><abstract>Nanotechnology refers to the interactions of cellular and molecular components and engineered materials-typically, clusters of atoms, molecules, and molecular fragments into incredibly small particles-between 1 and 100 nm. Nanometer-sized particles have novel optical, electronic, and structural properties that are not available either in individual molecules or bulk solids. The concept of nanoscale devices has led to the development of biodegradable self-assembled nanoparticles, which are being engineered for the targeted delivery of anticancer drugs and imaging contrast agents. Nanoconstructs such as these should serve as customizable, targeted drug delivery vehicles capable of ferrying large doses of chemotherapeutic agents or therapeutic genes into malignant cells while sparing healthy cells. Such &quot;smart&quot; multifunctional nanodevices hold out the possibility of radically changing the practice of oncology, allowing easy detection and then followed by effective targeted therapeutics at the earliest stages of the disease. In this article, we briefly discuss the use of bioconjugated nanoparticles for the delivery and targeting of anticancer drugs.</abstract><notes>Sinha, Rajni&#xD;Kim, Gloria J&#xD;Nie, Shuming&#xD;Shin, Dong M&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;United States&#xD;Molecular cancer therapeutics&#xD;Mol Cancer Ther. 2006 Aug;5(8):1909-17.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16928810</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>5.428</custom4><electronic-resource-num>5/8/1909 [pii]&#xD;10.1158/1535-7163.MCT-06-0141</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1785</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1785</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhao, J.</author><author>Das, A.</author><author>Zhang, X.</author><author>Schatz, G. C.</author><author>Sligar, S. G.</author><author>Van Duyne, R. P.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>Resonance surface plasmon spectroscopy: low molecular weight substrate binding to cytochrome p450</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>11004-5</pages><volume>128</volume><number>34</number><edition>2006/08/24</edition><keywords><keyword>Cytochrome P-450 Enzyme System/chemistry/*metabolism</keyword><keyword>Molecular Weight</keyword><keyword>Spectrophotometry, Ultraviolet</keyword><keyword>Substrate Specificity</keyword><keyword>Surface Plasmon Resonance/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 30</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16925400</accession-num><notes>Zhao, Jing&#xD;Das, Aditi&#xD;Zhang, Xiaoyu&#xD;Schatz, George C&#xD;Sligar, Stephen G&#xD;Van Duyne, Richard P&#xD;1 u54 ca119341-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Aug 30;128(34):11004-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16925400</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja0636082</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1693</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1693</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, J.</author><author>Sui, G.</author><author>Mocharla, V. P.</author><author>Lin, R. J.</author><author>Phelps, M. E.</author><author>Kolb, H. C.</author><author>Tseng, H. R.</author></authors></contributors><auth-address>Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, 700 Westwood Plaza, Los Angeles, CA 90095, USA.</auth-address><titles><title>Integrated microfluidics for parallel screening of an in situ click chemistry library</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>5276-81</pages><volume>45</volume><number>32</number><edition>2006/08/24</edition><keywords><keyword>Combinatorial Chemistry Techniques/*instrumentation/*methods</keyword><keyword>Ligands</keyword><keyword>Microfluidics/*instrumentation</keyword><keyword>Molecular Structure</keyword><keyword>Proteins/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 11</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>16927322</accession-num><notes>Wang, Jinyi&#xD;Sui, Guodong&#xD;Mocharla, Vani P&#xD;Lin, Rachel J&#xD;Phelps, Michael E&#xD;Kolb, Hartmuth C&#xD;Tseng, Hsian-Rong&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2006 Aug 11;45(32):5276-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16927322</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200601677</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1698</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1698</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, M. Y.</author><author>Lu, K. V.</author><author>Zhu, S.</author><author>Dia, E. Q.</author><author>Vivanco, I.</author><author>Shackleford, G. M.</author><author>Cavenee, W. K.</author><author>Mellinghoff, I. K.</author><author>Cloughesy, T. F.</author><author>Sawyers, C. L.</author><author>Mischel, P. S.</author></authors></contributors><auth-address>Departments of Pathology and Laboratory Medicine, Neurology, Medicine, Molecular and Medical Pharmacology, Henry E. Singleton Brain Tumor Program, and Howard Hughes Medical Institute, David Geffen School of Medicine, University of California at Los Angeles.</auth-address><titles><title>Mammalian Target of Rapamycin Inhibition Promotes Response to Epidermal Growth Factor Receptor Kinase Inhibitors in PTEN-Deficient and PTEN-Intact Glioblastoma Cells</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>7864-7869</pages><volume>66</volume><number>16</number><edition>2006/08/17</edition><dates><year>2006</year><pub-dates><date>Aug 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16912159</accession-num><abstract>The epidermal growth factor receptor (EGFR) is commonly amplified, overexpressed, and mutated in glioblastoma, making it a compelling molecular target for therapy. We have recently shown that coexpression of EGFRvIII and PTEN protein by glioblastoma cells is strongly associated with clinical response to EGFR kinase inhibitor therapy. PTEN loss, by dissociating inhibition of the EGFR from downstream phosphatidylinositol 3-kinase (PI3K) pathway inhibition, seems to act as a resistance factor. Because 40% to 50% of glioblastomas are PTEN deficient, a critical challenge is to identify strategies that promote responsiveness to EGFR kinase inhibitors in patients whose tumors lack PTEN. Here, we show that the mammalian target of rapamycin (mTOR) inhibitor rapamycin enhances the sensitivity of PTEN-deficient tumor cells to the EGFR kinase inhibitor erlotinib. In two isogenic model systems (U87MG glioblastoma cells expressing EGFR, EGFRvIII, and PTEN in relevant combinations, and SF295 glioblastoma cells in which PTEN protein expression has been stably restored), we show that combined EGFR/mTOR kinase inhibition inhibits tumor cell growth and has an additive effect on inhibiting downstream PI3K pathway signaling. We also show that combination therapy provides added benefit in promoting cell death in PTEN-deficient tumor cells. These studies provide strong rationale for combined mTOR/EGFR kinase inhibitor therapy in glioblastoma patients, particularly those with PTEN-deficient tumors. (Cancer Res 2006; 66(16): 7864-9).</abstract><notes>Journal article&#xD;Cancer Res. 2006 Aug 15;66(16):7864-7869.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16912159</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>7.980</custom4><electronic-resource-num>66/16/7864 [pii]&#xD;10.1158/0008-5472.CAN-04-4392</electronic-resource-num><language>Eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1552</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1552</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sathe, T. R.</author><author>Agrawal, A.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, 101 Woodruff Circle, Suite 2001, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Mesoporous silica beads embedded with semiconductor quantum dots and iron oxide nanocrystals: dual-function microcarriers for optical encoding and magnetic separation</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>5627-32</pages><volume>78</volume><number>16</number><edition>2006/08/16</edition><keywords><keyword>Ferric Compounds</keyword><keyword>*Magnetics</keyword><keyword>*Metal Nanoparticles</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>*Microspheres</keyword><keyword>Porosity</keyword><keyword>*Quantum Dots</keyword><keyword>*Semiconductors</keyword><keyword>Silicon Dioxide</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 15</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>16906704</accession-num><abstract>Mesoporous beads are promising materials for embedding functional nanoparticles because of their nanometer-sized pores and large surface areas. Here we report the development of silica microbeads embedded with both semiconductor quantum dots (QD) and iron oxide (Fe3O4) nanocrystals as a new class of dual-function carriers for optical encoding and magnetic separation. The embedding (doping) process is carried out by either simultaneous or sequential addition of quantum dots and iron oxide (Fe3O4) nanocrystals in solution. The doping process is fast and quantitative, but the incorporated iron oxide strongly attenuates the signal intensity of QD fluorescence. We find that this attenuation is not due to conventional fluorescence quenching but is caused by the broad optical absorption spectrum of mixed-valence Fe3O4. For improved biocompatibility and reduced nonspecific binding, the encoded beads are further coated with amphiphilic polymers such as octylamine poly(acrylic acid). The results indicate that the polymer-coated beads are well suited for target capturing and enrichment, yielding magnetic separation efficiencies higher than 99%. By combining the multiplexing capability of QDs with the superparamagnetic properties of iron oxide nanocrystals, this class of encoded beads is expected to find broad applications in high-throughput and multiplexed biomolecular assays.</abstract><notes>Sathe, Tushar R&#xD;Agrawal, Amit&#xD;Nie, Shuming&#xD;P20 gm072069/gm/nigms&#xD;R01 ca108468-01/ca/nci&#xD;U54ca119338/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2006 Aug 15;78(16):5627-32.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16906704</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac0610309</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1235</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1235</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hall, A. R.</author><author>An, L.</author><author>Liu, J.</author><author>Vicci, L.</author><author>Falvo, M. R.</author><author>Superfine, R.</author><author>Washburn, S.</author></authors></contributors><auth-address>Curriculum in Applied and Materials Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Experimental measurement of single-wall carbon nanotube torsional properties</title><secondary-title>Phys Rev Lett</secondary-title></titles><periodical><full-title>Phys Rev Lett</full-title></periodical><pages>256102</pages><volume>96</volume><number>25</number><edition>2006/08/16</edition><dates><year>2006</year><pub-dates><date>Jun 30</date></pub-dates></dates><isbn>0031-9007 (Print)</isbn><accession-num>16907325</accession-num><abstract>We report on the characterization of nanometer-scale torsional devices based on individual single-walled carbon nanotubes as the spring elements. The axial shear moduli of the nanotubes are obtained through modeling of device reaction to various amounts of applied electrostatic force and are compared to theoretical values.</abstract><notes>Hall, A R&#xD;An, L&#xD;Liu, J&#xD;Vicci, L&#xD;Falvo, M R&#xD;Superfine, R&#xD;Washburn, S&#xD;United States&#xD;Physical review letters&#xD;Phys Rev Lett. 2006 Jun 30;96(25):256102. Epub 2006 Jun 28.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16907325</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>7.134</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1617</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1617</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Song, J.</author><author>Zhou, J.</author><author>Wang, Z. L.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332-0245, USA.</auth-address><titles><title>Piezoelectric and semiconducting coupled power generating process of a single ZnO belt/wire. A technology for harvesting electricity from the environment</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>1656-62</pages><volume>6</volume><number>8</number><edition>2006/08/10</edition><keywords><keyword>Electric Conductivity</keyword><keyword>*Electric Power Supplies</keyword><keyword>*Electricity</keyword><keyword>Electrochemistry/*instrumentation/methods</keyword><keyword>Energy Transfer</keyword><keyword>Environment</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Mechanics</keyword><keyword>Motion</keyword><keyword>Nanotechnology/*instrumentation/methods</keyword><keyword>Nanotubes/*chemistry</keyword><keyword>Semiconductors</keyword><keyword>Technology</keyword><keyword>*Transducers</keyword><keyword>Vibration</keyword><keyword>Zinc Oxide/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>16895352</accession-num><abstract>This paper presents the experimental observation of piezoelectric generation from a single ZnO wire/belt for illustrating a fundamental process of converting mechanical energy into electricity at nanoscale. By deflecting a wire/belt using a conductive atomic force microscope tip in contact mode, the energy is first created by the deflection force and stored by piezoelectric potential, and later converts into piezoelectric energy. The mechanism of the generator is a result of coupled semiconducting and piezoelectric properties of ZnO. A piezoelectric effect is required to create electric potential of ionic charges from elastic deformation; semiconducting property is necessary to separate and maintain the charges and then release the potential via the rectifying behavior of the Schottky barrier at the metal-ZnO interface, which serves as a switch in the entire process. The good conductivity of ZnO is rather unique because it makes the current flow possible. This paper demonstrates a principle for harvesting energy from the environment. The technology has the potential of converting mechanical movement energy (such as body movement, muscle stretching, blood pressure), vibration energy (such as acoustic/ultrasonic wave), and hydraulic energy (such as flow of body fluid, blood flow, contraction of blood vessels) into electric energy that may be sufficient for self-powering nanodevices and nanosystems in applications such as in situ, real-time, and implantable biosensing, biomedical monitoring, and biodetection.</abstract><notes>Song, Jinhui&#xD;Zhou, Jun&#xD;Wang, Zhong Lin&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2006 Aug;6(8):1656-62.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16895352</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl060820v</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1196</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1196</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Faca, V.</author><author>Coram, M.</author><author>Phanstiel, D.</author><author>Glukhova, V.</author><author>Zhang, Q.</author><author>Fitzgibbon, M.</author><author>McIntosh, M.</author><author>Hanash, S.</author></authors></contributors><auth-address>Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA 98109, USA. vfaca@fhcrc.org</auth-address><titles><title>Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS</title><secondary-title>J Proteome Res</secondary-title></titles><periodical><full-title>J Proteome Res</full-title></periodical><pages>2009-18</pages><volume>5</volume><number>8</number><edition>2006/08/08</edition><keywords><keyword>Acrylamides/*chemistry</keyword><keyword>Algorithms</keyword><keyword>Alkylation</keyword><keyword>Amino Acid Sequence</keyword><keyword>Blood Proteins/*analysis/genetics</keyword><keyword>Carbon Radioisotopes/chemistry</keyword><keyword>*Chromatography, Liquid/instrumentation/methods</keyword><keyword>Cysteine/chemistry</keyword><keyword>Deuterium/chemistry</keyword><keyword>Humans</keyword><keyword>*Mass Spectrometry/instrumentation/methods</keyword><keyword>Molecular Sequence Data</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1535-3893 (Print)</isbn><accession-num>16889424</accession-num><abstract>Isotopic labeling of cysteine residues with acrylamide was previously utilized for relative quantitation of proteins by MALDI-TOF. Here, we explored and compared the application of deuterated and (13)C isotopes of acrylamide for quantitative proteomic analysis using LC-MS/MS and high-resolution FTICR mass spectrometry. The method was applied to human serum samples that were immunodepleted of abundant proteins. Our results show reliable quantitation of proteins across an abundance range that spans 5 orders of magnitude based on ion intensities and known protein concentration in plasma. The use of (13)C isotope of acrylamide had a slightly greater advantage relative to deuterated acrylamide, because of shifts in elution of deuterated acrylamide relative to its corresponding nondeuterated compound by reversed-phase chromatography. Overall, the use of acrylamide for differentially labeling intact proteins in complex mixtures, in combination with LC-MS/MS provides a robust method for quantitative analysis of complex proteomes.</abstract><notes>Faca, Vitor&#xD;Coram, Marc&#xD;Phanstiel, Doug&#xD;Glukhova, Veronika&#xD;Zhang, Qing&#xD;Fitzgibbon, Matthew&#xD;McIntosh, Martin&#xD;Hanash, Samir&#xD;United States&#xD;Journal of proteome research&#xD;J Proteome Res. 2006 Aug;5(8):2009-18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16889424</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>5.737</custom4><electronic-resource-num>10.1021/pr060102+</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1764</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1764</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yezhelyev, M. V.</author><author>Gao, X.</author><author>Xing, Y.</author><author>Al-Hajj, A.</author><author>Nie, S.</author><author>O&apos;Regan, R. M.</author></authors></contributors><auth-address>Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.</auth-address><titles><title>Emerging use of nanoparticles in diagnosis and treatment of breast cancer</title><secondary-title>Lancet Oncol</secondary-title></titles><periodical><full-title>Lancet Oncol</full-title></periodical><pages>657-67</pages><volume>7</volume><number>8</number><edition>2006/08/05</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/administration &amp; dosage</keyword><keyword>Breast Neoplasms/*diagnosis/*drug therapy</keyword><keyword>Diagnostic Imaging</keyword><keyword>Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>In Situ Hybridization, Fluorescence</keyword><keyword>Liposomes</keyword><keyword>*Nanostructures</keyword><keyword>Tumor Markers, Biological/analysis</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1470-2045 (Print)</isbn><accession-num>16887483</accession-num><abstract>The biological application of nanoparticles is a rapidly developing area of nanotechnology that raises new possibilities in the diagnosis and treatment of human cancers. In cancer diagnostics, fluorescent nanoparticles can be used for multiplex simultaneous profiling of tumour biomarkers and for detection of multiple genes and matrix RNA with fluorescent in-situ hybridisation. In breast cancer, three crucial biomarkers can be detected and accurately quantified in single tumour sections by use of nanoparticles conjugated to antibodies. In the near future, the use of conjugated nanoparticles will allow at least ten cancer-related proteins to be detected on tiny tumour sections, providing a new method of analysing the proteome of an individual tumour. Supermagnetic nanoparticles have exciting possibilities as contrast agents for cancer detection in vivo, and for monitoring the response to treatment. Several chemotherapy agents are available as nanoparticle formulations, and have at least equivalent efficacy and fewer toxic effects compared with conventional formulations. Ultimately, the use of nanoparticles will allow simultaneous tumour targeting and drug delivery in a unique manner. In this review, we give an overview of the use of clinically applicable nanoparticles in oncology, with particular focus on the diagnosis and treatment of breast cancer.</abstract><notes>Yezhelyev, Maksym V&#xD;Gao, Xiaohu&#xD;Xing, Yun&#xD;Al-Hajj, Ahmad&#xD;Nie, Shuming&#xD;O&apos;Regan, Ruth M&#xD;1 u54 ca119338-0/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;England&#xD;The lancet oncology&#xD;Lancet Oncol. 2006 Aug;7(8):657-67.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16887483</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>12.494</custom4><electronic-resource-num>S1470-2045(06)70793-8 [pii]&#xD;10.1016/S1470-2045(06)70793-8</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1631</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1631</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sui, G.</author><author>Wang, J.</author><author>Lee, C. C.</author><author>Lu, W.</author><author>Lee, S. P.</author><author>Leyton, J. V.</author><author>Wu, A. M.</author><author>Tseng, H. R.</author></authors></contributors><auth-address>Crump Institute for Molecular Imaging and Department of Molecular &amp; Medical Pharmacology, David Geffen School of Medicine at UCLA, 700 Westwood Plaza, Los Angeles, California 90095, USA.</auth-address><titles><title>Solution-phase surface modification in intact poly(dimethylsiloxane) microfluidic channels</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>5543-51</pages><volume>78</volume><number>15</number><edition>2006/08/02</edition><keywords><keyword>Amines/chemistry</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line, Tumor</keyword><keyword>DNA/analysis</keyword><keyword>Dimethylpolysiloxanes/*chemistry</keyword><keyword>Humans</keyword><keyword>Hydrogen Peroxide/*chemistry</keyword><keyword>Immunoassay</keyword><keyword>Microfluidic Analytical Techniques/instrumentation/*methods</keyword><keyword>Molecular Structure</keyword><keyword>Oxidation-Reduction</keyword><keyword>Peptides/analysis</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Proteins/analysis</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Silicones/*chemistry</keyword><keyword>Solutions/chemistry</keyword><keyword>Surface Properties</keyword><keyword>Time Factors</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>16878894</accession-num><abstract>An improved approach composed of an oxidation reaction in acidic H2O2 solution and a sequential silanization reaction using neat silane reagents for surface modification of poly(dimethylsiloxane) (PDMS) substrates was developed. This solution-phase approach is simple and convenient for some routine analytical applications in chemistry and biology laboratories and is designed for intact PDMS-based microfluidic devices, with no device postassembly required. Using this improved approach, two different functional groups, poly(ethylene glycol) (PEG) and amine (NH2), were introduced onto PDMS surfaces for passivation of nonspecific protein absorption and attachment of biomolecules, respectively. X-ray electron spectroscopy and temporal contact angle experiments were employed to monitor functional group transformation and dynamic characteristics of the PEG-grafted PDMS substrates; fluorescent protein solutions were introduced into the PEG-grafted PDMS microchannels to test their protein repelling characteristics. These analytical data indicate that the PEG-grafted PDMS surfaces exhibit improved short-term surface dynamics and robust long-term stability. The amino-grafted PDMS microchannels are also relatively stable and can be further activated for modifications with peptide, DNA, and protein on the surfaces of microfluidic channels. The resulting biomolecule-grafted PDMS microchannels can be utilized for cell immobilization and incubation, semiquantitative DNA hybridization, and immunoassay.</abstract><notes>Sui, Guodong&#xD;Wang, Jinyi&#xD;Lee, Chung-Cheng&#xD;Lu, Weixing&#xD;Lee, Stephanie P&#xD;Leyton, Jeffrey V&#xD;Wu, Anna M&#xD;Tseng, Hsian-Rong&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2006 Aug 1;78(15):5543-51.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16878894</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac060605z</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1778</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1778</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, J.</author><author>Yang, G.</author><author>Lee, Y. Z.</author><author>Chang, S.</author><author>Lu, J. P.</author><author>Zhou, O.</author></authors></contributors><auth-address>Zhang, J&#xD;Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Dept Phys &amp; Astron, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA&#xD;Univ N Carolina, Curr Appl &amp; Mat Sci, Chapel Hill, NC 27599 USA</auth-address><titles><title>Multiplexing radiography using a carbon nanotube based x-ray source</title><secondary-title>Applied Physics Letters</secondary-title></titles><periodical><full-title>Applied Physics Letters</full-title></periodical><pages>-</pages><volume>89</volume><number>6</number><edition>2006/08</edition><keywords><keyword>computed-tomography</keyword><keyword>tool</keyword><keyword>technology</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 7</date></pub-dates></dates><isbn>0003-6951</isbn><accession-num>ISI:000239690800121</accession-num><abstract>Speed and temporal resolution are critical for tomographic imaging of objects in rapid motion. Current x-ray scanners record images sequentially in the time domain. The serial approach limits their performance and demands increasingly high x-ray peak power and gantry speed. We have developed a multipixel carbon nanotube based field emission x-ray source that produces spatially and temporally modulated radiations. Using this device we show the feasibility of multiplexing radiography that enables simultaneous collection of multiple projection images using frequency multiplexing. A drastic increase of the speed and reduction of the x-ray peak power are achieved without compromising the imaging quality. (c) 2006 American Institute of Physics.</abstract><notes>072RN&#xD;Times Cited:0&#xD;Cited References Count:21</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000239690800121</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>4.096</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1559</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1559</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schwartz, M. P.</author><author>Derfus, A. M.</author><author>Alvarez, S. D.</author><author>Bhatia, S. N.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California-San Diego, 9500 Gilman Drive, Department 0358, La Jolla, CA 92093-0358, USA.</auth-address><titles><title>The smart Petri dish: a nanostructured photonic crystal for real-time monitoring of living cells</title><secondary-title>Langmuir</secondary-title></titles><periodical><full-title>Langmuir</full-title></periodical><pages>7084-90</pages><volume>22</volume><number>16</number><edition>2006/08</edition><keywords><keyword>Animals</keyword><keyword>*Cell Culture Techniques/instrumentation</keyword><keyword>Cell Survival</keyword><keyword>Cells, Cultured</keyword><keyword>Hepatocytes/*cytology</keyword><keyword>Oxygen</keyword><keyword>*Photons</keyword><keyword>Rats</keyword><keyword>Rats, Inbred Lew</keyword><keyword>Spectrophotometry</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0743-7463 (Print)</isbn><accession-num>16863264</accession-num><abstract>The intensity of light scattered from a porous Si photonic crystal is used to monitor physiological changes in primary rat hepatocytes. The cells are seeded on the surface of a porous Si photonic crystal that has been filled with polystyrene and treated with an O2 plasma. Light resonant with the photonic crystal is scattered by the cell layer and detected as an optical peak with a charge-coupled-device spectrometer. It is demonstrated that exposure of hepatocytes to the toxins cadmium chloride or acetaminophen leads to morphology changes that cause a measurable increase in scattered intensity. The increase in signal occurs before traditional assays are able to detect a decrease in viability, demonstrating the potential of the technique as a complementary tool for cell viability studies. The scattering method presented here is noninvasive and can be performed in real time, representing a significant advantage compared to other techniques for in vitro monitoring of cell morphology.</abstract><notes>N01 co 37117/co/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;the ACS journal of surfaces and colloids</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16863264 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom2>Yes- MIT and UCSD</custom2><custom3>2006</custom3><custom4>4.347</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1207</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1207</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Fulci, G.</author><author>Breymann, L.</author><author>Gianni, D.</author><author>Kurozomi, K.</author><author>Rhee, S. S.</author><author>Yu, J.</author><author>Kaur, B.</author><author>Louis, D. N.</author><author>Weissleder, R.</author><author>Caligiuri, M. A.</author><author>Chiocca, E. A.</author></authors></contributors><auth-address>Dardinger Center for Neuro-Oncology and Neurosciences, Department of Neurological Surgery, James Cancer Hospital and Solove Research Institute, Ohio State University Medical Center, Columbus, OH 43210, USA.</auth-address><titles><title>Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title><alt-title>Proceedings of the National Academy of Sciences of the United States of America</alt-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><alt-periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></alt-periodical><pages>12873-8</pages><volume>103</volume><number>34</number><edition>2006/08</edition><keywords><keyword>Animals</keyword><keyword>Brain Neoplasms/pathology/therapy/virology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation</keyword><keyword>Cyclophosphamide/administration &amp; dosage/*pharmacology/therapeutic use</keyword><keyword>Glioma/*immunology/pathology/*therapy/virology</keyword><keyword>Immunity, Natural/*drug effects/*immunology</keyword><keyword>Interferon Type II/metabolism</keyword><keyword>Male</keyword><keyword>Neoplasm Transplantation</keyword><keyword>*Oncolytic Virotherapy</keyword><keyword>Phagocytes</keyword><keyword>Rats</keyword><keyword>Simplexvirus/drug effects/*immunology</keyword><keyword>Virion/drug effects</keyword><keyword>Virus Replication/drug effects</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 22</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16908838</accession-num><abstract>Clinical trials are testing oncolytic viruses (OVs) as therapies for cancer. We have shown that animals that have brain tumors and are treated with a herpes simplex virus (HSV)-derived OV live significantly longer when cyclophosphamide (CPA) is preadministered. Here, we explore the mechanisms behind this finding. In a syngeneic rat glioma model, intratumoral HSV administration is associated with rapid increase of natural killer cells, microglia/macrophages (CD68+ and CD163+), and IFN-gamma. Pretreatment with CPA enhances HSV replication and oncolysis and reduces an HSV-mediated increase in CD68+ and CD163+ cells and intratumoral IFN-gamma. Molecular imaging shows CPA pretreatment to inhibit HSV-induced infiltration of tumor-associated phagocytic cells. Our results reveal molecular and cellular mechanisms that inhibit intratumoral spread of HSV and suggest a therapeutic path for improving the efficacy of virotherapy as a treatment for cancer.</abstract><notes>Ca16058/ca/nci&#xD;Ca68458/ca/nci&#xD;Ca95426/ca/nci&#xD;Ns41571/ns/ninds&#xD;P01 ca69246/ca/nci&#xD;R01 ca85139/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16908838 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>10.228</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1130</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1130</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Charest, A.</author><author>Wilker, E. W.</author><author>McLaughlin, M. E.</author><author>Lane, K.</author><author>Gowda, R.</author><author>Coven, S.</author><author>McMahon, K.</author><author>Kovach, S.</author><author>Feng, Y.</author><author>Yaffe, M. B.</author><author>Jacks, T.</author><author>Housman, D.</author></authors></contributors><auth-address>Department of Biology and Center for Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. charest@mit.edu</auth-address><titles><title>ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><alt-periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></alt-periodical><pages>7473-81</pages><volume>66</volume><number>15</number><edition>2006/08</edition><keywords><keyword>1-Phosphatidylinositol 3-Kinase/*metabolism</keyword><keyword>Animals</keyword><keyword>Astrocytoma/enzymology/metabolism/pathology</keyword><keyword>Brain Neoplasms/enzymology/*metabolism/pathology</keyword><keyword>Cyclin-Dependent Kinase Inhibitor p16/deficiency/genetics</keyword><keyword>Enzyme Activation</keyword><keyword>Glioblastoma/enzymology/*metabolism/pathology</keyword><keyword>Intracellular Signaling Peptides and Proteins/metabolism</keyword><keyword>Mice</keyword><keyword>Protein Kinases/*metabolism</keyword><keyword>Protein-Tyrosine Kinases/biosynthesis/genetics/*metabolism</keyword><keyword>Protein-Tyrosine-Phosphatase/metabolism</keyword><keyword>Proto-Oncogene Proteins/biosynthesis/genetics/*metabolism</keyword><keyword>Proto-Oncogene Proteins c-akt/metabolism</keyword><keyword>Recombinant Fusion Proteins/biosynthesis/genetics/metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Tumor Suppressor Protein p14ARF/deficiency/genetics</keyword><keyword>src Homology Domains</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16885344</accession-num><abstract>Glioblastoma multiforme is the most common and lethal form of primary brain cancer. Diagnosis of this advanced glioma has a poor prognosis due to the ineffectiveness of current therapies. Aberrant expression of receptor tyrosine kinases (RTK) in glioblastoma multiformes is suggestive of their role in initiation and maintenance of these tumors of the central nervous system. In fact, ectopic expression of the orphan RTK ROS is a frequent event in human brain cancers, yet the pathologic significance of this expression remains undetermined. Here, we show that a glioblastoma-associated, ligand-independent rearrangement product of ROS (FIG-ROS) cooperates with loss of the tumor suppressor gene locus Ink4a;Arf to produce glioblastomas in the mouse. We show that this FIG-ROS-mediated tumor formation in vivo parallels the activation of the tyrosine phosphatase SH2 domain-containing phosphatase-2 (SHP-2) and a phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling axis in tumors and tumor-derived cell lines. We have established a fully penetrant preclinical model for adult onset of glioblastoma multiforme in keeping with major genetic events observed in the human disease. These findings provide novel and important insights into the role of ROS and SHP-2 function in solid tumor biology and set the stage for preclinical testing of targeted therapeutic approaches.</abstract><notes>P01 ca 042063/ca/nci&#xD;R01 gm 060594/gm/nigms&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16885344 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>7.980</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1092</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1092</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Cerignoli, F.</author><author>Dawson, M. I.</author><author>Magrini, A.</author><author>Rosato, N.</author><author>Mustelin, T.</author></authors></contributors><auth-address>Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, California 92037, USA. mbottini@burnham.org</auth-address><titles><title>Full-length single-walled carbon nanotubes decorated with streptavidin-conjugated quantum dots as multivalent intracellular fluorescent nanoprobes</title><secondary-title>Biomacromolecules</secondary-title><alt-title>Biomacromolecules</alt-title></titles><periodical><full-title>Biomacromolecules</full-title></periodical><alt-periodical><full-title>Biomacromolecules</full-title></alt-periodical><pages>2259-63</pages><volume>7</volume><number>8</number><edition>2006/08</edition><keywords><keyword>Adsorption</keyword><keyword>Antigens, CD3/metabolism</keyword><keyword>Biological Transport</keyword><keyword>Drug Delivery Systems/methods</keyword><keyword>Endocytosis</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>Humans</keyword><keyword>Jurkat Cells</keyword><keyword>Lysosomes/metabolism</keyword><keyword>Molecular Probes/chemistry</keyword><keyword>*Nanotechnology/methods</keyword><keyword>Nanotubes, Carbon/*chemistry</keyword><keyword>*Quantum Dots</keyword><keyword>Streptavidin/*chemistry</keyword><keyword>Viruses/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug</date></pub-dates></dates><isbn>1525-7797 (Print)</isbn><accession-num>16903668</accession-num><abstract>We report the formation of a supramolecular luminescent nanoassembly composed of individual or small ropes of full-length, single-walled carbon nanotubes decorated with streptavidin-conjugated quantum dots. The supramolecular luminescent nanoassembly was stably dispersed under physiological conditions and was readily visible by both optical and confocal fluorescent microscopies. Jurkat T leukemia cells were able to internalize the nanoassembly by multivalent CD3 receptor-mediated endocytosis (adsorption by cell). Once internalized by cells, the nanoassembly was found to be transported to lysosomes. These properties should make this supramolecular luminescent nanoassembly an excellent building block for the construction of intracellular polyvalent nanoprobes, mimicking natural viral delivery entities with enhanced loading capacity compared to small molecules.</abstract><notes>U54 ca119335/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16903668 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>4.658</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1413</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1413</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Loening, A. M.</author><author>Fenn, T. D.</author><author>Wu, A. M.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>The CRUMP Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA.</auth-address><titles><title>Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output</title><secondary-title>Protein Eng Des Sel</secondary-title></titles><periodical><full-title>Protein Eng Des Sel</full-title></periodical><pages>391-400</pages><volume>19</volume><number>9</number><edition>2006/07/22</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Base Sequence</keyword><keyword>DNA Mutational Analysis</keyword><keyword>Luciferases, Renilla/*biosynthesis/blood/genetics</keyword><keyword>*Luminescence</keyword><keyword>Models, Genetic</keyword><keyword>*Models, Molecular</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>Molecular Sequence Data</keyword><keyword>Recombinant Proteins/*biosynthesis/blood/genetics</keyword><keyword>Renilla/*enzymology/genetics</keyword><keyword>Sequence Alignment</keyword><keyword>Sequence Analysis, DNA</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1741-0126 (Print)</isbn><accession-num>16857694</accession-num><abstract>Luciferases, which have seen expansive employment as reporter genes in biological research, could also be used in applications where the protein itself is conjugated to ligands to create probes that are appropriate for use in small animal imaging. As the bioluminescence activity of commonly used luciferases is too labile in serum to permit this application, specific mutations of Renilla luciferase, selected using a consensus sequence driven strategy, were screened for their ability to confer stability of activity in serum as well as their light output. Using this information, a total of eight favorable mutations were combined to generate a mutant Renilla luciferase (RLuc8) that, compared with the parental enzyme, is 200-fold more resistant to inactivation in murine serum and exhibits a 4-fold improvement in light output. Results of the mutational analysis were also used to generate a double mutant optimized for use as a reporter gene. The double mutant had half the resistance to inactivation in serum of the native enzyme while yielding a 5-fold improvement in light output. These variants of Renilla luciferase, which exhibit significantly improved properties compared with the native enzyme, will allow enhanced sensitivity in existing luciferase-based assays as well as enable the development of novel probes labeled with the luciferase protein.</abstract><notes>Loening, Andreas Markus&#xD;Fenn, Timothy David&#xD;Wu, Anna M&#xD;Gambhir, Sanjiv Sam&#xD;5 r01 ca082214-06/ca/nci&#xD;P50 ca114747/ca/nci&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Protein engineering, design &amp; selection : PEDS&#xD;Protein Eng Des Sel. 2006 Sep;19(9):391-400. Epub 2006 Jul 20.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16857694</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>2.651</custom4><electronic-resource-num>gzl023 [pii]&#xD;10.1093/protein/gzl023</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1692</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1692</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, J.</author><author>Bunimovich, Y. L.</author><author>Sui, G.</author><author>Savvas, S.</author><author>Guo, Y.</author><author>Heath, J. R.</author><author>Tseng, H. R.</author></authors></contributors><auth-address>Department of Molecular Medical Pharmacology and Crump Institute for Molecular Imaging. University of California, Los Angeles, 700 Westwood Plaza, Los Angeles, CA 90095, USA.</auth-address><titles><title>Electrochemical fabrication of conducting polymer nanowires in an integrated microfluidic system</title><secondary-title>Chem Commun (Camb)</secondary-title></titles><periodical><full-title>Chem Commun (Camb)</full-title></periodical><pages>3075-7</pages><number>29</number><edition>2006/07/21</edition><keywords><keyword>Biosensing Techniques</keyword><keyword>*Electric Conductivity</keyword><keyword>*Electrochemistry</keyword><keyword>*Microfluidics</keyword><keyword>*Nanotechnology</keyword><keyword>Polymers/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 7</date></pub-dates></dates><isbn>1359-7345 (Print)</isbn><accession-num>16855690</accession-num><abstract>In this paper, we introduce a new approach for the in situ electrochemical fabrication of an individually addressable array of conducting polymer nanowires (CPNWs) positioned within an integrated microfluidic device and also demonstrate that such an integrated device can be used as a chemical sensor immediately after its construction.</abstract><notes>Wang, Jun&#xD;Bunimovich, Yuri L&#xD;Sui, Guodong&#xD;Savvas, Stavros&#xD;Wang, Jinyi&#xD;Guo, Yaoyao&#xD;Heath, James R&#xD;Tseng, Hsian-Rong&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Chemical communications (Cambridge, England)&#xD;Chem Commun (Camb). 2006 Aug 7;(29):3075-7. Epub 2006 Jun 14.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16855690</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>4.997</custom4><electronic-resource-num>10.1039/b604426c</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1546</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1546</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rohde, R. D.</author><author>Agnew, H. D.</author><author>Yeo, W. S.</author><author>Bailey, R. C.</author><author>Heath, J. R.</author></authors></contributors><auth-address>Division of Chemistry and Chemical Engineering, MC 127-72, California Institute of Technology, Pasadena, California 91125, USA.</auth-address><titles><title>A non-oxidative approach toward chemically and electrochemically functionalizing Si(111)</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9518-25</pages><volume>128</volume><number>29</number><edition>2006/07/20</edition><keywords><keyword>Crystallization</keyword><keyword>Electrochemistry</keyword><keyword>Molecular Structure</keyword><keyword>Oxidation-Reduction</keyword><keyword>Semiconductors</keyword><keyword>Silicon/*chemistry</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 26</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16848489</accession-num><abstract>A general method for the non-oxidative functionalization of single-crystal silicon(111) surfaces is described. The silicon surface is fully acetylenylated using two-step chlorination/alkylation chemistry. A benzoquinone-masked primary amine is attached to this surface via Cu(I)-catalyzed Huisgen 1,3-dipolar cycloaddition (&quot;click&quot; chemistry). The benzoquinone is electrochemically reduced, resulting in quantitative cleavage of the molecule and exposing the amine terminus. Molecules presenting a carboxylic acid have been immobilized to the exposed amine sites. X-ray photoelectron spectroscopy (XPS), Fourier transform infrared spectroscopy (FTIR), cyclic voltammetry (CV), and contact angle goniometry were utilized to characterize and quantitate each step in the functionalization process. This work represents a strategy for providing a general platform that can incorporate organic and biological molecules on Si(111) with minimal oxidation of the silicon surface.</abstract><notes>Rohde, Rosemary D&#xD;Agnew, Heather D&#xD;Yeo, Woon-Seok&#xD;Bailey, Ryan C&#xD;Heath, James R&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Jul 26;128(29):9518-25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16848489</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja062012b</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1286</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1286</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Irish, J. M.</author><author>Czerwinski, D. K.</author><author>Nolan, G. P.</author><author>Levy, R.</author></authors></contributors><auth-address>Department of Medicine, Oncology Division, Stanford University, Stanford, CA 94305, USA.</auth-address><titles><title>Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry</title><secondary-title>J Immunol</secondary-title></titles><periodical><full-title>J Immunol</full-title></periodical><pages>1581-9</pages><volume>177</volume><number>3</number><edition>2006/07/20</edition><keywords><keyword>B-Lymphocyte Subsets/enzymology/*immunology/*metabolism</keyword><keyword>Flow Cytometry/*methods</keyword><keyword>Humans</keyword><keyword>Hydrogen Peroxide/chemistry</keyword><keyword>Immunoglobulin G/biosynthesis/metabolism</keyword><keyword>Immunoglobulin M/biosynthesis/metabolism</keyword><keyword>Intracellular Signaling Peptides and Proteins/metabolism</keyword><keyword>Kinetics</keyword><keyword>MAP Kinase Signaling System/*immunology</keyword><keyword>Mitogen-Activated Protein Kinase 1/metabolism/physiology</keyword><keyword>Mitogen-Activated Protein Kinase 3/metabolism/physiology</keyword><keyword>Peptide Mapping/methods</keyword><keyword>Phosphorylation</keyword><keyword>Protein-Tyrosine Kinases/metabolism</keyword><keyword>Receptors, Antigen, B-Cell/metabolism/*physiology</keyword></keywords><dates><year>2006</year><pub-dates><date>Aug 1</date></pub-dates></dates><isbn>0022-1767 (Print)</isbn><accession-num>16849466</accession-num><abstract>Differences in BCR signaling may govern outcomes as diverse as proliferation and cell death. We profiled BCR signaling kinetics in subsets of primary human B cells using flow cytometry. In the predominant population expressing IgM, BCR cross-linking led to a quick burst of Syk, ERK1/2, and p38 signaling. In contrast, IgG B cells sustained higher per-cell ERK1/2 phosphorylation over time. This dichotomy suggested a mechanism for dampening signals transmitted by IgM. Regulatory phosphatase activity in IgM B cells was BCR-mediated and initiated more slowly than kinase activity. This BCR-mediated phosphatase activity was sensitive to inhibition by H(2)O(2) and required to attenuate IgM BCR signaling. These results provide the first kinetic maps of BCR signaling in primary human B cell subsets and enable new studies of signaling in B cell disorders, such as autoimmunity and cancer.</abstract><notes>Irish, Jonathan M&#xD;Czerwinski, Debra K&#xD;Nolan, Garry P&#xD;Levy, Ronald&#xD;Ca 33399/ca/nci&#xD;Ca 34233/ca/nci&#xD;N01-hv-281831/hv/nhlbi&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of immunology (Baltimore, Md. : 1950)&#xD;J Immunol. 2006 Aug 1;177(3):1581-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16849466</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>6.165</custom4><electronic-resource-num>177/3/1581 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1048</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1048</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Adli, M.</author><author>Baldwin, A. S.</author></authors></contributors><auth-address>Lineberger Comprehensive Cancer Center, Department of Biology, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation</title><secondary-title>J Biol Chem</secondary-title></titles><periodical><full-title>J Biol Chem</full-title></periodical><pages>26976-84</pages><volume>281</volume><number>37</number><edition>2006/07/15</edition><keywords><keyword>Cell Line</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Proliferation</keyword><keyword>*Gene Expression Regulation, Neoplastic</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>I-kappa B Kinase/metabolism/*physiology</keyword><keyword>Inflammation</keyword><keyword>NF-kappa B/*metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Promoter Regions (Genetics)</keyword><keyword>Serine/*chemistry</keyword><keyword>Transcription Factor RelA/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep 15</date></pub-dates></dates><isbn>0021-9258 (Print)</isbn><accession-num>16840782</accession-num><abstract>Nuclear factor kappaB (NF-kappaB) has been studied extensively as an inducible transcriptional regulator of the immune and inflammatory response. NF-kappaB activation downstream of lipopolysaccharide or cytokine stimulation is controlled by the IkappaB kinase complex, which contains IKKalpha and IKKbeta. Significantly, the constitutive activity of NF-kappaB has been implicated as an important aspect of many cancer cells, but mechanisms associated with this activity are poorly understood. An inducible kinase, IKK-i/IKKepsilon, related to the catalytic forms of the IkappaB kinase, has been studied as an anti-viral, innate immune regulator through its ability to control the activity of the transcription factors IRF-3 and IRF-7. Here, we demonstrate that IKK-i/IKKepsilon is expressed in a number of cancer cells and is involved in regulating NF-kappaB activity through its ability to control basal/constitutive, but not cytokine-induced, p65/RelA phosphorylation at Ser-536, a modification proposed to contribute to the transactivation function of NF-kappaB. Knockdown of IKK-i/IKKepsilon or expression of a S536A mutant form of p65 suppresses HeLa cell proliferation. The data indicate a role for IKK-i/IKKepsilon in controlling proliferation of certain cancer cells through regulation of constitutive NF-kappaB activity.</abstract><notes>Adli, Mazhar&#xD;Baldwin, Albert S&#xD;Ai35098/ai/niaid&#xD;Ca73756/ca/nci&#xD;Ca75080/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Journal of biological chemistry&#xD;J Biol Chem. 2006 Sep 15;281(37):26976-84. Epub 2006 Jul 13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16840782</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2007</custom3><custom4>5.575</custom4><electronic-resource-num>M603133200 [pii]&#xD;10.1074/jbc.M603133200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1544</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1544</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rieter, W. J.</author><author>Taylor, K. M.</author><author>An, H.</author><author>Lin, W.</author></authors></contributors><auth-address>Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Nanoscale metal-organic frameworks as potential multimodal contrast enhancing agents</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>9024-5</pages><volume>128</volume><number>28</number><edition>2006/07/13</edition><keywords><keyword>Contrast Media/*chemistry</keyword><keyword>Gadolinium/*chemistry</keyword><keyword>Nanostructures/*chemistry/ultrastructure</keyword><keyword>Organic Chemicals/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 19</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16834362</accession-num><notes>Rieter, William J&#xD;Taylor, Kathryn M L&#xD;An, Hongyu&#xD;Lin, Weili&#xD;Lin, Wenbin&#xD;P20 rr020764-01/rr/ncrr&#xD;U54-ca119343-01/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Jul 19;128(28):9024-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16834362</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja0627444</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1287</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1287</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Irish, J. M.</author><author>Czerwinski, D. K.</author><author>Nolan, G. P.</author><author>Levy, R.</author></authors></contributors><auth-address>Department of Medicine, Oncology Division, Baxter Laboratory for Genetic Pharmacology, Stanford University Medical Center, Stanford, CA 94305-5151, USA.</auth-address><titles><title>Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells</title><secondary-title>Blood</secondary-title></titles><periodical><full-title>Blood</full-title></periodical><pages>3135-42</pages><volume>108</volume><number>9</number><edition>2006/07/13</edition><keywords><keyword>B-Lymphocytes/*immunology</keyword><keyword>Humans</keyword><keyword>Lymphocytes, Tumor-Infiltrating/*immunology</keyword><keyword>Lymphoma, B-Cell/*immunology</keyword><keyword>Lymphoma, Follicular/*immunology</keyword><keyword>Receptors, Antigen, B-Cell/*immunology</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2006</year><pub-dates><date>Nov 1</date></pub-dates></dates><isbn>0006-4971 (Print)</isbn><accession-num>16835385</accession-num><abstract>The B-cell receptor (BCR) transmits life and death signals throughout B-cell development, and altered BCR signaling may be required for survival of B-lymphoma cells. We used single-cell signaling profiles to compare follicular lymphoma (FL) B cells and nonmalignant host B cells within individual patient biopsies and identified BCR-mediated signaling events specific to lymphoma B cells. Expression of CD20, Bcl-2, and BCR light chain isotype (kappa or lambda) distinguished FL tumor B-cell and nontumor host B-cell subsets within FL patient biopsies. BCR-mediated signaling via phosphorylation of Btk, Syk, Erk1/2, and p38 occurred more rapidly in tumor B cells from FL samples than in infiltrating nontumor B cells, achieved greater levels of per-cell signaling, and sustained this level of signaling for hours longer than nontumor B cells. The timing and magnitude of BCR-mediated signaling in nontumor B cells within an FL sample instead resembled that observed in mature B cells from the peripheral blood of healthy subjects. BCR signaling pathways that are potentiated specifically in lymphoma cells should provide new targets for therapeutic attention.</abstract><notes>Irish, Jonathan M&#xD;Czerwinski, Debra K&#xD;Nolan, Garry P&#xD;Levy, Ronald&#xD;Ca 33399/ca/nci&#xD;Ca 34233/ca/nci&#xD;N01-hv-281831/hv/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Blood&#xD;Blood. 2006 Nov 1;108(9):3135-42. Epub 2006 Jul 11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16835385</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>9.691</custom4><electronic-resource-num>blood-2006-02-003921 [pii]&#xD;10.1182/blood-2006-02-003921</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1731</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1731</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Winter, P. M.</author><author>Neubauer, A. M.</author><author>Caruthers, S. D.</author><author>Harris, T. D.</author><author>Robertson, J. D.</author><author>Williams, T. A.</author><author>Schmieder, A. H.</author><author>Hu, G.</author><author>Allen, J. S.</author><author>Lacy, E. K.</author><author>Zhang, H.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.</auth-address><titles><title>Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis</title><secondary-title>Arterioscler Thromb Vasc Biol</secondary-title></titles><periodical><full-title>Arterioscler Thromb Vasc Biol</full-title></periodical><pages>2103-9</pages><volume>26</volume><number>9</number><edition>2006/07/11</edition><keywords><keyword>Angiogenesis Inhibitors/*administration &amp; dosage/pharmacology</keyword><keyword>Animals</keyword><keyword>Aorta, Abdominal/pathology</keyword><keyword>Atherosclerosis/complications/diagnosis/*metabolism</keyword><keyword>Cyclohexanes</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Endothelium, Vascular/*metabolism</keyword><keyword>Fatty Acids, Unsaturated/*administration &amp; dosage/pharmacology</keyword><keyword>Hyperlipidemias/blood</keyword><keyword>Integrin alphaVbeta3/*metabolism</keyword><keyword>Magnetic Resonance Imaging</keyword><keyword>*Nanostructures</keyword><keyword>Neovascularization, Pathologic/etiology/*prevention &amp; control</keyword><keyword>Rabbits</keyword><keyword>Sesquiterpenes</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>1524-4636 (Electronic)</isbn><accession-num>16825592</accession-num><abstract>OBJECTIVE: Angiogenic expansion of the vasa vasorum is a well-known feature of progressive atherosclerosis, suggesting that antiangiogenic therapies may stabilize or regress plaques. Alpha(v)beta3 integrin-targeted paramagnetic nanoparticles were prepared for noninvasive assessment of angiogenesis in early atherosclerosis, for site-specific delivery of antiangiogenic drug, and for quantitative follow-up of response. METHODS AND RESULTS: Expression of alpha(v)beta3 integrin by vasa vasorum was imaged at 1.5 T in cholesterol-fed rabbit aortas using integrin-targeted paramagnetic nanoparticles that incorporated fumagillin at 0 microg/kg or 30 microg/kg. Both formulations produced similar MRI signal enhancement (16.7%+/-1.1%) when integrated across all aortic slices from the renal arteries to the diaphragm. Seven days after this single treatment, integrin-targeted paramagnetic nanoparticles were readministered and showed decreased MRI enhancement among fumagillin-treated rabbits (2.9%+/-1.6%) but not in untreated rabbits (18.1%+/-2.1%). In a third group of rabbits, nontargeted fumagillin nanoparticles did not alter vascular alpha(v)beta3-integrin expression (12.4%+/-0.9%; P&gt;0.05) versus the no-drug control. In a second study focused on microscopic changes, fewer microvessels in the fumagillin-treated rabbit aorta were counted compared with control rabbits. CONCLUSIONS: This study illustrates the potential of combined molecular imaging and drug delivery with targeted nanoparticles to noninvasively define atherosclerotic burden, to deliver effective targeted drug at a fraction of previous levels, and to quantify local response to treatment.</abstract><notes>Winter, Patrick M&#xD;Neubauer, Anne M&#xD;Caruthers, Shelton D&#xD;Harris, Thomas D&#xD;Robertson, J David&#xD;Williams, Todd A&#xD;Schmieder, Anne H&#xD;Hu, Grace&#xD;Allen, John S&#xD;Lacy, Elizabeth K&#xD;Zhang, Huiying&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Eb-01704/eb/nibib&#xD;Hl-73646/hl/nhlbi&#xD;Hl-78631/hl/nhlbi&#xD;N01-co-37007/co/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Arteriosclerosis, thrombosis, and vascular biology&#xD;Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2103-9. Epub 2006 Jul 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16825592</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>7.221</custom4><electronic-resource-num>01.ATV.0000235724.11299.76 [pii]&#xD;10.1161/01.ATV.0000235724.11299.76</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1666</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1666</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>True, L.</author><author>Coleman, I.</author><author>Hawley, S.</author><author>Huang, C. Y.</author><author>Gifford, D.</author><author>Coleman, R.</author><author>Beer, T. M.</author><author>Gelmann, E.</author><author>Datta, M.</author><author>Mostaghel, E.</author><author>Knudsen, B.</author><author>Lange, P.</author><author>Vessella, R.</author><author>Lin, D.</author><author>Hood, L.</author><author>Nelson, P. S.</author></authors></contributors><auth-address>Department of Pathology, University of Washington, Seattle, WA 98195, USA.</auth-address><titles><title>A molecular correlate to the Gleason grading system for prostate adenocarcinoma</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>10991-6</pages><volume>103</volume><number>29</number><edition>2006/07/11</edition><keywords><keyword>Adenocarcinoma/classification/*genetics/metabolism/*pathology</keyword><keyword>Gene Expression Profiling</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Male</keyword><keyword>Neoplasm Staging</keyword><keyword>Prostatic Neoplasms/classification/*genetics/metabolism/*pathology</keyword><keyword>Tumor Markers, Biological/*genetics</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 18</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16829574</accession-num><abstract>Adenocarcinomas of the prostate can be categorized into tumor grades based on the extent to which the cancers histologically resemble normal prostate glands. Because grades are surrogates of intrinsic tumor behavior, characterizing the molecular phenotype of grade is of potential clinical importance. To identify molecular alterations underlying prostate cancer grades, we used microdissection to obtain specific cohorts of cancer cells corresponding to the most common Gleason patterns (patterns 3, 4, and 5) from 29 radical prostatectomy samples. We paired each cancer sample with matched benign lumenal prostate epithelial cells and profiled transcript abundance levels by microarray analysis. We identified an 86-gene model capable of distinguishing low-grade (pattern 3) from high-grade (patterns 4 and 5) cancers. This model performed with 76% accuracy when applied to an independent set of 30 primary prostate carcinomas. Using tissue microarrays comprising &gt;800 prostate samples, we confirmed a significant association between high levels of monoamine oxidase A expression and poorly differentiated cancers by immunohistochemistry. We also confirmed grade-associated levels of defender against death (DAD1) protein and HSD17 beta4 transcripts by immunohistochemistry and quantitative RT-PCR, respectively. The altered expression of these genes provides functional insights into grade-associated features of therapy resistance and tissue invasion. Furthermore, in identifying a profile of 86 genes that distinguish high- from low-grade carcinomas, we have generated a set of potential targets for modulating the development and progression of the lethal prostate cancer phenotype.</abstract><notes>True, Lawrence&#xD;Coleman, Ilsa&#xD;Hawley, Sarah&#xD;Huang, Ching-Ying&#xD;Gifford, David&#xD;Coleman, Roger&#xD;Beer, Tomasz M&#xD;Gelmann, Edward&#xD;Datta, Milton&#xD;Mostaghel, Elahe&#xD;Knudsen, Beatrice&#xD;Lange, Paul&#xD;Vessella, Robert&#xD;Lin, Daniel&#xD;Hood, Leroy&#xD;Nelson, Peter S&#xD;Dk65204/dk/niddk&#xD;P01ca85859/ca/nci&#xD;P50ca97186/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10991-6. Epub 2006 Jul 7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16829574</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>10.228</custom4><electronic-resource-num>0603678103 [pii]&#xD;10.1073/pnas.0603678103</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1935</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1935</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, X.</author><author>Zuo, T.</author><author>Olmstead, M. M.</author><author>Duchamp, J. C.</author><author>Glass, T. E.</author><author>Cromer, F.</author><author>Balch, A. L.</author><author>Dorn, H. C.</author></authors></contributors><auth-address>Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA.</auth-address><titles><title>Preparation and structure of CeSc2N@C80: an icosahedral carbon cage enclosing an acentric CeSc2N unit with buried f electron spin</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>8884-9</pages><volume>128</volume><number>27</number><edition>2006/07/06</edition><keywords><keyword>Cerium/ chemistry/isolation &amp; purification</keyword><keyword>Crystallography, X-Ray</keyword><keyword>Electrons</keyword><keyword>Fullerenes/ chemistry/isolation &amp; purification</keyword><keyword>Magnetic Resonance Spectroscopy/ methods</keyword><keyword>Models, Molecular</keyword><keyword>Scandium/ chemistry/isolation &amp; purification</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Spectrophotometry/methods</keyword><keyword>Spectrophotometry, Ultraviolet/methods</keyword><keyword>Spectrum Analysis</keyword><keyword>X-Rays</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 12</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16819883</accession-num><abstract>Herein, we report the preparation, purification, and characterization of a mixed trimetallic nitride endohedral metallofullerene, CeSc(2)N@C(80). Single-crystal X-ray diffraction shows that CeSc(2)N@C(80) consists of a four-atom asymmetric top (CeSc(2)N) inside a C(80) (I(h)()) carbon cage. Unlike the situation in most endohedrals of the M(3)N@C(2)(n)() type, the nitride ion is not located at the center of the carbon cage but is offset by 0.36 A in order to accommodate the large Ce(III) ion. The cage carbon atoms near the endohedral Ce and Sc atoms exhibit significantly larger pyramidal angles than the other carbon atoms on the C(80) cage. Surprisingly, at ambient temperature, the (13)C NMR spectrum exhibits isotropic motional averaging yielding only two signals (3 to 1 intensity ratio) for the icosahedral C(80) cage carbons. At the same temperature, the (45)Sc NMR exhibits a relatively narrow, symmetric signal (2700 Hz) with a small temperature-dependent Curie shift. A rotation energy barrier (E(a) = 79 meV) was derived from the (45)Sc NMR line-width analysis. Finally, the XPS spectrum for CeSc(2)N@C(80) confirms a +3 oxidation state for cerium, Ce(3+)(4f(1)5d(0)).This oxidation state and the Curie shift are consistent with a weakly paramagnetic system with a single buried f electron spin.</abstract><notes>Wang, Xuelei&#xD;Zuo, Tianming&#xD;Olmstead, Marilyn M&#xD;Duchamp, James C&#xD;Glass, Thomas E&#xD;Cromer, Frank&#xD;Balch, Alan L&#xD;Dorn, Harry C&#xD;1R01-CA119371-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Jul 12;128(27):8884-9.</notes><urls></urls><custom1>CNPP - V.C.U.</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja061434i [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1205</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1205</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Freeman, D.</author><author>Lesche, R.</author><author>Kertesz, N.</author><author>Wang, S.</author><author>Li, G.</author><author>Gao, J.</author><author>Groszer, M.</author><author>Martinez-Diaz, H.</author><author>Rozengurt, N.</author><author>Thomas, G.</author><author>Liu, X.</author><author>Wu, H.</author></authors></contributors><auth-address>Department of Molecular and Medical Pharmacology, University of California at Los Angeles School of Medicine, 650 C.E. Young Drive South, Los Angeles, CA 90095, USA.</auth-address><titles><title>Genetic background controls tumor development in PTEN-deficient mice</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>6492-6</pages><volume>66</volume><number>13</number><edition>2006/07/05</edition><keywords><keyword>Alleles</keyword><keyword>Animals</keyword><keyword>Female</keyword><keyword>Genes, Tumor Suppressor</keyword><keyword>Germ-Line Mutation</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Inbred BALB C</keyword><keyword>Mice, Knockout</keyword><keyword>Neoplasms, Experimental/*genetics</keyword><keyword>PTEN Phosphohydrolase/*deficiency/genetics</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16818619</accession-num><abstract>PTEN is one of the most frequently mutated tumor suppressor genes in human cancers. Germ line mutations of PTEN have been detected in three rare autosomal-dominant disorders. However, identical mutations in the PTEN gene may lead to different symptoms that have traditionally been described as different disorders, such as Cowden disease, Lhermitte-Duclos disease, and Bannayan-Zonana syndromes. This lack of genotype-phenotype correlation prompted us to directly test the possible effects of genetic background or modifier genes on PTEN-controlled tumorigenesis using genetically engineered mouse models. In this study, we generated two animal models in which either exon 5 (Pten(Delta5)) or promoter to exon 3 (Pten(-)) of the murine Pten gene were deleted and compared phenotypes associated with individual mutations on two genetic backgrounds. We found that the onset and spectrum of tumor formation depend significantly on the genetic background but less on the type of mutation generated. Our results suggest that PTEN plays a critical role in cancer development, and genetic background may influence the onset, the spectrum, and the progression of tumorigenesis caused by Pten mutation.</abstract><notes>Freeman, Dan&#xD;Lesche, Ralf&#xD;Kertesz, Nathalie&#xD;Wang, Shungyou&#xD;Li, Gang&#xD;Gao, Jing&#xD;Groszer, Matthias&#xD;Martinez-Diaz, Hilda&#xD;Rozengurt, Nora&#xD;Thomas, George&#xD;Liu, Xin&#xD;Wu, Hong&#xD;Ca 98013/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2006 Jul 1;66(13):6492-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16818619</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>7.980</custom4><electronic-resource-num>66/13/6492 [pii]&#xD;10.1158/0008-5472.CAN-05-4143</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1151</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1151</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cinteza, L. O.</author><author>Ohulchanskyy, T. Y.</author><author>Sahoo, Y.</author><author>Bergey, E. J.</author><author>Pandey, R. K.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, SUNY at Buffalo, Buffalo, New York 14260, USA.</auth-address><titles><title>Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy</title><secondary-title>Mol Pharm</secondary-title><alt-title>Molecular pharmaceutics</alt-title></titles><periodical><full-title>Mol Pharm</full-title></periodical><alt-periodical><full-title>Molecular Pharmaceutics</full-title></alt-periodical><pages>415-23</pages><volume>3</volume><number>4</number><edition>2006/07</edition><keywords><keyword>Chlorophyll/analogs &amp; derivatives/chemistry</keyword><keyword>Drug Carriers/*chemical synthesis/*chemistry</keyword><keyword>Drug Delivery Systems</keyword><keyword>Drug Design</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Magnetics/*therapeutic use</keyword><keyword>Micelles</keyword><keyword>Nanostructures</keyword><keyword>Nanotechnology</keyword><keyword>Phosphatidylethanolamines/chemistry</keyword><keyword>Photochemistry</keyword><keyword>Photochemotherapy/*methods</keyword><keyword>Polyethylene Glycols/chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul-Aug</date></pub-dates></dates><isbn>1543-8384 (Print)</isbn><accession-num>16889435</accession-num><abstract>We report the design, synthesis using nanochemistry, and characterization of a novel multifunctional polymeric micelle-based nanocarrier system, which demonstrates combined function of magnetophoretically guided drug delivery together with light-activated photodynamic therapy. Specifically, the nanocarrier consists of polymeric micelles of diacylphospholipid-poly(ethylene glycol) (PE-PEG) coloaded with the photosensitizer drug 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH), and magnetic Fe3O4 nanoparticles. The nanocarrier shows excellent stability and activity over several weeks. The physicochemical characterizations have been carried out by transmission electron micrography and optical spectroscopy. An efficient cellular uptake has been confirmed with confocal laser scanning microscopy. The loading efficiency of HPPH is practically unaffected upon coloading with the magnetic nanoparticles, and its phototoxicity is retained. The magnetic response of the nanocarriers was demonstrated by their magnetically directed delivery to tumor cells in vitro. The magnetophoretic control on the cellular uptake provides enhanced imaging and phototoxicity. These multifunctional nanocarriers demonstrate the exciting prospect offered by nanochemistry for targeting photodynamic therapy.</abstract><notes>Ca104492/ca/nci&#xD;Ca55791/ca/nci&#xD;In Vitro&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16889435 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2006</custom3><custom4>4.388</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1782</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1782</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zhang, Y.</author><author>So, M. K.</author><author>Loening, A. M.</author><author>Yao, H.</author><author>Gambhir, S. S.</author><author>Rao, J.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford, Department of Radiology, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA 94305-5484, USA.</auth-address><titles><title>HaloTag protein-mediated site-specific conjugation of bioluminescent proteins to quantum dots</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>4936-40</pages><volume>45</volume><number>30</number><edition>2006/06/30</edition><keywords><keyword>Hydrolases/*chemistry/genetics/metabolism</keyword><keyword>Kinetics</keyword><keyword>Luciferases, Renilla/*chemistry/genetics/metabolism</keyword><keyword>Luminescent Measurements</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>*Nanotechnology</keyword><keyword>*Protein Engineering</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 24</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>16807952</accession-num><notes>Zhang, Yan&#xD;So, Min-Kyung&#xD;Loening, Andreas M&#xD;Yao, Hequan&#xD;Gambhir, Sanjiv S&#xD;Rao, Jianghong&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2006 Jul 24;45(30):4936-40.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16807952</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>10.232</custom4><electronic-resource-num>10.1002/anie.200601197</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1614</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1614</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Soman, N. R.</author><author>Marsh, J. N.</author><author>Hughes, M. S.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Washington University, St. Louis, MO 63130, USA. nsoman@wustl.edu</auth-address><titles><title>Acoustic activation of targeted liquid perfluorocarbon nanoparticles does not compromise endothelial integrity</title><secondary-title>IEEE Trans Nanobioscience</secondary-title></titles><periodical><full-title>IEEE Trans Nanobioscience</full-title></periodical><pages>69-75</pages><volume>5</volume><number>2</number><edition>2006/06/30</edition><keywords><keyword>*Acoustics</keyword><keyword>Cells, Cultured</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Drug Delivery Systems</keyword><keyword>Echocardiography/*methods</keyword><keyword>Endothelial Cells/*cytology/physiology/*radiation effects/ultrasonography</keyword><keyword>Fluorocarbons/*diagnostic use/radiation effects</keyword><keyword>Humans</keyword><keyword>*Nanostructures</keyword><keyword>Particle Size</keyword><keyword>Radiation Dosage</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1536-1241 (Print)</isbn><accession-num>16805101</accession-num><abstract>Perfluorocarbon nanoparticles consisting essentially of liquid perfluoro-octyl bromide (PFOB) core surrounded by a lipid monolayer can serve as highly specific site-targeted contrast and therapeutic agents after binding to cellular biomarkers. Based on previous findings that ultrasound applied at 2 MHz and 1.9 mechanical index (MI) for a 5-min duration dramatically enhances the cellular interaction of targeted PFOB nanoparticles with melanoma cells in vitro without inducing apoptosis or other harmful effects to cells that are targeted, we sought to define mechanisms of interaction and the safety profile of ultrasound used in conjunction with liquid perfluorocarbon nanoparticles for targeted drug delivery, as compared with conventional microbubble ultrasound contrast agents under identical insonification conditions. Cell-culture inserts were used to grow a confluent monolayer of human umbilical vein endothelial cells. Definity in conjunction with continuous wave ultrasound (2.25 MHz for 1 and 5 min) increased the permeability of monolayer by four to six times above the normal, decreased transendothelial electrical resistance (a sign of reduced membrane integrity), and decreased cell viability by approximately 50%. Histological evaluation demonstrated extensive disruptions of cell monolayers. Nanoparticles (both nontargeted and targeted) elicited no changes in these different measures under similar insonification conditions and did not disrupt cell monolayers. We hypothesize that ultrasound facilitates drug transport from the perfluorocarbon nanoparticles not by cavitation-induced effects on cell membrane but rather by direct interaction with the nanoparticles that stimulate lipid exchange and drug delivery.</abstract><notes>Soman, Neelesh R&#xD;Marsh, Jon N&#xD;Hughes, Michael S&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Hl-42950/hl/nhlbi&#xD;Hl-59865/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;IEEE transactions on nanobioscience&#xD;IEEE Trans Nanobioscience. 2006 Jun;5(2):69-75.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16805101</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>1.899</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1626</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1626</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stoeva, S. I.</author><author>Lee, J. S.</author><author>Smith, J. E.</author><author>Rosen, S. T.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, Evanston, IL 60208, USA.</auth-address><titles><title>Multiplexed detection of protein cancer markers with biobarcoded nanoparticle probes</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>8378-9</pages><volume>128</volume><number>26</number><edition>2006/06/29</edition><keywords><keyword>Biosensing Techniques/*methods</keyword><keyword>DNA/chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>Oligonucleotide Probes/chemical synthesis/*chemistry</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Tumor Markers, Biological/analysis/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 5</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16802785</accession-num><notes>Stoeva, Savka I&#xD;Lee, Jae-Seung&#xD;Smith, Jennifer E&#xD;Rosen, Steven T&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Jul 5;128(26):8378-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16802785</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja0613106</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1934</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1934</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, T.</author><author>Xu, L.</author><author>Anderson, M. R.</author><author>Ge, Z.</author><author>Zuo, T.</author><author>Wang, X.</author><author>Olmstead, M. M.</author><author>Balch, A. L.</author><author>Gibson, H. W.</author><author>Dorn, H. C.</author></authors></contributors><auth-address>Departments of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, VA 24060-0212, USA.</auth-address><titles><title>Structure and enhanced reactivity rates of the D5h Sc3N@C80 and Lu3N@C80 metallofullerene isomers: the importance of the pyracylene motif</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>8581-9</pages><volume>128</volume><number>26</number><edition>2006/06/29</edition><keywords><keyword>Computer Simulation</keyword><keyword>Crystallography, X-Ray</keyword><keyword>Cyclization</keyword><keyword>Electrochemistry</keyword><keyword>Fullerenes/ chemistry</keyword><keyword>Isomerism</keyword><keyword>Kinetics</keyword><keyword>Lutetium/ chemistry</keyword><keyword>Models, Chemical</keyword><keyword>Models, Molecular</keyword><keyword>Molecular Structure</keyword><keyword>Organometallic Compounds/chemical synthesis/ chemistry</keyword><keyword>Oxazolidinones/chemistry</keyword><keyword>Scandium/ chemistry</keyword><keyword>Time Factors</keyword><keyword>Trityl Compounds/chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul 5</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16802825</accession-num><abstract>In this paper we report enhanced reactivity of the D(5h) isomers in comparison with the more common I(h) isomers of Sc(3)N@C(80) and Lu(3)N@C(80) toward Diels-Alder and 1,3-dipolar tritylazomethine ylide cycloaddition reactions. Also, the structure of the D(5h) isomer of Sc(3)N@C(80) has been determined through single-crystal X-ray diffraction on D(5h)-Sc(3)N@C(80).Ni(OEP).2benzene (OEP = octaethylporphyrin). The Sc(3)N portion of D(5h)-Sc(3)N@C(80) is strictly planar, but the plane of these four atoms is tipped out of the noncrystallographic, horizontal mirror plane of the fullerene by 30 degrees . The combination of short bond length and high degree of pyramidization for the central carbon atoms of the pyracylene sites situated along a belt that is perpendicular to the C(5) axis suggests that these are the sites of greatest reactivity in the D(5h) isomer of Sc(3)N@C(80). Consistent with the observation of higher reactivity observed for the D(5h) isomers, cyclic voltammetry and molecular orbital (MO) calculations demonstrate that the D(5h) isomers have slightly smaller energy gaps than those of the I(h) isomers. The first mono- and bis-adducts of D(5h) Sc(3)N@C(80) have been synthesized via 1,3-dipolar cycloaddition of tritylazomethine ylide. The NMR spectrum for the monoadduct 2b is consistent with reaction at the 6,6-ring juncture in the pyracylene unit of the D(5h) Sc(3)N@C(80) cage and is the thermodynamically stable isomer. On the other hand, monoadduct 2a undergoes thermal conversion to other isomeric monoadducts, and three possible structures are proposed.</abstract><notes>Cai, Ting&#xD;Xu, Liaosa&#xD;Anderson, Mark R&#xD;Ge, Zhongxin&#xD;Zuo, Tianming&#xD;Wang, Xuelei&#xD;Olmstead, Marilyn M&#xD;Balch, Alan L&#xD;Gibson, Harry W&#xD;Dorn, Harry C&#xD;1R01 CA 119371-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Jul 5;128(26):8581-9.</notes><urls></urls><custom1>CNPP - V.C.U.</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja0615573 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1493</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1493</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, S. Y.</author><author>Lee, J. S.</author><author>Georganopoulou, D.</author><author>Mirkin, C. A.</author><author>Schatz, G. C.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, Evanston, Illinois 60208, USA.</auth-address><titles><title>Structures of DNA-linked nanoparticle aggregates</title><secondary-title>J Phys Chem B</secondary-title></titles><periodical><full-title>J Phys Chem B</full-title></periodical><pages>12673-81</pages><volume>110</volume><number>25</number><edition>2006/06/28</edition><keywords><keyword>DNA/*chemistry</keyword><keyword>Models, Molecular</keyword><keyword>Nanoparticles/*chemistry</keyword><keyword>*Nucleic Acid Conformation</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun 29</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>16800601</accession-num><abstract>The room-temperature structure of DNA-linked gold nanoparticle aggregates is investigated using a combination of experiment and theory. The experiments involve extinction spectroscopy measurements and dynamic light scattering measurements of aggregates made using 60 and 80 nm gold particles and 30 base-pair DNA. The theoretical studies use calculated spectra for models of the aggregate structures to determine which structure matches the observations. These models include diffusion-limited cluster-cluster aggregation (DLCA), reaction-limited cluster-cluster aggregation (RLCA), and compact (nonfractal) cluster aggregation. The diameter of the nanoparticles used in the experiments is larger than has been considered previously, and this provides greater sensitivity of spectra to aggregate structure. We show that the best match between experiment and theory occurs for the RLCA fractal structures. This indicates that DNA hybridization takes place under irreversible conditions in the room-temperature aggregation. Some possible structural variations which might influence the result are considered, including the edge-to-edge distance between nanoparticles, variation in the diameter of the nanoparticles, underlying lattice structures of on-lattice compact clusters, and positional disorders in the lattice structures. We find that these variations do not change the conclusion that the room-temperature structure of the aggregates is fractal. We also examine the variation in extinction at 260 nm as temperature is increased, showing that the decrease in extinction at temperatures below the melting temperature is related to a morphological change from fractal toward compact structures.</abstract><notes>Park, Sung Yong&#xD;Lee, Jae-Seung&#xD;Georganopoulou, Dimitra&#xD;Mirkin, Chad A&#xD;Schatz, George C&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2006 Jun 29;110(25):12673-81.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16800601</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>4.688</custom4><electronic-resource-num>10.1021/jp062212+</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1147</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1147</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chu, T. C.</author><author>Marks, J. W., 3rd</author><author>Lavery, L. A.</author><author>Faulkner, S.</author><author>Rosenblum, M. G.</author><author>Ellington, A. D.</author><author>Levy, M.</author></authors></contributors><auth-address>Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas 78712, USA.</auth-address><titles><title>Aptamer:toxin conjugates that specifically target prostate tumor cells</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>5989-92</pages><volume>66</volume><number>12</number><edition>2006/06/17</edition><keywords><keyword>Antineoplastic Agents, Phytogenic/*administration &amp;</keyword><keyword>dosage/pharmacokinetics</keyword><keyword>Aptamers, Nucleotide/*genetics/pharmacokinetics</keyword><keyword>Cell Line, Tumor</keyword><keyword>Drug Delivery Systems/methods</keyword><keyword>Humans</keyword><keyword>Inhibitory Concentration 50</keyword><keyword>Male</keyword><keyword>Plant Proteins/*administration &amp; dosage/pharmacokinetics</keyword><keyword>Prostate-Specific Antigen/biosynthesis/genetics/metabolism</keyword><keyword>Prostatic Neoplasms/*drug therapy/*genetics/metabolism</keyword><keyword>Ribosome Inactivating Proteins, Type 1</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16778167</accession-num><abstract>We have used RNA aptamer:gelonin conjugates to target and specifically destroy cells overexpressing the known cancer biomarker prostate-specific membrane antigen (PSMA). Aptamer:toxin conjugates have an IC50 of 27 nmol/L and display an increased potency of at least 600-fold relative to cells that do not express PSMA. The aptamer not only promotes uptake into target cells but also decreases the toxicity of gelonin in non-target cells. These results validate the notion that &quot;escort aptamers&quot; may be useful for the treatment of specific tumors expressing unique antigen targets.</abstract><notes>Chu, Ted C&#xD;Marks, John W 3rd&#xD;Lavery, Laura A&#xD;Faulkner, Sarah&#xD;Rosenblum, Michael G&#xD;Ellington, Andrew D&#xD;Levy, Matthew&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2006 Jun 15;66(12):5989-92.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16778167</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>7.980</custom4><electronic-resource-num>66/12/5989 [pii]&#xD;10.1158/0008-5472.CAN-05-4583</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1140</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1140</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chignard, N.</author><author>Shang, S.</author><author>Wang, H.</author><author>Marrero, J.</author><author>Brechot, C.</author><author>Hanash, S.</author><author>Beretta, L.</author></authors></contributors><auth-address>Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.</auth-address><titles><title>Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera</title><secondary-title>Gastroenterology</secondary-title></titles><periodical><full-title>Gastroenterology</full-title></periodical><pages>2010-22</pages><volume>130</volume><number>7</number><edition>2006/06/10</edition><keywords><keyword>Carcinoma, Hepatocellular/genetics/metabolism</keyword><keyword>Electrophoresis, Gel, Two-Dimensional</keyword><keyword>Endoplasmic Reticulum/genetics/metabolism</keyword><keyword>Enzyme-Linked Immunosorbent Assay</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Immunoblotting</keyword><keyword>Liver Neoplasms/metabolism/pathology</keyword><keyword>Male</keyword><keyword>Mass Spectrometry</keyword><keyword>Neoplasm Proteins/genetics/metabolism</keyword><keyword>*Proteomics</keyword><keyword>Reference Values</keyword><keyword>Sampling Studies</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Tumor Cells, Cultured</keyword><keyword>Tumor Markers, Biological/*blood/*metabolism</keyword><keyword>mRNA Cleavage and Polyadenylation Factors/*genetics/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0016-5085 (Print)</isbn><accession-num>16762624</accession-num><abstract>BACKGROUND &amp; AIMS: In the past decade, there has been a rising incidence of hepatocellular carcinoma (HCC) and a progressive increase in HCC-related mortality in the United States and Western Europe. The poor survival of patients with HCC is largely related to the lack of reliable tools for early diagnosis. METHODS: We have applied proteomics tools to the comparative analysis of protein profiles between HCC and adjacent nontumor tissues as a means for discovering novel molecular markers. RESULTS: Forty-seven protein spots that showed reproducible variation were identified by mass spectrometry, corresponding to 23 distinct genes. A positive correlation between transcript and protein level variations was observed for only 7 out of the 23 genes. Proteolytic cleavage accounted for the discrepancies between messenger RNA and protein level changes for 7 genes including calreticulin, PDIA3, PDI, and GRP78. We detected a fragment of each of these 4 endoplasmic reticulum proteins in the culture supernatant of the PLC-PRF5 hepatoma cell line, suggesting that their cleavage leads to release of selected cleaved products in the extracellular compartment. We also detected calreticulin and PDIA3 cleavage products in sera of patients with HCC. A statistically highly significant difference in calreticulin and PDIA3 fragment serum levels between patients with HCC and healthy individuals was observed. Amounts of calreticulin and PDIA3 fragments were also significantly different between patients with HCC and at-risk patients (patients with chronic hepatitis or cirrhosis). CONCLUSIONS: Specific isoforms in general and cleavage products in particular should therefore be further evaluated as new markers for HCC.</abstract><notes>Chignard, Nicolas&#xD;Shang, Sufen&#xD;Wang, Hong&#xD;Marrero, Jorge&#xD;Brechot, Christian&#xD;Hanash, Samir&#xD;Beretta, Laura&#xD;R01 dk066840/dk/niddk&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Gastroenterology&#xD;Gastroenterology. 2006 Jun;130(7):2010-22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16762624</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>12.716</custom4><electronic-resource-num>S0016-5085(06)00737-2 [pii]&#xD;10.1053/j.gastro.2006.02.058</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1665</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1665</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Trehin, R.</author><author>Figueiredo, J. L.</author><author>Pittet, M. J.</author><author>Weissleder, R.</author><author>Josephson, L.</author><author>Mahmood, U.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.</auth-address><titles><title>Fluorescent nanoparticle uptake for brain tumor visualization</title><secondary-title>Neoplasia</secondary-title></titles><periodical><full-title>Neoplasia</full-title></periodical><pages>302-11</pages><volume>8</volume><number>4</number><edition>2006/06/08</edition><keywords><keyword>Animals</keyword><keyword>Antigens, CD11b/biosynthesis</keyword><keyword>Brain Neoplasms/*diagnosis/*pathology</keyword><keyword>Carbocyanines/pharmacology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Female</keyword><keyword>Fluorescent Dyes/*pharmacology</keyword><keyword>Gliosarcoma/*diagnosis/pathology</keyword><keyword>Green Fluorescent Proteins/metabolism</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microscopy, Fluorescence/instrumentation</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Rats</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1476-5586 (Electronic)</isbn><accession-num>16756722</accession-num><abstract>Accurate delineation of tumor margins is vital to the successful surgical resection of brain tumors. We have previously developed a multimodal nanoparticle CLIO-Cy5.5, which is detectable by both magnetic resonance imaging and fluorescence, to assist in intraoperatively visualizing tumor boundaries. Here we examined the accuracy of tumor margin determination of orthotopic tumors implanted in hosts with differing immune responses to the tumor. Using a nonuser-based signal intensity method applied to fluorescent micrographs of 9L gliosarcoma green fluorescent protein (GFP) tumors, mean overestimations of 2 and 24 microm were obtained using Cy5.5 fluorescence, compared to the true tumor margin determined by GFP fluorescence, in nude mice and rats, respectively. To resolve which cells internalized the nanoparticle and to quantitate degree of uptake, tumors were disaggregated and cells were analyzed by flow cytometry and fluorescence microscopy. Nanoparticle uptake was seen in both CD11b+ cells (representing activated microglia and macrophages) and tumor cells in both animal models by both methods. CD11b+ cells were predominantly found at the tumor margin in both hosts, but were more pronounced at the margin in the rat model. Additional metastatic (CT26 colon) and primary (Gli36 glioma) brain tumor models likewise demonstrated that the nanoparticle was internalized both by tumor cells and by host cells. Together, these observations suggest that fluorescent nanoparticles provide an accurate method of tumor margin estimation based on a combination of tumor cell and host cell uptake for primary and metastatic tumors in animal model systems and offer potential for clinical translation.</abstract><notes>Trehin, Rachel&#xD;Figueiredo, Jose-Luiz&#xD;Pittet, Mikael J&#xD;Weissleder, Ralph&#xD;Josephson, Lee&#xD;Mahmood, Umar&#xD;Eb001872/eb/nibib&#xD;P50 c 86355/phs&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Canada&#xD;Neoplasia (New York, N.Y.)&#xD;Neoplasia. 2006 Apr;8(4):302-11.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16756722</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>5.124</custom4><electronic-resource-num>10.1593/neo.05751</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1368</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1368</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Larson, A. C.</author><author>Rhee, T. K.</author><author>Deng, J.</author><author>Wang, D.</author><author>Sato, K. T.</author><author>Salem, R.</author><author>Paunesku, T.</author><author>Woloschak, G.</author><author>Mulcahy, M. F.</author><author>Li, D.</author><author>Omary, R. A.</author></authors></contributors><auth-address>Department of Radiology, Northwestern University, Chicago, Illinois, USA. alarson@radiology.northwestern.edu</auth-address><titles><title>Comparison between intravenous and intraarterial contrast injections for dynamic 3D MRI of liver tumors in the VX2 rabbit model</title><secondary-title>J Magn Reson Imaging</secondary-title></titles><periodical><full-title>J Magn Reson Imaging</full-title></periodical><pages>242-7</pages><volume>24</volume><number>1</number><edition>2006/06/08</edition><keywords><keyword>Animals</keyword><keyword>Contrast Media/*administration &amp; dosage/pharmacology</keyword><keyword>Disease Models, Animal</keyword><keyword>Gadolinium DTPA/*pharmacology</keyword><keyword>Infusions, Intra-Arterial/*methods</keyword><keyword>Infusions, Intravenous/*methods</keyword><keyword>Liver/pathology</keyword><keyword>Liver Neoplasms/*diagnosis/*pathology</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Rabbits</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>1053-1807 (Print)</isbn><accession-num>16758469</accession-num><abstract>PURPOSE: To test the hypothesis that catheter-directed intraarterial (IA) contrast agent injection increases tumor enhancement and conspicuity compared to intravenous (IV) injection. MATERIALS AND METHODS: Eight VX2 liver tumors were grown in five rabbits. After positioning a catheter in the hepatic artery, we performed 3D inversion recovery GRE MRI after IA and IV gadopentetate-dimeglumine contrast injections at doses of 0.04 and 0.1 mmol/kg, respectively. Peak enhancement (signal-to-noise ratio (SNR)) and conspicuity (contrast-to-noise ratio (CNR)) were measured for each acquisition. RESULTS: The peak SNR and CNR were 21.7 +/- 5.8 and 17.0 +/- 4.8 (mean +/- SD) after IA injection, and 16.9 +/- 10.2 and 6.2 +/- 2.6 after IV injection. The IA CNR was significantly greater than the IV CNR (P &lt; 0.05), with a &gt;60% increase in CNR for each tumor. For six of the eight tumors the IA SNR was greater than the IV SNR, but statistical significance was not achieved due to the small sample size of the study (P = 0.07). CONCLUSION: We demonstrated the feasibility of using IA injection techniques to improve tumor conspicuity. This strategy could be employed to enhance the detection of small liver tumors or to conserve contrast agent in future MRI-guided transcatheter liver therapies.</abstract><notes>Larson, Andrew C&#xD;Rhee, Thomas K&#xD;Deng, Jie&#xD;Wang, Dingxin&#xD;Sato, Kent T&#xD;Salem, Riad&#xD;Paunesku, Tatjana&#xD;Woloschak, Gayle&#xD;Mulcahy, Mary F&#xD;Li, Debiao&#xD;Omary, Reed A&#xD;R01 hl70859/hl/nhlbi&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Journal of magnetic resonance imaging : JMRI&#xD;J Magn Reson Imaging. 2006 Jul;24(1):242-7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16758469</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>3.041</custom4><electronic-resource-num>10.1002/jmri.20623</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1158</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1158</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cyrus, T.</author><author>Abendschein, D. R.</author><author>Caruthers, S. D.</author><author>Harris, T. D.</author><author>Glattauer, V.</author><author>Werkmeister, J. A.</author><author>Ramshaw, J. A.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Division of Cardiology, Washington University School of Medicine, Saint Louis, Missouri 63110, USA. tcyrus@cmrl.wustl.edu</auth-address><titles><title>MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles</title><secondary-title>J Cardiovasc Magn Reson</secondary-title></titles><periodical><full-title>J Cardiovasc Magn Reson</full-title></periodical><pages>535-41</pages><volume>8</volume><number>3</number><edition>2006/06/08</edition><keywords><keyword>Animals</keyword><keyword>Biological Markers/metabolism</keyword><keyword>Carotid Arteries/*metabolism</keyword><keyword>Collagen Type III/*metabolism</keyword><keyword>Emulsions</keyword><keyword>Extracellular Matrix/*metabolism</keyword><keyword>Fluorocarbons</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>Imaging, Three-Dimensional</keyword><keyword>Immunohistochemistry</keyword><keyword>Integrin alphaVbeta3/*metabolism</keyword><keyword>*Magnetic Resonance Angiography</keyword><keyword>Muscle, Smooth/cytology/*metabolism</keyword><keyword>*Nanostructures</keyword><keyword>Swine</keyword><keyword>Vascular Patency</keyword></keywords><dates><year>2006</year><pub-dates><date>June</date></pub-dates></dates><isbn>1097-6647 (Print)</isbn><accession-num>16755843</accession-num><abstract>In this study, porcine carotid arteries were subjected to balloon overstretch injury followed by local delivery of paramagnetic nanoparticles targeted to alphavbeta3-integrin expressed by smooth muscle cells or collagen III within the extracellular matrix. Carotid T1-weighted angiography and vascular imaging was performed at 1.5T. While MR angiograms were indistinguishable between control and targeted vessel segments, alphavbeta3-integrin-and collagen Ill-targeted nanoparticles spatially delineated patterns and volumes of stretch injury. In conclusion, MR molecular imaging with alphavbeta3-integrin or collagen Ill-targeted nanoparticles enables the non-invasive, three-dimensional characterization of arterial pathology unanticipated from routine angiography.</abstract><notes>Cyrus, Tillmann&#xD;Abendschein, Dana R&#xD;Caruthers, Shelton D&#xD;Harris, Thomas D&#xD;Glattauer, Veronica&#xD;Werkmeister, Jerome A&#xD;Ramshaw, John A M&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Eb-01704/eb/nibib&#xD;Hl-42950/hl/nhlbi&#xD;Hl-59865/hl/nhlbi&#xD;Hl-78631/hl/nhlbi&#xD;N01-co-37007/co/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance&#xD;J Cardiovasc Magn Reson. 2006;8(3):535-41.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16755843</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>2.327</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1149</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1149</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chu, T. C.</author><author>Twu, K. Y.</author><author>Ellington, A. D.</author><author>Levy, M.</author></authors></contributors><auth-address>Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712, USA.</auth-address><titles><title>Aptamer mediated siRNA delivery</title><secondary-title>Nucleic Acids Res</secondary-title></titles><periodical><full-title>Nucleic Acids Res</full-title></periodical><pages>e73</pages><volume>34</volume><number>10</number><edition>2006/06/03</edition><keywords><keyword>Aptamers, Nucleotide/*chemistry</keyword><keyword>Cell Line, Tumor</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword><keyword>Lamins/metabolism</keyword><keyword>Prostate-Specific Antigen/metabolism</keyword><keyword>*RNA Interference</keyword><keyword>RNA, Small Interfering/*administration &amp; dosage/chemistry</keyword><keyword>Streptavidin/chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>June</date></pub-dates></dates><isbn>1362-4962 (Electronic)</isbn><accession-num>16740739</accession-num><abstract>Nucleic acids that bind to cells and are subsequently internalized could prove to be novel delivery reagents. An anti-prostate specific membrane antigen aptamer that has previously been shown to bind to prostate tumor cells was coupled to siRNAs via a modular streptavidin bridge. The resulting conjugates could be simply added onto cells without any further preparation, and were taken up within 30 min. The siRNA-mediated inhibition of gene expression was as efficient as observed with conventional lipid-based reagents, and was dependent upon conjugation to the aptamer. These results suggest new venues for the therapeutic delivery of siRNAs and for the development of reagents that can be used to probe cellular physiology.</abstract><notes>Chu, Ted C&#xD;Twu, Karen Y&#xD;Ellington, Andrew D&#xD;Levy, Matthew&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nucleic acids research&#xD;Nucleic Acids Res. 2006 Jun 1;34(10):e73.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16740739</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>6.968</custom4><electronic-resource-num>34/10/e73 [pii]&#xD;10.1093/nar/gkl388</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2364</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2364</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thomas, J. C.</author><author>Pacholski, C.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0358, USA. msailor@ucsd.edu</auth-address><titles><title>Delivery of nanogram payloads using magnetic porous silicon microcarriers</title><secondary-title>Lab Chip</secondary-title></titles><periodical><full-title>Lab Chip</full-title></periodical><pages>782-7</pages><volume>6</volume><number>6</number><edition>2006/06/02</edition><keywords><keyword>Ferrosoferric Oxide/ chemistry</keyword><keyword>Horseradish Peroxidase/ chemistry</keyword><keyword>Magnetics</keyword><keyword>Nanotechnology/ methods</keyword><keyword>Pronase/ chemistry</keyword><keyword>Silicon/ chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1473-0197 (Print)</isbn><accession-num>16738731</accession-num><abstract>A transport and delivery system for nanogram quantities of molecular species that does not use microfluidic channels, pumps, or valves is described. Microparticles consisting of magnetic porous silicon are prepared, and loading and delivery of an enzymatic payload are demonstrated. The high porosity (60%) porous Si host particles are made magnetic by infusion of superparamagnetic iron oxide nanoparticles (30 nm-diameter magnetite, Fe(3)O(4)) under oxidative conditions. After magnetite incorporation, the porous microparticle is still empty enough to accommodate nanogram quantities of a molecular payload; the enzymes horseradish peroxidase or pronase E are used in the present work. The assembly can be transported to a microliter water droplet containing the enzyme substrate with the aid of an external magnetic field. The enzyme is released into the droplet upon contact. The particles can be transported through air or a hydrocarbon liquid without loss in enzymatic activity of the payload.</abstract><notes>Thomas, J Christopher&#xD;Pacholski, Claudia&#xD;Sailor, Michael J&#xD;N01 CO 37117/CO/NCI NIH HHS/United States&#xD;U54 CA 119335/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Lab on a chip&#xD;Lab Chip. 2006 Jun;6(6):782-7. Epub 2006 Mar 21.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom4>7.000</custom4><electronic-resource-num>10.1039/b516121e [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1580</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1580</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shi, X.</author><author>Bi, X.</author><author>Ganser, T. R.</author><author>Hong, S.</author><author>Myc, L. A.</author><author>Desai, A.</author><author>Holl, M. M.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, MI 48109, USA.</auth-address><titles><title>HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein</title><secondary-title>Analyst</secondary-title><alt-title>The Analyst</alt-title></titles><periodical><full-title>Analyst</full-title></periodical><alt-periodical><full-title>Analyst</full-title><abbr-1>The Analyst</abbr-1></alt-periodical><pages>842-8</pages><volume>131</volume><number>7</number><edition>2006/06</edition><keywords><keyword>Biocompatible Materials/analysis/chemistry</keyword><keyword>Carrier Proteins/*chemistry</keyword><keyword>Chromatography, Gel/methods</keyword><keyword>Chromatography, High Pressure Liquid/methods</keyword><keyword>Electrophoresis, Polyacrylamide Gel/methods</keyword><keyword>Polyamines/*analysis/chemistry</keyword><keyword>Receptors, Cell Surface/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0003-2654 (Print)</isbn><accession-num>16802031</accession-num><abstract>Poly(amidoamine) (PAMAM) dendrimers of different generations with carboxyl, acetyl, and hydroxyl terminal groups and a folic acid (FA)-dendrimer conjugate were separated and analyzed using reverse-phase high performance liquid chromatography (HPLC). Analysis of both the individual PAMAM derivatives and the separation of mixed generations can be achieved using a linear gradient 0-50% acetonitrile (ACN) (balance water) within 40 min. We also show that PAMAMs with defined acetylation and carboxylation degrees can be analyzed using HPLC. Furthermore, a generation 5 dendrimer-FA conjugate (G5.75Ac-FA4; Ac denotes acetyl) was analyzed and its specific binding with a bovine folic acid binding protein (FBP) was monitored. The HPLC and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) results indicate the formation of three complexes after the binding of G5.75Ac-FA4 with FBP. Dendrimers with FA moieties show much higher specific binding capability with FBP than those without FA moieties. Findings from this study indicate that HPLC is an effective technique not only for characterization and separation of functionalized PAMAM dendrimers and conjugates but also for investigation of the interaction between dendrimers and biomolecules.</abstract><notes>N01-co-97111/co/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16802031 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2006</custom3><custom4>3.472</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1488</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1488</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Park, J. H.</author><author>Derfus, A. M.</author><author>Segal, E.</author><author>Vecchio, K. S.</author><author>Bhatia, S. N.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0358, USA.</auth-address><titles><title>Local heating of discrete droplets using magnetic porous silicon-based photonic crystals</title><secondary-title>J Am Chem Soc</secondary-title><alt-title>Journal of the American Chemical Society</alt-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><alt-periodical><full-title>Journal of the American Chemical Society</full-title></alt-periodical><pages>7938-46</pages><volume>128</volume><number>24</number><edition>2006/06</edition><dates><year>2006</year><pub-dates><date>Jun 21</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16771508</accession-num><abstract>This paper describes a method for local heating of discrete microliter-scale liquid droplets. The droplets are covered with magnetic porous Si microparticles, and heating is achieved by application of an external alternating electromagnetic field. The magnetic porous Si microparticles consist of two layers. The top layer contains a photonic code and it is hydrophobic, with surface-grafted dodecyl moieties. The bottom layer consists of a hydrophilic silicon oxide host layer that is infused with Fe3O4 nanoparticles. The amphiphilic microparticles spontaneously align at the interface of a water droplet immersed in mineral oil, allowing manipulation of the droplets by application of a magnetic field. Application of an oscillating magnetic field (338 kHz, 18 A rms current in a coil surrounding the experiment) generates heat in the superparamagnetic particles that can raise the temperature of the enclosed water droplet to &gt;80 degrees C within 5 min. A simple microfluidics application is demonstrated: combining complementary DNA strands contained in separate droplets and then thermally inducing dehybridization of the conjugate. The complementary oligonucleotides were conjugated with the cyanine dye fluorophores Cy3 and Cy5 to quantify the melting/rebinding reaction by fluorescence resonance energy transfer (FRET). The magnetic porous Si microparticles were prepared as photonic crystals, containing spectral codes that allowed the identification of the droplets by reflectivity spectroscopy. The technique demonstrates the feasibility of tagging, manipulating, and heating small volumes of liquids without the use of conventional microfluidic channel and heating systems.</abstract><notes>N01-co-37117/co/nci&#xD;U54 ca 119335/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16771508 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom2>Yes- MIT and UCSD</custom2><custom3>2006</custom3><custom4>8.256</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1340</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1340</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kohler, N.</author><author>Sun, C.</author><author>Fichtenholtz, A.</author><author>Gunn, J.</author><author>Fang, C.</author><author>Zhang, M.</author></authors></contributors><auth-address>Department of Materials Science &amp; Engineering, University of Washington, Seattle, WA98195, USA.</auth-address><titles><title>Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery</title><secondary-title>Small</secondary-title><alt-title>Small (Weinheim an der Bergstrasse, Germany)</alt-title></titles><periodical><full-title>Small</full-title></periodical><pages>785-92</pages><volume>2</volume><number>6</number><edition>2006/06</edition><keywords><keyword>Adsorption</keyword><keyword>Animals</keyword><keyword>Antineoplastic Agents/administration &amp; dosage/diagnostic use</keyword><keyword>Brain Neoplasms/radionuclide imaging</keyword><keyword>Cell Line, Tumor</keyword><keyword>Coated Materials, Biocompatible/chemistry/diagnostic use/therapeutic use</keyword><keyword>Contrast Media/*chemistry</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Glioma/drug therapy/*radionuclide imaging</keyword><keyword>Image Enhancement/methods</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Magnetics/diagnostic use/therapeutic use</keyword><keyword>Methotrexate/*chemistry</keyword><keyword>Nanoparticles/*chemistry/ultrastructure</keyword><keyword>Polyethylene Glycols/*chemistry</keyword><keyword>Rats</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1613-6829 (Electronic)</isbn><accession-num>17193123</accession-num><abstract>We report the development of a biostable methotrexate-immobilized iron oxide nanoparticle drug carrier that may potentially be used for real-time monitoring of drug delivery through magnetic resonance imaging. Methotrexate (MTX) was immobilized on the nanoparticle surface via a poly(ethylene glycol) self-assembled monolayer (PEG SAM). The cytotoxicity of the nanoparticle-drug conjugate (NP-PEG-MTX) to target cells was studied with 9L glioma cells. Cellular uptake experiments showed that the uptake of NP-PEG-MTX conjugates by glioma cells was considerably higher than that of control nanoparticles. Magnetic resonance imaging in 9L cells cultured with NP-PEG-MTX of various concentrations showed significant contrast enhancement. NP-PEG-MTX demonstrated higher cytotoxicity in 9L cells to free MTX in vitro. Leucovorin, an MTX antidote, was used to rescue the cells that had been exposed to NP-PEG-MTX or free MTX, and the experiment verified the biocompatibility of NP-PEG-MTX conjugates and the MTX on NP-PEG-MTX conjugates to be the true source of the cytotoxicity to the target cells. TEM results showed that NP-PEG-MTX conjugates were internalized into the 9L cellular cytoplasm and retained its crystal structure therein for up to 144 h, as identified by electron diffraction. This prolonged particle retention may allow physicians to image tumor cells exposed to the NP-PEG-MTX conjugate over an extended therapeutic time course.</abstract><notes>Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17193123 </url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2006</custom3><custom4>7.292</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1095</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1095</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Magrini, A.</author><author>Rosato, N.</author><author>Bergamaschi, A.</author><author>Mustelin, T.</author></authors></contributors><titles><title>Dispersion of pristine single-walled carbon nanotubes in water by a thiolated organosilane: application in supramolecular nanoassemblies</title><secondary-title>J Phys Chem B Condens Matter Mater Surf Interfaces Biophys</secondary-title><alt-title>The journal of physical chemistry</alt-title></titles><periodical><full-title>J Phys Chem B Condens Matter Mater Surf Interfaces Biophys</full-title><abbr-1>The journal of physical chemistry</abbr-1></periodical><alt-periodical><full-title>J Phys Chem B</full-title><abbr-1>The journal of physical chemistry</abbr-1></alt-periodical><pages>13685-8</pages><volume>110</volume><number>28</number><edition>2006/06</edition><dates><year>2006</year><pub-dates><date>Jul 20</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>16836310</accession-num><abstract>We report a novel technique to disperse pristine single-walled carbon nanotubes in water by ultrasonication in the presence of a thiolated organosilane and subsequent ultracentrifugation. As revealed by the sharp features in the visible range of the absorption spectrum and by transmission electron microscopy, the collected supernatant fraction was composed of small bundles of nanotubes coated by a thin layer of organosilane molecules. We hypothesized and demonstrated that the organosilane adsorbed onto the nanotubes through the thiol group leaving the silane group extruding out. The pristine properties of the nanotubes and the versatile chemistry available for sol-gel materials make the reported dispersed nanotubes an excellent scaffold for the realization of supramolecular nanoassemblies suitable for different applications. As examples, we decorated them with silica nanobeads, by using a water-in-oil nanoemulsion system, and with gold nanoparticles, by a previous derivatization with a second layer of thiolated organosilane providing exposed thiol groups.</abstract><notes>U54 ca119335/ca/nci&#xD;Letter&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16836310 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>4.688</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1093</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1093</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Magrini, A.</author><author>Dawson, M. I.</author><author>Bergamaschi, A.</author><author>Mustelin, T.</author></authors></contributors><auth-address>Bottini, M&#xD;Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA&#xD;Burnham Inst Med Res, La Jolla, CA 92037 USA&#xD;Univ Roma Tor Vergata, Dept Environm Occupat &amp; Social Med, I-00133 Rome, Italy</auth-address><titles><title>Non-destructive decoration of full-length multi-walled carbon nanotubes with variable amounts of silica gel nanoparticles</title><secondary-title>Carbon</secondary-title></titles><periodical><full-title>Carbon</full-title></periodical><pages>1301-1303</pages><volume>44</volume><number>7</number><edition>2006/06</edition><keywords><keyword>carbon nanotubes</keyword><keyword>surface treatment</keyword><keyword>adsorption</keyword><keyword>transmission electron microscopy</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>0008-6223</isbn><accession-num>ISI:000236689000026</accession-num><notes>031FF&#xD;Times Cited:1&#xD;Cited References Count:9</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000236689000026</url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>4.260</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1087</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1087</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bhattarai, N.</author><author>Ramay, H. R.</author><author>Chou, S. H.</author><author>Zhang, M.</author></authors></contributors><auth-address>Department of Material Science and Engineering, University of Washington, Seattle,WA 98195, USA.</auth-address><titles><title>Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery</title><secondary-title>Int J Nanomedicine</secondary-title><alt-title>International journal of nanomedicine</alt-title></titles><periodical><full-title>Int J Nanomedicine</full-title></periodical><alt-periodical><full-title>International Journal of Nanomedicine</full-title></alt-periodical><pages>181-7</pages><volume>1</volume><number>2</number><edition>2006/06</edition><keywords><keyword>Chitosan/*chemistry</keyword><keyword>Delayed-Action Preparations/*chemical synthesis</keyword><keyword>Diffusion</keyword><keyword>Drug Carriers/*chemistry</keyword><keyword>Lactic Acid/*chemistry</keyword><keyword>Materials Testing</keyword><keyword>Nanoparticles/*chemistry/*ultrastructure</keyword><keyword>Particle Size</keyword><keyword>Pharmaceutical Preparations/administration &amp; dosage/chemistry</keyword><keyword>Serum Albumin, Bovine/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>June</date></pub-dates></dates><isbn>1176-9114 (Print)</isbn><accession-num>17722534</accession-num><abstract>Nanoparticles of approximately 10nm in diameter made with chitosan or lactic acid-grafted chitosan were developed for high drug loading and prolonged drug release. A drug encapsulation efficiency of 92% and a release rate of 28% from chitosan nanoparticles over a 4-week period were demonstrated with bovine serum protein. To further increase drug encapsulation, prolong drug release, and increase chitosan solubility in solution of neutral pH, chitosan was modified with lactic acid by grafting D,L-lactic acid onto amino groups in chitosan without using a catalyst. The lactic acid-grafted chitosan nanoparticles demonstrated a drug encapsulation efficiency of 96% and a protein release rate of 15% over 4 weeks. With increased protein concentration, the drug encapsulation efficiency decreased and drug release rate increased. Unlike chitosan, which is generally soluble only in acid solution, the chitosan modified with lactic acid can be prepared from solutions of neutral pH, offering an additional advantage of allowing proteins or drugs to be uniformly incorporated in the matrix structure with minimal or no denaturization.</abstract><notes>Journal Article&#xD;New Zealand</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17722534 </url></related-urls></urls><custom1>CNPP - U. of Wash.</custom1><custom3>2006</custom3><custom4>1.649</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1297</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1297</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Ji, H.</author><author>Li, D.</author><author>Chen, L.</author><author>Shimamura, T.</author><author>Kobayashi, S.</author><author>McNamara, K.</author><author>Mahmood, U.</author><author>Mitchell, A.</author><author>Sun, Y.</author><author>Al-Hashem, R.</author><author>Chirieac, L. R.</author><author>Padera, R.</author><author>Bronson, R. T.</author><author>Kim, W.</author><author>Janne, P. A.</author><author>Shapiro, G. I.</author><author>Tenen, D.</author><author>Johnson, B. E.</author><author>Weissleder, R.</author><author>Sharpless, N. E.</author><author>Wong, K. K.</author></authors></contributors><auth-address>Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.</auth-address><titles><title>The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies</title><secondary-title>Cancer Cell</secondary-title></titles><periodical><full-title>Cancer Cell</full-title></periodical><pages>485-95</pages><volume>9</volume><number>6</number><edition>2006/05/30</edition><keywords><keyword>Adenocarcinoma/drug therapy/*genetics/pathology</keyword><keyword>Adenocarcinoma, Bronchiolo-Alveolar/drug therapy/genetics/pathology</keyword><keyword>Animals</keyword><keyword>Antibodies, Monoclonal/therapeutic use</keyword><keyword>Antineoplastic Agents/*therapeutic use</keyword><keyword>Enzyme Activation</keyword><keyword>Exons</keyword><keyword>Humans</keyword><keyword>Lung/metabolism</keyword><keyword>Lung Neoplasms/drug therapy/*genetics/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Transgenic</keyword><keyword>Mutation</keyword><keyword>Protein Structure, Tertiary</keyword><keyword>Quinazolines/therapeutic use</keyword><keyword>Quinolines/therapeutic use</keyword><keyword>Receptor, Epidermal Growth Factor/antagonists &amp;</keyword><keyword>inhibitors/genetics/*metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1535-6108 (Print)</isbn><accession-num>16730237</accession-num><abstract>To understand the role of human epidermal growth factor receptor (hEGFR) kinase domain mutations in lung tumorigenesis and response to EGFR-targeted therapies, we generated bitransgenic mice with inducible expression in type II pneumocytes of two common hEGFR mutants seen in human lung cancer. Both bitransgenic lines developed lung adenocarcinoma after sustained hEGFR mutant expression, confirming their oncogenic potential. Maintenance of these lung tumors was dependent on continued expression of the EGFR mutants. Treatment with small molecule inhibitors (erlotinib or HKI-272) as well as prolonged treatment with a humanized anti-hEGFR antibody (cetuximab) led to dramatic tumor regression. These data suggest that persistent EGFR signaling is required for tumor maintenance in human lung adenocarcinomas expressing EGFR mutants.</abstract><notes>Ji, Hongbin&#xD;Li, Danan&#xD;Chen, Liang&#xD;Shimamura, Takeshi&#xD;Kobayashi, Susumu&#xD;McNamara, Kate&#xD;Mahmood, Umar&#xD;Mitchell, Albert&#xD;Sun, Yangping&#xD;Al-Hashem, Ruqayyah&#xD;Chirieac, Lucian R&#xD;Padera, Robert&#xD;Bronson, Roderick T&#xD;Kim, William&#xD;Janne, Pasi A&#xD;Shapiro, Geoffrey I&#xD;Tenen, Daniel&#xD;Johnson, Bruce E&#xD;Weissleder, Ralph&#xD;Sharpless, Norman E&#xD;Wong, Kwok-Kin&#xD;Ag024379/ag/nia&#xD;Ag2400401/ag/nia&#xD;Ca90679/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Cancer cell&#xD;Cancer Cell. 2006 Jun;9(6):485-95. Epub 2006 May 25.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16730237</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>23.332</custom4><electronic-resource-num>S1535-6108(06)00146-2 [pii]&#xD;10.1016/j.ccr.2006.04.022</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1718</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1718</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. weissleder@helix.mgh.harvard.edu</auth-address><titles><title>Molecular imaging in cancer</title><secondary-title>Science</secondary-title></titles><periodical><full-title>Science</full-title></periodical><pages>1168-71</pages><volume>312</volume><number>5777</number><edition>2006/05/27</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents/therapeutic use</keyword><keyword>*Diagnostic Imaging</keyword><keyword>Drug Evaluation, Preclinical</keyword><keyword>Humans</keyword><keyword>Indicators and Reagents</keyword><keyword>*Molecular Diagnostic Techniques</keyword><keyword>Neoplasms/chemistry/*diagnosis/*therapy</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Radiopharmaceuticals/*diagnostic use</keyword><keyword>Tumor Markers, Biological</keyword></keywords><dates><year>2006</year><pub-dates><date>May 26</date></pub-dates></dates><isbn>1095-9203 (Electronic)</isbn><accession-num>16728630</accession-num><abstract>Medical imaging technologies have undergone explosive growth over the past few decades and now play a central role in clinical oncology. But the truly transformative power of imaging in the clinical management of cancer patients lies ahead. Today, imaging is at a crossroads, with molecularly targeted imaging agents expected to broadly expand the capabilities of conventional anatomical imaging methods. Molecular imaging will allow clinicians to not only see where a tumor is located in the body, but also to visualize the expression and activity of specific molecules (e.g., proteases and protein kinases) and biological processes (e.g., apoptosis, angiogenesis, and metastasis) that influence tumor behavior and/or response to therapy. This information is expected to have a major impact on cancer detection, individualized treatment, and drug development, as well as our understanding of how cancer arises.</abstract><notes>Weissleder, Ralph&#xD;United States&#xD;Science (New York, N.Y.)&#xD;Science. 2006 May 26;312(5777):1168-71.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16728630</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>30.268</custom4><electronic-resource-num>312/5777/1168 [pii]&#xD;10.1126/science.1125949</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1547</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1547</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rosi, N. L.</author><author>Giljohann, D. A.</author><author>Thaxton, C. S.</author><author>Lytton-Jean, A. K.</author><author>Han, M. S.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113 USA.</auth-address><titles><title>Oligonucleotide-modified gold nanoparticles for intracellular gene regulation</title><secondary-title>Science</secondary-title></titles><periodical><full-title>Science</full-title></periodical><pages>1027-30</pages><volume>312</volume><number>5776</number><edition>2006/05/20</edition><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Deoxyribonucleases/metabolism</keyword><keyword>*Gene Expression Regulation</keyword><keyword>Glutathione/metabolism</keyword><keyword>*Gold</keyword><keyword>Green Fluorescent Proteins/genetics</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>*Nanostructures</keyword><keyword>*Oligodeoxyribonucleotides, Antisense/metabolism</keyword><keyword>RNA, Messenger</keyword></keywords><dates><year>2006</year><pub-dates><date>May 19</date></pub-dates></dates><isbn>1095-9203 (Electronic)</isbn><accession-num>16709779</accession-num><abstract>We describe the use of gold nanoparticle-oligonucleotide complexes as intracellular gene regulation agents for the control of protein expression in cells. These oligonucleotide-modified nanoparticles have affinity constants for complementary nucleic acids that are higher than their unmodified oligonucleotide counterparts, are less susceptible to degradation by nuclease activity, exhibit greater than 99% cellular uptake, can introduce oligonucleotides at a higher effective concentration than conventional transfection agents, and are nontoxic to the cells under the conditions studied. By chemically tailoring the density of DNA bound to the surface of gold nanoparticles, we demonstrated a tunable gene knockdown.</abstract><notes>Rosi, Nathaniel L&#xD;Giljohann, David A&#xD;Thaxton, C Shad&#xD;Lytton-Jean, Abigail K R&#xD;Han, Min Su&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Science (New York, N.Y.)&#xD;Science. 2006 May 19;312(5776):1027-30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16709779</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>30.268</custom4><electronic-resource-num>312/5776/1027 [pii]&#xD;10.1126/science.1125559</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1769</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1769</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Young, A. N.</author><author>Dale, J.</author><author>Yin-Goen, Q.</author><author>Harris, W. B.</author><author>Petros, J. A.</author><author>Datta, M. W.</author><author>Wang, M. D.</author><author>Marshall, F. F.</author><author>Amin, M. B.</author></authors></contributors><auth-address>Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. andrew.n.young@emory.edu</auth-address><titles><title>Current trends in molecular classification of adult renal tumors</title><secondary-title>Urology</secondary-title></titles><periodical><full-title>Urology</full-title></periodical><pages>873-80</pages><volume>67</volume><number>5</number><edition>2006/05/16</edition><keywords><keyword>Adult</keyword><keyword>Gene Expression Profiling</keyword><keyword>Genetic Markers</keyword><keyword>Humans</keyword><keyword>Kidney Neoplasms/*classification/diagnosis/*genetics</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Prognosis</keyword><keyword>Tumor Markers, Biological</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1527-9995 (Electronic)</isbn><accession-num>16698345</accession-num><notes>Young, Andrew N&#xD;Dale, Jennifer&#xD;Yin-Goen, Qiqin&#xD;Harris, Wayne B&#xD;Petros, John A&#xD;Datta, Milton W&#xD;Wang, May D&#xD;Marshall, Fray F&#xD;Amin, Mahul B&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Urology&#xD;Urology. 2006 May;67(5):873-80.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16698345</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>2.604</custom4><electronic-resource-num>S0090-4295(05)01695-X [pii]&#xD;10.1016/j.urology.2005.11.042</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1388</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1388</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lei, Q.</author><author>Jiao, J.</author><author>Xin, L.</author><author>Chang, C. J.</author><author>Wang, S.</author><author>Gao, J.</author><author>Gleave, M. E.</author><author>Witte, O. N.</author><author>Liu, X.</author><author>Wu, H.</author></authors></contributors><auth-address>Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California 90095, USA.</auth-address><titles><title>NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss</title><secondary-title>Cancer Cell</secondary-title></titles><periodical><full-title>Cancer Cell</full-title></periodical><pages>367-78</pages><volume>9</volume><number>5</number><edition>2006/05/16</edition><keywords><keyword>Acetylation</keyword><keyword>Animals</keyword><keyword>Cell Proliferation</keyword><keyword>Down-Regulation/genetics</keyword><keyword>Enzyme Activation</keyword><keyword>Epithelium/metabolism/pathology</keyword><keyword>Gene Expression</keyword><keyword>Histone Deacetylases/metabolism</keyword><keyword>Homeodomain Proteins/*metabolism</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>PTEN Phosphohydrolase/*deficiency/genetics</keyword><keyword>Promoter Regions (Genetics)/genetics</keyword><keyword>Prostatic Neoplasms/genetics/metabolism/*pathology</keyword><keyword>Protein Binding</keyword><keyword>Proto-Oncogene Proteins c-akt/*antagonists &amp; inhibitors/metabolism</keyword><keyword>Proto-Oncogene Proteins c-mdm2</keyword><keyword>Receptors, Androgen/genetics/metabolism</keyword><keyword>Transcription Factors/*metabolism</keyword><keyword>Transplants</keyword><keyword>Tumor Suppressor Protein p53/*metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1535-6108 (Print)</isbn><accession-num>16697957</accession-num><abstract>We demonstrate that PTEN loss causes reduced NKX3.1 expression in both murine and human prostate cancers. Restoration of Nkx3.1 expression in vivo in Pten null epithelium leads to decreased cell proliferation, increased cell death, and prevention of tumor initiation. Whereas androgen receptor (AR) positively regulates NKX3.1 expression, NKX3.1 negatively modulates AR transcription and consequently the AR-associated signaling events. Consistent with its tumor suppressor functions, NKX3.1 engages cell cycle and cell death machinery via association with HDAC1, leading to increased p53 acetylation and half-life through MDM2-dependent mechanisms. Importantly, overexpression of Nkx3.1 has little effect on Pten wild-type epithelium, suggesting that PTEN plays a predominant role in PTEN-NKX3.1 interplay. Manipulating NKX3.1 expression may serve as a therapeutic strategy for treating PTEN-deficient prostate cancers.</abstract><notes>Lei, Qunying&#xD;Jiao, Jing&#xD;Xin, Li&#xD;Chang, Chun-Ju&#xD;Wang, Shunyou&#xD;Gao, Jing&#xD;Gleave, Martin E&#xD;Witte, Owen N&#xD;Liu, Xin&#xD;Wu, Hong&#xD;P50 ca092131/ca/nci&#xD;R01 ca107166/ca/nci&#xD;U01 ca84128-06/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer cell&#xD;Cancer Cell. 2006 May;9(5):367-78.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16697957</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>23.332</custom4><electronic-resource-num>S1535-6108(06)00118-8 [pii]&#xD;10.1016/j.ccr.2006.03.031</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1333</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1333</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kim, S.</author><author>Pudavar, H. E.</author><author>Prasad, P. N.</author></authors></contributors><auth-address>Institute for Lasers, Photonics and Biophotonics, Department of Chemistry, State University of New York, Buffalo, New York 14260-3000, USA.</auth-address><titles><title>Dye-concentrated organically modified silica nanoparticles as a ratiometric fluorescent pH probe by one- and two-photon excitation</title><secondary-title>Chem Commun (Camb)</secondary-title><alt-title>Chemical communications (Cambridge, England)</alt-title></titles><periodical><full-title>Chem Commun (Camb)</full-title></periodical><pages>2071-3</pages><number>19</number><edition>2006/05</edition><keywords><keyword>Coloring Agents</keyword><keyword>Fluorescence</keyword><keyword>*Fluorescent Dyes</keyword><keyword>Hydrogen-Ion Concentration</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>*Nanostructures</keyword><keyword>Nanotechnology</keyword><keyword>*Photons</keyword><keyword>Radiometry</keyword><keyword>Silicon Dioxide/*chemistry</keyword><keyword>Spectrometry, Fluorescence</keyword></keywords><dates><year>2006</year><pub-dates><date>May 21</date></pub-dates></dates><isbn>1359-7345 (Print)</isbn><accession-num>16767279</accession-num><abstract>Basic dye-concentrated nanoparticles (approximately 33 nm in diameter) show fluorescence-based ratiometric pH response, by one- and two-photon excitations, with improved proton sensing ability (pKa approximately 6.4) through nanoscopic intraparticle energy transfer.</abstract><notes>Journal Article&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16767279 </url></related-urls></urls><custom1>CNPP - SUNY Buffalo</custom1><custom3>2006</custom3><custom4>4.997</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1243</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1243</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Harris, T. J.</author><author>von Maltzahn, G.</author><author>Derfus, A. M.</author><author>Ruoslahti, E.</author><author>Bhatia, S. N.</author></authors></contributors><auth-address>Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</auth-address><titles><title>Proteolytic actuation of nanoparticle self-assembly</title><secondary-title>Angew Chem Int Ed Engl</secondary-title><alt-title>Angewandte Chemie (International ed</alt-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><alt-periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></alt-periodical><pages>3161-5</pages><volume>45</volume><number>19</number><edition>2006/05</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Enzyme Inhibitors/pharmacology</keyword><keyword>Ferric Compounds/chemistry</keyword><keyword>Humans</keyword><keyword>Magnetics</keyword><keyword>Matrix Metalloproteinase 2/*antagonists &amp; inhibitors/metabolism</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>*Nanotechnology</keyword><keyword>Particle Size</keyword><keyword>Polyethylene Glycols/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>May 5</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>16642514</accession-num><notes>Eb 006324/eb/nibib&#xD;N01-co37117/co/nci&#xD;U54 ca119335/ca/nci&#xD;U54 ca119349/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16642514 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>Yes- MIT and UCSD</custom2><custom3>2006</custom3><custom4>11.025</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1200</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1200</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Farokhzad, O. C.</author><author>Karp, J. M.</author><author>Langer, R.</author></authors></contributors><auth-address>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women&apos;s Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. ofarokhzad@partners.org</auth-address><titles><title>Nanoparticle-aptamer bioconjugates for cancer targeting</title><secondary-title>Expert Opin Drug Deliv</secondary-title><alt-title>Expert opinion on drug delivery</alt-title></titles><periodical><full-title>Expert Opin Drug Deliv</full-title></periodical><alt-periodical><full-title>Expert Opin Drug Deliv</full-title><abbr-1>Expert opinion on drug delivery</abbr-1></alt-periodical><pages>311-24</pages><volume>3</volume><number>3</number><edition>2006/05</edition><keywords><keyword>Animals</keyword><keyword>Aptamers, Nucleotide/chemistry/isolation &amp; purification/*therapeutic use</keyword><keyword>Delayed-Action Preparations/chemistry/therapeutic use</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Humans</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Neoplasms/*drug therapy</keyword><keyword>SELEX Aptamer Technique</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1742-5247 (Print)</isbn><accession-num>16640493</accession-num><abstract>The combination of targeted drug delivery and controlled-release technology may pave the road for more effective yet safer chemotherapeutic options for cancer therapy. Drug-encapsulated polymeric nanoparticle-aptamer bioconjugates represent an emerging technology that can facilitate the delivery of chemotherapeutics to primary and metastatic tumours. Aptamers are short nucleic acid molecules with binding properties and biochemical characteristics that may make them suitable for use as targeting molecules. The goal of this review is to summarise the key components that are required for creating effective cancer targeting nanoparticle-aptamer bioconjugates. The field of controlled release and the structure and properties of aptamers, as well as the criteria for constructing effective conjugates, will be discussed.</abstract><notes>Ca 119349/ca/nci&#xD;Eb003647/eb/nibib&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16640493 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>1.424</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1094</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1094</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Magrini, A.</author><author>Di Venere, A.</author><author>Bellucci, S.</author><author>Dawson, M. I.</author><author>Rosato, N.</author><author>Bergamaschi, A.</author><author>Mustelin, T.</author></authors></contributors><auth-address>Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.</auth-address><titles><title>Synthesis and characterization of supramolecular nanostructures of carbon nanotubes and ruthenium-complex Luminophores</title><secondary-title>J Nanosci Nanotechnol</secondary-title><alt-title>Journal of nanoscience and nanotechnology</alt-title></titles><periodical><full-title>J Nanosci Nanotechnol</full-title></periodical><alt-periodical><full-title>J Nanosci Nanotechnol</full-title><abbr-1>Journal of nanoscience and nanotechnology</abbr-1></alt-periodical><pages>1381-6</pages><volume>6</volume><number>5</number><edition>2006/05</edition><keywords><keyword>Biosensing Techniques/instrumentation/*methods</keyword><keyword>Crystallization/*methods</keyword><keyword>Electric Power Supplies</keyword><keyword>Light</keyword><keyword>Luminescence</keyword><keyword>Luminescent Measurements/instrumentation/*methods</keyword><keyword>Macromolecular Substances/chemistry</keyword><keyword>Molecular Conformation</keyword><keyword>Nanotechnology/instrumentation/*methods</keyword><keyword>Nanotubes, Carbon/*chemistry/radiation effects/*ultrastructure</keyword><keyword>Particle Size</keyword><keyword>Ruthenium/*chemistry/radiation effects</keyword><keyword>Surface Properties</keyword><keyword>Transducers</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1533-4880 (Print)</isbn><accession-num>16792368</accession-num><abstract>We constructed and characterized supramolecular nanostructures consisting of ruthenium-complex luminophores, which were directly grafted onto short oxidized single-walled carbon nanotubes or physically entrapped in silica nanobeads, which had been covalently linked to short oxidized single-walled carbon nanotubes or hydrophobically adsorbed onto full-length multi-walled carbon nanotubes. These structures were evaluated as potential electron-acceptor complexes for use in the fabrication of photovoltaic devices, and for their properties as fluorescent nanocomposites for use in biosensors or nanoelectronics.</abstract><notes>U54 ca119335/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16792368 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>2.100</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1060</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1060</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Amoh, Y.</author><author>Nagakura, C.</author><author>Maitra, A.</author><author>Moossa, A. R.</author><author>Katsuoka, K.</author><author>Hoffman, R. M.</author><author>Bouvet, M.</author></authors></contributors><auth-address>AntiCancer, Inc., 7917 Ostrow Street, San Diego, California, USA.</auth-address><titles><title>Dual-color imaging of nascent angiogenesis and its inhibition in liver metastases of pancreatic cancer</title><secondary-title>Anticancer Res</secondary-title><alt-title>Anticancer research</alt-title></titles><periodical><full-title>Anticancer Res</full-title></periodical><alt-periodical><full-title>Anticancer Res</full-title><abbr-1>Anticancer research</abbr-1></alt-periodical><pages>3237-42</pages><volume>26</volume><number>5A</number><edition>2006/05</edition><keywords><keyword>Animals</keyword><keyword>Antimetabolites, Antineoplastic/therapeutic use</keyword><keyword>Deoxycytidine/analogs &amp; derivatives/therapeutic use</keyword><keyword>Green Fluorescent Proteins/genetics/*metabolism</keyword><keyword>Humans</keyword><keyword>Intermediate Filament Proteins/genetics/metabolism</keyword><keyword>Liver Neoplasms/blood supply/drug therapy/*pathology/secondary</keyword><keyword>Luminescent Proteins/genetics/*metabolism</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Nude</keyword><keyword>Mice, Transgenic</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Neovascularization, Pathologic/metabolism/*pathology/prevention &amp; control</keyword><keyword>Nerve Tissue Proteins/genetics/metabolism</keyword><keyword>Pancreatic Neoplasms/blood supply/drug therapy/*pathology</keyword><keyword>Transfection</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2006</year><pub-dates><date>Sep-Oct</date></pub-dates></dates><isbn>0250-7005 (Print)</isbn><accession-num>17094435</accession-num><abstract>As previously shown, the stem cell marker nestin is expressed in nascent blood vessels in transgenic nestin-driven green fluorescent protein (ND-GFP) nude mice. This mouse model was recently utilized to evaluate angiogenesis in primary tumors in an orthotopic model of pancreatic cancer. In the present study, nascent angiogenesis of pancreatic cancer liver metastasis in the ND-GFP transgenic nude mice after splenic injection of low-passage xPA-1 human pancreatic cancer cells expressing red fluorescent protein (RFP) was visualized by dual-color fluorescence imaging. ND-GFP was highly expressed in proliferating endothelial cells and nascent blood vessels in the growing liver metastasis. Immunohistochemical staining showed that CD31 co-localized in ND-GFP-expressing nascent blood vessels. The density of nascent blood vessels in the tumor was readily quantitated. Gemcitabine significantly decreased the mean nascent blood vessel density in the pancreatic liver metastases. In conclusion, the dual-color model of the ND-GFP nude mouse with RFP-expressing pancreatic cancer liver metastases, enabled the simultaneous visualization and quantitation of nascent angiogenesis and its response to angiogenesis inhibitors. This model will be useful for understanding the mechanism of angiogenesis of pancreatic cancer liver metastasis and for the discovery of effective new inhibitors of this process.</abstract><notes>Ca099258/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Greece</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=17094435 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2007</custom3><custom4>2.316</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1059</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1059</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Amoh, Y.</author><author>Li, L.</author><author>Tsuji, K.</author><author>Moossa, A. R.</author><author>Katsuoka, K.</author><author>Hoffman, R. M.</author><author>Bouvet, M.</author></authors></contributors><auth-address>Department of Surgery, University of California San Diego, San Diego, California, USA.</auth-address><titles><title>Dual-color imaging of nascent blood vessels vascularizing pancreatic cancer in an orthotopic model demonstrates antiangiogenesis efficacy of gemcitabine</title><secondary-title>J Surg Res</secondary-title><alt-title>The Journal of surgical research</alt-title></titles><periodical><full-title>J Surg Res</full-title></periodical><alt-periodical><full-title>J Surg Res</full-title><abbr-1>The Journal of surgical research</abbr-1></alt-periodical><pages>164-9</pages><volume>132</volume><number>2</number><edition>2006/05</edition><keywords><keyword>Angiogenesis Inhibitors/*therapeutic use</keyword><keyword>Animals</keyword><keyword>Antigens, CD31/analysis</keyword><keyword>Antimetabolites, Antineoplastic/therapeutic use</keyword><keyword>Deoxycytidine/*analogs &amp; derivatives/therapeutic use</keyword><keyword>Endothelium, Vascular/chemistry</keyword><keyword>Green Fluorescent Proteins/genetics</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Intermediate Filament Proteins/analysis/genetics</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Mice, Transgenic</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Neovascularization, Pathologic/*drug therapy</keyword><keyword>Nerve Tissue Proteins/analysis/genetics</keyword><keyword>Pancreatic Neoplasms/*blood supply/drug therapy</keyword><keyword>Transfection</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2006</year><pub-dates><date>May 15</date></pub-dates></dates><isbn>0022-4804 (Print)</isbn><accession-num>16500746</accession-num><abstract>BACKGROUND: The stem cell marker nestin recently has been shown to be expressed in nascent blood vessels in nestin-driven green fluorescent protein (ND-GFP) transgenic nude mice. MATERIALS AND METHODS: In the present study, we visualized by dual-color fluorescence imaging tumor angiogenesis in the ND-GFP transgenic nude mice after orthotopic transplantation of the MIA PaCa-2 human pancreatic cancer line expressing red fluorescent protein. Mice were treated with gemcitabine at 150 mg/kg/dose on days 3, 6, 10, and 13 after tumor implantation. At day 14, mice were sacrificed and mean nascent blood vessel density and tumor volume were calculated and compared to control mice. RESULTS: Nestin was highly expressed in proliferating endothelial cells and nascent blood vessels in the growing tumor. Results of immunohistochemical staining showed that CD31 co-localized in ND-GFP-expressing nascent blood vessels. The density of nascent blood vessels in the tumor was readily quantitated. Gemcitabine significantly decreased the mean nascent blood vessel density in the tumor as well as decreased tumor volume. CONCLUSION: The dual-color model of the ND-GFP nude mouse orthotopically implanted with RFP-expressing pancreatic tumor cells enabled the simultaneous visualization and quantitation of tumor angiogenesis and tumor volume. These results demonstrated for the first time that gemcitabine is an inhibitor of angiogenesis as well as tumor growth in pancreatic cancer. The results have important implications for the clinical application of gemcitabine in this disease.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16500746 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>1.977</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1743</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1743</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Xu, C.</author><author>Xing, B.</author><author>Rao, J.</author></authors></contributors><auth-address>Biophysics, Cancer Biology, and Molecular Imaging Programs, Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA.</auth-address><titles><title>A self-assembled quantum dot probe for detecting beta-lactamase activity</title><secondary-title>Biochem Biophys Res Commun</secondary-title></titles><periodical><full-title>Biochem Biophys Res Commun</full-title></periodical><pages>931-5</pages><volume>344</volume><number>3</number><edition>2006/04/25</edition><keywords><keyword>Fluorescence Resonance Energy Transfer/*methods</keyword><keyword>*Fluorescent Dyes</keyword><keyword>*Molecular Probe Techniques</keyword><keyword>*Quantum Dots</keyword><keyword>Staining and Labeling/methods</keyword><keyword>beta-Lactamases/*analysis</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun 9</date></pub-dates></dates><isbn>0006-291X (Print)</isbn><accession-num>16631595</accession-num><abstract>This communication describes a quantum dot probe that can be activated by a reporter enzyme, beta-lactamase. Our design is based on the principle of fluorescence resonance energy transfer (FRET). A biotinylated beta-lactamase substrate was labeled with a carbocyanine dye, Cy5, and immobilized on the surface of quantum dots through the binding of biotin to streptavidin pre-coated on the quantum dots. In assembling this nanoprobe, we have found that both the distance between substrates and the quantum dot surface, and the density of substrates are important for its function. The fluorescence emission from quantum dots can be efficiently quenched (up to 95%) by Cy5 due to FRET. Our final quantum dot probe, assembled with QD605 and 1:1 mixture of biotin and a Cy5-labeled lactam, can be activated by 32microg/mL of beta-lactamase with 4-fold increase in the fluorescence emission.</abstract><notes>Xu, Chenjie&#xD;Xing, Bengang&#xD;Rao, Jianghong&#xD;R21 eb 003803/eb/nibib&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Biochemical and biophysical research communications&#xD;Biochem Biophys Res Commun. 2006 Jun 9;344(3):931-5. Epub 2006 Apr 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16631595</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>2.823</custom4><electronic-resource-num>S0006-291X(06)00792-3 [pii]&#xD;10.1016/j.bbrc.2006.03.225</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1646</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1646</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tannous, B. A.</author><author>Grimm, J.</author><author>Perry, K. F.</author><author>Chen, J. W.</author><author>Weissleder, R.</author><author>Breakefield, X. O.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital-East, Building 149, 13th Street, Charlestown, Massachusetts 02129, USA.</auth-address><titles><title>Metabolic biotinylation of cell surface receptors for in vivo imaging</title><secondary-title>Nat Methods</secondary-title></titles><periodical><full-title>Nat Methods</full-title></periodical><pages>391-6</pages><volume>3</volume><number>5</number><edition>2006/04/22</edition><keywords><keyword>Base Sequence</keyword><keyword>Biosensing Techniques/*methods</keyword><keyword>Biotin/*metabolism</keyword><keyword>*Biotinylation</keyword><keyword>Cell Membrane/metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Genes, Reporter</keyword><keyword>Green Fluorescent Proteins/analysis</keyword><keyword>Humans</keyword><keyword>Magnetic Resonance Imaging/methods</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Peptides/chemistry</keyword><keyword>Receptors, Cell Surface/chemistry/*metabolism</keyword><keyword>Streptavidin/chemistry</keyword><keyword>Transduction, Genetic</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1548-7091 (Print)</isbn><accession-num>16628210</accession-num><abstract>We have developed a versatile, potent technique for imaging cells in culture and in vivo by expressing a metabolically biotinylated cell-surface receptor and visualizing it with labeled streptavidin moieties. The recombinant reporter protein, which incorporates a biotin acceptor peptide (BAP) between an N-terminal signal sequence and a transmembrane domain, (BAP-TM) was efficiently biotinylated by endogenous biotin ligase in mammalian cells with the biotin displayed on the cell surface. Tumors expressing the BAP-TM have high sensitivity for magnetic resonance and fluorescence tomographic imaging in vivo after intravascular injection of streptavidin conjugated to magnetic nanoparticles or fluorochromes, respectively. Moreover, streptavidin-horseradish peroxidase conjugates in conjunction with a peroxidase-sensitive gadolinium agent further increased and prolonged the magnetic resonance signal. This BAP-TM allows noninvasive real-time imaging of any cell type transduced to express this reporter protein in culture or in vivo.</abstract><notes>Tannous, Bakhos A&#xD;Grimm, Jan&#xD;Perry, Katherine F&#xD;Chen, John W&#xD;Weissleder, Ralph&#xD;Breakefield, Xandra O&#xD;Ca69246/ca/nci&#xD;Ca86355/ca/nci&#xD;Ca92782/ca/nci&#xD;R01 hl078641/hl/nhlbi&#xD;U01 hl080731/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature methods&#xD;Nat Methods. 2006 May;3(5):391-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16628210</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>15.011</custom4><electronic-resource-num>nmeth875 [pii]&#xD;10.1038/nmeth875</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1355</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1355</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Krutzik, P. O.</author><author>Nolan, G. P.</author></authors></contributors><auth-address>Department of Microbiology and Immunology, Baxter Laboratory in Genetic Pharmacology, Stanford University, Stanford, California 94305, USA.</auth-address><titles><title>Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling</title><secondary-title>Nat Methods</secondary-title></titles><periodical><full-title>Nat Methods</full-title></periodical><pages>361-8</pages><volume>3</volume><number>5</number><edition>2006/04/22</edition><keywords><keyword>Animals</keyword><keyword>Antigens, CD11b/metabolism</keyword><keyword>B-Lymphocytes/cytology/metabolism</keyword><keyword>CD4-Positive T-Lymphocytes/cytology/metabolism</keyword><keyword>*Cell Physiology</keyword><keyword>Cytokines/metabolism</keyword><keyword>Drug Evaluation, Preclinical/*methods</keyword><keyword>Flow Cytometry/*methods</keyword><keyword>Fluorescent Dyes</keyword><keyword>Interferon Type II/metabolism</keyword><keyword>Kinetics</keyword><keyword>Mice</keyword><keyword>Receptors, Antigen, T-Cell/antagonists &amp; inhibitors/metabolism</keyword><keyword>Receptors, Cell Surface/antagonists &amp; inhibitors/*metabolism</keyword><keyword>Signal Transduction/*physiology</keyword><keyword>Spleen/cytology/pathology</keyword></keywords><dates><year>2006</year><pub-dates><date>May</date></pub-dates></dates><isbn>1548-7091 (Print)</isbn><accession-num>16628206</accession-num><abstract>Flow cytometry allows high-content, multiparameter analysis of single cells, making it a promising tool for drug discovery and profiling of intracellular signaling. To add high-throughput capacity to flow cytometry, we developed a cell-based multiplexing technique called fluorescent cell barcoding (FCB). In FCB, each sample is labeled with a different signature, or barcode, of fluorescence intensity and emission wavelengths, and mixed with other samples before antibody staining and analysis by flow cytometry. Using three FCB fluorophores, we were able to barcode and combine entire 96-well plates, reducing antibody consumption 100-fold and acquisition time to 5-15 min per plate. Using FCB and phospho-specific flow cytometry, we screened a small-molecule library for inhibitors of T cell-receptor and cytokine signaling, simultaneously determining compound efficacy and selectivity. We also analyzed IFN-gamma signaling in multiple cell types from primary mouse splenocytes, revealing differences in sensitivity and kinetics between B cells, CD4+ and CD4- T cells and CD11b-hi cells.</abstract><notes>Krutzik, Peter O&#xD;Nolan, Garry P&#xD;Ai35304/ai/niaid&#xD;N01-hv-28183/hv/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature methods&#xD;Nat Methods. 2006 May;3(5):361-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16628206</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>15.011</custom4><electronic-resource-num>nmeth872 [pii]&#xD;10.1038/nmeth872</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1508</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1508</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Perez, O. D.</author><author>Nolan, G. P.</author></authors></contributors><auth-address>The Baxter Laboratory for Genetic Pharmacology, Department of Microbiology and Immunology, Stanford University, School of Medicine, Stanford, CA 94305, USA. operez@stanford.edu</auth-address><titles><title>Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level</title><secondary-title>Immunol Rev</secondary-title></titles><periodical><full-title>Immunol Rev</full-title></periodical><pages>208-28</pages><volume>210</volume><edition>2006/04/21</edition><keywords><keyword>*Diagnostic Techniques and Procedures</keyword><keyword>Epitopes/*analysis/immunology</keyword><keyword>*Flow Cytometry</keyword><keyword>Humans</keyword><keyword>Medicine</keyword><keyword>Phosphoproteins/*analysis/immunology</keyword><keyword>Proteomics/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0105-2896 (Print)</isbn><accession-num>16623773</accession-num><abstract>Understanding a molecular basis for cellular function is a common goal of biomedicine. The complex and dynamic cellular processes underlying physiological processes become subtly or grossly perturbed in human disease. A primary objective is to demystify this complexity by creating and establishing relevant model systems to study important aspects of human disease. Although significant technological advancements over the last decade in both genomic and proteomic arenas have enabled progress, accessing the complexity of cellular interactions that occur in vivo has been a difficult arena in which to make progress. Moreover, there are extensive challenges in translating research tools to clinical applications. Flow cytometry, over the course of the last 40 years, has revolutionized the field of immunology, in both the basic science and clinical settings, as well as having been instrumental to new and exciting areas of discovery such as stem cell biology. Multiparameter machinery and systems exist now to access the heterogeneity of cellular subsets and enable phenotypic characterization and functional assays to be performed on material from both animal models and humans. This review focuses primarily on the development and application of using activation-state readouts of intracellular activity for phospho-epitopes. We present recent work on how a flow cytometric platform is used to obtain mechanistic insight into cellular processes as well as highlight the clinical applications that our laboratory has explored. Furthermore, this review discusses the challenges faced with processing high-content multidimensional and multivariate data sets. Flow cytometry, as a platform that is well situated in both the research and clinical settings, can contribute to drug discovery as well as having utility for both biomarker and patient-stratification.</abstract><notes>Perez, Omar D&#xD;Nolan, Garry P&#xD;A1/GF41520-01/GF/United States NIH&#xD;AI35304/AI/United States NIAID&#xD;AR44565/AR/United States NIAMS&#xD;N01-AR-6-2227/AR/United States NIAMS&#xD;N01-HV-28183I/HV/United States NHLBI&#xD;P01-AI39646/AI/United States NIAID&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Review&#xD;Denmark&#xD;Immunological reviews&#xD;Immunol Rev. 2006 Apr;210:208-28.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16623773</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>10.536</custom4><electronic-resource-num>IMR364 [pii]&#xD;10.1111/j.0105-2896.2006.00364.x</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1712</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1712</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, Z. L.</author><author>Song, J.</author></authors></contributors><auth-address>School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA. zhong.wang@mse.gatech.edu</auth-address><titles><title>Piezoelectric nanogenerators based on zinc oxide nanowire arrays</title><secondary-title>Science</secondary-title></titles><periodical><full-title>Science</full-title></periodical><pages>242-6</pages><volume>312</volume><number>5771</number><edition>2006/04/15</edition><dates><year>2006</year><pub-dates><date>Apr 14</date></pub-dates></dates><isbn>1095-9203 (Electronic)</isbn><accession-num>16614215</accession-num><abstract>We have converted nanoscale mechanical energy into electrical energy by means of piezoelectric zinc oxide nanowire (NW) arrays. The aligned NWs are deflected with a conductive atomic force microscope tip in contact mode. The coupling of piezoelectric and semiconducting properties in zinc oxide creates a strain field and charge separation across the NW as a result of its bending. The rectifying characteristic of the Schottky barrier formed between the metal tip and the NW leads to electrical current generation. The efficiency of the NW-based piezoelectric power generator is estimated to be 17 to 30%. This approach has the potential of converting mechanical, vibrational, and/or hydraulic energy into electricity for powering nanodevices.</abstract><notes>Wang, Zhong Lin&#xD;Song, Jinhui&#xD;United States&#xD;Science (New York, N.Y.)&#xD;Science. 2006 Apr 14;312(5771):242-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16614215</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>30.268</custom4><electronic-resource-num>312/5771/242 [pii]&#xD;10.1126/science.1124005</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1238</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1238</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Han, M. S.</author><author>Lytton-Jean, A. K.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208-3113, USA.</auth-address><titles><title>A gold nanoparticle based approach for screening triplex DNA binders</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>4954-5</pages><volume>128</volume><number>15</number><edition>2006/04/13</edition><dates><year>2006</year><pub-dates><date>Apr 19</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16608320</accession-num><notes>Han, Min Su&#xD;Lytton-Jean, Abigail K R&#xD;Mirkin, Chad A&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Apr 19;128(15):4954-5.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16608320</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja0606475</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1116</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1116</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cai, W.</author><author>Shin, D. W.</author><author>Chen, K.</author><author>Gheysens, O.</author><author>Cao, Q.</author><author>Wang, S. X.</author><author>Gambhir, S. S.</author><author>Chen, X.</author></authors></contributors><auth-address>Molecular Imaging Program (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, California 94305, USA.</auth-address><titles><title>Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects</title><secondary-title>Nano Lett</secondary-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><pages>669-76</pages><volume>6</volume><number>4</number><edition>2006/04/13</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Coated Materials, Biocompatible/analysis/chemical synthesis</keyword><keyword>Glioblastoma/*blood supply/metabolism/*pathology</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microscopy, Fluorescence/*methods</keyword><keyword>Neovascularization, Pathologic/metabolism/*pathology</keyword><keyword>Oligopeptides/chemistry/*diagnostic use/pharmacokinetics</keyword><keyword>Particle Size</keyword><keyword>*Quantum Dots</keyword><keyword>Spectrophotometry, Infrared/*methods</keyword><keyword>Whole Body Imaging/methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>16608262</accession-num><abstract>We report the in vivo targeting and imaging of tumor vasculature using arginine-glycine-aspartic acid (RGD) peptide-labeled quantum dots (QDs). Athymic nude mice bearing subcutaneous U87MG human glioblastoma tumors were administered QD705-RGD intravenously. The tumor fluorescence intensity reached maximum at 6 h postinjection with good contrast. The results reported here open up new perspectives for integrin-targeted near-infrared optical imaging and may aid in cancer detection and management including imaging-guided surgery.</abstract><notes>Cai, Weibo&#xD;Shin, Dong-Woon&#xD;Chen, Kai&#xD;Gheysens, Olivier&#xD;Cao, Qizhen&#xD;Wang, Shan X&#xD;Gambhir, Sanjiv S&#xD;Chen, Xiaoyuan&#xD;1u54ca119367-01/ca/nci&#xD;P50 ca114747/ca/nci&#xD;R21 ca102123/ca/nci&#xD;R21 eb001785/eb/nibib&#xD;R24 ca93862/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Nano letters&#xD;Nano Lett. 2006 Apr;6(4):669-76.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16608262</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>12.189</custom4><electronic-resource-num>10.1021/nl052405t</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1497</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1497</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pau, S.</author><author>Pai, C. S.</author><author>Low, Y. L.</author><author>Moxom, J.</author><author>Reilly, P. T.</author><author>Whitten, W. B.</author><author>Ramsey, J. M.</author></authors></contributors><auth-address>The University of Arizona, Tucson, Arizona 85721, USA.</auth-address><titles><title>Microfabricated quadrupole ion trap for mass spectrometer applications</title><secondary-title>Phys Rev Lett</secondary-title></titles><periodical><full-title>Phys Rev Lett</full-title></periodical><pages>120801</pages><volume>96</volume><number>12</number><edition>2006/04/12</edition><dates><year>2006</year><pub-dates><date>Mar 31</date></pub-dates></dates><isbn>0031-9007 (Print)</isbn><accession-num>16605890</accession-num><abstract>An array of miniaturized cylindrical quadrupole ion traps, with a radius of 20 microm, is fabricated using silicon micromachining using phosphorus doped polysilicon and silicon dioxide for the purpose of creating a mass spectrometer on a chip. We have operated the array for mass-selective ion ejection and mass analysis using Xe ions at a pressure of 10(-4). The scaling rules for the ion trap in relation to operating pressure, voltage, and frequency are examined.</abstract><notes>Pau, S&#xD;Pai, C S&#xD;Low, Y L&#xD;Moxom, J&#xD;Reilly, P T A&#xD;Whitten, W B&#xD;Ramsey, J M&#xD;United States&#xD;Physical review letters&#xD;Phys Rev Lett. 2006 Mar 31;96(12):120801. Epub 2006 Mar 31.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16605890</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>7.134</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1751</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1751</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yamauchi, K.</author><author>Yang, M.</author><author>Jiang, P.</author><author>Xu, M.</author><author>Yamamoto, N.</author><author>Tsuchiya, H.</author><author>Tomita, K.</author><author>Moossa, A. R.</author><author>Bouvet, M.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., San Diego, California 92111, USA.</auth-address><titles><title>Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><alt-periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></alt-periodical><pages>4208-14</pages><volume>66</volume><number>8</number><edition>2006/04</edition><keywords><keyword>Animals</keyword><keyword>Carcinoma, Lewis Lung/blood supply/metabolism/pathology</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Nucleus/metabolism</keyword><keyword>Cytoplasm/metabolism</keyword><keyword>Diagnostic Imaging/instrumentation/*methods</keyword><keyword>Fibrosarcoma/blood supply/metabolism/pathology</keyword><keyword>Green Fluorescent Proteins/analysis</keyword><keyword>Humans</keyword><keyword>Luminescent Proteins/analysis</keyword><keyword>Mammary Neoplasms, Experimental/blood supply/metabolism/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Circulating Cells/metabolism/*pathology</keyword><keyword>Neoplasms, Experimental/blood supply/metabolism/*pathology</keyword><keyword>Subcellular Fractions/chemistry/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16618743</accession-num><abstract>With the use of dual-color fluorescent cells and a highly sensitive whole-mouse imaging system with both macro-optics and micro-optics, we report here the development of subcellular real-time imaging of cancer cell trafficking in live mice. To observe cytoplasmic and nuclear dynamics in the living mouse, tumor cells were labeled in the nucleus with green fluorescent protein and with red fluorescent protein in the cytoplasm. Dual-color cancer cells were injected by a vascular route in an abdominal skin flap in nude mice. The mice were imaged with an Olympus OV100 whole-mouse imaging system with a sensitive CCD camera and five objective lenses, parcentered and parfocal, enabling imaging from macrocellular to subcellular. We observed the nuclear and cytoplasmic behavior of cancer cells in real time in blood vessels as they moved by various means or adhered to the vessel surface in the abdominal skin flap. During extravasation, real-time dual-color imaging showed that cytoplasmic processes of the cancer cells exited the vessels first, with nuclei following along the cytoplasmic projections. Both cytoplasm and nuclei underwent deformation during extravasation. Different cancer cell lines seemed to strongly vary in their ability to extravasate. With the dual-color cancer cells and the highly sensitive whole-mouse imaging system described here, the subcellular dynamics of cancer metastasis can now be observed in live mice in real time. This imaging technology will enable further understanding of the critical steps of metastasis and provide visible targets for antimetastasis drug development.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16618743 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>7.980</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1726</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1726</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wieland, K. A.</author><author>Wang, Y.</author><author>Solin, S. A.</author><author>Girgis, A. M.</author><author>Ram-Mohan, L. R.</author></authors></contributors><auth-address>Wieland, KA&#xD;Washington Univ, Dept Phys, CB 1105,1 Brookings Dr, St Louis, MO 63130 USA&#xD;Washington Univ, Dept Phys, St Louis, MO 63130 USA&#xD;Washington Univ, Ctr Mat Innovat, St Louis, MO 63130 USA&#xD;Worcester Polytech Inst, Dept Phys, Worcester, MA 01609 USA</auth-address><titles><title>Experimental measurement and finite-element modeling of extraordinary optoconductance in GaAs-In metal-semiconductor hybrid structures</title><secondary-title>Physical Review B</secondary-title></titles><periodical><full-title>Physical Review B</full-title></periodical><pages>-</pages><volume>73</volume><number>15</number><edition>2006/04</edition><keywords><keyword>read-head sensors</keyword><keyword>gap semiconductors</keyword><keyword>magnetoresistance</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1098-0121</isbn><accession-num>ISI:000237155100055</accession-num><abstract>We present a detailed discussion of extraordinary optoconductance (EOC). (Here optoconductance is synonymous with photoconductance.) Experimental data were acquired via macroscopic metal-semiconductor hybrid structures composed of GaAs and In and subjected to illumination from an Ar ion laser. A drift diffusion model using the finite element method (FEM) provided a reasonable fit to the data. EOC is explored as a function of laser position, bias current, laser power density, and temperature. The positional dependence of the voltage is accounted for by the Dember effect, with the model incorporating the excess hole distribution based on the carrier mobility, and thus the mean free path. The bias current is found to produce a linear voltage offset and does not influence the EOC. A linear relationship is found between the laser power density and the voltage in the bare and hybrid devices. This dependence is reproduced in the model by a generation rate parameter which is related to the power density. Incorporating the mobility and diffusion temperature dependence, the model directly parallels the temperature dependence of the EOC without the use of fitting parameters.</abstract><notes>037OA&#xD;Times Cited:1&#xD;Cited References Count:27</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000237155100055</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>3.284</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1392</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1392</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Li, G. X.</author><author>Sun, S. H.</author><author>Wang, S. X.</author></authors></contributors><auth-address>Li, Gx&#xD;Stanford Univ, Dept Mat Sci &amp; Engn, Stanford, CA 94305 USA&#xD;Stanford Univ, Dept Mat Sci &amp; Engn, Stanford, CA 94305 USA&#xD;Western Digital Corp, Fremont, CA 94539 USA&#xD;Brown Univ, Dept Chem, Providence, RI 02912 USA</auth-address><titles><title>Spin valve biosensors: Signal dependence on nanoparticle position</title><secondary-title>Journal of Applied Physics</secondary-title></titles><periodical><full-title>Journal of Applied Physics</full-title></periodical><pages>-</pages><volume>99</volume><number>8</number><edition>2006/04</edition><keywords><keyword>magnetic nanoparticles</keyword><keyword>biological applications</keyword><keyword>sensitive diagnostics</keyword><keyword>sensors</keyword><keyword>biochips</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>0021-8979</isbn><accession-num>ISI:000237404200633</accession-num><abstract>Experimental and theoretical studies have been carried out on the spin valve sensor signal dependence on the spatial locations of magnetic nanoparticles as potential biomolecular labels in the magnetic biodetection technology. Superparamagnetic 16 nm magnetite (Fe3O4) nanoparticles were site specifically deposited at different positions relative to a submicron-wide spin valve sensor. The spin valve sensor signal showed both polarity and magnitude differences with the particles at different positions. A theoretical model including magnetic sensor-particle interaction confirms the experimental results and provides a design guide to the sensing area. Moreover, the theoretical calculations reveal a nonmonotonic signal dependence on the vertical particle-to-sensor distance due to the sensor-particle interaction, and show that an optimum distance exists for signal strength and quantification. (C) 2006 American Institute of Physics.</abstract><notes>040TV&#xD;Times Cited:2&#xD;Cited References Count:11</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000237404200633</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>2.479</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1199</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1199</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Farokhzad, O. C.</author><author>Cheng, J.</author><author>Teply, B. A.</author><author>Sherifi, I.</author><author>Jon, S.</author><author>Kantoff, P. W.</author><author>Richie, J. P.</author><author>Langer, R.</author></authors></contributors><auth-address>Department of Anesthesiology, Brigham and Women&apos;s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.</auth-address><titles><title>Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title><alt-title>Proceedings of the National Academy of Sciences of the United States of America</alt-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><alt-periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></alt-periodical><pages>6315-20</pages><volume>103</volume><number>16</number><edition>2006/04</edition><keywords><keyword>Animals</keyword><keyword>Antineoplastic Agents, Phytogenic/*administration &amp; dosage/therapeutic use</keyword><keyword>Aptamers, Nucleotide/*administration &amp; dosage/chemistry/therapeutic use</keyword><keyword>Capsules</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Polyglactin 910/chemistry</keyword><keyword>Prostatic Neoplasms/*drug therapy/pathology</keyword><keyword>Taxoids/*administration &amp; dosage/therapeutic use</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr 18</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16606824</accession-num><abstract>Targeted uptake of therapeutic nanoparticles in a cell-, tissue-, or disease-specific manner represents a potentially powerful technology. Using prostate cancer as a model, we report docetaxel (Dtxl)-encapsulated nanoparticles formulated with biocompatible and biodegradable poly(D,L-lactic-co-glycolic acid)-block-poly(ethylene glycol) (PLGA-b-PEG) copolymer and surface functionalized with the A10 2&apos;-fluoropyrimidine RNA aptamers that recognize the extracellular domain of the prostate-specific membrane antigen (PSMA), a well characterized antigen expressed on the surface of prostate cancer cells. These Dtxl-encapsulated nanoparticle-aptamer bioconjugates (Dtxl-NP-Apt) bind to the PSMA protein expressed on the surface of LNCaP prostate epithelial cells and get taken up by these cells resulting in significantly enhanced in vitro cellular toxicity as compared with nontargeted nanoparticles that lack the PSMA aptamer (Dtxl-NP) (P &lt; 0.0004). The Dtxl-NP-Apt bioconjugates also exhibit remarkable efficacy and reduced toxicity as measured by mean body weight loss (BWL) in vivo [body weight loss of 7.7 +/- 4% vs. 18 +/- 5% for Dtxl-NP-Apt vs. Dtxl-NP at nadir, respectively (mean +/- SD); n = 7]. After a single intratumoral injection of Dtxl-NP-Apt bioconjugates, complete tumor reduction was observed in five of seven LNCaP xenograft nude mice (initial tumor volume of approximately 300 mm3), and 100% of these animals survived our 109-day study. In contrast, two of seven mice in the Dtxl-NP group had complete tumor reduction with 109-day survivability of only 57%. Dtxl alone had a survivability of only 14%. Saline and nanoparticles without drug were similarly nonefficacious. This report demonstrates the potential utility of nanoparticle-aptamer bioconjugates for a therapeutic application.</abstract><notes>Ca 119349/ca/nci&#xD;Eb003647/eb/nibib&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16606824 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>10.228</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1696</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1696</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, L.</author><author>Zhao, G.</author><author>Olivares-Navarrete, R.</author><author>Bell, B. F.</author><author>Wieland, M.</author><author>Cochran, D. L.</author><author>Schwartz, Z.</author><author>Boyan, B. D.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, 315 Ferst Drive NW, Georgia 30332, USA.</auth-address><titles><title>Integrin beta1 silencing in osteoblasts alters substrate-dependent responses to 1,25-dihydroxy vitamin D3</title><secondary-title>Biomaterials</secondary-title></titles><periodical><full-title>Biomaterials</full-title></periodical><pages>3716-25</pages><volume>27</volume><number>20</number><edition>2006/03/30</edition><keywords><keyword>Animals</keyword><keyword>Antibodies/metabolism</keyword><keyword>Antigens, CD29/genetics/*metabolism</keyword><keyword>Bone Density Conservation Agents/*metabolism</keyword><keyword>Calcitriol/*metabolism</keyword><keyword>Cell Culture Techniques</keyword><keyword>Cell Line</keyword><keyword>Dinoprostone/genetics/metabolism</keyword><keyword>*Gene Silencing</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Osteoblasts/cytology/*physiology</keyword><keyword>Osteoprotegerin/genetics/metabolism</keyword><keyword>RNA, Small Interfering/metabolism</keyword><keyword>Surface Properties</keyword><keyword>Titanium/metabolism</keyword><keyword>Transforming Growth Factor beta1/genetics/metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Jul</date></pub-dates></dates><isbn>0142-9612 (Print)</isbn><accession-num>16569430</accession-num><abstract>Surface microroughness increases osteoblast differentiation and enhances responses of osteoblasts to 1,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3]. The observations that beta1 integrin expression is increased in osteoblasts grown on Ti substrates with rough microarchitecture, and that it is regulated by 1alpha,25(OH)2D3 in a surface-dependent manner, suggest that beta1 may play a role in mediating osteoblast response. To test this hypothesis, we silenced beta1 expression in MG63 human osteoblast-like cells using small interfering RNA (siRNA) and examined the responses of the beta1-silenced osteoblasts to surface microtopography and 1alpha,25(OH)2D3. To better understand the role of beta1, MG63 cells were also treated with two different monoclonal antibodies to human beta1 to block ligand binding. beta1-silenced MG63 cells grown on a tissue culture plastic had reduced alkaline phosphatase activity and levels of osteocalcin, transforming growth factor beta1, prostaglandin E2, and osteoprotegerin in comparison with control cells. Moreover, beta1-silencing inhibited the effects of surface roughness on these parameters and partially inhibited effects of 1alpha,25(OH)2D3. Anti beta1 antibody AIIB2 had no significant effect on cell number and osteocalcin, but decreased alkaline phosphatase; MAB2253Z caused dose-dependent decreases in cell number and alkaline phosphatase and an increase in osteocalcin. Effects of 1alpha,25(OH)2D3 on cell number and alkaline phosphatase were reduced and effects on osteocalcin were increased. These findings indicate that beta1 plays a major and complex role in osteoblastic differentiation modulated by either surface microarchitecture or 1alpha,25(OH)2D3. The results also show that beta1 mediates, in part, the synergistic effects of surface roughness and 1alpha,25(OH)2D3.</abstract><notes>Wang, Liping&#xD;Zhao, Ge&#xD;Olivares-Navarrete, Rene&#xD;Bell, Bryan F&#xD;Wieland, Marco&#xD;Cochran, David L&#xD;Schwartz, Zvi&#xD;Boyan, Barbara D&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Biomaterials&#xD;Biomaterials. 2006 Jul;27(20):3716-25. Epub 2006 Mar 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16569430</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>7.325</custom4><electronic-resource-num>S0142-9612(06)00158-X [pii]&#xD;10.1016/j.biomaterials.2006.02.022</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2363</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2363</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pacholski, C.</author><author>Yu, C.</author><author>Miskelly, G. M.</author><author>Godin, D.</author><author>Sailor, M. J.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, 92093-0358, USA.</auth-address><titles><title>Reflective interferometric fourier transform spectroscopy: a self-compensating label-free immunosensor using double-layers of porous SiO2</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>4250-2</pages><volume>128</volume><number>13</number><edition>2006/03/30</edition><keywords><keyword>Animals</keyword><keyword>Biosensing Techniques/ methods</keyword><keyword>Fourier Analysis</keyword><keyword>Immunoglobulin G/ chemistry</keyword><keyword>Interferometry/ methods</keyword><keyword>Rabbits</keyword><keyword>Silicon Dioxide/ chemistry</keyword><keyword>Staphylococcal Protein A/ analysis</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr 5</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16568999</accession-num><abstract>An interferometric biosensor comprised of two layers of porous Si, stacked one on top of the other, is described. A fast Fourier transform (FFT) of the reflectivity spectrum reveals three peaks that correspond to the optical thickness of the top layer, the bottom layer, and both layers together. Binding of immunoglobulin G to a protein A capture probe adsorbed to the surface of the top layer induces changes in reflectivity at the top layer/solution interface. The FFT method allows discrimination of target analyte binding from matrix effects due to nonspecific changes in the analyte solution. The sensor response is shown to be insensitive to the addition of 4000-fold excess sucrose or 80-fold excess bovine serum albumin interferents.</abstract><notes>Pacholski, Claudia&#xD;Yu, Christine&#xD;Miskelly, Gordon M&#xD;Godin, Denis&#xD;Sailor, Michael J&#xD;U54 CA 119335/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2006 Apr 5;128(13):4250-2.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom4>8.256</custom4><electronic-resource-num>10.1021/ja056702b [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1282</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1282</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hurst, S. J.</author><author>Payne, E. K.</author><author>Qin, L.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry and International Institute for Nanotechnology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113, USA.</auth-address><titles><title>Multisegmented one-dimensional nanorods prepared by hard-template synthetic methods</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>2672-92</pages><volume>45</volume><number>17</number><edition>2006/03/30</edition><keywords><keyword>Electrochemistry</keyword><keyword>Electrons</keyword><keyword>Metals/chemistry</keyword><keyword>Nanostructures/*chemistry/ultrastructure</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr 21</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>16570332</accession-num><abstract>In the science and engineering communities, the nanoscience revolution is intensifying. As many types of nanomaterials are becoming more reliably synthesized, they are being used for novel applications in all branches of nanoscience and nanotechnology. Since it is sometimes desirable for single nanomaterials to perform multiple functions simultaneously, multicomponent nanomaterials, such as core-shell, alloyed, and striped nanoparticles, are being more extensively researched. Nanoscientists hope to design multicomponent nanostructures and exploit their inherent multiple functionalities for use in many novel applications. This review highlights recent advances in the synthesis of multisegmented one-dimensional nanorods and nanowires with metal, semiconductor, polymer, molecular, and even gapped components. It also discusses the applications of these multicomponent nanomaterials in magnetism, self-assembly, electronics, biology, catalysis, and optics. Particular emphasis is placed on the new materials and devices achievable using these multicomponent, rather than single-component, nanowire structures.</abstract><notes>Hurst, Sarah J&#xD;Payne, Emma Kathryn&#xD;Qin, Lidong&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2006 Apr 21;45(17):2672-92.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16570332</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200504025</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1102</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1102</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bullitt, E.</author><author>Wolthusen, P. A.</author><author>Brubaker, L.</author><author>Lin, W.</author><author>Zeng, D.</author><author>Van Dyke, T.</author></authors></contributors><auth-address>Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Malignancy-associated vessel tortuosity: a computer-assisted, MR angiographic study of choroid plexus carcinoma in genetically engineered mice</title><secondary-title>AJNR Am J Neuroradiol</secondary-title></titles><periodical><full-title>AJNR Am J Neuroradiol</full-title></periodical><pages>612-9</pages><volume>27</volume><number>3</number><edition>2006/03/23</edition><keywords><keyword>Animals</keyword><keyword>Animals, Genetically Modified</keyword><keyword>Carcinoma/*blood supply/*diagnosis</keyword><keyword>Choroid Plexus Neoplasms/*blood supply/*diagnosis</keyword><keyword>*Diagnosis, Computer-Assisted</keyword><keyword>*Magnetic Resonance Angiography/methods</keyword><keyword>Mice/genetics</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0195-6108 (Print)</isbn><accession-num>16552004</accession-num><abstract>BACKGROUND AND PURPOSE: The ability to assess tumor malignancy and monitor treatment response noninvasively would be of value to both clinicians and animal investigators. This report describes the MR imaging characteristics of a genetically engineered mouse model of choroid plexus carcinoma (CPC) during tumor growth and progression to malignancy. We assess the ability of vessel tortuosity measurements, as calculated from high-resolution MR angiographic (MRA) images, to detect emerging CPC cancers. METHODS: MR images of 9 healthy mice and of 20 CPC mice with precancerous choroid dysplasia or with cancer over a wide range of sizes were analyzed. Two vessel tortuosity measures and a measure of vessel attenuation (vessel count) were calculated from MRA images. Malignancy assessment was based upon a statistical analysis of vessel tortuosity, by using an equation derived from an earlier study of human brain tumor patients. RESULTS: Choroid dysplasia was correctly judged nonmalignant. On the basis of vessel count, neoangiogenesis could not be detected until cancers were full-blown and had reached a volume of approximately 80 mm3. Vessel tortuosity measurements, however, correctly identified emerging malignancy in lesions larger than 0.3 mm3. CONCLUSION: To the best of our knowledge, this report provides the first description of in vivo, MR imaging characteristics of genetically engineered CPC mice during the progression from dysplasia to cancer. Vessel tortuosity measurements offer promise of correctly defining even tiny tumors as malignant.</abstract><notes>Bullitt, E&#xD;Wolthusen, P A&#xD;Brubaker, L&#xD;Lin, W&#xD;Zeng, D&#xD;Van Dyke, T&#xD;R01 eb000219/eb/nibib&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;AJNR. American journal of neuroradiology&#xD;AJNR Am J Neuroradiol. 2006 Mar;27(3):612-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16552004</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>2.279</custom4><electronic-resource-num>27/3/612 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1509</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1509</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pertz, O.</author><author>Hodgson, L.</author><author>Klemke, R. L.</author><author>Hahn, K. M.</author></authors></contributors><auth-address>University of North Carolina at Chapel Hill, Department of Pharmacology and Lineberger Cancer Center, Chapel Hill, North Carolina 27599, USA. khahn@med.unc.edu</auth-address><titles><title>Spatiotemporal dynamics of RhoA activity in migrating cells</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title></periodical><pages>1069-72</pages><volume>440</volume><number>7087</number><edition>2006/03/21</edition><keywords><keyword>3T3 Cells</keyword><keyword>Animals</keyword><keyword>Biosensing Techniques</keyword><keyword>*Cell Movement</keyword><keyword>Cell Surface Extensions/drug effects/*metabolism</keyword><keyword>Fibroblasts</keyword><keyword>Mice</keyword><keyword>Pinocytosis</keyword><keyword>Platelet-Derived Growth Factor/pharmacology</keyword><keyword>Time Factors</keyword><keyword>rac GTP-Binding Proteins/metabolism</keyword><keyword>rhoA GTP-Binding Protein/*metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr 20</date></pub-dates></dates><isbn>1476-4687 (Electronic)</isbn><accession-num>16547516</accession-num><abstract>Rho family GTPases regulate the actin and adhesion dynamics that control cell migration. Current models postulate that Rac promotes membrane protrusion at the leading edge and that RhoA regulates contractility in the cell body. However, there is evidence that RhoA also regulates membrane protrusion. Here we use a fluorescent biosensor, based on a novel design preserving reversible membrane interactions, to visualize the spatiotemporal dynamics of RhoA activity during cell migration. In randomly migrating cells, RhoA activity is concentrated in a sharp band directly at the edge of protrusions. It is observed sporadically in retracting tails, and is low in the cell body. RhoA activity is also associated with peripheral ruffles and pinocytic vesicles, but not with dorsal ruffles induced by platelet-derived growth factor (PDGF). In contrast to randomly migrating cells, PDGF-induced membrane protrusions have low RhoA activity, potentially because PDGF strongly activates Rac, which has previously been shown to antagonize RhoA activity. Our data therefore show that different extracellular cues induce distinct patterns of RhoA signalling during membrane protrusion.</abstract><notes>Pertz, Olivier&#xD;Hodgson, Louis&#xD;Klemke, Richard L&#xD;Hahn, Klaus M&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nature&#xD;Nature. 2006 Apr 20;440(7087):1069-72. Epub 2006 Mar 19.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16547516</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>31.210</custom4><electronic-resource-num>nature04665 [pii]&#xD;10.1038/nature04665</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1419</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1419</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lu, W.</author><author>Zhou, D.</author><author>Glusman, G.</author><author>Utleg, A. G.</author><author>White, J. T.</author><author>Nelson, P. S.</author><author>Vasicek, T. J.</author><author>Hood, L.</author><author>Lin, B.</author></authors></contributors><auth-address>Institute for Systems Biology, Seattle, Washington 98103, USA.</auth-address><titles><title>KLK31P is a novel androgen regulated and transcribed pseudogene of kallikreins that is expressed at lower levels in prostate cancer cells than in normal prostate cells</title><secondary-title>Prostate</secondary-title></titles><periodical><full-title>Prostate</full-title></periodical><pages>936-44</pages><volume>66</volume><number>9</number><edition>2006/03/17</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Androgens/*physiology</keyword><keyword>Blotting, Northern</keyword><keyword>Cell Line, Tumor</keyword><keyword>Chromosomes, Human, Pair 19/genetics</keyword><keyword>Cloning, Organism</keyword><keyword>DNA/analysis/genetics</keyword><keyword>DNA, Complementary/genetics</keyword><keyword>DNA, Neoplasm/analysis/genetics</keyword><keyword>Exons/genetics</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Humans</keyword><keyword>Kidney/chemistry</keyword><keyword>Male</keyword><keyword>Molecular Sequence Data</keyword><keyword>Multigene Family</keyword><keyword>Prostate/*chemistry/physiology</keyword><keyword>Prostatic Neoplasms/*chemistry/genetics/physiopathology</keyword><keyword>*Pseudogenes</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Tissue Kallikreins/*analysis/*genetics/physiology</keyword><keyword>Transcription, Genetic</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun 15</date></pub-dates></dates><isbn>0270-4137 (Print)</isbn><accession-num>16541416</accession-num><abstract>BACKGROUND: Fifteen human tissue kallikrein (KLK) genes have been identified as a cluster on chromosome 19. KLK expression is associated with various human diseases including cancers. Noncoding RNAs such as PCA3/DD3 and PCGEM1 have been identified in prostate cancer cells. METHODS: Using massively parallel signature sequencing (MPSS) technology, RT-PCR, and 5&apos; rapid amplification of cDNA ends (RACE), we identified and cloned a novel gene that maps to the KLK locus. RESULTS: We have characterized this gene, named as KLK31P by the HUGO Gene Nomenclature Committee, as an unprocessed KLK pseudogene. It contains five exons, two of which are KLK-derived while the rest are &quot;exonized&quot; interspersed repeats. KLK31P is expressed abundantly in prostate tissues and is androgen regulated. KLK31P is expressed at lower levels in localized and metastatic prostate cancer cells than in normal prostate cells. CONCLUSIONS: KLK31P is a novel androgen regulated and transcribed pseudogene of kallikreins that may play a role in prostate carcinogenesis or maintenance.</abstract><notes>Lu, Wei&#xD;Zhou, Daixing&#xD;Glusman, Gustavo&#xD;Utleg, Angelita G&#xD;White, James T&#xD;Nelson, Peter S&#xD;Vasicek, Thomas J&#xD;Hood, Leroy&#xD;Lin, Biaoyang&#xD;5p01ca085859-02/ca/nci&#xD;5p50ca097186-02/ca/nci&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;The Prostate&#xD;Prostate. 2006 Jun 15;66(9):936-44.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16541416</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>3.258</custom4><electronic-resource-num>10.1002/pros.20382</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1572</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1572</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Shazer, R. L.</author><author>Jain, A.</author><author>Galkin, A. V.</author><author>Cinman, N.</author><author>Nguyen, K. N.</author><author>Natale, R. B.</author><author>Gross, M.</author><author>Green, L.</author><author>Bender, L. I.</author><author>Holden, S.</author><author>Kaplan, L.</author><author>Agus, D. B.</author></authors></contributors><auth-address>Louis Warschaw Prostate Cancer Center, Cedars-Sinai Medical Center, 8631 West Third Street, Los Angeles, CA 90048, USA.</auth-address><titles><title>Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial</title><secondary-title>BJU Int</secondary-title></titles><periodical><full-title>BJU Int</full-title></periodical><pages>691-7</pages><volume>97</volume><number>4</number><edition>2006/03/16</edition><keywords><keyword>Aged</keyword><keyword>Aged, 80 and over</keyword><keyword>Animals</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Middle Aged</keyword><keyword>Pilot Projects</keyword><keyword>Prostate-Specific Antigen/blood</keyword><keyword>Prostatic Neoplasms/blood/*drug therapy/pathology</keyword><keyword>Raloxifene/*therapeutic use</keyword><keyword>Selective Estrogen Receptor Modulators/*therapeutic use</keyword><keyword>Treatment Outcome</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>1464-4096 (Print)</isbn><accession-num>16536755</accession-num><abstract>OBJECTIVES: To determine, in preclinical in vivo animal and in clinical studies, whether raloxifene (a selective oestrogen-receptor (ER) modulator that targets ER-beta and induces apoptosis in vitro in androgen-independent prostate cancer, AIPC cells) affects prostate cell differentiation, proliferation and carcinogenesis, and in the pilot phase II clinical trial, the response rate and duration of patients with AIPC treated with a daily oral dose of raloxifene. PATIENTS, MATERIALS AND METHODS: Tumour proliferation rate in response to raloxifene treatment, and molecular markers of cell cycle and apoptosis, were evaluated in established ER-beta-positive androgen-dependent (AD) CWR22 and AI CWRSA9 human xenograft prostate cancer models. Twenty-one patients with AIPC and evidence of disease progression were enrolled into the clinical trial and given daily oral raloxifene. RESULTS: There was significant growth inhibition by raloxifene in the ADPC and AIPC xenograft models (CWR22 68%, P &lt; 0.010; CWRSA9 64%, P &lt; 0.001), with no tumour regression. There was evidence of G1 arrest by increased p27kip1 expression in the raloxifene-treated group. Eighteen patients comprised the efficacy analysis, as three withdrew before the first evaluation. At the first evaluation, five men had stable disease and continued on the study for a median of five cycles. The longest response was 17 cycles. Drug related toxicity was minimal. CONCLUSION: Raloxifene has activity in xenograft models, slowing disease progression. This translated to possible disease stabilization in patients with AIPC. Further studies are warranted.</abstract><notes>Shazer, Ronald L&#xD;Jain, Anjali&#xD;Galkin, Anna V&#xD;Cinman, Nadya&#xD;Nguyen, Koo N&#xD;Natale, Ronald B&#xD;Gross, Mitchell&#xD;Green, Leland&#xD;Bender, Leon I&#xD;Holden, Stuart&#xD;Kaplan, Leslie&#xD;Agus, David B&#xD;Clinical Trial, Phase II&#xD;England&#xD;BJU international&#xD;BJU Int. 2006 Apr;97(4):691-7.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16536755</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>2.741</custom4><electronic-resource-num>BJU5974 [pii]&#xD;10.1111/j.1464-410X.2006.05974.x</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1168</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1168</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Deng, J.</author><author>Rhee, T. K.</author><author>Sato, K. T.</author><author>Salem, R.</author><author>Haines, K.</author><author>Paunesku, T.</author><author>Mulcahy, M. F.</author><author>Miller, F. H.</author><author>Omary, R. A.</author><author>Larson, A. C.</author></authors></contributors><auth-address>Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Il 60611, USA.</auth-address><titles><title>In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla</title><secondary-title>Invest Radiol</secondary-title></titles><periodical><full-title>Invest Radiol</full-title></periodical><pages>410-4</pages><volume>41</volume><number>4</number><edition>2006/03/09</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Feasibility Studies</keyword><keyword>*Image Processing, Computer-Assisted</keyword><keyword>Liver Neoplasms/*pathology</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>Necrosis</keyword><keyword>Rabbits</keyword></keywords><dates><year>2006</year><pub-dates><date>Apr</date></pub-dates></dates><isbn>0020-9996 (Print)</isbn><accession-num>16523024</accession-num><abstract>OBJECTIVES: We sought to demonstrate the feasibility of using single-shot spin-echo echo-planar imaging for imaging liver tumor necrosis in the in vivo VX2 rabbit model at 1.5 T. MATERIALS AND METHODS: VX2 liver tumors were grown in 4 rabbits. Diffusion-weighted images (DWIs) were acquired during breath-hold using twice refocused SE-EPI (b = 0, 700, 1400 seconds/mm). Anatomic images for tumor size measurements were acquired using T2W TSE. Rabbits were euthanized for subsequent necropsy. Viable and necrotic tumor tissue ADC measurements were performed with reference to hematoxylin and eosin pathology. RESULTS: A total of 8 tumors were grown with diameters ranging from 1.2 to 5.3 cm. Viable and necrotic tumor compartments were clearly differentiated. Apparent diffusion coefficient in necrotic tumor cores, 1.26 +/- 0.11 x 10 mm/s, were significantly greater than those in surrounding viable tumor tissues, 0.74 +/- 0.06 x 10 mm/s (mean +/- SD, P &lt; 0.05). CONCLUSIONS: In vivo DWI of liver tumor necrosis in the VX2 rabbit model is feasible using a 1.5 T clinical magnetic resonance imaging scanner. DWI may permit longitudinal assessment of liver tumor therapies in both preclinical and clinical studies.</abstract><notes>Deng, Jie&#xD;Rhee, Thomas K&#xD;Sato, Kent T&#xD;Salem, Riad&#xD;Haines, Kenneth&#xD;Paunesku, Tatjana&#xD;Mulcahy, Mary F&#xD;Miller, Frank H&#xD;Omary, Reed A&#xD;Larson, Andrew C&#xD;Evaluation Studies&#xD;United States&#xD;Investigative radiology&#xD;Invest Radiol. 2006 Apr;41(4):410-4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16523024</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>4.115</custom4><electronic-resource-num>10.1097/01.rli.0000201232.14903.da&#xD;00004424-200604000-00007 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1730</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1730</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Winter, P. M.</author><author>Caruthers, S. D.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Cardiovascular Magnetic Resonance Laboratories, Washington University, St. Louis, MO 63110, USA.</auth-address><titles><title>Molecular imaging by MRI</title><secondary-title>Curr Cardiol Rep</secondary-title></titles><periodical><full-title>Curr Cardiol Rep</full-title></periodical><pages>65-9</pages><volume>8</volume><number>1</number><edition>2006/03/02</edition><keywords><keyword>Antibiotics, Antineoplastic/administration &amp; dosage</keyword><keyword>Antifibrinolytic Agents/administration &amp; dosage</keyword><keyword>Atherosclerosis/*physiopathology/therapy</keyword><keyword>Contrast Media</keyword><keyword>Doxorubicin/administration &amp; dosage</keyword><keyword>Drug Carriers</keyword><keyword>Fibrin/adverse effects</keyword><keyword>Humans</keyword><keyword>*Magnetic Resonance Imaging</keyword><keyword>Nanostructures</keyword><keyword>Neovascularization, Pathologic/physiopathology/therapy</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1523-3782 (Print)</isbn><accession-num>16507239</accession-num><abstract>The goal of molecular imaging is to detect pathologic biomarkers, which can lead to early recognition of diseases, better therapeutic management, and improved monitoring for recurrence. MRI is a particularly attractive method for molecular imaging applications, due to its noninvasive nature, outstanding signal to noise ratio, high spatial resolution, exceptional tissue contrast, and short imaging times. Site-specific MRI contrast agents have been developed to target biologic processes that occur early in the development of atherosclerotic plaques, including angiogenesis and lipid accumulation, or biosignatures that appear later, such as fibrin and tissue factor resulting from plaque rupture. Moreover, targeted contrast agents can also serve as drug delivery vehicles, combining diagnosis and therapy. If ultimately successful, these emerging molecular imaging agents and techniques will allow early disease recognition and quantification prompting therapeutic intervention before serious sequelae ensue.</abstract><notes>Winter, Patrick M&#xD;Caruthers, Shelton D&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Review&#xD;United States&#xD;Current cardiology reports&#xD;Curr Cardiol Rep. 2006 Feb;8(1):65-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16507239</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>na</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1484</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1484</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Paliwal, S.</author><author>Pande, S.</author><author>Kovi, R. C.</author><author>Sharpless, N. E.</author><author>Bardeesy, N.</author><author>Grossman, S. R.</author></authors></contributors><auth-address>Department of Cancer Biology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, MA 01605, USA.</auth-address><titles><title>Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis</title><secondary-title>Mol Cell Biol</secondary-title></titles><periodical><full-title>Mol Cell Biol</full-title></periodical><pages>2360-72</pages><volume>26</volume><number>6</number><edition>2006/03/02</edition><keywords><keyword>ADP-Ribosylation Factors/genetics/*metabolism</keyword><keyword>Alcohol Oxidoreductases</keyword><keyword>Animals</keyword><keyword>Apoptosis/*physiology</keyword><keyword>Cell Nucleolus/metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Colonic Neoplasms/genetics/pathology</keyword><keyword>DNA-Binding Proteins/genetics/*metabolism/radiation effects</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Phosphoproteins/genetics/*metabolism/radiation effects</keyword><keyword>Proteasome Endopeptidase Complex/metabolism/radiation effects</keyword><keyword>Protein Transport</keyword><keyword>RNA, Small Interfering</keyword><keyword>Tumor Suppressor Protein p53/genetics/*metabolism</keyword><keyword>Two-Hybrid System Techniques</keyword><keyword>Ubiquitin/metabolism</keyword><keyword>Ultraviolet Rays</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0270-7306 (Print)</isbn><accession-num>16508011</accession-num><abstract>ARF encodes a potent tumor suppressor that antagonizes MDM2, a negative regulator of p53. ARF also suppresses the proliferation of cells lacking p53, and loss of ARF in p53-null mice, compared with ARF or p53 singly null mice, results in a broadened tumor spectrum and decreased tumor latency. To investigate the mechanism of p53-independent tumor suppression by ARF, potential interacting proteins were identified by yeast two-hybrid screen. The antiapoptotic transcriptional corepressor C-terminal binding protein 2 (CtBP2) was identified, and ARF interactions with both CtBP1 and CtBP2 were confirmed in vitro and in vivo. Interaction with ARF resulted in proteasome-dependent CtBP degradation. Both ARF-induced CtBP degradation and CtBP small interfering RNA led to p53-independent apoptosis in colon cancer cells. ARF induction of apoptosis was dependent on its ability to interact with CtBP, and reversal of ARF-induced CtBP depletion by CtBP overexpression abrogated ARF-induced apoptosis. CtBP proteins represent putative targets for p53-independent tumor suppression by ARF.</abstract><notes>Paliwal, Seema&#xD;Pande, Sandhya&#xD;Kovi, Ramesh C&#xD;Sharpless, Norman E&#xD;Bardeesy, Nabeel&#xD;Grossman, Steven R&#xD;5ko1-ca89548/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Molecular and cellular biology&#xD;Mol Cell Biol. 2006 Mar;26(6):2360-72.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16508011</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>6.426</custom4><electronic-resource-num>26/6/2360 [pii]&#xD;10.1128/MCB.26.6.2360-2372.2006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1466</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1466</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Nakamura, K.</author><author>Uhlik, M. T.</author><author>Johnson, N. L.</author><author>Hahn, K. M.</author><author>Johnson, G. L.</author></authors></contributors><auth-address>Department of Pharmacology, CB#7365, 1108 Mary Ellen Jones Building, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.</auth-address><titles><title>PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation</title><secondary-title>Mol Cell Biol</secondary-title></titles><periodical><full-title>Mol Cell Biol</full-title></periodical><pages>2065-79</pages><volume>26</volume><number>6</number><edition>2006/03/02</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Bacterial Proteins/genetics/metabolism</keyword><keyword>Cells, Cultured</keyword><keyword>Dimerization</keyword><keyword>Enzyme Activation</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Green Fluorescent Proteins/genetics/metabolism</keyword><keyword>Luminescent Proteins/genetics/metabolism</keyword><keyword>MAP Kinase Kinase 5/drug effects/genetics/*metabolism</keyword><keyword>MAP Kinase Kinase Kinase 2/genetics/metabolism</keyword><keyword>Mitogen-Activated Protein Kinase 7/drug effects/genetics/*metabolism</keyword><keyword>Molecular Sequence Data</keyword><keyword>Multiprotein Complexes</keyword><keyword>Mutation</keyword><keyword>Protein Interaction Mapping</keyword><keyword>Protein Structure, Tertiary</keyword><keyword>Recombinant Proteins/genetics/metabolism</keyword><keyword>*Signal Transduction</keyword><keyword>Sorbitol/pharmacology</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0270-7306 (Print)</isbn><accession-num>16507987</accession-num><abstract>MEKK2, MEK5, and extracellular signal-regulated kinase 5 (ERK5) are members of a three-kinase cascade for the activation of ERK5. MEK5 is the only MAP2K to express a PB1 domain, and we have shown that it heterodimerizes with the PB1 domain of MEKK2. Here we demonstrate the MEK5 PB1 domain is a scaffold that also binds ERK5, functionally forming a MEKK2-MEK5-ERK5 complex. Reconstitution assays and CFP/YFP imaging (fluorescence resonance energy transfer [FRET]) measuring YFP-MEKK2/CFP-MEK5 and CFP-MEK5/YFP-ERK5 interactions define distinct MEK5 PB1 domain binding sites for MEKK2 and ERK5, with a C-terminal extension of the PB1 domain contributing to ERK5 binding. Stimulus-dependent CFP/YFP FRET in combination with mutational analysis was used to define MEK5 PB1 domain residues critical for the interaction of MEKK2/MEK5 and MEK5/ERK5 required for activation of the ERK5 pathway in living cells. Fusion of the MEK5 PB1 domain to the N terminus of MEK1 confers ERK5 regulation by a MAP2K normally regulating only ERK1/2. The MEK5 PB1 domain confers stringent MAP3K regulation of ERK5 relative to more promiscuous MAP3K control of ERK1/2, JNK, and p38.</abstract><notes>Nakamura, Kazuhiro&#xD;Uhlik, Mark T&#xD;Johnson, Nancy L&#xD;Hahn, Klaus M&#xD;Johnson, Gary L&#xD;Gm30324/gm/nigms&#xD;Gm68820/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Molecular and cellular biology&#xD;Mol Cell Biol. 2006 Mar;26(6):2065-79.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16507987</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>6.426</custom4><electronic-resource-num>26/6/2065 [pii]&#xD;10.1128/MCB.26.6.2065-2079.2006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1122</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1122</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Caruthers, S. D.</author><author>Winter, P. M.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Cardiovascular MR Labs, Division of Cardiology, Washington University, St. Louis, Missouri, USA.</auth-address><titles><title>Targeted magnetic resonance imaging contrast agents</title><secondary-title>Methods Mol Med</secondary-title></titles><periodical><full-title>Methods Mol Med</full-title></periodical><pages>387-400</pages><volume>124</volume><edition>2006/03/02</edition><keywords><keyword>Contrast Media/*administration &amp; dosage</keyword><keyword>Drug Delivery Systems/*methods</keyword><keyword>Image Enhancement/*methods</keyword><keyword>Image Interpretation, Computer-Assisted/*methods</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>March</date></pub-dates></dates><isbn>1543-1894 (Print)</isbn><accession-num>16506431</accession-num><abstract>The era of personalized medicine is emerging as physicians attempt to diagnose disease in asymptomatic individuals and treat pathology early in its natural history. A novel tool in an emerging armamentarium, molecular imaging will allow noninvasive characterization and segmentation of patients for delivering custom-tailored therapy. Nanoparticulate agents, such as superparamagnetic agents, liposomes, perfluorocarbon nanoparticle emulsions, and dendrimers, are being intensively researched as formulation platforms for various targeted clinical applications. As exemplified by perfluorocarbon nanoparticles, these new agents, in combination with the rapid innovations in imaging hardware and software, will allow the emergence of new medical diagnostic and therapeutic paradigms.</abstract><notes>Caruthers, Shelton D&#xD;Winter, Patrick M&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Review&#xD;United States&#xD;Methods in molecular medicine&#xD;Methods Mol Med. 2006;124:387-400.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16506431</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>na</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1794</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1794</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Zimmer, J. P.</author><author>Kim, S. W.</author><author>Ohnishi, S.</author><author>Tanaka, E.</author><author>Frangioni, J. V.</author><author>Bawendi, M. G.</author></authors></contributors><auth-address>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, 02139, USA.</auth-address><titles><title>Size series of small indium arsenide-zinc selenide core-shell nanocrystals and their application to in vivo imaging</title><secondary-title>J Am Chem Soc</secondary-title><alt-title>Journal of the American Chemical Society</alt-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><alt-periodical><full-title>Journal of the American Chemical Society</full-title></alt-periodical><pages>2526-7</pages><volume>128</volume><number>8</number><edition>2006/03/1</edition><keywords><keyword>Animals</keyword><keyword>Arsenicals/*chemistry/diagnostic use</keyword><keyword>Blood Proteins/chemistry</keyword><keyword>Cadmium/chemistry</keyword><keyword>Diagnostic Imaging/*methods</keyword><keyword>Fluorescent Dyes/chemistry</keyword><keyword>Indium/*chemistry/diagnostic use</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Polyethylene Glycols/chemistry</keyword><keyword>Protein Binding</keyword><keyword>*Quantum Dots</keyword><keyword>Rats</keyword><keyword>Selenium Compounds/*chemistry/diagnostic use</keyword><keyword>Semiconductors</keyword><keyword>Sentinel Lymph Node Biopsy/methods</keyword><keyword>Spectrometry, Fluorescence</keyword><keyword>Spectroscopy, Near-Infrared</keyword><keyword>Thioctic Acid/analogs &amp; derivatives/chemistry</keyword><keyword>Zinc Compounds/*chemistry/diagnostic use</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar 1</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16492023</accession-num><notes>R01-ca-115296/ca/nci&#xD;R33-eb-000673/eb/nibib&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16492023 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>8.256</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1674</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1674</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>van Vlerken, L. E.</author><author>Amiji, M. M.</author></authors></contributors><auth-address>Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, USA.</auth-address><titles><title>Multi-functional polymeric nanoparticles for tumour-targeted drug delivery</title><secondary-title>Expert Opin Drug Deliv</secondary-title><alt-title>Expert opinion on drug delivery</alt-title></titles><periodical><full-title>Expert Opin Drug Deliv</full-title></periodical><alt-periodical><full-title>Expert Opin Drug Deliv</full-title><abbr-1>Expert opinion on drug delivery</abbr-1></alt-periodical><pages>205-16</pages><volume>3</volume><number>2</number><edition>2006/03</edition><keywords><keyword>Animals</keyword><keyword>*Drug Carriers</keyword><keyword>Ferrosoferric Oxide/chemistry</keyword><keyword>Gadolinium/chemistry</keyword><keyword>Gold/chemistry</keyword><keyword>Humans</keyword><keyword>*Nanostructures</keyword><keyword>Neoplasms/*drug therapy</keyword><keyword>Polymers/administration &amp; dosage/chemistry</keyword><keyword>Quantum Dots</keyword><keyword>Silicon Dioxide/chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1742-5247 (Print)</isbn><accession-num>16506948</accession-num><abstract>The use of nanoparticles as drug delivery vehicles for anticancer therapeutics has great potential to revolutionise the future of cancer therapy. As tumour architecture causes nanoparticles to preferentially accumulate at the tumour site, their use as drug delivery vectors results in the localisation of a greater amount of the drug load at the tumour site; thus improving cancer therapy and reducing the harmful nonspecific side effects of chemotherapeutics. In addition, formulation of these nanoparticles with imaging contrast agents provides a very efficient system for cancer diagnostics. Given the exhaustive possibilities available to polymeric nanoparticle chemistry, research has quickly been directed at multi-functional nanoparticles, combining tumour targeting, tumour therapy and tumour imaging in an all-in-one system, providing a useful multi-modal approach in the battle against cancer. This review will discuss the properties of nanoparticles that allow for such multiple functionality, as well as recent scientific advances in the area of multi-functional nanoparticles for cancer therapeutics.</abstract><notes>Journal Article&#xD;Review&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16506948 </url></related-urls></urls><custom1>CNPP - Northeastern</custom1><custom3>2006</custom3><custom4>1.424</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1527</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1527</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Quinti, L.</author><author>Weissleder, R.</author><author>Tung, C. H.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Charlestown, 02129, USA.</auth-address><titles><title>A fluorescent nanosensor for apoptotic cells</title><secondary-title>Nano Lett</secondary-title><alt-title>Nano letters</alt-title></titles><periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></periodical><alt-periodical><full-title>Nano Lett</full-title><abbr-1>Nano letters</abbr-1></alt-periodical><pages>488-90</pages><volume>6</volume><number>3</number><edition>2006/03</edition><keywords><keyword>*Apoptosis</keyword><keyword>Biosensing Techniques/*instrumentation/*methods</keyword><keyword>Flow Cytometry</keyword><keyword>Fluorescence</keyword><keyword>Fluorescent Dyes/*analysis</keyword><keyword>Humans</keyword><keyword>Jurkat Cells</keyword><keyword>Molecular Structure</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Nanotechnology/*instrumentation/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1530-6984 (Print)</isbn><accession-num>16522048</accession-num><abstract>A biocompatible surface-functionalized nanoparticle was designed to sense phosphatidylserine exposed on apoptotic cells. We conjugated synthetic artificial phosphatidylserine binding ligands in a multivalent fashion onto magnetofluorescent nanoparticles. Our results show that (1) the synthetic nanoparticles bind to apoptotic cells, (2) there is excellent correlation with annexin V staining by microscopy, and (3) FACS analysis with nanoparticles allows the measurement of therapeutic apoptosis induction. The described nanomaterials should be useful for a variety of biomedical applications including in vivo imaging of apoptosis.</abstract><notes>P50-ca86355/ca/nci&#xD;R01 ca99385/ca/nci&#xD;R21 ca114149/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16522048 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>12.189</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1454</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1454</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Montet, X.</author><author>Montet-Abou, K.</author><author>Reynolds, F.</author><author>Weissleder, R.</author><author>Josephson, L.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.</auth-address><titles><title>Nanoparticle imaging of integrins on tumor cells</title><secondary-title>Neoplasia</secondary-title><alt-title>Neoplasia (New York, N.Y</alt-title></titles><periodical><full-title>Neoplasia</full-title></periodical><alt-periodical><full-title>Neoplasia</full-title><abbr-1>Neoplasia (New York, N.Y</abbr-1></alt-periodical><pages>214-22</pages><volume>8</volume><number>3</number><edition>2006/03</edition><keywords><keyword>Animals</keyword><keyword>Breast Neoplasms/blood supply/chemistry/*pathology</keyword><keyword>Carcinoma/blood supply/chemistry/*pathology</keyword><keyword>Cell Line, Tumor/chemistry/ultrastructure</keyword><keyword>Diagnostic Imaging/methods</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Drug Delivery Systems</keyword><keyword>Feasibility Studies</keyword><keyword>Female</keyword><keyword>Fluorescent Dyes/analysis</keyword><keyword>Fluorometry/*methods</keyword><keyword>Gliosarcoma/chemistry/*pathology</keyword><keyword>Half-Life</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3/*analysis</keyword><keyword>Magnetic Resonance Imaging/*methods</keyword><keyword>*Nanostructures/analysis</keyword><keyword>Neoplasm Proteins/*analysis</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Oligopeptides/analysis</keyword><keyword>Particle Size</keyword><keyword>Rats</keyword><keyword>Tissue Distribution</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1476-5586 (Electronic)</isbn><accession-num>16611415</accession-num><abstract>Nanoparticles 10 to 100 nm in size can deliver large payloads to molecular targets, but undergo slow diffusion and/or slow transport through delivery barriers. To examine the feasibility of nanoparticles targeting a marker expressed in tumor cells, we used the binding of cyclic arginine-glycine-aspartic acid (RGD) nanoparticle targeting integrins on BT-20 tumor as a model system. The goals of this study were: 1) to use nanoparticles to image alpha(V)beta3 integrins expressed in BT-20 tumor cells by fluorescence-based imaging and magnetic resonance imaging, and, 2) to identify factors associated with the ability of nanoparticles to target tumor cell integrins. Three factors were identified: 1) tumor cell integrin expression (the alpha(V)beta3 integrin was expressed in BT-20 cells, but not in 9L cells); 2) nanoparticle pharmacokinetics (the cyclic RGD peptide cross-linked iron oxide had a blood half-life of 180 minutes and was able to escape from the vasculature over its long circulation time); and 3) tumor vascularization (the tumor had a dense capillary bed, with distances of &lt;100 microm between capillaries). These results suggest that nanoparticles could be targeted to the cell surface markers expressed in tumor cells, at least in the case wherein the nanoparticles and the tumor model have characteristics similar to those of the BT-20 tumor employed here.</abstract><notes>P50 ca86355/ca/nci&#xD;R01 eb00662/eb/nibib&#xD;R24 ca92782/ca/nci&#xD;Comparative Study&#xD;Evaluation Studies&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Canada</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16611415 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>5.124</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1301</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1301</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Jiang, P.</author><author>Yamauchi, K.</author><author>Yang, M.</author><author>Tsuji, K.</author><author>Xu, M.</author><author>Maitra, A.</author><author>Bouvet, M.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., San Diego, California 92111, USA.</auth-address><titles><title>Tumor cells genetically labeled with GFP in the nucleus and RFP in the cytoplasm for imaging cellular dynamics</title><secondary-title>Cell Cycle</secondary-title><alt-title>Cell cycle (Georgetown, Tex</alt-title></titles><periodical><full-title>Cell Cycle</full-title></periodical><alt-periodical><full-title>Cell Cycle</full-title><abbr-1>Cell cycle (Georgetown, Tex</abbr-1></alt-periodical><pages>1198-201</pages><volume>5</volume><number>11</number><edition>2006/03</edition><keywords><keyword>Animals</keyword><keyword>Cell Nucleus/pathology/ultrastructure</keyword><keyword>Cytological Techniques</keyword><keyword>Cytoplasm/pathology/ultrastructure</keyword><keyword>Diagnostic Imaging/*methods</keyword><keyword>Green Fluorescent Proteins/genetics</keyword><keyword>Humans</keyword><keyword>Luminescent Proteins/*genetics</keyword><keyword>Neoplasms/*pathology/ultrastructure</keyword><keyword>Transduction, Genetic</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2006</year><pub-dates><date>Jun</date></pub-dates></dates><isbn>1551-4005 (Electronic)</isbn><accession-num>16760659</accession-num><abstract>Dual-color fluorescent cells with one color fluorescent protein in the nucleus and another color fluorescent protein in the cytoplasm were genetically engineered. The dual-color cancer cells enable real-time nuclear-cytoplasmic dynamics to be visualized in living cells in vivo as well as in vitro. To obtain the dual-color cells, red fluorescent protein (RFP) was expressed in the cytoplasm of a series of human and rodent cancer cells, and green fluorescent protein (GFP) linked to histone H2B was expressed in the nucleus. Nuclear GFP expression enabled visualization of nuclear dynamics, whereas simultaneous cytoplasmic RFP expression enabled visualization of nuclear-cytoplasmic ratios as well as simultaneous cell and nuclear shape changes. Using the Olympus OV100 Whole-Mouse Imaging System, total sub-cellular dynamics can be visualized in the living dual-color cells in real time in the live mouse after cell injection. Highly elongated cancer cells and nuclei in narrow capillaries were visualized where both the nuclei and cytoplasm deform. Both cytoplasm and nuclei were visualized to undergo extreme deformation during extravasation with cytoplasmic processing exiting vessels first and nuclei following along these processes. The dual-color cells described here thus enable the sub-cellular dynamics of cancer cell trafficking to be imaged in the living animal.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16760659 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>4.120</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1610</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1610</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>So, M. K.</author><author>Xu, C.</author><author>Loening, A. M.</author><author>Gambhir, S. S.</author><author>Rao, J.</author></authors></contributors><auth-address>Molecular Imaging Program, Department of Radiology, Stanford University, 1201 Welch Road, Stanford, California 94305-5484, USA.</auth-address><titles><title>Self-illuminating quantum dot conjugates for in vivo imaging</title><secondary-title>Nat Biotechnol</secondary-title></titles><periodical><full-title>Nat Biotechnol</full-title></periodical><pages>339-43</pages><volume>24</volume><number>3</number><edition>2006/02/28</edition><keywords><keyword>Animals</keyword><keyword>Diagnostic Imaging</keyword><keyword>Energy Transfer</keyword><keyword>Fluorescence</keyword><keyword>Luciferases/genetics/metabolism</keyword><keyword>Luminescent Measurements/*methods</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>*Quantum Dots</keyword><keyword>Semiconductors</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1087-0156 (Print)</isbn><accession-num>16501578</accession-num><abstract>Fluorescent semiconductor quantum dots hold great potential for molecular imaging in vivo. However, the utility of existing quantum dots for in vivo imaging is limited because they require excitation from external illumination sources to fluoresce, which results in a strong autofluorescence background and a paucity of excitation light at nonsuperficial locations. Here we present quantum dot conjugates that luminesce by bioluminescence resonance energy transfer in the absence of external excitation. The conjugates are prepared by coupling carboxylate-presenting quantum dots to a mutant of the bioluminescent protein Renilla reniformis luciferase. We show that the conjugates emit long-wavelength (from red to near-infrared) bioluminescent light in cells and in animals, even in deep tissues, and are suitable for multiplexed in vivo imaging. Compared with existing quantum dots, self-illuminating quantum dot conjugates have greatly enhanced sensitivity in small animal imaging, with an in vivo signal-to-background ratio of &gt; 10(3) for 5 pmol of conjugate.</abstract><notes>So, Min-Kyung&#xD;Xu, Chenjie&#xD;Loening, Andreas M&#xD;Gambhir, Sanjiv S&#xD;Rao, Jianghong&#xD;5r01ca82214-7/ca/nci&#xD;P50 ca114747/ca/nci&#xD;R24ca92862/ca/nci&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Nature biotechnology&#xD;Nat Biotechnol. 2006 Mar;24(3):339-43. Epub 2006 Feb 26.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16501578</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>25.329</custom4><electronic-resource-num>nbt1188 [pii]&#xD;10.1038/nbt1188</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1148</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1148</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chu, T. C.</author><author>Shieh, F.</author><author>Lavery, L. A.</author><author>Levy, M.</author><author>Richards-Kortum, R.</author><author>Korgel, B. A.</author><author>Ellington, A. D.</author></authors></contributors><auth-address>Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712, United States.</auth-address><titles><title>Labeling tumor cells with fluorescent nanocrystal-aptamer bioconjugates</title><secondary-title>Biosens Bioelectron</secondary-title></titles><periodical><full-title>Biosens Bioelectron</full-title></periodical><pages>1859-66</pages><volume>21</volume><number>10</number><edition>2006/02/24</edition><dates><year>2006</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>0956-5663 (Print)</isbn><accession-num>16495043</accession-num><abstract>Aptamers that bind to prostate specific membrane antigen (PSMA) were conjugated to luminescent CdSe and CdTe nanocrystals for cell-labeling studies. The aptamer-nanocrystal conjugates showed specific targeting of both fixed and live cells that overexpressed PSMA. More importantly, aptamers were able to label cells dispersed in a collagen gel matrix simulating tissue. The specific binding abilities and synthetic accessibility of aptamers combined with the photostability and small size of semiconductor nanocrystals offers a powerful and general tool for cellular imaging.</abstract><notes>Chu, Ted C&#xD;Shieh, Felice&#xD;Lavery, Laura A&#xD;Levy, Matthew&#xD;Richards-Kortum, Rebecca&#xD;Korgel, Brian A&#xD;Ellington, Andrew D&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Biosensors &amp; bioelectronics&#xD;Biosens Bioelectron. 2006 Apr 15;21(10):1859-66. Epub 2006 Feb 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16495043</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>5.330</custom4><electronic-resource-num>S0956-5663(05)00403-3 [pii]&#xD;10.1016/j.bios.2005.12.015</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1139</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1139</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cheon, J.</author><author>Park, J. I.</author><author>Choi, J. S.</author><author>Jun, Y. W.</author><author>Kim, S.</author><author>Kim, M. G.</author><author>Kim, Y. M.</author><author>Kim, Y. J.</author></authors></contributors><auth-address>Department of Chemistry and Nano-Medical National Core Research Center, Yonsei University, Seoul, Korea. jcheon@yonsei.ac.kr</auth-address><titles><title>Magnetic superlattices and their nanoscale phase transition effects</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>3023-7</pages><volume>103</volume><number>9</number><edition>2006/02/24</edition><dates><year>2006</year><pub-dates><date>Feb 28</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16492783</accession-num><abstract>The systematic assembly of nanoscale constituents into highly ordered superlattices is of significant interest because of the potential of their multifunctionalities and the discovery of new collective properties. However, successful observations of such superlattice-associated nanoscale phenomena are still elusive. Here, we present magnetic superlattices of Co and Fe(3)O(4) nanoparticles with multidimensional symmetry of either AB (NaCl) or AB(2) (AlB(2)). The discovery of significant enhancement (approximately 25 times) of ferrimagnetism is further revealed by forming previously undescribed superlattices of magnetically soft-hard Fe(3)O(4)@CoFe(2)O(4) through the confined geometrical effect of thermally driven intrasuperlattice phase transition between the nanoparticulate components.</abstract><notes>Cheon, Jinwoo&#xD;Park, Jong-Il&#xD;Choi, Jin-sil&#xD;Jun, Young-wook&#xD;Kim, Sehun&#xD;Kim, Min Gyu&#xD;Kim, Young-Min&#xD;Kim, Youn Joong&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3023-7. Epub 2006 Feb 21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16492783</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>10.228</custom4><electronic-resource-num>0508877103 [pii]&#xD;10.1073/pnas.0508877103</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1767</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1767</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yoo, L. I.</author><author>Liu, D. W.</author><author>Le Vu, S.</author><author>Bronson, R. T.</author><author>Wu, H.</author><author>Yuan, J.</author></authors></contributors><auth-address>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.</auth-address><titles><title>Pten deficiency activates distinct downstream signaling pathways in a tissue-specific manner</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>1929-39</pages><volume>66</volume><number>4</number><edition>2006/02/21</edition><keywords><keyword>Animals</keyword><keyword>Cell Growth Processes/physiology</keyword><keyword>Cyclin-Dependent Kinase Inhibitor</keyword><keyword>p21/biosynthesis/deficiency/genetics/metabolism</keyword><keyword>Female</keyword><keyword>Hyperplasia</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Organ Specificity</keyword><keyword>PTEN Phosphohydrolase/*deficiency/genetics</keyword><keyword>Prostate/enzymology/pathology</keyword><keyword>Prostatic Neoplasms/enzymology/pathology</keyword><keyword>Proto-Oncogene Proteins c-akt/metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Up-Regulation</keyword><keyword>Urinary Bladder/enzymology/pathology</keyword><keyword>Urinary Bladder Neoplasms/enzymology/pathology</keyword><keyword>Urogenital Neoplasms/*enzymology/pathology</keyword><keyword>Urothelium/enzymology/pathology</keyword><keyword>Vagina/enzymology/pathology</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16488991</accession-num><abstract>PTEN deficiency predisposes to a subset of human cancers, but the mechanism that underlies such selectivity is unknown. We have generated a mouse line that conditionally deletes Pten in urogenital epithelium. These mice develop carcinomas at high frequency in the prostate but at relatively low frequency in the bladder, despite early and complete penetrance of hyperplasia in both organs. Cell proliferation is initially high in the bladder of newborn Pten-deficient mice but within days is inhibited by p21 induction. In contrast, proliferation remains elevated in Pten-deficient prostate, where p21 is never induced, suggesting that p21 induction is a bladder-specific compensatory mechanism to inhibit proliferation caused by Pten deletion. Furthermore, the AKT/mammalian target of rapamycin growth pathway, which is highly activated in Pten-deficient prostate, is not activated in bladder epithelium. Our results reveal alternative downstream signaling pathways activated by Pten deficiency that lead to tissue-specific susceptibilities to tumorigenesis.</abstract><notes>Yoo, Lina I&#xD;Liu, David W&#xD;Le Vu, Sandrine&#xD;Bronson, Roderick T&#xD;Wu, Hong&#xD;Yuan, Junying&#xD;Ca89434/ca/nci&#xD;R01ca107166/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2006 Feb 15;66(4):1929-39.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16488991</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>7.980</custom4><electronic-resource-num>66/4/1929 [pii]&#xD;10.1158/0008-5472.CAN-05-1986</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1239</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1239</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Han, M. S.</author><author>Lytton-Jean, A. K.</author><author>Oh, B. K.</author><author>Heo, J.</author><author>Mirkin, C. A.</author></authors></contributors><auth-address>Department of Chemistry, Evanston, IL, 60208-3113, USA.</auth-address><titles><title>Colorimetric screening of DNA-binding molecules with gold nanoparticle probes</title><secondary-title>Angew Chem Int Ed Engl</secondary-title></titles><periodical><full-title>Angew Chem Int Ed Engl</full-title><abbr-1>Angewandte Chemie (International ed</abbr-1></periodical><pages>1807-10</pages><volume>45</volume><number>11</number><edition>2006/02/17</edition><keywords><keyword>Colorimetry</keyword><keyword>DNA/chemistry/*metabolism</keyword><keyword>Gold/*chemistry/metabolism</keyword><keyword>Models, Biological</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Nucleic Acid Conformation</keyword><keyword>Oligonucleotide Probes/*chemistry</keyword><keyword>Thionucleotides/*chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar 3</date></pub-dates></dates><isbn>1433-7851 (Print)</isbn><accession-num>16482507</accession-num><notes>Han, Min Su&#xD;Lytton-Jean, Abigail K R&#xD;Oh, Byung-Keun&#xD;Heo, Jungseok&#xD;Mirkin, Chad A&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Germany&#xD;Angewandte Chemie (International ed. in English)&#xD;Angew Chem Int Ed Engl. 2006 Mar 3;45(11):1807-10.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16482507</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>11.025</custom4><electronic-resource-num>10.1002/anie.200504277</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1120</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1120</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Caruthers, S. D.</author><author>Neubauer, A. M.</author><author>Hockett, F. D.</author><author>Lamerichs, R.</author><author>Winter, P. M.</author><author>Scott, M. J.</author><author>Gaffney, P. J.</author><author>Wickline, S. A.</author><author>Lanza, G. M.</author></authors></contributors><auth-address>Division of Cardiology, Washington University Medical School, St. Louis, Missouri 63110, USA. SCaruthers@cmrl.wustl.edu</auth-address><titles><title>In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla</title><secondary-title>Invest Radiol</secondary-title></titles><periodical><full-title>Invest Radiol</full-title></periodical><pages>305-12</pages><volume>41</volume><number>3</number><edition>2006/02/17</edition><keywords><keyword>Animals</keyword><keyword>Dogs</keyword><keyword>Emulsions</keyword><keyword>Fibrin/*metabolism</keyword><keyword>Fluorine</keyword><keyword>Gadolinium DTPA/*diagnostic use</keyword><keyword>Hydrocarbons, Fluorinated/*diagnostic use</keyword><keyword>*Nanostructures</keyword><keyword>*Nuclear Magnetic Resonance, Biomolecular</keyword><keyword>Phantoms, Imaging</keyword><keyword>Thrombosis/*diagnosis</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>0020-9996 (Print)</isbn><accession-num>16481914</accession-num><abstract>OBJECTIVES: This study explored the use of F spectroscopy and imaging with targeted perfluorocarbon nanoparticles for the simultaneous identification of multiple bio-signatures at 1.5 T. MATERIALS AND METHODS: Two nanoparticle emulsions with perfluoro-15-crown-5-ether (CE) or perfluorooctylbromide (PFOB) cores were targeted in vitro to fibrin clot phantoms (n=12) in 4 progressive ratios using biotin-avidin interactions. The CE nanoparticles incorporated gadolinium. Fluorine images were acquired using steady-state gradient-echo techniques; spectra using volume-selective and nonselective sampling. RESULTS: On conventional T1-weighted imaging, clots with CE nanoparticles enhanced as expected, with intensity decreasing monotonically with CE concentration. All clots were visualized using wide bandwidth fluorine imaging, while restricted bandwidth excitation permitted independent imaging of CE or PFOB nanoparticles. Furthermore, F imaging and spectroscopy allowed visual and quantitative confirmation of relative perfluorocarbon nanoparticle distributions. CONCLUSIONS: F MRI/S molecular imaging of perfluorocarbon nanoparticles in vitro suggests that noninvasive phenotypic characterization of pathologic bio-signatures is feasible at clinical field strengths.</abstract><notes>Caruthers, Shelton D&#xD;Neubauer, Anne M&#xD;Hockett, Frank D&#xD;Lamerichs, Rolf&#xD;Winter, Patrick M&#xD;Scott, Michael J&#xD;Gaffney, Patrick J&#xD;Wickline, Samuel A&#xD;Lanza, Gregory M&#xD;Eb-01704/eb/nibib&#xD;Hl-42950/hl/nhlbi&#xD;Hl-59865/hl/nhlbi&#xD;Hl-78631/hl/nhlbi&#xD;N01-co-37007/co/nci&#xD;N019co-27031/co/nci&#xD;In Vitro&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Investigative radiology&#xD;Invest Radiol. 2006 Mar;41(3):305-12.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16481914</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>4.115</custom4><electronic-resource-num>10.1097/01.rli.0000199281.60135.6a&#xD;00004424-200603000-00014 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1051</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1051</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Agrawal, A.</author><author>Zhang, C.</author><author>Byassee, T.</author><author>Tripp, R. A.</author><author>Nie, S.</author></authors></contributors><auth-address>Departments of Biomedical Engineering and Chemistry, Emory University and Georgia Institute of Technology, 101 Woodruff Circle Suite 2001, Atlanta, GA 30322, USA.</auth-address><titles><title>Counting single native biomolecules and intact viruses with color-coded nanoparticles</title><secondary-title>Anal Chem</secondary-title></titles><periodical><full-title>Anal Chem</full-title></periodical><pages>1061-70</pages><volume>78</volume><number>4</number><edition>2006/02/16</edition><keywords><keyword>Base Sequence</keyword><keyword>Binding Sites</keyword><keyword>*Color</keyword><keyword>DNA Probes</keyword><keyword>Fluorescence</keyword><keyword>*Nanoparticles</keyword><keyword>Viruses/*isolation &amp; purification</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb 15</date></pub-dates></dates><isbn>0003-2700 (Print)</isbn><accession-num>16478096</accession-num><abstract>Nanometer-sized particles such as semiconductor quantum dots and energy-transfer nanoparticles have novel optical properties such as tunable light emission, signal brightness, and multicolor excitation that are not available from traditional organic dyes and fluorescent proteins. Here we report the use of color-coded nanoparticles and dual-color fluorescence coincidence for real-time detection of single native biomolecules and viruses in a microfluidic channel. Using green and red nanoparticles to simultaneously recognize two binding sites on a single target, we demonstrate that individual molecules of genes, proteins, and intact viruses can be detected and identified in complex mixtures without target amplification or probe/target separation. Real-time coincidence analysis of single-photon events allows rapid detection of bound targets and efficient discrimination of excess unbound probes. Quantitative studies indicate that the counting results are remarkably precise when the total numbers of counted molecules are more than 10. The use of bioconjugated nanoparticle probes for single-molecule detection is expected to have important applications in ultrasensitive molecular diagnostics, bioterrorism agent detection, and real-time imaging and tracking of single-molecule processes inside living cells.</abstract><notes>Agrawal, Amit&#xD;Zhang, Chunyang&#xD;Byassee, Tyler&#xD;Tripp, Ralph A&#xD;Nie, Shuming&#xD;P20 gm 072069/gm/nigms&#xD;R01 ca 108468-01/ca/nci&#xD;R01 gm 60562/gm/nigms&#xD;U01 hl 080711/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Analytical chemistry&#xD;Anal Chem. 2006 Feb 15;78(4):1061-70.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16478096</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>5.918</custom4><electronic-resource-num>10.1021/ac051801t</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1619</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1619</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Soper, S. A.</author><author>Brown, K.</author><author>Ellington, A.</author><author>Frazier, B.</author><author>Garcia-Manero, G.</author><author>Gau, V.</author><author>Gutman, S. I.</author><author>Hayes, D. F.</author><author>Korte, B.</author><author>Landers, J. L.</author><author>Larson, D.</author><author>Ligler, F.</author><author>Majumdar, A.</author><author>Mascini, M.</author><author>Nolte, D.</author><author>Rosenzweig, Z.</author><author>Wang, J.</author><author>Wilson, D.</author></authors></contributors><auth-address>Louisiana State University, Baton Rouge, LA 70803, United States. chsope@lsu.edu</auth-address><titles><title>Point-of-care biosensor systems for cancer diagnostics/prognostics</title><secondary-title>Biosens Bioelectron</secondary-title></titles><periodical><full-title>Biosens Bioelectron</full-title></periodical><pages>1932-42</pages><volume>21</volume><number>10</number><edition>2006/02/14</edition><dates><year>2006</year><pub-dates><date>Apr 15</date></pub-dates></dates><isbn>0956-5663 (Print)</isbn><accession-num>16473506</accession-num><abstract>With the growing number of fatalities resulting from the 100 or so cancer-related diseases, new enabling tools are required to provide extensive molecular profiles of patients to guide the clinician in making viable diagnosis and prognosis. Unfortunately with cancer-related diseases, there is not one molecular marker that can provide sufficient information to assist the clinician in making effective prognoses or even diagnoses. Indeed, large panels of markers must typically be evaluated that cut across several different classes (mutations in certain gene fragments--DNA; over/under-expression of gene activity as monitored by messenger RNAs; the amount of proteins present in serum or circulating tumor cells). The classical biosensor format (dipstick approach for monitoring the presence of a single element) is viewed as a valuable tool in many bioassays, but possesses numerous limitations in cancer due primarily to the single element nature of these sensing platforms. As such, if biosensors are to become valuable tools in the arsenal of the clinician to manage cancer patients, new formats are required. This review seeks to provide an overview of the current thinking on molecular profiling for diagnosis and prognosis of cancers and also, provide insight into the current state-of-the-art in the biosensor field and new strategies that must be considered to bring this important technology into the cancer field.</abstract><notes>Soper, Steven A&#xD;Brown, Kathlynn&#xD;Ellington, Andrew&#xD;Frazier, Bruno&#xD;Garcia-Manero, Guillermo&#xD;Gau, Vincent&#xD;Gutman, Steven I&#xD;Hayes, Daniel F&#xD;Korte, Brenda&#xD;Landers, James L&#xD;Larson, Dale&#xD;Ligler, Frances&#xD;Majumdar, Arun&#xD;Mascini, Marco&#xD;Nolte, David&#xD;Rosenzweig, Zeev&#xD;Wang, Joseph&#xD;Wilson, David&#xD;Review&#xD;England&#xD;Biosensors &amp; bioelectronics&#xD;Biosens Bioelectron. 2006 Apr 15;21(10):1932-42. Epub 2006 Feb 13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16473506</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>5.330</custom4><electronic-resource-num>S0956-5663(06)00012-1 [pii]&#xD;10.1016/j.bios.2006.01.006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1256</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1256</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hodgson, L.</author><author>Nalbant, P.</author><author>Shen, F.</author><author>Hahn, K.</author></authors></contributors><auth-address>Department of Pharmacology, University of North Carolina, Chapel Hill, USA.</auth-address><titles><title>Imaging and photobleach correction of Mero-CBD, sensor of endogenous Cdc42 activation</title><secondary-title>Methods Enzymol</secondary-title></titles><periodical><full-title>Methods Enzymol</full-title></periodical><pages>140-56</pages><volume>406</volume><edition>2006/02/14</edition><keywords><keyword>Biosensing Techniques/*methods</keyword><keyword>*Cell Movement</keyword><keyword>Fluorescence Recovery After Photobleaching/*methods</keyword><keyword>Fluorescent Dyes/chemistry</keyword><keyword>Green Fluorescent Proteins/genetics</keyword><keyword>Image Interpretation, Computer-Assisted/*methods</keyword><keyword>Peptide Fragments/chemistry</keyword><keyword>Pyrimidinones/chemistry</keyword><keyword>Software</keyword><keyword>Wiskott-Aldrich Syndrome Protein/chemistry</keyword><keyword>cdc42 GTP-Binding Protein/*metabolism</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0076-6879 (Print)</isbn><accession-num>16472656</accession-num><abstract>This chapter details quantitative imaging of the Mero-CBD biosensor, which reports activation of endogenous Cdc42 in living cells. The procedures described are appropriate for imaging any biosensor that uses two different fluorophores on a single molecule, including FRET biosensors. Of particular interest is an algorithm to correct for fluorophore photobleaching, useful when quantitating activity changes over time. Specific topics include procedures and caveats in production of the Mero-CBD sensor, image acquisition, motion artifacts, shading correction, background subtraction, registration, and ratio imaging.</abstract><notes>Hodgson, Louis&#xD;Nalbant, Perihan&#xD;Shen, Feimo&#xD;Hahn, Klaus&#xD;United States&#xD;Methods in enzymology&#xD;Methods Enzymol. 2006;406:140-56.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16472656</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>2.126</custom4><electronic-resource-num>S0076-6879(06)06012-5 [pii]&#xD;10.1016/S0076-6879(06)06012-5</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2362</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2362</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Balasubramanian, C.</author><author>Dawson, M. I.</author><author>Bergamaschi, A.</author><author>Bellucci, S.</author><author>Mustelin, T.</author></authors></contributors><auth-address>Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, California 92037, USA.</auth-address><titles><title>Isolation and characterization of fluorescent nanoparticles from pristine and oxidized electric arc-produced single-walled carbon nanotubes</title><secondary-title>J Phys Chem B</secondary-title></titles><periodical><full-title>J Phys Chem B</full-title></periodical><pages>831-6</pages><volume>110</volume><number>2</number><edition>2006/02/14</edition><keywords><keyword>Carbon/ chemistry</keyword><keyword>Microscopy, Electron, Scanning</keyword><keyword>Microscopy, Electron, Transmission</keyword><keyword>Nanotechnology</keyword><keyword>Oxidation-Reduction</keyword><keyword>Particle Size</keyword><keyword>Spectrometry, Fluorescence</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 19</date></pub-dates></dates><isbn>1520-6106 (Print)</isbn><accession-num>16471611</accession-num><abstract>Fluorescent nanoparticles were isolated from both pristine and nitric acid-oxidized commercially available carbon nanotubes that had been produced by an electric arc method. The pristine and oxidized carbon nanotube-derived fluorescent nanoparticles exhibited a molecular-weight-dependent photoluminescence in the violet-blue and blue to yellowish-green ranges, respectively. The molecular weight dependency of the photoluminescence was strongly related to the specific supplier. We analyzed the composition and morphology of the fluorescent nanoparticles derived from pristine and oxidized nanotubes from one supplier. We found that the isolated fluorescent materials were mainly composed of calcium and zinc. Moreover, the pristine carbon nanotube-derived fluorescent nanoparticles were hydrophobic and had a narrow distribution of maximal lateral dimension. In contrast, the oxidized carbon nanotube-derived fluorescent nanoparticles were superficially oxidized and/or coated by a thin carbon layer, had the ability to aggregate when dispersed in water, and exhibited a broader distribution of maximal lateral dimension.</abstract><notes>Bottini, Massimo&#xD;Balasubramanian, Chidambara&#xD;Dawson, Marcia I&#xD;Bergamaschi, Antonio&#xD;Bellucci, Stefano&#xD;Mustelin, Tomas&#xD;U54 CA119335/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;The journal of physical chemistry. B&#xD;J Phys Chem B. 2006 Jan 19;110(2):831-6.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom4>4.688</custom4><electronic-resource-num>10.1021/jp055503b [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1153</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1153</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Collier, J. H.</author><author>Mrksich, M.</author></authors></contributors><auth-address>Department of Chemistry and Institute for Biophysical Dynamics, University of Chicago, 5735 South Ellis Avenue, Chicago, IL 60637, USA.</auth-address><titles><title>Engineering a biospecific communication pathway between cells and electrodes</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>2021-5</pages><volume>103</volume><number>7</number><edition>2006/02/08</edition><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>*Biosensing Techniques/instrumentation</keyword><keyword>CHO Cells</keyword><keyword>Carboxylic Ester Hydrolases/chemistry/genetics/*metabolism</keyword><keyword>Cricetinae</keyword><keyword>Cricetulus</keyword><keyword>Electricity</keyword><keyword>*Electrodes</keyword><keyword>Fusarium/enzymology</keyword><keyword>Molecular Sequence Data</keyword><keyword>Protein Engineering</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb 14</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16461913</accession-num><abstract>Methods for transducing the cellular activities of mammalian cells into measurable electronic signals are important in many biotechnical applications, including biosensors, cell arrays, and other cell-based devices. This manuscript describes an approach for functionally integrating cellular activities and electrical processes in an underlying substrate. The cells are engineered with a cell-surface chimeric receptor that presents the nonmammalian enzyme cutinase. Action of this cell-surface cutinase on enzyme substrate self-assembled monolayers switches a nonelectroactive hydroxyphenyl ester to an electroactive hydroquinone, providing an electrical activity that can be identified with cyclic voltammetry. In this way, cell-surface enzymatic activity is transduced into electronic signals. The development of strategies to directly interface the activities of cells with materials will be important to enabling a broad class of hybrid microsystems that combine living and nonliving components.</abstract><notes>Collier, Joel H&#xD;Mrksich, Milan&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2021-5. Epub 2006 Feb 6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16461913</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>10.228</custom4><electronic-resource-num>0504349103 [pii]&#xD;10.1073/pnas.0504349103</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1605</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1605</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, A. M.</author><author>Ruan, G.</author><author>Rhyner, M. N.</author><author>Nie, S.</author></authors></contributors><auth-address>Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia 30322, USA.</auth-address><titles><title>Engineering luminescent quantum dots for in vivo molecular and cellular imaging</title><secondary-title>Ann Biomed Eng</secondary-title></titles><periodical><full-title>Ann Biomed Eng</full-title></periodical><pages>3-14</pages><volume>34</volume><number>1</number><edition>2006/02/02</edition><keywords><keyword>Animals</keyword><keyword>Fluorescence Resonance Energy Transfer/methods</keyword><keyword>Humans</keyword><keyword>Luminescent Agents/*chemistry/classification/pharmacology</keyword><keyword>Luminescent Measurements</keyword><keyword>Microscopy, Fluorescence/methods</keyword><keyword>Molecular Probes/*chemistry/classification/pharmacology</keyword><keyword>*Quantum Dots</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0090-6964 (Print)</isbn><accession-num>16450199</accession-num><abstract>Semiconductor quantum dots are luminescent nanoparticles that are under intensive development for use as a new class of optical imaging contrast agents. Their novel properties such as optical tunability, improved photostability, and multicolor light emission have opened new opportunities for imaging living cells and in vivo animal models at unprecedented sensitivity and spatial resolution. Combined with biomolecular engineering strategies for tailoring the particle surfaces at the molecular level, bio-conjugated quantum dot probes are well suited for imaging single-molecule dynamics in living cells, for monitoring protein-protein interactions within specific intracellular locations, and for detecting diseased sites and organs in deep tissue. In this article, we describe the engineering principles for preparing high-quality quantum dots and for conjugating the dots to biomolecular ligands. We also discuss recent advances in using quantum dots for in vivo molecular and cellular imaging.</abstract><notes>Smith, Andrew M&#xD;Ruan, Gang&#xD;Rhyner, Matthew N&#xD;Nie, Shuming&#xD;P20 gm072069/gm/nigms&#xD;R01 ca108468/ca/nci&#xD;R01 gm058173/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;United States&#xD;Annals of biomedical engineering&#xD;Ann Biomed Eng. 2006 Jan;34(1):3-14. Epub 2006 Feb 1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16450199</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>2.999</custom4><electronic-resource-num>10.1007/s10439-005-9000-9</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1427</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1427</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Majoros, I. J.</author><author>Myc, A.</author><author>Thomas, T.</author><author>Mehta, C. B.</author><author>Baker, J. R., Jr.</author></authors></contributors><auth-address>Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, 200 Zina Pitcher Place, 4027 Kresge II., Ann Arbor, 48109-0533, USA. majoros@umich.edu</auth-address><titles><title>PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality</title><secondary-title>Biomacromolecules</secondary-title><alt-title>Biomacromolecules</alt-title></titles><periodical><full-title>Biomacromolecules</full-title></periodical><alt-periodical><full-title>Biomacromolecules</full-title></alt-periodical><pages>572-9</pages><volume>7</volume><number>2</number><edition>2006/02</edition><keywords><keyword>*Antineoplastic Agents/chemical synthesis/chemistry/pharmacology</keyword><keyword>Cell Proliferation/drug effects</keyword><keyword>*Dendrimers/chemical synthesis/chemistry/pharmacology</keyword><keyword>*Drug Carriers/chemical synthesis/chemistry/pharmacology</keyword><keyword>Drug Design</keyword><keyword>Drug Screening Assays, Antitumor</keyword><keyword>Flow Cytometry</keyword><keyword>Fluorescein-5-isothiocyanate/chemistry</keyword><keyword>Folic Acid/chemistry</keyword><keyword>Humans</keyword><keyword>KB Cells</keyword><keyword>Molecular Conformation</keyword><keyword>Molecular Weight</keyword><keyword>Paclitaxel/chemistry</keyword><keyword>*Polyamines/chemical synthesis/chemistry/pharmacology</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1525-7797 (Print)</isbn><accession-num>16471932</accession-num><abstract>Poly(amidoamine) (PAMAM) dendrimer-based multifunctional cancer therapeutic conjugates have been designed and synthesized. The primary amino groups on the surface of the generation 5 (G5) PAMAM dendrimer were neutralized through partial acetylation, providing enhanced solubility of the dendrimer (in conjugation of FITC (fluorescein isothiocyanate)) and preventing nonspecific targeting interactions (in vitro and in vivo) during delivery. The functional molecules fluorescein isothiocyanate (FITC, an imaging agent), folic acid (FA, targets overexpressed folate receptors on specific cancer cells), and paclitaxel (taxol, a chemotherapeutic drug) were conjugated to the remaining nonacetylated primary amino groups. The appropriate control dendrimer conjugates have been synthesized as well. Characterization of the G5 PAMAM dendrimer and its nanosize conjugates, including the molecular weight and number of primary amine groups, has been determined by multiple analytical methods such as gel permeation chromatography (GPC), nuclear magnetic resonance spectroscopy (NMR), potentiometric titration, high-performance liquid chromatography (HPLC), and UV spectroscopy. These multifunctional dendrimer conjugates have been tested in vitro for targeted delivery of chemotherapeutic and imaging agents to specific cancer cells. We present here the synthesis, characterization, and functionality of these dendrimer conjugates.</abstract><notes>N01-cm-97065-32/cm/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16471932 </url></related-urls></urls><custom1>CNPP - U. of Michigan Med. </custom1><custom3>2006</custom3><custom4>4.658</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1529</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1529</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rabin, O.</author><author>Manuel Perez, J.</author><author>Grimm, J.</author><author>Wojtkiewicz, G.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA.</auth-address><titles><title>An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles</title><secondary-title>Nat Mater</secondary-title></titles><periodical><full-title>Nat Mater</full-title></periodical><pages>118-22</pages><volume>5</volume><number>2</number><edition>2006/01/31</edition><keywords><keyword>Animals</keyword><keyword>Bismuth/adverse effects/*analysis/*chemistry</keyword><keyword>Blood Vessels</keyword><keyword>Contrast Media/adverse effects/*analysis/*chemistry</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Drug Stability</keyword><keyword>Liver</keyword><keyword>Lymph Nodes</keyword><keyword>Mice</keyword><keyword>Nanostructures/adverse effects/analysis/*chemistry</keyword><keyword>Sulfides/adverse effects/*analysis/*chemistry</keyword><keyword>Tomography, X-Ray Computed/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1476-1122 (Print)</isbn><accession-num>16444262</accession-num><abstract>Nanomaterials have become increasingly important in the development of new molecular probes for in vivo imaging, both experimentally and clinically. Nanoparticulate imaging probes have included semiconductor quantum dots, magnetic and magnetofluorescent nanoparticles, gold nanoparticles and nanoshells, among others. However, the use of nanomaterials for one of the most common imaging techniques, computed tomography (CT), has remained unexplored. Current CT contrast agents are based on small iodinated molecules. They are effective in absorbing X-rays, but non-specific distribution and rapid pharmacokinetics have rather limited their microvascular and targeting performance. Here we propose the use of a polymer-coated Bi(2)S(3) nanoparticle preparation as an injectable CT imaging agent. This preparation demonstrates excellent stability at high concentrations (0.25 M Bi(3+)), high X-ray absorption (fivefold better than iodine), very long circulation times (&gt;2 h) in vivo and an efficacy/safety profile comparable to or better than iodinated imaging agents. We show the utility of these polymer-coated Bi(2)S(3) nanoparticles for enhanced in vivo imaging of the vasculature, the liver and lymph nodes in mice. These nanoparticles and their bioconjugates are expected to become an important adjunct to in vivo imaging of molecular targets and pathological conditions.</abstract><notes>Rabin, Oded&#xD;Manuel Perez, J&#xD;Grimm, Jan&#xD;Wojtkiewicz, Gregory&#xD;Weissleder, Ralph&#xD;P50 ca86355/ca/nci&#xD;R01-eb004626a01/eb/nibib&#xD;R24 ca92782/ca/nci&#xD;U54 ca119349/ca/nci&#xD;Uo1 hl080731/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England&#xD;Nature materials&#xD;Nat Mater. 2006 Feb;5(2):118-22. Epub 2006 Jan 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16444262</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>25.759</custom4><electronic-resource-num>nmat1571 [pii]&#xD;10.1038/nmat1571</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1658</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1658</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tickoo, S. K.</author><author>dePeralta-Venturina, M. N.</author><author>Harik, L. R.</author><author>Worcester, H. D.</author><author>Salama, M. E.</author><author>Young, A. N.</author><author>Moch, H.</author><author>Amin, M. B.</author></authors></contributors><auth-address>Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. tickoos@mskcc.org</auth-address><titles><title>Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia</title><secondary-title>Am J Surg Pathol</secondary-title></titles><periodical><full-title>Am J Surg Pathol</full-title></periodical><pages>141-53</pages><volume>30</volume><number>2</number><edition>2006/01/26</edition><keywords><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Carcinoma, Renal Cell/*complications/metabolism/*pathology</keyword><keyword>Diagnosis, Differential</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Kidney Failure, Chronic/*complications/metabolism/*pathology</keyword><keyword>Kidney Neoplasms/*complications/metabolism/*pathology</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Tumor Markers, Biological/analysis</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0147-5185 (Print)</isbn><accession-num>16434887</accession-num><abstract>Most (up to 71%) of renal cell neoplasms occurring in patients with end-stage renal disease (ESRD), particularly with acquired cystic disease of the kidney (ACDK), have been reported to be papillary renal cell carcinoma (RCC). Our initial experience with tumors in such a setting indicated that many tumors were histologically difficult to classify into the known subtypes of RCC or had features that were different from those in sporadically occurring RCCs. In this study on 66 ESRD kidneys (52 of which showed features of ACDK) removed because tumors were detected in them, we found two major groups of RCC. Overall, there were 261 grossly identified tumors in these kidneys, and many additional tumors were observed on microscopic evaluation in some. Of the two major groups of RCCs, one consisted of tumors similar to those seen in sporadic settings (ie, clear-cell, papillary, and chromophobe RCC), and these formed the dominant mass in 12 (18%), 10 (15%), and 5 (8%) of the 66 kidneys, respectively. The other group consisted of two subtypes of RCC that appear quite unique to ESRD. The more common tumor that we have designated as &quot;acquired cystic disease-associated RCC&quot; was seen as the dominant mass in 24 (36%) of 66 of the kidneys, and it formed the most common tumor type among the smaller nondominant masses, as well. It was characterized by a typical microcystic architecture, eosinophilic cytoplasm with Fuhrman&apos;s grade 3 nuclei, and frequent association with intratumoral oxalate crystals. Additionally, these tumors frequently, but usually focally, exhibited papillary architecture, and clear cytoplasm. These tumors occurred only in kidneys with ACDK, and not in noncystic ESRD. The other category was &quot;clear-cell papillary RCC of the end-stage kidneys,&quot; present as the dominant mass in 15 (23%) of the 66 kidneys and occurring in both the ACDK and noncystic ESRD. These predominantly cystic tumors showed prominent papillary architecture with purely clear-cell cytology. Immunohistochemical studies in tumors with histology similar to the known subtypes of sporadic RCC showed immunoprofiles similar to that reported in sporadically occurring tumors. The two subtypes of RCC unique to ESRD had distinctive immunoprofiles supporting their separate morphologic subcategorization. Only the acquired cystic disease-associated RCC showed lymph node metastases in 2 cases and sarcomatoid features in 2 more cases. One of the latter 2 died with widespread metastatic disease within 34 months of nephrectomy. Thus, a broad spectrum of renal cell tumors exist in ESRD, only some of which resemble the sporadic RCCs. Acquired cystic disease-associated RCC is the commonest tumor subtype in ESRD, and biologically it appears to be more aggressive than the other tumor subtypes in ESRD.</abstract><notes>Tickoo, Satish K&#xD;dePeralta-Venturina, Mariza N&#xD;Harik, Lara R&#xD;Worcester, Heath D&#xD;Salama, Mohamed E&#xD;Young, Andrew N&#xD;Moch, Holger&#xD;Amin, Mahul B&#xD;United States&#xD;The American journal of surgical pathology&#xD;Am J Surg Pathol. 2006 Feb;30(2):141-53.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16434887</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>4.833</custom4><electronic-resource-num>00000478-200602000-00001 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1700</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1700</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wang, S.</author><author>Garcia, A. J.</author><author>Wu, M.</author><author>Lawson, D. A.</author><author>Witte, O. N.</author><author>Wu, H.</author></authors></contributors><auth-address>Departments of Molecular and Medical Pharmacology and Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California-Los Angeles, 650 Charles E. Young Drive South, Los Angeles, CA 90095, USA.</auth-address><titles><title>Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation</title><secondary-title>Proc Natl Acad Sci U S A</secondary-title></titles><periodical><full-title>Proc Natl Acad Sci U S A</full-title><abbr-1>Proceedings of the National Academy of Sciences of the United States of America</abbr-1></periodical><pages>1480-5</pages><volume>103</volume><number>5</number><edition>2006/01/25</edition><keywords><keyword>Animals</keyword><keyword>Bromodeoxyuridine/pharmacology</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Line, Tumor</keyword><keyword>Cell Nucleus/metabolism</keyword><keyword>Cell Proliferation</keyword><keyword>Cell Separation</keyword><keyword>DNA-Binding Proteins</keyword><keyword>Disease Models, Animal</keyword><keyword>Disease Progression</keyword><keyword>Flow Cytometry</keyword><keyword>Gene Deletion</keyword><keyword>Genes, Tumor Suppressor</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Ki-67 Antigen/biosynthesis</keyword><keyword>Kinetics</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Knockout</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Neoplasms/metabolism</keyword><keyword>PTEN Phosphohydrolase/metabolism/*physiology</keyword><keyword>Phosphoproteins/metabolism</keyword><keyword>Prostatic Neoplasms/*genetics/pathology</keyword><keyword>Stem Cells/*cytology</keyword><keyword>Time Factors</keyword><keyword>Trans-Activators/metabolism</keyword><keyword>Tumor Suppressor Proteins</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 31</date></pub-dates></dates><isbn>0027-8424 (Print)</isbn><accession-num>16432235</accession-num><abstract>PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a potent tumor suppressor gene frequently mutated in human prostate cancers. Deletion of Pten in a murine model of prostate cancer recapitulates the disease progression seen in humans. Using defined cell lineage markers, we demonstrate that PTEN negatively regulates p63-positive prostatic basal cell proliferation without blocking differentiation. Concomitant with basal cell proliferation is the expansion of a prostate stem/progenitor-like subpopulation as evidenced by the progressive increase of stem cell antigen-1 (Sca-1)- and BCL-2-positive cells. This observation provides strong evidence that basal cell proliferation can be an initiating event for precancerous lesions. Sca-1(+) and BCL-2(+) progenitors may serve as cancer-initiating cells in this model.</abstract><notes>Wang, Shunyou&#xD;Garcia, Alejandro J&#xD;Wu, Michelle&#xD;Lawson, Devon A&#xD;Witte, Owen N&#xD;Wu, Hong&#xD;P50 ca 092131/ca/nci&#xD;P50 ca 86306/ca/nci&#xD;R01 ca 107166/ca/nci&#xD;R01 ca 107166-01s1/ca/nci&#xD;T32 ca 09056/ca/nci&#xD;U01 ca 84128/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Proceedings of the National Academy of Sciences of the United States of America&#xD;Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1480-5. Epub 2006 Jan 23.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16432235</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>10.228</custom4><electronic-resource-num>0510652103 [pii]&#xD;10.1073/pnas.0510652103</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1325</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1325</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Khodavirdi, A. C.</author><author>Song, Z.</author><author>Yang, S.</author><author>Zhong, C.</author><author>Wang, S.</author><author>Wu, H.</author><author>Pritchard, C.</author><author>Nelson, P. S.</author><author>Roy-Burman, P.</author></authors></contributors><auth-address>Department of Pathology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, Los Angeles, CA 90033, USA.</auth-address><titles><title>Increased expression of osteopontin contributes to the progression of prostate cancer</title><secondary-title>Cancer Res</secondary-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><pages>883-8</pages><volume>66</volume><number>2</number><edition>2006/01/21</edition><keywords><keyword>Adenocarcinoma/*genetics/*pathology</keyword><keyword>Animals</keyword><keyword>Chick Embryo</keyword><keyword>Disease Progression</keyword><keyword>*Gene Expression Profiling</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Osteopontin</keyword><keyword>Prostatic Neoplasms/*genetics/pathology</keyword><keyword>Sialoglycoproteins/*biosynthesis/physiology</keyword><keyword>Transduction, Genetic</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 15</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16424021</accession-num><abstract>Osteopontin is a secreted glycosylated phosphoprotein known to be involved in numerous physiologic functions and associated with the late stages of various cancers. We used preneoplastic and neoplastic mouse models of prostate cancer to determine the onset of elevated expression of osteopontin in the development of this disease. Osteopontin alterations occurred early in the disease with dysregulated expression observed in lesions of low-grade prostatic intraepithelial neoplasia (PIN). Over time, osteopontin expressing dysplastic cells seemed to increase in number in high-grade PIN and increased further in adenocarcinoma, and in metastasis, almost all of the cancer cells immunohistochemically stained positive for osteopontin overexpression. We examined the biological properties of human prostate cancer cell lines LNCaP and PC-3, in which osteopontin overexpression was achieved via lentiviral gene transduction. Evidence was obtained that osteopontin could contribute to a proliferative advantage in both cell types, although more significantly in LNCaP than PC-3. Osteopontin also influenced their in vitro invasive ability, and again, most strikingly in the weakly oncogenic LNCaP. Furthermore, excess osteopontin induced the LNCaP cells to acquire a strong intravasation potential in vivo in the chicken embryo chorioallantoic membrane assay for blood vessel penetration. These results establish a correlation between an increased gradient of osteopontin expression throughout the stages of murine prostate cancer, beginning from the preneoplastic lesions to distant metastases that suggests a proliferative and invasive advantages to those prostate tumor cells overexpressing osteopontin. Together, these findings support a strategy designed to target osteopontin in the context of prostate cancer therapy.</abstract><notes>Khodavirdi, Ani C&#xD;Song, Zhigang&#xD;Yang, Shangxin&#xD;Zhong, Chen&#xD;Wang, Shunyou&#xD;Wu, Hong&#xD;Pritchard, Colin&#xD;Nelson, Peter S&#xD;Roy-Burman, Pradip&#xD;R0-1 ca 59705/ca/nci&#xD;T32 ai 07078/ai/niaid&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Cancer research&#xD;Cancer Res. 2006 Jan 15;66(2):883-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16424021</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>7.980</custom4><electronic-resource-num>66/2/883 [pii]&#xD;10.1158/0008-5472.CAN-05-2816</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1638</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1638</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Sun, E. Y.</author><author>Josephson, L.</author><author>Kelly, K. A.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129-2060, USA.</auth-address><titles><title>Development of nanoparticle libraries for biosensing</title><secondary-title>Bioconjug Chem</secondary-title></titles><periodical><full-title>Bioconjug Chem</full-title></periodical><pages>109-13</pages><volume>17</volume><number>1</number><edition>2006/01/19</edition><keywords><keyword>Amines/chemistry</keyword><keyword>Anhydrides/chemistry</keyword><keyword>*Biosensing Techniques</keyword><keyword>Carboxylic Acids/chemistry</keyword><keyword>Epoxy Compounds/chemistry</keyword><keyword>Hydroxides/chemistry</keyword><keyword>*Magnetics</keyword><keyword>Nanostructures/*chemistry</keyword><keyword>Sulfhydryl Compounds/chemistry</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan-Feb</date></pub-dates></dates><isbn>1043-1802 (Print)</isbn><accession-num>16417258</accession-num><abstract>Magnetic and magnetofluorescent nanoparticles have become important materials for biological applications especially for sensing, separation, and imaging. To achieve target specificity, these nanomaterials are often covalently modified with binding proteins such as antibodies or proteins. Here we report on the creation of nanoparticle libraries that achieve specificity through multivalent modification with small molecules. We explore different synthetic routes to attach small molecules with anhydride, amine, hydroxyl carboxyl, thiol, and epoxy handles. We show that the derived nanomaterials have unique biological functions, possess different behaviors in cell screens, and can be used as substrates for biological screens.</abstract><notes>Sun, Eric Yi&#xD;Josephson, Lee&#xD;Kelly, Kim A&#xD;Weissleder, Ralph&#xD;P01 ca69246/ca/nci&#xD;P50 ca86355/ca/nci&#xD;R24 ca92782/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Bioconjugate chemistry&#xD;Bioconjug Chem. 2006 Jan-Feb;17(1):109-13.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16417258</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>4.802</custom4><electronic-resource-num>10.1021/bc050290e</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1138</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1138</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cheng, M. M.</author><author>Cuda, G.</author><author>Bunimovich, Y. L.</author><author>Gaspari, M.</author><author>Heath, J. R.</author><author>Hill, H. D.</author><author>Mirkin, C. A.</author><author>Nijdam, A. J.</author><author>Terracciano, R.</author><author>Thundat, T.</author><author>Ferrari, M.</author></authors></contributors><auth-address>Division of Hematology and Oncology, Internal Medicine, The Ohio State University, 473 West 12 Avenue, Columbus OH 43210-1002, USA.</auth-address><titles><title>Nanotechnologies for biomolecular detection and medical diagnostics</title><secondary-title>Curr Opin Chem Biol</secondary-title></titles><periodical><full-title>Curr Opin Chem Biol</full-title></periodical><pages>11-9</pages><volume>10</volume><number>1</number><edition>2006/01/19</edition><keywords><keyword>Biopolymers/*chemistry</keyword><keyword>Diagnostic Techniques and Procedures/*instrumentation</keyword><keyword>Humans</keyword><keyword>Nanostructures/chemistry</keyword><keyword>Nanotechnology/instrumentation/*methods</keyword><keyword>Protein Array Analysis/instrumentation/methods</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Silicon/chemistry</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2006</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>1367-5931 (Print)</isbn><accession-num>16418011</accession-num><abstract>Nanotechnology-based platforms for the high-throughput, multiplexed detection of proteins and nucleic acids in heretofore unattainable abundance ranges promise to bring substantial advances in molecular medicine. The emerging approaches reviewed in this article, with reference to their diagnostic potential, include nanotextured surfaces for proteomics, a two-particle sandwich assay for the biological amplification of low-concentration biomolecular signals, and silicon-based nanostructures for the transduction of molecular binding into electrical and mechanical signals, respectively.</abstract><notes>Cheng, Mark Ming-Cheng&#xD;Cuda, Giovanni&#xD;Bunimovich, Yuri L&#xD;Gaspari, Marco&#xD;Heath, James R&#xD;Hill, Haley D&#xD;Mirkin, Chad A&#xD;Nijdam, A Jasper&#xD;Terracciano, Rosa&#xD;Thundat, Thomas&#xD;Ferrari, Mauro&#xD;N01-co-12400/co/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;England&#xD;Current opinion in chemical biology&#xD;Curr Opin Chem Biol. 2006 Feb;10(1):11-9. Epub 2006 Jan 18.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16418011</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>7.744</custom4><electronic-resource-num>S1367-5931(06)00007-X [pii]&#xD;10.1016/j.cbpa.2006.01.006</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1534</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1534</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Rauch, A.</author><author>Bellew, M.</author><author>Eng, J.</author><author>Fitzgibbon, M.</author><author>Holzman, T.</author><author>Hussey, P.</author><author>Igra, M.</author><author>Maclean, B.</author><author>Lin, C. W.</author><author>Detter, A.</author><author>Fang, R.</author><author>Faca, V.</author><author>Gafken, P.</author><author>Zhang, H.</author><author>Whiteaker, J.</author><author>States, D.</author><author>Hanash, S.</author><author>Paulovich, A.</author><author>McIntosh, M. W.</author></authors></contributors><auth-address>Fred Hutchinson Cancer Research Center, Seattle, Washington, LabKey Software, Seattle, Washington 98109-1024, USA.</auth-address><titles><title>Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments</title><secondary-title>J Proteome Res</secondary-title></titles><periodical><full-title>J Proteome Res</full-title></periodical><pages>112-21</pages><volume>5</volume><number>1</number><edition>2006/01/07</edition><keywords><keyword>Computational Biology/*methods</keyword><keyword>*Database Management Systems</keyword><keyword>Proteomics/*methods</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1535-3893 (Print)</isbn><accession-num>16396501</accession-num><abstract>The open-source Computational Proteomics Analysis System (CPAS) contains an entire data analysis and management pipeline for Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) proteomics, including experiment annotation, protein database searching and sequence management, and mining LC-MS/MS peptide and protein identifications. CPAS architecture and features, such as a general experiment annotation component, installation software, and data security management, make it useful for collaborative projects across geographical locations and for proteomics laboratories without substantial computational support.</abstract><notes>Rauch, Adam&#xD;Bellew, Matthew&#xD;Eng, Jimmy&#xD;Fitzgibbon, Matthew&#xD;Holzman, Ted&#xD;Hussey, Peter&#xD;Igra, Mark&#xD;Maclean, Brendan&#xD;Lin, Chen Wei&#xD;Detter, Andrea&#xD;Fang, Ruihua&#xD;Faca, Vitor&#xD;Gafken, Phil&#xD;Zhang, Heidi&#xD;Whiteaker, Jeffrey&#xD;States, David&#xD;Hanash, Sam&#xD;Paulovich, Amanda&#xD;McIntosh, Martin W&#xD;23xs144a/phs&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Journal of proteome research&#xD;J Proteome Res. 2006 Jan;5(1):112-21.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16396501</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>5.737</custom4><electronic-resource-num>10.1021/pr0503533</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1667</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1667</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Tsuji, K.</author><author>Yamauchi, K.</author><author>Yang, M.</author><author>Jiang, P.</author><author>Bouvet, M.</author><author>Endo, H.</author><author>Kanai, Y.</author><author>Yamashita, K.</author><author>Moossa, A. R.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>AntiCancer, Inc., San Diego, California 92111, USA.</auth-address><titles><title>Dual-color imaging of nuclear-cytoplasmic dynamics, viability, and proliferation of cancer cells in the portal vein area</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><alt-periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></alt-periodical><pages>303-6</pages><volume>66</volume><number>1</number><edition>2006/01</edition><keywords><keyword>Animals</keyword><keyword>Cell Growth Processes/physiology</keyword><keyword>Cell Nucleus/metabolism</keyword><keyword>Cell Survival/physiology</keyword><keyword>Colonic Neoplasms/drug therapy/*metabolism/pathology</keyword><keyword>Cyclophosphamide/pharmacology</keyword><keyword>Cytoplasm/metabolism</keyword><keyword>Green Fluorescent Proteins/metabolism</keyword><keyword>HCT116 Cells</keyword><keyword>Humans</keyword><keyword>Image Processing, Computer-Assisted</keyword><keyword>Liver Neoplasms, Experimental/blood/secondary</keyword><keyword>Luminescent Proteins/metabolism</keyword><keyword>Male</keyword><keyword>Mammary Neoplasms, Experimental/blood/drug therapy/*metabolism/pathology</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>NIH 3T3 Cells</keyword><keyword>Neoplasm Circulating Cells/drug effects/*metabolism/pathology</keyword><keyword>Portal Vein</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16397243</accession-num><abstract>We used dual-color in vivo cellular imaging to visualize trafficking, nuclear-cytoplasmic dynamics, and the viability of cancer cells after their injection into the portal vein of mice. For these studies, we used dual-color fluorescent cancer cells that express green fluorescent protein (GFP) linked to histone H2B in the nucleus and retroviral red fluorescent protein (RFP) in the cytoplasm. Human HCT-116-GFP-RFP colon cancer and mouse mammary tumor (MMT) cells were HCT-116-GFP-RFP in the portal vein of nude mice. The cells were observed intravitally in the liver at the single-cell level using the Olympus OV100 whole-mouse imaging system. Most HCT-116-GFP-RFP cells remained in sinusoids near peripheral portal veins. Only a small fraction of the cancer cells invaded the lobular area. Extensive clasmocytosis (destruction of the cytoplasm) of the HCT-116-GFP-RFP cells occurred within 6 hours. The number of apoptotic cells rapidly increased within the portal vein within 12 hours of injection. Apoptosis was readily visualized in the dual-color cells by their altered nuclear morphology. The data suggest rapid death of HCT-116-GFP-RFP cells in the portal vein. In contrast, dual-color MMT-GFP-RFP cells injected into the portal vein mostly survived in the liver of nude mice 24 hours after injection. Many surviving MMT-GFP-RFP cells showed invasive figures with cytoplasmic protrusions. The cells grew aggressively and formed colonies in the liver. However, when the host mice were pretreated with cyclophosphamide, the HCT-116-GFP-RFP cells also survived and formed colonies in the liver after portal vein injection. These results suggest that a cyclophosphamide-sensitive host cellular system attacked the HCT-116-GFP-RFP cells but could not effectively kill the MMT-GFP-RFP cells.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16397243 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>7.980</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1319</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1319</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kelly, K. A.</author><author>Clemons, P. A.</author><author>Yu, A. M.</author><author>Weissleder, R.</author></authors></contributors><auth-address>Massachusetts General Hospital and Harvard Medical School, Charlestown 02129, USA. kkelly9@partners.org</auth-address><titles><title>High-throughput identification of phage-derived imaging agents</title><secondary-title>Mol Imaging</secondary-title></titles><periodical><full-title>Mol Imaging</full-title></periodical><pages>24-30</pages><volume>5</volume><number>1</number><edition>2006/01</edition><keywords><keyword>Affinity Labels/chemistry</keyword><keyword>Bacteriophages/*chemistry/genetics</keyword><keyword>Enzyme-Linked Immunosorbent Assay/methods</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry/methods</keyword><keyword>Lipopolysaccharides/pharmacology</keyword><keyword>Macrophages/*chemistry/drug effects/metabolism</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>Monocytes/chemistry/drug effects/metabolism</keyword><keyword>*Peptide Library</keyword><keyword>Peptides/*chemistry/genetics/metabolism</keyword><keyword>Protein Binding</keyword><keyword>U937 Cells</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan-Mar</date></pub-dates></dates><isbn>1535-3508 (Print)</isbn><accession-num>16779967</accession-num><abstract>The use of phage-displayed peptide libraries is a powerful method for selecting peptides with desired binding properties. However, the validation and prioritization of &quot;hits&quot; obtained from this screening approach remains challenging. Here, we describe the development and testing of a new analysis method to identify and display hits from phage-display experiments and high-throughput enzyme-linked immunosorbent assay screens. We test the method using a phage screen against activated macrophages to develop imaging agents with higher specificity for active disease processes. The new methodology should be useful in identifying phage hits and is extendable to other library screening methods such as small-molecule and nanoparticle libraries.</abstract><notes>P50 ca86355/ca/nci&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;official journal of the Society for Molecular Imaging</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16779967 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>3.329</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1091</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1091</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bottini, M.</author><author>Bruckner, S.</author><author>Nika, K.</author><author>Bottini, N.</author><author>Bellucci, S.</author><author>Magrini, A.</author><author>Bergamaschi, A.</author><author>Mustelin, T.</author></authors></contributors><auth-address>Infectious and Inflammatory Disease Center, The Burnham Institute, La Jolla, CA 92037, USA.</auth-address><titles><title>Multi-walled carbon nanotubes induce T lymphocyte apoptosis</title><secondary-title>Toxicol Lett</secondary-title><alt-title>Toxicology letters</alt-title></titles><periodical><full-title>Toxicol Lett</full-title><abbr-1>Toxicology letters</abbr-1></periodical><alt-periodical><full-title>Toxicol Lett</full-title><abbr-1>Toxicology letters</abbr-1></alt-periodical><pages>121-6</pages><volume>160</volume><number>2</number><edition>2006/01</edition><keywords><keyword>*Apoptosis</keyword><keyword>Cell Proliferation/drug effects</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Humans</keyword><keyword>Jurkat Cells</keyword><keyword>Nanotubes, Carbon/chemistry/*toxicity/ultrastructure</keyword><keyword>Oxidation-Reduction</keyword><keyword>Receptors, Antigen, T-Cell/chemistry/metabolism</keyword><keyword>T-Lymphocytes/*drug effects</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 5</date></pub-dates></dates><isbn>0378-4274 (Print)</isbn><accession-num>16125885</accession-num><abstract>Carbon nanotubes are a man-made form of carbon that did not exist in our environment until very recently. Due to their unique chemical, physical, optical, and magnetic properties, carbon nanotubes have found many uses in industrial products and in the field of nanotechnology, including in nanomedicine. However, very little is yet known about the toxicity of carbon nanotubes. Here, we compare the toxicity of pristine and oxidized multi-walled carbon nanotubes on human T cells and find that the latter are more toxic and induce massive loss of cell viability through programmed cell death at doses of 400 microg/ml, which corresponds to approximately 10 million carbon nanotubes per cell. Pristine, hydrophobic, carbon nanotubes were less toxic and a 10-fold lower concentration of either carbon nanotube type were not nearly as toxic. Our results suggest that carbon nanotubes indeed can be very toxic at sufficiently high concentrations and that careful toxicity studies need to be undertaken particularly in conjunction with nanomedical applications of carbon nanotubes.</abstract><notes>Comparative Study&#xD;Journal Article&#xD;Netherlands</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16125885 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>3.179</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1373</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1373</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Lee, H.</author><author>Liu, Y.</author><author>Westervelt, R. M.</author><author>Ham, D.</author></authors></contributors><titles><title>IC/microfluidic hybrid system for magnetic manipulation of biological cells</title><secondary-title>IEEE Journal of Solid-State Circuits</secondary-title></titles><periodical><full-title>IEEE Journal of Solid-State Circuits</full-title></periodical><pages>1471-1480</pages><volume>41</volume><number>6</number><edition>2006-05-30 </edition><dates><year>2006</year><pub-dates><date>June</date></pub-dates></dates><isbn>0018-9200</isbn><accession-num>8935015</accession-num><abstract>This paper introduces an integrated circuit (IC)/microfluidic hybrid system for magnetic manipulation of biological cells. The hybrid system consists of an IC and a microfluidic system fabricated on top. Biological cells attached to magnetic beads are suspended inside the microfluidic system that maintains biocompatibility. The IC contains a microcoil array circuit that produces spatially-patterned microscopic magnetic fields. Programmable, rapid reconfiguration of the field pattern made possible by the IC allows an efficient simultaneous manipulation of multiple individual bead-bound cells with precise position control. Two prototypes, SiGe/microfluidic and CMOS/microfluidic hybrid systems, validate the proposed approach. </abstract><urls><related-urls><url>http://people.seas.harvard.edu/~donhee/JSSC_june2006_lee_liu_westervelt_ham.pdf</url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>2.002</custom4><electronic-resource-num>10.1109/JSSC.2006.874331</electronic-resource-num></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1604</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1604</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Smith, A. M.</author><author>Duan, H. W.</author><author>Rhyner, M. N.</author><author>Ruan, G.</author><author>Nie, S. M.</author></authors></contributors><auth-address>Nie, SM&#xD;Georgia Tech, 101 Woodruff Circle,Suite 2001, Atlanta, GA 30322 USA&#xD;Georgia Tech, Atlanta, GA 30322 USA&#xD;Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA</auth-address><titles><title>A systematic examination of surface coatings on the optical and chemical properties of semiconductor quantum dots</title><secondary-title>Physical Chemistry Chemical Physics</secondary-title></titles><periodical><full-title>Physical Chemistry Chemical Physics</full-title></periodical><pages>3895-3903</pages><volume>8</volume><number>33</number><edition>2006</edition><keywords><keyword>cdse/cds core/shell nanocrystals</keyword><keyword>acid</keyword><keyword>photoluminescence</keyword><keyword>nanoparticles</keyword><keyword>fluorescence</keyword><keyword>thiols</keyword><keyword>growth</keyword><keyword>shell</keyword></keywords><dates><year>2006</year></dates><isbn>1463-9076</isbn><accession-num>ISI:000239937900018</accession-num><abstract>A number of procedures are currently available to encapsulate and solubilize hydrophobic semiconductor Quantum Dots (QDs) for biological applications. Most of these procedures are based on the use of small-molecule coordinating ligands, amphiphilic polymers, or amphiphilic lipids. However, it is still not clear how these different surface coating molecules affect the optical, colloidal, and chemical properties of the solubilized QDs. Here we report a systematic study to examine the effects of surface coating chemistry on the hydrodynamic size, fluorescence quantum yield, photostability, chemical stability, and biocompatibility of water-soluble QDs. The results indicate that quantum dots with the smallest hydrodynamic sizes are best prepared by direct ligand exchange with hydrophilic molecules, but the resulting particles are less stable than those encapsulated in amphiphilic polymers. For stability against chemical oxidation, QDs should be protected with a hydrophobic bilayer. For high stability under acidic conditions, the best QDs are prepared by using hyperbranched polyethylenimine. For stability in high salt buffers, it is preferable to have uncharged, sterically-stabilized QDs, like those coated with polyethylene glycol ( PEG). These insights are expected to benefit the development of quantum dots and related nanoparticle probes for molecular and cellular imaging applications.</abstract><notes>076DT&#xD;Times Cited:5&#xD;Cited References Count:36</notes><urls><related-urls><url>&lt;Go to ISI&gt;://000239937900018</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>3.139</custom4><language>English</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1313</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1313</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kashatus, D.</author><author>Cogswell, P.</author><author>Baldwin, A. S.</author></authors></contributors><auth-address>Curriculum in Genetics and Molecular Biology, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Expression of the Bcl-3 proto-oncogene suppresses p53 activation</title><secondary-title>Genes Dev</secondary-title></titles><periodical><full-title>Genes Dev</full-title></periodical><pages>225-35</pages><volume>20</volume><number>2</number><edition>2005/12/31</edition><keywords><keyword>Animals</keyword><keyword>Apoptosis/drug effects</keyword><keyword>Apoptosis Regulatory Proteins/antagonists &amp; inhibitors/metabolism</keyword><keyword>Cell Cycle/drug effects</keyword><keyword>DNA Damage/drug effects</keyword><keyword>Embryo/enzymology/metabolism</keyword><keyword>Fibroblasts/metabolism</keyword><keyword>Gene Expression Regulation</keyword><keyword>Germ-Line Mutation</keyword><keyword>Germinal Center/metabolism</keyword><keyword>Mice</keyword><keyword>NF-kappa B/metabolism</keyword><keyword>Proto-Oncogene Proteins/antagonists &amp;</keyword><keyword>inhibitors/genetics/*metabolism/pharmacology</keyword><keyword>Proto-Oncogene Proteins c-bcl-2/antagonists &amp; inhibitors/metabolism</keyword><keyword>Proto-Oncogene Proteins c-mdm2/metabolism</keyword><keyword>RNA, Small Interfering/metabolism</keyword><keyword>Recombination, Genetic</keyword><keyword>Transcription Factors</keyword><keyword>Tumor Cells, Cultured</keyword><keyword>Tumor Suppressor Protein p53/*metabolism</keyword><keyword>Up-Regulation</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 15</date></pub-dates></dates><isbn>0890-9369 (Print)</isbn><accession-num>16384933</accession-num><abstract>While Bcl-3 expression in cancer was originally thought to be limited to B-cell lymphomas with a 14;19 chromosomal translocation, more recent evidence indicates that expression of this presumptive oncoprotein is significantly more widespread in cancer. However, an oncogenic role for Bcl-3 has not been clearly identified. Experiments presented here indicate that Bcl-3 is inducible by DNA damage and is required for the induction of Hdm2 gene expression and the suppression of persistent p53 activity. Furthermore, constitutive expression of Bcl-3 suppresses DNA damage-induced p53 activation and inhibits p53-induced apoptosis through a mechanism that is at least partly dependent on the up-regulation of Hdm2. The results provide insight into a mechanism whereby altered expression of Bcl-3 leads to tumorigenic potential. Since Bcl-3 is required for germinal center formation, these results suggest functional similarities with the unrelated Bcl-6 oncoprotein in suppressing potential p53-dependent cell cycle arrest and apoptosis in response to somatic hypermutation and class switch recombination.</abstract><notes>Kashatus, David&#xD;Cogswell, Patricia&#xD;Baldwin, Albert S&#xD;Ai35098/ai/niaid&#xD;Ca73756/ca/nci&#xD;Ca75080/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Genes &amp; development&#xD;Genes Dev. 2006 Jan 15;20(2):225-35. Epub 2005 Dec 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16384933</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>14.795</custom4><electronic-resource-num>gad.1352206 [pii]&#xD;10.1101/gad.1352206</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1174</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1174</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Desiere, F.</author><author>Deutsch, E. W.</author><author>King, N. L.</author><author>Nesvizhskii, A. I.</author><author>Mallick, P.</author><author>Eng, J.</author><author>Chen, S.</author><author>Eddes, J.</author><author>Loevenich, S. N.</author><author>Aebersold, R.</author></authors></contributors><auth-address>Institute for Systems Biology, Seattle, WA, USA. fdesiere@yahoo.com</auth-address><titles><title>The PeptideAtlas project</title><secondary-title>Nucleic Acids Res</secondary-title></titles><periodical><full-title>Nucleic Acids Res</full-title></periodical><pages>D655-8</pages><volume>34</volume><number>Database issue</number><edition>2005/12/31</edition><keywords><keyword>Animals</keyword><keyword>Chromosome Mapping</keyword><keyword>*Databases, Protein/statistics &amp; numerical data</keyword><keyword>Drosophila Proteins/chemistry/genetics</keyword><keyword>Humans</keyword><keyword>Internet</keyword><keyword>Mass Spectrometry</keyword><keyword>Peptide Fragments/*analysis/chemistry</keyword><keyword>Proteome/chemistry/*genetics</keyword><keyword>Proteomics</keyword><keyword>Saccharomyces cerevisiae Proteins/chemistry/genetics</keyword><keyword>Sequence Analysis, Protein</keyword><keyword>User-Computer Interface</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 1</date></pub-dates></dates><isbn>1362-4962 (Electronic)</isbn><accession-num>16381952</accession-num><abstract>The completion of the sequencing of the human genome and the concurrent, rapid development of high-throughput proteomic methods have resulted in an increasing need for automated approaches to archive proteomic data in a repository that enables the exchange of data among researchers and also accurate integration with genomic data. PeptideAtlas (http://www.peptideatlas.org/) addresses these needs by identifying peptides by tandem mass spectrometry (MS/MS), statistically validating those identifications and then mapping identified sequences to the genomes of eukaryotic organisms. A meaningful comparison of data across different experiments generated by different groups using different types of instruments is enabled by the implementation of a uniform analytic process. This uniform statistical validation ensures a consistent and high-quality set of peptide and protein identifications. The raw data from many diverse proteomic experiments are made available in the associated PeptideAtlas repository in several formats. Here we present a summary of our process and details about the Human, Drosophila and Yeast PeptideAtlas builds.</abstract><notes>Desiere, Frank&#xD;Deutsch, Eric W&#xD;King, Nichole L&#xD;Nesvizhskii, Alexey I&#xD;Mallick, Parag&#xD;Eng, Jimmy&#xD;Chen, Sharon&#xD;Eddes, James&#xD;Loevenich, Sandra N&#xD;Aebersold, Ruedi&#xD;N01-hv-28179/hv/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Nucleic acids research&#xD;Nucleic Acids Res. 2006 Jan 1;34(Database issue):D655-8.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16381952</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>6.968</custom4><electronic-resource-num>34/suppl_1/D655 [pii]&#xD;10.1093/nar/gkj040</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1765</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1765</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Yin-Goen, Q.</author><author>Dale, J.</author><author>Yang, W. L.</author><author>Phan, J.</author><author>Moffitt, R.</author><author>Petros, J. A.</author><author>Datta, M. W.</author><author>Amin, M. B.</author><author>Wang, M. D.</author><author>Young, A. N.</author></authors></contributors><auth-address>Department of Pathology &amp; Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.</auth-address><titles><title>Advances in molecular classification of renal neoplasms</title><secondary-title>Histol Histopathol</secondary-title></titles><periodical><full-title>Histol Histopathol</full-title></periodical><pages>325-39</pages><volume>21</volume><number>3</number><edition>2005/12/24</edition><keywords><keyword>Carcinoma, Renal Cell/*classification/diagnosis/*genetics/pathology</keyword><keyword>Cluster Analysis</keyword><keyword>DNA, Neoplasm/*analysis</keyword><keyword>Gene Expression Profiling</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Histocytochemistry/methods</keyword><keyword>Humans</keyword><keyword>Kidney Neoplasms/*classification/diagnosis/*genetics/pathology</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Prognosis</keyword><keyword>World Health Organization</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1699-5848 (Electronic)</isbn><accession-num>16372253</accession-num><abstract>Kidney neoplasms are classified by light microscopy using the World Health Organization (WHO) system. The WHO system defines histopathologic tumor subtypes with distinct clinical behavior and underlying genetic mutations. In adults, the common malignant subtypes are variants of renal cell carcinoma (RCC). Histopathologic classification is critical for clinical management of RCC, but is becoming more complex with recognition of novel tumor subtypes, development of procedures yielding small diagnostic biopsies, and emergence of molecular therapies directed at tumor gene activity. Therefore, classification systems based on gene expression are likely to become essential for diagnosis, prognosis and treatment of kidney tumors. Recent DNA microarray studies have shown that clinically relevant renal tumor subtypes are characterized by distinct gene expression profiles, which are useful for discovery of novel diagnostic and prognostic biomarkers. In this review, we summarize the WHO classification system for renal tumors, general applications of microarray technology in cancer research, and specific microarray studies that have advanced knowledge of renal tumor diagnosis, prognosis, therapy and pathobiology.</abstract><notes>Yin-Goen, Q&#xD;Dale, J&#xD;Yang, W-L&#xD;Phan, J&#xD;Moffitt, R&#xD;Petros, J A&#xD;Datta, M W&#xD;Amin, M B&#xD;Wang, M D&#xD;Young, A N&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;Spain&#xD;Histology and histopathology&#xD;Histol Histopathol. 2006 Mar;21(3):325-39.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16372253</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>2.182</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1723</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1723</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Wickline, S. A.</author><author>Neubauer, A. M.</author><author>Winter, P.</author><author>Caruthers, S.</author><author>Lanza, G.</author></authors></contributors><auth-address>Department of Medicine, Washington University, St Louis, MO, USA. wicklines@aol.com</auth-address><titles><title>Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology</title><secondary-title>Arterioscler Thromb Vasc Biol</secondary-title></titles><periodical><full-title>Arterioscler Thromb Vasc Biol</full-title></periodical><pages>435-41</pages><volume>26</volume><number>3</number><edition>2005/12/24</edition><keywords><keyword>Animals</keyword><keyword>Atherosclerosis/*diagnosis/physiopathology/*therapy</keyword><keyword>Drug Delivery Systems/trends</keyword><keyword>Humans</keyword><keyword>Nanotechnology/*trends</keyword><keyword>Thrombosis/*diagnosis/physiopathology/*therapy</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1524-4636 (Electronic)</isbn><accession-num>16373609</accession-num><abstract>The role of nanotechnology in cardiovascular diagnosis is expanding rapidly. The goal of this brief review is to illustrate selected examples of nanosystems that have been applied to the arenas of atherosclerosis, thrombosis, and vascular biology. The technologies for producing targeted nanosystems are multifarious and reflect end uses in many cases. The results to date indicate rapid growth of interest and capability in the field. The future of cardiovascular diagnosis already is being impacted by nanosystems that can both diagnose pathology and treat it with targeted delivery systems.</abstract><notes>Wickline, Samuel A&#xD;Neubauer, Anne M&#xD;Winter, Patrick&#xD;Caruthers, Shelton&#xD;Lanza, Gregory&#xD;Review&#xD;United States&#xD;Arteriosclerosis, thrombosis, and vascular biology&#xD;Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):435-41. Epub 2005 Dec 22.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16373609</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>7.221</custom4><electronic-resource-num>01.ATV.0000201069.47550.8b [pii]&#xD;10.1161/01.ATV.0000201069.47550.8b</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1321</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1321</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kenanova, V.</author><author>Wu, A. M.</author></authors></contributors><auth-address>Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California-Los Angeles, 700 Westwood Plaza, Los Angeles, CA 90095, USA.</auth-address><titles><title>Tailoring antibodies for radionuclide delivery</title><secondary-title>Expert Opin Drug Deliv</secondary-title></titles><periodical><full-title>Expert Opin Drug Deliv</full-title></periodical><pages>53-70</pages><volume>3</volume><number>1</number><edition>2005/12/24</edition><keywords><keyword>Animals</keyword><keyword>Antibodies/diagnostic use/*therapeutic use</keyword><keyword>Antineoplastic Agents/therapeutic use</keyword><keyword>Humans</keyword><keyword>Immunoglobulin Fragments/diagnostic use/*therapeutic use</keyword><keyword>Neoplasms/immunology/radionuclide imaging/*radiotherapy</keyword><keyword>Radioimmunodetection/methods</keyword><keyword>Radioimmunotherapy/methods</keyword><keyword>Radioisotopes/diagnostic use/therapeutic use</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>1742-5247 (Print)</isbn><accession-num>16370940</accession-num><abstract>Therapeutic antibodies are well established as an important class of drugs in modern medicine. The exquisite specificity and affinity for a specific target offered by antibodies has also encouraged their development as delivery vehicles for agents such as radionuclides to target tissues, for radioimmunoimaging and radioimmunotherapy. Specifically, in nuclear medicine, radionuclide-conjugated antibody molecules make it possible to image diseased loci with greater sensitivity than other imaging modalities such as magnetic resonance imaging. Furthermore, two radionuclide-conjugated antibodies have recently been approved for the therapy of non-Hodgkin&apos;s lymphoma. However, optimal implementation of antibodies has been limited by the extended circulation persistence that is characteristic of native antibodies, which is responsible for increased background activity in radioimmunoimaging applications and dose-related normal organ toxicities in radioimmunotherapy. In this article the current status of radiolabelled intact antibodies is reviewed, focusing on strategies to improve their pharmacokinetic properties to suit a desired application. Examples from the literature that represent different approaches to accomplishing this task in terms of their successes as well as limitations, and perspectives for the future are discussed.</abstract><notes>Kenanova, Vania&#xD;Wu, Anna M&#xD;Ca 43904/ca/nci&#xD;Ca 86306/ca/nci&#xD;Ca 92131/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Review&#xD;England&#xD;Expert opinion on drug delivery&#xD;Expert Opin Drug Deliv. 2006 Jan;3(1):53-70.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16370940</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>1.424</custom4><electronic-resource-num>10.1517/17425247.3.1.53</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1371</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1371</key></foreign-keys><ref-type name="Government Document">46</ref-type><contributors><authors><author>Lee, C. C.</author><author>Sui, G.</author><author>Elizarov, A.</author><author>Shu, C. J.</author><author>Shin, Y. S.</author><author>Dooley, A. N.</author><author>Huang, J.</author><author>Daridon, A.</author><author>Wyatt, P.</author><author>Stout, D.</author><author>Kolb, H. C.</author><author>Witte, O. N.</author><author>Satyamurthy, N.</author><author>Heath, J. R.</author><author>Phelps, M. E.</author><author>Quake, S. R.</author><author>Tseng, H. R.</author></authors></contributors><auth-address>Department of Bioengineering, California Institute of Technology, Pasadena, CA 91125, USA.</auth-address><titles><title>Multistep synthesis of a radiolabeled imaging probe using integrated microfluidics</title><secondary-title>Science</secondary-title></titles><periodical><full-title>Science</full-title></periodical><pages>1793-6</pages><volume>310</volume><number>5755</number><edition>2005/12/17</edition><keywords><keyword>Animals</keyword><keyword>Automation</keyword><keyword>Fluorides</keyword><keyword>Fluorodeoxyglucose F18/*chemical synthesis</keyword><keyword>Gas Chromatography-Mass Spectrometry</keyword><keyword>Mice</keyword><keyword>*Microfluidics</keyword><keyword>Miniaturization</keyword><keyword>Molecular Probes/*chemical synthesis</keyword><keyword>Positron-Emission Tomography</keyword><keyword>Radiopharmaceuticals/*chemical synthesis</keyword><keyword>Rhabdomyosarcoma/radionuclide imaging</keyword><keyword>Solvents</keyword><keyword>Tomography, Emission-Computed</keyword></keywords><dates><year>2005</year><pub-dates><date>Dec 16</date></pub-dates></dates><isbn>1095-9203 (Electronic)</isbn><accession-num>16357255</accession-num><abstract>Microreactor technology has shown potential for optimizing synthetic efficiency, particularly in preparing sensitive compounds. We achieved the synthesis of an [(18)F]fluoride-radiolabeled molecular imaging probe, 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG), in an integrated microfluidic device. Five sequential processes-[18F]fluoride concentration, water evaporation, radiofluorination, solvent exchange, and hydrolytic deprotection-proceeded with high radio-chemical yield and purity and with shorter synthesis time relative to conventional automated synthesis. Multiple doses of [18F]FDG for positron emission tomography imaging studies in mice were prepared. These results, which constitute a proof of principle for automated multistep syntheses at the nanogram to microgram scale, could be generalized to a range of radiolabeled substrates.</abstract><notes>Lee, Chung-Cheng&#xD;Sui, Guodong&#xD;Elizarov, Arkadij&#xD;Shu, Chengyi Jenny&#xD;Shin, Young-Shik&#xD;Dooley, Alek N&#xD;Huang, Jiang&#xD;Daridon, Antoine&#xD;Wyatt, Paul&#xD;Stout, David&#xD;Kolb, Hartmuth C&#xD;Witte, Owen N&#xD;Satyamurthy, Nagichettiar&#xD;Heath, James R&#xD;Phelps, Michael E&#xD;Quake, Stephen R&#xD;Tseng, Hsian-Rong&#xD;5t32-gm07616/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;United States&#xD;Science (New York, N.Y.)&#xD;Science. 2005 Dec 16;310(5755):1793-6.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16357255</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom2>internal</custom2><custom3>2006</custom3><custom4>30.268</custom4><electronic-resource-num>310/5755/1793 [pii]&#xD;10.1126/science.1118919</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1157</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1157</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Crowder, K. C.</author><author>Hughes, M. S.</author><author>Marsh, J. N.</author><author>Barbieri, A. M.</author><author>Fuhrhop, R. W.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Department of Medicine, Washington University in St. Louis, School of Medicine, St. Louis, MO 63110, USA.</auth-address><titles><title>Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery</title><secondary-title>Ultrasound Med Biol</secondary-title></titles><periodical><full-title>Ultrasound Med Biol</full-title></periodical><pages>1693-700</pages><volume>31</volume><number>12</number><edition>2005/12/14</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Cytosol/metabolism</keyword><keyword>Drug Delivery Systems</keyword><keyword>Humans</keyword><keyword>Lipids/*administration &amp; dosage</keyword><keyword>Melanoma/*drug therapy/metabolism</keyword><keyword>Microscopy, Fluorescence</keyword><keyword>*Nanostructures</keyword><keyword>Nanotechnology</keyword><keyword>*Ultrasonics</keyword></keywords><dates><year>2005</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0301-5629 (Print)</isbn><accession-num>16344131</accession-num><abstract>Liquid perfluorocarbon nanoparticles serve as sensitive and specific targeted contrast and drug delivery vehicles by binding to specific cell surface markers. We hypothesized that application of acoustic energy at diagnostic power levels could promote nanoparticle-associated drug delivery by stimulating increased interaction between the nanoparticle&apos;s lipid layer and the targeted cell&apos;s plasma membrane. Ultrasound (mechanical index = 1.9) applied with a conventional ultrasound imaging system to nanoparticles targeted to alpha(v)beta3-integrins on C32 melanoma cancer cells in vitro produced no untoward effects. Within 5 min, lipid delivery from nanoparticles into cell cytoplasm was dramatically augmented. We also demonstrate the operation of a potential physical mechanism for this effect, the acoustic radiation force on the nanoparticles, which may contribute to the enhanced lipid delivery. Accordingly, we propose that local delivery of lipophilic substances (e.g., drugs) from targeted nanoparticles directly into cell cytoplasm can be augmented rapidly and safely with conventional ultrasound imaging devices through nondestructive mechanisms.</abstract><notes>Crowder, Kathryn C&#xD;Hughes, Michael S&#xD;Marsh, Jon N&#xD;Barbieri, Alejandro M&#xD;Fuhrhop, Ralph W&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Co-37007/co/nci&#xD;Hl-42950/hl/nhlbi&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;Ultrasound in medicine &amp; biology&#xD;Ultrasound Med Biol. 2005 Dec;31(12):1693-700.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16344131</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>2.884</custom4><electronic-resource-num>S0301-5629(05)00308-X [pii]&#xD;10.1016/j.ultrasmedbio.2005.07.022</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1486</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1486</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Paner, G. P.</author><author>Srigley, J. R.</author><author>Radhakrishnan, A.</author><author>Cohen, C.</author><author>Skinnider, B. F.</author><author>Tickoo, S. K.</author><author>Young, A. N.</author><author>Amin, M. B.</author></authors></contributors><auth-address>Department of Pathology, Emory University Hospital, 1364 Clifton Road NE, G-167, Atlanta, GA 30322, USA.</auth-address><titles><title>Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution</title><secondary-title>Am J Surg Pathol</secondary-title></titles><periodical><full-title>Am J Surg Pathol</full-title></periodical><pages>13-9</pages><volume>30</volume><number>1</number><edition>2005/12/07</edition><keywords><keyword>Adenocarcinoma, Mucinous/*diagnosis</keyword><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Carcinoma/*diagnosis</keyword><keyword>Carcinoma, Papillary/*diagnosis</keyword><keyword>Carcinoma, Renal Cell/*diagnosis</keyword><keyword>Diagnosis, Differential</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Kidney Neoplasms/*diagnosis</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Tumor Markers, Biological/*analysis</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan</date></pub-dates></dates><isbn>0147-5185 (Print)</isbn><accession-num>16330937</accession-num><abstract>Mucinous tubular and spindle cell carcinoma, a rare, recently described distinctive subtype of renal cell carcinoma, may have some morphologic similarities to the more common papillary renal cell carcinoma, particularly the basophilic (type 1) tumors with prominent solid growth pattern. Tumor circumscription, compact tubular architecture, focal papillations, mucin production and foam cells (features seen in both papillary renal cell carcinoma and mucinous tubular and spindle cell carcinoma), as well as spindle cell morphology, have resulted in some cases sent to us in consultation with a question of possible sarcomatoid papillary renal cell carcinoma. In this study, tissue microarrays with triplicate samples each from 27 mucinous tubular and spindle cell carcinomas and 20 papillary renal cell carcinomas were created to simulate experience in renal biopsy specimens. From immunohistochemistry (IHC) data, published in the contemporary literature, a panel consisting of alpha-methylacyl-CoA racemase (AMACR), cytokeratin 7 (CK7), epithelial membrane antigen (EMA), renal cell carcinoma marker (RCC Ma), CD10, high molecular weight cytokeratin (HMWK), and c-kit was designed to test its utility in differential diagnosis. The immunoreactivity in mucinous tubular and spindle cell carcinoma was AMACR 93%, CK7 81%, EMA 95%, RCC Ma 7%, CD10 15%, HMWK 15%, and c-kit 5% and in papillary renal cell carcinoma was AMACR 95%, CK7 65%, EMA 88%, RCC Ma 25%, CD10 80%, HWMK 15%, and c-kit 18%. This largest study to date on IHC of mucinous tubular and spindle cell carcinoma dispels the specificity of AMACR for papillary renal cell carcinoma among the RCC subtypes. The histogenesis of mucinous tubular and spindle cell carcinoma from the distal nephron continues to be debatable, as our study showed the expression of the proximal convoluted tubule-related marker AMACR among these tumors. Thus, in tumors with predominant compact tubular growth and focal papillary architectures, careful attention to the presence of a low-grade spindle cell population may be helpful in the distinction of mucinous tubular and spindle cell carcinoma, as the key immunohistochemical stains for papillary renal cell carcinoma are also expressed in this subtype of renal cell carcinoma.</abstract><notes>Paner, Gladell P&#xD;Srigley, John R&#xD;Radhakrishnan, Anuradha&#xD;Cohen, Cynthia&#xD;Skinnider, Brian F&#xD;Tickoo, Satish K&#xD;Young, Andrew N&#xD;Amin, Mahul B&#xD;Comparative Study&#xD;United States&#xD;The American journal of surgical pathology&#xD;Am J Surg Pathol. 2006 Jan;30(1):13-9.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16330937</url></related-urls></urls><custom1>CCNE - Emory/GT</custom1><custom3>2006</custom3><custom4>4.833</custom4><electronic-resource-num>00000478-200601000-00003 [pii]</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1625</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1625</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Stewart, J. J.</author><author>White, J. T.</author><author>Yan, X.</author><author>Collins, S.</author><author>Drescher, C. W.</author><author>Urban, N. D.</author><author>Hood, L.</author><author>Lin, B.</author></authors></contributors><auth-address>The Institute for Systems Biology, Seattle, Washington 98103, USA.</auth-address><titles><title>Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels</title><secondary-title>Mol Cell Proteomics</secondary-title></titles><periodical><full-title>Mol Cell Proteomics</full-title></periodical><pages>433-43</pages><volume>5</volume><number>3</number><edition>2005/12/02</edition><keywords><keyword>Cell Line, Tumor</keyword><keyword>Cisplatin/*pharmacology</keyword><keyword>*Drug Resistance, Neoplasm</keyword><keyword>Drug Therapy</keyword><keyword>Female</keyword><keyword>*Gene Expression Regulation, Neoplastic</keyword><keyword>Genes, Neoplasm/genetics</keyword><keyword>Humans</keyword><keyword>Neoplasm Proteins/analysis/genetics/*metabolism</keyword><keyword>Ovarian Neoplasms/*genetics/*metabolism/pathology</keyword><keyword>Protein Array Analysis</keyword><keyword>*Proteomics</keyword><keyword>RNA, Messenger/analysis/genetics/metabolism</keyword><keyword>Tumor Cells, Cultured</keyword></keywords><dates><year>2006</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1535-9476 (Print)</isbn><accession-num>16319398</accession-num><abstract>Nearly all women diagnosed with ovarian cancer receive combination chemotherapy including cis- or carboplatin. Despite high initial response rates, resistance to cisplatin develops in roughly one-third of women during primary treatment and in all women treated for recurrent disease. ICAT coupled with tandem MS is a quantitative proteomic technique for high throughput protein expression profiling of complex protein mixtures. Using ICAT/MS/MS we profiled the nuclear, cytosolic, and microsomal fractions obtained from IGROV-1 [corrected] (cisplatin-sensitive) and IGROV-1/CP [corrected] (cisplatin-resistant) ovarian cancer cell lines. The proteomes of cisplatin-sensitive and -resistant ovarian cancer cells were compared, and protein expression was correlated with mRNA expression profiles. A total of 1117 proteins were identified and quantified. The relative expression of 121 of these varied between the two cell lines. Sixty-three proteins were overexpressed in cisplatin-sensitive, and 58 were over expressed in cisplatin-resistant cells. Examples of proteins at least 5-fold overexpressed in resistant cells and with biological relevance to cancer include cell recognition molecule CASPR3 (13.3-fold), S100 protein family members (8.7-fold), junction adhesion molecule Claudin 4 (7.2-fold), and CDC42-binding protein kinase beta (5.4-fold). Examples of cancer-related proteins at least 5-fold overexpressed in sensitive cells include hepatocyte growth factor inhibitor 1B (13.3-fold) and programmed cell death 6-interacting protein (12.7-fold). The direction of changes in expression levels between proteins and mRNAs were not always in the same direction, possibly reflecting posttranscriptional control of protein expression. We identified proteins whose expression profiles correlate with cisplatin resistance in ovarian cancer cells. Several proteins may be involved in modulating response to cisplatin and have potential as markers of treatment response or treatment targets.</abstract><notes>Stewart, Jennifer J&#xD;White, James T&#xD;Yan, Xiaowei&#xD;Collins, Steven&#xD;Drescher, Charles W&#xD;Urban, Nicole D&#xD;Hood, Leroy&#xD;Lin, Biaoyang&#xD;2p50ca083636-06/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;United States&#xD;Molecular &amp; cellular proteomics : MCP&#xD;Mol Cell Proteomics. 2006 Mar;5(3):433-43. Epub 2005 Nov 30.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16319398</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>9.391</custom4><electronic-resource-num>M500140-MCP200 [pii]&#xD;10.1074/mcp.M500140-MCP200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1131</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1131</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Chen, A. A.</author><author>Derfus, A. M.</author><author>Khetani, S. R.</author><author>Bhatia, S. N.</author></authors></contributors><auth-address>Harvard-M.I.T. Division of Health Sciences and Technology/Electrical Engineering and Computer Science, Massachusetts Institute of Technology, MA, USA.</auth-address><titles><title>Quantum dots to monitor RNAi delivery and improve gene silencing</title><secondary-title>Nucleic Acids Res</secondary-title><alt-title>Nucleic acids research</alt-title></titles><periodical><full-title>Nucleic Acids Res</full-title></periodical><alt-periodical><full-title>Nucleic Acids Research</full-title></alt-periodical><pages>e190</pages><volume>33</volume><number>22</number><edition>2005/12</edition><keywords><keyword>Animals</keyword><keyword>Cadherins/genetics</keyword><keyword>Coculture Techniques</keyword><keyword>Female</keyword><keyword>Flow Cytometry</keyword><keyword>Fluorescent Dyes/*chemistry</keyword><keyword>*Quantum Dots</keyword><keyword>*RNA Interference</keyword><keyword>RNA, Small Interfering/*analysis</keyword><keyword>Rats</keyword><keyword>Rats, Inbred Lew</keyword><keyword>Transfection</keyword></keywords><dates><year>2005</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1362-4962 (Electronic)</isbn><accession-num>16352864</accession-num><abstract>A critical issue in using RNA interference for identifying genotype/phenotype correlations is the uniformity of gene silencing within a cell population. Variations in transfection efficiency, delivery-induced cytotoxicity and &apos;off target&apos; effects at high siRNA concentrations can confound the interpretation of functional studies. To address this problem, we have developed a novel method of monitoring siRNA delivery that combines unmodified siRNA with seminconductor quantum dots (QDs) as multi color biological probes. We co-transfected siRNA with QDs using standard transfection techniques, thereby leveraging the photostable fluorescent nanoparticles to track delivery of nucleic acid, sort cells by degree of transfection and purify homogenously-silenced subpopulations. Compared to alternative RNAi tracking methods (co-delivery of reporter plasmids and end-labeling the siRNA), QDs exhibit superior photostability and tunable optical properties for an extensive selection of non-overlapping colors. Thus this simple, modular system can be extended toward multiplexed gene knockdown studies, as demonstrated in a two color proof-of-principle study with two biological targets. When the method was applied to investigate the functional role of T-cadherin (T-cad) in cell-cell communication, a subpopulation of highly silenced cells obtained by QD labeling was required to observe significant downstream effects of gene knockdown.</abstract><notes>N01 co37117/co/nci&#xD;R01 dk065152/dk/niddk&#xD;R01 dk56966/dk/niddk&#xD;U54 ca119349/ca/nci&#xD;Evaluation Studies&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;England</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16352864 </url></related-urls></urls><custom1>CCNE - MIT/Harvard</custom1><custom3>2006</custom3><custom4>6.968</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1369</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1369</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Laux, I.</author><author>Jain, A.</author><author>Singh, S.</author><author>Agus, D. B.</author></authors></contributors><auth-address>Louis Warschaw Prostate Cancer Center, Cedar-Sinai Medical Center, 8631 West Third Street, Suite 1001E, Los Angeles, CA 90048, USA.</auth-address><titles><title>Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies</title><secondary-title>Br J Cancer</secondary-title></titles><periodical><full-title>Br J Cancer</full-title></periodical><pages>85-92</pages><volume>94</volume><number>1</number><edition>2005/11/25</edition><keywords><keyword>Antibodies, Monoclonal/*adverse effects</keyword><keyword>Antineoplastic Agents/*adverse effects</keyword><keyword>Cell Culture Techniques</keyword><keyword>Dimerization</keyword><keyword>Exanthema/*chemically induced/*physiopathology</keyword><keyword>Humans</keyword><keyword>Keratinocytes/physiology</keyword><keyword>Ligands</keyword><keyword>Quinazolines/*adverse effects</keyword><keyword>Receptor, Epidermal Growth Factor/drug effects/*physiology</keyword><keyword>Receptor, erbB-2/drug effects/*physiology</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2006</year><pub-dates><date>Jan 16</date></pub-dates></dates><isbn>0007-0920 (Print)</isbn><accession-num>16306877</accession-num><abstract>Skin toxicity, a common drug-related adverse event observed in cancer patients treated with epidermal growth factor receptor (EGFR)-directed therapies is rarely seen with therapies targeting HER2. This study reports the significance of the EGFR and HER2 dimerization status in skin with regard to these dermatologic side effects. We demonstrate the differential effect of HER-directed therapies on the ligand driven activation status of EGFR, HER2 and MAPK in normal human epidermal keratinocytes. EGFR-directed therapies, such as gefitinib and cetuximab, inhibited ligand-induced activation of EGFR and MAPK in human keratinocytes. Pertuzumab, an antibody interfering with functional HER2 heterodimerization, failed to block ligand-induced HER signaling in primary keratinocytes. Using a novel proximity-based dimerization assay (eTagtrade mark) we show that EGFR homodimers are the predominant HER dimer pair in normal primary kertinocytes and in normal skin tissue from 16 patients with solid malignancies. The presence of [p]EGFR and [p]MAPK, but the absence of [p]HER2, demonstrates productive signaling via EGFR but not HER2 in human skin. These data illustrate the importance of the EGFR dimerization partner in human skin and suggests that inhibition of EGFR homodimer signaling rather than EGFR/HER2 heterodimer signaling maybe the key molecular event determining dermatologic toxicity discrepancies observed between EGFR-targeted versus HER2-targeted therapies.</abstract><notes>Laux, I&#xD;Jain, A&#xD;Singh, S&#xD;Agus, D B&#xD;P50 ca92131/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;England&#xD;British journal of cancer&#xD;Br J Cancer. 2006 Jan 16;94(1):85-92.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16306877</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>4.637</custom4><electronic-resource-num>6602875 [pii]&#xD;10.1038/sj.bjc.6602875</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1536</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1536</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Reddig, P. J.</author><author>Juliano, R. L.</author></authors></contributors><auth-address>Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.</auth-address><titles><title>Clinging to life: cell to matrix adhesion and cell survival</title><secondary-title>Cancer Metastasis Rev</secondary-title></titles><periodical><full-title>Cancer Metastasis Rev</full-title></periodical><pages>425-39</pages><volume>24</volume><number>3</number><edition>2005/11/01</edition><keywords><keyword>1-Phosphatidylinositol 3-Kinase</keyword><keyword>Actins/metabolism</keyword><keyword>Animals</keyword><keyword>Anoikis</keyword><keyword>Apoptosis</keyword><keyword>Apoptosis Regulatory Proteins/metabolism</keyword><keyword>*Cell Adhesion</keyword><keyword>Cell Line, Transformed</keyword><keyword>Cell Survival</keyword><keyword>*Cell Transformation, Neoplastic</keyword><keyword>Cytoskeleton/metabolism</keyword><keyword>DNA Damage</keyword><keyword>Extracellular Matrix/metabolism</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases/metabolism</keyword><keyword>Homeostasis</keyword><keyword>Humans</keyword><keyword>Integrins/metabolism</keyword><keyword>Membrane Proteins/metabolism</keyword><keyword>Models, Biological</keyword><keyword>Protein-Serine-Threonine Kinases/metabolism</keyword><keyword>Proto-Oncogene Proteins/metabolism</keyword><keyword>Proto-Oncogene Proteins c-bcl-2/metabolism</keyword><keyword>Signal Transduction</keyword><keyword>bcl-2-Associated X Protein/metabolism</keyword></keywords><dates><year>2005</year><pub-dates><date>Sep</date></pub-dates></dates><isbn>0167-7659 (Print)</isbn><accession-num>16258730</accession-num><abstract>Cell to matrix adhesion regulates cellular homeostasis in multiple ways. Integrin attachment to the extracellular matrix mediates this regulation through direct and indirect connections to the actin cytoskeleton, growth factor receptors, and intracellular signal transduction cascades. Disruption of this connection to the extracellular matrix has deleterious effects on cell survival. It leads to a specific type of apoptosis known as anoikis in most non-transformed cell types. Anchorage independent growth is a critical step in the tumorigenic transformation of cells. Thus, breaching the anoikis barrier disrupts the cell&apos;s defenses against transformation. This review examines recent investigations into the molecular mechanisms of anoikis to illustrate current understanding of this important process.</abstract><notes>Reddig, Peter J&#xD;Juliano, Rudy L&#xD;Research Support, N.I.H., Extramural&#xD;Review&#xD;Netherlands&#xD;Cancer metastasis reviews&#xD;Cancer Metastasis Rev. 2005 Sep;24(3):425-39.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16258730</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>6.115</custom4><electronic-resource-num>10.1007/s10555-005-5134-3</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1097</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1097</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Bouvet, M.</author><author>Spernyak, J.</author><author>Katz, M. H.</author><author>Mazurchuk, R. V.</author><author>Takimoto, S.</author><author>Bernacki, R.</author><author>Rustum, Y. M.</author><author>Moossa, A. R.</author><author>Hoffman, R. M.</author></authors></contributors><auth-address>Department of Surgery, University of California at San Diego, CA 92111, USA.</auth-address><titles><title>High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer</title><secondary-title>Cancer Res</secondary-title><alt-title>Cancer research</alt-title></titles><periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></periodical><alt-periodical><full-title>Cancer Res</full-title><abbr-1>Cancer research</abbr-1></alt-periodical><pages>9829-33</pages><volume>65</volume><number>21</number><edition>2005/11</edition><keywords><keyword>Animals</keyword><keyword>Cell Line, Tumor</keyword><keyword>Disease Models, Animal</keyword><keyword>Fluorescent Antibody Technique/methods</keyword><keyword>Humans</keyword><keyword>Luminescent Proteins/*analysis/biosynthesis/genetics</keyword><keyword>Magnetic Resonance Imaging/methods</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Nude</keyword><keyword>Neoplasm Transplantation</keyword><keyword>Pancreatic Neoplasms/*diagnosis/genetics/metabolism</keyword><keyword>Transplantation, Heterologous</keyword></keywords><dates><year>2005</year><pub-dates><date>Nov 1</date></pub-dates></dates><isbn>0008-5472 (Print)</isbn><accession-num>16267005</accession-num><abstract>We have developed genetically fluorescent orthotopic models of human pancreatic cancer. In these models, noninvasive fluorescent protein imaging (FPI) of internal primary tumors and metastatic deposits has been carried out. Whole-body tumor images are easily and inexpensively obtained using FPI, permitting both detection and quantification of tumor load. In this study, we simultaneously compared single mice with a highly fluorescent, red fluorescent protein-expressing orthotopic pancreatic cancer xenografts with both FPI and high-resolution magnetic resonance imaging (MRI). Images were acquired at multiple time points after tumor implantation in the pancreas. Indwelling pancreatic primary tumors and metastatic foci were detected by both FPI and MRI. Moreover, a strong correlation existed between images taken with these two technologies. FPI permitted rapid, high-throughput imaging without the need for either anesthesia or contrast agents. Both FPI and MRI enabled accurate imaging of tumor growth and metastasis, although MRI enabled tissue structure to be visualized as well. FPI has high resolution and is exceedingly rapid with instant image capture. We suggest a complimentary role for these two imaging modalities.</abstract><notes>Ca099258/ca/nci&#xD;Ca101600/ca/nci&#xD;Ca103563/ca/nci&#xD;R21 ca109949-01/ca/nci&#xD;Comparative Study&#xD;Journal Article&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;United States</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16267005 </url></related-urls></urls><custom1>CCNE - UCSD</custom1><custom3>2006</custom3><custom4>7.980</custom4><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1164</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1164</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>De, A.</author><author>Gambhir, S. S.</author></authors></contributors><auth-address>Molecular Imaging Program at Stanford (MIPS) and Bio-X Program, Department of Radiology, School of Medicine, Stanford University, Stanford, California, USA.</auth-address><titles><title>Noninvasive imaging of protein-protein interactions from live cells and living subjects using bioluminescence resonance energy transfer</title><secondary-title>FASEB J</secondary-title></titles><periodical><full-title>FASEB J</full-title></periodical><pages>2017-9</pages><volume>19</volume><number>14</number><edition>2005/10/06</edition><keywords><keyword>Animals</keyword><keyword>Energy Transfer</keyword><keyword>Green Fluorescent Proteins/metabolism</keyword><keyword>Luciferases, Renilla/metabolism</keyword><keyword>Luminescent Measurements/*methods</keyword><keyword>Luminescent Proteins/*chemistry</keyword><keyword>Mice</keyword><keyword>Microscopy, Video</keyword><keyword>*Nanostructures</keyword><keyword>Photons</keyword><keyword>Protein Binding</keyword><keyword>*Protein Interaction Mapping</keyword><keyword>Protein Structure, Tertiary</keyword><keyword>Recombinant Fusion Proteins/metabolism</keyword><keyword>Sirolimus/pharmacology</keyword><keyword>Tacrolimus Binding Protein 1A/metabolism</keyword></keywords><dates><year>2005</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>1530-6860 (Electronic)</isbn><accession-num>16204354</accession-num><abstract>This study demonstrates a significant advancement of imaging of a distance-dependent physical process, known as the bioluminescent resonance energy transfer (BRET2) signal in living subjects, by using a cooled charge-coupled device (CCD) camera. A CCD camera-based spectral imaging strategy enables simultaneous visualization and quantitation of BRET signal from live cells and cells implanted in living mice. We used the BRET2 system, which utilizes Renilla luciferase (hRluc) protein and its substrate DeepBlueC (DBC) as an energy donor and a mutant green fluorescent protein (GFP2) as the acceptor. To accomplish this objective in this proof-of-principle study, the donor and acceptor proteins were fused to FKBP12 and FRB, respectively, which are known to interact only in the presence of the small molecule mediator rapamycin. Mammalian cells expressing these fusion constructs were imaged using a cooled-CCD camera either directly from culture dishes or by implanting them into mice. By comparing the emission photon yields in the presence and absence of rapamycin, the specific BRET signal was determined. The CCD imaging approach of BRET signal is particularly appealing due to its capacity to seamlessly bridge the gap between in vitro and in vivo studies. This work validates BRET as a powerful tool for interrogating and observing protein-protein interactions directly at limited depths in living mice.</abstract><notes>De, Abhijit&#xD;Gambhir, Sanjiv Sam&#xD;5r01 ca82214/ca/nci&#xD;P50 ca114747/ca/nci&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;The FASEB journal : official publication of the Federation of American Societies for Experimental Biology&#xD;FASEB J. 2005 Dec;19(14):2017-9. Epub 2005 Oct 4.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16204354</url></related-urls></urls><custom1>CCNE - Stanford</custom1><custom3>2006</custom3><custom4>7.128</custom4><electronic-resource-num>05-4628fje [pii]&#xD;10.1096/fj.05-4628fje</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1308</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1308</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kang, H.</author><author>DeLong, R.</author><author>Fisher, M. H.</author><author>Juliano, R. L.</author></authors></contributors><auth-address>Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599, USA.</auth-address><titles><title>Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides</title><secondary-title>Pharm Res</secondary-title></titles><periodical><full-title>Pharm Res</full-title></periodical><pages>2099-106</pages><volume>22</volume><number>12</number><edition>2005/09/27</edition><keywords><keyword>3T3 Cells</keyword><keyword>Animals</keyword><keyword>Boron Compounds</keyword><keyword>Cell Survival/drug effects</keyword><keyword>Chromatography, Gel</keyword><keyword>*Dendrimers</keyword><keyword>*Drug Delivery Systems</keyword><keyword>Fluorescent Dyes</keyword><keyword>Gene Products, tat/*chemistry</keyword><keyword>Genes, MDR/genetics</keyword><keyword>Mice</keyword><keyword>Microscopy, Confocal</keyword><keyword>Oligonucleotides/*administration &amp; dosage</keyword><keyword>P-Glycoprotein/metabolism</keyword><keyword>Polyamines/*chemistry</keyword><keyword>RNA, Antisense/*administration &amp; dosage</keyword><keyword>RNA, Small Interfering/*administration &amp; dosage</keyword><keyword>Ribonucleases/metabolism</keyword></keywords><dates><year>2005</year><pub-dates><date>Dec</date></pub-dates></dates><isbn>0724-8741 (Print)</isbn><accession-num>16184444</accession-num><abstract>PURPOSE: PAMAM G5 dendrimer (P) was conjugated to Tat peptide (T), a cell penetrating peptide, in search of an efficient cellular delivery vehicle for antisense and siRNA oligonucleotides. METHODS: PAMAM G5 dendrimer was reacted with 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid, sulfosuccinimidyl ester, sodium salt (BODIPY) for visualization to yield the conjugate BP. Bifunctional sulfosuccinimidyl 6-[alpha-methyl-alpha-(2-pyridyldithio)toluamido]hexanoate (sulfo-LC-SMPT) was then used to conjugate primary amino groups of BP to cysteine derivatized Tat peptide to give the designed conjugate, BPT. This conjugate was complexed with antisense and siRNA oligonucleotides designed to inhibit MDR1 gene expression. NIH 3T3 MDR cells were used for the evaluation of biological activity of the conjugate. RESULTS: Both antisense and siRNA readily formed complexes with the synthesized BPT, introduced into NIH 3T3 MDR cells, and primarily accumulated in intracellular vesicles. MDR1 gene expression was partially inhibited by the antisense-BPT complex and weakly inhibited by the siRNA-BPT complex when both were tested at nontoxic levels of dendrimer. Conjugation with Tat peptide did not improve the delivery efficiency of the dendrimer. CONCLUSIONS: Dendrimer-oligonucleotide complexes were moderately effective for delivery of antisense and only poorly effective for delivery of siRNA. Conjugation of the dendrimer with the Tat cell penetrating peptide failed to further enhance the effectiveness of the dendrimer.</abstract><notes>Kang, Hyunmin&#xD;DeLong, Robert&#xD;Fisher, Michael H&#xD;Juliano, Rudolph L&#xD;P01 gm59299/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;United States&#xD;Pharmaceutical research&#xD;Pharm Res. 2005 Dec;22(12):2099-106. Epub 2005 Oct 1.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16184444</url></related-urls></urls><custom1>CCNE - UNC</custom1><custom3>2006</custom3><custom4>3.831</custom4><electronic-resource-num>10.1007/s11095-005-8330-5</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1306</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1306</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Kandere-Grzybowska, K.</author><author>Campbell, C.</author><author>Komarova, Y.</author><author>Grzybowski, B. A.</author><author>Borisy, G. G.</author></authors></contributors><auth-address>Department of Cell and Molecular Biology, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, Illinois 60611-3008, USA.</auth-address><titles><title>Molecular dynamics imaging in micropatterned living cells</title><secondary-title>Nat Methods</secondary-title></titles><periodical><full-title>Nat Methods</full-title></periodical><pages>739-41</pages><volume>2</volume><number>10</number><edition>2005/09/24</edition><keywords><keyword>Animals</keyword><keyword>Cytoskeleton/*ultrastructure</keyword><keyword>Gold/*chemistry</keyword><keyword>*Microscopy, Electron</keyword><keyword>*Microscopy, Fluorescence</keyword><keyword>Platinum/*chemistry</keyword><keyword>*Replica Techniques</keyword><keyword>Sulfhydryl Compounds/chemistry</keyword></keywords><dates><year>2005</year><pub-dates><date>Oct</date></pub-dates></dates><isbn>1548-7091 (Print)</isbn><accession-num>16179919</accession-num><abstract>Micropatterning approaches using self-assembled monolayers of alkyl thiols on gold are not optimal for important imaging modalities in cell biology because of absorption of light and scattering of electrons by the gold layer. We report here an anisotropic solid microetching (ASOMIC) procedure that overcomes these limitations. The method allows molecular dynamics imaging by wide-field and total internal reflection fluorescence (TIRF) microscopy of living mammalian cells and correlative platinum replica electron microscopy.</abstract><notes>Kandere-Grzybowska, Kristiana&#xD;Campbell, Christopher&#xD;Komarova, Yulia&#xD;Grzybowski, Bartosz A&#xD;Borisy, Gary G&#xD;Gm 25062/gm/nigms&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;United States&#xD;Nature methods&#xD;Nat Methods. 2005 Oct;2(10):739-41.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16179919</url></related-urls></urls><custom1>CCNE - Northwestern</custom1><custom3>2006</custom3><custom4>15.011</custom4><electronic-resource-num>nmeth796 [pii]&#xD;10.1038/nmeth796</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>2361</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">2361</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Pacholski, C.</author><author>Sartor, M.</author><author>Sailor, M. J.</author><author>Cunin, F.</author><author>Miskelly, G. M.</author></authors></contributors><auth-address>Department of Chemistry and Biochemistry, The University of California, San Diego, 9500 Gillman Drive, La Jolla, California 92093-0358, USA.</auth-address><titles><title>Biosensing using porous silicon double-layer interferometers: reflective interferometric Fourier transform spectroscopy</title><secondary-title>J Am Chem Soc</secondary-title></titles><periodical><full-title>J Am Chem Soc</full-title></periodical><pages>11636-45</pages><volume>127</volume><number>33</number><edition>2005/08/18</edition><keywords><keyword>Biosensing Techniques/instrumentation/ methods</keyword><keyword>Membranes, Artificial</keyword><keyword>Porosity</keyword><keyword>Silicon/ chemistry</keyword><keyword>Spectroscopy, Fourier Transform Infrared/methods</keyword><keyword>Surface Properties</keyword></keywords><dates><year>2005</year><pub-dates><date>Aug 24</date></pub-dates></dates><isbn>0002-7863 (Print)</isbn><accession-num>16104739</accession-num><abstract>A simple, chip-based implementation of a double-beam interferometer that can separate biomolecules based on size and that can compensate for changes in matrix composition is introduced. The interferometric biosensor uses a double-layer of porous Si comprised of a top layer with large pores and a bottom layer with smaller pores. The structure is shown to provide an on-chip reference channel analogous to a double-beam spectrometer, but where the reference and sample compartments are stacked one on top of the other. The reflectivity spectrum of this structure displays a complicated interference pattern whose individual components can be resolved by fitting of the reflectivity data to a simple interference model or by fast Fourier transform (FFT). Shifts of the FFT peaks indicate biomolecule penetration into the different layers. The small molecule, sucrose, penetrates into both porous Si layers, whereas the large protein, bovine serum albumin (BSA), only enters the large pores. BSA can be detected even in a large (100-fold by mass) excess of sucrose from the FFT spectrum. Detection can be accomplished either by computing the weighted difference in the frequencies of two peaks or by computing the ratio of the intensities of two peaks in the FFT spectrum.</abstract><notes>Pacholski, Claudia&#xD;Sartor, Marta&#xD;Sailor, Michael J&#xD;Cunin, Frederique&#xD;Miskelly, Gordon M&#xD;N01-C0-37117/PHS HHS/United States&#xD;U54 CA119335-01/CA/NCI NIH HHS/United States&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Research Support, U.S. Gov&apos;t, Non-P.H.S.&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;United States&#xD;Journal of the American Chemical Society&#xD;J Am Chem Soc. 2005 Aug 24;127(33):11636-45.</notes><urls></urls><custom1>CCNE - UCSD</custom1><custom2>2568989</custom2><custom3>NIHMS63594</custom3><custom4>8.256</custom4><electronic-resource-num>10.1021/ja0511671 [doi]</electronic-resource-num><remote-database-provider>Nlm</remote-database-provider><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1084</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1084</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Berquin, I. M.</author><author>Min, Y.</author><author>Wu, R.</author><author>Wu, H.</author><author>Chen, Y. Q.</author></authors></contributors><auth-address>Department of Cancer Biology, Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157, USA.</auth-address><titles><title>Expression signature of the mouse prostate</title><secondary-title>J Biol Chem</secondary-title></titles><periodical><full-title>J Biol Chem</full-title></periodical><pages>36442-51</pages><volume>280</volume><number>43</number><edition>2005/08/02</edition><keywords><keyword>Actins/metabolism</keyword><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Movement</keyword><keyword>Cell Survival</keyword><keyword>Chemokines, CXC/metabolism</keyword><keyword>Chromosome Mapping</keyword><keyword>Collagen/metabolism</keyword><keyword>Cytoskeleton/metabolism</keyword><keyword>Epithelium/metabolism</keyword><keyword>Extracellular Matrix/metabolism</keyword><keyword>*Gene Expression Regulation</keyword><keyword>Gene Expression Regulation, Neoplastic</keyword><keyword>Genetic Engineering</keyword><keyword>Genome</keyword><keyword>Immunohistochemistry</keyword><keyword>Lasers</keyword><keyword>Ligands</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Mice, Inbred C57BL</keyword><keyword>Mice, Transgenic</keyword><keyword>Muscle Contraction</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Prostate/*metabolism</keyword><keyword>Prostatic Neoplasms/metabolism</keyword><keyword>Receptors, CXCR4/metabolism</keyword><keyword>Sarcomeres/metabolism</keyword><keyword>Tissue Distribution</keyword><keyword>Up-Regulation</keyword></keywords><dates><year>2005</year><pub-dates><date>Oct 28</date></pub-dates></dates><isbn>0021-9258 (Print)</isbn><accession-num>16055444</accession-num><abstract>Genetically engineered mice are being used increasingly for delineating the molecular mechanisms of prostate cancer development. Epithelium-stroma interactions play a critical role in prostate development and tumorigenesis. To better understand gene expression patterns in the normal sexually mature mouse prostate, epithelium and stroma were laser-capture microdissected from ventral, dorsolateral, and anterior prostate lobes. Genome-wide expression was measured by DNA microarrays. Our analysis indicated that the gene expression pattern in the mouse dorsolateral lobe was closest to that of the human prostate peripheral zone, supporting the hypothesis that these prostate compartments are functionally equivalent. Stroma from a given lobe had closer gene expression patterns with stroma from other lobes than epithelium from the same lobe. Stroma appeared to have higher expression complexity than epithelium. Specifically, stromal cells had higher expression levels of genes implicated in cell adhesion, muscle development, and contraction, in structural constituents of cytoskeleton and actin binding, and in components such as sarcomere and extracellular matrix collagen. Among the genes that were enriched in the epithelium were secretory proteins, including seminal vesicle protein secretion 2 and 5. Surprisingly, prostate stroma expressed many osteogenic molecules, as confirmed by immunohistochemistry. A &quot;bone-like&quot; environment in the prostate may predispose prostate cells for survival in the bone. Chemokine Cxcl12 but not its receptor, Cxcr4, was expressed in normal prostate. In prostate tumors, interestingly, Cxcl12 was up-regulated in epithelial cells with a concomitant expression of Cxcr4. Expression of both the receptor and ligand may provide an autocrine mechanism for tumor cell migration and invasion.</abstract><notes>Berquin, Isabelle M&#xD;Min, Younong&#xD;Wu, Ruping&#xD;Wu, Hong&#xD;Chen, Yong Q&#xD;R01ca107668/ca/nci&#xD;R01es11124/es/niehs&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;United States&#xD;The Journal of biological chemistry&#xD;J Biol Chem. 2005 Oct 28;280(43):36442-51. Epub 2005 Jul 29.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=16055444</url></related-urls></urls><custom1>CCNE - Caltech</custom1><custom3>2006</custom3><custom4>5.808</custom4><electronic-resource-num>M504945200 [pii]&#xD;10.1074/jbc.M504945200</electronic-resource-num><language>eng</language></record><record><database name="Alliance papers 2009 Copy.enl" path="T:\caNanoLab\Publications\EndNote October 2009\Alliance papers 2009 Copy.enl">Alliance papers 2009 Copy.enl</database><source-app name="EndNote" version="12.0">EndNote</source-app><rec-number>1274</rec-number><foreign-keys><key app="EN" db-id="559s2r9x2fxazledewtpxr2owt5zztz0a0ez">1274</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Hughes, M. S.</author><author>Marsh, J. N.</author><author>Hall, C. S.</author><author>Fuhrhop, R. W.</author><author>Lacy, E. K.</author><author>Lanza, G. M.</author><author>Wickline, S. A.</author></authors></contributors><auth-address>Washington University School of Medicine, Cardiovascular Division, St Louis, Missouri 63110, USA. msh@cvu.wustl</auth-address><titles><title>Acoustic characterization in whole blood and plasma of site-targeted nanoparticle ultrasound contrast agent for molecular imaging</title><secondary-title>J Acoust Soc Am</secondary-title></titles><periodical><full-title>J Acoust Soc Am</full-title></periodical><pages>964-72</pages><volume>117</volume><number>2</number><edition>2005/03/12</edition><keywords><keyword>Animals</keyword><keyword>*Blood</keyword><keyword>Contrast Media/*pharmacokinetics</keyword><keyword>Dose-Response Relationship, Drug</keyword><keyword>Emulsions</keyword><keyword>Image Enhancement</keyword><keyword>Microbubbles</keyword><keyword>*Nanostructures</keyword><keyword>*Plasma</keyword><keyword>Scattering, Radiation</keyword><keyword>Signal Processing, Computer-Assisted</keyword><keyword>Swine</keyword><keyword>Transducers</keyword><keyword>*Ultrasonography</keyword></keywords><dates><year>2005</year><pub-dates><date>Feb</date></pub-dates></dates><isbn>0001-4966 (Print)</isbn><accession-num>15759715</accession-num><abstract>The ability to enhance specific molecular markers of pathology with ultrasound has been previously demonstrated by our group employing a nanoparticle contrast agent [Lanza et al., Invest. Radiol. 35, 227-234 (2000); Ultrasound Med. Biol. 23, 863-870 (1997)]. One of the advantages of this agent is very low echogenicity in the blood pool that allows increased contrast between the blood pool and the bound, site-targeted agent. We measured acoustic backscatter and attenuation coefficient as a function of the contrast agent concentration, ambient pressure, peak acoustic pressure, and as an effect of duty cycle and wave form shape. Measurements were performed while the nanoparticles were suspended in either whole porcine blood or plasma. The nanoparticles were only detectable when insonified within plasma devoid of red blood cells and were shown to exhibit backscatter levels more than 30 dB below the backscatter from whole blood. Attenuation of nanoparticles in whole porcine blood was not measurably different from that of whole blood alone over a range of concentrations up to eight times the maximum in vivo dose. The resulting data provide upper bounds on blood pool attenuation coefficient and backscatter and will be needed to more precisely define levels of molecular contrast enhancement that may be obtained in vivo.</abstract><notes>Hughes, Michael S&#xD;Marsh, Jon N&#xD;Hall, Christopher S&#xD;Fuhrhop, Ralph W&#xD;Lacy, Elizabeth K&#xD;Lanza, Gregory M&#xD;Wickline, Samuel A&#xD;Hl-59865/hl/nhlbi&#xD;N01 c0-07013-32/phs&#xD;Comparative Study&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, U.S. Gov&apos;t, P.H.S.&#xD;United States&#xD;The Journal of the Acoustical Society of America&#xD;J Acoust Soc Am. 2005 Feb;117(2):964-72.</notes><urls><related-urls><url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=15759715</url></related-urls></urls><custom1>CCNE - Siteman</custom1><custom3>2006</custom3><custom4>2.018</custom4><language>eng</language></record></records></xml>